sample,ORF_ID,Contig,Start,Stop,Orientation,Cut_Off,Pass_Bitscore,Best_Hit_Bitscore,Best_Hit_ARO,Best_Identities,ARO,Model_type,SNPs_in_Best_Hit_ARO,Other_SNPs,DrugClass,ResistanceMechanism,AMRGeneFamily,Predicted_DNA,Predicted_Protein,CARD_Protein_Sequence,PercentageLengthofReferenceSequence,ID,Model_ID,Nudged,Note
LK1311,10_52 # 53364 # 54470 # 1 # ID=10_52;partial=00;start_type=ATG;rbs_motif=AGGA/GGAG/GAGG;rbs_spacer=11-12bp;gc_cont=0.734,10_52,53364,54470,+,Strict,50,78.1814,vanY gene in vanA cluster,31.25,3002955,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGGGGCGAGTGACCTCCTTCGACCCCGAGCTGTCGCCCCGGCGCGCCGCGCGCGCCGAGGCCGAACGGCGGGCGACGGAAGCGATCGAGGTGGTGGCGGTCGCGGAGAAGCCGGCGATGTCTCGACGCCTCCAGCGCGAATCGGCGGTCACCGCGGGTCGTGGGACCCGCTGGTCATCGCAACCGAGGGAAACCCGTCGACGCGTGGCGGTGCTCGCGCTCGGGCTGACGGTGATCGCGGCGAGCGGCGTGGCCATCGGCGCCGCCCGGGCGGGCAGCGACCCGGCTCCTCTCGCCGCGCCCGAGGTCGCCGCCGTGATCGAGGGGCCCCCGGCGGTGCCCGCCGAGGGACTCCCGGTCCCGGTGCTCGCCGAAGCTCCCGCCCCCGCGAGTCCGTGCGACGACCCCGCCTTCACCTCGGTGCTCTCGTCCGGCGACGACGCGGCCACGATCGCCGCGATCGGCGGTGCGGAGGCGTTCCGCTCCGCCGTGGCATCCGGGATCGCTCCGTGCATCTCGCTGTCGGATCCGAACCGGCGGTGGGTCGTGGTGAACAAGAAGCGTCCGTTCGATCCCAGCGACTACCGGCCCGGCGACATCGTGATGCCCGAGGGGGTGCGCGCGCTCAAGGAGTCGGGGCTGCGCCGACAGGCCGCCGATGCCCTCACGGCGCTCGTACGCGGAGCCGCCGACGCCGGCGCCGGCGAGATCGGGTACCTCAGCGCCTTCCGCTCCTACACGAACCAGCAGTCGACCTACGCGGAGCGGGTGGCGGTCGTGGGTGTGGAGGCCGCGGACCGCGAGAGCGCCCGTGCCGGCTTCAGCGAGCACCAGTCGGGACTCGCGGTCGACATCGTGCCGTGCGACCGGTCGTGCGGAAGCCTCGACGACGTCGCCGCGTCGAGCCAGGGGGCCTGGGTGCGCGATCACGCGTGGGAGTACGGCTACATCACGCGCTACGTCCAGGGGCGCACCGACGTGAGCGGGTACGAGCCCGAGGCGTGGCACCTGCGCTACATCGGCACCGACCTCGCGAAGGCGTACCACGATGGCGGGTACACGACGCTGGAGGAGTTCTTCGGCCTTCCCGGAGCGCCGACGTACTGA,MGRVTSFDPELSPRRAARAEAERRATEAIEVVAVAEKPAMSRRLQRESAVTAGRGTRWSSQPRETRRRVAVLALGLTVIAASGVAIGAARAGSDPAPLAAPEVAAVIEGPPAVPAEGLPVPVLAEAPAPASPCDDPAFTSVLSSGDDAATIAAIGGAEAFRSAVASGIAPCISLSDPNRRWVVVNKKRPFDPSDYRPGDIVMPEGVRALKESGLRRQAADALTALVRGAADAGAGEIGYLSAFRSYTNQQSTYAERVAVVGVEAADRESARAGFSEHQSGLAVDIVPCDRSCGSLDDVAASSQGAWVRDHAWEYGYITRYVQGRTDVSGYEPEAWHLRYIGTDLAKAYHDGGYTTLEEFFGLPGAPTY,MKKLFFLLLLLFLIYLGYDYVNEALFSQEKVEFQNYDQNPKEHLENSGTSENTQEKTITEEQVYQGNLLLINSKYPVRQESVKSDIVNLSKHDELINGYGLLDSNIYMSKEIAQKFSEMVNDAVKGGVSHFIINSGYRDFDEQSVLYQEMGAEYALPAGYSEHNSGLSLDVGSSLTKMERAPEGKWIEENAWKYGFILRYPEDKTELTGIQYEPWHIRYVGLPHSAIMKEKNFVLEEYMDYLKEEKTISVSVNGEKYEIFYYPVTKNTTIHVPTNLRYEISGNNIDGVIVTVFPGSTHTNSRR,121.45,gnl|BL_ORD_ID|4669|hsp_num:0,89,FALSE,None
LK1204,1_282 # 271011 # 272750 # 1 # ID=1_282;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.416,1_282,271011,272750,+,Strict,1100,1118.22,tetA(60),93.26,3004035,protein homolog model,n/a,n/a,tetracycline antibiotic,antibiotic efflux,ATP-binding cassette (ABC) antibiotic efflux pump,ATGAACGATTTAATAAAATTAGTGATAGGCTTTATAAAAAAACATCCGATGCGCTATCTTGTTAGTTTTGTATTAATGATTGGAAGTAGTATCGCTTCGGTTTATCCCGCTAGAATTGTGGGACAAGTAGTCGATAAAATCGTCGCGAATGAACTGAACGGCGATTGGCTCTGGACGCAACTTGTGATTTTAGTAGGGATTATTCTCGTGGCCTATATTACGGAGAGTATTTGGACAAATTTGATTTTTATGGGCTATTATGAAATGCAAAAGGAATTGCGTGTGAAATTATTGCGGAATAATTTGATGAAGAAAATTCCGTTTTATGCGCATTTTAGAACGGGGGACATTATTACCCGTAGCAGTGAAGATGTGATGACGATTGGCGATATGATGGGGTTCGGAATGTTTGCACTCATGAACTCAACATTGATGGTGACGGTATCGATTTATATGATGGTCACAACGATTTCGTTGCCACTGACCATCGTTGCGATTTTACCACTTCCAATCCTTTCATATCTCGTGTATAAATGGGGATTTGATCTCGAAGAAGAGTACAACAAGGCGCAAAACGCGGTCTCTCAACTGAATAATGAAGTACTGGAGATGATTGACGGTACTTACGTTATTCGAGCTTACGGGCAAGAAGACGCGATGATGGATGAGTTTCGTGCGAAAACGAAAAAGGCTATGAAACAAAATATCATTGTGTCAGAAATTGAATCTCGCTTTATTCCGCTCGCGCAATTATTTATGATGATCAGCTTTACAATTGCGCTTTTTTACGGTGGGTACTTGGTGTCGAATGGGACCATTCTCGTTGGGGATGTCATTGCCTTCCAAGTCTATATGGGAGCGATTATGTGGCCGATGTTTATGATTGGCGATATTATCACGAACTACAAACGCGGAAAAGTGGCAACCGAGCGTATTAATGAAATATTAAGATATGACGATGACATCGAACGTGGTGGAACAAAAGCGCTCGAGACGATTGAATCGATAGAGTTTAAAGACTTCCATTTTACGTATCCAGGAGAAGAGGCGTCCTTATTAAAAGGAATTAATCTTACTTTGAAAAAAGGCGAGACTCTTGGAATCGTGGGGAAAACAGGTTCTGGAAAAACAACACTCTTGATGCAATTATTACATCAGTTCCCCTACAAAGGAGAAAAGCTCTTTATTAACGAAGAACCGTTGATTGATTACGATCCTCAAACGGTGGCAGGGCATTTGGCCTATGTACCACAAGAGCATACACTTTTCTCACGGACGATTCGCGAGAATATGTTATTCGGAAAAGAGGATGCAACGGATGATGAAATTTGGGAAGCGTTGACGCTAGCCTCTTTTGAAGGAGACGTGAAACGAATGCCAGACGAGCTCGATACGATGGTCGGAGAAAAAGGGGTATCGCTCAGTGGAGGTCAAAAACAACGCTTATCGATTGCTCGTGCTTTCTTACGCAACCGTGAATGCTTAATTTTGGATGATGCGTTATCTGCAGTTGATGCGAAAACGGAAAGGGAAATTATCTCGCACTTGCAACAAGAACGCGGAGGTTGTATGAATATCATTTCTGCGCACAGACTTTCTGCAATTCGTCATGCGGATGAAATTATTGTGATGAATGAAGGACGTATTAGTGAGAGGGGTACCCACGAGGAGCTGCTCGAACAACGAGGATGGTACTATGAACAGTATCTCACACAAGAAATGGAGGAGGAAATCGAATGA,MNDLIKLVIGFIKKHPMRYLVSFVLMIGSSIASVYPARIVGQVVDKIVANELNGDWLWTQLVILVGIILVAYITESIWTNLIFMGYYEMQKELRVKLLRNNLMKKIPFYAHFRTGDIITRSSEDVMTIGDMMGFGMFALMNSTLMVTVSIYMMVTTISLPLTIVAILPLPILSYLVYKWGFDLEEEYNKAQNAVSQLNNEVLEMIDGTYVIRAYGQEDAMMDEFRAKTKKAMKQNIIVSEIESRFIPLAQLFMMISFTIALFYGGYLVSNGTILVGDVIAFQVYMGAIMWPMFMIGDIITNYKRGKVATERINEILRYDDDIERGGTKALETIESIEFKDFHFTYPGEEASLLKGINLTLKKGETLGIVGKTGSGKTTLLMQLLHQFPYKGEKLFINEEPLIDYDPQTVAGHLAYVPQEHTLFSRTIRENMLFGKEDATDDEIWEALTLASFEGDVKRMPDELDTMVGEKGVSLSGGQKQRLSIARAFLRNRECLILDDALSAVDAKTEREIISHLQQERGGCMNIISAHRLSAIRHADEIIVMNEGRISERGTHEELLEQRGWYYEQYLTQEMEEEIE,MNDLLKVIINFIKKHPMRYLVSFILMIGSSIAAVYPARIIGQVVDKIVASELNAEWLGTQLVILVGIILVAYITESIWTYFIFIGYYEIQKELRVKLLRNNLRKKIPFYAHFRTGEIITRSSEDVTTIGDMMGFGMFALMNSTLLMSVSIYMMVTTISLPLTIAAILPLPILSYLVYKWGFDLEEEYNKAQNAVSQLNNEVLEMIDGTYVIRAYGQEDAMMDEFRAKTKKAMKQNIIVTEIESRFIPLAQLFMMISFTIALFYGGYLVSTGAILVGDVIAFQVYMGAIMWPMFMIGDIITNYKRGKVATERINEVLKHDDEIERGGTKTLETIESIEFKDFHFMYPGEEAPLLKEINLTLRKGETLGIVGKTGSGKTTLLMQLLHQFPYRGEKLLINGEPLIDYDTQSVAGHLAYVPQEHTLFSRTIRENMLFGKEDATDDEIWEALTLASFEGDVKRMPDELDTMVGEKGVSLSGGQKQRLSIARAFLRNRECLILDDALSAVDAKTEREIISHLQQERGGCMNIISAHRLSAIRHADEIIVMNEGRISERGTHEELLEQRGWYYEQYLTQEMEEEIE,100,gnl|BL_ORD_ID|2312|hsp_num:0,2645,FALSE,None
LK1204,1_283 # 272747 # 274486 # 1 # ID=1_283;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.421,1_283,272747,274486,+,Strict,1100,1166.37,tetB(60),98.45,3004036,protein homolog model,n/a,n/a,tetracycline antibiotic,antibiotic efflux,ATP-binding cassette (ABC) antibiotic efflux pump,ATGAGAACGATGAAGCGATTATTAAGCTACCTCCGTTATGAGAAAAAAGGAGTTCTGATTGGACTCTTCTGCCTGTTACTCTCAACAGGAGCAACCTTAACAGGGCCACTCGTTGCCAAACACATTATCGATAATGTGATTACTCCGATGGGGCAGGCGCATGATTTCAAAGCAGGTGGCCTACTTTTATGGGTTGGTATTTACGTGACAGTGAACTTAGTGGGAGTTGCTGGGGCCTACTTAAACCGTGTATATATGAGGACTCTCTCAAACCGTATTGCAAAACGCATTCGTGACGAAGTATTCGAGCATGTACAAACCTTGCCGGTATCGTACTTCGACCATTTACCAGCTGGGAAAGTGGTTTCTAGAATTACAAGTGATACGGAATCAGTGCGTGCAAACTTCTACGTGAGTGGGATTTCGACGCTTTTCAGTACGATTGTGATGTTGGTAGGTGTTTATATAACCATTTTCTTATTAAACGCTACGCTAGGACTAGTGTTATTATTCCTAGTTCCTGTAATGATTTTATGGCAGAGAACTGTTGCTACGAAGCAGAAAAAATACTATTCCGAAAATCGTGAACTATACAGTCAGTTGAGTGGACAACTAAACGAAAGCATTCAAGGAGCAGGCATCGTTCAAGCCTTCCAGAAAGAAGAAAAAATTGTTGCAGAATATGATGCCACGGCAACTTCTTGGGAAGAAGTTGGTCGTAAGGAATTAATTCTGGATTCGTACTTCTCGTGGAGTCTTGTCGGCATGCTTCGAAACATTACTCATTTTGGAGTTATCTATTATTTCAGTATGCAGTTTATCGGTGGAACACTCGGGATTTCAGCAGGCCTTTTATATGCATTTATTGATTACATTAATCGAATCTATGAGCCGATTCAAACTTTTATGAATGTCGTGTCTGGCTTCCAACAATCAATGGCTGCCGGTGACCGTGTGTTTGAATTGATGGATACACCAAGCGAGGATTCAGGAGAAGAGCTTTTCACGTTTAGTGAAGGACGTATCGAATTCAAAGATGTGAGTTTTGAGTACACAGCGGGAGTTCCTGTGTTGAAGCACTTGAATTTCACGGTAGAACCTGGACAGACAGTTGCTTTTGTCGGACATACTGGTTCAGGGAAATCATCCATTATGAACTTACTGTTTCGCTTCTACGATCCAACGAGTGGTGCTATCTTCATCGATGGAAAAAACACACGCGACTTTAACAGACGTAGTGTTCGAAGCGAGATGGGAATCGTTCTTCAAGATCCGTACCTCTTTACAGGAACGATTGCTTCTAATGTTGGACTCAATAATGAATCGATTCAGCCTGAGACGATTAAAGAGGCGCTCATTAAAGTAGGCGGAGGCCATCTGCTCACGAAGAGTGACAAGGGACTCGACTACGAGGTGAAAGAAAAAGGAATGGATTTCTCTTCAGGGGAACGCCAACTCATTTCATTTGCTCGTGCAATTGTCTTTGATCCGAAAATCTTGATTTTAGATGAAGCGACTTCGCATATCGATACCGAGACAGAAGAAATTATTCAGAATGCAATTAATGTCGTAAAAGAAGGGCGTACAACCTTTATGATTGCTCACCGACTTTCTACCATTGCCCATGCTGACCAAATTTTTGTGTTGGATAAAGGAGAAATTGTGGAACGTGGAACGCATGATGAATTACTTCAACTGCAAGGTCAATATGCCGAAATGGTAGCCCTACAAAAAGGATAA,MRTMKRLLSYLRYEKKGVLIGLFCLLLSTGATLTGPLVAKHIIDNVITPMGQAHDFKAGGLLLWVGIYVTVNLVGVAGAYLNRVYMRTLSNRIAKRIRDEVFEHVQTLPVSYFDHLPAGKVVSRITSDTESVRANFYVSGISTLFSTIVMLVGVYITIFLLNATLGLVLLFLVPVMILWQRTVATKQKKYYSENRELYSQLSGQLNESIQGAGIVQAFQKEEKIVAEYDATATSWEEVGRKELILDSYFSWSLVGMLRNITHFGVIYYFSMQFIGGTLGISAGLLYAFIDYINRIYEPIQTFMNVVSGFQQSMAAGDRVFELMDTPSEDSGEELFTFSEGRIEFKDVSFEYTAGVPVLKHLNFTVEPGQTVAFVGHTGSGKSSIMNLLFRFYDPTSGAIFIDGKNTRDFNRRSVRSEMGIVLQDPYLFTGTIASNVGLNNESIQPETIKEALIKVGGGHLLTKSDKGLDYEVKEKGMDFSSGERQLISFARAIVFDPKILILDEATSHIDTETEEIIQNAINVVKEGRTTFMIAHRLSTIAHADQIFVLDKGEIVERGTHDELLQLQGQYAEMVALQKG,MRTMKRLLSYLRYEKKGVLIGLFCLLLSTGATLTGPLVAKHIIDNVITPMGQAHDFKAGGLLLWVGIYVTVNLVGVAGAYLNRVYMKTLSNRIAKRIRDEVFEHVQTLPVSYFDHLPAGKVVSRITSDTESVRANFYVSGISTLFSTIVMLVGVYITIFLLNATLGLVLLFLVPVMILWQRTVATKQKKYYSENRELYSQLSGQLNESIQGAGIVQAFQQEEKIVAEYDATATSWVEVGRKELILESYFSWSLVGMLRNITHFGVIYYFSMQFIGGTLGISAGLLYAFIDYINRIYEPIQTFMNVVSGFQQSMAAGDRVFELMDTPSEESGEELFTFDEGCIEFKDVSFEYTAGVPVLKHLNFTVEPGQTVAFVGHTGSGKSSIMNLLFRFYDPTSGAIFIDGKNTRDFNRRSVRSEMGIVLQDPYLFTGTIASNVGLNNESIEPETIKEAIIKVGGGHLLTKSDKGLDYEVKEKGMDFSSGERQLISFARAIVFDPKILILDEATSHIDTETEEIIQNAINVVKEGRTTFMIAHRLSTIAHADQIFVLDKGEIVERGTHDELLQLQGQYAEMVALQKG,100,gnl|BL_ORD_ID|2309|hsp_num:0,2646,FALSE,None
LK1204,3_85 # 70599 # 71378 # -1 # ID=3_85;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.444,3_85,70599,71378,-,Strict,50,97.0561,vanY gene in vanG cluster,28.68,3002959,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGATTCGCGTGAAAAAACAACTGTTATCGGCGGTTGTACTGAGCCTAGTTCTTCTTGGTTGCTCAAATAAAAACAATCCAAGTGAAACTACGACCTCTCCATCAACCTCTACGCAAACAACAAAAACCACAACTACTGACACAACGACAACGGCAAAAACAACTTCTGCTAGCACAGAGGCTTCCTCTGAAGAATCCTCTACTAAGGACATAGCGACAGAAAAACAACAATCCTCTCAAGGAAGTGGTATGGCGGATGTCTCTTTAGGCTATCAAATGGTTGTCAATAAGAAACACGCTCTTCCTTCGACTTATGCTCCGGGAGAAGATCCTACCGCTGGGGCACAAGTGAAGAAACTCATTCAAAAAATGCAAGAACTGGAATATCCGATTAGTGATGTTTACAGCGGATATCGCTCTTATGAATATCAAGAACAACTCTATAACAATTATGTCGCTCGTGAAGGTAAAGAGGCTGCGGATACCTATTCCGCAAGACCTGGCTACAGCGAACATCAAACAGGACTAGCCTTTGATCTCTTAGATACAACAGGGAATTTATTAGACGGTGAAGAAAATAAGGACGCCATCGCCTGGCTCCACACCCACGCCCATGAGTATGGATTTATTATCCGATTCCAAGCTGGGAAAGAAGCCATTACCGGATACCAAGCCGAAGCCTGGCATTTACGCTATGTAGGCGACAAAGCAACAGACATCTATAACTCCGGCCTTTCTCTTGAAGAGTACTACGGAGTAGAAGGTGGAGGATATGAATAG,MIRVKKQLLSAVVLSLVLLGCSNKNNPSETTTSPSTSTQTTKTTTTDTTTTAKTTSASTEASSEESSTKDIATEKQQSSQGSGMADVSLGYQMVVNKKHALPSTYAPGEDPTAGAQVKKLIQKMQELEYPISDVYSGYRSYEYQEQLYNNYVAREGKEAADTYSARPGYSEHQTGLAFDLLDTTGNLLDGEENKDAIAWLHTHAHEYGFIIRFQAGKEAITGYQAEAWHLRYVGDKATDIYNSGLSLEEYYGVEGGGYE,MNHMNMKHRRRKRRRNQSFLFTGILLLVVVSASSFLWYGFGNAAKKDSVIEEMPFTITQDGMQAKEEIKKTVLETSYGGKQQVAEENHGNTQNAGTDEAWNLMLVNRDNAIPDNYEVNLVEVEGGERVDERIYEPLMEMLNAAREENWGELPMVVSGYRTQEKQQSLYDEKIAKFKKEGYSDSEAVRQAEQWVAVPGHSEHQLGFAVDINGATYDVYLWLQENSYKYGFIFRYPGSKTDITGTAEEVWHYRYVGVEAATEMYENGLCLEEYLEKKQSEN,92.83,gnl|BL_ORD_ID|4732|hsp_num:0,298,FALSE,None
LK1204,6_95 # 94335 # 95450 # -1 # ID=6_95;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.417,6_95,94335,95450,-,Strict,175,182.956,vanT gene in vanG cluster,32.42,3002972,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,glycopeptide resistance gene cluster; vanT,ATGTTAGAAGCAATCCATCGAAACACGAGAGTTGTAGTGGATTTATCGATTATTAAACAAAATATTTCTAAACTAAAGTCTAAATTAAACCCTTCCAAACAAGTCTATGCAGTTGTAAAGGCGAATGCGTATGGGCATGGCATGATTCCTGTTGCCAAAGCTGCTTTAGAAGCAGGGGTTCAGGGATTTTGTGTCGCAAATATGGATGAGGCTTTGGCTTTAAGAGAAGCAGGGATTATGGAACCCATCTTAATCCTTGGATTAAGCCGAGTGGAAGATGCGCCGCTATTAGCAAGTAATCACATTACTGCTACTGTTGACTCTGTAGAATGGCTCCTGCAAGCTGCGCCACTATTAACAGAGGATCCTTTAAAAGTACATGTTGCTGTAGATTCGGGAATGGGTCGTATTGGCGTCGTGAACGAAAAAGAATTAACGGAAGTTGAGGCTGTTTTACGAAACGGTCCATTCGAGTTCGAAGGAATGTTTACCCATTTTGCAACAGCGGATGAAGAAGACACCGCACATTTAACAAAACAAGAAGAAAAATTCAATGGTATGATTGGAGAGTTGGAAGAAAGACCTCCTCACATTCATTGCTCCAATTCGGCTTATGCAATTTGGCATAGTGCCGGAGATAGTGATATTATCCGTTACGGCATTGGTTTGTATGGCATTAATCCTTCTAATGGAGACTTATGCATTGAAGATGAAGAACATCTAACCCCAGCCCTGCAATGGGAAACCGAGATGGTCAAGGTGAAGAAATTGGAATTTGGGGATACGGTGAGTTATGGGGCAACCTATACCGCTAGAGAGCCTCAATGGGTGGCTACTTTACCTGTAGGATATGCAGATGGGTATATACGTGCCTACAATAAAGGAGAGGTCATTGTAGATGGTGTTCGCTGTCCTATTATTGGAAGAGTGTGTATGGATCAATGTATGATTCGACTGCCTCATGAATATCCTGTCGGCACAAAGGTGACTCTTCTAGGAAAAAACAAAGAAGAGGAAATTACAGCAATTGAATTAGCTAAGCGTGCGGATACAATTGCTTATGAAGTCATTTGTATGATCTCTGATCGTGTGAAAAGGGAGTATATCAATGGTTGA,MLEAIHRNTRVVVDLSIIKQNISKLKSKLNPSKQVYAVVKANAYGHGMIPVAKAALEAGVQGFCVANMDEALALREAGIMEPILILGLSRVEDAPLLASNHITATVDSVEWLLQAAPLLTEDPLKVHVAVDSGMGRIGVVNEKELTEVEAVLRNGPFEFEGMFTHFATADEEDTAHLTKQEEKFNGMIGELEERPPHIHCSNSAYAIWHSAGDSDIIRYGIGLYGINPSNGDLCIEDEEHLTPALQWETEMVKVKKLEFGDTVSYGATYTAREPQWVATLPVGYADGYIRAYNKGEVIVDGVRCPIIGRVCMDQCMIRLPHEYPVGTKVTLLGKNKEEEITAIELAKRADTIAYEVICMISDRVKREYING,MTKNESYSGIDYFRFIAALLIVAIHTSPLSSFSETGNFIFTRIVARVAVPFFFMTSGFFLISRYTCNAEKLGAFIKKTTLIYGVAILLYIPINVYNGYFKMDNLLPNIIKDIVFDGTLYHLWYLPASIIGAAIAWYLVKKVHYRKAFLIASILYIIGLFGDSYYGIVKSVSCLNVFYNLIFQLTDYTRNGIFFAPIFFVLGGYISDSQNRLSLKRSIVGFIVCFALMFGEALTLHHFDIQKHDSMYVLLLPSVYCLFNLLLHFRGKRRTGLRTISLIIYIIHPFMIVVIRLFAKLLHLQSLLVENSLVHYIAVCFASVVLAVVITALLSSLKPKKAKHTADTDRAYLEINLNNLEHNVNTLQKAMSPKCELMAVVKAEAYGHGMYEVTTYLEQIGVSSFAVATIDEGIRLRKYGISSEILILGYTSPSRAKELCKYELTQTLIDYRYSLLLNKQGYDIKAHIKIDTGMHRLGFSTEDKDKILAAFSLKHIKVAGIFTHLCAADSLEENDVAFTNKQIGSFYKVLDWLKSSGLNIPKVHIQSSYGLLNYPELECDYIRVGVALYGVLSSTNDKTKLELDLRPVLSLKAKVVLIRKIKQGESVGYSRAFTATRDSLIAILPIGYADGFPRNLSCGNSYVLIGGRQAPIVGKICMDQLAVDVTDIPNVKTGSIATLIGKDGKEEITAPMVAESAESITNELLSRMGHRLNIIRRA,52.11,gnl|BL_ORD_ID|1522|hsp_num:0,1561,FALSE,None
LK1204,17_8 # 10129 # 11127 # -1 # ID=17_8;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.361,17_8,10129,11127,-,Strict,200,208.379,vanH gene in vanO cluster,36.83,3002948,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanH; glycopeptide resistance gene cluster,ATGAAAGTTTTAGCATATGGGGTTCGTGAAGTTGAATTACCAATTTTCGAACAAGTAAACAAGAAATTCGGATACGAATTAACATGTATTCCAGAATACTTAAATTCTGAAGAAACTGCCCGCAAAGCAGAAGGTTTCAAAGCTGTTATCTTACGTGGTAACTGCTGGGCAAACAAAGAAACTTTAGATATCTACAAAGAATTAGGAGTAGAGTACGTATTAACTCGTACTGTGGGTGTAAACCACATCGATGCTGAATACGCAAAATCATTAGGAATGAAATTAGGTTACGTTCCTTTCTATTCTCCAAACGCAATTAGTGAATTAGCAGTTACTTTAGCAATGACATTATTACGTAACGTTGCTTACACTGCAGCAAAAACTAGCCAACAAGATTTCACAGTAGATACTCAAATGTTTGCTAAAGAAATCCGTAACTGTACTGTTGGGGTTGTTGGTATCGGACGTATCGGTTTAACAACTGCAACATTATTCAAAGGTTTAGGCGCTAACGTATTAGCTTACGATGCTTTCCCTAAAGAAGGCGTTGATCATATCTGTACTCAAGTACCTTTAGATGAGTTATTAGCAAAATCAGACGTGATTTCAATTCACGCTCCATACATTCCAGCAAACGGAAAAGTAATCACTAAAGAATTCATCAGCAAAATGAAACCAGGTGCTATCTTAGTAAACACTGCTCGTGGTGAATTACAAGATATCGATGCGATCATCGAAGCATTAGAATCAGGTCACTTACGTGGTGTTGGTTTAGACGTTTTAGAAGGGGAAAGCGAAGTATTCTTCAAAGACTTACGTGGTCAAGAAATCAAAAATCCTGCTATCCGTAAATTAGTTGAATTATACCCACGTGTATTATTAACACCTCATATGGGTAGTTACACTGATGAAGCAGTATTAAACATGGTTGAAACAAGTTTTGAAAACTTAAAAGCATATGTTGAAACTGGTTCATGTAAAAATGACATTCAATGCTAA,MKVLAYGVREVELPIFEQVNKKFGYELTCIPEYLNSEETARKAEGFKAVILRGNCWANKETLDIYKELGVEYVLTRTVGVNHIDAEYAKSLGMKLGYVPFYSPNAISELAVTLAMTLLRNVAYTAAKTSQQDFTVDTQMFAKEIRNCTVGVVGIGRIGLTTATLFKGLGANVLAYDAFPKEGVDHICTQVPLDELLAKSDVISIHAPYIPANGKVITKEFISKMKPGAILVNTARGELQDIDAIIEALESGHLRGVGLDVLEGESEVFFKDLRGQEIKNPAIRKLVELYPRVLLTPHMGSYTDEAVLNMVETSFENLKAYVETGSCKNDIQC,MSYRDLGLIDSEVIAERRVRALDDSSPSAVPTTGVRVFGCGHDEAVLFREMGTRLGITPSITEEAISETNAELARGNRCISVSHKTQIDNSTLLALSRVGVEYISTRSVGYNHIDVEFAASIGISVGNVDYSPDSVGDYTLMLMLMTVRHAKSIVRRADTHDYRLNDTRGRELRDLTVGVIGTGRIGTAVIDRLQGFGCRVLAHDSGPHASADYVPLDELLRQSDIVTLHTPLTADTHHLLDRQRIDQMKHGAYIVNTGRGPLLDTEALLSALESGRLGGAALDVVEGEEGIFYADCRNRLIENKALVRLQRLPNVLISPHSAYYTDHALNDTVENSLVNCLNFESGRTA,94.86,gnl|BL_ORD_ID|761|hsp_num:0,786,FALSE,None
LK1366,4_41 # 51652 # 53346 # 1 # ID=4_41;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.654,4_41,51652,53346,+,Strict,50,78.1814,vanW gene in vanI cluster,31.95,3003724,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanW; glycopeptide resistance gene cluster,GTGACTACGGTAAATGCAACAGGTGCCCGCGGTGGGCGCGGGGTCAGCACCGGGAAGATTCTCCTCGGTGTGCTTCTCGGCGTGCTCGCGGTGCTGCTTGCGATCTACCTCGCCGACCTCGCAATGAACCGCGGGAACGTGCCGCGTGGCACCGCCGTCGGCGGTGTCGAGATCGGCGGCATGAGCCACGACGAGGCCACCGCGAAGCTCGAAGCAGAGCTCGGTGAGACGGCGAGCAACCCCGTGACGGTGAAGGCGGCATCGCAAAGCTCGCAGCTCGTGCCCGCCGAGTCCGGCCTCGGCATCGACTGGGAGGCGACCGTAGCAAGCGCGGGCGAAGAGTCCGCGAACCCGTTCACTCGCCTCGCCGGGCTGTTTCGCACCCGCGAAGTCGACATTGTGTCGACCGTGAACGAGGCCGCTCTCACCCCGCAGCTTGAGCGCGTGGCCGGCGAGTTGCACCTCGACCCCGCCGACGGCGCGATCGCCATCGAAGGCGGCGAGGCGAAAGTGACCGAACCGGTGCCGGGCCAGGAGGTTGACGAAACCGAGCTGTTCGAACGTGTCACCACCGGCTGGCTCAACCCCGACGGTGTAGAGGTCGAGCCGCGCGAAATCGAACCCGCTATCGGCGACCAGGCCATCAAGGAAGCCTTAGACGGGCCGGTTAAGGCGGCGCTGTCCGGAGCGTTGACACTGCACGGTCGCGACGGCGTCGACGGTGTCATTGCCCAAGAGCGCATCGGCGAGGTCGTCCAATTCCCCAACGTCGACGGCAAAATCGCCCCCGAGGTGAACGTGGAAAACGCCCAGGGCATCTTGGTCGAGCAGCTCGCTGCGACCGAGACGCAGATGAAAAACGCGCGCGTGCTGCCCGGCGGCGGGGTGGAACCGTCCGTCGATGGCTCCATCATCGACTGGGAGGCCGCGATGGACGGTTTCGACGAGCGGTTGATCGGTTCCGCCGAGCGCACCTGGGACGCGCAATACAAGGCCCGCCCGGCCGACTTCACTACAGAGGAAGCCCAACGTGCCAGGTTCGACGAGGTGGTGGGAAGTTTCACCACCGGCGGGTACAGCGGCGCATCCGGCACGAACATCGCTACGGTGGCCCGCGTTGTCAACGGCGCAATTGTCAACCCCGGTGAAACCTTCTCGCTCAACGGCTACACTGGCGCGCGCGGTGCCGCGCAGGGTTACGTCGAGTCGGGCATCATCGAAAATGGACGCCCCGGCAAGGCAGTGGGCGGCGGAATCTCCCAATTTGCCACGACCTTGTACAACGCGGCTTACTTTGCCGGCATGACGGATGTCGCCTCCACCCCGCACTCCTACTACATTTCACGCTACCCGGCTGGCAGGGAGGCGACCGTGTATGAAGGGGCGATTGACCTGCAATTCCGCAACGATTCGCCCCACCCGGTCAAGATTTCCACGAGCGTCGGGGGCGGCGAGGTGACGGTGAGCCTGATGGGCACCAAGACCGTCGAGGTGGAGTCCATCAACGGAGGGCGCTGGAACTACACCTCGCCGAAGCCCGTGACCGTCACCAGTGGTGACTGCATTCCCTCGGGCGGGGTGCAGGGCTTTACCACCTCCGATACCCGGATTGTGCGTGACCTCAGCGGCAATGAGATCAGTCGCAACACCTCCACCACGGTCTACGACCCGCAGCCCATCGTGCGCTGCGAGTAG,MTTVNATGARGGRGVSTGKILLGVLLGVLAVLLAIYLADLAMNRGNVPRGTAVGGVEIGGMSHDEATAKLEAELGETASNPVTVKAASQSSQLVPAESGLGIDWEATVASAGEESANPFTRLAGLFRTREVDIVSTVNEAALTPQLERVAGELHLDPADGAIAIEGGEAKVTEPVPGQEVDETELFERVTTGWLNPDGVEVEPREIEPAIGDQAIKEALDGPVKAALSGALTLHGRDGVDGVIAQERIGEVVQFPNVDGKIAPEVNVENAQGILVEQLAATETQMKNARVLPGGGVEPSVDGSIIDWEAAMDGFDERLIGSAERTWDAQYKARPADFTTEEAQRARFDEVVGSFTTGGYSGASGTNIATVARVVNGAIVNPGETFSLNGYTGARGAAQGYVESGIIENGRPGKAVGGGISQFATTLYNAAYFAGMTDVASTPHSYYISRYPAGREATVYEGAIDLQFRNDSPHPVKISTSVGGGEVTVSLMGTKTVEVESINGGRWNYTSPKPVTVTSGDCIPSGGVQGFTTSDTRIVRDLSGNEISRNTSTTVYDPQPIVRCE,MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVLAEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPELLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGMETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGGEFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSHSLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDEPDGYPVKPREWSK,151.21,gnl|BL_ORD_ID|4748|hsp_num:0,2242,FALSE,None
LK1041,17_11 # 10102 # 11796 # -1 # ID=17_11;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.657,17_11,10102,11796,-,Strict,50,81.2629,vanW gene in vanI cluster,34.78,3003724,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanW; glycopeptide resistance gene cluster,GTGACTACGGTAAATGCAACAGGTGCCCGCGGTGGGCGCGGGGTCAGCACCGGGAAGATTCTCCTCGGTGTGCTGCTCGGTGTGCTCGCGGTGCTGCTCGCGATCTACCTCGCCGACCTCGCAATGAACCGCGGGAACGTGCCGCGTGGCACCGCCGTCGGCGGTGTCGAGATCGGCGGCATGAGCCAGGACGAGGCCACCGCGAAGCTCGAAGCAGAGCTCGGCGAGACGGCGAGTAACCCGGTGACGGTGAAGGCGGCGACGCAAAGCTCGCAGCTCGTGCCCGCCGAATCCGGCCTCGGCATCGACTGGGAGGCGACCGTAGCAAGCGCGGGCGAAGAGTCCGCGAACCCGTTCACTCGCCTCGCCGGGTTGTTTCGCACACGCGAAGTCGACATTGTGTCGACCGTGAACGAGGCCGCTCTCACCCCGCAGCTTGAGCGAGTGGCCGGCGAGTTGCACCTCGACCCCGCCGACGGCGCGATCGCCATCGACGGTGGCGAGGCGAAAGTGACCGAACCGGTGCCGGGCCAGGAGGTTGACAAAACCGAGCTGTTCGAACGTGTCACCACCGGCTGGCTCAACCCCGACGGTGTAGAGGTCGAGCCGCGCGAAATCGAACCCGCTATCGGCGACCAGGCCATCAAGGAAGCCTTAGACGGGCCGGTTAAGGCGGCGCTGTCCGGAGCGTTGACACTGCACGGTCGCGACGGCGTCGACGGTGTCATTGCCCAAGAGCGCATCGGCGAGGTCGTCCAGTTCCCCAACGTCGACGGCAAAATCGCCCCCGAGGTGAACGTGGAAAGCGCCCAGGGCATCTTGGGCGAGCAGCTCGCTGCGACCGAGACGCAGATGAAAAACGCGCGCGTGCTGCCCGGCGGCGGGGTGGAACCGTCCGTCGACGGCTCCATTATCGACTGGGAGGCCGCGATGGACGGTTTCGACGAGCGGTTGATCGGTTCCGCCGAGCGCACCTGGGACGCGCAATACAAGGCCCGCCCGGCAGACTTCACTACAGAGGAAGCCCAACGTGCCACCTTCGACCAGGTGGTGGGAAGTTTCACCACCGGCGGGTACAGCGGCGCATCCGGCACGAACATCGCTACGGTGGCCCGCGTTGTCAACGGCGCAATTGTCAACCCCGGTGAAACCTTCTCGCTCAACGGCTACACCGGCGCGCGCGGTGCCGCGCAGGGTTACGTCGAGTCGGTCATCATCGAAAACGGCCGGCCCGGCACCGCTGTCGGCGGTGGTATCTCCCAGTTCGCCACCACCTTGTACAACGCGGCCTACTTTGCGGGAATGACCGACGTGGCCTCCACGCCGCACTCCTACTACATCTCCCGCTACCCCACGGGCCGCGAGGCAACCGTCTTCGAGGGCGCGATCGACCTGCAGTTCCGAAACGACTCGCCTTATCCGGTGAAGATCACCTCCAACGTCGGCGGTGGGGAGGTCACCGTGAGCCTGATGGGTGTGAAAACCGTCGAGGTGGAGTCCATCAATGGAGGGCGCTGGGCCTACACCTCGCCGAAGCCCGTGACCGTCACCAGTGGTGACTGCATTCCCTCGGGCGGGGTGCAGGGCTTTACCACCTCCGATACCCGGATTGTGCGTGACCTCAGCGGCAATGAGATCAGTCGCAACACCTCCACCACGGTCTACGACCCGCAGCCCATCGTGCGCTGCGAGTAG,MTTVNATGARGGRGVSTGKILLGVLLGVLAVLLAIYLADLAMNRGNVPRGTAVGGVEIGGMSQDEATAKLEAELGETASNPVTVKAATQSSQLVPAESGLGIDWEATVASAGEESANPFTRLAGLFRTREVDIVSTVNEAALTPQLERVAGELHLDPADGAIAIDGGEAKVTEPVPGQEVDKTELFERVTTGWLNPDGVEVEPREIEPAIGDQAIKEALDGPVKAALSGALTLHGRDGVDGVIAQERIGEVVQFPNVDGKIAPEVNVESAQGILGEQLAATETQMKNARVLPGGGVEPSVDGSIIDWEAAMDGFDERLIGSAERTWDAQYKARPADFTTEEAQRATFDQVVGSFTTGGYSGASGTNIATVARVVNGAIVNPGETFSLNGYTGARGAAQGYVESVIIENGRPGTAVGGGISQFATTLYNAAYFAGMTDVASTPHSYYISRYPTGREATVFEGAIDLQFRNDSPYPVKITSNVGGGEVTVSLMGVKTVEVESINGGRWAYTSPKPVTVTSGDCIPSGGVQGFTTSDTRIVRDLSGNEISRNTSTTVYDPQPIVRCE,MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVLAEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPELLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGMETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGGEFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSHSLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDEPDGYPVKPREWSK,151.21,gnl|BL_ORD_ID|4748|hsp_num:0,2242,FALSE,None
LK697,84_4 # 968 # 1711 # -1 # ID=84_4;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.781,84_4,968,1711,-,Strict,50,80.8777,vanY gene in vanF cluster,34.67,3002958,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGTCGCACCCTCCCTCTCGCCGCGCTGGCCGCGCTCGCGCTGCTCGTGGCCGGTTGCGGCACGCCCGCCGCGGGCCCGTCCCCGGCGACGCCGGCTTCCGGCTCCGCGAGCGCGGCCGCGTCGTCCCGCGCCGCCTCGAGCACGGCGCCGTCGTCGAGCACGCACGCCGACCCGGCCGCCCTCGACGTCGTCGTGAACAAGACCCGCCCCGTGGCTCCGCCCGACTGGGCGCCCTCGGATCTGCTGGCCGTGCCCGGCAGCGAGCTGCCCCTGCGGGCGGAGGCCGCGACGGCGGCCGGCGACCTGCTGGATGCCGCCGCGGCGGCGGGCCACCGCCTCACCACCCTGAGCGCCTACCGCTCGTACGACTACCAGGTCCGGACGTACGGCCACTGGGTCGACGAGCTGGGCCGCGCCGAGGCCGACCGCGTCTCGGCGCGTCCGGGGTACTCCGAGCACCAGACCGGCCTGGCCTGGGACGTGGGCGACGCCGCGACCCCCGCGTGTGACCTGGAAGCGTGCTTCGGCGACACCGCCGCGGGCCGCTGGGTGGCCGCGCACGCCGCCGAGCACGGGTTCGTCATCCGCTACCCCGCCGGGGCCGAGGACGTGACGGGCTTCGCCCACGAGCCCTGGCACCTGCGCTATGTCGGGTCCGCGGAGGCGGCCCGGGTCGAGGCGGTCGGCGGCGTCCTCGAGACCGCATGGGGTCTGCCTCCGGCGCCCGACTACGCGGACTGA,MRRTLPLAALAALALLVAGCGTPAAGPSPATPASGSASAAASSRAASSTAPSSSTHADPAALDVVVNKTRPVAPPDWAPSDLLAVPGSELPLRAEAATAAGDLLDAAAAAGHRLTTLSAYRSYDYQVRTYGHWVDELGRAEADRVSARPGYSEHQTGLAWDVGDAATPACDLEACFGDTAAGRWVAAHAAEHGFVIRYPAGAEDVTGFAHEPWHLRYVGSAEAARVEAVGGVLETAWGLPPAPDYAD,MKKWGLLLVFALFLVFIFNILPISQDKVEDRIYEQNDKDTSDDKMTAENMQKIELTEEQIYQGNLLLVNNEHPVHQKSIKSDIINLFTHKELTKGYGLLDNEIKLSEEIAGKFSEMIAAAEEDGVSNFLISSGYRDLDEQSRLYEEMGSDFALPAGHSEHNLGLSLDVGSTQMKMDKAPEGKWIEKNCWEYGFILRYPLDKTDVTGIQYEPWHIRYVGLPHSAIMQEMNLALEEYLDYLKEEKSISVRVDGKKYTISYDPISQNETIEVEVPADEQYEISGNNIDGVIVTTFS,84.3,gnl|BL_ORD_ID|1808|hsp_num:0,1899,FALSE,None
LK1176,3_8 # 8010 # 9290 # 1 # ID=3_8;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.728,3_8,8010,9290,+,Strict,175,176.407,vanT gene in vanG cluster,30.98,3002972,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,glycopeptide resistance gene cluster; vanT,ATGCCTGACCAGACCCCAGCACCCTCCGCGCACCCGGCCTCGGGTCACCGCGCCTCCAGCCTTCCGCCAGCCTCCTCCATGCCGCCGACCGGTGAGCACAGCGTGCCGGGAGGGGCAGGACCGGCTGAGCGGGCCGTCGTCGTGGACCTGGCGGCGATCCGCCACAATGTGGCGACCCTGCGCTCCTGGGTGCAGCCCGCCGCTCTGATGGCCGTGGTGAAGGCCGACGCCTACGGGCACGGCATGATCCCTGTGGCCCAGGCCGCCCTGCAGGCCGGGGCCACCTGGCTGGGCGTGGCCCACGTCACCGAGGCGCTGAGCCTGCGCTCGACCGGGATCACCGCGCCCGTGGTGGCGTGGCTGCACACCCGGTCCACCCCGTTCGGGCGGGCGATCGAGGAGGGGATCGACCTGGGCGTCTCCGGGTGGGAGCTGGAGGCGATCGCCGAATCTGCTCGCCGACTCCAGCAGCCGGCCCGCGTGCATCTGAAGGTGGACACCGGACTCGGACGCAACGGCGCCACCCTGGCCGACTGGCCCACCGTGACCGCCCGGGCGGCAACGCTGCAGGAACAGGGGCTGATCCGCGTGGTGGGCGTCTTCTCCCACCTGGCCGTGGCCGACGACCTGGACCGCGAGGAGGAGACCGACGAGCAGCTGGCCCAGTTCCACCAAGCAGTGGAGATCGCCCGCGGGGCCGGTCTGCACGTGGACGTGCGCCACCTGGCCAACACTCCCGCCACGCTGGTGCGTCCCGAGACCCACCTGGACCTGGTGCGGGTGGGGCTGGGCATCTACGGGCTGACTCCCTTCGACCGGCGTCCGGCCAGCGACTTCGGCCTGCGCCCGGCGATGAGCCTGACCACCACGGTGGCCAACAGCAAGACGGTTCCCGCCGGGCAGGGCATCTCCTACGGTTACCTGTACCGCACCCCTGAACCCACCCGGCTGGCTCTGGTGCCCCTGGGCTATGGCGACGGCATCCCGCGCACGGCCATGGAGGCCCCCGTGTGGATCGGCGGCCGGCGGGCCGAGGTGACCGGGCGGATCGCCATGGACCAGTTCGTGGTGGACCTGGGCACCGAAGAGGACGTGGCACCCGTGGGATCCCCCGTGGAGCTGTTCGGGCCGGCCTCCGGCATCACCGCCGACGACTGGGCCCGGGCCGCGCGCACCATCAACTACGAGATCGTCACCCGGGTGGGCGCGCGCATCCCCAAGGTCCACGTGGACACCCGCCCCGGCGAGGACATCGGCTCACCCACGGGGGAGGGGCGATGA,MPDQTPAPSAHPASGHRASSLPPASSMPPTGEHSVPGGAGPAERAVVVDLAAIRHNVATLRSWVQPAALMAVVKADAYGHGMIPVAQAALQAGATWLGVAHVTEALSLRSTGITAPVVAWLHTRSTPFGRAIEEGIDLGVSGWELEAIAESARRLQQPARVHLKVDTGLGRNGATLADWPTVTARAATLQEQGLIRVVGVFSHLAVADDLDREEETDEQLAQFHQAVEIARGAGLHVDVRHLANTPATLVRPETHLDLVRVGLGIYGLTPFDRRPASDFGLRPAMSLTTTVANSKTVPAGQGISYGYLYRTPEPTRLALVPLGYGDGIPRTAMEAPVWIGGRRAEVTGRIAMDQFVVDLGTEEDVAPVGSPVELFGPASGITADDWARAARTINYEIVTRVGARIPKVHVDTRPGEDIGSPTGEGR,MTKNESYSGIDYFRFIAALLIVAIHTSPLSSFSETGNFIFTRIVARVAVPFFFMTSGFFLISRYTCNAEKLGAFIKKTTLIYGVAILLYIPINVYNGYFKMDNLLPNIIKDIVFDGTLYHLWYLPASIIGAAIAWYLVKKVHYRKAFLIASILYIIGLFGDSYYGIVKSVSCLNVFYNLIFQLTDYTRNGIFFAPIFFVLGGYISDSQNRLSLKRSIVGFIVCFALMFGEALTLHHFDIQKHDSMYVLLLPSVYCLFNLLLHFRGKRRTGLRTISLIIYIIHPFMIVVIRLFAKLLHLQSLLVENSLVHYIAVCFASVVLAVVITALLSSLKPKKAKHTADTDRAYLEINLNNLEHNVNTLQKAMSPKCELMAVVKAEAYGHGMYEVTTYLEQIGVSSFAVATIDEGIRLRKYGISSEILILGYTSPSRAKELCKYELTQTLIDYRYSLLLNKQGYDIKAHIKIDTGMHRLGFSTEDKDKILAAFSLKHIKVAGIFTHLCAADSLEENDVAFTNKQIGSFYKVLDWLKSSGLNIPKVHIQSSYGLLNYPELECDYIRVGVALYGVLSSTNDKTKLELDLRPVLSLKAKVVLIRKIKQGESVGYSRAFTATRDSLIAILPIGYADGFPRNLSCGNSYVLIGGRQAPIVGKICMDQLAVDVTDIPNVKTGSIATLIGKDGKEEITAPMVAESAESITNELLSRMGHRLNIIRRA,59.83,gnl|BL_ORD_ID|1522|hsp_num:0,1561,FALSE,None
LK1176,9_16 # 16102 # 17526 # 1 # ID=9_16;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.707,9_16,16102,17526,+,Strict,50,100.138,vanY gene in vanA cluster,31.65,3002955,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGACCGAACAGCACGCAGCACCGCGTCCGCACCGGACCCTGCGCCGAGTCATCACCGCCCTGATGGCGGCGGCCTTGACGCTGACCATGGCCGGACCGGCACCCGGAGCACTCCCATCCGTCCCGGTCCAGACCGCGCTGATCAACCGGACCGCGTCCAGCCTCACGGTCCTGGTGAACAAGACCTACCCGCTGAGCCCGCTGACCTACGTGCCGGCACAGCTCACCACGGTGGACGGATTCCAGATGCGCCCGGAGACCGCCACCGCCTGGTCCCGGCTGAAGAAGGACGCCGCCGCCCGCGGGTACAGCCTGCGGATGGTCAGCGCGTACCGGTCCTACAGCTACCAGCGCGACCTCTACCACCGCTACGTCCAGCAGTACGGGCAGGCCCACGCAGACCGGATCTCCGCACGGCCGGGCCATTCGGAGCACCAGACCGGCCTGGCGATCGACATCGGGCTCTCCTCCGGCTCCTGTCAGCTGACCTCCTGCTTCGGGGACACCGCCGCCGGGAAGTGGGTGGCCGCCAACGCCTGGCGGTACGGGCTGATCCTGCGCTACCCGCAGGGCACCGAGTCCATCACCGGCTACATGTACGAGCCCTGGCATTTCCGCTACGTCGGTCCGTCCCTGGCCGCGGAGCTGAAGACCCGGAGCATCACCCTGCTCGAGCGGTACTACGACGGCCGGAACCCCTCCGTCACCACCGATGCCAGCCTGGTGTACGCGATCGCGGGCCAGGGGGCCACCCGGAACGCCACCTTCCGCGGCGGGTACCGCGGTGCCCGGTCGATCCCCCTGGGCGTGCCCTCGGACGTGGTGGCGGCGTTCACCGCGGACTGGGACGTGGACGGGCTGCAGGACGTGCTGATGCAGCGCCGCGACGGAACACTGGTGCTGCGGCTGGGCCGGCGGGGCGGCGGCTTCGGCGGTGGCGTGGTGGTGGCGCGTGGCCTGACCGGGCGTCAGCTGACGGTGGGTCGTTGGGCCTCCGAGGGCCGTGATCGTCTGATCAGCGTGAGCTCCACCGGGACGGTCTATCGCCACACGCACTCCACCGGTCCGGTGACCGGCTCCACCGTGATCGGACGAGTGGCCGCGCCGCGCGAGGTCTTCCTGGCCCGGCTGGACGGCAACTCCTCCATGGACCTGGGCGTCGTGGACCGCAATGGCACGCTGCGCGCCTACCCGAGCAGCAGCACGCGGACCCTGACCGGCACCTCACGGGTGATGGCCACCGGATGGAACTCGTCCACAACCCTGCACGTGGTCCAGGGATTCGACGGACCCGGCACCCAGGCACTGTTGGCACGCCGTCCCAGCAACGGACTGCTGCACGCCCGCACGCTCTCCTCCACCGGCACCCTCGGTGCCGAGCGTGGCCTGGTCCAGGGCCTGGCCTCGGCGCTCATCTTCCGCTAG,MTEQHAAPRPHRTLRRVITALMAAALTLTMAGPAPGALPSVPVQTALINRTASSLTVLVNKTYPLSPLTYVPAQLTTVDGFQMRPETATAWSRLKKDAAARGYSLRMVSAYRSYSYQRDLYHRYVQQYGQAHADRISARPGHSEHQTGLAIDIGLSSGSCQLTSCFGDTAAGKWVAANAWRYGLILRYPQGTESITGYMYEPWHFRYVGPSLAAELKTRSITLLERYYDGRNPSVTTDASLVYAIAGQGATRNATFRGGYRGARSIPLGVPSDVVAAFTADWDVDGLQDVLMQRRDGTLVLRLGRRGGGFGGGVVVARGLTGRQLTVGRWASEGRDRLISVSSTGTVYRHTHSTGPVTGSTVIGRVAAPREVFLARLDGNSSMDLGVVDRNGTLRAYPSSSTRTLTGTSRVMATGWNSSTTLHVVQGFDGPGTQALLARRPSNGLLHARTLSSTGTLGAERGLVQGLASALIFR,MKKLFFLLLLLFLIYLGYDYVNEALFSQEKVEFQNYDQNPKEHLENSGTSENTQEKTITEEQVYQGNLLLINSKYPVRQESVKSDIVNLSKHDELINGYGLLDSNIYMSKEIAQKFSEMVNDAVKGGVSHFIINSGYRDFDEQSVLYQEMGAEYALPAGYSEHNSGLSLDVGSSLTKMERAPEGKWIEENAWKYGFILRYPEDKTELTGIQYEPWHIRYVGLPHSAIMKEKNFVLEEYMDYLKEEKTISVSVNGEKYEIFYYPVTKNTTIHVPTNLRYEISGNNIDGVIVTVFPGSTHTNSRR,156.44,gnl|BL_ORD_ID|4669|hsp_num:0,89,FALSE,None
LK1176,21_24 # 25169 # 25870 # 1 # ID=21_24;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.726,21_24,25169,25870,+,Strict,50,93.2041,vanY gene in vanF cluster,31.18,3002958,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGTCCTCGTCCGAGGACACACCATCAACGCGGCCCCCCTCCCCCACAGCGGCTCCTTCCCCCACGGCCCCCACCACCGTCGCGCCGACCGCGGCTGGCTCGTCCCTCGCGCCCCTCCACCGGGATCCGGACTCGCTGCAGGTCCTGGTGAACAAGCATCACCCCGTCCCGGCGAACTGGACGGCACCTGACCTGGTCAGCGCCGGCGTCGTGGGCAACCGTCAGGGCATGCTCCTGCGGAAGCCGGCCGCCCAGGCCCTGCAGGGGATGGTGGCCGCCGCGCGGGCCGACGGGATCGAGCTGATCCTGGTCAGCGCGCACCGCACGTACGACTACCAGGCCGGGCTGTACTCCAACAGCATCCAGCGCAACGGTCAGGCCCACGCCAACCGGTACTCCGCCCGCCCGGGCCACTCCGAACACCACACCGGGCTGGCCGCGGACCTGGCCGCCGCGGACGGAACGTGCACCCTGCAGGGCTGTTTCGCGGACACCCCGGAGGGCCGGTGGATCGCCCAGCACGCCGTGGAGCACGGCTTCGTGGTCCGCTACCCGCAGGGCTCCGAGCCGATCACCGGGTACGGAGCCGAACCCTGGCACCTGCGCTACCTGGGCGTGGAGCAGGCTCAGGCCGTGATGGAGGCCGGAGGGATCGTGGAGACCGCCTGGGGCGCCGACCCCGCACCGGACTACCTCCCGTAG,MSSSEDTPSTRPPSPTAAPSPTAPTTVAPTAAGSSLAPLHRDPDSLQVLVNKHHPVPANWTAPDLVSAGVVGNRQGMLLRKPAAQALQGMVAAARADGIELILVSAHRTYDYQAGLYSNSIQRNGQAHANRYSARPGHSEHHTGLAADLAAADGTCTLQGCFADTPEGRWIAQHAVEHGFVVRYPQGSEPITGYGAEPWHLRYLGVEQAQAVMEAGGIVETAWGADPAPDYLP,MKKWGLLLVFALFLVFIFNILPISQDKVEDRIYEQNDKDTSDDKMTAENMQKIELTEEQIYQGNLLLVNNEHPVHQKSIKSDIINLFTHKELTKGYGLLDNEIKLSEEIAGKFSEMIAAAEEDGVSNFLISSGYRDLDEQSRLYEEMGSDFALPAGHSEHNLGLSLDVGSTQMKMDKAPEGKWIEKNCWEYGFILRYPLDKTDVTGIQYEPWHIRYVGLPHSAIMQEMNLALEEYLDYLKEEKSISVRVDGKKYTISYDPISQNETIEVEVPADEQYEISGNNIDGVIVTTFS,79.52,gnl|BL_ORD_ID|1808|hsp_num:0,1899,FALSE,None
LK1176,22_38 # 37588 # 38028 # 1 # ID=22_38;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.707,22_38,37588,38028,+,Strict,700,23.8682,CMY-129,100,3003137,protein homolog model,n/a,n/a,cephamycin,antibiotic inactivation,CMY beta-lactamase,ATGATGGTGGACGTCACGAGTCGGTCGCGTTCCTCGGTGCTCGCGATGCAGGCTGTCTGCGCGCTGCTGTTGACGGCCCCCTTCCTACGCGACGTCTATGTGGTGACGGCGGAACCGACCGACGGCCCTTCGTCTCCTCTGTACTGGATGAGGGAGTCAGCGGTGGGCGTGGCCCTGGTGGCCGCCCTCGTGCTCTGCTGGGCAACGGCGCGGCAGGGCGAGCGCGGTGCACGGACCTGGGCCGTGGTGGCCCTGATCCTGGTGGGGATCCGCGGGGTGGGGACACTGGTGAGGGCCGCCAGTGTCAACAGCATCGGCGCGGGGGTCGTGGAGCTGGCCTCCGGGGCGCTGCTGGCCCTCTGCGCGATGGTGCTGCTGGTCCTGACCGTCCGGCGGTGGCGAGTGCTGCGTCGGGTCAGCGCTGCAGGTCCGGGTCGGTGA,MMVDVTSRSRSSVLAMQAVCALLLTAPFLRDVYVVTAEPTDGPSSPLYWMRESAVGVALVAALVLCWATARQGERGARTWAVVALILVGIRGVGTLVRAASVNSIGAGVVELASGALLALCAMVLLVLTVRRWRVLRRVSAAGPGR,MMKKSLCCALLLTAPFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYYFTWGKADITNNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWQGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWAPGAKRLYANSSIGLFGALAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKAVHVSPGQLDAEAYGVKSSVIDMARWVQVNMDANRVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLANKSYPNPVRVEAAWRILEKLQ,38.32,gnl|BL_ORD_ID|2921|hsp_num:0,3936,TRUE,loose hit with at least 95 percent identity pushed strict
LK705,91_5 # 3124 # 3873 # -1 # ID=91_5;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.783,91_5,3124,3873,-,Strict,50,83.5741,vanY gene in vanM cluster,34.46,3002961,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGTCGCCCCCTCCCGCTCGCCGCGCTGGCCGCGCTCGCGCTGCTCGCGGCCGGCTGCGGCACGCCCGCCGCGGGCCCGTCCTCGACGCCGACGACGCCGACGTCCGGCTCCGCGAGCGCGGCCGCGTCGTCCCGCGCCGCCTCGAGCACGGCGCCGTCGTCGGGCACGCACGCCGACCCGGCCACCCTCGACGTCGTCGTGAACAAGACCCGCCCCGTGGCCCCGCCCGACTGGGCGCCCTCGGATCTGGTGGCCGTGCCCGGCAGCGAGCTGCCCCTGCGGGCGGAGGCCGCGACGGCGGCCGCTGACCTGCTGGATGCCGCCGCGGCGGCGGGCCACCGCCTCACCACCCTGAGCGCCTACCGCTCGTACGACTACCAGGTCCGGACGTACGGCCACTGGGTCGACGAGCTGGGCCGCGCCGAGGCCGACCGCGTCTCCGCGCGTCCGGGGTACTCCGAGCATCAGACCGGCCTGGCCTGGGACGTGGGCGACGCCGCGACCCCCGCGTGTGACCTGGAAGCGTGCTTCGGCGACACCGCCGCGGGCCGTTGGGTGGCCGCGCACGCCGCCGAGTACGGGTTCGTCATCCGCTACCCCGCCGGGGCCGAGGACGTGACGGGCTTCGCCCACGAGCCCTGGCATCTGCGCTACGTCGGGTCCGCGGAGGCGGCCCGGGTCGAGGCGGCCGGCGGCGTCCTCGAGACCGCGTGGGGTCTGCCGCCGGCGCCGGACTACACGGACTGA,MRRPLPLAALAALALLAAGCGTPAAGPSSTPTTPTSGSASAAASSRAASSTAPSSGTHADPATLDVVVNKTRPVAPPDWAPSDLVAVPGSELPLRAEAATAAADLLDAAAAAGHRLTTLSAYRSYDYQVRTYGHWVDELGRAEADRVSARPGYSEHQTGLAWDVGDAATPACDLEACFGDTAAGRWVAAHAAEYGFVIRYPAGAEDVTGFAHEPWHLRYVGSAEAARVEAAGGVLETAWGLPPAPDYTD,MVFQGNLLLVNNEYPVLEESIKTDVVNLFKHDELTKGYELLNREIYLSEKVAREFSEMVDAAEKEGVRHFSINSGFRNFDEQNALYQEMGSDYALPAGYSEHNLGLALDIGSTQMEMSEAPEGKWLEDNAWEYGFILRYPMDKTAITGIQYEPWHFRYVGLPHSAIIEEKNFALEEYLDFLKEQKSISGTIHGENYEISYYPITEKTDIEMPANLHYEISGNNMDGVIVTVYR,106.87,gnl|BL_ORD_ID|1673|hsp_num:0,1713,FALSE,None
LK712,9_38 # 36030 # 36836 # 1 # ID=9_38;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.397,9_38,36030,36836,+,Strict,50,113.235,vanY gene in vanG cluster,31.21,3002959,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCTTACTTTCCTTTTGACAGGATGCAGTAAATTGGATGGCATTACAGATCATATACCTTTCTTAAACAAAGAAAAGGAATCGGAAGAAACAGCCGTGAATAATAACAATTCAGAACCAACAAACGATCAAGATACTGGAGATAGTACAGAAGAGCTTCCATGGACTTTAGAAGCTGCTTTTTTCAATGATATTAAGGTTGTGGATGGCAGGAACATCATCCAAAATCCAACAAATACAGTGTCATTGGTTAACAAAAGCTTTGGATTGCCAGATGGATACGCACCAGAGGATCTTATCAGGCCAGAAGTTCAGTTTTCCTTTGGTGATCAAGATATAGAGAAAAGCTATATGAGAAAGGAAGCTGCGAATTCTTTAGCTGGCATGTTTAATGCTGCCAAAAAGGACGGTATTATCCTTTATGCAGTATCAGGCTATCGTTCTTATGACCGTCAGACTGTTCTGTATGATGCAGAGGTTGACAAGGTTGGACAGAAGAAAGCAGAGGAAGCAGTCGCATATCCTGGTAACAGCGAGCACCAGACAGGTTTAGCAATGGATATATCAGCTGAAAGTGTCGACTTCCTGCTTACAGAGGACTTCGAGGCTACGAAAGAAGGCAAATGGCTGAAAGATAATGCGCATCTTTATGGGTATATTCTGCGTTATCCGAAAGGAAAAGAGGATATTACCAAATATAAATTTGAGCCATGGCATTTCCGCTATGTCGGGGAAAAATCTGCAAACGATATATATGAAAACGATTGGACATTAGAGGAATATTTTGACCAGGTTAGAAAAATCTAA,MLTFLLTGCSKLDGITDHIPFLNKEKESEETAVNNNNSEPTNDQDTGDSTEELPWTLEAAFFNDIKVVDGRNIIQNPTNTVSLVNKSFGLPDGYAPEDLIRPEVQFSFGDQDIEKSYMRKEAANSLAGMFNAAKKDGIILYAVSGYRSYDRQTVLYDAEVDKVGQKKAEEAVAYPGNSEHQTGLAMDISAESVDFLLTEDFEATKEGKWLKDNAHLYGYILRYPKGKEDITKYKFEPWHFRYVGEKSANDIYENDWTLEEYFDQVRKI,MNHMNMKHRRRKRRRNQSFLFTGILLLVVVSASSFLWYGFGNAAKKDSVIEEMPFTITQDGMQAKEEIKKTVLETSYGGKQQVAEENHGNTQNAGTDEAWNLMLVNRDNAIPDNYEVNLVEVEGGERVDERIYEPLMEMLNAAREENWGELPMVVSGYRTQEKQQSLYDEKIAKFKKEGYSDSEAVRQAEQWVAVPGHSEHQLGFAVDINGATYDVYLWLQENSYKYGFIFRYPGSKTDITGTAEEVWHYRYVGVEAATEMYENGLCLEEYLEKKQSEN,96.06,gnl|BL_ORD_ID|4732|hsp_num:0,298,FALSE,None
LK712,12_126 # 133960 # 135117 # 1 # ID=12_126;partial=00;start_type=TTG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.419,12_126,133960,135117,+,Strict,175,211.075,vanT gene in vanG cluster,34.52,3002972,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,glycopeptide resistance gene cluster; vanT,TTGATGCTAGAGAATGAGTATTTTCGTGATACTTGGGCAGAAATAAATTTAGACGATATAGAAGAGAATGTAAAAAACATGAGAAGCAGGATGGCGGAAGCCAGCAAGCTATTTGCAGTCGTGAAGGCTAATGGTTACGGCCATGGTGCAGTAGAGGTAGCTCGCACTGCTCTTCTTGCAGGTGCAGATTATTTGGCCGTAGCATTTTTGGATGAGGCACTTGCTTTAAGAAATGCAGGTATCGATGCACCGATATTGGTGCTTGGAGCAAGCAGGCCCGCTGATATTCTCGTAGCTGCTAAACAAGACATTATTTTAACCGTTTTTGACGTAGAATGGTTAACAAGAGCGACAGAGCGTCTGCAAGGAAACAAGATAAAAATCCATGTTAAAATCGACTCAGGTATGGGGAGGTTAGGGATTAGAAAAGAACAGGAAGTCAAAGAAATAGAAGAATTCCTCATGTGTCATCAAGAATTCATCTTGGAAGGAATTTATACTCATTTTGCAACAGCAGATGAGAAAAATCCCAGCTACTTGAATGAACAGGCAAAGAAATTTGCGGACATATTAGCTTCCTTTAAAGCGAAGCCTCCCATTATACATTGCAGCAACAGTGCGGCAGGGCTGCTTTACCCAGAACTTGCTTTCAATGGAGTGCGGCTGGGAATTTCCATGTATGGCCTGACTCCTTCCATGGAAATTAAAGAAATGCTGCCATTTTCATTAAAAGAAGCATTTTCACTTCATACAAAAATCGTGCAAGTAAAGAAGCTTCATAAAGGTGATAAAGTAAGCTATGGTGCCACATATGAAGCAAAGGAAGACGAGTGGATAGCGACATTGCCAATCGGTTATGCAGATGGCTGGCTTAGAAAGCTGCAAGGCCAAGAGGTTCTGGTAAATGGAGTCAGGGTTCCAATTGTAGGAAGAGTTTGTATGGACCAGTGTATGATAAGGCTGCCTCATGAAATAGCGGTTGGAACGAAGGTTACCTTAATAGGGACGCAGCAGGAACAGTGCATTTCCGTTAATGAGATTGCCAAAAAGCTTGATACGATTAATTATGAAGTAACCTGTACCATTGCGAATAGGGTCCCGAGAATCTATCTCAAGAATGGAGCAGTGGATAGCATTGTGAATAACCTTCTAAATTAA,MMLENEYFRDTWAEINLDDIEENVKNMRSRMAEASKLFAVVKANGYGHGAVEVARTALLAGADYLAVAFLDEALALRNAGIDAPILVLGASRPADILVAAKQDIILTVFDVEWLTRATERLQGNKIKIHVKIDSGMGRLGIRKEQEVKEIEEFLMCHQEFILEGIYTHFATADEKNPSYLNEQAKKFADILASFKAKPPIIHCSNSAAGLLYPELAFNGVRLGISMYGLTPSMEIKEMLPFSLKEAFSLHTKIVQVKKLHKGDKVSYGATYEAKEDEWIATLPIGYADGWLRKLQGQEVLVNGVRVPIVGRVCMDQCMIRLPHEIAVGTKVTLIGTQQEQCISVNEIAKKLDTINYEVTCTIANRVPRIYLKNGAVDSIVNNLLN,MTKNESYSGIDYFRFIAALLIVAIHTSPLSSFSETGNFIFTRIVARVAVPFFFMTSGFFLISRYTCNAEKLGAFIKKTTLIYGVAILLYIPINVYNGYFKMDNLLPNIIKDIVFDGTLYHLWYLPASIIGAAIAWYLVKKVHYRKAFLIASILYIIGLFGDSYYGIVKSVSCLNVFYNLIFQLTDYTRNGIFFAPIFFVLGGYISDSQNRLSLKRSIVGFIVCFALMFGEALTLHHFDIQKHDSMYVLLLPSVYCLFNLLLHFRGKRRTGLRTISLIIYIIHPFMIVVIRLFAKLLHLQSLLVENSLVHYIAVCFASVVLAVVITALLSSLKPKKAKHTADTDRAYLEINLNNLEHNVNTLQKAMSPKCELMAVVKAEAYGHGMYEVTTYLEQIGVSSFAVATIDEGIRLRKYGISSEILILGYTSPSRAKELCKYELTQTLIDYRYSLLLNKQGYDIKAHIKIDTGMHRLGFSTEDKDKILAAFSLKHIKVAGIFTHLCAADSLEENDVAFTNKQIGSFYKVLDWLKSSGLNIPKVHIQSSYGLLNYPELECDYIRVGVALYGVLSSTNDKTKLELDLRPVLSLKAKVVLIRKIKQGESVGYSRAFTATRDSLIAILPIGYADGFPRNLSCGNSYVLIGGRQAPIVGKICMDQLAVDVTDIPNVKTGSIATLIGKDGKEEITAPMVAESAESITNELLSRMGHRLNIIRRA,54.07,gnl|BL_ORD_ID|1522|hsp_num:0,1561,FALSE,None
LK712,20_30 # 26934 # 27809 # -1 # ID=20_30;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.357,20_30,26934,27809,-,Strict,50,125.176,vanW gene in vanI cluster,40.41,3003724,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanW; glycopeptide resistance gene cluster,ATGTTACTTAGTTGGATGCTTGCACTTTTAATTTATACGCAGCAGGAAAATGTACAAGATAACTTAATTATTACGAACAAGGGCGATGAAATGTACGTTGTAAATCGGTCTAACTTTTCCATGCAGTTCCCTATACTGCCTTTTATAGACACGAAAAAAGTGAAAGACTTTATGGATGAAATAGATGAGCAAGTAAGCAAAAAACCTAAAAATGCTTCTTTGGACGCTAACGGAAATATTACATCAGAACAAGTTGGCTATCGCTTAAACAGAAGAGTTTTCACAGAGGAAATGCTTTCTTATTTTTTTAATAAAGGCACATCGACTATAGAGCTGCCGATAGTCGCTAATTATCCTCGGGTGGACAGTGAGTTACTTGGAAACATTAAAGGGGAAAAGATTGGGGAATATATAACATTTTATAATCCTTACAATAAACAAAGAAAAAATAATATTGACCTCGCAGCAAAGGCAATCAATAATTATGTTCTATTTCCAGGAGAGGTGTTTTCCTTTAATAAGGTGGTTGGAGAAAGAACGGTTGATAGAGGATATATGCCTTCAACTGCAATCGTTAACGGGGAATATTCTGAAGAATTCGGCGGAGGAATTTGCCAAGTTTCCTCTACGCTTTTTAATGCTGTCGATAGTGCAGGTTTAAATATTGTGAAGCGCTTTACACACAGTAAAGGGGTTGCGTACGTTCCAGTTAACAGGGATGCAACAGTAAGCTGGGATGGACCGGATTTTATCTTTAAAAATGATTATAATCAGCCTATCCTCATCCTTGCAAAAGCAGTTAATAACCATGTAAAAGTTGAGATTTATTCATCTGATGTAATTACATATACGCCTAAAAAAATTCCATATCTTTAA,MLLSWMLALLIYTQQENVQDNLIITNKGDEMYVVNRSNFSMQFPILPFIDTKKVKDFMDEIDEQVSKKPKNASLDANGNITSEQVGYRLNRRVFTEEMLSYFFNKGTSTIELPIVANYPRVDSELLGNIKGEKIGEYITFYNPYNKQRKNNIDLAAKAINNYVLFPGEVFSFNKVVGERTVDRGYMPSTAIVNGEYSEEFGGGICQVSSTLFNAVDSAGLNIVKRFTHSKGVAYVPVNRDATVSWDGPDFIFKNDYNQPILILAKAVNNHVKVEIYSSDVITYTPKKIPYL,MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVLAEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPELLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGMETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGGEFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSHSLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDEPDGYPVKPREWSK,78.02,gnl|BL_ORD_ID|4748|hsp_num:0,2242,FALSE,None
LK712,32_26 # 19163 # 19510 # -1 # ID=32_26;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.414,32_26,19163,19510,-,Strict,75,78.1814,qacJ,44.44,3007014,protein homolog model,n/a,n/a,disinfecting agents and antiseptics,antibiotic efflux,small multidrug resistance (SMR) antibiotic efflux pump,ATGAAGGGATATGTTTATTTAACCATTTCCATCATTTCTGAGGTTTTTGCGACAACAATGCTTAAGTTGGCAGAGGGCTTTACAGTGCTCCTCCCTTCCATCTGCGTCATTATTGGCTATGTACTTGCCTTTTATTTTATCTCAAAAGCACTACAATCACTACCTTTAAGCTTATCCTATGCTATTTGGTCTGGCGTTGGGACAGCTGCAACAGCGTTGATTGGCGTCATTCTTTGGAAGGAACTAATTAACCCTGTCATGCTATGTGGTATTGTCCTCATTATCGGCGGTGTTTTTTTGTTAAATGGTGCGGAAAAAGGAGAAACAGCCAAAAAGCCGGCAAACTGA,MKGYVYLTISIISEVFATTMLKLAEGFTVLLPSICVIIGYVLAFYFISKALQSLPLSLSYAIWSGVGTAATALIGVILWKELINPVMLCGIVLIIGGVFLLNGAEKGETAKKPAN,MPYLYLVIAIITEIIGTSFLKTAEGFTKLWPTLGTLISFGICFYFLSVTMKYLPLNVSYATWAGLGLVLTTIVSVVIFKESVNLISIFSIILIIIGVVLLNVFGSSH,107.48,gnl|BL_ORD_ID|4662|hsp_num:0,5730,FALSE,None
LK712,32_27 # 19528 # 19851 # -1 # ID=32_27;partial=00;start_type=ATG;rbs_motif=AGGAGG;rbs_spacer=5-10bp;gc_cont=0.423,32_27,19528,19851,-,Strict,75,86.6557,qacJ,47.56,3007014,protein homolog model,n/a,n/a,disinfecting agents and antiseptics,antibiotic efflux,small multidrug resistance (SMR) antibiotic efflux pump,ATGAATCCATATTTATTACTGGCAATTTCCATAATTAGTGAAGTATTTGCAAGCTCCATGCTTAAGGCAACGGACGGCTTCAGGAGACTTTTGCCGACAGTTGGGGTTGCAGTCGGCTATAGTATTGCCTTTTATGCTCTTTCCTTAACATTAAAAACATTGCCGCTTGGTACTGCATATGCCATTTGGGCAGGTGTTGGTACGGCACTTACTGCATTGGCGGGAGCATTATTTTATAAAGAGAGCTTAAACAAAAAGAAAATACTTGGCCTTTTACTCGTTATCGGCGGGGTTGTCCTCTTAAATATTGGCGGGACCCATTAA,MNPYLLLAISIISEVFASSMLKATDGFRRLLPTVGVAVGYSIAFYALSLTLKTLPLGTAYAIWAGVGTALTALAGALFYKESLNKKKILGLLLVIGGVVLLNIGGTH,MPYLYLVIAIITEIIGTSFLKTAEGFTKLWPTLGTLISFGICFYFLSVTMKYLPLNVSYATWAGLGLVLTTIVSVVIFKESVNLISIFSIILIIIGVVLLNVFGSSH,100,gnl|BL_ORD_ID|4662|hsp_num:0,5730,FALSE,None
LK712,32_52 # 37411 # 38205 # 1 # ID=32_52;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.397,32_52,37411,38205,+,Strict,50,119.013,vanY gene in vanG cluster,39.18,3002959,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGAAAAAAGTACTTACAGCGTCAGCCATTGCTTTAATGTTAAGCGGCTGCAGCACGATCCAACAAGATAATCAGCAAAAGGAAAACACTAATCAATCTGCCTCACAGCAGGATACTGTTAAAAAGGAAGAGACGCAAACAACAGAGTGGACAATCCCCACACAAAACCAAAATAAAGTAAAAAAAGAAGATGGACACTTTGTCCTTGAAAATCCAGAAAATATGTTAGCACTTGTCAATAAGGAATATTATTTGCCGAGTGATTATGAACCAAAGGATCTCGTCAGACCAGATGTTGCGTTTTCTTTTGGTGATGAGGATATAGAAAAAAGTCATATGAGAAAAGAAGCGGCAGAGGCACTAGCAGATATGTTTAATGCAGCAAAAGAAGAGGGAAACATTCTTTATGCAGCATCAGGATACCGCTCGTATGAGAGACAATCTGCTGTATTTAAGCAAGAGGTTGCCAATGTAGGAGAGGAAGATGCAGAACAGGCTGTTGCTATCCCTGGCTCAAGTGAACATCAAAGTGGCTTAGCGATGGATATCACGTCACAAAAGCAAAATTTCCTGTTAACAGAGGAATTTGGCGAGGATAAGGAAGGCAAATGGTTAATGGCAAATGCCTATAAGTACGGATTTATCCTGCGCTATCCAAAAGATAAGGTAGACATCACTCAATATGAATATGAACCTTGGCACTATCGTTATGTTGGCAAAGATGCCGCAAAAATGATGAAGGATAAGGACTGGACACTTGAAGAGTATTTCGAGAATGGAGCTAAACAACAATAA,MKKVLTASAIALMLSGCSTIQQDNQQKENTNQSASQQDTVKKEETQTTEWTIPTQNQNKVKKEDGHFVLENPENMLALVNKEYYLPSDYEPKDLVRPDVAFSFGDEDIEKSHMRKEAAEALADMFNAAKEEGNILYAASGYRSYERQSAVFKQEVANVGEEDAEQAVAIPGSSEHQSGLAMDITSQKQNFLLTEEFGEDKEGKWLMANAYKYGFILRYPKDKVDITQYEYEPWHYRYVGKDAAKMMKDKDWTLEEYFENGAKQQ,MNHMNMKHRRRKRRRNQSFLFTGILLLVVVSASSFLWYGFGNAAKKDSVIEEMPFTITQDGMQAKEEIKKTVLETSYGGKQQVAEENHGNTQNAGTDEAWNLMLVNRDNAIPDNYEVNLVEVEGGERVDERIYEPLMEMLNAAREENWGELPMVVSGYRTQEKQQSLYDEKIAKFKKEGYSDSEAVRQAEQWVAVPGHSEHQLGFAVDINGATYDVYLWLQENSYKYGFIFRYPGSKTDITGTAEEVWHYRYVGVEAATEMYENGLCLEEYLEKKQSEN,94.62,gnl|BL_ORD_ID|4732|hsp_num:0,298,FALSE,None
LK729,1_54 # 52957 # 54357 # 1 # ID=1_54;partial=00;start_type=ATG;rbs_motif=AGGAG(G)/GGAGG;rbs_spacer=13-15bp;gc_cont=0.353,1_54,52957,54357,+,Strict,525,543.888,norC,60.48,3007010,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGGACACTTCGAAACAATTTAGAGGTGACAATCGTTTGTTATTAGGTATTGTCTTAGGTGTCATTACCTTTTGGCTATTCGCACAGTCACTTGTTAATCTTGTTGTCCCGTTGCAAGCAACATACAGTAGTGACGTCGGTACGATAAATATTGCTGTTAGTTTATCAGCGCTGTTTGCTGGATTATTTATCGTGGGTGCTGGAGATGTAGCTGATAAGCTTGGCCGCGTTAAAATTACATATGTGGGTCTTATTTTAAATGTCATCGGTTCATTACTCATCATTATCACACCGTTACCAGCATTTTTAATTATAGGTAGAATAATTCAAGGTTTGTCTGCAGCCTGCATTATGCCTGCGACACTTGCCATTATAAATGAGTATTATATTGGAACGCGCAGACAACGTGCCTTAAGTTACTGGTCAATTGGTTCTTGGGGCGGTAGTGGTATTTGTACGTTGTTTGGTGGCTTAATGGCTACTTATATAGGCTGGCGTTCAATATTTATAGTTTCAATTTTATTAACATTATTATCGATGTATTTAATTAAACATACACCTGAAACTAAAGCTGAACCGGTAAAAAGCTTAAAAGGTGAAACGAAAAAGTTTGATGTTATTGGATTAATCATTTTAGTGGTGACAATGTTAAGTCTTAACGTGATTATTACGCAGACATCTCATTTCGGTTTAGTTTCACCAATGATACTAAGTTTAATTGTTATTTTTATCTTGTCATTAATAGGTTTTGTCTACTATGAAAATAAGATTAAATATCCGCTTGTAGATTTTTCTATTTTTAAAAATAGAGGATACAGTGGGGCGACGATATCTAACTTTCTATTAAATGGTGTTGCTGGTGGTGCATTAATCGTCATTAACACTTATTACCAACAACAATTAGGTTTTAATTCATCTCAAACAGGATATATCTCATTAACGTATTTAATTGCAGTATTGTTAATGATCCGTGTAGGTGAAAAGATTTTAACTCAGTTTGGTCCGAAGCGTCCACTATTATTAGGTAGTGGATTTACAGTAATTGGACTTATCTTATTGTCATTAACATTTTTGCCTGAAATGTGGTATATCGTGTCTAGCATTGTCGGCTACTTACTGTTTGGTACGGGTTTAGGACTGTATGCTACCCCTTCTACAGATACAGCAGTTGCGAGTGCGCCAGATGACAAATCAGGTGTAGCTTCAGGTGTTTATAAAATGGCTTCGTCATTAGGAAATGCATTTGGTGTGGCAGTATCTGGTACGATTTATACAGTTTTAGCAGCAAATTTAAATTTACATTTAGGCGGCTTCTCTGGCATGATGTTTAATGTCATTTTAGCAGTGATTGCATTTTTAGTTATTCTATTTTTAGTTCCGAAAAATCAAACGAATTTGTAA,MDTSKQFRGDNRLLLGIVLGVITFWLFAQSLVNLVVPLQATYSSDVGTINIAVSLSALFAGLFIVGAGDVADKLGRVKITYVGLILNVIGSLLIIITPLPAFLIIGRIIQGLSAACIMPATLAIINEYYIGTRRQRALSYWSIGSWGGSGICTLFGGLMATYIGWRSIFIVSILLTLLSMYLIKHTPETKAEPVKSLKGETKKFDVIGLIILVVTMLSLNVIITQTSHFGLVSPMILSLIVIFILSLIGFVYYENKIKYPLVDFSIFKNRGYSGATISNFLLNGVAGGALIVINTYYQQQLGFNSSQTGYISLTYLIAVLLMIRVGEKILTQFGPKRPLLLGSGFTVIGLILLSLTFLPEMWYIVSSIVGYLLFGTGLGLYATPSTDTAVASAPDDKSGVASGVYKMASSLGNAFGVAVSGTIYTVLAANLNLHLGGFSGMMFNVILAVIAFLVILFLVPKNQTNL,MNETYRGGNKLILGIVLGVITFWLFAQSLVNVVPNLQQSFGADMGTISIAVSLTALFSGMFVVGAGGLADKIGRVKMTNIGLLLSIIGSALIIITNLPALLILGRIIQGVSAACIMPSTLAIMKTYYEGAERQRALSYWSIGSWGGSGICSLFGGAVATTMGWRWIFIFSIIVAVLSMLLIKGTPETKSEVTNTHKFDVAGLIVLVVMLLSLNVVITKGAALGYTSLWFFGLIAIVIVAFFIFLNVEKKVDNPLIDFKLFENKPYTGATISNFLLNGVAGTLIVANTFVQQGLGYTALQAGYLSITYLIMVLLMIRVGEKLLQKMGSKRPMLLGTFIVIIGIALISLVFLPGIFYVISCVVGYLCFGLGLGIYATPSTDTAISNAPLDKVGVASGIYKMASSLGGAFGVAISGAVYAGAVAATSIHTGAMIALWVNVLMGIMAFIAILFAIPNDDKRVKDAK,100.87,gnl|BL_ORD_ID|4656|hsp_num:0,5726,FALSE,None
LK729,2_93 # 88605 # 89048 # -1 # ID=2_93;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.329,2_93,88605,89048,-,Perfect,270,301.212,mgrA,100,3000815,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; cephalosporin; penam; tetracycline antibiotic; peptide antibiotic; disinfecting agents and antiseptics,antibiotic efflux,ATP-binding cassette (ABC) antibiotic efflux pump; major facilitator superfamily (MFS) antibiotic efflux pump,ATGTCTGATCAACATAATTTAAAAGAACAGCTATGCTTTAGTTTGTACAATGCTCAAAGACAAGTTAATCGCTACTACTCTAACAAAGTTTTTAAGAAGTACAATCTAACATACCCACAATTTCTTGTCTTAACAATTTTATGGGATGAATCTCCTGTAAACGTCAAGAAAGTCGTAACTGAATTAGCACTCGATACTGGTACAGTATCACCATTATTAAAACGAATGGAACAAGTAGACTTAATTAAGCGTGAACGTTCCGAAGTCGATCAACGTGAAGTATTTATTCACTTGACTGACAAAAGTGAAACTATTAGACCAGAATTAAGTAATGCATCTGACAAAGTCGCTTCAGCTTCTTCTTTATCTCAAGATGAAGTTAAAGAACTTAATCGCTTATTAGGTAAAGTCATTCATGCATTTGATGAAACAAAGGAAAAATAA,MSDQHNLKEQLCFSLYNAQRQVNRYYSNKVFKKYNLTYPQFLVLTILWDESPVNVKKVVTELALDTGTVSPLLKRMEQVDLIKRERSEVDQREVFIHLTDKSETIRPELSNASDKVASASSLSQDEVKELNRLLGKVIHAFDETKEK,MSDQHNLKEQLCFSLYNAQRQVNRYYSNKVFKKYNLTYPQFLVLTILWDESPVNVKKVVTELALDTGTVSPLLKRMEQVDLIKRERSEVDQREVFIHLTDKSETIRPELSNASDKVASASSLSQDEVKELNRLLGKVIHAFDETKEK,100,gnl|BL_ORD_ID|133|hsp_num:0,154,FALSE,None
LK729,2_102 # 96699 # 97865 # 1 # ID=2_102;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.335,2_102,96699,97865,+,Perfect,700,765.377,Staphylococcus aureus norA,100,3004667,protein homolog model,n/a,n/a,fluoroquinolone antibiotic,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGAATAAACAGATTTTTGTCTTATATTTTAATATTTTCTTGATTTTTTTAGGTATCGGTTTAGTAATACCAGTCTTGCCTGTTTATTTAAAAGATTTGGGATTAACTGGTAGTGATTTAGGATTACTAGTTGCTGCTTTTGCGTTATCTCAAATGATTATATCGCCGTTTGGTGGTACGCTAGCTGACAAATTAGGGAAGAAATTAATTATATGTATAGGATTAATTTTGTTTTCAGTGTCAGAATTTATGTTTGCAGTTGGCCACAATTTTTCGGTATTGATGTTATCGAGAGTGATTGGTGGTATGAGTGCTGGTATGGTAATGCCTGGTGTGACAGGTTTAATAGCTGACATTTCACCAAGCCATCAAAAAGCAAAAAACTTTGGCTACATGTCAGCGATTATCAATTCTGGATTCATTTTAGGACCAGGGATTGGTGGATTTATGGCAGAAGTTTCACATCGTATGCCATTTTACTTTGCAGGAGCATTAGGTATTCTAGCATTTATAATGTCAATTGTATTGATTCACGATCCGAAAAAGTCTACGACAAGTGGTTTCCAAAAGTTAGAGCCACAATTGCTAACGAAAATTAACTGGAAAGTGTTTATTACACCAGTTATTTTAACACTTGTATTATCGTTTGGTTTATCTGCATTTGAAACATTGTATTCACTATACACAGCTGACAAGGTAAATTATTCACCTAAAGATATTTCGATTGCTATTACGGGTGGCGGTATATTTGGGGCACTTTTCCAAATCTATTTCTTCGATAAATTTATGAAGTATTTCTCAGAGTTAACATTTATAGCTTGGTCATTATTATATTCAGTTGTTGTCTTAATATTATTAGTTTTTGCTAATGGCTATTGGTCAATAATGTTAATCAGTTTTGTTGTCTTCATAGGTTTTGATATGATACGACCAGCCATTACAAATTATTTTTCTAATATTGCTGGAGAAAGGCAAGGCTTTGCAGGCGGATTGAACTCGACATTCACTAGTATGGGTAATTTCATAGGTCCTTTAATCGCAGGTGCGTTATTTGATGTACACATTGAAGCACCAATTTATATGGCTATAGGTGTTTCATTAGCAGGTGTTGTTATTGTTTTAATTGAAAAGCAACATAGAGCAAAATTGAAAGAACAAAATATGTAG,MNKQIFVLYFNIFLIFLGIGLVIPVLPVYLKDLGLTGSDLGLLVAAFALSQMIISPFGGTLADKLGKKLIICIGLILFSVSEFMFAVGHNFSVLMLSRVIGGMSAGMVMPGVTGLIADISPSHQKAKNFGYMSAIINSGFILGPGIGGFMAEVSHRMPFYFAGALGILAFIMSIVLIHDPKKSTTSGFQKLEPQLLTKINWKVFITPVILTLVLSFGLSAFETLYSLYTADKVNYSPKDISIAITGGGIFGALFQIYFFDKFMKYFSELTFIAWSLLYSVVVLILLVFANGYWSIMLISFVVFIGFDMIRPAITNYFSNIAGERQGFAGGLNSTFTSMGNFIGPLIAGALFDVHIEAPIYMAIGVSLAGVVIVLIEKQHRAKLKEQNM,MNKQIFVLYFNIFLIFLGIGLVIPVLPVYLKDLGLTGSDLGLLVAAFALSQMIISPFGGTLADKLGKKLIICIGLILFSVSEFMFAVGHNFSVLMLSRVIGGMSAGMVMPGVTGLIADISPSHQKAKNFGYMSAIINSGFILGPGIGGFMAEVSHRMPFYFAGALGILAFIMSIVLIHDPKKSTTSGFQKLEPQLLTKINWKVFITPVILTLVLSFGLSAFETLYSLYTADKVNYSPKDISIAITGGGIFGALFQIYFFDKFMKYFSELTFIAWSLLYSVVVLILLVFANGYWSIMLISFVVFIGFDMIRPAITNYFSNIAGERQGFAGGLNSTFTSMGNFIGPLIAGALFDVHIEAPIYMAIGVSLAGVVIVLIEKQHRAKLKEQNM,100,gnl|BL_ORD_ID|2208|hsp_num:0,3367,FALSE,None
LK729,10_9 # 7507 # 8655 # -1 # ID=10_9;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.360,10_9,7507,8655,-,Strict,175,182.956,vanT gene in vanG cluster,33.88,3002972,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,glycopeptide resistance gene cluster; vanT,ATGTCGGATAAATATTATAGATCTGCGTATATGAATGTAGATTTAAACGCTGTTGCATCAAATTTCAAAGTATTCAGTACATTGCATCCAAATAAAACAGTGATGGCTGTCGTTAAAGCCAATGCCTATGGACTAGGTAGTGTTAAAGTAGCACGTCATTTAATGGAAAATGGCGCCACATTTTTTGCTGTAGCAACGTTAGATGAAGCGATAGAACTTAGAATGCATGGGATTACTGCTAAAATTTTAGTCTTAGGTGTGTTACCAGCTAAAGATATTGATAAAGCGATACAACACCGAGTTGCCTTAACGGTTCCGTCTAAACAGTGGTTGAAAGAAGCAATTAAAAACATTTCTGGTGAGCAAGAGAAAAAGTTATGGTTGCACATTAAATTAGATACAGGAATGGGACGTTTAGGTATTAAAGATACTAATACGTATCAAGAAGTGATTGAAATCATTCAACAATATGAGCAACTTGTATTTGAAGGCGTGTTTACACACTTTGCCTGTGCTGACGAACCAGGAGATATGACAACTGAACAATATCAACGTTTTAAAGATATGGTCAATGAAGCAATTAAACCTGAATATATACATTGTCAGAACTCAGCAGGCTCTCTATTAATGGATTGCCAATTCTGTAATGCAATAAGACCAGGAATTTCCCTTTATGGATATTATCCATCAGAGTATGTACAGCAAAAAGTTAAAGTACACCTTAAACCAAGTGTGCAATTAATTGCTAATGTAGTTCAAACAAAGACGCTACAAGCGGGTGAGTCTGTAAGTTATGGTGCAACTTATACAGCTACTGACCCAACTACAATAGCTTTGTTACCTATTGGATATGCAGATGGCTATTTACGCATAATGCAAGGTAGCTTTGTAAATGTAAATGGTCATCAATGCGAAGTTATTGGTCGCGTATGTATGGATCAGACAATTGTTAAAGTGCCAGATCAAGTTAAAGCTGGAGATTCGGTGATTTTAATAGATAATCATAGAGAAAGTCCACAGTCGGTAGAGGTGGTAGCTGAAAAGCAACATACTATTAATTATGAAGTGCTTTGTAACTTGTCGAGACGTTTGCCACGAATCTATCATGATGGTGATCAACGTTTTGTAACAAATGAATTGTTAAAATAA,MSDKYYRSAYMNVDLNAVASNFKVFSTLHPNKTVMAVVKANAYGLGSVKVARHLMENGATFFAVATLDEAIELRMHGITAKILVLGVLPAKDIDKAIQHRVALTVPSKQWLKEAIKNISGEQEKKLWLHIKLDTGMGRLGIKDTNTYQEVIEIIQQYEQLVFEGVFTHFACADEPGDMTTEQYQRFKDMVNEAIKPEYIHCQNSAGSLLMDCQFCNAIRPGISLYGYYPSEYVQQKVKVHLKPSVQLIANVVQTKTLQAGESVSYGATYTATDPTTIALLPIGYADGYLRIMQGSFVNVNGHQCEVIGRVCMDQTIVKVPDQVKAGDSVILIDNHRESPQSVEVVAEKQHTINYEVLCNLSRRLPRIYHDGDQRFVTNELLK,MTKNESYSGIDYFRFIAALLIVAIHTSPLSSFSETGNFIFTRIVARVAVPFFFMTSGFFLISRYTCNAEKLGAFIKKTTLIYGVAILLYIPINVYNGYFKMDNLLPNIIKDIVFDGTLYHLWYLPASIIGAAIAWYLVKKVHYRKAFLIASILYIIGLFGDSYYGIVKSVSCLNVFYNLIFQLTDYTRNGIFFAPIFFVLGGYISDSQNRLSLKRSIVGFIVCFALMFGEALTLHHFDIQKHDSMYVLLLPSVYCLFNLLLHFRGKRRTGLRTISLIIYIIHPFMIVVIRLFAKLLHLQSLLVENSLVHYIAVCFASVVLAVVITALLSSLKPKKAKHTADTDRAYLEINLNNLEHNVNTLQKAMSPKCELMAVVKAEAYGHGMYEVTTYLEQIGVSSFAVATIDEGIRLRKYGISSEILILGYTSPSRAKELCKYELTQTLIDYRYSLLLNKQGYDIKAHIKIDTGMHRLGFSTEDKDKILAAFSLKHIKVAGIFTHLCAADSLEENDVAFTNKQIGSFYKVLDWLKSSGLNIPKVHIQSSYGLLNYPELECDYIRVGVALYGVLSSTNDKTKLELDLRPVLSLKAKVVLIRKIKQGESVGYSRAFTATRDSLIAILPIGYADGFPRNLSCGNSYVLIGGRQAPIVGKICMDQLAVDVTDIPNVKTGSIATLIGKDGKEEITAPMVAESAESITNELLSRMGHRLNIIRRA,53.65,gnl|BL_ORD_ID|1522|hsp_num:0,1561,FALSE,None
LK729,10_17 # 16328 # 19057 # 1 # ID=10_17;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.316,10_17,16328,19057,+,Strict,1500,1795.79,kdpD,98.87,3004047,protein homolog model,n/a,n/a,aminoglycoside antibiotic,antibiotic efflux,kdpDE,GTGTATGCAGAAATAAATTTTATAGCATTTAATTGTGAAGAATATTATGATATTGCTATCGAGGTGAAGGTTATGTCAAACACTGAATCGCTAAACATAGGAAAAAAGCGTGGATTTTTAACAATTTACATCGGTTACAGTCCAGGTGTTGGTAAAACATTTGAGATGCTTTCAAATGCCATTGAACTATTTCAAAGTAACGTTGATATTAAAATAGGATATATTGAACCGCATCAGCGTGATGAAACAAATGCATTAGCTGAACAATTACCTAAAATCACAACCAATTTTACTAAACATGGTAGTCATCATTTTCAATATTTAGATGTCGACCGCATAATCGAAGAATCGCCGACAATAGTACTTATCGATGAGTTAGCACATACGAATATTTCTAGAGATCGTCATGAGAAACGATATATGGATATTGAAGAAATTTTAAATCATGGTATCGATGTTCATACCACTTTGAACATTCAACATATTGAAAGTTTAAGTAGTCAAATTGAACTGATGACCGGTGTACATGTTAAAGAACGTGTACCCGACTATTTCATAATGAGCGCCGATGTATTAGAAGTCGTAGATATCTCACCTGAACAATTAATTAAACGCTTAAAAGCTGGCAAGGTATATAAAAAGGATAGGCTAGATGTAGCATTTAGTAATTTCTTTACGTATGCCCACCTAAGCGAACTGCGTACATTGACGTTAAGAACAGTTGCCGACTTGATGAGTGATAAAGAAAAAGTCCGACACAATCATAAAACGTCACTCAAACCTCATATTGCTGTGGCAATTAGTGGGAGCATTTATAATGAAGCAGTAATTAAAGAGGCATTCCATATTGCTCAAAAAGAACATGCGAAATTCACTGCTATTTATATAGATGTATTCGAAAAAAACAGGCAATATAAAGATAGTCAAAAGCAAGTGCATCAACATCTCATGCTTGCAAAATCATTAGGAGCAAAAGTAAAAGTAGTTTATAGCCAAACCGTTGCATTAGGATTAGACGAATGGTGTAAAAATCAAGATGTAACCAAATTAATTATCGGACAACATATTAGAAATAAGTGGCGAGACTTTTTCAATACACCTTTAATTGACCATTTAATGTCCTTTGAACATAGCTATAAAGTCGAAATCGTTCCAATCAAACAAATACCTGTTGAATTGAAAATGAACAAATCACCCTATCGTCCTAAAGGCAAACGTTTCGCCATAGATATGTTAAAAATGATTTTGATTCAAATAATTTGTGTAATGATGGGACTGTGGATTTATCAACTTGATAAGCATGAGTCTAGTACGATTATTTTAATGATTTTTCTCATCGGCATCATTTTGTTATCCATTTGGACGCGATCCTTCATCATTGGCTTTTTAGCAGCAATTATTAACGTATTTGTTTTTAATTATTTTTTTACGGAACCTAGATATACATTTGAAGTATATCGCTTTGACTATCCTATTACATTTATCGTTAGCATTTTAACAAGTATTTTAACGAGTGCTTTATTAAAACAAATTAAATTCCAATACTCCATTACTAAAAAGCAACTTTATCGTACAGATTTATTATTTCAATTTAATGATTCGATTAAACAAACTTATACAGTTGAAAACTTACTAATAAATGCTGGATACCAAATTAATCAATTATTGCAACAATCAATTACTATATACGTTATCAATCAATCGAAAGTAATTAAAACAATACCATTGCAAAACCATATCGATAATACGACTCAACAGCATGAACAAGCATTAAGCTGGGTAATTAAAAATGAAAGACAAGCTGGTGCAACAACAGATACATTTCCAGGCATTAATAAATGGTTGATACCAATTGGCACATCTCCGATTAAAGGCATTCTATCCATTGATTACCAAAGTTCTCAAGTGATTAATCCATATGATGCATCAATATTAGAATCAATGTTAAATGAACTTTCTCTCGCCGTTGAAAATGTGACGTTACTTAAACAAACGAGAGAATCCATGTTACAGGCTGAACGTCAACTGACACATTCAAATTTTTTAAGATCAATTTCGCATGACATACGTACACCGTTAACAACAATTATGGGAAATTTAGATATTTTAGTATCACATAGTAAAGATATGTCTATCATAGAAAAGGAACAATTACTTGTGCATAGTTTTCAAGAAAGTCAGTATTTATATCTATTAGTGACAAATATTTTATCATTAACAAAATTACAGTCATCAAATGTTCAAATAAAATTGCAACCTTATCTTGTTAGTGAATTAGTAGAAGAAATCGATATGATTTTAGAACGTCGCCATTTAAAAAAGCGTATAACTGTATCATCCTCAGTAGATTTACAGTTTATACACATTGACAGTAAGTTGATTTTACAAGCTTTATTCAATTTGATTGAAAATGCAGTTAAACACACTTCTACTGACACCAAAATCAATTTATCTATTCGTTATGCTAGCGATGAACAAATCGAATTTGCCGTTATAGACGAAGGACCTGGAATTAGTTTAGAAGAACAACAAAAGATATTCGAGCCTTTTTACACAGGATCAAATAAATATTTTAAAGATAACCAAAAAGAAAGCATGGGACTAGGCTTATATTTAGTACAGACTATCCTACACAAACATCAATCAAACTTACAATATAAACCGAACCAACCACACGGCAGTATATTCTATTTCAATATAGATACAGACTTTAATGAAGGAGACATATAA,MYAEINFIAFNCEEYYDIAIEVKVMSNTESLNIGKKRGFLTIYIGYSPGVGKTFEMLSNAIELFQSNVDIKIGYIEPHQRDETNALAEQLPKITTNFTKHGSHHFQYLDVDRIIEESPTIVLIDELAHTNISRDRHEKRYMDIEEILNHGIDVHTTLNIQHIESLSSQIELMTGVHVKERVPDYFIMSADVLEVVDISPEQLIKRLKAGKVYKKDRLDVAFSNFFTYAHLSELRTLTLRTVADLMSDKEKVRHNHKTSLKPHIAVAISGSIYNEAVIKEAFHIAQKEHAKFTAIYIDVFEKNRQYKDSQKQVHQHLMLAKSLGAKVKVVYSQTVALGLDEWCKNQDVTKLIIGQHIRNKWRDFFNTPLIDHLMSFEHSYKVEIVPIKQIPVELKMNKSPYRPKGKRFAIDMLKMILIQIICVMMGLWIYQLDKHESSTIILMIFLIGIILLSIWTRSFIIGFLAAIINVFVFNYFFTEPRYTFEVYRFDYPITFIVSILTSILTSALLKQIKFQYSITKKQLYRTDLLFQFNDSIKQTYTVENLLINAGYQINQLLQQSITIYVINQSKVIKTIPLQNHIDNTTQQHEQALSWVIKNERQAGATTDTFPGINKWLIPIGTSPIKGILSIDYQSSQVINPYDASILESMLNELSLAVENVTLLKQTRESMLQAERQLTHSNFLRSISHDIRTPLTTIMGNLDILVSHSKDMSIIEKEQLLVHSFQESQYLYLLVTNILSLTKLQSSNVQIKLQPYLVSELVEEIDMILERRHLKKRITVSSSVDLQFIHIDSKLILQALFNLIENAVKHTSTDTKINLSIRYASDEQIEFAVIDEGPGISLEEQQKIFEPFYTGSNKYFKDNQKESMGLGLYLVQTILHKHQSNLQYKPNQPHGSIFYFNIDTDFNEGDI,MSNTESLNIGKKRGSLTIYIGYSPGVGKTFEMLSNAIELFQSNIDIKIGYIEPHQRDETNALAEQLPKIATNFTKHGSHHFQYLDVDRIIKESPTIVLIDELAHTNISRDRHEKRYMDIEEILNHGIDVHTTLNIQHIESLSSQIELMTGVHVKERVPDYFIMSADVLEVVDISPEQLIKRLKAGKVYKKDRLDVAFSNFFTYTHLSELRTLTLRTVADLMSDKEKVRHNHKTSLKPHIAVAISGSIYNEAVIKEAFHIAQKEHAKFTAIYIDVFEKNRQYKDSQKQVHQHLMLAKSLGAKVKVVYSQTVALGLDEWCKNQDVTKLIIGQHIRNKWRDFFNTPLIDHLMSFEHSYKIEIVPIKQIPVELKMNKSPYRPKGKRFAIDMLKMILIQIICVMMGLWIYQLDKHESSTIILMIFLIGIILLSIWTRSYIIGFLAAIINVFVFNYFFTEPRYTFEVYRFDYPITFIVSILTSILTSALLKQIKFQYSITKKQLYRTDLLFQFNDSIKQTYTVENLLINAGYQINQLLQQSITVYVINQSKVIKTIPLQNHIDNTTQQHEQALSWVIKNERQAGATTDTFPGINKWLIPIGTSPIKGILAIDYQSSQVINPYDASILESMLNELSLAVENVSLLKQTRESMLQAERQLTHSNFLRSISHDIRTPLTTIMGNLDILVSHSKDMSIIEKEQLLVHSFQESQYLYLLVTNILSLTKLQSSNVQIKLQPYLVSELVEEIDMILERRHLKKRITVSSSVDLQFIHIDSKLILQALFNLIENAVKHTSTDTKINLSIRYASDEQIEFAVIDEGPGISLEEQQKIFEPFYTGSNKYFKDNQKESMGLGLYLVQTILHKHQSNLQYKPNQPHGSIFYFNIDTDFNEGDI,102.71,gnl|BL_ORD_ID|4926|hsp_num:0,5918,FALSE,None
LK729,10_76 # 73843 # 75201 # -1 # ID=10_76;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.321,10_76,73843,75201,-,Strict,850,871.692,tet(38),99.78,3000565,protein homolog model,n/a,n/a,tetracycline antibiotic,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGATTATGAATGTTGAATATTCTAAAATAAAGAAAGCAGTACCTATTTTATTATTCTTATTTGTATTCAGTTTGGTTATAGACAACTCATTTAAATTGATTTCTGTAGCCATTGCTGATGACTTAAACATATCTGTAACGACAGTAAGTTGGCAAGCGACATTAGCCGGTTTAGTAATTGGTATTGGCGCTGTAGTATACGCTTCATTATCTGATGCCATTAGTATACGCACACTATTTATTTATGGCGTGATATTAATCATTATCGGATCAATTATTGGTTACATTTTCCAACATCAATTCCCATTACTTTTAGTTGGACGTATTATTCAAACTGCCGGTTTAGCTGCTGCAGAGACATTATATGTGATATATGTTGCAAAGTATCTTTCTAAAGAGGACCAGAAGACTTACCTTGGCTTAAGTACGAGCAGTTATTCCTTGTCATTAGTTATCGGTACATTATCAGGTGGATTTATTTCTACGTATTTACACTGGACAAATATGTTTTTAATTGCATTAATCGTAGTATTTACGTTGCCATTCCTATTTAAATTATTACCAAAAGAAAATAATACGAATAAAGCTCATTTAGATTTTGTTGGCTTAATTCTAGTGGCAACTATTGCTACAACAGTCATGCTGTTTATTACGAACTTTAATTGGTTATATATGATTGGTGCCTTAATTGCGATTATCGTTTTTGCGCTATATATTAAAAATGCGCAACGTCCATTAGTAAATAAATCATTTTTCCAAAATAAACGTTATGCTTCATTTTTATTTATAGTATTTGTAATGTATGCTATCCAATTGGGTTATATTTTTACGTTCCCATTCATAATGGAGCAAATTTATCATCTGCAACTAGACACAACATCACTGTTATTAGTACCGGGTTATATAGTAGCAGTCATCGTTGGTGCACTAAGTGGTAAAATCGGCGAATATCTGAATTCAAAACAAGCGATTATCACAGCAATTATTTTAATCGCACTGAGCTTGATTTTACCTGCATTTGCAGTAGGTAATCACATTTCAATCTTCGTTATTTCTATGATATTCTTTGCAGGTAGCTTTGCTTTAATGTATGCACCTTTACTTAACGAAGCCATTAAAACAATAGATCTTAATATGACAGGTGTGGCTATTGGTTTTTATAATTTAATTATTAATGTGGCGGTATCTGTAGGTATTGCGATTGCTGCGGCTCTAATCGATTTTAAAGCATTAAATTTCCCAGGCAATGATGCATTAAGTTCACATTTCGGTATTATTTTAATTATTTTAGGTTTAATGAGTATTGTCGGATTAGTTTTATTCGTCAGCTTAAATCGTTGGACACAATCTGAAAAATAA,MIMNVEYSKIKKAVPILLFLFVFSLVIDNSFKLISVAIADDLNISVTTVSWQATLAGLVIGIGAVVYASLSDAISIRTLFIYGVILIIIGSIIGYIFQHQFPLLLVGRIIQTAGLAAAETLYVIYVAKYLSKEDQKTYLGLSTSSYSLSLVIGTLSGGFISTYLHWTNMFLIALIVVFTLPFLFKLLPKENNTNKAHLDFVGLILVATIATTVMLFITNFNWLYMIGALIAIIVFALYIKNAQRPLVNKSFFQNKRYASFLFIVFVMYAIQLGYIFTFPFIMEQIYHLQLDTTSLLLVPGYIVAVIVGALSGKIGEYLNSKQAIITAIILIALSLILPAFAVGNHISIFVISMIFFAGSFALMYAPLLNEAIKTIDLNMTGVAIGFYNLIINVAVSVGIAIAAALIDFKALNFPGNDALSSHFGIILIILGLMSIVGLVLFVSLNRWTQSEK,MNVEYSKIKKAVPILLFLFVFSLVIDNSFKLISVAIADDLNISVTTVSWQATLAGLVIGIGAVVYASLSDAISIRTLFIYGVILIIIGSIIGYIFQHQFPLLLVGRIIQTAGLAAAETLYVIYVAKYLSKEDQKTYLGLSTSSYSLSLVIGTLSGGFISTYLHWTNMFLIALIVVFTLPFLFKLLPKENNTNKAHLDFVGLILVATIATTVMLFITNFNWLYMIGALIAIIVFALYIKNAQRPLVNKSFFQNKRYASFLFIVFVMYAIQLGYIFTFPFIMEQIYHLQLDTTSLLLVPGYIVAVIVGALSGKIGEYLNSKQAIITAIILIALSLILPAFAVGNHISIFVISMIFFAGSFALMYAPLLNEAIKTIDLNMTGVAIGFYNLIINVAVSVGIAIAAALIDFKALNFPGNDALSSHFGIILIILGLMSIVGLVLFVILNRWTQSEK,100.44,gnl|BL_ORD_ID|1791|hsp_num:0,1835,FALSE,None
LK729,11_52 # 52843 # 53262 # 1 # ID=11_52;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.336,11_52,52843,53262,+,Perfect,250,285.804,mepR,100,3000746,protein homolog model,n/a,n/a,glycylcycline; tetracycline antibiotic,antibiotic efflux,multidrug and toxic compound extrusion (MATE) transporter,ATGGAATTCACTTATTCGTATTTATTTAGAATGATTAGTCATGAGATGAAACAAAAGGCTGATCAAAAGTTAGAGCAATTTGATATTACAAATGAGCAAGGTCATACGTTAGGTTATCTTTATGCACATCAACAAGATGGACTGACACAAAATGATATTGCTAAAGCATTACAACGAACAGGTCCAACTGTCAGTAATTTATTAAGGAACCTTGAACGTAAAAAGCTGATCTATCGCTATGTCGATGCACAAGATACGAGAAGAAAGAATATAGGGCTGACTACCTCTGGGATTAAACTCGTAGAAGCATTCACTTCGATATTTGATGAAATGGAACAAACACTCGTATCGCAGTTATCTGAAGAAGAAAATGAACAAATGAAAGCAAACTTAACTAAAATGTTATCTAGTTTACAATAA,MEFTYSYLFRMISHEMKQKADQKLEQFDITNEQGHTLGYLYAHQQDGLTQNDIAKALQRTGPTVSNLLRNLERKKLIYRYVDAQDTRRKNIGLTTSGIKLVEAFTSIFDEMEQTLVSQLSEEENEQMKANLTKMLSSLQ,MEFTYSYLFRMISHEMKQKADQKLEQFDITNEQGHTLGYLYAHQQDGLTQNDIAKALQRTGPTVSNLLRNLERKKLIYRYVDAQDTRRKNIGLTTSGIKLVEAFTSIFDEMEQTLVSQLSEEENEQMKANLTKMLSSLQ,100,gnl|BL_ORD_ID|791|hsp_num:0,856,FALSE,None
LK729,11_53 # 53369 # 54724 # 1 # ID=11_53;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.331,11_53,53369,54724,+,Strict,850,876.315,mepA,98.89,3000026,protein homolog model,n/a,n/a,glycylcycline; tetracycline antibiotic,antibiotic efflux,multidrug and toxic compound extrusion (MATE) transporter,ATGAAAGACGAACAATTATATTATTTTGAGAAATCGCCAGTATTTAAAGCGATGATGCATTTCTCATTGCCAATGATGATAGGGACTTTATTAAGCGTTATTTATGGCATATTAAATATTTACTTTATAGGATTTTTAGAAGATAGCCACATGATTTCTGCTATCTCTCTAACACTGCCAGTATTTGCTATCTTAATGGGGTTAGGTAATTTATTTGGCGTTGGTGCAGGAACTTATATTTCACGTTTATTAGGTGCGAAAGACTATAGTAAGAGTAAATTTGTAAGTAGTTTCTCTATTTATGGTGGTATTGCACTAGGACTTATCGTGATTTTAGTTACTTTACCATTCAGTGATCAAATCGCAGCAATTTTAGGGGCGAGAGGTGAAACGTTAGCTTTAACAAGTAATTATTTGAAAGTAATGTTTTTAAGTGCACCTTTTGTAATTTTGTTCTTCATATTAGAACAATTTGCACGTGCAATTGGAGCACCAATGATTTCTATGATTGGTATGTTAGCTAGTGTAGGCTTAAATATTATTTTAGATCCAATTTTAATTTTTGGTTTTGATTTAAACGTTGTTGGTGCAGCTTTGGGTACTGCAATCAGTAATGTTGCTGCTGCTCTGTTCTTTATCGTTTATTTTATGAAAAATAGTGACGTTGTGTCAGTTAATATTAAACTTGCGAAACCTAATAAAGAAATGCTTTCTGAAATCTTTAAAATCGGTATTCCTGCATTTTTAATGAGTATCTTAATGGGATTCACAGGATTAGTTTTAAATTTATTTTTAGCACATTATGGAAACTTCGCGATTGCAAGTTATGGTATCTCATTTAGACTTGTGCAATTTCCAGAACTTATTATCATGGGATTATGTGAAGGTGTTGTACCACTAATTGCATATAACTTTATGGCAAATAAAGGTCGTATGAAAGACGTTATCAAAGCAGTTATCATGTCTATCGGTGTTATCTTTGTTGTATGTATGATTGCTGTATTTACAATTGGACATCATATGGTCGGACTATTTACTACTGATCAAGACATCGTTGAGATGGCGACATTTATTTTGAAAGTAACAATGACATCATTGTTATTAAATGGTATAGGTTTCTTGTTTACTGGTATGCTTCAAGCGACTGGGCAAGGTCGTGGTGCTACAATTATGGCCATTTTACAAGGTGCGATTATCATTCCTGTATTATTTATTATGAATGCTTTGTTCGGCCTCACAGGTGTCATATGGTCATTATTAATTGCTGAGTCACTTTGTGCTTTGGCAGCAATGTTAATCGTCTATTTATTACGTGATCGTTTGACAGTTGATACATCTGAATTAATAGAAGGTTAA,MKDEQLYYFEKSPVFKAMMHFSLPMMIGTLLSVIYGILNIYFIGFLEDSHMISAISLTLPVFAILMGLGNLFGVGAGTYISRLLGAKDYSKSKFVSSFSIYGGIALGLIVILVTLPFSDQIAAILGARGETLALTSNYLKVMFLSAPFVILFFILEQFARAIGAPMISMIGMLASVGLNIILDPILIFGFDLNVVGAALGTAISNVAAALFFIVYFMKNSDVVSVNIKLAKPNKEMLSEIFKIGIPAFLMSILMGFTGLVLNLFLAHYGNFAIASYGISFRLVQFPELIIMGLCEGVVPLIAYNFMANKGRMKDVIKAVIMSIGVIFVVCMIAVFTIGHHMVGLFTTDQDIVEMATFILKVTMTSLLLNGIGFLFTGMLQATGQGRGATIMAILQGAIIIPVLFIMNALFGLTGVIWSLLIAESLCALAAMLIVYLLRDRLTVDTSELIEG,MKDEQLYYFEKSPVFKAMMHFSLPMMIGTLLSVIYGILNIYFIGFLEDSHMISAISLTLPVFAILMGLGNLFGVGAGTYISRLLGAKDYSKSKFVSSFSIYGGIALGLIVILVTLPFSDQIAAILGARGETLALTSNYLKVMFLSAPFVILFFILEQFARAIGAPMVSMIGMLASVGLNIILDPILIFGFDLNVVGAALGTAISNVAAALFFIIYFMKNSDVVSVNIKLAKPNKEMLSEIFKIGIPAFLMSILMGFTGLVLNLFLAHYGNFAIASYGISFRLVQFPELIIMGLCEGVVPLIAYNFMANKGRMKDVIKAVIMSIGVIFVVCMSAVFTIGHHMVGLFTTDQAIVEMATFILKVTMASLLLNGIGFLFTGMLQATGQGRGATIMAILQGAIIIPVLFIMNALFGLTGVIWSLLIAESLCALAAMLIVYLLRDRLTVDTSELIEG,100,gnl|BL_ORD_ID|344|hsp_num:0,377,FALSE,None
LK729,17_30 # 30332 # 31675 # 1 # ID=17_30;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.306,17_30,30332,31675,+,Perfect,200,870.537,sdrM,100,3007013,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGCGATTAAAGTCAATCATAACTGTTATAGCTTTAATATTAATTATGTTTATGTCAGCGATTGAATCATCTATTATTTCGCTTGCATTACCTACAATTAAACAAGATTTAAATGCAGGAAATTTAATTTCATTAATTTTCACAGCGTATTTTATCGCATTAGTAATTGCCAATCCTATAGTGGGCGAATTACTTTCGAGATTTAAAATTATTTATGTGGCAATTGCAGGATTACTTTTATTTAGTATAGGTAGTTTTATGTGTGGTTTAAGTACTAATTTTACTATGCTAATTATATCACGCGTGATACAAGGTTTTGGATCAGGTGTATTGATGTCATTATCGCAAATTGTTCCAAAGTTAGCATTTGAAATTCCGTTACGATATAAAATTATGGGCATAGTTGGCAGTGTTTGGGGTATTTCGAGTATCATTGGACCGCTTCTAGGTGGTGGTATATTAGAATTTGCAACATGGCATTGGTTATTCTACATAAATATACCGATTGCGATCATTGCCATTATATTAGTTATATGGACATTTCATTTTCCAGAGGAAGAAACAGTTGCTAAATCAAAATTTGATACTAAAGGGCTCACGCTATTTTATGTATTTATTGGATTGATTATGTTTGCTTTATTAAACCAACAGCTATTACTTTTAAATTTCTTGAGTTTTATCTTAGCTATCGTTGTGGCAATGTGTTTATTTAAAGTAGAAAAACATGTTTCTTCACCATTTTTACCTGTGGTGGAATTTAATCGTTCAATTACTTTAGTTTTTATAACAGACCTTCTAACAGCTATTTGTTTAATGGGATTCAATTTATATATTCCAGTCTACCTTCAAGAACAACTAGGATTATCTCCATTGCAAAGTGGATTGGTTATTTTTCCTTTATCTGTAGCTTGGATTACATTGAATTTTAATTTACATCGAATTGAAGCAAAACTATCAAGGAAAGTTATTTACTTACTATCATTTACATTGCTACTAGTAAGTAGTATTATCATTTCATTTGGTATTAAATTGCCGGTACTTATAGCATTTGTGTTAATTTTGGCAGGATTAAGTTTTGGATATATTTATACGAAAGATAGTGTAATTGTCCAAGAGGAAACTAGCCCATTACAAATGAAGAAAATGATGTCATTTTATGGATTAACTAAAAATCTTGGGGCATCAATAGGTTCAACAATAATGGGATATCTTTATGCGATACAATCAGGAATCTTTGGTCCAAACTTACACAATGTGTTAAGTGCTGTTGCTGTAATTAGCATTGGGCTTATTGTTTTATGGGTCGTATTTTTTAAAGAACAGTCATCTCAATCAAAAGAATAG,MRLKSIITVIALILIMFMSAIESSIISLALPTIKQDLNAGNLISLIFTAYFIALVIANPIVGELLSRFKIIYVAIAGLLLFSIGSFMCGLSTNFTMLIISRVIQGFGSGVLMSLSQIVPKLAFEIPLRYKIMGIVGSVWGISSIIGPLLGGGILEFATWHWLFYINIPIAIIAIILVIWTFHFPEEETVAKSKFDTKGLTLFYVFIGLIMFALLNQQLLLLNFLSFILAIVVAMCLFKVEKHVSSPFLPVVEFNRSITLVFITDLLTAICLMGFNLYIPVYLQEQLGLSPLQSGLVIFPLSVAWITLNFNLHRIEAKLSRKVIYLLSFTLLLVSSIIISFGIKLPVLIAFVLILAGLSFGYIYTKDSVIVQEETSPLQMKKMMSFYGLTKNLGASIGSTIMGYLYAIQSGIFGPNLHNVLSAVAVISIGLIVLWVVFFKEQSSQSKE,MRLKSIITVIALILIMFMSAIESSIISLALPTIKQDLNAGNLISLIFTAYFIALVIANPIVGELLSRFKIIYVAIAGLLLFSIGSFMCGLSTNFTMLIISRVIQGFGSGVLMSLSQIVPKLAFEIPLRYKIMGIVGSVWGISSIIGPLLGGGILEFATWHWLFYINIPIAIIAIILVIWTFHFPEEETVAKSKFDTKGLTLFYVFIGLIMFALLNQQLLLLNFLSFILAIVVAMCLFKVEKHVSSPFLPVVEFNRSITLVFITDLLTAICLMGFNLYIPVYLQEQLGLSPLQSGLVIFPLSVAWITLNFNLHRIEAKLSRKVIYLLSFTLLLVSSIIISFGIKLPVLIAFVLILAGLSFGYIYTKDSVIVQEETSPLQMKKMMSFYGLTKNLGASIGSTIMGYLYAIQSGIFGPNLHNVLSAVAVISIGLIVLWVVFFKEQSSQSKE,100,gnl|BL_ORD_ID|4661|hsp_num:0,5729,FALSE,None
LK729,17_31 # 31774 # 32247 # 1 # ID=17_31;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=3-4bp;gc_cont=0.264,17_31,31774,32247,+,Strict,100,300.827,sepA,95.54,3007012,protein homolog model,n/a,n/a,disinfecting agents and antiseptics,antibiotic efflux,small multidrug resistance (SMR) antibiotic efflux pump,ATGATTGTGAATTATCTTAAACATAAGTTTTATAACTTGTTATCTACAATGATTGTTCTCTTTATTTTTGTACTTTCTGGTGCGATTTTTTTAACATTTCTAGGGTTTGGTTTATATGGATTAAGTAGAATACTTATTTATTTTAGGTTGGGTGACTTTACATATAATAGAAGTATGTACGATAACCTATTATATTATGGCAGTTATATAATCTTTGGGTACTTCATCATATTTGCAGTCGAGCATTTAATGGATTATTTTAGAAAAATGTTGCCTGAAAATGCATATTTTAGAGGCGCGACTTTTCATTTGATTTCTTACACAGTTGCAACAACGTTATTTTATTTCATCATTCATTTAAATTATATTTATATCAATATCGATTTTTGGGTCATCATGGTTATTATAGGGTTCTTATATGTTTGTAAGCTTCAATTTTACCCTGAAAGTAAAAATTTAAATAATAGAAAATAG,MIVNYLKHKFYNLLSTMIVLFIFVLSGAIFLTFLGFGLYGLSRILIYFRLGDFTYNRSMYDNLLYYGSYIIFGYFIIFAVEHLMDYFRKMLPENAYFRGATFHLISYTVATTLFYFIIHLNYIYINIDFWVIMVIIGFLYVCKLQFYPESKNLNNRK,MIVNFFKHKFYNLLTTMIVLFVFVLSGAIFLTFLGFGLYGLSRILIYFRLGDFTYNRNMYDNLLYYGSYIIFGYFIIFAVEHLMDYFRKMLPENAYFRGATFHLISYTVATTLFYFIIHLHYVYINIDFWVIMVIIGFLYVCKLQFYPESKNLNNRK,100,gnl|BL_ORD_ID|4660|hsp_num:0,5728,FALSE,None
LK729,17_32 # 32567 # 33670 # 1 # ID=17_32;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.332,17_32,32567,33670,+,Strict,800,697.967,Staphylococcus aureus LmrS,99.15,3004572,protein homolog model,n/a,n/a,macrolide antibiotic; aminoglycoside antibiotic; oxazolidinone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGATGGCTAAAGTTGAATTAACAACCCGGAGACGAAACTTCATAGTTGCTGTTATGTTGATTAGTGCGTTTGTAGCTATTTTAAATCAAACATTATTAAATACAGCGTTACCTAGTATAATGAGAGAATTAAATATTAATGAAAGTACATCGCAATGGCTAGTTACTGGGTTTATGCTTGTTAATGGCGTCATGATACCTCTGACGGCATATCTAATGGATAGAATTAAAACTAGACCTTTATACTTAGCGGCGATGGGGACATTTTTATTAGGTTCTATTGTTGCAGCCTTAGCTCCGAATTTTGGAGTTTTAATGTTAGCACGTGTAATTCAAGCGATGGGTGCAGGCGTACTTATGCCCTTAATGCAATTTACGTTATTTACATTGTTCAGTAAAGAACATCGAGGTTTTGCAATGGGACTAGCAGGTTTAGTAATTCAATTTGCACCAGCAATAGGCCCTACAGTTACAGGATTAATTATTGATCAAGCGAGTTGGCGAGTACCATTTATTATAATTGTAGGAATTGCTTTAGTTGCCTTTGTTTTCGGCTTAGTTTCAATCTCAAGTTACAATGAAGTGAAATATACGAAATTAGATAAGCGCTCAGTAATGTATTCAACTATTGGATTCGGGTTAATGCTATACGCATTTAGTAGTGCAGGAGATTTAGGATTTACAAGTCCAATAGTAATAGGTGCGTTGATAATAAGTATGGTTATTATCTATTTATTTATACGTAGACAATTTAATATTACTAATGCACTTTTAAATTTAAGGGTTTTTAAAAATAGAACATTTGCATTATGTACGATTAGTTCAATGATTATAATGATGTCAATGGTTGGACCTGCGCTGCTTATACCGCTATATGTTCAAAACAGTTTATCTTTATCTGCCTTGTTATCAGGACTTGTTATCATGCCTGGTGCAATAATAAATGGTATTATGTCAGTTTTTACAGGTAAATTTTATGATAAGTATGGTCCTAGACCATTGATTTATACTGGTTTTACAATTTTAACAATTACTACAATTATGTTGTGTTTCTTGCATACAAGACACATCTTATACGTATTTAATAGTCGTATATGCAATTAG,MMAKVELTTRRRNFIVAVMLISAFVAILNQTLLNTALPSIMRELNINESTSQWLVTGFMLVNGVMIPLTAYLMDRIKTRPLYLAAMGTFLLGSIVAALAPNFGVLMLARVIQAMGAGVLMPLMQFTLFTLFSKEHRGFAMGLAGLVIQFAPAIGPTVTGLIIDQASWRVPFIIIVGIALVAFVFGLVSISSYNEVKYTKLDKRSVMYSTIGFGLMLYAFSSAGDLGFTSPIVIGALIISMVIIYLFIRRQFNITNALLNLRVFKNRTFALCTISSMIIMMSMVGPALLIPLYVQNSLSLSALLSGLVIMPGAIINGIMSVFTGKFYDKYGPRPLIYTGFTILTITTIMLCFLHTRHILYVFNSRICN,MAKVELTTRRRNFIVAVMLISAFVAILNQTLLNTALPSIMRELNINESTSQWLVTGFMLVNGVMIPLTAYLMDRIKTRPLYLAAMGTFLLGSIVAALAPNFGVLMLARVIQAMGAGVLMPLMQFTLFTLFSKEHRGFAMGLAGLVIQFAPAIGPTVTGLIIDQASWRVPFIIIVGIAILAFVFGLVSISSYNEVKYTKLDKRSVMYSTIGFGLMLYAFSSAGDLGFTSPIVIGALILSMVIIYLFIRRQFNITNALLNLRVFKNRTFALCTISSMIIMMSMVGPALLIPLYVQNSLSLSALLSGLVIMPGAIINGIMSVFTGKFYDKYGPRPLIYTGFTILTITTIMLCFLHTDTSYTYLIVVYAIRMFSVSLLMMPINTTGINSLRNEEISHGTAIMNFGRVMAGSLGTALMVTLMSFGAKIFLSTSPSHLTATEIKQQSIAIGVDISFAFVAVLVMAAYVIALFIREPKEIESNRRKF,76.46,gnl|BL_ORD_ID|2871|hsp_num:0,3276,TRUE,loose hit with at least 95 percent identity pushed strict
LK729,17_33 # 33693 # 34013 # 1 # ID=17_33;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.346,17_33,33693,34013,+,Strict,800,215.312,Staphylococcus aureus LmrS,100,3004572,protein homolog model,n/a,n/a,macrolide antibiotic; aminoglycoside antibiotic; oxazolidinone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGATGCCGATAAATACTACAGGAATTAATTCTTTGAGAAATGAAGAAATCTCACATGGCACGGCTATTATGAACTTTGGTCGTGTAATGGCTGGTTCACTAGGCACAGCTTTAATGGTTACATTAATGAGTTTTGGTGCAAAAATATTTTTATCTACATCGCCATCGCATTTAACTGCAACTGAAATTAAACAGCAATCCATTGCTATAGGGGTGGATATCTCATTTGCTTTTGTAGCTGTGCTTGTTATGGCAGCTTATGTGATAGCACTTTTTATAAGAGAACCTAAAGAAATAGAAAGTAATAGAAGGAAATTTTAA,MMPINTTGINSLRNEEISHGTAIMNFGRVMAGSLGTALMVTLMSFGAKIFLSTSPSHLTATEIKQQSIAIGVDISFAFVAVLVMAAYVIALFIREPKEIESNRRKF,MAKVELTTRRRNFIVAVMLISAFVAILNQTLLNTALPSIMRELNINESTSQWLVTGFMLVNGVMIPLTAYLMDRIKTRPLYLAAMGTFLLGSIVAALAPNFGVLMLARVIQAMGAGVLMPLMQFTLFTLFSKEHRGFAMGLAGLVIQFAPAIGPTVTGLIIDQASWRVPFIIIVGIAILAFVFGLVSISSYNEVKYTKLDKRSVMYSTIGFGLMLYAFSSAGDLGFTSPIVIGALILSMVIIYLFIRRQFNITNALLNLRVFKNRTFALCTISSMIIMMSMVGPALLIPLYVQNSLSLSALLSGLVIMPGAIINGIMSVFTGKFYDKYGPRPLIYTGFTILTITTIMLCFLHTDTSYTYLIVVYAIRMFSVSLLMMPINTTGINSLRNEEISHGTAIMNFGRVMAGSLGTALMVTLMSFGAKIFLSTSPSHLTATEIKQQSIAIGVDISFAFVAVLVMAAYVIALFIREPKEIESNRRKF,22.08,gnl|BL_ORD_ID|2871|hsp_num:0,3276,TRUE,loose hit with at least 95 percent identity pushed strict
LK729,21_4 # 3740 # 5260 # 1 # ID=21_4;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.325,21_4,3740,5260,+,Strict,525,643.654,norC,70.55,3007010,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGGATGGACTACTAATAAATTTAAAGTTTTACACATTAAAATCAAAACCATTCAATTATTCTAACGAACAGACAAATTTCTGTTATGGAATTTGTCTGTTTTTCAAAAGTATAGGGAGGCAAATAGAGATGGAAAAGCCGTCAAGAGAGGCATTTGAAGGCAATAATAAGTTGTTAATAGGAATTGTTTTAAGTGTAATAACGTTTTGGCTATTTGCACAATCATTGGTTAATGTTGTACCAATACTTGAAGATAGTTTCAATACAGATATTGGAACGGTTAATATCGCCGTTAGTATAACTGCTTTATTTTCAGGAATGTTTGTAGTAGGAGCAGGTGGTCTTGCTGATAAATATGGCAGAATTAAACTCACGAACATTGGTATTATCTTAAATATATTGGGTTCATTATTAATCATTATTTCAAATATTCCTTTATTACTTATTATAGGAAGATTAATTCAAGGACTTTCAGCAGCATGTATTATGCCTGCAACTTTGTCTATTATTAAGTCATATTACATTGGGAAAGATAGACAACGCGCTTTAAGTTATTGGTCAATTGGCTCATGGGGCGGCTCTGGTGTTTGTTCATTTTTTGGAGGTGCAGTTGCAACGCTTTTAGGTTGGCGTTGGATTTTCATCCTATCAATTATAATTTCATTAATTGCACTGTTTCTTATTAAAGGCACACCTGAAACTAAATCTAAATCGATTTCTCTAAATAAATTTGACATTAAAGGTCTGGTTCTTTTAGTCATTATGCTCCTCAGTTTAAATATTTTAATTACTAAAGGATCAGAATTAGGTGTAACCTCACTTCTTTTTATTACTTTATTAGCTATTGCAATTGGATCTTTTAGTTTATTTATAGTTCTTGAAAAGCGTGCTACAAATCCTTTAATCGATTTTAAATTATTTAAAAATAAAGCTTACACAGGTGCAACAGCTTCAAACTTTTTGTTAAATGGTGTTGCAGGAACATTAATAGTAGCCAACACATTTGTTCAAAGAGGTTTAGGATATTCTTCATTGCAAGCAGGAAGTTTATCAATCACTTATTTAGTAATGGTACTAATTATGATTCGTGTTGGTGAAAAGTTACTTCAAACACTCGGATGCAAGAAACCAATGTTAATTGGAACAGGAGTTCTTATTGTCGGAGAATGTCTCATTTCATTAACTTTCTTGCCAGAAATATTGTATGTCATTTGTTGTATTATAGGTTATTTATTCTTTGGTTTAGGACTAGGGATATATGCTACACCATCAACAGATACAGCAATTGCAAATGCACCGTTAGAAAAAGTAGGCGTTGCTGCAGGTATCTATAAAATGGCTTCTGCATTAGGTGGAGCATTTGGCGTCGCATTGAGTGGTGCAGTTTATGCAATCGTATCAAATATGACAAACATTTATACTGGTGCAATGATTGCATTATGGTTAAACGCAGGTATGGGAATATTATCATTCGTTATCATTTTGTTACTTGTGCCTAAACAAAACGACACTCAATTATGA,MDGLLINLKFYTLKSKPFNYSNEQTNFCYGICLFFKSIGRQIEMEKPSREAFEGNNKLLIGIVLSVITFWLFAQSLVNVVPILEDSFNTDIGTVNIAVSITALFSGMFVVGAGGLADKYGRIKLTNIGIILNILGSLLIIISNIPLLLIIGRLIQGLSAACIMPATLSIIKSYYIGKDRQRALSYWSIGSWGGSGVCSFFGGAVATLLGWRWIFILSIIISLIALFLIKGTPETKSKSISLNKFDIKGLVLLVIMLLSLNILITKGSELGVTSLLFITLLAIAIGSFSLFIVLEKRATNPLIDFKLFKNKAYTGATASNFLLNGVAGTLIVANTFVQRGLGYSSLQAGSLSITYLVMVLIMIRVGEKLLQTLGCKKPMLIGTGVLIVGECLISLTFLPEILYVICCIIGYLFFGLGLGIYATPSTDTAIANAPLEKVGVAAGIYKMASALGGAFGVALSGAVYAIVSNMTNIYTGAMIALWLNAGMGILSFVIILLLVPKQNDTQL,MNETYRGGNKLILGIVLGVITFWLFAQSLVNVVPNLQQSFGADMGTISIAVSLTALFSGMFVVGAGGLADKIGRVKMTNIGLLLSIIGSALIIITNLPALLILGRIIQGVSAACIMPSTLAIMKTYYEGAERQRALSYWSIGSWGGSGICSLFGGAVATTMGWRWIFIFSIIVAVLSMLLIKGTPETKSEVTNTHKFDVAGLIVLVVMLLSLNVVITKGAALGYTSLWFFGLIAIVIVAFFIFLNVEKKVDNPLIDFKLFENKPYTGATISNFLLNGVAGTLIVANTFVQQGLGYTALQAGYLSITYLIMVLLMIRVGEKLLQKMGSKRPMLLGTFIVIIGIALISLVFLPGIFYVISCVVGYLCFGLGLGIYATPSTDTAISNAPLDKVGVASGIYKMASSLGGAFGVAISGAVYAGAVAATSIHTGAMIALWVNVLMGIMAFIAILFAIPNDDKRVKDAK,109.52,gnl|BL_ORD_ID|4656|hsp_num:0,5726,FALSE,None
LK729,26_4 # 3361 # 4020 # 1 # ID=26_4;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.326,26_4,3361,4020,+,Perfect,410,442.58,arlR,100,3000838,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGACGCAAATTTTAATAGTAGAAGATGAACAAAACTTAGCAAGATTTCTTGAATTGGAACTCACACATGAAAATTACAATGTGGACACAGAGTATGATGGACAAGACGGTTTAGATAAAGCGCTTAGCCATTACTATGATTTAATCATATTAGATTTAATGTTGCCGTCAATTAATGGCTTAGAAATTTGTCGCAAAATTAGACAACAACAATCTACACCTATCATTATAATTACAGCGAAAAGTGATACGTATGACAAAGTTGCTGGGCTTGATTACGGTGCAGACGATTATATAGTTAAGCCATTTGATATTGAAGAACTTTTAGCAAGAATACGTGCGATTTTACGTCGTCAGCCACAAAAAGATATTATCGATGTCAATGGTATTACAATTGATAAGAATGCTTTTAAAGTGACGGTAAATGGCGCAGAAATTGAATTAACAAAAACAGAGTATGATTTACTATATCTTCTTGCTGAAAATAAAAACCATGTTATGCAACGGGAACAAATTTTAAATCATGTATGGGGTTATAATAGTGAAGTAGAAACAAATGTCGTAGATGTTTATATAAGATATTTACGAAACAAATTAAAACCATACGATCGTGACAAAATGATTGAAACAGTTCGTGGCGTTGGGTATGTGATACGATGA,MTQILIVEDEQNLARFLELELTHENYNVDTEYDGQDGLDKALSHYYDLIILDLMLPSINGLEICRKIRQQQSTPIIIITAKSDTYDKVAGLDYGADDYIVKPFDIEELLARIRAILRRQPQKDIIDVNGITIDKNAFKVTVNGAEIELTKTEYDLLYLLAENKNHVMQREQILNHVWGYNSEVETNVVDVYIRYLRNKLKPYDRDKMIETVRGVGYVIR,MTQILIVEDEQNLARFLELELTHENYNVDTEYDGQDGLDKALSHYYDLIILDLMLPSINGLEICRKIRQQQSTPIIIITAKSDTYDKVAGLDYGADDYIVKPFDIEELLARIRAILRRQPQKDIIDVNGITIDKNAFKVTVNGAEIELTKTEYDLLYLLAENKNHVMQREQILNHVWGYNSEVETNVVDVYIRYLRNKLKPYDRDKMIETVRGVGYVIR,100,gnl|BL_ORD_ID|1274|hsp_num:0,1390,FALSE,None
LK729,26_5 # 4017 # 5372 # 1 # ID=26_5;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.291,26_5,4017,5372,+,Perfect,880,911.753,arlS,100,3000839,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGACAAAACGTAAATTGCGCAATAACTGGATTATTGTTACCACGATGATTACGTTTGTCACGATATTTTTGTTTTGTTTAATTATTATTTTTTTCTTGAAAGATACACTGCATAATAGTGAGCTTGATGATGCAGAACGAAGCTCAAGCGATATTAATAATTTATTTCATTCTAAGCCTGTTAAAGATATATCTGCATTAGACTTGAATGCATCTTTAGGTAATTTTCAAGAGATAATTATTTATGATGAGCATAATAATAAATTATTTGAGACATCGAATGATAACACAGTGAGAGTTGAACCAGGTTATGAACACCGTTATTTTGACCGCGTAATAAAAAAACGCTATAAAGGCATTGAATATTTAATTATTAAAGAACCAATTACAACGCAAGATTTCAAAGGGTATAGCTTGTTAATTCATTCACTAGAAAATTATGATAACATCGTAAAATCATTGTATATCATTGCGCTGGCATTTGGAGTGATTGCAACAATTATAACTGCCACAATCAGTTATGTATTTTCAACACAAATTACTAAACCGCTTGTCAGTTTATCAAATAAAATGATTGAGATTCGACGAGATGGTTTTCAAAATAAATTGCAATTAAATACAAATTATGAAGAAATAGATAATTTAGCAAATACGTTTAATGAGATGATGAGCCAAATTGAAGAATCATTTAATCAACAAAGACAATTTGTTGAAGATGCGTCACATGAATTACGAACACCATTACAAATTATTCAAGGTCATTTAAATTTGATTCAGCGATGGGGAAAAAAAGACCCAGCAGTATTAGAAGAATCGTTAAATATTTCTATTGAAGAAATGAATCGTATCATAAAATTAGTCGAAGAATTACTTGAATTGACTAAAGGAGATGTAAATGACATTTCTTCTGAAGCACAGACCGTGCATATTAATGATGAAATTCGTTCGCGAATACACTCATTAAAACAATTGCATCCTGATTATCAATTTGATACGGATCTGACATCTAAAAATCTAGAAATTAAAATGAAACCTCATCAATTCGAACAATTATTTTTAATCTTTATTGATAATGCAATCAAATATGATGTGAAGAATAAGAAAATTAAAGTTAAGACAAGGTTAAAAAATAAGCAAAAAATAATTGAAATTACAGATCATGGAATTGGTATTCCAGAGGAAGATCAAGATTTCATTTTTGATCGCTTTTATCGAGTGGATAAATCTCGTTCAAGAAGTCAAGGCGGTAATGGACTCGGATTATCTATTGCTCAAAAAATCATTCAATTAAACGGTGGATCGATTAAAATTAAAAGTGAAATTAACAAAGGAACAACGTTTAAAATCATATTTTAA,MTKRKLRNNWIIVTTMITFVTIFLFCLIIIFFLKDTLHNSELDDAERSSSDINNLFHSKPVKDISALDLNASLGNFQEIIIYDEHNNKLFETSNDNTVRVEPGYEHRYFDRVIKKRYKGIEYLIIKEPITTQDFKGYSLLIHSLENYDNIVKSLYIIALAFGVIATIITATISYVFSTQITKPLVSLSNKMIEIRRDGFQNKLQLNTNYEEIDNLANTFNEMMSQIEESFNQQRQFVEDASHELRTPLQIIQGHLNLIQRWGKKDPAVLEESLNISIEEMNRIIKLVEELLELTKGDVNDISSEAQTVHINDEIRSRIHSLKQLHPDYQFDTDLTSKNLEIKMKPHQFEQLFLIFIDNAIKYDVKNKKIKVKTRLKNKQKIIEITDHGIGIPEEDQDFIFDRFYRVDKSRSRSQGGNGLGLSIAQKIIQLNGGSIKIKSEINKGTTFKIIF,MTKRKLRNNWIIVTTMITFVTIFLFCLIIIFFLKDTLHNSELDDAERSSSDINNLFHSKPVKDISALDLNASLGNFQEIIIYDEHNNKLFETSNDNTVRVEPGYEHRYFDRVIKKRYKGIEYLIIKEPITTQDFKGYSLLIHSLENYDNIVKSLYIIALAFGVIATIITATISYVFSTQITKPLVSLSNKMIEIRRDGFQNKLQLNTNYEEIDNLANTFNEMMSQIEESFNQQRQFVEDASHELRTPLQIIQGHLNLIQRWGKKDPAVLEESLNISIEEMNRIIKLVEELLELTKGDVNDISSEAQTVHINDEIRSRIHSLKQLHPDYQFDTDLTSKNLEIKMKPHQFEQLFLIFIDNAIKYDVKNKKIKVKTRLKNKQKIIEITDHGIGIPEEDQDFIFDRFYRVDKSRSRSQGGNGLGLSIAQKIIQLNGGSIKIKSEINKGTTFKIIF,100,gnl|BL_ORD_ID|165|hsp_num:0,182,FALSE,None
LK729,52_2 # 829 # 2217 # -1 # ID=52_2;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.373,52_2,829,2217,-,Strict,525,900.582,norC,99.13,3007010,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGAATGAAACGTATCGCGGGGGCAACAAGTTAACCTTAGGTATTGTATTAGGTGTTATTACATTTTGGTTGTTTGCACAATCACTTGTAAATGTTGTACCAAATTTACAACAAAGTTTTGGCACAGACATGGGGACAATTAGTATAGCGGTCAGTCTAACTGCACTATTTTCAGGTATGTTTGTCGTTGGAGCAGGTGGTCTAGCAGATAAAATTGGGCGCGTGAAAATGACGAATATCGGTTTATTGTTAAGTATTATTGGTTCAGCATTAATTATTATTACGAATTTACCGGCATTATTAATTTTAGGTCGTATTATACAAGGCGTATCAGCAGCGTGTATTATGCCTTCCACATTGGCCATTATGAAAACTTATTATGAGGGTGCTGAACGTCAGCGCGCCTTAAGCTACTGGTCTATCGGTTCTTGGGGTGGCAGTGGTATCTGTTCACTCTTCGGTGGTGCAGTTGCGACAACTATGGGTTGGAGATGGATTTTCATCTTCTCAATTATCGTTGCCGTACTTTCAATGTTACTCATCAAAGGGACGCCTGAAACGAAATCAGAAGTTACCAATACACATAAATTTGACGTTGCAGGGCTAATTGTTCTAGTAGTTATGTTGCTAAGTTTAAACGTTGTCATTACTAAAGGTGCAGCACTTGGTTACACATCATTATGGTTCTTTGGTTTAATTGCAATCGTAATTGTAGCATTCTTTATTTTCTTAAAAGTTGAGAAAAAAGTAGATAATCCGCTTATTGATTTTAAATTATTTGAAAATAAACCATATACAGGTGCAACGATTTCGAACTTCTTATTAAACGGTGTTGCAGGTACATTAATTGTAGCGAATACATTCGTGCAACAAGGTTTAGGTTATACAGCATTGCAGGCAGGATACTTATCAATTACTTATTTAATCATGGTGTTATTGATGATTCGAGTTGGTGAAAAATTATTACAAAAAATGGGTTCTAAGCGACCAATGTTATTAGGTACATTCATTGTGGTCATTGGTATTGCACTTATTTCATTAGTATTCTTACCAGGCATATTTTATGTTATCAGTTGTGTCGTAGGATATTTATGTTTCGGACTAGGCTTAGGTATTTATGCAACACCTTCTACAGATACAGCTATTTCGAATGCACCGTTAGATAAAGTTGGCGTTGCTTCAGGTATTTATAAAATGGCTTCATCACTTGGTGGCGCATTCGGTGTCGCAATTAGTGGTGCTGTATATGCTGGTGCAGTTGCTGCAACGAGCATTCATACAGGTGCGATGATTGCACTTTGGGTTAACGTATTAATGGGAATCATGGCATTTATCGCAATTTTATTCGCGATTCCTAATGATGATAAACGTGTCAAAGATGCGAAATAA,MNETYRGGNKLTLGIVLGVITFWLFAQSLVNVVPNLQQSFGTDMGTISIAVSLTALFSGMFVVGAGGLADKIGRVKMTNIGLLLSIIGSALIIITNLPALLILGRIIQGVSAACIMPSTLAIMKTYYEGAERQRALSYWSIGSWGGSGICSLFGGAVATTMGWRWIFIFSIIVAVLSMLLIKGTPETKSEVTNTHKFDVAGLIVLVVMLLSLNVVITKGAALGYTSLWFFGLIAIVIVAFFIFLKVEKKVDNPLIDFKLFENKPYTGATISNFLLNGVAGTLIVANTFVQQGLGYTALQAGYLSITYLIMVLLMIRVGEKLLQKMGSKRPMLLGTFIVVIGIALISLVFLPGIFYVISCVVGYLCFGLGLGIYATPSTDTAISNAPLDKVGVASGIYKMASSLGGAFGVAISGAVYAGAVAATSIHTGAMIALWVNVLMGIMAFIAILFAIPNDDKRVKDAK,MNETYRGGNKLILGIVLGVITFWLFAQSLVNVVPNLQQSFGADMGTISIAVSLTALFSGMFVVGAGGLADKIGRVKMTNIGLLLSIIGSALIIITNLPALLILGRIIQGVSAACIMPSTLAIMKTYYEGAERQRALSYWSIGSWGGSGICSLFGGAVATTMGWRWIFIFSIIVAVLSMLLIKGTPETKSEVTNTHKFDVAGLIVLVVMLLSLNVVITKGAALGYTSLWFFGLIAIVIVAFFIFLNVEKKVDNPLIDFKLFENKPYTGATISNFLLNGVAGTLIVANTFVQQGLGYTALQAGYLSITYLIMVLLMIRVGEKLLQKMGSKRPMLLGTFIVIIGIALISLVFLPGIFYVISCVVGYLCFGLGLGIYATPSTDTAISNAPLDKVGVASGIYKMASSLGGAFGVAISGAVYAGAVAATSIHTGAMIALWVNVLMGIMAFIAILFAIPNDDKRVKDAK,100,gnl|BL_ORD_ID|4656|hsp_num:0,5726,FALSE,None
LK1246,34_2 # 638 # 1390 # -1 # ID=34_2;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.707,34_2,638,1390,-,Strict,50,85.8853,vanY gene in vanG cluster,30.92,3002959,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGACCACCCCCCTCCCCCGCCGCCTGGCCGCCTCCGTCACCCTGCTGGGCCTTCTGGGCCTCTCGGCATGCGGATCCGAGCAGCCGCAGGAGGACTCCAGCAGCTCCGCCGCCGCGGACTCCGCCCAGAGCGGCGGCGCGGAGGCAGAGGCTGAATCCGGTGCGGCCGCCGTGTCCGACGCCGACGTCGACACCTCCACCTCGACCGATGTGGTCGTCAACAAGGCGCGCCCGCTGGATCCGGAGGACTACGCCCCGGAGCCGCTCGAGGACATCGAGGGCCAGCAGCTGCGCGAGGACGCAGCCGGAGCCGCCCAGCAGATGCTCTCGGACATGCGAGACGAGGGCATCACCGTGAGCATCACCTCGGCCTACCGCCCCTACGACGAGCAGGTCACCACCTATCAGCACTGGGTCGACGTCAACGGCCAGGAGACCGCCGACACCATCTCGGCCCGCCCCGGGCACTCGGAGCACCAGACGGGTCTGGTCATGGACATCGCCGACGGCTCCGGCTGCGACCTGCAGGAGTGCTTCGCCGACACGGCAGCGGCCCAGTGGGCCGCCGAGCACGCGCAGGACTACGGATTCGTGCTGCGCTACCCCCAGGACGGCGAGGACGTCACGGGCTACGCCTACGAGCCCTGGCACTTCCGCTACATCGGCGAGGAGCGCGCCCAGGAGTTCGCCGACTCCGGAGCTGCCACGCTCGAGGAGTTCTACGGAACGGGCCCCGCACCGGACTACTCCTGA,MTTPLPRRLAASVTLLGLLGLSACGSEQPQEDSSSSAAADSAQSGGAEAEAESGAAAVSDADVDTSTSTDVVVNKARPLDPEDYAPEPLEDIEGQQLREDAAGAAQQMLSDMRDEGITVSITSAYRPYDEQVTTYQHWVDVNGQETADTISARPGHSEHQTGLVMDIADGSGCDLQECFADTAAAQWAAEHAQDYGFVLRYPQDGEDVTGYAYEPWHFRYIGEERAQEFADSGAATLEEFYGTGPAPDYS,MNHMNMKHRRRKRRRNQSFLFTGILLLVVVSASSFLWYGFGNAAKKDSVIEEMPFTITQDGMQAKEEIKKTVLETSYGGKQQVAEENHGNTQNAGTDEAWNLMLVNRDNAIPDNYEVNLVEVEGGERVDERIYEPLMEMLNAAREENWGELPMVVSGYRTQEKQQSLYDEKIAKFKKEGYSDSEAVRQAEQWVAVPGHSEHQLGFAVDINGATYDVYLWLQENSYKYGFIFRYPGSKTDITGTAEEVWHYRYVGVEAATEMYENGLCLEEYLEKKQSEN,89.61,gnl|BL_ORD_ID|4732|hsp_num:0,298,FALSE,None
LK1246,78_12 # 13891 # 14127 # 1 # ID=78_12;partial=01;start_type=ATG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.688,78_12,13891,14127,+,Strict,1900,22.3274,MuxC,100,3004075,protein homolog model,n/a,n/a,macrolide antibiotic; monobactam; tetracycline antibiotic; aminocoumarin antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGGCACATAAGAAGGGCGCAAGCTCCACCCGCAACGGCCGCGACTCCAACGCCCAGTACCTGGGCGTCAAGCGCTTCGGCGGCGAGTCCGTCAACGCCGGCTCGATCATCGTGCGTCAGCGCGGCACCCACTTCCACCCCGGTGAGAACGTGGGCCGCGGCAAGGACGACACCCTGTTCGCCCTGGCCACCGGCCAGGTGGCCTTCGGGACCAAGCGCGGCCGCAAGGTCGTCAAC,MAHKKGASSTRNGRDSNAQYLGVKRFGGESVNAGSIIVRQRGTHFHPGENVGRGKDDTLFALATGQVAFGTKRGRKVVN,MSLSTPFIRRPVATTLLTLALLLAGTLSFGLLPVAPLPNVDFPAIVVSASLPGASPETMASSVATPLERSLGRIAGISEMTSSSSLGSTTVVLVFDLEKDIDGAAREVQAAINGAMSLLPSGMPNNPSYRKANPSDMPIMVLTLTSETQSRGEMYDLASTVLAPKLSQVQGVGQVSIGGSSLPAVRVDLNPDAMSQYGLSLDSVRTAIAAANSNGPKGAVEKDDKHWQVDANDQLRKAREYEPLVIHYNADNGAAVRLGDVAKVSDSVEDVRNAGFSDDLPAVLLIVTRQPGANIIEATDAIHAQLPVLQELLGPQVKLNVMDDRSPSIRASLEEAELTLLISVALVILVVFLFLRNGRATLIPSLAVPVSLIGTFAVMYLCDFSLNNLSLMALIIATGFVVDDAIVVVENIARRIEEGDPPIQAAITGARQVGFTVLSMTLSLVAVFIPLLLMGGLTGRLFREFAVTLSAAILVSLVVSLTLTPMLCARLLRPLKRPEGASLARRSDRFFAAFMLRYRASLGWALEHSRLMVVIMLACIAMNLWLFVVVPKGFLPQQDSGRLRGYAVADQSISFQSLSAKMGEYRKILSSDPAVENVVGFIGGGRWQSSNTGSFFVTLKPIGERDPVEKVLTRLRERIAKVPGAALYLNAGQDVRLGGRDSNAQYEFTLRSDDLTLLREWAPKVEAAMRKLPQLVDVNSDSQDKGVQTRLVIDRDRAATLGINVEMVDAVLNDSFGQRQVSTIFNPLNQYRVVMEVDQQYQQSPEILRQVQVIGNDGQRVPLSAFSHYEPSRAPLEVNHQGQFAATTLSFNLAPGAQIGPTREAIMQALEPLHIPVDVQTSFEGNAGAVQDTQNQMPWLILLALLAVYIVLGILYESYVHPLTILSTLPSAGVGALLALILCRSELSLIALIGIILLIGIVKKNAIMMIDFALEAERNHGLSPREAILEACMMRFRPIMMTTLAALLGALPLIFGIGGDAALRRPLGITIVGGLIGSQLLTLYTTPVVYLYLDRLRHWVNQKRGVRTDGALETPL,7.63,gnl|BL_ORD_ID|2369|hsp_num:0,2720,TRUE,loose hit with at least 95 percent identity pushed strict
LK1246,105_9 # 7845 # 8717 # 1 # ID=105_9;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.685,105_9,7845,8717,+,Strict,50,129.028,vanW gene in vanG cluster,31.62,3002965,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanW; glycopeptide resistance gene cluster,ATGGCACGCCGTCTCTTCTCCGAGCTCTCGCCGACGACCTATCAGATCGCCCTCGCCCGCCGCCGGATGCAGCGCAGGATCGCCGACGGCCTCCGGCGCAGCAGCTTCGCGCGGCAGGCGTCGCAGGAGTCGCTGCCGGTCAAGGTCTACACCCACAACTCGCTGATCCGCCGCCGTCTGGGCAATGCGCAGCCCGAGCTGCAGGAGGGGAAGGCCGTCTCGCTCGGTCTGGCCGCCCCGCACGTGGACGGGATCCTGATCCGCCCCGGAGAGACGTTCTCCTTCTGGCGGCTGGTGGGCGAGCCCAGCTCCCGGCGAGGGTTCCAGCCCGGCGTGGTGATCTTCGACGACCGCGCGGAGACCGGGGTGGGAGGCGGGCTGTGCCAGTTCACCAACCTCCTGCACTGGATGGCGCTTCATTCGCCGCTGAGCATCGTGGAGCACCACCACCACTCCGGCCTGGATCTCTTCCCCGACTTCAAGCGACAGATCCCGTTCGGCACCGGCACCTCCATCGTGTGGAACTTCCTGGACTACCGCCTGCGCAACGACACCGGCATCACCTTCCAGTTCCGGGTCCGCACGGATGACGAGCACCTGCGCGGCGAGCTGCGCGCCGATGCTCCCCTGGACCAGAAGTTCCATGTCCGCGAGGAGGACGGGTGGTTCTACGAGGCGCTGGACCCGCAGACCGGGAAGCTGCAGGTGCGCCGGCACAACATCGTCAGCCGGAGCACCAGGGACAAGCGCACGGGCAACATCGTGGCGAGCGAGACGCTGCTCGAGAACGACGCCCTGGTGGTCTACGACCGCGACCGGATCACCGAGCCCATCCGCCCGCTGTCGGAATCCGAGTCCGCCCAGCGCCGATAG,MARRLFSELSPTTYQIALARRRMQRRIADGLRRSSFARQASQESLPVKVYTHNSLIRRRLGNAQPELQEGKAVSLGLAAPHVDGILIRPGETFSFWRLVGEPSSRRGFQPGVVIFDDRAETGVGGGLCQFTNLLHWMALHSPLSIVEHHHHSGLDLFPDFKRQIPFGTGTSIVWNFLDYRLRNDTGITFQFRVRTDDEHLRGELRADAPLDQKFHVREEDGWFYEALDPQTGKLQVRRHNIVSRSTRDKRTGNIVASETLLENDALVVYDRDRITEPIRPLSESESAQRR,MIEVYKLTQRKRLTQLFPFLLPLRKWQRKKYFYFKMKFDGNRYAKKTSEKLLPNTVFETSSLMLNENSGFDMKYQINKVHNLKLAAKTINKVIIEPKETFSFWQLVRWADRHEKYKDGLNLVNGKIVGSYGGGLCQLSNMLFWLFLHTPLVIVERHGHAVESFPSTTEDLPCGTDATINEGWLDLKLRNDTDNTFQIEISFDDNFMYGRILSQSSVNIEYTVFNSSVSYFKREEKVYQIASVCRTEKDKMTGSQTEKELYVNQCEIAYKLPDDVKIEERGV,103.2,gnl|BL_ORD_ID|4743|hsp_num:0,1622,FALSE,None
LK1263,73_3 # 2918 # 3697 # 1 # ID=73_3;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.735,73_3,2918,3697,+,Strict,50,85.1149,vanY gene in vanM cluster,33.53,3002961,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCCCCGACTGCGCCTGATCGCCGCACCCGCCGTCCTGCTGCTCGGGCTGACCGGCTGCGCCGCCGGATCCTACGACGACGCCGGATCCCCCGCCCCGACGGCCTCGGCCGGGACCGCGACGACCGCGACCGAGCCGTCCGCGGCAGCCAGCGACACCGCGAGCGCTCCCGCCGCCTCTGCCTCGGCCGCACCCGGGGAGCACCTGGACATCTCCTCCCCGGACTCCCCCACGGTGCTGGTGAACAAGACCCACCCGATGGACCCGATCGACTGGGCCCCGCAGGACCTGCAGACCGTGGGCTCGGTGCAGTTGCGAGCCGACGCCGCCGCGGCCGCCCGCCGGATGATCGAAGCCGCGGCTCGGGACGGGGTGAGCCTGAGCCCCATCTCCGGCTACCGCTCCCACCAGACCCAGGAGGCCACCTACCGGCAGTGGGTGAGCACCTACGGGCAGGAGCGGGCCGACGTCGCCTCCGCCCGGCCCGGGTACTCGGAGCACCAGACGGGGCTGGCCGTGGACTTCGGCGGGTCCGGGGGGTGCGATCTGCAGCCGTGCTTCCGGGACACCCCGGCGGCGCACTGGCTCGCCGAGCACGGCGCAGAGTACGGGTTCATCCTGCGTTTTCCCTGGCAGCAGCAGGACACCACCGGGTACTGGTACGAGTCCTGGCACCTGCGCTGGATCGGGCAGGAGCAGGCCCAGCGGTACCGGGATTCCGGAGTCCACAGCTACGAGGAGTTCGTGGGGGCTGGGCCGGCCCCGAGCTACCGGGACTGA,MPRLRLIAAPAVLLLGLTGCAAGSYDDAGSPAPTASAGTATTATEPSAAASDTASAPAASASAAPGEHLDISSPDSPTVLVNKTHPMDPIDWAPQDLQTVGSVQLRADAAAAARRMIEAAARDGVSLSPISGYRSHQTQEATYRQWVSTYGQERADVASARPGYSEHQTGLAVDFGGSGGCDLQPCFRDTPAAHWLAEHGAEYGFILRFPWQQQDTTGYWYESWHLRWIGQEQAQRYRDSGVHSYEEFVGAGPAPSYRD,MVFQGNLLLVNNEYPVLEESIKTDVVNLFKHDELTKGYELLNREIYLSEKVAREFSEMVDAAEKEGVRHFSINSGFRNFDEQNALYQEMGSDYALPAGYSEHNLGLALDIGSTQMEMSEAPEGKWLEDNAWEYGFILRYPMDKTAITGIQYEPWHFRYVGLPHSAIIEEKNFALEEYLDFLKEQKSISGTIHGENYEISYYPITEKTDIEMPANLHYEISGNNMDGVIVTVYR,111.16,gnl|BL_ORD_ID|1673|hsp_num:0,1713,FALSE,None
LK1263,82_4 # 1798 # 2601 # -1 # ID=82_4;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.695,82_4,1798,2601,-,Strict,50,111.309,vanW gene in vanG cluster,25.68,3002965,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanW; glycopeptide resistance gene cluster,ATGGCTCGCAGACTCTTCTCGGACATCTCCCCGCTGACGTATCAGATCGCGATCCAGCGGCAGCGCCTGCAGCGGCACCTGGCCGACCTGCCGCGGCGTCTGAGCTTCGCCGCGCCGCGCAGCGCCGAGGATCTGCCGACGCGGATCTACGGGCACAACTCGCTGATCCGGCGTCGCCTGGGCAGCACGGAGCAGCACCTGCAGGAGGGCAAGGCCCGGTCCCTGGCCATCGCCGCCCCCCTGGTGGACGGGATCCTGATCCGGCCGGGGCAGACCTTCTCCTTCTGGCGGCTGGTGGGCGACCCCACCGCCGCCCGCGGCTTCCAGCCCGGGGTGGTCATCCAGGGGGACCACGCGGAGTCGGGCATCGGCGGCGGGATGTGCCAGTTCACCAACCTGCTGCACTGGATGGCGCTGCACTCCGAGCTGACCATCACCGAGCACCACCACCACTCCGGGCTGGACCTGTTCCCGGACTTCAAGCGCCAGATCCCCTACGGCACCGGGACCTCGATCATCTACAACTTCCTGGATTATCGGGTGCACAACGGCACGGACCGCACCCACCAGTTCCGGGTCGCCGTGGACGGGGAGCACCTGCGGGGCCAGCTGCGCGCGGAGCGGCCGGGGGAGTTCAAGTACCACATCCTCGAGGAGGACGCGTACTTCTACGAGGACGCCGACGACGCCGGGGCCGCCCAGGTGCGTCGGCACAACGTCATCGTGCGCGAGACCCGCAGCCGACGCACCGGGGACACCATCGGGCGCGAGCGCCTCCTGGAGAACGACGCCCTGGTGTGCTAA,MARRLFSDISPLTYQIAIQRQRLQRHLADLPRRLSFAAPRSAEDLPTRIYGHNSLIRRRLGSTEQHLQEGKARSLAIAAPLVDGILIRPGQTFSFWRLVGDPTAARGFQPGVVIQGDHAESGIGGGMCQFTNLLHWMALHSELTITEHHHHSGLDLFPDFKRQIPYGTGTSIIYNFLDYRVHNGTDRTHQFRVAVDGEHLRGQLRAERPGEFKYHILEEDAYFYEDADDAGAAQVRRHNVIVRETRSRRTGDTIGRERLLENDALVC,MIEVYKLTQRKRLTQLFPFLLPLRKWQRKKYFYFKMKFDGNRYAKKTSEKLLPNTVFETSSLMLNENSGFDMKYQINKVHNLKLAAKTINKVIIEPKETFSFWQLVRWADRHEKYKDGLNLVNGKIVGSYGGGLCQLSNMLFWLFLHTPLVIVERHGHAVESFPSTTEDLPCGTDATINEGWLDLKLRNDTDNTFQIEISFDDNFMYGRILSQSSVNIEYTVFNSSVSYFKREEKVYQIASVCRTEKDKMTGSQTEKELYVNQCEIAYKLPDDVKIEERGV,95.02,gnl|BL_ORD_ID|4743|hsp_num:0,1622,FALSE,None
LK1198,1_62 # 49462 # 49992 # 1 # ID=1_62;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.499,1_62,49462,49992,+,Perfect,280,361.303,emrR,100,3000516,protein homolog model,n/a,n/a,fluoroquinolone antibiotic,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGGATAGTTCGTTTACGCCCATTGAACAAATGCTAAAATTTCGCGCCAGCCGCCACGAAGATTTTCCTTATCAGGAGATCCTTCTGACCCGTCTTTGCATGCATATGCAAAGCAAGCTGCTGGAAAACCGCAATAAAATGCTGAAGGCTCAGGGGATTAACGAGACGTTGTTTATGGCGTTGATTACGCTGGAGTCTCAGGAAAACCACAGTATTCAGCCTTCTGAATTGAGTTGTGCTCTTGGATCATCCCGTACCAACGCGACGCGTATTGCCGATGAACTGGAAAAACGCGGTTGGATCGAACGTCGTGAAAGCGATAACGATCGCCGCTGCCTGCATCTGCAATTAACGGAAAAAGGTCACGAGTTTTTGCGCGAGGTTCTACCGCCGCAGCATAACTGCCTGCATCAACTCTGGTCCGCGCTCAGCACAACAGAAAAAGACCAGCTCGAGCAAATCACCCGCAAATTGCTCTCCCGTCTCGACCAGATGGAACAGGACGGTGTGGTTCTCGAAGCGATGAGCTAA,MDSSFTPIEQMLKFRASRHEDFPYQEILLTRLCMHMQSKLLENRNKMLKAQGINETLFMALITLESQENHSIQPSELSCALGSSRTNATRIADELEKRGWIERRESDNDRRCLHLQLTEKGHEFLREVLPPQHNCLHQLWSALSTTEKDQLEQITRKLLSRLDQMEQDGVVLEAMS,MDSSFTPIEQMLKFRASRHEDFPYQEILLTRLCMHMQSKLLENRNKMLKAQGINETLFMALITLESQENHSIQPSELSCALGSSRTNATRIADELEKRGWIERRESDNDRRCLHLQLTEKGHEFLREVLPPQHNCLHQLWSALSTTEKDQLEQITRKLLSRLDQMEQDGVVLEAMS,100,gnl|BL_ORD_ID|1225|hsp_num:0,1330,FALSE,None
LK1198,1_63 # 50119 # 51291 # 1 # ID=1_63;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.534,1_63,50119,51291,+,Strict,675,791.186,emrA,99.74,3000027,protein homolog model,n/a,n/a,fluoroquinolone antibiotic,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGAGCGCAAATGCGGAGACTCAAACCCCGCAGCAACCGGTAAAGAAGAGCGGCAAACGTAAGCGTCTGCTCCTCCTTCTCACCTTGCTCTTTATAATTATTGCCGTAGCGATAGGGATTTATTGGTTTTTGGTACTGCGTCATTTCGAAGAAACCGATGACGCATACGTGGCAGGGAATCAGATTCAAATTATGTCTCAGGTGTCTGGCAGCGTGACGAAAGTCTGGGCCGATAACACCGATTTTGTAAAAGAAGGCGACGTGCTGGTCACTCTCGACCCGACAGATGCTCGCCAGGCATTTGAAAAAGCCAAAACTGCACTGGCTTCCAGCGTTCGCCAAACCCACCAGCTGATGATTAACAGCAAACAGTTGCAGGCGAATATTGAGGTGCAAAAAATCGCCCTCGCGAAAGCACAAAGCGACTACAACCGCCGTGTGCCGCTGGGCAATGCCAACCTGATTGGTCGCGAAGAGCTGCAACACGCCCGCGACGCCGTCACCAGTGCCCAGGCGCAACTGGACGTCGCTATTCAACAATACAATGCCAATCAGGCGATGATTCTGGGGACGAAACTGGAAGATCAGCCTGCCGTACAACAGGCTGCCACCGAAGTACGTAACGCCTGGCTGGCGCTGGAGCGTACCCGTATTGTCAGTCCGATGACCGGTTATGTCTCCCGCCGCGCGGTACAGCCTGGGGCGCAAATTAGCCCAACGACGCCGCTGATGGCGGTCGTTCCAGCCACCAATATGTGGGTGGATGCCAACTTTAAAGAGACGCAGATTGCCAATATGCGTATCGGTCAGCCGGTCACCATCACCACCGATATTTACGGCGATGATGTGAAATACACCGGTAAAGTGGTTGGTCTGGATATGGGCACAGGTAGCGCGTTCTCACTGCTTCCGGCGCAAAACGCCACCGGTAACTGGATCAAAGTCGTTCAGCGTCTGCCTGTGCGTATTGAACTGGACCAGAAACAGCTGGAGCAATACCCGCTGCGTATCGGTTTATCCACGCTGGTGAGTGTCAATACCACTAACCGTGACGGTCAGGTACTGGCAAATAAAGTACGTTCCACACCGGTCGCGGTAAGCACCGCGCGTGAAATCAGCCTGGCACCTGTCAATAAACTGATCGACGATATCGTAAAAGCTAACGCTGGCTAA,MSANAETQTPQQPVKKSGKRKRLLLLLTLLFIIIAVAIGIYWFLVLRHFEETDDAYVAGNQIQIMSQVSGSVTKVWADNTDFVKEGDVLVTLDPTDARQAFEKAKTALASSVRQTHQLMINSKQLQANIEVQKIALAKAQSDYNRRVPLGNANLIGREELQHARDAVTSAQAQLDVAIQQYNANQAMILGTKLEDQPAVQQAATEVRNAWLALERTRIVSPMTGYVSRRAVQPGAQISPTTPLMAVVPATNMWVDANFKETQIANMRIGQPVTITTDIYGDDVKYTGKVVGLDMGTGSAFSLLPAQNATGNWIKVVQRLPVRIELDQKQLEQYPLRIGLSTLVSVNTTNRDGQVLANKVRSTPVAVSTAREISLAPVNKLIDDIVKANAG,MSANAETQTPQQPVKKSGKRKRLLLLLTLLFIIIAVAIGIYWFLVLRHFEETDDAYVAGNQIQIMSQVSGSVTKVWADNTDFVKEGDVLVTLDPTDARQAFEKAKTALASSVRQTHQLMINSKQLQANIEVQKIALAKAQSDYNRRVPLGNANLIGREELQHARDAVTSAQAQLDVAIQQYNANQAMILGTKLEDQPAVQQAATEVRNAWLALERTRIISPMTGYVSRRAVQPGAQISPTTPLMAVVPATNMWVDANFKETQIANMRIGQPVTITTDIYGDDVKYTGKVVGLDMGTGSAFSLLPAQNATGNWIKVVQRLPVRIELDQKQLEQYPLRIGLSTLVSVNTTNRDGQVLANKVRSTPVAVSTAREISLAPVNKLIDDIVKANAG,100,gnl|BL_ORD_ID|1610|hsp_num:0,1757,FALSE,None
LK1198,1_64 # 51308 # 52846 # 1 # ID=1_64;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.562,1_64,51308,52846,+,Strict,900,1028.08,emrB,99.8,3000074,protein homolog model,n/a,n/a,fluoroquinolone antibiotic,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGCAACAGCAAAAACCGCTGGAAGGCGCACAACTGGTCATTATGACGATTGCGCTGTCACTGGCGACATTCATGCAGGTGCTGGACTCCACCATTGCTAACGTGGCGATCCCCACTATCGCCGGGAATCTGGGCTCATCACTCAGTCAGGGAACGTGGGTGATCACTTCTTTCGGGGTGGCGAATGCCATCTCGATCCCGCTTACCGGCTGGCTGGCAAAGCGCGTCGGGGAAGTGAAATTGTTCCTCTGGTCAACCATCGCCTTTGCTATTGCGTCGTGGGCGTGTGGTGTCTCCAGCAGCCTGAATATGCTGATCTTCTTCCGCGTGATTCAGGGGATTGTCGCCGGGCCGCTGATCCCGCTTTCGCAAAGTCTATTGCTGAATAACTACCCGCCAGCCAAACGCTCGATCGCGCTGGCGTTGTGGTCGATGACGGTGATTGTTGCGCCAATTTGCGGCCCGATCCTCGGCGGTTATATCAGTGATAATTACCACTGGGGCTGGATATTCTTCATCAACGTGCCGATTGGCGTGGCGGTGGTGTTGATGACACTGCAAACTCTGCGCGGACGTGAAACCCGCACCGAACGGCGGCGGATTGATGCCGTGGGGCTGGCACTGCTGGTTATTGGTATCGGCAGCCTGCAGATTATGCTCGACCGCGGTAAAGAGCTGGACTGGTTCTCATCACAGGAAATTATCATCCTCACCGTGGTGGCGGTGGTGGCTATCTGCTTCCTGATTGTCTGGGAGCTGACCGACGATAACCCGATAGTCGATCTGTCGTTGTTTAAGTCGCGCAACTTCACCATCGGCTGCTTGTGTATCAGCCTCGCGTATATGCTCTACTTCGGCGCGATTGTTCTGCTGCCGCAGTTGTTGCAGGAGGTCTACGGTTACACGGCGACGTGGGCAGGGCTGGCCTCTGCGCCGGTAGGGATTATTCCGGTGATCCTGTCGCCGATTATCGGCCGCTTTGCGCATAAACTGGATATGCGCCGACTGGTAACCTTCAGCTTTATTATGTATGCCGTCTGCTTCTACTGGCGTGCCTATACCTTTGAACCGGGTATGGATTTTGGCGCGTCGGCCTGGCCACAGTTTATCCAGGGTTTTGCGGTGGCCTGCTTCTTTATGCCGCTGACCACCATTACGCTGTCCGGTTTGCCACCGGAACGACTGGCGGCGGCATCAAGCCTCTCCAACTTTACGCGAACGCTGGCGGGGTCTATCGGCACGTCGATAACCACGACCATGTGGACCAACCGCGAGTCACTGCACCATGCACAGTTGACTGAGTCGGTAAACCCGTTCAACCCGAATGCTCAGGCGATGTACAGTCAACTGGAAGGGCTTGGTATGACGCAACAGCAGGCATCAGGCTGGATTGCCCAGCAGATAACCAATCAGGGGCTGATTATTTCCGCCAATGAGATCTTCTGGATGTCAGCCGGGATATTCCTCGTCCTGCTGGGGCTGGTGTGGTTTGCTAAACCGCCATTTGGCGCAGGTGGCGGCGGAGGTGGTGCGCACTAA,MQQQKPLEGAQLVIMTIALSLATFMQVLDSTIANVAIPTIAGNLGSSLSQGTWVITSFGVANAISIPLTGWLAKRVGEVKLFLWSTIAFAIASWACGVSSSLNMLIFFRVIQGIVAGPLIPLSQSLLLNNYPPAKRSIALALWSMTVIVAPICGPILGGYISDNYHWGWIFFINVPIGVAVVLMTLQTLRGRETRTERRRIDAVGLALLVIGIGSLQIMLDRGKELDWFSSQEIIILTVVAVVAICFLIVWELTDDNPIVDLSLFKSRNFTIGCLCISLAYMLYFGAIVLLPQLLQEVYGYTATWAGLASAPVGIIPVILSPIIGRFAHKLDMRRLVTFSFIMYAVCFYWRAYTFEPGMDFGASAWPQFIQGFAVACFFMPLTTITLSGLPPERLAAASSLSNFTRTLAGSIGTSITTTMWTNRESLHHAQLTESVNPFNPNAQAMYSQLEGLGMTQQQASGWIAQQITNQGLIISANEIFWMSAGIFLVLLGLVWFAKPPFGAGGGGGGAH,MQQQKPLEGAQLVIMTIALSLATFMQVLDSTIANVAIPTIAGNLGSSLSQGTWVITSFGVANAISIPLTGWLAKRVGEVKLFLWSTIAFAIASWACGVSSSLNMLIFFRVIQGIVAGPLIPLSQSLLLNNYPPAKRSIALALWSMTVIVAPICGPILGGYISDNYHWGWIFFINVPIGVAVVLMTLQTLRGRETRTERRRIDAVGLALLVIGIGSLQIMLDRGKELDWFSSQEIIILTVVAVVAICFLIVWELTDDNPIVDLSLFKSRNFTIGCLCISLAYMLYFGAIVLLPQLLQEVYGYTATWAGLASAPVGIIPVILSPIIGRFAHKLDMRRLVTFSFIMYAVCFYWRAYTFEPGMDFGASAWPQFIQGFAVACFFMPLTTITLSGLPPERLAAASSLSNFTRTLAGSIGTSITTTMWTNRESMHHAQLTESVNPFNPNAQAMYSQLEGLGMTQQQASGWIAQQITNQGLIISANEIFWMSAGIFLVLLGLVWFAKPPFGAGGGGGGAH,100,gnl|BL_ORD_ID|1706|hsp_num:0,1847,FALSE,None
LK1198,1_73 # 59443 # 59628 # -1 # ID=1_73;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.495,1_73,59443,59628,-,Strict,100,109.383,rsmA,85.25,3005069,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGCTGATTCTGACTCGTCGAGTTGGTGAGACCCTCATGATTGGGGATGAGGTCACCGTGACAGTTTTAGGGGTAAAGGGCAACCAGGTACGTATTGGCGTAAATGCCCCGAAGGAAGTTTCTGTTCACCGTGAAGAGATCTACCAGCGTATCCAGGCTGAAAAATCCCAGCAGTCCAGTTACTAA,MLILTRRVGETLMIGDEVTVTVLGVKGNQVRIGVNAPKEVSVHREEIYQRIQAEKSQQSSY,MLILTRRVGETLMVGDDVTVTVLGVKGNQVRIGVNAPKEVAVHREEIYQRIQKEKDQEPNH,100,gnl|BL_ORD_ID|2794|hsp_num:0,3807,FALSE,None
LK1198,1_457 # 487676 # 489157 # 1 # ID=1_457;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.513,1_457,487676,489157,+,Strict,900,991.875,TolC,99.8,3000237,protein homolog model,n/a,n/a,macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; peptide antibiotic; aminocoumarin antibiotic; rifamycin antibiotic; phenicol antibiotic; penem; disinfecting agents and antiseptics,antibiotic efflux,ATP-binding cassette (ABC) antibiotic efflux pump; major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGAAGAAATTGCTCCCCATTCTTATCGGCCTGAGCCTCTCTGGGTTCAGTTCGTTGAGCCAGGCCGAGAACCTGATGCAAGTTTATCAGCAAGCACGCCTTAGTAACCCGGAATTGCGTAAGTCTGCCGCCGATCGTGATGCTGCCTTTGAAAAAATTAATGAAGCGCGCAGTCCATTACTGCCACAGCTAGGTTTAGGTGCAGATTACACCTATAGCAACGGCTACCGCGACGCGAACGGCATCAACTCTAACGCGACCAGTGCGTCCCTGCAGTTAACTCAATCCATTTTTGATATGTCGAAATGGCGTGCGTTAACGCTGCAGGAAAAAGCAGCTGGGATTCAGGACGTCACGTATCAGACCGATCAACAAACCTTGATCCTCAACACCGCGACCGCTTATTTCAACGTGTTGAATGCTATTGACGTTCTTTCCTATACACAGGCGCAAAAAGAAGCGATCTACCGTCAATTAGATCAAACCACCCAACGTTTTAACGTGGGCCTGGTAGCGATCACCGACGTGCAGAACGCCCGCGCACAGTACGATACCGTGCTGGCGAACGAAGTGACCGCACGTAATAACCTTGATAACGCGGTAGAGCAGCTGCGCCAGATCACCGGTAACTACTATCCGGAACTGGCGGCGCTGAATGTCGAAAACTTTAAAACCGACAAACCACAGCCGGTTAACACGCTGCTGAAAGAAGCCGAAAAACGTAACCTGTCGTTGTTACAGGCGCGCTTGAGCCAGGACCTGGCGCGCGAGCAAATTCGCCAGGCGCAGGATGGTCACTTACCGACTCTGGATTTAACGGCTTCTACCGGGATTTCTGACACCTCTTATAGCGGTTCGAAAACCCGTGGTGCCGCTGGTACCCAGTATGACGATAGCAATATGGGCCAGAACAAAGTTGGCCTGAGCTTCTCGCTGCCGATTTATCAGGGCGGAATGGTTAACTCGCAGGTGAAACAGGCCCAGTACAACTTTGTTGGTGCCAGCGAGCAACTGGAAAGCGCGCATCGTAGCGTCGTGCAAACCGTACGTTCCTCCTTCAACAACATTAATGCTTCTATCAGTAGCATTAACGCCTACAAACAAGCCGTAGTTTCCGCTCAAAGCTCATTAGACGCGATGGAAGCGGGTTACTCGGTTGGTACGCGTACCATTGTTGATGTGTTGGATGCGACCACCACGCTGTACAACGCTAAGCAAGAGCTGGCAAATGCGCGTTATAACTACCTGATTAACCAGTTGAATATTAAGTCAGCTCTGGGTACGTTGAACGAGCAGGATCTGCTGGCACTGAACAATGCGCTGAGCAAACCGGTTTCCACTAATCCGGAAAACGTTGCCCCGCAAACGCCGGAACAGAATGCTATTGCTGATGGTTATGCGCCTGATAGCCCGGCACCCGTCGTTCAGCAAACATCCGCACGCACTACCACCAGTAACGGTCATAACCCTTTCCGTAACTGA,MKKLLPILIGLSLSGFSSLSQAENLMQVYQQARLSNPELRKSAADRDAAFEKINEARSPLLPQLGLGADYTYSNGYRDANGINSNATSASLQLTQSIFDMSKWRALTLQEKAAGIQDVTYQTDQQTLILNTATAYFNVLNAIDVLSYTQAQKEAIYRQLDQTTQRFNVGLVAITDVQNARAQYDTVLANEVTARNNLDNAVEQLRQITGNYYPELAALNVENFKTDKPQPVNTLLKEAEKRNLSLLQARLSQDLAREQIRQAQDGHLPTLDLTASTGISDTSYSGSKTRGAAGTQYDDSNMGQNKVGLSFSLPIYQGGMVNSQVKQAQYNFVGASEQLESAHRSVVQTVRSSFNNINASISSINAYKQAVVSAQSSLDAMEAGYSVGTRTIVDVLDATTTLYNAKQELANARYNYLINQLNIKSALGTLNEQDLLALNNALSKPVSTNPENVAPQTPEQNAIADGYAPDSPAPVVQQTSARTTTSNGHNPFRN,MQMKKLLPILIGLSLSGFSSLSQAENLMQVYQQARLSNPELRKSAADRDAAFEKINEARSPLLPQLGLGADYTYSNGYRDANGINSNATSASLQLTQSIFDMSKWRALTLQEKAAGIQDVTYQTDQQTLILNTATAYFNVLNAIDVLSYTQAQKEAIYRQLDQTTQRFNVGLVAITDVQNARAQYDTVLANEVTARNNLDNAVEQLRQITGNYYPELAALNVENFKTDKPQPVNALLKEAEKRNLSLLQARLSQDLAREQIRQAQDGHLPTLDLTASTGISDTSYSGSKTRGAAGTQYDDSNMGQNKVGLSFSLPIYQGGMVNSQVKQAQYNFVGASEQLESAHRSVVQTVRSSFNNINASISSINAYKQAVVSAQSSLDAMEAGYSVGTRTIVDVLDATTTLYNAKQELANARYNYLINQLNIKSALGTLNEQDLLALNNALSKPVSTNPENVAPQTPEQNAIADGYAPDSPAPVVQQTSARTTTSNGHNPFRN,99.6,gnl|BL_ORD_ID|4678|hsp_num:0,826,FALSE,None
LK1198,1_481 # 514939 # 515760 # -1 # ID=1_481;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.530,1_481,514939,515760,-,Strict,500,543.117,bacA,99.63,3002986,protein homolog model,n/a,n/a,peptide antibiotic,antibiotic target alteration,undecaprenyl pyrophosphate related proteins,ATGAGCGATATGCACTCGCTGCTGATAGCGGCAATATTGGGTGTGGTCGAAGGATTGACAGAATTTCTGCCGGTATCCAGCACGGGCCATATGATTATTGTCGGTCACTTGTTGGGGTTTGAGGGCGACACGGCGAAAACCTTTGAAGTCGTGATCCAGTTAGGATCAATTCTGGCGGTAGTAGTGATGTTCTGGCGGCGTCTGTTTGGCCTGATTGGCATCCACTTTGGTCGCCCGTTGCAGCACGAAGGAGAAAGCAAAGGTCGTTTAACGCTGATCCACATCTTGCTGGGGATGATTCCGGCGGTGGTACTGGGGCTGTTGTTCCACGACACGATTAAATCATTGTTTAACCCGATAAATGTCATGTATGCACTGGTCGTTGGCGGTCTGTTGCTGATTGCCGCCGAATGCCTGAAGCCGAAAGAGCCGCGTGCGCCGGGTCTTGATGATATGACCTATCGTCAGGCGTTTATGATTGGCTGTTTCCAGTGTCTGGCGCTGTGGCCGGGTTTCTCCCGTTCCGGGGCGACCATTTCAGGTGGGATGCTGATGGGGGTGAGCCGTTACGCTGCTTCCGAGTTCTCGTTCCTGCTGGCGGTGCCGATGATGATGGGCGCAACGGCGCTCGATCTCTACAAAAGCTGGGGCTTCCTGACTACCGGCGATATCCCGATGTTTGCCGTTGGGTTTATCACCGCTTTTGTGGTGGCGCTGATAGCGATTAAAACCTTCCTGCAATTGATTAAGCGCATTTCGTTTATCCCGTTCGCCATTTATCGCTTTATTGTGGCGGCTGCGGTGTACGTTGTGTTCTTTTGA,MSDMHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAVVVMFWRRLFGLIGIHFGRPLQHEGESKGRLTLIHILLGMIPAVVLGLLFHDTIKSLFNPINVMYALVVGGLLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATISGGMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSWGFLTTGDIPMFAVGFITAFVVALIAIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF,MSDMHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAVVVMFWRRLFGLIGIHFGRPLQHEGESKGRLTLIHILLGMIPAVVLGLLFHDTIKSLFNPINVMYALVVGGLLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATISGGMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSWGFLTSGDIPMFAVGFITAFVVALIAIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF,100,gnl|BL_ORD_ID|1681|hsp_num:0,1820,FALSE,None
LK1198,1_673 # 716166 # 716828 # -1 # ID=1_673;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.439,1_673,716166,716828,-,Strict,380,453.366,AcrS,98.64,3000656,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGGCAAAAAGAACCAAAGCTGAAGCCCTGAAGACCCGGCAAGAACTGATTGAAACTGCCATCGCCCAGTTTGCGCAGCATGGCGTAAGCAAGACGACGCTCAACGACATTGCCGACGCTGCTAACGTTACGCGTGGCGCTATCTACTGGCACTTCGAAAACAAGACTCAACTGTTTAATGAGATGTGGTTGCAACAGCCTTCATTGCGGGAGTTAATCCAGGATCACTTGACCGCTGGGTTAGAGCATGACCCGTTTCAGCAATTGCGTGAAAAATTGATTGTCGGTTTGCAATATATTGCCAAAATTCCCCGCCAGCAGGCGTTGCTGAAAATCTTATATCACAAATGTGAATTTAATGATGAGATGCTGGCCGAGGGAGTGATACGCGAAAAGATGGGCTTTAATCCGCAGACTCTCCGCGAAGTATTGCAGGCGTGTCAGCAACAAGGTTGTGTAGCAAATAATCTCGATTTAGATGTTGTGATGATTATTATTGATGGTGCCTTCAGCGGAATTGTTCAAAACTGGTTAATGAATATGGCGGGTTATGATCTTTATAAACAAGCCCCCGCTCTGGTCGATAACGTATTAAGAATGTTCATGCCAGATGAAAACATAACGAAATTAATTCATAAAACGAATGAATTAAGTGTCATATAA,MAKRTKAEALKTRQELIETAIAQFAQHGVSKTTLNDIADAANVTRGAIYWHFENKTQLFNEMWLQQPSLRELIQDHLTAGLEHDPFQQLREKLIVGLQYIAKIPRQQALLKILYHKCEFNDEMLAEGVIREKMGFNPQTLREVLQACQQQGCVANNLDLDVVMIIIDGAFSGIVQNWLMNMAGYDLYKQAPALVDNVLRMFMPDENITKLIHKTNELSVI,MAKRTKAEALKTRQELIETAIAQFAQHGVSKTTLNDIADAANVTRGAIYWHFENKTQLFNEMWLQQPSLRELIQEHLTAGLEHDPFQQLREKLIVGLQYIAKIPRQQALLKILYHKCEFNDEMLAEGVIREKMGFNPQTLREVLQACQQQGCVANNLDLDVVMIIIDGAFSGIVQNWLMNMAGYDLYKQAPALVDNVLRMFMPDENITKLIHQTNELSVM,100,gnl|BL_ORD_ID|601|hsp_num:0,520,FALSE,None
LK1198,1_674 # 717227 # 718384 # 1 # ID=1_674;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.526,1_674,717227,718384,+,Strict,675,781.556,AcrE,99.48,3000499,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; cephalosporin; cephamycin; penam,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGACGAAACATGCCAGGTTTTTCCTCCTGCCCTCCTTTATTCTGATCTCCGCGGCTTTAATCGCCGGTTGTAACGATAAGGGAGAAGAGAAAGCTCACGTCGGTGAACCGCAGGTTACCGTTCATATTGTGAAAACGGCCCCGTTAGAAGTTAAGACTGAATTACCAGGCCGCACCAATGCTTACCGTATAGCCGAAGTTCGCCCACAGGTTAGCGGGATCGTACTGAATCGCAATTTCACTGAAGGCAGCGATGTGCAAGCAGGCCAGTCCCTGTACCAGATCGATCCCGCGACCTATCAGGCAAGTTATGACAGCGCGAAAGGCGAACTGGCGAAAAGTGAAGCCGCCGCCGCCATCGCGCATTTGACGGTAAAACGTTACGTTCCGCTCGTGGGTACGAAATACATCAGTCAGCAGGAGTACGACCAGGCCATTGCTGATGCTCGCCAGGCCGATGCCGCCGTGATTGCCGCAAAAGCCACAGTCGAAAGCGCTCGCATCAATCTCGCTTATACCAAAGTGACTGCGCCAATTAGCGGACGTATCGGCAAATCGACCGTGACCGAAGGCGCTCTTGTCACTAATGGGCAAACGACTGAACTGGCGACTGTCCAGCAGCTCGATCCTATCTACGTTGATGTGACCCAATCCAGCAACGATTTTATGAGGCTGAAGCAATCCGTAGAGCAAGGAAATTTGCATAAGGAAAACGCCACCAGCAACGTAGAGTTGGTCATGGAGAACGGTCAAACCTATCCCCTGAAAGGTACGCTGCAATTCTCCGATGTGACCGTTGATGAAAGCACCGGCTCCATAACCCTACGTGCTGTCTTCCCTAACCCGCAACATACGCTTTTGCCGGGTATGTTTGTGCGCGCACGGATTGATGAAGGCGTCCAACCTGACGCCATTCTTATCCCGCAACAAGGCGTTAGCCGCACACCACGTGGTGATGCAACCGTGCTGATTGTTAACAATAAAAGTCAGGTTGAAGCGCGCCCTGTCGTTGCCAGTCAGGCGATTGGCGATAAATGGTTGATTAGCGAAGGTCTGAAATCTGGCGATCAAGTCATTGTCAGCGGCCTGCAAAAAGCGCGTCCGGGAGAGCAGGTTAAAGCCACTACCGATACCCCCGCAGATACTGCATCGAAGTAA,MTKHARFFLLPSFILISAALIAGCNDKGEEKAHVGEPQVTVHIVKTAPLEVKTELPGRTNAYRIAEVRPQVSGIVLNRNFTEGSDVQAGQSLYQIDPATYQASYDSAKGELAKSEAAAAIAHLTVKRYVPLVGTKYISQQEYDQAIADARQADAAVIAAKATVESARINLAYTKVTAPISGRIGKSTVTEGALVTNGQTTELATVQQLDPIYVDVTQSSNDFMRLKQSVEQGNLHKENATSNVELVMENGQTYPLKGTLQFSDVTVDESTGSITLRAVFPNPQHTLLPGMFVRARIDEGVQPDAILIPQQGVSRTPRGDATVLIVNNKSQVEARPVVASQAIGDKWLISEGLKSGDQVIVSGLQKARPGEQVKATTDTPADTASK,MTKHARFFLLPSFILISAALIAGCNDKGEEKAHVGEPQVTVHIVKTAPLEVKTELPGRTNAYRIAEVRPQVSGIVLNRNFTEGSDVQAGQSLYQIDPATYQANYDSAKGELAKSEAAAAIAHLTVKRYVPLVGTKYISQQEYDQAIADARQADAAVIAAKATVESARINLAYTKVTAPISGRIGKSTVTEGALVTNGQTTELATVQQLDPIYVDVTQSSNDFMRLKQSVEQGNLHKENATSNVELVMENGQTYPLKGTLQFSDVTVDESTGSITLRAVFPNPQHTLLPGMFVRARIDEGVQPDAILIPQQGVSRTPRGDATVLIVNDKSQVEARPVVASQAIGDKWLISEGLKSGDQVIVSGLQKARPGEQVKATTDTPADTASK,100,gnl|BL_ORD_ID|1354|hsp_num:0,1445,FALSE,None
LK1198,1_675 # 718396 # 721500 # 1 # ID=1_675;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.513,1_675,718396,721500,+,Strict,1900,2093.93,AcrF,99.61,3000502,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; cephalosporin; cephamycin; penam,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGGCAAACTTTTTTATTCGACGACCGATATTTGCATGGGTGCTGGCCATTATTCTGATGATGGCGGGCGCACTGGCGATCCTACAATTGCCCGTCGCCCAGTATCCAACCATTGCGCCGCCTGCGGTTTCTGTTTCGGCAAACTATCCGGGTGCTGATGCGCAGACCGTGCAGGATACAGTGACGCAGGTTATCGAACAGAATATGAACGGTATCGATAACCTGATGTATATGTCCTCCACCAGCGATTCCGCCGGTAGCGTGACAATTACCCTTACCTTCCAGTCCGGGACCGATCCTGATATCGCGCAAGTACAGGTGCAGAACAAACTCCAGCTCGCCACGCCGTTGCTGCCGCAGGAGGTTCAGCAGCAGGGGATCAGTGTTGAAAAGTCCAGTAGCAGCTATTTGATGGTGGCGGGCTTTGTCTCTGATAACCCTGGCACCACACAGGACGATATCTCGGACTATGTGGCCTCTAACGTTAAAGATACGCTTAGCCGTCTGAATGGCGTCGGTGACGTACAGCTTTTCGGCGCACAGTATGCGATGCGTATCTGGCTGGACGCCGATCTGCTAAACAAATATAAACTGACACCGGTTGATGTGATTAACCAGTTGAAGGTACAGAACGATCAGATCGCTGCCGGACAGTTGGGCGGAACGCCAGCGTTACCAGGGCAACAGTTGAACGCCTCGATTATTGCTCAGACGCGGTTAAAAAATCCGGAAGAATTCGGCAAAGTGACCTTGCGCGTAAACAGTGACGGCTCGGTGGTACGCCTGAAAGATGTCGCACGGGTTGAACTTGGCGGTGAAAACTATAACGTTATCGCTCGCATCAACGGTAAACCGGCGGCGGGCCTGGGTATTAAGCTGGCAACCGGCGCGAATGCTCTCGATACCGCGAAAGCCATTAAGGCAAAACTGGCGGAATTACAGCCATTCTTCCCGCAGGGAATGAAGGTTCTCTACCCTTATGACACCACACCATTCGTCCAGCTTTCTATTCACGAAGTGGTAAAAACGCTGTTCGAAGCCATTATGCTGGTGTTCCTGGTGATGTATCTGTTCTTGCAGAATATGCGAGCAACGCTGATCCCCACCATTGCGGTACCCGTGGTGTTGTTAGGGACGTTTGCCATCCTCGCCGCTTTTGGTTACTCCATCAACACACTAACGATGTTCGGGATGGTGCTTGCCATCGGGCTGCTCGTCGATGATGCGATAGTCGTTGTGGAGAACGTCGAGCGCGTAATGATGGAGGATAAACTCCCCCCCAGAGAAGCGACGGAAAAATCGATGTCGCAAATCCAGGGCGCGCTGGTAGGTATCGCGATGGTACTGTCGGCGGTATTTATTCCGATGGCATTCTTCGGTGGCTCAACAGGGGCAATTTATCGCCAGTTCTCTATCACTATTGTTTCAGCAATGGCGCTTTCAGTACTGGTTGCGCTGATTCTCACCCCCGCGTTATGTGCAACATTGCTGAAACCAGTCTCTGCCGAGCATCACGAAAATAAGGGAGGATTCTTCGGCTGGTTTAACACCACTTTCGATCATAGCGTTAATCACTACACCAATAGCGTTGGCAAAATCCTCGGTTCCACAGGGCGATATTTACTGATCTATGCGCTGATTGTTGCAGGAATGGTGGTGTTGTTTTTACGTCTTCCGTCTTCCTTCTTACCTGAAGAGGATCAGGGTGTCTTTCTGACCATGATTCAGTTACCCGCTGGCGCGACGCAAGAGCGGACGCAAAAAGTGTTGGATCAAGTGACGGATTACTATCTGAAGAACGAGAAAGCGAACGTTGAAAGTGTCTTTACAGTTAACGGCTTTAGCTTCAGCGGCCAGGCACAAAACGCCGGTATGGCCTTCGTCAGTCTGAAACCGTGGGAAGAGCGTAGTGGTGACGAAAACAGTGCGGAAGCAGTAATCCATCGTGCCAAAATGGAATTGGGCAAGATCCGCGACGGTTTTGTCATTCCATTTAATATGCCAGCCATTGTTGAACTAGGCACGGCAACGGGTTTCGACTTTGAGTTAATTGATCAGGCTGGGCTGGGTCACGATGCCCTGACCCAGGCCCGTAACCAGTTGCTTGGCATGGCGGCGCAACATCCTGCCAGCTTAGTCAGCGTGCGCCCTAATGGCCTGGAAGACACCGCGCAGTTTAAACTGGAAGTTGACCAGGAAAAGGCGCAGGCATTAGGTGTTTCACTTTCTGACATCAATCAGACCATTTCAACGGCGTTGGGTGGGACTTACGTTAACGACTTCATCGACCGTGGTCGCGTGAAAAAGGTGTATGTTCAGGCGGATGCCAAATTCCGTATGCTGCCAGAAGATGTCGATAAACTTTATGTCCGCAGCGCCAACGGCGAAATGGTGCCATTCTCTGCCTTTACCACTTCACATTGGGTGTATGGCTCTCCGCGACTGGAACGCTACAACGGTCTGCCGTCAATGGAGATTCAGGGGGAAGCCGCGCCAGGAACCAGTTCCGGCGATGCTATGGCGTTGATGGAAAACCTTGCGTCAAAATTACCGGCGGGCATTGGTTATGACTGGACGGGTATGTCATATCAGGAACGTTTATCGGGAAACCAGGCTCCCGCTCTGGTAGCAATTTCCTTTGTGGTTGTTTTCCTGTGCCTTGCTGCACTCTATGAAAGCTGGTCAATTCCTGTCTCGGTTATGTTGGTCGTGCCGTTAGGGATTGTCGGCGTGCTACTGGCGGCAACACTCTTTAATCAAAAAAATGACGTCTACTTTATGGTGGGCTTGCTAACGACAATTGGCTTGTCGGCCAAAAACGCTATTTTGATTGTTGAGTTCGCTAAAGATCTCATGGAGAAAGAGGGTAAAGGTGTTGTTGAAGCGACACTAATGGCAGTACGTATGCGTCTGCGTCCTATCCTGATGACCTCTCTCGCCTTTATTCTCGGCGTATTACCGCTGGCTATCAGTAACGGGGCCGGCAGTGGCGCGCAAAACGCAGTCGGTATCGGGGTAATGGGCGGAATGGTCTCTGCAACGTTGCTGGCAATCTTCTTCGTGCCAGTGTTCTTTGTGGTGATCCGTCGATGCTTTAAAGGATAA,MANFFIRRPIFAWVLAIILMMAGALAILQLPVAQYPTIAPPAVSVSANYPGADAQTVQDTVTQVIEQNMNGIDNLMYMSSTSDSAGSVTITLTFQSGTDPDIAQVQVQNKLQLATPLLPQEVQQQGISVEKSSSSYLMVAGFVSDNPGTTQDDISDYVASNVKDTLSRLNGVGDVQLFGAQYAMRIWLDADLLNKYKLTPVDVINQLKVQNDQIAAGQLGGTPALPGQQLNASIIAQTRLKNPEEFGKVTLRVNSDGSVVRLKDVARVELGGENYNVIARINGKPAAGLGIKLATGANALDTAKAIKAKLAELQPFFPQGMKVLYPYDTTPFVQLSIHEVVKTLFEAIMLVFLVMYLFLQNMRATLIPTIAVPVVLLGTFAILAAFGYSINTLTMFGMVLAIGLLVDDAIVVVENVERVMMEDKLPPREATEKSMSQIQGALVGIAMVLSAVFIPMAFFGGSTGAIYRQFSITIVSAMALSVLVALILTPALCATLLKPVSAEHHENKGGFFGWFNTTFDHSVNHYTNSVGKILGSTGRYLLIYALIVAGMVVLFLRLPSSFLPEEDQGVFLTMIQLPAGATQERTQKVLDQVTDYYLKNEKANVESVFTVNGFSFSGQAQNAGMAFVSLKPWEERSGDENSAEAVIHRAKMELGKIRDGFVIPFNMPAIVELGTATGFDFELIDQAGLGHDALTQARNQLLGMAAQHPASLVSVRPNGLEDTAQFKLEVDQEKAQALGVSLSDINQTISTALGGTYVNDFIDRGRVKKVYVQADAKFRMLPEDVDKLYVRSANGEMVPFSAFTTSHWVYGSPRLERYNGLPSMEIQGEAAPGTSSGDAMALMENLASKLPAGIGYDWTGMSYQERLSGNQAPALVAISFVVVFLCLAALYESWSIPVSVMLVVPLGIVGVLLAATLFNQKNDVYFMVGLLTTIGLSAKNAILIVEFAKDLMEKEGKGVVEATLMAVRMRLRPILMTSLAFILGVLPLAISNGAGSGAQNAVGIGVMGGMVSATLLAIFFVPVFFVVIRRCFKG,MANFFIRRPIFAWVLAIILMMAGALAILQLPVAQYPTIAPPAVSVSANYPGADAQTVQDTVTQVIEQNMNGIDNLMYMSSTSDSAGSVTITLTFQSGTDPDIAQVQVQNKLQLATPLLPQEVQQQGISVEKSSSSYLMVAGFVSDNPGTTQDDISDYVASNVKDTLSRLNGVGDVQLFGAQYAMRIWLDADLLNKYKLTPVDVINQLKVQNDQIAAGQLGGTPALPGQQLNASIIAQTRFKNPEEFGKVTLRVNSDGSVVRLKDVARVELGGENYNVIARINGKPAAGLGIKLATGANALDTAKAIKAKLAELQPFFPQGMKVLYPYDTTPFVQLSIHEVVKTLFEAIMLVFLVMYLFLQNMRATLIPTIAVPVVLLGTFAILAAFGYSINTLTMFGMVLAIGLLVDDAIVVVENVERVMMEDKLPPKEATEKSMSQIQGALVGIAMVLSAVFIPMAFFGGSTGAIYRQFSITIVSAMALSVLVALILTPALCATLLKPVSAEHHENKGGFFGWFNTTFDHSVNHYTNSVGKILGSTGRYLLIYALIVAGMVVLFLRLPSSFLPEEDQGVFLTMIQLPAGATQERTQKVLDQVTDYYLKNEKANVESVFTVNGFSFSGQAQNAGMAFVSLKPWEERNGDENSAEAVIHRAKMELGKIRDGFVIPFNMPAIVELGTATGFDFELIDQAGLGHDALTQARNQLLGMAAQHPASLVSVRPNGLEDTAQFKLEVDQEKAQALGVSLSDINQTISTALGGTYVNDFIDRGRVKKLYVQADAKFRMLPEDVDKLYVRSANGEMVPFSAFTTSHWVYGSPRLERYNGLPSMEIQGEAAPGTSSGDAMALMENLASKLPAGIGYDWTGMSYQERLSGNQAPALVAISFVVVFLCLAALYESWSIPVSVMLVVPLGIVGVLLAATLFNQKNDVYFMVGLLTTIGLSAKNAILIVEFAKDLMEKEGKGVVEATLMAVRMRLRPILMTSLAFILGVLPLAISNGAGSGAQNAVGIGVMGGMVSATLLAIFFVPVFFVVIRRCFKG,100,gnl|BL_ORD_ID|1353|hsp_num:0,1437,FALSE,None
LK1198,2_26 # 21711 # 22877 # -1 # ID=2_26;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.434,2_26,21711,22877,-,Strict,700,791.956,ugd,99.23,3003577,protein homolog model,n/a,n/a,peptide antibiotic,antibiotic target alteration,pmr phosphoethanolamine transferase,ATGAAAATCACCATTTCCGGTACTGGCTATGTAGGCTTGTCAAACGGGCTTCTAATCGCACAAAATCATGAGGTTGTGGCATTAGATATTTTACCGTCACGCGTTGCTATGCTGAATGATCGGATATCTCCTATTGTTGATAAGGAAATTCAGCAGTTTTTGCAATCAGATAAAATACACTTTAATGCCACATTAGATAAAAATGAAGCCTACCGGGATGCTGATTATGTCATCATCGCCACTCCAACCGACTATGATCCTAAAACTAATTATTTCAATACATCCAGTGTAGAATCAGTAATTAAAGACGTAGTTGAGATAAATCCTTATGCGGTTATGGTCATCAAATCAACGGTTCCCGTTGGTTTTACTGCAGCGATGCATAAGAAATATCGTACTGAAAATATTATTTTCTCTCCGGAATTCCTCCGCGAAGGTAAAGCCCTTTACGATAATCTCCATCCGTCACGTATTGTCATCGGTGAGCGTTCAGAACGCGCAGAACGTTTTGCTGCGTTGTTACAGGAAGGCGCGATTAAGCAAAATATCCCGACCCTGTTTACCGACTCCACTGAAGCAGAAGCGATTAAACTGTTTGCTAATACCTATCTGGCGATGCGCGTAGCATACTTTAATGAACTGGATAGCTATGCAGAAAGTTTAGGTCTGAATACTCGCCAGATTATCGAAGGCGTTTGTCTCGATCCGCGTATTGGCAACCATTACAACAATCCGTCGTTTGGTTATGGTGGTTATTGTCTGCCGAAAGATACCAAGCAGTTACTGGCGAACTATCAGTCTGTGCCGAATAATCTGATCTCGGCAATTGTCGATGCTAACCGCACGCGTAAAGACTTTATTGCCGATGCCATTTTGTCACGCAAACCGCAAGTGGTGGGTATTTATCGTCTGATTATGAAGAGCGGGTCAGATAACTTCCGCGCGTCTTCCATTCAGGGGATTATGAAACGTATTAAGGCGAAAGGCGTTGAAGTGCTCATCTACGAACCGGTGATGAAAGAAGATTCATTCTTCAACTCTCGCCTGGAACGTGATCTCGCCACCTTCAAACAACAAGCCGACGTCATTATTTCCAACCGTATGGCAGAAGAGCTTAAGGATGTGGCAGATAAAGTCTACACCCGCGATCTCTTTGGCAGCGACTAA,MKITISGTGYVGLSNGLLIAQNHEVVALDILPSRVAMLNDRISPIVDKEIQQFLQSDKIHFNATLDKNEAYRDADYVIIATPTDYDPKTNYFNTSSVESVIKDVVEINPYAVMVIKSTVPVGFTAAMHKKYRTENIIFSPEFLREGKALYDNLHPSRIVIGERSERAERFAALLQEGAIKQNIPTLFTDSTEAEAIKLFANTYLAMRVAYFNELDSYAESLGLNTRQIIEGVCLDPRIGNHYNNPSFGYGGYCLPKDTKQLLANYQSVPNNLISAIVDANRTRKDFIADAILSRKPQVVGIYRLIMKSGSDNFRASSIQGIMKRIKAKGVEVLIYEPVMKEDSFFNSRLERDLATFKQQADVIISNRMAEELKDVADKVYTRDLFGSD,MKITISGTGYVGLSNGLLIAQNHEVVALDILPSRVAMLNDRISPIVDKEIQQFLQSDKIHFNATLDKNEAYRDADYVIIATPTDYDPKTNYFNTSSVESVIKDVVEINPYAVMVIKSTVPVGFTAAMHKKYRTENIIFSPEFLREGKALYDNLHPSRIVIGERSERAERFAALLQEGAIKQNIPMLFTDSTEAEAIKLFANTYLAMRVAYFNELDSYAESLGLNSRQIIEGVCLDPRIGNHYNNPSFGYGGYCLPKDTKQLLANYQSVPNNLISAIVDANRTRKDFIADAILSRKPQVVGIYRLIMKSGSDNFRASSIQGIMKRIKAKGVEVIIYEPVMKEDSFFNSRLERDLATFKQQADVIISNRMAEELKDVADKVYTRDLFGSD,100,gnl|BL_ORD_ID|894|hsp_num:0,842,FALSE,None
LK1198,2_75 # 78977 # 80224 # 1 # ID=2_75;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=11-12bp;gc_cont=0.547,2_75,78977,80224,+,Strict,725,828.165,mdtA,99.04,3000792,protein homolog model,n/a,n/a,aminocoumarin antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGAAAGGCAGTTATAAATCCCGTTGGGTAATCGTAATCGTGGTGGTTATCGCCGCCATCGCCGCATTCTGGTTCTGGCAAGGCCGCAATGACTCCCAGAGTGCAACCCCAGGGGCGACGAAACAAGCGCAGCAATCGCCAGCGGGTGGTCGCCGTGGTATGCGTGCCGGCCCATTAGCTCCGGTTCAGGCGGCGACCGCAGTAGAACAGGCTGTTCCGCGTTACCTCACCGGGCTTGGCACCATTACCGCCGCTAATACTGTTACGGTGCGCAGCCGCGTGGACGGTCAACTGATGGCGTTACATTTCCAGGAAGGCCAGCAGGTCAAAGCAGGCGATTTACTGGCAGAAATTGACCCAAGCCAGTTCAAAGTTGCATTAGCACAAGCCCAGGGCCAACTGGCAAAAGATAAAGCCACGCTCGCCAACGCCCGCCGTGACCTGGCGCGTTATCAACAACTGGCAAAAACCAATCTCGTATCTCGTCAGGAACTGGATGCCCAACAAGCGCTGGTCAGTGAAACCGAAGGTACCATTAAGGCTGATGAAGCAAGCGTCGCCAGCGCGCAATTGCAACTCGACTGGAGCCGTATCACCGCACCAGTTGATGGTCGCGTTGGTCTCAAGCAGGTTGATGTTGGTAACCAAATCTCCAGTGGCGACACCACCGGGATTGTGGTGATCACCCAAACACATCCTATCGATCTGGTCTTTACTCTGCCGGAAAGCGATATCGCCACCGTTGTACAGGCACAAAAAGCCGGAAAACCGCTGGTGGTAGAAGCCTGGGATCGCACCAACTCGAAGAAGTTAAGTGAAGGCACGCTGTTAAGCCTTGATAACCAAATCGATGCCACTACCGGTACGATTAAAGTGAAAGCACGCTTTAATAATCAGGATGATGCGCTGTTTCCCAATCAGTTTGTTAACGCGCGCATGTTAGTCGACACCGAACAAAACGCCGTGGTGATCCCCACCGCCGCTCTGCAAATGGGCAACGAAGGCCATTTTGTCTGGGTACTGAATAGCGAAAACAAAGTCAGCAAACATCTGGTGACACCGGGCATTCAGGACAGTCAGAAAGTGGTGATCCGCGCAGGTATTTCTGCGGGCGACCGCGTAGTGACGGACGGCATTGATCGCCTGACCGAAGGGGCGAAAGTGGAAGTGGTGGAAGCCCAGAGCGCCACTACTCCGGAAGAGAAAGCCACCAGCCGCGAATACGCGAAAAAAGGAGCACGCTCCTGA,MKGSYKSRWVIVIVVVIAAIAAFWFWQGRNDSQSATPGATKQAQQSPAGGRRGMRAGPLAPVQAATAVEQAVPRYLTGLGTITAANTVTVRSRVDGQLMALHFQEGQQVKAGDLLAEIDPSQFKVALAQAQGQLAKDKATLANARRDLARYQQLAKTNLVSRQELDAQQALVSETEGTIKADEASVASAQLQLDWSRITAPVDGRVGLKQVDVGNQISSGDTTGIVVITQTHPIDLVFTLPESDIATVVQAQKAGKPLVVEAWDRTNSKKLSEGTLLSLDNQIDATTGTIKVKARFNNQDDALFPNQFVNARMLVDTEQNAVVIPTAALQMGNEGHFVWVLNSENKVSKHLVTPGIQDSQKVVIRAGISAGDRVVTDGIDRLTEGAKVEVVEAQSATTPEEKATSREYAKKGARS,MKGSYKSRWVIVIVVVIAAIAAFWFWQGRNDSRSAAPGATKQAQQSPAGGRRGMRSGPLAPVQAATAVEQAVPRYLTGLGTITAANTVTVRSRVDGQLIALHFQEGQQVKAGDLLAEIDPSQFKVALAQAQGQLAKDKATLANARRDLARYQQLAKTNLVSRQELDAQQALVSETEGTIKADEASVASAQLQLDWSRITAPVDGRVGLKQVDVGNQISSGDTTGIVVITQTHPIDLVFTLPESDIATVVQAQKAGKPLVVEAWDRTNSKKLSEGTLLSLDNQIDATTGTIKVKARFNNQDDALFPNQFVNARMLVDTEQNAVVIPTAALQMGNEGHFVWVLNSENKVSKHLVTPGIQDSQKVVIRAGISAGDRVVTDGIDRLTEGAKVEVVEAQSATTPEEKATSREYAKKGARS,100,gnl|BL_ORD_ID|353|hsp_num:0,387,FALSE,None
LK1198,2_76 # 80224 # 83346 # 1 # ID=2_76;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.564,2_76,80224,83346,+,Strict,1800,2075.44,mdtB,99.52,3000793,protein homolog model,n/a,n/a,aminocoumarin antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGCAGGTGTTACCCCCGAGCAGCACAGGCGGCCCGTCGCGCCTGTTTATTATGCGTCCTGTCGCCACCACGCTGCTGATGGTGGCGATCTTACTCGCCGGGATTATCGGTTATCGCGCCCTGCCCGTTTCGGCGCTGCCGGAAGTGGACTATCCAACCATTCAGGTGGTCACGCTTTATCCAGGTGCGAGCCCGGATGTCATGACCTCTGCCGTTACCGCGCCGCTCGAACGCCAGTTCGGGCAGATGTCTGGCCTGAAACAGATGTCGTCGCAAAGTTCCGGCGGTGCGTCAGTTATCACTTTACAGTTCCAGCTAACATTGCCGCTGGATGTCGCCGAGCAGGAAGTGCAGGCCGCGATTAACGCTGCGACCAACCTGCTACCGAGCGATCTGCCTAACCCGCCGGTTTACAGCAAAGTGAACCCGGCAGATCCACCGATCATGACGCTCGCTGTCACCTCAACCGCCATGCCGATGACGCAGGTGGAAGATATGGTGGAAACCCGCGTCGCGCAGAAAATCTCGCAGATTTCCGGCGTAGGGCTGGTCACACTTTCCGGCGGGCAGCGTCCGGCGGTACGCGTAAAACTCAACGCTCAGGCAATTGCCGCTCTCGGCCTGACCAGCGAAAGTGTGCGCACCGCTATTACTGGCGCGAACGTTAACTCAGCGAAAGGGAGCCTTGACGGCCCTTCTCGCGCGGTCACGCTTTCCGCGAACGACCAGATGCAATCGGCAGAAGAGTATCGTCAGTTGATTATCGCTTATCAGAACGGCGCACCAATTCGTCTTGGCGATGTCGCTACTGTAGAGCAAGGAGCAGAAAACAGCTGGCTCGGCGCGTGGGCGAACAAAGAACAGGCCATTGTGATGAATGTTCAGCGCCAGCCCGGTGCTAACATTATCTCCACCGCCGACAGCATCCGGCAGATGCTACCACAGCTCACCGAGAGTCTGCCGAAATCGCTGAAGGTGACGGTACTTTCTGACCGTACCACCAATATCCGCGCATCGGTCGACGATACCCAGTTTGAGCTGATGATGGCTATCGCGCTGGTAGTCATGATTATCTACCTGTTTTTGCGCAATATTCCGGCGACCATCATTCCCGGTGTCGCAGTGCCGCTGTCGTTAATCGGCACCTTCGCGGTCATGGTGTTTCTCGATTTTTCAATCAATAACCTGACGCTGATGGCACTAACCATCGCCACCGGATTTGTGGTCGATGACGCCATCGTGGTGATCGAGAACATTTCCCGCTATATCGAAAAAGGCGAAAAACCGTTGGCGGCGGCGCTCAAAGGCGCGGGTGAAATCGGCTTTACCATTATCTCGCTGACCTTCTCGCTGATTGCGGTGTTGATCCCCCTGCTGTTTATGGGCGATATCGTCGGGCGACTGTTCCGCGAATTTGCTATTACCCTGGCAGTCGCGATTTTGATCTCAGCGGTGGTGTCGCTAACCCTGACACCGATGATGTGCGCACGGATGCTCAGCCAGGAGTCGCTGCGTAAACAGAACCGCTTCTCCCGTGCCTCGGAGAAAATGTTCGACAGGATAATCGCCGCCTATGGTCGTGGACTGGCGAAAGTGCTGAATCATCCGTGGCTGACCTTAAGCGTGGCGCTCAGCACGCTGCTGCTTAGCGTGCTGCTGTGGGTGTTCATTCCGAAAGGTTTCTTCCCGGTGCAGGACAACGGCATTATTCAGGGCACTTTGCAGGCACCGCAATCCAGCTCCTTTGCCAATATGGCCCAGCGGCAACGCCAGGTCGCGGACGTGATTTTGCAGGATCCGGCAGTGCAAAGTTTGACCTCATTTGTTGGCGTTGATGGCACTAACCCGTCGCTGAACAGTGCGCGTTTACAGATCAATCTCAAACCACTGGATGAACGAGATGACCGGGTGCAAAAAGTCATCGCCCGTCTGCAAACGGCGGTGGATAAAGTGCCGGGCGTCGATCTCTTCCTGCAACCAACGCAGGACCTGACTATTGATACTCAGGTCAGCCGCACCCAGTACCAGTTTACCTTGCAGGCCACGTCACTGGATGCGCTCAGTACCTGGGTGCCACAGTTGATGGAAAAACTCCAGCAGCTGCCACAGCTTTCTGATGTCTCCAGCGACTGGCAGGACAAAGGGCTGGTGGCGTATGTCAATGTCGACAGGGACAGCGCCAGCCGTCTGGGGATCAGCATGGCGGATGTCGATAACGCCCTGTACAACGCGTTTGGTCAGCGACTGATTTCCACTATTTATACTCAGGCTAACCAGTATCGCGTGGTACTGGAACACAACACCGAAAATACCCCAGGCCTCGCGGCTCTGGATACCATTCGCCTGACCAGCAGCGACGGTGGCGTGGTGCCGTTAAGCTCAATTGCCAAAATTGAGCAGCGTTTTGCGCCGCTTTCCATCAACCATCTGGATCAGTTCCCGGTAACGACTATCTCCTTTAACGTGCCGGATAACTATTCGCTGGGCGATGCGGTGCAAGCGATTATGGACACAGAGAAGACGCTGAATCTGCCGGTGGATATCACCACGCAGTTCCAGGGCAGCACCCTCGCCTTCCAGTCGGCATTGGGCAGCACTGTCTGGCTGATTGTCGCGGCGGTGGTGGCGATGTATATCGTGCTCGGCATTCTGTACGAGAGCTTTATTCACCCGATCACCATTCTCTCGACGCTACCCACCGCAGGGGTCGGCGCGCTGCTGGCGTTAATGATTGCCGGTAGCGAACTGGATGTGATTTCCATTATCGGCATTATTTTGCTGATCGGTATCGTGAAGAAGAACGCCATCATGATGATCGACTTCGCGCTGGCTGCTGAGCGCGAGCAAGGCATGTCGCCGCGCGAAGCTATTTACCAGGCTTGTCTGTTGCGTTTTCGTCCGATCCTGATGACCACTCTGGCGGCGCTGTTGGGCGCGCTGCCGTTAATGTTGAGCACGGGTGTCGGCGCGGAATTGCGTCGCCCGTTAGGCATTGGCATGGTCGGCGGTCTCATTGTCAGCCAGGTGCTGACGCTGTTCACCACGCCGGTGATTTATCTGCTGTTCGACCGCCTGGCATTATGGGCCAAAAGCCGCTTTGCCCGTCATGAAGAGGAGGCGTAA,MQVLPPSSTGGPSRLFIMRPVATTLLMVAILLAGIIGYRALPVSALPEVDYPTIQVVTLYPGASPDVMTSAVTAPLERQFGQMSGLKQMSSQSSGGASVITLQFQLTLPLDVAEQEVQAAINAATNLLPSDLPNPPVYSKVNPADPPIMTLAVTSTAMPMTQVEDMVETRVAQKISQISGVGLVTLSGGQRPAVRVKLNAQAIAALGLTSESVRTAITGANVNSAKGSLDGPSRAVTLSANDQMQSAEEYRQLIIAYQNGAPIRLGDVATVEQGAENSWLGAWANKEQAIVMNVQRQPGANIISTADSIRQMLPQLTESLPKSLKVTVLSDRTTNIRASVDDTQFELMMAIALVVMIIYLFLRNIPATIIPGVAVPLSLIGTFAVMVFLDFSINNLTLMALTIATGFVVDDAIVVIENISRYIEKGEKPLAAALKGAGEIGFTIISLTFSLIAVLIPLLFMGDIVGRLFREFAITLAVAILISAVVSLTLTPMMCARMLSQESLRKQNRFSRASEKMFDRIIAAYGRGLAKVLNHPWLTLSVALSTLLLSVLLWVFIPKGFFPVQDNGIIQGTLQAPQSSSFANMAQRQRQVADVILQDPAVQSLTSFVGVDGTNPSLNSARLQINLKPLDERDDRVQKVIARLQTAVDKVPGVDLFLQPTQDLTIDTQVSRTQYQFTLQATSLDALSTWVPQLMEKLQQLPQLSDVSSDWQDKGLVAYVNVDRDSASRLGISMADVDNALYNAFGQRLISTIYTQANQYRVVLEHNTENTPGLAALDTIRLTSSDGGVVPLSSIAKIEQRFAPLSINHLDQFPVTTISFNVPDNYSLGDAVQAIMDTEKTLNLPVDITTQFQGSTLAFQSALGSTVWLIVAAVVAMYIVLGILYESFIHPITILSTLPTAGVGALLALMIAGSELDVISIIGIILLIGIVKKNAIMMIDFALAAEREQGMSPREAIYQACLLRFRPILMTTLAALLGALPLMLSTGVGAELRRPLGIGMVGGLIVSQVLTLFTTPVIYLLFDRLALWAKSRFARHEEEA,MQVLPPSSTGGPSRLFIMRPVATTLLMVAILLAGIIGYRALPVSALPEVDYPTIQVVTLYPGASPDVMTSAVTAPLERQFGQMSGLKQMSSQSSGGASVITLQFQLTLPLDVAEQEVQAAINAATNLLPSDLPNPPVYSKVNPADPPIMTLAVTSTAMPMTQVEDMVETRVAQKISQISGVGLVTLSGGQRPAVRVKLNAQAIAALGLTSETVRTAITGANVNSAKGSLDGPSRAVTLSANDQMQSAEEYRQLIIAYQNGAPIRLGDVATVEQGAENSWLGAWANKEQAIVMNVQRQPGANIISTADSIRQMLPQLTESLPKSVKVTVLSDRTTNIRASVDDTQFELMMAIALVVMIIYLFLRNIPATIIPGVAVPLSLIGTFAVMVFLDFSINNLTLMALTIATGFVVDDAIVVIENISRYIEKGEKPLAAALKGAGEIGFTIISLTFSLIAVLIPLLFMGDIVGRLFREFAITLAVAILISAVVSLTLTPMMCARMLSQESLRKQNRFSRASEKMFDRIIAAYGRGLAKVLNHPWLTLSVALSTLLLSVLLWVFIPKGFFPVQDNGIIQGTLQAPQSSSFANMAQRQRQVADVILQDPAVQSLTSFVGVDGTNPSLNSARLQINLKPLDERDDRVQKVIARLQTAVDKVPGVDLFLQPTQDLTIDTQVSRTQYQFTLQATSLDALSTWVPQLMEKLQQLPQLSDVSSDWQDKGLVAYVNVDRDSASRLGISMADVDNALYNAFGQRLISTIYTQANQYRVVLEHNTENTPGLAALDTIRLTSSDGGVVPLSSIAKIEQRFAPLSINHLDQFPVTTISFNVPDNYSLGDAVQAIMDTEKTLNLPVDITTQFQGSTLAFQSALGSTVWLIVAAVVAMYIVLGILYESFIHPITILSTLPTAGVGALLALLIAGSELDVIAIIGIILLIGIVKKNAIMMIDFALAAEREQGMSPREAIYQACLLRFRPILMTTLAALLGALPLMLSTGVGAELRRPLGIGMVGGLIVSQVLTLFTTPVIYLLFDRLALWTKSRFARHEEEA,100,gnl|BL_ORD_ID|757|hsp_num:0,820,FALSE,None
LK1198,2_77 # 83347 # 86424 # 1 # ID=2_77;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.557,2_77,83347,86424,+,Strict,1800,2041.93,mdtC,98.24,3000794,protein homolog model,n/a,n/a,aminocoumarin antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,GTGAAGTTTTTTGCCCTCTTCATTTACCGCCCGGTGGCGACGATTTTACTGTCGGTCGCCATTACCCTGTGCGGCATACTGGGTTTCCGTATGCTGCCGGTCGCCCCGCTGCCGCAGGTCGATTTTCCGGTGATTATGGTCAGCGCCTCGCTGCCCGGAGCATCGCCAGAGACAATGGCGTCTTCCGTAGCCACACCGCTGGAACGCTCGCTGGGGCGCATTGCCGGGGTTAGTGAAATGACGTCCAGCAGTTCACTCGGCAGCACGCGTATTATTTTGCAGTTTGATTTTGACCGGGATATCAACGGCGCGGCCCGCGATGTCCAGGCGGCGATCAACGCCGCACAAAGTCTGTTGCCCAGCGGGATGCCCAGCCGTCCGACCTATCGCAAAGCGAACCCGTCGGATGCACCGATTATGATCCTGACGCTGACATCCGATACATATTCGCAAGGGCAACTGTACGATTTCGCCTCAACGCAACTGGCCCCGACGATTTCACAAATCGACGGTGTCGGTGATGTTGATGTCGGCGGCAGCTCGCTGCCTGCGGTACGCGTCGGGCTGAACCCGCAGGCGTTGTTTAATCAGGGCGTATCGCTGGACGATGTACGCACTGCCATCAGCAATGCCAACGTGCGTAAACCGCAGGGCGCACTGGAAGATGGCACCCACCGCTGGCAAATCCAGACCAATGACGAACTGAAAACCGCCGCCGAATATCAGCCGCTGATTATTCATTACAACAACGGCGGCGCGGTTCGTCTGGGCGATGTGGCGACGGTGATCGACTCAGTGCAGGATGTGCGTAACGCCGGGATGACCAACGCCAAACCGGCCATTTTGCTGATGATCCGCAAACTGCCGGAAGCCAACATTATCCAGACGGTAGACAGCATCCGCGCCCGTCTGCCGGAATTACAATCCACCATCCCGGCAGCAATTGATCTGCAAATTGCCCAGGATCGCTCCCCTACTATCCGCGCGTCGCTGGAAGAGGTTGAGCAGACACTGGTAATCTCAGTTGCACTGGTGATTCTGGTGGTGTTTTTGTTCCTGCGTTCGGGTCGCGCCACCATTATTCCCGCTGTTGCGGTGCCCGTTTCGCTGATTGGTACATTTGCGACGATGTACCTGTGCGGTTTCAGTCTCAATAACCTGTCGTTAATGGCGCTCACCATTGCCACCGGCTTTGTGGTGGATGACGCCATCGTGGTTCTGGAGAATATTGCCCGTCATCTGGAGGCGGGGATGAAACCGCTACAGGCCGCGCTACAAGGCACTCGTGAAGTCGGCTTTACAGTGCTGTCAATGAGCCTGTCGCTGGTTGCCGTGTTCCTGCCGTTACTGTTGATGGGCGGATTGCCGGGGCGCCTGTTACGCGAGTTTGCCGTGACACTTTCTGTCGCCATTGGTATTTCGTTGCTGGTTTCCCTGACGCTGACGCCGATGATGTGCGGCTGGATGCTGAAAGCCAGTAAACCGCGCAAACAAACGCGACTACGTGGTTTTGGTCGGATGCTGGTTGCCCTGCAACAAGGCTACGGCAAGTCACTAAAATGGGTGCTCAATCATACCCGTCTGGTGGGCGTGGTGCTGCTTGGCACCATTGCGCTGAATATCTGGCTGTATATCTCGATCCCGAAAACCTTCTTCCCGGAGCAGGACACCGGCGTACTGATGGGCGGGATACAGGCTGACCAGAGTATTTCGTTTCAGGCGATGCGCGGTAAGTTGCAGGACTTCATGAAAATTATCCGTGACGATCCGGCGGTGGATAATGTCACCGGCTTTACCGGCGGTTCACGGGTGAACAGTGGAATGATGTTTATCACCCTTAAACCACGCGGCGAGCGGAGCGAAACGGCCCAACAGATTATCGATCGCTTGCGTAAAAAACTGGCGAAAGAACCGGGAGCGAATCTGTTCCTGATGGCGGTACAGGATATTCGCGTTGGCGGACGTCAGGCTAACGCCAGTTACCAGTACACGTTGTTATCCGACGACCTGGCGGCACTGCGCGAATGGGAGCCAAAAATCCGCAAAAAACTGGCGACATTGCCAGAGCTGGCTGATGTTAACTCCGATCAGGAAGATAATGGCGCGGAGATGAACCTTATTTACGATCGCGACACTATGGCGCGATTGGGAATTGACGTGCAAGCCGCCAACAGCCTGTTAAATAACGCCTTCGGTCAGCGGCAAATCTCGACCATTTACCAGCCGATGAACCAGTACAAAGTGGTGATGGAAGTTGATCCGCGCTATACCCAGGACATCAGTGCACTGGAAAAAATGTTCGTTATCAATAACGAAGGAAAAGCGATCCCGCTGTCGTATTTCGCTAAATGGCAACCGGCGAACGCTCCACTGTCGGTGAATCATCAGGGATTATCGGCGGCCTCGACCATTTCGTTCAACCTGCCGACCGGGAAATCGCTCTCGGACGCCAGTGCGGCGATCGATCGCGCAATGACCCAGCTTGGTGTGCCTTCGACGGTGCGCGGCAGTTTTGCCGGAACAGCGCAAGTGTTCCAGGAGACGATGAACTCACAGGTGATCCTGATTATCGCCGCCATCGCCACGGTATATATCGTACTGGGTATCCTTTACGAGAGTTATGTGCATCCACTGACGATTCTCTCCACCCTACCCTCGGCGGGCGTCGGAGCGCTGTTGGCGCTGGAGCTGTTCAATGCCCCGTTCAGCCTAATTGCGCTGATAGGGATCATGTTATTAATCGGCATCGTGAAGAAAAACGCCATTATGATGGTCGATTTTGCGCTTGAAGCCCAACGGCACGGTAACCTGACGCCGCAGGAAGCTATTTTCCAGGCCTGTCTGCTGCGTTTTCGCCCGATTATGATGACTACCCTGGCGGCGCTGTTTGGTGCGCTGCCGCTGGTATTGTCGGGCGGTGACGGCTCGGAGTTGCGGCAACCATTGGGGATCACCATTGTCGGCGGTCTGGTCATGAGCCAGCTTCTGACGCTGTATACCACGCCGGTGGTGTATCTCTTTTTCGACCGTCTGCGGATGCGTTTTTCGCGTAAACCTAAACAAGCGGTAACCGAGTAA,MKFFALFIYRPVATILLSVAITLCGILGFRMLPVAPLPQVDFPVIMVSASLPGASPETMASSVATPLERSLGRIAGVSEMTSSSSLGSTRIILQFDFDRDINGAARDVQAAINAAQSLLPSGMPSRPTYRKANPSDAPIMILTLTSDTYSQGQLYDFASTQLAPTISQIDGVGDVDVGGSSLPAVRVGLNPQALFNQGVSLDDVRTAISNANVRKPQGALEDGTHRWQIQTNDELKTAAEYQPLIIHYNNGGAVRLGDVATVIDSVQDVRNAGMTNAKPAILLMIRKLPEANIIQTVDSIRARLPELQSTIPAAIDLQIAQDRSPTIRASLEEVEQTLVISVALVILVVFLFLRSGRATIIPAVAVPVSLIGTFATMYLCGFSLNNLSLMALTIATGFVVDDAIVVLENIARHLEAGMKPLQAALQGTREVGFTVLSMSLSLVAVFLPLLLMGGLPGRLLREFAVTLSVAIGISLLVSLTLTPMMCGWMLKASKPRKQTRLRGFGRMLVALQQGYGKSLKWVLNHTRLVGVVLLGTIALNIWLYISIPKTFFPEQDTGVLMGGIQADQSISFQAMRGKLQDFMKIIRDDPAVDNVTGFTGGSRVNSGMMFITLKPRGERSETAQQIIDRLRKKLAKEPGANLFLMAVQDIRVGGRQANASYQYTLLSDDLAALREWEPKIRKKLATLPELADVNSDQEDNGAEMNLIYDRDTMARLGIDVQAANSLLNNAFGQRQISTIYQPMNQYKVVMEVDPRYTQDISALEKMFVINNEGKAIPLSYFAKWQPANAPLSVNHQGLSAASTISFNLPTGKSLSDASAAIDRAMTQLGVPSTVRGSFAGTAQVFQETMNSQVILIIAAIATVYIVLGILYESYVHPLTILSTLPSAGVGALLALELFNAPFSLIALIGIMLLIGIVKKNAIMMVDFALEAQRHGNLTPQEAIFQACLLRFRPIMMTTLAALFGALPLVLSGGDGSELRQPLGITIVGGLVMSQLLTLYTTPVVYLFFDRLRMRFSRKPKQAVTE,MKFFALFIYRPVATILLSVAITLCGILGFRMLPVAPLPQVDFPVIIVSASLPGASPETMASSVATPLERSLGRIAGVSEMTSSSSLGSTRIILQFDFDRDINGAARDVQAAINAAQSLLPSGMPSRPTYRKANPSDAPIMILTLTSDTYSQGELYDFASTQLAPTISQIDGVGDVDVGGSSLPAVRVGLNPQALFNQGVSLDDVRTAVSNANVRKPQGALEDGTHRWQIQTNDELKTAAEYQPLIIHYNNGGAVRLGDVATVTDSVQDVRNAGMTNAKPAILLMIRKLPEANIIQTVDSIRAKLPELQETIPAAIDLQIAQDRSPTIRASLEEVEQTLIISVALVILVVFLFLRSGRATIIPAVSVPVSLIGTFAAMYLCGFSLNNLSLMALTIATGFVVDDAIVVLENIARHLEAGMKPLQAALQGTREVGFTVLSMSLSLVAVFLPLLLMGGLPGRLLREFAVTLSVAIGISLLVSLTLTPMMCGWMLKASKPREQKRLRGFGRMLVALQQGYGKSLKWVLNHTRLVGVVLLGTIALNIWLYISIPKTFFPEQDTGVLMGGIQADQSISFQAMRGKLQDFMKIIRDDPAVDNVTGFTGGSRVNSGMMFITLKPRDERSETAQQIIDRLRVKLAKEPGANLFLMAVQDIRVGGRQSNASYQYTLLSDDLAALREWEPKIRKKLATLPELADVNSDQQDNGAEMNLVYDRDTMARLGIDVQAANSLLNNAFGQRQISTIYQPMNQYKVVMEVDPRYTQDISALEKMFVINNEGKAIPLSYFAKWQPANAPLSVNHQGLSAASTISFNLPTGKSLSDASAAIDRAMTQLGVPSTVRGSFAGTAQVFQETMNSQVILIIAAIATVYIVLGILYESYVHPLTILSTLPSAGVGALLALELFNAPFSLIALIGIMLLIGIVKKNAIMMVDFALEAQRHGNLTPQEAIFQACLLRFRPIMMTTLAALFGALPLVLSGGDGSELRQPLGITIVGGLVMSQLLTLYTTPVVYLFFDRLRLRFSRKPKQTVTE,100,gnl|BL_ORD_ID|1212|hsp_num:0,1315,FALSE,None
LK1198,2_79 # 87837 # 89240 # 1 # ID=2_79;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.533,2_79,87837,89240,+,Strict,850,897.886,baeS,96.15,3000829,protein homolog model,n/a,n/a,aminoglycoside antibiotic; aminocoumarin antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGAAGTTCTGGCGACCCGGTATTACCGGCAAACTGTTTCTGGCGATTTTCGCCACCTGCATTGTCTTATTGATCACGATGCACTGGGCGGTACGTATCAGTTTTGAGCGCGGCTTTATCGATTACATCAAGCATGGTAATGAACAACGGCTGCAAATGCTCGGCGATGCGCTTGGTGAGCAGTACGCCCAGCACGGGAACTGGCGCTTCCTGCGTAATAACGATCGCTTTGTATTTCAGATCCTACGTTCACTGGAGCATGATAACAACGAAGATAAGCCCGGCCCCGGTATGCCACCACACGGCTGGCGCACGCAATTTTGGGTGGTTGATCAAAATAATAAAGTGCTGGTTGGCCCGCGAGCACCGGTTCCACCCGACGGCACACGGCGGCCCATTATGGTCAATGGTGCGGAAGTTGGCGCGGTGATCGCCTCCCCTGTTGAACGACTGACCCGTAATACTGATATCAATTTTGACAGACAACAGCGGCAAACCAGTTGGCTGATTGTGGCTTTATCTACCTTATTAGCGGCGCTGGCGACATTCCCACTGGCGCGCGGTTTGCTGGCTCCGGTAAAACGACTGGTGGATGGCACGCACAAACTGGCAGCGGGTGATTTCACTACTCGCGTAGCCCCCACCAGCGAAGATGAGTTGGGCAGACTGGCAGAGGATTTCAATCAACTCGCCAGCACACTGGAGAAAAACCAGCAGATGCGCCGCGATTTTATGGCCGATATTTCTCATGAACTGCGCACGCCTTTAGCAGTACTGCGCGGCGAACTGGAAGCCATTCAGGATGGTGTGCGTAAATTCACGCCGGAGACGCTGGCTTCTTTACAGGCAGAAGTCGGTACGCTGACAAAACTGGTTGACGATCTCCATCAATTGTCTATGTCTGATGAAGGCGCTCTCGCCTATCAAAAAGCACCGGTAGATTTGATCCCACTGCTGGAAGTGGCGGGAGGCGCATTTCGCGAACGATTCGCCAGCCGTGGCCTGAAATTGCAATTTTCCCTGCCAGACAGTATTACCGTATTTGGCGATCGCGATCGTTTAATGCAGTTGTTCAATAACTTACTGGAAAACAGCCTGCGCTACACTGACAGCGGCGGCAGCCTGAAAATCTCTGCCGAGCAGCACGACAAAACGGTGCGCCTGACCTTTGCCGACAGTGCGCCGGGTGTCAGTGACGATCAGCTACAAAAATTGTTTGAACGTTTTTATCGCACCGAAGGTTCCCGCAACCGCGCCAGCGGTGGTTCCGGGCTGGGGCTGGCGATTTGCCTGAACATTGTTGAAGCACATAACGGCCGCATTATTGCCGCCCATTCGCCTTTTGGCGGGCTTAGCATTACAGTAGAGTTACCGCTGGAACGGGATTTACAGAGAGAAGTATGA,MKFWRPGITGKLFLAIFATCIVLLITMHWAVRISFERGFIDYIKHGNEQRLQMLGDALGEQYAQHGNWRFLRNNDRFVFQILRSLEHDNNEDKPGPGMPPHGWRTQFWVVDQNNKVLVGPRAPVPPDGTRRPIMVNGAEVGAVIASPVERLTRNTDINFDRQQRQTSWLIVALSTLLAALATFPLARGLLAPVKRLVDGTHKLAAGDFTTRVAPTSEDELGRLAEDFNQLASTLEKNQQMRRDFMADISHELRTPLAVLRGELEAIQDGVRKFTPETLASLQAEVGTLTKLVDDLHQLSMSDEGALAYQKAPVDLIPLLEVAGGAFRERFASRGLKLQFSLPDSITVFGDRDRLMQLFNNLLENSLRYTDSGGSLKISAEQHDKTVRLTFADSAPGVSDDQLQKLFERFYRTEGSRNRASGGSGLGLAICLNIVEAHNGRIIAAHSPFGGLSITVELPLERDLQREV,MKFWRPGITGKLFLAIFATCIVLLISMHWAVRISFERGFIDYIKHGNEQRLQLLSDALGEQYAQHGNWRFLRNNDRFVFQILRSFEHDNSEDKPGPGMPPHGWRTQFWVVDQNNKVLVGPRAPIPPDGTRRPILVNGAEVGAVIASPVERLTRNTDINFDKQQRQTSWLIVALATLLAALATFLLARGLLAPVKRLVDGTHKLAAGDFTTRVTPTSEDELGKLAQDFNQLASTLEKNQQMRRDFMADISHELRTPLAVLRGELEAIQDGVRKFTPETVASLQAEVGTLTKLVDDLHQLSMSDEGALAYQKAPVDLIPLLEVAGGAFRERFASRGLKLQFSLPDSITVFGDRDRLMQLFNNLLENSLRYTDSGGSLQISAGQRDKTVRLTFADSAPGVSDDQLQKLFERFYRTEGSRNRASGGSGLGLAICLNIVEAHNGRIIAAHSPFGGVSITVELPLERDLQREV,100,gnl|BL_ORD_ID|913|hsp_num:0,986,FALSE,None
LK1198,2_80 # 89237 # 89959 # 1 # ID=2_80;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.539,2_80,89237,89959,+,Perfect,450,486.493,baeR,100,3000828,protein homolog model,n/a,n/a,aminoglycoside antibiotic; aminocoumarin antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGACCGAGTTACCAATCGACGAAAACACACCGCGTATTTTGATCGTGGAAGATGAACCGAAGCTGGGGCAGTTGCTCATTGATTATCTGCGTGCTGCGAGCTATGCGCCAACGTTGATTAGCCACGGCGATCAGGTACTGCCATATGTGCGCCAGACACCACCGGATCTGATCCTGTTGGATCTGATGCTCCCTGGCACCGATGGCCTGACGCTGTGCCGGGAAATTCGTCGTTTTTCTGACATTCCGATCGTGATGGTGACGGCAAAAATCGAAGAGATCGACCGCCTGCTGGGGTTGGAGATTGGCGCAGATGACTATATCTGCAAGCCGTACAGCCCACGGGAAGTGGTAGCGCGCGTCAAAACCATTTTGCGCCGTTGCAAACCGCAGCGTGAGTTGCAGCAACAGGATGCTGAAAGCCCGTTGATTATCGACGAAGGTCGTTTTCAGGCTTCCTGGCGCGGTAAAATGCTTGACCTGACGCCTGCAGAATTTCGTCTGCTGAAAACGCTCTCTCATGAACCAGGAAAAGTGTTCTCCCGCGAGCAGTTGCTGAACCATCTTTATGACGACTACCGCGTGGTAACCGACCGTACCATCGACAGCCACATTAAAAACTTGCGCCGCAAGCTGGAATCTCTCGACGCCGAACAGTCATTTATCCGCGCCGTTTACGGCGTCGGTTACCGCTGGGAAGCCGACGCCTGCCGCATCGTTTAA,MTELPIDENTPRILIVEDEPKLGQLLIDYLRAASYAPTLISHGDQVLPYVRQTPPDLILLDLMLPGTDGLTLCREIRRFSDIPIVMVTAKIEEIDRLLGLEIGADDYICKPYSPREVVARVKTILRRCKPQRELQQQDAESPLIIDEGRFQASWRGKMLDLTPAEFRLLKTLSHEPGKVFSREQLLNHLYDDYRVVTDRTIDSHIKNLRRKLESLDAEQSFIRAVYGVGYRWEADACRIV,MTELPIDENTPRILIVEDEPKLGQLLIDYLRAASYAPTLISHGDQVLPYVRQTPPDLILLDLMLPGTDGLTLCREIRRFSDIPIVMVTAKIEEIDRLLGLEIGADDYICKPYSPREVVARVKTILRRCKPQRELQQQDAESPLIIDEGRFQASWRGKMLDLTPAEFRLLKTLSHEPGKVFSREQLLNHLYDDYRVVTDRTIDSHIKNLRRKLESLDAEQSFIRAVYGVGYRWEADACRIV,100,gnl|BL_ORD_ID|1231|hsp_num:0,1337,FALSE,None
LK1198,2_206 # 225848 # 227491 # -1 # ID=2_206;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.533,2_206,225848,227491,-,Strict,1050,1106.66,YojI,99.63,3003952,protein homolog model,n/a,n/a,peptide antibiotic,antibiotic efflux,ATP-binding cassette (ABC) antibiotic efflux pump,ATGGAACTTCTTGTACTTGTCTGGCGGCAGTATCGCTGGCCATTTATCAGTGTGATGGCGCTAAGCCTCGCCAGTGCGGCATTAGGCATTGGCTTAATTGCTTTTATCAATCAGCGCCTTATCGAAACGGCGGATACCAGTCTGCTGGTATTGCCGGAGTTTCTGGGGTTATTGCTGCTGTTGATGGCCGTCACTCTCGGATCGCAACTGGCGCTCACCACTTTGGGGCATCACTTCGTTTACCGACTGCGTAGTGAATTTATCAAGCGGATTCTCGATACTCACGTCGAGCGCATTGAACAACTCGGTAGCGCCTCGTTGCTGGCGGGATTAACCAGCGATGTGCGCAATATCACCATTGCTTTTGTGCGTCTGCCGGAACTGGTGCAGGGGATCATTCTCACTATCGGTTCAGCGGCGTATTTGTGGATGCTGTCGGGCAAAATGTTGCTGGTAACGGCTATCTGGATGGCAGTCACCATCTGGGGCGGTTTTGTGCTGGTGGCGCGGGTGTACAAACATATGGCGACCCTGCGTGAAACCGAAGATAAGCTGTACACGGATTTTCAAACTGTACTCGAAGGGCGCAAAGAGCTGACTCTGAACCGTGAACGCGCCGAGTATGTGTTTAACAACCTCTACATTCCTGATGCGCAAGAGTATCGCCATCATATTATTCGCGCAGACACCTTCCATCTTAGTGCCGTGAACTGGTCAAACATCATGATGCTGGGCGCTATCGGCCTGGTGTTCTGGATGGCGAACAGTCTCGGTTGGGCTGATACCAACGTTGCTGCGACCTATTCGTTGACGCTGTTATTCCTGCGTACGCCGCTGCTTTCGGCGGTTGGCGCATTGCCGACGCTGCTGACGGCGCAGGTGGCGTTTAACAAGCTGAACAAATTCGCGCTCGCGCCTTTCAAAGCAGAGTTTCCGCGCCCGCAGGCTTTTCCCAACTGGCAAACGCTGGAGCTGCGTAACGTGACGTTTGCTTATCAGGATAACGCGTTTTCCGTTGGGCCGATTAACCTCACCATCAAACGTGGTGAACTGCTGTTTCTGATTGGTGGCAACGGTAGTGGAAAATCGACGCTGGCGATGTTGCTGACGGGCTTGTACCAACCACAAAGCGGCGAAATCTTGCTGGATGGCAAACCTGTCAGCGGCGAACAACCGGAAGATTATCGCAAACTGTTTTCGGCAGTGTTTACCGATGTCTGGCTGTTTGATCAACTGCTGGGGCCGGAGGGGCAACCCGCTAACCCGCAACTGGTTGAGAAGTGGCTGGCGCAGCTGAAAATGGCTCATAAGCTTGAGTTAAGCAACGGGCGTATTGTTAACCTGAAGTTATCAAAAGGGCAGAAAAAACGCGTGGCGCTGTTGCTGGCGCTGGCAGAAGAACGCGATATTATCCTGCTGGATGAATGGGCGGCGGATCAGGATCCACACTTCCGTCGTGAGTTTTATCAGGTGCTGCTGCCGCTGATGCAGGAGATGGGTAAAACTATTTTCGCCATCAGTCATGATGATCATTACTTTATCCACGCCGACCGCCTGCTGGAAATGCGCAACGGGCAACTTAGCGAGCTGACAGGCGAAGAGCGCGATGCTGCTTCGCGTGATGCCGTTGCCCGGACGGCATAA,MELLVLVWRQYRWPFISVMALSLASAALGIGLIAFINQRLIETADTSLLVLPEFLGLLLLLMAVTLGSQLALTTLGHHFVYRLRSEFIKRILDTHVERIEQLGSASLLAGLTSDVRNITIAFVRLPELVQGIILTIGSAAYLWMLSGKMLLVTAIWMAVTIWGGFVLVARVYKHMATLRETEDKLYTDFQTVLEGRKELTLNRERAEYVFNNLYIPDAQEYRHHIIRADTFHLSAVNWSNIMMLGAIGLVFWMANSLGWADTNVAATYSLTLLFLRTPLLSAVGALPTLLTAQVAFNKLNKFALAPFKAEFPRPQAFPNWQTLELRNVTFAYQDNAFSVGPINLTIKRGELLFLIGGNGSGKSTLAMLLTGLYQPQSGEILLDGKPVSGEQPEDYRKLFSAVFTDVWLFDQLLGPEGQPANPQLVEKWLAQLKMAHKLELSNGRIVNLKLSKGQKKRVALLLALAEERDIILLDEWAADQDPHFRREFYQVLLPLMQEMGKTIFAISHDDHYFIHADRLLEMRNGQLSELTGEERDAASRDAVARTA,MELLVLVWRQYRWPFISVMALSLASAALGIGLIAFINQRLIETADTSLLVLPEFLGLLLLLMAVTLGSQLALTTLGHHFVYRLRSEFIKRILDTHVERIEQLGSASLLAGLTSDVRNITIAFVRLPELVQGIILTIGSAAYLWMLSGKMLLVTAIWMAITIWGGFVLVARVYKHMATLRETEDKLYTDFQTVLEGRKELTLNRERAEYVFNNLYIPDAQEYRHHIIRADTFHLSAVNWSNIMMLGAIGLVFWMANSLGWADTNVAATYSLTLLFLRTPLLSAVGALPTLLTAQVAFNKLNKFALAPFKAEFPRPQAFPNWQTLELRNVTFAYQDNAFSVGPINLTIKRGELLFLIGGNGSGKSTLAMLLTGLYQPQSGEILLDGKPVSGEQPEDYRKLFSAVFTDVWLFDQLLGPEGKPANPQLVEKWLAQLKMAHKLELSNGRIVNLKLSKGQKKRVALLLALAEERDIILLDEWAADQDPHFRREFYQVLLPLMQEMGKTIFAISHDDHYFIHADRLLEMRNGQLSELTGEERDAASRDAVARTA,100,gnl|BL_ORD_ID|4709|hsp_num:0,2424,FALSE,None
LK1198,2_249 # 285734 # 286702 # 1 # ID=2_249;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.510,2_249,285734,286702,+,Strict,550,662.914,PmrF,99.38,3003578,protein homolog model,n/a,n/a,peptide antibiotic,antibiotic target alteration,pmr phosphoethanolamine transferase,ATGTTTGAAATCCACCCTGTTAAGAAAGTCTCGGTGGTTATTCCCGTTTATAACGAGCAGGAAAGCTTACCGGAATTAATCAGGCGCACCACCGCAGCCTGTGAATCACTGGGGAAAGAGTATGAAATCCTGCTGATTGATGACGGCAGTAGCGATAATTCCGCGCATATGCTGGTCGAAGCCTCACAAGCGGAGGGCAGCCATATTGTGTCTATCTTGCTTAACCGCAATTACGGGCAACATTCAGCGATTATGGCGGGATTCAGTCACGTCACCGGCGACTTAATTATTACCCTCGATGCCGATCTCCAGAATCCGCCAGAGGAAATCCCCCGTCTGGTGGCAAAAGCCGATGAAGGTTACGACGTGGTAGGGACTGTACGCCAGAACCGCCAGGACAGCTGGTTTCGTAAAACCGCTTCGAAGATGATTAACCGGCTTATTCAGCGCACCACTGGCAAAGCGATGGGTGACTATGGTTGTATGCTGCGCGCCTATCGCCGTCATATTGTCGATGCGATGTTGCACTGCCATGAACGCAGCACCTTTATCCCGATTCTGGCGAATATCTTCGCCCGCCGTGCCATTGAAATTCCAGTGCACCATGCCGAGCGTGAGTTTGGTGAATCCAAATACAGCTTTATGCGCCTGATTAATTTGATGTACGACCTGGTGACCTGTCTTACCACAACGCCGCTACGTATGCTGAGTCTGCTCGGCAGCATTATTGCGATTGGCGGTTTTAGCATTGCGGTGCTGCTGGTGATTTTACGCCTGACCTTCGGACCCCAATGGGCGGCAGAAGGCGTCTTTATGCTATTTGCCGTGCTGTTTACTTTTATTGGCGCTCAGTTTATCGGCATGGGATTGCTCGGTGAATATATCGGCAGGATCTACACCGATGTCCGCGCCCGCCCCCGCTATTTTGTTCAGCAAGTTATCCGTCCATCCAGCAAGGAAAATGAATAA,MFEIHPVKKVSVVIPVYNEQESLPELIRRTTAACESLGKEYEILLIDDGSSDNSAHMLVEASQAEGSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEGYDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHERSTFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLGSIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYTDVRARPRYFVQQVIRPSSKENE,MFEIHPVKKVSVVIPVYNEQESLPELIRRTTTACESLGKEYEILLIDDGSSDNSAHMLVEASQAENSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEGYDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHERSTFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLGSIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYTDVRARPRYFVQQVIRPSSKENE,100,gnl|BL_ORD_ID|1937|hsp_num:0,2014,FALSE,None
LK1198,2_342 # 384107 # 385645 # -1 # ID=2_342;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.417,2_342,384107,385645,-,Strict,900,1021.92,emrY,99.8,3000254,protein homolog model,n/a,n/a,tetracycline antibiotic,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGGCAATCACTAAATCAACTCCTGCACCATTAACCGGTGGGACGTTATGGTGCGTCACTATTGCATTGTCATTAGCGACGTTTATGCAAATGTTGGATTCCACTATTTCTAACGTCGCAATACCGACAATATCTGGCTTTCTGGGAGCATCAACAGACGAAGGCACCTGGGTTATCACCTCGTTTGGCGTAGCAAATGCCATTGCGATCCCTGTTACCGGCAGGCTGGCACAAAGAATAGGCGAATTAAGGTTATTTTTACTTTCAGTAACCTTTTTTTCGCTGTCTTCATTAATGTGTAGTTTATCGACCAATCTAGATGTGCTGATATTTTTTAGAGTCGTTCAGGGGTTAATGGCGGGGCCGTTAATTCCACTGTCACAGAGTTTATTATTAAGGAATTATCCACCAGAAAAAAGAACATTTGCTCTGGCATTATGGTCAATGACCGTGATTATCGCTCCGATATGTGGGCCGATATTGGGCGGCTATATTTGCGATAACTTTAGCTGGGGTTGGATATTTTTAATCAATGTCCCTATGGGGATTATCGTCCTGACATTATGCTTAACCTTACTTAAAGGAAGAGAAACTGAGACTTCACCGGTCAAAATGAATCTACCAGGACTGACCCTGTTAGTGCTCGGTGTTGGTGGCTTGCAAATTATGCTTGATAAAGGGCGCGATCTGGATTGGTTCAACTCGAGTACAATAATACTACTAACAGTAGTATCAGTTATTTCTCTGATCTCTTTAGTCATTTGGGAGTCGACCTCAGAGAATCCGATTCTTGACCTCAGTTTGTTTAAGTCCCGTAATTTCACCATTGGTATTGTGAGTATCACATGCGCGTATTTATTTTACTCTGGAGCGATAGTTCTTATGCCGCAGTTACTCCAGGAAACGATGGGGTATAATGCGATATGGGCCGGACTTGCCTATGCGCCCATCGGTATCATGCCGCTATTAATATCACCTTTGATAGGACGTTATGGCAACAAAATTGATATGCGGTTGTTGGTGACATTTAGTTTTTTGATGTATGCGGTTTGCTATTACTGGCGTTCTGTGACATTTATGCCAACGATTGATTTTACAGGCATCATTTTGCCACAGTTTTTTCAGGGATTCGCCGTTGCCTGTTTCTTTTTACCCTTAACAACGATTTCGTTTTCAGGCTTGCCAGATAATAAATTTGCCAATGCCTCGAGTATGAGTAATTTTTTTCGCACCTTGTCAGGATCAGTTGGTACGTCGTTGACAATGACACTGTGGGGACGCCGCGAATCGTTACACCATAGTCAGTTGACAGCAACCATCGATCAATTTAACCCCGTGTTTAATTCATCGTCACAAATTATGGATAAATACTATGGTTCGCTTTCAGGAGTTCTTAATGAAATTAATAATGAAATAACTCAGCAGTCACTTTCTATTTCTGCAAATGAGATTTTCCGTATGGCGGCTATTGCTTTTATCTTACTTACGGTTTTGGTTTGGTTTGCGAAACCGCCGTTTACAGCGAAAGGCGTTGGGTGA,MAITKSTPAPLTGGTLWCVTIALSLATFMQMLDSTISNVAIPTISGFLGASTDEGTWVITSFGVANAIAIPVTGRLAQRIGELRLFLLSVTFFSLSSLMCSLSTNLDVLIFFRVVQGLMAGPLIPLSQSLLLRNYPPEKRTFALALWSMTVIIAPICGPILGGYICDNFSWGWIFLINVPMGIIVLTLCLTLLKGRETETSPVKMNLPGLTLLVLGVGGLQIMLDKGRDLDWFNSSTIILLTVVSVISLISLVIWESTSENPILDLSLFKSRNFTIGIVSITCAYLFYSGAIVLMPQLLQETMGYNAIWAGLAYAPIGIMPLLISPLIGRYGNKIDMRLLVTFSFLMYAVCYYWRSVTFMPTIDFTGIILPQFFQGFAVACFFLPLTTISFSGLPDNKFANASSMSNFFRTLSGSVGTSLTMTLWGRRESLHHSQLTATIDQFNPVFNSSSQIMDKYYGSLSGVLNEINNEITQQSLSISANEIFRMAAIAFILLTVLVWFAKPPFTAKGVG,MAITKSTPAPLTGGTLWCVTIALSLATFMQMLDSTISNVAIPTISGFLGASTDEGTWVITSFGVANAIAIPVTGRLAQRIGELRLFLLSVTFFSLSSLMCSLSTNLDVLIFFRVVQGLMAGPLIPLSQSLLLRNYPPEKRTFALALWSMTVIIAPICGPILGGYICDNFSWGWIFLINVPMGIIVLTLCLTLLKGRETETSPVKMNLPGLTLLVLGVGGLQIMLDKGRDLDWFNSSTIIILTVVSVISLISLVIWESTSENPILDLSLFKSRNFTIGIVSITCAYLFYSGAIVLMPQLLQETMGYNAIWAGLAYAPIGIMPLLISPLIGRYGNKIDMRLLVTFSFLMYAVCYYWRSVTFMPTIDFTGIILPQFFQGFAVACFFLPLTTISFSGLPDNKFANASSMSNFFRTLSGSVGTSLTMTLWGRRESLHHSQLTATIDQFNPVFNSSSQIMDKYYGSLSGVLNEINNEITQQSLSISANEIFRMAAIAFILLTVLVWFAKPPFTAKGVG,100,gnl|BL_ORD_ID|491|hsp_num:0,540,FALSE,None
LK1198,2_343 # 385645 # 386808 # -1 # ID=2_343;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.413,2_343,385645,386808,-,Strict,600,712.22,emrK,98.86,3000206,protein homolog model,n/a,n/a,tetracycline antibiotic,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,GTGGAACAGATTAATTCAAATAAAAAACATTCTGACAGAAGAAAATATTTTGCTTTGTTAGCGGTAGTTTTATTTATTGCGTTTTCAGGTGCCTATGCCTATTGGTCAATGGAATTAAAAGACATGATTAGTACAGATGACGCCTATGTCACGGGAAATGCAGATCCAATTTCTGCACAAGTCTCAGGCAGTGTCACTGTCGTTAATCATAAAGATACGAACTACGTTCGACAAGGTGACATTTTAGTTTCACTGGATAAAACTGATGCCACTATCGCACTCAATAAAGCTAAAAATAATCTGGCAAATATTGTTCGGCAAACGAATAAACTATACTTACAGGATAAACAATACAGTGCCGAAGTCGCTTCAGCACGTATTCAGTATCAACAATCTTTAGAAGATTATAACCGTCGTGTGCCTTTAGCGAAGCAAGGGGTTATTTCAAAAGAAGCGCTGGAGCATACCAAAGATACGTTAATAAGTAGCAAAGCGGCATTGAATGCTGCTATCCAGGCTTATAAAGCGAATAAAGCTTTAGTAATGAACACACCATTAAACCGTCAGCCACAAGTCATTGAAGCTGCAGATGCAACCAAAGAAGCCTGGTTGGCGCTTAAACGTACGGATATTAAGAGTCCGGTTACCGGTTATATTGCCCAGAGAAGTGTTCAGGTCGGCGAAACAGTGAGTCCCGGACAATCGTTAATGGCTGTCGTACCGGCGCGTCAAATGTGGGTTAATGCCAACTTTAAAGAAACACAACTCACGGATGTACGGATTGGTCAATCGGTCAATATTATCAGCGATCTTTATGGTGAAAATGTTGTGTTTCATGGTCGGGTGACAGGGATCAATATGGGAACCGGCAATGCGTTCTCCTTATTACCTGCACAAAATGCGACAGGGAACTGGATCAAAATCGTTCAGCGTGTACCGGTTGAAGTTTCTCTGGATCCAAAAGAACTCATGGAACACCCTTTGCGTATTGGTTTATCGATGACTGCAACTATTGATACGAAGAATGAAGACATTGCCGAGATGCCCGATCTGGCTTCAACCGTGACGTCCATGCCTGCTTATACCAGTAAGGCTTTAGTTATCGATACCAGTCCGATAGAAAAAGAAATTAGCAACATTATTTCGCATAATGGACAACTTTAA,MEQINSNKKHSDRRKYFALLAVVLFIAFSGAYAYWSMELKDMISTDDAYVTGNADPISAQVSGSVTVVNHKDTNYVRQGDILVSLDKTDATIALNKAKNNLANIVRQTNKLYLQDKQYSAEVASARIQYQQSLEDYNRRVPLAKQGVISKEALEHTKDTLISSKAALNAAIQAYKANKALVMNTPLNRQPQVIEAADATKEAWLALKRTDIKSPVTGYIAQRSVQVGETVSPGQSLMAVVPARQMWVNANFKETQLTDVRIGQSVNIISDLYGENVVFHGRVTGINMGTGNAFSLLPAQNATGNWIKIVQRVPVEVSLDPKELMEHPLRIGLSMTATIDTKNEDIAEMPDLASTVTSMPAYTSKALVIDTSPIEKEISNIISHNGQL,MELEDMISTDDAYVTGNADPISAQVSGSVTVVNHKDTNYVRQGDILVSLDKTDATIALNKAKNNLANIVRQTNKLYLQDKQYSAEVASARIQYQQSLEDYNRRVPLAKQGVISKETLEHTKDTLISSKAALNAAIQAYKANKALVMNTPLNRQPQVVEAADATKEAWLALKRTDIKSPVTGYIAQRSVQVGETVSPGQSLMAVVPARQMWVNANFKETQLTDVRIGQSVNIISDLYGENVVFHGRVTGINMGTGNAFSLLPAQNATGNWIKIVQRVPVEVSLDPKELMEHPLRIGLSMTATIDTKNEDIAEMPELASTVTSMPAYTSKALVIDTSPIEKEISNIISHNGQL,110.26,gnl|BL_ORD_ID|556|hsp_num:0,609,FALSE,None
LK1198,2_344 # 387224 # 387838 # 1 # ID=2_344;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.397,2_344,387224,387838,+,Perfect,390,417.157,evgA,100,3000832,protein homolog model,n/a,n/a,macrolide antibiotic; fluoroquinolone antibiotic; penam; tetracycline antibiotic,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGAACGCAATAATTATTGATGACCATCCTCTTGCTATCGCAGCAATTCGTAATTTATTGATCAAAAACGATATTGAAATCTTAGCAGAGTTGACTGAAGGCGGAAGCGCCGTTCAGCGGGTGGAAACACTTAAGCCTGATATCGTCATCATTGATGTCGATATCCCCGGAGTTAACGGTATCCAGGTGTTAGAAACGCTGAGAAAGCGCCAATATAGCGGAATTATTATTATTGTCTCCGCTAAAAATGACCATTTTTACGGGAAACATTGTGCTGATGCTGGCGCTAATGGTTTCGTGAGTAAAAAAGAAGGCATGAACAATATCATTGCGGCTATTGAAGCTGCAAAAAATGGCTACTGCTATTTCCCCTTCTCTCTCAACCGGTTTGTTGGAAGTTTAACGTCCGACCAACAAAAACTCGACTCCTTATCGAAACAAGAAATTAGTGTCATGCGGTATATTCTTGATGGCAAGGATAATAATGACATTGCTGAAAAAATGTTCATCAGCAACAAAACTGTCAGCACTTATAAAAGTCGCTTGATGGAAAAATTAGAATGCAAATCACTGATGGATCTTTACACATTCGCACAACGTAACAAAATCGGCTAA,MNAIIIDDHPLAIAAIRNLLIKNDIEILAELTEGGSAVQRVETLKPDIVIIDVDIPGVNGIQVLETLRKRQYSGIIIIVSAKNDHFYGKHCADAGANGFVSKKEGMNNIIAAIEAAKNGYCYFPFSLNRFVGSLTSDQQKLDSLSKQEISVMRYILDGKDNNDIAEKMFISNKTVSTYKSRLMEKLECKSLMDLYTFAQRNKIG,MNAIIIDDHPLAIAAIRNLLIKNDIEILAELTEGGSAVQRVETLKPDIVIIDVDIPGVNGIQVLETLRKRQYSGIIIIVSAKNDHFYGKHCADAGANGFVSKKEGMNNIIAAIEAAKNGYCYFPFSLNRFVGSLTSDQQKLDSLSKQEISVMRYILDGKDNNDIAEKMFISNKTVSTYKSRLMEKLECKSLMDLYTFAQRNKIG,100,gnl|BL_ORD_ID|936|hsp_num:0,1015,FALSE,None
LK1198,2_345 # 387843 # 391436 # 1 # ID=2_345;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.409,2_345,387843,391436,+,Strict,2300,2409.41,evgS,96.66,3000833,protein homolog model,n/a,n/a,macrolide antibiotic; fluoroquinolone antibiotic; penam; tetracycline antibiotic,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGAAGTTTTTACCCTATATTTTTCTTCTCTGTTGTGGTCTTTGGTCGACCATAAGTTTCGCAGACGGAGATTACATCGAATATCGTGGCATCAGTAGTAACAACCGTGTCACACTTGATCCACTACGTCTGAGCAACAAGGAATTACGTTGGCTCGCGAGCAAAAAAAATCTTGTGATTGCAGTACACAAGTCCCAAACAGCTACGTTGTTGCATACCGATTCGCAGCAACGGATTCGTGGTATTAATGCTGATTATTTAAATCTTTTAAAAAGAGCGTTAAATATCAAATTAACACTCCGGGAATACGCAGATCATCAAAAAGCAATGGACGCGCTGGAAGACGGTGAAGTTGATATAGTGTTATCACATTTAGTTGCTTCGCCGCCTCTTAATGATGACATTGCTGCAACTAATCCTCTGATAATTACCTTTCCGGCGCTGGTCACTACCCTTCACGATTCAATGCGACCGCTTACCTCATCAAAACCAGTAAATATTGCTCGAGTAGCAAATTATCCCCCAGACGAGGTAATTCATCAATCATTTCCAAAAGCAACAATTATCTCTTTTACAAATTTATATCAGGCATTAGCATCCGTCTCAGCCGGACAGAATGATTACTTTATTGGTAGTAACATCATTACCAGCAGTATGATTTCCCGTTATTTTACTCACTCCTTAAATGTAGTGAAGTATTATAACTCACCGCGTCAATATAACTTTTTATTAACCAGAAAAGATTCAATCGTTCTTAATGAAGTACTCAATCGATTTGTTGATGCTTTAACAAATGAAGTTCGCTATGAAGTATCACAAAATTGGCTTGATACAGGAAACCTGGCCTTTCTGAACAAACCATTAGAACTCACTGAACATGAAAAACAGTGGATTAAGCAGCATCCCGATTTAAAGGTGCTAGAAAATCCTTACTCGCCACCCTATTCTATGACAGATGAAACTGGCTCAGTTCGGGGCGTGATGGGTGATATTCTTAATATTATTACCTTGCAAACAGGTTTAAATTTTTCTCCGATCACCGTTTCACATAATATTCATGCTGGGACACAGCTTAACCCCGGTGGATGGGATATATTGCCCGCCGCTATTTATAGTGAAGATCGAGAAAATAATGTTTCATTTGCTGAAGTCTTCATAACAACGCCTTACGTTTTTGTCATGCAAAAAGCGCCTGACAGTGAACAAACATTAAAAAAAGGAATGAAAGTTGCCATTCCATATTATTATGAGCTTCATTCGCAATTAAAAGAGATGTATCCGGAGGTAGAGTGGATAAAAGTCGATAACGCCAGCGCTGCATTTCACAAGGTCAAGGAAGGTGAACTTGATGCTCTGGTCGCGACACAGTTAAATTCGCGTTACATGATCGACCATTACTATCCTAATGAACTTTATCATTTTCTTATTCCCGGCGTTCAGAATGCATCACTTTCGTTCGCTTTTCCTCGCGGAGAACCGGAACTTAAGGATATTATTAATAAAGCACTGAATGCAATTCCCCCAAGCGAAGTTCTGCGCCTGACCGAAAAATGGATTAAAATGCCCAATGTGACCATTGACACATGGGACCTCTATAGCGAGCAGTTTTATATTGTTACGACATTATCCGTTTTATTAGTTGGCAGTAGCCTTTTATGGGGATTCTACCTGTTACGCTCAGTTCGTCGTCGTAAAGTTATTCAGGGTGATTTAGAAAACCAAATATCATTCCGGAAAGCACTCTCGGACTCCTTACCGAATCCAACTTATGTTGTAAACTGGCAAGGTAATGTCATTAGTCATAATAGTGCATTTGAACATTATTTCACTGATGATTACTACAAAAATGCAATGTTGCCATTAGAAAACAGTGAATCCCCCTTTAAAGATGTTTTTTCTAATACGCATGAAGTCACAGCAGAAACGAAAGAAAACCGAACAATATACACACAGGTATTTGAAATTGATAATGGCATCGAGAAAAGATGCATTAATCACTGGCATACCTTATGTAATCTGCCAGCAAGCGAACATGCTGTTTATATTTGTGGTTGGCAAGATATTACCGAGACGCGTGATTTAATTCATGCACTCGAAGTAGAGAGAAATAAAGCGATCAATGCAACTGTCGCAAAAAGCCAGTTTCTGGCAACAATGAGTCACGAAATAAGAACACCAATAAGCTCCATTATGGGCTTCCTGGAACTTCTGTCGGGTTCTGGTCTTAGCAAGGAACAACGGGTGGAGGCGATTTCACTTGCCTACGCCACCGGACAATCACTCCTCGGCTTAATTGGTGAAATCCTTGATGTCGACAAAATTGAATCGGGTAACTATCAACTTCAACCACAATGGGTCGATATCCCTACTTTAGTCCAGAACACTTGTCACTCTTTCGCTGCGATTGCTGCAAGCAAATCGATCGCATTAAGTTGCAGCAGTACGCTTCCTGAACGCTACCTGGTTAAGATCGACCCTCAGGCGTTTAAGCAGGTCTTATCTAATTTACTGAGTAATGCTCTCAAATTTACTACCGAGGGGGCAGTAAAAATTACGACCTCCCTGGGTCACATTGATGACAACCACGCTGTTATCAAAATGACGATTATGGATTCTGGAAGTGGATTATCTCAGGAAGAGCAACAACAACTGTTTAAACGCTATAGCCAAACAAGTGCAGGTCGTCAGCAAACAGGTTCTGGTTTAGGCTTAATGATCTGCAAAGAATTAATTAAAAACATGCAGGGCGATTTGTCATTAGAAAGTCATCCAGGCATAGGAACGATATTTACGATCACAATCCCGGTAGAAATTACCCAACAAGTGGCGGCTGTCGAGGCAAAAGCAGAACAACCTATAACACTACCTGAAAAGTTGAGCATATTAATCGCGGATGATCATCCGACCAACAGGCTATTACTCAAACGCCAGCTAAATCTATTAGGATATGATGTTGATGAAGCCACTGATGGTGTGCAAGCGCTACACAAAGTCAGTATGCAACATTATGATCTGCTTATTACTGACGTTAATATGCCGAATATGGATGGTTTTGAGTTGACTCGCAAACTCCGTGAGCAAAATTCTTCCTTACCCATCTGGGGGCTTACAGCCAACGCACAGGCTAACGAACGTGAAAAAGGGTTAAATTGCGGCATGAACTTATGTTTGTTCAAACCGTTGACTCTGGATGTACTGAAAACACATTTAAGTCAGTTACACCAGGTTGCGCATATTGCACCTCAGTATCGCCACCTTGATATCGAGGCCCTGAAGAATAATACGGCGAATGATCTACAACTGATGCAGGAGATTCTCATGACTTTCCAGCATGAAACGCATAAAGATCTACCCGCTGCGTTTCATGCACTAGAAGCTGGCGATAACAGAACTTTCCATCAGTGTATTCATCGCATCCACGGTGCGGCTAACATCCTGAATTTGCAAAAGTTGATTAATATTAGCCACCAGTTAGAAATAACACCTGTTTCAGATGACAGTAAGCCTGAAATTCTTCAGTTGCTGAACTCTGTAAAAGAACACATTGCAGAGCTGGACCAGGAGATTACTGTTTTCTGTCAGCAAAATGACTAA,MKFLPYIFLLCCGLWSTISFADGDYIEYRGISSNNRVTLDPLRLSNKELRWLASKKNLVIAVHKSQTATLLHTDSQQRIRGINADYLNLLKRALNIKLTLREYADHQKAMDALEDGEVDIVLSHLVASPPLNDDIAATNPLIITFPALVTTLHDSMRPLTSSKPVNIARVANYPPDEVIHQSFPKATIISFTNLYQALASVSAGQNDYFIGSNIITSSMISRYFTHSLNVVKYYNSPRQYNFLLTRKDSIVLNEVLNRFVDALTNEVRYEVSQNWLDTGNLAFLNKPLELTEHEKQWIKQHPDLKVLENPYSPPYSMTDETGSVRGVMGDILNIITLQTGLNFSPITVSHNIHAGTQLNPGGWDILPAAIYSEDRENNVSFAEVFITTPYVFVMQKAPDSEQTLKKGMKVAIPYYYELHSQLKEMYPEVEWIKVDNASAAFHKVKEGELDALVATQLNSRYMIDHYYPNELYHFLIPGVQNASLSFAFPRGEPELKDIINKALNAIPPSEVLRLTEKWIKMPNVTIDTWDLYSEQFYIVTTLSVLLVGSSLLWGFYLLRSVRRRKVIQGDLENQISFRKALSDSLPNPTYVVNWQGNVISHNSAFEHYFTDDYYKNAMLPLENSESPFKDVFSNTHEVTAETKENRTIYTQVFEIDNGIEKRCINHWHTLCNLPASEHAVYICGWQDITETRDLIHALEVERNKAINATVAKSQFLATMSHEIRTPISSIMGFLELLSGSGLSKEQRVEAISLAYATGQSLLGLIGEILDVDKIESGNYQLQPQWVDIPTLVQNTCHSFAAIAASKSIALSCSSTLPERYLVKIDPQAFKQVLSNLLSNALKFTTEGAVKITTSLGHIDDNHAVIKMTIMDSGSGLSQEEQQQLFKRYSQTSAGRQQTGSGLGLMICKELIKNMQGDLSLESHPGIGTIFTITIPVEITQQVAAVEAKAEQPITLPEKLSILIADDHPTNRLLLKRQLNLLGYDVDEATDGVQALHKVSMQHYDLLITDVNMPNMDGFELTRKLREQNSSLPIWGLTANAQANEREKGLNCGMNLCLFKPLTLDVLKTHLSQLHQVAHIAPQYRHLDIEALKNNTANDLQLMQEILMTFQHETHKDLPAAFHALEAGDNRTFHQCIHRIHGAANILNLQKLINISHQLEITPVSDDSKPEILQLLNSVKEHIAELDQEITVFCQQND,MKFLPYIFLLCCGLWSTISFADEDYIEYRGISSNNRVTLDPLRLSNKELRWLASKKNLVIAVHKSQTATLLHTDSQQRVRGINADYLNLLKRALNIKLTLREYADHQKAMDALAEGEVDIVLSHLVTSPPLNNDIAATKPLIITFPALVTTLHDSMRPLTSPKPVNIARVANYPPDEVIHQSFPKATIISFTNLYQALASVSAGHNDYFIGSNIITSSMISRYFTHSLNVVKYYNSPRQYNFFLTRKESVILNEVLNRFVDALTNEVRYEVSQNWLDTGNLAFLNKPLELTEHEKQWIKQHPNLKVLENPYSPPYSMTDENGSVRGVMGDILNIITLQTGLNFSPITVSHNIHAGTQLSPGGWDIIPGAIYSEDRENNVLFAEAFITTPYVFVMQKAPDSEQTLKKGMKVAIPYYYELHSQLKEMYPEVEWIQVDNASAAFHKVKEGELDALVATQLNSRYMIDHYYPNELYHFLIPGVPNASLSFAFPRGEPELKDIINKALNAIPPSEVLRLTEKWIKMPNVTIDTWDLYSEQFYIVTTLSVLLVGSSLLWGFYLLRSVRRRKVIQGDLENQISFRKALSDSLPNPTYVVNWQGNVISHNSAFEHYFTADYYKNAMLPLENSDSPFKDVFSNAHEVTAETKENRTIYTQVFEIDNGIEKRCINHWHTLCNLPASDNAVYICGWQDITETRDLINALEVEKNKAIKATVAKSQFLATMSHEIRTPISSIMGFLELLSGSGLSKEQRVEAISLAYATGQSLLGLIGEILDVDKIESGNYQLQPQWVDIPTLVQNTCHSFGAIAASKSIALSCSSTFPEHYLVKIDPQAFKQVLSNLLSNALKFTTEGAVKITTSLGHIDDNHAVIKMTIMDSGSGLSQEEQQQLFKRYSQTSAGRQQTGSGLGLMICKELIKNMQGDLSLESHPGIGTTFTITIPVEISQQVATVEAKAEQPITLPEKLSILIADDHPTNRLLLKRQLNLLGYDVDEATDGVQALHKVSMQHYDLLITDVNMPNMDGFELTRKLREQNSSLPIWGLTANAQANEREKGLSCGMNLCLFKPLTLDVLKTHLSQLHQVAHIAPQYRHLDIEALKNNTANDLQLMQEILMTFQHETHKDLPAAFQALEAGDNRTFHQCIHRIHGAANILNLQKLINISHQLEITPVSDDSKPEILQLLNSVKEHIAELDQEIAVFCQKND,100,gnl|BL_ORD_ID|1214|hsp_num:0,1318,FALSE,None
LK1198,2_426 # 479300 # 482413 # 1 # ID=2_426;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.546,2_426,479300,482413,+,Strict,1900,2125.13,acrD,99.9,3000491,protein homolog model,n/a,n/a,aminoglycoside antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGGCGAATTTCTTTATTGATCGCCCCATTTTTGCCTGGGTGCTGGCAATCCTGTTGTGTCTGACAGGTACCCTGGCGATTTTTTCATTGCCCGTTGAACAATACCCCGATCTCGCGCCACCGAATGTGCGAGTGACCGCTAACTATCCCGGCGCATCGGCCCAGACGCTGGAAAACACCGTGACCCAGGTTATCGAGCAAAATATGACGGGCCTCGATAATCTGATGTATATGTCATCTCAGAGCAGCGGCACCGGTCAGGCATCTGTCACGTTAAGTTTTAAAGCAGGCACCGATCCGGACGAAGCCGTGCAGCAAGTACAAAACCAGCTGCAATCAGCCATGCGAAAGTTACCGCAGGCGGTGCAAAATCAGGGCGTGACGGTGCGTAAAACCGGCGATACCAACATTCTGACCATTGCCTTCGTCTCTACCGATGGTTCGATGGATAAGCAGGATATTGCCGATTATGTTGCCAGTAATATTCAGGACCCGTTAAGCCGCGTGAATGGCGTCGGGGATATCGATGCCTATGGTTCGCAATATTCCATGCGTATCTGGCTGGACCCGGCGAAACTCAACAGTTTCCAGATGACGGCTAAAGATGTCACCGATGCCATTGAATCACAGAACGCGCAGATTGCGGTTGGGCAACTTGGTGGTACGCCTTCCGTCGATAAGCAGGCGCTCAACGCCACCATTAACGCCCAGTCACTGCTGCAAACACCAGAACAGTTCCGCGATATCACCTTGCGGGTGAATCAGGACGGCTCAGAGGTAAGGCTGGGCGATGTCGCCACCGTCGAAATGGGGGCGGAGAAATACGATTATCTTAGCCGCTTCAATGGTAAGCCAGCCTCCGGGCTGGGGGTTAAACTGGCCTCCGGCGCGAACGAAATGGCGACAGCGGAGCTGGTGCTCAATCGTCTCGACGAGCTGGCGCAGTATTTTCCACACGGACTGGAATACAAGGTGGCGTATGAAACCACCTCGTTTGTTAAAGCCTCCATTGAAGACGTGGTGAAAACGCTTCTGGAAGCTATCGCCCTGGTTTTCCTCGTTATGTATCTGTTCCTGCAAAACTTCCGCGCCACGCTGATACCCACTATCGCCGTGCCGGTGGTGTTGATGGGAACCTTCTCCGTGCTTTACGCCTTCGGTTACAGTGTCAACACCTTAACCATGTTCGCGATGGTGCTGGCGATCGGTCTGCTGGTGGATGATGCCATCGTGGTGGTGGAAAACGTCGAACGTATTATGAGTGAGGAAGGACTCACTCCTCGCGAAGCCACACGTAAATCGATGGGGCAGATCCAGGGGGCACTGGTCGGGATTGCGATGGTGCTTTCGGCGGTATTTGTGCCAATGGCCTTCTTCGGCGGCACCACCGGTGCCATCTATCGCCAGTTCTCTATTACCATTGTTGCGGCGATGGTGCTGTCAGTACTGGTAGCGATGATCCTCACTCCGGCTCTGTGTGCCACGCTACTTAAGCCACTGAAAAAAGGTGAGCATCACGGGCAAAAAGGCTTTTTTGCCTGGTTTAACCAGATGTTTAACCGCAACGCCGAACGCTACGAAAAAGGGGTGGCGAAAATTCTCCACCGTAGCCTGCGCTGGATTGTGATTTATGTCCTGCTGCTTGGCGGCATGGTGTTCCTGTTCCTGCGTTTGCCGACGTCGTTCTTACCGCTGGAAGACCGTGGCATGTTTACTACCTCGGTACAGTTGCCCAGCGGTTCAACCCAGCAACAGACCCTGAAAGTCGTTGAGCAAATCGAGAAATATTACTTCACCCATGAAAAAGACAACATCATGTCGGTGTTTGCCACCGTGGGTTCTGGCCCTGGGGGTAACGGGCAAAACGTGGCGCGAATGTTTATCCGCCTGAAAGACTGGAGCGAACGCGACAGTAAGACCGGCACCTCGTTTGCCATTATCGAGCGTGCAACGAAGGCGTTTAACAAGATTAAAGAAGCTCGCGTTATCGCCAGCAGCCCGCCAGCAATTAGCGGTCTTGGTAGTTCTGCGGGTTTTGATATGGAGTTGCAGGACCACGCTGGGGCAGGTCACGATGCGCTGATGGCAGCACGAAACCAGTTGCTGGCGCTGGCGGCGGAAAATCCGGAGTTAACCCGTGTACGCCATAACGGCCTCGACGACAGTCCGCAGTTGCAGATTGATATCGATCAGCGTAAAGCTCAGGCGCTGGGCGTTGCTATCGACGATATTAACGACACGCTGCAAACCGCGTGGGGTTCGAGCTATGTGAATGACTTTATGGATCGCGGTCGCGTGAAGAAAGTCTATGTGCAGGCAGCTGCGCCGTATCGCATGCTGCCAGATGACATCAATCTCTGGTATGTCCGAAATAAAGATGGCGGCATGGTGCCCTTCTCTGCTTTCGCGACCTCACGCTGGGAGACAGGCTCGCCGCGTCTGGAACGCTATAACGGTTATTCTGCGGTTGAGATTGTTGGGGAAGCCGCACCGGGGGTCAGTACCGGTACGGCGATGGATATTATGGAATCGTTAGTGAAGCAGCTGCCAAACGGCTTTGGTCTGGAGTGGACGGCGATGTCGTATCAGGAGCGGCTTTCCGGCGCGCAGGCTCCGGCGCTGTACGCCATTTCCTTGCTGGTGGTATTCCTGTGTCTGGCGGCATTGTATGAAAGCTGGTCGGTGCCGTTCTCGGTAATGCTGGTCGTGCCGCTGGGGGTTATCGGCGCGCTGCTGGCAACCTGGATGCGCGGGCTGGAAAACGATGTTTACTTCCAGGTGGGTCTGTTAACGGTCATTGGTTTATCGGCGAAAAACGCTATCCTGATCGTCGAGTTTGCTAACGAGATGAACCAAAAAGGCCACGACCTGTTTGAAGCGACGCTCCACGCCTGCCGTCAGCGTTTACGCCCGATTCTGATGACCTCGCTGGCATTTATCTTCGGCGTATTGCCAATGGCAACCAGCACAGGTGCCGGTTCCGGTGGTCAGCATGCGGTGGGTACTGGCGTAATGGGCGGGATGATTTCGGCCACTATTCTGGCTATTTACTTCGTGCCGCTGTTCTTTGTGCTGGTGCGCCGCCGCTTCCCGCTGAAGCCGCGCCCGGAATAA,MANFFIDRPIFAWVLAILLCLTGTLAIFSLPVEQYPDLAPPNVRVTANYPGASAQTLENTVTQVIEQNMTGLDNLMYMSSQSSGTGQASVTLSFKAGTDPDEAVQQVQNQLQSAMRKLPQAVQNQGVTVRKTGDTNILTIAFVSTDGSMDKQDIADYVASNIQDPLSRVNGVGDIDAYGSQYSMRIWLDPAKLNSFQMTAKDVTDAIESQNAQIAVGQLGGTPSVDKQALNATINAQSLLQTPEQFRDITLRVNQDGSEVRLGDVATVEMGAEKYDYLSRFNGKPASGLGVKLASGANEMATAELVLNRLDELAQYFPHGLEYKVAYETTSFVKASIEDVVKTLLEAIALVFLVMYLFLQNFRATLIPTIAVPVVLMGTFSVLYAFGYSVNTLTMFAMVLAIGLLVDDAIVVVENVERIMSEEGLTPREATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGTTGAIYRQFSITIVAAMVLSVLVAMILTPALCATLLKPLKKGEHHGQKGFFAWFNQMFNRNAERYEKGVAKILHRSLRWIVIYVLLLGGMVFLFLRLPTSFLPLEDRGMFTTSVQLPSGSTQQQTLKVVEQIEKYYFTHEKDNIMSVFATVGSGPGGNGQNVARMFIRLKDWSERDSKTGTSFAIIERATKAFNKIKEARVIASSPPAISGLGSSAGFDMELQDHAGAGHDALMAARNQLLALAAENPELTRVRHNGLDDSPQLQIDIDQRKAQALGVAIDDINDTLQTAWGSSYVNDFMDRGRVKKVYVQAAAPYRMLPDDINLWYVRNKDGGMVPFSAFATSRWETGSPRLERYNGYSAVEIVGEAAPGVSTGTAMDIMESLVKQLPNGFGLEWTAMSYQERLSGAQAPALYAISLLVVFLCLAALYESWSVPFSVMLVVPLGVIGALLATWMRGLENDVYFQVGLLTVIGLSAKNAILIVEFANEMNQKGHDLFEATLHACRQRLRPILMTSLAFIFGVLPMATSTGAGSGGQHAVGTGVMGGMISATILAIYFVPLFFVLVRRRFPLKPRPE,MANFFIDRPIFAWVLAILLCLTGTLAIFSLPVEQYPDLAPPNVRVTANYPGASAQTLENTVTQVIEQNMTGLDNLMYMSSQSSGTGQASVTLSFKAGTDPDEAVQQVQNQLQSAMRKLPQAVQNQGVTVRKTGDTNILTIAFVSTDGSMDKQDIADYVASNIQDPLSRVNGVGDIDAYGSQYSMRIWLDPAKLNSFQMTAKDVTDAIESQNAQIAVGQLGGTPSVDKQALNATINAQSLLQTPEQFRDITLRVNQDGSEVRLGDVATVEMGAEKYDYLSRFNGKPASGLGVKLASGANEMATAELVLNRLDELAQYFPHGLEYKVAYETTSFVKASIEDVVKTLLEAIALVFLVMYLFLQNFRATLIPTIAVPVVLMGTFSVLYAFGYSVNTLTMFAMVLAIGLLVDDAIVVVENVERIMSEEGLTPREATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGTTGAIYRQFSITIVAAMVLSVLVAMILTPALCATLLKPLKKGEHHGQKGFFAWFNQMFNRNAERYEKGVAKILHRSLRWIVIYVLLLGGMVFLFLRLPTSFLPLEDRGMFTTSVQLPSGSTQQQTLKVVEQIEKYYFTHEKDNIMSVFATVGSGPGGNGQNVARMFIRLKDWSERDSKTGTSFAIIERATKAFNQIKEARVIASSPPAISGLGSSAGFDMELQDHAGAGHDALMAARNQLLALAAENPELTRVRHNGLDDSPQLQIDIDQRKAQALGVAIDDINDTLQTAWGSSYVNDFMDRGRVKKVYVQAAAPYRMLPDDINLWYVRNKDGGMVPFSAFATSRWETGSPRLERYNGYSAVEIVGEAAPGVSTGTAMDIMESLVKQLPNGFGLEWTAMSYQERLSGAQAPALYAISLLVVFLCLAALYESWSVPFSVMLVVPLGVIGALLATWMRGLENDVYFQVGLLTVIGLSAKNAILIVEFANEMNQKGHDLFEATLHACRQRLRPILMTSLAFIFGVLPMATSTGAGSGGQHAVGTGVMGGMISATILAIYFVPLFFVLVRRRFPLKPRPE,100,gnl|BL_ORD_ID|1309|hsp_num:0,1427,FALSE,None
LK1198,3_40 # 42472 # 42855 # 1 # ID=3_40;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.448,3_40,42472,42855,+,Strict,230,265.003,marA,99.21,3000263,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; penem; disinfecting agents and antiseptics,antibiotic efflux; reduced permeability to antibiotic,resistance-nodulation-cell division (RND) antibiotic efflux pump; General Bacterial Porin with reduced permeability to beta-lactams,ATGTCCAGACGCAATACTGACGCTATTACCATTCATAGCATTTTGGACTGGATCGAGGACAACCTGGAATCGCCACTGTCACTGGAGAAAGTGTCAGAGCGTTCGGGTTACTCCAAATGGCACCTGCAACGGATGTTTAAAAAAGAAACCGGTCATTCATTAGGTCAATACATCCGTAGCCGTAAGATGACGGAAATCGCGCAAAAGCTGAAGGAAAGTAACGAGCCGATACTCTATCTGGCAGAACGATATGGCTTCGAGTCCCAACAAACTCTGACCCGAACCTTCAAAAATTACTTTGATGTTCCGCCGCATAAATACCGGATGACCAATATGCAGGGTGAATCGCGCTTTTTACATCCATTAAATCATTACAACAACTAG,MSRRNTDAITIHSILDWIEDNLESPLSLEKVSERSGYSKWHLQRMFKKETGHSLGQYIRSRKMTEIAQKLKESNEPILYLAERYGFESQQTLTRTFKNYFDVPPHKYRMTNMQGESRFLHPLNHYNN,MSRRNTDAITIHSILDWIEDNLESPLSLEKVSERSGYSKWHLQRMFKKETGHSLGQYIRSRKMTEIAQKLKESNEPILYLAERYGFESQQTLTRTFKNYFDVPPHKYRMTNMQGESRFLHPLNHYNS,100,gnl|BL_ORD_ID|1772|hsp_num:0,1922,FALSE,None
LK1198,3_79 # 80520 # 80849 # -1 # ID=3_79;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.515,3_79,80520,80849,-,Strict,150,183.726,Klebsiella pneumoniae KpnF,83.49,3004583,protein homolog model,n/a,n/a,macrolide antibiotic; aminoglycoside antibiotic; cephalosporin; tetracycline antibiotic; peptide antibiotic; rifamycin antibiotic; disinfecting agents and antiseptics,antibiotic efflux,small multidrug resistance (SMR) antibiotic efflux pump,ATGGCGCAGTTTGAATGGGTTCACGCCGCCTGGCTGGCATTGGCAATCGTGCTGGAAATCGTTGCTAACGTCTTTTTGAAATTTTCTGACGGCTTTCGTTGCAAAATATTTGGCTTGCTTTCCCTGGCGGCGGTGCTGGCTGCCTTTAGTGCGCTTTCTCAGGCCGTTAAAGGGATCGACTTGTCTGTCGCTTATGCATTGTGGGGCGGGTTTGGTATTGCCGCCACGTTAGCCGCAGGTTGGATCTTGTTTGGTCAACGGTTAAATCGTAAAGGCTGGATTGGCCTGGTGCTGCTGTTGGCTGGAATGATCATGGTGAAACTTGCCTGA,MAQFEWVHAAWLALAIVLEIVANVFLKFSDGFRCKIFGLLSLAAVLAAFSALSQAVKGIDLSVAYALWGGFGIAATLAAGWILFGQRLNRKGWIGLVLLLAGMIMVKLA,MQQFEWIHAAWLAIAIVLEIIANVFLKFSDGFRRKIYGILSLAAVLGAFSALSQAVKGIDLSVAYALWGGFGIAATIAAGWVLFGQRLNNKGWAGVILLVAGMVLIKLA,100,gnl|BL_ORD_ID|2723|hsp_num:0,3286,FALSE,None
LK1198,3_80 # 80836 # 81201 # -1 # ID=3_80;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.432,3_80,80836,81201,-,Strict,150,182.57,Klebsiella pneumoniae KpnE,82.2,3004580,protein homolog model,n/a,n/a,macrolide antibiotic; aminoglycoside antibiotic; cephalosporin; tetracycline antibiotic; peptide antibiotic; rifamycin antibiotic; disinfecting agents and antiseptics,antibiotic efflux,small multidrug resistance (SMR) antibiotic efflux pump,ATGTATATTTATTGGATTTTATTAGGTCTGGCTATTGCTACAGAAATTACCGGTACGCTGTCCATGAAATGGGCGAGCGTCAGTGAGGGAAATGGCGGCTTTATTTTAATGCTGGTGATGATTTCTCTGTCGTATATATTTCTCTCTTTCGCCGTTAAAAAAATCGCCTTAGGCGTGGCTTATGCGCTGTGGGAAGGTATCGGTATTTTATTTATTACCTTGTTTAGCGTTTTGTTATTCGACGAAAGTTTATCGCTGATGAAAATTGCCGGGTTAACCACCCTGGTCGCCGGGATTGTATTGATCAAATCAGGTACCCGTAAAGCGCGTAAACCTGAACTGGAGGTGAACCATGGCGCAGTTTGA,MYIYWILLGLAIATEITGTLSMKWASVSEGNGGFILMLVMISLSYIFLSFAVKKIALGVAYALWEGIGILFITLFSVLLFDESLSLMKIAGLTTLVAGIVLIKSGTRKARKPELEVNHGAV,MFYWILLALAIIAEITGTLSMKWASVSGGHTGFILMLAMIALSYIFLAFAVKKIALGVAYALWEGIGILLITLFSVLLFDESLSLLKIAGLTTLVIGIVLIKSGTQKKASSQQEVAHAAV,100.83,gnl|BL_ORD_ID|2721|hsp_num:0,3283,FALSE,None
LK1198,3_423 # 420318 # 420650 # -1 # ID=3_423;partial=00;start_type=ATG;rbs_motif=AGGA/GGAG/GAGG;rbs_spacer=11-12bp;gc_cont=0.438,3_423,420318,420650,-,Strict,190,216.083,Escherichia coli emrE,98.18,3004039,protein homolog model,n/a,n/a,macrolide antibiotic,antibiotic efflux,small multidrug resistance (SMR) antibiotic efflux pump,ATGAACCCTTATATTTATCTTGGTGGCGCAATACTTGCAGAGGTCATTGGTACAACCTTAATGAAGTTTTCAGAGGGGTTTACACGGTTATGGCCCTCTGTTGGCACAATTATTTGCTATTGTGCCTCATTCTGGTTATTAGCTCAGACGCTGGCTTATATACCTACAGGGATTGCTTATGCTATCTGGTCAGGAGTCGGTATCGTTCTGATTAGTTTGCTTTCCTGGGGATTTTTTGGTCAACGACTGGACCTGCCAGCTATCATAGGCATGATGTTGATTTGTGCCGGTGTGTTAGTCATTAACTTGTTGTCACGAAGTGCACCGCATTAA,MNPYIYLGGAILAEVIGTTLMKFSEGFTRLWPSVGTIICYCASFWLLAQTLAYIPTGIAYAIWSGVGIVLISLLSWGFFGQRLDLPAIIGMMLICAGVLVINLLSRSAPH,MNPYIYLGGAILAEVIGTTLMKFSEGFTRLWPSVGTIICYCASFWLLAQTLAYIPTGIAYAIWSGVGIVLISLLSWGFFGQRLDLPAIIGMMLICAGVLIINLLSRSTPH,100,gnl|BL_ORD_ID|2319|hsp_num:0,2656,FALSE,None
LK1198,4_69 # 77701 # 79449 # -1 # ID=4_69;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.504,4_69,77701,79449,-,Strict,1000,1189.48,msbA,99.66,3003950,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic efflux,ATP-binding cassette (ABC) antibiotic efflux pump,ATGCATAACGACAAAGATCTCTCTACGTGGCAGACGTTCCGCCGACTGTGGCCAACCATTGCGCCTTTTAAAGCGGGTCTGATCGTGGCGGGCGTAGCGTTAATCCTCAACGCAGCCAGCGATACCTTCATGTTATCGCTCCTTAAGCCACTTCTTGATGATGGCTTTGGTAAAACAGATCGCTCCGTGCTGATGTGGATGCCGCTGGTGGTGATCGGGCTGATGATTTTACGTGGTATCACCAGCTATATCTCCAGCTACTGTATCTCCTGGGTATCAGGAAAGGTGGTAATGACTATGCGTCGCCGCCTGTTTGGTCACATGATGGGAATGCCGGTTTCATTCTTTGACAAACAGTCAACGGGTACGCTGTTGTCACGTATCACCTACGATTCCGAACAGGTCGCTTCTTCTTCTTCCGGCGCACTGATTACTGTTGTGCGTGAAGGTGCGTCGATCATCGGCCTGTTCATCATGATGTTCTATTACAGTTGGCAACTGTCGATCATTTTGATTGTGCTGGCACCGATTGTTTCGATTGCGATTCGCGTTGTATCGAAGCGTTTTCGCAACATCAGTAAAAACATGCAGAACACCATGGGGCAGGTGACCACCAGCGCCGAACAAATGCTGAAAGGCCATAAAGAAGTATTGATTTTCGGTGGTCAGGAAGTGGAAACGAAACGCTTCGATAAAGTCAGCAACCGAATGCGTCTTCAGGGGATGAAAATGGTTTCAGCCTCTTCTATCTCTGATCCGATCATTCAGCTGATCGCCTCTTTGGCGCTGGCGTTTGTTCTGTATGCGGCAAGCTTCCCAAGTGTCATGGATAGCCTGACTGCCGGTACGATTACCGTTGTTTTCTCTTCAATGATTGCACTTATGCGTCCGCTGAAATCGCTGACCAACGTTAACGCCCAGTTCCAGCGTGGTATGGCGGCTTGTCAGACGCTGTTTACCATTCTGGACAGTGAGCAGGAGAAAGACGAAGGTAAGCGCGTGATCGAGCGTGCGACTGGCGACGTGGAATTTCGCAATGTCACCTTTACTTATCCAGGACGTGACGTGCCCGCATTGCGTAACATCAACCTGAAAATTCCGGCAGGGAAGACGGTTGCTCTGGTTGGACGATCTGGTTCAGGTAAATCAACCATCGCCAGCCTAATCACACGTTTTTACGATATTGATGAAGGCGAAATCCTGATGGATGGTCACGATCTGCGCGAGTATACCCTGGCGTCGTTACGTAACCAGGTTGCTCTGGTGTCGCAGAATGTCCATCTGTTTAACGATACGGTTGCCAACAACATTGCTTACGCAAGGACTGAACAGTACAGCCGTGAGCAAATTGAAGAAGCTGCGCGTATGGCCTACGCCATGGACTTCATCAATAAGATGGATAACGGTCTCGATACAGTCATTGGTGAAAACGGCGTGCTGCTCTCTGGCGGTCAGCGTCAGCGTATTGCTATCGCTCGAGCCTTGTTGCGTGATAGCCCGATACTGATTCTGGACGAAGCTACCTCGGCGTTGGATACCGAATCCGAACGTGCGATTCAGGCGGCACTGGATGAGTTGCAGAAAAACCGTACCTCTCTGGTGATTGCCCACCGCTTGTCTACCATTGAAAAGGCAGACGAAATCGTGGTTGTCGAGGATGGTGTCATTGTGGAACGCGGTACGCATAACGATTTGCTTGAGCACCGTGGCGTTTACGCGCAACTTCACAAAATGCAGTTTGGCCAATGA,MHNDKDLSTWQTFRRLWPTIAPFKAGLIVAGVALILNAASDTFMLSLLKPLLDDGFGKTDRSVLMWMPLVVIGLMILRGITSYISSYCISWVSGKVVMTMRRRLFGHMMGMPVSFFDKQSTGTLLSRITYDSEQVASSSSGALITVVREGASIIGLFIMMFYYSWQLSIILIVLAPIVSIAIRVVSKRFRNISKNMQNTMGQVTTSAEQMLKGHKEVLIFGGQEVETKRFDKVSNRMRLQGMKMVSASSISDPIIQLIASLALAFVLYAASFPSVMDSLTAGTITVVFSSMIALMRPLKSLTNVNAQFQRGMAACQTLFTILDSEQEKDEGKRVIERATGDVEFRNVTFTYPGRDVPALRNINLKIPAGKTVALVGRSGSGKSTIASLITRFYDIDEGEILMDGHDLREYTLASLRNQVALVSQNVHLFNDTVANNIAYARTEQYSREQIEEAARMAYAMDFINKMDNGLDTVIGENGVLLSGGQRQRIAIARALLRDSPILILDEATSALDTESERAIQAALDELQKNRTSLVIAHRLSTIEKADEIVVVEDGVIVERGTHNDLLEHRGVYAQLHKMQFGQ,MHNDKDLSTWQTFRRLWPTIAPFKAGLIVAGVALILNAASDTFMLSLLKPLLDDGFGKTDRSVLVWMPLVVIGLMILRGITSYVSSYCISWVSGKVVMTMRRRLFGHMMGMPVSFFDKQSTGTLLSRITYDSEQVASSSSGALITVVREGASIIGLFIMMFYYSWQLSIILIVLAPIVSIAIRVVSKRFRNISKNMQNTMGQVTTSAEQMLKGHKEVLIFGGQEVETKRFDKVSNRMRLQGMKMVSASSISDPIIQLIASLALAFVLYAASFPSVMDSLTAGTITVVFSSMIALMRPLKSLTNVNAQFQRGMAACQTLFTILDSEQEKDEGKRVIERATGDVEFRNVTFTYPGRDVPALRNINLKIPAGKTVALVGRSGSGKSTIASLITRFYDIDEGEILMDGHDLREYTLASLRNQVALVSQNVHLFNDTVANNIAYARTEQYSREQIEEAARMAYAMDFINKMDNGLDTVIGENGVLLSGGQRQRIAIARALLRDSPILILDEATSALDTESERAIQAALDELQKNRTSLVIAHRLSTIEKADEIVVVEDGVIVERGTHNDLLEHRGVYAQLHKMQFGQ,100,gnl|BL_ORD_ID|2187|hsp_num:0,2423,FALSE,None
LK1198,4_145 # 167863 # 169095 # -1 # ID=4_145;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.521,4_145,167863,169095,-,Strict,700,786.949,Escherichia coli mdfA,97.07,3001328,protein homolog model,n/a,n/a,tetracycline antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGCAAAATAAATTAGCTTCCGGTGCCAGGCTTGGACGTCAGGCGTTACTTTTCCCTCTCTGTCTGGTGCTTTACGAATTTTCAACCTATATCGGCAACGATATGATTCAACCCGGTATGTTGGCCGTGGTGGAACAATATCAGGCGGGCATTGATTGGGTTCCTACTTCGATGACTGCGTATCTGGCGGGCGGGATGTTTTTACAATGGCTCCTGGGGCCGTTGTCGGATCGTATTGGCCGCCGTCCGGTGATGTTGGCGGGAGTGGTGTGGTTTATCGTCACCTGTCTGGCAATATTACTGGCGCAAAACATTGAACAATTCACCCTGTTGCGCTTCTTGCAGGGCATAAGCCTCTGTTTCATTGGCGCTGTGGGATACGCCGCAATTCAGGAATCCTTCGAAGAGGCCGTTTGTATCAAGATCACCGCGCTAATGGCGAACGTGGCGCTGATTGCTCCACTACTTGGTCCGCTGGTGGGCGCGGCGTGGATCCATGTGCTGCCCTGGGAAGGGATGTTTGTCTTGTTTGCCGCATTGGCAGCGATCTCCTTTTTCGGTCTGCAACGAGCTATGCCTGAAACCGCCACGCGTATAGGCGAGAAACTGTCGCTGAAAGAACTCGGTCGTGACTATAAGCTGGTGCTGAAGAACGGCCGCTTTGTGGCGGGGGCGCTGGCGCTGGGATTCGTTAGCCTGCCGTTGTTGGCGTGGATCGCCCAGTCGCCGATTATCATTATTACCGGTGAGCAGTTGAGCAGCTATGAATATGGCTTGCTGCAAGTGCCTATTTTCGGGGCGTTAATTGCGGGTAACTTGCTGTTAGCGCGTCTGACCTCGCGCCGCACCGTACGTTCGCTGATTATTATGGGTGGCTGGCCGATTATGATTGGTCTGTTGGTCGCTGCTGCGGCAACGGTTATCTCATCGCACGCGTATTTATGGATGACCGCCGGGTTAAGTATTTATGCTTTCGGTATTGGTCTGGCGAATGCGGGACTGGTGCGATTAACCCTGTTTGCCAGCGATATGAGTAAAGGTACGGTTTCTGCGGCGATGGGGATGCTGCAAATGCTGATCTTTACCGTCGGTATTGAAATCAGCAAACATGCCTGGCTGAACGGGGGCAACGGACTGTTTAATCTCTTCAACCTTGTCAACGGCATTTTGTGGCTGTCGCTGATGGTTATCTTTTTAAAAGATAAACAGATGGGAAATTCTCACGAAGGGTAA,MQNKLASGARLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVEQYQAGIDWVPTSMTAYLAGGMFLQWLLGPLSDRIGRRPVMLAGVVWFIVTCLAILLAQNIEQFTLLRFLQGISLCFIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWIHVLPWEGMFVLFAALAAISFFGLQRAMPETATRIGEKLSLKELGRDYKLVLKNGRFVAGALALGFVSLPLLAWIAQSPIIIITGEQLSSYEYGLLQVPIFGALIAGNLLLARLTSRRTVRSLIIMGGWPIMIGLLVAAAATVISSHAYLWMTAGLSIYAFGIGLANAGLVRLTLFASDMSKGTVSAAMGMLQMLIFTVGIEISKHAWLNGGNGLFNLFNLVNGILWLSLMVIFLKDKQMGNSHEG,MQNKLASGARLGRQALLFPLCLVLYEFSTYIGNDMRQPGMLENVEQYQAGIEWVPTSMNAYLAGGMFIQWLLGPLSDRIGRRPVMLAGVVWFIVTCLAILLAQNIEQFTLLRFLHGISLCFIGAVGYDAIQESFEEAVCIKITALMANVALIAPLLGPLVGASWIHVLPWEGMFVLFAALAAISFFGLQRAMPETATRIGEKLSLKELGRDYKLVLKNGRFVAGALALGFLSLPLLAWIAQSPIIIITGEQLSSYEYGLLQVPIFGALIAGNLLLARLTSRRTVRSLIIMGGWPIMIGLLVAAAATVISSHAYLWMTAGLSIYAFGIGLANAGLVRLTLFASVMSKGTVSAAMGMLQMLIFTVGIEISKHAWLNGGNGLFNLFNLVNGILLLSLMVIFLKDKQMGNSHEG,100,gnl|BL_ORD_ID|2421|hsp_num:0,37,FALSE,None
LK1198,4_274 # 311683 # 312360 # 1 # ID=4_274;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.569,4_274,311683,312360,+,Strict,400,450.669,kdpE,99.55,3003841,protein homolog model,n/a,n/a,aminoglycoside antibiotic,antibiotic efflux,kdpDE,GTGACAAACGTTCTAATTGTTGAAGATGAACAGGCTATTCGTCGCTTTCTGCGCACGGCGCTGGAGGGCGACGGTATGCGCGTCTTTGAGGCCGAAACGCTGCAACGCGGCTTGCTGGAAGCGGCAACCCGTAAGCCAGATTTGATTATTCTCGATCTCGGCCTGCCCGACGGTGATGGGATTGAGTTTATCCGCGACCTGCGCCAGTGGAGCGCGGTGCCGGTGATTGTGCTTTCCGCACGCAGCGAAGAGAGCGATAAAATCGCCGCGCTGGATGCCGGAGCGGATGATTATCTGAGTAAGCCGTTTGGCATTGGCGAATTGCAGGCCCGTCTGCGCGTCGCATTACGCCGCCACTCCGCCACCACCACGCCCGATCCGCTGGTGAAATTTTCTGATGTTACCGTCGATTTAGCCGCCCGCGTTATCCACCGCGGCGAGGAAGAGGTGCATCTCACACCGATTGAGTTCCGCCTGCTGGCCGTGCTGCTCAACAACGCCGGAAAAGTGCTCACCCAGCGCCAGTTACTCAATCAGGTGTGGGGACCAAACGCGGTCGAACACAGCCACTATTTGCGTATTTATATGGGGCATCTGCGACAAAAACTGGAGCAAGATCCCGCCCGCCCCCGCCATTTTATTACTGAAACCGGTATTGGGTATCGGTTTATGCCATGA,MTNVLIVEDEQAIRRFLRTALEGDGMRVFEAETLQRGLLEAATRKPDLIILDLGLPDGDGIEFIRDLRQWSAVPVIVLSARSEESDKIAALDAGADDYLSKPFGIGELQARLRVALRRHSATTTPDPLVKFSDVTVDLAARVIHRGEEEVHLTPIEFRLLAVLLNNAGKVLTQRQLLNQVWGPNAVEHSHYLRIYMGHLRQKLEQDPARPRHFITETGIGYRFMP,MTNVLIVEDEQAIRRFLRTALEGDGMRVFEAETLQRGLLEAATRKPDLIILDLGLPDGDGIEFIRDLRQWSAVPVIVLSARSEESDKIAALDAGADDYLSKPFGIGELQARLRVALRRHSATTAPDPLVKFSDVTVDLAARVIHRGEEEVHLTPIEFRLLAVLLNNAGKVLTQRQLLNQVWGPNAVEHSHYLRIYMGHLRQKLEQDPARPRHFITETGIGYRFML,100,gnl|BL_ORD_ID|2103|hsp_num:0,2331,FALSE,None
LK1198,5_195 # 205331 # 206275 # 1 # ID=5_195;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.462,5_195,205331,206275,+,Perfect,500,655.981,leuO,100,3003843,protein homolog model,n/a,n/a,nucleoside antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGCCAGAGGTTCAAACAGATCATCCAGAGACGGCGGAGTTAAGCAAGCCACAGCTACGCATGGTCGATCTCAACTTATTAACCGTTTTCGATGCCGTGATGCAGGAGCAAAACATCACCCGTGCCGCTCATGCTCTGGGAATGTCGCAACCTGCGGTCAGTAACGCTGTTGCACGCCTGAAGGTGATGTTTAATGACGAGCTTTTTGTTCGTTATGGCCGTGGTATTCAACCGACTGCTCGCGCATTTCAACTTTTTGGCTCAGTTCGTCAGGCATTGCAACTAGTACAAAATGAATTGCCTGGTTCAGGTTTTGAACCCGCGAGCAGTGAACGTGTATTTCATCTTTGTGTTTGCAGCCCGTTAGACAGCATTCTGACCTCGCAGATTTATAATCACATTGAGCAGATTGCGCCAAATATACATGTTATGTTCAAGTCTTCATTAAATCAGAACACTGAACATCAGCTGCGTTATCAGGAAACGGAGTTTGTGATTAGTTATGAAGACTTCCATCGCCCTGAATTTACCAGTGTGCCATTATTTAAAGATGAAATGGTGTTGGTAGCCAGCAAAAATCATCCAACAATTAAAGGCCCGTTACTGAAGCATGATGTTTATAACGAACAACACGCTGCGGTTTCGCTCGATCGTTTCGCATCATTTAGTCAAACCTGGTATGACACGGTAGATAAGCAAGCCAGTATCGCGTATCAGGGCATGGCAATGATGAGCGTACTTAGCGTGGTGTCGCAAACGCATCTGGTCGCTATTGCGCCGCGTTGGTTGGCTGAAGAGTTCGCTGAATCCTTAGAGTTACAGGTATTACCGCTGCCGTTAAAACAAAACAGCAGAACCTGTTATCTCTCCTGGCATGAAGCTGCCGGGCGCGATAAAGGCCATCAGTGGATGGAAGAGCAATTAGTCTCAATTTGCAAACGCTAA,MPEVQTDHPETAELSKPQLRMVDLNLLTVFDAVMQEQNITRAAHALGMSQPAVSNAVARLKVMFNDELFVRYGRGIQPTARAFQLFGSVRQALQLVQNELPGSGFEPASSERVFHLCVCSPLDSILTSQIYNHIEQIAPNIHVMFKSSLNQNTEHQLRYQETEFVISYEDFHRPEFTSVPLFKDEMVLVASKNHPTIKGPLLKHDVYNEQHAAVSLDRFASFSQTWYDTVDKQASIAYQGMAMMSVLSVVSQTHLVAIAPRWLAEEFAESLELQVLPLPLKQNSRTCYLSWHEAAGRDKGHQWMEEQLVSICKR,MPEVQTDHPETAELSKPQLRMVDLNLLTVFDAVMQEQNITRAAHALGMSQPAVSNAVARLKVMFNDELFVRYGRGIQPTARAFQLFGSVRQALQLVQNELPGSGFEPASSERVFHLCVCSPLDSILTSQIYNHIEQIAPNIHVMFKSSLNQNTEHQLRYQETEFVISYEDFHRPEFTSVPLFKDEMVLVASKNHPTIKGPLLKHDVYNEQHAAVSLDRFASFSQTWYDTVDKQASIAYQGMAMMSVLSVVSQTHLVAIAPRWLAEEFAESLELQVLPLPLKQNSRTCYLSWHEAAGRDKGHQWMEEQLVSICKR,100,gnl|BL_ORD_ID|4928|hsp_num:0,5921,FALSE,None
LK1198,7_9 # 8777 # 10243 # -1 # ID=7_9;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.561,7_9,8777,10243,-,Strict,875,978.008,mdtP,98.16,3003550,protein homolog model,n/a,n/a,nucleoside antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGATCAATCGTCAACTTTCACGCCTGCTGTTGTGCAGCATTCTCGGCAGCACGACGCTGATTTCCGGCTGTGCCCTGGTACGTAAGGATTCTGCGCCTCATCAACAGCTCAAACCGGAACAAATCAAACTGGCCGATGATATTCATCTTGCCAGCTCCGGCTGGCCGCAGGCGCAGTGGTGGAAACAACTCAATGACCCGCAGTTGGATGCGCTGATCCAACGGACGCTAAGTGGTTCACACACCCTCGCCGAAGCGAAACTGCGGGAAGAAAAAGCGCAGTCCCAGGCCGATTTGTTAGATGCCGGTTCACAATTACAGGTCGCAGCGTTAGGGATGCTCAACCGCCAACGCGTCTCGGCGAACGGCTTTTTAAGCCCTTATGCGATGGATGCGCCAGCACTGGGTATGGACGGGCCGTACTATACGGAAGCCACAGTCGGTTTGTTTGCCGGACTGGATCTCGATTTGTGGGGTGTGCATCGCTCAGCGGTTGCTGCCGCCATTGGCGCGCATAATGCCGCGCTGGCAGAAACCGCAGCAGTAGAGCTATCGCTGACCACGGGCGTAGCGCAGCTTTATTACAGTATGCAGGCCAGCTATCAGATGCTCGATCTGTTAGAACAAACTCGCGATGTGATTGATTACGCGGTGAAAGCGCACCAGAGTAAAGTGGCGCACGGTCTGGAAGCGCAAGTGCCTTTCCACGGCGCGCGGGCACAGATTCTGGCGGTCGATAAACAAATTGCTGCCGTCAAAGGGCAAATCACTGAAACGCGAGAATCTCTGCGTGCATTGATTGGCGCGGGAGCCAGCGATATGCCGGAGATCAAACCGGTGGCATTACCACGAGTACAGACCGGCATTCCGGCAACGCTCTCTTATGAGTTGCTCGCCAGACGCCCGGATCTGCAAGCCATGCGCTGGTATGTTCAGGCGTCATTAGATCAGGTGGATTCCGCGCGGGCGCTGTTCTACCCGAGCTTTGATATCAAAGCGTTTTTCGGTCTGGACTCCATCCACCTGGATACCTTATTCAAAAAAACCAGTCGCCAGTTCAACTTCATCCCGGGTCTGAAATTGCCGCTGTTTGACGGTGGACGGTTGAATGCCAATCTCGAAGGCACTCGCGCCGCCAGCAACATGATGATTGAACGTTACAACCAGTCAGTACTGAACGCGGTGCGTGACGTTGCCGTCAACGGCACACGTCTGCAAACGCTCAACGACGAGCGAGAGATGCAGGCTGAACGCGTAGAAGCAACGCGCTTCACCCAGCGCGCAGCCGAGGCCGCCTATCAGCGCGGCTTAACCAGCCGCTTACAGGCCACCGAAGCCCGGTTGCCAGTGCTTGCCGAGGAGATGTCATTACTGATGCTGGACAGCCGCCGGGTGATCCAAAGCATTCAGTTGATGAAATCGCTGGGCGGCGGGTATCAGACGGCTCCCGTCGTCGAGAAAAAATAA,MINRQLSRLLLCSILGSTTLISGCALVRKDSAPHQQLKPEQIKLADDIHLASSGWPQAQWWKQLNDPQLDALIQRTLSGSHTLAEAKLREEKAQSQADLLDAGSQLQVAALGMLNRQRVSANGFLSPYAMDAPALGMDGPYYTEATVGLFAGLDLDLWGVHRSAVAAAIGAHNAALAETAAVELSLTTGVAQLYYSMQASYQMLDLLEQTRDVIDYAVKAHQSKVAHGLEAQVPFHGARAQILAVDKQIAAVKGQITETRESLRALIGAGASDMPEIKPVALPRVQTGIPATLSYELLARRPDLQAMRWYVQASLDQVDSARALFYPSFDIKAFFGLDSIHLDTLFKKTSRQFNFIPGLKLPLFDGGRLNANLEGTRAASNMMIERYNQSVLNAVRDVAVNGTRLQTLNDEREMQAERVEATRFTQRAAEAAYQRGLTSRLQATEARLPVLAEEMSLLMLDSRRVIQSIQLMKSLGGGYQTAPVVEKK,MINRQLSRLLLCSILGSTTLISGCALVRKDSAPHQQLKPEQIKLADDIHLASSGWPQAQWWKQLNDPQLDALIQRTLSGSHTLAEAKLREEKAQSQADLLDAGSQLQVAALGMLNRQRVSANGFLSPYSMDAPALGMDGPYYTEATVGLFAGLDLDLWGVHRSAVAAAIGAHNAALAETAAVELSLATGVAQLYYSMQASYQMLDLLEQTHDVIDYAVKAHQSKVAHGLEAQVPFHGARAQILAVDKQIVAVKGQITETRESLRALIGAGASDMPEIRPVALPQVQTGIPATLSYELLARRPDLQAMRWYVQASLDQVDSARALFYPSFDIKAFFGLDSIHLHTLFKKTSRQFNFIPGLKLPLFDGGRLNANLEGTRAASNMMIERYNQSVLNAVRDVAVNGTRLQTLNDEREMQAERVEATRFTQRAAEAAYQRGLTSRLQATEARLPVLAEEMSLLMLDSRRVIQSIQLMKSLGGGYQAGPVVEKK,100,gnl|BL_ORD_ID|36|hsp_num:0,45,FALSE,None
LK1198,7_10 # 10240 # 12291 # -1 # ID=7_10;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.545,7_10,10240,12291,-,Strict,1300,1373.99,mdtO,97.51,3003549,protein homolog model,n/a,n/a,nucleoside antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGAGCGCGCTCAACTCCCTGCCATTACCGGTGGTCAGGCTGCTGGCGTTCTTTCATGAAGAGTTAAGCGAGCGGCGACCAGGGCGCGTGCCACAGACTATGCAACTCTGGGTAGGCTGCCTGCTGGTGATTCTGATCTCGATGACTTTTGAGATCCCTTTTGTGGCGTTATCACTGGCAGTGCTGTTTTACGGTATTCAGTCGAACGCGTTTTACACCAAATTTGTCGCGATCTTGTTTGTGGTTGCCACGGTGCTGGAGATCGGCAGCCTGTTTTTGATCTACAAATGGTCATATGGCGAACCGTTGATCCGATTGATCATCTCCGGGCCGATCCTGATGGGCTGCATGTTTTTGATGCGCACCCATCGGCTGGGACTGGTCTTTTTCGCCGTCGCCATTGTCGCTATTTACGGGCAAACCTTCCCCGCCATGCTCGACTATCCGGAAGTGGTCGTGCGCTTAACGCTGTGGTGTATCGTTGTTGGCCTCTATCCAACCTTGCTGATGACGTTAATCGGCGTGCTGTGGTTTCCCAGTCGTGCCATTACGCAGATGCATCAGGCGCTTAATGATCGGCTTGATGATGCCATTAGCCACCTGACGGACAGCCTCGCACCGCTACCCGAAACGCGGATTGAAAGAGAGGCGCTGGCGCTGCAAAAACTCAATGTCTTTTGCCTCGCGGATGATGCCAACTGGCGAACCCAGAGCGCATGGTGGCAAAGCTGCGTGGCAACGGTAACCTACATTTACTCGACGCTGAATCGCTACGATCCCACCTCTTTTGCTGATTCTCAGGCAATTATTGAATTTCGGCAAAAATTAGTCTCAGAAATCAACAAGCTGCAACATACCATTGCCGAAGGTCAGTGCTGGCAAAGCGACTGGCGGCTTAGTGAAGATGAAGCGGTGGCGGCACGAGAATGTAACCTGGAGAATATCTGCCAGACGTTATTGCAACTGGGTCAGATGGACCCGAATACGCCGCCTACGCCTGCAGCCAAGCCGCCATCAATGGTCGCCGATGCCTTTACCAATCCAGACTATATGCGCTACGCGGTAAAAACGCTGCTCGCCTGTTTGATCTGTTACACCTTCTACAGCGGCGTGGACTGGGAAGGCATTCACACCTGTATGCTGACCTGCGTGATCGTCGCTAATCCCAATGTCGGTTCGTCGTACCAGAAGATGGTGCTGCGTTTTGGCGGGGCCTTTTGCGGCGCGATTCTGGCGCTGTTATTCACGTTATTGGTCATGCCCTGGCTGGACAATATTGTCGAATTGCTGTTTGTGCTGGCACCGATTTTCCTGTTGGGCGCATGGATTGCCACCAGCTCTGAACGCTCTTCTTATATCGGCACACAGATGGTGGTCACCTTCGCGCTCGCCACGCTCGAAAACGTTTTTGGCCCGGTGTACGACCTGGTGGAAATTCGCGATCGCGCCCTGGGTATCATCATTGGTACCGTGGTGTCCGCGGTGATTTACACCTTTGTCTGGCCTGAAAGCGAAGCGCGCACGCTGCCGCAAAAACTGGCTGGCGCGCTGGGTATGTTGAGTAAAGTAATGCGGATCCCACGCCAGCAGGAAGTCACGGCTCTGCGCACTTATCTGCAAATTCGCATAGGTCTGCATGCGGCGTTTAATGCCTGTGAAGAGATGTGCCAACGCGTGGTGCTGGAGCGTCAACTGGACAGCGAAGAACGCGCATTACTGATTGAACGTTCGCAAACGGTTATTCGTCAGGGCCGCGATATTCTTCACGCCTGGGATGCCACCTGGAACTCGGCGCAGGCGCTGGATAACGCACTACAGCCGGACAGAGCAGGTCAGTTTGCCGATGCCCTGGAGAAATACGCCGCCGGTGTGGCTACCGCACTCAGTCATTCTCCTCAAATAACGCTTGAAGAAACACCCGCCTCGCAGGCCATCCTGCCGACCTTATTAAAACAGGAGCAACACGTCTGCCAGCTTTTCGCCCGCTTGCCAGACTGGACAGCCCCGGCATTAACGCCCACCACGGAACAGGCACAAGGAGCCACGCAATGA,MSALNSLPLPVVRLLAFFHEELSERRPGRVPQTMQLWVGCLLVILISMTFEIPFVALSLAVLFYGIQSNAFYTKFVAILFVVATVLEIGSLFLIYKWSYGEPLIRLIISGPILMGCMFLMRTHRLGLVFFAVAIVAIYGQTFPAMLDYPEVVVRLTLWCIVVGLYPTLLMTLIGVLWFPSRAITQMHQALNDRLDDAISHLTDSLAPLPETRIEREALALQKLNVFCLADDANWRTQSAWWQSCVATVTYIYSTLNRYDPTSFADSQAIIEFRQKLVSEINKLQHTIAEGQCWQSDWRLSEDEAVAARECNLENICQTLLQLGQMDPNTPPTPAAKPPSMVADAFTNPDYMRYAVKTLLACLICYTFYSGVDWEGIHTCMLTCVIVANPNVGSSYQKMVLRFGGAFCGAILALLFTLLVMPWLDNIVELLFVLAPIFLLGAWIATSSERSSYIGTQMVVTFALATLENVFGPVYDLVEIRDRALGIIIGTVVSAVIYTFVWPESEARTLPQKLAGALGMLSKVMRIPRQQEVTALRTYLQIRIGLHAAFNACEEMCQRVVLERQLDSEERALLIERSQTVIRQGRDILHAWDATWNSAQALDNALQPDRAGQFADALEKYAAGVATALSHSPQITLEETPASQAILPTLLKQEQHVCQLFARLPDWTAPALTPTTEQAQGATQ,MSALNSLPLPVVRLLAFFHEELSERRPGRVPQTVQLWVGCLLVILISMTFEIPFVALSLAVLFYGIQSNAFYTKFVAILFVVATVLEIGSLFLIYKWSYGEPLIRLIIAGPILMGCMFLMRTHRLGLVFFAVAIVAIYGQTFPAMLDYPEVVVRLTLWCIVVGLYPTLLMTLIGVLWFPSRAISQMHQALNDRLDDAISHLTDSLAPLPETRIEREALALQKLNVFCLADDANWRTQNAWWQSCVATVTYIYSTLNRYDPTSFADSQAIIEFRQKLASEINKLQHAVAEGQCWQSDWRISESEAMAARECNLENICQTLLQLGQMDPNTPPTPAAKPPSMAADAFTNPDYMRYAVKTLLACLICYTFYSGVDWEGIHTCMLTCVIVANPNVGSSYQKMVLRFGGAFCGAILALLFTLLVMPWLDNIVELLFVLAPIFLLGAWIATSSERSSYIGTQMVVTFALATLENVFGPVYDLVEIRDRALGIIIGTVVSAVIYTFVWPESEARTLPQKLAGTLGMLSKVMRIPRQQEVTALRTYLQIRIGLHAAFNACEEMCQRVALERQLDSEERALLIERSQTVIRQGRDLLHAWDATWNSAQALDNALQPDRAGQFADALEKYAAGLATALSRSPQITLEETPASQAILPTLLKQEQHVCQLFARLPDWTAPALTPATEQAQGATQ,100,gnl|BL_ORD_ID|1893|hsp_num:0,2056,FALSE,None
LK1198,7_11 # 12291 # 13322 # -1 # ID=7_11;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.563,7_11,12291,13322,-,Strict,600,677.167,mdtN,98.54,3003548,protein homolog model,n/a,n/a,nucleoside antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGGAAAGTACGCCGAAAAAAGCTCCTCGCAGTAAATTCCCTGCTCTGTTAGTGGTTGCGTTGGCGCTGGTTGCCCTTGTTTTCGTTATCTGGCGCGTAGACAGTGCGCCATCAACTAATGACGCTTACGCGTCAGCAGATACCATTGATGTGGTGCCGGAAGTCAGCGGTCGCATTGTAGAACTGGCGGTCACCGACAACCAGGCGGTGAAACAGGGCGATTTGCTGTTCCGCATTGACCCGCGCCCGTACGAAGCCAATCTGGCGAAAGCTGAAGCCTCCCTCGCGGCGCTGGATAAGCAAATTATGCTCACCCAGCGTAGCGTTGACGCACAACAGTTTGGTGCCGACTCGGTTAATGCCACGGTAGAAAAAGCCCGTGCCGCCGCGAAACAAGCCAGCGATACGTTACGCCGTACCGAACCGCTACTGCGAGAAGGTTTTGTTTCTGCGGAAGAGGTTGACCGTGCAAGAACCGCACAGCGTGCGGCAGAAGCGGACCTTAATGCCGTATTGTTGCAGGCGCAGTCAGCCGCCAGCTCCGTCAGCGGCGTGGATGCGCTGGTGGCGCAACGTGCGGCAGTCGAAGCGGATATTGCGTTGACGAAACTGCATCTGGAAATGGCGACCGTTCGCGCGCCGTTTGATGGCCGGGTCATTTCCCTCAAAACCTCCGTCGGGCAGTTTGCATCTGCGATGCGCCCTATTTTCACTCTAATCGACACTCGTCACTGGTACGTGATTGCCAACTTCCGCGAAACCGATCTGAAAAATATTCGCTCGGGTACACTCGCAACCATTCGCCTGATGAGCGACAGCGGCAAAACCTTCGAGGGTAAAGTGGATTCGATTGGCTACGGCGTGCTACCGGATGACGGCGGCCTGGTGCTGGGCGGCCTGCCGAAAGTGTCACGGTCTATTAACTGGGTCCGCGTTGCCCAGCGTTTTCCGGTCAAAATCATGGTTGATAAACCTGACCCGGAAATGTTCCGCATCGGCGCTTCGGCAGTCGCTAATCTTGAGCCACAATAA,MESTPKKAPRSKFPALLVVALALVALVFVIWRVDSAPSTNDAYASADTIDVVPEVSGRIVELAVTDNQAVKQGDLLFRIDPRPYEANLAKAEASLAALDKQIMLTQRSVDAQQFGADSVNATVEKARAAAKQASDTLRRTEPLLREGFVSAEEVDRARTAQRAAEADLNAVLLQAQSAASSVSGVDALVAQRAAVEADIALTKLHLEMATVRAPFDGRVISLKTSVGQFASAMRPIFTLIDTRHWYVIANFRETDLKNIRSGTLATIRLMSDSGKTFEGKVDSIGYGVLPDDGGLVLGGLPKVSRSINWVRVAQRFPVKIMVDKPDPEMFRIGASAVANLEPQ,MESTPKKAPRSKFPALLVVALALVALVFVIWRVDSAPSTNDAYASADTIDVVPEVSGRIVELAVTDNQAVKQGDLLFRIDPRPYEANLAKAEASLAALDKQIMLTQRSVDAQQFGADSVNATVEKARAAAKQATDTLRRTEPLLKEGFVSAEDVDRARTAQRAAEADLNAVLLQAQSAASAVSGVDALVAQRAAVEADIALTKLHLEMATVRAPFDGRVISLKTSVGQFASAMRPIFTLIDTRHWYVIANFRETDLKNIRSGTPATIRLMSDSGKTFEGKVDSIGYGVLPDDGGLVLGGLPKVSRSINWVRVAQRFPVKIMVDKPDPEMFRIGASAVANLEPQ,100,gnl|BL_ORD_ID|1321|hsp_num:0,1442,FALSE,None
LK1198,7_44 # 42537 # 44180 # -1 # ID=7_44;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.490,7_44,42537,44180,-,Strict,1000,1101.66,eptA,96.16,3003576,protein homolog model,n/a,n/a,peptide antibiotic,antibiotic target alteration,pmr phosphoethanolamine transferase,ATGTTGAAGCGCCTACTAAAAAGACCCTCTTTAAATTTATTCTCCTGGTTATTACTTGCTACTTTTTATATCTCAGTCTGCCTGAATATCGCCTTTTTTAAACAGGTGCTACAGGTGTTACCGCTGGATTCACTGCATAACGTGCTGGTTTTCTTGTCGATGCCGGTCGTCGCATTCAGCGTGATTAATATTGTCCTGACACTAGGCTCTTTCTTATGGCTTAATCGTCCACTCGCCTGCCTGTTTATTCTGGTCGGTGCGGCTGCACAATATTTCATCATGACCTATGGCATCGTCATCGACCGTTCAATGATCACCAATATCATTGATACTACGCCGGCGGAAAGTTATGCGTTGATGACGCCACGAATGTTATTAACGCTGGGGTTAAGTGGCGTGTTGGCCGCGATTATTGCCTGCTGGATCAAAATCAAACCCACCACCTCACGCCTGCGCAGCGTTCTTTTCCGCGGGGCCAACATCCTGATTTCTGTACTGCTGATTCTGCTGGTTGCCGCACTGTTCTACAAAGACTATGCCTCGCTGTTTCGCAACAACAAAGAACTGGTGAAATCCTTAAGCCCGTCCAACAGCATTGTTGCTAGCTGGTCGTGGTACTCTCACCAGCGGTCAGCCAACCTGCCACTGATACGCATTGGTGAAGATGCTCACCGCAACCCATTAATGCAAAATGGGAAACGCAAAAACCTGACCATTTTGATCGTCGGAGAAACGTCGCGCGCAGAGAATTTCTCGCTGAATGGTTATCCACGCGAAACCAATCCTCGTCTGGCAAAAGATAACGTGGTCTATTTCCCTAATACCGCCTCTTGCGGCACGGCAACGGCAGTTTCAGTACCGTGCATGTTCTCGGATATGCCGCGTGAGCACTACAAAGAAGAGTTGGCACAGCACCAGGAAGGCGTGCTGGATATCATTCAGCGAGCGGGCATCAACGTGCTGTGGAATGACAACGATGGCGGCTGTAAAGGCGTTTGCGATCGCGTACCTCACCAGAACATCACCGCGCTGAACCTGCCTGGTCAGTGCATCAACGGCGAATGCTATGACGAAGTGCTGTTCCACGGGCTGGAAGAGTACATCAATAATCTGCAAAGCGATGGCCTCATTGTATTACACACCATCGGCAGCCACGGCCCGACCTATTACAACCGCTATCCGCCGCAGTTCAGGAAATTTACCCCAACCTGCGACACTAACGAGATCCAGACCTGTACCCAAGAGCAACTGGTGAACACTTACGACAACACGCTGGTTTACGTCGACTATATTGTTGATAAAGCGATTAATCTGCTGAAAGAACATCAGGATAAATTTACCACCAGCCTGGTTTATCTTTCTGACCACGGTGAATCGTTAGGTGAAAATGGCATCTATCTGCACGGTCTGCCTTATGCCATCGCCCCGGATAGCCAAAAACAGGTGCCGATGCTGCTGTGGCTATCGGAGGATTATCAAAAACGGTATCAGGTTGACCAGAACTGCCTGCAAAAACAGGCGCAAACGCAACACTATTCACAAGACAATTTATTCTCAACCTTATTGGGCCTGACTGGCGTTGAGACGAAGTATTACCAGGCTGCGGATGATATTCTGCAAACTTGCAGGAGAGTGAGTGAATGA,MLKRLLKRPSLNLFSWLLLATFYISVCLNIAFFKQVLQVLPLDSLHNVLVFLSMPVVAFSVINIVLTLGSFLWLNRPLACLFILVGAAAQYFIMTYGIVIDRSMITNIIDTTPAESYALMTPRMLLTLGLSGVLAAIIACWIKIKPTTSRLRSVLFRGANILISVLLILLVAALFYKDYASLFRNNKELVKSLSPSNSIVASWSWYSHQRSANLPLIRIGEDAHRNPLMQNGKRKNLTILIVGETSRAENFSLNGYPRETNPRLAKDNVVYFPNTASCGTATAVSVPCMFSDMPREHYKEELAQHQEGVLDIIQRAGINVLWNDNDGGCKGVCDRVPHQNITALNLPGQCINGECYDEVLFHGLEEYINNLQSDGLIVLHTIGSHGPTYYNRYPPQFRKFTPTCDTNEIQTCTQEQLVNTYDNTLVYVDYIVDKAINLLKEHQDKFTTSLVYLSDHGESLGENGIYLHGLPYAIAPDSQKQVPMLLWLSEDYQKRYQVDQNCLQKQAQTQHYSQDNLFSTLLGLTGVETKYYQAADDILQTCRRVSE,MLKRLLKRPSLNLLAWLLLAAFYISICLNIAFFKQVLQALPLDSLHNVLVFLSMPVVAFSVINIVLTLSSFLWLNRPLACLFILVGAAAQYFIMTYGIVIDRSMIANIIDTTPAESYALMTPQMLLTLGFSGVLAALIACWIKIKPATSRLRSVLFRGANILVSVLLILLVAALFYKDYASLFRNNKELVKSLSPSNSIVASWSWYSHQRLANLPLVRIGEDAHRNPLMQNEKRKNLTILIVGETSRAENFSLNGYPRETNPRLAKDNVVYFPNTASCGTATAVSVPCMFSDMPREHYKEELAQHQEGVLDIIQRAGINVLWNDNDGGCKGACDRVPHQNVTALNLPDQCINGECYDEVLFHGLEEYINNLQGDGVIVLHTIGSHGPTYYNRYPPQFRKFTPTCDTNEIQTCTKEQLVNTYDNTLVYVDYIVDKAINLLKEHQDKFTTSLVYLSDHGESLGENGIYLHGLPYAIAPDSQKQVPMLLWLSEDYQKRYQVDQNCLQKQAQTQHYSQDNLFSTLLGLTGVETKYYQAADDILQTCRRVSE,100,gnl|BL_ORD_ID|595|hsp_num:0,516,FALSE,None
LK1198,7_80 # 84457 # 85590 # -1 # ID=7_80;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=11-12bp;gc_cont=0.497,7_80,84457,85590,-,Strict,725,764.607,EC-5,98.41,3006880,protein homolog model,n/a,n/a,cephalosporin,antibiotic inactivation,EC beta-lactamase,ATGCTCAAAACGACGCTCTGCACCTTATTAATTACCGCCTCTTGCTCCACATTTGCCGCCCCTCAACAAATCAACGATATTGTGCATCGCACAATTACCCCGCTTATAGATCAACAAAAGATCCCCGGTATGGCGGTGGCGGTAATTTATCAGGGTAAACCTTATTACTTTACCTGGGGCTATGCGGACATCGCCAAAAAGCAGCCCGTCACACAGCAAACGTTGTTTGAGTTAGGTTCGGTCAGCAAAACATTTACGGGCGTGCTTGGTGGCGACGCTATTGCTCGAGGGGAAATCAAGTTAAGCGATCCCACAACAAAATACTGGCCTGAACTTACCGCTAAACAGTGGAATGGGATCACACTATTACATCTCGCAACCTACACCGCTGGCGGCCTGCCATTGCAGGTGCCGGATGAGGTGAAATCCTCAAGCGACCTGCTGCGCTTCTATCAAAACTGGCAGCCTGCATGGGCTCCAGGAACACAACGTCTGTATGCCAACTCCAGTATCGGTTTGTTCGGCGCACTGGCTGTGAAGCCGTCTGGTTTGAGTTTTGAGCAGGCGATGAAAACTCGTGTCTTCCAGCCACTCAAACTCAATCATACGTGGATTAATGTACCGTCCGCAGAAGAAAAGAACTACGCCTGGGGATATCGCGAAGGTAAGGCAGTACATGTTTCGCCAGGGGCGTTAGATGCTGAAGCTTATGGTGTGAAGTCGACCATTGAAGATATGGCCCGCTGGGTGCAAAGCAATTTAAAACCCTTTGATATCAATGAGAAAATACTTCAACAAGGGATACAGCTGGCACAATCTCGCTACTGGCAAACCGGCGATATGTATCAGGGTCTGGGCTGGGAAATGCTGGACTGGCCGGTAAATCCTGACATCATCATTAACGGCAGTGACAATAAAATTGCACTGGCAGCACGCCCCGTAAAACCGATTACGCCCCCAACTCCTGCAGTACGCGCATCATGGGTACATAAAACGGGGGCGACCGGCGGATTTGGTAGCTATGTCGCGTTTATTCCAGAAAAAGAGCTGGGTATCGTGATGCTGGCTAACAAAAACTATCCCAATCCAGCGAGAGTTACCGCCGCCTGGCAGATTCTCAACACTCTACAGTAA,MLKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIDQQKIPGMAVAVIYQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVKSTIEDMARWVQSNLKPFDINEKILQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIINGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNYPNPARVTAAWQILNTLQ,MFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVKSTIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIINGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNYPNPARVAAAWQILNALQ,100,gnl|BL_ORD_ID|3527|hsp_num:0,4594,FALSE,None
LK1198,8_119 # 126931 # 127344 # 1 # ID=8_119;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.471,8_119,126931,127344,+,Perfect,240,276.944,H-NS,100,3000676,protein homolog model,n/a,n/a,macrolide antibiotic; fluoroquinolone antibiotic; cephalosporin; cephamycin; penam; tetracycline antibiotic,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGAGCGAAGCACTTAAAATTCTGAACAACATCCGTACTCTTCGTGCGCAGGCAAGAGAATGTACACTTGAAACGCTGGAAGAAATGCTGGAAAAATTAGAAGTTGTTGTTAACGAACGTCGCGAAGAAGAAAGCGCGGCTGCTGCTGAAGTTGAAGAGCGCACTCGTAAACTGCAGCAATATCGCGAAATGCTGATCGCTGACGGTATTGACCCGAACGAACTGCTGAATAGCCTTGCTGCCGTTAAATCTGGCACCAAAGCTAAGCGTGCTCAGCGTCCGGCAAAATATAGCTACGTTGACGAAAACGGCGAAACTAAAACCTGGACTGGCCAGGGCCGTACTCCAGCTGTAATCAAAAAAGCAATGGATGAGCAAGGTAAATCCCTCGACGATTTCCTGATCAAGCAATAA,MSEALKILNNIRTLRAQARECTLETLEEMLEKLEVVVNERREEESAAAAEVEERTRKLQQYREMLIADGIDPNELLNSLAAVKSGTKAKRAQRPAKYSYVDENGETKTWTGQGRTPAVIKKAMDEQGKSLDDFLIKQ,MSEALKILNNIRTLRAQARECTLETLEEMLEKLEVVVNERREEESAAAAEVEERTRKLQQYREMLIADGIDPNELLNSLAAVKSGTKAKRAQRPAKYSYVDENGETKTWTGQGRTPAVIKKAMDEQGKSLDDFLIKQ,100,gnl|BL_ORD_ID|1144|hsp_num:0,1248,FALSE,None
LK1198,9_20 # 14926 # 15558 # 1 # ID=9_20;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.499,9_20,14926,15558,+,Strict,400,434.491,CRP,99.52,3000518,protein homolog model,n/a,n/a,macrolide antibiotic; fluoroquinolone antibiotic; penam,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGGTGCTTGGCAAACCGCAAACAGACCCGACTCTCGAATGGTTCTTGTCTCATTGCCACATTCATAAGTACCCATCCAAGAGCACGCTTATTCACCAGGGTGAAAAAGCGGAAACGCTGTACTACATCGTTAAAGGCTCTGTGGCAGTGCTGATCAAAGACGAAGAGGGTAAAGAAATGATCCTCTCCTATCTGAATCAGGGTGATTTTATTGGCGAACTGGGCCTGTTTGAAGAGGGCCAGGAACGTAGCGCATGGGTACGTGCGAAAACCGCCTGTGAAGTGGCTGAAATTTCGTACAAAAAATTTCGCCAATTGATTCAGGTAAACCCGGACATTCTGATGCGTCTGTCTGCACAGATGGCGCGTCGTCTGCAAGTCACTTCAGAGAAAGTGGGCAACCTGGCGTTCCTCGACGTGACGGGCCGCATTGCACAGACTCTGCTGAATCTGGCAAAACAACCGGATGCTATGACTCACCCGGACGGTATGCAAATCAAAATTACCCGTCAGGAAATCGGTCAGATTGTCGGCTGTTCTCGTGAAACCGTGGGACGCATTCTGAAGATGCTGGAAGATCAGAACCTGATCTCCGCACACGGTAAAACCATCGTCGTCTACGGCACTCGTTAA,MVLGKPQTDPTLEWFLSHCHIHKYPSKSTLIHQGEKAETLYYIVKGSVAVLIKDEEGKEMILSYLNQGDFIGELGLFEEGQERSAWVRAKTACEVAEISYKKFRQLIQVNPDILMRLSAQMARRLQVTSEKVGNLAFLDVTGRIAQTLLNLAKQPDAMTHPDGMQIKITRQEIGQIVGCSRETVGRILKMLEDQNLISAHGKTIVVYGTR,MVLGKPQTDPTLEWFLSHCHIHKYPSKSKLIHQGEKAETLYYIVKGSVAVLIKDEEGKEMILSYLNQGDFIGELGLFEEGQERSAWVRAKTACEVAEISYKKFRQLIQVNPDILMRLSAQMARRLQVTSEKVGNLAFLDVTGRIAQTLLNLAKQPDAMTHPDGMQIKITRQEIGQIVGCSRETVGRILKMLEDQNLISAHGKTIVVYGTR,100,gnl|BL_ORD_ID|803|hsp_num:0,869,FALSE,None
LK1198,9_185 # 191168 # 192325 # 1 # ID=9_185;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.544,9_185,191168,192325,+,Strict,675,776.548,mdtE,99.74,3000795,protein homolog model,n/a,n/a,macrolide antibiotic; fluoroquinolone antibiotic; penam,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGAACAGAAGAAGAAAACTGTTAATACCGTTGTTATTCTGCGGCGCGATGCTCACCGCCTGCGATGACAAATCGGCGGAAAACGCCGCCGCCATGACGCCTGAGGTCGGTGTCGTCACACTCTCCCCCGGTTCGGTCAATGTGTTGAGCGAATTGCCCGGTAGAACCGTTCCTTATGAAGTTGCCGAGATACGTCCCCAGGTGGGCGGTATTATCATTAAACGCAACTTTATCGAAGGCGATAAAGTGAACCAGGGCGATTCGCTGTATCAGATTGATCCTGCGCCTTTACAGGCAGAGCTGAACTCCGCCAAAGGTTCGCTGGCGAAAGCGCTCTCTACCGCCAGCAATGCCCGCATCACCTTTAACCGCCAGGCATCGTTGCTGAAGACCAACTATGTTAGCCGTCAGGATTACGACACCGCACGCACCCAGTTGAATGAAGCAGAAGCCAATGTCACCGTCGCCAAAGCGGCTGTTGAACAGGCGACGATCAATCTGCAATACGCGAATGTCACCTCGCCGATTACGGGCGTCAGCGGGAAATCGTCGGTGACCGTCGGCGCACTCGTTACCGCTAATCAGGCAGATTCGCTGGTTACCGTACAACGTCTGGACCCGATTTATGTCGATCTCACGCAGTCGGTGCAGGATTTCTTGCGCATGAAAGAAGAGGTCGCCAGTGGGCAAATCAAACAGGTTCAGGGCAGTACGCCAGTACAGCTCAATCTGGAAAATGGTAAACGTTACGGCCAGACCGGCACGCTGAAATTCTCCGACCCGACGGTGGATGAAACCACGGGCTCCGTGACGTTACGGGCGATTTTCCCCAACCCAAATGGTGACTTGCTGCCTGGCATGTATGTCACGGCATTAGTGGATGAAGGTAGCCGCCAGAATGTATTACTGGTGCCGCAGGAAGGCGTCACCCACAACGCCCAGGGTAAAGCAACGGCACTCATTCTGGATAAAGACGATGTCGTGCAGCTACGCGAAATCGAAGCCAGCAAAGCCATCGGCGACCAGTGGGTTGTCACCTCTGGCTTGCAGGCTGGCGATCGGGTGATCGTTTCCGGTTTGCAACGCATTCGTCCGGGTATCAAAGCACGTGCAATTTCCTCCAGCCAGGAAAACGCCAGCACCGAATCGAAACAATAA,MNRRRKLLIPLLFCGAMLTACDDKSAENAAAMTPEVGVVTLSPGSVNVLSELPGRTVPYEVAEIRPQVGGIIIKRNFIEGDKVNQGDSLYQIDPAPLQAELNSAKGSLAKALSTASNARITFNRQASLLKTNYVSRQDYDTARTQLNEAEANVTVAKAAVEQATINLQYANVTSPITGVSGKSSVTVGALVTANQADSLVTVQRLDPIYVDLTQSVQDFLRMKEEVASGQIKQVQGSTPVQLNLENGKRYGQTGTLKFSDPTVDETTGSVTLRAIFPNPNGDLLPGMYVTALVDEGSRQNVLLVPQEGVTHNAQGKATALILDKDDVVQLREIEASKAIGDQWVVTSGLQAGDRVIVSGLQRIRPGIKARAISSSQENASTESKQ,MNRRRKLLIPLLFCGAMLTACDDKSAENAAAMTPEVGVVTLSPGSVNVLSELPGRTVPYEVAEIRPQVGGIIIKRNFIEGDKVNQGDSLYQIDPAPLQAELNSAKGSLAKALSTASNARITFNRQASLLKTNYVSRQDYDTARTQLNEAEANVTVAKAAVEQATINLQYANVTSPITGVSGKSSVTVGALVTANQADSLVTVQRLDPIYVDLTQSVQDFLRMKEEVASGQIKQVQGSTPVQLNLENGKRYSQTGTLKFSDPTVDETTGSVTLRAIFPNPNGDLLPGMYVTALVDEGSRQNVLLVPQEGVTHNAQGKATALILDKDDVVQLREIEASKAIGDQWVVTSGLQAGDRVIVSGLQRIRPGIKARAISSSQENASTESKQ,100,gnl|BL_ORD_ID|1756|hsp_num:0,1903,FALSE,None
LK1198,9_186 # 192350 # 195463 # 1 # ID=9_186;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.528,9_186,192350,195463,+,Strict,1850,2093.93,mdtF,99.32,3000796,protein homolog model,n/a,n/a,macrolide antibiotic; fluoroquinolone antibiotic; penam,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGGCTAACTATTTTATTGATCGCCCGGTTTTTGCCTGGGTACTTGCCATTATTATGATGCTTGCAGGCGGTCTGGCGATCATGAACTTACCGGTTGCGCAGTATCCGCAGATTGCGCCACCGACCATTACCATCAGCGCTACCTATCCAGGTGCCGATGCGCAAACAGTAGAAGACTCGGTCACTCAGGTGATTGAGCAAAATATGAATGGGCTTGATGGCCTGATGTACATGTCTTCAACCAGCGATGCGGCAGGTAATGCCTCCATCACTCTGACCTTCGAGACGGGGACATCACCTGATATCGCACAGGTTCAGGTGCAAAATAAACTGCAACTCGCTATGCCTTCATTACCTGAAGCGGTGCAGCAGCAGGGAATTAGCGTCGATAAGTCGAGCAGTAATATCCTGATGGTAGCGGCATTTATTTCTGATAACGGCAGCCTCAACCAGTACGATATCGCGGACTATGTAGCGTCTAATATCAAAGACCCGCTAAGCCGTACCGCGGGCGTTGGTAGCGTACAGCTCTTTGGTTCCGAGTACGCCATGCGTATCTGGCTGGACCCGCAAAAACTCAATAAATATAACCTGGTACCTTCCGATGTTATTTCCCAGATTAAGGTGCAAAATAACCAGATTTCCGGTGGTCAACTGGGTGGCATGCCACAGGCGGCAGACCAGCAACTGAACGCCTCGATCATTGTGCAGACGCGTCTGCAAACGCCGGAAGAATTTGGCAAAATCCTGTTGAAAGTTCAGCAAGATGGTTCGCAAGTACTGCTGCGTGATGTCGCCCGCGTCGAACTTGGGGCGGAAGATTATTCCACCGTGGCGCGCTATAACGGCAAACCTGCTGCCGGGATCGCCATCAAACTGGCTACCGGAGCAAACGCCCTGGATACCTCGCGAGCGGTGAAAGAGGAGCTGAACCGTTTATCGGCTTATTTCCCTGCAAGCCTGAAGACGGTTTATCCTTACGACACCACACCGTTTATCAAAATTTCTATTCAGGAAGTTTTCAAAACGCTGGTTGAGGCTATCATCCTCGTCTTCCTGGTCATGTATCTGTTTTTGCAGAATTTCCGCGCCACAATCATCCCGACGATTGCCGTACCGGTGGTTATTCTCGGGACGTTTGCGATCTTGTCGGCGGTCGGTTTCACCATCAACACGTTAACTATGTTCGGGATGGTGCTGGCGATAGGGTTACTGGTGGATGACGCCATCGTGGTGGTGGAGAACGTCGAGCGTGTCATTGCGGAAGATAAGCTACCGCCGAAGGAAGCGACGCATAAATCGATGGGGCAGATCCAACGTGCGCTGGTCGGGATTGCCGTTGTTCTTTCCGCAGTGTTTATGCCGATGGCCTTTATGAGCGGTGCGACCGGGGAGATCTACCGCCAGTTCTCCATCACGCTGATCTCCTCCATGCTGCTTTCAGTATTTGTAGCAATGAGCCTGACCCCTGCCCTGTGCGCCACCATTCTGAAAGCCGCGCCGGAGGGCGATCACAAACCTAACGCCCTGTTCGCACGCTTCAACACGCTGTTTGAAAAATCAACTCAGCACTATACCGACAGCACCCGCTCGCTGTTGCGTTGTACCGGTCGCTACATGGTGGTCTACCTGCTGATTTGCGCCGGGATGGCGGTGCTGTTCCTGCGTACGCCGACCTCTTTCTTACCAGAAGAGGATCAGGGGGTATTTATGACCACCGCGCAGTTACCTTCCGGTGCAACCATGGTTAACACCACGAAAGTGCTACAACAGGTGACGGATTATTATCTGACAAAAGAGAAAAATAATGTTCAGTCGGTGTTTACCGTTGGTGGCTTTGGCTTCAGTGGTCAGGGGCAAAACAACGGTCTGGCGTTTATCAGCCTCAAGCCGTGGTCTGAACGTGTCGGCGAGGAAAACTCGGTTACCGCGATTATTCAGCGGGCAATGATTGCGCTAAGCAGTATCAATAAAGCCGTCGTCTTCCCGTTCAACTTACCCGCGGTGGCTGAACTGGGTACCGCGTCAGGTTTTGATATGGAACTGCTGGACAACGGCAATCTGGGGCACGAAAAGCTGACCCAGGCGCGAAACGAGCTGTTATCACTGGCAGCGCAATCACCGAATCAGGTCATCGGGGTACGCCCGAACGGCCTGGAAGATACGCCGATGTTCAAAGTGAACGTCAACGCTGCGAAAGCCGAGGCTATGGGTGTGGCGCTGTCTGATATCAACCAGACAATTTCCACCGCCTTCGGCAGCAGCTACGTGAACGACTTCCTCAACCAGGGGCGGGTGAAAAAAGTGTATGTCCAGGCAGGCACGCCGTTCCGTATGTTGCCGGATAACATCAACCAATGGTATGTACGCAACGCCTCTGGCACGATGGCACCGCTTTCTGCCTATTCGTCTACCGAATGGACCTATGGTTCACCGCGACTGGAACGCTACAACGGCATCCCGTCAATGGAGATTTTAGGTGAAGCGGCTGCCGGGAAAAGTACCGGTGACGCCATGAAATTTATGGCAGACCTGGTCGCAAAACTTCCGGCAGGCGTCGGCTACTCATGGACCGGACTGTCGTATCAGGAAGCGTTATCCTCAAATCAGGCTCCCGCGCTATATGCCATTTCACTGGTCGTGGTGTTCCTCGCCCTCGCCGCACTTTATGAAAGCTGGTCAATTCCGTTCTCGGTGATGTTGGTTGTTCCGTTAGGCGTCGTTGGCGCATTACTGGCCACCGATCTGCGCGGCTTAAGTAATGACGTTTACTTCCAGGTTGGTTTGCTGACCACCATCGGGCTTTCCGCCAAGAACGCCATCCTGATTGTCGAATTTGCCGTTGAGATGATGCAGAAAGAAGGGAAAACGCCGGTAGAGGCAATCATCGAAGCAGCGCGTATGCGTTTACGCCCAATCCTGATGACTTCTCTGGCCTTTATTCTCGGCGTGCTGCCGCTGGTTATCAGTCATGGTGCCGGCTCTGGCGCGCAAAACGCGGTAGGTACCGGCGTAATGGGCGGGATGTTTGCCGCAACAGTGCTGGCAATTTACTTCGTTCCGGTCTTTTTCGTTGTAGTGGAACATCTCTTTGCCCGCTTTAAAAAAGCGTAA,MANYFIDRPVFAWVLAIIMMLAGGLAIMNLPVAQYPQIAPPTITISATYPGADAQTVEDSVTQVIEQNMNGLDGLMYMSSTSDAAGNASITLTFETGTSPDIAQVQVQNKLQLAMPSLPEAVQQQGISVDKSSSNILMVAAFISDNGSLNQYDIADYVASNIKDPLSRTAGVGSVQLFGSEYAMRIWLDPQKLNKYNLVPSDVISQIKVQNNQISGGQLGGMPQAADQQLNASIIVQTRLQTPEEFGKILLKVQQDGSQVLLRDVARVELGAEDYSTVARYNGKPAAGIAIKLATGANALDTSRAVKEELNRLSAYFPASLKTVYPYDTTPFIKISIQEVFKTLVEAIILVFLVMYLFLQNFRATIIPTIAVPVVILGTFAILSAVGFTINTLTMFGMVLAIGLLVDDAIVVVENVERVIAEDKLPPKEATHKSMGQIQRALVGIAVVLSAVFMPMAFMSGATGEIYRQFSITLISSMLLSVFVAMSLTPALCATILKAAPEGDHKPNALFARFNTLFEKSTQHYTDSTRSLLRCTGRYMVVYLLICAGMAVLFLRTPTSFLPEEDQGVFMTTAQLPSGATMVNTTKVLQQVTDYYLTKEKNNVQSVFTVGGFGFSGQGQNNGLAFISLKPWSERVGEENSVTAIIQRAMIALSSINKAVVFPFNLPAVAELGTASGFDMELLDNGNLGHEKLTQARNELLSLAAQSPNQVIGVRPNGLEDTPMFKVNVNAAKAEAMGVALSDINQTISTAFGSSYVNDFLNQGRVKKVYVQAGTPFRMLPDNINQWYVRNASGTMAPLSAYSSTEWTYGSPRLERYNGIPSMEILGEAAAGKSTGDAMKFMADLVAKLPAGVGYSWTGLSYQEALSSNQAPALYAISLVVVFLALAALYESWSIPFSVMLVVPLGVVGALLATDLRGLSNDVYFQVGLLTTIGLSAKNAILIVEFAVEMMQKEGKTPVEAIIEAARMRLRPILMTSLAFILGVLPLVISHGAGSGAQNAVGTGVMGGMFAATVLAIYFVPVFFVVVEHLFARFKKA,MANYFIDRPVFAWVLAIIMMLAGGLAIMNLPVAQYPQIAPPTITVSATYPGADAQTVEDSVTQVIEQNMNGLDGLMYMSSTSDAAGNASITLTFETGTSPDIAQVQVQNKLQLAMPSLPEAVQQQGISVDKSSSNILMVAAFISDNGSLNQYDIADYVASNIKDPLSRTAGVGSVQLFGSEYAMRIWLDPQKLNKYNLVPSDVISQIKVQNNQISGGQLGGMPQAADQQLNASIIVQTRLQTPEEFGKILLKVQQDGSQVLLRDVARVELGAEDYSTVARYNGKPAAGIAIKLAAGANALDTSRAVKEELNRLSAYFPASLKTVYPYDTTPFIEISIQEVFKTLVEAIILVFLVMYLFLQNFRATIIPTIAVPVVILGTFAILSAVGFTINTLTMFGMVLAIGLLVDDAIVVVENVERVIAEDKLPPKEATHKSMGQIQRALVGIAVVLSAVFMPMAFMSGATGEIYRQFSITLISSMLLSVFVAMSLTPALCATILKAAPEGGHKPNALFARFNTLFEKSTQHYTDSTRSLLRCTGRYMVVYLLICAGMAVLFLRTPTSFLPEEDQGVFMTTAQLPSGATMVNTTKVLQQVTDYYLTKEKDNVQSVFTVGGFGFSGQGQNNGLAFISLKPWSERVGEENSVTAIIQRAMIALSSINKAVVFPFNLPAVAELGTASGFDMELLDNGNLGHEKLTQARNELLSLAAQSPNQVTGVRPNGLEDTPMFKVNVNAAKAEAMGVALSDINQTISTAFGSSYVNDFLNQGRVKKVYVQAGTPFRMLPDNINQWYVRNASGTMAPLSAYSSTEWTYGSPRLERYNGIPSMEILGEAAAGKSTGDAMKFMADLVAKLPAGVGYSWTGLSYQEALSSNQAPALYAISLVVVFLALAALYESWSIPFSVMLVVPLGVVGALLATDLRGLSNDVYFQVGLLTTIGLSAKNAILIVEFAVEMMQKEGKTPIEAIIEAARMRLRPILMTSLAFILGVLPLVISHGAGSGAQNAVGTGVMGGMFAATVLAIYFVPVFFVVVEHLFARFKKA,100,gnl|BL_ORD_ID|103|hsp_num:0,121,FALSE,None
LK1198,9_188 # 195826 # 196554 # -1 # ID=9_188;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.409,9_188,195826,196554,-,Perfect,470,498.049,gadW,100,3003838,protein homolog model,n/a,n/a,macrolide antibiotic; fluoroquinolone antibiotic; penam,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGGCTCATGTCTGCTCGGTGATCCTCGTTCGTCGTTCATTCGATATTCATCATGAACAGCAAAAAATATCGTTGCATAACGAGAGTATCCTGCTGCTGGATAAAAATTTGGCAGACGATTTTGCGTTTTGTTCACTGGATACGCGACGGCTGGATATCGAAGAGCTGACAGTTTGCCATTACTTACAAAATATTCGTCAGTTGCCACGCAATTTAGGATTGCATAGCAAAGACCGTTTGTTAATTAACCAGTCACCCCCCATACAGCTGGTGACGGCGATTTTTGATAGTTTCAATGACCCCCGGGTCAATTCGCCGATACTGAGCAAAATGCTCTATCTTTCCTGTTTATCAATGTTTTCTCATAAGAAAGAACTGATCCCCTTACTTTTCAATAGTATCAGTACTGTTTCAGGAAAAGTTGAACGCCTTATTAGCTTTGATATCGCTAAACGTTGGTATCTACGCGATATCGCAGAAAGAATGTATACCAGCGAGAGTCTCATCAAAAAAAAGTTGCAGGATGAAAATACCTGTTTCAGTAAAATATTACTCGCCTCCAGGATGTCGATGGCCAGACGATTACTCGAGTTACGTCAAATACCTCTGCATACTATTGCGGAAAAATGTGGCTATAGCAGTACGTCATACTTTATAAATACATTTAGACAATATTATGGTGTAACGCCACATCAGTTTTCGCAACATTCGCCGGGTACCTTTTCCTGA,MAHVCSVILVRRSFDIHHEQQKISLHNESILLLDKNLADDFAFCSLDTRRLDIEELTVCHYLQNIRQLPRNLGLHSKDRLLINQSPPIQLVTAIFDSFNDPRVNSPILSKMLYLSCLSMFSHKKELIPLLFNSISTVSGKVERLISFDIAKRWYLRDIAERMYTSESLIKKKLQDENTCFSKILLASRMSMARRLLELRQIPLHTIAEKCGYSSTSYFINTFRQYYGVTPHQFSQHSPGTFS,MAHVCSVILVRRSFDIHHEQQKISLHNESILLLDKNLADDFAFCSLDTRRLDIEELTVCHYLQNIRQLPRNLGLHSKDRLLINQSPPIQLVTAIFDSFNDPRVNSPILSKMLYLSCLSMFSHKKELIPLLFNSISTVSGKVERLISFDIAKRWYLRDIAERMYTSESLIKKKLQDENTCFSKILLASRMSMARRLLELRQIPLHTIAEKCGYSSTSYFINTFRQYYGVTPHQFSQHSPGTFS,100,gnl|BL_ORD_ID|2082|hsp_num:0,2324,FALSE,None
LK1198,9_189 # 196923 # 197747 # -1 # ID=9_189;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.412,9_189,196923,197747,-,Strict,450,526.554,gadX,93.07,3000508,protein homolog model,n/a,n/a,macrolide antibiotic; fluoroquinolone antibiotic; penam,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGCAACCACTACATGGTAATTGTCTAATTGCGTACGCAAGACATAAATATATTCTCACCATGGTTAATGGTGAATATCGCTATTTTAATGGCGGTGATCTGGTTTTTGCGGATGCAAGCCAAATTCAAGTGGATAAGTGTGTTGAGAATTTCGTATTAGTTTCAAGAGACACGCTTTCATTATTTCTCCCGATGCTCAAGGAGGAGGCATTAAAACTTCATGTACATAAAAAAGTTCCTTCATTACTCGTTCATCACTGTACCAGAGATATTCCTGTTTTTCAGGAAGTTGCGCAACTATCGCAGAATAAGAATCTTCGCTATGCAGAAATGCTACGTAAAAGGGCATTAATCTTTGCGTTGTTATCTGTTTTTCTTGAGGATACGCAGTTTATACCGTTACTTCTGAACGTGTTGCAACCGAATATGCGAACACGAGTTTGTACGGTCATCAATAATAATATCGCCCATGAGTGGACATTAGCCCGAATTGCTAGCGAATTGTTGATGAGTCCAAGCCTGTTAAAGAAAAAATTGCGCGAAGAAGGTACGTCATATTCACAGTTGCTTACTGAGTGTAGGATGCAGCGTGCTTTACAACTTATTGTTATATATGGGGTTTCAATTAAGCGAGTTGCAGTATCCTGTGGATATCACAGCGTGTCGTATTTCATTTACGTTTTTCGAAATTATTATGGGATGACGCCCACAGAGTATCAGGAGCGATCGGCGCAGGAATTACCGAACTGTGGCTCGGCGGCAAGTATGGCTGCGCAAGGGATTTTTTACGGCACTGACCGTTCTGCGGAAGGAATAAGATTATAG,MQPLHGNCLIAYARHKYILTMVNGEYRYFNGGDLVFADASQIQVDKCVENFVLVSRDTLSLFLPMLKEEALKLHVHKKVPSLLVHHCTRDIPVFQEVAQLSQNKNLRYAEMLRKRALIFALLSVFLEDTQFIPLLLNVLQPNMRTRVCTVINNNIAHEWTLARIASELLMSPSLLKKKLREEGTSYSQLLTECRMQRALQLIVIYGVSIKRVAVSCGYHSVSYFIYVFRNYYGMTPTEYQERSAQELPNCGSAASMAAQGIFYGTDRSAEGIRL,MQSLHGNCLIAYARHKYILTMVNGEYRYFNGGDLVFADASQIRVDKCVENFVFVSRDTLSLFLPMLKEEALNLHAHKKVSSLLVHHCSRDIPVFQEVAQLSQNKNLRYAEMLRKRALIFALLSVFLEDEHFIPLLLNVLQPNMRTRVCTVINNNIAHEWTLARIASELLMSPSLLKKKLREEETSYSQLLTECRMQRALQLIVIHGFSIKRVAVSCGYHSVSYFIYVFRNYYGMTPTEYQERSAQRLSNRDSAASIVAQGNFYGTDRSAEGIRL,100,gnl|BL_ORD_ID|78|hsp_num:0,91,FALSE,None
LK1198,10_65 # 68357 # 69550 # 1 # ID=10_65;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.538,10_65,68357,69550,+,Strict,670,795.808,Escherichia coli acrA,99.75,3004043,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGAACAAAAACAGAGGGTTTACGCCTCTGGCGGTCGTTCTGATGCTCTCAGGCAGCTTAGCCCTAACAGGATGTGACGACAAACAGGCCCAACAAGGTGGCCAGCAGATGCCCGCCGTTGGCGTAGTAACAGTCAAAACTGAACCTCTGCAGATCACAACCGAGCTTCCGGGTCGCACCAGTGCCTACCGGATCGCAGAAGTTCGTCCTCAAGTTAGCGGGATTATCCTGAAGCGTAATTTCAAAGAAGGTAGCGACATCGAAGCAGGTGTCTCTCTCTATCAGATTGATCCTGCGACCTATCAGGCGGCATACGACAGTGCGAAAGGTGATCTGGCGAAAGCCCAGGCTGCAGCCAATATCGCGCAATTGACGGTGAATCGTTATCAGAAATTGCTCGGTACTCAGTACATCAGTAAGCAAGAGTACGATCAGGCTCTGGCTGATGCGCAACAGGCGAATGCTGCGGTAACTGCGGCGAAAGCTGCCGTTGAAACTGCGCGAATCAATCTGGCTTACACCAAAGTCACCTCTCCGATTAGTGGTCGCATTGGTAAGTCAAACGTGACGGAAGGCGCATTGGTACAGAACGGTCAGGCGACTGCGCTGGCAACCGTGCAGCAACTTGATCCGATCTACGTTGATGTGACCCAGTCCAGCAACGACTTCCTGCGCCTGAAACAGGAACTGGCGAATGGCACGCTGAAACAAGAGAACGGCAAAGCCAAAGTGTCGCTGATCACCAGTGACGGCATTAAGTTCCCGCAGGACGGTACGCTGGAATTCTCTGACGTTACCGTTGATCAGACCACTGGGTCTATCACCCTACGCGCTATCTTCCCGAACCCGGATCACACTCTGCTGCCGGGTATGTTCGTGCGTGCACGTCTGGAAGAAGGGCTTAATCCAAACGCTATTTTAGTCCCGCAACAGGGCGTAACCCGTACGCCGCGTGGCGATGCCACCGTACTGGTGGTTGGCGCGGATGACAAAGTGGAAACCCGTCCGATCGTTGCAAGCCAGGCTATCGGCGATAAGTGGCTGGTGACAGAAGGTCTGAAAGCAGGCGATCGCGTAGTAATAAGTGGGCTGCAGAAAGTGCGTCCTGGTGTCCAGGTAAAAGCACAAGAAGTTACCGCTGATAATAACCAGCAAGCCGCAAGCGGTGCTCAGCCTGAACAGTCCAAGTCTTAA,MNKNRGFTPLAVVLMLSGSLALTGCDDKQAQQGGQQMPAVGVVTVKTEPLQITTELPGRTSAYRIAEVRPQVSGIILKRNFKEGSDIEAGVSLYQIDPATYQAAYDSAKGDLAKAQAAANIAQLTVNRYQKLLGTQYISKQEYDQALADAQQANAAVTAAKAAVETARINLAYTKVTSPISGRIGKSNVTEGALVQNGQATALATVQQLDPIYVDVTQSSNDFLRLKQELANGTLKQENGKAKVSLITSDGIKFPQDGTLEFSDVTVDQTTGSITLRAIFPNPDHTLLPGMFVRARLEEGLNPNAILVPQQGVTRTPRGDATVLVVGADDKVETRPIVASQAIGDKWLVTEGLKAGDRVVISGLQKVRPGVQVKAQEVTADNNQQAASGAQPEQSKS,MNKNRGFTPLAVVLMLSGSLALTGCDDKQAQQGGQQMPAVGVVTVKTEPLQITTELPGRTSAYRIAEVRPQVSGIILKRNFKEGSDIEAGVSLYQIDPATYQATYDSAKGDLAKAQAAANIAQLTVNRYQKLLGTQYISKQEYDQALADAQQANAAVTAAKAAVETARINLAYTKVTSPISGRIGKSNVTEGALVQNGQATALATVQQLDPIYVDVTQSSNDFLRLKQELANGTLKQENGKAKVSLITSDGIKFPQDGTLEFSDVTVDQTTGSITLRAIFPNPDHTLLPGMFVRARLEEGLNPNAILVPQQGVTRTPRGDATVLVVGADDKVETRPIVASQAIGDKWLVTEGLKAGDRVVISGLQKVRPGVQVKAQEVTADNNQQAASGAQPEQSKS,100,gnl|BL_ORD_ID|2323|hsp_num:0,2661,FALSE,None
LK1198,10_66 # 69573 # 72722 # 1 # ID=10_66;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.535,10_66,69573,72722,+,Strict,1900,2134.76,acrB,99.9,3000216,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGCCTAATTTCTTTATCGATCGCCCGATTTTTGCGTGGGTGATCGCCATTATCATCATGTTGGCAGGGGGGCTGGCGATCCTCAAACTGCCGGTGGCGCAATATCCTACGATTGCACCGCCGGCAGTAACGATCTCCGCCTCCTACCCTGGCGCTGATGCGAAAACAGTGCAGGACACGGTGACACAGGTTATCGAACAGAATATGAACGGTATCGATAACCTGATGTACATGTCCTCTAACAGTGACTCCACGGGTACCGTGCAGATCACCCTGACCTTTGAGTCTGGTACTGATGCGGATATCGCGCAGGTTCAGGTACAGAACAAACTGCAGTTGGCGATGCCGTTGCTGCCACAAGAAGTACAGCAGCAAGGGGTGAGCGTTGAGAAATCATCCAGCAGCTTCCTGATGGTTGTCGGCGTTATCAACACCGATGGCACCATGACGCAGGAGGATATCTCCGACTACGTGGCGGCGAATATGAAAGATGCCATCAGCCGTACGTCGGGCGTGGGTGACGTTCAGTTGTTCGGTTCACAGTACGCGATGCGTATCTGGATGAACCCGAATGAACTAAACAAATTCCAGCTAACACCGGTTGATGTCATTACCGCCATCAAAGCGCAGAACGCCCAGGTTGCGGCGGGTCAGCTCGGTGGTACGCCGCCGGTGAAAGGCCAACAGCTTAACGCCTCTATTATTGCTCAGACGCGTCTGACCTCTACTGAAGAGTTCGGCAAAATCCTGCTGAAAGTGAATCAGGATGGTTCCCGCGTGCTGCTGCGTGATGTGGCGAAAATTGAGCTGGGTGGTGAGAACTACGACATCATCGCAGAGTTTAACGGCCAACCGGCTTCCGGTCTGGGGATCAAGCTGGCGACCGGTGCAAACGCGCTGGATACCGCTGCGGCAATCCGTGCTGAACTGGCGAAGATGGAACCGTTCTTCCCGTCGGGTCTGAAAATTGTTTACCCGTACGACACCACGCCGTTCGTGAAAATCTCTATTCACGAAGTGGTTAAAACACTGGTCGAAGCGATCATCCTCGTGTTCCTAGTAATGTATCTGTTCTTGCAGAACTTCCGCGCGACGTTGATTCCGACCATTGCCGTACCGGTGGTATTGCTCGGGACCTTTGCCGTCCTTGCCGCCTTTGGCTTCTCGATAAACACGCTAACAATGTTCGGGATGGTGCTCGCCATCGGCCTGTTGGTGGATGACGCTATCGTTGTGGTAGAAAACGTTGAGCGTGTGATGGCGGAAGAAGGTTTGCCGCCAAAAGAAGCCACCCGTAAGTCGATGGGGCAGATTCAGGGCGCTCTGGTCGGTATCGCGATGGTACTGTCGGCGGTATTCGTACCGATGGCCTTCTTTGGCGGTTCTACTGGTGCTATCTATCGTCAGTTCTCTATTACCATTGTTTCAGCAATGGCGCTGTCGGTACTGGTGGCGTTGATCCTGACTCCGGCTCTTTGTGCCACCATGCTGAAACCGATTGCCAAAGGCGATCACGGGGAAGGTAAAAAAGGCTTCTTCGGCTGGTTTAACCGCATGTTCGAGAAGAGCACGCACCACTACACCGACAGCGTAGGCGGTATTCTGCGCAGTACGGGGCGCTACCTGGTGCTGTATCTGATCATCGTGGTCGGCATGGCCTATCTGTTCGTGCGTCTGCCAAGCTCCTTCTTGCCAGATGAGGACCAGGGCGTATTTATGACCATGGTTCAGCTGCCAGCAGGTGCAACGCAGGAACGTACGCAGAAAGTGCTCAATGAGGTAACGAATTACTATCTGACCAAAGAAAAGAACAACGTTGAGTCGGTGTTCGCCGTTAACGGCTTCGGCTTTGCGGGACGTGGTCAGAATACCGGTATTGCGTTCGTTTCCTTGAAGGACTGGGCCGATCGTCCGGGCGAAGAAAACAAAGTTGAAGCGATTACCATGCGTGCAACACGTGCTTTCTCGCAAATCAAAGATGCGATGGTTTTCGCCTTTAACCTGCCCGCAATCGTGGAACTGGGTACCGCAACCGGCTTTGACTTTGAGCTGATTGACCAAGCTGGCCTTGGTCACGAAAAACTGACTCAGGCGCGTAACCAGTTGCTTGCAGAAGCAGCGAAGCACCCTGATATGTTGACCAGCGTACGTCCAAACGGTCTGGAAGATACCCCGCAGTTTAAGATTGATATCGACCAGGAAAAAGCGCAGGCGCTGGGTGTTTCTATCAACGACATTAACACCACTCTGGGCGCTGCATGGGGCGGTAGCTATGTGAACGACTTTATCGACCGCGGTCGTGTGAAGAAAGTTTACGTCATGTCAGAAGCGAAATACCGTATGCTGCCGGATGATATCGGCGACTGGTATGTTCGTGCTGCTGATGGTCAGATGGTGCCGTTCTCGGCGTTCTCCTCTTCTCGTTGGGAGTACGGTTCGCCGCGTCTGGAACGTTACAACGGCCTGCCATCTATGGAAATCTTAGGCCAGGCGGCACCGGGTAAAAGTACCGGTGAAGCAATGGAGCTGATGGAACAACTGGCGAGCAAACTGCCTACCGGTGTTGGCTATGACTGGACGGGAATGTCCTATCAGGAACGTCTCTCCGGCAACCAGGCACCTTCACTGTACGCGATTTCGTTGATTGTCGTGTTCCTGTGTCTGGCTGCGCTGTACGAGAGCTGGTCGATTCCGTTCTCCGTTATGCTGGTCGTTCCGCTGGGGGTTATCGGTGCGTTGCTGGCTGCCACCTTCCGTGGCCTGACCAATGACGTTTACTTCCAGGTAGGCCTGCTCACAACCATTGGTTTGTCGGCGAAGAACGCGATACTTATCGTCGAATTCGCCAAAGACTTGATGGATAAAGAAGGTAAAGGTCTGATTGAAGCGACGCTTGATGCGGTGCGGATGCGTTTACGCCCAATCCTGATGACCTCGTTGGCGTTTATCCTCGGCGTTATGCCGCTGGTTATCAGTACTGGTGCTGGTTCCGGCGCGCAGAACGCAGTAGGTACCGGTGTAATGGGCGGGATGGTGACCGCAACGGTACTGGCAATCTTCTTCGTTCCGGTATTCTTTGTGGTGGTTCGCCGCCGCTTTAGCCGCAAGAATGAAGATATCGAGCACAGCCATACTGTCGATCATCATTGA,MPNFFIDRPIFAWVIAIIIMLAGGLAILKLPVAQYPTIAPPAVTISASYPGADAKTVQDTVTQVIEQNMNGIDNLMYMSSNSDSTGTVQITLTFESGTDADIAQVQVQNKLQLAMPLLPQEVQQQGVSVEKSSSSFLMVVGVINTDGTMTQEDISDYVAANMKDAISRTSGVGDVQLFGSQYAMRIWMNPNELNKFQLTPVDVITAIKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRLTSTEEFGKILLKVNQDGSRVLLRDVAKIELGGENYDIIAEFNGQPASGLGIKLATGANALDTAAAIRAELAKMEPFFPSGLKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQNFRATLIPTIAVPVVLLGTFAVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVMAEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGSTGAIYRQFSITIVSAMALSVLVALILTPALCATMLKPIAKGDHGEGKKGFFGWFNRMFEKSTHHYTDSVGGILRSTGRYLVLYLIIVVGMAYLFVRLPSSFLPDEDQGVFMTMVQLPAGATQERTQKVLNEVTNYYLTKEKNNVESVFAVNGFGFAGRGQNTGIAFVSLKDWADRPGEENKVEAITMRATRAFSQIKDAMVFAFNLPAIVELGTATGFDFELIDQAGLGHEKLTQARNQLLAEAAKHPDMLTSVRPNGLEDTPQFKIDIDQEKAQALGVSINDINTTLGAAWGGSYVNDFIDRGRVKKVYVMSEAKYRMLPDDIGDWYVRAADGQMVPFSAFSSSRWEYGSPRLERYNGLPSMEILGQAAPGKSTGEAMELMEQLASKLPTGVGYDWTGMSYQERLSGNQAPSLYAISLIVVFLCLAALYESWSIPFSVMLVVPLGVIGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGLIEATLDAVRMRLRPILMTSLAFILGVMPLVISTGAGSGAQNAVGTGVMGGMVTATVLAIFFVPVFFVVVRRRFSRKNEDIEHSHTVDHH,MPNFFIDRPIFAWVIAIIIMLAGGLAILKLPVAQYPTIAPPAVTISASYPGADAKTVQDTVTQVIEQNMNGIDNLMYMSSNSDSTGTVQITLTFESGTDADIAQVQVQNKLQLAMPLLPQEVQQQGVSVEKSSSSFLMVVGVINTDGTMTQEDISDYVAANMKDAISRTSGVGDVQLFGSQYAMRIWMNPNELNKFQLTPVDVITAIKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRLTSTEEFGKILLKVNQDGSRVLLRDVAKIELGGENYDIIAEFNGQPASGLGIKLATGANALDTAAAIRAELAKMEPFFPSGLKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQNFRATLIPTIAVPVVLLGTFAVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVMAEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGSTGAIYRQFSITIVSAMALSVLVALILTPALCATMLKPIAKGDHGEGKKGFFGWFNRMFEKSTHHYTDSVGGILRSTGRYLVLYLIIVVGMAYLFVRLPSSFLPDEDQGVFMTMVQLPAGATQERTQKVLNEVTHYYLTKEKNNVESVFAVNGFGFAGRGQNTGIAFVSLKDWADRPGEENKVEAITMRATRAFSQIKDAMVFAFNLPAIVELGTATGFDFELIDQAGLGHEKLTQARNQLLAEAAKHPDMLTSVRPNGLEDTPQFKIDIDQEKAQALGVSINDINTTLGAAWGGSYVNDFIDRGRVKKVYVMSEAKYRMLPDDIGDWYVRAADGQMVPFSAFSSSRWEYGSPRLERYNGLPSMEILGQAAPGKSTGEAMELMEQLASKLPTGVGYDWTGMSYQERLSGNQAPSLYAISLIVVFLCLAALYESWSIPFSVMLVVPLGVIGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGLIEATLDAVRMRLRPILMTSLAFILGVMPLVISTGAGSGAQNAVGTGVMGGMVTATVLAIFFVPVFFVVVRRRFSRKNEDIEHSHTVDHH,100,gnl|BL_ORD_ID|1011|hsp_num:0,1104,FALSE,None
LK1198,10_145 # 152816 # 153910 # 1 # ID=10_145;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.515,10_145,152816,153910,+,Strict,250,266.929,vanG,39.5,3002909,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,glycopeptide resistance gene cluster; Van ligase,ATGGAAAAACTGCGGGTAGGAATCGTTTTTGGTGGTAAATCAGCGGAACATGAAGTGTCTCTGCAATCGGCAAAAAACATTGTCGATGCCATTGATAAAAGTCGCTTCGATGTTGTGCTGCTGGGCATTGATAAACAAGGGCAATGGCACGTCAGCGATGCCAGCAATTATCTGCTAAATGCAGACGATCCTGCCCATATTGCGTTGCGCCCTTCGGCGACCAGCCTTGCGCAGGTGCCAGGTAAACATGAGCATCAGCTTATCGACGCACAAAACGGTCAGCCGTTGCCGACGGTGGATGTCATTTTCCCGATTGTCCACGGTACGCTGGGCGAAGATGGTTCCTTGCAGGGAATGCTGCGGGTCGCCAATTTACCGTTTGTAGGTTCTGATGTTCTGGCTTCAGCGGCCTGTATGGATAAAGATGTCACCAAACGTCTGCTGCGCGATGCCGGGCTGAACATTGCGCCATTTATTACCCTGACGCGCGCTAATCGTCACAACATCAGTTTTGCCGAAGTGGAGTCTAAACTGGGGTTACCGCTGTTTGTAAAACCGGCTAATCAGGGCTCTTCTGTTGGTGTCAGCAAAGTAACCAGTGAAGAACAGTACACAATTGCCGTCGATCTGGCGTTCGAGTTCGATCATAAAGTGATCGTTGAGCAAGGGATCAAAGGTCGAGAGATCGAATGCGCAGTTCTTGGCAACGATAACCCGCAAGCAAGCACCTGTGGCGAGATCGTACTCACCAGCGATTTCTATGCCTACGACACCAAGTACATTGACGAAGATGGCGCGAAAGTGGTAGTTCCGGCAGCCATTGCGCCAGAAATCAACGATAAGATCCGGGCGATTGCCGTTCAGGCTTATCAGACGTTGGGATGCGCAGGCATGGCGCGTGTAGACGTGTTTTTAACCCCAGAGAACGAAGTGGTGATCAACGAGATCAACACCCTGCCTGGCTTCACCAACATCAGTATGTATCCGAAGCTGTGGCAAGCCAGCGGTCTGGGTTACACCGACCTGATCACGCGTTTGATTGAGCTGGCGCTGGAGCGTCACGCTGCGGATAACGCACTGAAAACCACAATGTAA,MEKLRVGIVFGGKSAEHEVSLQSAKNIVDAIDKSRFDVVLLGIDKQGQWHVSDASNYLLNADDPAHIALRPSATSLAQVPGKHEHQLIDAQNGQPLPTVDVIFPIVHGTLGEDGSLQGMLRVANLPFVGSDVLASAACMDKDVTKRLLRDAGLNIAPFITLTRANRHNISFAEVESKLGLPLFVKPANQGSSVGVSKVTSEEQYTIAVDLAFEFDHKVIVEQGIKGREIECAVLGNDNPQASTCGEIVLTSDFYAYDTKYIDEDGAKVVVPAAIAPEINDKIRAIAVQAYQTLGCAGMARVDVFLTPENEVVINEINTLPGFTNISMYPKLWQASGLGYTDLITRLIELALERHAADNALKTTM,MQNKKIAVIFGGNSTEYEVSLQSASAVFENINTNKFDIIPIGITRSGEWYHYTGEKEKILNNTWFEDSKNLCPVVVSQNRSVKGFLEIASDKYRIIKVDLVFPVLHGKNGEDGTLQGIFELAGIPVVGCDTLSSALCMDKDRAHKLVSLAGISVPKSVTFKRFNEEAAMKEIEANLTYPLFIKPVRAGSSFGITKVIEKQELDAAIELAFEHDTEVIVEETINGFEVGCAVLGIDELIVGRVDEIELSSGFFDYTEKYTLKSSKIYMPARIDAEAEKRIQEAAVTIYKALGCSGFSRVDMFYTPSGEIVFNEVNTIPGFTSHSRYPNMMKGIGLSFSQMLDKLIGLYVE,104.3,gnl|BL_ORD_ID|1069|hsp_num:0,1157,FALSE,None
LK1198,12_64 # 74070 # 75443 # 1 # ID=12_64;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.548,12_64,74070,75443,+,Perfect,890,926.391,cpxA,100,3000830,protein homolog model,n/a,n/a,aminoglycoside antibiotic; aminocoumarin antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGATAGGCAGCTTAACCGCGCGCATCTTCGCCATCTTCTGGCTGACGCTGGCGCTGGTGTTGATGTTGGTTTTGATGTTACCCAAGCTCGATTCACGCCAGATGACCGAGCTTCTGGATAGCGAACAGCGTCAGGGTCTGATGATTGAGCAGCATGTCGAAGCGGAGCTGGCGAACGATCCGCCCAACGATTTAATGTGGTGGCGGCGTCTGTTCCGGGCGATTGATAAGTGGGCACCGCCAGGACAGCGTTTGTTATTGGTGACCACCGAAGGCCGCGTGATCGGCGCTGAACGCAGCGAAATGCAGATCATTCGTAACTTTATTGGTCAGGCCGATAACGCCGATCATCCGCAGAAGAAAAAGTATGGCCGCGTGGAACTGGTCGGTCCGTTCTCCGTGCGTGATGGCGAAGATAATTACCAACTTTATCTGATTCGTCCGGCCAGCAGTTCTCAATCCGATTTCATCAACTTACTGTTTGACCGCCCGCTATTACTGCTGATTGTCACCATGCTGGTCAGTACGCCGCTGCTGTTGTGGTTGGCCTGGAGTCTGGCAAAACCGGCGCGTAAGCTGAAAAACGCTGCCGATGAAGTTGCCCAGGGAAACTTACGCCAGCACCCGGAACTGGAAGCGGGGCCACAGGAATTCCTTGCCGCCGGTGCCAGTTTTAACCAGATGGTCACCGCGCTGGAGCGCATGATGACCTCTCAGCAGCGTCTACTTTCTGATATCTCTCACGAACTGCGCACCCCGCTGACGCGTCTGCAACTGGGTACGGCGTTACTGCGCCGTCGTAGCGGTGAAAGCAAGGAACTGGAGCGTATTGAAACTGAAGCGCAACGTCTGGACAGCATGATCAACGATCTGTTGGTGATGTCACGTAATCAGCAGAAAAATGCGCTGGTTAGCGAGACCATCAAAGCCAACCAGTTGTGGAGTGAAGTGCTGGATAACGCGGCGTTCGAAGCCGAGCAAATGGGCAAGTCGTTGACGGTTAACTTCCCACCTGGGCCGTGGCCGCTGTACGGCAACCCGAACGCCCTGGAAAGTGCGCTGGAAAACATTGTTCGTAATGCTCTGCGTTATTCCCATACGAAGATTGAAGTGGGCTTTGCGGTAGATAAAGACGGTATCACCATTACGGTGGACGACGATGGTCCTGGCGTTAGCCCGGAAGATCGCGAACAGATTTTCCGTCCGTTCTATCGGACCGACGAAGCACGCGATCGTGAATCTGGCGGTACAGGTTTGGGGCTGGCGATTGTTGAAACCGCCATTCAGCAGCATCGTGGCTGGGTGAAGGCAGAAGACAGCCCGCTGGGCGGTTTACGGCTGGTGATTTGGTTGCCGCTGTATAAGCGGAGTTAA,MIGSLTARIFAIFWLTLALVLMLVLMLPKLDSRQMTELLDSEQRQGLMIEQHVEAELANDPPNDLMWWRRLFRAIDKWAPPGQRLLLVTTEGRVIGAERSEMQIIRNFIGQADNADHPQKKKYGRVELVGPFSVRDGEDNYQLYLIRPASSSQSDFINLLFDRPLLLLIVTMLVSTPLLLWLAWSLAKPARKLKNAADEVAQGNLRQHPELEAGPQEFLAAGASFNQMVTALERMMTSQQRLLSDISHELRTPLTRLQLGTALLRRRSGESKELERIETEAQRLDSMINDLLVMSRNQQKNALVSETIKANQLWSEVLDNAAFEAEQMGKSLTVNFPPGPWPLYGNPNALESALENIVRNALRYSHTKIEVGFAVDKDGITITVDDDGPGVSPEDREQIFRPFYRTDEARDRESGGTGLGLAIVETAIQQHRGWVKAEDSPLGGLRLVIWLPLYKRS,MIGSLTARIFAIFWLTLALVLMLVLMLPKLDSRQMTELLDSEQRQGLMIEQHVEAELANDPPNDLMWWRRLFRAIDKWAPPGQRLLLVTTEGRVIGAERSEMQIIRNFIGQADNADHPQKKKYGRVELVGPFSVRDGEDNYQLYLIRPASSSQSDFINLLFDRPLLLLIVTMLVSTPLLLWLAWSLAKPARKLKNAADEVAQGNLRQHPELEAGPQEFLAAGASFNQMVTALERMMTSQQRLLSDISHELRTPLTRLQLGTALLRRRSGESKELERIETEAQRLDSMINDLLVMSRNQQKNALVSETIKANQLWSEVLDNAAFEAEQMGKSLTVNFPPGPWPLYGNPNALESALENIVRNALRYSHTKIEVGFAVDKDGITITVDDDGPGVSPEDREQIFRPFYRTDEARDRESGGTGLGLAIVETAIQQHRGWVKAEDSPLGGLRLVIWLPLYKRS,100,gnl|BL_ORD_ID|131|hsp_num:0,152,FALSE,None
LK1198,14_27 # 20208 # 21434 # -1 # ID=14_27;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.521,14_27,20208,21434,-,Strict,700,805.438,mdtG,99.51,3001329,protein homolog model,n/a,n/a,phosphonic acid antibiotic,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGTCACCCTGTGAAAATGACACCCCTATAAACTGGAAACGAAACCTGATCGTCGCCTGGCTAGGCTGTTTTCTTACCGGTGCCGCCTTCAGCCTGGTAATGCCCTTCTTACCCCTCTACGTTGAGCAGCTTGGCGTTACCGGCCACTCCGCCCTGAATATGTGGTCCGGTATTGTCTTCAGCATTACATTTTTATTTTCGGCCATCGCCTCACCGTTTTGGGGTGGACTCGCCGACCGTAAAGGCCGAAAAATCATGCTATTACGCTCTGCTCTCGGCATGGGCATCGTGATGGTGTTGATGGGACTGGCACAAAATATCTGGCAGTTTTTGATCCTGCGGGCGCTTCTTGGTTTACTTGGCGGATTTGTCCCCAACGCTAATGCTCTTATCGCCACACAAGTACCGCGTAATAAAAGCGGCTGGGCGCTGGGTACGCTCTCCACAGGCGGCGTTAGCGGCGCGTTGCTCGGCCCAATGGCTGGCGGTTTGCTCGCCGATAGCTACGGCTTACGTCCGGTATTCTTTATTACCGCCAGTGTGCTCATACTCTGCTTTTTCGTCACCCTGTTTTGCATCAGAGAAAAATTCCAGCCGGTCAGCAAAAAAGAGATGCTGCATATGCGGGAAGTGGTGACATCACTTAAAAACCCGAAACTGGTACTCAGCCTGTTTGTCACCACGTTAATCATCCAGGTGGCGACGGGCTCAATTGCCCCCATTCTGACGCTGTATGTCCGCGAACTGGCGGGTAACGTCAGTAACGTCGCCTTTATCAGTGGCATGATCGCCTCGGTGCCAGGCGTGGCGGCTCTGCTAAGTGCACCACGACTCGGCAAACTTGGCGATCGAATCGGACCCGAAAAGATCCTGATTACAGCGCTGATCTTTTCTGTACTGCTGTTGATCCCAATGTCTTACGTTCAGACGCCATTACAACTTGGGATTTTACGTTTTTTGCTCGGTGCCGCCGATGGTGCACTACTCCCCGCCGTACAGACACTATTAGTTTATAACTCGAGCAACCAGATCGCCGGGCGTATCTTCAGCTATAACCAATCGTTTCGTGATATTGGCAACGTTACCGGACCATTGATGGGAGCAGCGATTTCAGCGAACTACGGTTTCAGGGCGGTATTTCTCGTCACCGCTGGCGTAGTGTTATTCAACGCAGTCTATTCATGGAACAGTCTACGTCGTCGTCGAATCCCCCAGATATCGAACTGA,MSPCENDTPINWKRNLIVAWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSALNMWSGIVFSITFLFSAIASPFWGGLADRKGRKIMLLRSALGMGIVMVLMGLAQNIWQFLILRALLGLLGGFVPNANALIATQVPRNKSGWALGTLSTGGVSGALLGPMAGGLLADSYGLRPVFFITASVLILCFFVTLFCIREKFQPVSKKEMLHMREVVTSLKNPKLVLSLFVTTLIIQVATGSIAPILTLYVRELAGNVSNVAFISGMIASVPGVAALLSAPRLGKLGDRIGPEKILITALIFSVLLLIPMSYVQTPLQLGILRFLLGAADGALLPAVQTLLVYNSSNQIAGRIFSYNQSFRDIGNVTGPLMGAAISANYGFRAVFLVTAGVVLFNAVYSWNSLRRRRIPQISN,MSPCENDTPINWKRNLIVAWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSALNMWSGIVFSITFLFSAIASPFWGGLADRKGRKLMLLRSALGMGIVMVLMGLAQNIWQFLILRALLGLLGGFVPNANALIATQVPRNKSGWALGTLSTGGVSGALLGPMAGGLLADSYGLRPVFFITASVLILCFFVTLFCIREKFQPVSKKEMLHMREVVTSLKNPKLVLSLFVTTLIIQVATGSIAPILTLYVRELAGNVSNVAFISGMIASVPGVAALLSAPRLGKLGDRIGPEKILITALIFSVLLLIPMSYVQTPLQLGILRFLLGAADGALLPAVQTLLVYNSSNQIAGRIFSYNQSFRDIGNVTGPLMGAAISANYGFRAVFLVTAGVVLFNAVYSWNSLRRRRIPQVSN,100,gnl|BL_ORD_ID|550|hsp_num:0,603,FALSE,None
LK1198,14_39 # 30065 # 31273 # -1 # ID=14_39;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=3-4bp;gc_cont=0.553,14_39,30065,31273,-,Perfect,750,801.201,mdtH,100,3001216,protein homolog model,n/a,n/a,fluoroquinolone antibiotic,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGTCCCGCGTGTCGCAGGCGAGGAACCTGGGTAAATATTTCCTGCTCATCGATAATATGCTGGTCGTGCTGGGGTTCTTTGTTGTCTTCCCGCTGATCTCTATCCGCTTCGTTGATCAAATGGGCTGGGCCGCCGTCATGGTCGGTATTGCCCTCGGTCTACGCCAGTTTATTCAGCAAGGTCTGGGTATTTTCGGCGGCGCAATTGCCGACCGCTTTGGTGCCAAACCGATGATTGTCACCGGTATGCTGATGCGTGCCGCCGGATTCGCCACAATGGGTATCGCCCACGAACCGTGGCTACTGTGGTTTTCATGCCTGCTTTCGGGACTCGGCGGCACGTTGTTTGATCCTCCGCGTTCGGCGCTGGTGGTGAAATTAATCCGTCCACAGCAGCGTGGTCGTTTTTTCTCGCTGTTGATGATGCAGGACAGTGCCGGTGCGGTCATTGGCGCATTGTTGGGGAGCTGGCTGTTGCAATACGACTTTCGCCTGGTCTGCGCCACAGGGGCAGTTTTGTTTGTGCTGTGTGCAGCGTTCAATGCGTGGTTGTTACCGGCATGGAAACTCTCCACCGTACGCACGCCCGTTCGCGAAGGCATGACCCGCGTGATGCGTGACAAGCGTTTTGTCACCTATGTCCTGACGCTGGCGGGTTACTACATGCTGGCTGTACAAGTGATGCTGATGCTGCCAATTATGGTCAACGACGTGGCGGGCGCGCCCTCTGCCGTTAAATGGATGTATGCCATTGAAGCGTGTCTGTCGTTAACGTTGCTCTACCCTATCGCCCGCTGGAGTGAAAAGCATTTTCGTCTGGAACACCGGTTAATGGCTGGGCTGTTGATAATGTCATTAAGCATGATGCCAGTAGGCATGGTCAGCGGCCTGCAACAACTTTTCACCCTGATTTGTCTGTTTTATATCGGGTCGATCATTGCCGAGCCTGCGCGTGAAACCTTAAGTGCTTCGCTGGCAGACGCAAGAGCTCGCGGCAGCTATATGGGGTTTAGCCGTCTGGGTCTGGCGATTGGCGGCGCTATTGGTTATATCGGTGGCGGCTGGCTGTTTGACCTGGGCAAATCGGCGCACCAGCCAGAGCTTCCGTGGATGATGCTGGGCATTATTGGCATCTTCACTTTCCTTGCGCTGGGTTGGCAGTTTAGCCAGAAACGCGCCGCGCGTCGTTTGCTTGAACGCGACGCCTGA,MSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGIALGLRQFIQQGLGIFGGAIADRFGAKPMIVTGMLMRAAGFATMGIAHEPWLLWFSCLLSGLGGTLFDPPRSALVVKLIRPQQRGRFFSLLMMQDSAGAVIGALLGSWLLQYDFRLVCATGAVLFVLCAAFNAWLLPAWKLSTVRTPVREGMTRVMRDKRFVTYVLTLAGYYMLAVQVMLMLPIMVNDVAGAPSAVKWMYAIEACLSLTLLYPIARWSEKHFRLEHRLMAGLLIMSLSMMPVGMVSGLQQLFTLICLFYIGSIIAEPARETLSASLADARARGSYMGFSRLGLAIGGAIGYIGGGWLFDLGKSAHQPELPWMMLGIIGIFTFLALGWQFSQKRAARRLLERDA,MSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGIALGLRQFIQQGLGIFGGAIADRFGAKPMIVTGMLMRAAGFATMGIAHEPWLLWFSCLLSGLGGTLFDPPRSALVVKLIRPQQRGRFFSLLMMQDSAGAVIGALLGSWLLQYDFRLVCATGAVLFVLCAAFNAWLLPAWKLSTVRTPVREGMTRVMRDKRFVTYVLTLAGYYMLAVQVMLMLPIMVNDVAGAPSAVKWMYAIEACLSLTLLYPIARWSEKHFRLEHRLMAGLLIMSLSMMPVGMVSGLQQLFTLICLFYIGSIIAEPARETLSASLADARARGSYMGFSRLGLAIGGAIGYIGGGWLFDLGKSAHQPELPWMMLGIIGIFTFLALGWQFSQKRAARRLLERDA,100,gnl|BL_ORD_ID|342|hsp_num:0,375,FALSE,None
LK1198,30_12 # 5742 # 6074 # 1 # ID=30_12;partial=00;start_type=ATG;rbs_motif=AGGA/GGAG/GAGG;rbs_spacer=11-12bp;gc_cont=0.414,30_12,5742,6074,+,Strict,190,218.009,Escherichia coli emrE,99.09,3004039,protein homolog model,n/a,n/a,macrolide antibiotic,antibiotic efflux,small multidrug resistance (SMR) antibiotic efflux pump,ATGAACCCTTATATTTATCTTGGTGGTGCAATACTTGCAGAGGTCATTGGTACAACCTTAATGAAGTTTTCAGAAGGTTTTACACGGTTATGGCCATCTGTTGGTACAATTATTTGTTATTGTGCATCATTCTGGTTATTAGCTCAGACGCTGGCTTATATTCCTACAGGGATTGCTTATGCTATCTGGTCAGGAGTCGGTATTGTCCTGATTAGCTTACTGTCATGGGGATTTTTCGGCCAACGGCTGGACCTGCCAGCCATTATAGGCATGATGTTGATTTGTGCCGGTGTGTTGGTTATTAATTTATTGTCACGAAGCACACCACATTAA,MNPYIYLGGAILAEVIGTTLMKFSEGFTRLWPSVGTIICYCASFWLLAQTLAYIPTGIAYAIWSGVGIVLISLLSWGFFGQRLDLPAIIGMMLICAGVLVINLLSRSTPH,MNPYIYLGGAILAEVIGTTLMKFSEGFTRLWPSVGTIICYCASFWLLAQTLAYIPTGIAYAIWSGVGIVLISLLSWGFFGQRLDLPAIIGMMLICAGVLIINLLSRSTPH,100,gnl|BL_ORD_ID|2319|hsp_num:0,2656,FALSE,None
LK1198,50_3 # 1644 # 1757 # 1 # ID=50_3;partial=01;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=11-12bp;gc_cont=0.421,50_3,1644,1757,+,Strict,300,20.0162,AAC(2')-IIa,100,3004628,protein homolog model,n/a,n/a,aminoglycoside antibiotic,antibiotic inactivation,AAC(2'),ATGGAACATGAACTTCATTATATCGGTATCGACACCGCTAAAGAGAAACTGGATGTCGATGTGTTGTGTCCTGATGGTCGTCATCGCACCAAAAAATTCGCTAACACCACTAAA,MEHELHYIGIDTAKEKLDVDVLCPDGRHRTKKFANTTK,MKDRSHDDSMAEVCRNTSENHWLKTDYRTLFRLCPDGRIERENDPDCSPGPRFWLAGCSEGNVFGVRADVPDDIALKLEELASVEPPFTPPAIPKHLERYLSLLGSDGPVTHDLGLIYELPHAQQYPSKARLIGSGSEEGESLMQSWAEDRVPEALFELGFREVADFWTPWCAAVVDGEVASIAFAARLADAGAELGLVTAKAFRGQGFAAAATAGWSRLSALRSRTLFYSTDRDNISSQRVAARLGLRLRGASLRISRA,14.62,gnl|BL_ORD_ID|2211|hsp_num:0,3327,TRUE,loose hit with at least 95 percent identity pushed strict
LK1198,2_234 # 269619 # 270977 # -1 # ID=2_234;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.527,2_234,269619,270977,-,Strict,850,919.842,Escherichia coli GlpT with mutation conferring resistance to fosfomycin,99.78,3003889,protein variant model,E448K,n/a,phosphonic acid antibiotic,antibiotic target alteration,antibiotic-resistant GlpT,ATGTTGAGTATTTTTAAACCAGCGCCACACAAAGCGCGCTTACCTGCCGCGGAGATCGATCCGACTTATCGTCGATTGCGCTGGCAAATTTTCCTGGGGATATTCTTTGGCTATGCTGCTTACTATTTGGTTCGTAAGAACTTTGCGCTCGCTATGCCTTATCTGGTTGAGCAGGGATTCTCACGCGGTGATTTAGGTTTTGCCCTTTCGGGGATCTCGATTGCTTATGGATTTTCGAAATTCATCATGGGTTCGGTATCGGATCGCTCGAATCCGCGCGTTTTCCTGCCCGCAGGTTTGATTCTGGCGGCGGCAGTGATGTTGTTTATGGGCTTTGTGCCATGGGCGACGTCGAGCATTGCGGTGATGTTTGTACTGTTGTTCCTCTGCGGTTGGTTCCAGGGGATGGGGTGGCCGCCGTGTGGTCGTACTATGGTGCACTGGTGGTCGCAGAAAGAACGTGGCGGTATTGTGTCAGTGTGGAACTGTGCGCACAACGTCGGTGGTGGTATTCCGCCGCTGCTGTTCCTGCTGGGGATGGCCTGGTTCAATGACTGGCACGCGGCGCTCTATATGCCAGCTTTCTGTGCCATTCTGGTGGCACTGTTCGCCTTTGCGATGATGCGCGATACCCCGCAATCCTGTGGCCTGCCGCCGATCGAAGAGTACAAAAATGATTATCCGGACGACTATAACGAAAAAGCGGAACAGGAGCTGACCGCGAAGCAGATCTTCATGCAGTACGTGCTGCCGAACAAACTGCTGTGGTACATCGCCATTGCCAACGTGTTCGTTTATCTGCTGCGTTACGGCATCCTCGACTGGTCACCGACTTATCTGAAAGAGGTTAAGCATTTCGCGCTGGATAAATCCTCCTGGGCCTACTTCCTTTATGAATATGCAGGTATTCCGGGCACCCTGCTGTGCGGCTGGATGTCGGATAAAGTCTTTCGTGGTAACCGTGGGGCAACCGGCGTCTTCTTTATGACACTGGTGACCATCGCGACTATCGTTTACTGGATGAACCCGGCAGGTAACCCAACCGTCGATATGATTTGTATGATTGTTATCGGCTTCCTGATCTATGGCCCTGTGATGCTGATCGGTCTACATGCGCTGGAACTGGCACCGAAAAAAGCGGCAGGTACGGCAGCGGGTTTTACCGGGCTGTTTGGTTACCTCGGCGGTTCGGTGGCGGCGAGCGCGATTGTTGGCTACACCGTGGACTTCTTCGGCTGGGATGGCGGCTTTATGGTAATGATTGGCGGCAGCATTCTGGCGGTTATCTTGTTGATTGTTGTGATGATTGGCGAAAAACGTCGCCATGAACAATTACTGCAAAAACGCAACGGAGGCTAA,MLSIFKPAPHKARLPAAEIDPTYRRLRWQIFLGIFFGYAAYYLVRKNFALAMPYLVEQGFSRGDLGFALSGISIAYGFSKFIMGSVSDRSNPRVFLPAGLILAAAVMLFMGFVPWATSSIAVMFVLLFLCGWFQGMGWPPCGRTMVHWWSQKERGGIVSVWNCAHNVGGGIPPLLFLLGMAWFNDWHAALYMPAFCAILVALFAFAMMRDTPQSCGLPPIEEYKNDYPDDYNEKAEQELTAKQIFMQYVLPNKLLWYIAIANVFVYLLRYGILDWSPTYLKEVKHFALDKSSWAYFLYEYAGIPGTLLCGWMSDKVFRGNRGATGVFFMTLVTIATIVYWMNPAGNPTVDMICMIVIGFLIYGPVMLIGLHALELAPKKAAGTAAGFTGLFGYLGGSVAASAIVGYTVDFFGWDGGFMVMIGGSILAVILLIVVMIGEKRRHEQLLQKRNGG,MLSIFKPAPHKARLPAAEIDPTYRRLRWQIFLGIFFGYAAYYLVRKNFALAMPYLVEQGFSRGDLGFALSGISIAYGFSKFIMGSVSDRSNPRVFLPAGLILAAAVMLFMGFVPWATSSIAVMFVLLFLCGWFQGMGWPPCGRTMVHWWSQKERGGIVSVWNCAHNVGGGIPPLLFLLGMAWFNDWHAALYMPAFCAILVALFAFAMMRDTPQSCGLPPIEEYKNDYPDDYNEKAEQELTAKQIFMQYVLPNKLLWYIAIANVFVYLLRYGILDWSPTYLKEVKHFALDKSSWAYFLYEYAGIPGTLLCGWMSDKVFRGNRGATGVFFMTLVTIATIVYWMNPAGNPTVDMICMIVIGFLIYGPVMLIGLHALELAPKKAAGTAAGFTGLFGYLGGSVAASAIVGYTVDFFGWDGGFMVMIGGSILAVILLIVVMIGEKRRHEQLLQERNGG,100,gnl|BL_ORD_ID|2130|hsp_num:0,2372,FALSE,None
LK1198,5_202 # 212376 # 214142 # 1 # ID=5_202;partial=00;start_type=ATG;rbs_motif=AGGA/GGAG/GAGG;rbs_spacer=11-12bp;gc_cont=0.537,5_202,212376,214142,+,Strict,500,597.816,Haemophilus influenzae PBP3 conferring resistance to beta-lactam antibiotics,53.29,3004446,protein variant model,"D350N, S357N",n/a,cephalosporin; cephamycin; penam,antibiotic target alteration,Penicillin-binding protein mutations conferring resistance to beta-lactam antibiotics,ATGAAAGCAGCGGCGAAAACGCAGAAACCAAAACGTCAGGAAGAACATGCCAACTTTATCAGTTGGCGTTTTGCGTTGTTATGCGGCTGTATTCTCCTGGCGCTGGCTTTTCTGCTCGGACGCGTAGCGTGGTTACAAGTTATCTCCCCGGATATGCTGGTGAAAGAGGGCGACATGCGTTCTCTTCGCGTTCAGCAAGTTTCCACCTCCCGCGGCATGATTACTGACCGTTCTGGTCGCCCGTTAGCGGTGAGCGTGCCGGTTAAAGCGATTTGGGCTGACCCGAAAGAAGTGCATGACGCTGGCGGTATCAGCGTCGGTGATCGCTGGAAGGCGCTGGCTAACGCGCTCAATATTCCGCTGGATCAGCTCTCAGCCCGCATTAACGCCAACCCGAAAGGGCGCTTTATTTATCTGGCGCGTCAGGTAAACCCTGACATGGCGGACTACATCAAAAAACTGAAACTGCCGGGGATTCATCTGCGTGAAGAATCTCGCCGTTATTATCCATCCGGCGAAGTGACTGCTCACCTCATCGGTTTTACTAACGTCGATAGCCAAGGGATTGAGGGTGTCGAGAAGAGTTTCGATAAATGGCTTACCGGGCAGCCGGGTGAGCGCATTGTGCGTAAAGACCGCTATGGTCGCGTAATTGAAGATATTTCTTCTACTGACAGCCAGGCAGCGCACAACCTGACGCTGAGTATTGATGAACGCCTGCAGGCGCTGGTTTATCGCGAACTGAACAACGCAGTGGCCTTTAACAAGGCTGAATCTGGTAGCGCCGTGCTGGTGGATGTCAACACCGGTGAAGTGCTGGCGATGGCTAACAGCCCGTCATACAACCCAAATAATCTGAGCGGCACGCCGAAAGAAGCGATGCGTAACCGTACCATCACCGACGTGTTTGAACCGGGCTCAACGGTTAAACCGATGGTGGTGATGACCGCGTTGCAACGTGGCGTGGTGCGGGAAAACTCGGTACTCAATACCGTTCCTTATCGAATTAACGGCCACGAAATCAAAGACGTGGCGCGCTACAGCGAATTAACCCTGACCGGGGTATTACAGAAGTCGAGTAACGTCGGTGTTTCCAAACTGGCGTTAGCGATGCCGTCCTCAGCGTTAGTAGATACTTACTCACGTTTTGGACTGGGAAAAGCGACCAATTTGGGGTTGGTCGGAGAACGCAGTGGCTTATATCCTCAAAAACAACGGTGGTCTGACATAGAGAGGGCCACCTTCTCTTTCGGCTACGGGCTAATGGTAACACCGTTACAGTTAGCGCGAGTCTACGCAACTATCGGCAGCTACGGCATTTATCGCCCACTGTCGATTACCAAAGTTGACCCCCCGGTTCCCGGTGAACGTGTCTTCCCGGAATCCATTGTTCGCACCGTGGTGCATATGATGGAAAGCGTGGCGCTACCGGGCGGCGGCGGCGTGAAGGCGGCGATTAAAGGCTATCGTATCGCCATTAAAACCGGTACCGCGAAAAAGGTCGGGCCGGACGGTCGCTACATCAATAAATATATTGCTTATACCGCAGGCGTTGCGCCTGCGAGTCAGCCGCGCTTCGCGCTGGTTGTTGTTATCAACGATCCGCAGGCGGGTAAATACTACGGCGGCGCCGTTTCCGCGCCGGTCTTTGGTGCCATCATGGGCGGCGTATTGCGTACCATGAACATCGAGCCGGATGCGCTGACAACGGGCGATAAAAATGAATTTGTGATTAATCAAGGCGAGGGTACAGGTGGCAGATCGTAA,MKAAAKTQKPKRQEEHANFISWRFALLCGCILLALAFLLGRVAWLQVISPDMLVKEGDMRSLRVQQVSTSRGMITDRSGRPLAVSVPVKAIWADPKEVHDAGGISVGDRWKALANALNIPLDQLSARINANPKGRFIYLARQVNPDMADYIKKLKLPGIHLREESRRYYPSGEVTAHLIGFTNVDSQGIEGVEKSFDKWLTGQPGERIVRKDRYGRVIEDISSTDSQAAHNLTLSIDERLQALVYRELNNAVAFNKAESGSAVLVDVNTGEVLAMANSPSYNPNNLSGTPKEAMRNRTITDVFEPGSTVKPMVVMTALQRGVVRENSVLNTVPYRINGHEIKDVARYSELTLTGVLQKSSNVGVSKLALAMPSSALVDTYSRFGLGKATNLGLVGERSGLYPQKQRWSDIERATFSFGYGLMVTPLQLARVYATIGSYGIYRPLSITKVDPPVPGERVFPESIVRTVVHMMESVALPGGGGVKAAIKGYRIAIKTGTAKKVGPDGRYINKYIAYTAGVAPASQPRFALVVVINDPQAGKYYGGAVSAPVFGAIMGGVLRTMNIEPDALTTGDKNEFVINQGEGTGGRS,MVKFNSSRKSGKSKKTIRKLTAPETVKQNKPQKVFEKCFMRGRYMLSTVLILLGLCALVARAAYVQSINADTLSNEADKRSLRKDEVLSVRGSILDRNGQLLSVSVPMSAIVADPKTMLKENSLADKERIAALAEELGMTENDLVKKIEKNSKSGYLYLARQVELSKANYIRRLKIKGIILETEHRRFYPRVEEAAHVVGYTDIDGNGIEGIEKSFNSLLVGKDGSRTVRKDKRGNIVAHISDEKKYDAQDVTLSIDEKLQSMVYREIKKAVSENNAESGTAVLVDVRTGEVLAMATAPSYNPNNRVGVKSELMRNRAITDTFEPGSTVKPFVVLTALQRGVVKRDEIIDTTSFKLSGKEIVDVAPRAQQTLDEILMNSSNRGVSRLALRMPPSALMETYQNAGLSKPTDLGLIGEQVGILNANRKRWADIERATVAYGYGITATPLQIARAYATLGSFGVYRPLSITKVDPPVIGKRVFSEKITKDIVGILEKVAIKNKRAMVEGYRVGVKTGTARKIENGHYVNKYVAFTAGIAPISDPRYALVVLINDPKAGEYYGGAVSAPVFSNIMGYALRANAIPQDAEAAENTTTKSAKRIVYIGEHKNQKVN,96.39,gnl|BL_ORD_ID|2497|hsp_num:0,2886,FALSE,None
LK1198,63_1 # 1 # 1029 # 1 # ID=63_1;partial=11;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.540,63_1,1,1029,+,Strict,700,697.582,Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin,100,3003369,protein variant model,R234F,n/a,elfamycin antibiotic,antibiotic target alteration,elfamycin resistant EF-Tu,GCATTCGACCAGATCGATAACGCGCCGGAAGAAAAAGCTCGTGGTATCACCATCAACACTTCTCACGTTGAATACGACACCCCGACCCGTCACTACGCGCACGTAGACTGCCCGGGGCACGCCGACTATGTTAAAAACATGATCACCGGTGCTGCTCAGATGGACGGCGCGATCCTGGTAGTTGCTGCGACTGACGGCCCGATGCCGCAGACTCGTGAGCACATCCTGCTGGGTCGTCAGGTAGGCGTTCCGTACATCATCGTGTTCCTGAACAAATGCGACATGGTTGATGACGAAGAGCTGCTGGAACTGGTTGAAATGGAAGTTCGTGAACTTCTGTCTCAGTACGACTTCCCGGGCGACGACACTCCGATCGTTCGTGGTTCTGCTCTGAAAGCGCTGGAAGGCGACGCAGAGTGGGAAGCGAAAATCCTGGAACTGGCTGGCTTCCTGGATTCTTACATTCCGGAACCAGAGCGTGCGATTGACAAGCCGTTCCTGCTGCCGATCGAAGACGTATTCTCCATCTCCGGTCGTGGTACCGTTGTTACCGGTCGTGTAGAACGCGGTATCATCAAAGTTGGTGAAGAAGTTGAAATCGTTGGTATCAAAGAGACTCAGAAGTCTACCTGTACTGGCGTTGAAATGTTCCGCAAACTGCTGGACGAAGGCCGTGCTGGTGAGAACGTAGGTGTTCTGCTGCGTGGTATCAAACGTGAAGAAATCGAACGTGGTCAGGTACTGGCTAAGCCGGGCACCATCAAGCCGCACACCAAGTTCGAATCTGAAGTGTACATTCTGTCCAAAGATGAAGGCGGTCGTCATACTCCGTTCTTCAAAGGCTACCGTCCGCAGTTCTACTTCCGTACTACTGACGTGACTGGTACCATCGAACTGCCGGAAGGTGTAGAGATGGTAATGCCGGGCGACAACATCAAAATGGTTGTTACCCTGATCCACCCGATCGCGATGGACGACGGTCTGCGTTTCGCAATCCGTGAAGGCGGCCGTACCGTTGGCGCGGGCGTT,AFDQIDNAPEEKARGITINTSHVEYDTPTRHYAHVDCPGHADYVKNMITGAAQMDGAILVVAATDGPMPQTREHILLGRQVGVPYIIVFLNKCDMVDDEELLELVEMEVRELLSQYDFPGDDTPIVRGSALKALEGDAEWEAKILELAGFLDSYIPEPERAIDKPFLLPIEDVFSISGRGTVVTGRVERGIIKVGEEVEIVGIKETQKSTCTGVEMFRKLLDEGRAGENVGVLLRGIKREEIERGQVLAKPGTIKPHTKFESEVYILSKDEGGRHTPFFKGYRPQFYFRTTDVTGTIELPEGVEMVMPGDNIKMVVTLIHPIAMDDGLRFAIREGGRTVGAGV,MLSPEGESTIVRNIAVSKEKFERTKPHVNVGTIGHVDHGKTTLTAAITTVLAKTYGGAARAFDQIDNAPEEKARGITINTSHVEYDTPTRHYAHVDCPGHADYVKNMITGAAQMDGAILVVAATDGPMPQTREHILLGRQVGVPYIIVFLNKCDMVDDEELLELVEMEVRELLSQYDFPGDDTPIVRGSALKALEGDAEWEAKILELAGFLDSYIPEPERAIDKPFLLPIEDVFSISGRGTVVTGRVERGIIKVGEEVEIVGIKETQKSTCTGVEMFRKLLDEGRAGENVGVLLRGIKREEIERGQVLAKPGTIKPHTKFESEVYILSKDEGGRHTPFFKGYRPQFYFRTTDVTGTIELPEGVEMVMPGDNIKMVVTLIHPIAMDDGLRFAIREGGRTVGAGVVAKVLG,83.86,gnl|BL_ORD_ID|1970|hsp_num:0,2158,TRUE,loose hit with at least 95 percent identity pushed strict
LK1198,3_39 # 42017 # 42451 # 1 # ID=3_39;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.490,3_39,42017,42451,+,Strict,210,288.115,Escherichia coli AcrAB-TolC with MarR mutations conferring resistance to ciprofloxacin and tetracycline,97.92,3003378,protein overexpression model,"Y137H, G103S, S3N",n/a,fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics,antibiotic target alteration; antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,GTGAAAAATACCAGCGATCTGTTCAATGAAATTATTCCATTGGGTCGCTTAATCCATATGGTTAATCAGAAGAAAGATCGCCTGCTTAACGAGTATCTGTCTCCGCTGGATATTACCGCGGCACAGTTTAAGGTGCTCTGCTCTATCCGCTGCGCGGCGTGTATTACTCCGGTTGAACTGAAAAAAGTGTTGTCGGTCGACCTGGGGGCACTGACCCGTATGCTGGATCGCCTGGTCTGTAAAGGCTGGGTGGAAAGGTTGCCGAACCCGAATGATAAGCGCGGCGTACTGGTAAAACTTACCACCAGCGGCGCGGCAATATGTGAACAATGCCATCAATTAGTTGGCCAGGACCTGCATCAAGAATTAACAAAAAACCTGACGGCGGACGAAGTGGCAACACTTGAGCATTTGCTTAAGAAAGTCCTGCCGTAA,VKNTSDLFNEIIPLGRLIHMVNQKKDRLLNEYLSPLDITAAQFKVLCSIRCAACITPVELKKVLSVDLGALTRMLDRLVCKGWVERLPNPNDKRGVLVKLTTSGAAICEQCHQLVGQDLHQELTKNLTADEVATLEHLLKKVLP,MKSTSDLFNEIIPLGRLIHMVNQKKDRLLNEYLSPLDITAAQFKVLCSIRCAACITPVELKKVLSVDLGALTRMLDRLVCKGWVERLPNPNDKRGVLVKLTTGGAAICEQCHQLVGQDLHQELTKNLTADEVATLEYLLKKVLP,100,gnl|BL_ORD_ID|1984|hsp_num:0,431,FALSE,None
LK1198,10_64 # 67568 # 68215 # -1 # ID=10_64;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.452,10_64,67568,68215,-,Strict,375,446.047,"Escherichia coli AcrAB-TolC with AcrR mutation conferring resistance to ciprofloxacin, tetracycline, and ceftazidime",100,3003807,protein overexpression model,n/a,n/a,fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics,antibiotic target alteration; antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGGCACGAAAAACCAAACAAGAAGCGCAAGAAACGCGCCAACACATCCTCGATGTGGCTCTACGTCTTTTCTCACAGCAGGGGGTATCATCCACCTCGCTGGGTGAGATTGCAAAAGCAGCTGGCGTTACGCGCGGTGCAATCTACTGGCATTTTAAAGACAAGTCGGATTTGTTCAGTGAGATCTGGGAACTGTCAGAATCCAATATTGGTGAACTAGAGCTTGAGTATCAGGCAAAATTCCCTGGCGATCCACTCTCAGTATTAAGAGAGATATTAATTCATGTTCTTGAATCCACGGTGACAGAAGAACGGCGTCGATTATTGATGGAGATTATATTCCACAAATGCGAATTTGTCGGAGAAATGGCTGTTGTGCAACAGGCACAACGTAATCTCTGTCTGGAAAGTTATGACCGTATAGAACAAACGTTAAAACATTGTATTGAAGCGAAAATGTTGCCTGCGGATTTAATGACGCGTCGGGCAGCAATTATTATGCGCGGCTATATTTCCGGCCTGATGGAAAACTGGCTCTTTGCCCCGCAATCTTTTGATCTTAAAAAAGAAGCCCGCGATTACGTCGCCATCTTACTGGAGATGTATCTCCTGTGTCCCACGCTTCGTAATCCTGCCACTAACGAATAA,MARKTKQEAQETRQHILDVALRLFSQQGVSSTSLGEIAKAAGVTRGAIYWHFKDKSDLFSEIWELSESNIGELELEYQAKFPGDPLSVLREILIHVLESTVTEERRRLLMEIIFHKCEFVGEMAVVQQAQRNLCLESYDRIEQTLKHCIEAKMLPADLMTRRAAIIMRGYISGLMENWLFAPQSFDLKKEARDYVAILLEMYLLCPTLRNPATNE,MARKTKQEAQETRQHILDVALRLFSQQGVSSTSLGEIAKAAGVTRGAIYWHFKDKSDLFSEIWELSESNIGELELEYQAKFPGDPLSVLREILIHVLESTVTEERRRLLMEIIFHKCEFVGEMAVVQQAQRNLCLESYDRIEQTLKHCIEAKMLPADLMTRRAAIIMRGYISGLMENWLFAPQSFDLKKEARDYVAILLEMYLLCPTLRNPATNE,100,gnl|BL_ORD_ID|2090|hsp_num:0,2306,FALSE,None
LK1198,15_17 # 18649 # 19113 # -1 # ID=15_17;partial=00;start_type=ATG;rbs_motif=AGGA/GGAG/GAGG;rbs_spacer=11-12bp;gc_cont=0.510,15_17,18649,19113,-,Strict,300,310.457,Escherichia coli soxR with mutation conferring antibiotic resistance,99.35,3003381,protein overexpression model,n/a,n/a,fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics,antibiotic target alteration; antibiotic efflux,ATP-binding cassette (ABC) antibiotic efflux pump; major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGGAAAAGAAATTACCCCGCATTAAAGCGCTGCTAACCCCCGGCGAAGTGGCGAAACGCAGCGGTGTGGCGGTATCGGCGCTGCATTTCTATGAAAGCAAAGGGTTGATTACCAGTATCCGTAATAGCGGCAATCAGCGGCGATATAAACGTGATGTGTTGCGATATGTCGCAATTATCAAAATTGCTCAGCGTATTGGCATTCCGCTCGCAACCATTCGTGAAGCGTTTGGCGTGTTGCCAGAAGGGCATACGTTAAGTGCGAAAGAGTGGAAACAGCTTTCGTCCCAATGGCGAGAAGAGTTGGATCGGCGCATTCATACCTTAGTGGCGCTGCGTGACGAACTGGATGGATGTATTGGTTGTGGCTGCCTTTCGCGCAGTGATTGCCCGTTGCGTAACCCGGGCGACCGATTAGGAGAAGAAGGTACCGGCGCACGCTTACTGGAAGATGAACAAAACTAA,MEKKLPRIKALLTPGEVAKRSGVAVSALHFYESKGLITSIRNSGNQRRYKRDVLRYVAIIKIAQRIGIPLATIREAFGVLPEGHTLSAKEWKQLSSQWREELDRRIHTLVALRDELDGCIGCGCLSRSDCPLRNPGDRLGEEGTGARLLEDEQN,MEKKLPRIKALLTPGEVAKRSGVAVSALHFYESKGLITSIRNSGNQRRYKRDVLRYVAIIKIAQRIGIPLATIGEAFGVLPEGHTLSAKEWKQLSSQWREELDRRIHTLVALRDELDGCIGCGCLSRSDCPLRNPGDRLGEEGTGARLLEDEQN,100,gnl|BL_ORD_ID|1973|hsp_num:0,1005,FALSE,None
LK1198,15_18 # 19199 # 19522 # 1 # ID=15_18;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.515,15_18,19199,19522,+,Strict,200,220.32,Escherichia coli soxS with mutation conferring antibiotic resistance,100,3003511,protein overexpression model,n/a,n/a,fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; penem; disinfecting agents and antiseptics,antibiotic target alteration; antibiotic efflux; reduced permeability to antibiotic,ATP-binding cassette (ABC) antibiotic efflux pump; major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump; General Bacterial Porin with reduced permeability to beta-lactams,ATGTCCCATCAGAAAATTATTCAGGATCTTATCGCATGGATTGACGAGCATATTGACCAGCCGCTTAACATTGATGTCGTCGCAAAAAAATCTGGCTATTCAAAGTGGTACTTGCAACGGATGTTCCGCACGGTGACGCATCAGACGCTTGGCGATTACATTCGCCAGCGCCGTCTGTTACTGGCCGCCGTTGAGTTGCGCACCACCGAGCGTCCGATTTTTGATATCGCAATGGACCTGGGTTATGTCTCTCAGCAGACCTTCTCCCGCGTTTTCCGTCGGCAGTTTGATCGCACTCCCAGCGATTATCGCCACCGCCTGTAG,MSHQKIIQDLIAWIDEHIDQPLNIDVVAKKSGYSKWYLQRMFRTVTHQTLGDYIRQRRLLLAAVELRTTERPIFDIAMDLGYVSQQTFSRVFRRQFDRTPSDYRHRL,MSHQKIIQDLIAWIDEHIDQPLNIDVVAKKSGYSKWYLQRMFRTVTHQTLGDYIRQRRLLLAAVELRTTERPIFDIAMDLGYVSQQTFSRVFRRQFDRTPSDYRHRL,100,gnl|BL_ORD_ID|1975|hsp_num:0,2066,FALSE,None
LK1257,1_153 # 181335 # 182189 # 1 # ID=1_153;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.564,1_153,181335,182189,+,Strict,400,488.419,ErmX,84.86,3000596,protein homolog model,n/a,n/a,macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic,antibiotic target alteration,Erm 23S ribosomal RNA methyltransferase,ATGTCTACATACGGATACGGCCGTCACGAACATGGCCAAAATTTTCTCACAGACCACAAGATCATCAACTCCATCGTCGATCTTGTAAAACAAACCTCCGGCCCCATCATTGAGATCGGGCCAGGAAGCGGTGCCCTCACTCACCCGATATCCCACTTGGGGAGGGCAATAACGGCAGTTGAGGTAGACGCAAAACTAGCTGCCAAACTCACAAAAAAGACCGCCTCGGCGTCGGTCGAAGTGGTCCATGATGATTTCCTCAACTTCCCGTTACCCGCCACTCCCTGCGTCATTGTGGGAAACATTCCCTTTCACCTCACCACTGCCATTCTTCGAAAGTTGTTGCATGCGCCGGCATGGACTGACGCTGTACTCCTCATGCAGTGGGAAGTCGCTCGCCGCCGGGCCGGGGTAGGTGCAAGCACGATGATGACGGCTCAGTGGTCCCCATGGTTCACGTTTCACCTTGGTTCCCGAGTACCAAGGTCTGCTTTCCGGCCACAGCCAAACGTTGACGGGGGGATCTTAGTGATCCGCCGGGTGGGTGACCCGAAGATCCCGATAGAGCAACGCAAAGCCTTTCAGGCGATGGTGCACACCGTTTTCACCGCCCGGGGACGCGGGATAGGGGAAATTCTCCGAAGGGCAGGGTTGTTTTCATCACGTTCAGAGACACAATCATGGTTGCGCTCGCGAGGAATCGACCCCGCAACCCTACCTCCCAGATTGCACACCAGCGACTGGATCGATCTCTTCCAGGTGACTGGTTCCTCTCCACCGCGCCATCGGCCCATTTCACAATCGGGAAGTAGTCAACGCCCTCCTCAACGGAAAAATCGAGGCCGGCGGCGGTAA,MSTYGYGRHEHGQNFLTDHKIINSIVDLVKQTSGPIIEIGPGSGALTHPISHLGRAITAVEVDAKLAAKLTKKTASASVEVVHDDFLNFPLPATPCVIVGNIPFHLTTAILRKLLHAPAWTDAVLLMQWEVARRRAGVGASTMMTAQWSPWFTFHLGSRVPRSAFRPQPNVDGGILVIRRVGDPKIPIEQRKAFQAMVHTVFTARGRGIGEILRRAGLFSSRSETQSWLRSRGIDPATLPPRLHTSDWIDLFQVTGSSPPRHRPISQSGSSQRPPQRKNRGRRR,MSAYGQGRHEHGQNFLTNHKIINSIIDLVKQTSGPIIEIGPGSGALTHPMAHLGRAITAVEVDAKLAAKITQETSSAAVEVVHDDFLNFRLPATPCVIVGNIPFHLTTAILRKLLHAPAWTDAVLLMQWEVARRRAGVGATTMMTAQWSPWFTFHLGSRVPRSAFRPQPNVDGGILVIRRVGDPKIPIEQRKAFQAMVHTVFTARGRGIGEILRRQGCFHHVQKHNHGCAREESTPRPYLPDCYTNDWIDLFQVTGSSLPHHRPISPSGSSQRPPQRKNRSRRR,100,gnl|BL_ORD_ID|872|hsp_num:0,950,FALSE,None
LK1257,41_2 # 1499 # 2674 # 1 # ID=41_2;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.636,41_2,1499,2674,+,Perfect,700,728.013,cmx,100,3002703,protein homolog model,n/a,n/a,phenicol antibiotic,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGCCTTTTGCCCTCTACATGCTTGCCCTGGCGGTCTTCGTCATGGGCACTTCAGAATTCATGCTCGCGGGATTGCTCCCCGCGATCGCGACCGAACTTGACGTCTCGGTCGGCACTGCGGGCCTGCTGACCTCCGCATTCGCAGTCGGTATGGTCGTCGGCGCGCCAGTGATGGCGGCATTCGCTCGCCGTTGGCCACCGCGGCTCACATTGATCGTTTGCCTTCTCGTGTTCGCGGGAAGCCACGTCATCGGAGCGATGACACCAGTGTTCTCTCTCCTGCTCATCACCCGGGTGCTCAGCGCTCTCGCAAACGCAGGATTCCTCGCCGTAGCACTGAGCACGGCCACTACCCTCGTGCCAGCGAACCAGAAGGGGCGTGCACTGTCGATCCTGCTCTCCGGCACGACGATCGCAACCGTCGTGGGCGTCCCCGCCGGGGCACTGCTCGGCACAGCGCTGGGCTGGCGAACGACGTTCTGGGCGATCGCCATCCTCTGTATTCCCGCGGCCGTTGGAGTCATTCGTGGCGTCACGAACAATGTTGGTCGGAGCGAGACTAGCGCGACCTCACCAAGGCTCCGTGTCGAGCTCAGCCAGTTGGCGACGCCGCGGCTCATCCTGGCCATGGCACTCGGAGCGCTGATCAACGGAGGGACCTTTGCGGCATTCACCTTCCTGGCACCCATCGTGACCGAGACCGCGGGCTTGGCCGAAGCGTGGGTGTCCGTCGCGCTGGTGATGTTCGGCATCGGATCGTTCCTTGGCGTCACGATCGCAGGACGACTATCAGATCAACGACCTGGCCTCGTGCTCGCAGTCGGCGGACCGCTATTGCTGACAGGCTGGATCGTGTTGGCAGTGGTCGCATCTCATCCCGTTGCGCTTATCGTCCTCGTCCTCGTTCAGGGATTCCTGTCGTTCGGCGTCGGCAGTACTCTGATCACGCGTGTGCTGTATGCAGCATCGGGTGCGCCAACGATGGGCGGTTCGTACGCAACCGCAGCATTGAATATCGGAGCTGCAGCGGGGCCCGTGCTTGGTGCGCTCGGGCTCGCGACCGGGCTGGGGCTGCTCGCGCCGGTTTGGGTCGCTTCGGTGCTGACAGCGATCGCTCTCGTCATCATGCTTCTCACCAGACGCGCGCTTACGAAGACCGCGGCGGAGGCCAATTGA,MPFALYMLALAVFVMGTSEFMLAGLLPAIATELDVSVGTAGLLTSAFAVGMVVGAPVMAAFARRWPPRLTLIVCLLVFAGSHVIGAMTPVFSLLLITRVLSALANAGFLAVALSTATTLVPANQKGRALSILLSGTTIATVVGVPAGALLGTALGWRTTFWAIAILCIPAAVGVIRGVTNNVGRSETSATSPRLRVELSQLATPRLILAMALGALINGGTFAAFTFLAPIVTETAGLAEAWVSVALVMFGIGSFLGVTIAGRLSDQRPGLVLAVGGPLLLTGWIVLAVVASHPVALIVLVLVQGFLSFGVGSTLITRVLYAASGAPTMGGSYATAALNIGAAAGPVLGALGLATGLGLLAPVWVASVLTAIALVIMLLTRRALTKTAAEAN,MPFALYMLALAVFVMGTSEFMLAGLLPAIATELDVSVGTAGLLTSAFAVGMVVGAPVMAAFARRWPPRLTLIVCLLVFAGSHVIGAMTPVFSLLLITRVLSALANAGFLAVALSTATTLVPANQKGRALSILLSGTTIATVVGVPAGALLGTALGWRTTFWAIAILCIPAAVGVIRGVTNNVGRSETSATSPRLRVELSQLATPRLILAMALGALINGGTFAAFTFLAPIVTETAGLAEAWVSVALVMFGIGSFLGVTIAGRLSDQRPGLVLAVGGPLLLTGWIVLAVVASHPVALIVLVLVQGFLSFGVGSTLITRVLYAASGAPTMGGSYATAALNIGAAAGPVLGALGLATGLGLLAPVWVASVLTAIALVIMLLTRRALTKTAAEAN,100,gnl|BL_ORD_ID|1252|hsp_num:0,1366,FALSE,None
LK1257,41_4 # 2878 # 3714 # -1 # ID=41_4;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.559,41_4,2878,3714,-,Strict,500,568.155,APH(6)-Id,99.64,3002660,protein homolog model,n/a,n/a,aminoglycoside antibiotic,antibiotic inactivation,APH(6),ATGTTCATGCCGCCTGTTTTTCCTGCTCATTGGCACGTTTCGCAACCTGTTCTCATTGCGGACACCTTTTCCAGCCTCGTTTGGAAAGTTTCATTGCCAGACGGGACTCCTGCAATCGTCAAGGGATTGAAACCTATAGAAGACATTGCTGATGAACTGCGCGGGGCCGACTATCTGGTATGGCGCAATGGGAGGGGAGCAGTCCGGTTGCTCGGTCGTGAGAACAATCTGATGTTGCTCGAATATGCCGGGGAGCGAATGCTCTCTCACATCGTTGCCGAGCACGGCGACTACCAGGCGACCGAAATTGCAGCGGAACTAATGGCGAAGCTGTATGCCGCATCTGAGGAACCCCTGCCTTCTGCCCTTCTCCCGATCCGGGATCGCTTTGCAGCTTTGTTTCAGCGGGCGCGCGATGATCAAAACGCAGGTTGTCAAACTGACTACGTCCACGCGGCGATTATAGCCGATCAAATGATGAGCAATGCCTCGGAACTGCGTGGGCTACATGGCGATCTGCATCATGAAAACATCATGTTCTCCAGTCGCGGCTGGCTGGTGATAGATCCCGTCGGTCTGGTCGGTGAAGTGGGCTTTGGCGCCGCCAATATGTTCTACGATCCGGCTGACAGAGACGACCTTTGTCTCGATCCTAGACGCATTGCACAGATGGCGGACGCATTCTCTCGTGCGCTGGACGTCGATCCGCGTCGCCTGCTCGACCAGGCGTACGCTTATGGGTGCCTTTCCGCAGCTTGGAACGCGGATGGAGAAGAGGAGCAACGCGATCTAGCTATCGCGGCCGCGATCAAGCAGGTGCGACAGACGTCATACTAG,MFMPPVFPAHWHVSQPVLIADTFSSLVWKVSLPDGTPAIVKGLKPIEDIADELRGADYLVWRNGRGAVRLLGRENNLMLLEYAGERMLSHIVAEHGDYQATEIAAELMAKLYAASEEPLPSALLPIRDRFAALFQRARDDQNAGCQTDYVHAAIIADQMMSNASELRGLHGDLHHENIMFSSRGWLVIDPVGLVGEVGFGAANMFYDPADRDDLCLDPRRIAQMADAFSRALDVDPRRLLDQAYAYGCLSAAWNADGEEEQRDLAIAAAIKQVRQTSY,MFMPPVFPAHWHVSQPVLIADTFSSLVWKVSLPDGTPAIVKGLKPIEDIADELRGADYLVWRNGRGAVRLLGRENNLMLLEYAGERMLSHIVAEHGDYQATEIAAELMAKLYAASEEPLPSALLPIRDRFAALFQRARDDQNAGCQTDYVHAAIIADQMMSNASELRGLHGDLHHENIMFSSRGWLVIDPVGLVGEVGFGAANMFYDPADRDDLCLDPRRIAQMADAFSRALDVDPRRLLDQAYAYGCLSAAWNADGEQEQRDLAIAAAIKQVRQTSY,100,gnl|BL_ORD_ID|950|hsp_num:0,1031,FALSE,None
LK1257,41_5 # 3714 # 4133 # -1 # ID=41_5;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.569,41_5,3714,4133,-,Strict,500,283.108,APH(3'')-Ib,100,3002639,protein homolog model,n/a,n/a,aminoglycoside antibiotic,antibiotic inactivation,APH(3''),ATGTTCGGACGCGCCGTTGATGTGGTGTCCCGCAATGCCGTCAATCCCGACTTCTTACCGGACGAGGACAAGAGTACGCCGCAGCTCGATCTTTTGGCTCGTGTCGAACGAGAGCTACCGGTGCGGCTCGACCAAGAGCGCACCGATATGGTTGTTTGCCATGGTGATCCCTGCATGCCGAACTTCATGGTGGACCCTAAAACTCTTCAATGCACGGGTCTGATCGACCTTGGGCGGCTCGGAACAGCAGATCGCTATGCCGATTTGGCACTCATGATTGCTAACGCCGAAGAGAACTGGGCAGCGCCAGATGAAGCAGAGCGCGCCTTCGCTGTCCTATTCAATGTATTGGGGATCGAAGCCCCCGACCGCGAACGCCTTGCCTTCTATCTGCGATTGGACCCTCTGACTTGGGGTTGA,MFGRAVDVVSRNAVNPDFLPDEDKSTPQLDLLARVERELPVRLDQERTDMVVCHGDPCMPNFMVDPKTLQCTGLIDLGRLGTADRYADLALMIANAEENWAAPDEAERAFAVLFNVLGIEAPDRERLAFYLRLDPLTWG,MNRTNIFFGESHSDWLPVRGGESGDFVFRRGDGHAFAKIAPASRRGELAGERDRLIWLKGRGVACPEVINWQEEQEGACLVITAIPGVPAADLSGADLLKAWPSMGQQLGAVHSLLVDQCPFERRLSRMFGRAVDVVSRNAVNPDFLPDEDKSTPQLDLLARVERELPVRLDQERTDMVVCHGDPCMPNFMVDPKTLQCTGLIDLGRLGTADRYADLALMIANAEENWAAPDEAERAFAVLFNVLGIEAPDRERLAFYLRLDPLTWG,52.06,gnl|BL_ORD_ID|1690|hsp_num:0,1830,TRUE,loose hit with at least 95 percent identity pushed strict
LK1257,51_1 # 94 # 909 # -1 # ID=51_1;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.440,51_1,94,909,-,Perfect,500,565.459,APH(3')-Ia,100,3002641,protein homolog model,n/a,n/a,aminoglycoside antibiotic,antibiotic inactivation,APH(3'),ATGAGCCATATTCAACGGGAAACGTCTTGCTCGAGGCCGCGATTAAATTCCAACCTGGATGCTGATTTATATGGGTATAGATGGGCTCGCGATAATGTCGGGCAATCAGGTGCGACAATCTATCGATTGTATGGGAAGCCCAATGCGCCAGAGTTGTTTCTGAAACATGGCAAAGGTAGCGTTGCCAATGATGTTACAGATGAGATGGTCAGACTAAACTGGCTGACGGCATTTATGCCTCTTCCGACCATCAAGCATTTTATCCGTACTCCTGATGATGCATGGTTACTCACCACTGCGATCCCCGGGAAAACAGCATTCCAGGTATTAGAAGAATATCCTGATTCAGGTGAAAATATTGTTGATGCGCTGGCAGTGTTCCTGCGCCGGTTGCATTCGATTCCTGTTTGTAATTGTCCTTTTAACAGCGATCGCGTATTTCGTCTCGCTCAGGCGCAATCACGAATGAATAACGGATTGGTTGATGCTAGTGATTTTGATGACGAGCGTAATGGCTGGCCTGTTGAACAAGTCTGGAAAGAAATGCATAAGCTTTTGCCATTCTCACCGGATTCAGTCGTCACTCATGGTGATTTCTCACTTGATAACCTTATTTTTGACGAGGGGAAATTAATAGGTTGTATTGATGTTGGACGAGTCGGAATCGCAGACCGATACCAGGATCTTGCCATCCTATGGAACTGCCTCGGTGAGTTTTCTCCTTCATTACAGAAACGGCTTTTTCAAAAATATGGTATTGATAATCCTGATATGAATAAATTGCAGTTTCATTTGATGCTCGATGAGTTTTTCTGA,MSHIQRETSCSRPRLNSNLDADLYGYRWARDNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIADRYQDLAILWNCLGEFSPSLQKRLFQKYGIDNPDMNKLQFHLMLDEFF,MSHIQRETSCSRPRLNSNLDADLYGYRWARDNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIADRYQDLAILWNCLGEFSPSLQKRLFQKYGIDNPDMNKLQFHLMLDEFF,100,gnl|BL_ORD_ID|262|hsp_num:0,291,FALSE,None
LK1334,88_5 # 3026 # 3775 # -1 # ID=88_5;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.776,88_5,3026,3775,-,Strict,50,83.9593,vanY gene in vanM cluster,34.46,3002961,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGTCGCACCCTCCCTCTCGCCGCGCTGGCCGCGCTCGCGCTGCTCGTGGCCGGTTGCGGCACGCCCGCCGCGGGCCCGTCCTCGACGCCGACGACGCCGACGTCCGGCGCCGCGAGCGCGGCCGCGTCGTCCGGCGCCGCCTCGAGCACGGCGCCGTCGTCGAGCACGCACGCCGACCCGGCCGCCCTCGACGTCGTCGTGAACAAGACCCGCCCCGTGGCTCCGCCCGACTGGGCGCCCTCGGATCTGGTGGCCGTGCCCGGCAGCGAGCTGTCCCTGCGGGCGGAGGCCGCGACGGCGGCCGGTGACCTGCTGGATGCCGCCGCGGCGGCGGGTCACCGCCTCACCACCCTGAGCGCCTACCGCTCGTACGACTACCAGGTCCGGACGTACGGCCACTGGGTCGACGAGCTGGGCCGCGCCGAGGCCGACCGCGTCTCGGCGCGTCCGGGGTACTCCGAGCACCAGACCGGCCTGGCCTGGGACGTGGGCGACGCCGCGACCCCCGCGTGTGACCTGGAAGCGTGCTTCGGCGACACTGCCGCGGGCCGCTGGGTGGCCGCGCACGCCGCCGAGTACGGGTTCGTCATCCGCTATCCCGTCGGGGCCGAGGACGTGACGGGCTTCGCCCACGAGCCGTGGCACCTGCGCTACGTCGGGTCCGCGGAGGCGGCCCGGGTCGAGGCGGCCGGCGGCGTCCTCGAGACCGCGTGGGGCCTGCCTCCGGCGCCGGACTACGCGGACTGA,MRRTLPLAALAALALLVAGCGTPAAGPSSTPTTPTSGAASAAASSGAASSTAPSSSTHADPAALDVVVNKTRPVAPPDWAPSDLVAVPGSELSLRAEAATAAGDLLDAAAAAGHRLTTLSAYRSYDYQVRTYGHWVDELGRAEADRVSARPGYSEHQTGLAWDVGDAATPACDLEACFGDTAAGRWVAAHAAEYGFVIRYPVGAEDVTGFAHEPWHLRYVGSAEAARVEAAGGVLETAWGLPPAPDYAD,MVFQGNLLLVNNEYPVLEESIKTDVVNLFKHDELTKGYELLNREIYLSEKVAREFSEMVDAAEKEGVRHFSINSGFRNFDEQNALYQEMGSDYALPAGYSEHNLGLALDIGSTQMEMSEAPEGKWLEDNAWEYGFILRYPMDKTAITGIQYEPWHFRYVGLPHSAIIEEKNFALEEYLDFLKEQKSISGTIHGENYEISYYPITEKTDIEMPANLHYEISGNNMDGVIVTVYR,106.87,gnl|BL_ORD_ID|1673|hsp_num:0,1713,FALSE,None
LK1027,7_45 # 41810 # 42379 # 1 # ID=7_45;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.702,7_45,41810,42379,+,Strict,50,61.2326,vanY gene in vanB cluster,31.16,3002956,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGAACGCACAGATCATCACCCTCACCCTTGTCTCGGCCCTCGTCCTCGGCCTCACCGGCTGCGCCTCGACCGCACCCGTCGAGGAGGCTGCCGTGACCGTCCATGCCGGTGGTTCGGAGACCGACGGCGGGGCCCTTCCCGCGGCTGCGAGGATCGACGACGTCGACCTGCCGGGTATCGCGAACCTCGATGCGGACCTGCGCGCTGCGGTCAGGGACGCCGCCGCCGAGGCCCGCGAGGACGGTGTCGTCTTCACCGTCAACAGCGGATGGCGCTCAGCCTCCTACCAGCAGGGTCTCCTCGACGACGCGGTGAGCACGTACGGCTCGCGGACCGAAGCCGCCCGGTGGGTGGCCACCCCCGAGTCCTCACCGCACGTCACCGGCGACGCGGTCGACATCGGTCCCGTCGACGCCTCGAGCTGGCTCTCCCAGCACGGCGCGGACTTCGGGCTGTGCCAGATCTACGGCAACGAGATCTGGCACTACGAACTCCGCCCGGACGCCGCGACCTCCGGCTGCCCGCAACAGTACGCCGACCCGACCGAGGACCCACGCATGCGAAGATGA,MNAQIITLTLVSALVLGLTGCASTAPVEEAAVTVHAGGSETDGGALPAAARIDDVDLPGIANLDADLRAAVRDAAAEAREDGVVFTVNSGWRSASYQQGLLDDAVSTYGSRTEAARWVATPESSPHVTGDAVDIGPVDASSWLSQHGADFGLCQIYGNEIWHYELRPDAATSGCPQQYADPTEDPRMRR,MEKSNYHSNVNHHKRHMKQSGEKRAFLWAFIISFTVCTLFLGWRLVSVLEATQLPPIPATHTGSGTGVAENPEENTLATAKEQGDEQEWSLILVNRQNPIPAQYDVELEQLSNGERIDIRISPYLQDLFDAARADGVYPIVASGYRTTEKQQEIMDEKVAEYKAKGYTSAQAKAEAETWVAVPGTSEHQLGLAVDINADGIHSTGNEVYRWLDENSYRFGFIRRYPPDKTEITGVSNEPWHYRYVGIEAATKIYHQGLCLEEYLNTEK,70.52,gnl|BL_ORD_ID|602|hsp_num:0,556,FALSE,None
LK1027,24_37 # 41898 # 43643 # 1 # ID=24_37;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.660,24_37,41898,43643,+,Strict,50,100.523,vanW gene in vanI cluster,28.03,3003724,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanW; glycopeptide resistance gene cluster,ATGTCCACCCAGACCCTCGCAGGCAGCGCGCCTGATCCCTCGGCCGGCACCTCGGCGGGCAGGCGCAAGCGACCCTGGATCATCGCGCTCCTCATCCTCGTCGGGCTCGCCGTCGTCTACCTCGCGATCGGCTTCTTCAGCGGCCGGGTCGTCGCCCCCGGCACGACCGTGGCCGGCGTCGACATCGGCTCGCAGAGCGCAGCCGATGCGAAGTCGACCCTTGAGGACGCCCTCGGGGAGAAGGCGAAGCAGGAGATCGAGCTCAGCGCCAAGGAGGCCACGGCGACGATCGATCCGGTGAAGTCGGGACTGGCACTCGACGTCGACGGCACCGTCGCCCAGGTCACCGGGTTCACACTCAACCCTGCCATCCTCGCCGACCGGCTCTTCGGCGACAATGAGGTCTCACCCGTCCTCGCTGTCGACGACGCGACCTTCGACAAGAGCGCCGAGGCGGCCGCGAAGGGACTCGAGGTCGAACCCGTCGATGCGGAGCTGAGCTACGACAAGACGACGCCTGCGGTCAAGGACGCCGTGACCGGGCAGAGCGTGAGCGTGGAGAACATCCGCTCCGCCGTCGCCGCACAGTGGCTGGTCAAGGACAATCCGCTGCCCGTCGTCGTCGACGAGGTCGAACCCGACATCACGACCGCTGAAGCCAAGGACGTCGCCGACGGCTTCGCCGCCGATGCGGTCAAGGCCGACGTCACCGTCAAGGCCGTACCCGGCAAGGACGCCGACTCCGACGTCAAGGGCGGGGACCTGACGATCTCGCCGACGACGATCGCGAAGACCCTGAGCTTCGAGGCGAAGGACTCGAAGCTCGTGCCGAAGTTCGACGCCGAGAAGCTGCAGAAGCGGGCACTCGACGAGAACGAGGAGATCGGACGTCCCGCCAAGGACGCGACCTTCAAGGTCGTCGACGGCAAGCCGCAGGTCGTCGACTCCGAACCCGGCATCGGCATCAAGCCCGACGACCTCTCGAAGGCCGTGACCGATGCGATCAACGGCGACACCGCAGCCGCCGAGGTGACCCTGGCCTCCGTCGAACCGGAGTTCACGACCGAGGACGCGAAGAAGGTCGACGTCTCGCAGACCGTCTCGGAGTTCTCCACCCCGTACAAGTCCGATCCCAACCGCGACAACAACCTCCGCGTCGCCTCGAAAGAGGTCTCGGGCACGGTCCTTCAGCCCGGCGAGCAGTTCTCCCTCAATGAGACGCTCGGCCCGCGGACCGCGGCCAACGGCTACAAGCCCGCAGGCGTCATCTCCGAAGGGCAGATGAAGGAGGACTTCGGCGGAGGAGTCTCGCAGGTGTCGACGACCCTGTTCAACGCCGCGTTCTTCGCCGGCTTCGAACTCAACGAGCATCAGGCGCATTCGCGCTACATCTCCCGCTACCCGGAGGGCCGGGAGACGACGCTCGACTACACCTCGATCGACCTCAAGTTCACGAACAACCAGAAGACCCCCGTCGTCCTCGACATGTACCTCTCGGGCGGAAAGGTCTACGCGAAGGTCTACGGAGTCAAGTACTACGACGTCGAAGCCGACTCTTCGGGCCGGTACGCCTTCACCTCGCCGGCGACGGTGACCGAGTCCGGTCCGTCGTGCACCCCGCAGTCACCGCGCGAGGGCTGGTCGATCAAGATCACGCGGACGATGAAGGAGATCGCGACCGGACGGGAGACGAAGGACTCCTTCGTCACGACCTACCGACCGGTCAACAAGGTCGAGTGCAAGTAG,MSTQTLAGSAPDPSAGTSAGRRKRPWIIALLILVGLAVVYLAIGFFSGRVVAPGTTVAGVDIGSQSAADAKSTLEDALGEKAKQEIELSAKEATATIDPVKSGLALDVDGTVAQVTGFTLNPAILADRLFGDNEVSPVLAVDDATFDKSAEAAAKGLEVEPVDAELSYDKTTPAVKDAVTGQSVSVENIRSAVAAQWLVKDNPLPVVVDEVEPDITTAEAKDVADGFAADAVKADVTVKAVPGKDADSDVKGGDLTISPTTIAKTLSFEAKDSKLVPKFDAEKLQKRALDENEEIGRPAKDATFKVVDGKPQVVDSEPGIGIKPDDLSKAVTDAINGDTAAAEVTLASVEPEFTTEDAKKVDVSQTVSEFSTPYKSDPNRDNNLRVASKEVSGTVLQPGEQFSLNETLGPRTAANGYKPAGVISEGQMKEDFGGGVSQVSTTLFNAAFFAGFELNEHQAHSRYISRYPEGRETTLDYTSIDLKFTNNQKTPVVLDMYLSGGKVYAKVYGVKYYDVEADSSGRYAFTSPATVTESGPSCTPQSPREGWSIKITRTMKEIATGRETKDSFVTTYRPVNKVECK,MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVLAEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPELLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGMETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGGEFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSHSLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDEPDGYPVKPREWSK,155.76,gnl|BL_ORD_ID|4748|hsp_num:0,2242,FALSE,None
LK524,1_117 # 121448 # 122293 # -1 # ID=1_117;partial=00;start_type=TTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.277,1_117,121448,122293,-,Strict,500,517.309,PC1 beta-lactamase (blaZ),96.09,3000621,protein homolog model,n/a,n/a,penam,antibiotic inactivation,BlaZ beta-lactamase,TTGAAAAAGTTAATATTTTTAATTGTAATTGCTTTAGTTTTAAGTGCATGTAATTCAAACAGTTCACATGCCAAAGAGTTAAATGATTTAGAAAAAAAATATAATGCTCATATTGGTGTTTATGCTTTAGATACTAAAAGTGGTAAGGAAGTAAAATTTAATTCAGATAAGAGATTTGCCTATGCTTCAACTTCAAAAGCGATAAATAGTGCTATTTTGTTAGAACAAGTACCTTATAATAAGTTAAATAAAAAAGTACATATTAACAAAGATGATATAGTTGCTTATTCTCCTATTTTAGAAAAATATGTAGGAAAAGATATCACTTTAAAAGCACTTATTGAGGCTTCAATGACATATAGTGATAATACAGCAAACAATAAAATTATAAAAGAAATCGGTGGAATCAAAAAAGTTAAACAACGTCTAAAAGAACTAGGAGATAAAGTAACAAATCCAGTTAGATATGAGATAGAATTAAATTACTATTCACCAAAGAGCAAAAAAGATACTTCAACACCTGCTGCTTTCGGTAAGACTTTAAATAAACTTATCGCAAATGGAAAATTAAGCAAAGAAAACAAAAAATTCTTACTTGATTTAATGTTAAATAATAAAAGCGGAGATACTTTAATTAAAGACGGTGTTCCAAAAGACTATAAGGTTGCTGATAAAAGTGGTCAAGCAATAACATATGCTTCTAGAAATGATGTTGCTTTTGTTTATCCTAAGGGCCAATCTGAACCTATTGTTTTAGTCATTTTTACGAATAAAGACAATAAAAGTGATAAGCCAAATGATAAGTTGATAAGTGAAACCGCCAAGAGTGTAATGAAGGAATTTTAA,MKKLIFLIVIALVLSACNSNSSHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFAYASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKALIEASMTYSDNTANNKIIKEIGGIKKVKQRLKELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKTLNKLIANGKLSKENKKFLLDLMLNNKSGDTLIKDGVPKDYKVADKSGQAITYASRNDVAFVYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF,MKKLIFLIVIALVLSACNSNSSHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFAYASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDIALKELIEASMKYSDNTANNKIINEIGGIKKIKKRLKKLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKTLNKLIANGKLSKKNKNFLLDLMLNNKNGDTLIKDGIPKDYKVADKSGQAITYASRNDVAFVYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF,100,gnl|BL_ORD_ID|670|hsp_num:0,726,FALSE,None
LK524,8_41 # 35036 # 36391 # -1 # ID=8_41;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.330,8_41,35036,36391,-,Strict,850,872.848,mepA,98.45,3000026,protein homolog model,n/a,n/a,glycylcycline; tetracycline antibiotic,antibiotic efflux,multidrug and toxic compound extrusion (MATE) transporter,ATGAAAGACGAACAATTATATTATTTTGAGAAATCGCCAGTATTTAAAGCGATGATGCATTTCTCATTGCCAATGATGATAGGGACTTTATTAAGCGTTATTTATGGCATATTAAATATTTACTTTATAGGATTTTTAGAAGATAGCCACATGATTTCTGCTATCTCACTAACACTGCCAGTATTTGCTATCTTAATGGGGTTGGGTAATTTATTTGGCGTTGGTGCAGGAACTTATATTTCACGTTTATTAGGTGCGAAAGACTATAGTAAGAGTAAATTTGTAAGTAGTTTCTCTATTTATGGTGGTATTGCACTAGGACTTATCGTAATTTTAGTTGCTTTACCATTCAGTGATCAAATCGCAGCAATTTTAGGGGCGAGAGGTGAAACGTTAGCTTTAACAAGTAATTATTTGAAAGTAATGTTTTTAAGTGCACCTTTTGTAATTTTGTTCTTCATATTAGAACAATTTGCACGTGCAATTGGGGCACCAATGATTTCTATGATTGGTATGTTAGCTAGTGTAGGCTTAAATATTATTTTAGATCCAATTTTAATTTTTGGTTTTGATTTAAACGTTGTTGGTGCAGCTTTGGGTACTGCAATCAGTAATGTTGCTGCTGCTCTGTTCTTTATCATTTATTTTATGAAAAATAGTGACGTTGTGTCAGTTAATATTAAACTTGCGAAACCTAATAAAGAAATGCTTTCTGAAATCTTTAAAATCGGTATTCCTGCATTTTTAATGAGTATCTTAATGGGATTCACAGGATTAGTTTTAAATTTATTTTTAGCACATTATGGAAACTTCGCGATTGCAAGTTATGGTATCTCATTTAGACTTGTGCAATTTCCAGAACTTATTATCATGGGCTTATGTGAAGGTGTTGTACCATTAATTGCATATAACTTTATGTCAAATAAAGGTCGTATGAAAGACGTTATCAAAGCAGTTATCATGTCTATCGGCGTTATCTTTGTTGTATGTATGATTGCGGTATTTACAATTGGACATCATATGGTCGGACTATTTACTACTGATCAAGCCATTGTTGAGATGGCGACATTTATTTTGAAAGTAACAATGACATCATTGTTATTAAATGGTATAGGTTTCTTGTTTACTGGTATGCTTCAAGCAACTGGTCAAGGTCGCGGTGCTACAATTATGGCCATTTTACAAGGTGTGGTTATCATTCCAGTACTATTTATTATGAATGCTTTGTTTGGACTAACAGGTGTCATTTGGTCATTATTAATTGCTGAGTCACTTTGTGCTTTAGCAGCAATGTTAATCGTCTATTTATTACGTGATCGTTTGACAGTTGATACATCTGAATTAATAGAAGGTTAA,MKDEQLYYFEKSPVFKAMMHFSLPMMIGTLLSVIYGILNIYFIGFLEDSHMISAISLTLPVFAILMGLGNLFGVGAGTYISRLLGAKDYSKSKFVSSFSIYGGIALGLIVILVALPFSDQIAAILGARGETLALTSNYLKVMFLSAPFVILFFILEQFARAIGAPMISMIGMLASVGLNIILDPILIFGFDLNVVGAALGTAISNVAAALFFIIYFMKNSDVVSVNIKLAKPNKEMLSEIFKIGIPAFLMSILMGFTGLVLNLFLAHYGNFAIASYGISFRLVQFPELIIMGLCEGVVPLIAYNFMSNKGRMKDVIKAVIMSIGVIFVVCMIAVFTIGHHMVGLFTTDQAIVEMATFILKVTMTSLLLNGIGFLFTGMLQATGQGRGATIMAILQGVVIIPVLFIMNALFGLTGVIWSLLIAESLCALAAMLIVYLLRDRLTVDTSELIEG,MKDEQLYYFEKSPVFKAMMHFSLPMMIGTLLSVIYGILNIYFIGFLEDSHMISAISLTLPVFAILMGLGNLFGVGAGTYISRLLGAKDYSKSKFVSSFSIYGGIALGLIVILVTLPFSDQIAAILGARGETLALTSNYLKVMFLSAPFVILFFILEQFARAIGAPMVSMIGMLASVGLNIILDPILIFGFDLNVVGAALGTAISNVAAALFFIIYFMKNSDVVSVNIKLAKPNKEMLSEIFKIGIPAFLMSILMGFTGLVLNLFLAHYGNFAIASYGISFRLVQFPELIIMGLCEGVVPLIAYNFMANKGRMKDVIKAVIMSIGVIFVVCMSAVFTIGHHMVGLFTTDQAIVEMATFILKVTMASLLLNGIGFLFTGMLQATGQGRGATIMAILQGAIIIPVLFIMNALFGLTGVIWSLLIAESLCALAAMLIVYLLRDRLTVDTSELIEG,100,gnl|BL_ORD_ID|344|hsp_num:0,377,FALSE,None
LK524,8_42 # 36498 # 36917 # -1 # ID=8_42;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.343,8_42,36498,36917,-,Perfect,250,285.804,mepR,100,3000746,protein homolog model,n/a,n/a,glycylcycline; tetracycline antibiotic,antibiotic efflux,multidrug and toxic compound extrusion (MATE) transporter,ATGGAATTCACTTATTCGTATTTATTTAGAATGATTAGTCATGAGATGAAACAAAAGGCTGATCAAAAGTTAGAGCAATTTGATATTACAAATGAGCAAGGGCATACGTTAGGTTATCTTTATGCACATCAACAAGATGGGCTGACACAAAATGATATTGCTAAAGCATTACAACGAACAGGTCCAACTGTCAGTAATTTATTAAGGAACCTTGAACGTAAAAAGCTGATCTATCGCTATGTCGATGCACAGGATACGAGAAGAAAGAATATAGGACTGACTACCTCTGGGATTAAACTTGTAGAAGCATTCACTTCGATATTTGATGAAATGGAGCAAACACTCGTATCGCAGTTATCTGAAGAAGAAAATGAACAGATGAAAGCAAACTTAACTAAAATGTTATCTAGTTTACAATAA,MEFTYSYLFRMISHEMKQKADQKLEQFDITNEQGHTLGYLYAHQQDGLTQNDIAKALQRTGPTVSNLLRNLERKKLIYRYVDAQDTRRKNIGLTTSGIKLVEAFTSIFDEMEQTLVSQLSEEENEQMKANLTKMLSSLQ,MEFTYSYLFRMISHEMKQKADQKLEQFDITNEQGHTLGYLYAHQQDGLTQNDIAKALQRTGPTVSNLLRNLERKKLIYRYVDAQDTRRKNIGLTTSGIKLVEAFTSIFDEMEQTLVSQLSEEENEQMKANLTKMLSSLQ,100,gnl|BL_ORD_ID|791|hsp_num:0,856,FALSE,None
LK524,9_5 # 6037 # 7437 # -1 # ID=9_5;partial=00;start_type=ATG;rbs_motif=AGGAG(G)/GGAGG;rbs_spacer=13-15bp;gc_cont=0.347,9_5,6037,7437,-,Strict,525,534.643,norC,59.4,3007010,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGGACACATCAAAACAATTTAGAGGTGACAACCGATTGCTTTTAGGTATCGTTTTAGGGGTTATTACCTTCTGGCTATTCGCGCAGTCACTTGTTAATCTTGTTGTCCCATTACAATCAACATATAGTAGTGACGTTGGAACGATAAATATCGCTGTTAGCTTATCTGCCTTATTTGCTGGTTTGTTTATCGTAGGTGCTGGTGATGTTGCTGATAAATTTGGTCGCGTCAAAATTACTTATGTAGGATTGATATTAAATGTTGTAGGTTCATTACTCATCATTATTACACCTTTGCCAGCATTTTTAATTATAGGTAGAATAATTCAAGGTTTGTCTGCAGCATGTATTATGCCATCCACACTTGCTATTATTAACGAATATTATATTGGTACAAGAAGACAACGTGCCTTAAGCTATTGGTCTATTGGTTCTTGGGGTGGTAGTGGTATTTGTACGTTGTTTGGTGGCTTAGTGGCTACATATATAGGTTGGCGTTCAATATTTGTTGTTTCAATTCTATTAACATTATTAGCAATGTACTTAATCAAACATGCACCTGAGACTAAAGCAGAACCAATCAAAGGTATGAAAGCAGAAGCTAAAAAGTTTGACGTTATCGGGTTAGTCATTTTAGTAGTGACAATGTTAAGTTTAAATGTAATCATTACACAGACGTCCCATTTTGGTTTAGTTTCACCGTTAATTCTAGGTTTAATTGTAGTGTTTATCTGTTCATTAGTTGGTTTTGTATATTACGAAAATAAAATAAAGCACCCACTCGTTGATTTTTCAATTTTTAAAAATAGAGGATACAGTGGTGCAACTATTTCAAACTTCTTATTAAATGGTGTAGCAGGTGGTGCACTTATCGTCATTAACACGTATTATCAACAACAATTAGGATTTAATTCTTCGCAAACGGGTTATATTTCATTAACGTATTTAATAGCAGTGTTGTCTATGATTCGTGTAGGTGAAAAGATTTTATCTCAACATGGTCCGAAACGCCCACTATTACTAGGAAGTGGCTTTACAGTGATTGGGTTAATCTTATTGTCGTTAACATTTTTACCAGAAATGTGGTATATCGTATCTAGTATAGTTGGATATTTATTGTTTGGTACTGGTTTAGGATTATATGCTACACCATCAACTGATACAGCAGTTGCTAGTGCGCCAGATGATAAGTCGGGTGTTGCTTCAGGCGTATATAAAATGGCGTCATCATTAGGAAATGCATTTGGAGTAGCAGTATCTGGTACGGTTTATACTGTGTTAGCAGCTAATTTAAATTTGAACTTAGGTGGTTTCACAGGTATGATGTTTAATGCCTTGCTAGCAATTGTTGCATTTTTAGTCATTTTACTATTAGTTCCTAAAAATCAAACGAATTTGTAA,MDTSKQFRGDNRLLLGIVLGVITFWLFAQSLVNLVVPLQSTYSSDVGTINIAVSLSALFAGLFIVGAGDVADKFGRVKITYVGLILNVVGSLLIIITPLPAFLIIGRIIQGLSAACIMPSTLAIINEYYIGTRRQRALSYWSIGSWGGSGICTLFGGLVATYIGWRSIFVVSILLTLLAMYLIKHAPETKAEPIKGMKAEAKKFDVIGLVILVVTMLSLNVIITQTSHFGLVSPLILGLIVVFICSLVGFVYYENKIKHPLVDFSIFKNRGYSGATISNFLLNGVAGGALIVINTYYQQQLGFNSSQTGYISLTYLIAVLSMIRVGEKILSQHGPKRPLLLGSGFTVIGLILLSLTFLPEMWYIVSSIVGYLLFGTGLGLYATPSTDTAVASAPDDKSGVASGVYKMASSLGNAFGVAVSGTVYTVLAANLNLNLGGFTGMMFNALLAIVAFLVILLLVPKNQTNL,MNETYRGGNKLILGIVLGVITFWLFAQSLVNVVPNLQQSFGADMGTISIAVSLTALFSGMFVVGAGGLADKIGRVKMTNIGLLLSIIGSALIIITNLPALLILGRIIQGVSAACIMPSTLAIMKTYYEGAERQRALSYWSIGSWGGSGICSLFGGAVATTMGWRWIFIFSIIVAVLSMLLIKGTPETKSEVTNTHKFDVAGLIVLVVMLLSLNVVITKGAALGYTSLWFFGLIAIVIVAFFIFLNVEKKVDNPLIDFKLFENKPYTGATISNFLLNGVAGTLIVANTFVQQGLGYTALQAGYLSITYLIMVLLMIRVGEKLLQKMGSKRPMLLGTFIVIIGIALISLVFLPGIFYVISCVVGYLCFGLGLGIYATPSTDTAISNAPLDKVGVASGIYKMASSLGGAFGVAISGAVYAGAVAATSIHTGAMIALWVNVLMGIMAFIAILFAIPNDDKRVKDAK,100.87,gnl|BL_ORD_ID|4656|hsp_num:0,5726,FALSE,None
LK524,11_48 # 52895 # 54286 # 1 # ID=11_48;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.325,11_48,52895,54286,+,Strict,525,647.506,norC,70.77,3007010,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGGAAAAGCCGTCAAGAGAGACATTTGAAGGCAATAATAAGTTGTTAATAGGAATTGTTTTAAGTGTAATAACGTTTTGGCTATTTGCACAATCATTGGTTAATGTTGTACCAATACTTGAAGATAGTTTTAATACAGATATTGGAACGGTTAATATCGCTGTTAGTATAACTGCTTTATTTTCAGGAATGTTTGTAGTAGGAGCAGGTGGTCTTGCTGATAAATATGGCAGAATTAAACTCACGAACATTGGTATTATCTTAAATATATTGGGTTCATTATTAATCATTATTTCAAATATTCCTTTATTACTTATTATAGGAAGATTAATTCAAGGACTTTCAGCAGCATGTATTATGCCTGCAACTTTGTCTATTATTAAGTCATATTACATTGGGAAAGATAGACAACGCGCTTTAAGTTATTGGTCAATTGGCTCATGGGGCGGCTCTGGTGTTTGTTCATTTTTTGGAGGTGCAGTTGCAACACTTTTAGGTTGGCGTTGGATTTTCATCTTATCAATTATAATTTCATTAATTGCGCTGTTTCTTATTAAAGGCACACCTGAAACTAAATCTAAATCGATTTCTCTAAATAAATTTGACATTAAAGGTCTGGTTCTTTTAGTCATTATGCTTCTCAGTTTAAATATTTTAATTACTAAAGGATCAGAATTAGGTGTTACCTCACTTCTTTTTATCACTATATTAGCAATTGCAATTGTATCTTTTAGTTTATTTATAGTTCTTGAAAAGCGTGCTACAAATCCTTTAATCGATTTTAAATTATTTAAAAATAAAGCTTATACAGGTGCAACAGCTTCAAACTTTTTGTTAAATGGTGTTGCAGGAACATTAATAGTAGCCAACACATTTGTTCAAAGAGGTTTAGGATATTCTTCCTTGCAAGCAGGAAGTTTATCAATCACTTATTTAGTAATGGTACTAATTATGATTCGTGTTGGTGAAAAGTTACTTCAAACATTCGGATGCAAGAAACCAATGCTAATTGGAACAGCAGTTCTTATTGTCGGAGAATGTCTCATTTCATTAACATTTTTGCCAGAAATATTATATGTCATTTGTTGTATTATAGGTTATTTATTCTTTGGTTTAGGACTAGGAATATATGCTACACCATCAACAGATACAGCAATTGCAAATGCACCGTTAGAAAAAGTAGGCGTAGCTGCAGGTATCTATAAAATGGCTTCTGCATTAGGAGGAGCATTTGGCGTCGCATTGAGTGGTGCAGTTTATGCAATCGTATCAAATATGACAAACATTGATACTGGTGCAATGATTGCATTATGGTTAAACGCAGGTATGGGAATTTTATCATTCGTTATCATTTTGTTACTTGTGCCTAAACAAAACGACACTCAATTATGA,MEKPSRETFEGNNKLLIGIVLSVITFWLFAQSLVNVVPILEDSFNTDIGTVNIAVSITALFSGMFVVGAGGLADKYGRIKLTNIGIILNILGSLLIIISNIPLLLIIGRLIQGLSAACIMPATLSIIKSYYIGKDRQRALSYWSIGSWGGSGVCSFFGGAVATLLGWRWIFILSIIISLIALFLIKGTPETKSKSISLNKFDIKGLVLLVIMLLSLNILITKGSELGVTSLLFITILAIAIVSFSLFIVLEKRATNPLIDFKLFKNKAYTGATASNFLLNGVAGTLIVANTFVQRGLGYSSLQAGSLSITYLVMVLIMIRVGEKLLQTFGCKKPMLIGTAVLIVGECLISLTFLPEILYVICCIIGYLFFGLGLGIYATPSTDTAIANAPLEKVGVAAGIYKMASALGGAFGVALSGAVYAIVSNMTNIDTGAMIALWLNAGMGILSFVIILLLVPKQNDTQL,MNETYRGGNKLILGIVLGVITFWLFAQSLVNVVPNLQQSFGADMGTISIAVSLTALFSGMFVVGAGGLADKIGRVKMTNIGLLLSIIGSALIIITNLPALLILGRIIQGVSAACIMPSTLAIMKTYYEGAERQRALSYWSIGSWGGSGICSLFGGAVATTMGWRWIFIFSIIVAVLSMLLIKGTPETKSEVTNTHKFDVAGLIVLVVMLLSLNVVITKGAALGYTSLWFFGLIAIVIVAFFIFLNVEKKVDNPLIDFKLFENKPYTGATISNFLLNGVAGTLIVANTFVQQGLGYTALQAGYLSITYLIMVLLMIRVGEKLLQKMGSKRPMLLGTFIVIIGIALISLVFLPGIFYVISCVVGYLCFGLGLGIYATPSTDTAISNAPLDKVGVASGIYKMASSLGGAFGVAISGAVYAGAVAATSIHTGAMIALWVNVLMGIMAFIAILFAIPNDDKRVKDAK,100.22,gnl|BL_ORD_ID|4656|hsp_num:0,5726,FALSE,None
LK524,12_30 # 28928 # 29347 # 1 # ID=12_30;partial=00;start_type=ATG;rbs_motif=AGxAG;rbs_spacer=5-10bp;gc_cont=0.288,12_30,28928,29347,+,Strict,260,287.345,Staphylococcus aureus FosB,99.28,3004661,protein homolog model,n/a,n/a,phosphonic acid antibiotic,antibiotic inactivation,fosfomycin thiol transferase,ATGTTAAAATCTATTAATCATATATGCTTTTCAGTCAGAAATTTAAACGATTCAATACATTTTTATAGAGATATTTTACTTGGAAAATTGCTATTGACTGGTAAAAAAACTGCTTATTTTAAGCTTGCAGGCCTATGGATTGCTTTAAATGAAGAAAAAGATATACCACGTAATGAAATCCACTTTTCATATACACATATAGCTTTCACTATAGATGACAGCGAATTTAAATATTGGCATCAGAGGTTAAAAGATAATAACGTGAATATCTTAGAAGGAAGAGTTAGAGATATTAGAGATAGACAATCAATTTACTTTACTGACCCTGATGGTCATAAGCTAGAATTACATACTGGCACACTTGAGAACAGATTAAATTATTATAAAGAGGCTAAACCACATATGACATTTTACAAATAA,MLKSINHICFSVRNLNDSIHFYRDILLGKLLLTGKKTAYFKLAGLWIALNEEKDIPRNEIHFSYTHIAFTIDDSEFKYWHQRLKDNNVNILEGRVRDIRDRQSIYFTDPDGHKLELHTGTLENRLNYYKEAKPHMTFYK,MLKSINHICFSVRNLNDSIHFYRDILLGKLLLTGKKTAYFELAGLWIALNEEKDIPRNEIHFSYTHIAFTIDDSEFKYWHQRLKDNNVNILEGRVRDIRDRQSIYFTDPDGHKLELHTGTLENRLNYYKEAKPHMTFYK,100,gnl|BL_ORD_ID|2205|hsp_num:0,3362,FALSE,None
LK524,13_12 # 9455 # 9898 # -1 # ID=13_12;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.329,13_12,9455,9898,-,Perfect,270,301.212,mgrA,100,3000815,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; cephalosporin; penam; tetracycline antibiotic; peptide antibiotic; disinfecting agents and antiseptics,antibiotic efflux,ATP-binding cassette (ABC) antibiotic efflux pump; major facilitator superfamily (MFS) antibiotic efflux pump,ATGTCTGATCAACATAATTTAAAAGAACAGCTATGCTTTAGTTTGTACAATGCTCAAAGACAAGTTAATCGCTACTACTCTAACAAAGTTTTTAAGAAGTACAATCTAACATACCCACAATTTCTTGTCTTAACTATTTTATGGGATGAATCTCCTGTAAACGTCAAGAAAGTCGTAACTGAATTAGCACTCGATACTGGTACAGTATCACCATTATTAAAACGAATGGAACAAGTAGACTTAATTAAGCGTGAACGTTCCGAAGTCGATCAACGTGAAGTATTTATTCACTTGACTGACAAAAGTGAAACTATTAGACCAGAATTAAGTAATGCATCTGACAAAGTCGCTTCAGCTTCTTCTTTATCTCAAGATGAAGTTAAAGAACTTAATCGCTTATTAGGTAAAGTCATTCATGCATTTGATGAAACAAAGGAAAAATAA,MSDQHNLKEQLCFSLYNAQRQVNRYYSNKVFKKYNLTYPQFLVLTILWDESPVNVKKVVTELALDTGTVSPLLKRMEQVDLIKRERSEVDQREVFIHLTDKSETIRPELSNASDKVASASSLSQDEVKELNRLLGKVIHAFDETKEK,MSDQHNLKEQLCFSLYNAQRQVNRYYSNKVFKKYNLTYPQFLVLTILWDESPVNVKKVVTELALDTGTVSPLLKRMEQVDLIKRERSEVDQREVFIHLTDKSETIRPELSNASDKVASASSLSQDEVKELNRLLGKVIHAFDETKEK,100,gnl|BL_ORD_ID|133|hsp_num:0,154,FALSE,None
LK524,13_20 # 17551 # 18717 # 1 # ID=13_20;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.344,13_20,17551,18717,+,Strict,700,743.036,Staphylococcus aureus norA,95.62,3004667,protein homolog model,n/a,n/a,fluoroquinolone antibiotic,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGAATAAACAGATTTTTGTCTTATATTTTAATATTTTCTTGATTTTTTTAGGTATCGGTTTAGTAATACCAGTCTTGCCTGTTTATTTAAAAGATTTGGGATTAACTGGTAGTGATTTAGGGTTACTTGTTGCTGCTTTTGCGTTATCTCAAATGATTATATCGCCGTTTGGTGGTACGCTAGCTGACAAATTAGGGAAGAAATTAATTATATGTATAGGGTTAATTTTATTCTCAGTGTCAGAATTTATGTTTGCAGTTGGCCACAATTTTTCGGTATTGATGTTATCGAGAGTGATTGGTGGTATGAGTGCTGGTATGGTAATGCCGGGTGTGACAGGTTTGATTGCAGATGTTTCACCAAGCCATCAAAAAGCAAAAAACTTTGGCTACATGTCAGCGATTATCAATTCTGGATTCATTTTAGGACCAGGGATTGGTGGATTTATGGCAGAAGTTTCACATCGTATGCCATTTTATTTTGCAGGTGCATTAGGCATTTTAGCTTTCATAATGTCAGTTGTATTGATTCATGATCCGAAAAAGTCTACGACAAGCGGCTTCCAAAAACTTGAGCCCCAATTATTAACAAAAATTAATTGGAAAGTCTTTATTACGCCAGCAATTTTAACGCTCGTCTTAGCGTTCGGTTTATCGGCATTTGAAACACTGTATTCTTTATATACATCGTATAAAGTAAATTATTCACCTAAAGATATTTCGATTGCGATTACGGGTGGCGGTATCTTTGGTGCACTTTTCCAAATTTATTTCTTTGATAAATTTATGAAATACTTCTCTGAGTTAACATTTATTGCATGGTCATTAATATATTCAGTTATTGTATTAGTGCTATTAGTTATTGCCGATGGTTACTGGACAATTATGGTAATTAGCTTTGTTGTCTTTATCGGGTTCGATATGATAAGACCTGCTATTACAAATTATTTCTCAAATATTGCTGGTGATAGACAGGGATTTGCAGGTGGGTTAAACTCGACATTCACTAGTATGGGTAATTTCATAGGTCCTTTAATCGCAGGTGCGTTATTTGATGTACACATTGAAGCACCAATTTATATGGCTATAGGTGTGTCATTAGCAGGTGTTGTTATTGTTTTAATTGAAAAGCAACATAGAGCTAAGTTAAAACAACAAGATTTGTAA,MNKQIFVLYFNIFLIFLGIGLVIPVLPVYLKDLGLTGSDLGLLVAAFALSQMIISPFGGTLADKLGKKLIICIGLILFSVSEFMFAVGHNFSVLMLSRVIGGMSAGMVMPGVTGLIADVSPSHQKAKNFGYMSAIINSGFILGPGIGGFMAEVSHRMPFYFAGALGILAFIMSVVLIHDPKKSTTSGFQKLEPQLLTKINWKVFITPAILTLVLAFGLSAFETLYSLYTSYKVNYSPKDISIAITGGGIFGALFQIYFFDKFMKYFSELTFIAWSLIYSVIVLVLLVIADGYWTIMVISFVVFIGFDMIRPAITNYFSNIAGDRQGFAGGLNSTFTSMGNFIGPLIAGALFDVHIEAPIYMAIGVSLAGVVIVLIEKQHRAKLKQQDL,MNKQIFVLYFNIFLIFLGIGLVIPVLPVYLKDLGLTGSDLGLLVAAFALSQMIISPFGGTLADKLGKKLIICIGLILFSVSEFMFAVGHNFSVLMLSRVIGGMSAGMVMPGVTGLIADISPSHQKAKNFGYMSAIINSGFILGPGIGGFMAEVSHRMPFYFAGALGILAFIMSIVLIHDPKKSTTSGFQKLEPQLLTKINWKVFITPVILTLVLSFGLSAFETLYSLYTADKVNYSPKDISIAITGGGIFGALFQIYFFDKFMKYFSELTFIAWSLLYSVVVLILLVFANGYWSIMLISFVVFIGFDMIRPAITNYFSNIAGERQGFAGGLNSTFTSMGNFIGPLIAGALFDVHIEAPIYMAIGVSLAGVVIVLIEKQHRAKLKEQNM,100,gnl|BL_ORD_ID|2208|hsp_num:0,3367,FALSE,None
LK524,18_22 # 22774 # 24162 # 1 # ID=18_22;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.366,18_22,22774,24162,+,Perfect,525,905.59,norC,100,3007010,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGAATGAAACGTATCGCGGGGGCAACAAGTTAATCTTAGGTATTGTATTAGGTGTTATTACATTTTGGTTGTTTGCACAATCACTTGTAAATGTTGTGCCAAATTTACAACAAAGTTTTGGTGCAGACATGGGAACAATTAGTATTGCGGTAAGTCTAACCGCACTATTTTCAGGCATGTTTGTTGTTGGAGCAGGCGGCCTAGCAGATAAAATTGGACGCGTGAAAATGACAAATATCGGCTTATTATTAAGTATTATTGGTTCAGCATTAATTATTATTACAAATTTACCAGCATTGCTAATTTTAGGCCGTATTATACAAGGCGTATCAGCAGCGTGTATTATGCCTTCCACATTGGCCATTATGAAAACTTATTATGAGGGTGCTGAACGTCAGCGTGCCTTAAGCTATTGGTCTATCGGTTCTTGGGGTGGAAGTGGTATCTGTTCACTCTTCGGTGGGGCAGTTGCGACAACTATGGGTTGGAGATGGATTTTCATCTTCTCAATCATCGTTGCCGTACTTTCAATGTTACTCATCAAAGGGACGCCTGAAACGAAATCAGAAGTTACCAATACACATAAATTTGACGTTGCAGGTCTAATTGTTCTAGTAGTTATGTTATTAAGTTTAAACGTTGTCATTACTAAAGGTGCAGCACTTGGTTATACATCATTATGGTTCTTTGGTTTGATTGCAATCGTAATTGTAGCATTCTTTATTTTCTTAAATGTTGAGAAAAAAGTAGATAATCCGCTTATTGATTTTAAATTATTTGAAAATAAACCATATACAGGTGCAACGATTTCGAACTTCTTATTAAACGGTGTTGCAGGTACATTAATTGTAGCGAATACATTCGTACAACAAGGTTTAGGTTATACAGCATTGCAGGCAGGATACTTATCAATCACTTATTTAATCATGGTGTTATTGATGATTAGAGTTGGTGAAAAATTATTACAAAAAATGGGTTCTAAGCGACCAATGTTATTAGGTACATTCATTGTGATCATTGGTATTGCACTTATTTCATTAGTATTCTTACCAGGCATATTTTATGTTATCAGTTGTGTCGTAGGATATTTATGTTTTGGACTAGGCTTAGGTATTTATGCAACACCTTCTACAGATACAGCTATTTCAAATGCACCGTTAGATAAAGTTGGCGTTGCTTCAGGTATTTATAAAATGGCTTCATCACTTGGTGGTGCATTCGGTGTCGCAATTAGTGGTGCAGTATATGCCGGTGCAGTTGCTGCAACGAGCATTCATACAGGTGCGATGATTGCACTTTGGGTTAACGTATTAATGGGAATCATGGCATTTATCGCAATTTTATTTGCGATTCCTAATGATGATAAACGTGTCAAAGATGCGAAATAA,MNETYRGGNKLILGIVLGVITFWLFAQSLVNVVPNLQQSFGADMGTISIAVSLTALFSGMFVVGAGGLADKIGRVKMTNIGLLLSIIGSALIIITNLPALLILGRIIQGVSAACIMPSTLAIMKTYYEGAERQRALSYWSIGSWGGSGICSLFGGAVATTMGWRWIFIFSIIVAVLSMLLIKGTPETKSEVTNTHKFDVAGLIVLVVMLLSLNVVITKGAALGYTSLWFFGLIAIVIVAFFIFLNVEKKVDNPLIDFKLFENKPYTGATISNFLLNGVAGTLIVANTFVQQGLGYTALQAGYLSITYLIMVLLMIRVGEKLLQKMGSKRPMLLGTFIVIIGIALISLVFLPGIFYVISCVVGYLCFGLGLGIYATPSTDTAISNAPLDKVGVASGIYKMASSLGGAFGVAISGAVYAGAVAATSIHTGAMIALWVNVLMGIMAFIAILFAIPNDDKRVKDAK,MNETYRGGNKLILGIVLGVITFWLFAQSLVNVVPNLQQSFGADMGTISIAVSLTALFSGMFVVGAGGLADKIGRVKMTNIGLLLSIIGSALIIITNLPALLILGRIIQGVSAACIMPSTLAIMKTYYEGAERQRALSYWSIGSWGGSGICSLFGGAVATTMGWRWIFIFSIIVAVLSMLLIKGTPETKSEVTNTHKFDVAGLIVLVVMLLSLNVVITKGAALGYTSLWFFGLIAIVIVAFFIFLNVEKKVDNPLIDFKLFENKPYTGATISNFLLNGVAGTLIVANTFVQQGLGYTALQAGYLSITYLIMVLLMIRVGEKLLQKMGSKRPMLLGTFIVIIGIALISLVFLPGIFYVISCVVGYLCFGLGLGIYATPSTDTAISNAPLDKVGVASGIYKMASSLGGAFGVAISGAVYAGAVAATSIHTGAMIALWVNVLMGIMAFIAILFAIPNDDKRVKDAK,100,gnl|BL_ORD_ID|4656|hsp_num:0,5726,FALSE,None
LK524,18_52 # 60423 # 61781 # 1 # ID=18_52;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.319,18_52,60423,61781,+,Strict,850,871.307,tet(38),99.78,3000565,protein homolog model,n/a,n/a,tetracycline antibiotic,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGATTATGAATGTTGAATATTCTAAAATAAAGAAAGCAGTACCTATTTTATTATTCTTATTTGTATTCAGTTTGGTTATAGACAACTCATTCAAATTGATTTCTGTAGCCATTGCTGATGACTTAAACATTTCAGTAACGACAGTAAGTTGGCAAGCGACATTAGCCGGTTTAGTAATTGGTATTGGCGCTGTAGTATACGCTTCATTATCTGATGCCATTAGTATACGCACACTATTTATTTATGGCGTGATATTAATCATTATCGGATCAATTATTGGTTACATTTTCCAACATCAATTCGCATTACTTTTAGTTGGACGTATTATTCAAACTGCAGGTTTAGCTGCTGCAGAGACATTATATGTGATATATGTTGCAAAGTATCTTTCTAAAGAGGACCAGAAGACTTACCTTGGCTTAAGTACGAGCAGTTATTCCTTGTCATTAGTTATCGGTACATTATCAGGTGGATTTATTTCTACGTATTTACACTGGACAAATATGTTTTTAATTGCATTAATCGTAGTATTTACGTTGCCATTCCTATTTAAATTATTACCAAAAGAAAATAATACAAATAAAGCTCATTTAGATTTTGTTGGCTTAATTCTAGTGGCAACTATCGCTACAACAGTTATGCTGTTTATTACGAACTTTAATTGGTTATATATGATTGGTGCCTTAATTGCGATTATCGTTTTTGCGCTATATATTAAAAATGCGCAACGTCCATTAGTAAACAAATCATTTTTCCAAAATAAACGTTATGCTTCATTTTTATTTATAGTATTTGTAATGTATGCCATCCAATTGGGTTATATTTTTACGTTCCCATTCATAATGGAACAAATTTATCATCTTCAGCTAGACACAACATCACTGCTATTAGTACCGGGTTATATTGTAGCAGTCATCGTTGGTGCACTAAGTGGTAAAATCGGCGAATATCTTAATTCAAAACAAGCGATTATCACAGCAATTATTTTAATCGCACTGAGCTTGATTTTACCTGCATTTGCAGTAGGTAATCACATTTCAATCTTCGTCATTTCTATGATATTCTTTGCAGGTAGCTTTGCTTTAATGTATGCACCTTTACTTAACGAAGCCATTAAAACAATAGATCTTAATATGACAGGTGTGGCTATTGGTTTTTATAATTTAATTATTAATGTGGCGGTATCTGTAGGTATTGCGATTGCTGCGGCTTTAATCGATTTTAAAGCATTAAATTTCCCAGGCAATGATGCATTAAGTTCACATTTCGGTATTATTTTAATTATTTTAGGTTTAATGAGTATTGTCGGATTAGTTTTATTCGTCATCTTAAATCGTTGGACACAATCTGAAAAATAA,MIMNVEYSKIKKAVPILLFLFVFSLVIDNSFKLISVAIADDLNISVTTVSWQATLAGLVIGIGAVVYASLSDAISIRTLFIYGVILIIIGSIIGYIFQHQFALLLVGRIIQTAGLAAAETLYVIYVAKYLSKEDQKTYLGLSTSSYSLSLVIGTLSGGFISTYLHWTNMFLIALIVVFTLPFLFKLLPKENNTNKAHLDFVGLILVATIATTVMLFITNFNWLYMIGALIAIIVFALYIKNAQRPLVNKSFFQNKRYASFLFIVFVMYAIQLGYIFTFPFIMEQIYHLQLDTTSLLLVPGYIVAVIVGALSGKIGEYLNSKQAIITAIILIALSLILPAFAVGNHISIFVISMIFFAGSFALMYAPLLNEAIKTIDLNMTGVAIGFYNLIINVAVSVGIAIAAALIDFKALNFPGNDALSSHFGIILIILGLMSIVGLVLFVILNRWTQSEK,MNVEYSKIKKAVPILLFLFVFSLVIDNSFKLISVAIADDLNISVTTVSWQATLAGLVIGIGAVVYASLSDAISIRTLFIYGVILIIIGSIIGYIFQHQFPLLLVGRIIQTAGLAAAETLYVIYVAKYLSKEDQKTYLGLSTSSYSLSLVIGTLSGGFISTYLHWTNMFLIALIVVFTLPFLFKLLPKENNTNKAHLDFVGLILVATIATTVMLFITNFNWLYMIGALIAIIVFALYIKNAQRPLVNKSFFQNKRYASFLFIVFVMYAIQLGYIFTFPFIMEQIYHLQLDTTSLLLVPGYIVAVIVGALSGKIGEYLNSKQAIITAIILIALSLILPAFAVGNHISIFVISMIFFAGSFALMYAPLLNEAIKTIDLNMTGVAIGFYNLIINVAVSVGIAIAAALIDFKALNFPGNDALSSHFGIILIILGLMSIVGLVLFVILNRWTQSEK,100.44,gnl|BL_ORD_ID|1791|hsp_num:0,1835,FALSE,None
LK524,20_51 # 52952 # 54307 # -1 # ID=20_51;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.291,20_51,52952,54307,-,Strict,880,907.131,arlS,99.56,3000839,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGACAAAACGTAAATTGCGCAATAACTGGATTATTGTTACCACGATGATTACGTTTGTCACGATATTTTTGTTTTGTTTAATTATTATCTTTTTCTTGAAAGATACACTGCATAATAGTGAGCTTGATGATGCAGAAAGAAGCTCAAGCGATATTAATAATTTATTTCATTCTAAGCCTGTTAAAGATATATCTGCATTAGACTTGAATGCATCTTTAGGTAATTTTCAAGAGATTATTATTTATGATGAGCATAATAATAAATTATTTGAGACATCGAATGATAACACAGTGAGAGTTGAACCTGGTTATGAACACCGGTATTTTGACCGCGTAATAAAAAAACGTTATAAAGGCATTGATTATTTAATTATTAAAGAATCAATCACAACGCAAGATTTCAAAGGGTATAGTTTGTTAATTCATTCACTAGAAAATTATGATAACATCGTAAAATCATTGTATATTATTGCGCTCGCATTTGGAGTGATTGCAACAATTATAACTGCCACAATTAGTTATGTATTTTCAACTCAAATTACTAAACCGCTTGTCAGTTTATCAAATAAAATGATTGAGATCCGACGAGATGGTTTTCAAAATAAATTGCAATTAAATACAAATTATGAAGAAATAGATAATTTAGCAAATACGTTTAATGAGATGATGAGCCAAATTGAAGAATCATTTAATCAACAAAGACAATTTGTTGAAGATGCATCACATGAATTACGAACACCATTACAAATTATTCAAGGTCATTTAAATTTGATTCAGCGATGGGGAAAAAAAGACCCAGCAGTATTAGAAGAATCGTTAAATATTTCTATTGAAGAAATGAATCGTATCATAAAATTAGTCGAAGAATTACTTGAATTGACTAAAGGAGATGTAAATGACATTTCTTCTGAAGCGCAGACCGTTCATATTAATGATGAAATTCGCTCGCGAATACACTCATTAAAACAATTGCATCCTGATTATCAATTTGATACGGATCTGACATCTAAAAATCTAGAAATTAAAATGAAACCTCATCAATTTGAACAATTATTTTTAATCTTTATTGATAATGCAATTAAATATGATGTGAAGAATAAGAAAATTAAAGTTAAGACAAGGTTAAAAAATAAGCAAAAAATAATTGAAATTACAGATCATGGAATTGGTATTCCAGAGGAAGATCAAGATTTCATTTTTGATCGCTTTTATCGAGTGGATAAATCTCGTTCAAGAAGTCAAGGTGGTAATGGACTCGGATTATCTATTGCGCAAAAAATCATTCAATTAAACGGTGGATCGATTAAAATTAAAAGTGAGATTAACAAAGGAACAACGTTTAAAATCATATTTTAA,MTKRKLRNNWIIVTTMITFVTIFLFCLIIIFFLKDTLHNSELDDAERSSSDINNLFHSKPVKDISALDLNASLGNFQEIIIYDEHNNKLFETSNDNTVRVEPGYEHRYFDRVIKKRYKGIDYLIIKESITTQDFKGYSLLIHSLENYDNIVKSLYIIALAFGVIATIITATISYVFSTQITKPLVSLSNKMIEIRRDGFQNKLQLNTNYEEIDNLANTFNEMMSQIEESFNQQRQFVEDASHELRTPLQIIQGHLNLIQRWGKKDPAVLEESLNISIEEMNRIIKLVEELLELTKGDVNDISSEAQTVHINDEIRSRIHSLKQLHPDYQFDTDLTSKNLEIKMKPHQFEQLFLIFIDNAIKYDVKNKKIKVKTRLKNKQKIIEITDHGIGIPEEDQDFIFDRFYRVDKSRSRSQGGNGLGLSIAQKIIQLNGGSIKIKSEINKGTTFKIIF,MTKRKLRNNWIIVTTMITFVTIFLFCLIIIFFLKDTLHNSELDDAERSSSDINNLFHSKPVKDISALDLNASLGNFQEIIIYDEHNNKLFETSNDNTVRVEPGYEHRYFDRVIKKRYKGIEYLIIKEPITTQDFKGYSLLIHSLENYDNIVKSLYIIALAFGVIATIITATISYVFSTQITKPLVSLSNKMIEIRRDGFQNKLQLNTNYEEIDNLANTFNEMMSQIEESFNQQRQFVEDASHELRTPLQIIQGHLNLIQRWGKKDPAVLEESLNISIEEMNRIIKLVEELLELTKGDVNDISSEAQTVHINDEIRSRIHSLKQLHPDYQFDTDLTSKNLEIKMKPHQFEQLFLIFIDNAIKYDVKNKKIKVKTRLKNKQKIIEITDHGIGIPEEDQDFIFDRFYRVDKSRSRSQGGNGLGLSIAQKIIQLNGGSIKIKSEINKGTTFKIIF,100,gnl|BL_ORD_ID|165|hsp_num:0,182,FALSE,None
LK524,20_52 # 54304 # 54963 # -1 # ID=20_52;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.327,20_52,54304,54963,-,Perfect,410,442.58,arlR,100,3000838,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGACGCAAATTTTAATAGTAGAAGATGAACAAAACTTAGCAAGATTTCTTGAATTGGAACTCACACATGAAAATTACAATGTGGACACAGAGTATGATGGACAAGACGGTTTAGATAAAGCGCTTAGCCATTACTATGATTTAATCATATTAGATTTAATGTTGCCGTCAATTAATGGCTTAGAAATTTGTCGCAAAATTAGACAACAACAATCTACACCTATCATTATAATTACAGCGAAAAGTGATACGTATGACAAAGTTGCTGGGCTTGATTACGGTGCAGACGATTATATAGTTAAGCCATTTGATATTGAAGAACTTTTAGCAAGAATTCGTGCGATTTTACGTCGTCAGCCACAAAAAGATATTATCGATGTCAACGGTATTACAATTGATAAGAATGCTTTTAAAGTGACGGTAAATGGCGCAGAAATTGAATTAACAAAAACGGAGTATGATTTACTATATCTTCTAGCTGAAAATAAAAACCATGTTATGCAACGGGAACAAATTTTAAATCATGTATGGGGTTATAATAGTGAAGTAGAAACAAATGTCGTAGATGTTTATATAAGATATTTACGAAACAAATTAAAACCATACGATCGTGACAAAATGATTGAAACAGTTCGTGGCGTTGGGTATGTGATACGATGA,MTQILIVEDEQNLARFLELELTHENYNVDTEYDGQDGLDKALSHYYDLIILDLMLPSINGLEICRKIRQQQSTPIIIITAKSDTYDKVAGLDYGADDYIVKPFDIEELLARIRAILRRQPQKDIIDVNGITIDKNAFKVTVNGAEIELTKTEYDLLYLLAENKNHVMQREQILNHVWGYNSEVETNVVDVYIRYLRNKLKPYDRDKMIETVRGVGYVIR,MTQILIVEDEQNLARFLELELTHENYNVDTEYDGQDGLDKALSHYYDLIILDLMLPSINGLEICRKIRQQQSTPIIIITAKSDTYDKVAGLDYGADDYIVKPFDIEELLARIRAILRRQPQKDIIDVNGITIDKNAFKVTVNGAEIELTKTEYDLLYLLAENKNHVMQREQILNHVWGYNSEVETNVVDVYIRYLRNKLKPYDRDKMIETVRGVGYVIR,100,gnl|BL_ORD_ID|1274|hsp_num:0,1390,FALSE,None
LK524,21_47 # 49291 # 50634 # 1 # ID=21_47;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.321,21_47,49291,50634,+,Strict,200,732.25,sdrM,87.47,3007013,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGCGTTTAAAATCAATTGTAACTGTAATAGCTTTAATATTAATCATGTTTATGGCTGCAATCGAATCATCAATTATTTCTTTAGCGTTACCAACAATTAAGCAAGATTTAAATGCAGGGAATTTAATTTCATTAATTTTTACCGCGTATTTTATCGCATTAGTAATTGCCAATCCTATAGTAGGTGAATTATTAACTCGTTTTAAAATTATTTATATTGCTATCGCAGGTCTTACACTATTCACGGTTGGTAGTTTAATGTCAGGTTTAAGCACACATTTTAGTATGTTGGTTATATCACGTGTAATTCAAGGGTTTGGATCTGGTGTCATGATGTCCTTGTCACAAATTGTGCCCAAATTAGCATTTGAAATTCCATTACGCTATAAAATTATGGGTATCGTTGGTAGCGTTTGGGGGATTTCGAGTATCATTGGACCACTTCTAGGTGGTGGCATATTAGAATTTGCAACATGGCATTGGTTATTCTACATAAACATACCGATTGCGATTATTGCAATAATATTGGTTGTCTGGACATTTCATTTTCCAGAAGAAGAAACTGTGGCTAAATCAAAATTCGATACTAAAGGTATCACCCTGTTTTATATTTTCATTGGTTTAATTATGTTTGCATTGTTAAACCAACAACATTTATATTTAAATATCATAGGTTTTGTCTTAGCAATATTAGTTGCACTTCGATTATTTAATGTTGAGAAAAAAGTTTCATCCCCATTCTTACCAGTAGCAGAATTTAATCGAATGATTACTTTGGTCTTTATTACAGATCTTCTTACAGCTGTTTGTTTAATGGGCTTTAATTTATATATTCCTGTGTATCTTCAAGAACAACTGGGGTTATCGCCATTGCAAAGTGGATTAGTTATTTTTCCACTTTCTGTAGCGTGGATTACATTGAATTTTAATTTGCACCATATTGAAGCGAAGTTATCAAGAAAAGTTATCTATTTGTCGTCTTTTACATTATTATTATTAAGTAGTATAATCATTGCGTTTGGTATAAAATTACCAATTCTTATAGCATGTGTCTTAATTTTAAGTGGACTAAGCTTTGGATATATTTATACAAAAGATAGTGTAATTGTCCAAGAGGAAACAAGTCCAATACAAATGAAGAAAATGATGTCGTTTTATGGATTAACAAAAAACCTTGGCGCATCAATAGGTTCGACGATTATGGGATACCTTTATGCGTTAAAATCAGGATTGTTTGGTGCAAACTTGCATAATATTTTAGGCGTTGTATCCTTGATAAGTGTAGGGCTCATCGTTGTATGGCTCATATTTTATAGAGAAGCGGCGTCACAAACAAAAGAATAG,MRLKSIVTVIALILIMFMAAIESSIISLALPTIKQDLNAGNLISLIFTAYFIALVIANPIVGELLTRFKIIYIAIAGLTLFTVGSLMSGLSTHFSMLVISRVIQGFGSGVMMSLSQIVPKLAFEIPLRYKIMGIVGSVWGISSIIGPLLGGGILEFATWHWLFYINIPIAIIAIILVVWTFHFPEEETVAKSKFDTKGITLFYIFIGLIMFALLNQQHLYLNIIGFVLAILVALRLFNVEKKVSSPFLPVAEFNRMITLVFITDLLTAVCLMGFNLYIPVYLQEQLGLSPLQSGLVIFPLSVAWITLNFNLHHIEAKLSRKVIYLSSFTLLLLSSIIIAFGIKLPILIACVLILSGLSFGYIYTKDSVIVQEETSPIQMKKMMSFYGLTKNLGASIGSTIMGYLYALKSGLFGANLHNILGVVSLISVGLIVVWLIFYREAASQTKE,MRLKSIITVIALILIMFMSAIESSIISLALPTIKQDLNAGNLISLIFTAYFIALVIANPIVGELLSRFKIIYVAIAGLLLFSIGSFMCGLSTNFTMLIISRVIQGFGSGVLMSLSQIVPKLAFEIPLRYKIMGIVGSVWGISSIIGPLLGGGILEFATWHWLFYINIPIAIIAIILVIWTFHFPEEETVAKSKFDTKGLTLFYVFIGLIMFALLNQQLLLLNFLSFILAIVVAMCLFKVEKHVSSPFLPVVEFNRSITLVFITDLLTAICLMGFNLYIPVYLQEQLGLSPLQSGLVIFPLSVAWITLNFNLHRIEAKLSRKVIYLLSFTLLLVSSIIISFGIKLPVLIAFVLILAGLSFGYIYTKDSVIVQEETSPLQMKKMMSFYGLTKNLGASIGSTIMGYLYAIQSGIFGPNLHNVLSAVAVISIGLIVLWVVFFKEQSSQSKE,100,gnl|BL_ORD_ID|4661|hsp_num:0,5729,FALSE,None
LK524,21_48 # 50762 # 51229 # 1 # ID=21_48;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.267,21_48,50762,51229,+,Strict,100,293.123,sepA,94.19,3007012,protein homolog model,n/a,n/a,disinfecting agents and antiseptics,antibiotic efflux,small multidrug resistance (SMR) antibiotic efflux pump,ATGAATTATCTTAAACATAAGTTTTATAATTTATTAACAACAATTATTGTTCTCTTTATCTTTGTGCTTTCTGGTGCGATATTCTTAACGTTTTTAGGGTTCGGACTATATGGATTAAGTAGAATTCTTATTTATTTTAGGTTAGGTGACTTCACATATAACAGAAGTATGTACGACAATTTGCTATATTATGGTAGTTATATTATATTTGGCTACTTTATCGTATTTGCAGTTGAACATTTGATGGATTATTTTAGAAAAATGTTACCTGAAAATGCTTATTTTAGAGGTGCAACTTTTCATTTAATCTCTTATATGGTTGCAACAACGTTATTTTATTTTATTATTCATCTGAACTATGTGTATATCAACATTGATTTTTGGGTCATCATGGTTATTATAGGCTTTTTATATGTTTGTAAGCTGCAGTTTTACCCTGAAAGTAAAAATCTAAATAATAGAAAATAG,MNYLKHKFYNLLTTIIVLFIFVLSGAIFLTFLGFGLYGLSRILIYFRLGDFTYNRSMYDNLLYYGSYIIFGYFIVFAVEHLMDYFRKMLPENAYFRGATFHLISYMVATTLFYFIIHLNYVYINIDFWVIMVIIGFLYVCKLQFYPESKNLNNRK,MIVNFFKHKFYNLLTTMIVLFVFVLSGAIFLTFLGFGLYGLSRILIYFRLGDFTYNRNMYDNLLYYGSYIIFGYFIIFAVEHLMDYFRKMLPENAYFRGATFHLISYTVATTLFYFIIHLHYVYINIDFWVIMVIIGFLYVCKLQFYPESKNLNNRK,98.73,gnl|BL_ORD_ID|4660|hsp_num:0,5728,FALSE,None
LK524,21_49 # 51415 # 51813 # 1 # ID=21_49;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.368,21_49,51415,51813,+,Strict,800,224.557,Staphylococcus aureus LmrS,98.25,3004572,protein homolog model,n/a,n/a,macrolide antibiotic; aminoglycoside antibiotic; oxazolidinone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGATGGCTAAAGTTGAATTAACAACCCGGAGACGAAACTTCATAGTTGCTGTTATGTTGATTAGTGCGTTTGTAGCTATTTTAAATCAAACATTATTAAATACAGCGTTACCTAGTATAATGAGAGAATTAAATATTAATGAAAGTACATCGCAATGGCTAGTTACTGGGTTTATGCTTGTTAATGGCGTCATGATACCTCTAACAGCATACTTAATGGACAGGATTAAAACTAGACCTTTATACTTAGCAGCGATGGGGACATTTTTAGTAGGATCAATTGTTGCAGCCATGGCACCCAATTTTGGAGTTTTAATGTTAGCACGTGTCATCCAAGCTATGGGGGGCAGGCGTACTCATGCCTTTAATGCAATTCACATTGTTTACGTTATTCAGTAA,MMAKVELTTRRRNFIVAVMLISAFVAILNQTLLNTALPSIMRELNINESTSQWLVTGFMLVNGVMIPLTAYLMDRIKTRPLYLAAMGTFLVGSIVAAMAPNFGVLMLARVIQAMGGRRTHAFNAIHIVYVIQ,MAKVELTTRRRNFIVAVMLISAFVAILNQTLLNTALPSIMRELNINESTSQWLVTGFMLVNGVMIPLTAYLMDRIKTRPLYLAAMGTFLLGSIVAALAPNFGVLMLARVIQAMGAGVLMPLMQFTLFTLFSKEHRGFAMGLAGLVIQFAPAIGPTVTGLIIDQASWRVPFIIIVGIAILAFVFGLVSISSYNEVKYTKLDKRSVMYSTIGFGLMLYAFSSAGDLGFTSPIVIGALILSMVIIYLFIRRQFNITNALLNLRVFKNRTFALCTISSMIIMMSMVGPALLIPLYVQNSLSLSALLSGLVIMPGAIINGIMSVFTGKFYDKYGPRPLIYTGFTILTITTIMLCFLHTDTSYTYLIVVYAIRMFSVSLLMMPINTTGINSLRNEEISHGTAIMNFGRVMAGSLGTALMVTLMSFGAKIFLSTSPSHLTATEIKQQSIAIGVDISFAFVAVLVMAAYVIALFIREPKEIESNRRKF,27.5,gnl|BL_ORD_ID|2871|hsp_num:0,3276,TRUE,loose hit with at least 95 percent identity pushed strict
LK524,21_50 # 51773 # 52861 # 1 # ID=21_50;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.332,21_50,51773,52861,+,Strict,800,659.062,Staphylococcus aureus LmrS,95.58,3004572,protein homolog model,n/a,n/a,macrolide antibiotic; aminoglycoside antibiotic; oxazolidinone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGCCTTTAATGCAATTCACATTGTTTACGTTATTCAGTAAAGAACATAGAGGATTTGCAATGGGATTAGCTGGTTTAGTTATTCAATTTGCACCAGCAATCGGGCCTACTGTTACTGGATTAATCATTGATCAAGCGAGTTGTCGAGTACCATTTATTATAATTGTAGGAATTGCTTTAGTCGCATTCATCTTCGGTTTAATTTCAATTTCAAGCTATAATGAAGTGAAATATACTAAGCTAGATAAGCGCTCTGTAATGTATTCAACGATTGGATTTGGATTAATGTTATATGCATTCAGTAGTGCAGGCGACCTAGGATTTACTAGCCCGGTAGTCATTGGTGCAATGATAATTAGTTCTATTATCATCTACTTATTTATTCGTAGACAATTCAATATAAGCAATGCACTTTTAAATTTAAGTGTTTTTAAGAATAGAACATTTGCATTATGTACGATTAGTTCAATGATTATAATGATGTCAATGGTTGGTCCAGCGTTATTAATACCGCTCTATGTTCAAAATAGCTTAGCTCTATCTGCATTATTGTTTGGACTTGTTATCATGCCAGGTGCAATCATAAATGGTATTATGTCGGTTTTTACAGGTAAATTTTATGATAAGTATGGTCCTAGACCACTGATTTATACTGGTTTTACGATTTTAACAATTACTACTATTATGTTGTGTTTCTTGCATACAGACACATCTTATACGTATTTAATAGTCGTATATGCAATTAGAATGTTTTCAGTTTCTTTACTCATGATGCCGATAAATACTACAGGAATTAATTCTTTGAAAAATGAAGAAATCTCACATGGCACGGCTATTATGAACTTTGGTCGTGTAATGGCTGGCTCATTAGGAACAGCATTAATGGTTACTTTGATGAGTTTTGGCGCAAAAATATTCTCATCTACATCGCCATCGCATTTAACTGCAACTGAAATTAAACAGCAATCAATTGCTATAGGGGTGGATATCTCATTTGCTTTTGTAGCTGTGCTTGTTATGGCAGCTTATGTGATAGCGCTTTTTATAAGAGAACCTAAAGAAATAGAAAGTAATAGAAGGAAATTTTAA,MPLMQFTLFTLFSKEHRGFAMGLAGLVIQFAPAIGPTVTGLIIDQASCRVPFIIIVGIALVAFIFGLISISSYNEVKYTKLDKRSVMYSTIGFGLMLYAFSSAGDLGFTSPVVIGAMIISSIIIYLFIRRQFNISNALLNLSVFKNRTFALCTISSMIIMMSMVGPALLIPLYVQNSLALSALLFGLVIMPGAIINGIMSVFTGKFYDKYGPRPLIYTGFTILTITTIMLCFLHTDTSYTYLIVVYAIRMFSVSLLMMPINTTGINSLKNEEISHGTAIMNFGRVMAGSLGTALMVTLMSFGAKIFSSTSPSHLTATEIKQQSIAIGVDISFAFVAVLVMAAYVIALFIREPKEIESNRRKF,MAKVELTTRRRNFIVAVMLISAFVAILNQTLLNTALPSIMRELNINESTSQWLVTGFMLVNGVMIPLTAYLMDRIKTRPLYLAAMGTFLLGSIVAALAPNFGVLMLARVIQAMGAGVLMPLMQFTLFTLFSKEHRGFAMGLAGLVIQFAPAIGPTVTGLIIDQASWRVPFIIIVGIAILAFVFGLVSISSYNEVKYTKLDKRSVMYSTIGFGLMLYAFSSAGDLGFTSPIVIGALILSMVIIYLFIRRQFNITNALLNLRVFKNRTFALCTISSMIIMMSMVGPALLIPLYVQNSLSLSALLSGLVIMPGAIINGIMSVFTGKFYDKYGPRPLIYTGFTILTITTIMLCFLHTDTSYTYLIVVYAIRMFSVSLLMMPINTTGINSLRNEEISHGTAIMNFGRVMAGSLGTALMVTLMSFGAKIFLSTSPSHLTATEIKQQSIAIGVDISFAFVAVLVMAAYVIALFIREPKEIESNRRKF,75.42,gnl|BL_ORD_ID|2871|hsp_num:0,3276,TRUE,loose hit with at least 95 percent identity pushed strict
LK524,23_9 # 7605 # 8753 # -1 # ID=23_9;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.359,23_9,7605,8753,-,Strict,175,180.259,vanT gene in vanG cluster,33.6,3002972,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,glycopeptide resistance gene cluster; vanT,ATGTCAGATAAATATTATAGATCTGCGTATATGAATGTAGATTTAAACGCTGTTGCATCAAATTTCAAAGTATTCAGTACATTGCATCCAAATAAAACAGTGATGGCTGTCGTTAAAGCCAATGCCTATGGACTAGGTAGTGTTAAAGTAGCACGTCATTTAATGGAAAATGGTGCCACATTTTTTGCTGTAGCAACGTTAGATGAAGCGATAGAACTTAGAATGCATGGGATTACTGCTAAAATTTTAGTCTTAGGTGTGTTACCAGCTAAAGATATTGATAAAGCGATACAACACCGAGTTGCCTTAACGGTTCCGTCTAAACAGTGGTTGAAAGAAGCAATTAAAAACATTTCTGGTGAGCAAGAGAAAAAGTTATGGTTGCATATTAAATTAGATACAGGAATGGGACGTTTAGGTATTAAAGATACTAAAACGTATCAAGAAGTGATTGAAATCATTCAACAATATGAGCAACTTGTATTTGAAGGCGTGTTTACACACTTTGCCTGTGCTGACGAACCAGGAGATATGACAACTGAACAATATCACCGTTTTAAAGATATGGTCAATGAAGCAATTAAACCTGAATATATACATTGTCAGAACTCAGCAGGTTCTCTATTAATGGATTGCCAATTCTGTAATGCAATAAGACCAGGAATTTCCCTTTATGGATATTATCCATCAGAGTATGTACAGCAAAAAGTTAAAGTACACCTTAAACCAAGTGTGCAATTAATTGCTAATGTAGTTCAAACAAAGACGCTACAAGCGGGTGAGTCTGTAAGTTATGGTGCAACTTATACAGCTACTGATCCAACAACAATAGCATTGTTACCTATTGGATATGCAGATGGCTATTTACGCATTATGCAAGGTAGCTTTGTAAATGTAAATGGTCATCAATGCGAAGTTATTGGTCGCGTATGTATGGATCAGACAATTGTAAAAGTGCCAGATCAAGTTAAAGCTGGAGATTCGGTGATTTTAATAGATAATCATAGAGAAAGTCCACAGTCGGTAGAGGTGGCAGCTGAAAAGCAACATACTATTAATTATGAAGTGCTTTGTAACTTGTCGAGACGTTTGCCGCGAATCTATCATGATGGTGATCAACGTTTTGTAACAAATGAATTGTTAAAATAA,MSDKYYRSAYMNVDLNAVASNFKVFSTLHPNKTVMAVVKANAYGLGSVKVARHLMENGATFFAVATLDEAIELRMHGITAKILVLGVLPAKDIDKAIQHRVALTVPSKQWLKEAIKNISGEQEKKLWLHIKLDTGMGRLGIKDTKTYQEVIEIIQQYEQLVFEGVFTHFACADEPGDMTTEQYHRFKDMVNEAIKPEYIHCQNSAGSLLMDCQFCNAIRPGISLYGYYPSEYVQQKVKVHLKPSVQLIANVVQTKTLQAGESVSYGATYTATDPTTIALLPIGYADGYLRIMQGSFVNVNGHQCEVIGRVCMDQTIVKVPDQVKAGDSVILIDNHRESPQSVEVAAEKQHTINYEVLCNLSRRLPRIYHDGDQRFVTNELLK,MTKNESYSGIDYFRFIAALLIVAIHTSPLSSFSETGNFIFTRIVARVAVPFFFMTSGFFLISRYTCNAEKLGAFIKKTTLIYGVAILLYIPINVYNGYFKMDNLLPNIIKDIVFDGTLYHLWYLPASIIGAAIAWYLVKKVHYRKAFLIASILYIIGLFGDSYYGIVKSVSCLNVFYNLIFQLTDYTRNGIFFAPIFFVLGGYISDSQNRLSLKRSIVGFIVCFALMFGEALTLHHFDIQKHDSMYVLLLPSVYCLFNLLLHFRGKRRTGLRTISLIIYIIHPFMIVVIRLFAKLLHLQSLLVENSLVHYIAVCFASVVLAVVITALLSSLKPKKAKHTADTDRAYLEINLNNLEHNVNTLQKAMSPKCELMAVVKAEAYGHGMYEVTTYLEQIGVSSFAVATIDEGIRLRKYGISSEILILGYTSPSRAKELCKYELTQTLIDYRYSLLLNKQGYDIKAHIKIDTGMHRLGFSTEDKDKILAAFSLKHIKVAGIFTHLCAADSLEENDVAFTNKQIGSFYKVLDWLKSSGLNIPKVHIQSSYGLLNYPELECDYIRVGVALYGVLSSTNDKTKLELDLRPVLSLKAKVVLIRKIKQGESVGYSRAFTATRDSLIAILPIGYADGFPRNLSCGNSYVLIGGRQAPIVGKICMDQLAVDVTDIPNVKTGSIATLIGKDGKEEITAPMVAESAESITNELLSRMGHRLNIIRRA,53.65,gnl|BL_ORD_ID|1522|hsp_num:0,1561,FALSE,None
LK524,23_17 # 16426 # 19155 # 1 # ID=23_17;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.320,23_17,16426,19155,+,Strict,1500,1787.31,kdpD,98.53,3004047,protein homolog model,n/a,n/a,aminoglycoside antibiotic,antibiotic efflux,kdpDE,GTGTATGCAGAAATAAATTTTATAGCATTTAATTGTGAAGAATATTATGATATTGCTATCGAGGTGAAGGTTATGTCAAACACTGAATCGCTAAACATAGGAAAAAAGCGTGGATCTTTAACAATTTACATCGGTTACAGTCCAGGTGTTGGTAAAACATTTGAGATGCTTTCAAATGCCATTGAACTATTTCAAAGTAACGTTGATATTAAACTAGGATATATTGAACCGCATCAACGTGATGAAACAAATGCATTAGCTGAACAATTACCTAAAATCGCAACCAATTTTACTAAACATGGTAGTCATCATTTTCAATATTTAGATGTCGACCGCATAATCGAAGAATCGCCGACAATAGTACTTATCGATGAGTTAGCACATACGAACATTTCTAGAGATCGTCATGAGAAACGATATATGGATATTGAAGAAATTTTAAATCATGGTATCGATGTTCATACTACTTTGAACATTCAACATATTGAAAGTTTAAGTAGTCAAATTGAACTGATGACCGGTGTACATGTTAAAGAACGTGTACCCGACTATTTCATAATGAGCGCCGATGTATTAGAAGTCGTAGATATCTCACCTGAACAATTAATTAAACGCTTAAAAGCTGGCAAGGTATATAAAAAGGATAGGCTAGATGTAGCATTTAGTAATTTCTTTACGTATGCCCACCTAAGCGAACTGCGTACATTGACGTTAAGAACAGTTGCCGACTTGATGAGTGATAAAGAAAAAGTCCGACACAATCATAAAACGTCACTCAAACCTCATATTGCTGTGGCAATTAGTGGGAGTATTTATAATGAAGCAGTAATTAAAGAGGCATTCCATATTGCTCAAAAAGAACATGCAAAATTCACTGCTATTTATATAGATGCATTCGAAAAAAGCAGGCAATATAAAGATAGTCAAAAGCAAGTGCATCAACATCTCATGCTTGCAAAATCTTTAGGAGCAAAAGTAAAAGTAGTTTATAGCCAAACCGTTGCATTAGGATTAGACGAATGGTGTAAAAATCAAGATGTAACCAAATTAATTATCGGACAACATATTAGAAATAAGCGGCGAGACTTTTTCAATAAACCTTTAATTGACCATTTAATGTCCTTTGAACATAGCTATAAAATCGAAATCGTTCCAATCAAACAAATACCTGTTGAATTGAAAATGAACAAATCACCCTATCGTCCTAAAGGCAAACGGTTCGCCATAGATATGTTAAAAATGATTCTGATTCAAATAATTTGTGTAATGATGGGACTGTGGATTTATCAACTTGATAAGCATGAGTCTAGTACGATTATTTTAATGATTTTTCTCATCGGCATCATTTTGTTATCCATTTGGACGCGGTCCTACATCATTGGCTTTTTAGCAGCAATTATTAACGTATTTGTTTTTAATTATTTTTTTACGGAACCTAGATATACATTTGAAGTATACCGCTTTGACTATCCTATTACATTTATCGTCAGCATTTTAACAAGTATTTTAACGAGTGCTTTATTAAAACAAATTAAATTCCAATACGCCATTACTAAAAAGCAACTTTATCGTACAGATTTATTATTTCAATTTAATGATTCGATTAAACAAACTTATACAGTTGAAAACTTACTAATAAATGCTGGATACCAAATTAATCAATTATTGCAACAATCAATTACTATATACGTTATCAATCAATCCAAAGTAATTAAAACAATACCATTGCAAAACCATATCGATAATAAGACTCAACAGCATGAACAAGCATTAAGCTGGGTAATTAAAAATGAAAGACAAGCTGGTGCAACAACAGATACATTTCCAGGCATTAATAAATGGTTGATACCAATTGGCACATCTCCGATTAAAGGCATTCTAGCCATTGATTACCAAAGTTCTCAAGTGATTAATCCATATGATGCATCAATATTAGAATCAATGTTAAATGAACTTTCTCTCGCCGTTGAAAATGTGACGTTGCTTAAACAAACAAGAGAATCCATGTTACAGGCTGAACGTCAACTGACACATTCAAATTTTTTAAGATCAATTTCGCATGACATACGTACACCGTTAACAACAATTATGGGAAATTTAGATATTTTAGTGTCACATAGTAAAGATATGTCTATCATAGAAAAGGAACAATTACTTGTGCATAGTTTTCAAGAAAGTCAGTATTTATATCTATTAGTGACAAATATTTTATCATTAACAAAATTACAGTCATCAAATGTTCAGATAAAATTGCAACCTTATCTCGTTAGTGAATTAGTAGAAGAAATCGATATGATTTTAGAACGTCGCCATTTAAAAAAGCGTATAACTGTATCATCCTCAGTAGATTTACAGTTTATACACATTGACAGTAAGTTGATTTTACAAGCTTTATTCAATTTGATTGAAAATGCAGTTAAACACACTTCTACTGACACCAAAATCAATTTATCTATTCGTTATGCTAGCGATGAACAAATCGAATTTGCTGTTATAGACGAAGGACCTGGAATTAGTATAGAAGAACAACAAAAGATATTCGAGCCTTTTTACACAGGGTCAAATAAATATTTTAAAGATAACCAAAAAGAAAGCATGGGACTAGGCTTATATTTAGTACAGACTATCCTACACAAACATCAATCAAACCTACAATATAAACCGAACCAACCACATGGCAGTATATTCTATTTCAATATAGATACAGACTTTAATGAAGGAGACATATAA,MYAEINFIAFNCEEYYDIAIEVKVMSNTESLNIGKKRGSLTIYIGYSPGVGKTFEMLSNAIELFQSNVDIKLGYIEPHQRDETNALAEQLPKIATNFTKHGSHHFQYLDVDRIIEESPTIVLIDELAHTNISRDRHEKRYMDIEEILNHGIDVHTTLNIQHIESLSSQIELMTGVHVKERVPDYFIMSADVLEVVDISPEQLIKRLKAGKVYKKDRLDVAFSNFFTYAHLSELRTLTLRTVADLMSDKEKVRHNHKTSLKPHIAVAISGSIYNEAVIKEAFHIAQKEHAKFTAIYIDAFEKSRQYKDSQKQVHQHLMLAKSLGAKVKVVYSQTVALGLDEWCKNQDVTKLIIGQHIRNKRRDFFNKPLIDHLMSFEHSYKIEIVPIKQIPVELKMNKSPYRPKGKRFAIDMLKMILIQIICVMMGLWIYQLDKHESSTIILMIFLIGIILLSIWTRSYIIGFLAAIINVFVFNYFFTEPRYTFEVYRFDYPITFIVSILTSILTSALLKQIKFQYAITKKQLYRTDLLFQFNDSIKQTYTVENLLINAGYQINQLLQQSITIYVINQSKVIKTIPLQNHIDNKTQQHEQALSWVIKNERQAGATTDTFPGINKWLIPIGTSPIKGILAIDYQSSQVINPYDASILESMLNELSLAVENVTLLKQTRESMLQAERQLTHSNFLRSISHDIRTPLTTIMGNLDILVSHSKDMSIIEKEQLLVHSFQESQYLYLLVTNILSLTKLQSSNVQIKLQPYLVSELVEEIDMILERRHLKKRITVSSSVDLQFIHIDSKLILQALFNLIENAVKHTSTDTKINLSIRYASDEQIEFAVIDEGPGISIEEQQKIFEPFYTGSNKYFKDNQKESMGLGLYLVQTILHKHQSNLQYKPNQPHGSIFYFNIDTDFNEGDI,MSNTESLNIGKKRGSLTIYIGYSPGVGKTFEMLSNAIELFQSNIDIKIGYIEPHQRDETNALAEQLPKIATNFTKHGSHHFQYLDVDRIIKESPTIVLIDELAHTNISRDRHEKRYMDIEEILNHGIDVHTTLNIQHIESLSSQIELMTGVHVKERVPDYFIMSADVLEVVDISPEQLIKRLKAGKVYKKDRLDVAFSNFFTYTHLSELRTLTLRTVADLMSDKEKVRHNHKTSLKPHIAVAISGSIYNEAVIKEAFHIAQKEHAKFTAIYIDVFEKNRQYKDSQKQVHQHLMLAKSLGAKVKVVYSQTVALGLDEWCKNQDVTKLIIGQHIRNKWRDFFNTPLIDHLMSFEHSYKIEIVPIKQIPVELKMNKSPYRPKGKRFAIDMLKMILIQIICVMMGLWIYQLDKHESSTIILMIFLIGIILLSIWTRSYIIGFLAAIINVFVFNYFFTEPRYTFEVYRFDYPITFIVSILTSILTSALLKQIKFQYSITKKQLYRTDLLFQFNDSIKQTYTVENLLINAGYQINQLLQQSITVYVINQSKVIKTIPLQNHIDNTTQQHEQALSWVIKNERQAGATTDTFPGINKWLIPIGTSPIKGILAIDYQSSQVINPYDASILESMLNELSLAVENVSLLKQTRESMLQAERQLTHSNFLRSISHDIRTPLTTIMGNLDILVSHSKDMSIIEKEQLLVHSFQESQYLYLLVTNILSLTKLQSSNVQIKLQPYLVSELVEEIDMILERRHLKKRITVSSSVDLQFIHIDSKLILQALFNLIENAVKHTSTDTKINLSIRYASDEQIEFAVIDEGPGISLEEQQKIFEPFYTGSNKYFKDNQKESMGLGLYLVQTILHKHQSNLQYKPNQPHGSIFYFNIDTDFNEGDI,102.71,gnl|BL_ORD_ID|4926|hsp_num:0,5918,FALSE,None
LK524,8_39 # 33048 # 34406 # 1 # ID=8_39;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.367,8_39,33048,34406,+,Strict,800,903.664,Staphylococcus aureus GlpT with mutation conferring resistance to fosfomycin,100,3003901,protein variant model,"A100V, V213I",n/a,phosphonic acid antibiotic,antibiotic target alteration,antibiotic-resistant GlpT,ATGAATTTTCTTAAACCTGCAAAGCATATTAAGCCTTTGCCAGAAAATCAGATAGATGATACCTATAAACGATTACGTCTCCAAGTATTTCTTGGTATTTTCATCGGTTACGCTGGGTACTATTTATTACGTAAAAACTTTTCATTAGCGATGCCGGCATTGCAAGAGCAAGGTTTTACAAAAGCAGAACTAGGTTTTGCGCTTTCTGCTGTTTCCATCGCATATGGATTTAGTAAGTTCTTTATGGGTACTGTAAGTGATCGGAGCAATGCACGGATATTCTTAGTTCTTGGATTAGTACTCACTGCTATCGTCAATTTGTTAATGGGATTTGTACCGTTCTTTACATCAGGTATCGGTATTATGTTTGTCCTATTATTCTTAAATGGATGGTTTCAAGGTATGGGCTGGCCACCTTCAGGCCGTGTTCTCGTTCACTGGTTTAGTGTAAGTGAACGCGGAAGTAAGACTGCTCTTTGGAACGTTGCGCATAATGTTGGTGGAGGTATTATGGCACCTATTGCTGCTTGGGGTATTACAACAACAGCATTTATCAACTTTGGTTATTTAAAAGGTTTTGAAGGTGTATTCATTTACCCTGCACTCTTAGCACTTATCATTGCCGCAATTTCATATATATTGATTAGAGACACACCTCAATCTCAAGGTTTACCTCCAATCGAAATTTATAAAAATGACTTTGCTACAAGCGATAAGAAAACATTAGAAACAGAATTAACTACAAAAGAAATTTTATTTAAATATGTACTGAACAATAAATGGGTATGGGCAATTGCCTTTGCAAATATATTTGTTTATTTCGTGCGTTATGGTGTACTTGATTGGGCGCCAGTCTACTTAAGTGAAGAAAAACATTTCGACTTAAAAGCATCAGGTTGGGCATACTTCTTATACGAATGGGCTGGAATTCCTGGTACATTATTATGTGGTTACATTTCTGATAAATTATTCAAAGGTCGCCGTGGACCTGCTGGTTTCTTCTTTATGTTAGGTGTCACAGTATTTGTATTAATTTATTGGTTAAATCCTCCAGGCAATGCTTGGTTAGACAATGTCTCATTAATTGCCATTGGTTTCTTAATATATGGACCAGTTATGTTAATTGGTTTACAAGCATTAGATTATGTACCTAAAAAAGCAGCTGGCACAGCAGCTGGATTAACTGGATTATTTGGTTATCTGTTTGGTGCTGTAATGGCCAACATCGTCTTAGGTGCTGTAGTTGATAAATTCGGATGGGATGTCGGTTTTATTTTATTAACAGCAATCAGTGTGTTTGCAATGTTGAGCTTTATCCTCACTTGGAATAAAGTAGGACAAGAAACTGTTCATCATTAA,MNFLKPAKHIKPLPENQIDDTYKRLRLQVFLGIFIGYAGYYLLRKNFSLAMPALQEQGFTKAELGFALSAVSIAYGFSKFFMGTVSDRSNARIFLVLGLVLTAIVNLLMGFVPFFTSGIGIMFVLLFLNGWFQGMGWPPSGRVLVHWFSVSERGSKTALWNVAHNVGGGIMAPIAAWGITTTAFINFGYLKGFEGVFIYPALLALIIAAISYILIRDTPQSQGLPPIEIYKNDFATSDKKTLETELTTKEILFKYVLNNKWVWAIAFANIFVYFVRYGVLDWAPVYLSEEKHFDLKASGWAYFLYEWAGIPGTLLCGYISDKLFKGRRGPAGFFFMLGVTVFVLIYWLNPPGNAWLDNVSLIAIGFLIYGPVMLIGLQALDYVPKKAAGTAAGLTGLFGYLFGAVMANIVLGAVVDKFGWDVGFILLTAISVFAMLSFILTWNKVGQETVHH,MNFLKPAKHIKPLPENQIDDTYKRLRLQVFLGIFIGYAGYYLLRKNFSLAMPALQEQGFTKAELGFALSAVSIAYGFSKFFMGTVSDRSNARIFLVLGLVLTAIVNLLMGFVPFFTSGIGIMFVLLFLNGWFQGMGWPPSGRVLVHWFSVSERGSKTALWNVAHNVGGGIMAPIAAWGITTTAFINFGYLKGFEGVFIYPALLALIIAAISYILIRDTPQSQGLPPIEIYKNDFATSDKKTLETELTTKEILFKYVLNNKWVWAIAFANIFVYFVRYGVLDWAPVYLSEEKHFDLKASGWAYFLYEWAGIPGTLLCGYISDKLFKGRRGPAGFFFMLGVTVFVLIYWLNPPGNAWLDNVSLIAIGFLIYGPVMLIGLQALDYVPKKAAGTAAGLTGLFGYLFGAVMANIVLGAVVDKFGWDVGFILLTAISVFAMLSFILTWNKVGQETVHH,100,gnl|BL_ORD_ID|2179|hsp_num:0,2380,FALSE,None
LK524,23_40 # 38237 # 39502 # -1 # ID=23_40;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.359,23_40,38237,39502,-,Strict,800,847.81,Staphylococcus aureus murA with mutation conferring resistance to fosfomycin,100,3003776,protein variant model,"D278E, E291D",n/a,phosphonic acid antibiotic,antibiotic target alteration,antibiotic-resistant murA transferase,ATGGATAAAATAGTAATCAAAGGTGGAAATAAATTAACGGGTGAAGTTAAAGTAGAAGGTGCTAAAAATGCAGTATTACCTATATTAACAGCATCTTTATTAGCTTCTGATAAACCGAGCAAATTAGTTAATGTTCCAGCTTTAAGTGATGTAGAAACAATAAATAATGTATTAACAACCTTAAATGCTGACGTTACATACAAAAAGGACGAAAATGCTGTTGTCGTTGATGCAACAAAGACTCTAAATGAAGAGGCACCATATGAATATGTTAGTAAAATGCGTGCAAGTATTTTAGTTATGGGACCTCTTTTAGCAAGACTAGGACATGCTATTGTTGCATTGCCTGGTGGTTGTGCAATTGGAAGTAGACCGATTGAGCAACACATTAAAGGTTTTGAAGCTTTAGGCGCAGAAATTCATCTTGAAAATGGTAATATTTATGCTAATGCTAAAGATGGATTAAAAGGTACATCAATTCATTTAGATTTTCCAAGTGTAGGAGCAACACAAAATATTATTATGGCAGCATCATTAGCTAAGGGTAAGACTTTAATTGAAAATGCAGCTAAAGAACCTGAAATTGTTGATTTAGCAAACTACATTAATGAAATGGGCGGTAGAATTACTGGTGCTGGTACAGACACAATTACAATCAATGGTGTAGAATCATTACATGGTGTAGAACATGCTATCATTCCAGATAGAATTGAAGCAGGCACATTACTGATCGCTGGTGCCATTACTCGTGGCGATATTTTTGTACGTGGTGCAATCAAAGAACATATGGCTAGTTTAGTGTATAAATTAGAAGAAATGGGCGTTGAATTGGAATATCAAGAAGATGGTATTCGTGTACGTGCTGAAGGAGATTTACAGCCTGTTGACATCAAAACATTACCGCATCCTGGTTTTCCAACCGATATGCAGTCACAAATGATGGCATTATTATTAACAGCAAACGGACATAAAGTAGTAACTGAAACTGTATTTGAAAATCGTTTTATGCATGTTGCAGAGTTCAAACGTATGAATGCTAATATCAATGTAGAAGGTCGTAGTGCTAAACTTGAAGGTAAAAGTCAATTGCAAGGTGCACAAGTTAAAGCGACTGATTTAAGAGCAGCAGCAGCCTTAATTTTAGCTGGATTAGTTGCTGATGGTAAAACAAGCGTTACTGAATTAACGCACCTAGATAGAGGCTATGTTGACTTACACGGTAAATTGAAGCAATTAGGTGCAGACATTGAACGTATTAACGATTAA,MDKIVIKGGNKLTGEVKVEGAKNAVLPILTASLLASDKPSKLVNVPALSDVETINNVLTTLNADVTYKKDENAVVVDATKTLNEEAPYEYVSKMRASILVMGPLLARLGHAIVALPGGCAIGSRPIEQHIKGFEALGAEIHLENGNIYANAKDGLKGTSIHLDFPSVGATQNIIMAASLAKGKTLIENAAKEPEIVDLANYINEMGGRITGAGTDTITINGVESLHGVEHAIIPDRIEAGTLLIAGAITRGDIFVRGAIKEHMASLVYKLEEMGVELEYQEDGIRVRAEGDLQPVDIKTLPHPGFPTDMQSQMMALLLTANGHKVVTETVFENRFMHVAEFKRMNANINVEGRSAKLEGKSQLQGAQVKATDLRAAAALILAGLVADGKTSVTELTHLDRGYVDLHGKLKQLGADIERIND,MDKIVIKGGNKLTGEVKVEGAKNAVLPILTASLLASDKPSKLVNVPALSDVETINNVLTTLNADVTYKKDENAVVVDATKTLNEEAPYEYVSKMRASILVMGPLLARLGHAIVALPGGCAIGSRPIEQHIKGFEALGAEIHLENGNIYANAKDGLKGTSIHLDFPSVGATQNIIMAASLAKGKTLIENAAKEPEIVDLANYINEMGGRITGAGTDTITINGVESLHGVEHAIIPDRIEAGTLLIAGAITRGDIFVRGAIKEHMASLVYKLEEMGVELEYQEDGIRVRAEGDLQPVDIKTLPHPGFPTDMQSQMMALLLTANGHKVVTETVFENRFMHVAEFKRMNANINVEGRSAKLEGKSQLQGAQVKATDLRAAAALILAGLVADGKTSVTELTHLDRGYVDLHGKLKQLGADIERIND,100,gnl|BL_ORD_ID|2071|hsp_num:0,2285,FALSE,None
LK1289,1_206 # 210127 # 211233 # -1 # ID=1_206;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.596,1_206,210127,211233,-,Strict,175,179.489,vanT gene in vanG cluster,32.4,3002972,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,glycopeptide resistance gene cluster; vanT,ATGGTGGACATGCTGAAAACCACCATTGATCTCTCCGCCATCGCGCACAACGTCCGCCTCATCAAGGAAAAGGTAGGGCCTGAGGTCAAGCTCATGTGCGTGGTTAAGGCCGATGCCTATGGCCACGGCGCGGCTAAGGTTGTACCGGTGATGGCGCGCGCGGGCGCGGATTGCTTTGGCGTGGCCACCTTGCGGGAGGCCGTGGAGCTGCGCCGCGCGGGCGTGGATTCACCCATCGTGGCGTGGATCTGGCAGACGGAAGAAATCCTCGAAGAAGCGCTTGCCTGCGGCATTGAGGTGGCGGTCAACTCACTCGAGCAGGCGCATCAATTGGTCAAGTCCGAAATTCCCGCGGAGATTTACGTCAAGGTGGAAACCGGTATGCATCGCGCCGGCGTGGATGAGGACGATTGGGTAGAGACCTTTAAGGTGCTGCGCGATGCCCCACACATCAAGGTGCTCGGCCTCATGTCCCACTTTGCGTGTGCCGATGAGCCGGATAATCCGCACAATGACGCCCAGGAAGAGGTGTTCCGCACGGCCCTGCGTCTCGCGCGCGAGATTGGGCTGGAGTGCCCAGTCAATCACCTCGCCAATTCGCCGGCCGCGCTGACGCGTCCTTCTTCTTATTTTGAGCAGGTACGTGTAGGCGCCGCCTGCTATGGTTTGGAGCCTATTGACGGCCGCGAGCATGGTCTGCGCCCAGCCATGACTTGGTCCGGGCAGATCTTCAACGTAAAGCCCATTCAACCAGGGGAAGGTACCTGCTATGGACTGACCTGGAAGGCGGATAAGCCGGGATTTTTAGCCACCGTGGATTGCGGCTACGCAGATGGCTTGCCGCGTGGTTATCAAGGCGATCTGCACGTGGGCATTGGCGGGCACCTGTATCCACAGGTAGGCCGAATCTGTATGGATCAGATTGTGGTGGACTTGGGCGATAACCCGCATGGCGTGGACACGGGTCAAGATGCCGTGATTTTTGGCAACGGGGGAGTATCGGCTACGGATCTCGCCGCGGCAGCAGGCACCATTAACTACGAGGTTGTCTGCCTGCCCGATGGCCGCACCGAACGCGAATACATAGGAGAAGAAGATGCGCAGTAG,MVDMLKTTIDLSAIAHNVRLIKEKVGPEVKLMCVVKADAYGHGAAKVVPVMARAGADCFGVATLREAVELRRAGVDSPIVAWIWQTEEILEEALACGIEVAVNSLEQAHQLVKSEIPAEIYVKVETGMHRAGVDEDDWVETFKVLRDAPHIKVLGLMSHFACADEPDNPHNDAQEEVFRTALRLAREIGLECPVNHLANSPAALTRPSSYFEQVRVGAACYGLEPIDGREHGLRPAMTWSGQIFNVKPIQPGEGTCYGLTWKADKPGFLATVDCGYADGLPRGYQGDLHVGIGGHLYPQVGRICMDQIVVDLGDNPHGVDTGQDAVIFGNGGVSATDLAAAAGTINYEVVCLPDGRTEREYIGEEDAQ,MTKNESYSGIDYFRFIAALLIVAIHTSPLSSFSETGNFIFTRIVARVAVPFFFMTSGFFLISRYTCNAEKLGAFIKKTTLIYGVAILLYIPINVYNGYFKMDNLLPNIIKDIVFDGTLYHLWYLPASIIGAAIAWYLVKKVHYRKAFLIASILYIIGLFGDSYYGIVKSVSCLNVFYNLIFQLTDYTRNGIFFAPIFFVLGGYISDSQNRLSLKRSIVGFIVCFALMFGEALTLHHFDIQKHDSMYVLLLPSVYCLFNLLLHFRGKRRTGLRTISLIIYIIHPFMIVVIRLFAKLLHLQSLLVENSLVHYIAVCFASVVLAVVITALLSSLKPKKAKHTADTDRAYLEINLNNLEHNVNTLQKAMSPKCELMAVVKAEAYGHGMYEVTTYLEQIGVSSFAVATIDEGIRLRKYGISSEILILGYTSPSRAKELCKYELTQTLIDYRYSLLLNKQGYDIKAHIKIDTGMHRLGFSTEDKDKILAAFSLKHIKVAGIFTHLCAADSLEENDVAFTNKQIGSFYKVLDWLKSSGLNIPKVHIQSSYGLLNYPELECDYIRVGVALYGVLSSTNDKTKLELDLRPVLSLKAKVVLIRKIKQGESVGYSRAFTATRDSLIAILPIGYADGFPRNLSCGNSYVLIGGRQAPIVGKICMDQLAVDVTDIPNVKTGSIATLIGKDGKEEITAPMVAESAESITNELLSRMGHRLNIIRRA,51.69,gnl|BL_ORD_ID|1522|hsp_num:0,1561,FALSE,None
LK1289,8_89 # 98791 # 99645 # -1 # ID=8_89;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.564,8_89,98791,99645,-,Strict,400,514.612,ErmX,90.14,3000596,protein homolog model,n/a,n/a,macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic,antibiotic target alteration,Erm 23S ribosomal RNA methyltransferase,ATGTCTGCATACGGACACGGCCGTCACGAGCATGGCCAAAATTTTCTCACCAACCACAAGATCATCAACTCCATCATCGACCTTGTGAAACAAACCTCCGGCCCCATCATTGAGATCGGACCAGGAAGCGGTGCCCTCACTCACCCGATGGCCCACTTGGGGAGGGCGATAACGGCAGTTGAAGTGGACGCAAAACTAGCTGCCAAAATCACACAAGAAACCTCCTCGGCGGCGGTCGAAGTGGTCCATGATGATTTCCTTAACTTCCGGTTACCCGCCACTCCCTGCGTCATTGTGGGAAACATTCCCTTTCACCTCACCACTGCCATTCTTCGAAAGTTGCTGCATGCGCCAGCATGGACTGACGCTGTACTCCTCATGCAGTGGGAAGTCGCTCGCCGCCGGGCCGGGGTAGGCGCAAGCACGATGATGACGGCTCAGTGGTCCCCATGGTTCACATTTCACCTGGGTTCTCGGGTACCAAGGCCTGCTTTCCGGCCACAGCCAAACGTTGACGGGGGGATCTTAGTGATCCGCCGGGTGGGTGACCCGAAGATTCCGATAGAGCAGCGCAAAGCCTTTCAGGCGATGGTGCACACCGTTTTCACTGCCCGGGGACGCGGGATAGGGGAAATTCTCCGAAGGGCAGGGTTGTTTTCATCACGTTCAGAAACACAATCATGGTTGCGCTCGCGAGGAATCGACCCCGCGACCCTACCTCCCAGATTGCACACCAACGACTGGATCGATCTCTTCCAGGTGACTGGTTCCTCTCTACCTCACCATCGACCCATTTCACCATCGGGAAGTAGTCAACGACCTCCTCAACGGAAAAACCGAAGCCGGCGGCGTTAA,MSAYGHGRHEHGQNFLTNHKIINSIIDLVKQTSGPIIEIGPGSGALTHPMAHLGRAITAVEVDAKLAAKITQETSSAAVEVVHDDFLNFRLPATPCVIVGNIPFHLTTAILRKLLHAPAWTDAVLLMQWEVARRRAGVGASTMMTAQWSPWFTFHLGSRVPRPAFRPQPNVDGGILVIRRVGDPKIPIEQRKAFQAMVHTVFTARGRGIGEILRRAGLFSSRSETQSWLRSRGIDPATLPPRLHTNDWIDLFQVTGSSLPHHRPISPSGSSQRPPQRKNRSRRR,MSAYGQGRHEHGQNFLTNHKIINSIIDLVKQTSGPIIEIGPGSGALTHPMAHLGRAITAVEVDAKLAAKITQETSSAAVEVVHDDFLNFRLPATPCVIVGNIPFHLTTAILRKLLHAPAWTDAVLLMQWEVARRRAGVGATTMMTAQWSPWFTFHLGSRVPRSAFRPQPNVDGGILVIRRVGDPKIPIEQRKAFQAMVHTVFTARGRGIGEILRRQGCFHHVQKHNHGCAREESTPRPYLPDCYTNDWIDLFQVTGSSLPHHRPISPSGSSQRPPQRKNRSRRR,100,gnl|BL_ORD_ID|872|hsp_num:0,950,FALSE,None
LK1289,28_2 # 259 # 1947 # -1 # ID=28_2;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.599,28_2,259,1947,-,Strict,50,81.2629,vanW gene in vanI cluster,34.18,3003724,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanW; glycopeptide resistance gene cluster,GTGAACAAATCAGAAGGAAAAAACGGTGCTAAAGGCTGGCTCATCGCGCTCGGCGCATTGGTCGGCCTTGTCCTGATCGCGGGCATTGCTTATGCCTGGGATGTCGCGGCAAACCAGGACAAGATTCCGCGCGCCGTCTCCGTCAACGGCGTGGACATCGCCGCCATGGATCGCACCGCAGCCGTGGAGAAGCTCGAAGACGAGCTTGCGGGTGTAGAAACCGAGCCCGTGAGCGTTACCTCCGGCGACCTGCACACCGATTTCGTTCCCTCCGAGTCGGGCCTCGCCCTGGATAACCAGCGCGCCGTAGACAATATTGAAGAGCCTTCCCTCAATCCTTTTACCCGTCTGTATAGCTTCTTCCGCTCCACCCGGGATATTCCGGTGGAGACCAACGTGGATGAGGCACAGCTGCAACCGGCTCTGGACCGTGTGAAGAAGGATCTCTCCACCGATCCAGTTGATGGCATGTTGGAGCTCAACAATGGTGAGCTCAAGGTTACCGACCCCAAGCTCGGTCAAACCGTGGATGCTGGCACCCTGCACAATGCGGTTACGGATAATTGGCTCGCTTCCGAGGGCGTAAATGTGGACCCAGAAGAAGTAGAACCAGCCATCAATGATGCGGCTATCGAGGCCATGCGCACCGGTGATGCCGCCAAGGCGCTGGATAATCCCATTACCTTGAAGGCCAAGAATGATGTCAGCGCTACCCTGAATAAGCCGGAAATCTCCCAGTTCACCAGCATTGAAAAGAAGGACGGCAAGCTTAAGCTCGCCGTGGATACTAACCGCGCGCAAGAGCTGCTGGCCGAGCGCTCCGAGGGCGCCGATGTCCCCGGCGTAAATGCCAAGATTTCCTTCAACGGCAACGACAAGCAGGTGACCCCGTCCGAAGATGGCGAAATCATCGACTGGGAGCCGACCATGAAGGACTTTGATAAGCGCGTGACCGGCGATGACCGCGAGTGGGACGCTACCTATAAGCCGGACCCGGCTGAGTTCACCACCGAAGATGCCAAGAAGGCGACCTTTAACGACACCGTGGGCGAGTTCACCACCGAGGGCTACTCGGCTGCCTCCGGCAAGAATATCGAGTTGGTGGCCCAGGAGGTCAATGGCGCTGTGGTCAATCCCGGCGAAACCTTCTCCCTCAACGGCCACACCGGTCCCCGCGGCACGGCGCAAGGCTACGTTGAGTCCGGCATCATTATCGATGGCCACTCCGGCTCCGCCGTGGGCGGCGGCATTTCCCAGTTCGCCACCACCTTGTACAACGCTGCCTACTTCGCGGGCATGGAAGATACCGCCCACACCCCGCACTCGTACTACATTTCCCGCTACCCCGCCGGCCGCGAAGCCACCGTTTACGAAGGCGCCATCGACCTGCAGTTCACCAATACCTTCAATACCCCGGTCCGTCTTGAGACCGACTTCGGCGGCGGCAAGATTACCGTGCGTCTGAAGGGTACCAAGACTGTCGACGTCGAGTCTGTGAACAACGGCCGTTGGGCCAAGACCTCCCCACAGCCTATGTCCGTCCCAGGCAGCGACTGCTCGCCTTCTTCTGGCGCGCCGGGCTTTACGACGTCCGATACCCGCATCATCAAGGACCTTGGCGGCAAGGAGCTCTCCCGCGAGACCACCACCACGGTCTACGACCCGCAGCCCATCGTCCGCTGTGGCTAG,MNKSEGKNGAKGWLIALGALVGLVLIAGIAYAWDVAANQDKIPRAVSVNGVDIAAMDRTAAVEKLEDELAGVETEPVSVTSGDLHTDFVPSESGLALDNQRAVDNIEEPSLNPFTRLYSFFRSTRDIPVETNVDEAQLQPALDRVKKDLSTDPVDGMLELNNGELKVTDPKLGQTVDAGTLHNAVTDNWLASEGVNVDPEEVEPAINDAAIEAMRTGDAAKALDNPITLKAKNDVSATLNKPEISQFTSIEKKDGKLKLAVDTNRAQELLAERSEGADVPGVNAKISFNGNDKQVTPSEDGEIIDWEPTMKDFDKRVTGDDREWDATYKPDPAEFTTEDAKKATFNDTVGEFTTEGYSAASGKNIELVAQEVNGAVVNPGETFSLNGHTGPRGTAQGYVESGIIIDGHSGSAVGGGISQFATTLYNAAYFAGMEDTAHTPHSYYISRYPAGREATVYEGAIDLQFTNTFNTPVRLETDFGGGKITVRLKGTKTVDVESVNNGRWAKTSPQPMSVPGSDCSPSSGAPGFTTSDTRIIKDLGGKELSRETTTTVYDPQPIVRCG,MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVLAEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPELLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGMETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGGEFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSHSLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDEPDGYPVKPREWSK,150.67,gnl|BL_ORD_ID|4748|hsp_num:0,2242,FALSE,None
LK1059,2_60 # 54303 # 55157 # 1 # ID=2_60;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.563,2_60,54303,55157,+,Strict,400,486.878,ErmX,84.51,3000596,protein homolog model,n/a,n/a,macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic,antibiotic target alteration,Erm 23S ribosomal RNA methyltransferase,ATGTCTACATACGGATACGGCCGTCACGAACATGGCCAAAATTTTCTCACAGACCACAAGATCATCAACTCCATCGTCGATCTTGTAAAACAAACCTCCGGCCCCATCATTGAGATCGGGCCAGGAAGCGGTGCCCTCACTCACCCGATATCCCACTTGGGGAGGGCAATAACGGCAGTTGAGGTAGACGCAAAACTAGCTGCCAAACTCACAAAAAAGACCGCCTCGGCGTCGGTCGAAGTGGTCCATGATGATTTCCTCAACTTCCCGTTACCCGCCACTCCCTGCGTCATTGTGGGAAACATTCCCTTTCACCTCACCACTGCCATTCTTCGAAAGTTGTTGCATGCGCCGGCATGGACTGCCGCTGTACTCCTCATGCAGTGGGAAGTCGCTCGCCGCCGGGCCGGGGTAGGTGCAAGCACGATGATGACAGCTCAGTGGTCCCCATGGTTCACGTTTCACCTTGGTTCCCGAGTACCAAGGTCTGCTTTCCGGCCACAGCCAAACGTTGACGGGGGGATCTTAGTGATCCGCCGGGTGGGTGACCCGAAGATCCCGATAGAGCAACGCAAAGCCTTTCAGGCGATGGTGCACACCGTTTTCACCGCCCGGGGACGCGGGATAGGGGAAATTCTCCGAAGGGCAGGGTTGTTTTCATCACGTTCAGAGACACAATCATGGTTGCGCTCGCGAGGAATCGACCCCGCAACCCTACCTCCCAGATTGCACACCAGCGACTGGATCGATCTCTTCCAGGTGACTGGTTCCTCTTCACCGCGCCATCGGCCCATTTCACAATCGGGAAGTAGTCAACGCCCTCCTCAACGGAAAAATCGAGGCCGGCGGCGGTAA,MSTYGYGRHEHGQNFLTDHKIINSIVDLVKQTSGPIIEIGPGSGALTHPISHLGRAITAVEVDAKLAAKLTKKTASASVEVVHDDFLNFPLPATPCVIVGNIPFHLTTAILRKLLHAPAWTAAVLLMQWEVARRRAGVGASTMMTAQWSPWFTFHLGSRVPRSAFRPQPNVDGGILVIRRVGDPKIPIEQRKAFQAMVHTVFTARGRGIGEILRRAGLFSSRSETQSWLRSRGIDPATLPPRLHTSDWIDLFQVTGSSSPRHRPISQSGSSQRPPQRKNRGRRR,MSAYGQGRHEHGQNFLTNHKIINSIIDLVKQTSGPIIEIGPGSGALTHPMAHLGRAITAVEVDAKLAAKITQETSSAAVEVVHDDFLNFRLPATPCVIVGNIPFHLTTAILRKLLHAPAWTDAVLLMQWEVARRRAGVGATTMMTAQWSPWFTFHLGSRVPRSAFRPQPNVDGGILVIRRVGDPKIPIEQRKAFQAMVHTVFTARGRGIGEILRRQGCFHHVQKHNHGCAREESTPRPYLPDCYTNDWIDLFQVTGSSLPHHRPISPSGSSQRPPQRKNRSRRR,100,gnl|BL_ORD_ID|872|hsp_num:0,950,FALSE,None
LK1059,5_77 # 87318 # 88931 # -1 # ID=5_77;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.659,5_77,87318,88931,-,Strict,50,79.7221,vanW gene in vanI cluster,35.16,3003724,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanW; glycopeptide resistance gene cluster,GTGCTCGCGGTGCTGCTCGCGATCTACCTCGCCGACCTCGCAATGAACCGCGGGAACGTGCCGCGTGGCACCGCCGTCGGCGGTGTCGAGATCGGCGGCATGAGCCACGACGAGGCCACCGCGAAGCTCGAAGCAGAGCTCGGCGAGACGGCGAGTAACCCGGTGACGGTGAAGGCGGCGACGCAAAGCTCGCAGCTCGTGCCCGCCGAATCCGGCCTCGGCATCGACTGGGAGGCGACCGTAGCAAGCGCGGGCGAAGAGTCCGCGAACCCGTTCACTCGCCTCGCCGGGTTGTTTCGCACACGCGAAGTCGACATTGTGTCGACCGTGAACGAGGCCGCTCTCACCCCGCAGCTTGAGCGAGTGGCCGGCGAGTTGCACCTCGACCCCGCCGACGGCGCGATCGCCATCGACGGTGGCGAGGCGAAAGTGACCGAACCGGTGCCGGGCCAGGAGGTTGACAAAACCGAGCTGTTCGAACGTGTCACCACCGGCTGGCTCAACCCCGACGGTGTGGAGGTCGAGCCGCGCGAGATCGAACCCGCTATCGGCGACCAGGCGATCAAGGAAGCCTTAGACGGGCCGGTTAAGGCGGCGCTGTCCGGCGCCTTGACGCTGCACGGCCGCGACGGCGTCGACGGTGTCATTGCCCAAGAGCGCATCGGCGAGGTCGTCCAGTTCCCCAACGTCGACGGCAAAATCGCCCCCGAGGTGAACGTGGAAAGCGCCCAGGGCATCTTGGGCGAGCAGCTCGCTGCGACCGAGACGCAGATGAAAAACGCGCGCGTGCTGCCCGGCGGCGGGGTGGAACCGTCCGTCGACGGCTCCATTATCGACTGGGAGGCCGCGATGGACGGTTTCGACGAGCGGTTGATCGGTTCCGCCGAGCGCACCTGGGACGCGCAATACAAGGCCCGCCCGGCAGACTTCACTACAGAGGAAGCCCAACGTGCCACCTTCGACCAGGTGGTGGGAAGTTTCACCACCGGCGGGTACAGCGGCGCATCCGGCACGAACATCGCTACGGTGGCCCGCGTTGTCAACGGCGCAATTGTCAACCCCGGTGAAACCTTCTCGCTCAACGGCTACACCGGCGCGCGCGGTGCCGCGCAGGGTTACGTCGAGTCGGTCATCATCGAAAATGGACGCCCCGGCAAGGCAGTGGGTGGCGGAATCTCCCAATTTGCCACGACCTTGTACAACGCGGCTTACTTTGCCGGCATGACGGATGTCGCCTCCACCCCGCACTCCTACTACATCTCACGCTACCCGGCTGGCAGGGAGGCGACCGTGTATGAAGGGGCGATTGACCTGCAATTCCGCAACGATTCGCCCCACCCGGTCAAGATTTCCACGAGCGTCGGGGGCGGCGAGGTGACGGTGAGCCTGATGGGCACCAAGACCGTCGAGGTGGAGTCCATCAACGGAGGGCGCTGGGCCTACACCTCGCCGAAGCCCGTGACCGTCACCAGTGGTGACTGCATTCCCTCGGGCGGGGCGCAGGGCTTTACCACCTCCGATACCCGGATTGTGCGTGACCTCAGCGGCAATGAGATCAGTCGCAACACCTCCACCACGGTCTACGACCCGCAGCCGATAGTGCGCTGCGAGTAG,MLAVLLAIYLADLAMNRGNVPRGTAVGGVEIGGMSHDEATAKLEAELGETASNPVTVKAATQSSQLVPAESGLGIDWEATVASAGEESANPFTRLAGLFRTREVDIVSTVNEAALTPQLERVAGELHLDPADGAIAIDGGEAKVTEPVPGQEVDKTELFERVTTGWLNPDGVEVEPREIEPAIGDQAIKEALDGPVKAALSGALTLHGRDGVDGVIAQERIGEVVQFPNVDGKIAPEVNVESAQGILGEQLAATETQMKNARVLPGGGVEPSVDGSIIDWEAAMDGFDERLIGSAERTWDAQYKARPADFTTEEAQRATFDQVVGSFTTGGYSGASGTNIATVARVVNGAIVNPGETFSLNGYTGARGAAQGYVESVIIENGRPGKAVGGGISQFATTLYNAAYFAGMTDVASTPHSYYISRYPAGREATVYEGAIDLQFRNDSPHPVKISTSVGGGEVTVSLMGTKTVEVESINGGRWAYTSPKPVTVTSGDCIPSGGAQGFTTSDTRIVRDLSGNEISRNTSTTVYDPQPIVRCE,MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVLAEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPELLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGMETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGGEFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSHSLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDEPDGYPVKPREWSK,143.97,gnl|BL_ORD_ID|4748|hsp_num:0,2242,FALSE,None
LK1208,87_4 # 4103 # 4846 # 1 # ID=87_4;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.777,87_4,4103,4846,+,Strict,50,80.1073,vanY gene in vanF cluster,34.67,3002958,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGTCGCACCCTCCCTCTCGCCGCGCTGGCCGCGCTCGCGCTGCTCGTGGCCGGTTGCGGCACGCCCGCCGCGGGCCCGTCCTCGGCGACGCCGGCTTCCGGCTCCGCGAGCGCGGCCGCGTCGTCCCGCGCCGCCTCGAGCACGGCGCCGTCGTCGAGCACGCACGCCGACCCGGCCGCCCTCGACGTCGTCGTGAACAAGACCCGCCCCGTGGCTCCGCCCGACTGGGCGCCCTCGGATCTGGTGGCCGTGCCCGGCAGCGAGCTGTCCCTGCGGGCGGAGGCCGCGACGGCGGCCGGTGACCTGCTGGATGCCGCCGCGGCGGCGGGCCACCGCCTCACCACCCTGAGCGCCTACCGCTCGTACGACTACCAGGTCCGGACGTACGGCCACTGGGTCGACGAGCTGGGCCGCGCCGAGGCCGACCGCGTCTCGGCGCGTCCGGGGTACTCCGAGCACCAGACCGGCCTGGCCTGGGACGTGGGCGACGCCGCGACCCCCGCGTGTGACCTGGAAGCGTGCTTCGGCGACACCGCCGCGGGCCGCTGGGTGGCCGCGCACGCCGCCGAGCACGGGTTCGTCATCCGCTACCCCGGCGGGGCCGAGGACGTGACGGGCTTCGCCCACGAGCCCTGGCACCTGCGCTATGTCGGGTCCGCGGAGGCGGCCCGGGTCGAGGCGGTCGGCGGCGTCCTCGAGACCGCATGGGGCCTGCCTCCGGCGCCGGACTACGCGGACTGA,MRRTLPLAALAALALLVAGCGTPAAGPSSATPASGSASAAASSRAASSTAPSSSTHADPAALDVVVNKTRPVAPPDWAPSDLVAVPGSELSLRAEAATAAGDLLDAAAAAGHRLTTLSAYRSYDYQVRTYGHWVDELGRAEADRVSARPGYSEHQTGLAWDVGDAATPACDLEACFGDTAAGRWVAAHAAEHGFVIRYPGGAEDVTGFAHEPWHLRYVGSAEAARVEAVGGVLETAWGLPPAPDYAD,MKKWGLLLVFALFLVFIFNILPISQDKVEDRIYEQNDKDTSDDKMTAENMQKIELTEEQIYQGNLLLVNNEHPVHQKSIKSDIINLFTHKELTKGYGLLDNEIKLSEEIAGKFSEMIAAAEEDGVSNFLISSGYRDLDEQSRLYEEMGSDFALPAGHSEHNLGLSLDVGSTQMKMDKAPEGKWIEKNCWEYGFILRYPLDKTDVTGIQYEPWHIRYVGLPHSAIMQEMNLALEEYLDYLKEEKSISVRVDGKKYTISYDPISQNETIEVEVPADEQYEISGNNIDGVIVTTFS,84.3,gnl|BL_ORD_ID|1808|hsp_num:0,1899,FALSE,None
LK1306,84_5 # 3138 # 3887 # -1 # ID=84_5;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.779,84_5,3138,3887,-,Strict,50,83.5741,vanY gene in vanM cluster,34.46,3002961,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGTCGCACCCTCCCTCTCGCCGCGCTGGCCGCGCTCGCGCTGCTCGCGGCCGGTTGCGGCACGCCCGCCGCGGGCCCGTCCTCGACGCCGACGACGCCGACGTCCGGCTCCGCGAGCGCGGCCGCGTCGTCCCGCGCCGCCTCGAGCACGGCGCCGTCGTCGGGCACGCACGCCGACCCGGCCACCCTCGACGTCGTCGTGAACAAGACCCGCCCCGTGGCCCCGCCCGACTGGGCGCCCTCGGATCTGGTGGCCGTGCCCGGCAGCGAGCTGCCCCTGCGGGCGGAGGCCGCGACGGCGGCCGCTGACCTGCTGGATGCCGCCGCGGCGGCGGGCCACCGCCTCACCACCCTGAGCGCCTACCGCTCGTACGACTACCAGGTCCGGACGTACGGCCACTGGGTCGACGAGCTGGGCCGCGCCGAGGCCGACCGCGTCTCCGCGCGTCCGGGGTACTCCGAGCACCAGACCGGCCTGGCCTGGGACGTGGGCGACGCCGCGACCCCCGCGTGTGACCTGGAAGCGTGCTTCGGCGACACCGCCGCGGGCCGTTGGGTGGCCGCGCACGCCGCCGAGTACGGGTTCGTCATCCGCTATCCCGCCGGGGCCGAGGACGTGACGGGCTTCGATCACGAGCCGTGGCACCTGCGCTACGTCGGGTCCGCGGAGGCGGCCCGGGTCGAGGCGGCCGGCGGCGTCCTCGAGACCGCGTGGGGTCTGCCGCCGGCGCCGGACTACGCGGACTGA,MRRTLPLAALAALALLAAGCGTPAAGPSSTPTTPTSGSASAAASSRAASSTAPSSGTHADPATLDVVVNKTRPVAPPDWAPSDLVAVPGSELPLRAEAATAAADLLDAAAAAGHRLTTLSAYRSYDYQVRTYGHWVDELGRAEADRVSARPGYSEHQTGLAWDVGDAATPACDLEACFGDTAAGRWVAAHAAEYGFVIRYPAGAEDVTGFDHEPWHLRYVGSAEAARVEAAGGVLETAWGLPPAPDYAD,MVFQGNLLLVNNEYPVLEESIKTDVVNLFKHDELTKGYELLNREIYLSEKVAREFSEMVDAAEKEGVRHFSINSGFRNFDEQNALYQEMGSDYALPAGYSEHNLGLALDIGSTQMEMSEAPEGKWLEDNAWEYGFILRYPMDKTAITGIQYEPWHFRYVGLPHSAIIEEKNFALEEYLDFLKEQKSISGTIHGENYEISYYPITEKTDIEMPANLHYEISGNNMDGVIVTVYR,106.87,gnl|BL_ORD_ID|1673|hsp_num:0,1713,FALSE,None
LK934,19_32 # 38247 # 38501 # -1 # ID=19_32;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.682,19_32,38247,38501,-,Strict,1900,22.3274,MuxC,100,3004075,protein homolog model,n/a,n/a,macrolide antibiotic; monobactam; tetracycline antibiotic; aminocoumarin antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGGCACACAAGAAGGGTGCGAGCTCCACTCGCAACGGCCGTGACTCCAACGCCCAGTACCTGGGTGTCAAGCGCTTCGGCGGCCAGTCCGTCAACGCCGGCGAGATCATCGTCCGCCAGCGCGGAACCCACTTCCACCCGGGCCTGAACATGGGCCGCGGCAAGGACGACACCCTGTTCGCCCTGGCCGCCGGTGTCGTCGAGTTCGGCACCCGTCGTGGCCGCCGCGTGGTCAACATCCAGACCGCCGAGTAG,MAHKKGASSTRNGRDSNAQYLGVKRFGGQSVNAGEIIVRQRGTHFHPGLNMGRGKDDTLFALAAGVVEFGTRRGRRVVNIQTAE,MSLSTPFIRRPVATTLLTLALLLAGTLSFGLLPVAPLPNVDFPAIVVSASLPGASPETMASSVATPLERSLGRIAGISEMTSSSSLGSTTVVLVFDLEKDIDGAAREVQAAINGAMSLLPSGMPNNPSYRKANPSDMPIMVLTLTSETQSRGEMYDLASTVLAPKLSQVQGVGQVSIGGSSLPAVRVDLNPDAMSQYGLSLDSVRTAIAAANSNGPKGAVEKDDKHWQVDANDQLRKAREYEPLVIHYNADNGAAVRLGDVAKVSDSVEDVRNAGFSDDLPAVLLIVTRQPGANIIEATDAIHAQLPVLQELLGPQVKLNVMDDRSPSIRASLEEAELTLLISVALVILVVFLFLRNGRATLIPSLAVPVSLIGTFAVMYLCDFSLNNLSLMALIIATGFVVDDAIVVVENIARRIEEGDPPIQAAITGARQVGFTVLSMTLSLVAVFIPLLLMGGLTGRLFREFAVTLSAAILVSLVVSLTLTPMLCARLLRPLKRPEGASLARRSDRFFAAFMLRYRASLGWALEHSRLMVVIMLACIAMNLWLFVVVPKGFLPQQDSGRLRGYAVADQSISFQSLSAKMGEYRKILSSDPAVENVVGFIGGGRWQSSNTGSFFVTLKPIGERDPVEKVLTRLRERIAKVPGAALYLNAGQDVRLGGRDSNAQYEFTLRSDDLTLLREWAPKVEAAMRKLPQLVDVNSDSQDKGVQTRLVIDRDRAATLGINVEMVDAVLNDSFGQRQVSTIFNPLNQYRVVMEVDQQYQQSPEILRQVQVIGNDGQRVPLSAFSHYEPSRAPLEVNHQGQFAATTLSFNLAPGAQIGPTREAIMQALEPLHIPVDVQTSFEGNAGAVQDTQNQMPWLILLALLAVYIVLGILYESYVHPLTILSTLPSAGVGALLALILCRSELSLIALIGIILLIGIVKKNAIMMIDFALEAERNHGLSPREAILEACMMRFRPIMMTTLAALLGALPLIFGIGGDAALRRPLGITIVGGLIGSQLLTLYTTPVVYLYLDRLRHWVNQKRGVRTDGALETPL,8.11,gnl|BL_ORD_ID|2369|hsp_num:0,2720,TRUE,loose hit with at least 95 percent identity pushed strict
LK934,58_1 # 167 # 1150 # -1 # ID=58_1;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.726,58_1,167,1150,-,Strict,50,98.5969,vanY gene in vanF cluster,38.93,3002958,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGAAACCGTTCACGCGCCTGCCCTCCGCCCTTCTTGCCGTTCCGCTCGCCGCGACCCTGCTCTCGGCCGGAACGACTCCCGCGTCCGCCATGACGGGCATCGAGGCCGAGTACGACGCTCTGCCGCAGGCCCAGGACTGGCTCGGCGAGCCCACGTCCGAGGAGTCGTGCGAGCTCCGGGACGAGGGGTGCTACCGCGAGTACGACAAGGGCGCCATCTACTGGTCGCCCGACACGGGCGCGCGGGCGCAGCGCGGAGCGATCTACGCCCGGTGGCGAGCCGAGGGATCCGAGCACGGGCCGCTCGGCTACCCGGTGAGCCGGGAAACCTGTTCCGACGGGACGTGCGAGGTGCGCTACCAGCGCGGGAGCATCACGTGGACCGAGGCGGACGGCACCACCGTGCACCGGGACGTGGACGAGGCAGCCAGCGCGGGCGTCGTCGTCAACAAGCAGCGGGCGCTGTCCCCGCAGGACTACGCGCCCGCGCCGCTGCGGGACGTGGGCGGGGGCGTGCAGCTGCGCGACGACGCCGCGGCCGCGTACGAGCGGATGTCACGCGCCGCGGCGGAGCAGGGGGTGGAGCTCACGGCCGTGAGCGGGTACCGGGACTACGCCACGCAGGCGGGACTGTACGAGCAGTACACCGCGACGTATGGACGGGAGACCGCCGACTCGATCTCCGCGCGCCCCGGGCACTCGGAGCACCAGACCGGTCTGGCCATCGACGTGGGCGCGCCGGACGGTTCGTGCGCCCTGCTCGCGTGCTTCGAGGACACCCCTCAGGGCCGCTGGGTGGCCGATCACGCGCACGAGTACGGGTTCGTGGTGCGGTACCCGGACGGGCGCACGGGCACCACCGGCTACGCCTACGAGCCGTGGCACCTGCGCTACGTGGGCGAGGACACCGCCACGAGCGTGAAGGACAGTGGGGAACCCGATCTGGAGTCCTACCTGGGCCTGCCCGACGCTCCCAGCTACTGA,MKPFTRLPSALLAVPLAATLLSAGTTPASAMTGIEAEYDALPQAQDWLGEPTSEESCELRDEGCYREYDKGAIYWSPDTGARAQRGAIYARWRAEGSEHGPLGYPVSRETCSDGTCEVRYQRGSITWTEADGTTVHRDVDEAASAGVVVNKQRALSPQDYAPAPLRDVGGGVQLRDDAAAAYERMSRAAAEQGVELTAVSGYRDYATQAGLYEQYTATYGRETADSISARPGHSEHQTGLAIDVGAPDGSCALLACFEDTPQGRWVADHAHEYGFVVRYPDGRTGTTGYAYEPWHLRYVGEDTATSVKDSGEPDLESYLGLPDAPSY,MKKWGLLLVFALFLVFIFNILPISQDKVEDRIYEQNDKDTSDDKMTAENMQKIELTEEQIYQGNLLLVNNEHPVHQKSIKSDIINLFTHKELTKGYGLLDNEIKLSEEIAGKFSEMIAAAEEDGVSNFLISSGYRDLDEQSRLYEEMGSDFALPAGHSEHNLGLSLDVGSTQMKMDKAPEGKWIEKNCWEYGFILRYPLDKTDVTGIQYEPWHIRYVGLPHSAIMQEMNLALEEYLDYLKEEKSISVRVDGKKYTISYDPISQNETIEVEVPADEQYEISGNNIDGVIVTTFS,111.6,gnl|BL_ORD_ID|1808|hsp_num:0,1899,FALSE,None
LK1090,42_5 # 3116 # 3859 # -1 # ID=42_5;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.782,42_5,3116,3859,-,Strict,50,83.1889,vanY gene in vanM cluster,34.46,3002961,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGTCGCACCCTCCCCTTCGCCGCGCTGGCCGCGCTCGCGCTGCTCGCGGCCGGCTGCGGCACGCCCGCCGCGGGCCCGTCCTCGGCGACGCCGGCTTCCGGCTCCTCGAGCGCGGCCGCGTCGTCCCGCGCCGCCTCGAGCACGACGCCGTCGTCGGGCACGCACGCCGACCCGGCCGCCCTCGACGTCGTCGTGAACAAGACCCGCCCCGTGGCCCCGCCCGACTGGGCGCCCTCGGATCTGGTGGCCGTGCCCGGCAGCGAGCTGTCCCTGCGCGCGGAGGCCGCGACGGCGGCCGGTGACCTGCTGGATGCCGCCGCGGCGGCGGGCCACCGCCTCACCACCCTGAGCGCCTACCGCTCGTACGACTACCAGGTCCGGACGTACGGCCACTGGGTCGACGAGCTGGGCCGCGCCGAGGCCGACCGCGTCTCGGCGCGTCCGGGGTACTCCGAGCACCAGACCGGCCTGGCCTGGGACGTGGGCGACGCCGCGACCCCCGCGTGTGACCTGGAAGCGTGCTTCGGCGACACCGCCGCGGGCCGCTGGGTGGCCGCGCACGCCGCCGAGTACGGGTTCGTCATCCGCTATCCCGCCGGGGCCGAGGACGTGACGGGCTTCGCCCACGAGCCGTGGCACCTGCGCTACGTCGGGTCCGCGGAGGCGGCCCGGGTCGAGGCGGCCGGCGGCGTCCTCGAGACCGCGTGGGGCCTGCCTCCGGCGCCGGACTACGCGGACTGA,MRRTLPFAALAALALLAAGCGTPAAGPSSATPASGSSSAAASSRAASSTTPSSGTHADPAALDVVVNKTRPVAPPDWAPSDLVAVPGSELSLRAEAATAAGDLLDAAAAAGHRLTTLSAYRSYDYQVRTYGHWVDELGRAEADRVSARPGYSEHQTGLAWDVGDAATPACDLEACFGDTAAGRWVAAHAAEYGFVIRYPAGAEDVTGFAHEPWHLRYVGSAEAARVEAAGGVLETAWGLPPAPDYAD,MVFQGNLLLVNNEYPVLEESIKTDVVNLFKHDELTKGYELLNREIYLSEKVAREFSEMVDAAEKEGVRHFSINSGFRNFDEQNALYQEMGSDYALPAGYSEHNLGLALDIGSTQMEMSEAPEGKWLEDNAWEYGFILRYPMDKTAITGIQYEPWHFRYVGLPHSAIIEEKNFALEEYLDFLKEQKSISGTIHGENYEISYYPITEKTDIEMPANLHYEISGNNMDGVIVTVYR,106.01,gnl|BL_ORD_ID|1673|hsp_num:0,1713,FALSE,None
LK930,4_81 # 89282 # 90937 # 1 # ID=4_81;partial=00;start_type=ATG;rbs_motif=GGxGG;rbs_spacer=5-10bp;gc_cont=0.699,4_81,89282,90937,+,Strict,50,84.3445,vanW gene in vanI cluster,35.62,3003724,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanW; glycopeptide resistance gene cluster,ATGGGGCGCGGCAGCAAGATCGCGCTCGGCACCTTTTTGGGCATCCTCACTGTTGTGCTGGCGCTGTACCTGGCTGATTTGGCTATGCACCGCGGCAACGTGCCCCGCGGCACGCACGTCGGCGGCGTCAACATCGGCGCGATGGCACCGGCGGACGCGAAGGAGAAGCTGAAGGCGGAGCTTGGCGGCACCGCCGACGAGGCCGTCATGGTGCGAGCGGGGGAGCAGCGCGCCGAGTTCGTTCCCGCGCAATCCGGCCTAGGCATCGATTTCGACGCGACCGTGGACGCCGCCGGCATCGCGTCCGCCAACCCGGTCGAGCGACTGCGCAGGCTGTTTACCACCCGTGAGGTGGACGTCGTGCCCACCGTGGACGATGTCGCGCTGAACCGCCAGCTGGACCGGCTGGTCGGCGAGCTGCACGTGGACCCCGCCGACGGCGTCATCCGCGTCGAAGGCGGCCAGGCCGAAACGCAAGACCCGAAGCCTGGCCAGGACGTGGAGCGCGCCGCACTGCGCGACGAGGTCACCACCGGCTGGCTCAACCCGGACGGCGTGGAGGTCGAGCCGACGCAGGTGCAGCCCGCCGTCGACGAGGCCGCGATGCAGGCCGCGCTCGACGGTCCCGTCCGGGCGGCCCTGGACGGCCCGGTCACCGTCACCGGCAAGGATGAGTTCGCGGCCGCGGTGCCGCAGGACCGCCTCGGGGAGATCGTGCAGTTCCCCGTGGTGGACGGCCGTATCACGCCGAGCGTGAACCAGGACGCCGCCCGCGCCATCCTCGGCGAGCAGCTCGCGCAGACTGAGGTGGAGGGCCAGAACGCCCGGGTGCTCGAAGGCGGCGGGGTTGAGCCGTCTGTGGACGGCTCCGTGGTGGACTGGGACGCGACCATGGACGGCTTCAACGAACGCGTGCTGGGCGCTAAGCCCCGCGAGTGGGATGCGGTGTACAAGGACGTGCCGGCGCAGTTCACCACCGCGCAGGCGGAAAACGCCACGTTCAACGACGTGGTGGGGTCGTTCACCACAGGTGGCTACTCAGGCGCGTCCGGCACCAACATTGCGCTGGTGGCCAGCACCGTCAACGGGGCCATTGTGAACCCGGGCGAGACGTTCTCCCTCAACGGCTACACCGGCCCGCGCGGCACCGCGCAGGGCTACGTGGAGTCCGGCATCATCCTGGACGGGCACGCGGACACCGCGGTCGGCGGCGGCATCTCGCAGTTCGCCACCACCTTGTACAACGCCTCGTACTTCGCCGGCATGACGGATGTCGCGCACACCCCGCACTCCTACTACATCTCCCGCTACCCGGCCGGGCGCGAGGCCACCGTATACGAGGGCGCGATCGATCTGCAGTTCAGGAACGACAGCCCCTACCCGGTGCGCATCGCCACCAGCGTCGGGGGCGGCGAGGTGACCGTCAGCCTGATGGGTGTCAAGACCGTCACCGTCGATTCCATCAACGGCGGCCGCTGGGCGGAGACGGCGCCGGAGCCGATGAGCGTGCCGGGCTCCAGCTGCGTGCCGTCGTCAGGCACACCGGGCTTCACCACCTCGGACACCCGCGTCATCTACGACCTGGCGGGCAACGAGCTCAGCCGCGAGACGCAGACCACGGTCTACGACCCGCAGCCAATCGTGCGCTGCAGCTAG,MGRGSKIALGTFLGILTVVLALYLADLAMHRGNVPRGTHVGGVNIGAMAPADAKEKLKAELGGTADEAVMVRAGEQRAEFVPAQSGLGIDFDATVDAAGIASANPVERLRRLFTTREVDVVPTVDDVALNRQLDRLVGELHVDPADGVIRVEGGQAETQDPKPGQDVERAALRDEVTTGWLNPDGVEVEPTQVQPAVDEAAMQAALDGPVRAALDGPVTVTGKDEFAAAVPQDRLGEIVQFPVVDGRITPSVNQDAARAILGEQLAQTEVEGQNARVLEGGGVEPSVDGSVVDWDATMDGFNERVLGAKPREWDAVYKDVPAQFTTAQAENATFNDVVGSFTTGGYSGASGTNIALVASTVNGAIVNPGETFSLNGYTGPRGTAQGYVESGIILDGHADTAVGGGISQFATTLYNASYFAGMTDVAHTPHSYYISRYPAGREATVYEGAIDLQFRNDSPYPVRIATSVGGGEVTVSLMGVKTVTVDSINGGRWAETAPEPMSVPGSSCVPSSGTPGFTTSDTRVIYDLAGNELSRETQTTVYDPQPIVRCS,MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVLAEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPELLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGMETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGGEFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSHSLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDEPDGYPVKPREWSK,147.72,gnl|BL_ORD_ID|4748|hsp_num:0,2242,FALSE,None
LK930,15_18 # 16270 # 17382 # 1 # ID=15_18;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.677,15_18,16270,17382,+,Strict,900,670.618,Corynebacterium striatum tetA,95.07,3004639,protein homolog model,n/a,n/a,penam; tetracycline antibiotic,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGAAGACGTACAGCTGGTTCGTCCCGCCCGCGCCGCCAGCGGACGATCCGGCACGGCTTCATCCGGCACGCTGGAGTAGCGGGAACCGGGTGGTCAGGGACATGGTTGGTGCATATCCGGGCGCGTCGGTGCTGCACATTCTGAGCTACCTCATCGGCTCCGGCATCGCCGCCTTTGTGCCGGTAGTGGTGGGCATGATCGTGGACGGCCTGGTGGGGGAAGAAAAGTTCAACACGTGGTGGCTCTTCGCTGTGCTGGTCGGCATCTTCATCATCCAGTTCGTCGGTGAGGCCTCCGGAGATGGCCTGGCCACAGCCTCGGTGCGCCGCGTGACCCACAACGCGCGGCAGCACCTGTCCTCGGGCGTGCTGCGCCGCGGAGCGGGAGCGATGAGCCCCGGCACGGTGCTCAACACCATCGACGCGGACGCGAACACCGTCGGTCGCTACCGTGAGCTGCTGTCGTTTCCGCTGATGGCCATCGGCTACGCGGCCGGCGCGATGGTGGCGATGTGGTCGGTCTCCCCGTGGATCTCGCTGGCCATCCCGGCGAGCGCGTTAATCATCGCTCTATTCGCCGCGTGGACCGCGGGGCCGGTGACGCGGGTGTCGCTGAAGCGCCGCGCCGCAGAGGCTGATGTTGCTGGCTTGGCCACGGATGCGTCGCAAGGCATCCGCACCGTCAAAGGCCTCGGCGCGGGCGCAACCGTGGCAACACGTTTTCACTCGGAAACGGCGAAGGCGAAGCAGTTGATGCTCACTCACCTACGTGTGGAGGTGTGGCTGGGTTTTGCCAGGTTCTGCGTGGCGTGGCTGTGCAACCTTGCCATCGTGGGCTTCAGCGCGTGGATGACGCTGCGCGGGGAGATCACCCCGGGGCAGCTGACGTCCGTGGCACTGTTGGTGCCGCCGGCGTTGAACATGGCGGGCTTCGCGTTCGGCGATTTAGCCAGCGGGTGGGGCAGGGCCGTCGCGAGCGGTCAGCGAATCGAGCAGCTGCACCACGCGGGCGACGACACCGCCGGGCCTGAGCCGACAGACACCCCGGTCCCAGGCGCGGGGCTGTGGATCCTCGAGCCGGCGGAGCGCTCCTACGCCACAGCCGCCGCGTGA,MKTYSWFVPPAPPADDPARLHPARWSSGNRVVRDMVGAYPGASVLHILSYLIGSGIAAFVPVVVGMIVDGLVGEEKFNTWWLFAVLVGIFIIQFVGEASGDGLATASVRRVTHNARQHLSSGVLRRGAGAMSPGTVLNTIDADANTVGRYRELLSFPLMAIGYAAGAMVAMWSVSPWISLAIPASALIIALFAAWTAGPVTRVSLKRRAAEADVAGLATDASQGIRTVKGLGAGATVATRFHSETAKAKQLMLTHLRVEVWLGFARFCVAWLCNLAIVGFSAWMTLRGEITPGQLTSVALLVPPALNMAGFAFGDLASGWGRAVASGQRIEQLHHAGDDTAGPEPTDTPVPGAGLWILEPAERSYATAAA,MKTYSWFVPPAPPADDPARLHPARWSSGNRVVRDMVGAYPGVLVLHILSYLIGSGISAFVPVVVGMIVDGLVGEEKFNAWWLFAVLVGIFIIQFIGEATGDGLATASVRRVTHNAQQHLSSGVLRRGAGAMSPGTVLNTIDADANTVGRYRELLSFPLMAIGYAVCAMVAMWSVSPWISLAIPASALIIALFAAWTAGPVTRVSLKRRAAEADVAGLATDASQGIRTVKGLGAGATVATRFHAETAKANGLMLTHLRVEVWLGFARFCVAWLCNLGIVGLSAWMTLRGEITPGQLTSVALLVQPALTMAGLAFGDLASGWGRAVASGQRIEQLHHAGDDAAGPEPTDTPVPGAGLWILEPAERSYATAAAWAQRADVLFPPHTVNVFEGTIADNVNPRGDVPEDVVKQALAAAHCQDILRRLGGINEAGELPDAPLGEAGLNLSGGQRQRVALARALAADPEVLILDDPTTGLDSVTQADVVAAVAALRADKTTVVITGNAAWQHAGTELEVA,72.12,gnl|BL_ORD_ID|2120|hsp_num:0,3337,TRUE,loose hit with at least 95 percent identity pushed strict
LK930,20_2 # 598 # 1452 # -1 # ID=20_2;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.561,20_2,598,1452,-,Strict,400,486.878,ErmX,84.51,3000596,protein homolog model,n/a,n/a,macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic,antibiotic target alteration,Erm 23S ribosomal RNA methyltransferase,ATGTCTACATACGGATACGGCCGTCACGAACATGGCCAAAATTTTCTCACAGACCACAAGATCATCAACTCCATCGTCGATCTTGTAAAACAAACCTCCGGCCCCATCATTGAGATCGGGCCAGGAAGCGGTGCCCTCACTCACCCGATATCCCACTTGGGGAGGGCAATAACGGCAGTTGAGGTAGACGCAAAACTAGCTGCCAAACTCACAAAAAAGACCGCCTCGGCGTCGGTCGAAGTGGTCCATGATGATTTCCTCAACTTCCCGTTACCCGCCACTCCCTGCGTCATTGTGGGAAACATTCCCTTTCACCTCACCACTGCCATTCTTCGAAAGTTGTTGCATGCGCCGGCATGGACTGCCGCTGTACTCCTCATGCAGTGGGAAGTCGCTCGCCGCCGGGCCGGGGTAGGTGCAAGCACGATGATGACAGCTCAGTGGTCCCCATGGTTCACGTTTCACCTTGGTTCCCGAGTACCAAGGTCTGCTTTCCGGCCACAGCCAAACGTTGACGGGGGGATCTTAGTGATCCGCCGGGTGGGTGACCCGAAGATCCCGATAGAGCAACGCAAAGCCTTTCAGGCGATGGTGCACACCGTTTTCACCGCCCGGGGACGCGGGATAGGGGAAATTCTCCGAAGGGCAGGGTTGTTTTCATCACGTTCAGAGACACAATCATGGTTGCGCTCGCGAGGAATCGACCCCGCAACCCTACCTCCCAGATTGCACACCAGCGACTGGATCGATCTCTTCCAGGTGACTGGTTCCTCTTCACCGCGCCATCGGCCCATTTCACAATCGGGAAGTAGTCAACGCCCTCCTCAACGGAAAAATCGAGGCCGGCGGCGGTAA,MSTYGYGRHEHGQNFLTDHKIINSIVDLVKQTSGPIIEIGPGSGALTHPISHLGRAITAVEVDAKLAAKLTKKTASASVEVVHDDFLNFPLPATPCVIVGNIPFHLTTAILRKLLHAPAWTAAVLLMQWEVARRRAGVGASTMMTAQWSPWFTFHLGSRVPRSAFRPQPNVDGGILVIRRVGDPKIPIEQRKAFQAMVHTVFTARGRGIGEILRRAGLFSSRSETQSWLRSRGIDPATLPPRLHTSDWIDLFQVTGSSSPRHRPISQSGSSQRPPQRKNRGRRR,MSAYGQGRHEHGQNFLTNHKIINSIIDLVKQTSGPIIEIGPGSGALTHPMAHLGRAITAVEVDAKLAAKITQETSSAAVEVVHDDFLNFRLPATPCVIVGNIPFHLTTAILRKLLHAPAWTDAVLLMQWEVARRRAGVGATTMMTAQWSPWFTFHLGSRVPRSAFRPQPNVDGGILVIRRVGDPKIPIEQRKAFQAMVHTVFTARGRGIGEILRRQGCFHHVQKHNHGCAREESTPRPYLPDCYTNDWIDLFQVTGSSLPHHRPISPSGSSQRPPQRKNRSRRR,100,gnl|BL_ORD_ID|872|hsp_num:0,950,FALSE,None
LK1036,74_4 # 978 # 1721 # -1 # ID=74_4;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.778,74_4,978,1721,-,Strict,50,80.1073,vanY gene in vanF cluster,34.67,3002958,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGTCGCACCCTCCCTCTCGCCGCGCTGGCCGCGCTCGCGCTGCTCGTGGCCGGTTGCGGCACGCCCGCCGCGGGCCCGTCCTCGGCGACGCCGGCTTCCGGCTCCGCGAGCGCGGCCGCGTCGTCCCGCGCCGCCTCGAGCACGGCGCCGTCGTCGAGCACGCACGCCGACCCGGCCGCCCTCGACGTCGTCGTGAACAAGACCCGCCCCGTGGCTCCGCCCGACTGGGCGCCCTCGGATCTGGTGGCCGTGCCCGGCAGCGAGCTGTCCCTGCGGGCGGAGGCCGCGACGGCGGCCGGTGACCTGCTGGATGCCGCCGCGGCGGCGGGCCACCGCCTCACCACCCTGAGCGCCTACCGCTCGTACGACTACCAGGTCCGGACGTACGGCCACTGGGTCGACGAGCTGGGCCGCGCCGAGGCCGACCGCGTCTCGGCGCGTCCGGGGTACTCCGAGCACCAGACCGGCCTGGCCTGGGACGTGGGCGACGCCGCGACCCCCGCGTGTGACCTGGAAGCGTGCTTCGGCGACACCGCCGCGGGCCGCTGGGTGGCCGCGCACGCCGCCGAGCACGGGTTCGTCATCCGCTACCCCGGCGGGGCCGAGGACGTGACGGGCTTCGCCCACGAGCCCTGGCACCTGCGCTATGTCGGGTCCGCGGAGGCGGCCCGGGTCGAGGCGGTCGGCGGCGTCCTCGAGACCGCATGGGGCCTGCCTCCGGCGCCGGACTACGCGGACTGA,MRRTLPLAALAALALLVAGCGTPAAGPSSATPASGSASAAASSRAASSTAPSSSTHADPAALDVVVNKTRPVAPPDWAPSDLVAVPGSELSLRAEAATAAGDLLDAAAAAGHRLTTLSAYRSYDYQVRTYGHWVDELGRAEADRVSARPGYSEHQTGLAWDVGDAATPACDLEACFGDTAAGRWVAAHAAEHGFVIRYPGGAEDVTGFAHEPWHLRYVGSAEAARVEAVGGVLETAWGLPPAPDYAD,MKKWGLLLVFALFLVFIFNILPISQDKVEDRIYEQNDKDTSDDKMTAENMQKIELTEEQIYQGNLLLVNNEHPVHQKSIKSDIINLFTHKELTKGYGLLDNEIKLSEEIAGKFSEMIAAAEEDGVSNFLISSGYRDLDEQSRLYEEMGSDFALPAGHSEHNLGLSLDVGSTQMKMDKAPEGKWIEKNCWEYGFILRYPLDKTDVTGIQYEPWHIRYVGLPHSAIMQEMNLALEEYLDYLKEEKSISVRVDGKKYTISYDPISQNETIEVEVPADEQYEISGNNIDGVIVTTFS,84.3,gnl|BL_ORD_ID|1808|hsp_num:0,1899,FALSE,None
LK935,2_130 # 130875 # 131981 # 1 # ID=2_130;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.646,2_130,130875,131981,+,Strict,175,176.407,vanT gene in vanG cluster,32.87,3002972,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,glycopeptide resistance gene cluster; vanT,ATGGAACTTACTACGCTCACCATTGATCTGGATGCTATCGCCTCCAACGCCCGCGAGGTGCGAAAAGCTGCAGGTAACGCCGACGTGATGGCCGTGGTGAAAGCGAACGCCTACAACCACGGAGTCGATCTCGTCGTTCCCGTCTTGGAGAAGGCGGGTATCGCGGGTTTCGGCGTGGCGACGATCCCCGAGGCGCGCCAGGTGCGCGAGGTGACTGAGCTTCCCGTCCTCGCCTGGATTTGGCACCCTGAGCAGGATTTGCCTAGGCAGGAGGAGCACATTGACCTGGGGCTTGCGTCGATGGCACAGGCGCGGGCGCTCGCGGCGGATCCCACTCCACGCACCGTCACCCTCGTCATTGATACGGGGCTGAACCGCTCCGGGGTGGATGAGGAGAACTGGGAGGAGCTCTGCCGGTTCGTCGCCGGTGTTCCGCACCTTACGGTCACGGGTCTGTTCACCCACCTGGCCTGCGCCGACGAGGAGGACAATCCGCTGACGGGTGAGCAGGTGGACACCCTCACCCGCGCCCTCGCCGTCGCCCGTGCCTGCGGTCTCAACCCCACGCGCAACCACGTTGCGAACTCTCCGGGGGTTCTCACCAAGGGTGATCTTGGCTTTTCGACGGTTCGTCCCGGCCTTATTCTCTACGGCTACAGCCCCCTTCCCGAGGGCGATACCGCCGGGTACACCCTCCGCCCCGCGATGACGTGGAGCGCCCACGTGACCATCGTGAAGAAGATCCACGCCGGCGAGGGGGCGTCCTACGGCATGACGTGGCACGCTCCGACGGATCGTTACACCGCCATCGTCCCCGTGGGCTACGCCGACGGCCTACCCCGCCGGATGCAGGGCAAACTGGAGGTCGCTATCGGTGGCAAGCGATACCCGCAGGTGGGGCGCGTGTGCATGGATCAGATTGTCGTTGATCTCGGCCCCGAAGAGCCACAGGTTCACCCCGGTGACGAGGCCTTCCTGTTTGGGCCCGGTGACCACGGTGAGATGACGGTGGATGAGTGGGCCGAGCACCTGGAGACCATCAACTATGAGGTGTTGTGCAGCCCGCGTGGGCGCGTGCAGCGTACGTATAGTGGGCGTGGAGAATAA,MELTTLTIDLDAIASNAREVRKAAGNADVMAVVKANAYNHGVDLVVPVLEKAGIAGFGVATIPEARQVREVTELPVLAWIWHPEQDLPRQEEHIDLGLASMAQARALAADPTPRTVTLVIDTGLNRSGVDEENWEELCRFVAGVPHLTVTGLFTHLACADEEDNPLTGEQVDTLTRALAVARACGLNPTRNHVANSPGVLTKGDLGFSTVRPGLILYGYSPLPEGDTAGYTLRPAMTWSAHVTIVKKIHAGEGASYGMTWHAPTDRYTAIVPVGYADGLPRRMQGKLEVAIGGKRYPQVGRVCMDQIVVDLGPEEPQVHPGDEAFLFGPGDHGEMTVDEWAEHLETINYEVLCSPRGRVQRTYSGRGE,MTKNESYSGIDYFRFIAALLIVAIHTSPLSSFSETGNFIFTRIVARVAVPFFFMTSGFFLISRYTCNAEKLGAFIKKTTLIYGVAILLYIPINVYNGYFKMDNLLPNIIKDIVFDGTLYHLWYLPASIIGAAIAWYLVKKVHYRKAFLIASILYIIGLFGDSYYGIVKSVSCLNVFYNLIFQLTDYTRNGIFFAPIFFVLGGYISDSQNRLSLKRSIVGFIVCFALMFGEALTLHHFDIQKHDSMYVLLLPSVYCLFNLLLHFRGKRRTGLRTISLIIYIIHPFMIVVIRLFAKLLHLQSLLVENSLVHYIAVCFASVVLAVVITALLSSLKPKKAKHTADTDRAYLEINLNNLEHNVNTLQKAMSPKCELMAVVKAEAYGHGMYEVTTYLEQIGVSSFAVATIDEGIRLRKYGISSEILILGYTSPSRAKELCKYELTQTLIDYRYSLLLNKQGYDIKAHIKIDTGMHRLGFSTEDKDKILAAFSLKHIKVAGIFTHLCAADSLEENDVAFTNKQIGSFYKVLDWLKSSGLNIPKVHIQSSYGLLNYPELECDYIRVGVALYGVLSSTNDKTKLELDLRPVLSLKAKVVLIRKIKQGESVGYSRAFTATRDSLIAILPIGYADGFPRNLSCGNSYVLIGGRQAPIVGKICMDQLAVDVTDIPNVKTGSIATLIGKDGKEEITAPMVAESAESITNELLSRMGHRLNIIRRA,51.69,gnl|BL_ORD_ID|1522|hsp_num:0,1561,FALSE,None
LK935,15_8 # 9711 # 11630 # -1 # ID=15_8;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.531,15_8,9711,11630,-,Strict,300,1279.23,tet(W),97.18,3000194,protein homolog model,n/a,n/a,tetracycline antibiotic,antibiotic target protection,tetracycline-resistant ribosomal protection protein,ATGAAAATAATCAATATTGGAATTCTTGCCCATGTAGACGCTGGAAAGACGACCTTGACGGAGAGCCTGCTATATGCCAGCGGAGCCATTTCAGAACCGGGGAGCGTCGAAAAAGGGACAACGAGGACGGACACCATGTTTTTGGAGCGGCAGCGTGGGATTACCATTCAAGCGGCAGTCACTTCCTTCCAGTGGCACAGATGTAAAGTCAACATTGTGGATACGCCCGGCCACATGGATTTTTTGGCGGAGGTGTACCGCTCTTTGGCTGTTTTAGATGGGGCCATCTTGGTGATCTCCGCTAAAGATGGCGTGCAGGCCCAGACCCGTATTCTGTTCCATGCCCTGCGGAAAATGAACATTCCCACCGTTATCTTTATCAACAAGATCGACCAGGCTGGCGTTGATTTGCAGAGCGTGGTTCAGTCTGTTCGGGATAAGCTCTCCGCCGATATTATCATCAAGCAGACGGTGTCGCTGTCCCCGGAAATAGTCCTGGAGGAAAATACCGACATAGAAGCATGGGATGCGGTCATCGAAAATAACGATAAATTATTGGAAAAGTATATCGCAGGAGAACCAATCAGCCGGGAAAAACTTGTGCGGGAGGAACAGCGGCGGGTTCAAGACGCCTCCCTGTTCCCGGTCTATTATGGCAGCGCCAAAAAGGGCCTTGGCATTCAACCGTTGATGGATGCGGTGACAGGGCTGTTCCAACCGATTGGGGAACAGGGGAGCGCCGCCCTATGCGGCAGCGTTTTCAAGGTGGAGTATACAGATTGCGGCCAGCGGCGTGTCTATCTACGGCTATACAGCGGAACGCTGCGCCTGCGGGATACGGTGGCCCTGGCCGGGAGAGAAAAGCTGAAAATCACAGAGATGCGTATTCCATCCAAAGGGGAAATTGTTCGGACAGACACCGCTTATCCGGGTGAAATTGTTATCCTTCCCAGCGACAGCGTGAGGTTAAACGATGTATTAGGGGACCCAACCCGGCTCCCTCGTAAAAGGTGGCGTGAGGACCCCCTCCCCATGCTGCGGACGTCGATTGCGCCGAAAACGGCAGCGCAAAGAGAACGGCTGCTGGACGCTCTTACGCAACTTGCGGATACTGACCCGCTTTTGCGCTGCGAGGTGGATTCCATCACCCATGAGATCATTCTTTCTTTTTTGGGCCGGGTGCAGTTGGAGGTTGTTTCCGCTTTGCTGTCGGAAAAATACAAGCTTGAAACAGTGGTAAAGGAACCCACCGTCATTTATATGGAGCGGCCGCTCAAAGCAGCCAGCCACACCATCCATATCGAGGTGCCGCCCAACCCGTTTTGGGCATCCATCGGACTGTCTGTTACACCACTCCCGCTTGGCTCCGGTGTACAATACGAGAGCCGGGTTTCGCTGGGATACTTGAACCAGAGTTTTCAAAACGCTGTCAGGGATGGTATCCGTTACGGGCTGGAGCAGGGCTTGTTCGGCTGGAACGTAACGGACTGTAAGATTTGCTTTGAATACGGGCTTTATTACAGTCCGGTCAGCACGCCGGCGGACTTCCGCTCATTGGCCCCGATTGTATTGGAACAGGCATTGAAGGAATCAGGGACGCAACTGCTGGAACCTTATCTCTCCTTCACCCTCTATGCGCCCCGGGAATATCTTTCCAGGGCTTATCATGATGCACCGAAATACTGTGCCACCATCGAAACGGTCCAGGTAAAAAAGGATGAAGTTGTCTTTACTGGCGAGATTCCCGCCCGCTGTATACAGGCATACCGTACTGATCTGGCCTTTTACACCAACGGGCAGAGCGTATGCCTTACAGAACTGAAAGGGTATCAGGCCGCTGTCGGCAAGCCAGTCATCCAGCCCCGCCGTCCAAACAGCCGCCTGGACAAGGTGCGCTATATGTTTCAGAAGATAATGTAA,MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAVTSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMNIPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIENNDKLLEKYIAGEPISREKLVREEQRRVQDASLFPVYYGSAKKGLGIQPLMDAVTGLFQPIGEQGSAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKGEIVRTDTAYPGEIVILPSDSVRLNDVLGDPTRLPRKRWREDPLPMLRTSIAPKTAAQRERLLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPTVIYMERPLKAASHTIHIEVPPNPFWASIGLSVTPLPLGSGVQYESRVSLGYLNQSFQNAVRDGIRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYLSFTLYAPREYLSRAYHDAPKYCATIETVQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGQSVCLTELKGYQAAVGKPVIQPRRPNSRLDKVRYMFQKIM,MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAVTSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMNIPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIENNDELLEKYIAGEPISREKLAREEQQRVQDASLFPVYHGSAKNGLGIQPLMDAVTGLFQPIGEQGGAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKGEIVRTDTAYQGEIVILPSDSVRLNDVLGDQTRLPRKRWREDPLPMLRTTIAPKTAAQRERLLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPSVIYMERPLKAASHTIHIEVPPNPFWASIGLSVTPLSLGSGVQYESRVSLGYLNQSFQNAVRDGIRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYLSFILYAPQEYLSRAYHDAPKYCATIETAQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGRSVCLTELKGYQAAVGQPVIQPRRPNSRLDKVRHMFQKVM,100,gnl|BL_ORD_ID|456|hsp_num:0,389,FALSE,None
LK935,19_2 # 1119 # 1973 # -1 # ID=19_2;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.559,19_2,1119,1973,-,Strict,400,498.049,ErmX,86.27,3000596,protein homolog model,n/a,n/a,macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic,antibiotic target alteration,Erm 23S ribosomal RNA methyltransferase,ATGTCTACATACGGACACGGCCGTCACGAACATGGCCAAAATTTTCTCACAGACCACAAGATCATCAACTCCATCGTCGATCTTGTAAAACAAACCTCCGGCCCCATCATTGAGATCGGGCCAGGAAGCGGTGCCCTCACTCACCCGATATCCCACTTGGGGAGGGCAATAACGGCAGTTGAGGTAGACGCAAAACTAGCTGCCAAACTCACAAAAAAGACCGCCTCGGCGTCGGTCGAAGTGGTCCATGATGATTTCCTCAACTTCCCGTTACCCGCCACTCCCTGCGTCATTGTGGGAAACATTCCCTTTCACCTCACCACTGCCATTCTTCGAAAGTTGTTGCATGCGCCGGCATGGACTGCCGCTGTACTCCTCATGCAGTGGGAAGTCGCTCGCCGCCGGGCCGGGGTAGGTGCAAGCACGATGATGACAGCTCAGTGGTCCCCATGGTTCACGTTTCACCTTGGTTCCCGAGTACCAAGGTCTGCTTTCCGGCCACAGCCAAACGTTGACGGGGGGATCTTAGTGATCCGCCGGGTGGGTGACCCGAAGATCCCGATAGAGCAACGCAAAGCCTTTCAGGCGATGGTGCACACCGTTTTCACCGCCCGGGGACGCGGGATAGGGGAAATTCTCCGAAGGGCAGGGTTGTTTTCATCACGTTCAGAAACACAATCATGGTTGCGCTCGCGAGGAATCGACCCCGCGACCCTACCTCCCAGATTGCACACCAACGACTGGATCGATCTCTTCCAGGTGACTGGTTCCTCTCTACCTCACCATCGACCCATTTCACCATCGGGAAGTAGTCAACGCCCTCCTCAACGGAAAAACCGAAGCCGGCGGCGTTAA,MSTYGHGRHEHGQNFLTDHKIINSIVDLVKQTSGPIIEIGPGSGALTHPISHLGRAITAVEVDAKLAAKLTKKTASASVEVVHDDFLNFPLPATPCVIVGNIPFHLTTAILRKLLHAPAWTAAVLLMQWEVARRRAGVGASTMMTAQWSPWFTFHLGSRVPRSAFRPQPNVDGGILVIRRVGDPKIPIEQRKAFQAMVHTVFTARGRGIGEILRRAGLFSSRSETQSWLRSRGIDPATLPPRLHTNDWIDLFQVTGSSLPHHRPISPSGSSQRPPQRKNRSRRR,MSAYGQGRHEHGQNFLTNHKIINSIIDLVKQTSGPIIEIGPGSGALTHPMAHLGRAITAVEVDAKLAAKITQETSSAAVEVVHDDFLNFRLPATPCVIVGNIPFHLTTAILRKLLHAPAWTDAVLLMQWEVARRRAGVGATTMMTAQWSPWFTFHLGSRVPRSAFRPQPNVDGGILVIRRVGDPKIPIEQRKAFQAMVHTVFTARGRGIGEILRRQGCFHHVQKHNHGCAREESTPRPYLPDCYTNDWIDLFQVTGSSLPHHRPISPSGSSQRPPQRKNRSRRR,100,gnl|BL_ORD_ID|872|hsp_num:0,950,FALSE,None
LK935,19_3 # 2162 # 3721 # 1 # ID=19_3;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.690,19_3,2162,3721,+,Strict,900,1007.28,Corynebacterium striatum tetA,98.83,3004639,protein homolog model,n/a,n/a,penam; tetracycline antibiotic,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGCCACCGCCGCGCAGAATGAAGACGTACAGCTGGTTCGTCCCGCCCGCGCCGCCAGCGGACGATCCGGCGCGGCTCCACCCGGCGCGCTGGAGCAGCGGGAACCGCGTGGTCAGGGACATGGTTGGCGCCTACCCGGGCGTGCTGGTGCTGCACATTCTGAGCTACCTCATCGGCTCCGGCATCGCCGCGTTTGTGCCGGTGGTGGTGGGCATGATCGTGGACGGCCTGGTGGGGGAAGAAAAGTTCAACGCATGGTGGCTCTTCGCGGTGCTGGTCGGCATCTTCATCATCCAATTCATCGGCGAGGCCACCGGCGACGGCCTGGCCACAGCCTCGGTGCGCCGCGTGACCCACAACGCGCAGCAGCACCTGTCCTCGGGCGTGCTGCGCCGCGGGGCGGGAGCGATGAGCCCCGGCACCGTACTCAACACCATCGACGCGGACGCGAACACCGTCGGCCGCTACCGCGAGCTGCTGTCGTTTCCGCTCATGGCCATCGGCTACGCGGTCTGCGCGATGGTGGCGATGTGGTCGGTCTCCCCGTGGATCTCACTGGCCATCCCGGCCAGCGCGCTGATCATCGCTCTGTTCGCCGCGTGGACCGCGGGGCCGGTGACGCGGGTGTCGTTGAAGCGTCGCGCCGCGGAGGCGGATGTCGCTGGCTTGGCCACGGATGCGTCGCAAGGCATTCGCACCGTCAAAGGCCTAGGCGCGGGTGCAACCGTGGCAACACGTTTTCACGCCGAAACGGCGAAGGCGAAGCGCTTGATGCTCACGCACCTGCGTGTGGAGGTGTGGCTCGGTTTCGCCAGGTTTTGCGTGGCGTGGCTGTGCAACCTTGGCATCGTGGGCTTGAGCGCGTGGATGACGCTGCGCGGGGAGATCACCCCGGGGCAGCTGACATCCGTGGCACTGTTGGTGCAGCCTGCGTTGACCATGGCGGGCTTCGCGTTCGGCGACCTGGCCAGCGGGTGGGGCAGGGCCGTCGCGAGTGGCCAGCGCATCGAGCAGCTGCACCACGCGGGCGACGACACCGCGGGGCCCGAGCTAACAGACACACCGGTCCCAGGCGCGGGGCTGTGGATTCTCGAGCCGGCGGAGCGTTCCTACGCCACCGCCGCCGCGTGGGCGCAGCGCGCAGACGTGCTGTTCCCGCCGCACACCGTCAACGTGTTTGAGGGCACCATCGCAGACAACGTGAACCCGCGCGGGGATGTGCCGGAGGACGTCGTCAAGCAGGCGCTCGCCGCCGCCCACTGCCAAGACATCCTCCGCAGGCTCGGCGGTATCAACGAAGCAGGCGAGTTGCCGGACGCGCCGCTGGGGGAGGCCGGCCTGAACCTTTCCGGCGGGCAGCGCCAGCGCGTCGCGCTTGCCAGGGCGCTCGCCGCCGACCCGGAGGTGCTCATCCTGGACGACCCGACCACGGGGCTCGATTCCGTGACACAGGCGGACGTCGTGGCAGCCGTCGCCGCGCTCAGAGCAGACAAAACCACCGTGGTCATCACCGGAAACGCCGCGTGGCAGCACGCTGGAACCGAATTGGAGGTGGCGTAG,MPPPRRMKTYSWFVPPAPPADDPARLHPARWSSGNRVVRDMVGAYPGVLVLHILSYLIGSGIAAFVPVVVGMIVDGLVGEEKFNAWWLFAVLVGIFIIQFIGEATGDGLATASVRRVTHNAQQHLSSGVLRRGAGAMSPGTVLNTIDADANTVGRYRELLSFPLMAIGYAVCAMVAMWSVSPWISLAIPASALIIALFAAWTAGPVTRVSLKRRAAEADVAGLATDASQGIRTVKGLGAGATVATRFHAETAKAKRLMLTHLRVEVWLGFARFCVAWLCNLGIVGLSAWMTLRGEITPGQLTSVALLVQPALTMAGFAFGDLASGWGRAVASGQRIEQLHHAGDDTAGPELTDTPVPGAGLWILEPAERSYATAAAWAQRADVLFPPHTVNVFEGTIADNVNPRGDVPEDVVKQALAAAHCQDILRRLGGINEAGELPDAPLGEAGLNLSGGQRQRVALARALAADPEVLILDDPTTGLDSVTQADVVAAVAALRADKTTVVITGNAAWQHAGTELEVA,MKTYSWFVPPAPPADDPARLHPARWSSGNRVVRDMVGAYPGVLVLHILSYLIGSGISAFVPVVVGMIVDGLVGEEKFNAWWLFAVLVGIFIIQFIGEATGDGLATASVRRVTHNAQQHLSSGVLRRGAGAMSPGTVLNTIDADANTVGRYRELLSFPLMAIGYAVCAMVAMWSVSPWISLAIPASALIIALFAAWTAGPVTRVSLKRRAAEADVAGLATDASQGIRTVKGLGAGATVATRFHAETAKANGLMLTHLRVEVWLGFARFCVAWLCNLGIVGLSAWMTLRGEITPGQLTSVALLVQPALTMAGLAFGDLASGWGRAVASGQRIEQLHHAGDDAAGPEPTDTPVPGAGLWILEPAERSYATAAAWAQRADVLFPPHTVNVFEGTIADNVNPRGDVPEDVVKQALAAAHCQDILRRLGGINEAGELPDAPLGEAGLNLSGGQRQRVALARALAADPEVLILDDPTTGLDSVTQADVVAAVAALRADKTTVVITGNAAWQHAGTELEVA,101.17,gnl|BL_ORD_ID|2120|hsp_num:0,3337,FALSE,None
LK935,46_6 # 3517 # 5154 # -1 # ID=46_6;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.629,46_6,3517,5154,-,Strict,50,88.9669,vanW gene in vanI cluster,28.57,3003724,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanW; glycopeptide resistance gene cluster,ATGAAACGCATCGGACTTGCCGTAGGCCTGTTTGTGTTGCTCCTCTTGGGCCTGTATGGCGTGGATACGGTCCTCACGCAGGGCACCGTTCCCCGTGGCACCACTGTGGGTGGGGTCGCAATCGGTGGGATGAACCCTGCCGATGCTAAAAATAAATTAACTTCCACCTTCACCTACCGCCCCGTCGAGGTTTCGGCGAACGACATGCGCACCACCATCGATCCGCAGGCCGCGGGTCTGGCCCCCGACTGGGACGCGACCATCGAATCTGCGGGCACGCCGTCGCTCAACCCGATCACCAAGATCACCTCCTTCTTCACCACCACCGAGGTCCCGATCCAGTCCCACGTTAGTGATGCATTTTCACCTGCCATGCGGGCGGTCGCCACGGAGCTCACCCGTGACCCCGTCGACGGTGGTCTTTCGCTTGTCGACGGTTCCGTGAACCGCATTCCTCCCGTCATCGGTCAGACCGCTACCGAGGAGGCTGCATCCGATGCTGTCCTCCACAATTGGCTCAACCCCGACGGCGTCATCGTCGAGGTGACCGAGGTTCCGCCCGCCATCGGCGACGAGGAGATCGACGCCGCGGAGAAGGGACCCGCCAAGAAGGCCCTGGCCGCCGACATTGTCGCCCACGGCAACGACAAGGTTGATGGCATCATCCCTCGTAACCGGATGGGGGAGATTCTCACTTTCGCGCCGGAGAACGTAGTGCTCCGGCCCGAGGTCAACGTTGACCGCGCCCGCGAGATCCTGAACGAGAACTTGCAGACCACCGACGTCGCCCACAAGAACGCCACCCTCACCCTGACCGGCGGCGGCCGCTCCGTCACCCCGCACGTCGACGGCACCGTCATCGACTGGGAGAAAACCCTCGAAGGCTTCCCCGAGCGCGTTCTAGGCGACGAGAAGGAATTCGACGTCACCTACAAACCCGACCCCGCCACCTTCACCACGGAGCAGGCTAACGCCGCCACCTTTAACGACGTCGTGGGTTCTTTCACTACCGGCGGCTTCTCCGGCCCGTCGGGGACGAATATTGCCCTGGTAGCGAAGACTGTCAACGGTGCCATCGTCGCCCCCGGCGAGACCTTCTCTTTGAATGGATATACAGGCCCCCGCGGCACCGCCCAGGGTTATGTCTCGTCCGGCGTGATTCTTAACGGCCACGCCGACACCGCCGTCGGTGGTGGTATTTCGCAATTTGCGACAACCCTCTACAACGCCTCGTACTTCTCGGCAATGACCGACATCGCCCACACCCCGCACAGCTACTACATCTCCCGCTACCCCGCGGGCCGCGAGGCCACCGTTTACGAGGGTGCCATCGACCTCGTCTTCCGCAACGACACCCCGAACCCCGTCCTCATCGAGGCAGGCGTGAGCGGCAACGAGGTCACCGTCACCTTCAAGGGCGTAAAGACGACGAACGTCCAGTCCATCCCCGGCGGCAAGTGGAACTACACCCAGCCCCAGCCGATGAGCGTCAGCGGGTCGAGTTGTTCGCCCTCAAACGGTGCCCCCGGCTTCACCACATCGGATACACGGGTAGTGACTGACCTCGCCGGAAATGAGTTGTCGCGTACCTCCACCACCACGGTCTACGACCCGGTCCCCATCGTCCGCTGCTCCTAG,MKRIGLAVGLFVLLLLGLYGVDTVLTQGTVPRGTTVGGVAIGGMNPADAKNKLTSTFTYRPVEVSANDMRTTIDPQAAGLAPDWDATIESAGTPSLNPITKITSFFTTTEVPIQSHVSDAFSPAMRAVATELTRDPVDGGLSLVDGSVNRIPPVIGQTATEEAASDAVLHNWLNPDGVIVEVTEVPPAIGDEEIDAAEKGPAKKALAADIVAHGNDKVDGIIPRNRMGEILTFAPENVVLRPEVNVDRAREILNENLQTTDVAHKNATLTLTGGGRSVTPHVDGTVIDWEKTLEGFPERVLGDEKEFDVTYKPDPATFTTEQANAATFNDVVGSFTTGGFSGPSGTNIALVAKTVNGAIVAPGETFSLNGYTGPRGTAQGYVSSGVILNGHADTAVGGGISQFATTLYNASYFSAMTDIAHTPHSYYISRYPAGREATVYEGAIDLVFRNDTPNPVLIEAGVSGNEVTVTFKGVKTTNVQSIPGGKWNYTQPQPMSVSGSSCSPSNGAPGFTTSDTRVVTDLAGNELSRTSTTTVYDPVPIVRCS,MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVLAEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPELLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGMETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGGEFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSHSLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDEPDGYPVKPREWSK,146.11,gnl|BL_ORD_ID|4748|hsp_num:0,2242,FALSE,None
LK935,61_1 # 153 # 968 # 1 # ID=61_1;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.441,61_1,153,968,+,Perfect,500,565.459,APH(3')-Ia,100,3002641,protein homolog model,n/a,n/a,aminoglycoside antibiotic,antibiotic inactivation,APH(3'),ATGAGCCATATTCAACGGGAAACGTCTTGCTCGAGGCCGCGATTAAATTCCAACCTGGATGCTGATTTATATGGGTATAGATGGGCTCGCGATAATGTCGGGCAATCAGGTGCGACAATCTATCGATTGTATGGGAAGCCCAATGCGCCAGAGTTGTTTCTGAAACATGGCAAAGGTAGCGTTGCCAATGATGTTACAGATGAGATGGTCAGACTAAACTGGCTGACGGCATTTATGCCTCTTCCGACCATCAAGCATTTTATCCGTACTCCTGATGATGCATGGTTACTCACCACTGCGATCCCCGGGAAAACAGCATTCCAGGTATTAGAAGAATATCCTGATTCAGGTGAAAATATTGTTGATGCGCTGGCAGTGTTCCTGCGCCGGTTGCATTCGATTCCTGTTTGTAATTGTCCTTTTAACAGCGATCGCGTATTTCGTCTCGCTCAGGCGCAATCACGAATGAATAACGGTTTGGTTGATGCTAGTGATTTTGATGACGAGCGTAATGGCTGGCCTGTTGAACAAGTCTGGAAAGAAATGCATAAGCTTTTGCCATTCTCACCGGATTCAGTCGTCACTCATGGTGATTTCTCACTTGATAACCTTATTTTTGACGAGGGGAAATTAATAGGTTGTATTGATGTTGGACGAGTCGGAATCGCAGACCGATACCAGGATCTTGCCATCCTATGGAACTGCCTCGGTGAGTTTTCTCCTTCATTACAGAAACGGCTTTTTCAAAAATATGGTATTGATAATCCTGATATGAATAAATTGCAGTTTCATTTGATGCTCGATGAGTTTTTCTGA,MSHIQRETSCSRPRLNSNLDADLYGYRWARDNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIADRYQDLAILWNCLGEFSPSLQKRLFQKYGIDNPDMNKLQFHLMLDEFF,MSHIQRETSCSRPRLNSNLDADLYGYRWARDNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIADRYQDLAILWNCLGEFSPSLQKRLFQKYGIDNPDMNKLQFHLMLDEFF,100,gnl|BL_ORD_ID|262|hsp_num:0,291,FALSE,None
LK698,22_25 # 28122 # 28376 # 1 # ID=22_25;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.671,22_25,28122,28376,+,Strict,1900,22.3274,MuxC,100,3004075,protein homolog model,n/a,n/a,macrolide antibiotic; monobactam; tetracycline antibiotic; aminocoumarin antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGGCACACAAGAAGGGTGCGAGCTCCACTCGCAACGGCCGTGACTCCAACGCCCAGTACTTGGGTGTGAAGCGCTTCGGCGGCCAGTCCGTTAACGCCGGCGAGATCATCGTCCGCCAGCGCGGCACGCACTTCCACCCGGGCGTGAACGTGGGCCGCGGCAAGGACGACACCTTGTTCGCCCTGGCCGCTGGCGCCGTCGAATTCGGCACCCGCCGCGGTCGCCGCGTGGTCAACATTCAGACCGCCGAGTAA,MAHKKGASSTRNGRDSNAQYLGVKRFGGQSVNAGEIIVRQRGTHFHPGVNVGRGKDDTLFALAAGAVEFGTRRGRRVVNIQTAE,MSLSTPFIRRPVATTLLTLALLLAGTLSFGLLPVAPLPNVDFPAIVVSASLPGASPETMASSVATPLERSLGRIAGISEMTSSSSLGSTTVVLVFDLEKDIDGAAREVQAAINGAMSLLPSGMPNNPSYRKANPSDMPIMVLTLTSETQSRGEMYDLASTVLAPKLSQVQGVGQVSIGGSSLPAVRVDLNPDAMSQYGLSLDSVRTAIAAANSNGPKGAVEKDDKHWQVDANDQLRKAREYEPLVIHYNADNGAAVRLGDVAKVSDSVEDVRNAGFSDDLPAVLLIVTRQPGANIIEATDAIHAQLPVLQELLGPQVKLNVMDDRSPSIRASLEEAELTLLISVALVILVVFLFLRNGRATLIPSLAVPVSLIGTFAVMYLCDFSLNNLSLMALIIATGFVVDDAIVVVENIARRIEEGDPPIQAAITGARQVGFTVLSMTLSLVAVFIPLLLMGGLTGRLFREFAVTLSAAILVSLVVSLTLTPMLCARLLRPLKRPEGASLARRSDRFFAAFMLRYRASLGWALEHSRLMVVIMLACIAMNLWLFVVVPKGFLPQQDSGRLRGYAVADQSISFQSLSAKMGEYRKILSSDPAVENVVGFIGGGRWQSSNTGSFFVTLKPIGERDPVEKVLTRLRERIAKVPGAALYLNAGQDVRLGGRDSNAQYEFTLRSDDLTLLREWAPKVEAAMRKLPQLVDVNSDSQDKGVQTRLVIDRDRAATLGINVEMVDAVLNDSFGQRQVSTIFNPLNQYRVVMEVDQQYQQSPEILRQVQVIGNDGQRVPLSAFSHYEPSRAPLEVNHQGQFAATTLSFNLAPGAQIGPTREAIMQALEPLHIPVDVQTSFEGNAGAVQDTQNQMPWLILLALLAVYIVLGILYESYVHPLTILSTLPSAGVGALLALILCRSELSLIALIGIILLIGIVKKNAIMMIDFALEAERNHGLSPREAILEACMMRFRPIMMTTLAALLGALPLIFGIGGDAALRRPLGITIVGGLIGSQLLTLYTTPVVYLYLDRLRHWVNQKRGVRTDGALETPL,8.11,gnl|BL_ORD_ID|2369|hsp_num:0,2720,TRUE,loose hit with at least 95 percent identity pushed strict
LK698,50_8 # 7421 # 8401 # -1 # ID=50_8;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.712,50_8,7421,8401,-,Strict,50,103.219,vanY gene in vanA cluster,35,3002955,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGAACCGTCATGCGTCGTCCGGCCCTGCTCACCGCCCTGTTGGCCGCGCTGCTGCTCGTGGGCGGCATGGTACCGGCCCACGCCGGGGCGGGGATCGACAACGAGTACCGCGCCCTGCCGAATCCCGGCGCATGGTTGGGCAAGCCCACGTCCGCCGAACGCTGTGGCCTGCGGGACCGCGGCTGCTATCGGCAGTACCAGAAGGGCACGATCCACTGGACGTCCACGACCGGTGCGCGGGCCCAGCGCGGCGGGATCCTGGCGAAGTGGCGCGCGGAGGGCTCCGAGCACGGGGCCCTGGGGTACCCCGTGACGCGTGAGACCTGCACGGGTGGCACGTGCGAGGTCCGCTACCAGCGCGGCCGCATCACCTGGACCGCCCAGGGAGGAGCGCGGGTGCACCGGGACATCGACGATGCCCGCAGCGTGTCCGTGGTCGTGAACAAGAAACGCCCGCTGTCCCCGCGCACCTACGCCCCGGCTCCGTTACGTTCGGTGGGCGGGGGAGTCCTGCTACGGGACGACGCCGCAGCGGCCTACCAGCGCATGAGCCGTGCCGCGGCCGCACAGGGGGTCACGCTGGTCCCGGTGAGCGGCTACCGCGACTACGGCACCCAAGCGCGCCTCTACCGCGAGTACACGGCCCTGTACGGACAGGCCACCGCCGACACCATTTCCGCGCGGGCCGGTCACTCCGAACATCAGACCGGCCTCGCGATCGACGTGGGCACCCCCGGGGCCACCTGCGGTCTGCTCCCGTGCTTCGGCAACACCCCACAGGGGAAGTGGATCGCCGCGAACGGGCACACCTACGGGTTCGTGGTGCGCTACCCCAACGGGCACACCGCAACCACCGGGTACGCCTACGAACCGTGGCACCTGCGCTACGTGGGCACCGCCACGGCCACGAGTTTGAAGAACAGCGGGTCCGCGACGGTGGAGTCCTACATGGGTCTGCCGCGGGCCCCGAAGTACTGA,MRTVMRRPALLTALLAALLLVGGMVPAHAGAGIDNEYRALPNPGAWLGKPTSAERCGLRDRGCYRQYQKGTIHWTSTTGARAQRGGILAKWRAEGSEHGALGYPVTRETCTGGTCEVRYQRGRITWTAQGGARVHRDIDDARSVSVVVNKKRPLSPRTYAPAPLRSVGGGVLLRDDAAAAYQRMSRAAAAQGVTLVPVSGYRDYGTQARLYREYTALYGQATADTISARAGHSEHQTGLAIDVGTPGATCGLLPCFGNTPQGKWIAANGHTYGFVVRYPNGHTATTGYAYEPWHLRYVGTATATSLKNSGSATVESYMGLPRAPKY,MKKLFFLLLLLFLIYLGYDYVNEALFSQEKVEFQNYDQNPKEHLENSGTSENTQEKTITEEQVYQGNLLLINSKYPVRQESVKSDIVNLSKHDELINGYGLLDSNIYMSKEIAQKFSEMVNDAVKGGVSHFIINSGYRDFDEQSVLYQEMGAEYALPAGYSEHNSGLSLDVGSSLTKMERAPEGKWIEENAWKYGFILRYPEDKTELTGIQYEPWHIRYVGLPHSAIMKEKNFVLEEYMDYLKEEKTISVSVNGEKYEIFYYPVTKNTTIHVPTNLRYEISGNNIDGVIVTVFPGSTHTNSRR,107.59,gnl|BL_ORD_ID|4669|hsp_num:0,89,FALSE,None
LK1034,1_91 # 106736 # 107911 # 1 # ID=1_91;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.607,1_91,106736,107911,+,Strict,175,240.736,vanT gene in vanG cluster,36.49,3002972,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,glycopeptide resistance gene cluster; vanT,ATGACAACGATGCAATCGAGGGTCTCCACCCCTACCGGCTATCGGGAAACTTGGGCGGAAGTGTCGCTGGACGCCATCGCCCACAATACGGGGCTCTTCCGTAAGCAAATCGCCGAGGGCTGCCGGCTGATGGCCGTAGTCAAAGCGAACGGCTACGGACACGGAGCGGTGCAAGCGGCGCAAGCCGCCATCCATGCCGGCGCCGATTGTCTCGGCGTTGCCCTCGTTGATGAGGCGCTGCAGCTGCGAGCGGCCGGTATATCACAACCTATTCTAGTGCTCGGCTACACGCCACCGTTTGGCGTCGAAGCGGCGGTTCGGCAGGGCATCACCTTGACGGTGGATACCCAGGAAGTCCTGCAGGAGACGATCGCTTGCGCCAAAAAGCAAGGGTGCGCGGCGCGCATCCACTTGAAGGTGGATACCGGGATGTCCCGGATCGGCTTATCTACCACCCGGGCGGTGATTGAGCTCGCTGAACTTGCGGCAGCCGCTGCGCCCTTCGTCATCCTTGAAGGCGTGTTTACCCATTTCGCTGATGCGGATGGACCTGACCCGGCGTATACGTTGGAGCAATTCGCCCGGTTCCAGGCTTGCCTCGATGCCCTTGAGGCCCACGGCCTGCATGTGCCGATCAAGCACTGCTGCAATAGTGCCGCCACGATGCGGTTCCCGCAAATGCACCTGGATCTGGTTCGCATCGGGATCGCACTCTACGGGCTATATCCTTCGGCGCAGCTGCGTTTGCCGGAATATCCTTTGCAGCAGGCGATGCAGCTCAAGACGAAAATCGCTTCGCTGCGGCGGATCAAGCCGGGCCAAACCGTCGGCTACGGCCGGACGTACCGGGCAGCCGAGGAGCGGCTGATCGCCACCGTGCCCATCGGGTACGCCGACGGGCTGTCGCGGACGATCTCAAACCGAGGGTTTGCGCTCGTTCGCGGGCAGCGGGCGCCAATCATTGGCCGAGTTTGCATGGACCAGACGATGTTGGATGTCACCGATATAGAGAGCGTCCAAGCGGGAGAGGAGGTCATCCTCTTCGGCGGAACGGGCGAAGCGGCGTCGATATCGATTGACGAGGTCGCCGATTGGATTGGAACAATCAACTATGAGGTCGTTTGTCAGCTCGGAGTCAGAGTTCCGCGCGTTTACCCTCAAAACTTAAATATGTAA,MTTMQSRVSTPTGYRETWAEVSLDAIAHNTGLFRKQIAEGCRLMAVVKANGYGHGAVQAAQAAIHAGADCLGVALVDEALQLRAAGISQPILVLGYTPPFGVEAAVRQGITLTVDTQEVLQETIACAKKQGCAARIHLKVDTGMSRIGLSTTRAVIELAELAAAAAPFVILEGVFTHFADADGPDPAYTLEQFARFQACLDALEAHGLHVPIKHCCNSAATMRFPQMHLDLVRIGIALYGLYPSAQLRLPEYPLQQAMQLKTKIASLRRIKPGQTVGYGRTYRAAEERLIATVPIGYADGLSRTISNRGFALVRGQRAPIIGRVCMDQTMLDVTDIESVQAGEEVILFGGTGEAASISIDEVADWIGTINYEVVCQLGVRVPRVYPQNLNM,MTKNESYSGIDYFRFIAALLIVAIHTSPLSSFSETGNFIFTRIVARVAVPFFFMTSGFFLISRYTCNAEKLGAFIKKTTLIYGVAILLYIPINVYNGYFKMDNLLPNIIKDIVFDGTLYHLWYLPASIIGAAIAWYLVKKVHYRKAFLIASILYIIGLFGDSYYGIVKSVSCLNVFYNLIFQLTDYTRNGIFFAPIFFVLGGYISDSQNRLSLKRSIVGFIVCFALMFGEALTLHHFDIQKHDSMYVLLLPSVYCLFNLLLHFRGKRRTGLRTISLIIYIIHPFMIVVIRLFAKLLHLQSLLVENSLVHYIAVCFASVVLAVVITALLSSLKPKKAKHTADTDRAYLEINLNNLEHNVNTLQKAMSPKCELMAVVKAEAYGHGMYEVTTYLEQIGVSSFAVATIDEGIRLRKYGISSEILILGYTSPSRAKELCKYELTQTLIDYRYSLLLNKQGYDIKAHIKIDTGMHRLGFSTEDKDKILAAFSLKHIKVAGIFTHLCAADSLEENDVAFTNKQIGSFYKVLDWLKSSGLNIPKVHIQSSYGLLNYPELECDYIRVGVALYGVLSSTNDKTKLELDLRPVLSLKAKVVLIRKIKQGESVGYSRAFTATRDSLIAILPIGYADGFPRNLSCGNSYVLIGGRQAPIVGKICMDQLAVDVTDIPNVKTGSIATLIGKDGKEEITAPMVAESAESITNELLSRMGHRLNIIRRA,54.92,gnl|BL_ORD_ID|1522|hsp_num:0,1561,FALSE,None
LK1034,2_131 # 137339 # 138520 # -1 # ID=2_131;partial=00;start_type=GTG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.548,2_131,137339,138520,-,Strict,175,221.861,vanT gene in vanG cluster,34.68,3002972,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,glycopeptide resistance gene cluster; vanT,GTGCAAGTGATGTATCGACCAACCCATGCGGAAATTGATTTGGACGCGCTGCGCAGCAATTTCGAAGAATTGCGGAGAAGACAACCGAAGGACATGAAAATGCTGGCATGTGTAAAAGCTAACGCGTATGGGCATGGTGCTGTACCTGTGGCGAAGGAGTTGGAACAGATCGGCGCGGATTATCTCAGCGTCGCCTTTCTGGACGAAGCGCTGGAGCTTCGGAAAGCCGGCATTCAGCTGCCGATTCTCGTGCTAGGATATACGCCGCCACACGGGGTTCGCACCGCTTGGGAGCATGATGTCACGCTAAATGTCTTCAGCAACGAAGTGCTGGAGGCGATTGAAGCGCTGAATCCTGCTGAATTCCCGCATAAGCTGAGAGTCCATATCAAGATCGATTCCGGCATGGGCCGCGTCGGACTGCTGCCTGGAGATGAGGCGGTCGCCTTCGTACGCAAGGCTATGCAAGTGCCGCATGTGGAAGTAGAAGGCTTGTTCACCCACTATGCCACGGCGGACGAGGAAGACAAAAGCTATACATTGGAACAATATCGCCGGTTTCAGGGCGTGGTGGAAGCGCTGCGGGAGCATAATATTCGCATCCCGATCATACATACGGGAAATAGCGCAATCGCCATTGATATGCCGGAACTGTCGGTGCAAATGGTCCGCATTGGCATCGCACTGTACGGCTTGTATCCATCCGACGAGGTGAGACGCGATCAAGTGAAGCTCACCCCGGTTCTCTCGCTGAAAACGGAAACGGTACGGGTGAAGACGTTGCCTGCCCATTCCGCCATTAGTTATGGAGCGAGATACATCACCGAGCAGGAAGAGCGGATTGCCACGCTTCCGATCGGGTATGCCGACGGATATTCACGGATGTTAAACGGCAAGGCGCAGGTACTAATACGCGGCCGCCGTGTCCCTGTAACAGGCGTCATATGCATGGACCAATGTATGGTATCGCTTCAAGCTTTGGCTGAGGAAGCCGAAGAAATTCAAGCCGGCGAAGAGGTTGTGCTCATCGGCCGGCAAGCCGGCGAGGAAATTACCGCCGGGGAGCTGGCTTCCGCCATGGGAACGATCCATTACGAGTTGATTTGCATGCTGGCCCACCGAGTGCCCCGGGTATACAAACGAAAGGGCGAATCGGTCTTATTGCTGAACCCGCTGCTGTGA,MQVMYRPTHAEIDLDALRSNFEELRRRQPKDMKMLACVKANAYGHGAVPVAKELEQIGADYLSVAFLDEALELRKAGIQLPILVLGYTPPHGVRTAWEHDVTLNVFSNEVLEAIEALNPAEFPHKLRVHIKIDSGMGRVGLLPGDEAVAFVRKAMQVPHVEVEGLFTHYATADEEDKSYTLEQYRRFQGVVEALREHNIRIPIIHTGNSAIAIDMPELSVQMVRIGIALYGLYPSDEVRRDQVKLTPVLSLKTETVRVKTLPAHSAISYGARYITEQEERIATLPIGYADGYSRMLNGKAQVLIRGRRVPVTGVICMDQCMVSLQALAEEAEEIQAGEEVVLIGRQAGEEITAGELASAMGTIHYELICMLAHRVPRVYKRKGESVLLLNPLL,MTKNESYSGIDYFRFIAALLIVAIHTSPLSSFSETGNFIFTRIVARVAVPFFFMTSGFFLISRYTCNAEKLGAFIKKTTLIYGVAILLYIPINVYNGYFKMDNLLPNIIKDIVFDGTLYHLWYLPASIIGAAIAWYLVKKVHYRKAFLIASILYIIGLFGDSYYGIVKSVSCLNVFYNLIFQLTDYTRNGIFFAPIFFVLGGYISDSQNRLSLKRSIVGFIVCFALMFGEALTLHHFDIQKHDSMYVLLLPSVYCLFNLLLHFRGKRRTGLRTISLIIYIIHPFMIVVIRLFAKLLHLQSLLVENSLVHYIAVCFASVVLAVVITALLSSLKPKKAKHTADTDRAYLEINLNNLEHNVNTLQKAMSPKCELMAVVKAEAYGHGMYEVTTYLEQIGVSSFAVATIDEGIRLRKYGISSEILILGYTSPSRAKELCKYELTQTLIDYRYSLLLNKQGYDIKAHIKIDTGMHRLGFSTEDKDKILAAFSLKHIKVAGIFTHLCAADSLEENDVAFTNKQIGSFYKVLDWLKSSGLNIPKVHIQSSYGLLNYPELECDYIRVGVALYGVLSSTNDKTKLELDLRPVLSLKAKVVLIRKIKQGESVGYSRAFTATRDSLIAILPIGYADGFPRNLSCGNSYVLIGGRQAPIVGKICMDQLAVDVTDIPNVKTGSIATLIGKDGKEEITAPMVAESAESITNELLSRMGHRLNIIRRA,55.2,gnl|BL_ORD_ID|1522|hsp_num:0,1561,FALSE,None
LK1034,3_64 # 62035 # 62451 # 1 # ID=3_64;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.465,3_64,62035,62451,+,Strict,150,179.104,FosBx1,60.58,3007372,protein homolog model,n/a,n/a,phosphonic acid antibiotic,antibiotic inactivation,fosfomycin thiol transferase,ATGAAAATTAATGGCATTAATCATTTCTGTTTCTCCGTATCGGATTTGGATCGATCCATGGCGTTCTATGAGCAGGTCTTTGGAGCGACTCCCCTGGTGAAAGGACATAAGCTTGCCTATTTCGACCTGAACGGGCTGTGGATCGCCTTAAATCAGGAAGACATTCCGCGGGACAAGCAGCATCGTACATATACGCATATCGCTTTTTCGATCGATGAGGGGGATTTCGAGGCCTTTCAGAACCGGCTCCGGGAATTAAACGTTGAAGTGCTGCCAGGGCGTGAAAGAGATCAGCGCGACAAAAAGTCGATTTATTTTCTGGACCCGGACGGGCATATGTTCGAATTCCATACCGGAACGTTACAAGACCGACTGGATTACTATAAAGCGGACAAAGACCACATGATCTTTTATTAA,MKINGINHFCFSVSDLDRSMAFYEQVFGATPLVKGHKLAYFDLNGLWIALNQEDIPRDKQHRTYTHIAFSIDEGDFEAFQNRLRELNVEVLPGRERDQRDKKSIYFLDPDGHMFEFHTGTLQDRLDYYKADKDHMIFY,MLRGINHICFSVSNLENSIMFYEKVLEGELLVKGRKLAYFNICGVWIALNEETHIPRNEIHQSYTHIAFSVEKEDFKCLIQRLEENDVHILQGRERDVRDCESIYFVDPDGHKFEFHSGTLQDRLNYYRDEKPHMTFY,100,gnl|BL_ORD_ID|4909|hsp_num:0,5900,FALSE,None
LK1034,6_16 # 22616 # 23479 # 1 # ID=6_16;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=11-12bp;gc_cont=0.545,6_16,22616,23479,+,Strict,50,309.686,vanY gene in vanA cluster,58.9,3002955,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCTCCTGGTGCTGCTGGGATACGGGGTTTCTAAATTTAAGACCGAAACGGCCCGATCACCGCAGGATTCAGCGCCGCCCGTAGAGGACGTTGAGCCGAATGAGGTTTCGGATTCGTCGCTGGCTGCAGAAGGAATGACGATCCACGTCACCAAGGAGATGATATATCAGGGCGATTTGCTGCTGGTGAACAAGGACCATCCGGTTCCGAAGGGGCTGCACCCCGATAAGGAAGCCGTTAGTCTGGTGAAGAACCCCGAATTGATCGACGGATTTGGAGTGTTGGATAATAAAGTGCTGTTGTCGCCGCGCATGGCGGAACGTTTTGCAACGATGGTGAAGGCCGCCGGGGAGGAAGGAATCAACCATTTCCTGATCAGCAGCGGGTACCGGGACGAAGAGAAGCAGGACGAGCTGTACCGCCAAATGGGTTCCAAGCTGGCGCTGCCTGCCGGATACAGCGAGCATAACCTGGGGCTGTCGCTGGACATCGGGTCGTCCCAAGCGGAGATGAATGTCGCCCCGGAAGGCCGGTGGTTGAAGGAGAATGCATGGAAATATGGATTTATTTTGCGATACCCGGACGACAAAACGGCGATCACAGGCATTCAGTTCGAGCCTTGGCACTTCCGGTACGTGGGTCTGCCGCATAGCGCCATCATTCACGAAAACGGGTTTGTGCTGGAGCAATACTTGGATTATCTGAAGGAGCAACAGTCGGTGAGCATCACAGTACAAGGCCAGAAGTATCACGTCTTCTACTATCCGGTATCCAAAGATCGGACCATTGAGGTGCCGGCGCAGGGCAGTTATGAGATTTCCGGCAACAACATGGACGGAGTTATTGTGACCGTTCGCGAGTAA,MLLVLLGYGVSKFKTETARSPQDSAPPVEDVEPNEVSDSSLAAEGMTIHVTKEMIYQGDLLLVNKDHPVPKGLHPDKEAVSLVKNPELIDGFGVLDNKVLLSPRMAERFATMVKAAGEEGINHFLISSGYRDEEKQDELYRQMGSKLALPAGYSEHNLGLSLDIGSSQAEMNVAPEGRWLKENAWKYGFILRYPDDKTAITGIQFEPWHFRYVGLPHSAIIHENGFVLEQYLDYLKEQQSVSITVQGQKYHVFYYPVSKDRTIEVPAQGSYEISGNNMDGVIVTVRE,MKKLFFLLLLLFLIYLGYDYVNEALFSQEKVEFQNYDQNPKEHLENSGTSENTQEKTITEEQVYQGNLLLINSKYPVRQESVKSDIVNLSKHDELINGYGLLDSNIYMSKEIAQKFSEMVNDAVKGGVSHFIINSGYRDFDEQSVLYQEMGAEYALPAGYSEHNSGLSLDVGSSLTKMERAPEGKWIEENAWKYGFILRYPEDKTELTGIQYEPWHIRYVGLPHSAIMKEKNFVLEEYMDYLKEEKTISVSVNGEKYEIFYYPVTKNTTIHVPTNLRYEISGNNIDGVIVTVFPGSTHTNSRR,94.72,gnl|BL_ORD_ID|4669|hsp_num:0,89,FALSE,None
LK1034,18_30 # 35448 # 36311 # -1 # ID=18_30;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.583,18_30,35448,36311,-,Strict,500,503.827,LlmA 23S ribosomal RNA methyltransferase,86.01,3003982,protein homolog model,n/a,n/a,lincosamide antibiotic,antibiotic target alteration,Llm 23S ribosomal RNA methyltransferase,ATGTATGTAGCAAACGATTGGCAGGATTATGAAGTAATGGACACCGGAAACGGGGAAAAGCTGGAGCGCTGGGGGGATATCATTTTGCGGCGCCCCGACCCGCAGATCATCTGGCCGATCGCCAATGAGGATCGCCGCTGGCACGATGTGCACGGGCATTACCACCGCAGCTCCTCCGGCGGCGGACAGTGGGAGATGAAGAAGCAGATTCCCGACCGTTGGACGATTTCCTATGACCGGCTGAAATTTTATATCCGCCCAACCAATTTCAAACATACCGGATTGTTTCCGGAGCAAGCCGCCAACTGGCGGTGGATGATGGACAAGATCGCCGGCGCGGGTCGGCCGATTCAGGTGCTGAACCTGTTCGCATATACCGGCGGCGCCACCGTAGCCGTAGCTTCGGCCGGCGCTTCGGTCGTTCACGTCGATGCAGCGAAAGGGATGGTCCAATGGGCTAAGGAGAACCTGGCGCTGTCCGGTTTGGCCGACCGCCATGTACGCTTCATCACGGATGACGTGTTCAAATTCGTGCAGCGGGAGCAACGGCGCGGCAACCGTTATGACGCGATTATCATGGATCCTCCGTCCTACGGGCGTGGTCCGGGCGGTGAGATGTGGAAGCTGGAGACGAGCCTCTACCCGTTCGTGGAATCTTGCTTGTCGATTCTGTCGGACAAGCCGCTCTTCTTCCTCATCAACTCGTATACGACCGGCATTTCCCCTACCGTACTGAACAACATTCTGACGATGACCGTCAAGAAGCGTTACGGAGGACGGATCTCGGCCGGCGAACTGGGACTGCCGATCACCCGCTCGGGGCTTCACCTCCCTTGCGGCATTCTCGGACGCTGGGAGGAATAA,MYVANDWQDYEVMDTGNGEKLERWGDIILRRPDPQIIWPIANEDRRWHDVHGHYHRSSSGGGQWEMKKQIPDRWTISYDRLKFYIRPTNFKHTGLFPEQAANWRWMMDKIAGAGRPIQVLNLFAYTGGATVAVASAGASVVHVDAAKGMVQWAKENLALSGLADRHVRFITDDVFKFVQREQRRGNRYDAIIMDPPSYGRGPGGEMWKLETSLYPFVESCLSILSDKPLFFLINSYTTGISPTVLNNILTMTVKKRYGGRISAGELGLPITRSGLHLPCGILGRWEE,MYVAQDWQDYEVIDTGGGEKLERWGDVILRRPDPQIIWPIEREDGQWRSVHGHYHRSSSGGGQWDMKKQLPDRWTISYDQLKFHIRPTNFKHTGLFPEQAANWRWMMDKIASAGRPVSVLNLFAYTGGATVAAASAGAQVVHVDAAKGMVQWAKENAALSGLADRPIRYITDDVFKFVQREQRRGNKYDAIIMDPPSYGRGPSGETWKLEQSLYPFLESCMSIVSDNPLFMLINSYTTGISPTVLNNMLTMTMKPKYGGTISAGEIGLPITRSGMNLPCGILGRWES,100,gnl|BL_ORD_ID|2229|hsp_num:0,2519,FALSE,None
LK1034,24_55 # 56187 # 57083 # -1 # ID=24_55;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.580,24_55,56187,57083,-,Strict,50,101.293,vanY gene in vanB cluster,32.64,3002956,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGAACAGCAAGAAAGGCGTGGTGACTGCGGCGATGGCGCTGTTGTTAACAGCGGTATTAATCGCAGGCTGCGGCAAACAAGCGGCCGACGCTCCGCAGACACCGGCACAGAACAGCACGAACACGGCCGCCGGCGCAAATAACGGTGCGGGGGACAATGCCGCCAACGACACCGACACCATGGACGACCAAGCTACGGAAGGCAATAACGCAGCAAACGGCGGCATTACCGGGAACGGGGATTCCAGCGATTCGGCACAGGCCCCTGACGGTTCCAGCGACAGCAGCGGAGGGGACCGCGCAGCGATGGGGGATCCGTACAGCGTGGCGGTGCTGATCAACAAGCAATTTGCTTTACCGGAGGATTACGAGCCGAAGGATCTGGTCTATCCCGACGTCCGGTTTACATTCAAAGAAAAAATCGAAAAACGCATGATGCGCAAAGAGGCGGCAAAGGCGCTCGAGGAGCTGTTCGCTGGAGCCGAGAAAGACGGTATCTATCTGGCCGGCGTGTCGGCGTACCGTTCACATAAGACCCAAACGGCGCTGTTTAACCGTTACGTGGAGAAGGACGGCGAGGAAGTCGCGAAGACGTACAGCGCGGTTCCGGGCCACAGCGAGCATGAGACGGGTCTGGCGATCGACGTATCAGGCAGCGATGGCAAATGCGCAGCGGAAAGCTGCTTCGGTGACACGAAGGAAGCGGCCTGGCTGGCGGATCATGCCACCGAATACGGCTTTATCATTCGTTATCCGAAAGGGAAGGAAGACATTACCGGCTACAAATATGAGCCATGGCACCTGCGTTATGTAGGGAAAGAAATCGCGGCCGACATCGGCAAACGCGGCATTACGTTGGAAGAATACTATGATGCCGTCCCGGTTTCGGGCCAGTGA,MNSKKGVVTAAMALLLTAVLIAGCGKQAADAPQTPAQNSTNTAAGANNGAGDNAANDTDTMDDQATEGNNAANGGITGNGDSSDSAQAPDGSSDSSGGDRAAMGDPYSVAVLINKQFALPEDYEPKDLVYPDVRFTFKEKIEKRMMRKEAAKALEELFAGAEKDGIYLAGVSAYRSHKTQTALFNRYVEKDGEEVAKTYSAVPGHSEHETGLAIDVSGSDGKCAAESCFGDTKEAAWLADHATEYGFIIRYPKGKEDITGYKYEPWHLRYVGKEIAADIGKRGITLEEYYDAVPVSGQ,MEKSNYHSNVNHHKRHMKQSGEKRAFLWAFIISFTVCTLFLGWRLVSVLEATQLPPIPATHTGSGTGVAENPEENTLATAKEQGDEQEWSLILVNRQNPIPAQYDVELEQLSNGERIDIRISPYLQDLFDAARADGVYPIVASGYRTTEKQQEIMDEKVAEYKAKGYTSAQAKAEAETWVAVPGTSEHQLGLAVDINADGIHSTGNEVYRWLDENSYRFGFIRRYPPDKTEITGVSNEPWHYRYVGIEAATKIYHQGLCLEEYLNTEK,111.19,gnl|BL_ORD_ID|602|hsp_num:0,556,FALSE,None
LK1034,26_47 # 48883 # 50490 # -1 # ID=26_47;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.573,26_47,48883,50490,-,Strict,50,115.161,vanW gene in vanI cluster,38.1,3003724,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanW; glycopeptide resistance gene cluster,ATGAAAAAGAAACATTTGGCAGCTATATTACTCTGCGTTGGGCTTCTCGGCGCCGCAAGTTGGGGAGCGCTCGCACTCTATGTCTCGCAGGACACCTTGCCTTCGGGCACGGTCGTGGCCGGATTGGATCTGGGCCGGCGCCAGCGCGATGAAGCTCTGCGGCTCCTTGACCAGGAGATCGCCGCATTAAACCGGAAGCAAGCTGTGTTTACGGTCGACGGCAGCACGAAAACCCTCACCTGGGCGGAAGCCGGGGTTACGTTTGATGCAGAAGCTTTTCGCGAAGAGGTGCAACGGCTGGAAGAGGGCTCCTTATGGGAACGAGGAGTGGCGAGAAGAAGTTTTCATCGGCAGTGGACGCTCACCATCACCTTCGATCCGCAGAAGCTGCAGACGGTGTTTTCCCCTGAATGGGAAAAGAATCGATTCGGCTCCCCGGTGAACGCTGTGCGGACGATTACTCCTCAAGACCAAATTCGCTATTTGCCGGGAACGGCCGTGCAGCGCATCGACTGGGACCGTTTGTTGGAGATGGTGCCGAAGCAGCTTGGAGAAGAAGTACGCCGTTTGGAGAAAAATTCATGGCATGAACCAACCCCAAACGCGTTGTCGAAGCAGCTTCCCACCTTTCAATTTACCGTGCCGCTCAAGACAGTAGAGCCTGAAATCACGGTGGAACGGCTGAAAAAAGAAGGCATCCGCCGAAAAATCGTCCAGTTCTCCACGAGCCTGATGACTAGCGGGGCCGGGCGGGTGCATAACGTGGACGCGGCGGCTCGCAGCATCGACGGGATGGTACTGGCTCCGGACGAAATTTTCGACTATGGTGAAGTCATTGAATATGCGGAGAAGACGTACGGCTTCCGGGAGGCGCCAGTCATTTTTGGAGGGCGGCTGACCCCTGGGGTAGGAGGCGGCATTTGCCAGGTCTCGAGTACGCTCTACAATGCGGCGGTTCGTGCCGGGCTAACGATCGTGGAGCGGCGCAATCACTCCCTGCCGGTCAGATACTTGCCCAAAGGCCAGGACGCCACGTTCGCCAAAGGCTACATCAATTTCCGTTTCAAAAACACCTCCGGCCACCATCTCCTCATCCGCGCCGAGGTGAAAAACGGCCAACTGACCGTTAAGCTTTTTGGCGATATGCCGGAGAACGTGAGTTACTCGCTTGAATCCCGTACAACTGAGGTCATTTCCCCGCCAAACAAATATGTGATAAACCGATCCTTGCCTGCCGGAAGTCAACAAGTGCTCGTGCGTGGGAAGCAGGGATATGTCGTCGAGACGTACCGTATCAAGAAAGTGGACGGCCAGACGGTCGAGCGCACGTTGCTCTCCAAAGACACGTATCCGGCGCAACCAAACGTAATCGCGGTGCGTGAGGTCAAGGCTGGTTCGACCGGGAGCAGCAAAGGCGGGGGTTCGGGTAGTGGCGGCAGCAACCGCGGGAGCAACGGGAGTCGTAACAGCGGTAGTAACAGCGGTGGTGCAGGGGCTGGGGGCCAAGGTGGCACGGGTGGATCGGGCAATTCCAGCGGCAACACCTCTTCGGAACGCCTACCCAAACAGATCTTGGAGGACGGCGTAACTGGGCCGAATTTTCGATGA,MKKKHLAAILLCVGLLGAASWGALALYVSQDTLPSGTVVAGLDLGRRQRDEALRLLDQEIAALNRKQAVFTVDGSTKTLTWAEAGVTFDAEAFREEVQRLEEGSLWERGVARRSFHRQWTLTITFDPQKLQTVFSPEWEKNRFGSPVNAVRTITPQDQIRYLPGTAVQRIDWDRLLEMVPKQLGEEVRRLEKNSWHEPTPNALSKQLPTFQFTVPLKTVEPEITVERLKKEGIRRKIVQFSTSLMTSGAGRVHNVDAAARSIDGMVLAPDEIFDYGEVIEYAEKTYGFREAPVIFGGRLTPGVGGGICQVSSTLYNAAVRAGLTIVERRNHSLPVRYLPKGQDATFAKGYINFRFKNTSGHHLLIRAEVKNGQLTVKLFGDMPENVSYSLESRTTEVISPPNKYVINRSLPAGSQQVLVRGKQGYVVETYRIKKVDGQTVERTLLSKDTYPAQPNVIAVREVKAGSTGSSKGGGSGSGGSNRGSNGSRNSGSNSGGAGAGGQGGTGGSGNSSGNTSSERLPKQILEDGVTGPNFR,MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVLAEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPELLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGMETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGGEFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSHSLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDEPDGYPVKPREWSK,143.43,gnl|BL_ORD_ID|4748|hsp_num:0,2242,FALSE,None
LK1382,85_4 # 4105 # 4854 # 1 # ID=85_4;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.783,85_4,4105,4854,+,Strict,50,82.0333,vanY gene in vanM cluster,33.78,3002961,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGTCGCCCCCTCCCGCTCGCCGCGCTGGCCGCGCTCGCGCTGCTCGCGGCCGGCTGCGGCACGCCCGCCGCGGGCCCGTCCTCGACGCCGACGACGCCGACGTCCGGCTCCGCGAGCGCGGCCGCGTCGTCCCGCGCCGCCTCGAGCACGGCGCCGTCGTCGGGCACGCACGCCGACCCGGCCACCCTCGACGTCGTCGTGAACAAGACCCGCCCCGTGGCCCCGCCCGACTGGGCGCCCTCGGATCTGGTGGCCGTGCCCGGCAGCGAGCTGCCCCTGCGGGCGGAGGCCGCGACGGCGGCCGCTGACCTGCTGGATGCCGCCGCGGCGGCGGGCCACCGCCTCACCACCCTGAGCGCCTACCGCTCGTACGACTACCAGGTCCGGACGTACGGCCACTGGGTCGACGAGCTGGGCCGCGCCGAGGCCGACCGCGTCTCCGCGCGTCCGGGGTACTCCGAGCATCAGACCGGCCTGGCCTGGGACGTGGGCGACGCCGCGACCCCCGCGTGTGACCTGGAAGCGTGCTTCGGCGACACCGCCGCGGGCCGTTGGGTGGCCGCGCACGCCGCCGAGCACGGGTTCGTCATCCGCTACCCCGCCGGGGCCGAGGACGTGACGGGCTTCGCCCACGAGCCCTGGCATCTGCGCTACGTCGGGTCCGCGGAGGCGGCCCGGGTCGAGGCGGCCGGCGGCGTCCTCGAGACCGCGTGGGGTCTGCCGCCGGCGCCGGACTACACGGACTGA,MRRPLPLAALAALALLAAGCGTPAAGPSSTPTTPTSGSASAAASSRAASSTAPSSGTHADPATLDVVVNKTRPVAPPDWAPSDLVAVPGSELPLRAEAATAAADLLDAAAAAGHRLTTLSAYRSYDYQVRTYGHWVDELGRAEADRVSARPGYSEHQTGLAWDVGDAATPACDLEACFGDTAAGRWVAAHAAEHGFVIRYPAGAEDVTGFAHEPWHLRYVGSAEAARVEAAGGVLETAWGLPPAPDYTD,MVFQGNLLLVNNEYPVLEESIKTDVVNLFKHDELTKGYELLNREIYLSEKVAREFSEMVDAAEKEGVRHFSINSGFRNFDEQNALYQEMGSDYALPAGYSEHNLGLALDIGSTQMEMSEAPEGKWLEDNAWEYGFILRYPMDKTAITGIQYEPWHFRYVGLPHSAIIEEKNFALEEYLDFLKEQKSISGTIHGENYEISYYPITEKTDIEMPANLHYEISGNNMDGVIVTVYR,106.87,gnl|BL_ORD_ID|1673|hsp_num:0,1713,FALSE,None
LK485,7_61 # 69409 # 70104 # 1 # ID=7_61;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.414,7_61,69409,70104,+,Strict,1950,26.1794,MexB,100,3000378,protein homolog model,n/a,n/a,macrolide antibiotic; fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; peptide antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; sulfonamide antibiotic; phenicol antibiotic; penem,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGAACCAAAACTTTGTTATCATTGTTGCCGCGGGTAGCGGTTCGCGCATGTCTAGCGATCTTCCAAAACAATATATGTTGCTAGACACTAAGCCTATCCTCATGCATACCATAGCGAAGTTCGCCGAGGCAAACATTCAAGCCAAGATCATCCTGGTTATTTCAGAAAATATGCAGACTTTCTGGAAAGAACAATGCAAGGAGTATGGTTTCGAAATTCCCCATCAAATATGCTTCGGCGGCGCCAGCAGATTTCAAAGTGTAAGAAATGGATTGCGTTACATACAAAATAGCTATCAACTAACTCCCGGCGATGTGATTGGTGTACATGACGCTGCAAGACCCCTCGTATCTCAGACATTAATCGAAAACCTATATCAAGCCTGTTGTACGGAAAATCCAGCGATTATCCCTGCCGTTCAGAGCAGCAACTCCGTTCGATTAGGTAATTTGAAAGAAAGTAAAGCGATAGATCGAGATCAAGTGTGGTTGGTTCAGACGCCTCAGGTATTTGAAGCATGCCTATTCCAAGAGGCTTATAAACAGCAAGAGGAAACCACGTTTACCGACGATGCCTCTGTAATAGAAAAAATGAGCAACGGCTTAACCATCTATCCAGGTGATCATAAGAATATTAAAATCACCTTTAAGGAAGATATCGCCATTGCTCAATATTACTTAAATAATACTATTTAA,MNQNFVIIVAAGSGSRMSSDLPKQYMLLDTKPILMHTIAKFAEANIQAKIILVISENMQTFWKEQCKEYGFEIPHQICFGGASRFQSVRNGLRYIQNSYQLTPGDVIGVHDAARPLVSQTLIENLYQACCTENPAIIPAVQSSNSVRLGNLKESKAIDRDQVWLVQTPQVFEACLFQEAYKQQEETTFTDDASVIEKMSNGLTIYPGDHKNIKITFKEDIAIAQYYLNNTI,MSKFFIDRPIFAWVIALVIMLAGGLSILSLPVNQYPAIAPPAIAVQVSYPGASAETVQDTVVQVIEQQMNGIDNLRYISSESNSDGSMTTTVTFEQGTDPDIAQVQVQNKLQLATPLLPQEVQRQGIRVTKAVKNFLMVVGVVSTDGSMTKEDLSNYIVSNIQDPLSRTKGVGDFQVFGSQYSMRIWLDPAKLNSYQLTPGDVSSAIQAQNVQISSGQLGGLPAVKGQQLNATIIGKTRLQTAEQFENILLKVNPDGSQVRLKDVADVGLGGQDYSINAQFNGSPASGIAIKLATGANALDTAKAIRQTIANLEPFMPQGMKVVYPYDTTPVVSASIHEVVKTLGEAILLVFLVMYLFLQNFRATLIPTIAVPVVLLGTFGVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVMAEEGLSPREAARKSMGQIQGALVGIAMVLSAVFLPMAFFGGSTGVIYRQFSITIVSAMALSVIVALILTPALCATMLKPIEKGDHGEHKGGFFGWFNRMFLSTTHGYERGVASILKHRAPYLLIYVVIVAGMIWMFTRIPTAFLPDEDQGVLFAQVQTPPGSSAERTQVVVDSMREYLLEKESSSVSSVFTVTGFNFAGRGQSSGMAFIMLKPWEERPGGENSVFELAKRAQMHFFSFKDAMVFAFAPPSVLELGNATGFDLFLQDQAGVGHEVLLQARNKFLMLAAQNPALQRVRPNGMSDEPQYKLEIDDEKASALGVSLADINSTVSIAWGSSYVNDFIDRGRVKRVYLQGRPDARMNPDDLSKWYVRNDKGEMVPFNAFATGKWEYGSPKLERYNGVPAMEILGEPAPGLSSGDAMAAVEEIVKQLPKGVGYSWTGLSYEERLSGSQAPALYALSLLVVFLCLAALYESWSIPFSVMLVVPLGVIGALLATSMRGLSNDVFFQVGLLTTIGLSAKNAILIVEFAKELHEQGKGIVEAAIEACRMRLRPIVMTSLAFILGVVPLAISTGAGSGSQHAIGTGVIGGMVTATVLAIFWVPLFYVAVSTLFKDEASKQQASVEKGQ,22.08,gnl|BL_ORD_ID|1789|hsp_num:0,1925,TRUE,loose hit with at least 95 percent identity pushed strict
LK485,28_37 # 42260 # 45391 # 1 # ID=28_37;partial=00;start_type=ATG;rbs_motif=TAAAAA;rbs_spacer=14bp;gc_cont=0.447,28_37,42260,45391,+,Strict,750,751.895,adeF,42.04,3000777,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; tetracycline antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGGTTATCTCCATATTGATCACCATCATTGGAGCTATTTCCATCACGACCCTACCTATCAGTCAGTATCCCAATATTGCGCCACCTACGGTATCCGTAATGGCGAACTATACCGGTGCTGATGCCCAAACAGTAGAGAAAACAGTAACAACCCCGATTGAAAGCCAGATCAACGGTACGCCGGGGATGATTTATATGAGTTCGAACAGTACCTCTGACGGTGGTTCTCGTATTACGGTAACCTTCGAAGTAGGTACAGATATCGATATCGCGACGCTAGATGTACAAAACCGTGTAAGTATCGCTGAACCTGTATTGCCTGAAGCAGTACGCCGTTTAGGGGTAACCACTCGTAAAGTGAACACGGATATCTTAATGATGGTATCCCTGACCTCACCTGACGGATCACGTGATGCGAACTTCTTGGCAAACTATGTCAACCTGTATCTGAAAGACGCCCTATTGCGTGTTAAAGGTGTGGGTGATGTGCAGGCCTTCGGACAGCCTTTCGCCATGCGTGTCTGGCTAGATGCCAACAAACTGACGAACTTAGGATTAACACCATCCGATGTGAGTACTGCAATTGCTGAGCAAAACTCACGTATGGCTGGGGGTAGCGTTGGTGCGCGTCCGCAAGAGAATGCACAAGTATTCGAATACCCGATTATCCTTGACTCCGATTTGGAAGAAGTCGAAGATTTCGAGAATATCGTCGTTAAAACAAACACCGACGGTTCCATCGTTTTATTACAAGATGTAGCCCGCGTAGAGCTCGGACAATTTAACTACGGTATCACGACGAAAGTAAACGGTGAGACAACCTCTGGTATGATGATCTCCCAAACACCGGGAGGAAATGCCGTAGAGACTGCCGATGGTATTTACAAGGCATTAGAGGAGTTAAAAAAATCATTTCCTAAGGGCGTAGACTATGTAGTCGCTTACGAAACGGTTTCTGTTGTTAATGCATCCATCAGCTCGGTAATTCATACCTTGATCGAAGCATTGATCTTAGTAACCCTTGTTGTTTTCTTCTTCCTACAGAGTTGGAGAGCAACGTTGATCCCATTGCTAGCGATTCCAGTTTCCATCGTCGGTACGTTCATCTTCTTTACGATATTCGGATTCTCGGTAAACAACTTAACGATGCTTGCCTTCGTCCTCGCGATCGGTATTGTGGTGGATGATGCCATCGTTGTGGTGGAAGCCGTGCAGCACTATATCGACCATTATAAGATGGATGCCAAAGAAGCTACGCGACGCGCGATGCAAGATATTACCGCACCGGTTATTGCTATTGCCCTCATCTTGGCGGCAGTATTCGTTCCAGTAGGCTTTATCCCGGGAATGGTTGGTCAGCTCTATCAACAGTTTGCTATTACCATTGCGGTATCCGTAATGTTATCAGCATTCATCGCACTTTCCCTGACGCCAGCATTATGTTCGATCATGTTGAAGCCAACAGCAATTCACAAGGATTCTAAAGGTCTAAACAAGTTCTTCTACAAATTCAACGTCTGGTTCGATAAAGTAACTTATCGTTATTCAAAAGGCGTTAAAAAGGTGATAAAAGCGGCTCCATTAGCCTTGATTATCTTGCTTTGTATTTTTGTGGGAACAGGACTGATGTTCACGAATAAGAAAACAGGCTTTATTCCTGCTGAGGACGCTGGTATATTCTTTATGGGGGTCAACCTTCCAGAAGGTGCATCTAGTGCCCGTACAGAGGCTGTATTACAGGAATTATCGGAAGATTTGAGAAAGACATTCCCAGAAATTCAATACGTAACGGCAATTAACGGTATGAACCTATTGAATAGATCGGCGAAACCTAACGGGGCCAGTTTATTCGTTTCGCTTTACCCTTGGGGAGAGCGTGAGAAAACAGTAACGGATATTACCGGAGCGATCATGGGTAAATACCGAGGATACACCAAAGCTTCTGTTATTGCGGCCACACCTCCACCAATTCCGGGTCTTGGATCATCCGGTGGTTTCACCATGGAAATTCAGGATAGGCAAACAGTAGATATTAAACAGTTTGAGGCGATGATCGGTAAATTCTTAGCCGCAGCAAATCAACGTCCTGAGATAGGGATGGCTTATACCCTATTTAATAGTAATTCGCCAAACTACAAACTCAATGTAGATCGTGAGATGGCCAAAAGAATGGGGGTACCTCTGACCAATATCTACAGCACTATTTCGGCTTATATGGGTAGTAGCTATGTGAATGACTTTACCAAATATGGTCGTAACTTCCGCGTCGTAACACAGGCAGATACCAGCTATAGAATGCACATTGAGGATCTAAATAAATTATACGTCAAGAATGTACAAGGACAACCTGTTCCATTGACCAACTTAGTACGTTATGATTTGATTACGAATCCTTCGATTGTCAACCACTTTAACATTTTCCGTTCGATCCAGTTATCGGGTGAAGCGGCTCCTGGATACTCCTCAGGGGATGCTATTGCAGCATTAGAAGAAGTGGCAGCACAAACATTAACAGACGGTTATTCATACGAGTTCTCCGGAATATCGTTACAAGAGAAGCAGTCCGGCAGCAAGACCATACAGATCTTCGCGCTCTGTATTCTGTTTGTATTCCTGCTTTTAGCCTCGCTTTACGAAAGTTGGTCTGTGCCATTCTCTATCCTGCTATCCGTTCCATTAGGCGTGTTCGGAGCAATCCTTGCGCTGACTTTATTACCAAAACTGGATAACAACATCTTTGCGCAAATCGGTCTCGTAACTATCATCGGTCTTGCTGCGAAAAACGCGATCTTGATCGTGGAGTTTGCAAAAGAACGTGTGGATATCGGAATGAACCTATTGGATGCAACATTAGACGCCGTAAAACTTCGTCTTCGTCCAATTATCATGACGTCCCTGGCGTTTATCTTAGGTATTATTCCTTTGATGCTTTCAACGGGCGCAGGTGCTGTTTCCCGCCAAACAATCGGCTGGACGGTATTCGGAGGGATGACCGCAGCAACATTCTTAGCCATCTTCTTTGTACCGGTACTATTCGTCGTGATTACACGTTTAGCGTACGGAAAAAAGAAACTTGCCGAATTGGAAGCGAATTTCGATGAAGAGAAGAAAAAGAATTTGAGTGCGCACTAG,MVISILITIIGAISITTLPISQYPNIAPPTVSVMANYTGADAQTVEKTVTTPIESQINGTPGMIYMSSNSTSDGGSRITVTFEVGTDIDIATLDVQNRVSIAEPVLPEAVRRLGVTTRKVNTDILMMVSLTSPDGSRDANFLANYVNLYLKDALLRVKGVGDVQAFGQPFAMRVWLDANKLTNLGLTPSDVSTAIAEQNSRMAGGSVGARPQENAQVFEYPIILDSDLEEVEDFENIVVKTNTDGSIVLLQDVARVELGQFNYGITTKVNGETTSGMMISQTPGGNAVETADGIYKALEELKKSFPKGVDYVVAYETVSVVNASISSVIHTLIEALILVTLVVFFFLQSWRATLIPLLAIPVSIVGTFIFFTIFGFSVNNLTMLAFVLAIGIVVDDAIVVVEAVQHYIDHYKMDAKEATRRAMQDITAPVIAIALILAAVFVPVGFIPGMVGQLYQQFAITIAVSVMLSAFIALSLTPALCSIMLKPTAIHKDSKGLNKFFYKFNVWFDKVTYRYSKGVKKVIKAAPLALIILLCIFVGTGLMFTNKKTGFIPAEDAGIFFMGVNLPEGASSARTEAVLQELSEDLRKTFPEIQYVTAINGMNLLNRSAKPNGASLFVSLYPWGEREKTVTDITGAIMGKYRGYTKASVIAATPPPIPGLGSSGGFTMEIQDRQTVDIKQFEAMIGKFLAAANQRPEIGMAYTLFNSNSPNYKLNVDREMAKRMGVPLTNIYSTISAYMGSSYVNDFTKYGRNFRVVTQADTSYRMHIEDLNKLYVKNVQGQPVPLTNLVRYDLITNPSIVNHFNIFRSIQLSGEAAPGYSSGDAIAALEEVAAQTLTDGYSYEFSGISLQEKQSGSKTIQIFALCILFVFLLLASLYESWSVPFSILLSVPLGVFGAILALTLLPKLDNNIFAQIGLVTIIGLAAKNAILIVEFAKERVDIGMNLLDATLDAVKLRLRPIIMTSLAFILGIIPLMLSTGAGAVSRQTIGWTVFGGMTAATFLAIFFVPVLFVVITRLAYGKKKLAELEANFDEEKKKNLSAH,MNISKFFIDRPIFAGVLSVLILLAGLLSVFQLPISEYPEVVPPSVVVRAQYPGANPKVIAETVASPLEESINGVEDMLYMQSQANSDGNLTITVNFKLGIDPDKAQQLVQNRVSQAMPRLPEDVQRLGVTTLKSSPTLTMVVHLTSPDNRYDMTYLRNYAVLNVKDRLARLQGVGEVGLFGSGDYAMRVWLDPQKVAQRNLTATEIVNAIREQNIQVAAGTIGASPSNSPLQLSVNAQGRLTTEQEFADIILKTAPDGAVTRLGDVARVELAASQYGLRSLLDNKQAVAIPIFQAPGANALQVSDQVRSTMKELSKDFPSSIKYDIVYDPTQFVRASIKAVVHTLLEAITLVVVVVILFLQTWRASIIPLLAVPVSIIGTFALMLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVERNIEAGLNPREATYRAMREVSGPIIAIALTLVAVFVPLAFMTGLTGQFYKQFAMTIAISTVISAFNSLTLSPALAALLLKGHDAKPDALTRIMNRVFGRFFALFNRVFSRASDRYSQGVSRVISHKASAMGVYAALLGLTVGISYIVPGGFVPAQDKQYLISFAQLPNGASLDRTEAVIRKMSDTALKQPGVESAVAFPGLSINGFTNSSSAGIVFVTLKPFDERKAKDLSANAIAGALNQKYSAIQDAYIAVFPPPPVMGLGTMGGFKLQLEDRGALGYSALNDAAQNFMKAAQSAPELGPMFSSYQINVPQLNVDLDRVKAKQQGVAVTDVFNTMQIYLGSQYVNDFNRFGRVYQVRAQADAPFRANPEDILQLKTRNSAGQMVPLSSLVNVTQTYGPEMVVRYNGYTSADINGGPAPGYSSSQAEAAVERIAAQTLPRGIKFEWTDLTYQKILAGNAGLWVFPISVLLVFLVLAAQYESLTLPLAVILIVPMGILAALTGVWLTAGDNNIFTQIGLMVLVGLACKNAILIVEFARELEMQGATAFKAAVEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMIGVTFFGLFLTPAFYVLIRTLNSKHKLHSAAVHEAPLASPHDH,98.49,gnl|BL_ORD_ID|132|hsp_num:0,153,FALSE,None
LK485,55_2 # 715 # 3150 # 1 # ID=55_2;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.413,55_2,715,3150,+,Strict,175,181.415,vanT gene in vanG cluster,36.14,3002972,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,glycopeptide resistance gene cluster; vanT,ATGTATACTATCGATTTAATACGCGAGGTTTTAGAGTTAAAGAGTTATAGAATAGCGGATTATAATCAACAAATTACAGAACTAGTATACGACAGTAGAAAGGTTAATCAACCTGAACATAGCTTGTTTTTTGCGCTTACTGCCGCCCGTGATGGTCATGATTTCGTAAATGATGCCTACCAGCGGGGAGTTCGTAGTTTTGTTGTTTCCAAAAACGTGCCTTTCCTCGAGACACTTTCTGATATTAATGTGCTGATTGTTGCGGATGTACTCGATGCATTACAACGCCTTGCTGTGTATCATAGGCTAACCTTTGATGGGACGGTGGTTGGAATTGCAGGAAGTAATGGTAAGTCGGTCGTGAAGGAATGGCTGTTCCAACTACTCTCGATCGATAAGAGAGTGTATCAGAGTCCGAAAAGCTATAACTCGCAGCTTGGTGTCGCGTTGTCGCTTTGGAATCTAACTGCGCAATATGATATAGCATTGATAGAAGCAGGGATTTCAGAACCGGGAGAGATGGACCGCTTACAGTCGCTTATACAGCCTGAAGTAGGAATTTTTACCAATATTGGGTTAGCCCATTCGCAGCATTTTATTTCGAAGCAAGCAAAACTCTCAGAGAAGCTGAAACTGTTTCAACGATCCAACGTGCTCATCGCTGGCTCCAAATATGTTAATGCCGGTCAAGTTCCTTCAAATATTAAATTATTGCAGTGGGGAGAAGAGGAGATTGATTTAATACATTTGTTAAGTCAAGAACCGTCAGGAAAAGGAACGGAATTGACAATTAAATCTAAAGATAACATTCACACTTTTGAAGTCCCTTTCAGGGATAGAGCTTCGATTGAGAATATTCTGACCTGCTTCACGGCAATGACGTACTTTGGTTATACCGAACCACAGATCATTGAACGGTTGCAGCAGTTAAGACCCTTAGAAATGCGTTTACAGTTGAAAAAGGGAATTGCTAATAGTTCCTTAATCGATGATTCGTATTCTAATGATTTAGCATCTCTTCAGATATCATTAGATTTTCTTGCGCAGCAAAATCAGCACCCTAGAAAAACGCTTATTCTATCCGACATGGAAGGCTTGTCTAGCAGTGAGAAGTTGCAGGAGAAGCTTCTAGGTATACTTTCTCGAACTTCTCTTAGCCGAATGATATGGGTTGGTCCTGATTATCAATGGTTGGACAAGCTTTCAACAACAACAATACAGCGCTTTGCAAGTACGGAGGATTTGCTACATCAGTTAGAGACTTTAAACATCAAGGATGAAACTGTTTTGATCAAAGGAGGGCGTGCGTTCCGATTTGAACAGATTGTACAGCGATTGACTTTGAGATCACATGGAACAGTTCTTGAAATTAACCTGAATGCGCTATCGCATAATCTTATGCATTATCGGGCGATGATCCCCAATCAAGTTAAACTGATGGCTATGGTGAAAGCTTTCTCCTATGGAAGCGGCAGCTTCGAAGTTGCTAATCTATTACAGTTCAGTAAAGTCGATTACCTAACGGTCGCTTTTGCGGACGAAGGTGTCGAATTAAGGCTGGGGGGCATCACATTGCCTATTATGGTGCTGAGTCCGGATAGCGATACTTTTCAGACGCTTCTCCAATACGATCTTGAGCCCGAAGTCTACTCCATGCGTTTCTTAAATCAATTTATAGAGTTCTTAAAAGCCAATAAGCGTGAAGGATATAAGATTCATGTAAAGTTAGATACGGGTATGCATCGATTGGGATTCTTGCCAAATGAAGTTGATGAACTTATCGAGTGCCTGAACCAACATAAGGAAGTTAAAGTACAATCCTGCTTCACCCACTTGGTTGCTTCCGGAGATGCTAATCAAGATAATTTCACCCAACAGCAAATCGATACATATACAAATTGCATTACCAAATTAGAAGCCGGAGTCGGTTATTCCTTCATCAAGCATGTTGCGAATACATCGGCAATCGTACGCTGGCCACAAGCACATTTTGATATGGTGCGCTTAGGAATAGGGCTCTATGGGGTCGATATGGACAACGGAAATGGCGTTTTAGAGAAGGTGAGTACGCTTCGAACAACAGTAACGCAGATTAAAGATTTACCGAAGACCGAGACCGTTGGTTATGATCGAAAAGGCGTGTTAACACGTGACAGTACAATTGCTACTGTTAAAATTGGGTATGCTGACGGATATAATCGTAAATTTGGGAACGGAATTGGAAAAATGAAAATCAATAATCAGTTGGTCCCAACGGTAGGTACTATCTGTATGGATATGTGTATGCTCGATGTGACCGATATTGAAGTCAAGGAAGGGGATACCGTGGAGGTATTTCCGGATATCATGCAGGCGTCCAAGGATATTGGCACCATTCCGTATGAACTATTGGTCAATATATCAAGCAGGGTAAAAAGAGTCTATTATTTTGAATAA,MYTIDLIREVLELKSYRIADYNQQITELVYDSRKVNQPEHSLFFALTAARDGHDFVNDAYQRGVRSFVVSKNVPFLETLSDINVLIVADVLDALQRLAVYHRLTFDGTVVGIAGSNGKSVVKEWLFQLLSIDKRVYQSPKSYNSQLGVALSLWNLTAQYDIALIEAGISEPGEMDRLQSLIQPEVGIFTNIGLAHSQHFISKQAKLSEKLKLFQRSNVLIAGSKYVNAGQVPSNIKLLQWGEEEIDLIHLLSQEPSGKGTELTIKSKDNIHTFEVPFRDRASIENILTCFTAMTYFGYTEPQIIERLQQLRPLEMRLQLKKGIANSSLIDDSYSNDLASLQISLDFLAQQNQHPRKTLILSDMEGLSSSEKLQEKLLGILSRTSLSRMIWVGPDYQWLDKLSTTTIQRFASTEDLLHQLETLNIKDETVLIKGGRAFRFEQIVQRLTLRSHGTVLEINLNALSHNLMHYRAMIPNQVKLMAMVKAFSYGSGSFEVANLLQFSKVDYLTVAFADEGVELRLGGITLPIMVLSPDSDTFQTLLQYDLEPEVYSMRFLNQFIEFLKANKREGYKIHVKLDTGMHRLGFLPNEVDELIECLNQHKEVKVQSCFTHLVASGDANQDNFTQQQIDTYTNCITKLEAGVGYSFIKHVANTSAIVRWPQAHFDMVRLGIGLYGVDMDNGNGVLEKVSTLRTTVTQIKDLPKTETVGYDRKGVLTRDSTIATVKIGYADGYNRKFGNGIGKMKINNQLVPTVGTICMDMCMLDVTDIEVKEGDTVEVFPDIMQASKDIGTIPYELLVNISSRVKRVYYFE,MTKNESYSGIDYFRFIAALLIVAIHTSPLSSFSETGNFIFTRIVARVAVPFFFMTSGFFLISRYTCNAEKLGAFIKKTTLIYGVAILLYIPINVYNGYFKMDNLLPNIIKDIVFDGTLYHLWYLPASIIGAAIAWYLVKKVHYRKAFLIASILYIIGLFGDSYYGIVKSVSCLNVFYNLIFQLTDYTRNGIFFAPIFFVLGGYISDSQNRLSLKRSIVGFIVCFALMFGEALTLHHFDIQKHDSMYVLLLPSVYCLFNLLLHFRGKRRTGLRTISLIIYIIHPFMIVVIRLFAKLLHLQSLLVENSLVHYIAVCFASVVLAVVITALLSSLKPKKAKHTADTDRAYLEINLNNLEHNVNTLQKAMSPKCELMAVVKAEAYGHGMYEVTTYLEQIGVSSFAVATIDEGIRLRKYGISSEILILGYTSPSRAKELCKYELTQTLIDYRYSLLLNKQGYDIKAHIKIDTGMHRLGFSTEDKDKILAAFSLKHIKVAGIFTHLCAADSLEENDVAFTNKQIGSFYKVLDWLKSSGLNIPKVHIQSSYGLLNYPELECDYIRVGVALYGVLSSTNDKTKLELDLRPVLSLKAKVVLIRKIKQGESVGYSRAFTATRDSLIAILPIGYADGFPRNLSCGNSYVLIGGRQAPIVGKICMDQLAVDVTDIPNVKTGSIATLIGKDGKEEITAPMVAESAESITNELLSRMGHRLNIIRRA,113.9,gnl|BL_ORD_ID|1522|hsp_num:0,1561,FALSE,None
LK1255,2_3 # 3145 # 3612 # -1 # ID=2_3;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.252,2_3,3145,3612,-,Strict,100,234.958,sepA,74.19,3007012,protein homolog model,n/a,n/a,disinfecting agents and antiseptics,antibiotic efflux,small multidrug resistance (SMR) antibiotic efflux pump,ATGAAATTCTTTAAAAATAAATTTTATAATTTAGCTGTAACACTTATTGTTCTCGCTATTTTTGTATTATCCGGGGCGATATTCTTAACATTTCTTGGTTTTGGATTATATGGGTTAAGTAGGATTTTAATATTTTTTCATTTAGGTTATTTTGGCTACAATAAAGGATTTTATGACAATTTGTTTTACTATGGTAGTTATATAGTATTGGGATATTTTACTCTTTTTGCTGTTGAGCATTTAATGGACTACTTTAAGAAGAAATTGCCTAACAATCCTTATTTTCAGGGTATTACATTTCATCTTATTTCTTATATAGTAACGACAGTGATGTTTTATTTTATAGTACATATTCACTATGTATATATTAATATTCAATTTTGGGTAATTATGTTAATCATAGGATTTCTATTTATTTGTAAGGAGATATTTTATCCTGAAAGTGAAAACTTGAATAACAAGAAATAG,MKFFKNKFYNLAVTLIVLAIFVLSGAIFLTFLGFGLYGLSRILIFFHLGYFGYNKGFYDNLFYYGSYIVLGYFTLFAVEHLMDYFKKKLPNNPYFQGITFHLISYIVTTVMFYFIVHIHYVYINIQFWVIMLIIGFLFICKEIFYPESENLNNKK,MIVNFFKHKFYNLLTTMIVLFVFVLSGAIFLTFLGFGLYGLSRILIYFRLGDFTYNRNMYDNLLYYGSYIIFGYFIIFAVEHLMDYFRKMLPENAYFRGATFHLISYTVATTLFYFIIHLHYVYINIDFWVIMVIIGFLYVCKLQFYPESKNLNNRK,98.73,gnl|BL_ORD_ID|4660|hsp_num:0,5728,FALSE,None
LK1255,2_4 # 3730 # 5076 # -1 # ID=2_4;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=11-12bp;gc_cont=0.305,2_4,3730,5076,-,Strict,200,600.897,sdrM,71.69,3007013,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGAAGTTTAGGTCGATATTAACAGTAACCGCATTGATACTAATCATGTTTATGGCTGCAATTGAGACATCTATTATATCTCTAGCCTTACCAACGATTAAGATAAATTTACATGCAGGTAATTTAGTATCTTTAGTTTTTACTGTTTATTTTATTGCTTTGGTCATAGCTAACCCTATTGTAGGTGAGCTGTTATCTCGTTTTAAGATATTATATATTGCCGTTGCAGGTGTTTCTTTATTTGCAATTGGTAGTTTGATGTCAGGTTTAAGTGAAACATTTACTTTTTTAATTATCTCAAGAATGATTCAAGGTTTTGGGGCAGGGGTCATGATGTCTTTATCTCAGATAGTCCCTAAACTAGCGTTTGAAATTCCTTTAAGATATAAAATTATGGGAATTGTAGGTAGTGTTTGGGGAATTTCCAGTATCATTGGACCCATACTCGGTGGTGCGATTTTAGAATTCGCGACATGGCACTGGCTGTTCTTTATTAATATACCTATAGCAATTATTGCTATTGTATTAGTACTAATGACATTTCATTTTCCAGAGGAAGAACATGGTAATCAAACACACTTTGATGTGAAAGGATTATCAATCTTTTATATATTTATAGCATTGCTTATGTTTGGATTATTAAATCAACAACATTTATATCTCAATATTATTGCAATCATCTTGGCTTTATTAGTATTGATTGGCTTGTTTAAAATAGAACAAAAACAAAATAATCCATTTCTTCCGACTAATGAGTTTAATAGATCGATAATGCTTGCTTTCATTACTGATTTATTTATAGCTATGTCATTAATAGGATATAACCTGTATATACCAGTATATTTACAAGAACAATTAGGTTTATCACCTCTTCAAAGTGGGTTTGTTATTTTACCACTATCAGTTGCATGGATTATATTAAACTTTAATTTAGCGAAGATTGAAGCAAACTTTACTAGAAAAGCATTATATATTAGTGCGTTTACAGTTCTCTTAATTTGCAGTGTTATTATTTTATTTGGCATGAAAGTGCCATTGTTGATAGCATTTTCAGTTATCTTTGCTGGACTTAGTTTTGGATATGTATACACTAAAGATAGCGTGATTGTACAAGAGGAAAGCTCTCCTAGAAATATGAAGAAGATGATGTCATTTTATGCATTAACTAAAAACTTAGGTTCATCTGTAGGGTCTACAATTATGGGATATATGTATGCTTTAAAATCAGGTTTATTCGGCACTCATCTACACAATGTATTAGGTTTGATTGCCGTCATTTCAATTTGCTTGTCAATGATGTGGATTTTATTTTATAAATCTAATAAAACTTCAAATTTTAATAATTAA,MKFRSILTVTALILIMFMAAIETSIISLALPTIKINLHAGNLVSLVFTVYFIALVIANPIVGELLSRFKILYIAVAGVSLFAIGSLMSGLSETFTFLIISRMIQGFGAGVMMSLSQIVPKLAFEIPLRYKIMGIVGSVWGISSIIGPILGGAILEFATWHWLFFINIPIAIIAIVLVLMTFHFPEEEHGNQTHFDVKGLSIFYIFIALLMFGLLNQQHLYLNIIAIILALLVLIGLFKIEQKQNNPFLPTNEFNRSIMLAFITDLFIAMSLIGYNLYIPVYLQEQLGLSPLQSGFVILPLSVAWIILNFNLAKIEANFTRKALYISAFTVLLICSVIILFGMKVPLLIAFSVIFAGLSFGYVYTKDSVIVQEESSPRNMKKMMSFYALTKNLGSSVGSTIMGYMYALKSGLFGTHLHNVLGLIAVISICLSMMWILFYKSNKTSNFNN,MRLKSIITVIALILIMFMSAIESSIISLALPTIKQDLNAGNLISLIFTAYFIALVIANPIVGELLSRFKIIYVAIAGLLLFSIGSFMCGLSTNFTMLIISRVIQGFGSGVLMSLSQIVPKLAFEIPLRYKIMGIVGSVWGISSIIGPLLGGGILEFATWHWLFYINIPIAIIAIILVIWTFHFPEEETVAKSKFDTKGLTLFYVFIGLIMFALLNQQLLLLNFLSFILAIVVAMCLFKVEKHVSSPFLPVVEFNRSITLVFITDLLTAICLMGFNLYIPVYLQEQLGLSPLQSGLVIFPLSVAWITLNFNLHRIEAKLSRKVIYLLSFTLLLVSSIIISFGIKLPVLIAFVLILAGLSFGYIYTKDSVIVQEETSPLQMKKMMSFYGLTKNLGASIGSTIMGYLYAIQSGIFGPNLHNVLSAVAVISIGLIVLWVVFFKEQSSQSKE,100.22,gnl|BL_ORD_ID|4661|hsp_num:0,5729,FALSE,None
LK1255,2_285 # 263053 # 264453 # -1 # ID=2_285;partial=00;start_type=ATG;rbs_motif=AGGA/GGAG/GAGG;rbs_spacer=11-12bp;gc_cont=0.353,2_285,263053,264453,-,Strict,525,540.036,norC,59.4,3007010,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGAATACTTCAAAAGAATTTAGGGGAGATAACCGCCTTTTACTAGGGATTATATTAGGAGTTATCACGTTTTGGTTATTTGCACAGTCACTGGTTAACTTGGTTGTCCCGTTACAATCATCATATAACAGTGATATCGGTACGATAAATATTGCTGTGAGTTTATCTGCATTATTTTCTGGCTTATTTATTGTTGGTGCCGGTGATATCGCGGATAAATTTGGACGCGTTAAACTTACATATATTGGATTAGCATTAAATATCATTGGTTCAATTCTTATCATTATTACACCATTACCGAGTCTATTAATTATTGGTCGTGCAGTTCAAGGACTTTCTGCTGCATGTATAATGCCCGCGACGTTAGCGATTATTAATGAATATTACATCGGCACAGCTAGACAACGCGCGCTCAGTTATTGGTCTATTGGCTCATGGGGTGGTAGTGGCGTCTGTACATTATTTGGTGGATTAATGGCGACAAATTTTGGCTGGCGTTCTATTTTTATTATCTCTATTATTTTGACGATATTAGCAATGTTTTTAATGAAACATACTCCCGAGACGAAAGCTGAACCTATCGGCAATAAACCTCTGGAACCTAAGAAATTTGATGTTATTGGATTAATCATTTTAGTGATTTGTATGTTAAGTATTAATGTTATTATTACTCAAACATCTAATTATGGCTTGATGTCTCCACTTATATTAGGTTTAATTGCCGTTTTCGTTATCTCACTCATCGTATTCGTTATGTATGAGAATAGAATCAAACATCCTCTTGTTGACTTTGATTTATTTAAAAATAAAGGCTATACCGGTGCAACAGTTTCAAACTTTATGTTAAATGGTGTTGCAGGTGGTACGTTAATTGTGGTTAACACTTATTATCAACAGCAATTAGATTTTAATTCTCAACAAACAGGCTATATTTCACTTACATATTTAGTAGCGGTATTAATTATGATTCGTGTAGGTGAAAAGATTTTACAAGCATTAGGACCTAAACGACCACTACTTATGGGAAGTGGTTTTACAGTTATAGGTTTAATTCTACTTTCTTTAACATTTTTACCTGACGCATGGTACATCGCAGCGAGTGTTGTAGGGTATTTATTATTTGGTACTGGTTTAGGTATCTATGCGACGCCTTCAACAGATACAGCTGTTGCTCAAGCACCAGACGAAAAAGTAGGTGTAGCTTCAGGTGTATACAAAATGGCTTCTTCTTTAGGGAATGCCTTTGGTGTCGCTATTTCAAGTACAGTTTATAGTGTGCTTGCTGCGCAATTAAATTTATCACTCGGTGGTTTTATGGGTGTGATATTTAACGCAATTGTAGCACTCCTTGCTCTAATAGCTATCTTGTTTTTAGTTCCTAAAAAACAATCAAATTTATAA,MNTSKEFRGDNRLLLGIILGVITFWLFAQSLVNLVVPLQSSYNSDIGTINIAVSLSALFSGLFIVGAGDIADKFGRVKLTYIGLALNIIGSILIIITPLPSLLIIGRAVQGLSAACIMPATLAIINEYYIGTARQRALSYWSIGSWGGSGVCTLFGGLMATNFGWRSIFIISIILTILAMFLMKHTPETKAEPIGNKPLEPKKFDVIGLIILVICMLSINVIITQTSNYGLMSPLILGLIAVFVISLIVFVMYENRIKHPLVDFDLFKNKGYTGATVSNFMLNGVAGGTLIVVNTYYQQQLDFNSQQTGYISLTYLVAVLIMIRVGEKILQALGPKRPLLMGSGFTVIGLILLSLTFLPDAWYIAASVVGYLLFGTGLGIYATPSTDTAVAQAPDEKVGVASGVYKMASSLGNAFGVAISSTVYSVLAAQLNLSLGGFMGVIFNAIVALLALIAILFLVPKKQSNL,MNETYRGGNKLILGIVLGVITFWLFAQSLVNVVPNLQQSFGADMGTISIAVSLTALFSGMFVVGAGGLADKIGRVKMTNIGLLLSIIGSALIIITNLPALLILGRIIQGVSAACIMPSTLAIMKTYYEGAERQRALSYWSIGSWGGSGICSLFGGAVATTMGWRWIFIFSIIVAVLSMLLIKGTPETKSEVTNTHKFDVAGLIVLVVMLLSLNVVITKGAALGYTSLWFFGLIAIVIVAFFIFLNVEKKVDNPLIDFKLFENKPYTGATISNFLLNGVAGTLIVANTFVQQGLGYTALQAGYLSITYLIMVLLMIRVGEKLLQKMGSKRPMLLGTFIVIIGIALISLVFLPGIFYVISCVVGYLCFGLGLGIYATPSTDTAISNAPLDKVGVASGIYKMASSLGGAFGVAISGAVYAGAVAATSIHTGAMIALWVNVLMGIMAFIAILFAIPNDDKRVKDAK,100.87,gnl|BL_ORD_ID|4656|hsp_num:0,5726,FALSE,None
LK1255,2_530 # 520970 # 522352 # -1 # ID=2_530;partial=00;start_type=TTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.329,2_530,520970,522352,-,Strict,200,216.083,mdeA,36.5,3007011,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; aminoglycoside antibiotic; penam; tetracycline antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,TTGAACATTTCTTCTAAAGATTTTGATTATTTAGTTGTTTTTACCGCAGGCATAGGAATGTTTTTATCTACCTTAGATAGTGGGATTATTAACCTTGCATTACCTACTTTATCGAAATCATTTAATGTTGATACATCATTGATAACATGGAGTGTCACTTTATATACTTTATTATTGACGGGAACGATTATCATATTTGGAAGATTGAGTGACAAATTTAGTCGAATAAATATCTATAGTATCGGGCTTATTGTGTTTTTAATAGCTTCAATTTTATGTGGTTTTTCAAGTAATATTATCCAATTGATCACATTTCGAGGTTTGCAAGGCATCGGAGCAGCAATGTTGCAAGGCACTGCCACTGCTATTATTACAACTAGTATTCCTGAAGATAGACAAGGATCGGCCCTAGGAACGCTAAGTATACTTTTAGGAATAGGACCAGTTTTAGGACCTAGTGTAGGAGGGAGTTTACTCTCTTTAGGAAGTTGGAGATGGATATTTTGGATGAATATTCCCTTTATCGTAGTAGGGTTAGTTGGCTGTTTAATATTGAAGAGAAATATTAAAGAAAATAGAAGTACATCTATTCACCTGGATTTGCGAGGAAATATATTGTTATTTCTATCTATATTTTGTTTATTAATCAGTCTAACTGCATGGTCTCATAATTCTATTAAAAGTTTACTCGTTTATGGGAATTTAATAACTTTTATCATACTATTTAGTTTGTTTGTAGTATGGGAATTAAAAAATAGTCATCCAATCATAGATTTACGCATGTTTAAAAATATATCTTTTTCTTCTCCTATTTTTGCGATATTTGTGTTTGGCGGTACGACCTCTCTAGGATTTATCGTTCCACCGTACATATTAGAGAAAGCTAACCATCTCGGTTCATGGCAAGTGGGCTTAGTTAATTTAGCATCTCCTTTAGGCTTAGTCATTGTTTCAAAACTTGCCGGAAAGTTGATATCTCGTTTAGGAAGTACCATATTAATGGTGATTGGATTAATTATAATGACTATTGCTTATACAAGTTTAGGAGGCTTCCAATTTATTTTAAGTCCAATAGCATTAAGTCTATTATTACTACTATATGGTTTAGGAGGTGGATTCTTTCTTCCTTCTAATACTTCAGCAATTATGGGCTCCGTTTCTCAGTATATGCAAGGTACAGTAGGAGCAGCTCAAAGAATGGTTCAAAATATAGGTATTGCTATTTATACAGCTATAACTTCATTATTTATTAATAACTCCTCAAGTTCTAATAAACTAATAGCAGGGGCTAGTGAAGCGTGGTTATTTGCAGCTGCATCTTTATTTATAGCACTACTCCCTTTCTTATTAAAAATCTTACGAAACAAACAACGTGCTGAATAA,MNISSKDFDYLVVFTAGIGMFLSTLDSGIINLALPTLSKSFNVDTSLITWSVTLYTLLLTGTIIIFGRLSDKFSRINIYSIGLIVFLIASILCGFSSNIIQLITFRGLQGIGAAMLQGTATAIITTSIPEDRQGSALGTLSILLGIGPVLGPSVGGSLLSLGSWRWIFWMNIPFIVVGLVGCLILKRNIKENRSTSIHLDLRGNILLFLSIFCLLISLTAWSHNSIKSLLVYGNLITFIILFSLFVVWELKNSHPIIDLRMFKNISFSSPIFAIFVFGGTTSLGFIVPPYILEKANHLGSWQVGLVNLASPLGLVIVSKLAGKLISRLGSTILMVIGLIIMTIAYTSLGGFQFILSPIALSLLLLLYGLGGGFFLPSNTSAIMGSVSQYMQGTVGAAQRMVQNIGIAIYTAITSLFINNSSSSNKLIAGASEAWLFAAASLFIALLPFLLKILRNKQRAE,MTKHLQDFLITVIAGMGMLLSTLDTGIINVALSFLRGQFQTTTNIASFTITGYTLALAISILPLGVLSDKFGKLKISYLGFVLFGLSSLFCGFANSIGWLITGRIIQGMGAAALQATSAALITTLVSEDRKNSAISILGVMIGLGPVLGPSLGGILLSLNLWRFIFWINVPFALIVIICNHYLLTKVSEQTSEWTLDSLGTVLNASMLVCLLLGLSLLSKPHLLGISLILIIISFLIGIWFYRLECSKESALVNVKGLSENPRVLSYLFQTVAFGFASAMIFLLPPFIFEQLYHLGVGQTGFLVLGAPAGLVLFSRISGKINDGSKNKSFSHIGLGIIILSLIFLLLLTPSWPYLFLTLGLFIYGIGGGYFQPANMASIMLASPMKMQGSTGALQRMVQNIAISAGSAIGSTCLNLWSNNLLLATRIGWGITLVLVILSLKELTPFKMTNKTE,101.55,gnl|BL_ORD_ID|4659|hsp_num:0,5727,FALSE,None
LK1255,3_174 # 171897 # 172337 # -1 # ID=3_174;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.340,3_174,171897,172337,-,Strict,270,285.419,mgrA,95.21,3000815,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; cephalosporin; penam; tetracycline antibiotic; peptide antibiotic; disinfecting agents and antiseptics,antibiotic efflux,ATP-binding cassette (ABC) antibiotic efflux pump; major facilitator superfamily (MFS) antibiotic efflux pump,ATGTCTGATCAACATAATTTAAAAGAGCAGCTATGCTTTAGTTTGTACAATGCTCAAAGACAAGTTAATCGCTACTACTCTAACAAAGTCTTTAAAAAGTACAACCTAACTTACCCACAATTTCTTGTATTAACGATTTTATGGGACGAGTCACCTGTTAATGTCAAAAAAGTCGTTACAGAATTAGCACTAGATACAGGGACTGTATCACCATTACTTAAACGAATGGAACAAGTTGATTTAATTAAACGCGAACGTTCTGAAGTGGATCAACGTGAAGTATTTATTCACTTAACAGATAAGAGCGAAACAATTAGACCTGAATTAAGCACAGCATCGGAGAAAGTTGCAACAGCTTCATCTTTATCTAAAGAAGAAGTCAAAGAACTTAATCGCTTATTAGGTAAAGTCATCGATGCATTTACTGAAACGAAAGAATAA,MSDQHNLKEQLCFSLYNAQRQVNRYYSNKVFKKYNLTYPQFLVLTILWDESPVNVKKVVTELALDTGTVSPLLKRMEQVDLIKRERSEVDQREVFIHLTDKSETIRPELSTASEKVATASSLSKEEVKELNRLLGKVIDAFTETKE,MSDQHNLKEQLCFSLYNAQRQVNRYYSNKVFKKYNLTYPQFLVLTILWDESPVNVKKVVTELALDTGTVSPLLKRMEQVDLIKRERSEVDQREVFIHLTDKSETIRPELSNASDKVASASSLSQDEVKELNRLLGKVIHAFDETKEK,99.32,gnl|BL_ORD_ID|133|hsp_num:0,154,FALSE,None
LK1255,3_183 # 179937 # 181106 # 1 # ID=3_183;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.341,3_183,179937,181106,+,Strict,700,703.36,norA,89.92,3000391,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGAGAAAGCAATTATTTACATTGTACTTTAATATATTTCTAATTTTCTTAGGAATTGGCCTTGTTATCCCAGTATTACCAGTTTATTTAAAAGATTTAGGTTTAAAAGGGAGCGATTTAGGAGTATTAGTTGCCGCATTTGCACTGTCACAAATGGTTATTTCTCCATTTGGAGGTACTTTGGCGGATAAATTAGGCAAGAAACTTATCATTTGCATAGGCCTTGTTTTATTTTCAATTTCAGAATTTATGTTTGCTGCTGGACAGACTTTTACTATTCTTATGATTTCACGTGTGTTAGGTGGATTTAGTGCAGGAATGGTAATGCCAGGCGTCACAGGCATGATTGCTGATATTTCTAAAGGCGCAGATAAAGCTAAGAATTTCGGGTATATGTCAGCCATTATTAATTCTGGCTTTATATTAGGACCTGGGTTTGGTGGATTTCTAGCTGAAATCTCACATAGATTGCCGTTCTATTTTGCAGGATCTTTAGGAGCTATCGCGTTTACAATGTCTCTCGTTTTAATTCATAATCCTAAAAAAGAAACGACAGATGGCTTTCATCAATATCAACCTGAATTATTTACTAAAATCAATTGGAAAGTGTTCATTACACCCGTTATATTAACGTTAGTTTTGGCATTTGGTTTGTCAGCTTTTGAAACATTATTCTCATTATACACTTCTGAGAAAGCCAATTATTCACCTAAAGATATCTCAATTGCGATTACGGGTGGAGGCATCTTTGGTGCTGTATTCCAAGTTTTCTTCTTTGATAAATTTATGAAGTATATGACTGAACTTAATTTTATAGCAAGCTCCTTACTCTATTCAGCAATAGTTCTTGTGATGTTGATACTAGCCAATGGTTACTGGACAATTATGGTAATTAGTTTCATTGTATTTATAGGTTTTGATATGATTCGTCCAGCTTTAACGAATTATTTCTCAAATATTGCAGGTGATCGCCAAGGATTTGCTGGAGGTCTTAATTCCACTTTTACCAGTATGGGTAATTTTATTGGACCTTTAGTAGCAGGAGCCTTATTCGATGTAAATTTAGAGTTTCCATTATATATGGCTATAGCAGTTTCTTTAAGTGGTATTGTAATTATCTTTATTGAAAAGTGGCTAAGAACTAGGCGTAAGCAATCACAATCTTCATAA,MRKQLFTLYFNIFLIFLGIGLVIPVLPVYLKDLGLKGSDLGVLVAAFALSQMVISPFGGTLADKLGKKLIICIGLVLFSISEFMFAAGQTFTILMISRVLGGFSAGMVMPGVTGMIADISKGADKAKNFGYMSAIINSGFILGPGFGGFLAEISHRLPFYFAGSLGAIAFTMSLVLIHNPKKETTDGFHQYQPELFTKINWKVFITPVILTLVLAFGLSAFETLFSLYTSEKANYSPKDISIAITGGGIFGAVFQVFFFDKFMKYMTELNFIASSLLYSAIVLVMLILANGYWTIMVISFIVFIGFDMIRPALTNYFSNIAGDRQGFAGGLNSTFTSMGNFIGPLVAGALFDVNLEFPLYMAIAVSLSGIVIIFIEKWLRTRRKQSQSS,MKKQLFILYFNIFLIFLGIGLVIPVLPVYLKDLGLKGSDLGMLVAAFALSQMIISPFGGTLADKLGKKLIICIGLVFFAVSEFMFAAGQSFTILIISRVLGGFSAGMVMPGVTGMIADISPGADKAKNFGYMSAIINSGFILGPGFGGFLAEISHRLPFYVAGTLGVVAFIMSVLLIHNPQKATTDGFHQYQPELFTKINWKVFITPVILTLVLAFGLSAFETLFSLYTADKVNYTPKDISIAIIGGGVFGALFQVFFFDKFMKYMSELNFIAWSLLYSAIVLVMLVLANGYWTIMIISFVVFIGFDMIRPALTNYFSNIAGKRQGFAGGLNSTFTSMGNFIGPLVAGALFDVNLEFPLYMAIAVSLSGIIIIFIEKGLKSRRKEAN,100.52,gnl|BL_ORD_ID|1427|hsp_num:0,1554,FALSE,None
LK1255,4_71 # 81624 # 82085 # -1 # ID=4_71;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.249,4_71,81624,82085,-,Strict,150,170.244,FosBx1,58.09,3007372,protein homolog model,n/a,n/a,phosphonic acid antibiotic,antibiotic inactivation,fosfomycin thiol transferase,ATGAATATTCAAGGTATTAATCATATATGTTTTTCAGTTAGTAATTTAGTTGAATCAATTAAATTTTATAGAGATGTTTTAAAAGGGGAATTATTAGTTAGTGGCAAAACTACTGTGTATTTTAATATTGGTGGTTTATGGGTTGCTTTAAATGAAGAGGTTAATGTACCTAGAACAGAAATTAAATATTCTTATACACATATTGCATTTTCAATTAATGAAAATGAGTTTGAAGAATGGTACAAATGGCTTCAAAAACATAATGTAAATATATTAGAAGGACGAAAGAGAAGTCATCAAGATAAAAAGTCAATTTACTTTACTGATCCAGATGGTCACAAATTAGAATTACACACTGGTACTTTAAACGATAGATTAGATTATTATAAAAAAGAAAAAAACACATATGACTTTTTATTACTAGTCTCTAAAATACTATTTAACTTCATAATAAAAGGTTGA,MNIQGINHICFSVSNLVESIKFYRDVLKGELLVSGKTTVYFNIGGLWVALNEEVNVPRTEIKYSYTHIAFSINENEFEEWYKWLQKHNVNILEGRKRSHQDKKSIYFTDPDGHKLELHTGTLNDRLDYYKKEKNTYDFLLLVSKILFNFIIKG,MLRGINHICFSVSNLENSIMFYEKVLEGELLVKGRKLAYFNICGVWIALNEETHIPRNEIHQSYTHIAFSVEKEDFKCLIQRLEENDVHILQGRERDVRDCESIYFVDPDGHKFEFHSGTLQDRLNYYRDEKPHMTFY,110.87,gnl|BL_ORD_ID|4909|hsp_num:0,5900,FALSE,None
LK1255,9_23 # 17189 # 18034 # -1 # ID=9_23;partial=00;start_type=TTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.278,9_23,17189,18034,-,Strict,500,512.301,PC1 beta-lactamase (blaZ),95.02,3000621,protein homolog model,n/a,n/a,penam,antibiotic inactivation,BlaZ beta-lactamase,TTGAAAAAGTTAATATTTTTAATTGCAATTGCTTTAGTTTTAAGTGCATGTAATTCAAACAGTCCACATGCCAAAGAGTTAAATGATTTAGAAAAAAAATATAATGCTCATATTGGTGTTTATGCTTTAGATACTAAAAGTGGTAAGGAAGTAAAATTTAATTCAGATAAGAGATTTGCCTATGCTTCGACTTCAAAAGCGATAAATAGTGCTATTTTGTTAGAACAAGTACCTTATAATAAGTTAAATAAAAAAATACATATTAACAAAGATGATATAGTTGCTTATTCTCCTATTTTAGAAAAATATGTAGGAAAAGATATCACTTTAAAAGAACTTATTGAGGCTTCAATGACATATAGTGATAATACAGCAAACAATAAAATTATAAAAGAAATCGGTGGGATCAAAAAAGTTAAACAACGTCTAAAAGAACTAGGAGATAAAGTAACAAATCCAGTTAGATATGAGATAGAATTAAATTACTATTCACCAAAGAGCAAAAAAGATACTTCAACACCTGCTGCTTTCGGTAAGACTTTAAATAAACTTATCGCAAATGGAAAATTAAGCAAAGAAAACAAAAAATTCTTACTTGATTTAATGTTAAATAATAAAAGCGGAGATACTTTAATTAAAGACGGTGTTTCAAAAGACTATAAGGTTGCTGATAAAAGTGGTCAAGCAATAACATATGCTTCTAGAAATGATGTTGCTTTTGTTTATCCTAAGGGCCAATCTGAACCTATTGTTTTAGTCATTTTTACGAATAAAGACAATAAAAGTGATAAGCCAAATGATAAGTTGATAAGTGAAACCGCCAAGAGTGTAATGAAGGAATTTTAA,MKKLIFLIAIALVLSACNSNSPHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFAYASTSKAINSAILLEQVPYNKLNKKIHINKDDIVAYSPILEKYVGKDITLKELIEASMTYSDNTANNKIIKEIGGIKKVKQRLKELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKTLNKLIANGKLSKENKKFLLDLMLNNKSGDTLIKDGVSKDYKVADKSGQAITYASRNDVAFVYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF,MKKLIFLIVIALVLSACNSNSSHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFAYASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDIALKELIEASMKYSDNTANNKIINEIGGIKKIKKRLKKLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKTLNKLIANGKLSKKNKNFLLDLMLNNKNGDTLIKDGIPKDYKVADKSGQAITYASRNDVAFVYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF,100,gnl|BL_ORD_ID|670|hsp_num:0,726,FALSE,None
LK1386,46_12 # 11546 # 13264 # 1 # ID=46_12;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.649,46_12,11546,13264,+,Strict,50,67.3958,vanW gene in vanI cluster,29.41,3003724,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanW; glycopeptide resistance gene cluster,GTGAGCGACGACGCACGGGACGCATCTGCGCGCCGAGGGAAGAAGGGCCTGCTCATCGGCAGTGGCGTCGGTGTCGTCGCTCTTGCCGCGGCCGCCTACGTCGGCGCGTGCTACCACTACAAGGACGCCATCCCCGAGGGCACGACCGTCGCGGGTAAGAGCATCGGTGGCATGACGTCCGAACAGGCCACCCGCCAGGTCCTCACGCTCAAGCACCCGAACGCCTCGACGAAGGCGAACGTCACGGCCGGCGATGAGTCCTTCGACCTGGCGCCGGCATCCGCGTGGAAGCCCGACGCCGAGAAGACCCTCGACGGCGTCACCGAGTTCAGCCTCTCCCCGGGCCGACTGCTCGATCAGATCAACGGCGGAGGCGAGAAGATCGAGCCGGTGTACTCCGTCGACAAAACCGCCCTGACGACCTTGGTCAAGAAGGCCGCGGAGTCGAAGATCGACGGCGCTCCGAAGCAGGGACGCGTCAAGTTCATCGGTGGCAAGGTGTCCATCGTCGACGGGGCACCGGGCCACGGCGTCGACGAGAAGAAGGTCGCCGACGCCATCGCGAGCGGCTGGCCGAAGAAGACGGACTACACGACCGAGCTCGTCGAGAAGAACTCCGACGCCTCGGACAACGCCGTGCAGGCGTTCGCGGAGGGCGACGCCAAGAAGGCGATGTCTGCCCCGCTGGAGGTCAGTGCCAACGGACAGAGCGTCACCCTGACGCCGGCTCAGGTCTCCGACGTCATCTCCTCCACGACCGGGGCCGACGGCAAGCCGGCGATCAAGGTCGACACCAAGGCTCTGCTGACGACGGTTCTCTCGCGCGGCGACAAAATGCGCGTTCCGGCAGTCGACGCCAAGGTCGTCTGGAAGGACGGTCAGCCGTCCGTCGTCGAGGGTCGCTCGGGTAAGGAGATCGACGAGTCGAAGGTCGCCAAGATCGTCGGTGACGCCCTCGTGGGCGATCACAAGGCCACGCTCGCCATGAAGGAGCAGAAGCCGGCGGTCATGGCCAAGGACGTCAACGTCGAGGCACTGCCCAGCACCTCCATGGCTCACTTCGAGTCGCCGTTCCCCACGGGCCCCAGCCAGCAGGCTCGCATTCACAACATCACGACGGCCATCAACCGCCTCAACGGCATCGTCGTCCAGCCGGGCGAGCAGTTCAGCCTGCTGCGCGCGCTCGGGTACGAGTTCACGAAGGAATCCGGGTACGTCGAAGCGGGCACGCTGCAGGGTGGTCTGCACCTCGACGGCATGGGCGGCGGCGTCTCGCAGGTCTCCACGACGATGTACAACACGGCGTTCTTCGCCGGTGTCCAGCTCGATGAGCACACGGCGCACGCCGTGTACATCTCGCGCTACCCGATGGGTCGCGAAGCGACGATCTGGAACCCCGGTATCGACAACAAGTGGACGAACGACACCGGCAAGCCCATTCTCATCAAGGCCCACGTCGAGTCGAACAAGGTCGTCATGGACTTCTACGGCACGAAGAAGTACGACGTGGCCACCCGCACGAGCGGCAAGTACAACATTCAGCCGCCCAAGCACCGCACGGTCAAGAACGTCAAGGGTTGTGAGAACACGGTCGGTGGCGGTGTTCCGGGCTTCGACGTCGACGTCTACCGAGAACTGAAGTCGGGCTCGACGACCGTGCGTACGGAGAAGATCCACACGAAGTACAAGCCGGACGACATCATCACGTGTCAGAACTGA,MSDDARDASARRGKKGLLIGSGVGVVALAAAAYVGACYHYKDAIPEGTTVAGKSIGGMTSEQATRQVLTLKHPNASTKANVTAGDESFDLAPASAWKPDAEKTLDGVTEFSLSPGRLLDQINGGGEKIEPVYSVDKTALTTLVKKAAESKIDGAPKQGRVKFIGGKVSIVDGAPGHGVDEKKVADAIASGWPKKTDYTTELVEKNSDASDNAVQAFAEGDAKKAMSAPLEVSANGQSVTLTPAQVSDVISSTTGADGKPAIKVDTKALLTTVLSRGDKMRVPAVDAKVVWKDGQPSVVEGRSGKEIDESKVAKIVGDALVGDHKATLAMKEQKPAVMAKDVNVEALPSTSMAHFESPFPTGPSQQARIHNITTAINRLNGIVVQPGEQFSLLRALGYEFTKESGYVEAGTLQGGLHLDGMGGGVSQVSTTMYNTAFFAGVQLDEHTAHAVYISRYPMGREATIWNPGIDNKWTNDTGKPILIKAHVESNKVVMDFYGTKKYDVATRTSGKYNIQPPKHRTVKNVKGCENTVGGGVPGFDVDVYRELKSGSTTVRTEKIHTKYKPDDIITCQN,MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVLAEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPELLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGMETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGGEFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSHSLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDEPDGYPVKPREWSK,153.35,gnl|BL_ORD_ID|4748|hsp_num:0,2242,FALSE,None
LK1386,51_4 # 3226 # 4122 # 1 # ID=51_4;partial=00;start_type=ATG;rbs_motif=AGxAG;rbs_spacer=5-10bp;gc_cont=0.687,51_4,3226,4122,+,Strict,50,83.9593,vanY gene in vanG cluster,28.23,3002959,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGAGTGACCTGACTCGCCGCGAGGCGATCGCAGGATCCGGTGCTGCCCTGACTCTGGCGATGCTGGGTGCCGGAACGGCACAGGCCGCACGAAGCGACGAGAACGAACCACGCGTCGTCGTCCTCCCCGTGACGCCGGATCGCGTCGCCGTCGTCGCCCGGATGCACTCGGGCGAGGTGCTGACAGCTTCCCAGGGCTCCGAGCGCCGTAGCCGGACGGCTGAGAAGAACGTCGCCGTTCTCGGACTCGCGGTCGCGAAGAGCGCCCGTTCGCGTGTCGTCGTCGAGGTCGCCGGGGCGAGCCGCACGCTCGACGTCGACACCAGGGTCGAGGCGCTGCGCGCGTCCGAGCTGCGCGTCGTCAACAAGCGTGTGGCTCTCACGAACAAGGACAAGCCGAAGAAGCTCGCGACCGCAGGTGCGGTTGTCGTCGATGCGCGCCTGCAGCACCCCATCAAGCGCATGATCAAGGCGGCGAAGAAGGACAAGGTCGACCTCGAGGCCGTCAGTGGCTACCGCTCGTTCGAGTATCAGGAGAGCCTCTACGCCCGCTACGAACGTCGTGACGGTCGCAAGGCCGCCGACACGTATTCGGCGCGCGCGGGCCACAGTGAGCACCAGCTCGGCCTGACGATCGACGTGCGCGGCGCCGACGCCGTGCACGAGCTGGAGGAGTCGTTCAAGGACACCCCCACGGGCAAGTGGGTGGCCGCCCACGCGCACGAGTTCGGCTTCGTCGTGCGCTACCAGGACGGCCAGGAGAAGACGACGGGCTACCGCGCCGAGCCGTGGCACCTGCGCTACGTCGGTGACGACGTCGCCCGCTTCCTCCACCAGCGCCGCGACATCAAGACGCTCGAGCAGCTCTTCGACCTGCCGGCCGCGCCCGGCTACTGA,MSDLTRREAIAGSGAALTLAMLGAGTAQAARSDENEPRVVVLPVTPDRVAVVARMHSGEVLTASQGSERRSRTAEKNVAVLGLAVAKSARSRVVVEVAGASRTLDVDTRVEALRASELRVVNKRVALTNKDKPKKLATAGAVVVDARLQHPIKRMIKAAKKDKVDLEAVSGYRSFEYQESLYARYERRDGRKAADTYSARAGHSEHQLGLTIDVRGADAVHELEESFKDTPTGKWVAAHAHEFGFVVRYQDGQEKTTGYRAEPWHLRYVGDDVARFLHQRRDIKTLEQLFDLPAAPGY,MNHMNMKHRRRKRRRNQSFLFTGILLLVVVSASSFLWYGFGNAAKKDSVIEEMPFTITQDGMQAKEEIKKTVLETSYGGKQQVAEENHGNTQNAGTDEAWNLMLVNRDNAIPDNYEVNLVEVEGGERVDERIYEPLMEMLNAAREENWGELPMVVSGYRTQEKQQSLYDEKIAKFKKEGYSDSEAVRQAEQWVAVPGHSEHQLGFAVDINGATYDVYLWLQENSYKYGFIFRYPGSKTDITGTAEEVWHYRYVGVEAATEMYENGLCLEEYLEKKQSEN,106.81,gnl|BL_ORD_ID|4732|hsp_num:0,298,FALSE,None
LK1358,5_89 # 87704 # 88558 # -1 # ID=5_89;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.559,5_89,87704,88558,-,Strict,400,478.404,ErmX,83.1,3000596,protein homolog model,n/a,n/a,macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic,antibiotic target alteration,Erm 23S ribosomal RNA methyltransferase,ATGTCTACATACGGATACGGCCGTCACGAACATGGCCAAAATTTTCTCACAGACCAAAAGATCATCAACACCATCGTCGATCTTGTAAAACAAACCACCGGCCCCATCATCGAGATCGGGCCGGGAAGCGGTGCCCTCACTCACCCGATATCCCGCTTGGGGAGGGCAATAACGGCAGTTGAGGTAGACGCAAAACTAGCTGCCAAACTCACAAAAAAGACCGCCTCGGCGTCGGTCGAAGTGGTCCATGATGATTTCCTTAACTTCCCGTTACCCGCCACTCCCTGCGTCATTGTGGGAAACATTCCCTTTCACCTCACCACTGCCATTCTTCGAAAGTTGTTGCATGCGCCGGCATGGACTGACGCTGTACTCCTCATGCAGTGGGAAGTCGCTCGCCGCCGGGCCGGGGTAGGCGCAAGCACGATGATGACGGCTCAGTGGTCCCCATGGTTCACGTTTCACCTTGGTTCCCGAGTACCAAGGTCTGCTTTCCGTCCACAGCCTAACGTTGACGGGGGGATCTTAGTGATCCGCCGGGTGGGTGACCCGAAGATCCCGATAGAGCAACGCAAAGCCTTTCAGGCTATGGTGCACACCGTTTTCACCGCCCGGGGACGCGGGATAGGGGAAATTCTCCGAAGGGCAGGGTTGTTTTCATCACGTTCAGATACACAATCATGGTTGCGCTCGCGAGGAATCGACCCCGCAACCCTACCCCCCAGATTGCGCACCAGCGACTGGATCGATCTCTTTCAGGTGACTGGTTCCTCTCCATCGCACCATCGGCCAATTTCACAATCGGGAAGTAGTCAACGCCCTCCTCAACGCAAAAAACGAGGCCGGCGGCGTTAA,MSTYGYGRHEHGQNFLTDQKIINTIVDLVKQTTGPIIEIGPGSGALTHPISRLGRAITAVEVDAKLAAKLTKKTASASVEVVHDDFLNFPLPATPCVIVGNIPFHLTTAILRKLLHAPAWTDAVLLMQWEVARRRAGVGASTMMTAQWSPWFTFHLGSRVPRSAFRPQPNVDGGILVIRRVGDPKIPIEQRKAFQAMVHTVFTARGRGIGEILRRAGLFSSRSDTQSWLRSRGIDPATLPPRLRTSDWIDLFQVTGSSPSHHRPISQSGSSQRPPQRKKRGRRR,MSAYGQGRHEHGQNFLTNHKIINSIIDLVKQTSGPIIEIGPGSGALTHPMAHLGRAITAVEVDAKLAAKITQETSSAAVEVVHDDFLNFRLPATPCVIVGNIPFHLTTAILRKLLHAPAWTDAVLLMQWEVARRRAGVGATTMMTAQWSPWFTFHLGSRVPRSAFRPQPNVDGGILVIRRVGDPKIPIEQRKAFQAMVHTVFTARGRGIGEILRRQGCFHHVQKHNHGCAREESTPRPYLPDCYTNDWIDLFQVTGSSLPHHRPISPSGSSQRPPQRKNRSRRR,100,gnl|BL_ORD_ID|872|hsp_num:0,950,FALSE,None
LK1358,9_2 # 874 # 2523 # -1 # ID=9_2;partial=00;start_type=GTG;rbs_motif=AGGA/GGAG/GAGG;rbs_spacer=11-12bp;gc_cont=0.666,9_2,874,2523,-,Strict,50,89.7373,vanW gene in vanI cluster,36.42,3003724,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanW; glycopeptide resistance gene cluster,GTGAAAGTCGCCGCCGGGTTCTTCGTCGGACTCGTCGTCCTCCTACTGGGGCTCTACCTGGCAGATCTCGCGTTCAACCGGGGAAATGTTCCCCGCGGCACCGCCGTCGGTGGGGTGGAAGTCGGGGGGATGGCACCTGCGGCGGCCGTCGATAAGCTGAGCTTAGAGCTTGGCGACGTCAACGACGACCCCGTCACCGTCACCGCCGGCGACGAGAAAACCGAATTCGTCCCCGCTAGCGCCGGCCTCGGCCCCGACTGGCAAGCCACCATCGACGCCGCCGGCACCGAATCCCCCAACCCCATCTCCCGCCTGATGGGCCTGTTCCGCACCAGAGAAGTCGACATCGTCTCCACCGCCGACGAAGCAGCCTTGGCGCCCACCGTCGAGCGCGTCGCCACAGACCTCACCGTCGAACCCGCCGACGGTGAAGTGGCCATCAAAGACGGCAAAACCGACGTCAAGGACCCCAAGCCCGGCCAAGACGTCCCCGCTGACGAGCTCAAACGCGCCATGAGCTCCAACTGGCTCAACCCCGACGGAGTCTCGGTCGACCCCACCGTCACCGAGCCCGCGATCAACGAGAAACTCGTCAAAGACGCCGTCGACGGCCCCGCCGCCCGCGCCCTCGACGGACCGCTGACCCTGAAAGGCCGCGACGACACCGACGCCGTCATCGACTCCGAGCGCATCGGCGACATCGTGACCTTCCGCAACGACCCCGAGCAGCACCGCATCGTCCCTGAAGTCAACGCTGAAGCCGCCCAAGGCATCTTCGCCGAGCAACTCAAAGACACCGTCAAAGAAGGCAAGAACGCCACGATCTCCGCGTCCGGCGATGTCACCCCGTCCGTCGACGGCATCGAGATCCGCTGGGACGACACCATGAAAGACTTCGGCGAGCGCGTGCTTGGCGACGAATCCCGCACCTGGGACGCCACCTACCGCGACACCCCCGCCACGTTCACCACCGAACAGGCCAACAAGGCCACCTTCGACGACGTCGTCGGCGAATTCACCACCGGCGGGTACAGCTCCGCCTCCGGCACCAATATCTCGATCGTCGCCGACACCGTCAACGGTGCCGTCGTCAGCCCTGGCGAGACCTTCTCCCTCAACGGCTACACCGGCCCCCGCGGCACCGCCCAGGGGTACGTGTCCTCCGGCATCATCATCGACGGACGCGCCGGCAACGCCGTCGGCGGCGGCATCTCGCAGTTCGCCACCACCTTGTACAACGCCTCCTACTTCGCGGGCATGACTGACGTCGACCACACGCCGCACTCCTACTACATCTCCCGCTACCCGGCCGGCCGCGAAGCTACCGTCTACGAAGGCGCCATCGACCTCGCCTTCAAAAACGACACCCCGCACCCGGTGAAGATCGAGACCGCCTTCGGCGGCGGCGAGATCACCGTCCGCCTCAAGGGCGTCAAGGACCGCGAAGTCGAATCCGTCAACGGCGGGCGCTGGGCGTACACCTCCCCGAGCCCGAAGACCGTCTCCGGTGGCGAGTGCATCCCCTCCGGCGGTGCCCAGGGCTTCACCACCTCCGACACCCGCATCATCCGCGACCTGTCCGGCAACGAGCTCTCCCGCGAAACCCAGACCACGGTGTACAACCCGCAGCCGATCGTGCAGTGCGGTTAA,MKVAAGFFVGLVVLLLGLYLADLAFNRGNVPRGTAVGGVEVGGMAPAAAVDKLSLELGDVNDDPVTVTAGDEKTEFVPASAGLGPDWQATIDAAGTESPNPISRLMGLFRTREVDIVSTADEAALAPTVERVATDLTVEPADGEVAIKDGKTDVKDPKPGQDVPADELKRAMSSNWLNPDGVSVDPTVTEPAINEKLVKDAVDGPAARALDGPLTLKGRDDTDAVIDSERIGDIVTFRNDPEQHRIVPEVNAEAAQGIFAEQLKDTVKEGKNATISASGDVTPSVDGIEIRWDDTMKDFGERVLGDESRTWDATYRDTPATFTTEQANKATFDDVVGEFTTGGYSSASGTNISIVADTVNGAVVSPGETFSLNGYTGPRGTAQGYVSSGIIIDGRAGNAVGGGISQFATTLYNASYFAGMTDVDHTPHSYYISRYPAGREATVYEGAIDLAFKNDTPHPVKIETAFGGGEITVRLKGVKDREVESVNGGRWAYTSPSPKTVSGGECIPSGGAQGFTTSDTRIIRDLSGNELSRETQTTVYNPQPIVQCG,MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVLAEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPELLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGMETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGGEFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSHSLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDEPDGYPVKPREWSK,147.18,gnl|BL_ORD_ID|4748|hsp_num:0,2242,FALSE,None
LK1358,2_113 # 106540 # 106911 # -1 # ID=2_113;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.653,2_113,106540,106911,-,Strict,200,223.402,Mycobacterium tuberculosis rpsL mutations conferring resistance to Streptomycin,90.91,3003395,protein variant model,K88R,n/a,aminoglycoside antibiotic,antibiotic target alteration,antibiotic-resistant rpsL,ATGCCAACTATCCAGCAGCTGGTCCGCAAGGGCCGTCACGACAAAAGCAAGAAGGTGGCGACTGCTGCGCTGAAGGGCTCCCCGCAGCGCCGCGGCGTGTGCACCCGCGTGTACACCACCACCCCGAAGAAGCCGAACTCTGCTCTCCGTAAGGTCGCGCGTGTCCGCCTGACCTCCGGCATCGAGGTCTCCGCCTACATTCCGGGCGAAGGCCACAACCTCCAGGAGCACTCCATGGTCCTCGTCCGCGGCGGCCGTGTGAGGGACCTCCCGGGTGTTCGCTACAAGATCATCCGCGGCGCACTGGATACCCAGGGCGTCAAGGACCGCAAGCAGGCTCGCTCCCGTTACGGCGCGAAGAAGGGACAGTAA,MPTIQQLVRKGRHDKSKKVATAALKGSPQRRGVCTRVYTTTPKKPNSALRKVARVRLTSGIEVSAYIPGEGHNLQEHSMVLVRGGRVRDLPGVRYKIIRGALDTQGVKDRKQARSRYGAKKGQ,MPTIQQLVRKGRRDKISKVKTAALKGSPQRRGVCTRVYTTTPKKPNSALRKVARVKLTSQVEVTAYIPGEGHNLQEHSMVLVRGGRVKDLPGVRYKIIRGSLDTQGVKNRKQARSRYGAKKEKG,99.19,gnl|BL_ORD_ID|1956|hsp_num:0,1197,FALSE,None
LK1019,95_4 # 4113 # 4862 # 1 # ID=95_4;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.777,95_4,4113,4862,+,Strict,50,83.5741,vanY gene in vanM cluster,34.46,3002961,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGTCGCACCCTCCCTCTCGCCGCGCTGGCCGCGCTCGCGCTGCTCGCGGCCGGTTGCGGCACGCCCGCCGCGGGCCCGTCCTCGACGCCGACGACGCCGACGTCCGGCTCCGCGAGCGCGGCCGCGTCGTCCCGCGCCGCCTCGAGCACGGCGCCGTCGTCGGGCACGCACGCCGACCCGGCCACCCTCGACGTCGTCGTGAACAAGACCCGCCCCGTGGCCCCGCCCGACTGGGCGCCCTCGGATCTGGTGGCCGTGCCCGGCAGCGAGCTGCCCCTGCGGGCGGAGGCCGCGACGGCGGCCGCTGACCTGCTGGATGCCGCCGCGGCGGCGGGCCACCGCCTCACCACCCTGAGCGCCTACCGCTCGTACGACTACCAGGTCCGGACGTACGGCCACTGGGTCGACGAGCTGGGCCGCGCCGAGGCCGACCGCGTCTCCGCGCGTCCGGGGTACTCCGAGCACCAGACCGGCCTGGCCTGGGACGTGGGCGACGCCGCGACCCCCGCGTGTGACCTGGAAGCGTGCTTCGGCGACACCGCCGCGGGCCGTTGGGTGGCCGCGCACGCCGCCGAGTACGGGTTCGTCATCCGCTATCCCGCCGGGGCCGAGGACGTGACGGGCTTCGATCACGAGCCGTGGCACCTGCGCTACGTCGGGTCCGCGGAGGCGGCCCGGGTCGAGGCGGCCGGCGGCGTCCTCGAGACCGCGTGGGGTCTGCCGCCGGCGCCGGACTACGCGGACTGA,MRRTLPLAALAALALLAAGCGTPAAGPSSTPTTPTSGSASAAASSRAASSTAPSSGTHADPATLDVVVNKTRPVAPPDWAPSDLVAVPGSELPLRAEAATAAADLLDAAAAAGHRLTTLSAYRSYDYQVRTYGHWVDELGRAEADRVSARPGYSEHQTGLAWDVGDAATPACDLEACFGDTAAGRWVAAHAAEYGFVIRYPAGAEDVTGFDHEPWHLRYVGSAEAARVEAAGGVLETAWGLPPAPDYAD,MVFQGNLLLVNNEYPVLEESIKTDVVNLFKHDELTKGYELLNREIYLSEKVAREFSEMVDAAEKEGVRHFSINSGFRNFDEQNALYQEMGSDYALPAGYSEHNLGLALDIGSTQMEMSEAPEGKWLEDNAWEYGFILRYPMDKTAITGIQYEPWHFRYVGLPHSAIIEEKNFALEEYLDFLKEQKSISGTIHGENYEISYYPITEKTDIEMPANLHYEISGNNMDGVIVTVYR,106.87,gnl|BL_ORD_ID|1673|hsp_num:0,1713,FALSE,None
LK553,26_5 # 3119 # 3862 # -1 # ID=26_5;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.781,26_5,3119,3862,-,Strict,50,83.5741,vanY gene in vanF cluster,31.58,3002958,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGTCGCCCCCTCCCCCTCGCCGCGCTGGCCGCGCTCGCGCTGCTCGCGGCCGGCTGCGGCACGCCCGCCGCGGGCCCATCCTCGGCGACGCCGGCTTCCGGCTCCTCGAGCGCGGCCGCGTCGTCCGGCGCCGCCTCGAGCGCGGCGCCGTCGTCGAGCACGCACGCCGACCCGGCCGCCCTCGACGTCGTCGTGAACAAGACCCGCCCCGTGGCCCCGCCCGACTGGGCGCCCTCGGATCTGGTGGCCGTGCCCGGCAGCGAGCTGCCCCTGCGGGCGGAGGCCGCGACGGCGGCCGGTGACCTGCTGGGTGCGGCCGCGGCGGCGGGCCACGACCTCACCACCCTGAGCGCCTACCGCTCGTACGACTACCAGGTCCGGACGTACGGCCACTGGGTCGACGAGCTGGGCCGCGCCGAGGCCGACCGCGTCTCGGCGCGTCCGGGGTACTCCGAGCACCAGACCGGCCTGGCCTGGGACGTGGGCGACGCCGCGACCCCCGCGTGTGACCTGGAGGCGTGCTTCGGCGACACCGCCGCGGGCCACTGGGTGGCCGCGCACGCCGCCGAGTACGGGTTCGTCATCCGCTATCCCGCCGGGGCCGAGGACGTGACGGGCTTCGACCACGAGCCCTGGCACCTGCGCTACGTCGGGTCCGCGGAGGCGGCCCGGGTCGAGGCGGCCGGCGGCGTCCTCGAGACCGCCTGGGATCTGCCTCCGGCGCCCGACTACACGGACTGA,MRRPLPLAALAALALLAAGCGTPAAGPSSATPASGSSSAAASSGAASSAAPSSSTHADPAALDVVVNKTRPVAPPDWAPSDLVAVPGSELPLRAEAATAAGDLLGAAAAAGHDLTTLSAYRSYDYQVRTYGHWVDELGRAEADRVSARPGYSEHQTGLAWDVGDAATPACDLEACFGDTAAGHWVAAHAAEYGFVIRYPAGAEDVTGFDHEPWHLRYVGSAEAARVEAAGGVLETAWDLPPAPDYTD,MKKWGLLLVFALFLVFIFNILPISQDKVEDRIYEQNDKDTSDDKMTAENMQKIELTEEQIYQGNLLLVNNEHPVHQKSIKSDIINLFTHKELTKGYGLLDNEIKLSEEIAGKFSEMIAAAEEDGVSNFLISSGYRDLDEQSRLYEEMGSDFALPAGHSEHNLGLSLDVGSTQMKMDKAPEGKWIEKNCWEYGFILRYPLDKTDVTGIQYEPWHIRYVGLPHSAIMQEMNLALEEYLDYLKEEKSISVRVDGKKYTISYDPISQNETIEVEVPADEQYEISGNNIDGVIVTTFS,84.3,gnl|BL_ORD_ID|1808|hsp_num:0,1899,FALSE,None
LK557,2_209 # 233189 # 234043 # -1 # ID=2_209;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.560,2_209,233189,234043,-,Strict,400,486.108,ErmX,84.51,3000596,protein homolog model,n/a,n/a,macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic,antibiotic target alteration,Erm 23S ribosomal RNA methyltransferase,ATGTCTACATACGGATACGGCCGTCACGAACATGGCCAAAATTTTCTCACAGACCACAAGATCATCAACTCCATCGTCGATCTTGTAAAACAAACCTCCGGCCCCATCATTGAGATCGGGCCAGGAAGCGGTGCCCTCACCCACCCGATATCCCACTTGGGGAGGGCAATAACGGCAGTTGAGGTAGACGCAAAACTAGCTGCCAAACTCACAAAAAAGACCGCCTCGGCGTCGGTCGAAGTGGTCCATGATGATTTCCTCAACTTCCCGTTACCCGCCACTCCCTGCGTCATTGTGGGAAACATTCCCTTTCACCTCACCACTGCCATTCTTCGAAAGTTGTTGCATGCGCCGGCATGGACTGACGCTGTACTCCTCATGCAGTGGGAAGTCGCTCGCCGCCGGGCCGGGGTAGGTGCAAGCACGATGATGACAGCTCAGTGGTCCCCATGGTTCACGTTTCACCTTGGTTCCCGAGTACCAAGGTTTGCTTTCCGGCCACAGCCAAACGTTGACGGGGGGATCTTAGTGATCCGCCGGGTGGGTGACCCGAAGATCCCGATAGAGCAACGCAAAGCCTTTCAGGCGATGGTGCACACCGTTTTCACCGCCCGGGGACGCGGGATAGGGGAAATTCTCCGAAGGGCAGGGTTGTTTTCATCACGTTCAGAGACACAATCATGGTTGCGCTCGCGAGGAATCGACCCCGCAACCCTACCTCCCAGATTGCACACCAGCGACTGGATCGATCTCTTCCAGGTGACTGGTTCCTCTTCACCGCGCCATCGGCCCATTTCACAATCGGGAAGTAGTCAACGCCCTCCTCAACGGAAAAATCGAGGCCGGCGGCGGTAA,MSTYGYGRHEHGQNFLTDHKIINSIVDLVKQTSGPIIEIGPGSGALTHPISHLGRAITAVEVDAKLAAKLTKKTASASVEVVHDDFLNFPLPATPCVIVGNIPFHLTTAILRKLLHAPAWTDAVLLMQWEVARRRAGVGASTMMTAQWSPWFTFHLGSRVPRFAFRPQPNVDGGILVIRRVGDPKIPIEQRKAFQAMVHTVFTARGRGIGEILRRAGLFSSRSETQSWLRSRGIDPATLPPRLHTSDWIDLFQVTGSSSPRHRPISQSGSSQRPPQRKNRGRRR,MSAYGQGRHEHGQNFLTNHKIINSIIDLVKQTSGPIIEIGPGSGALTHPMAHLGRAITAVEVDAKLAAKITQETSSAAVEVVHDDFLNFRLPATPCVIVGNIPFHLTTAILRKLLHAPAWTDAVLLMQWEVARRRAGVGATTMMTAQWSPWFTFHLGSRVPRSAFRPQPNVDGGILVIRRVGDPKIPIEQRKAFQAMVHTVFTARGRGIGEILRRQGCFHHVQKHNHGCAREESTPRPYLPDCYTNDWIDLFQVTGSSLPHHRPISPSGSSQRPPQRKNRSRRR,100,gnl|BL_ORD_ID|872|hsp_num:0,950,FALSE,None
LK941,35_5 # 3158 # 3901 # -1 # ID=35_5;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.778,35_5,3158,3901,-,Strict,50,80.1073,vanY gene in vanF cluster,34.67,3002958,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGTCGCACCCTCCCTCTCGCCGCGCTGGCCGCGCTCGCGCTGCTCGTGGCCGGTTGCGGCACGCCCGCCGCGGGCCCGTCCTCGGCGACGCCGGCTTCCGGCTCCGCGAGCGCGGCCGCGTCGTCCCGCGCCGCCTCGAGCACGGCGCCGTCGTCGAGCACGCACGCCGACCCGGCCGCCCTCGACGTCGTCGTGAACAAGACCCGCCCCGTGGCTCCGCCCGACTGGGCGCCCTCGGATCTGGTGGCCGTGCCCGGCAGCGAGCTGTCCCTGCGGGCGGAGGCCGCGACGGCGGCCGGTGACCTGCTGGATGCCGCCGCGGCGGCGGGCCACCGCCTCACCACCCTGAGCGCCTACCGCTCGTACGACTACCAGGTCCGGACGTACGGCCACTGGGTCGACGAGCTGGGCCGCGCCGAGGCCGACCGCGTCTCGGCGCGTCCGGGGTACTCCGAGCACCAGACCGGCCTGGCCTGGGACGTGGGCGACGCCGCGACCCCCGCGTGTGACCTGGAAGCGTGCTTCGGCGACACCGCCGCGGGCCGCTGGGTGGCCGCGCACGCCGCCGAGCACGGGTTCGTCATCCGCTACCCCGGCGGGGCCGAGGACGTGACGGGCTTCGCCCACGAGCCCTGGCACCTGCGCTATGTCGGGTCCGCGGAGGCGGCCCGGGTCGAGGCGGTCGGCGGCGTCCTCGAGACCGCATGGGGCCTGCCTCCGGCGCCGGACTACGCGGACTGA,MRRTLPLAALAALALLVAGCGTPAAGPSSATPASGSASAAASSRAASSTAPSSSTHADPAALDVVVNKTRPVAPPDWAPSDLVAVPGSELSLRAEAATAAGDLLDAAAAAGHRLTTLSAYRSYDYQVRTYGHWVDELGRAEADRVSARPGYSEHQTGLAWDVGDAATPACDLEACFGDTAAGRWVAAHAAEHGFVIRYPGGAEDVTGFAHEPWHLRYVGSAEAARVEAVGGVLETAWGLPPAPDYAD,MKKWGLLLVFALFLVFIFNILPISQDKVEDRIYEQNDKDTSDDKMTAENMQKIELTEEQIYQGNLLLVNNEHPVHQKSIKSDIINLFTHKELTKGYGLLDNEIKLSEEIAGKFSEMIAAAEEDGVSNFLISSGYRDLDEQSRLYEEMGSDFALPAGHSEHNLGLSLDVGSTQMKMDKAPEGKWIEKNCWEYGFILRYPLDKTDVTGIQYEPWHIRYVGLPHSAIMQEMNLALEEYLDYLKEEKSISVRVDGKKYTISYDPISQNETIEVEVPADEQYEISGNNIDGVIVTTFS,84.3,gnl|BL_ORD_ID|1808|hsp_num:0,1899,FALSE,None
LK1337,15_11 # 13335 # 15053 # 1 # ID=15_11;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.655,15_11,13335,15053,+,Strict,50,99.3673,vanW gene in vanI cluster,35.71,3003724,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanW; glycopeptide resistance gene cluster,ATGGCCTCTGACTCCACTTCGGCGCGCGGCCGCCGTACGACGATCATCGCCATCGTCGCCGCCGTCCTCGCCCTCGGCGCTGCTTACGTGGCAACGGCGTTCTTCGCCTCCAACGGCATGCCGCGTCACACGCAGGTCGCCGCGATCGACGTCGGCGGGATGTCCGAGACCGAGGCGAAGCGGACCCTCGACGAGCAGCTCGCACCGCGTGCCGAGGAGCCGATCGAGATCGCCGCAGAGGACAACACCGCGAAGATCGATCCGGCGGATGCCGGGATCGCGCTGGACACCCAGGCGACCGTCAATCGCGGCGCCGGCTTCACTCTCAACCCGGTGCGCATCTACCAGCGGCTGTTCGACGACAACGTCATCGATCCGGTCATCACCGTCGACGAGTCGAAGAAGTCCGTCATTGCGGAAGTCGGCTCGGAGATGTCGACCGAACCCGTCGACGCGACGCTGGACTACGACGAAGACGGCAAGCCGAAGGTCACCGACAGCAGCGACGGCACGGTTGTGACCGCCGATGCGATCCGGGAAGCGATCGAAACGGCATGGCTGCGCGAAGACGGACCGCTGACGGTGGCGGCGCAGGAGAGGGAAGCCGACATCACCACCGCCGAGGCCGAGCGGGCCCGCACGGAGATCGCCGAGCCGGCGATCAGCGATGATGTCACGGTCAGCGCCGACCCCGGTGACCATGAAGACGTGACGGGCGGGACGATCACGGTCTCGCCGGAGACCGTGTCGCAGACGCTGGAGTTCGAGACGAAGGACAGCGACCTGACACCGGTGTTCGACGACAAGCGGCTCAAGCGGCTGGCGCTGGCTGAGAGCCCGCAGGTTGGCCAGGAGATGAAGAACGCCAGCTACGAGATCGTCGACGGGAAACCGAAGGTGGTGCCGAGCGAGAAGGGCATCTCCGTCGACGAGAAGGAGTTCGCTGCCGCAGTGCTGCCGGCGCTGACCTCCGATGACCGCACCGCCGAGGTGACGCTGACCGAGACCGATCCGGAGTTCTCCACCGAGGAGGCCGAGAAGGCCGATGTCGACACCGTCATCTCCGAGTTCGCAACCCCGTACAACTCCGAGCCGAACCGCGACACCAACCTGCGGGTGGCCTCGAAGAAGGTCTCGGGCACTGTGCTGCTGCCTGGTGAGCAGTTCAGCCTCAACGAAACGCTGGGCAAGCGCACCGCAGCCAACGGCTACAAGCCGGCCGGTGTGATCTCCGAAGGTCAGATGAAGACCGACTTCGGCGGCGGTGTCTCCCAGGTGTCGACGACGCTGTTCAACGCGGCCTTCTTCGCCGGCCTCGACCTCGATGAGCATCGCGCGCACTCCCGGTACATCTCCCGCTACCCGGAGGGCCGGGAGACGACCCTGGACTGGACGTCGATCGATCTGAAGTTCACCAACAGCACCGACAAGCCGATGGTGCTCGACATGTATCTCAAGGACGGCGAAGTCCACGCCCGGGTCTTCGGCGTCAAGACCGTCGATGTCGAAGCCGATGCCTCCAGCCGGTTCGCATTCACCTCGCCGAGCACCGTGACCGAATCAGGTCCCTCCTGCTCACCGCAGTCACCGCGGGAAGGCTGGTCGATCACGATCTACCGCACGATCAAGGACCACTCGACCGGCAAGGTCGTGAAGAAGGACGACTTCACCACCGTCTACCGTCCGGTCAACCGCGTGCAGTGCAGGACGGGCGACTGA,MASDSTSARGRRTTIIAIVAAVLALGAAYVATAFFASNGMPRHTQVAAIDVGGMSETEAKRTLDEQLAPRAEEPIEIAAEDNTAKIDPADAGIALDTQATVNRGAGFTLNPVRIYQRLFDDNVIDPVITVDESKKSVIAEVGSEMSTEPVDATLDYDEDGKPKVTDSSDGTVVTADAIREAIETAWLREDGPLTVAAQEREADITTAEAERARTEIAEPAISDDVTVSADPGDHEDVTGGTITVSPETVSQTLEFETKDSDLTPVFDDKRLKRLALAESPQVGQEMKNASYEIVDGKPKVVPSEKGISVDEKEFAAAVLPALTSDDRTAEVTLTETDPEFSTEEAEKADVDTVISEFATPYNSEPNRDTNLRVASKKVSGTVLLPGEQFSLNETLGKRTAANGYKPAGVISEGQMKTDFGGGVSQVSTTLFNAAFFAGLDLDEHRAHSRYISRYPEGRETTLDWTSIDLKFTNSTDKPMVLDMYLKDGEVHARVFGVKTVDVEADASSRFAFTSPSTVTESGPSCSPQSPREGWSITIYRTIKDHSTGKVVKKDDFTTVYRPVNRVQCRTGD,MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVLAEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPELLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGMETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGGEFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSHSLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDEPDGYPVKPREWSK,153.35,gnl|BL_ORD_ID|4748|hsp_num:0,2242,FALSE,None
LK489,1_206 # 219968 # 221104 # 1 # ID=1_206;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.300,1_206,219968,221104,+,Strict,400,460.685,salE,58.2,3007029,protein homolog model,n/a,n/a,lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; pleuromutilin antibiotic,antibiotic target protection,sal-type ABC-F protein,ATGCTAGATAATTTAATTATAGAAATAAATAAGTCTAAGCAAACGATACTCTACGTTTCACATCACCGTGGTTTTATAAATCAAACTGCGAGTCATGTTTATGAAATCACTAGAAAAACATCGAGAAAATTTCAAGGTGATTATAATCAATACCATTCAGTCAAACAATTAGAATTTCAATCTCATAAAAATGCATATGATAAGCAACAAAAAGAAATCAAAGCGCTGGAAGAATCAATTGCACGCGTGAATGAATGGCATTCAACTGCCAAAGCTACGACCAGTGTGCGTGACCCTAAACAACAAAAGCGTCTTAGCAAACTAGCTAAAAAAGCAAAAGTAAAAAATGCTCAGTTAACACATAAATTAAATGAAAAGCAGTTTGAGTCTCCGGATAAACAAGATAGAAAGTTTCATTTTAATGATGAACAATTAGTGCGTAATCGAGAATTAGTGAAATTAGAAGATATATGTATAAGTATTGAACAAAAAATAATTTATAACAAAGCAAATTTTGAAATTAAAAAAGATGAACATATTTTATTAACTGGTCCGAATGGTAGTGGTAAATCATTACTAATTGCGCTTATAAGACAACAAGTGAAACCGGATAAAGGTACAGTTTATGTAACGCCTTCAGTAAAAATTGCGTATTTTGATCAACAAAATAATAATTTGAATTACAGACAAACACCATTAGATATGGTCATGTCAATATATCATATGACACGTAGTTATGCTCAAACAATCTTGGCTTCGTTCGGTTTTGATAAAGATAAAATACAACAAACGATTCGTTCTTTATCTATGGGTGAAAAAAGCAGATTGCAATTTGTACTATTGTTTTTTTCAAATGCTAATTTACTCATTTTAGATGAACCAACGAATTACTTTGATATTACAACGCAAAGCTTAATTTTAAATATGATCAAACAGTTCAAAGGACAAGTGTTGATTGTTACACATGATTCATATTTGCAAAAGCATTTTGATGCGACACATTGGGTTGTAAAAAACAAACAATTACTTAATGTTACAATGAATAGTGAACAAAAGATTAATACGCAGAATACGTTGAATTTATTAAATGATTTCAGAGATATAGATGAAAATGGCCATTTTGAAACAGACGACTAG,MLDNLIIEINKSKQTILYVSHHRGFINQTASHVYEITRKTSRKFQGDYNQYHSVKQLEFQSHKNAYDKQQKEIKALEESIARVNEWHSTAKATTSVRDPKQQKRLSKLAKKAKVKNAQLTHKLNEKQFESPDKQDRKFHFNDEQLVRNRELVKLEDICISIEQKIIYNKANFEIKKDEHILLTGPNGSGKSLLIALIRQQVKPDKGTVYVTPSVKIAYFDQQNNNLNYRQTPLDMVMSIYHMTRSYAQTILASFGFDKDKIQQTIRSLSMGEKSRLQFVLLFFSNANLLILDEPTNYFDITTQSLILNMIKQFKGQVLIVTHDSYLQKHFDATHWVVKNKQLLNVTMNSEQKINTQNTLNLLNDFRDIDENGHFETDD,MSFYFAQKPFEMFGKTLIQSVDLQFEKGEHIAVIGNNGVGKTTLLKALNNKYKEDTYLMDQNMTTFGNMTGIDYVISLNTELFHLKQALMDNYEKVSDYIALNGYEFEQTIITKAKQMALTEADLDKPIKVLSGGQQTRLALLRAFISNKPLILLDEPTNHLDQEMIDQLINHIQQSKRTIIYVSHHRGFIDQTASHVIEITPESTRKFNGNYKQYKEIKDLESQTEQRIYNKQQKEIQDLERTIKRVQTWHHSAQQKASVRNPIEQKKLSKLAQRAKVKEKQLNQKLQEKHIQEPSKETKSYYFSHQTSLPKRFLIRFEDVSVNIDGQAIYKHAHFEMKQNENILLTGPNGSGKSLFIALIRQHLSPDEGIIEITPSLKIGYFDHTNNNLNEAESPLSMLLVRTNITRSQAQTLLASFNFDKDQIKKPIRYLSMGEKSRLQFVLLYFSGANLLVLDEPTNYFDIVTQDLILSMIQSFTGQVLIVTHDSYLQSQFKAVHWEIKNQQLYNVSLTHTRESNLDETLKLLGEYKFIDENGHFETDN,69.61,gnl|BL_ORD_ID|4730|hsp_num:0,5740,FALSE,None
LK489,2_229 # 223232 # 223771 # 1 # ID=2_229;partial=00;start_type=ATG;rbs_motif=AGGA/GGAG/GAGG;rbs_spacer=11-12bp;gc_cont=0.326,2_229,223232,223771,+,Strict,375,362.073,fusD,97.77,3003731,protein homolog model,n/a,n/a,fusidane antibiotic,antibiotic target protection,Target protecting FusB-type protein conferring resistance to Fusidic acid,ATGGAAAAACAACTTTACCCTTATCAATTTAATTATATAAAAGAACGCGTTGCACATTTAGTCAATGCTTATAATTCGGTCAACGATCCCAATACAATCGCTTCAATCAAAGATGTCACACGCGATGAAATACTCAATACATTTAACTCGAGAGACACTACAATTCGTTCAAATGTTGAAAAGCTCATGAATGTACAACTAACTAAAGAACAAGCTCAAAAAATTTTAACGACCATACAAATGTATGTTAAGCCATTTGAACATCCGAGTAAAAAGCAAGTCACTAACCTTTTTAAAAAAGTTAAAAAGCTAAAAACACCTCTTATCAGTGATGAAGTACTACAAACAAGTACGTATATCGGTTGGAATGATATTGCTTCAAATAGAAAATTCATCATTTATTATGATAACTTTGGAAAATTAAACGGTGTATACGGAGACATTTCTAACCAAACTGTCAAAGGTTTCTGCTCTATTTGCAATAAAGAATCCCGTGTTGCTCTATTTATGCGAAAAACACGTACTGGCAATGATGGCTAA,MEKQLYPYQFNYIKERVAHLVNAYNSVNDPNTIASIKDVTRDEILNTFNSRDTTIRSNVEKLMNVQLTKEQAQKILTTIQMYVKPFEHPSKKQVTNLFKKVKKLKTPLISDEVLQTSTYIGWNDIASNRKFIIYYDNFGKLNGVYGDISNQTVKGFCSICNKESRVALFMRKTRTGNDG,MEKQLYPYQFNYIKERVAHLVNAYNSVNDPNTIASIKDVTRDEILSTFNSRNTTIRSNVEKLMNVQLTKEQAQKILTTIQMYVKPFEHPSNKQVTNLFKKVKKLKTPLISDEVLQTSTYIGWNDIASNRKFIIYYDNFGKLNGVYGDISNQTVKSFCSICNKESRVALFMRKTRTGNDGQYTKKGDYICFDSTLCNHQISDLSHFHHFLNKIQ,84.04,gnl|BL_ORD_ID|2037|hsp_num:0,2248,TRUE,loose hit with at least 95 percent identity pushed strict
LK489,3_8 # 4953 # 5372 # 1 # ID=3_8;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.293,3_8,4953,5372,+,Strict,150,182.57,FosBx1,57.97,3007372,protein homolog model,n/a,n/a,phosphonic acid antibiotic,antibiotic inactivation,fosfomycin thiol transferase,ATGATTCAATCTATAAACCATATTACCTATTCTGTATCAGAAATTAATAAGTCTATTGTTTTCTATAAAGATATTTTAAAAGCTGAAATTTTAGTAGAGAGTGGCAAAACAGCGTATTTCACATTAGGTGGTCTGTGGTTAGCTTTAAATGAAGAAAAAGATATACCTAGAAATGAAATCCAACACTCGTATACGCATATGGCTTTTACAATTAAGGAAAGTGAATTTGATGAATGGTATCAATGGTTAAAAGATAACAATGTGAATATATTAGAAGGACGTAATAGAGATGTAAGAGATAAACAATCAATATACTTCACTGATCCAGACGGTCACAAGTTAGAATTACATACAGGTACGTTGCAAGATAGGCTAGATTATTATAAAGAAGAAAAGTCACATATGAAATTTTATGTATAA,MIQSINHITYSVSEINKSIVFYKDILKAEILVESGKTAYFTLGGLWLALNEEKDIPRNEIQHSYTHMAFTIKESEFDEWYQWLKDNNVNILEGRNRDVRDKQSIYFTDPDGHKLELHTGTLQDRLDYYKEEKSHMKFYV,MLRGINHICFSVSNLENSIMFYEKVLEGELLVKGRKLAYFNICGVWIALNEETHIPRNEIHQSYTHIAFSVEKEDFKCLIQRLEENDVHILQGRERDVRDCESIYFVDPDGHKFEFHSGTLQDRLNYYRDEKPHMTFY,100.72,gnl|BL_ORD_ID|4909|hsp_num:0,5900,FALSE,None
LK489,4_195 # 206811 # 208208 # 1 # ID=4_195;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.340,4_195,206811,208208,+,Strict,525,634.41,norC,70.09,3007010,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGACACAACAGGGAAATACACAAAATTATAAAGGGGATAATAAACTCATATTAGGTATTGTGTTAGGCGTTGTTACGTTTTGGTTATTTGCACAATCTTTACTTAATGTGGTCCCAACGTTACAGCAATCTTTTGATAGTAATATTGGAACAATTAGCATTGCAGTTAGTATTACAGCTTTATTTTCAGGTATGTTTGTTGTAGGTGCGGGGAGTCTTGCTGATAAAGTGGGACGCGTAAGAATTACTTATATTGGTTTATGGCTCAGTATTATTGGATCATTATTAATCATTATCAGTAATTTACCACTATTATTAATTGTTGGAAGGGTTATTCAAGGATTGTCTGCGGCTGCTATTATGCCATCAACATTAGCAATTATGAAAACTTATTTTGAAGGAAAAGAGAGACAACGTGCGTTAAGTTACTGGTCTATAGGATCTTGGGGAGGTTCAGGACTAGCATCATTATTTGGAGGTATGGTTGCTACTTTTGTGGGATGGCGCTGGATATATATTTTATCTATTATCATTGCATTATTAGCAATGTATTTAATCAAAGGAACACCCGAAACAAAATCAGAAAGCACACTGAAGCAACGTTTTGATTATAGTGGACTGATATTATTTGTGATTATGATGTTGAGTATTAACGTTGTTATAACGCAAAGTGGAACATTCGGTATCACGTCGCCATTGATTTTAGGTCTTATTATTATATTTATAGTAGCAACAATCATATTCTTAAAAGTTGAAAACAGGGTGGGTAATCCATTAATTGATTTTAAATTATTTAATAATAAAGCATATACAGGTGCCACATTATCTAATTTCTTATTGAATGGTGTTGCAGGTGCACTTTTAGTTGCTAATACATTTGTACAACAAGGACTAGGATTTAATGCATTTCAAACAGGACTGTTATCCATTACTTACTTAATAACTGTGTTATTAATGATCCGTGTAGGTGAGAAAGTATTGCAAAAGGTGGGCGCTAAAAAGCCGATGCTATTAGGGACACTTTTTAATATGGTAGGTATTATGCTCATATCGCTGACATTCTTACCTAGTGTTATTTATGTAGTAGTTTGTATTATTGGTTATTTATTATATGGTTTAGGCTTAGGATTCTATGCGACACCGTCTACAGATATGGCAATTTCTAATTCTCCAGAAGATAAAGTGGGCGTTGCCTCAGGTATATATAAAATGGCATCATCACTTGGTGGTGCATTTGGTATTGCATTATCAGGCGCACTTTTTGGTGTTATAGCAAGTGCAACAAATGTTCAAATTGGTGCATTCGTAGGTCTTTGGTTAAATGTCATTATGGCACTATTATCTTTAATCATTATCATGTTTATGGTGCCAGCTACTAAAACAAAAGCTAAGTGTTAA,MTQQGNTQNYKGDNKLILGIVLGVVTFWLFAQSLLNVVPTLQQSFDSNIGTISIAVSITALFSGMFVVGAGSLADKVGRVRITYIGLWLSIIGSLLIIISNLPLLLIVGRVIQGLSAAAIMPSTLAIMKTYFEGKERQRALSYWSIGSWGGSGLASLFGGMVATFVGWRWIYILSIIIALLAMYLIKGTPETKSESTLKQRFDYSGLILFVIMMLSINVVITQSGTFGITSPLILGLIIIFIVATIIFLKVENRVGNPLIDFKLFNNKAYTGATLSNFLLNGVAGALLVANTFVQQGLGFNAFQTGLLSITYLITVLLMIRVGEKVLQKVGAKKPMLLGTLFNMVGIMLISLTFLPSVIYVVVCIIGYLLYGLGLGFYATPSTDMAISNSPEDKVGVASGIYKMASSLGGAFGIALSGALFGVIASATNVQIGAFVGLWLNVIMALLSLIIIMFMVPATKTKAKC,MNETYRGGNKLILGIVLGVITFWLFAQSLVNVVPNLQQSFGADMGTISIAVSLTALFSGMFVVGAGGLADKIGRVKMTNIGLLLSIIGSALIIITNLPALLILGRIIQGVSAACIMPSTLAIMKTYYEGAERQRALSYWSIGSWGGSGICSLFGGAVATTMGWRWIFIFSIIVAVLSMLLIKGTPETKSEVTNTHKFDVAGLIVLVVMLLSLNVVITKGAALGYTSLWFFGLIAIVIVAFFIFLNVEKKVDNPLIDFKLFENKPYTGATISNFLLNGVAGTLIVANTFVQQGLGYTALQAGYLSITYLIMVLLMIRVGEKLLQKMGSKRPMLLGTFIVIIGIALISLVFLPGIFYVISCVVGYLCFGLGLGIYATPSTDTAISNAPLDKVGVASGIYKMASSLGGAFGVAISGAVYAGAVAATSIHTGAMIALWVNVLMGIMAFIAILFAIPNDDKRVKDAK,100.65,gnl|BL_ORD_ID|4656|hsp_num:0,5726,FALSE,None
LK489,5_116 # 115575 # 117026 # -1 # ID=5_116;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.365,5_116,115575,117026,-,Strict,525,541.191,norC,59.96,3007010,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,GTGTATATCTTTTTTGAAGTGATGCAATGCTTTTTGGGGGATATAGGAGGAAAAAAGAATATGGAGTCATCACAATCATTTGAAGGAGATAATAGGCTTCTTGTAGGTATATTTTTAGGAGTTATTACATTCTGGTTATTTGCACAATCTCTTGTAAATATCGTACCAGATCTTCAGTCATCGTTTGATACAAATTATGGCACAATTAACGTGGCAGTAAGTATCACAGCATTATTGTGTGGGCTGTTTGTTGTCGGTGCTGGTGGGCTAGCTGACCGATATGGTAGAGTTAAAATGACATATATAGGATTGATTTTAAGTATTGTCGGTTCATTACTGATTATTATTCCTGGATTTATACCATTGTTAGTAGTTGGTAGAGCCATACAAGGCTTATCTGCTGCGTGTATTATGCCATCAACGTTAGCAATCATTAACGAGTATTACATAGGAAGCCGACGTCAACGCGCCCTGAGCTATTGGTCTATTGGTTCATGGGGCGGTACAGGTATTTGTTCATTATTCGGTGGCATGGTGTCTACCTTTGTAGGTTGGAGATCAATTTTTATTATCTCTATTATTGTGGCACTCGCAGCGATGTATTTAATGAAGCATGCGCCAGAAACAAAGGCGGTTCAAACAAAAGAAACGAAACGCGCCAAATTTGATACGATTGGACTTATTATTTTAATTATTGCAATGTTGAGTGTCAATTTGATTATTACACAAGCTTCAAATTATGGTTTATTTTCACCACTCATTTTGTCATTGATGTTCATTTTTATTGTTGCAGTTATTGGATTCTTATTTTATGAAACAAGAATACACAATCCGCTGATTGATTTTAGGATATTTAAAAATAAAGGTTACACGGGTGCAACAGTATCGAACTTTTTATTAAATGCCGTTGCCGGTACTTTAATTGTAGCGAATACTTATTTTCAATCAGGCCTTCATTTTACATCATTCCAATCTGGCGCAATGACGATTACTTATCTTGTGGCTGTACTTGTAATGATTAGAGTCGGAGAAAAAATACTTCAACACATTGGACCTAAACGTCCAATGTTAATCGGTGCAGGGTTAAATGCTGTTGGTATTATTTTAATTTCACTCACATTCCTACCTACACCGATGTATATCGTTATGTGTATACTTGGTTACTTAATTTATGGTATCGGATTAGGTATGTATGCAACGCCATCTACAGACACTGCTGTTACGACAGCGCCTGATGACAAAGTAGGTGTCGCTTCTGGTGTCTATAAAATGGCGTCCTCTTTAGGTAATTCGTTTGGTGTTGCGTTGTCAGGAACAATATTTACGGTTATGACAACCACTGCGAATATACATGTAGGTGCCATGTATGGTTTGTTATTTAATGCAGCATTAGCTATTATTGCATTTTTAGCTGTTCTATTACTCGTGCCTAAACATCAATTTAATAATTAA,MYIFFEVMQCFLGDIGGKKNMESSQSFEGDNRLLVGIFLGVITFWLFAQSLVNIVPDLQSSFDTNYGTINVAVSITALLCGLFVVGAGGLADRYGRVKMTYIGLILSIVGSLLIIIPGFIPLLVVGRAIQGLSAACIMPSTLAIINEYYIGSRRQRALSYWSIGSWGGTGICSLFGGMVSTFVGWRSIFIISIIVALAAMYLMKHAPETKAVQTKETKRAKFDTIGLIILIIAMLSVNLIITQASNYGLFSPLILSLMFIFIVAVIGFLFYETRIHNPLIDFRIFKNKGYTGATVSNFLLNAVAGTLIVANTYFQSGLHFTSFQSGAMTITYLVAVLVMIRVGEKILQHIGPKRPMLIGAGLNAVGIILISLTFLPTPMYIVMCILGYLIYGIGLGMYATPSTDTAVTTAPDDKVGVASGVYKMASSLGNSFGVALSGTIFTVMTTTANIHVGAMYGLLFNAALAIIAFLAVLLLVPKHQFNN,MNETYRGGNKLILGIVLGVITFWLFAQSLVNVVPNLQQSFGADMGTISIAVSLTALFSGMFVVGAGGLADKIGRVKMTNIGLLLSIIGSALIIITNLPALLILGRIIQGVSAACIMPSTLAIMKTYYEGAERQRALSYWSIGSWGGSGICSLFGGAVATTMGWRWIFIFSIIVAVLSMLLIKGTPETKSEVTNTHKFDVAGLIVLVVMLLSLNVVITKGAALGYTSLWFFGLIAIVIVAFFIFLNVEKKVDNPLIDFKLFENKPYTGATISNFLLNGVAGTLIVANTFVQQGLGYTALQAGYLSITYLIMVLLMIRVGEKLLQKMGSKRPMLLGTFIVIIGIALISLVFLPGIFYVISCVVGYLCFGLGLGIYATPSTDTAISNAPLDKVGVASGIYKMASSLGGAFGVAISGAVYAGAVAATSIHTGAMIALWVNVLMGIMAFIAILFAIPNDDKRVKDAK,104.55,gnl|BL_ORD_ID|4656|hsp_num:0,5726,FALSE,None
LK489,9_17 # 19592 # 20266 # -1 # ID=9_17;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.308,9_17,19592,20266,-,Strict,50,102.834,vanY gene in vanM cluster,33.13,3002961,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGTCAAAAAAAGTGATGCTTTTTCTGTTCACTTTAGTATGTTTATGTCTTATTGTTATTTTTATTATGATTCTATCAGCTAATAATTTTAAACCAACTAATGACAATATTGTTAAACCCAAGAATGCCTTACCACTCAAATATGAAAACAATGGTGTAACTTATGTCAATGGTCATGTCATTGTGAATAAACAACTTGCACTTCCGGCGAAATATAAACCAGGCGAAAATAAAATAGCTAAAAAGCAACTAAACAAATTATTGAAGCAAGCAGAAAAAAGAAATTTAGATTTGACCATGACAAGTGGATATAGAAATTTTGAGAATCAAGAAAAAGTGGTAGATACTTTTGTTGAGAAGGATGGTAAGCAAAAGACAACTAAATATGCTGCTAAACCTGGACATTCTGAACACCAAACAGGTTTAGCATTTGATGTAGGAACAAGCCAACCATTAAATGATTTTCATACAGATTTTGAAAAAACTAAAGAAGCACAATGGTTAGCTAAACATGCAGCCAATTATGGTTTTATTATTAGGTATCCTAAGAACCAATCAAAACAAACTGGCTATGCTTATGAACCATGGCATTTAAGGTATGTAGGACCTCAATTGGCAAAAACAATCAATGAGAAAAATACAAATTTAGAAAGCTATTACCATCTTAATAAGTAA,MSKKVMLFLFTLVCLCLIVIFIMILSANNFKPTNDNIVKPKNALPLKYENNGVTYVNGHVIVNKQLALPAKYKPGENKIAKKQLNKLLKQAEKRNLDLTMTSGYRNFENQEKVVDTFVEKDGKQKTTKYAAKPGHSEHQTGLAFDVGTSQPLNDFHTDFEKTKEAQWLAKHAANYGFIIRYPKNQSKQTGYAYEPWHLRYVGPQLAKTINEKNTNLESYYHLNK,MVFQGNLLLVNNEYPVLEESIKTDVVNLFKHDELTKGYELLNREIYLSEKVAREFSEMVDAAEKEGVRHFSINSGFRNFDEQNALYQEMGSDYALPAGYSEHNLGLALDIGSTQMEMSEAPEGKWLEDNAWEYGFILRYPMDKTAITGIQYEPWHFRYVGLPHSAIIEEKNFALEEYLDFLKEQKSISGTIHGENYEISYYPITEKTDIEMPANLHYEISGNNMDGVIVTVYR,96.14,gnl|BL_ORD_ID|1673|hsp_num:0,1713,FALSE,None
LK489,13_28 # 27040 # 28377 # 1 # ID=13_28;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.301,13_28,27040,28377,+,Strict,200,526.554,sdrM,63.21,3007013,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGAATATAAAATCATTAGGCATTATTATTGCGTTAATATTAATTATGTTTATGTCTGCAATAGAAACTTCAATCGTTTCCTTAGCATTGCCAACTATAAAAAATGATTTAAACGTAACGTCATCTATTTCATTGATATTTGCTGTGTATTTTATTGCAATTGTTATTGCAAACCCGATTGTTGGAGAATTGTTAGATCGTACTAAAATTATATATATTACATTATTAGGGCTTATGTTATTTACAATAGGAAGTTTATTTTCAGGGCTAAGTGACACATTTACCATGTTAATCATCTCTCGCTTTATTCAAGGATTGGGTGCAGGTGTCATGATGGCATTAAGCCAAATTGTCCCAAAACTGGCATTTGAGATACCTTTACGCTATAAAATCATGGGAATCGTTGGAAGTGTATGGGGGATATCCAGTATTATAGGACCTGTTTTAGGTGGCGGTATTTTAGAGTTTGCTACATGGCATTGGCTATTCTTCGTGAATATTCCAATTTCAATTATTGCAATCATACTTGTAGTGATTACATTTCATTTCGAGAATGAAAGTACATCAACTAGTGCTAAATTAGATGTAAAAGGCTTATCGTTATTTTATACTTTTGTATTCTTTTTAATATTTGCAGTGATGTATACAGCCAATATTTATTTAAATATCATTTCAATCATATTAGCTACGGTTGTCGGTGTTGTGTTATATAGAAATGAAAAGACAATAAAAACACCTTTTATACCAGTGCAAGAATTTAATAAAACAATTGTTTTAATATTTTTTACTGATTTTGCATATGCAATTATACTTATGGGTTATAACCTCTATATGCCAATTTATTTACAAGAAGATCTTGGCTTATCTCCATTACAAAGTGGGTTTGTTATTTTTCCAATTTCGTTTGCGTGGCTAGTATTGAATTTTAATTTAGATAAAATAGAAGCAAAAATGACTAGGAAGGCATTATATATATTTGCATTTACATGTTTAATGCTTTGTGGCATTTTAGTATTTATAGGAACTAACTCTCCAATTTTTATTGCTTGTAGTTTGTTATTAGCAGGTATAAGCTTTGGTACAGTTTATACTAAAGATAGTGTTATCACACAAGAAGAAACCTCTCCTAAAAATATGAAGCGTATGATGTCATTATACACTTTGACTAAGAGCCTGGGTAATTCAGTCGGATCGACAATTATGGGCTATGTCTATGCGTTATCTATTCCAATTATTGGTTTGCATATTCATAACATTGTAATTTTGAGCTTTGTCATCTTGTTTATACTTATAATATTATGGTCCATCACATATCGAAAACAAGATACATTAACTTAA,MNIKSLGIIIALILIMFMSAIETSIVSLALPTIKNDLNVTSSISLIFAVYFIAIVIANPIVGELLDRTKIIYITLLGLMLFTIGSLFSGLSDTFTMLIISRFIQGLGAGVMMALSQIVPKLAFEIPLRYKIMGIVGSVWGISSIIGPVLGGGILEFATWHWLFFVNIPISIIAIILVVITFHFENESTSTSAKLDVKGLSLFYTFVFFLIFAVMYTANIYLNIISIILATVVGVVLYRNEKTIKTPFIPVQEFNKTIVLIFFTDFAYAIILMGYNLYMPIYLQEDLGLSPLQSGFVIFPISFAWLVLNFNLDKIEAKMTRKALYIFAFTCLMLCGILVFIGTNSPIFIACSLLLAGISFGTVYTKDSVITQEETSPKNMKRMMSLYTLTKSLGNSVGSTIMGYVYALSIPIIGLHIHNIVILSFVILFILIILWSITYRKQDTLT,MRLKSIITVIALILIMFMSAIESSIISLALPTIKQDLNAGNLISLIFTAYFIALVIANPIVGELLSRFKIIYVAIAGLLLFSIGSFMCGLSTNFTMLIISRVIQGFGSGVLMSLSQIVPKLAFEIPLRYKIMGIVGSVWGISSIIGPLLGGGILEFATWHWLFYINIPIAIIAIILVIWTFHFPEEETVAKSKFDTKGLTLFYVFIGLIMFALLNQQLLLLNFLSFILAIVVAMCLFKVEKHVSSPFLPVVEFNRSITLVFITDLLTAICLMGFNLYIPVYLQEQLGLSPLQSGLVIFPLSVAWITLNFNLHRIEAKLSRKVIYLLSFTLLLVSSIIISFGIKLPVLIAFVLILAGLSFGYIYTKDSVIVQEETSPLQMKKMMSFYGLTKNLGASIGSTIMGYLYAIQSGIFGPNLHNVLSAVAVISIGLIVLWVVFFKEQSSQSKE,99.55,gnl|BL_ORD_ID|4661|hsp_num:0,5729,FALSE,None
LK489,13_29 # 28564 # 29022 # 1 # ID=13_29;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.229,13_29,28564,29022,+,Strict,100,208.764,sepA,70.34,3007012,protein homolog model,n/a,n/a,disinfecting agents and antiseptics,antibiotic efflux,small multidrug resistance (SMR) antibiotic efflux pump,ATGAAATATTTAAGATATTTATTAACAACGCTTATTGTGCTTTCTGTATTTATTATTTCTGGTGCGATTTTTTTAACTTTTTTAGGATTTGGTTTATACGGATTAAGTAGAATTTTAATCTACTTTCATCTTGCATATTTTGGTTATAATAAAAGTTTTTACGATAACTTGATATATTACGGTAGTTATATTGTATTAGGCTATTTCAATTTATTCATTGTAGAAAATTTAATGGATTATTTTAGAAAAAAATTACCTGAAAATCTTTACTTTCAAGGACTTACCTTTCAATTAATTACGTTTTCAGTAACTACATTGTTGTTTTATTTTATAGTGCACATACATTATACCTATATCGACATCGACTTTTGGGTAATTGTATTAATTATTGGCGTATTATTCATCTGTAAAGAAATATTTTATCCTGATAGTAAAAATTTAAATCAAAAAAATAAATAA,MKYLRYLLTTLIVLSVFIISGAIFLTFLGFGLYGLSRILIYFHLAYFGYNKSFYDNLIYYGSYIVLGYFNLFIVENLMDYFRKKLPENLYFQGLTFQLITFSVTTLLFYFIVHIHYTYIDIDFWVIVLIIGVLFICKEIFYPDSKNLNQKNK,MIVNFFKHKFYNLLTTMIVLFVFVLSGAIFLTFLGFGLYGLSRILIYFRLGDFTYNRNMYDNLLYYGSYIIFGYFIIFAVEHLMDYFRKMLPENAYFRGATFHLISYTVATTLFYFIIHLHYVYINIDFWVIMVIIGFLYVCKLQFYPESKNLNNRK,96.82,gnl|BL_ORD_ID|4660|hsp_num:0,5728,FALSE,None
LK489,18_5 # 3044 # 4588 # -1 # ID=18_5;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.355,18_5,3044,4588,-,Strict,990,997.268,qacA,99.61,3003046,protein homolog model,n/a,n/a,fluoroquinolone antibiotic,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGATTTCATTTTTTACAAAAACTACTGATATGATGACATCAAAAAAAAGATGGACTGCACTAGTAGTATTAGCTGTTAGTTTGTTTGTTGTTACAATGGATATGACAATATTAATTATGGCTTTACCGGAATTAGTAAGAGAGTTAGAGCCTTCTGGTACCCAACAGTTATGGATAGTTGATATATACTCTCTTGTTTTAGCTGGCTTTATAATTCCATTGAGTGCCTTTGCTGATAAATGGGGAAGAAAAAAAGCATTATTAACTGGATTTGCTTTATTTGGCCTCGTTTCATTAGCTATATTTTTCGCAGAAAGTGCAGAGTTCGTAATAGCTATTCGATTTTTACTTGGTATTGCAGGTGCTTTAATAATGCCAACTACTCTTTCAATGATAAGAGTAATTTTTGAAAACCCTAAAGAAAGGGCCACTGCATTAGCTGTATGGTCAATCGCTTCATCGATAGGTGCTGTTTTTGGACCAATTATCGGAGGAGCTTTACTTGAGCAATTTTCATGGCACTCGGCATTTTTAATTAATGTACCGTTTGCGATAATAGCAGTTGTAGCAGGTTTATTTTTATTACCAGAGTCTAAGTTATCAAAAGAAAAGTCTCACTCGTGGGATATTCCTTCTACAATTTTATCAATTGCAGGCATGATTGGACTGGTATGGAGTATCAAAGAATTTTCAAAAGAAGGACTAGCAGATATTATTCCATGGGTTGTAATAGTATTAGCAATTACCATGATAGTGATATTTGTTAAACGTAATTTATCAAGTTCTGATCCAATGTTAGACGTAAGACTTTTTAAAAAGAGATCATTTTCAGCTGGTACAATTGCTGCATTTATGACAATGTTTGCAATGGCATCTGTTTTGTTATTAGCTTCACAATGGTTACAGGTTGTGGAAGAACTTTCTCCTTTTAAAGCTGGCTTATACCTATTACCTATGGCAATAGGAGCTATGGTGTTTGCACCAATTGCACCCGGATTAGCGGCGCGATTTGGACCGAAAATAGTGTTACCTTCCGGAATTGGAATTGCAGCCATTGGCATGTTTATTATGTATTTCTTTGGTCATCCATTATCATATTCTACAATGGCTTTAGCATTAATTTTAGTTGGAGCTGGTATGGCTTCACTAGCAGTTGCATCTGCTCTAATAATGTTAGAAACACCTACATCAAAAGCAGGTAATGCAGCTGCTGTTGAAGAGTCTATGTATGACCTTGGAAATGTTTTTGGTGTAGCAGTACTTGGTAGCCTATCTTCTATGCTTTATCGTGTATTTTTAGATATTTCATCTTTTTCATCAAAAGGTATAGTTGGAGATTTAGCTCATGTAGCTGAAGAATCTGTAGTGGGCGCTGTCGAAGTAGCTAAAGCTACGGGGATAAAACAGCTTGCAAACGAGGCTGTAACATCATTTAATGATGCTTTTGTAGCAACTGCTTTAGTAGGTGGGATTATCATGATTATCATTTCAATAGTTGTCTATTTGTTAATTCCCAAATCACTTGATATAACTAAACAAAAATAG,MISFFTKTTDMMTSKKRWTALVVLAVSLFVVTMDMTILIMALPELVRELEPSGTQQLWIVDIYSLVLAGFIIPLSAFADKWGRKKALLTGFALFGLVSLAIFFAESAEFVIAIRFLLGIAGALIMPTTLSMIRVIFENPKERATALAVWSIASSIGAVFGPIIGGALLEQFSWHSAFLINVPFAIIAVVAGLFLLPESKLSKEKSHSWDIPSTILSIAGMIGLVWSIKEFSKEGLADIIPWVVIVLAITMIVIFVKRNLSSSDPMLDVRLFKKRSFSAGTIAAFMTMFAMASVLLLASQWLQVVEELSPFKAGLYLLPMAIGAMVFAPIAPGLAARFGPKIVLPSGIGIAAIGMFIMYFFGHPLSYSTMALALILVGAGMASLAVASALIMLETPTSKAGNAAAVEESMYDLGNVFGVAVLGSLSSMLYRVFLDISSFSSKGIVGDLAHVAEESVVGAVEVAKATGIKQLANEAVTSFNDAFVATALVGGIIMIIISIVVYLLIPKSLDITKQK,MISFFTKTTDMMTSKKRWTALVVLAVSLFVVTMDMTILIMALPELVRELDPSGTQQLWIVDIYSLVLAGFIIPLSAFADKWGRKKALLTGFALFGLVSLAIFFAESAEFVIAIRFLLGIAGALIMPTTLSMIRVIFENPKERATALAVWSIASSIGAVFGPIIGGALLEQFSWHSAFLINVPFAIIAVVAGLFLLPESKLSKEKSHSWDIPSTILSIAGMIGLVWSIKEFSKEGLADIIPWVVIVLAITMIVIFVKRNLSSSDPMLDVRLFKKRSFSAGTIAAFMTMFAMASVLLLASQWLQVVEELSPFKAGLYLLPMAIGDMVFAPIAPGLAARFGPKIVLPSGIGIAAIGMFIMYFFGHPLSYSTMALALILVGAGMASLAVASALIMLETPTSKAGNAAAVEESMYDLGNVFGVAVLGSLSSMLYRVFLDISSFSSKGIVGDLAHVAEESVVGAVEVAKATGIKQLANEAVTSFNDAFVATALVGGIIMIIISIVVYLLIPKSLDITKQK,100,gnl|BL_ORD_ID|339|hsp_num:0,372,FALSE,None
LK489,18_9 # 6631 # 7530 # -1 # ID=18_9;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.368,18_9,6631,7530,-,Strict,500,616.305,mphC,98.66,3000319,protein homolog model,n/a,n/a,macrolide antibiotic,antibiotic inactivation,macrolide phosphotransferase (MPH),ATGACTCGACATAATGAAATTATTAAATGTGCAGAAAAATATCAATTACACATCCAACCTCAAACAATCTCATTGAATGAATCGGGACTTGATTTTCAAGTTGCATTTGGAAAAGATAAACATGGAGTAGAATGGGTTTTGAGACTACCAAGAAGACCTGACGTTTATAAACGAACAAAACCCGAAAAACAAACGGTAGACTTCTTACAGAAGAATGTTTCATTTGAAATACCGAAGTGGAAAGTACATGCAAAAGACCTTATTGCTTACCCAAAACTTACAGGTAAACCCGCAGCCACAATAGATCCAGAAATACAAAATTATGTATGGGAAATTGAACACAAACCATTACCAGAAAACTTTATTAACACATTAGCTGAAACACTCGTAGATTTACACAACATACCAGAAGAAAACATTAACGTTCAGCATATAAATATCAAAACCATACAAGAAATAAAAAATGACTTTCAAAGAAGAATGAATAAAGTTAAAGAAACTTATGGCGTATCAGATGAATTATGGAACAGATGGAAACAATGGTTAGAAAACGACGAACTATGGCCTCGACATGCGACCATGATACATGGGGACTTACATCCAGGACATATAATGGTAGATAACCAAGCAAACGTCACAGGTCTCATAGACTGGACTGAAGCAACCCACTCCGACCCATCAATGGACTTTATAGGACACCATCGTGTATTCGACGACGAAGGATTAGAGCAACTTATAACAGCATACGGTAAAGCTGGAGGTGAAATATGGCCACGAATGAAAGAGCATATAATAGAACTCAATGCAGTATTCCCAATGTTTATCGCTGAGTTTGCTATGGAATCAGGAGAATCGGCGTATGAAACGATGGCATTGAAAGAGTTAGGTATGAAAGAGTAG,MTRHNEIIKCAEKYQLHIQPQTISLNESGLDFQVAFGKDKHGVEWVLRLPRRPDVYKRTKPEKQTVDFLQKNVSFEIPKWKVHAKDLIAYPKLTGKPAATIDPEIQNYVWEIEHKPLPENFINTLAETLVDLHNIPEENINVQHINIKTIQEIKNDFQRRMNKVKETYGVSDELWNRWKQWLENDELWPRHATMIHGDLHPGHIMVDNQANVTGLIDWTEATHSDPSMDFIGHHRVFDDEGLEQLITAYGKAGGEIWPRMKEHIIELNAVFPMFIAEFAMESGESAYETMALKELGMKE,MTRHNEIIKCAEKYQLHIQPQTISLNESGLDFQVAFGKDKHGVEWVLRLPRRPDVYKRTKPEKQTVDFLQKNVSFEVPKWKVHERDLIAYPKLTGKPAATIDPEIQNYVWEIEHKPLPENFINTLAETLVDLHNIPEENINVQHINIKTIQEIKNDFQRRMNKVKETYGVSDELWNRWKQWLENDELWPRHATMIHGDLHPGHIMVDNQANVTGLIDWTEATHSDPSMDFMGHHRVFDDEGLEQLITAYGKAGGEIWPRMKEHIIELNAVFPMFIAEFAMESGESAYETMALKELGMKE,100,gnl|BL_ORD_ID|1899|hsp_num:0,2062,FALSE,None
LK489,18_10 # 7629 # 9095 # -1 # ID=18_10;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.314,18_10,7629,9095,-,Strict,800,996.112,msrA,98.57,3000251,protein homolog model,n/a,n/a,macrolide antibiotic; streptogramin antibiotic; streptogramin B antibiotic,antibiotic target protection,msr-type ABC-F protein,ATGGAACAATATACAATTAAATTTAACCAAATCAATCATAAATTGACAGATTTACGATCACTTAACATCGGTCATCTTTACGCTTACCAATTTGAAAAAATAGCACTTATTGGGGGTAATGGTACTGGCAAAACCACATTACTAAATATGATTGCTCAAAAAACAAAACCAGAATCTGGAACAGTTGAAACGGTTGGCGAAATTCAATATTTTGAACAGCTTAACATGGATGTGGAAAATGATTTTAACACGTTAGACGGTAGTTTAATGAGTGAACTCCATATACCTATGCATACAACCGACAGTATGAGTGGTGGTGAAAAAGCAAAATATAAATTAGCTAATGTCATATCAAATTATAGTCCGATATTACTTTTAGATGAACCTACAAATCACTTGGATAAAATTGGTAAAGATTATCTGAAAAATATTTTAAAATATTACTATGGTACTTTAATTATAGTAAGTCATGATAGAGCACTTATAGACCAAATTGCTGACACAATTTGGGATATACAAGAAGATGGCACAATAAGAGTGTTTAAAGGTAATTACACACAGTATCAAAATCAATATGAACAAGAACAGTTAGAACAACAACGTCAATATGAACAGTATATAAGTGAAAAACAAAGATTGTCCCAAGCCAGTAAAGCTAAACGAAATCAAGCGCAACAAATGGCACAAGCATCATCAAAACAAAAAAACAAAAGTATAGCACCAGATCGTTTAAGTGCATCAAAACAAAAAGGCACGGTTGAGAAGGCTGCTCAAAAACAAGCTAAGCATATTGAAAAAAGAATGGAACATTTGGAAGAAGTTGAAAAACCACAAAGTTATCATGAATTCAATTTCCCACAAAATAAAATTTATGATATCCATAATAATTATCCAATCATTGCACAAAATCTAACATTGGTTAAAGGAAGTCAAAAACTGCTAACACAAGTACGATTCCAAATACCATATGGCAAAAATATAGCGCTCGTAGGTGCAAATGGTGTAGGTAAGACAACTTTACTTGAAGCTATTTACCACCAAATAGAGGGAATTGATTGTTCTCCTAAAGTGCAAATGGCATACTATCGTCAACTTGCTTATGAAGACATGCGTGACGTTTCATTATTGCAATATTTAATGGATGAAACGGATTCATCAGAATCATTCAGTAGAGCTATTTTAAATAACTTGGGTTTAAATGAAGCACTTGATCGTTCTTGTAATGTTTTGAGTGGTGGGGAAAGAACGAAATTATCGTTAGCAGTATTATTTTCAACGAAAGCGAATATGTTAATTTTGGATGAACCAACTAATTTTTTAGATATTAAAACATTAGAAGCATTAGAAATGTTTATGAATAAATATCCTGGAATCATTTTGTTTACATCACATGATACAAGGTTTGTTAAACATGTATCAGATAAAAAATGGGAATTAACAGGACAATCTATTCATGATATAACTTAA,MEQYTIKFNQINHKLTDLRSLNIGHLYAYQFEKIALIGGNGTGKTTLLNMIAQKTKPESGTVETVGEIQYFEQLNMDVENDFNTLDGSLMSELHIPMHTTDSMSGGEKAKYKLANVISNYSPILLLDEPTNHLDKIGKDYLKNILKYYYGTLIIVSHDRALIDQIADTIWDIQEDGTIRVFKGNYTQYQNQYEQEQLEQQRQYEQYISEKQRLSQASKAKRNQAQQMAQASSKQKNKSIAPDRLSASKQKGTVEKAAQKQAKHIEKRMEHLEEVEKPQSYHEFNFPQNKIYDIHNNYPIIAQNLTLVKGSQKLLTQVRFQIPYGKNIALVGANGVGKTTLLEAIYHQIEGIDCSPKVQMAYYRQLAYEDMRDVSLLQYLMDETDSSESFSRAILNNLGLNEALDRSCNVLSGGERTKLSLAVLFSTKANMLILDEPTNFLDIKTLEALEMFMNKYPGIILFTSHDTRFVKHVSDKKWELTGQSIHDIT,MEQYTIKFNQINHKLTDLRSLNIDHLYAYQFEKIALIGGNGTGKTTLLNMIAQKTKPESGTVETNGEIQYFEQLNMDVENDFNTLDGSLMSELHIPMHTTDSMSGGEKAKYKLRNVISNYSPILLLDEPTNHLDKIGKDYLNNILKYYYGTLIIVSHDRALIDQIADTIWDIQEDGTIRVFKGNYTQYQNQYEQEQLEQQRKYEQYISEKQRLSQASKAKRNQAQQMAQASSKQKNKSIAPDRLSASKEKGTVEKAAQKQAKHIEKRMEHLEEVEKPQSYHEFNFPQNKIYDIHNNYPIIAQNLTLVKGSQKLLTQVRFQIPYGKNIALVGANGVGKTTLLEAIYHQIEGIDCSPKVQMAYYRQLAYEDMRDVSLLQYLMDETDSSESFSRAILNNLGLNEALERSCNVLSGGERTKLSLAVLFSTKANMLILDEPTNFLDIKTLEALEMFMNKYPGIILFTSHDTRFVKHVSDKKWELTGQSIHDIT,100,gnl|BL_ORD_ID|1105|hsp_num:0,1200,FALSE,None
LK489,23_1 # 4 # 489 # -1 # ID=23_1;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.284,23_1,4,489,-,Strict,300,332.413,lnuA,99.38,3002835,protein homolog model,n/a,n/a,lincosamide antibiotic,antibiotic inactivation,lincosamide nucleotidyltransferase (LNU),ATGAAAAATAATAATGTAACAGAAAAAGAATTATTTTATATTTTAGATTTATTTGAACACATGAAAGTAACTTATTGGTTAGATGGTGGCTGGGGGGTAGATGTATTAACTGGAAAACAACAAAGAGAACACAGAGATATAGATATAGATTTTGACGCTCAACACACTCAAAAAGTTATACAAAAATTAGAAGATATAGGATACAAAATAGAAGTTGATTGGATGCCTTCACGTATGGAACTTAAGCATGAAGAATATGGGTATTTAGATATTCATCCTATAAATCTAAATGATGATGGATCAATTACCCAAGCAAACCCAGAAGGTGGTAATTATGTTTTCCAAAATGACTGGTTTTCAGAAACTAATTACAAAGATCGAAAAATACCATGTATTTCAAAAGAAGCTCAACTTCTTTTTCATTCTGGTTATGATTTAACAGAAACAGACCATTTTGATATAAAAAATTTAAAATCAATAACATAA,MKNNNVTEKELFYILDLFEHMKVTYWLDGGWGVDVLTGKQQREHRDIDIDFDAQHTQKVIQKLEDIGYKIEVDWMPSRMELKHEEYGYLDIHPINLNDDGSITQANPEGGNYVFQNDWFSETNYKDRKIPCISKEAQLLFHSGYDLTETDHFDIKNLKSIT,MKNNNVTEKELFYILDLFEHMKVTYWLDGGWGVDVLTGKQQREHRDIDIDFDAQHTQKVIQKLEDIGYKIEVHWMPSRMELKHEEYGYLDIHPINLNDDGSITQANPEGGNYVFQNDWFSETNYKDRKIPCISKEAQLLFHSGYDLTETDHFDIKNLKSIT,100,gnl|BL_ORD_ID|22|hsp_num:0,27,FALSE,None
LK1056,2_5 # 3146 # 3694 # -1 # ID=2_5;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.769,2_5,3146,3694,-,Strict,50,79.7221,vanY gene in vanF cluster,34.67,3002958,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,GTGAACAAGACCCGCCCCGTGGCCCCGCCCGACTGGGCGCCCTCGGATCTGCTGGCCGTGCCCGGCAGCGAGCTGCCCCTGCGGGCGGAGGCCGCGACGGCGGCCGGCGACCTGCTGGATGCCGCCGCGGCGGCGGGCCACCGCCTCACCACCCTGAGCGCCTACCGCTCGTACGACTACCAGGTCCGGACGTACGGCCACTGGGTCGACGAGCTGGGCCGCGCCGAGGCCGACCGCGTCTCGGCGCGTCCGGGGTACTCCGAGCACCAGACCGGCCTGGCCTGGGACGTGGGCGACGCCGCGACCCCCGCGTGTGACCTGGAAGCGTGCTTCGGCGACACCGCCGCGGGCCGCTGGGTGGCCGCGCACGCCGCCGAGCACGGGTTCGTCATCCGCTACCCCGCCGGGGCCGAGGACGTGACGGGCTTCGCCCACGAGCCCTGGCACCTGCGCTATGTCGGGTCCGCGGAGGCGGCCCGGGTCGAGGCGGTCGGCGGCGTCCTCGAGACCGCATGGGGTCTGCCTCCGGCGCCCGACTACGCGGACTGA,MNKTRPVAPPDWAPSDLLAVPGSELPLRAEAATAAGDLLDAAAAAGHRLTTLSAYRSYDYQVRTYGHWVDELGRAEADRVSARPGYSEHQTGLAWDVGDAATPACDLEACFGDTAAGRWVAAHAAEHGFVIRYPAGAEDVTGFAHEPWHLRYVGSAEAARVEAVGGVLETAWGLPPAPDYAD,MKKWGLLLVFALFLVFIFNILPISQDKVEDRIYEQNDKDTSDDKMTAENMQKIELTEEQIYQGNLLLVNNEHPVHQKSIKSDIINLFTHKELTKGYGLLDNEIKLSEEIAGKFSEMIAAAEEDGVSNFLISSGYRDLDEQSRLYEEMGSDFALPAGHSEHNLGLSLDVGSTQMKMDKAPEGKWIEKNCWEYGFILRYPLDKTDVTGIQYEPWHIRYVGLPHSAIMQEMNLALEEYLDYLKEEKSISVRVDGKKYTISYDPISQNETIEVEVPADEQYEISGNNIDGVIVTTFS,62.12,gnl|BL_ORD_ID|1808|hsp_num:0,1899,FALSE,None
LK538,1_117 # 124726 # 126477 # -1 # ID=1_117;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.687,1_117,124726,126477,-,Strict,50,98.2117,vanW gene in vanI cluster,35.03,3003724,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanW; glycopeptide resistance gene cluster,ATGACCGACCACGACAGCTGGACCGAGGACGAGGTCCTCGATCGTCCACGCCGCGGGCGCACCCTCCTGGCCGTGGCCTTCGTGCTCATGGTGCTCGCCGGCCTGTACGCCGCGGCGGCGCTGTACTTCGGCGACAAGGTGCCTGCCGACACCCGCATCGGCGGGGTGGCCATCGGCGGCAAGACCCCGTCGGAGGCGCAGCAGGCTCTCGAGGACGAGCTCTCCGACGAGGAGGCGCGGCCGGTCACCGTGACGGTGGACGGCAAGGACGTCGAGCTGGAGCCCGCGGACGCCGGGCTGTCCTACGACTACGCGGGCTCCGTCGACGGGCTGACCGGCTTCAGCCTCAACCCCGTCGACCTGTGGCACCACGTGCGCGGTGGCGTCGAGCGTGACGTCGAGGTGGCCGTCGACGAGCAGGCGCTCGCCGACGCCGTCGACGCCAAGACGTCGATGCTCGACAAGGAGCCGGTCGAGGGCAAGGTGACCCTTGAGGGCGCGACGGTGAAGAAGACCGCCTCCAAGCCCGGGCTGAGCGTCGACCGTGACGCCGTGGTCGAGTCCATCGCGGACGAGTGGCCCGCCCAGCGCTCCTTCGACGCACCCACCACGGAGCCGGCGCCCCAGCTCACCCAGGCCGAGATCGACCGCTTCGCCAAGGACGACCTCGAGCCGCTCGTCGCCGGTCCGGTGACCGTGACGACGACCGACCCGCAGGGCGAAGGGGAGGACAAGACCATCTCCTTCACCGTGCCGGCCGACCAGCTCGCCGGTGCCATCTCGATCAAGGACGACAAGGGCAAGCTCTCGGCGAGCGTCGACGAGGCCAAGGTCGCCAAGGCAACCCTGTCGGCCGGCTCGTCGTCGGGTCTCTTCCGCGAGGCCAAGGACGCCGGGGTGGTCCACCGCGGCGGCTCCGACTTCGACGTCACTCCCTCGAGCACCGGACTGGCGCTCAAGGAGGACGGCCTGGGCGCCAAGGTCGCCGAGGCGATGAAGAAGAAGGGCGACGAGCGCAAGGTCGCCGCCGACTCGCAGGAGTCGCAGCCGGAGCTGACGACCGCCGAGGCGAAGAAGACCCTCCCGGAGGAGGAGCTGTCGACCTTCACGACCTACCTGCCGGACACGGGTGGCGTGCGGACCAACAACATCAAGATCGCGGCCCGCCAGCTCGACGGTGCCTACGTGGCGCCGGGCGAGACCTTTTCGCTCAACCAGCAGCTCGGGCAGCGCACCGCGGCCAAGGGCTACCAGAAGGCCGGCGTCATCAGCGGTGGTCGGCTGACCAACGACTACGGCGGCGGCATCTCGCAGCTGTCGACGACGCTCTTCAACGCGGTCTTCTTCTCCGGGGCCAAGATCGAGGAATTCCACCCGCACTCCTTCTACATCTCCCGCTACCCGGAGGGTCGCGAGGCGACGATCTCGTGGCCCGACGTCGACAACCGCTTCACCAACGACTCCGGCGCCGGCATCCTCATCTCGGCCTCGGTGAGGGGCAACGAGGTCACCGTGACCTTCCACGGCCGCAAGAAGTACGACGAGATCAAGGCGACCAAGAGCGCCCGCAAGAACATCACGCCGCCCAAGACGATCACCGACAACACGAAGGGCTGCGTGCCCCAGTCGCCGGCCCCCGGCTTTTCGGTCGACATCGGGCGCCAGTTCATCAAGGACGGCAAGACGGTGAAGAGCTCGAGCTTCACCACCCGCTACATCCCCCAGGACGACGTGACCTGTACGAACGCTTGA,MTDHDSWTEDEVLDRPRRGRTLLAVAFVLMVLAGLYAAAALYFGDKVPADTRIGGVAIGGKTPSEAQQALEDELSDEEARPVTVTVDGKDVELEPADAGLSYDYAGSVDGLTGFSLNPVDLWHHVRGGVERDVEVAVDEQALADAVDAKTSMLDKEPVEGKVTLEGATVKKTASKPGLSVDRDAVVESIADEWPAQRSFDAPTTEPAPQLTQAEIDRFAKDDLEPLVAGPVTVTTTDPQGEGEDKTISFTVPADQLAGAISIKDDKGKLSASVDEAKVAKATLSAGSSSGLFREAKDAGVVHRGGSDFDVTPSSTGLALKEDGLGAKVAEAMKKKGDERKVAADSQESQPELTTAEAKKTLPEEELSTFTTYLPDTGGVRTNNIKIAARQLDGAYVAPGETFSLNQQLGQRTAAKGYQKAGVISGGRLTNDYGGGISQLSTTLFNAVFFSGAKIEEFHPHSFYISRYPEGREATISWPDVDNRFTNDSGAGILISASVRGNEVTVTFHGRKKYDEIKATKSARKNITPPKTITDNTKGCVPQSPAPGFSVDIGRQFIKDGKTVKSSSFTTRYIPQDDVTCTNA,MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVLAEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPELLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGMETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGGEFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSHSLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDEPDGYPVKPREWSK,156.3,gnl|BL_ORD_ID|4748|hsp_num:0,2242,FALSE,None
LK538,25_3 # 1908 # 3260 # -1 # ID=25_3;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.706,25_3,1908,3260,-,Strict,50,50.8322,vanY gene in vanB cluster,35.29,3002956,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGTCGTGCCACCCGTCGCGCCACCGCGACCGTCCGGGCCGTGCTCGCTCTGGGCTGCGCCACAGGTCTGGCCCTGGCGCCCTCGGCATCCGCCGAGCCCACCGACCCGGTGACCCCGTCGACGACGCCGGCCCCCTCCCCCTCCCCCTCCAGCACCGGCGGCACGAGCCCGAGCGTCGCGTGGACCGAGGACACGACCTCCCCGCAGGGTGACAACAACGACACCCCGCTCGGTGGCGAGGACCTCGACAGCCAGATCGCCGAGGCCGACGCCCTGGCGGCGGACCTGCTCAAGGACAACAAGGACATCGCCGCGGCGGTGAAGTCGCTCAGGTCCTACTCCAAGAAGGCCAACTCGCTGCTGCAGAAGAAGGCGAAGGCGCAGGAGGAGTACGACGACGCCAAGAGCGAGGCCGACCAGGCGCAGAAGGACCTCGACGCCTACAGGTCACGGCTGTCGAAGGGGCGCAAGGACCTGCGCAGCTGGGCCTTCGACACCTACACGCAGGGTGGTGGCTACACCGACACGATGACGATGTTTGGCACCATCACCGGCGGCTCGCAGACCTCGGGCAACTCGGCGGGTGACCTCTCCTACCTCACCGACGAGCGCATCCGCACCGTCGACCTCGTCCGTGAGGACACCGTCACGCAGGCGTCCCTGACGAAGAAGAAGGACAAGGCCCTCGCTCGGGCCTCCGCGGCGAAGAAGCGCGCCGACCGGGCCAAGGCCCGCGCCGACAAGGTCCTCACGGAGCGCAAGACCGAGCTGGCCGCGCTGCGCCGCAAGCACGCCGACGAGCTGAAGAAGGCCGGCCCGATCGTCAACGCGCTCATCGGCCAGCCGGACTCCCGGGCCCAGGGCGCCAGCGACCGGCTGACGGGCGCGCTCGAGGACCTCGGGCAGGACATCAGCGAGTTCGAGGACGCCAAGCCCTGCTCGACCAACACCGAGACCTACCCCAACGGCCAGATCCCGCCGAGTGCCCTCTGCCCGCTGCTCGGCGCTCCGGGTGAGTCGCTGCGGCCCAAGGCGGCGGCGGCCTTCAACGCGATGAGCAAGGCCTACCAGCGCGACACGGGCAACCTGCTGTGCGTCACCGACAGCTACCGCTCGTACGCGGAGCAGGTCGTCACCAAGCAGAACCGCGGTGGCTGGGCCGCGGCCCCCGGCACGAGCAACCACGGTCTGGGCAAAGCGCTCGACCTGTGCGGCGGCATCAACAACTTCGGTCACCCGGCACACGCCTGGATGCAGCAGAACGCGCCGCTCTACGGCTGGTTCCACCCCTCGTGGGCCGCGGCCGGTGGCAGCCTCCCCGAGCCGTGGCACTGGGAGTTCGCCGGCTGA,MRRATRRATATVRAVLALGCATGLALAPSASAEPTDPVTPSTTPAPSPSPSSTGGTSPSVAWTEDTTSPQGDNNDTPLGGEDLDSQIAEADALAADLLKDNKDIAAAVKSLRSYSKKANSLLQKKAKAQEEYDDAKSEADQAQKDLDAYRSRLSKGRKDLRSWAFDTYTQGGGYTDTMTMFGTITGGSQTSGNSAGDLSYLTDERIRTVDLVREDTVTQASLTKKKDKALARASAAKKRADRAKARADKVLTERKTELAALRRKHADELKKAGPIVNALIGQPDSRAQGASDRLTGALEDLGQDISEFEDAKPCSTNTETYPNGQIPPSALCPLLGAPGESLRPKAAAAFNAMSKAYQRDTGNLLCVTDSYRSYAEQVVTKQNRGGWAAAPGTSNHGLGKALDLCGGINNFGHPAHAWMQQNAPLYGWFHPSWAAAGGSLPEPWHWEFAG,MEKSNYHSNVNHHKRHMKQSGEKRAFLWAFIISFTVCTLFLGWRLVSVLEATQLPPIPATHTGSGTGVAENPEENTLATAKEQGDEQEWSLILVNRQNPIPAQYDVELEQLSNGERIDIRISPYLQDLFDAARADGVYPIVASGYRTTEKQQEIMDEKVAEYKAKGYTSAQAKAEAETWVAVPGTSEHQLGLAVDINADGIHSTGNEVYRWLDENSYRFGFIRRYPPDKTEITGVSNEPWHYRYVGIEAATKIYHQGLCLEEYLNTEK,167.91,gnl|BL_ORD_ID|602|hsp_num:0,556,FALSE,None
LK411,16_10 # 10118 # 11812 # -1 # ID=16_10;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.653,16_10,10118,11812,-,Strict,50,79.337,vanW gene in vanI cluster,33.12,3003724,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanW; glycopeptide resistance gene cluster,GTGACTACGGTAAATGCAACAGGTGCCCGCGGTGGGCGCGGGGTCGGCACCGGGAAGATTCTCCTCGGTGTGCTTCTCGGCGTGCTCGCGGTGCTGCTCGCGATCTACCTCGCCGACCTCGCAATGAACCGCGGGAACGTGCCGCGTGGCACCGCCGTCGGCGGTGTCGAGATCGGCGGCATGAGCCACGACGAGGCCACCGCGAAGCTCGAAGCAGAGCTCGGCGAGACGGCGAGCAACCCGGTGACGGTGAAGGCGGCATCGCAAAGCTCGCAGCTCGTGCCCGCCGAGTCCGGCCTCGGCATCGACTGGGAGGCGACCGTAGCAAGCGCGGGCGAAGAGTCCGCGAACCCGTTCACTCGCCTCGCCGGGTTGTTTCGCACCCGCGAAGTCGACATTGTGTCGACCGTGAACGAGGCCGCTCTCACCCCGCAGCTTGAGCGCGTGGCCGGCGAGTTGCACCTCGACCCCGCCGACGGCGCGATCGCCATCGAAGGCGGCGAGGCGAAAGTGACCGAACCGGTGCCGGGCCAGGAGGTTGACAAAACCGAGCTGTTCGAACGTGTCACCACCGGCTGGCTCAACCCTGACGGTGTAGAGGTCGAGCCGCGCGAAATCGAACCCGCTATCGGCGACCAGGCCATCAAGGAAGCCTTAGACGGGCCGGTTAAGGCGGCGCTGTCCGGAGCGTTGACACTGCACGGTCGCGACGGCATCGACGGTGTCATTGCCCAAGAGCGCATCGGCGAGGTCGTCCAATTCCCTAACGTCGACGGCAAAATCGCCCCCGAGGTGAACGTGGAAAACGCCCAGGGCATCTTGGTCGAGCAGCTCGCTGCGACCGAGACGCAGATGAAAAACGCGCGCGTGCTGCCCGGCGGCGGGGTGGAACCGTCCGTCGACGGCTCCATCATCGACTGGGAGGCCGCGATGGACGGTTTCGACGAGCGGTTGATCGGTTCCGCCGAGCGCACCTGGGACGCGCAATATAAGGCCCGCCCGGCCGACTTCACCACTGAAGAGGCCAACAATGCCACCTTCGACCAGGTCGTCGGCTCCTTTACCACCAGCGGCTACAGCTCGGCCTCGGGCACCAACATCGCGGTGGTGGCACGCGCGGTCGAAGGAGCGATTGTCAACCCAGGCGAGACGTTCTCGCTCAACGGCTACACCGGCCCGCGCGGCACCGCGCAGGGTTACGTCGAGTCGGTCATCATCGAAAATGGACGCCCCGGCAAGGCAGTGGGTGGCGGAATCTCCCAATTTGCCACGACCTTGTACAACGCGGCTTACTTTGCCGGCATGACGGATGTCGCCTCCACGCCGCACTCCTACTACATCTCCCGCTACCCCACGGGCCGCGAGGCAACCGTCTTCGAGGGCGCGATCGACCTGCAGTTCCGAAACGACTCGCCTTATCCGGTGAAGATCACCTCCAAGGTCGGCGGTGGGGAGGTCACCGTGAGTCTGATGGGTGTGAAAACCGTCGAGGTGGAGTCCATCAATGGAGGGCGCTGGGCCTACACCTCGCCGAAGCCCGTGACCGTCACCAGTGGTGACTGCATTCCCTCGGGCGGGGTGCAGGGCTTTACCACCTCCGATACCCGGATTGTGCGTGACCTCAGCGGCAATGAGATCAGTCGCAACACCTCCACCACGGTCTACGACCCGCAGCCCATCGTTCGCTGCGAGTAG,MTTVNATGARGGRGVGTGKILLGVLLGVLAVLLAIYLADLAMNRGNVPRGTAVGGVEIGGMSHDEATAKLEAELGETASNPVTVKAASQSSQLVPAESGLGIDWEATVASAGEESANPFTRLAGLFRTREVDIVSTVNEAALTPQLERVAGELHLDPADGAIAIEGGEAKVTEPVPGQEVDKTELFERVTTGWLNPDGVEVEPREIEPAIGDQAIKEALDGPVKAALSGALTLHGRDGIDGVIAQERIGEVVQFPNVDGKIAPEVNVENAQGILVEQLAATETQMKNARVLPGGGVEPSVDGSIIDWEAAMDGFDERLIGSAERTWDAQYKARPADFTTEEANNATFDQVVGSFTTSGYSSASGTNIAVVARAVEGAIVNPGETFSLNGYTGPRGTAQGYVESVIIENGRPGKAVGGGISQFATTLYNAAYFAGMTDVASTPHSYYISRYPTGREATVFEGAIDLQFRNDSPYPVKITSKVGGGEVTVSLMGVKTVEVESINGGRWAYTSPKPVTVTSGDCIPSGGVQGFTTSDTRIVRDLSGNEISRNTSTTVYDPQPIVRCE,MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVLAEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPELLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGMETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGGEFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSHSLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDEPDGYPVKPREWSK,151.21,gnl|BL_ORD_ID|4748|hsp_num:0,2242,FALSE,None
LK411,3_146 # 135712 # 136083 # -1 # ID=3_146;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.656,3_146,135712,136083,-,Strict,200,223.402,Mycobacterium tuberculosis rpsL mutations conferring resistance to Streptomycin,90.91,3003395,protein variant model,K88R,n/a,aminoglycoside antibiotic,antibiotic target alteration,antibiotic-resistant rpsL,ATGCCAACTATCCAGCAGCTGGTCCGCAAAGGCCGCCACGATAAGCGCACCAAGGTCGCTACCGCGGCCCTGAAGGGCTCCCCGCAGCGCCGCGGTGTGTGCACCCGTGTATACACCACCACCCCGAAGAAGCCGAACTCCGCTCTGCGTAAGGTTGCCCGCGTGCGCCTGACCTCGGGCATCGAGGTCTCCGCATACATCCCCGGCGAGGGCCACAACCTGCAGGAGCACTCCATGGTGCTCGTACGCGGCGGCCGTGTGAGGGACCTTCCGGGCGTTCGCTACAAGATCATCCGCGGCGCGCTTGACACCCAGGGTGTTAAGGACCGCAAGCAGGCTCGCTCCCGCTACGGCGCGAAGAAGGGACAGTAA,MPTIQQLVRKGRHDKRTKVATAALKGSPQRRGVCTRVYTTTPKKPNSALRKVARVRLTSGIEVSAYIPGEGHNLQEHSMVLVRGGRVRDLPGVRYKIIRGALDTQGVKDRKQARSRYGAKKGQ,MPTIQQLVRKGRRDKISKVKTAALKGSPQRRGVCTRVYTTTPKKPNSALRKVARVKLTSQVEVTAYIPGEGHNLQEHSMVLVRGGRVKDLPGVRYKIIRGSLDTQGVKNRKQARSRYGAKKEKG,99.19,gnl|BL_ORD_ID|1956|hsp_num:0,1197,FALSE,None
LK904,15_34 # 36033 # 36521 # 1 # ID=15_34;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.703,15_34,36033,36521,+,Strict,50,60.077,vanY gene in vanB cluster,29.21,3002956,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGAACGCACAGATCATCACCCTCACCCTTGCCTCGGCCCTCGTCCTCGGCCTCACCGGCTGCGCCTCGACCGCACCCGCCGAGGAGGCCGCCGTGACCGTCCATGCCGCAGGTTCGGAGACCGACGGCGGGGCCCTTCCCGCGGCTGCGAGGATCGACGACGTCGACCTGCCGGGCATCGCGAACCTCGATGCGGACCTGCGCGCTGCGGTCAGGGACGCCGCCGCCGAGGCCCGCGAGGACGGTGTCGTCTTCACCGTCAACAGCGGATGGCGCTCAGCCTCCTACCAGCAGGGTCTCCTCGACGACGCGGTGAGCACGTACGGCTCGCGGACCGAAGCCGCCCGGTGGGTGGCCACCCCCGAATCCTCACCGCACGTCACCGGCGACGCGGTCGACATCGGTCCCGTCGACGCCTCGAGCTGGCTCTCCCAGCACGGCGCGGACTTCGGACTGTGCCAGATCTACGGCAACGAGATCTGGCACTAA,MNAQIITLTLASALVLGLTGCASTAPAEEAAVTVHAAGSETDGGALPAAARIDDVDLPGIANLDADLRAAVRDAAAEAREDGVVFTVNSGWRSASYQQGLLDDAVSTYGSRTEAARWVATPESSPHVTGDAVDIGPVDASSWLSQHGADFGLCQIYGNEIWH,MEKSNYHSNVNHHKRHMKQSGEKRAFLWAFIISFTVCTLFLGWRLVSVLEATQLPPIPATHTGSGTGVAENPEENTLATAKEQGDEQEWSLILVNRQNPIPAQYDVELEQLSNGERIDIRISPYLQDLFDAARADGVYPIVASGYRTTEKQQEIMDEKVAEYKAKGYTSAQAKAEAETWVAVPGTSEHQLGLAVDINADGIHSTGNEVYRWLDENSYRFGFIRRYPPDKTEITGVSNEPWHYRYVGIEAATKIYHQGLCLEEYLNTEK,60.45,gnl|BL_ORD_ID|602|hsp_num:0,556,FALSE,None
LK904,97_4 # 3425 # 5170 # 1 # ID=97_4;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.660,97_4,3425,5170,+,Strict,50,100.523,vanW gene in vanI cluster,28.03,3003724,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanW; glycopeptide resistance gene cluster,ATGTCCACCCAGACCCTCGCAGGCAGCGCGCCTGATCCCTCGGCCGGCACCTCGGCGGGCAGGCGCAAGCGACCCTGGATCATCGCGCTCCTCATCCTCGTCGGGCTCGCCGTCGTCTACCTCGCGATCGGCTTCTTCAGCGGCCGGGTCGTCGCCCCCGGCACGACCGTGGCCGGCGTCGACATCGGCTCGCAGAGCGCAGCCGATGCGAAGTCGACCCTTGAGGACGCCCTCGGGGAGAAGGCGAAGCAGGAGATCGAGCTCAGCGCCAAGGAGGCCACGGCGACGATCGATCCGGTGAAGTCGGGACTGGCACTCGACGTCGACGGCACCGTCGCCCAGGTCACCGGGTTCACACTCAACCCTGCCATCCTCGCCGACCGGCTCTTCGGCGACAATGAGGTCTCACCCGTCCTCGCTGTCGACGACGCGACCTTCGACAAGAGCGCCGAGGCGGCCGCGAAGGGACTCGAGGTCGAACCCGTCGATGCGGAGCTGAGCTACGACAAGACGACGCCTGCGGTCAAGGACGCCGTGACCGGGCAGAGCGTGAGCGTGGAGAACATCCGCTCCGCCGTCGCCGCACAGTGGCTGGTCAAGGACAATCCGCTGCCCGTCGTCGTCGACGAGGTCGAACCCGACATCACGACCGCTGAAGCCAAGGACGTCGCCGACGGCTTCGCCGCCGATGCGGTCAAGGCCGACGTCACCGTCAAGGCCGTACCCGGCAAGGACGCCGACTCCGACGTCAAGGGCGGGGACCTGACGATCTCGCCGACGACGATCGCGAAGACCCTGAGCTTCGAGGCGAAGGACTCGAAGCTCGTGCCGAAGTTCGACGCCGAGAAGCTGCAGAAGCGGGCACTCGACGAGAACGAGGAGATCGGACGTCCCGCCAAGGACGCGACCTTCAAGGTCGTCGACGGCAAGCCGCAGGTCGTCGACTCCGAACCCGGCATCGGCATCAAGCCCGACGACCTCTCGAAGGCCGTGACCGATGCGATCAACGGCGACACCGCAGCCGCCGAGGTGACCCTGGCCTCCGTCGAACCGGAGTTCACGACCGAGGACGCGAAGAAGGTCGACGTCTCGCAGACCGTCTCGGAGTTCTCCACCCCGTACAAGTCCGATCCCAACCGCGACAACAACCTCCGCGTCGCCTCGAAAGAGGTCTCGGGCACGGTCCTTCAGCCCGGCGAGCAGTTCTCCCTCAATGAGACGCTCGGCCCGCGGACCGCGGCCAACGGCTACAAGCCCGCAGGCGTCATCTCCGAAGGGCAGATGAAGGAGGACTTCGGCGGAGGAGTCTCGCAGGTGTCGACGACCCTGTTCAACGCCGCGTTCTTCGCCGGCTTCGAACTCAACGAGCATCAGGCGCATTCGCGCTACATCTCCCGCTACCCGGAGGGCCGGGAGACGACGCTCGACTACACCTCGATCGACCTCAAGTTCACGAACAACCAGAAGACCCCCGTCGTCCTCGACATGTACCTCTCGGGCGGAAAGGTCTACGCGAAGGTCTACGGAGTCAAGTACTACGACGTCGAAGCCGACTCTTCGGGCCGGTACGCCTTCACCTCGCCGGCGACGGTGACCGAGTCCGGTCCGTCGTGCACCCCGCAGTCACCGCGCGAGGGCTGGTCGATCAAGATCACGCGGACGATGAAGGAGATCGCGACCGGACGGGAGACGAAGGACTCCTTCGTCACGACCTACCGACCGGTCAACAAGGTCGAGTGCAAGTAG,MSTQTLAGSAPDPSAGTSAGRRKRPWIIALLILVGLAVVYLAIGFFSGRVVAPGTTVAGVDIGSQSAADAKSTLEDALGEKAKQEIELSAKEATATIDPVKSGLALDVDGTVAQVTGFTLNPAILADRLFGDNEVSPVLAVDDATFDKSAEAAAKGLEVEPVDAELSYDKTTPAVKDAVTGQSVSVENIRSAVAAQWLVKDNPLPVVVDEVEPDITTAEAKDVADGFAADAVKADVTVKAVPGKDADSDVKGGDLTISPTTIAKTLSFEAKDSKLVPKFDAEKLQKRALDENEEIGRPAKDATFKVVDGKPQVVDSEPGIGIKPDDLSKAVTDAINGDTAAAEVTLASVEPEFTTEDAKKVDVSQTVSEFSTPYKSDPNRDNNLRVASKEVSGTVLQPGEQFSLNETLGPRTAANGYKPAGVISEGQMKEDFGGGVSQVSTTLFNAAFFAGFELNEHQAHSRYISRYPEGRETTLDYTSIDLKFTNNQKTPVVLDMYLSGGKVYAKVYGVKYYDVEADSSGRYAFTSPATVTESGPSCTPQSPREGWSIKITRTMKEIATGRETKDSFVTTYRPVNKVECK,MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVLAEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPELLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGMETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGGEFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSHSLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDEPDGYPVKPREWSK,155.76,gnl|BL_ORD_ID|4748|hsp_num:0,2242,FALSE,None
LK455,31_24 # 24453 # 25202 # 1 # ID=31_24;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.780,31_24,24453,25202,+,Strict,50,83.9593,vanY gene in vanM cluster,35.33,3002961,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGTCGCACCCTCCCTCTCGCCGCGCTGGCCGCGCTCGCGCTGCTCGCGGCCGGCTGCGGCACGCCCGCCGCGGGCCCGTCCTCGGCGCCGGCGACGCCGGCTCCCGGCTCCTCGAGCGCGGCCGCGTCGTCCGGCGCCGCCTCGAGCACGGCGCCGTCGTCGAGCGCGCACGCCGACCCGGCCGCCCTCGACGTCGTCGTGAACAAGACCCGCCCCGTGGCCCCGCCCGACTGGGCGCCCTCGGATCTGGTGGCCGTGCCCGGCAGCGAGCTGCCCCTGCGCGCGGAGGCCGCGACGGCGGCCGGCGACCTGGTGGATGCCGCCGCGGCGGCGGGCCACCGCCTCACCACCCTGAGCGCCTACCGTTCGTACGACTACCAGGTCCGGACGTATGGCCACTGGGTCGACGAGCTGGGCCACGCCGAGGCCGACCGCGTCTCCGCGCGTCCGGGGTACTCCGAGCATCAGACCGGCCTGGCCTGGGACGTGGGCGACGCCGCGACCCCCGCGTGTGACCTGGAAGCGTGCTTCGGCGACACCGCCGCGGGCCGTTGGGTGGCGGCGCACGCCGCCGAGTACGGGTTCGTCGTCCGCTATCCCGCCGGGGCCGAGGACGTGACGGGCTTCGATCACGAGCCGTGGCACCTGCGCTACGTCGGGTCCGCGGAGGCGGCCCGGGTCGAGGCGGCCGGCGGCGTCCTCGAGACCGCGTGGGGTCTGCCGCCGGCGCCGGACTACGCGGACTGA,MRRTLPLAALAALALLAAGCGTPAAGPSSAPATPAPGSSSAAASSGAASSTAPSSSAHADPAALDVVVNKTRPVAPPDWAPSDLVAVPGSELPLRAEAATAAGDLVDAAAAAGHRLTTLSAYRSYDYQVRTYGHWVDELGHAEADRVSARPGYSEHQTGLAWDVGDAATPACDLEACFGDTAAGRWVAAHAAEYGFVVRYPAGAEDVTGFDHEPWHLRYVGSAEAARVEAAGGVLETAWGLPPAPDYAD,MVFQGNLLLVNNEYPVLEESIKTDVVNLFKHDELTKGYELLNREIYLSEKVAREFSEMVDAAEKEGVRHFSINSGFRNFDEQNALYQEMGSDYALPAGYSEHNLGLALDIGSTQMEMSEAPEGKWLEDNAWEYGFILRYPMDKTAITGIQYEPWHFRYVGLPHSAIIEEKNFALEEYLDFLKEQKSISGTIHGENYEISYYPITEKTDIEMPANLHYEISGNNMDGVIVTVYR,106.87,gnl|BL_ORD_ID|1673|hsp_num:0,1713,FALSE,None
LK508,8_44 # 48436 # 49185 # 1 # ID=8_44;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.780,8_44,48436,49185,+,Strict,50,83.9593,vanY gene in vanM cluster,35.33,3002961,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGTCGCACCCTCCCTCTCGCCGCGCTGGCCGCGCTCGCGCTGCTCGCGGCCGGCTGCGGCACGCCCGCCGCGGGCCCGTCCTCGGCGCCGGCGACGCCGGCTCCCGGCTCCTCGAGCGCGGCCGCGTCGTCCGGCGCCGCCTCGAGCACGGCGCCGTCGTCGAGCGCGCACGCCGACCCGGCCGCCCTCGACGTCGTCGTGAACAAGACCCGCCCCGTGGCCCCGCCCGACTGGGCGCCCTCGGATCTGGTGGCCGTGCCCGGCAGCGAGCTGCCCCTGCGCGCGGAGGCCGCGACGGCGGCCGGCGACCTGGTGGATGCCGCCGCGGCGGCGGGCCACCGCCTCACCACCCTGAGCGCCTACCGTTCGTACGACTACCAGGTCCGGACGTATGGCCACTGGGTCGACGAGCTGGGCCACGCCGAGGCCGACCGCGTCTCCGCGCGTCCGGGGTACTCCGAGCATCAGACCGGCCTGGCCTGGGACGTGGGCGACGCCGCGACCCCCGCGTGTGACCTGGAAGCGTGCTTCGGCGACACCGCCGCGGGCCGTTGGGTGGCGGCGCACGCCGCCGAGTACGGGTTCGTCGTCCGCTATCCCGCCGGGGCCGAGGACGTGACGGGCTTCGATCACGAGCCGTGGCACCTGCGCTACGTCGGGTCCGCGGAGGCGGCCCGGGTCGAGGCGGCCGGCGGCGTCCTCGAGACCGCGTGGGGTCTGCCGCCGGCGCCGGACTACGCGGACTGA,MRRTLPLAALAALALLAAGCGTPAAGPSSAPATPAPGSSSAAASSGAASSTAPSSSAHADPAALDVVVNKTRPVAPPDWAPSDLVAVPGSELPLRAEAATAAGDLVDAAAAAGHRLTTLSAYRSYDYQVRTYGHWVDELGHAEADRVSARPGYSEHQTGLAWDVGDAATPACDLEACFGDTAAGRWVAAHAAEYGFVVRYPAGAEDVTGFDHEPWHLRYVGSAEAARVEAAGGVLETAWGLPPAPDYAD,MVFQGNLLLVNNEYPVLEESIKTDVVNLFKHDELTKGYELLNREIYLSEKVAREFSEMVDAAEKEGVRHFSINSGFRNFDEQNALYQEMGSDYALPAGYSEHNLGLALDIGSTQMEMSEAPEGKWLEDNAWEYGFILRYPMDKTAITGIQYEPWHFRYVGLPHSAIIEEKNFALEEYLDFLKEQKSISGTIHGENYEISYYPITEKTDIEMPANLHYEISGNNMDGVIVTVYR,106.87,gnl|BL_ORD_ID|1673|hsp_num:0,1713,FALSE,None
LK1335,14_5 # 3155 # 3898 # -1 # ID=14_5;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.780,14_5,3155,3898,-,Strict,50,84.7297,vanY gene in vanF cluster,32.26,3002958,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGTCGCACCCTCCCTCTCGCCGCGCTGGCCGCGCTCGCGCTGCTCGTGGCCGGTTGCGGCACGCCCGCCGCGGGCCCGTCCTCGGCGACGCCGGCTTCCGGCTCCGCGAGCGCGGCCGCGTCGTCCCGCGCCGCCTCGAGCACGGCGCCGTCGTCGAGCACGCACGCCGACCCGGCCGCCCTCGACGTCGTCGTGAACAAGACCCGCCCCGTGGCCCCGCCCGACTGGGCGCCCTCGGATCTGGTGGCCGTGCCCGGCAGCGAGCTGCCCCTGCGCGCGGAGGCCGCGACGGCGGCCGGCGACCTGCTGGATGCCGCCGCGGCGGCGGGCCACCGCCTCACCACCCTGAGCGCCTACCGCTCGTACGACTACCAGGTCCGGACGTACGGCCACTGGGTCGACGAGCTGGGCCGCGCCGAGGCCGACCGCGTCTCGGCGCGTCCGGGGCACTCCGAGCACCAGACCGGCCTGGCCTGGGACGTGGGCGACGCCGCGACCCCCGCGTGTGACCTGGAAGCGTGCTTCGGCGACACCGCCGCGGGCCGCTGGGTGGCCGCACACGCCACCGAGTACGGGTTCGTCATCCGCTATCCCGCCGGGGCCGAGGACGTGACGGGCTTCGACCACGAGCCCTGGCACCTGCGCTACGTCGGGTCCGCGGAGGCGGCCCGGGTCGAGGCGGCCGGCGGCGTCCTCGAGACCGCCTGGGGTCTGCCTCCGGCGCCCGACTACGCGGACTGA,MRRTLPLAALAALALLVAGCGTPAAGPSSATPASGSASAAASSRAASSTAPSSSTHADPAALDVVVNKTRPVAPPDWAPSDLVAVPGSELPLRAEAATAAGDLLDAAAAAGHRLTTLSAYRSYDYQVRTYGHWVDELGRAEADRVSARPGHSEHQTGLAWDVGDAATPACDLEACFGDTAAGRWVAAHATEYGFVIRYPAGAEDVTGFDHEPWHLRYVGSAEAARVEAAGGVLETAWGLPPAPDYAD,MKKWGLLLVFALFLVFIFNILPISQDKVEDRIYEQNDKDTSDDKMTAENMQKIELTEEQIYQGNLLLVNNEHPVHQKSIKSDIINLFTHKELTKGYGLLDNEIKLSEEIAGKFSEMIAAAEEDGVSNFLISSGYRDLDEQSRLYEEMGSDFALPAGHSEHNLGLSLDVGSTQMKMDKAPEGKWIEKNCWEYGFILRYPLDKTDVTGIQYEPWHIRYVGLPHSAIMQEMNLALEEYLDYLKEEKSISVRVDGKKYTISYDPISQNETIEVEVPADEQYEISGNNIDGVIVTTFS,84.3,gnl|BL_ORD_ID|1808|hsp_num:0,1899,FALSE,None
LK1379,20_5 # 3156 # 3899 # -1 # ID=20_5;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.781,20_5,3156,3899,-,Strict,50,82.8037,vanY gene in vanA cluster,30.14,3002955,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGTCGCCCCCTCCCCCTCGCCGCGCTGGCCGCGCTCGCGCTGCTCGCGGCCGGCTGCGGCACGCCCGCCGCGGGCCCGTCCTCGGCGACGCCGGCTTCCGGCTCCTCGAGCGCGGCCGCGTCGTCCGGCGCCGCCTCGAGCACGGCGCCGTCGTCGAGCACGCACGCCGACCCGGCCGCCCTCGACGTCGTCGTGAACAAGACCCGCCCCGTGGCCCCGCCCGACTGGGCGCCCTCGGATCTGGTGGCCGTGCCCGGCAGCGAGCTGCCCCTGCGGGCGGAGGCCGCCACGGCCGCCGGTGACCTGCTGGATGCGGCCACGGCGGCGGGCCACGACCTCACCACCCTGAGCGCCTACCGCTCGTACGACTACCAGGTCCGGACGTACGGCCACTGGGTCGACGAGCTGGGCCGCGCCGAGGCCGACCGCGTCTCGGCGCGTCCGGGGTACTCCGAGCACCAGACCGGCCTGGCCTGGGACGTGGGCGACGCCGCGACCCCCGCGTGTGACCTGGAGGCGTGCTTCGGCGACACCGCCGCGGGCCGCTGGGTGGCCGCGCACGCCGCCGAGTACGGGTTCGTCATCCGCTATCCCGCCGGGGCCGAGGACGTGACGGGCTTCGACCACGAGCCCTGGCACCTGCGCTACGTCGGGTCCACGGAGGCGGCCCGGGTCGAGGCGGCCGGCGGCGTCCTCGAGACCGCGTGGGGTCTGCCTCCGGCGCCCGACTACGCGGACTGA,MRRPLPLAALAALALLAAGCGTPAAGPSSATPASGSSSAAASSGAASSTAPSSSTHADPAALDVVVNKTRPVAPPDWAPSDLVAVPGSELPLRAEAATAAGDLLDAATAAGHDLTTLSAYRSYDYQVRTYGHWVDELGRAEADRVSARPGYSEHQTGLAWDVGDAATPACDLEACFGDTAAGRWVAAHAAEYGFVIRYPAGAEDVTGFDHEPWHLRYVGSTEAARVEAAGGVLETAWGLPPAPDYAD,MKKLFFLLLLLFLIYLGYDYVNEALFSQEKVEFQNYDQNPKEHLENSGTSENTQEKTITEEQVYQGNLLLINSKYPVRQESVKSDIVNLSKHDELINGYGLLDSNIYMSKEIAQKFSEMVNDAVKGGVSHFIINSGYRDFDEQSVLYQEMGAEYALPAGYSEHNSGLSLDVGSSLTKMERAPEGKWIEENAWKYGFILRYPEDKTELTGIQYEPWHIRYVGLPHSAIMKEKNFVLEEYMDYLKEEKTISVSVNGEKYEIFYYPVTKNTTIHVPTNLRYEISGNNIDGVIVTVFPGSTHTNSRR,81.52,gnl|BL_ORD_ID|4669|hsp_num:0,89,FALSE,None
LK1099,22_24 # 27038 # 27781 # 1 # ID=22_24;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.781,22_24,27038,27781,+,Strict,50,77.0258,vanY gene in vanF cluster,31.22,3002958,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGTCGCACCCTCCCCCTCGCCGCGTTGGCCGCGCTCGCGCTGCTCGCGGCCGGCTGCGGCACGCCCGCCGCGGGCCCGTCCCCGGCGACGCCGGCTTCCGGCTCCTCGAGCGCGGCCGCGTCGTCCCGCGCCGCCTCGAGCACGGCGCCGTCGTCGAGCACGCACGCCGACCCGGCCGCCCTCGACGTCGTCGTGAACAAGACCCGCCCCGTGGCCCCGCCCGACTGGGCGCCCTCGGATCTGGTGGCCGTGCCCGGCAGCGAGCTGCCCCTGCGGGCGGAGGCCGCGACGGCGGCCGGTGACCTGCAGGATGCGGCCGCGGCGGCGGACCACGACCTCACCACCCTGAGCGCCTACCGCTCGTACGACTACCAGGTCCGGACGTACGGCCACTGGGTCGACGAGCTGGGCCGCGCCGAGGCCGACCGCGTCTCGGCGCGTCCGGGGTACTCCGAGCACCAGACCGGCCTGGCGTGGGACGTGGGCGACGCCGCGACCCCCACGTGTGACCTGGAGGCGTGCTTCGGCGACACCGCCGCGGGCCGCTGGGTGGCCGCGCACGCCGCCGAGCACGGGTTCGTCATCCGCTATCCCGCCGGGGCCGAGGACGAGACGGGCTTCGCCCACGAGCCCTGGCACCTGCGCTACGTCGGGTCCGCGGAGGCGGCCCGGGTCGAGGCGGCCGGCGGCGTCCTCGAGACCGCGTGGGGTCTGCCTCCGGCGCCGGACTACGCGGACTGA,MRRTLPLAALAALALLAAGCGTPAAGPSPATPASGSSSAAASSRAASSTAPSSSTHADPAALDVVVNKTRPVAPPDWAPSDLVAVPGSELPLRAEAATAAGDLQDAAAAADHDLTTLSAYRSYDYQVRTYGHWVDELGRAEADRVSARPGYSEHQTGLAWDVGDAATPTCDLEACFGDTAAGRWVAAHAAEHGFVIRYPAGAEDETGFAHEPWHLRYVGSAEAARVEAAGGVLETAWGLPPAPDYAD,MKKWGLLLVFALFLVFIFNILPISQDKVEDRIYEQNDKDTSDDKMTAENMQKIELTEEQIYQGNLLLVNNEHPVHQKSIKSDIINLFTHKELTKGYGLLDNEIKLSEEIAGKFSEMIAAAEEDGVSNFLISSGYRDLDEQSRLYEEMGSDFALPAGHSEHNLGLSLDVGSTQMKMDKAPEGKWIEKNCWEYGFILRYPLDKTDVTGIQYEPWHIRYVGLPHSAIMQEMNLALEEYLDYLKEEKSISVRVDGKKYTISYDPISQNETIEVEVPADEQYEISGNNIDGVIVTTFS,84.3,gnl|BL_ORD_ID|1808|hsp_num:0,1899,FALSE,None
LK426,73_4 # 4103 # 4852 # 1 # ID=73_4;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.776,73_4,4103,4852,+,Strict,50,83.9593,vanY gene in vanM cluster,34.46,3002961,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGTCGCACCCTCCCTCTCGCCGCGCTGGCCGCGCTCGCGCTGCTCGTGGCCGGTTGCGGCACGCCCGCCGCGGGCCCGTCCTCGACGCCGACGACGCCGACGTCCGGCTCCGCGAGCGCGGCCGCGTCGTCCGGCGCCGCCTCGAGCACGGCGCCGTCGTCGGGCACGCACGCCGACCCGGCCACCCTCGACGTCGTCGTGAACAAGACCCGCCCCGTGGCCCCGCCCGACTGGGCGCCCTCGGATCTGGTGGCCGTGCCCGGCAGCGAGCTGTCCCTGCGGGCGGCGGCCGCGACGGCGGCCGGTGACCTGCTGGATGCCGCCGCGGCGGCGGGCCACCGCCTCACCACCCTGAGCGCCTACCGCTCGTACGACTACCAGGTCCGGACGTACGGCCACTGGGTCGACGAGCTGGGCCGCGCCGAGGCCGACCGCGTCTCGGCGCGTCCGGGGTACTCCGAGCACCAGACCGGCCTGGCCTGGGACGTGGGCGACGCCGCGACCCCCGCGTGTGACCTGGAAGCGTGCTTCGGCGACACCGCCGCGGGCCGCTGGGTGGCCGCGCACGCCGCCGAGTACGGGTTCGTCATCCGCTATCCCGTCGGGGCCGAGGACGTGACGGGCTTCGCCCACGAGCCCTGGCACCTGCGCTACGTCGGGTCCGCGGAGGCGGCCCGGGTCGAGGCGGCCGGCGGCGTCCTCGAGACCGCGTGGGGTCTGCCTCCGGCACCCGACTACGCGGACTGA,MRRTLPLAALAALALLVAGCGTPAAGPSSTPTTPTSGSASAAASSGAASSTAPSSGTHADPATLDVVVNKTRPVAPPDWAPSDLVAVPGSELSLRAAAATAAGDLLDAAAAAGHRLTTLSAYRSYDYQVRTYGHWVDELGRAEADRVSARPGYSEHQTGLAWDVGDAATPACDLEACFGDTAAGRWVAAHAAEYGFVIRYPVGAEDVTGFAHEPWHLRYVGSAEAARVEAAGGVLETAWGLPPAPDYAD,MVFQGNLLLVNNEYPVLEESIKTDVVNLFKHDELTKGYELLNREIYLSEKVAREFSEMVDAAEKEGVRHFSINSGFRNFDEQNALYQEMGSDYALPAGYSEHNLGLALDIGSTQMEMSEAPEGKWLEDNAWEYGFILRYPMDKTAITGIQYEPWHFRYVGLPHSAIIEEKNFALEEYLDFLKEQKSISGTIHGENYEISYYPITEKTDIEMPANLHYEISGNNMDGVIVTVYR,106.87,gnl|BL_ORD_ID|1673|hsp_num:0,1713,FALSE,None
LK467,81_8 # 4793 # 5542 # -1 # ID=81_8;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.776,81_8,4793,5542,-,Strict,50,83.9593,vanY gene in vanM cluster,34.46,3002961,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGTCGCACCCTCCCTCTCGCCGCGCTGGCCGCGCTCGCGCTGCTCGTGGCCGGTTGCGGCACGCCCGCCGCGGGCCCGTCCTCGACGCCGACGACGCCGACGTCCGGCGCCGCGAGCGCGGCCGCGTCGTCCGGCGCCGCCTCGAGCACGGCGCCGTCGTCGAGCACGCACGCCGACCCGGCCGCCCTCGACGTCGTCGTGAACAAGACCCGCCCCGTGGCTCCGCCCGACTGGGCGCCCTCGGATCTGGTGGCCGTGCCCGGCAGCGAGCTGTCCCTGCGGGCGGAGGCCGCGACGGCGGCCGGTGACCTGCTGGATGCCGCCGCGGCGGCGGGTCACCGCCTCACCACCCTGAGCGCCTACCGCTCGTACGACTACCAGGTCCGGACGTACGGCCACTGGGTCGACGAGCTGGGCCGCGCCGAGGCCGACCGCGTCTCGGCGCGTCCGGGGTACTCCGAGCACCAGACCGGCCTGGCCTGGGACGTGGGCGACGCCGCGACCCCCGCGTGTGACCTGGAAGCGTGCTTCGGCGACACTGCCGCGGGCCGCTGGGTGGCCGCGCACGCCGCCGAGTACGGGTTCGTCATCCGCTATCCCGTCGGGGCCGAGGACGTGACGGGCTTCGCCCACGAGCCGTGGCACCTGCGCTACGTCGGGTCCGCGGAGGCGGCCCGGGTCGAGGCGGCCGGCGGCGTCCTCGAGACCGCGTGGGGCCTGCCTCCGGCGCCGGACTACGCGGACTGA,MRRTLPLAALAALALLVAGCGTPAAGPSSTPTTPTSGAASAAASSGAASSTAPSSSTHADPAALDVVVNKTRPVAPPDWAPSDLVAVPGSELSLRAEAATAAGDLLDAAAAAGHRLTTLSAYRSYDYQVRTYGHWVDELGRAEADRVSARPGYSEHQTGLAWDVGDAATPACDLEACFGDTAAGRWVAAHAAEYGFVIRYPVGAEDVTGFAHEPWHLRYVGSAEAARVEAAGGVLETAWGLPPAPDYAD,MVFQGNLLLVNNEYPVLEESIKTDVVNLFKHDELTKGYELLNREIYLSEKVAREFSEMVDAAEKEGVRHFSINSGFRNFDEQNALYQEMGSDYALPAGYSEHNLGLALDIGSTQMEMSEAPEGKWLEDNAWEYGFILRYPMDKTAITGIQYEPWHFRYVGLPHSAIIEEKNFALEEYLDFLKEQKSISGTIHGENYEISYYPITEKTDIEMPANLHYEISGNNMDGVIVTVYR,106.87,gnl|BL_ORD_ID|1673|hsp_num:0,1713,FALSE,None
LK1363,39_7 # 6756 # 8501 # -1 # ID=39_7;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.660,39_7,6756,8501,-,Strict,50,100.523,vanW gene in vanI cluster,28.03,3003724,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanW; glycopeptide resistance gene cluster,ATGTCCACCCAGACCCTCGCAGGCAGCGCGCCTGATCCCTCGGCCGGCACCTCGGCGGGCAGGCGCAAGCGACCCTGGATCATCGCGCTCCTCATCCTCGTCGGGCTCGCCGTCGTCTACCTCGCGATCGGCTTCTTCAGCGGCCGGGTCGTCGCCCCCGGCACGACCGTGGCCGGCGTCGACATCGGCTCGCAGAGCGCAGCCGATGCGAAGTCGACCCTTGAGGACGCCCTCGGGGAGAAGGCGAAGCAGGAGATCGAGCTCAGCGCCAAGGAGGCCACGGCGACGATCGATCCGGTGAAGTCGGGACTGGCACTCGACGTCGACGGCACCGTCGCCCAGGTCACCGGGTTCACACTCAACCCTGCCATCCTCGCCGACCGGCTCTTCGGCGACAATGAGGTCTCACCCGTCCTCGCTGTCGACGACGCGACCTTCGACAAGAGCGCCGAGGCGGCCGCGAAGGGACTCGAGGTCGAACCCGTCGATGCGGAGCTGAGCTACGACAAGACGACGCCTGCGGTCAAGGACGCCGTGACCGGGCAGAGCGTGAGCGTGGAGAACATCCGCTCCGCCGTCGCCGCACAGTGGCTGGTCAAGGACAATCCGCTGCCCGTCGTCGTCGACGAGGTCGAACCCGACATCACGACCGCTGAAGCCAAGGACGTCGCCGACGGCTTCGCCGCCGATGCGGTCAAGGCCGACGTCACCGTCAAGGCCGTACCCGGCAAGGACGCCGACTCCGACGTCAAGGGCGGGGACCTGACGATCTCGCCGACGACGATCGCGAAGACCCTGAGCTTCGAGGCGAAGGACTCGAAGCTCGTGCCGAAGTTCGACGCCGAGAAGCTGCAGAAGCGGGCACTCGACGAGAACGAGGAGATCGGACGTCCCGCCAAGGACGCGACCTTCAAGGTCGTCGACGGCAAGCCGCAGGTCGTCGACTCCGAACCCGGCATCGGCATCAAGCCCGACGACCTCTCGAAGGCCGTGACCGATGCGATCAACGGCGACACCGCAGCCGCCGAGGTGACCCTGGCCTCCGTCGAACCGGAGTTCACGACCGAGGACGCGAAGAAGGTCGACGTCTCGCAGACCGTCTCGGAGTTCTCCACCCCGTACAAGTCCGATCCCAACCGCGACAACAACCTCCGCGTCGCCTCGAAAGAGGTCTCGGGCACGGTCCTTCAGCCCGGCGAGCAGTTCTCCCTCAATGAGACGCTCGGCCCGCGGACCGCGGCCAACGGCTACAAGCCCGCAGGCGTCATCTCCGAAGGGCAGATGAAGGAGGACTTCGGCGGAGGAGTCTCGCAGGTGTCGACGACCCTGTTCAACGCCGCGTTCTTCGCCGGCTTCGAACTCAACGAGCATCAGGCGCATTCGCGCTACATCTCCCGCTACCCGGAGGGCCGGGAGACGACGCTCGACTACACCTCGATCGACCTCAAGTTCACGAACAACCAGAAGACCCCCGTCGTCCTCGACATGTACCTCTCGGGCGGAAAGGTCTACGCGAAGGTCTACGGAGTCAAGTACTACGACGTCGAAGCCGACTCTTCGGGCCGGTACGCCTTCACCTCGCCGGCGACGGTGACCGAGTCCGGTCCGTCGTGCACCCCGCAGTCACCGCGCGAGGGCTGGTCGATCAAGATCACGCGGACGATGAAGGAGATCGCGACCGGACGGGAGACGAAGGACTCCTTCGTCACGACCTACCGACCGGTCAACAAGGTCGAGTGCAAGTAG,MSTQTLAGSAPDPSAGTSAGRRKRPWIIALLILVGLAVVYLAIGFFSGRVVAPGTTVAGVDIGSQSAADAKSTLEDALGEKAKQEIELSAKEATATIDPVKSGLALDVDGTVAQVTGFTLNPAILADRLFGDNEVSPVLAVDDATFDKSAEAAAKGLEVEPVDAELSYDKTTPAVKDAVTGQSVSVENIRSAVAAQWLVKDNPLPVVVDEVEPDITTAEAKDVADGFAADAVKADVTVKAVPGKDADSDVKGGDLTISPTTIAKTLSFEAKDSKLVPKFDAEKLQKRALDENEEIGRPAKDATFKVVDGKPQVVDSEPGIGIKPDDLSKAVTDAINGDTAAAEVTLASVEPEFTTEDAKKVDVSQTVSEFSTPYKSDPNRDNNLRVASKEVSGTVLQPGEQFSLNETLGPRTAANGYKPAGVISEGQMKEDFGGGVSQVSTTLFNAAFFAGFELNEHQAHSRYISRYPEGRETTLDYTSIDLKFTNNQKTPVVLDMYLSGGKVYAKVYGVKYYDVEADSSGRYAFTSPATVTESGPSCTPQSPREGWSIKITRTMKEIATGRETKDSFVTTYRPVNKVECK,MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVLAEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPELLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGMETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGGEFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSHSLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDEPDGYPVKPREWSK,155.76,gnl|BL_ORD_ID|4748|hsp_num:0,2242,FALSE,None
LK956,1_90 # 95597 # 97210 # 1 # ID=1_90;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.655,1_90,95597,97210,+,Strict,50,78.1814,vanW gene in vanI cluster,33.33,3003724,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanW; glycopeptide resistance gene cluster,GTGCTCGCGGTGCTGCTTGCGATCTACCTCGCCGACCTCGCAATGAACCGCGGGAACGTGCCGCGTGGCACCGCCGTCGGCGGTGTCGAGATCGGCGGCATGAGCCACGACGAGGCCACCGCGAAGCTCGAAGCAGAGCTCGGTGAGACGGCGAGCAACCCCGTGACGGTGAAGGCGGCATCGCAAAGCTCGCAGCTCGTGCCCGCCGAGTCCGGCCTCGGCATCGACTGGGAGGCGACCGTAGCAAGCGCGGGCGAAGAGTCCGCGAACCCGTTCACTCGCCTCGCCGGGCTGTTTCGCACCCGCGAAGTCGACATTGTGTCGACCGTGAACGAGGCCGCTCTCACCCCGCAGCTTGAGCGCGTGGCCGGCGAGTTGCACCTCGACCCCGCCGACGGCGCGATCGCCATCGAAGGCGGCGAGGCGAAAGTGACCGAACCGGTGCCGGGCCAGGAGGTTGACGAAACCGAGCTGTTCGAACGTGTCACCACCGGCTGGCTCAACCCCGACGGTGTAGAGGTCGAGCCGCGCGAAATCGAACCCGCTATCGGCGACCAGGCCATCAAGGAAGCCTTAGACGGGCCGGTTAAGGCGGCGCTGTCCGGAGCGTTGACACTGCACGGTCGCGACGGCGTCGACGGTGTCATTGCCCAAGAGCGCATCGGCGAGGTCGTCCAATTCCCCAACGTCGACGGCAAAATCGCCCCCGAGGTGAACGTGGAAAACGCCCAGGGCATCTTGGTCGAGCAGCTCGCTGCGACCGAGACGCAGATGAAAAACGCGCGCGTGCTGCCCGGCGGCGGGGTGGAACCGTCCGTCGATGGCTCCATCATCGACTGGGAGGCCGCGATGGACGGTTTCGACGAGCGGTTGATCGGTTCCGCCGAGCGCACCTGGGACGCGCAATACAAGGCCCGCCCGGCCGACTTCACTACAGAGGAAGCCCAACGTGCCAGGTTCGACGAGGTGGTGGGAAGTTTCACCACCGGCGGGTACAGCGGCGCATCCGGCACGAACATCGCTACGGTGGCCCGCGTTGTCAACGGCGCAATTGTCAACCCCGGTGAAACCTTCTCGCTCAACGGCTACACTGGCGCGCGCGGTGCCGCGCAGGGTTACGTCGAGTCGGGCATCATCGAAAATGGACGCCCCGGCAAGGCAGTGGGCGGCGGAATCTCCCAATTTGCCACGACCTTGTACAACGCGGCTTACTTTGCCGGCATGACGGATGTCGCCTCCACCCCGCACTCCTACTACATTTCACGCTACCCGGCTGGCAGGGAGGCGACCGTGTATGAAGGGGCGATTGACCTGCAATTCCGCAACGATTCGCCCCACCCGGTCAAGATTTCCACGAGCGTCGGGGGCGGCGAGGTGACGGTGAGCCTGATGGGCACCAAGACCGTCGAGGTGGAGTCCATCAACGGAGGGCGCTGGAACTACACCTCGCCGAAGCCCGTGACCGTCACCAGTGGTGACTGCATTCCCTCGGGCGGGGTGCAGGGCTTTACCACCTCCGATACCCGGATTGTGCGTGACCTCAGCGGCAATGAGATCAGTCGCAACACCTCCACCACGGTCTACGACCCGCAGCCCATCGTGCGCTGCGAGTAG,MLAVLLAIYLADLAMNRGNVPRGTAVGGVEIGGMSHDEATAKLEAELGETASNPVTVKAASQSSQLVPAESGLGIDWEATVASAGEESANPFTRLAGLFRTREVDIVSTVNEAALTPQLERVAGELHLDPADGAIAIEGGEAKVTEPVPGQEVDETELFERVTTGWLNPDGVEVEPREIEPAIGDQAIKEALDGPVKAALSGALTLHGRDGVDGVIAQERIGEVVQFPNVDGKIAPEVNVENAQGILVEQLAATETQMKNARVLPGGGVEPSVDGSIIDWEAAMDGFDERLIGSAERTWDAQYKARPADFTTEEAQRARFDEVVGSFTTGGYSGASGTNIATVARVVNGAIVNPGETFSLNGYTGARGAAQGYVESGIIENGRPGKAVGGGISQFATTLYNAAYFAGMTDVASTPHSYYISRYPAGREATVYEGAIDLQFRNDSPHPVKISTSVGGGEVTVSLMGTKTVEVESINGGRWNYTSPKPVTVTSGDCIPSGGVQGFTTSDTRIVRDLSGNEISRNTSTTVYDPQPIVRCE,MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVLAEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPELLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGMETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGGEFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSHSLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDEPDGYPVKPREWSK,143.97,gnl|BL_ORD_ID|4748|hsp_num:0,2242,FALSE,None
LK1106,32_5 # 3056 # 3799 # -1 # ID=32_5;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.774,32_5,3056,3799,-,Strict,50,82.8037,vanY gene in vanM cluster,34.46,3002961,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGTCGCACCCTCCCTCTCGCCGCGCTGGCCGCGCTCGCGCTGCTCGTGGCCGGTTGCGGCACGCCCGCCGCGGGCCCGTCCCCGGCGACGCCGGCTTCCGGCTCCGCGAGCGCGGCCGCGTCGTCCCGCGCCGCCTCGAGCACGGCGCCGTCGTCGAGCACGCACGCCGACCCGGCCGCCCTCGACGTCGTCGTGAACAAGACCCGCCCCGTGGCTCCGCCCGACTGGGCGCCCTCGGATCTGGTGGCCGTGCCCGGCAGCGAGCTGCCCCTGCGGGCGGAGGCCGCGACGGCGGCCGGTGACCTGCTGGATGCCGCCGCGGCGGCGGGTCACCGCCTCACCACCCTGAGCGCCTACCGCTCGTACGACTACCAGGTCCGGACGTACGGCCACTGGGTCGACGAGCTGGGCCGCGCCGAGGCCGACCGCGTCTCGGCGCGTCCGGGGTACTCCGAGCATCAGACCGGCCTGGCCTGGGACGTGGGCGACGCCGCGACCCCCGCGTGTGACCTGGAAGCGTGCTTCGGCGACACCGCCGCGGGCCGTTGGGTGGCCGCGCACGCCGCCGAGTACGGGTTCGTCATCCGCTATCCCGCCGGGGCCGAGGACGTGACGGGCTTCGATCACGAGCCGTGGCACCTGCGCTACGTCGGGTCCGCGGAGGCGGCCCGGGTCGAGGCGGCCGGCGGCGTCCTCGAGACCGCGTGGGGTCTGCCGCCGGCACCCGACTACGCGGACTGA,MRRTLPLAALAALALLVAGCGTPAAGPSPATPASGSASAAASSRAASSTAPSSSTHADPAALDVVVNKTRPVAPPDWAPSDLVAVPGSELPLRAEAATAAGDLLDAAAAAGHRLTTLSAYRSYDYQVRTYGHWVDELGRAEADRVSARPGYSEHQTGLAWDVGDAATPACDLEACFGDTAAGRWVAAHAAEYGFVIRYPAGAEDVTGFDHEPWHLRYVGSAEAARVEAAGGVLETAWGLPPAPDYAD,MVFQGNLLLVNNEYPVLEESIKTDVVNLFKHDELTKGYELLNREIYLSEKVAREFSEMVDAAEKEGVRHFSINSGFRNFDEQNALYQEMGSDYALPAGYSEHNLGLALDIGSTQMEMSEAPEGKWLEDNAWEYGFILRYPMDKTAITGIQYEPWHFRYVGLPHSAIIEEKNFALEEYLDFLKEQKSISGTIHGENYEISYYPITEKTDIEMPANLHYEISGNNMDGVIVTVYR,106.01,gnl|BL_ORD_ID|1673|hsp_num:0,1713,FALSE,None
LK1116,1_353 # 407533 # 408018 # 1 # ID=1_353;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.366,1_353,407533,408018,+,Strict,300,332.028,dfrC,99.38,3002865,protein homolog model,n/a,n/a,diaminopyrimidine antibiotic,antibiotic target replacement,trimethoprim resistant dihydrofolate reductase dfr,ATGACATTATCAATAATTGTCGCTCACGATAAACAAAGAGTCATTGGGTACCAAAATCAATTACCATGGCATTTACCAAATGATTTAAAGCATGTTAAACAACTGACCACTGGAAATACACTTGTAATGGGACGAAAAACTTTTAATTCTATCGGGAAACCACTGCCAAATAGACGTAACGTTGTGCTCACTAACCAAGCTTCATTTCACCATGAAGGGGTAGATGTTATAAACTCTCTTGATGAAATTAAAGAGTTATCTGGTCATGTTTTTATATTTGGAGGACAAACGTTATTCGAAGCAATGATTGACCAGGTAGATGATATGTATATCACCGTAATAGATGGGAAGTTTCAAGGAGACACTTTCTTTCCACCGTACACATTCGAAAACTGGGAGGTCGAATCTTCAGTGGAAGGTCAACTAGATGAAAAAAATACTATACCGCATACATTCTTACATTTAGTGCGTAGAAAAGGGGAATAG,MTLSIIVAHDKQRVIGYQNQLPWHLPNDLKHVKQLTTGNTLVMGRKTFNSIGKPLPNRRNVVLTNQASFHHEGVDVINSLDEIKELSGHVFIFGGQTLFEAMIDQVDDMYITVIDGKFQGDTFFPPYTFENWEVESSVEGQLDEKNTIPHTFLHLVRRKGE,MTLSIIVAHDKQRVIGYQNQLPWHLPNDLKHVKQLTTGNTLVMGRKTFNSIGKPLPNRRNVVLTNQASFHHEGVDVINSLDEIKELSGHVFIFGGQTLFEAMIDQVDDMYITVIDGKFQGDTFFPPYTFENWEVESSVEGQLDEKNTIPHTFLHLVRRKGK,100,gnl|BL_ORD_ID|1279|hsp_num:0,1397,FALSE,None
LK1116,3_7 # 5264 # 5368 # -1 # ID=3_7;partial=00;start_type=ATG;rbs_motif=AGxAG;rbs_spacer=5-10bp;gc_cont=0.295,3_7,5264,5368,-,Strict,500,22.7126,bacA,100,3002986,protein homolog model,n/a,n/a,peptide antibiotic,antibiotic target alteration,undecaprenyl pyrophosphate related proteins,ATGAGTTATAATAATCTATCTGAAGAAATAAATACTAATAATTATGATGATAAGGTAGAACAACCACCTAAAAAGGGTTTCTGGAGGCGTTTGTTCGGTAATTAA,MSYNNLSEEINTNNYDDKVEQPPKKGFWRRLFGN,MSDMHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAVVVMFWRRLFGLIGIHFGRPLQHEGESKGRLTLIHILLGMIPAVVLGLLFHDTIKSLFNPINVMYALVVGGLLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATISGGMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSWGFLTSGDIPMFAVGFITAFVVALIAIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF,12.45,gnl|BL_ORD_ID|1681|hsp_num:0,1820,TRUE,loose hit with at least 95 percent identity pushed strict
LK1116,5_107 # 117238 # 118638 # 1 # ID=5_107;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.346,5_107,117238,118638,+,Strict,525,560.836,norC,62.42,3007010,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGAATACATCACAAAAGTTTAGGGGAGATAATCGCTTATTATTAGGGATTATTTTAGGGGTTATTACATTTTGGTTATTTGCACAATCACTTGTAAATCTAGTCGTGCCATTACAATCATCATACAATAGTGATATTGGTACCATTAATATAGCAGTTAGCTTATCGGCACTATTTTCTGGTTTGTTTATTGTAGGTGCAGGAGATATTGCAGATAAAATTGGTAGAGTAAAAATGACATACATAGGCTTAGCACTTAATATTGTTGGGTCAGTTTTAATCATTATTACACCATTACCAAGTTTATTGATTATTGGACGTGCTATTCAAGGATTGTCAGCGGCGTGTATAATGCCAGCGACACTCGCAATCATTAATGAATATTATATTGGGACAGCACGACAACGTGCATTAAGCTACTGGTCCATTGGTTCATGGGGAGGTAGTGGTGTTTGTACTTTGTTTGGTGGTTTAATGGCAACTAACCTTGGATGGCGCTCAATCTTTATTGTTTCAATTATTCTGACAATATTATCCATGTTTCTCATTAAACATACTCCCGAAACAAAAGCAGAGCCTATAGGAGATCAACCGACAGAGACAAAGAAATTTGATGTTATTGGTTTAATCATCTTAGTGGTTAGCATGTTAAGTATTAATGTGATAATAACTCAAACCTCTCAATTTGGTTTGTTCTCACCATTTATTTTGGGACTTATTGCAATTTTTGTTATATCGTTAATTATATTCGTGATTTACGAAAATAAAATAAAACAACCGCTTGTCGATTTTGATATCTTTAAAAACAAAGGTTATACAGGTGCAACGATTTCAAACTTTATGTTGAATGGTGTAGCTGGTGGTACATTGATTGTAGTAAATACTTTTTATCAGCAAAAATTAGATTTTAACTCTCAGGAAACTGGATATATCTCACTTACATATCTAGTTGCAGTATTAATTATGATACGTGTGGGTGAAATGATATTACAATCGCTAGGACCTAAAAGACCTTTGTTACTCGGAAGTGCCTTGACCGTCATAGGATTAATATTATTATCTTTGACGTTTTTACCTAATGCTTGGTATATAGCGTCAAGTGTCGTTGGTTATTTATTATTTGGTACCGGTTTAGGTATTTATGCAACACCATCCACGGATACAGCTGTTGCACAAGCACCAGATGATAAAGTAGGCGTCGCATCCGGTGTATATAAGATGGCATCATCTTTAGGAAATGCATTTGGTGTGGCCATCTCAAGTACAGTTTACAGCGTACTTGCAGCTCAACTGAATCTGACTTTAGGTGGTTTTACTGGAGTAATGTTTAATGCGCTTATAGCATTATTAGCATTCCTATCTATTTTGTTCTTAATACCGAAAAAACAATCTAATGTATAA,MNTSQKFRGDNRLLLGIILGVITFWLFAQSLVNLVVPLQSSYNSDIGTINIAVSLSALFSGLFIVGAGDIADKIGRVKMTYIGLALNIVGSVLIIITPLPSLLIIGRAIQGLSAACIMPATLAIINEYYIGTARQRALSYWSIGSWGGSGVCTLFGGLMATNLGWRSIFIVSIILTILSMFLIKHTPETKAEPIGDQPTETKKFDVIGLIILVVSMLSINVIITQTSQFGLFSPFILGLIAIFVISLIIFVIYENKIKQPLVDFDIFKNKGYTGATISNFMLNGVAGGTLIVVNTFYQQKLDFNSQETGYISLTYLVAVLIMIRVGEMILQSLGPKRPLLLGSALTVIGLILLSLTFLPNAWYIASSVVGYLLFGTGLGIYATPSTDTAVAQAPDDKVGVASGVYKMASSLGNAFGVAISSTVYSVLAAQLNLTLGGFTGVMFNALIALLAFLSILFLIPKKQSNV,MNETYRGGNKLILGIVLGVITFWLFAQSLVNVVPNLQQSFGADMGTISIAVSLTALFSGMFVVGAGGLADKIGRVKMTNIGLLLSIIGSALIIITNLPALLILGRIIQGVSAACIMPSTLAIMKTYYEGAERQRALSYWSIGSWGGSGICSLFGGAVATTMGWRWIFIFSIIVAVLSMLLIKGTPETKSEVTNTHKFDVAGLIVLVVMLLSLNVVITKGAALGYTSLWFFGLIAIVIVAFFIFLNVEKKVDNPLIDFKLFENKPYTGATISNFLLNGVAGTLIVANTFVQQGLGYTALQAGYLSITYLIMVLLMIRVGEKLLQKMGSKRPMLLGTFIVIIGIALISLVFLPGIFYVISCVVGYLCFGLGLGIYATPSTDTAISNAPLDKVGVASGIYKMASSLGGAFGVAISGAVYAGAVAATSIHTGAMIALWVNVLMGIMAFIAILFAIPNDDKRVKDAK,100.87,gnl|BL_ORD_ID|4656|hsp_num:0,5726,FALSE,None
LK1116,7_48 # 57157 # 57585 # -1 # ID=7_48;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.298,7_48,57157,57585,-,Strict,150,188.348,FosBx1,60.58,3007372,protein homolog model,n/a,n/a,phosphonic acid antibiotic,antibiotic inactivation,fosfomycin thiol transferase,ATGGAAATAACAAGTGTTAATCATATTTGTTTTTCAGTAAGTGATTTAAATACCTCTATACAATTTTATAAAGATATTTTACAAGGTGACTTATTAGTATCAGGGAGAACGACAGCATATTTAACTATTGGTCATACTTGGATTGCACTGAATCAAGAAAAAAATATACCAAGGAATGAAATAAACCATTCCTATACACACGTTGCTTTCTCCATAGATGAAGAAGATTTTCAAAAATGGATTCAATGGCTTAAAGAGAATCAAGTAAATATTTTAAAAGGGCGACCAAGAGATATTAAAGACAAAAAGTCGATATATTTTACAGATCCGGATGGGCATAAAATTGAATTACATACTGGGACATTAAAAGATAGAATGGAATATTATAAAAGTGAGAAGACGCATATGCAATTTTACGGTGAGTTTTGA,MEITSVNHICFSVSDLNTSIQFYKDILQGDLLVSGRTTAYLTIGHTWIALNQEKNIPRNEINHSYTHVAFSIDEEDFQKWIQWLKENQVNILKGRPRDIKDKKSIYFTDPDGHKIELHTGTLKDRMEYYKSEKTHMQFYGEF,MLRGINHICFSVSNLENSIMFYEKVLEGELLVKGRKLAYFNICGVWIALNEETHIPRNEIHQSYTHIAFSVEKEDFKCLIQRLEENDVHILQGRERDVRDCESIYFVDPDGHKFEFHSGTLQDRLNYYRDEKPHMTFY,102.9,gnl|BL_ORD_ID|4909|hsp_num:0,5900,FALSE,None
LK1116,9_3 # 3273 # 3740 # -1 # ID=9_3;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.235,9_3,3273,3740,-,Strict,100,227.639,sepA,69.68,3007012,protein homolog model,n/a,n/a,disinfecting agents and antiseptics,antibiotic efflux,small multidrug resistance (SMR) antibiotic efflux pump,ATGAAATTTTTAAAAAATAAATCATATCATTTATTAGTAACACTTATTGTTCTCACTATATTTATTATTTCCGGAGCCATTTTTTTAACGTTTTTAGGCTTTGGTTTGTACGGTTTGAGTCGCATCCTTATTTATTTACACTTAGGCGATTTTAGTTACAATAAAGGCTTTTATGATAATTTAATATACTACGGTAGTTATATCGTTTTAGGCTATTTTACTTTATTTTCAATTGAGCATTTAATGGATTATTTTAAAAAGAATCTTCCAAAAAATCCATACTTTCAAGGTATTAACTTTCATCTTATCTCCTATATTGTTACTACAATTATGTTTTATTTTATAGTTCACATACACTATGTACATGTTAATATACATTTTTGGGTAATTATGATTATTATAGGATTTTTATTTGGATGTAAAGAAGTTTTTTATCCTGAAAGTAAAAATTTGAATAATAAAAAGTAA,MKFLKNKSYHLLVTLIVLTIFIISGAIFLTFLGFGLYGLSRILIYLHLGDFSYNKGFYDNLIYYGSYIVLGYFTLFSIEHLMDYFKKNLPKNPYFQGINFHLISYIVTTIMFYFIVHIHYVHVNIHFWVIMIIIGFLFGCKEVFYPESKNLNNKK,MIVNFFKHKFYNLLTTMIVLFVFVLSGAIFLTFLGFGLYGLSRILIYFRLGDFTYNRNMYDNLLYYGSYIIFGYFIIFAVEHLMDYFRKMLPENAYFRGATFHLISYTVATTLFYFIIHLHYVYINIDFWVIMVIIGFLYVCKLQFYPESKNLNNRK,98.73,gnl|BL_ORD_ID|4660|hsp_num:0,5728,FALSE,None
LK1116,9_4 # 3934 # 5271 # -1 # ID=9_4;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.298,9_4,3934,5271,-,Strict,200,608.601,sdrM,73.93,3007013,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGAATCTTAAGTCCATCATTACTGTAATGGCACTCATACTAATAATGTTTATGGCAGCTATAGAAACATCAATCATTTCATTAGCATTACCAACAATAAAAAATAGTTTGAATGCCGGTAATCTAGTTTCATTAGTATTTACCGTATATTTTATTGCTTTAGTCATAGCTAACCCTATCGTTGGTGAGCTCATGTCTAGATTTAAAATTATTAACATTGCTGTTCTAGGGGTATCATTGTTTGCCTTAGGTAGTTTAATGTCGGGATTAAGTCAGACGTTTACTTTTTTAATTATCTCTCGAATAGTACAAGGTTTTGGAGCAGGAGTTATGATGTCACTCTCACAAATAGTTCCAAAGTTGGCTTTTGAAATTCCGTTAAGATATAAAATTATGGGTATCGTCGGAAGTGTCTGGGGGATTTCGAGTATTATTGGTCCATTATTAGGTGGTGCGATTTTAGAGTTCGCTTCATGGCATTGGCTATTCTATATCAATATTCCTATTGCTATATTGGCAATAATACTTGTATTTATGACTTTTCATTTTCCTGATGAGACACAAGTACAACAGAGTCGTTTTGATATAAAAGGATTGATTATCTTTTATATCTTTATAGCTTTATTAATGTTTGGTTTACTCAACCAACATCATATTATTTTTAATATATTCTCAATTATTTTAGCTTTAGTTGTTTTATGGATGCTATTTAAAGTAGAAAATAGTTTCGAACAACCATTTTTACCAACGAAAGAATTTAACATATCAATAGTTCTAGTTTTTATAACGGATTTACTAATTGCGATAACATTGATGGGATATAATTTATATATACCAGTATATTTACAAGAAAAACTTGGTTTATCACCTTTACAAAGTGGATTTGTAATATTCCCGTTGTCTGTTGCTTGGATTACGCTTAATTTCAATTTAGCTAAAATAGAAGCGCATTTTACTAGAAAAACATTATATATTTGCTCATTTTTTGTTTTATTAGTTTGTAGTCTGATGATAATTTTTGGCTTAAAACTCCCATTGCTTATAGCTTTTGCGGTTATATTTGCAGGTTTAAGTTTTGGCTATATTTATACAAAAGATAGTGTTATTGTCCAAGAGGAAACTTCTCCAAAAAATATGAAAAAGATGATGTCGTTTTATGCATTGACAAAAAATTTAGGTTCGTCTGTCGGATCTACGATTATGGGATATATGTATGCACTAAATGTTGGATTATTTGGTTCTAATTTACACAATGTATTAGGATTAGTATCAATAATTTCAGTATGTTTAATTGTAATGTGGATGACATTATTTAAGAGCAATCCTATTCAATCTTAG,MNLKSIITVMALILIMFMAAIETSIISLALPTIKNSLNAGNLVSLVFTVYFIALVIANPIVGELMSRFKIINIAVLGVSLFALGSLMSGLSQTFTFLIISRIVQGFGAGVMMSLSQIVPKLAFEIPLRYKIMGIVGSVWGISSIIGPLLGGAILEFASWHWLFYINIPIAILAIILVFMTFHFPDETQVQQSRFDIKGLIIFYIFIALLMFGLLNQHHIIFNIFSIILALVVLWMLFKVENSFEQPFLPTKEFNISIVLVFITDLLIAITLMGYNLYIPVYLQEKLGLSPLQSGFVIFPLSVAWITLNFNLAKIEAHFTRKTLYICSFFVLLVCSLMIIFGLKLPLLIAFAVIFAGLSFGYIYTKDSVIVQEETSPKNMKKMMSFYALTKNLGSSVGSTIMGYMYALNVGLFGSNLHNVLGLVSIISVCLIVMWMTLFKSNPIQS,MRLKSIITVIALILIMFMSAIESSIISLALPTIKQDLNAGNLISLIFTAYFIALVIANPIVGELLSRFKIIYVAIAGLLLFSIGSFMCGLSTNFTMLIISRVIQGFGSGVLMSLSQIVPKLAFEIPLRYKIMGIVGSVWGISSIIGPLLGGGILEFATWHWLFYINIPIAIIAIILVIWTFHFPEEETVAKSKFDTKGLTLFYVFIGLIMFALLNQQLLLLNFLSFILAIVVAMCLFKVEKHVSSPFLPVVEFNRSITLVFITDLLTAICLMGFNLYIPVYLQEQLGLSPLQSGLVIFPLSVAWITLNFNLHRIEAKLSRKVIYLLSFTLLLVSSIIISFGIKLPVLIAFVLILAGLSFGYIYTKDSVIVQEETSPLQMKKMMSFYGLTKNLGASIGSTIMGYLYAIQSGIFGPNLHNVLSAVAVISIGLIVLWVVFFKEQSSQSKE,99.55,gnl|BL_ORD_ID|4661|hsp_num:0,5729,FALSE,None
LK1116,11_6 # 5621 # 6784 # -1 # ID=11_6;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.327,11_6,5621,6784,-,Strict,700,755.362,norA,99.22,3000391,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGAAAAAGCAATTATTTATTCTTTATTTTAATATATTTCTTATATTTTTAGGAATTGGGTTAGTTATTCCTGTACTTCCTGTATATTTAAAGGATTTAGGATTAAAAGGTAGTGACTTAGGAATGCTAGTTGCTGCCTTTGCATTATCACAAATGATTATTTCACCATTTGGTGGGACACTAGCTGATAAATTGGGGAAAAAATTAATTATATGTATCGGTTTAGTATTCTTTTCTGTCTCTGAATTTATGTTCGCAGCCGGTCAAAGTTTTACCATTTTAATCATTTCACGTGTTTTAGGTGGTTTTAGTGCAGGCATGGTCATGCCTGGTGTAACAGGTATGATTGCAGATATTTCTCCAGGAGCTGATAAAGCTAAAAACTTTGGATATATGTCGGCAATTATTAATTCAGGTTTCATATTAGGGCCTGGATTTGGAGGGTTTTTAGCTGAAATTTCACATAGATTACCTTTCTATGTTGCTGGAACATTAGGTGTTGTTGCATTCATTATGTCAGTTTTATTAATTCATAATCCTCACAAAGCAACCACAGATGGATTCCACCAATATCAACCCGAATTATTCACTAAAATTAATTGGAAAGTATTTATTACGCCAGTTATATTAACACTTGTATTAGCATTTGGTTTATCTGCTTTTGAAACATTGTTTTCTTTATATACAGCTGACAAAGTAAATTATACTCCTAAAGATATTTCGATAGCTATTATCGGTGGAGGCGTGTTCGGCGCATTATTCCAGGTATTCTTCTTTGATAAATTTATGAAATATATGAGTGAACTTAATTTTATTGCATGGTCATTACTATATTCAGCTATTGTTCTCGTTATGTTAGTGCTTGCAAACGGTTATTGGACGATTATGATGATTAGCTTTGTTGTTTTTATAGGCTTTGATATGATTAGACCGGCTTTAACCAATTACTTCTCGAATATAGCAGGTAAACGGCAAGGTTTTGCAGGTGGATTGAATTCAACTTTTACCAGTATGGGTAACTTTATAGGTCCTCTTGTAGCTGGTGCATTATTCGATGTTAATTTAGAGTTTCCTTTATATATGGCTATTGCGGTTTCATTAAGTGGAATTATCATTATTTTTATTGAAAAAGGACTTAAGTCACGTCGTAAAGAAGCAAATTAA,MKKQLFILYFNIFLIFLGIGLVIPVLPVYLKDLGLKGSDLGMLVAAFALSQMIISPFGGTLADKLGKKLIICIGLVFFSVSEFMFAAGQSFTILIISRVLGGFSAGMVMPGVTGMIADISPGADKAKNFGYMSAIINSGFILGPGFGGFLAEISHRLPFYVAGTLGVVAFIMSVLLIHNPHKATTDGFHQYQPELFTKINWKVFITPVILTLVLAFGLSAFETLFSLYTADKVNYTPKDISIAIIGGGVFGALFQVFFFDKFMKYMSELNFIAWSLLYSAIVLVMLVLANGYWTIMMISFVVFIGFDMIRPALTNYFSNIAGKRQGFAGGLNSTFTSMGNFIGPLVAGALFDVNLEFPLYMAIAVSLSGIIIIFIEKGLKSRRKEAN,MKKQLFILYFNIFLIFLGIGLVIPVLPVYLKDLGLKGSDLGMLVAAFALSQMIISPFGGTLADKLGKKLIICIGLVFFAVSEFMFAAGQSFTILIISRVLGGFSAGMVMPGVTGMIADISPGADKAKNFGYMSAIINSGFILGPGFGGFLAEISHRLPFYVAGTLGVVAFIMSVLLIHNPQKATTDGFHQYQPELFTKINWKVFITPVILTLVLAFGLSAFETLFSLYTADKVNYTPKDISIAIIGGGVFGALFQVFFFDKFMKYMSELNFIAWSLLYSAIVLVMLVLANGYWTIMIISFVVFIGFDMIRPALTNYFSNIAGKRQGFAGGLNSTFTSMGNFIGPLVAGALFDVNLEFPLYMAIAVSLSGIIIIFIEKGLKSRRKEAN,100,gnl|BL_ORD_ID|1427|hsp_num:0,1554,FALSE,None
LK1116,11_14 # 13921 # 14364 # 1 # ID=11_14;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.331,11_14,13921,14364,+,Strict,270,286.189,mgrA,95.24,3000815,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; cephalosporin; penam; tetracycline antibiotic; peptide antibiotic; disinfecting agents and antiseptics,antibiotic efflux,ATP-binding cassette (ABC) antibiotic efflux pump; major facilitator superfamily (MFS) antibiotic efflux pump,ATGTCTGAACAACATAATTTAAAAGAGCAGCTATGCTTTAGTTTGTACAACGCTCAAAGACAAGTTAATCGCTACTATTCAAACAAAGTCTTTAAAAAGTACAATCTAACATACCCACAATTTCTTGTTTTAACAATATTATGGGATGAATCACCTGTTAACGTCAAAAAGGTCGTTACAGAATTAGCACTTGATACTGGAACTGTATCACCATTACTCAAGAGAATGGAACAAGTTGATTTAATCAAACGTGAACGTTCTGAAGTAGATCAACGTGAAGTATTTATTCACTTAACAGACAAAAGTGAAATGATTAGGCCCGAATTAAGCAACGCATCTGAGAAAGTTGCAACTGCTTCTTCTTTATCTAAAGATGAGGTCAAAGAACTTAATCGTTTATTAGGTAAAGTCATCGATGCATTTATCGAAACAAAAGAAAAGTAA,MSEQHNLKEQLCFSLYNAQRQVNRYYSNKVFKKYNLTYPQFLVLTILWDESPVNVKKVVTELALDTGTVSPLLKRMEQVDLIKRERSEVDQREVFIHLTDKSEMIRPELSNASEKVATASSLSKDEVKELNRLLGKVIDAFIETKEK,MSDQHNLKEQLCFSLYNAQRQVNRYYSNKVFKKYNLTYPQFLVLTILWDESPVNVKKVVTELALDTGTVSPLLKRMEQVDLIKRERSEVDQREVFIHLTDKSETIRPELSNASDKVASASSLSQDEVKELNRLLGKVIHAFDETKEK,100,gnl|BL_ORD_ID|133|hsp_num:0,154,FALSE,None
LK1116,20_19 # 15524 # 16990 # 1 # ID=20_19;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.312,20_19,15524,16990,+,Strict,800,1006.51,msrA,99.59,3000251,protein homolog model,n/a,n/a,macrolide antibiotic; streptogramin antibiotic; streptogramin B antibiotic,antibiotic target protection,msr-type ABC-F protein,ATGGAACAATATACAATTAAATTTAACCAAATCAATCATAAATTGACAGATTTACGATCACTTAACATCGATCATCTTTATGCTTACCAATTTGAAAAAATAGCACTTATTGGGGGTAATGGTACTGGCAAAACCACATTACTAAATATGATTGCTCAAAAAACAAAACCAGAATCTGGAACAGTTGAAACGAATGGCGAAATTCAATATTTTGAACAGCTTAACATGGATGTGGAAAATGATTTTAACACGTTAGACGGTAGTTTAATGAGTGAACTCCATATACCTATGCATACAACCGACAGTATGAGTGGTGGTGAAAAAGCAAAATATAAATTAGCTAATGTCATATCAAATTATAGTCCGATATTACTTTTAGATGAACCTACAAATCACTTGGATAAAATTGGTAAAGATTATCTGAATAATATTTTAAAATATTACTATGGTACTTTAATTATAGTAAGTCACGATAGAGCACTTATAGACCAAATTGCTGACACAATTTGGGATATACAAGAAGATGGCACAATAAGAGTGTTTAAAGGTAATTACACACAGTATCAAAATCAATATGAACAAGAACAGTTAGAACAACAACGTAAATATGAACAGTATATAAGTGAAAAACAAAGATTGTCCCAAGCCAGTAAAGCTAAACGAAATCAAGCGCAACAAATGGCACAAGCATCATCAAAACAAAAAAATAAAAGTATAGCACCAGATCGTTTAAGTGCATCAAAACAAAAAGGCACGGTTGAGAAGGCTGCTCAAAAACAAGCTAAGCATATTGAAAAAAGAATGGAACATTTGGAAGAAGTTGAAAAACCACAAAGTTATCATGAATTCAATTTTCCACAAAATAAAATTTATGATATCCATAATAATTATCCAATCATTGCACAAAATCTAACATTGGTTAAAGGAAGTCAAAAACTGCTAACACAAGTACGATTCCAAATACCATATGGCAAAAATATAGCGCTCGTAGGTGCAAATGGTGTAGGTAAGACAACTTTACTTGAAGCTATTTACCACCAAATAGAGGGAATTGATTGTTCTCCTAAAGTGCAAATGGCATACTATCGTCAACTTGCTTATGAAGACATGCGTGACGTTTCATTATTGCAATATTTAATGGATGAAACGGATTCATCAGAATCATTCAGTAGAGCTATTTTAAATAACTTGGGTTTAAATGAAGCACTTGAGCGTTCTTGTAATGTTTTGAGTGGTGGGGAAAGAACGAAATTATCGTTAGCAGTATTATTTTCAACGAAAGCGAATATGTTAATTTTGGATGAACCAACTAATTTTTTAGATATTAAAACATTAGAAGCATTAGAAATGTTTATGAATAAATATCCTGGAATCATTTTGTTTACATCACATGATACAAGGTTTGTTAAACATGTATCAGATAAAAAATGGGAATTAACAGGACAATCTATTCATGATATAACTTAA,MEQYTIKFNQINHKLTDLRSLNIDHLYAYQFEKIALIGGNGTGKTTLLNMIAQKTKPESGTVETNGEIQYFEQLNMDVENDFNTLDGSLMSELHIPMHTTDSMSGGEKAKYKLANVISNYSPILLLDEPTNHLDKIGKDYLNNILKYYYGTLIIVSHDRALIDQIADTIWDIQEDGTIRVFKGNYTQYQNQYEQEQLEQQRKYEQYISEKQRLSQASKAKRNQAQQMAQASSKQKNKSIAPDRLSASKQKGTVEKAAQKQAKHIEKRMEHLEEVEKPQSYHEFNFPQNKIYDIHNNYPIIAQNLTLVKGSQKLLTQVRFQIPYGKNIALVGANGVGKTTLLEAIYHQIEGIDCSPKVQMAYYRQLAYEDMRDVSLLQYLMDETDSSESFSRAILNNLGLNEALERSCNVLSGGERTKLSLAVLFSTKANMLILDEPTNFLDIKTLEALEMFMNKYPGIILFTSHDTRFVKHVSDKKWELTGQSIHDIT,MEQYTIKFNQINHKLTDLRSLNIDHLYAYQFEKIALIGGNGTGKTTLLNMIAQKTKPESGTVETNGEIQYFEQLNMDVENDFNTLDGSLMSELHIPMHTTDSMSGGEKAKYKLRNVISNYSPILLLDEPTNHLDKIGKDYLNNILKYYYGTLIIVSHDRALIDQIADTIWDIQEDGTIRVFKGNYTQYQNQYEQEQLEQQRKYEQYISEKQRLSQASKAKRNQAQQMAQASSKQKNKSIAPDRLSASKEKGTVEKAAQKQAKHIEKRMEHLEEVEKPQSYHEFNFPQNKIYDIHNNYPIIAQNLTLVKGSQKLLTQVRFQIPYGKNIALVGANGVGKTTLLEAIYHQIEGIDCSPKVQMAYYRQLAYEDMRDVSLLQYLMDETDSSESFSRAILNNLGLNEALERSCNVLSGGERTKLSLAVLFSTKANMLILDEPTNFLDIKTLEALEMFMNKYPGIILFTSHDTRFVKHVSDKKWELTGQSIHDIT,100,gnl|BL_ORD_ID|1105|hsp_num:0,1200,FALSE,None
LK1116,20_24 # 21025 # 21870 # 1 # ID=20_24;partial=00;start_type=TTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.277,20_24,21025,21870,+,Strict,500,511.531,PC1 beta-lactamase (blaZ),95.02,3000621,protein homolog model,n/a,n/a,penam,antibiotic inactivation,BlaZ beta-lactamase,TTGAAAAAGTTAATATTTTTAATTGCAATTGCTTTAGTTTTAAGTGCATGTAATTCAAACAGTTCACATGCCAAAGAGTTAAATGATTTAGAAAAAAAATATAATGCTCATATTGGTGTTTATGCTTTAGATACTAAAAGTGGTAAGGAAGTAAAATTTAATTCAGATAAGAGATTTGCCTATGCTTCGACTTCAAAAGCGATAAATAGTGCTATTTTGTTAGAACAAGTACCTTATAATAAGTTAAATAAAAAAATACATATTAACAAAGATGATATAGTTGCTTATTCTCCTATTTTAGAAAAATATGTAGGAAAAGATATCACTTTAAAAGAACTTATTGAGGCTTCAATGGCATATAGTGATAATACAGCAAACAATAAAATTATAAAAGAAATTGGTGGAATCAAAAAAGTTAAACAACGTCTAAAAGAACTAGGAGATAAAGTAACAAATCCAGTTAGATATGAGATAGAATTAAATTACTATTCACCAAAGAGCAAAAAAGATACTTCAACACCTGCTGCTTTCGGTAAGACTTTAAATAAACTTATCGCAAATGGAAAATTAAGCAAAGAAAACAAAAAATTCTTACTTGATTTAATGTTAAATAATAAAAGCGGAGATACTTTAATTAAAGACGGTGTTTCAAAAGACTGTAAGGTTGCTGATAAAAGTGGTCAAGCAATAACATATGCTTCTAGAAATGATGTTGCTTTTGTTTATCCTAAGGGCCAATCTGAACCTATTGTTTTAGTCATTTTTACGAATAAAGACAATAAAAGTGATAAGCCAAATGATAAGTTGATAAGTGAAACCGCCAAGAGTGTAATGAAGGAATTTTAA,MKKLIFLIAIALVLSACNSNSSHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFAYASTSKAINSAILLEQVPYNKLNKKIHINKDDIVAYSPILEKYVGKDITLKELIEASMAYSDNTANNKIIKEIGGIKKVKQRLKELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKTLNKLIANGKLSKENKKFLLDLMLNNKSGDTLIKDGVSKDCKVADKSGQAITYASRNDVAFVYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF,MKKLIFLIVIALVLSACNSNSSHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFAYASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDIALKELIEASMKYSDNTANNKIINEIGGIKKIKKRLKKLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKTLNKLIANGKLSKKNKNFLLDLMLNNKNGDTLIKDGIPKDYKVADKSGQAITYASRNDVAFVYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF,100,gnl|BL_ORD_ID|670|hsp_num:0,726,FALSE,None
LK1116,28_4 # 2452 # 5526 # 1 # ID=28_4;partial=00;start_type=TTG;rbs_motif=AGGAGG;rbs_spacer=5-10bp;gc_cont=0.287,28_4,2452,5526,+,Strict,2000,2086.23,Staphylococcus aureus mupA conferring resistance to mupirocin,99.41,3000521,protein homolog model,n/a,n/a,mupirocin-like antibiotic,antibiotic target alteration,antibiotic-resistant isoleucyl-tRNA synthetase (ileS),TTGACAAAGAAATATTTAAACACCCAGAATGAAATATCATCATTTTGGAATACTCAAAAGATATTTAGAAAATCAATTGACAATAGAAAAGGACAGGAAAGTTTTGTTTTTTATGACGGCCCCCCAACTGCAAATGGCCTTCCTCATGCTGGCCATGTTCTTGGAAGAGTAATCAAGGATTTAGTTGCAAGATTAAAAACTATGCAAGGTTTTTATGTAGAAAGAAAAGCAGGATGGGATACCCATGGCTTACCAGTTGAATTAGAGGTTGAAAAAAAAATTGGAATTAAAGGAAAACAAGACATTGAAAAGTATGGAATAGAAAATTTTATAAATGAATGTAAAAAAAGTGTATTTAATTATGAAAAAGAATGGCGGGATTTTTCTAAAGATTTAGGATACTGGGTTGACATGGACTCCCCCTATATAACTCTTGAGAATAATTATATTGAAAGTGTATGGAATATATTATCTACATTCCATAAAAAAGGACTATTATATAAGGGACATAAGGTGACTCCTTATTGTACACATGATCAAACCGCTTTAAGTTCTCATGAAGTAGCGCAAGGCTATAAAAACGTTAAAGATTTATCAGCTGTTGTTAAATTTCAACTTACAAATAGTAAAGATACTTATTTCTTAAGTTGGACTACCACTCCCTGGACTTTGCCTGCAAATGTAGCATTAGCTATAAATAAAGATCTTAATTATTCAAAAATTCGGGTAGAAAATGAGTATTATATCTTAGCTACAGATCTAATTAATTCTATAATAACTGAAAAATACGAAATTATTGATACCTTTTCAGGAAGTAATTTAATTAATTTAAAATACATTCCTCCTTTTGAAAGCGACGGTTTAGTTAATGCATATTACGTTGTTGATGGAGAATTTGTTACTAACTCAGAAGGAACTGGTATTGTTCATATAGCACCAGCTCATGGGGAAGATGACTACCAATTGGTTTTAGAGCGTGATTTGGATTTCTTAAATGTTATAACAAGAGAAGGAGTATATAATGATAGGTTCCCTGAATTAGTTGGTAATAAAGCTAAAAATAGTGATATAGAAATCATAAAATTATTATCCAAAAAACAACTTTTATATAAAAAACAAAAATATGAGCATAATTATCCTCATTGTTGGAGATGTGGTAATCCTTTGATATATTATGCGATGGAAGGTTGGTTTATTAAAACAACTAATTTTAAGAATGAAATTATTAACAATAATAATAATATAGAGTGGTTTCCTTCTCATATTAAGGAAGGGAGAATGGGAAATTTCTTAGAAAATATGGTTGATTGGAACATTGGTAGAAATAGATATTGGGGAACACCATTAAATGTATGGATTTGCAATGATTGTAATCACGAATACGCACCAAGTAGTATTAAGGATTTACAAAATAATTCCATCAATAAAATTGATGAAGATATTGAGTTGCATAGACCTTATGTTGATAATATCACTCTTAGTTGCCCTAAGTGTAATGGGAAAATGTCTCGAGTAGAAGAAGTAATCGATGTTTGGTTTGATAGCGGCTCTATGCCGTTTGCTCAGCATCATTATCCTTTTGATAACCAGAAAATTTTTAATCAACACTTTCCAGCTGATTTTATTGCAGAAGGAGTTGATCAAACGAGAGGCTGGTTTTACAGTTTACTAGTAATTTCTACTATTCTAAAAGGAAAATCTTCTTATAAACGTGCTTTATCTTTAGGACATATTCTAGACAGTAATGGTAAAAAAATGTCTAAAAGTAAAGGAAACGTTATTAATCCAACTGAATTAATTAATAAGTACGGAGCCGATTCTTTAAGATGGGCCTTAATTTCGGATAGTGCTCCATGGAATAACAAAAGATTCTCAGAAAATATAGTAGCTCAGACCAAATCGAAATTTATAGATACGCTTGATAATATTTATAAATTTTATAATATGTATAATAAAATAGATCACTATAATCCTAATAATGAAATTACAAAAAGTAGAAATACATTAGATAATTGGGCTCTTTCTCGCTTAAACACCTTAATAAAAGAAAGTAATATTTATGTAAATAATTACGATTTCACTTCCGCAGCCAGATTAATTAACGAATATACCAATACAATAAGTAATTGGTATATTCGGAGATCGAGAGGACGATTTTGGGAACAAGGAATTTCTAACGATAAAAAAGATGCGTACAATACGCTTTATGAAATTTTAACAACTTTATCAAGACTAGTGGCTCCATTTGTTCCATTTATATCTGAAAAAATCCATTATAATTTGACTGGAAAAAGTGTGCATTTACAAGATTATCCACAATATAAAGAAAGTTTTATTAATCAAGCATTGGAAGATGAAATGCATACCGTTATAAAAATTGTAGAATTATCTAGACAGGCTCGCAAAAATGCAGATTTAAAAATTAAGCAACCTTTATCGAAAATGGTGATTAAACCTAATAGTCAATTAAACTTAAGTTTTTTACCTAATTACTATTCAATAATAAAAGACGAATTAAATATAAAAAACATTGAATTAACTGATAATATTAATGACTATATTACCTATGAGCTTAAATTGAATTTTTCTTCTGTGGGACCAAAACTAGGGAACAAAACGAAAAATATTCAAACATTGATAGACTCCCTATCAGAGTATGATAAAAAAAGTTTAATTGAGTCTAATAACTTCAAAAGTTTATCTTCTGATGCTGAGTTAACTAAGGATGATTTTATAATTAAAACCTTACCTAAGGATAGTTATCAACTCAGTGAAGATAATGACTGCGTTATATTATTAGATAAAAATTTATCTCCTGAATTAATTCGCGAAGGACATGCTAGAGAGCTCATTAGATTAATTCAACAATTAAGAAAAAAGAAAAATTTACCAATAAATCAACGTATTGATATTTATATCGGTGTAACTGGGGAATTATTAGAATCAATAAAAACCAATAAAAATATGTTTAAAGAAAATTTGCTGATTAAAAATATACACTTAAATGTTATAGATGAATATGAAAATACTATTCATTTTAATAATAAAGAAATAAAAATTTCCTTATTATATTAA,MTKKYLNTQNEISSFWNTQKIFRKSIDNRKGQESFVFYDGPPTANGLPHAGHVLGRVIKDLVARLKTMQGFYVERKAGWDTHGLPVELEVEKKIGIKGKQDIEKYGIENFINECKKSVFNYEKEWRDFSKDLGYWVDMDSPYITLENNYIESVWNILSTFHKKGLLYKGHKVTPYCTHDQTALSSHEVAQGYKNVKDLSAVVKFQLTNSKDTYFLSWTTTPWTLPANVALAINKDLNYSKIRVENEYYILATDLINSIITEKYEIIDTFSGSNLINLKYIPPFESDGLVNAYYVVDGEFVTNSEGTGIVHIAPAHGEDDYQLVLERDLDFLNVITREGVYNDRFPELVGNKAKNSDIEIIKLLSKKQLLYKKQKYEHNYPHCWRCGNPLIYYAMEGWFIKTTNFKNEIINNNNNIEWFPSHIKEGRMGNFLENMVDWNIGRNRYWGTPLNVWICNDCNHEYAPSSIKDLQNNSINKIDEDIELHRPYVDNITLSCPKCNGKMSRVEEVIDVWFDSGSMPFAQHHYPFDNQKIFNQHFPADFIAEGVDQTRGWFYSLLVISTILKGKSSYKRALSLGHILDSNGKKMSKSKGNVINPTELINKYGADSLRWALISDSAPWNNKRFSENIVAQTKSKFIDTLDNIYKFYNMYNKIDHYNPNNEITKSRNTLDNWALSRLNTLIKESNIYVNNYDFTSAARLINEYTNTISNWYIRRSRGRFWEQGISNDKKDAYNTLYEILTTLSRLVAPFVPFISEKIHYNLTGKSVHLQDYPQYKESFINQALEDEMHTVIKIVELSRQARKNADLKIKQPLSKMVIKPNSQLNLSFLPNYYSIIKDELNIKNIELTDNINDYITYELKLNFSSVGPKLGNKTKNIQTLIDSLSEYDKKSLIESNNFKSLSSDAELTKDDFIIKTLPKDSYQLSEDNDCVILLDKNLSPELIREGHARELIRLIQQLRKKKNLPINQRIDIYIGVTGELLESIKTNKNMFKENLLIKNIHLNVIDEYENTIHFNNKEIKISLLY,MTKKYLNTQNEISAFWNTQKIFKKSIDNRKGQESFVFYDGPPTANGLPHAGHVLGRVIKDLVARLKTMQGFYVERKAGWDTHGLPVELEVEKKIGIKGKQDIEKYGIENFINECKKSVFNYEKEWRDFSKDLGYWVDMDSPYITLENNYIESVWNILSTFHKKGLLYKGHKVTPYCTHDQTALSSHEVAQGYKNVKDLSAVVKFQLTNSKDTYFLSWTTTPWTLPANVALAINKDLNYSKIRVENEYYILATDLINSIITEKYEIIDTFSGSNLINLKYIPPFESDGLVNAYYVVDGEFVTNSEGTGIVHIAPAHGEDDYQLVLERDLDFLNVITREGVYNDRFPELVGNKAKNSDIEIIKLLSKKQLLYKKQKYEHNYPHCWRCGNPLIYYAMEGWFIKTTNFKNEIINNNNNIEWFPSHIKEGRMGNFLENMVDWNIGRNRYWGTPLNVWICNDCNHEYAPSSIKDLQNNSINKIDEDIELHRPYVDNITLSCPKCNGKMSRVEEVIDVWFDSGSMPFAQHHYPFDNQKIFNQHFPADFIAEGVDQTRGWFYSLLVISTILKGKSSYKRALSLGHILDSNGKKMSKSKGNVINPTELINKYGADSLRWALISDSAPWNNKRFSENIVAQTKSKFIDTLDNIYKFYNMYNKIDHYNPNNEITKSRNTLDNWALSRLNTLIKESNIYVNNYDFTSAARLINEYTNTISNWYIGDSRGRFWEQGISNDKKDAYNTLYEILTTLSRLVAPFVPFISEKIHYNLTGKSVHLQDYPQYKESFINQALEDEMHTVIKIVELSRQARKNADLKIKQPLSKMVIKPNSQLNLSFLPNYYSIIKDELNIKNIELTDNINDYITYELKLNFSSVGPKLGNKTKNIQTLIDSLSEYDKKSLIESNNFKSLSSDAELTKDDFIIKTLPKDSYQLSEDNDCVILLDKNLSPELIREGHARELIRLIQQLRKKKNLPINQRIDIYIGVTGELLESIKTNKNMFKENFVIKNIHLNVIDEYENTIHFNNKEIKISLLY,100,gnl|BL_ORD_ID|4701|hsp_num:0,2270,FALSE,None
LK1116,34_3 # 1304 # 1945 # -1 # ID=34_3;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.254,34_3,1304,1945,-,Perfect,375,430.254,fusB,100,3003552,protein homolog model,n/a,n/a,fusidane antibiotic,antibiotic target protection,Target protecting FusB-type protein conferring resistance to Fusidic acid,ATGAAAACAATGATTTATCCTCACCAATATAATTATATCAGATCGGTTATTTTAAGATTGAAAAATGTATATAAAACGGTAAATGATAAAGAAACCGTCAAAGTTATTCAATCGGAAACCTATAATGATATTAATGAGATTTTTGGTCATATAGATGACGATATTGAAGAATCTTTAAAAGTATTAATGAACATCAGATTATCAAACAAAGAAATTGAAGCAATACTTAATAAATTTTTAGAATATGTAGTACCTTTTGAACTACCTAGTCCGCAAAAACTTCAGAAAGTATTTAAGAAAGTTAAAAAAATAAAAATACCTCAATTTGAAGAATATGATTTGAAGGTAAGTTCATTTGTAGGATGGAATGAACTTGCATCAAATCGGAAATATATAATATATTACGATGAAAAAAAACAATTAAAAGGACTTTATGGAGAAATTTCTAATCAGGTTGTAAAGGGGTTCTGCACAATTTGTAATAAAGAATCTAATGTTTCATTATTCATGAAAAAGTCAAAAACCAATTCGGATGGTCAATATGTAAAAAAAGGTGACTATATATGTCGAGATAGCATTCATTGTAATAAACAATTAACAGATATTAATCAGTTTTATAATTTTATTGATAAACTAGATTAA,MKTMIYPHQYNYIRSVILRLKNVYKTVNDKETVKVIQSETYNDINEIFGHIDDDIEESLKVLMNIRLSNKEIEAILNKFLEYVVPFELPSPQKLQKVFKKVKKIKIPQFEEYDLKVSSFVGWNELASNRKYIIYYDEKKQLKGLYGEISNQVVKGFCTICNKESNVSLFMKKSKTNSDGQYVKKGDYICRDSIHCNKQLTDINQFYNFIDKLD,MKTMIYPHQYNYIRSVILRLKNVYKTVNDKETVKVIQSETYNDINEIFGHIDDDIEESLKVLMNIRLSNKEIEAILNKFLEYVVPFELPSPQKLQKVFKKVKKIKIPQFEEYDLKVSSFVGWNELASNRKYIIYYDEKKQLKGLYGEISNQVVKGFCTICNKESNVSLFMKKSKTNSDGQYVKKGDYICRDSIHCNKQLTDINQFYNFIDKLD,100,gnl|BL_ORD_ID|19|hsp_num:0,24,FALSE,None
LK1116,35_1 # 105 # 428 # -1 # ID=35_1;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.290,35_1,105,428,-,Strict,75,142.51,qacJ,71.96,3007014,protein homolog model,n/a,n/a,disinfecting agents and antiseptics,antibiotic efflux,small multidrug resistance (SMR) antibiotic efflux pump,ATGCCTTATATTTATTTAATAATAGCCATAAGTACTGAAGTTATTGGAAGTGCATTTCTTAAATCTTCAGAAGGCTTTTCAAAATTTATACCATCCTTAGGAACAATAATTTCATTTGGAATTTGTTTCTATTTTTTAAGTAAAACAATGCAACACCTACCACTAAATATAACTTATGCAACTTGGGCGGGACTAGGTTTAGTCTTAACAACCGTAGTCTCAATAATTATTTTCAAAGAACAAATAAATCTAATAACTATAGTATCTATAGTTTTAATCATAGTCGGCGTAGTTTCGTTAAACATTTTCGGAACATCGCATTAA,MPYIYLIIAISTEVIGSAFLKSSEGFSKFIPSLGTIISFGICFYFLSKTMQHLPLNITYATWAGLGLVLTTVVSIIIFKEQINLITIVSIVLIIVGVVSLNIFGTSH,MPYLYLVIAIITEIIGTSFLKTAEGFTKLWPTLGTLISFGICFYFLSVTMKYLPLNVSYATWAGLGLVLTTIVSVVIFKESVNLISIFSIILIIIGVVLLNVFGSSH,100,gnl|BL_ORD_ID|4662|hsp_num:0,5730,FALSE,None
LK1172,1_614 # 683712 # 684848 # -1 # ID=1_614;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.395,1_614,683712,684848,-,Strict,175,210.69,vanT gene in vanG cluster,34.14,3002972,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,glycopeptide resistance gene cluster; vanT,ATGAAAGTAACAAGTTATCGCGATGCGTGGGTGGAAGTTTCTCTCGATGCATTAACTTATAATGTACGTCAATTTAAGAATCATTTACGTGGACAGTCGAGATTGATGGTAGTTGTAAAAGCAGATGGTTACGGACATGGGGCTGTTCCCATAGCACGAAGATCCTTAGAAGCAGGAGCGGAATTTCTTGGGGTAGCTTTTATAGATGAGGCACTTCAAATTCGGGAAGCTGGAATATTAGCTCCGATTCTATTACTCGGTTATACACCGAGTCACGCTGTAAGAGAAGCGGTTAAACATGATCTCACTCTCACCGTATACTCTGCGGAAACATTGGAGGCGATAAAGGATGCAGCTCATTCTTTGCAAAAAAAGGCAAAAGTTCATATAAAAATTGATAGTGGTATGAGTCGGATAGGTTTAAGATCTTCCGATGAGGTCCTTTCTCTAATGACATCGCTACAATCCCAATCCGAACATATAGAAGTAGAAGGGATTTTCACCCATTTTGCGGATGCGGATAATGGTGAAAGTGATGCGTATACATATAAACAATTTGAAGCCTTTCAAGGTATTATTGAGGCTTTAGAAAATGAAGGATATACGATACCAATCAAACATTGCTGTAATAGTGCTGCCACGATAGCCTTTCCTGAGATGCATATGGACATGGTTCGAGTCGGAATAAGTTTATATGGGTTATATCCAGGACAACATTTAAAAGAAATAATGTCCTTACAGCAAGTGATGAGTTTTAAAGCAAAGCCTGTGCTCGTAAAAGAAGTTCCCCCTCATCAGCCTATTAGCTATGGCTTAACGTATGAGACAAAGGAAACAACAAAAATAGCTACACTTCCTATTGGTTATGCAGATGGTTTTTCCCGTTTGTTATCGAACAAAGGCCATGTGACTGTACACGAAATAGAGTGTCCTATTGTAGGGCGAATTTGTATGGATCAGTCTATGATAGATGTAACTGCTGTTCAGACCGACGTAACAAAAGATGATATTGTAACCATTTTTGGTGATGAGAGTGCAGGGTTTATTCCGTTAGATGTTGTTGCTGACCAAATGCAAACAATTCATTATGAAACAGTGTGTCTTATTGGTAAACGGGTACCAAGACATTATGTGTAA,MKVTSYRDAWVEVSLDALTYNVRQFKNHLRGQSRLMVVVKADGYGHGAVPIARRSLEAGAEFLGVAFIDEALQIREAGILAPILLLGYTPSHAVREAVKHDLTLTVYSAETLEAIKDAAHSLQKKAKVHIKIDSGMSRIGLRSSDEVLSLMTSLQSQSEHIEVEGIFTHFADADNGESDAYTYKQFEAFQGIIEALENEGYTIPIKHCCNSAATIAFPEMHMDMVRVGISLYGLYPGQHLKEIMSLQQVMSFKAKPVLVKEVPPHQPISYGLTYETKETTKIATLPIGYADGFSRLLSNKGHVTVHEIECPIVGRICMDQSMIDVTAVQTDVTKDDIVTIFGDESAGFIPLDVVADQMQTIHYETVCLIGKRVPRHYV,MTKNESYSGIDYFRFIAALLIVAIHTSPLSSFSETGNFIFTRIVARVAVPFFFMTSGFFLISRYTCNAEKLGAFIKKTTLIYGVAILLYIPINVYNGYFKMDNLLPNIIKDIVFDGTLYHLWYLPASIIGAAIAWYLVKKVHYRKAFLIASILYIIGLFGDSYYGIVKSVSCLNVFYNLIFQLTDYTRNGIFFAPIFFVLGGYISDSQNRLSLKRSIVGFIVCFALMFGEALTLHHFDIQKHDSMYVLLLPSVYCLFNLLLHFRGKRRTGLRTISLIIYIIHPFMIVVIRLFAKLLHLQSLLVENSLVHYIAVCFASVVLAVVITALLSSLKPKKAKHTADTDRAYLEINLNNLEHNVNTLQKAMSPKCELMAVVKAEAYGHGMYEVTTYLEQIGVSSFAVATIDEGIRLRKYGISSEILILGYTSPSRAKELCKYELTQTLIDYRYSLLLNKQGYDIKAHIKIDTGMHRLGFSTEDKDKILAAFSLKHIKVAGIFTHLCAADSLEENDVAFTNKQIGSFYKVLDWLKSSGLNIPKVHIQSSYGLLNYPELECDYIRVGVALYGVLSSTNDKTKLELDLRPVLSLKAKVVLIRKIKQGESVGYSRAFTATRDSLIAILPIGYADGFPRNLSCGNSYVLIGGRQAPIVGKICMDQLAVDVTDIPNVKTGSIATLIGKDGKEEITAPMVAESAESITNELLSRMGHRLNIIRRA,53.09,gnl|BL_ORD_ID|1522|hsp_num:0,1561,FALSE,None
LK1172,1_700 # 775956 # 777137 # 1 # ID=1_700;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.386,1_700,775956,777137,+,Strict,175,210.69,vanT gene in vanG cluster,34.59,3002972,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,glycopeptide resistance gene cluster; vanT,ATGATCCAAGGAAGTTATCGTGAAACATGGACAGAAGTATCTTTAGATGCCATCTATCATAATGTAACAGCATTTAAAAATCATATCGATCATCATACAAAGCTAATGGCAGTTGTAAAAGCTGATGGATACGGGCACGGTGCTGTAGAGGTTGCACAAGAGTCTTTAAAAGCTGGTGCGGATTATTTGGCTGTTGCAATCTTAGACGAAGCTATCCAACTAAGAGATTCAGGAATTGATACTCCGCTACTTGTTCTAGGATACACTCACCCCGATGGTTTAAGAACAGCAATCGAGCAACAGATTTCACTCACTGTTTTCACAAAAGAAGGTGCAGAACAAGTGAAAATAGCTGCTGAGTCTCTACAAATGACAGCCCGTGTACACCTTAAAATCGAATCTGGCATGAATCGTATTGGCATTGCTACGAAAGAAGAAGCTGTCGATGTAGCAAAAACACTTCATTCTTCTTTTGTCATACTTGAGGGTGCATTTACTCATTTTGCGGATGCGGACAATACAGATCCCGCGTATACAGAGATGCAGTTTCACCGTTTTAATCAGATTATTTCTTATTTAAGAACCTATTGCCATATTCCTATCGTCCATTGCTGTAATACAGCTGGGACAATTGCTTATCCAGATATGCATTTAGATATGGTTCGTGTTGGTATCGGCTTGTATGGATTATATCCAGAAACACACTTGAAAGAATTGATAGATTTAAAACAAGCAATGAGTTTAAAGACAAAACCTGTTTATGTTAAAACGGTTGATAAGGACACAGCAATTAGTTATGGTCTTACCTTTACGACAGAGCGTAAAAGCGTCATTGCAACAATGCCAATTGGTTATGCAGATGGATTTTCTCGTCTACTTTCTAACCGTGGAAATGTTGTCATAAATGGTGAACATGCTCCTATCGTCGGAAGAATTTGCATGGATCAATCTATGATAGATGTTACTGACATAGTGGAGGATGTTAGTCTAAATGATGTAATTACTATTTTTGGTGAACCTTCAGAAGGGTATATCGCGATGGAAGAAGTAGCCAATCTAATGGGGACGATACATTATGAAACAGCATGCCTAATTGGAAAGCGTGTTCCACGTATATATATGAGCCACAATGAAGTGGTCAATTATAGGGGATTAATGAAGAAAGAAATTGTTACGTCCTAG,MIQGSYRETWTEVSLDAIYHNVTAFKNHIDHHTKLMAVVKADGYGHGAVEVAQESLKAGADYLAVAILDEAIQLRDSGIDTPLLVLGYTHPDGLRTAIEQQISLTVFTKEGAEQVKIAAESLQMTARVHLKIESGMNRIGIATKEEAVDVAKTLHSSFVILEGAFTHFADADNTDPAYTEMQFHRFNQIISYLRTYCHIPIVHCCNTAGTIAYPDMHLDMVRVGIGLYGLYPETHLKELIDLKQAMSLKTKPVYVKTVDKDTAISYGLTFTTERKSVIATMPIGYADGFSRLLSNRGNVVINGEHAPIVGRICMDQSMIDVTDIVEDVSLNDVITIFGEPSEGYIAMEEVANLMGTIHYETACLIGKRVPRIYMSHNEVVNYRGLMKKEIVTS,MTKNESYSGIDYFRFIAALLIVAIHTSPLSSFSETGNFIFTRIVARVAVPFFFMTSGFFLISRYTCNAEKLGAFIKKTTLIYGVAILLYIPINVYNGYFKMDNLLPNIIKDIVFDGTLYHLWYLPASIIGAAIAWYLVKKVHYRKAFLIASILYIIGLFGDSYYGIVKSVSCLNVFYNLIFQLTDYTRNGIFFAPIFFVLGGYISDSQNRLSLKRSIVGFIVCFALMFGEALTLHHFDIQKHDSMYVLLLPSVYCLFNLLLHFRGKRRTGLRTISLIIYIIHPFMIVVIRLFAKLLHLQSLLVENSLVHYIAVCFASVVLAVVITALLSSLKPKKAKHTADTDRAYLEINLNNLEHNVNTLQKAMSPKCELMAVVKAEAYGHGMYEVTTYLEQIGVSSFAVATIDEGIRLRKYGISSEILILGYTSPSRAKELCKYELTQTLIDYRYSLLLNKQGYDIKAHIKIDTGMHRLGFSTEDKDKILAAFSLKHIKVAGIFTHLCAADSLEENDVAFTNKQIGSFYKVLDWLKSSGLNIPKVHIQSSYGLLNYPELECDYIRVGVALYGVLSSTNDKTKLELDLRPVLSLKAKVVLIRKIKQGESVGYSRAFTATRDSLIAILPIGYADGFPRNLSCGNSYVLIGGRQAPIVGKICMDQLAVDVTDIPNVKTGSIATLIGKDGKEEITAPMVAESAESITNELLSRMGHRLNIIRRA,55.2,gnl|BL_ORD_ID|1522|hsp_num:0,1561,FALSE,None
LK1172,2_756 # 728664 # 729560 # -1 # ID=2_756;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.328,2_756,728664,729560,-,Strict,50,123.635,vanW gene in vanI cluster,38.89,3003724,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanW; glycopeptide resistance gene cluster,ATGAAGGTATATTGTATGATTTTTTTTATTTGTCTTATAATTATGGTTCCTAAGGTAACAAATGCTGGAATTATTGAACTGTATATTGATGAAAGAGAACGTGGGAATTTGGATTTAAATCAATATCAGCTTTTAGGAAATGAAGGATTTTTGAATTTACAGAAGTTATATTCATTTATGGATGAATTACAAAATGAAGTGTACACAGAACCAAAAGACGCTTACTATGATTCCGCTGGGCAACTAAAAATAGAAAAAGAAGGTTATACTCTAGATCGAGAAAGGTTCTTAGAGCTTATTTATCAAATTTATTACACGAAAAATACTGACAAAATAACAGTCCCGACACGCCCTATTCATGCTAGGGTTAATCATGCACTATTACGAGAAATTAGTCAAAAACAAATTGGATTTTATACTACTACATTTCGTGAAAGTAATAAACAGCGAGCAAATAATATTAAGTTAGCTACAGAGTCGATAAATAATACAGTATTGTTTCCGGGAGAAGTCTTTTCATTTAATGATACTGTTGGGGAACGTACAAGAGAAAGGGGATATCAAAAAGCTCCTGTTATTATCAAAGGTGAGCTAGATGAAGATATTGGAGGGGGAATATGTCAGGTATCATCAACATTATTTAATGCAGTTGATTTAAAGGGAATACAGATAACAGAAAGGTATGCACATAGTAAGAGAGTTCCTTATGTTCCTCCAGGAAGAGATGCAACGGTAAGTTGGTGGGGACCTGACTTTGCATTTAAAAATTTATATAATGAGCCGTTATTAATTAGGGCAAGGTCGGAAAAAGGGAAGTTGTCTATTTTCGTTTATTCTTCAGAGAACATTGATCTTTTCAAAAAAGAGACCATGGATTTACAGACAAAAAATGAATGA,MKVYCMIFFICLIIMVPKVTNAGIIELYIDERERGNLDLNQYQLLGNEGFLNLQKLYSFMDELQNEVYTEPKDAYYDSAGQLKIEKEGYTLDRERFLELIYQIYYTKNTDKITVPTRPIHARVNHALLREISQKQIGFYTTTFRESNKQRANNIKLATESINNTVLFPGEVFSFNDTVGERTRERGYQKAPVIIKGELDEDIGGGICQVSSTLFNAVDLKGIQITERYAHSKRVPYVPPGRDATVSWWGPDFAFKNLYNEPLLIRARSEKGKLSIFVYSSENIDLFKKETMDLQTKNE,MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVLAEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPELLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGMETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGGEFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSHSLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDEPDGYPVKPREWSK,79.89,gnl|BL_ORD_ID|4748|hsp_num:0,2242,FALSE,None
LK1172,4_148 # 138784 # 139806 # 1 # ID=4_148;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.372,4_148,138784,139806,+,Strict,50,106.686,vanY gene in vanA cluster,34.76,3002955,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCAACGTTTGCTTTGGTTGTTGCTATTGATCGGTGTACTACTATTTTTCATGACCTCATGCCAATCTAATGATGATACCAATTCATCTTCTCAAAATAATTCAGAGAAACCATCAGATGAAGAAGATGTAACAGCTAATCAAGAATATGAAAAGTTACCCAAAACTCCTCTACAAAAACTAGATCAAGGAGAACAGGTAGTTGCACTTCAGTATTTTCTCGAACAGTTAGGGTACAGCTTTTCTGATCAAGGTAACTATAACGAACAGGTGACTTGGGCTATAACTGATTTTCAAATACAACAAGAAGATTTATTGGTCTCTGGGATATACGATGAAGACACCAAACAAAAAATAGAGGAAGTCATTCAATCCGAGAAGACATATAAACCAGGTAAGGGGCTACCAGCACCGACAGAACCTGCGTTTACAGATGCAGGTACAGAAGTTATTTCAAACCCATATGATCAGTTAGTTCTTGTTAATAAAGATTTTTCATTGCCTGCGGACTATATTCCAGATGATTTAGTTATACCAAATGTTCCTTTCCCTTTCATTGAGGACATTCCAAAAAAATATATGCGCCAAGCTGCCGCTGACGCATTAGAAGAATTGTTTGCAGATGCACAAGAAGAAGGCTTAGAGCTATATGCACAATCTGGATACCGATCATACGACCGCCAGGATACTATTTTTGCAGCAAATGCCGCTGAAAATGGTGAAAAGCACGCAAACAAGTATAGTGCTCGTCCTGGAGAAAGTGAACATCAAACGGGACTGGCTATGGATGTAACAAGTCCGGAAGTTAACTTTAGTCTAGAAACAGAATTTGGTGAAACAAAAGAAGGAAAATGGGTAAAAGAAAATGCTACGAACTATGGTTTTATAATTCGGTTCCCAGAAGGTAAAGAAGAAATTACTAAATATCAATTTGAACCTTGGCATTTACGATATGTAGGGCAAAAAGCAGCAGAAGAAATCATGAATCAAAACATTACTTTAGAAGAATATTTGGAGAAATAA,MQRLLWLLLLIGVLLFFMTSCQSNDDTNSSSQNNSEKPSDEEDVTANQEYEKLPKTPLQKLDQGEQVVALQYFLEQLGYSFSDQGNYNEQVTWAITDFQIQQEDLLVSGIYDEDTKQKIEEVIQSEKTYKPGKGLPAPTEPAFTDAGTEVISNPYDQLVLVNKDFSLPADYIPDDLVIPNVPFPFIEDIPKKYMRQAAADALEELFADAQEEGLELYAQSGYRSYDRQDTIFAANAAENGEKHANKYSARPGESEHQTGLAMDVTSPEVNFSLETEFGETKEGKWVKENATNYGFIIRFPEGKEEITKYQFEPWHLRYVGQKAAEEIMNQNITLEEYLEK,MKKLFFLLLLLFLIYLGYDYVNEALFSQEKVEFQNYDQNPKEHLENSGTSENTQEKTITEEQVYQGNLLLINSKYPVRQESVKSDIVNLSKHDELINGYGLLDSNIYMSKEIAQKFSEMVNDAVKGGVSHFIINSGYRDFDEQSVLYQEMGAEYALPAGYSEHNSGLSLDVGSSLTKMERAPEGKWIEENAWKYGFILRYPEDKTELTGIQYEPWHIRYVGLPHSAIMKEKNFVLEEYMDYLKEEKTISVSVNGEKYEIFYYPVTKNTTIHVPTNLRYEISGNNIDGVIVTVFPGSTHTNSRR,112.21,gnl|BL_ORD_ID|4669|hsp_num:0,89,FALSE,None
LK1172,8_86 # 80868 # 81263 # -1 # ID=8_86;partial=00;start_type=TTG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.343,8_86,80868,81263,-,Strict,150,185.652,FosBx1,61.83,3007372,protein homolog model,n/a,n/a,phosphonic acid antibiotic,antibiotic inactivation,fosfomycin thiol transferase,TTGCTGTTTTCTGTGTCTAATTTGGAACAATCTATCGACTTTTACCAACAGGTTTTTGATGCAAAGCTGTTAGTTAAAGGAAGATCCACAGCATATTTTGATTTGAATGGGATCTGGTTAGCGTTAAATGAAGAAAAACATGTCCCGCGAAATGAAATTAATGAATCTTATACTCACATGGCATTTTCTATCGATGAATCAGAGCTAGAAAGTACTTATCAGCAATTAAAAGCGTTGAATGTTAACATTCTAGAAGGTCGAGAACGTGCTGAGCAAGATAAGCAATCCATTTATTTTACAGATCCAGATGGGCATAAATTTGAGTTCCACACGGGGACATTGCAAGATAGATTAGACTATTATCGTAATCAAAAAAAGCATATGACTTTTTATTAA,MLFSVSNLEQSIDFYQQVFDAKLLVKGRSTAYFDLNGIWLALNEEKHVPRNEINESYTHMAFSIDESELESTYQQLKALNVNILEGRERAEQDKQSIYFTDPDGHKFEFHTGTLQDRLDYYRNQKKHMTFY,MLRGINHICFSVSNLENSIMFYEKVLEGELLVKGRKLAYFNICGVWIALNEETHIPRNEIHQSYTHIAFSVEKEDFKCLIQRLEENDVHILQGRERDVRDCESIYFVDPDGHKFEFHSGTLQDRLNYYRDEKPHMTFY,94.93,gnl|BL_ORD_ID|4909|hsp_num:0,5900,FALSE,None
LK1022,61_5 # 3151 # 3894 # -1 # ID=61_5;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.776,61_5,3151,3894,-,Strict,50,83.5741,vanY gene in vanM cluster,35.14,3002961,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGTCGCACCCTCCCCCTCGCCGCGCTGGCCGCGCTCGCGCTGCTCGTGGCCGGTTGCGGCACGCCCGCCGCGGGCCCGTCCTCGGCGACGCCGGCTTCCGGCTCCTCGAGCGCGGCCGCGTCGTCCCGCGCCGCCTCGAGCACGGCGCCGTCGTCGGGCACGCACGCCGACCCGGCCGCCCTCGACGTCGTCGTGAACAAGACCCGCCCCATGGCCCCGCCCGACTGGGCGCCCTCGGATCTGGTGGCCGTGCCCGGCAGCGAGCTGCCCCTGCGGGCGGAGGCCGCGACGGCGGCCGGTGACCTGCTGGATGCCGCCGCGGCGGCGGGTCACCGCCTCACCACCCTGAGCGCCTACCGCTCGTACGACTACCAGGTCCGGACGTACGGCCACTGGGTCGACGAGCTGGGCCACGCCGAGGCCGACCGCGTCTCCGCTCGTCCGGGGTACTCCGAGCACCAGACCGGCCTGGCCTGGGACGTGGGCGACGCCGCGACCCCCGCGTGTGACCTGGAAGCGTGCTTCGGCGACACCGCCGCGGGCCGTTGGGTGGCCGCGCACGCCGCCGAGTACGGGTTCGTCATCCGCTATCCCGTCGGGGCCGAGGACGTGACGGGCTTCGCCCACGAGCCCTGGCATCTGCGCTACGTCGGGTCCGCGGAGGCGGCCCGGGTCGAGGCGGCCGGCGGCGTCCTCGAGACCGCGCGGGGTCTGCCGCCGGCGCCGGACTACGCGGACTGA,MRRTLPLAALAALALLVAGCGTPAAGPSSATPASGSSSAAASSRAASSTAPSSGTHADPAALDVVVNKTRPMAPPDWAPSDLVAVPGSELPLRAEAATAAGDLLDAAAAAGHRLTTLSAYRSYDYQVRTYGHWVDELGHAEADRVSARPGYSEHQTGLAWDVGDAATPACDLEACFGDTAAGRWVAAHAAEYGFVIRYPVGAEDVTGFAHEPWHLRYVGSAEAARVEAAGGVLETARGLPPAPDYAD,MVFQGNLLLVNNEYPVLEESIKTDVVNLFKHDELTKGYELLNREIYLSEKVAREFSEMVDAAEKEGVRHFSINSGFRNFDEQNALYQEMGSDYALPAGYSEHNLGLALDIGSTQMEMSEAPEGKWLEDNAWEYGFILRYPMDKTAITGIQYEPWHFRYVGLPHSAIIEEKNFALEEYLDFLKEQKSISGTIHGENYEISYYPITEKTDIEMPANLHYEISGNNMDGVIVTVYR,106.01,gnl|BL_ORD_ID|1673|hsp_num:0,1713,FALSE,None
LK1362,7_49 # 53733 # 55427 # -1 # ID=7_49;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.658,7_49,53733,55427,-,Strict,50,77.7962,vanW gene in vanI cluster,33.12,3003724,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanW; glycopeptide resistance gene cluster,GTGACTACGGTAAATGCAACAGGTGCCCGCGGTGGGCGCGGGGTCAGCACCGGGAAGATTCTCCTCGGTGTGCTTCTCGGCGTGCTCGCGGTGCTGCTCGCGATCTACCTCGCCGACCTCGCAATGAACCGCGGGAACGTGCCGCGTGGCACCGCCGTCGGCGGTGTCGAGATCGGCGGCATGAGCCACGACGAGGCCACCGCGAAGCTCGAAGCAGAGCTCGGCGAGACGGCGAGCAACCCCGTGACGGTGAAGGCGGCATCGCAAAGCTCGCAGCTCGTGCCCGCCGAGTCCGGTCTCGGCATCGACTGGGAGGCGACCGTAGCAAGCGCGGGCGAAGAGTCCGCGAACCCGTTCACTCGCCTCGCCGGGCTGTTTCGCACCCGCGAAGTCGACATTGTGTCGACCGTGAACGAGGCCGCTCTCACCCCGCAGCTTGAGCGCGTGGCCGGCGAGTTGCACCTCGACCCCGCCGACGGCGCGATCGCCATCGAAGGCGGCGAGGCGAAAGTGACCGAACCGGTGCCGGGCCAGGAGGTTGACGAAACCGAGCTGTTCGAACGTGTCACCACCGGCTGGCTCAACCCCGACGGTGTAGAGGTCGAGCCGCGCGAAATCGAACCCGCTATCGGCGACCAGGCCATCAAGGAAGCCTTAGACGGGCCGGTTAAGGCGGCGCTGTCCGGAGCGTTGACACTGCACGGTCGCGACGGCGTCGACGGTGTCATTGCCCAAGAGCGCATCGGCGAGGTCGTCCAATTCCCCAACGTCGACGGCAAAATCTCCCCCGAGGTGAACGTGGAAAACGCCCAGGGCATCTTGGTCGAGCAGCTCGCTGCGACCGAGACGCAGATGAAAAACGCGCGCGTGCTGCCCGGCGGCGGGGTGGAACCGTCCGTCGACGGCTCCATCATCGACTGGGAGGCCGCGATGGACGGTTTCGACGAGCGGTTGATCGGTTCCGCCGAGCGCACCTGGGACGCGCAATACAAGGCCCGCCCGGCCGACTTCACCACTGAAGAGGCCAACAATGCCACCTTCGACCAGGTCGTCGGCTCCTTTACCACCAGCGGCTACAGCTCGGCCTCGGGCACCAACATCGCGGTGGTGGCACGCGAGGTCGAAGGAGCGATTGTCAACCCAGGCGAGACGTTCTCGCTCAACGGCTACACCGGCCCGCGCGGCACCGCGCAGGGCTACGTTTCGTCCGGGATCATCGAAAACGGCCGGCCCGGCACCGCTGTCGGCGGTGGTATCTCCCAGTTCGCCACCACCTTGTACAACGCGGCCTACTTTGCGGGAATGACCGACGTGGCCTCCACGCCGCACTCCTACTACATCTCCCGCTACCCCACGGGCCGCGAGGCAACCGTCTTCGAGGGCGCGATCGACCTGCAGTTCCGAAACGACTCGCCTTATCCGGTGAAGATCACCTCCAACGTCGGTGGTGGGGAGGTCACCGTGAGCCTGATGGGTGTGAAAACCGTCGAGGTGGAGTCCATCAATGGAGGGCGCTGGGCCTACACCTCGCCCAAGCCCGTGACCGTCACCAGTGGTGACTGCATTCCCTCGGGCGGGGTGCAGGGCTTTACCACCTCCGATACCCGGATTGTGCGTGACCTCAGCGGCAATGAGATCAGTCGCAACACCTCCACCACGGTCTATGACCCGCAGCCCATCGTGCGCTGCGAGTAG,MTTVNATGARGGRGVSTGKILLGVLLGVLAVLLAIYLADLAMNRGNVPRGTAVGGVEIGGMSHDEATAKLEAELGETASNPVTVKAASQSSQLVPAESGLGIDWEATVASAGEESANPFTRLAGLFRTREVDIVSTVNEAALTPQLERVAGELHLDPADGAIAIEGGEAKVTEPVPGQEVDETELFERVTTGWLNPDGVEVEPREIEPAIGDQAIKEALDGPVKAALSGALTLHGRDGVDGVIAQERIGEVVQFPNVDGKISPEVNVENAQGILVEQLAATETQMKNARVLPGGGVEPSVDGSIIDWEAAMDGFDERLIGSAERTWDAQYKARPADFTTEEANNATFDQVVGSFTTSGYSSASGTNIAVVAREVEGAIVNPGETFSLNGYTGPRGTAQGYVSSGIIENGRPGTAVGGGISQFATTLYNAAYFAGMTDVASTPHSYYISRYPTGREATVFEGAIDLQFRNDSPYPVKITSNVGGGEVTVSLMGVKTVEVESINGGRWAYTSPKPVTVTSGDCIPSGGVQGFTTSDTRIVRDLSGNEISRNTSTTVYDPQPIVRCE,MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVLAEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPELLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGMETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGGEFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSHSLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDEPDGYPVKPREWSK,151.21,gnl|BL_ORD_ID|4748|hsp_num:0,2242,FALSE,None
LK1362,11_18 # 25918 # 26289 # 1 # ID=11_18;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.656,11_18,25918,26289,+,Strict,200,223.402,Mycobacterium tuberculosis rpsL mutations conferring resistance to Streptomycin,90.91,3003395,protein variant model,K88R,n/a,aminoglycoside antibiotic,antibiotic target alteration,antibiotic-resistant rpsL,ATGCCAACTATCCAGCAGCTGGTCCGCAAAGGCCGCCACGATAAGCGCACCAAGGTCGCTACCGCGGCCCTGAAGGGCTCCCCGCAGCGCCGCGGTGTGTGCACCCGTGTATACACCACCACCCCGAAGAAGCCGAACTCCGCTCTGCGTAAGGTTGCCCGCGTGCGCCTGACCTCGGGCATCGAGGTCTCCGCATACATCCCCGGCGAGGGCCACAACCTGCAGGAGCACTCCATGGTGCTCGTACGCGGCGGCCGTGTGAGGGACCTTCCGGGCGTTCGCTACAAGATCATCCGCGGCGCGCTTGACACCCAGGGTGTTAAGGACCGCAAGCAGGCTCGCTCCCGCTACGGCGCGAAGAAGGGACAGTAA,MPTIQQLVRKGRHDKRTKVATAALKGSPQRRGVCTRVYTTTPKKPNSALRKVARVRLTSGIEVSAYIPGEGHNLQEHSMVLVRGGRVRDLPGVRYKIIRGALDTQGVKDRKQARSRYGAKKGQ,MPTIQQLVRKGRRDKISKVKTAALKGSPQRRGVCTRVYTTTPKKPNSALRKVARVKLTSQVEVTAYIPGEGHNLQEHSMVLVRGGRVKDLPGVRYKIIRGSLDTQGVKNRKQARSRYGAKKEKG,99.19,gnl|BL_ORD_ID|1956|hsp_num:0,1197,FALSE,None
LK1383,33_24 # 24472 # 25221 # 1 # ID=33_24;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.775,33_24,24472,25221,+,Strict,50,83.9593,vanY gene in vanM cluster,34.46,3002961,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGTCGCACCCTCCCTCTCGCCGCGCTGGCCGCGCTCGCGCTGCTCGTGGCCGGTTGCGGCACGCCCGCCGCGGGCCCGTCCTCGACGCCGACGACGCCGACGTCCGGCGCCGCGAGCGCGGCCGCGTCGTCCGGCGCCGCCTCGAGCACGGCGCCGTCGTCGAGCACGCACGCCGACCCGGCCGCCCTCGACGTCGTCGTGAACAAGACCCGCCCCGTGGCTCCGCCCGACTGGGCGCCCTCGGATCTGGTGGCCGTGCCCGGCAGCGAGCTGTCCCTGCGGGCGGAGGCCGCGACGGCGGCCGGTGACCTGCTGGATGCCGCCGCGGCGGCGGGTCACCGCCTCACCACCCTGAGCGCCTACCGCTCGTACGACTACCAGGTCCGGACGTACGGCCACTGGGTCGACGAGCTGGGCCGCGCCGAGGCCGACCGCGTCTCGGCGCGTCCGGGGTACTCCGAGCACCAGACCGGCCTGGCCTGGGACGTGGGCGACGCCGCGACCCCCGCGTGTGACCTGGAAGCGTGCTTCGGCGACACTGCCGCGGGCCGCTGGGTGGCCGCGCACGCCGCCGAGTACGGGTTCGTCATCCGCTATCCCGTCGGGGCCGAGGACGTGACGGGCTTCGCCCACGAGCCGTGGCACCTGCGCTACGTCGGGTCCGCGGAGGCGGCCCGGGTCGAGGCGGCCGGCGGCGTCCTCGAGACCGCGTGGGGCCTGCCTCCGGCGCCGGACTACGCGGACTGA,MRRTLPLAALAALALLVAGCGTPAAGPSSTPTTPTSGAASAAASSGAASSTAPSSSTHADPAALDVVVNKTRPVAPPDWAPSDLVAVPGSELSLRAEAATAAGDLLDAAAAAGHRLTTLSAYRSYDYQVRTYGHWVDELGRAEADRVSARPGYSEHQTGLAWDVGDAATPACDLEACFGDTAAGRWVAAHAAEYGFVIRYPVGAEDVTGFAHEPWHLRYVGSAEAARVEAAGGVLETAWGLPPAPDYAD,MVFQGNLLLVNNEYPVLEESIKTDVVNLFKHDELTKGYELLNREIYLSEKVAREFSEMVDAAEKEGVRHFSINSGFRNFDEQNALYQEMGSDYALPAGYSEHNLGLALDIGSTQMEMSEAPEGKWLEDNAWEYGFILRYPMDKTAITGIQYEPWHFRYVGLPHSAIIEEKNFALEEYLDFLKEQKSISGTIHGENYEISYYPITEKTDIEMPANLHYEISGNNMDGVIVTVYR,106.87,gnl|BL_ORD_ID|1673|hsp_num:0,1713,FALSE,None
LK1053,77_7 # 7498 # 8247 # 1 # ID=77_7;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.777,77_7,7498,8247,+,Strict,50,83.5741,vanY gene in vanM cluster,34.46,3002961,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGTCGCACCCTCCCTCTCGCCGCGCTGGCCGCGCTCGCGCTGCTCGCGGCCGGTTGCGGCACGCCCGCCGCGGGCCCGTCCTCGACGCCGACGACGCCGACGTCCGGCTCCGCGAGCGCGGCCGCGTCGTCCCGCGCCGCCTCGAGCACGGCGCCGTCGTCGGGCACGCACGCCGACCCGGCCACCCTCGACGTCGTCGTGAACAAGACCCGCCCCGTGGCCCCGCCCGACTGGGCGCCCTCGGATCTGGTGGCCGTGCCCGGCAGCGAGCTGCCCCTGCGGGCGGAGGCCGCGACGGCGGCCGCTGACCTGCTGGATGCCGCCGCGGCGGCGGGCCACCGCCTCACCACCCTGAGCGCCTACCGCTCGTACGACTACCAGGTCCGGACGTACGGCCACTGGGTCGACGAGCTGGGCCGCGCCGAGGCCGACCGCGTCTCCGCGCGTCCGGGGTACTCCGAGCACCAGACCGGCCTGGCCTGGGACGTGGGCGACGCCGCGACCCCCGCGTGTGACCTGGAAGCGTGCTTCGGCGACACCGCCGCGGGCCGTTGGGTGGCCGCGCACGCCGCCGAGTACGGGTTCGTCATCCGCTATCCCGCCGGGGCCGAGGACGTGACGGGCTTCGATCACGAGCCGTGGCACCTGCGCTACGTCGGGTCCGCGGAGGCGGCCCGGGTCGAGGCGGCCGGCGGCGTCCTCGAGACCGCGTGGGGTCTGCCGCCGGCGCCGGACTACGCGGACTGA,MRRTLPLAALAALALLAAGCGTPAAGPSSTPTTPTSGSASAAASSRAASSTAPSSGTHADPATLDVVVNKTRPVAPPDWAPSDLVAVPGSELPLRAEAATAAADLLDAAAAAGHRLTTLSAYRSYDYQVRTYGHWVDELGRAEADRVSARPGYSEHQTGLAWDVGDAATPACDLEACFGDTAAGRWVAAHAAEYGFVIRYPAGAEDVTGFDHEPWHLRYVGSAEAARVEAAGGVLETAWGLPPAPDYAD,MVFQGNLLLVNNEYPVLEESIKTDVVNLFKHDELTKGYELLNREIYLSEKVAREFSEMVDAAEKEGVRHFSINSGFRNFDEQNALYQEMGSDYALPAGYSEHNLGLALDIGSTQMEMSEAPEGKWLEDNAWEYGFILRYPMDKTAITGIQYEPWHFRYVGLPHSAIIEEKNFALEEYLDFLKEQKSISGTIHGENYEISYYPITEKTDIEMPANLHYEISGNNMDGVIVTVYR,106.87,gnl|BL_ORD_ID|1673|hsp_num:0,1713,FALSE,None
LK430,87_5 # 3124 # 3873 # -1 # ID=87_5;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.777,87_5,3124,3873,-,Strict,50,83.9593,vanY gene in vanM cluster,34.46,3002961,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGTCGCACCCTCCCTCTCGCCGCGCTGGCCGCGCTCGCGCTGCTCGTGGCCGGTTGCGGCACGCCCGCCGCGGGCCCGTCCTCGACGCCGACGACGCCGACGTCCGGCTCCGCGAGCGCGGCCGCGTCGTCCGGCGCCGCCTCGAGCACGGCGCCGTCGTCGGGCACGCACGCCGACCCGGCCACCCTCGACGTCGTCGTGAACAAGACCCGCCCCGTGGCCCCGCCCGACTGGGCGCCCTCGGATCTGGTGGCCGTGCCCGGCAGCGAGCTGTCCCTGCGGGCGGCGGCCGCGACGGCGGCCGGTGACCTGCTGGATGCCGCCGCGGCGGCGGGCCACCGCCTCACCACCCTGAGCGCCTACCGCTCGTACGACTACCAGGTCCGGACGTACGGCCACTGGGTCGACGAGCTGGGCCGCGCCGAGGCCGACCGCGTCTCGGCGCGTCCGGGGTACTCCGAGCACCAGACCGGCCTGGCCTGGGACGTGGGCGACGCCGCGACCCCCGCGTGTGACCTGGAAGCGTGCTTCGGCGACACCGCCGCGGGCCGCTGGGTGGCCGCGCACGCCGCCGAGTACGGGTTCGTCATCCGCTATCCCGTCGGGGCCGAGGACGTGACGGGCTTCGCCCACGAGCCCTGGCACCTGCGCTACGTCGGGTCCGCGGAGGCGGCCCGGGTCGAGGCGGCCGGCGGCGTCCTCGAGACCGCGTGGGGTCTGCCTCCGGCACCCGACTACGCGGACTGA,MRRTLPLAALAALALLVAGCGTPAAGPSSTPTTPTSGSASAAASSGAASSTAPSSGTHADPATLDVVVNKTRPVAPPDWAPSDLVAVPGSELSLRAAAATAAGDLLDAAAAAGHRLTTLSAYRSYDYQVRTYGHWVDELGRAEADRVSARPGYSEHQTGLAWDVGDAATPACDLEACFGDTAAGRWVAAHAAEYGFVIRYPVGAEDVTGFAHEPWHLRYVGSAEAARVEAAGGVLETAWGLPPAPDYAD,MVFQGNLLLVNNEYPVLEESIKTDVVNLFKHDELTKGYELLNREIYLSEKVAREFSEMVDAAEKEGVRHFSINSGFRNFDEQNALYQEMGSDYALPAGYSEHNLGLALDIGSTQMEMSEAPEGKWLEDNAWEYGFILRYPMDKTAITGIQYEPWHFRYVGLPHSAIIEEKNFALEEYLDFLKEQKSISGTIHGENYEISYYPITEKTDIEMPANLHYEISGNNMDGVIVTVYR,106.87,gnl|BL_ORD_ID|1673|hsp_num:0,1713,FALSE,None
LK542,17_4 # 972 # 1721 # -1 # ID=17_4;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.780,17_4,972,1721,-,Strict,50,84.7297,vanY gene in vanF cluster,36,3002958,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGTCGCACCCTCCCTCTCGCCGCGCTGGCCGCGCTCGCGCTGCTCGCGGCCGGTTGCGGCACGCCCGCCGCGGGCCCGTCCTCGACGCCGACGACGCCGACGTCCGGCTCCGCGAGCGCGGCCGCGTCGTCCCGCGCCGCCTCGAGCACGGCGCCGTCGTCGGGCACGCACGCCGACCCGGCCACCCTCGACGTCGTCGTGAACAAGACCCGCCCCATGGCCCCGCCCGACTGGGCGCCCTCGGATCTGGTGGCCGTGCCCGGCAGCGAGCTGCCCCTGCGCGCGGAGGCCGCGACGGCGGCCGGCGACCTGCTGGATGCGGCCGCGGCGGCGGGCCACGACCTCACCACCCTGAGCGCCTACCGCTCGTACGACTACCAGGTCCGGACGTACGGCCACTGGGTCGACGAGCTGGGCCGCGCCGAGGCCGACCGCGTCTCGGCGCGTCCGGGGTACTCCGAGCACCAGGCCGGCCTGTCCTGGGACGTGGGCGACGCCGCGACCCCCGCGTGTGACCTGGAAGCGTGCTTCGGCGACACCGCCGCGGGCCGCTGGGTGGCCGCGCACGCCGCCGAGTACGGGTTCGTCATCCGCTATCCCGTCGGGGCCGAGGACGTGACGGGCTTCGCCCACGAGCCGTGGCACCTGCGCTACGTCGGGTCCGCGGAGGCGGCCCGGGTCGAGGCGGCCGGCGGCGTCCTCGAGACCGCGTGGGGCCTGCCTCCGGCGCCGGACTACGCGGACTGA,MRRTLPLAALAALALLAAGCGTPAAGPSSTPTTPTSGSASAAASSRAASSTAPSSGTHADPATLDVVVNKTRPMAPPDWAPSDLVAVPGSELPLRAEAATAAGDLLDAAAAAGHDLTTLSAYRSYDYQVRTYGHWVDELGRAEADRVSARPGYSEHQAGLSWDVGDAATPACDLEACFGDTAAGRWVAAHAAEYGFVIRYPVGAEDVTGFAHEPWHLRYVGSAEAARVEAAGGVLETAWGLPPAPDYAD,MKKWGLLLVFALFLVFIFNILPISQDKVEDRIYEQNDKDTSDDKMTAENMQKIELTEEQIYQGNLLLVNNEHPVHQKSIKSDIINLFTHKELTKGYGLLDNEIKLSEEIAGKFSEMIAAAEEDGVSNFLISSGYRDLDEQSRLYEEMGSDFALPAGHSEHNLGLSLDVGSTQMKMDKAPEGKWIEKNCWEYGFILRYPLDKTDVTGIQYEPWHIRYVGLPHSAIMQEMNLALEEYLDYLKEEKSISVRVDGKKYTISYDPISQNETIEVEVPADEQYEISGNNIDGVIVTTFS,84.98,gnl|BL_ORD_ID|1808|hsp_num:0,1899,FALSE,None
LK542,95_3 # 1387 # 2232 # 1 # ID=95_3;partial=00;start_type=ATG;rbs_motif=AGGA/GGAG/GAGG;rbs_spacer=11-12bp;gc_cont=0.637,95_3,1387,2232,+,Perfect,400,567.385,Erm(36),100,3000605,protein homolog model,n/a,n/a,macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic,antibiotic target alteration,Erm 23S ribosomal RNA methyltransferase,ATGCCCACTTACCGTGGCGGCCGACATGAGCACGGCCAGAACTTCCTCACTGACCACACCACGATCGACCGGCTCTCACGGCTGGTAGGCGACTCGACCGGTCCGATCGTCGAGATCGGCCCGGGCCAGGGCAGGCTCACAAGAGAGCTGCAGAAGCTCGGCCGGTCCCTGACTGCTGTCGAGATCGACAGCCGGCTGGCGGACCGACTTGCATCGGCCAGTCAGTTCCGCGAGCAGAAACACGTAACCGTCGTCAACGCAGACTTCCTTCACTGGCCGCTACCGACCACTCCGTATGTGGTGGTCGGCAACGTTCCGTTCCACCTGACCACAGCCATCCTGCGCAGACTGCTGCACGATGGAGCATGGACCCAGGTGGTCCTGCTCGTGCAGTGGGAAGTGGCCCGCCGGCGTGCCGGCATCGGTGGTAGCAGCATGATGACCGCGCAGTGGTGGCCTTGGATCGACTTCAGCTTGCACGGGCGCGTGCCCCGGTCGGCGTTCAAGCCAGCCCCGAGCGTGGACGGTGGCCTCTTGGAGATGACTCGTCGTCCGGACCCATTGCTCAGCCCAGACGCGAGAGAGTCCTACCGACAGTTCGTCCATGACGTTTTCACCAGTAGGGGCAGGGGTATCGGCGAGATCCTGGCTAACGTATCCAGCTCACTCGGAAAGCGGGGAGCGCTCCAGTTGTTGAAGAGCGAGGGGATTCGCTCCTCGTCCCTGCCCAAAGATCTCTCAGCGGAGCAGTGGGCTCGCCTCTTTACCAGCGCGTCGCCTACGAAGAGTGCCAAAACCGGAAGGAACGCACACCCCGCCCACTCCGCACGGCGGCAAGGTCGATGA,MPTYRGGRHEHGQNFLTDHTTIDRLSRLVGDSTGPIVEIGPGQGRLTRELQKLGRSLTAVEIDSRLADRLASASQFREQKHVTVVNADFLHWPLPTTPYVVVGNVPFHLTTAILRRLLHDGAWTQVVLLVQWEVARRRAGIGGSSMMTAQWWPWIDFSLHGRVPRSAFKPAPSVDGGLLEMTRRPDPLLSPDARESYRQFVHDVFTSRGRGIGEILANVSSSLGKRGALQLLKSEGIRSSSLPKDLSAEQWARLFTSASPTKSAKTGRNAHPAHSARRQGR,MPTYRGGRHEHGQNFLTDHTTIDRLSRLVGDSTGPIVEIGPGQGRLTRELQKLGRSLTAVEIDSRLADRLASASQFREQKHVTVVNADFLHWPLPTTPYVVVGNVPFHLTTAILRRLLHDGAWTQVVLLVQWEVARRRAGIGGSSMMTAQWWPWIDFSLHGRVPRSAFKPAPSVDGGLLEMTRRPDPLLSPDARESYRQFVHDVFTSRGRGIGEILANVSSSLGKRGALQLLKSEGIRSSSLPKDLSAEQWARLFTSASPTKSAKTGRNAHPAHSARRQGR,100,gnl|BL_ORD_ID|818|hsp_num:0,888,FALSE,None
LK1117,27_6 # 3957 # 4700 # -1 # ID=27_6;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.781,27_6,3957,4700,-,Strict,50,82.8037,vanY gene in vanA cluster,30.14,3002955,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGTCGCCCCCTCCCCCTCGCCGCGCTGGCCGCGCTCGCGCTGCTCGCGGCCGGCTGCGGCACGCCCGCCGCGGGCCCGTCCTCGGCGACGCCGGCTTCCGGCTCCTCGAGCGCGGCCGCGTCGTCCGGCGCCGCCTCGAGCACGGCGCCGTCGTCGAGCACGCACGCCGACCCGGCCGCCCTCGACGTCGTCGTGAACAAGACCCGCCCCGTGGCCCCGCCCGACTGGGCGCCCTCGGATCTGGTGGCCGTGCCCGGCAGCGAGCTGCCCCTGCGGGCGGAGGCCGCCACGGCCGCCGGTGACCTGCTGGATGCGGCCACGGCGGCGGGCCACGACCTCACCACCCTGAGCGCCTACCGCTCGTACGACTACCAGGTCCGGACGTACGGCCACTGGGTCGACGAGCTGGGCCGCGCCGAGGCCGACCGCGTCTCGGCGCGTCCGGGGTACTCCGAGCACCAGACCGGCCTGGCCTGGGACGTGGGCGACGCCGCGACCCCCGCGTGTGACCTGGAGGCGTGCTTCGGCGACACCGCCGCGGGCCGCTGGGTGGCCGCGCACGCCGCCGAGTACGGGTTCGTCATCCGCTATCCCGCCGGGGCCGAGGACGTGACGGGCTTCGACCACGAGCCCTGGCACCTGCGCTACGTCGGGTCCACGGAGGCGGCCCGGGTCGAGGCGGCCGGCGGCGTCCTCGAGACCGCGTGGGGTCTGCCTCCGGCGCCCGACTACGCGGACTGA,MRRPLPLAALAALALLAAGCGTPAAGPSSATPASGSSSAAASSGAASSTAPSSSTHADPAALDVVVNKTRPVAPPDWAPSDLVAVPGSELPLRAEAATAAGDLLDAATAAGHDLTTLSAYRSYDYQVRTYGHWVDELGRAEADRVSARPGYSEHQTGLAWDVGDAATPACDLEACFGDTAAGRWVAAHAAEYGFVIRYPAGAEDVTGFDHEPWHLRYVGSTEAARVEAAGGVLETAWGLPPAPDYAD,MKKLFFLLLLLFLIYLGYDYVNEALFSQEKVEFQNYDQNPKEHLENSGTSENTQEKTITEEQVYQGNLLLINSKYPVRQESVKSDIVNLSKHDELINGYGLLDSNIYMSKEIAQKFSEMVNDAVKGGVSHFIINSGYRDFDEQSVLYQEMGAEYALPAGYSEHNSGLSLDVGSSLTKMERAPEGKWIEENAWKYGFILRYPEDKTELTGIQYEPWHIRYVGLPHSAIMKEKNFVLEEYMDYLKEEKTISVSVNGEKYEIFYYPVTKNTTIHVPTNLRYEISGNNIDGVIVTVFPGSTHTNSRR,81.52,gnl|BL_ORD_ID|4669|hsp_num:0,89,FALSE,None
LK523,1_148 # 173855 # 174340 # 1 # ID=1_148;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.364,1_148,173855,174340,+,Strict,300,332.028,dfrC,99.38,3002865,protein homolog model,n/a,n/a,diaminopyrimidine antibiotic,antibiotic target replacement,trimethoprim resistant dihydrofolate reductase dfr,ATGACATTATCAATAATTGTCGCTCACGATAAACAAAGAGTCATTGGGTACCAAAATCAATTACCATGGCATTTACCAAATGATTTAAAGCATGTTAAACAACTGACCACTGGAAATACACTTGTAATGGGACGAAAAACTTTTAATTCTATCGGGAAACCACTGCCAAATAGACGTAACGTTGTGCTCACTAACCAAGCTTCATTTCACCATGAAGGGGTAGATGTTATAAACTCTCTTGATGAAATTAAAGAGTTATCTGGTCATGTTTTTATATTTGGAGGACAAACGTTATTCGAAGCAATGATTGACCAGGTAGATGATATGTATATCACAGTAATAGATGGGAAGTTTCAAGGAGACACTTTCTTTCCACCGTACACATTCGAAAACTGGGAGGTCGAATCTTCAGTGGAAGGTCAACTAGATGAAAAAAATACTATACCGCATACATTCTTACATTTAGTGCGTAGAAAAGGGGAATAG,MTLSIIVAHDKQRVIGYQNQLPWHLPNDLKHVKQLTTGNTLVMGRKTFNSIGKPLPNRRNVVLTNQASFHHEGVDVINSLDEIKELSGHVFIFGGQTLFEAMIDQVDDMYITVIDGKFQGDTFFPPYTFENWEVESSVEGQLDEKNTIPHTFLHLVRRKGE,MTLSIIVAHDKQRVIGYQNQLPWHLPNDLKHVKQLTTGNTLVMGRKTFNSIGKPLPNRRNVVLTNQASFHHEGVDVINSLDEIKELSGHVFIFGGQTLFEAMIDQVDDMYITVIDGKFQGDTFFPPYTFENWEVESSVEGQLDEKNTIPHTFLHLVRRKGK,100,gnl|BL_ORD_ID|1279|hsp_num:0,1397,FALSE,None
LK523,2_244 # 217681 # 218124 # -1 # ID=2_244;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.329,2_244,217681,218124,-,Strict,270,286.189,mgrA,95.24,3000815,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; cephalosporin; penam; tetracycline antibiotic; peptide antibiotic; disinfecting agents and antiseptics,antibiotic efflux,ATP-binding cassette (ABC) antibiotic efflux pump; major facilitator superfamily (MFS) antibiotic efflux pump,ATGTCTGAACAACATAATTTAAAAGAGCAGCTATGCTTTAGTTTGTACAACGCTCAAAGACAAGTTAATCGCTACTATTCAAACAAAGTCTTTAAAAAGTACAATCTAACATACCCACAATTTCTTGTTTTAACAATATTATGGGATGAATCACCTGTTAACGTCAAAAAGGTCGTTACAGAATTAGCACTTGATACTGGTACTGTATCACCATTACTCAAGAGAATGGAACAAGTTGATTTAATCAAACGTGAACGTTCTGAAGTAGATCAACGTGAAGTATTTATTCACTTAACAGACAAAAGTGAAATGATTAGGCCCGAATTAAGCAACGCATCTGAGAAAGTTGCAACTGCTTCTTCTTTATCTAAAGATGAGGTCAAAGAACTTAATCGTTTATTAGGTAAAGTCATCGATGCATTTATCGAAACAAAAGAAAAGTAA,MSEQHNLKEQLCFSLYNAQRQVNRYYSNKVFKKYNLTYPQFLVLTILWDESPVNVKKVVTELALDTGTVSPLLKRMEQVDLIKRERSEVDQREVFIHLTDKSEMIRPELSNASEKVATASSLSKDEVKELNRLLGKVIDAFIETKEK,MSDQHNLKEQLCFSLYNAQRQVNRYYSNKVFKKYNLTYPQFLVLTILWDESPVNVKKVVTELALDTGTVSPLLKRMEQVDLIKRERSEVDQREVFIHLTDKSETIRPELSNASDKVASASSLSQDEVKELNRLLGKVIHAFDETKEK,100,gnl|BL_ORD_ID|133|hsp_num:0,154,FALSE,None
LK523,2_252 # 225219 # 226424 # 1 # ID=2_252;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.323,2_252,225219,226424,+,Strict,700,751.125,norA,98.71,3000391,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGATTGGTATGCTTACCACATTAGAAAAAAGGGGGTGTCCTATGAAAAAACAATTATTTATTCTTTATTTTAATATATTTCTTATATTTTTAGGAATTGGGTTAGTTATTCCTGTACTTCCTGTATATTTAAAGGATTTAGGATTAAAAGGTAGTGATTTAGGAATGCTAGTTGCTGCCTTTGCATTATCACAAATGATTATTTCACCATTTGGTGGGACACTAGCTGATAAATTGGGGAAAAAATTAATTATATGTATCGGTTTAGTATTCTTTTCAGTCTCTGAATTTATGTTCGCAGCCGGTCAAAGTTTTACCATTTTAATCATTTCACGTATTTTAGGTGGTTTTAGTGCAGGCATGGTCATGCCTGGTGTAACAGGTATGATTGCAGATATTTCTCCAGGAGCTGATAAAGCTAAAAACTTTGGTTATATGTCGGCAATTATTAATTCAGGTTTTATATTAGGGCCTGGATTTGGAGGGTTTTTAGCTGAAATTTCACATAGATTACCTTTCTATGTTGCTGGAACATTAGGTGTTGTTGCATTCATTATGTCAGTTTTATTAATTCATAATCCTCACAAAGCAACCACAGATGGATTCCACCAATATCAACCAGAATTATTCACTAAAATTAATTGGAAAGTATTTATTACGCCAGTTATATTAACACTTGTATTAGCATTTGGTTTATCTGCTTTTGAAACATTGTTTTCTTTATATACAGCTGACAAAGTAAATTATACTTCTAAAGATATTTCGATAGCTATTATCGGTGGAGGCGTGTTCGGCGCATTATTCCAGGTATTCTTCTTTGATAAATTTATGAAACATATGAGTGAACTTAATTTTATTGCATGGTCATTACTATATTCAGCTATTGTTCTCGTTATGTTAGTGCTTGCAAACGGTTATTGGACGATTATGATTATTAGCTTTGTTGTTTTTATAGGTTTTGATATGATTAGACCGGCTTTAACCAATTACTTCTCGAATATAGCAGGTAAACGGCAAGGTTTTGCAGGGGGATTGAATTCAACTTTTACCAGTATGGGTAATTTTATAGGTCCTCTTGTAGCTGGTGCATTATTCGATGTTAATTTAGAGTTTCCTTTATATATGGCTATTGCGGTTTCATTAAGTGGAATTATCATTATTTTTATTGAAAAAGGACTTAAGTCACGTCGTAAAGAAGCAAATTAA,MIGMLTTLEKRGCPMKKQLFILYFNIFLIFLGIGLVIPVLPVYLKDLGLKGSDLGMLVAAFALSQMIISPFGGTLADKLGKKLIICIGLVFFSVSEFMFAAGQSFTILIISRILGGFSAGMVMPGVTGMIADISPGADKAKNFGYMSAIINSGFILGPGFGGFLAEISHRLPFYVAGTLGVVAFIMSVLLIHNPHKATTDGFHQYQPELFTKINWKVFITPVILTLVLAFGLSAFETLFSLYTADKVNYTSKDISIAIIGGGVFGALFQVFFFDKFMKHMSELNFIAWSLLYSAIVLVMLVLANGYWTIMIISFVVFIGFDMIRPALTNYFSNIAGKRQGFAGGLNSTFTSMGNFIGPLVAGALFDVNLEFPLYMAIAVSLSGIIIIFIEKGLKSRRKEAN,MKKQLFILYFNIFLIFLGIGLVIPVLPVYLKDLGLKGSDLGMLVAAFALSQMIISPFGGTLADKLGKKLIICIGLVFFAVSEFMFAAGQSFTILIISRVLGGFSAGMVMPGVTGMIADISPGADKAKNFGYMSAIINSGFILGPGFGGFLAEISHRLPFYVAGTLGVVAFIMSVLLIHNPQKATTDGFHQYQPELFTKINWKVFITPVILTLVLAFGLSAFETLFSLYTADKVNYTPKDISIAIIGGGVFGALFQVFFFDKFMKYMSELNFIAWSLLYSAIVLVMLVLANGYWTIMIISFVVFIGFDMIRPALTNYFSNIAGKRQGFAGGLNSTFTSMGNFIGPLVAGALFDVNLEFPLYMAIAVSLSGIIIIFIEKGLKSRRKEAN,103.62,gnl|BL_ORD_ID|1427|hsp_num:0,1554,FALSE,None
LK523,3_46 # 51803 # 52231 # 1 # ID=3_46;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.296,3_46,51803,52231,+,Strict,150,188.348,FosBx1,60.58,3007372,protein homolog model,n/a,n/a,phosphonic acid antibiotic,antibiotic inactivation,fosfomycin thiol transferase,ATGGAAATAACAAGTGTTAATCATATTTGTTTTTCAGTAAGTGATTTAAATACTTCTATACAATTTTATAAAGATATTTTACAAGGTGACTTATTAGTATCAGGTAGAACGACAGCATATTTAACTATTGGTCATACTTGGATTGCACTGAATCAAGAAAAAAATATACCAAGGAATGAAATAAACCATTCCTATACGCATGTTGCTTTCTCCATAGATGAAGAAGATTTTCAAAAGTGGATTCAATGGCTTAAAGAGAATCAAGTAAATATTTTAAAAGGGCGACCAAGAGATATTAAAGACAAAAAGTCGATATATTTTACAGATCCGGATGGGCATAAAATTGAATTACATACTGGGACACTAAAAGATAGAATGGAATATTATAAAAGTGAGAAGACCCATATGCAATTTTACGATGAGTTTTGA,MEITSVNHICFSVSDLNTSIQFYKDILQGDLLVSGRTTAYLTIGHTWIALNQEKNIPRNEINHSYTHVAFSIDEEDFQKWIQWLKENQVNILKGRPRDIKDKKSIYFTDPDGHKIELHTGTLKDRMEYYKSEKTHMQFYDEF,MLRGINHICFSVSNLENSIMFYEKVLEGELLVKGRKLAYFNICGVWIALNEETHIPRNEIHQSYTHIAFSVEKEDFKCLIQRLEENDVHILQGRERDVRDCESIYFVDPDGHKFEFHSGTLQDRLNYYRDEKPHMTFY,102.9,gnl|BL_ORD_ID|4909|hsp_num:0,5900,FALSE,None
LK523,5_87 # 93674 # 95074 # 1 # ID=5_87;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.348,5_87,93674,95074,+,Strict,525,561.992,norC,62.42,3007010,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGAATACATCACAAAAGTTTAGGGGAGATAATCGCTTATTATTAGGGATTATTTTAGGGGTTATTACATTTTGGTTATTTGCACAATCACTTGTAAATCTAGTCGTGCCATTACAATCATCATACAATAGTGATATTGGCACCATTAATATAGCAGTTAGCTTATCGGCACTATTTTCTGGTTTGTTTATTGTAGGTGCAGGAGATATTGCAGATAAAATTGGTAGAGTAAAAATGACATACATAGGCTTAGCACTTAATATTGTTGGGTCAGTTTTAATCATTATTACACCATTACCAAGTTTATTGATTATTGGACGTGCTATTCAAGGATTGTCAGCGGCGTGTATAATGCCAGCGACACTCGCAATCATTAATGAATATTATATTGGGACAGCACGACAACGTGCATTAAGCTACTGGTCTATCGGTTCATGGGGAGGTAGTGGTGTTTGTACTTTGTTTGGTGGTTTAATGGCAACTAACCTTGGATGGCGCTCAATCTTTATTGTTTCAATTATTCTGACAATATTATCCATGTTTCTCATTAAACATACACCCGAAACAAAAGCAGAGCCTATAGGAGATCAACCGACAGAGACAAAGAAATTTGATGTTGTTGGTTTAATCATCTTAGTGGTTAGCATGTTAAGTATTAATGTGATAATAACTCAAACCTCTCAATTTGGTTTGTTCTCACCATTTATTTTGGGACTTATTGCAATTTTTGTTATATCGTTAATTATATTCGTGATTTACGAAAATAAAATCAAACAACCACTTGTCGATTTTGATATCTTTAAAAACAAAGGTTATACAGGTGCAACGATTTCAAACTTTATGTTGAATGGTGTAGCTGGTGGTACATTGATTGTAGTAAATACTTTTTATCAGCAAAAATTAGATTTTAACTCTCAGGAAACTGGATATATTTCACTTACATACCTAATTGCAGTATTAATTATGATACGTGTGGGTGAAATGATATTACAATCGCTAGGACCTAAAAGACCATTGTTACTCGGAAGTGCCTTGACCGTCATAGGATTAATATTATTATCTTTGACGTTTTTACCTAATGCTTGGTATATAACGTCAAGTGTCATTGGTTATTTATTATTTGGTACCGGTTTAGGTATTTATGCAACACCATCCACGGATACAGCTGTTGCACAAGCACCAGATGATAAAGTAGGCGTCGCATCCGGTGTATATAAGATGGCATCATCCTTAGGAAATGCATTTGGTGTGGCCATCTCAAGTACAGTTTACAGCGTACTTGCAGCCCAACTGAATCTAACTTTAGGTGGTTTTACAGGAGTAATGTTCAATGCGCTTATAGCATTATTAGCATTCCTATCTATTTTGTTCTTAATACCGAAAAAACAGTCTAATGTATAA,MNTSQKFRGDNRLLLGIILGVITFWLFAQSLVNLVVPLQSSYNSDIGTINIAVSLSALFSGLFIVGAGDIADKIGRVKMTYIGLALNIVGSVLIIITPLPSLLIIGRAIQGLSAACIMPATLAIINEYYIGTARQRALSYWSIGSWGGSGVCTLFGGLMATNLGWRSIFIVSIILTILSMFLIKHTPETKAEPIGDQPTETKKFDVVGLIILVVSMLSINVIITQTSQFGLFSPFILGLIAIFVISLIIFVIYENKIKQPLVDFDIFKNKGYTGATISNFMLNGVAGGTLIVVNTFYQQKLDFNSQETGYISLTYLIAVLIMIRVGEMILQSLGPKRPLLLGSALTVIGLILLSLTFLPNAWYITSSVIGYLLFGTGLGIYATPSTDTAVAQAPDDKVGVASGVYKMASSLGNAFGVAISSTVYSVLAAQLNLTLGGFTGVMFNALIALLAFLSILFLIPKKQSNV,MNETYRGGNKLILGIVLGVITFWLFAQSLVNVVPNLQQSFGADMGTISIAVSLTALFSGMFVVGAGGLADKIGRVKMTNIGLLLSIIGSALIIITNLPALLILGRIIQGVSAACIMPSTLAIMKTYYEGAERQRALSYWSIGSWGGSGICSLFGGAVATTMGWRWIFIFSIIVAVLSMLLIKGTPETKSEVTNTHKFDVAGLIVLVVMLLSLNVVITKGAALGYTSLWFFGLIAIVIVAFFIFLNVEKKVDNPLIDFKLFENKPYTGATISNFLLNGVAGTLIVANTFVQQGLGYTALQAGYLSITYLIMVLLMIRVGEKLLQKMGSKRPMLLGTFIVIIGIALISLVFLPGIFYVISCVVGYLCFGLGLGIYATPSTDTAISNAPLDKVGVASGIYKMASSLGGAFGVAISGAVYAGAVAATSIHTGAMIALWVNVLMGIMAFIAILFAIPNDDKRVKDAK,100.87,gnl|BL_ORD_ID|4656|hsp_num:0,5726,FALSE,None
LK523,6_164 # 170779 # 172143 # -1 # ID=6_164;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.276,6_164,170779,172143,-,Strict,50,138.658,vanW gene in vanG cluster,30.27,3002965,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanW; glycopeptide resistance gene cluster,ATGAATCCTCTTTTTCCTTCAACTTCAGTAGAGAGTGTGTTTTCAATAGATTATCTAAAATTAAAAGGAATGGGTTATAAAGCAATAATCTTTGATATTGATAGTACACTAGTTCCCCATGGTGACGATACAACAAATGAAATAGATCAATTATTTAAATACCTTCATAAATTAGGTTTTAAGACTTTATTATTATCTAACAATAGTGAAGAGCGTATTTCTACATTCAATAGAAATATTAAGACATTATTTATACCTATGGCGAATAAGCCTCATAGAGCAAATTATTTAAAAGCGATTAGGATGTTAAATGTTAATTATTCAGAAGTGATACTTGTAGGAGATCAATTATTTACAGATATCATTGGGGCGAATTTATGTGGTATAAAAAGTATTTTAGTCAAATTTTTAAAACATCCAGAAGATATAAAAATTGGCAAAAAAAGACAGTTAGAACGATTAATTTTAAAACTTTTTGCTTTAAATAATAAGTTTTTTAATCATTTTCCTAATATTGAAAAGGAGTATTCTAACAAGGTGGTTGAACAGAAAAAATCTCTTAGTGAACGTTACCCTATATTTTATTCAATGGCTGTAAAAAAAGAAACGGTAAAACGTCATATCAAAAATTATAAATCCAATATAAAGTTTGCTACATATAAACAGGATAAAGCTTTACCTAATGTGGTACATCAATATAGTTCCTATCTTATAAAAGAGGGAAAAGATATTGATCCCACTTTACAATATAATAAATCCTTTAATATAGGCTTATCTGCTTCAAAAATAAATAAGGTTATTATTCGACCAGGAGAAACATTTTCTTTTTGGAATTTAGTTGGGAAAATAGATAAAAAAAGAGGATATAGAGACGGAAGAGTTATTATTAATAACAAGGTTCAAGCTGGTTTAGGTGGAGGTTTATGTAATTTAGCTAATACATTAAATTTATTAATCATGCACAGTCCATTAGAAGTTACTGAATTACATACTCATTCAGACGCTTTATCTCCTGATCATGGTAAACGTGTACCATTTGGTACGGGAACTTCAATCTCCTATAATTATGTAGATTATAGATTTGAGAATACTACTAACCAAAACGTTCAGATTCTAATATGGGTAGAGAATAACTATCTAAATGCTGAATTGAGAAGTGAAAAACCATTTGATTATAAATATGAACTTTCTGAAGAAAATCATCATTTTACAAAGATAAATGGTAAATTTTATCGCAAATCAAAAGTGTATAAAAACACAGTTAACCCTTCCGATAATAAAATTATAGATAAACAACTTGTTTACGATAATAAATCAAGAGTGATGTTTGACTATGACTTAATTCCTAAAGAACTAATCAAATGA,MNPLFPSTSVESVFSIDYLKLKGMGYKAIIFDIDSTLVPHGDDTTNEIDQLFKYLHKLGFKTLLLSNNSEERISTFNRNIKTLFIPMANKPHRANYLKAIRMLNVNYSEVILVGDQLFTDIIGANLCGIKSILVKFLKHPEDIKIGKKRQLERLILKLFALNNKFFNHFPNIEKEYSNKVVEQKKSLSERYPIFYSMAVKKETVKRHIKNYKSNIKFATYKQDKALPNVVHQYSSYLIKEGKDIDPTLQYNKSFNIGLSASKINKVIIRPGETFSFWNLVGKIDKKRGYRDGRVIINNKVQAGLGGGLCNLANTLNLLIMHSPLEVTELHTHSDALSPDHGKRVPFGTGTSISYNYVDYRFENTTNQNVQILIWVENNYLNAELRSEKPFDYKYELSEENHHFTKINGKFYRKSKVYKNTVNPSDNKIIDKQLVYDNKSRVMFDYDLIPKELIK,MIEVYKLTQRKRLTQLFPFLLPLRKWQRKKYFYFKMKFDGNRYAKKTSEKLLPNTVFETSSLMLNENSGFDMKYQINKVHNLKLAAKTINKVIIEPKETFSFWQLVRWADRHEKYKDGLNLVNGKIVGSYGGGLCQLSNMLFWLFLHTPLVIVERHGHAVESFPSTTEDLPCGTDATINEGWLDLKLRNDTDNTFQIEISFDDNFMYGRILSQSSVNIEYTVFNSSVSYFKREEKVYQIASVCRTEKDKMTGSQTEKELYVNQCEIAYKLPDDVKIEERGV,161.57,gnl|BL_ORD_ID|4743|hsp_num:0,1622,FALSE,None
LK523,8_108 # 90246 # 91583 # 1 # ID=8_108;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.297,8_108,90246,91583,+,Strict,200,611.683,sdrM,73.93,3007013,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGAATCTTAAGTCCATCATTACTGTAATGGCACTCATACTAATAATGTTTATGGCAGCTATAGAAACATCAATCATTTCATTAGCATTACCAACAATAAAAAATAGTTTGAATGCCGGTAATCTAGTTTCATTAGTATTTACCGTATATTTTATTGCTTTAGTCATAGCTAACCCTATTGTTGGTGAGCTCATGTCTAGATTTAAAATTATTAACATCGCTGTTATAGGGGTAACATTGTTTGCTTTAGGTAGTTTAATGTCGGGATTAAGTCAGACGTTTACTTTTTTAATTATCTCTCGAATAGTACAAGGTTTTGGAGCAGGAGTGATGATGTCACTCTCACAAATAGTTCCTAAGTTGGCTTTTGAAATTCCGTTAAGATATAAAATTATGGGTATCGTCGGAAGTGTCTGGGGAATTTCGAGTATTATTGGTCCATTATTAGGTGGTGCGATTTTAGAGTTCGCTTCATGGCATTGGCTATTCTATATCAATATTCCTATTGCTATATTGGCAATAATACTTGTATTTATGACTTTTCATTTTCCTGATGAGACACAAGTACAACAGAGTCGTTTTGATATAAAAGGATTGATTATCTTTTATATCTTTATAGCTTTATTAATGTTTGGTTTACTCAACCAACATCATATTATTTTTAATATATTCTCAATTATTTTAGCTTTAGTTGTTTTATGGATACTATTTAAAGTAGAAAATAGTATCGAACAACCATTTTTACCAACAAAAGAATTTAACATATCAATAGTTCTAGTTTTTATAACGGATTTACTAATTGCGATAACATTGATGGGATATAATTTATATATACCAGTATATTTACAAGAAAAACTTGGTTTATCACCTTTACAAAGTGGATTTGTAATATTCCCGTTGTCTGTTGCTTGGATTACGCTTAATTTCAATTTAGCTAAAATAGAAGCGCATTTTACTAGAAAAACATTATATATTTGTTCATTTTTTGTTTTATTAGTTTGTAGTCTGATGATAATGTTTGGCTTAAAACTCCCATTGCTTATTGCTTTTGCGGTTATATTTGCAGGTTTAAGTTTTGGCTACATTTATACAAAAGATAGTGTTATTGTCCAAGAGGAAACTTCTCCAAAAAATATGAAAAAGATGATGTCGTTTTATGCATTGACAAAAAATTTAGGTTCGTCTGTCGGATCTACGATTATGGGATATATGTATGCACTGAATGTTGGTTTATTTGGTTCTAATTTACACAATGTATTAGGATTAGTATCAATAATTTCAGTATGTTTAATTGTAATGTGGATGACATTATTTAAGAGCAATCCTATTCAATCTTAG,MNLKSIITVMALILIMFMAAIETSIISLALPTIKNSLNAGNLVSLVFTVYFIALVIANPIVGELMSRFKIINIAVIGVTLFALGSLMSGLSQTFTFLIISRIVQGFGAGVMMSLSQIVPKLAFEIPLRYKIMGIVGSVWGISSIIGPLLGGAILEFASWHWLFYINIPIAILAIILVFMTFHFPDETQVQQSRFDIKGLIIFYIFIALLMFGLLNQHHIIFNIFSIILALVVLWILFKVENSIEQPFLPTKEFNISIVLVFITDLLIAITLMGYNLYIPVYLQEKLGLSPLQSGFVIFPLSVAWITLNFNLAKIEAHFTRKTLYICSFFVLLVCSLMIMFGLKLPLLIAFAVIFAGLSFGYIYTKDSVIVQEETSPKNMKKMMSFYALTKNLGSSVGSTIMGYMYALNVGLFGSNLHNVLGLVSIISVCLIVMWMTLFKSNPIQS,MRLKSIITVIALILIMFMSAIESSIISLALPTIKQDLNAGNLISLIFTAYFIALVIANPIVGELLSRFKIIYVAIAGLLLFSIGSFMCGLSTNFTMLIISRVIQGFGSGVLMSLSQIVPKLAFEIPLRYKIMGIVGSVWGISSIIGPLLGGGILEFATWHWLFYINIPIAIIAIILVIWTFHFPEEETVAKSKFDTKGLTLFYVFIGLIMFALLNQQLLLLNFLSFILAIVVAMCLFKVEKHVSSPFLPVVEFNRSITLVFITDLLTAICLMGFNLYIPVYLQEQLGLSPLQSGLVIFPLSVAWITLNFNLHRIEAKLSRKVIYLLSFTLLLVSSIIISFGIKLPVLIAFVLILAGLSFGYIYTKDSVIVQEETSPLQMKKMMSFYGLTKNLGASIGSTIMGYLYAIQSGIFGPNLHNVLSAVAVISIGLIVLWVVFFKEQSSQSKE,99.55,gnl|BL_ORD_ID|4661|hsp_num:0,5729,FALSE,None
LK523,8_109 # 91776 # 92243 # 1 # ID=8_109;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.237,8_109,91776,92243,+,Strict,100,230.72,sepA,70.32,3007012,protein homolog model,n/a,n/a,disinfecting agents and antiseptics,antibiotic efflux,small multidrug resistance (SMR) antibiotic efflux pump,ATGAAATTTTTAAAAAATAAATCATATCATTTATTAGTAACACTTATTGTTCTCACTATATTTATTATTTCCGGAGCCATTTTTTTAACCTTTTTAGGCTTTGGTTTGTACGGTTTGAGTCGCATCCTTATTTATTTACACTTAGGCGATTTTAGTTACAATAAAGGCTTTTATGATAATTTAATATACTACGGTAGTTATATCGTTTTAGGCTATTTTACTTTATTTTCAATTGAGCATTTAATGGATTATTTTAAAAAGAATCTTCCAAAAAATCCATACTTTCAAGGTATTAACTTTCATCTCATCTCCTACATTGTTACTACAATTATGTTTTATTTTATAGTTCACATACACTATGTACATGTTAATATACATTTTTGGGTAATTATGATTATTATAGGATTTTTATTTGTATGTAAAGAAGTTTTTTATCCTGAAAGTAAAAATTTGAATAATAAAAAGTAA,MKFLKNKSYHLLVTLIVLTIFIISGAIFLTFLGFGLYGLSRILIYLHLGDFSYNKGFYDNLIYYGSYIVLGYFTLFSIEHLMDYFKKNLPKNPYFQGINFHLISYIVTTIMFYFIVHIHYVHVNIHFWVIMIIIGFLFVCKEVFYPESKNLNNKK,MIVNFFKHKFYNLLTTMIVLFVFVLSGAIFLTFLGFGLYGLSRILIYFRLGDFTYNRNMYDNLLYYGSYIIFGYFIIFAVEHLMDYFRKMLPENAYFRGATFHLISYTVATTLFYFIIHLHYVYINIDFWVIMVIIGFLYVCKLQFYPESKNLNNRK,98.73,gnl|BL_ORD_ID|4660|hsp_num:0,5728,FALSE,None
LK523,10_2 # 523 # 1206 # -1 # ID=10_2;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.319,10_2,523,1206,-,Strict,50,104.375,vanY gene in vanB cluster,34.07,3002956,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGAAAAAATTATCTGTAATATTGATGACTAGCGCTTTATTACTTTCAGCTTGTTCACATCAATCTGAAAGCCACAATGACAAAGATGAAAGTAAAACTGCACATACAAATCAATCCCATAATAACGATAACAACCAAAAGAAACATCGAAAAGTTGTTAAAGATGGTCGGACGTATGCAGATGGAATTTTAATTGTAAACAAAAATATTGATTTACCTTCCTCTTATAATCCGGGTGAAAATCCAAAAGCACAAAAAGCCTTAAAGCAATTATTTGATGGTGCACAAAAAGATGATATTCACTTATATAAAATAAGTGGATATAGAAGCTATCCTACACAAGTTAAGTTATATAATAATTATGCTAAGCGTGATGGTAAAAAAGCAGCAGATAAATACAGTGCACGTCCAGGCTATTCTGAACACCAAACAGGTCTTACATTTGATGTTGGTGGCGTCGATTCAAATAAAAATCTATATGATAGTTTTGGTAAAACTGAGGAAGGACGCTGGATAGCTAAGAATGCCCATAATTATGGATTTATTATAAGATATCCTAAAAACAAAGAAAGCATCACAGGATATCAATATGAACCTTGGCATTTACGTTATTTAGGAAAAAAGAAAGCAACAAAAGTGTACAAATCTGGTGAAACATTAGAAGAATTTGTAGGCTTAAAATAA,MKKLSVILMTSALLLSACSHQSESHNDKDESKTAHTNQSHNNDNNQKKHRKVVKDGRTYADGILIVNKNIDLPSSYNPGENPKAQKALKQLFDGAQKDDIHLYKISGYRSYPTQVKLYNNYAKRDGKKAADKYSARPGYSEHQTGLTFDVGGVDSNKNLYDSFGKTEEGRWIAKNAHNYGFIIRYPKNKESITGYQYEPWHLRYLGKKKATKVYKSGETLEEFVGLK,MEKSNYHSNVNHHKRHMKQSGEKRAFLWAFIISFTVCTLFLGWRLVSVLEATQLPPIPATHTGSGTGVAENPEENTLATAKEQGDEQEWSLILVNRQNPIPAQYDVELEQLSNGERIDIRISPYLQDLFDAARADGVYPIVASGYRTTEKQQEIMDEKVAEYKAKGYTSAQAKAEAETWVAVPGTSEHQLGLAVDINADGIHSTGNEVYRWLDENSYRFGFIRRYPPDKTEITGVSNEPWHYRYVGIEAATKIYHQGLCLEEYLNTEK,84.7,gnl|BL_ORD_ID|602|hsp_num:0,556,FALSE,None
LK523,13_15 # 10121 # 10966 # 1 # ID=13_15;partial=00;start_type=TTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.270,13_15,10121,10966,+,Strict,500,552.362,PC1 beta-lactamase (blaZ),99.64,3000621,protein homolog model,n/a,n/a,penam,antibiotic inactivation,BlaZ beta-lactamase,TTGAAAAAGTTAATATTTTTAATTGTAATTGCTTTAGTTTTAAGTGCATGTAATTCAAACAGTTCACATGCCAAAGAGTTAAATGATTTAGAAAAAAAATATAATGCTCATATTGGTGTTTATGCTTTAGATACTAAAAGTGGTAAGGAAGTAAAATTTAATTCAGATAAGAGATTTGCCTATGCTTCGACTTCAAAAGCGATAAATAGTGCTATTTTGTTAGAACAAGTACCTTATAATAAGTTAAATAAAAAAGTACATATTAACAAAGATGATATAGTTGCTTATTCTCCTATTTTAGAAAAATATGTAGGAAAAGATATCACTTTAAAAGAACTTATTGAGGCTTCAATGAAGTACAGTGATAATACAGCAAACAATAAAATTATAAACGAAATCGGTGGAATCAAAAAAATTAAAAAACGTTTAAAAAAATTGGGAGATAAAGTAACAAATCCAGTTAGATATGAAATAGAATTAAATTACTATTCACCAAAGAGCAAAAAAGATACTTCAACGCCTGCTGCTTTCGGCAAGACTTTAAATAAACTTATCGCAAATGGAAAATTAAGCAAAAAAAATAAAAATTTCTTACTTGATTTAATGTTAAATAATAAAAACGGAGACACTTTAATTAAAGATGGTATTCCAAAAGACTATAAAGTTGCTGATAAAAGTGGTCAAGCAATAACATATGCTTCTAGAAATGATGTTGCTTTTGTTTATCCTAAGGGCCAATCTGAACCTATTGTTTTAGTCATTTTTACGAATAAAGACAATAAAAGTGATAAGCCAAATGATAAGTTGATAAGTGAAACCGCCAAGAGTGTAATGAAGGAATTTTAA,MKKLIFLIVIALVLSACNSNSSHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFAYASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMKYSDNTANNKIINEIGGIKKIKKRLKKLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKTLNKLIANGKLSKKNKNFLLDLMLNNKNGDTLIKDGIPKDYKVADKSGQAITYASRNDVAFVYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF,MKKLIFLIVIALVLSACNSNSSHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFAYASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDIALKELIEASMKYSDNTANNKIINEIGGIKKIKKRLKKLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKTLNKLIANGKLSKKNKNFLLDLMLNNKNGDTLIKDGIPKDYKVADKSGQAITYASRNDVAFVYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF,100,gnl|BL_ORD_ID|670|hsp_num:0,726,FALSE,None
LK1346,3_88 # 95666 # 97279 # 1 # ID=3_88;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.656,3_88,95666,97279,+,Strict,50,78.1814,vanW gene in vanI cluster,35.16,3003724,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanW; glycopeptide resistance gene cluster,GTGCTCGCGGTGCTGCTTGCGATCTACCTCGCCGACCTCGCAATGAACCGCGGGAACGTGCCGCGTGGCACCGCCGTCGGCGGTGTCGAGATCGGCGGCATGAGCCACGACGAGGCCACCGCGAAGCTCGAAGCAGAGCTCGGTGAGACGGCGAGCAACCCCGTGACGGTGAAGGCGGCATCGCAAAGCTCGCAGCTCGTGCCCGCCGAGTCCGGCCTCGGCATCGACTGGGAGGCGACCGTAGCAAGCGCGGGCGAAGAGTCCGCGAACCCGTTCACTCGCCTCGCCGGGCTGTTTCGCACCCGCGAAGTCGACATTGTGTCGACCGTGAACGAGGCCGCTCTCACCCCGCAGCTTGAGCGCGTGGCCGGCGAGTTGCACCTCGACCCCGCCGACGGCGCGATCGCCATCGAAGGCGGCGAGGCGAAAGTGACCGAACCGGTGCCGGGCCAGGAGGTTGACGAAACCGAGCTGTTCGAACGTGTCACCACCGGCTGGCTCAACCCCGACGGTGTAGAGGTCGAGCCGCGCGAAATCGAACCCGCTATCGGCGACCAGGCCATCAAGGAAGCCTTAGACGGGCCGGTTAAGGCGGCGCTGTCCGGAGCGTTGACACTGCACGGTCGCGACGGCGTCGACGGTGTCATTGCCCAAGAGCGCATCGGCGAGGTCGTCCAATTCCCCAACGTCGACGGCAAAATCGCCCCCGAGGTGAACGTGGAAAACGCCCAGGGCATCTTGGTCGAGCAGCTCGCTGCGACCGAGACGCAGATGAAAAACGCGCGCGTGCTGCCCGGCGGCGGGGTGGAACCGTCCGTCGATGGCTCCATCATCGACTGGGAGGCCGCGATGGACGGTTTCGACGAGCGGTTGATCGGTTCCGCCGAGCGCACCTGGGACGCGCAATACAAGGCCCGCCCGGCCGACTTCACTACAGAGGAAGCCCAACGTGCCAGCTTCGACGAGGTGGTGGGAAGTTTCACCACCGGCGGGTACAGCGGCGCATCCGGCACGAACATCGCTACGGTGGCCCGCGTTGTCAACGGCGCAATTGTCAACCCCGGTGAAACCTTCTCGCTCAACGGCTACACTGGCGCGCGCGGTGCCGCGCAGGGTTACGTCGAGTCGGGCATCATCGAAAATGGACGCCCCGGCAAGGCAGTGGGCGGCGGAATCTCCCAATTTGCCACGACCTTGTACAACGCGGCTTACTTTGCCGGCATGACGGATGTCGCCTCCACCCCGCACTCCTACTACATTTCACGCTACCCGGCTGGCAGGGAGGCGACCGTGTATGAAGGGGCGATTGACCTGCAATTCCGCAACGATTCGCCCCACCCGGTCAAGATTTCCACGAGCGTCGGGGGCGGCGAGGTGACGGTGAGCCTGATGGGCACCAAGACCGTCGAGGTGGAGTCCATCAACGGAGGGCGCTGGGCCTACACCTCGCCGAAGCCCGTGACCGTCACCAGTGGTGACTGCATTCCCTCGGGCGGGGTACAGGGCTTTACCACCTCCGATACCCGGATTGTGCGTGACCTCAGCGGCAATGAGATCAGTCGCAACACCTCCACCACGGTCTACGACCCGCAGCCCATCGTGCGCTGCGAGTAG,MLAVLLAIYLADLAMNRGNVPRGTAVGGVEIGGMSHDEATAKLEAELGETASNPVTVKAASQSSQLVPAESGLGIDWEATVASAGEESANPFTRLAGLFRTREVDIVSTVNEAALTPQLERVAGELHLDPADGAIAIEGGEAKVTEPVPGQEVDETELFERVTTGWLNPDGVEVEPREIEPAIGDQAIKEALDGPVKAALSGALTLHGRDGVDGVIAQERIGEVVQFPNVDGKIAPEVNVENAQGILVEQLAATETQMKNARVLPGGGVEPSVDGSIIDWEAAMDGFDERLIGSAERTWDAQYKARPADFTTEEAQRASFDEVVGSFTTGGYSGASGTNIATVARVVNGAIVNPGETFSLNGYTGARGAAQGYVESGIIENGRPGKAVGGGISQFATTLYNAAYFAGMTDVASTPHSYYISRYPAGREATVYEGAIDLQFRNDSPHPVKISTSVGGGEVTVSLMGTKTVEVESINGGRWAYTSPKPVTVTSGDCIPSGGVQGFTTSDTRIVRDLSGNEISRNTSTTVYDPQPIVRCE,MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVLAEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPELLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGMETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGGEFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSHSLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDEPDGYPVKPREWSK,143.97,gnl|BL_ORD_ID|4748|hsp_num:0,2242,FALSE,None
LK716,3_308 # 258355 # 258678 # -1 # ID=3_308;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.432,3_308,258355,258678,-,Strict,75,85.1149,qacJ,46.84,3007014,protein homolog model,n/a,n/a,disinfecting agents and antiseptics,antibiotic efflux,small multidrug resistance (SMR) antibiotic efflux pump,ATGACGGCTTTTAGTTTTTTAATGCTCGCTATTATAGCAGAGGTTTTTGCCAGTTCCTTGCTCAAGCGTACGGAGGGCTTCACACGAATTGGGCCATCAATTGGCGTAGTAGTAGGCTATGGAACGGCATTTTATTGTTTAGCCTTAACATTAAAAGTGATTCCTATTGGCACAGCCTATGCAATTTGGGCAGGTTTAGGGACAGCGTTAACCGCTATTGTGGGAGTTGTCCTCTATAAGGAACGATTTAATCGCAAGAAGGTATTAGGGATTCTATGCATTATCTTGGGTGTTGTGGTACTCAATCTTGCTGGTGGTCATTAG,MTAFSFLMLAIIAEVFASSLLKRTEGFTRIGPSIGVVVGYGTAFYCLALTLKVIPIGTAYAIWAGLGTALTAIVGVVLYKERFNRKKVLGILCIILGVVVLNLAGGH,MPYLYLVIAIITEIIGTSFLKTAEGFTKLWPTLGTLISFGICFYFLSVTMKYLPLNVSYATWAGLGLVLTTIVSVVIFKESVNLISIFSIILIIIGVVLLNVFGSSH,100,gnl|BL_ORD_ID|4662|hsp_num:0,5730,FALSE,None
LK716,6_72 # 79691 # 80632 # -1 # ID=6_72;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.380,6_72,79691,80632,-,Strict,50,127.487,vanW gene in vanI cluster,41.67,3003724,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanW; glycopeptide resistance gene cluster,ATGACGGGTCTCGTAGGTTGTGAAAAAACAGCAGTCCCTGATAACAAGCTAGAACAAGAAATTCAACAACGTGAGGAAATACAGCAACCTGTTACATATGAACAAGAACAAATGATTGATCCTATTGTAGAGGTTGTTGATCCAACTACGAGTAAGGTACTTAAAACAATATCTCCAAAGGAATTTGGCTTCGATACGGACCCACAAGCCTATCAAAAGCATATCGAACAATTAGCAAGGGAATGGGCGAGAGGAACGGACACATCAAATGGCTATGATCAGCGTATGATGCTTGATCGATTGGATGAAAACGGGCAAGTGATCAAAGGGAAGCCGCAAATCATTTTAAAGGAAAGTGAGCTAGTGGAGCGTATTATCGAAGCTTCTGCGACTGGCGGTCAGGTAGAAATGCCGCTCTATATAACAGAAAGTGGCTATTATTTTGAGGATCTTCCTTTATTAGAGGAAGTGGTTGTTGCATCTTATACAACTTATTTCAATCGTGCTGATTTAGGAAGAAATAAAAATATTGAGCTCTCTGCTAGAGCCATTCATAATGTGATTGTAGGCAGTGGCGATTATTTTTCTTTTAATACAATTGTAGGTCCAAGAGATGAGGCAAATGGCTATCAACCCGCACCTGAAATTATTAATAAGAAGGTAGTCATGGGAATTGGTGGTGGAATCTGTCAAACTTCTTCAACCTTGTTTAATGCAGTAGACCAAATTCCCGTCAAATATGTTGAGCGCCATCATCATTCGTTAGATGTAGGATATGTCCCAAAAGGAAGAGATGCTACGGTTTCTTATGATACGTTAGATTTTAGGTTTCAAAACTCAAATGATGTACCATTTTTAATTAAGGCAAATTATGGAGAGAATTCTCTAACAATTGAAATTCGAACGGCAGAAAAATATGTAGAATTATTGAAAAAAACATAA,MTGLVGCEKTAVPDNKLEQEIQQREEIQQPVTYEQEQMIDPIVEVVDPTTSKVLKTISPKEFGFDTDPQAYQKHIEQLAREWARGTDTSNGYDQRMMLDRLDENGQVIKGKPQIILKESELVERIIEASATGGQVEMPLYITESGYYFEDLPLLEEVVVASYTTYFNRADLGRNKNIELSARAIHNVIVGSGDYFSFNTIVGPRDEANGYQPAPEIINKKVVMGIGGGICQTSSTLFNAVDQIPVKYVERHHHSLDVGYVPKGRDATVSYDTLDFRFQNSNDVPFLIKANYGENSLTIEIRTAEKYVELLKKT,MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVLAEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPELLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGMETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGGEFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSHSLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDEPDGYPVKPREWSK,83.91,gnl|BL_ORD_ID|4748|hsp_num:0,2242,FALSE,None
LK716,7_10 # 8120 # 9289 # -1 # ID=7_10;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.383,7_10,8120,9289,-,Strict,175,187.963,vanT gene in vanG cluster,34.9,3002972,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,glycopeptide resistance gene cluster; vanT,ATGTATGTCCTACATAATGTTTTAATTAAAAATAAAGAGGGTATTCTTATGAAGACACAGCAGTTTTTTCGTCCAACAAAAGCAATAATAGACTTACAAGCAATTCAACAAAATGTAAAAAACTTAAAAGAATTTTTACGACCTAATGTTCAAATTATCGCTGTAGTAAAAGCAAATGCGTATGGTCATGGAGATGTAGCCGTTGCACGGGCAGCTCTTAAAGCTGGTGCCACAGTACTTGCAGTGGCAACGCCCGATGAGGCATTACATATTCGAGCACATTTTGAAGAACCAGACATATTAATATTAGGTGCATCTCCAGTTTCGTTTGCTCCTTATGCAGCGCAGCAACGTATTATACTTACGGCATTTGCCGATGATTGGATTCAGCAAGCTGCTTCTCTTTTAGTAGATGAAGCGCTTCCTTTACGACTTCATATAAAAATAGATAGCGGAATGGGTAGAATAGGTATTCGCTCAGAGCAGGAATTATTAGAGCTCTATCAAACAATACAGTCTACAGATCACATGGAGCTGGATGGAATATTTACACACTTTGCGACAGCTGATGAAGAGGATACGCTACATTTTGATCAACAGGTACAATTTTTTGAGAAATGTTTAGCTGTAATACCTAATAAGCCGCGACTTGTTCATGCATCTAATACAGCCGCCTCATTAGTAAAAGATCCGCATTTACAATATGATGCTGTTAGATTTGGTATTTCGATGTATGGATTATCACCCTCTTCATATGTGAAAAGTATATTACCTTTTCCCTTGTTACCAGCGTTCTCGCTTGAAAGTGAACTTGTTCATGTAAAGCAAATAAAATCAGGTGATCCAGTTGGCTATGGAGCTACATATGTTGCTCCGACAGATATGTGGATAGGAACAATTCCAATTGGCTATGCAGATGGCGTGATTCGCAAGTTAGGTGGACAAGAGGTTTTAATTGATGGACAAAGAATGCCGATTGTTGGACGAATTTGTATGGACCAATGTATGGTTGCCCTACCAAAAGCATATGATATAGGTGAGAAGGTAACACTCATTGGTCGACAAGGAAATACTGGAGTATCGATCGATGAATGGGCAACAAAGCTCGAAACAATTAATTATGAAATACCATGCATTATAACAACAAGAGTTCCTAGAACATATCTTTAG,MYVLHNVLIKNKEGILMKTQQFFRPTKAIIDLQAIQQNVKNLKEFLRPNVQIIAVVKANAYGHGDVAVARAALKAGATVLAVATPDEALHIRAHFEEPDILILGASPVSFAPYAAQQRIILTAFADDWIQQAASLLVDEALPLRLHIKIDSGMGRIGIRSEQELLELYQTIQSTDHMELDGIFTHFATADEEDTLHFDQQVQFFEKCLAVIPNKPRLVHASNTAASLVKDPHLQYDAVRFGISMYGLSPSSYVKSILPFPLLPAFSLESELVHVKQIKSGDPVGYGATYVAPTDMWIGTIPIGYADGVIRKLGGQEVLIDGQRMPIVGRICMDQCMVALPKAYDIGEKVTLIGRQGNTGVSIDEWATKLETINYEIPCIITTRVPRTYL,MTKNESYSGIDYFRFIAALLIVAIHTSPLSSFSETGNFIFTRIVARVAVPFFFMTSGFFLISRYTCNAEKLGAFIKKTTLIYGVAILLYIPINVYNGYFKMDNLLPNIIKDIVFDGTLYHLWYLPASIIGAAIAWYLVKKVHYRKAFLIASILYIIGLFGDSYYGIVKSVSCLNVFYNLIFQLTDYTRNGIFFAPIFFVLGGYISDSQNRLSLKRSIVGFIVCFALMFGEALTLHHFDIQKHDSMYVLLLPSVYCLFNLLLHFRGKRRTGLRTISLIIYIIHPFMIVVIRLFAKLLHLQSLLVENSLVHYIAVCFASVVLAVVITALLSSLKPKKAKHTADTDRAYLEINLNNLEHNVNTLQKAMSPKCELMAVVKAEAYGHGMYEVTTYLEQIGVSSFAVATIDEGIRLRKYGISSEILILGYTSPSRAKELCKYELTQTLIDYRYSLLLNKQGYDIKAHIKIDTGMHRLGFSTEDKDKILAAFSLKHIKVAGIFTHLCAADSLEENDVAFTNKQIGSFYKVLDWLKSSGLNIPKVHIQSSYGLLNYPELECDYIRVGVALYGVLSSTNDKTKLELDLRPVLSLKAKVVLIRKIKQGESVGYSRAFTATRDSLIAILPIGYADGFPRNLSCGNSYVLIGGRQAPIVGKICMDQLAVDVTDIPNVKTGSIATLIGKDGKEEITAPMVAESAESITNELLSRMGHRLNIIRRA,54.63,gnl|BL_ORD_ID|1522|hsp_num:0,1561,FALSE,None
LK716,7_26 # 25512 # 26291 # -1 # ID=7_26;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.390,7_26,25512,26291,-,Strict,50,106.301,vanY gene in vanM cluster,44.06,3002961,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,GTGAAAAACAATCGTCTTCCGCTTATCGTTGGTGCTTTCATATCTATCGCGTTAATTGTAGCAATTTTTGTAGTCTATAACTATAAAAATAATCAAGTAAATAGTGCATCTGATGAGCAGCCAAAAACAACAGAAACAAACAAAACAACTGAACAAGATTCTACTGTAACAGAGAAACCAGACAATACTGAAACTCCTGCAAAGCCAGAGCAACAACCAGACGAAAATGGATATCTCCCAAATCAAACATTACCTACGGAACCAACCTATATCAATGGAATTCTGTTAGCTAATAAAATTTATCCGCTTCCATCTACCTTTGCACCTGAAGAAAATCCAGAAGCACGAGAAGCGTTAAATCAAATGTTAGCAGCTGCCAAGCAGCAAGGATTTGATTTAGTTGCATTTAGTGGCTACCGATCTTTTGAATATCAAACAACCCTTTATGATAACTATGTTAAACGTGATGGACAGGCAGCGGCAGATCGATATAGTGCTCGTCCTGGCTACTCAGAACATCAAACAGGCTTAGCGTTTGATATAGGAGAGCGTGGAAAAGAAGATGTGTGGCTGACAGAAGAGTTTGGGGAAACTCCAGCAGGGCAATGGCTATTTGCACATGCACAGGAGTATGGCTTTATTTTGCGTTTCCCTCAAAACAAAGAAGCGATAACAGGTTATATGTATGAGTCATGGCACTATCGTTATGTGGGCAAAGAGATTGCAAAAGAGATAACAAAGAAAAACATTACGTTGGAAGAATATTTAGGCGTAAAATAA,MKNNRLPLIVGAFISIALIVAIFVVYNYKNNQVNSASDEQPKTTETNKTTEQDSTVTEKPDNTETPAKPEQQPDENGYLPNQTLPTEPTYINGILLANKIYPLPSTFAPEENPEAREALNQMLAAAKQQGFDLVAFSGYRSFEYQTTLYDNYVKRDGQAAADRYSARPGYSEHQTGLAFDIGERGKEDVWLTEEFGETPAGQWLFAHAQEYGFILRFPQNKEAITGYMYESWHYRYVGKEIAKEITKKNITLEEYLGVK,MVFQGNLLLVNNEYPVLEESIKTDVVNLFKHDELTKGYELLNREIYLSEKVAREFSEMVDAAEKEGVRHFSINSGFRNFDEQNALYQEMGSDYALPAGYSEHNLGLALDIGSTQMEMSEAPEGKWLEDNAWEYGFILRYPMDKTAITGIQYEPWHFRYVGLPHSAIIEEKNFALEEYLDFLKEQKSISGTIHGENYEISYYPITEKTDIEMPANLHYEISGNNMDGVIVTVYR,111.16,gnl|BL_ORD_ID|1673|hsp_num:0,1713,FALSE,None
LK716,7_129 # 134315 # 134800 # -1 # ID=7_129;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.358,7_129,134315,134800,-,Strict,150,187.578,FosBx1,61.31,3007372,protein homolog model,n/a,n/a,phosphonic acid antibiotic,antibiotic inactivation,fosfomycin thiol transferase,GTGGAAGCAAATAGCCAAGGGAATGAAAAAGGGGAAGAAATAATCAATAGGAGCACAACCATGACAATTCAAAACATCAATCATTTATTGTTTTCAGTTTCTAATTTAGAGGAATCCATCACTTTTTATGAAAAAGTATTCGATGCCAAGTTGCTAGTAAAGGGGAACAGCACAGCCTATTTTGATGTAAATGGACTGTGGCTAGCTCTGAATGTAGAAAAGGATATACCCCGTAATGACATCCATCATTCCTATACACACATTGCCTTCACAATCGCTGAGGATGACTTTGATAAGGTGTATGACAGATTGGTGCAGCTAAAGGTCAATATTTTAGCAGGTCGGCAAAGAGATGAAAAGGATAAAAAATCAATTTACTTTACAGATCCTGATGGTCATAAATTTGAATTTCATACAGGAACTTTGCAGGATCGTTTGGATTATTATAAGCAAGAAAAGCAGCATATGGCGTTTTTTGATAACTAA,MEANSQGNEKGEEIINRSTTMTIQNINHLLFSVSNLEESITFYEKVFDAKLLVKGNSTAYFDVNGLWLALNVEKDIPRNDIHHSYTHIAFTIAEDDFDKVYDRLVQLKVNILAGRQRDEKDKKSIYFTDPDGHKFEFHTGTLQDRLDYYKQEKQHMAFFDN,MLRGINHICFSVSNLENSIMFYEKVLEGELLVKGRKLAYFNICGVWIALNEETHIPRNEIHQSYTHIAFSVEKEDFKCLIQRLEENDVHILQGRERDVRDCESIYFVDPDGHKFEFHSGTLQDRLNYYRDEKPHMTFY,116.67,gnl|BL_ORD_ID|4909|hsp_num:0,5900,FALSE,None
LK716,7_226 # 215669 # 217117 # -1 # ID=7_226;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.367,7_226,215669,217117,-,Strict,600,740.725,msr(G),74.01,3007042,protein homolog model,n/a,n/a,macrolide antibiotic; streptogramin antibiotic,antibiotic target protection,msr-type ABC-F protein,ATGGAAAAGGTTTGCTTTGAGTTAGAGAATGTAGTCGTTACTTATTTAGATAAAGAACTATTAAATATTGAAAAATTAGCTGTGCATCAATTTGACCGAATAGGAATCGTTGGTAAAAATGGTGCAGGTAAAAGTACGTTGATGAAGTTACTTGCTGGCAAGATACAACCAATAAGTGGGAAATTGAAAAGGCATGTTCATTTCGGATACTTTGAACAGATGGAGGCACCAACGTTAATAGAGGCAGATCCACAGTTATTAGGGAAATTAGCAGTACCTACGTATTCTGAAGGATTAAGTGGTGGAGAGCAAACAAGATTAAAGCTAGCACAATTATTTACTTCTTATGAGGAAGCTTTGCTTATTGATGAGCCGACAACACATTTGGATCAACTCGGCATCTCATTTTTATTAGATGAATTACGTTATTATTATGGGGCCCTCATACTCATTAGCCATGATCGTGCTGTACTAGATGAGCTGGTTACAACGATATGGGAGGTAGATGGTGGTAAGGTAACGATCTACTCAGGGAATTACAGCGAGTATGCCATGCAAAAGCAATTAGAGCAAGATCAACAAAATCAGGCTCATGAACAATACTTGAAAGAAAAGAGCAGGCTTGAAAAAGCTGTAGATGAAAAAATGAAAAAAGCTGAAAAAATTGCTCAGGCAGGCAATATGTCTAAAAGAGAGGCTAACGCTAAACCTAATCGTATGTTTATGACAAAGTCCAAAGGCACAAGTCAAAAAGCCGTACAGCGTGCAGCAAAAGCTATCGAACATCGGATAGGGAAGCTTCATAAAGCAGAAGCGGTTCAGGAAGAAAGAAAAATTGTTTTTCGACAATCAAAAGCCTTGGCATTGCATAATAAGTACCCCATTATGGCAGATCGATTCACTTTACATGCTCAAGATAAGGTACTATTACACGAGGTGAGCTTCCAAATCCCGTTAGGTAAAAAAATTGCGCTTAAGGGTAACAATGGTAGTGGTAAAAGTACATTACTAAAACATATAGCCAATAATGGTGAGGGTATAACTATTTCTCCAAAGGCTAAAATAGGTTATTTTCATCAGATGAGCTACCAATTTGCTGGTGAGGAAACAGTGCTACAATTTTTAAAGAATCGCTCTGAATATGATGAAAGTTTATTACGAAGCGTACTTCATTCCATGCAGTTTGCTGGCACTGATTTACAAAAGAAAATTACCACACTTAGTGGTGGTGAGGCCATACGCCTTCAGCTTTGTCAGCTATTTTTAGGAAATTATAATATTTTGCTGTTGGATGAACCAACTAATTTCTTAGATATTCAAGCACTCGAAGCCCTTGAACAATTTATAGCTGCTTATGAGGGAACAATAATCTTTGTCACACATGATAAAAATTTTATCGACAATGTAGCAGATATTCAGTTTACTGTTCATAATAAAAAAATACTTTAA,MEKVCFELENVVVTYLDKELLNIEKLAVHQFDRIGIVGKNGAGKSTLMKLLAGKIQPISGKLKRHVHFGYFEQMEAPTLIEADPQLLGKLAVPTYSEGLSGGEQTRLKLAQLFTSYEEALLIDEPTTHLDQLGISFLLDELRYYYGALILISHDRAVLDELVTTIWEVDGGKVTIYSGNYSEYAMQKQLEQDQQNQAHEQYLKEKSRLEKAVDEKMKKAEKIAQAGNMSKREANAKPNRMFMTKSKGTSQKAVQRAAKAIEHRIGKLHKAEAVQEERKIVFRQSKALALHNKYPIMADRFTLHAQDKVLLHEVSFQIPLGKKIALKGNNGSGKSTLLKHIANNGEGITISPKAKIGYFHQMSYQFAGEETVLQFLKNRSEYDESLLRSVLHSMQFAGTDLQKKITTLSGGEAIRLQLCQLFLGNYNILLLDEPTNFLDIQALEALEQFIAAYEGTIIFVTHDKNFIDNVADIQFTVHNKKIL,MEQICFELENVEVTYLDKEVLKIERLAVHQFDRIGIVGKNGAGKSTLLKLLAGIIKPTTGKVNRLVENGYFEQLETPSVRDADPVLLGKLDVPKDSNQLSGGEQTRMKLAKLFTHYYEALLIDEPTTHLDQEGISFLLDELRYYYGALVLISHDRSVLDELVTTIWEVHEGKVRIYSGNYSDYMAQKKLEREQQSQAHEQFIKEKSRLEKAAQEKMKKAEKVAQAGRLSKKDANAKPDKSFMTKSKGTSQKAMQRAAKAIEQRMEKLQEVDAVKEDRQINFHQSRNLELHNKFPIMADRFTLQVDNKVLLNEVSFQMPLGKKIAISGKNGAGKSTLLHHIAINAPGLTISPKAKIGYFRQMSYQYTRDETVLEFLKNRSEYDERFLRSVLHSMLFVGTDILKSVKSLSGGEAIRLQLCQLFLGEYNILLLDEPTNFLDIYAIEALERFITAYKGTIIFVSHDRRFIDCVADCIYFIEDQQLKLRG,99.38,gnl|BL_ORD_ID|4751|hsp_num:0,5743,FALSE,None
LK716,8_100 # 83435 # 84265 # -1 # ID=8_100;partial=00;start_type=ATG;rbs_motif=AGGAGG;rbs_spacer=5-10bp;gc_cont=0.372,8_100,83435,84265,-,Strict,450,24.6386,ErmO-srmA,100,3001303,protein homolog model,n/a,n/a,macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic,antibiotic target alteration,Erm 23S ribosomal RNA methyltransferase,ATGACGATTGTGGAAGAATGGCACGAACTAAGACAAAAATTTAATCCTTCCAATCCGATAACCATTAATCAAATGCATATTTTTAAAGATCAATTAAAGCAGGTTCAACAAACAGAAGAAACATTAAGGATATTAGTAGAGGTCTACTGTTTACTTAGGATGTATCCTGAGGCATATCAGTTATTTACTGTCATTATGAATAAAGACGATAAAAAGGATCGAAAAAAGTATGGCGTTCTCCAGACCTACATAGATAAACCAAATTCGGTGAATCCTCTGCTGCCAAGAAAAATTAGAGACCATCAGCAGCTTAAAACGAAAATTCCAACGTTTAAATATCTACCAAACCCTCTAGAGGCTGAAATTTTTGAAACAGATGAAATCGTTGTATGTGATTGTTGTGAGCAAGAAGTGGATGTCTATTATACTGGTGGTATTTATGCAATTGAGGAAGTAGATTATCTTTGTCCTTCCTGCATCCATAGTGGGGAAGCAGCTCAAAAATATGATGGTTCTTTCCAGCAAGACTTAATGGATGATGAACAGGTTACGAACCCCAAGTTTGCTGAGGAAGTACTCTTTCGGACGCCTGGCTATGTAAGCTGGCAGGGCAATAATTGGGTGGCACATTGCTCTGACTATTGTGCGTTTATCGGCTATGTTGGTTGGCGTGATTTAGTAGAGCTAGGAATTGAGGATCAATTTGATAATTATACCGGCTTTTCAAAAGAAGAACTTTCTGCATCCTTAATGAACAATGGTCATCATCAAGGCTATTTATTTCAATGCTTGGAATGTGACCGTTATGTCCTTTATTCAGATTTTAGTTAG,MTIVEEWHELRQKFNPSNPITINQMHIFKDQLKQVQQTEETLRILVEVYCLLRMYPEAYQLFTVIMNKDDKKDRKKYGVLQTYIDKPNSVNPLLPRKIRDHQQLKTKIPTFKYLPNPLEAEIFETDEIVVCDCCEQEVDVYYTGGIYAIEEVDYLCPSCIHSGEAAQKYDGSFQQDLMDDEQVTNPKFAEEVLFRTPGYVSWQGNNWVAHCSDYCAFIGYVGWRDLVELGIEDQFDNYTGFSKEELSASLMNNGHHQGYLFQCLECDRYVLYSDFS,MARPTQRARTLSQNFLADRAAAAHVARLTAPDRRHPPLVLEVGAGKGALTEPLARRSRELHAYEIDSRLVPGLRTRFAAAPHVRVVAGDFLAARPPRTPFSVAGNVPFSRTADIVDWCLGAPALTDATLITQLEYARKRTGDYGRWTLLTVRTWPHHEWRLVGRVSRYGFRPAPRVDAGVLRIERRATPLLTGAAQHGWRDLVELGFSGVGGSLHASLRRAHPRRRVDAAFRAARLDPGVLVGEVAPARWLRLHEELAS,106.56,gnl|BL_ORD_ID|1054|hsp_num:0,1045,TRUE,loose hit with at least 95 percent identity pushed strict
LK1118,55_11 # 8672 # 9343 # 1 # ID=55_11;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.726,55_11,8672,9343,+,Strict,50,58.5362,vanY gene in vanB cluster,25.64,3002956,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGAACGACCTCCACACCCCCCGAGCCGTCCGTGCCCGGCGCCGTCGGCGGATCGCCACCACGGCGTCCGTGCTGGCGCTCGCCGTGGTCGCCGCCGTCGCCGTGCAGCAGTCGCTGTCGGCCGCGTTCGCCGAGACCGCCCCGATCGTCACGCCCGCCACCACCGGTTCCGATTCAGAGCCGCACACGCCGACCGGGTCGGTGCTCGCCCCGAGCGAGGCCGACGGCGTGATCCGCGACGGCGATCAGCCCACGGTGTTCGACGTCGACAGGGTCGCCGTCGGCAATCTCGACCCCGCCCTGCTCGACGCCCTCCAGCGCGCCGCCTCCGATGCGGAGGCCGACGGGGTGACGTTCCTCGTGAACAGCGGATGGCGTTCGGCGGCGCTGCAGGAGCAGCTACTCCGCGACGCGATCGACGACTACGGCTCGGAAGAGGAGGCGCGCCGCTGGGTGGCGACCGCGGAGACCTCGGCGCACGTCTCCGGCGACGCCGTCGACCTCGGTCCCCTGCCCACTCTCGACTGGCTCACCCAGCGCGGATGGCGCTACGGCCTCTGCCAGACCTACGGCAACGAGTCCTGGCACTACGAGCTGCGACCGGAGGCCGTCGAGGACGGCTGCCCCGCACAGTACGCCGACCCCACCGAAGACCCGAGGATGCAGCGATGA,MNDLHTPRAVRARRRRRIATTASVLALAVVAAVAVQQSLSAAFAETAPIVTPATTGSDSEPHTPTGSVLAPSEADGVIRDGDQPTVFDVDRVAVGNLDPALLDALQRAASDAEADGVTFLVNSGWRSAALQEQLLRDAIDDYGSEEEARRWVATAETSAHVSGDAVDLGPLPTLDWLTQRGWRYGLCQTYGNESWHYELRPEAVEDGCPAQYADPTEDPRMQR,MEKSNYHSNVNHHKRHMKQSGEKRAFLWAFIISFTVCTLFLGWRLVSVLEATQLPPIPATHTGSGTGVAENPEENTLATAKEQGDEQEWSLILVNRQNPIPAQYDVELEQLSNGERIDIRISPYLQDLFDAARADGVYPIVASGYRTTEKQQEIMDEKVAEYKAKGYTSAQAKAEAETWVAVPGTSEHQLGLAVDINADGIHSTGNEVYRWLDENSYRFGFIRRYPPDKTEITGVSNEPWHYRYVGIEAATKIYHQGLCLEEYLNTEK,83.21,gnl|BL_ORD_ID|602|hsp_num:0,556,FALSE,None
LK1118,68_7 # 8954 # 9907 # 1 # ID=68_7;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.749,68_7,8954,9907,+,Strict,50,83.5741,vanY gene in vanM cluster,35.33,3002961,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGTTCGAATGGAAGAATGGACGCATGCCCTCCTCGCCGTACGCTCAGCATGCGGCGCCGCGCTCCCCGATCCTCGGGCCCGCCCTCCCGGTCGGGCTGGCGGTGACCGCGCTCGGCGTGGTGCTCTCCCTCACCGGGGCGGCCGCGACCCCCGTGGCGTCAGAGCCCCTCCCGCGCCCCGTCGCGGTGATGCAGGTACCGTCGGTGCAGAACGCGGCGACGCCGGCGGCGGACCCTTGCGCCGACCCCGGGGTGCAGGAGGCGATCGCGGCGGGGGACGACGCCGCCACCATCGCGGGGTTCGGCGGCGGAGCGCGCTTCCGTGAGGCGGTGGTCGCCGGGAACGCGCCCTGCGTCTCGCTCAGCGATCCCGCCCGGATCTGGGTGGTGGTCAACAAGGGGCGTCCGCTCGACCCCGCCGCCTACGAGCCCGAGGGGCTGGGCCAGGTGCCGCTGCAGATGACGACGCCGTCGGGCCGCGTGCGCGCGGAGGTCGCCGACGCGGCCGGGCGCATGGCGGAGGCCGCCGAGGCTGCGGGCGTCGGCCGCCTCGGCGCGAACAACGGCTACCGGTCCTATGGGCTGCAGGTCGCGACCTACGGCGCGCACGTGCGGGACCAGGGGCAGGCCGACGCGGACGCCGGCTCGGCGCGACCGGGTCACAGCGAGCATCAGACCGGTCTCGCCCTCGACGTCGTGGCCTGCGATGCCGGGTGCGGCGGTCTCGACGGCTTCGGGGCGACGCGGCAGAGCGAATGGGTGGCCGCGCACGCCTGGGAGTACGGGTTCATCGTGCGCTACGAGCAGGTCGGCACCCCCGTCACCGGATACGCGCCGGAGCCCTGGCACCTGCGCTACGTCGGCACGGAGCTCGCGGCGGCGTATCACGAGGGCGGCTTCCACACCCTCGAGGAGTTCTTCGGCCTGCCCGCCGCTCCCGACTACGAGCACTGA,MFEWKNGRMPSSPYAQHAAPRSPILGPALPVGLAVTALGVVLSLTGAAATPVASEPLPRPVAVMQVPSVQNAATPAADPCADPGVQEAIAAGDDAATIAGFGGGARFREAVVAGNAPCVSLSDPARIWVVVNKGRPLDPAAYEPEGLGQVPLQMTTPSGRVRAEVADAAGRMAEAAEAAGVGRLGANNGYRSYGLQVATYGAHVRDQGQADADAGSARPGHSEHQTGLALDVVACDAGCGGLDGFGATRQSEWVAAHAWEYGFIVRYEQVGTPVTGYAPEPWHLRYVGTELAAAYHEGGFHTLEEFFGLPAAPDYEH,MVFQGNLLLVNNEYPVLEESIKTDVVNLFKHDELTKGYELLNREIYLSEKVAREFSEMVDAAEKEGVRHFSINSGFRNFDEQNALYQEMGSDYALPAGYSEHNLGLALDIGSTQMEMSEAPEGKWLEDNAWEYGFILRYPMDKTAITGIQYEPWHFRYVGLPHSAIIEEKNFALEEYLDFLKEQKSISGTIHGENYEISYYPITEKTDIEMPANLHYEISGNNMDGVIVTVYR,136.05,gnl|BL_ORD_ID|1673|hsp_num:0,1713,FALSE,None
LK630,47_18 # 29535 # 29909 # 1 # ID=47_18;partial=00;start_type=GTG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.672,47_18,29535,29909,+,Strict,200,216.853,Mycobacterium tuberculosis rpsL mutations conferring resistance to Streptomycin,86.18,3003395,protein variant model,K88R,n/a,aminoglycoside antibiotic,antibiotic target alteration,antibiotic-resistant rpsL,GTGCCAACTATCCAGCAGCTGGTGCGCAAGGGGCGGAAGGACAAGTCCTCCGCCTCGAAGACGCCGGCGCTCAAGGGTTCGCCCCAGCGCCGCGGTGTCTGCACGCGCGTCTACACCACCACCCCGAAGAAGCCGAACTCGGCCCTGCGGAAGATCGCCCGTGTGCGTCTGTCCACCGGCATCGAGGTCACCGCATACATCCCGGGTGTGGGCCACAACCTCCAGGAGCACTCGATCGTGCTCGTCCGCGGCGGCCGTGTGAGGGACCTGCCCGGCGTGCGCTACAAGATCGTGCGCGGCTCCCTCGACACCCAGGGTGTCAAGGGCCGTCAGCAGGCCCGTTCCCGCTACGGCGCGAAGAAGGAGAAGAAGTAA,MPTIQQLVRKGRKDKSSASKTPALKGSPQRRGVCTRVYTTTPKKPNSALRKIARVRLSTGIEVTAYIPGVGHNLQEHSIVLVRGGRVRDLPGVRYKIVRGSLDTQGVKGRQQARSRYGAKKEKK,MPTIQQLVRKGRRDKISKVKTAALKGSPQRRGVCTRVYTTTPKKPNSALRKVARVKLTSQVEVTAYIPGEGHNLQEHSMVLVRGGRVKDLPGVRYKIIRGSLDTQGVKNRKQARSRYGAKKEKG,100,gnl|BL_ORD_ID|1956|hsp_num:0,1197,FALSE,None
LK946,11_8 # 6296 # 7945 # -1 # ID=11_8;partial=00;start_type=GTG;rbs_motif=GGxGG;rbs_spacer=5-10bp;gc_cont=0.664,11_8,6296,7945,-,Strict,50,89.7373,vanW gene in vanI cluster,33.92,3003724,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanW; glycopeptide resistance gene cluster,GTGAAGGTCGCCGTCGGCTTCCTCATCGGCCTGATCGTGATCCTGCTGGGGCTGTACCTGGCGGACATCGCGTTCAACCGCGGCAATGTCCCGCGCGGCACCGCCGTCGGCGGAGTCGAGGTCGGCGGGATGGCGCCCGCGGCAGCCGTGGAGAAGCTCGGCAGCGAACTCGGTGACGTCAACGACAAGCCGGTGACCGTCACCGCTGCGGAGGAGAAGACCGAGTTCGTTCCGGCCAGCGCGGGTCTCGGCCCCGACTGGCAGGCAACCGTGGATGCCGCGGGAACAGAATCGTTCAACCCCGTCACCCGGCTGCTGGGGTTGTTCCGCACCAATGAAGTCGACATCGTTTCCACCTCCGACGACTCCGCGCTGGTGCCCACCGTCGAGCGTGTGGCTAAGGACCTGACCGTCGAACCCGCCGACGGCGCCGTCGCCATCGAAGGTGGTGAGCCCAAGGTCACCGACCCCAAGCTGGGCCAGGACATCGACACCGACGAGCTCAAGCGCGCCATGAGCGCCAACTGGCTCAACCCCGCCGGCGTCGAAATCGAGCCGGAGGTCACCGAGCCCGCCATCGGCGAGGACCTCGTCAAGGAAACCGTCGACGGTCCTGTCGCCCGTGCGCTCGACGGTCCACTGACGCTGAAAGGCCAGAAAGAGACTGACGCAGTGATCGACGGTGAGAAGATGGGCGAAGTGGTCACCTTCCGCAACGACCCCAAACAGCGCCGCATCGTGCCCGAGGTCAACACCGAAGCTGCGCAGGGCATCTTCGCCGAGCAGCTCAAAGACACCGTGAAGGAAGGCAAAAACGCCACTATCTCCGCCTCCGGCGAGGTCAGCCCGTCCGTCGACGGCAACGAGATTCGCTGGGAGGAGACCATGAGGGGCTTCGGCGACCGCGTCCTCGGCGACCAGCCCCGCACGTGGGAGGCCCAGTACAAAGAGGTTCCCGCCACCTTCACCACCGAACAAGCGAAGAACGCGACCTTCGACGATGTCGTCGGCGAGTTCACCACCGGCGGTTACAGCTCCGCCTCCGGCACCAACATCTCGATCGTCGCCGACACCGTCAACGGCGCGGTGGTCAGCCCCGGCGAGACCTTCTCCCTTAACGGCTACACCGGTCCCCGAGGCACGGCCCAGGGCTACGTCTCCTCCGGCATCATCATCGACGGCCGCGCCGGCAACGCCGTCGGCGGCGGCATCTCCCAGTTCGCCACCACCCTGTACAACGCCTCCTACTTCGCGGGGATGACAGACGTCGACCACACGCCGCACTCCTACTACATCTCCCGCTACCCGGCCGGCCGCGAAGCCACCGTCTATGAGGGTGCGATTGACCTGGCGTTCAAGAACGACACCCCGCACCCCGTCAAGATCGAAACCAGCTTCGGCGGCGGCGAGATCACCGTCCGGCTCAAGGGTGTCAAGGACCGCGAAGTCGAGTCCATCAACGGTGGGCGCTGGGCCTACACCTCCCCGAGCCCCAAGACGGTCTCCGGCGGCGAATGCATCCCGTCCGGCGGCGCCCAGGGATTCACCACCTCCGACACCCGCATCGTCCGCGACCTGTCCGGCAAGGAAATCTCCCGCGAGACCCAGACCACGGTGTATAACCCGCAGCCGATCGTGCAGTGCGGCTAG,MKVAVGFLIGLIVILLGLYLADIAFNRGNVPRGTAVGGVEVGGMAPAAAVEKLGSELGDVNDKPVTVTAAEEKTEFVPASAGLGPDWQATVDAAGTESFNPVTRLLGLFRTNEVDIVSTSDDSALVPTVERVAKDLTVEPADGAVAIEGGEPKVTDPKLGQDIDTDELKRAMSANWLNPAGVEIEPEVTEPAIGEDLVKETVDGPVARALDGPLTLKGQKETDAVIDGEKMGEVVTFRNDPKQRRIVPEVNTEAAQGIFAEQLKDTVKEGKNATISASGEVSPSVDGNEIRWEETMRGFGDRVLGDQPRTWEAQYKEVPATFTTEQAKNATFDDVVGEFTTGGYSSASGTNISIVADTVNGAVVSPGETFSLNGYTGPRGTAQGYVSSGIIIDGRAGNAVGGGISQFATTLYNASYFAGMTDVDHTPHSYYISRYPAGREATVYEGAIDLAFKNDTPHPVKIETSFGGGEITVRLKGVKDREVESINGGRWAYTSPSPKTVSGGECIPSGGAQGFTTSDTRIVRDLSGKEISRETQTTVYNPQPIVQCG,MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVLAEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPELLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGMETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGGEFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSHSLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDEPDGYPVKPREWSK,147.18,gnl|BL_ORD_ID|4748|hsp_num:0,2242,FALSE,None
LK1393,85_4 # 4113 # 4853 # 1 # ID=85_4;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.791,85_4,4113,4853,+,Strict,50,82.0333,vanY gene in vanM cluster,35.14,3002961,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,GTGCGTCGTCCCCTCCCCCGCGCCGCGCTGGCCGCGCTCGCGCTGCTCGCGGCCGGCTGCGGCACGCCCGCCGCGGGCCCGTCCTCGGCGCCGGCTCCCGGCTCCTCGAGCGCGGCCGCGTCGTCCGGCGCCGCCTCGAGCACGGCGCCGTCGTCGAGCGCGCACGCCGACCCGGCCGCCCTCGACGTCGTCGTGAACAAGACCCGCCCCATGGCCCCGCCCGACTGGGCGCCCTCGGATCTGGTGGCCGTGCCCGGCAGCGAGCTGCCCCTGCGCGCGGAGGCCGCGACGGCGGCCGGCGACCTGCTGGATGCCGCCGCGGCGGCGGGCCACCGCCTCACCACCCTGAGCGCCTACCGCTCGTACGACTACCAGGTCCGGACGTACGGCCACTGGGTCGACGAGCTGGGCCACGCCGAGGCCGACCGCGTCTCGGCGCGTCCGGGGTACTCCGAGCACCAGACCGGCCTGGCCTGGGACGTGGGCGACGCCGCGACCCCCGCGTGTGACCTGGAAGCGTGCTTCGGCGACACCGCCGCGGGCCGCTGGGTGGCCGCGCACGCCGCCGAGTACGGGTTCGTCGTCCGCTACCCCGCCGGGGCCGAGGACGTGACGGGCTTCGCCCACGAGCCGTGGCACCTGCGCTACGTCGGGTCCGCGGAGGCGGCCCGGGTCGAGGCGGCCGGCGGCGTCCTCGAGACCGCGTGGGGCCTGCCTCCGGCGCCGGACTACGCGGACTGA,MRRPLPRAALAALALLAAGCGTPAAGPSSAPAPGSSSAAASSGAASSTAPSSSAHADPAALDVVVNKTRPMAPPDWAPSDLVAVPGSELPLRAEAATAAGDLLDAAAAAGHRLTTLSAYRSYDYQVRTYGHWVDELGHAEADRVSARPGYSEHQTGLAWDVGDAATPACDLEACFGDTAAGRWVAAHAAEYGFVVRYPAGAEDVTGFAHEPWHLRYVGSAEAARVEAAGGVLETAWGLPPAPDYAD,MVFQGNLLLVNNEYPVLEESIKTDVVNLFKHDELTKGYELLNREIYLSEKVAREFSEMVDAAEKEGVRHFSINSGFRNFDEQNALYQEMGSDYALPAGYSEHNLGLALDIGSTQMEMSEAPEGKWLEDNAWEYGFILRYPMDKTAITGIQYEPWHFRYVGLPHSAIIEEKNFALEEYLDFLKEQKSISGTIHGENYEISYYPITEKTDIEMPANLHYEISGNNMDGVIVTVYR,105.58,gnl|BL_ORD_ID|1673|hsp_num:0,1713,FALSE,None
LK1237,12_41 # 51583 # 51837 # 1 # ID=12_41;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.663,12_41,51583,51837,+,Strict,1900,22.3274,MuxC,100,3004075,protein homolog model,n/a,n/a,macrolide antibiotic; monobactam; tetracycline antibiotic; aminocoumarin antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGGCACACAAGAAGGGTGCGAGCTCCACTCGCAACGGCCGTGACTCCAACGCCCAGTACTTGGGTGTGAAGCGCTTCGGCGGCCAGTCCGTTAACGCTGGCGAGATCATCGTCCGCCAGCGCGGCACGCACTTCCACCCGGGCGTGAACGTGGGCCGCGGCAAGGACGACACCTTGTTCGCCCTGGCTGCTGGCGCCGTCGAATTCGGCACCCGCCGCGGTCGCCGCGTGGTCAACATTCAGACCGCCGAGTAA,MAHKKGASSTRNGRDSNAQYLGVKRFGGQSVNAGEIIVRQRGTHFHPGVNVGRGKDDTLFALAAGAVEFGTRRGRRVVNIQTAE,MSLSTPFIRRPVATTLLTLALLLAGTLSFGLLPVAPLPNVDFPAIVVSASLPGASPETMASSVATPLERSLGRIAGISEMTSSSSLGSTTVVLVFDLEKDIDGAAREVQAAINGAMSLLPSGMPNNPSYRKANPSDMPIMVLTLTSETQSRGEMYDLASTVLAPKLSQVQGVGQVSIGGSSLPAVRVDLNPDAMSQYGLSLDSVRTAIAAANSNGPKGAVEKDDKHWQVDANDQLRKAREYEPLVIHYNADNGAAVRLGDVAKVSDSVEDVRNAGFSDDLPAVLLIVTRQPGANIIEATDAIHAQLPVLQELLGPQVKLNVMDDRSPSIRASLEEAELTLLISVALVILVVFLFLRNGRATLIPSLAVPVSLIGTFAVMYLCDFSLNNLSLMALIIATGFVVDDAIVVVENIARRIEEGDPPIQAAITGARQVGFTVLSMTLSLVAVFIPLLLMGGLTGRLFREFAVTLSAAILVSLVVSLTLTPMLCARLLRPLKRPEGASLARRSDRFFAAFMLRYRASLGWALEHSRLMVVIMLACIAMNLWLFVVVPKGFLPQQDSGRLRGYAVADQSISFQSLSAKMGEYRKILSSDPAVENVVGFIGGGRWQSSNTGSFFVTLKPIGERDPVEKVLTRLRERIAKVPGAALYLNAGQDVRLGGRDSNAQYEFTLRSDDLTLLREWAPKVEAAMRKLPQLVDVNSDSQDKGVQTRLVIDRDRAATLGINVEMVDAVLNDSFGQRQVSTIFNPLNQYRVVMEVDQQYQQSPEILRQVQVIGNDGQRVPLSAFSHYEPSRAPLEVNHQGQFAATTLSFNLAPGAQIGPTREAIMQALEPLHIPVDVQTSFEGNAGAVQDTQNQMPWLILLALLAVYIVLGILYESYVHPLTILSTLPSAGVGALLALILCRSELSLIALIGIILLIGIVKKNAIMMIDFALEAERNHGLSPREAILEACMMRFRPIMMTTLAALLGALPLIFGIGGDAALRRPLGITIVGGLIGSQLLTLYTTPVVYLYLDRLRHWVNQKRGVRTDGALETPL,8.11,gnl|BL_ORD_ID|2369|hsp_num:0,2720,TRUE,loose hit with at least 95 percent identity pushed strict
LK1237,41_11 # 11552 # 12532 # -1 # ID=41_11;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.707,41_11,11552,12532,-,Strict,50,107.842,vanY gene in vanA cluster,36.25,3002955,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGAACCGTCATGCGTCGTCCGGCCCTGCTCACCGCCCTGTTGGCCGCGCTGCTGCTCGTGGGCGGCATGGCACCGGCCCACGCCGGGGCGGGGATCGACAACGAGTACCGCGCCCTGCCGAATCCCGGCGCATGGTTGGGCAAGCCCACGTCCGCCGAACGCTGTGGCCTGCGGGACCGCGGCTGCTATCGGCAGTACCAGAAGGGCACGATCCACTGGACGTCCACGACCGGTGCGCGGGCCCAGCGCGGCGGGATCCTGGCGAAGTGGCGCGCGGAGGGTTCCGAGCACGGGGCCCTGGGGTACCCCGTGACGCGTGAGACCTGCACGGGTGGCACGTGCGAGGTCCGCTACCAGCGCGGCCGCATCACCTGGACCGCCCAGGGAGGAGCGCGGGTGCACCGGGACATCGACGATGCCCGCAGCGTGTCCGTGGTCGTGAACAAGAAACGCCCGCTGTCCCCGCGCACCTACGCCCCGGCTCCGTTGCGTTCGGTGGGCGGGGGAGTCCTGCTACGGGACGACGCTGCAGCGGCCTACCAGCGCATGAGCCGTGCCGCGGCCGCACAGGGGGTCACGCTGGTCCCGGTGAGCGGGTACCGCGACTACGACACCCAAGCGCGCCTCTACCGCGAGTACACGGCCCTGTACGGACAGGCCACCGCCGACACCATTTCCGCGCGGGCCGGTCACTCCGAACATCAGACCGGCCTCGCGATCGACGTGGGCGCCCCCGGGGCCACCTGCGGTCTGCTCCCGTGCTTCGGCAACACCCCACAGGGGAAGTGGATCGCCGCGAATGGGCACACCTACGGGTTCGTGGTGCGCTACCCCAACGGGCACACCGCAACCACCGGGTACGCCTACGAACCGTGGCACCTGCGCTACGTGGGCACCGCCACGGCCACGAGTTTGAAGAACAACAAGTCCGCGACGGTGGAGTCCTACATGGGTCTGCCGCGGGCCCCGAAGTACTGA,MRTVMRRPALLTALLAALLLVGGMAPAHAGAGIDNEYRALPNPGAWLGKPTSAERCGLRDRGCYRQYQKGTIHWTSTTGARAQRGGILAKWRAEGSEHGALGYPVTRETCTGGTCEVRYQRGRITWTAQGGARVHRDIDDARSVSVVVNKKRPLSPRTYAPAPLRSVGGGVLLRDDAAAAYQRMSRAAAAQGVTLVPVSGYRDYDTQARLYREYTALYGQATADTISARAGHSEHQTGLAIDVGAPGATCGLLPCFGNTPQGKWIAANGHTYGFVVRYPNGHTATTGYAYEPWHLRYVGTATATSLKNNKSATVESYMGLPRAPKY,MKKLFFLLLLLFLIYLGYDYVNEALFSQEKVEFQNYDQNPKEHLENSGTSENTQEKTITEEQVYQGNLLLINSKYPVRQESVKSDIVNLSKHDELINGYGLLDSNIYMSKEIAQKFSEMVNDAVKGGVSHFIINSGYRDFDEQSVLYQEMGAEYALPAGYSEHNSGLSLDVGSSLTKMERAPEGKWIEENAWKYGFILRYPEDKTELTGIQYEPWHIRYVGLPHSAIMKEKNFVLEEYMDYLKEEKTISVSVNGEKYEIFYYPVTKNTTIHVPTNLRYEISGNNIDGVIVTVFPGSTHTNSRR,107.59,gnl|BL_ORD_ID|4669|hsp_num:0,89,FALSE,None
LK792,63_5 # 3114 # 3863 # -1 # ID=63_5;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.779,63_5,3114,3863,-,Strict,50,83.5741,vanY gene in vanM cluster,34.46,3002961,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGTCGCACCCTCCCTCTCGCCGCGCTGGCCGCGCTCGCGCTGCTCGCGGCCGGTTGCGGCACGCCCGCCGCGGGCCCGTCCTCGACGCCGACGACGCCGACGTCCGGCTCCGCGAGCGCGGCCGCGTCGTCCCGCGCCGCCTCGAGCACGGCGCCGTCGTCGGGCACGCACGCCGACCCGGCCACCCTCGACGTCGTCGTGAACAAGACCCGCCCCGTGGCCCCGCCCGACTGGGCGCCCTCGGATCTGGTGGCCGTGCCCGGCAGCGAGCTGCCCCTGCGGGCGGAGGCCGCGACGGCGGCCGCTGACCTGCTGGATGCCGCCGCGGCGGCGGGCCACCGCCTCACCACCCTGAGCGCCTACCGCTCGTACGACTACCAGGTCCGGACGTACGGCCACTGGGTCGACGAGCTGGGCCGCGCCGAGGCCGACCGCGTCTCCGCGCGTCCGGGGTACTCCGAGCACCAGACCGGCCTGGCCTGGGACGTGGGCGACGCCGCGACCCCCGCGTGTGACCTGGAAGCGTGCTTCGGCGACACCGCCGCGGGCCGTTGGGTGGCCGCGCACGCCGCCGAGTACGGGTTCGTCATCCGCTATCCCGCCGGGGCCGAGGACGTGACGGGCTTCGATCACGAGCCGTGGCACCTGCGCTACGTCGGGTCCGCGGAGGCGGCCCGGGTCGAGGCGGCCGGCGGCGTCCTCGAGACCGCGTGGGGTCTGCCGCCGGCGCCGGACTACGCGGACTGA,MRRTLPLAALAALALLAAGCGTPAAGPSSTPTTPTSGSASAAASSRAASSTAPSSGTHADPATLDVVVNKTRPVAPPDWAPSDLVAVPGSELPLRAEAATAAADLLDAAAAAGHRLTTLSAYRSYDYQVRTYGHWVDELGRAEADRVSARPGYSEHQTGLAWDVGDAATPACDLEACFGDTAAGRWVAAHAAEYGFVIRYPAGAEDVTGFDHEPWHLRYVGSAEAARVEAAGGVLETAWGLPPAPDYAD,MVFQGNLLLVNNEYPVLEESIKTDVVNLFKHDELTKGYELLNREIYLSEKVAREFSEMVDAAEKEGVRHFSINSGFRNFDEQNALYQEMGSDYALPAGYSEHNLGLALDIGSTQMEMSEAPEGKWLEDNAWEYGFILRYPMDKTAITGIQYEPWHFRYVGLPHSAIIEEKNFALEEYLDFLKEQKSISGTIHGENYEISYYPITEKTDIEMPANLHYEISGNNMDGVIVTVYR,106.87,gnl|BL_ORD_ID|1673|hsp_num:0,1713,FALSE,None
LK661,108_5 # 3123 # 3872 # -1 # ID=108_5;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.775,108_5,3123,3872,-,Strict,50,83.1889,vanY gene in vanA cluster,30.14,3002955,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGTCGCACCCTCCCTCTCGCCGCGCTGGCCGCGCTCGCGCTGCTCGTGGCCGGTTGCGGCACGCCCGCCGCGGGCCCGTCCTCGACGCCGACGACGCCGACGTCCGGCTCCGCGAGCGCGGCCGCGTCGTCCGGCGCCGCCTCGAGCACGGCGCCGTCGTCGGGCACGCACGCCGACCCGGCCGCCCTCGACGTCGTCGTGAACAAGACCCGCCCCGTGGCTCCGCCCGACTGGGCGCCCTCGGATCTGGTGGCCGTGCCCGGCAGCGAGCTGCCCCTGCGGGCGGAGGCCGCGACGGCGGCCGGTGACCTGCTGGATGCCGCCGCGGCGGCGGGTCACCGCCTCACCACCCTGAGCGCCTACCGCTCGTACGACTACCAGGTCCGGACGTACGGCCACTGGGTCGACGAGCTGGGCCGCGCCGAGGCCGACCGCGTCTCCGCGCGTCCGGGGTACTCCGAGCATCAGACCGGCCTGGCCTGGGACGTGGGCGACGCCGCGACCCCCGCGTGTGACCTGGAAGCGTGCTTCGGCGACACCGCCGCGGGCCGTTGGGTGGCCGCGCACGCCGCCGAGTACGGGTTCGTCATCCGCTATCCCGCCGGGGCCGAGGACGTGACGGGCTTCGATCACGAGCCGTGGCACCTGCGCTACGTCGGGTCCGCGGAGGCGGCCCGGGTCGAGGCGGCCGGCGGCGTCCTCGAGACCGCGTGGGGTCTGCCGCCGGCGCCGGACTACGCGGACTGA,MRRTLPLAALAALALLVAGCGTPAAGPSSTPTTPTSGSASAAASSGAASSTAPSSGTHADPAALDVVVNKTRPVAPPDWAPSDLVAVPGSELPLRAEAATAAGDLLDAAAAAGHRLTTLSAYRSYDYQVRTYGHWVDELGRAEADRVSARPGYSEHQTGLAWDVGDAATPACDLEACFGDTAAGRWVAAHAAEYGFVIRYPAGAEDVTGFDHEPWHLRYVGSAEAARVEAAGGVLETAWGLPPAPDYAD,MKKLFFLLLLLFLIYLGYDYVNEALFSQEKVEFQNYDQNPKEHLENSGTSENTQEKTITEEQVYQGNLLLINSKYPVRQESVKSDIVNLSKHDELINGYGLLDSNIYMSKEIAQKFSEMVNDAVKGGVSHFIINSGYRDFDEQSVLYQEMGAEYALPAGYSEHNSGLSLDVGSSLTKMERAPEGKWIEENAWKYGFILRYPEDKTELTGIQYEPWHIRYVGLPHSAIMKEKNFVLEEYMDYLKEEKTISVSVNGEKYEIFYYPVTKNTTIHVPTNLRYEISGNNIDGVIVTVFPGSTHTNSRR,82.18,gnl|BL_ORD_ID|4669|hsp_num:0,89,FALSE,None
LK417,2_92 # 95663 # 97063 # 1 # ID=2_92;partial=00;start_type=ATG;rbs_motif=AGGA/GGAG/GAGG;rbs_spacer=11-12bp;gc_cont=0.338,2_92,95663,97063,+,Strict,525,533.487,norC,59.31,3007010,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGGAGTCTTCAAAAGAATTTAAGGGAGATAATCGGTTACTCGTTGGAATTATTATTAGTGTATTAACATTTTGGTTGTTTGCGCAATCGTTACTTAATATTGTGCCCACACTACAATCATCATTTAATACCGATTTGGGTACCATTAATATTGCAGTGAGCTTATCTGCCTTATTTTCTGGTTTGTTTATTGTAGGTGCTGGAGATGTTGCTGATAAATTTGGTCGCGTCAAAATGACTTATTTGGGACTAGGCTTAAATATCATTGGTTCATTATTATTGATTATTACACCAGTTCCATGGTTATTACTGATTGGACGTGCTTTGCAAGGTTTATCAGGTGCATTCATTATGCCATCAACTCTTGCGATAATTAATGAATATTACATAGGAAAAGAAAGACAACGTGCATTAAGTTTTTGGTCTATTGGTTCATGGGGCGGAAGTGGAATATGTTCATTGTTCGGTGGATTTATCGCTTCAACAATAGGATGGCAATGGATTTTTATTATTTCTATTGCTTTGTCGATACTTTCATTTTTCTTAATTAAACACACGCCAGAAACAAAAAATGAACCAGATACTGATACAGACAATAGCGGTTCAAAATTTGATGTTATAGGTTTGATTTTATTAGTTATTACATTATTAAGTGTCAATGTGATGGTAACACAAGCATCTGATCGTGGATTATTATCACCTGTCATTCTATCATTATTTGGAATATTTTTAATTGCTGGTATATTCTTTGTCCTTCGTGAATTTAAAACTGAGAACCCACTTGTTGATTTTAGTTTATTTAAGAATAAAGGATATAGTGGTGCTACACTTTCAAACTTCATGTTAAATGGAGTAGCAGGTGGTACGCTCATCGTAGTAAATACATACTACCAAAGTCATTTAGGTTTCACTTCATTACAAGCAGGATTAATCTCTATCACTTATTTAGTAGCAGTTCTTGTAATGATTCGTGTAGGTGAAAAACTATTACAAAAATTAGGTGCTAAAAAGCCATTGCTCATAGGTAGTGGATTTACATTTTTAGGGTTACTACTTTTATCACTAACCTTCTTACCTAATTTGTTTTATATTATTTCAAGTATTATTGGTTATCTATTATTTGGTATTGGGCTCGGTATGTATGCAACACCATCTACAGATACAGCAGTTGATCAAGCGCCAGATGATAAAGTGGGGGTTGCCTCTGGATTGTATAAAATGGCTTCATCATTAGGAAATGCATTTGGTGTAGCTTTATCAAGTACGATTTATGGTGTTTGTGCAGCGAAAATGAATTTAGAACTTGGAGGTTTGGCGGGCGTACTCTTTAATGCCATCATCGTTTTAACTGCTTTCTTTGTCATTTTCTTCTTAATTCCAAGTAAAACTAAACGTGCTTAA,MESSKEFKGDNRLLVGIIISVLTFWLFAQSLLNIVPTLQSSFNTDLGTINIAVSLSALFSGLFIVGAGDVADKFGRVKMTYLGLGLNIIGSLLLIITPVPWLLLIGRALQGLSGAFIMPSTLAIINEYYIGKERQRALSFWSIGSWGGSGICSLFGGFIASTIGWQWIFIISIALSILSFFLIKHTPETKNEPDTDTDNSGSKFDVIGLILLVITLLSVNVMVTQASDRGLLSPVILSLFGIFLIAGIFFVLREFKTENPLVDFSLFKNKGYSGATLSNFMLNGVAGGTLIVVNTYYQSHLGFTSLQAGLISITYLVAVLVMIRVGEKLLQKLGAKKPLLIGSGFTFLGLLLLSLTFLPNLFYIISSIIGYLLFGIGLGMYATPSTDTAVDQAPDDKVGVASGLYKMASSLGNAFGVALSSTIYGVCAAKMNLELGGLAGVLFNAIIVLTAFFVIFFLIPSKTKRA,MNETYRGGNKLILGIVLGVITFWLFAQSLVNVVPNLQQSFGADMGTISIAVSLTALFSGMFVVGAGGLADKIGRVKMTNIGLLLSIIGSALIIITNLPALLILGRIIQGVSAACIMPSTLAIMKTYYEGAERQRALSYWSIGSWGGSGICSLFGGAVATTMGWRWIFIFSIIVAVLSMLLIKGTPETKSEVTNTHKFDVAGLIVLVVMLLSLNVVITKGAALGYTSLWFFGLIAIVIVAFFIFLNVEKKVDNPLIDFKLFENKPYTGATISNFLLNGVAGTLIVANTFVQQGLGYTALQAGYLSITYLIMVLLMIRVGEKLLQKMGSKRPMLLGTFIVIIGIALISLVFLPGIFYVISCVVGYLCFGLGLGIYATPSTDTAISNAPLDKVGVASGIYKMASSLGGAFGVAISGAVYAGAVAATSIHTGAMIALWVNVLMGIMAFIAILFAIPNDDKRVKDAK,100.87,gnl|BL_ORD_ID|4656|hsp_num:0,5726,FALSE,None
LK417,2_320 # 314093 # 315433 # 1 # ID=2_320;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.291,2_320,314093,315433,+,Strict,200,581.637,sdrM,68.39,3007013,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGAAATTAAAATCAATAGGTATTGTAGTGACTTTGGTTTTAACAATGTTTATGGCAGCAATTGAAAGTTCAATTATTTCACTAGCATTGCCTACCATTCGTAAAGATTTGAATGCTGGTACAGCAGTGCCATTAGTCTTTACCGTTTATTTTATAGCACTTGTTGTAGCAAATCCTATTGTGGGTGAACTTCTCACAAGATTTAAGATTCTATATATAGCTGTAGTCGGCATACTATTATTTGGTATTGGAAGTTTTATGTCAGGTATGAGTGAAACGTTTACAATGTTAATTATTTCAAGAGTCATACAGGGACTTGGCGCAGGAGTTATGATGTCTTTGACTCAAATTGTACCAAAACTAGCATTTGAAATTCCGCTTCGTTACAAAATAATGGGCATCGTTGGAAGTGTCTGGGGAATTTCAAGTATTCTTGGACCGTTATTAGGTGGTGGAATATTAGAAGTTGCAACATGGCATTGGTTGTTTTATATCAACATACCCATAGCATTGATAGCTATTGTTTTAGCTTTTCTTACTTTTCATTTTCCAGAAGAAGCGGAAGTACAACACATACACTTTGATGCAAAAGGATTATCTTTGTTTTATATATTTATCGGACTTCTTATGTTTAGTTTATTAAATAAAACAGGTGTTACTTTTAATATTATTGCATTTATACTAGCAATAGTTATATTATTCGTTTTATTCAAATATGAAAATAAAAAAAATATGCCTTTTTTACCAATAAGTGAATTTAATAAATCAATTTCACTGGTATTTATAACTGATTTACTTATAGCAATATGTCTAATGGGGTATAACTTATATATACCTGTTTATTTACAAGATTATTTAAAATTATCTCCAATACAAAGTGGATTAGTTATATTTCCACTTTCTGTTGCATGGTTAGCTTTAAACTTCAATTTAGCTAAGGTAGAATCAAAATTTTCAAGAAAAAAATTATATATCGGAGCTTTCATATCATTAATTTTAAGTAATATGATTTTAGTATTTGGACTTCATATTCCTCTTATTATTGCGGGAGCTGTGATTCTTGCAGGATTGAGTTTTGGTTTCGTTTATACTAAAGACAGTGTAATTGTGCAAGAAGAAACAAGTCCTAAATATATGAAAAAAATGATGTCATTCTATGCATTAACTAAAAATTTAGGATCATCTATAGGATCTACATTGATGGGGTCATTATATGCACTTCAATTTGGTTTATTAGGAGGTAACTTTTATAATATATTAACTGTAATCACAATTGTTGCGCTTATATTAATTTTAATGTGGGTATTTTTATTTAAAGAGAATAAAGAAAGTATAAAATAA,MKLKSIGIVVTLVLTMFMAAIESSIISLALPTIRKDLNAGTAVPLVFTVYFIALVVANPIVGELLTRFKILYIAVVGILLFGIGSFMSGMSETFTMLIISRVIQGLGAGVMMSLTQIVPKLAFEIPLRYKIMGIVGSVWGISSILGPLLGGGILEVATWHWLFYINIPIALIAIVLAFLTFHFPEEAEVQHIHFDAKGLSLFYIFIGLLMFSLLNKTGVTFNIIAFILAIVILFVLFKYENKKNMPFLPISEFNKSISLVFITDLLIAICLMGYNLYIPVYLQDYLKLSPIQSGLVIFPLSVAWLALNFNLAKVESKFSRKKLYIGAFISLILSNMILVFGLHIPLIIAGAVILAGLSFGFVYTKDSVIVQEETSPKYMKKMMSFYALTKNLGSSIGSTLMGSLYALQFGLLGGNFYNILTVITIVALILILMWVFLFKENKESIK,MRLKSIITVIALILIMFMSAIESSIISLALPTIKQDLNAGNLISLIFTAYFIALVIANPIVGELLSRFKIIYVAIAGLLLFSIGSFMCGLSTNFTMLIISRVIQGFGSGVLMSLSQIVPKLAFEIPLRYKIMGIVGSVWGISSIIGPLLGGGILEFATWHWLFYINIPIAIIAIILVIWTFHFPEEETVAKSKFDTKGLTLFYVFIGLIMFALLNQQLLLLNFLSFILAIVVAMCLFKVEKHVSSPFLPVVEFNRSITLVFITDLLTAICLMGFNLYIPVYLQEQLGLSPLQSGLVIFPLSVAWITLNFNLHRIEAKLSRKVIYLLSFTLLLVSSIIISFGIKLPVLIAFVLILAGLSFGYIYTKDSVIVQEETSPLQMKKMMSFYGLTKNLGASIGSTIMGYLYAIQSGIFGPNLHNVLSAVAVISIGLIVLWVVFFKEQSSQSKE,99.78,gnl|BL_ORD_ID|4661|hsp_num:0,5729,FALSE,None
LK417,2_321 # 315457 # 315978 # 1 # ID=2_321;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.238,2_321,315457,315978,+,Strict,100,210.305,sepA,62.58,3007012,protein homolog model,n/a,n/a,disinfecting agents and antiseptics,antibiotic efflux,small multidrug resistance (SMR) antibiotic efflux pump,ATGATAAAGTATCATTATAAAGTATTATTGATGAAAAGAGGAGGAAAGAGAGGAATGAAATTTTCTAATCAAAAATTTAACGGTATCTTTCCGGCTCTTCTTATTCTTATTATTTTTATTCTATCAGGTTGTATATTTTTAATATTTTTAGGATTTGGGTTATTTGGATTAAGTCGAATTCTTATTTTTTTAAAATTAGGATTTTTTACATACAATAGGGATTTATTCAGCAATTTAGTATATTACGGTAGCTATATAGTATTTGGATACTTTTTGCTATTTGCTATTGAGCATTTAATGGATTACTTTAGAAAACAATTACCTAATAATCCATATTTTAATGGAACACTATTTCATTTAATTTCATATGTAATTACGACTATCCTATTCTATTTTGTTATTCATATTCATTACGTATATATTAAAATTGAATTTTGGGTTATTGCATTAATTATTGGAATACTATATTTATGTAAAATGATTTTTTATCCAGATAGCGAAGACTTGAATGATAAGAAGTAG,MIKYHYKVLLMKRGGKRGMKFSNQKFNGIFPALLILIIFILSGCIFLIFLGFGLFGLSRILIFLKLGFFTYNRDLFSNLVYYGSYIVFGYFLLFAIEHLMDYFRKQLPNNPYFNGTLFHLISYVITTILFYFVIHIHYVYIKIEFWVIALIIGILYLCKMIFYPDSEDLNDKK,MIVNFFKHKFYNLLTTMIVLFVFVLSGAIFLTFLGFGLYGLSRILIYFRLGDFTYNRNMYDNLLYYGSYIIFGYFIIFAVEHLMDYFRKMLPENAYFRGATFHLISYTVATTLFYFIIHLHYVYINIDFWVIMVIIGFLYVCKLQFYPESKNLNNRK,110.19,gnl|BL_ORD_ID|4660|hsp_num:0,5728,FALSE,None
LK417,4_40 # 35735 # 36415 # 1 # ID=4_40;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.332,4_40,35735,36415,+,Strict,50,110.923,vanY gene in vanB cluster,31.4,3002956,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGAAAAAATTCTCTGCAATCTTAATAACAAGCGCTTTATTACTTTCAGCTTGCTCACATAGTAATGATAATAATGGTAAAAATGAAAATAATACTAAACAAACATCTCAACCTAATAAAAGTGATGACAAGCAACAAAGACATACAAAAGTCATTAAAAACGGTCGTACGTATGTCGATGGTGTCTTAATTGTAAACAAAGATATCGGTCTTCCTTCAAATTATAATCCTGGTGAAGATCCAAAAGCCCAACAAGCTTTACAACAATTATTTAGTGCTGCACAAAAAGATGGCATTCAATTATACAAAATGAGTGGTTACAGAAGTTATCCTACTCAAGTACAACTATACAATCGCTACGTTGCACGTGATGGTAAAAAAGCTGCAGATAAGTATAGCGCACGTCCTGGCTACTCAGAACATCAAACAGGTCTTACATTTGACATCGGTGGCGTTAATTCAGATAAAAACTTATATGCAAGTTTCGGAAAAACAAAAGAAGGTCAATGGATTGCGAAAAACGCACATAAATACGGCTTTATTGTGAGATATCCTAAAGGAAAAGAAAAAATTACTGGTTATCAATACGAACCATGGCATTTACGTTATTTAGGAAAAGATACTGCAACCAAAGTATATCAATCTGGTAAAACATTAGAAGAATATGTAGGATTAAAATAA,MKKFSAILITSALLLSACSHSNDNNGKNENNTKQTSQPNKSDDKQQRHTKVIKNGRTYVDGVLIVNKDIGLPSNYNPGEDPKAQQALQQLFSAAQKDGIQLYKMSGYRSYPTQVQLYNRYVARDGKKAADKYSARPGYSEHQTGLTFDIGGVNSDKNLYASFGKTKEGQWIAKNAHKYGFIVRYPKGKEKITGYQYEPWHLRYLGKDTATKVYQSGKTLEEYVGLK,MEKSNYHSNVNHHKRHMKQSGEKRAFLWAFIISFTVCTLFLGWRLVSVLEATQLPPIPATHTGSGTGVAENPEENTLATAKEQGDEQEWSLILVNRQNPIPAQYDVELEQLSNGERIDIRISPYLQDLFDAARADGVYPIVASGYRTTEKQQEIMDEKVAEYKAKGYTSAQAKAEAETWVAVPGTSEHQLGLAVDINADGIHSTGNEVYRWLDENSYRFGFIRRYPPDKTEITGVSNEPWHYRYVGIEAATKIYHQGLCLEEYLNTEK,84.33,gnl|BL_ORD_ID|602|hsp_num:0,556,FALSE,None
LK417,11_22 # 20249 # 20620 # -1 # ID=11_22;partial=00;start_type=ATG;rbs_motif=TAA;rbs_spacer=4bp;gc_cont=0.258,11_22,20249,20620,-,Perfect,200,244.973,mecI,100,3000124,protein homolog model,n/a,n/a,penam,antibiotic target replacement,methicillin resistant PBP2,ATGGATAATAAAACGTATGAAATATCATCTGCAGAATGGGAAGTTATGAATATCATTTGGATGAAAAAATATGCAAGTGCGAATAATATAATAGAAGAAATACAAATGCAAAAGGACTGGAGTCCAAAAACCATTCGTACACTTATAACGAGATTGTATAAAAAGGGATTTATAGATCGTAAAAAAGACAATAAAATTTTTCAATATTACTCTCTTGTAGAAGAAAGTGATATAAAATATAAAACATCTAAAAACTTTATCAATAAAGTATACAAAGGCGGTTTCAATTCACTTGTCTTAAACTTTGTAGAAAAAGAAGATCTATCACAAGATGAAATAGAAGAATTGAGAAATATATTGAATAAAAAATAA,MDNKTYEISSAEWEVMNIIWMKKYASANNIIEEIQMQKDWSPKTIRTLITRLYKKGFIDRKKDNKIFQYYSLVEESDIKYKTSKNFINKVYKGGFNSLVLNFVEKEDLSQDEIEELRNILNKK,MDNKTYEISSAEWEVMNIIWMKKYASANNIIEEIQMQKDWSPKTIRTLITRLYKKGFIDRKKDNKIFQYYSLVEESDIKYKTSKNFINKVYKGGFNSLVLNFVEKEDLSQDEIEELRNILNKK,100,gnl|BL_ORD_ID|855|hsp_num:0,948,FALSE,None
LK417,11_23 # 20620 # 22275 # -1 # ID=11_23;partial=00;start_type=ATG;rbs_motif=AAAA;rbs_spacer=4bp;gc_cont=0.290,11_23,20620,22378,-,Perfect,1100,1137.87,mecR1,100,3000215,protein homolog model,n/a,n/a,penam,antibiotic target replacement,methicillin resistant PBP2,GTGTTATCATCTTTTTTAATGTTAAGTATAATCAGTTCATTGCTCACGATATGTGTAATTTTTTTAGTGAGAATGCTCTATATAAAATATACTCAAAATATTATGTCACATAAGATTTGGTTATTAGTGCTCGTCTCCACGTTAATTCCATTAATACCATTTTACAAAATATCGAATTTTACATTTTCAAAAGATATGATGAATCGAAATGTATCTGACACGACTTCTTCGGTTAGTCATATGTTAGATGGTCAACAATCATCTGTTACGAAAGACTTAGCAATTAATGTTAATCAGTTTGAGACCTCAAATATAACGTATATGATTCTTTTGATATGGGTATTTGGTAGTTTGTTGTGCTTATTTTATATGATTAAGGCATTCCGACAAATTGATGTTATTAAAAGTTCGTCATTGGAATCGTCATATCTTAATGAACGACTTAAAGTATGTCAAAGTAAGATGCAGTTCTACAAAAAGCATATAACAATTAGTTATAGTTCAAACATTGATAATCCGATGGTATTTGGTTTAGTGAAATCCCAAATTGTACTACCAACTGTCGTAGTCGAAACCATGAATGACAAAGAAATTGAATATATTATTCTACATGAACTATCACATGTGAAAAGTCATGACTTAATATTCAACCAGCTTTATGTTGTTTTTAAAATGATATTCTGGTTTAATCCTGCACTATATATAAGTAAAACAATGATGGACAATGACTGTGAAAAAGTATGTGATAGAAACGTTTTAAAAATTTTGAATCGCCATGAACATATACGTTATGGTGAATCGATATTAAAATGCTCTATTTTAAAATCTCAGCACATAAATAATGTGGCAGCACAATATTTACTAGGTTTTAATTCAAATATTAAAGAACGTGTTAAGTATATTGCACTTTATGATTCAATGCCTAAACCTAATCGAAACAAGCGTATTGTTGCGTATATTGTATGTAGTATATCGCTTTTAATACAAGCACCGTTACTATCTGCACATGTTCAACAAGACAAATATGAAACAAATGTATCATATAAAAAATTAAATCAACTAGCTCCGTATTTCAAAGGATTTGATGGAAGTTTTGTGCTTTATAATGAACGGGAGCAAGCTTATTCTATTTATAATGAACCAGAAAGTAAACAACGATATTCACCTAATTCTACTTACAAAATTTATTTAGCGTTAATGGCATTCGACCAAAATTTACTCTCATTAAATCATACTGAACAACAATGGGATAAACATCAATATCCATTTAAAGAATGGAACCAAGATCAAAATTTAAATTCTTCAATGAAATATTCAGTAAATTGGTATTACGAAAATTTAAACAAACATTTAAGACAAGATGAGGTTAAATCTTATTTAGATCTAATTGAATATGGTAATGAAGAAATATCAGGGAATGAAAATTATTGGAATGAATCTTCATTAAAAATTTCTGCAATAGAACAGGTTAATTTGTTGAAAAATATGAAACAACATAACATGCATTTTGATAATAAGGCTATTGAAAAAGTTGAAAATAGTATGACTTTGAAACAAAAAGATACTTATAAATATGTAGGTAAAACTGGAACAGGAATCGTGAATCACAAAGAAGCAAATGGATGGTTCGTAGGTTATGTTGAAACGAAAGATAATACGTATTATTTTGCTACACATTTAAAAGGCGAAGACAATGCGAATGGCGAAAAAGCACAACAAATTTCTGAGCGTATTTTAAAAGAAATGGAGTTAATATAA,MLSSFLMLSIISSLLTICVIFLVRMLYIKYTQNIMSHKIWLLVLVSTLIPLIPFYKISNFTFSKDMMNRNVSDTTSSVSHMLDGQQSSVTKDLAINVNQFETSNITYMILLIWVFGSLLCLFYMIKAFRQIDVIKSSSLESSYLNERLKVCQSKMQFYKKHITISYSSNIDNPMVFGLVKSQIVLPTVVVETMNDKEIEYIILHELSHVKSHDLIFNQLYVVFKMIFWFNPALYISKTMMDNDCEKVCDRNVLKILNRHEHIRYGESILKCSILKSQHINNVAAQYLLGFNSNIKERVKYIALYDSMPKPNRNKRIVAYIVCSISLLIQAPLLSAHVQQDKYETNVSYKKLNQLAPYFKGFDGSFVLYNEREQAYSIYNEPESKQRYSPNSTYKIYLALMAFDQNLLSLNHTEQQWDKHQYPFKEWNQDQNLNSSMKYSVNWYYENLNKHLRQDEVKSYLDLIEYGNEEISGNENYWNESSLKISAIEQVNLLKNMKQHNMHFDNKAIEKVENSMTLKQKDTYKYVGKTGTGIVNHKEANGWFVGYVETKDNTYYFATHLKGEDNANGEKAQQISERILKEMELI,MLSSFLMLSIISSLLTICVIFLVRMLYIKYTQNIMSHKIWLLVLVSTLIPLIPFYKISNFTFSKDMMNRNVSDTTSSVSHMLDGQQSSVTKDLAINVNQFETSNITYMILLIWVFGSLLCLFYMIKAFRQIDVIKSSSLESSYLNERLKVCQSKMQFYKKHITISYSSNIDNPMVFGLVKSQIVLPTVVVETMNDKEIEYIILHELSHVKSHDLIFNQLYVVFKMIFWFNPALYISKTMMDNDCEKVCDRNVLKILNRHEHIRYGESILKCSILKSQHINNVAAQYLLGFNSNIKERVKYIALYDSMPKPNRNKRIVAYIVCSISLLIQAPLLSAHVQQDKYETNVSYKKLNQLAPYFKGFDGSFVLYNEREQAYSIYNEPESKQRYSPNSTYKIYLALMAFDQNLLSLNHTEQQWDKHQYPFKEWNQDQNLNSSMKYSVNWYYENLNKHLRQDEVKSYLDLIEYGNEEISGNENYWNESSLKISAIEQVNLLKNMKQHNMHFDNKAIEKVENSMTLKQKDTYKYVGKTGTGIVNHKEANGWFVGYVETKDNTYYFATHLKGEDNANGEKAQQISERILKEMELI,94.19,gnl|BL_ORD_ID|586|hsp_num:0,645,TRUE,"possible complete gene, missing n-terminus"
LK417,11_24 # 22477 # 24483 # 1 # ID=11_24;partial=00;start_type=ATG;rbs_motif=TATAA;rbs_spacer=11bp;gc_cont=0.306,11_24,22477,24483,+,Strict,1250,1339.32,mecA,99.7,3000617,protein homolog model,n/a,n/a,penam,antibiotic target replacement,methicillin resistant PBP2,ATGAAAAAGATAAAAATTGTTCCACTTATTTTAATAGTTGTAGTTGTCGGGTTTGGTATATATTTTTATGCTTCAAAAGATAAAGAAATTAATAATACTATTGATGCAATTGAAGATAAAAATTTCAAACAAGTTTATAAAGATAGCAGTTATATTTCTAAAAGCGATAATGGTGAAGTAGAAATGACTGAACGTCCGATAAAAATATATAATAGTTTAGGCGTTAAAGATATAAACATTCAGGATCGTAAAATAAAAAAAGTATCTAAAAATAAAAAACGAGTAGATGCTCAATATAAAATTAAAACAAACTACGGTAACATTGATCGCAACGTTCAATTTAATTTTGTTAAAGAAGATGGTATGTGGAAGTTAGATTGGGATCATAGCGTCATTATTCCAGGAATGCAGAAAGACCAAAGCATACATATTGAAAATTTAAAATCAGAACGTGGTAAAATTTTAGACCGAAACAATGTGGAATTGGCCAATACAGGAACAGCATATGAGATAGGCATCGTTCCAAAGAATGTATCTAAAAAAGATTATAAAGCAATCGCTAAAGAACTAAGTATTTCTGAAGACTATATCAAACAACAAATGGATCAAAATTGGGTACAAGATGATACCTTCGTTCCACTTAAAACCGTTAAAAAAATGGATGAATATTTAAGTGATTTCGCAAAAAAATTTCATCTTACAACTAATGAAACAGAAAGTCGTAACTATCCTCTAGGAAAAGCGACTTCACATCTATTAGGTTATGTTGGTCCCATTAACTCTGAAGAATTAAAACAAAAAGAATATAAAGGCTATAAAGATGATGCAGTTATTGGTAAAAAGGGACTCGAAAAACTTTACGATAAAAAGCTCCAACATGAAGATGGCTATCGTGTCACAATCGTTGACGATAATAGCAATACAATCGCACATACATTAATAGAGAAAAAGAAAAAAGATGGCAAAGATATTCAACTAACTATTGATGCTAAAGTTCAAAAGAGTATTTATAACAACATGAAAAATGATTATGGCTCAGGTACTGCTATCCACCCTCAAACAGGTGAATTATTAGCACTTGTAAGCACACCTTCATATGACGTCTATCCATTTATGTATGGCATGAGTAACGAAGAATATAATAAATTAACCGAAGATAAAAAAGAACCTCTGCTCAACAAGTTCCAGATTACAACTTCACCAGGTTCAACTCAAAAAATATTAACAGCAATGATTGGGTTAAATAACAAAACATTAGACGATAAAACAAGTTATAAAATCGATGGTAAAGGTTGGCAAAAAGATAAATCTTGGGGTGGTTACAACGTTACAAGATATGAAGTGGTAAATGGTAATATCGACTTAAAACAAGCAATAGAATCATCAGATAACATTTTCTTTGCTAGAGTAGCACTCGAATTAGGCAGTAAGAAATTTGAAAAAGGCATGAAAAAACTAGGTGTTGGTGAAGATATACCAAGTGATTATCCATTTTATAATGCTCAAATTTCAAACAAAAATTTAGATAATGAAATATTATTAGCTGATTCAGGTTACGGACAAGGTGAAATACTGATTAACCCAGTACAGATCCTTTCAATCTATAGCGCATTAGAAAATAATGGCAATATTAACGCACCTCACTTATTAAAAGACACGAAAAACAAAGTTTGGAAGAAAAATATTATTTCCAAAGAAAATATCAATCTATTAACTGATGGTATGCAACAAGTCGTAAATAAAACACATAAAGAAGATATTTATAGATCTTATGCAAACTTAATTGGCAAATCCGGTACTGCAGAACTCAAAATGAAACAAGGAGAAACTGGCAGACAAATTGGGTGGTTTATATCATATGATAAAGATAATCCAAACATGATGATGGCTATTAATGTTAAAGATGTACAAGATAAAGGAATGGCTAGCTACAATGCCAAAATCTCAGGTAAAGTGTATGATGAGCTATATGAGAACGGTAATAAAAAATACGATATAGATGAATAA,MKKIKIVPLILIVVVVGFGIYFYASKDKEINNTIDAIEDKNFKQVYKDSSYISKSDNGEVEMTERPIKIYNSLGVKDINIQDRKIKKVSKNKKRVDAQYKIKTNYGNIDRNVQFNFVKEDGMWKLDWDHSVIIPGMQKDQSIHIENLKSERGKILDRNNVELANTGTAYEIGIVPKNVSKKDYKAIAKELSISEDYIKQQMDQNWVQDDTFVPLKTVKKMDEYLSDFAKKFHLTTNETESRNYPLGKATSHLLGYVGPINSEELKQKEYKGYKDDAVIGKKGLEKLYDKKLQHEDGYRVTIVDDNSNTIAHTLIEKKKKDGKDIQLTIDAKVQKSIYNNMKNDYGSGTAIHPQTGELLALVSTPSYDVYPFMYGMSNEEYNKLTEDKKEPLLNKFQITTSPGSTQKILTAMIGLNNKTLDDKTSYKIDGKGWQKDKSWGGYNVTRYEVVNGNIDLKQAIESSDNIFFARVALELGSKKFEKGMKKLGVGEDIPSDYPFYNAQISNKNLDNEILLADSGYGQGEILINPVQILSIYSALENNGNINAPHLLKDTKNKVWKKNIISKENINLLTDGMQQVVNKTHKEDIYRSYANLIGKSGTAELKMKQGETGRQIGWFISYDKDNPNMMMAINVKDVQDKGMASYNAKISGKVYDELYENGNKKYDIDE,MKKIKIVPLILIVVVVGFGIYFYASKDKEINNTIDAIEDKNFKQVYKDSSYISKSDNGEVEMTERPIKIYNSLGVKDINIQDRKIKKVSKNKKRVDAQYKIKTNYGNIDRNVQFNFVKEDGMWKLDWDHSVIIPGMQKDQSIHIENLKSERGKILDRNNVELANTGTAYEIGIVPKNVSKKDYKAIAKELSISEDYIKQQMDQNWVQDDTFVPLKTVKKMDEYLSDFAKKFHLTTNETKSRNYPLEKATSHLLGYVGPINSEELKQKEYKGYKDDAVIGKKGLEKLYDKKLQHEDGYRVTIVDDNSNTIAHTLIEKKKKDGKDIQLTIDAKVQKSIYNNMKNDYGSGTAIHPQTGELLALVSTPSYDVYPFMYGMSNEEYNKLTEDKKEPLLNKFQITTSPGSTQKILTAMIGLNNKTLDDKTSYKIDGKGWQKDKSWGGYNVTRYEVVNGNIDLKQAIESSDNIFFARVALELGSKKFEKGMKKLGVGEDIPSDYPFYNAQISNKNLDNEILLADSGYGQGEILINPVQILSIYSALENNGNINAPHLLKDTKNKVWKKNIISKENINLLTDGMQQVVNKTHKEDIYRSYANLIGKSGTAELKMKQGETGRQIGWFISYDKDNPNMMMAINVKDVQDKGMASYNAKISGKVYDELYENGNKKYDIDE,100,gnl|BL_ORD_ID|1216|hsp_num:0,1321,FALSE,None
LK417,12_24 # 18553 # 19452 # -1 # ID=12_24;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.368,12_24,18553,19452,-,Strict,500,616.305,mphC,98.66,3000319,protein homolog model,n/a,n/a,macrolide antibiotic,antibiotic inactivation,macrolide phosphotransferase (MPH),ATGACTCGACATAATGAAATTATTAAATGTGCAGAAAAATATCAATTACACATCCAACCTCAAACAATCTCATTGAATGAATCGGGACTTGATTTTCAAGTTGCATTTGGAAAAGATAAACATGGAGTAGAATGGGTTTTGAGACTACCAAGAAGACCTGACGTTTATAAACGAACAAAACCCGAAAAACAAACGGTAGACTTCTTACAGAAGAATGTTTCATTTGAAATACCGAAGTGGAAAGTACATGCAAAAGACCTTATTGCTTACCCAAAACTTACAGGTAAACCCGCAGCCACAATAGATCCAGAAATACAAAATTATGTATGGGAAATTGAACACAAACCATTACCAGAAAACTTTATTAACACATTAGCTGAAACACTCGTAGATTTACACAACATACCAGAAGAAAACATTAACGTTCAGCATATAAATATCAAAACCATACAAGAAATAAAAAATGACTTTCAAAGAAGAATGAATAAAGTTAAAGAAACTTATGGCGTATCAGATGAATTATGGAACAGATGGAAACAATGGTTAGAAAACGACGAACTATGGCCTCGACATGCGACCATGATACATGGGGACTTACATCCAGGACATATAATGGTAGATAACCAAGCAAACGTCACAGGTCTCATAGACTGGACTGAAGCAACCCACTCCGACCCATCAATGGACTTTATAGGACACCATCGTGTATTCGACGACGAAGGATTAGAGCAACTTATAACAGCATACGGTAAAGCTGGAGGTGAAATATGGCCACGAATGAAAGAGCATATAATAGAACTCAATGCAGTATTCCCAATGTTTATCGCTGAGTTTGCTATGGAATCAGGAGAATCGGCGTATGAAACGATGGCATTGAAAGAGTTAGGTATGAAAGAGTAG,MTRHNEIIKCAEKYQLHIQPQTISLNESGLDFQVAFGKDKHGVEWVLRLPRRPDVYKRTKPEKQTVDFLQKNVSFEIPKWKVHAKDLIAYPKLTGKPAATIDPEIQNYVWEIEHKPLPENFINTLAETLVDLHNIPEENINVQHINIKTIQEIKNDFQRRMNKVKETYGVSDELWNRWKQWLENDELWPRHATMIHGDLHPGHIMVDNQANVTGLIDWTEATHSDPSMDFIGHHRVFDDEGLEQLITAYGKAGGEIWPRMKEHIIELNAVFPMFIAEFAMESGESAYETMALKELGMKE,MTRHNEIIKCAEKYQLHIQPQTISLNESGLDFQVAFGKDKHGVEWVLRLPRRPDVYKRTKPEKQTVDFLQKNVSFEVPKWKVHERDLIAYPKLTGKPAATIDPEIQNYVWEIEHKPLPENFINTLAETLVDLHNIPEENINVQHINIKTIQEIKNDFQRRMNKVKETYGVSDELWNRWKQWLENDELWPRHATMIHGDLHPGHIMVDNQANVTGLIDWTEATHSDPSMDFMGHHRVFDDEGLEQLITAYGKAGGEIWPRMKEHIIELNAVFPMFIAEFAMESGESAYETMALKELGMKE,100,gnl|BL_ORD_ID|1899|hsp_num:0,2062,FALSE,None
LK417,12_25 # 19551 # 21017 # -1 # ID=12_25;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.314,12_25,19551,21017,-,Strict,800,996.112,msrA,98.57,3000251,protein homolog model,n/a,n/a,macrolide antibiotic; streptogramin antibiotic; streptogramin B antibiotic,antibiotic target protection,msr-type ABC-F protein,ATGGAACAATATACAATTAAATTTAACCAAATCAATCATAAATTGACAGATTTACGATCACTTAACATCGGTCATCTTTACGCTTACCAATTTGAAAAAATAGCACTTATTGGGGGTAATGGTACTGGCAAAACCACATTACTAAATATGATTGCTCAAAAAACAAAACCAGAATCTGGAACAGTTGAAACGGTTGGCGAAATTCAATATTTTGAACAGCTTAACATGGATGTGGAAAATGATTTTAACACGTTAGACGGTAGTTTAATGAGTGAACTCCATATACCTATGCATACAACCGACAGTATGAGTGGTGGTGAAAAAGCAAAATATAAATTAGCTAATGTCATATCAAATTATAGTCCGATATTACTTTTAGATGAACCTACAAATCACTTGGATAAAATTGGTAAAGATTATCTGAAAAATATTTTAAAATATTACTATGGTACTTTAATTATAGTAAGTCATGATAGAGCACTTATAGACCAAATTGCTGACACAATTTGGGATATACAAGAAGATGGCACAATAAGAGTGTTTAAAGGTAATTACACACAGTATCAAAATCAATATGAACAAGAACAGTTAGAACAACAACGTCAATATGAACAGTATATAAGTGAAAAACAAAGATTGTCCCAAGCCAGTAAAGCTAAACGAAATCAAGCGCAACAAATGGCACAAGCATCATCAAAACAAAAAAACAAAAGTATAGCACCAGATCGTTTAAGTGCATCAAAACAAAAAGGCACGGTTGAGAAGGCTGCTCAAAAACAAGCTAAGCATATTGAAAAAAGAATGGAACATTTGGAAGAAGTTGAAAAACCACAAAGTTATCATGAATTCAATTTCCCACAAAATAAAATTTATGATATCCATAATAATTATCCAATCATTGCACAAAATCTAACATTGGTTAAAGGAAGTCAAAAACTGCTAACACAAGTACGATTCCAAATACCATATGGCAAAAATATAGCGCTCGTAGGTGCAAATGGTGTAGGTAAGACAACTTTACTTGAAGCTATTTACCACCAAATAGAGGGAATTGATTGTTCTCCTAAAGTGCAAATGGCATACTATCGTCAACTTGCTTATGAAGACATGCGTGACGTTTCATTATTGCAATATTTAATGGATGAAACGGATTCATCAGAATCATTCAGTAGAGCTATTTTAAATAACTTGGGTTTAAATGAAGCACTTGATCGTTCTTGTAATGTTTTGAGTGGTGGGGAAAGAACGAAATTATCGTTAGCAGTATTATTTTCAACGAAAGCGAATATGTTAATTTTGGATGAACCAACTAATTTTTTAGATATTAAAACATTAGAAGCATTAGAAATGTTTATGAATAAATATCCTGGAATCATTTTGTTTACATCACATGATACAAGGTTTGTTAAACATGTATCAGATAAAAAATGGGAATTAACAGGACAATCTATTCATGATATAACTTAA,MEQYTIKFNQINHKLTDLRSLNIGHLYAYQFEKIALIGGNGTGKTTLLNMIAQKTKPESGTVETVGEIQYFEQLNMDVENDFNTLDGSLMSELHIPMHTTDSMSGGEKAKYKLANVISNYSPILLLDEPTNHLDKIGKDYLKNILKYYYGTLIIVSHDRALIDQIADTIWDIQEDGTIRVFKGNYTQYQNQYEQEQLEQQRQYEQYISEKQRLSQASKAKRNQAQQMAQASSKQKNKSIAPDRLSASKQKGTVEKAAQKQAKHIEKRMEHLEEVEKPQSYHEFNFPQNKIYDIHNNYPIIAQNLTLVKGSQKLLTQVRFQIPYGKNIALVGANGVGKTTLLEAIYHQIEGIDCSPKVQMAYYRQLAYEDMRDVSLLQYLMDETDSSESFSRAILNNLGLNEALDRSCNVLSGGERTKLSLAVLFSTKANMLILDEPTNFLDIKTLEALEMFMNKYPGIILFTSHDTRFVKHVSDKKWELTGQSIHDIT,MEQYTIKFNQINHKLTDLRSLNIDHLYAYQFEKIALIGGNGTGKTTLLNMIAQKTKPESGTVETNGEIQYFEQLNMDVENDFNTLDGSLMSELHIPMHTTDSMSGGEKAKYKLRNVISNYSPILLLDEPTNHLDKIGKDYLNNILKYYYGTLIIVSHDRALIDQIADTIWDIQEDGTIRVFKGNYTQYQNQYEQEQLEQQRKYEQYISEKQRLSQASKAKRNQAQQMAQASSKQKNKSIAPDRLSASKEKGTVEKAAQKQAKHIEKRMEHLEEVEKPQSYHEFNFPQNKIYDIHNNYPIIAQNLTLVKGSQKLLTQVRFQIPYGKNIALVGANGVGKTTLLEAIYHQIEGIDCSPKVQMAYYRQLAYEDMRDVSLLQYLMDETDSSESFSRAILNNLGLNEALERSCNVLSGGERTKLSLAVLFSTKANMLILDEPTNFLDIKTLEALEMFMNKYPGIILFTSHDTRFVKHVSDKKWELTGQSIHDIT,100,gnl|BL_ORD_ID|1105|hsp_num:0,1200,FALSE,None
LK417,13_21 # 14417 # 17491 # -1 # ID=13_21;partial=00;start_type=TTG;rbs_motif=AGGAGG;rbs_spacer=5-10bp;gc_cont=0.287,13_21,14417,17491,-,Strict,2000,2088.54,Staphylococcus aureus mupA conferring resistance to mupirocin,99.61,3000521,protein homolog model,n/a,n/a,mupirocin-like antibiotic,antibiotic target alteration,antibiotic-resistant isoleucyl-tRNA synthetase (ileS),TTGACAAAGAAATATTTAAACACCCAGAATGAAATATCAGCATTTTGGAATACTCAAAAGATATTTAAAAAATCAATTGACAATAGAAAAGGACAGGAAAGTTTTGTTTTTTATGACGGCCCCCCAACTGCAAATGGCCTTCCTCATGCTGGCCATGTTCTTGGAAGAGTAATCAAGGATTTAGTTGCAAGATTAAAAACTATGCAAGGTTTTTATGTAGAAAGAAAAGCAGGATGGGATACCCATGGCTTACCAGTTGAATTAGAGGTTGAAAAAAAAATTGGAATTAAAGGAAAACAAGACATTGAAAAGTATGGAATAGAAAATTTTATAAATGAATGTAAAAAAAGTGTATTTAATTATGAAAAAGAATGGCGGGATTTTTCTAAAGATTTAGGATACTGGGTTGACATGGACTCCCCCTATATAACTCTTGAGAATAATTATATTGAAAGTGTATGGAATATATTATCTACATTCCATAAAAAAGGACTATTATATAAGGGACATAAGGTGACTCCTTATTGTACACATGATCAAACCGCTTTAAGTTCTCATGAAGTAGCGCAAGGCTATAAAAACGTTAAAGATTTATCAGCTGTTGTTAAATTTCAACTTACAAATAGTAAAGATACTTATTTCTTAAGTTGGACTACCACTCCCTGGACTTTGCCTGCAAATGTAGCATTAGCTATAAATAAAGATCTTAATTATTCAAAAATTCGGGTAGAAAATGAGTATTATATCTTAGCTACAGATCTAATTAATTCTATAATAACTGAAAAATACGAAATTATTGATACCTTTTCAGGAAGTAATTTAATTAATTTAAAATACATTCCTCCTTTTGAAAGCGACGGTTTAGTTAATGCATATTACGTTGTTGATGGAGAATTTGTTACTAACTCAGAAGGAACTGGTATTGTTCATATAGCACCAGCTCATGGGGAAGATGACTACCAATTGGTTTTAGAGCGTGATTTGGATTTCTTAAATGTTATAACAAGAGAAGGAGTATATAATGATAGGTTCCCTGAATTAGTTGGTAATAAAGCTAAAAATAGTGATATAGAAATCATAAAATTATTATCCAAAAAACAACTTTTATATAAAAAACAAAAATATGAGCATAATTATCCTCATTGTTGGAGATGTGGTAATCCTTTGATATATTATGCGATGGAAGGTTGGTTTATTAAAACAACTAATTTTAAGAATGAAATTATTAACAATAATAATAATATAGAGTGGTTTCCTTCTCATATTAAGGAAGGGAGAATGGGAAATTTCTTAGAAAATATGGTTGATTGGAACATTGGTAGAAATAGATATTGGGGAACACCATTAAATGTATGGATTTGCAATGATTGTAATCACGAATACGCACCAAGTAGTATTAAGGATTTACAAAATAATTCCATCAATAAAATTGATGAAGATATTGAGTTGCATAGACCTTATGTTGATAATATCACTCTTAGTTGCCCTAAGTGTAATGGGAAAATGTCTCGAGTAGAAGAAGTAATCGATGTTTGGTTTGATAGCGGCTCTATGCCGTTTGCTCAGCATCATTATCCTTTTGATAACCAGAAAATTTTTAATCAACACTTTCCAGCTGATTTTATTGCAGAAGGAGTTGATCAAACGAGAGGCTGGTTTTACAGTTTACTAGTAATTTCTACTATTCTAAAAGGAAAATCTTCTTATAAACGTGCTTTATCTTTAGGACATATTCTAGACAGTAATGGTAAAAAAATGTCTAAAAGTAAAGGAAACGTTATTAATCCAACTGAATTAATTAATAAGTACGGAGCCGATTCTTTAAGATGGGCCTTAATTTCGGATAGTGCTCCATGGAATAACAAAAGATTCTCAGAAAATATAGTAGCTCAGACCAAATCGAAATTTATAGATACGCTTGATAATATTTATAAATTTTATAATATGTATAATAAAATAGATCACTATAATCCTAATAATGAAATTACAAAAAGTAGAAATACATTAGATAATTGGGCTCTTTCTCGCTTAAACACCTTAATAAAAGAAAGTAATATTTATGTAAATAATTACGATTTCACTTCCGCAGCCAGATTAATTAACGAATATACCAATACAATAAGTAATTGGTATATTCGGAGATCGAGAGGACGATTTTGGGAACAAGGAATTTCTAACGATAAAAAAGATGCGTACAATACGCTTTATGAAATTTTAACAACTTTATCAAGACTAGTGGCTCCATTTGTTCCATTTATATCTGAAAAAATCCATTATAATTTGACTGGAAAAAGTGTGCATTTACAAGATTATCCACAATATAAAGAAAGTTTTATTAATCAAGCATTGGAAGATGAAATGCATACCGTTATAAAAATTGTAGAATTATCTAGACAGGCTCGCAAAAATGCAGATTTAAAAATTAAGCAACCTTTATCGAAAATGGTGATTAAACCTAATAGTCAATTAAACTTAAGTTTTTTACCTAATTACTATTCAATAATAAAAGACGAATTAAATATAAAAAACATTGAATTAACTGATAATATTAATGACTATATTACCTATGAGCTTAAATTGAATTTTTCTTCTGTGGGACCAAAACTAGGGAACAAAACGAAAAATATTCAAACATTGATAGACTCCCTATCAGAGTATGATAAAAAAAGTTTAATTGAGTCTAATAACTTCAAAAGTTTATCTTCTGATGCTGAGTTAACTAAGGATGATTTTATAATTAAAACCTTACCTAAGGATAGTTATCAACTCAGTGAAGATAATGACTGCGTTATATTATTAGATAAAAATTTATCTCCTGAATTAATTCGCGAAGGACATGCTAGAGAGCTCATTAGATTAATTCAACAATTAAGAAAAAAGAAAAATTTACCAATAAATCAACGTATTGATATTTATATCGGTGTAACTGGGGAATTATTAGAATCAATAAAAACCAATAAAAATATGTTTAAAGAAAATTTGCTGATTAAAAATATACACTTAAATGTTATAGATGAATATGAAAATACTATTCATTTTAATAATAAAGAAATAAAAATTTCCTTATTATATTAA,MTKKYLNTQNEISAFWNTQKIFKKSIDNRKGQESFVFYDGPPTANGLPHAGHVLGRVIKDLVARLKTMQGFYVERKAGWDTHGLPVELEVEKKIGIKGKQDIEKYGIENFINECKKSVFNYEKEWRDFSKDLGYWVDMDSPYITLENNYIESVWNILSTFHKKGLLYKGHKVTPYCTHDQTALSSHEVAQGYKNVKDLSAVVKFQLTNSKDTYFLSWTTTPWTLPANVALAINKDLNYSKIRVENEYYILATDLINSIITEKYEIIDTFSGSNLINLKYIPPFESDGLVNAYYVVDGEFVTNSEGTGIVHIAPAHGEDDYQLVLERDLDFLNVITREGVYNDRFPELVGNKAKNSDIEIIKLLSKKQLLYKKQKYEHNYPHCWRCGNPLIYYAMEGWFIKTTNFKNEIINNNNNIEWFPSHIKEGRMGNFLENMVDWNIGRNRYWGTPLNVWICNDCNHEYAPSSIKDLQNNSINKIDEDIELHRPYVDNITLSCPKCNGKMSRVEEVIDVWFDSGSMPFAQHHYPFDNQKIFNQHFPADFIAEGVDQTRGWFYSLLVISTILKGKSSYKRALSLGHILDSNGKKMSKSKGNVINPTELINKYGADSLRWALISDSAPWNNKRFSENIVAQTKSKFIDTLDNIYKFYNMYNKIDHYNPNNEITKSRNTLDNWALSRLNTLIKESNIYVNNYDFTSAARLINEYTNTISNWYIRRSRGRFWEQGISNDKKDAYNTLYEILTTLSRLVAPFVPFISEKIHYNLTGKSVHLQDYPQYKESFINQALEDEMHTVIKIVELSRQARKNADLKIKQPLSKMVIKPNSQLNLSFLPNYYSIIKDELNIKNIELTDNINDYITYELKLNFSSVGPKLGNKTKNIQTLIDSLSEYDKKSLIESNNFKSLSSDAELTKDDFIIKTLPKDSYQLSEDNDCVILLDKNLSPELIREGHARELIRLIQQLRKKKNLPINQRIDIYIGVTGELLESIKTNKNMFKENLLIKNIHLNVIDEYENTIHFNNKEIKISLLY,MTKKYLNTQNEISAFWNTQKIFKKSIDNRKGQESFVFYDGPPTANGLPHAGHVLGRVIKDLVARLKTMQGFYVERKAGWDTHGLPVELEVEKKIGIKGKQDIEKYGIENFINECKKSVFNYEKEWRDFSKDLGYWVDMDSPYITLENNYIESVWNILSTFHKKGLLYKGHKVTPYCTHDQTALSSHEVAQGYKNVKDLSAVVKFQLTNSKDTYFLSWTTTPWTLPANVALAINKDLNYSKIRVENEYYILATDLINSIITEKYEIIDTFSGSNLINLKYIPPFESDGLVNAYYVVDGEFVTNSEGTGIVHIAPAHGEDDYQLVLERDLDFLNVITREGVYNDRFPELVGNKAKNSDIEIIKLLSKKQLLYKKQKYEHNYPHCWRCGNPLIYYAMEGWFIKTTNFKNEIINNNNNIEWFPSHIKEGRMGNFLENMVDWNIGRNRYWGTPLNVWICNDCNHEYAPSSIKDLQNNSINKIDEDIELHRPYVDNITLSCPKCNGKMSRVEEVIDVWFDSGSMPFAQHHYPFDNQKIFNQHFPADFIAEGVDQTRGWFYSLLVISTILKGKSSYKRALSLGHILDSNGKKMSKSKGNVINPTELINKYGADSLRWALISDSAPWNNKRFSENIVAQTKSKFIDTLDNIYKFYNMYNKIDHYNPNNEITKSRNTLDNWALSRLNTLIKESNIYVNNYDFTSAARLINEYTNTISNWYIGDSRGRFWEQGISNDKKDAYNTLYEILTTLSRLVAPFVPFISEKIHYNLTGKSVHLQDYPQYKESFINQALEDEMHTVIKIVELSRQARKNADLKIKQPLSKMVIKPNSQLNLSFLPNYYSIIKDELNIKNIELTDNINDYITYELKLNFSSVGPKLGNKTKNIQTLIDSLSEYDKKSLIESNNFKSLSSDAELTKDDFIIKTLPKDSYQLSEDNDCVILLDKNLSPELIREGHARELIRLIQQLRKKKNLPINQRIDIYIGVTGELLESIKTNKNMFKENFVIKNIHLNVIDEYENTIHFNNKEIKISLLY,100,gnl|BL_ORD_ID|4701|hsp_num:0,2270,FALSE,None
LK417,15_4 # 1262 # 2806 # 1 # ID=15_4;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.355,15_4,1262,2806,+,Strict,990,1000.35,qacA,99.81,3003046,protein homolog model,n/a,n/a,fluoroquinolone antibiotic,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGATTTCATTTTTTACAAAAACTACTGATATGATGACATCAAAAAAAAGATGGACTGCACTAGTAGTATTAGCTGTTAGTTTGTTTGTTGTTACAATGGATATGACAATATTAATTATGGCTTTACCGGAATTAGTAAGAGAGTTAGAGCCTTCTGGTACCCAACAGTTATGGATAGTTGATATATACTCTCTTGTTTTAGCTGGCTTTATAATTCCATTGAGTGCCTTTGCTGATAAATGGGGAAGAAAAAAAGCATTATTAACTGGATTTGCTTTATTTGGCCTCGTTTCATTAGCTATATTTTTCGCAGAAAGTGCAGAGTTCGTAATAGCTATTCGATTTTTACTTGGTATTGCAGGTGCTTTAATAATGCCAACTACTCTTTCAATGATAAGAGTAATTTTTGAAAACCCTAAAGAAAGGGCCACTGCATTAGCTGTATGGTCAATCGCTTCATCGATAGGTGCTGTTTTTGGACCAATTATCGGAGGAGCTTTACTTGAGCAATTTTCATGGCACTCGGCATTTTTAATTAATGTACCGTTTGCGATAATAGCAGTTGTAGCAGGTTTATTTTTATTACCAGAGTCTAAGTTATCAAAAGAAAAGTCTCACTCGTGGGATATTCCTTCTACAATTTTATCAATTGCAGGCATGATTGGACTGGTATGGAGTATCAAAGAATTTTCAAAAGAAGGACTAGCAGATATTATTCCATGGGTTGTAATAGTATTAGCAATTACCATGATAGTGATATTTGTTAAACGTAATTTATCAAGTTCTGATCCAATGTTAGACGTAAGACTTTTTAAAAAGAGATCATTTTCAGCTGGTACAATTGCTGCATTTATGACAATGTTTGCAATGGCATCTGTTTTGTTATTAGCTTCACAATGGTTACAGGTTGTGGAAGAACTTTCTCCTTTTAAAGCTGGCTTATACCTATTACCTATGGCAATAGGAGATATGGTGTTTGCACCAATTGCACCCGGATTAGCGGCGCGATTTGGACCGAAAATAGTGTTACCTTCCGGAATTGGAATTGCAGCCATTGGCATGTTTATTATGTATTTCTTTGGTCATCCATTATCATATTCTACAATGGCTTTAGCATTAATTTTAGTTGGAGCTGGTATGGCTTCACTAGCAGTTGCATCTGCTCTAATAATGTTAGAAACACCTACATCAAAAGCAGGTAATGCAGCTGCTGTTGAAGAGTCTATGTATGACCTTGGAAATGTTTTTGGTGTAGCAGTACTTGGTAGCCTATCTTCTATGCTTTATCGTGTATTTTTAGATATTTCATCTTTTTCATCAAAAGGTATAGTTGGAGATTTAGCTCATGTAGCTGAAGAATCTGTAGTGGGCGCTGTCGAAGTAGCTAAAGCTACGGGGATAAAACAGCTTGCAAACGAGGCTGTAACATCATTTAATGATGCTTTTGTAGCAACTGCTTTAGTAGGTGGGATTATCATGATTATCATTTCAATAGTTGTCTATTTGTTAATTCCCAAATCACTTGATATAACTAAACAAAAATAG,MISFFTKTTDMMTSKKRWTALVVLAVSLFVVTMDMTILIMALPELVRELEPSGTQQLWIVDIYSLVLAGFIIPLSAFADKWGRKKALLTGFALFGLVSLAIFFAESAEFVIAIRFLLGIAGALIMPTTLSMIRVIFENPKERATALAVWSIASSIGAVFGPIIGGALLEQFSWHSAFLINVPFAIIAVVAGLFLLPESKLSKEKSHSWDIPSTILSIAGMIGLVWSIKEFSKEGLADIIPWVVIVLAITMIVIFVKRNLSSSDPMLDVRLFKKRSFSAGTIAAFMTMFAMASVLLLASQWLQVVEELSPFKAGLYLLPMAIGDMVFAPIAPGLAARFGPKIVLPSGIGIAAIGMFIMYFFGHPLSYSTMALALILVGAGMASLAVASALIMLETPTSKAGNAAAVEESMYDLGNVFGVAVLGSLSSMLYRVFLDISSFSSKGIVGDLAHVAEESVVGAVEVAKATGIKQLANEAVTSFNDAFVATALVGGIIMIIISIVVYLLIPKSLDITKQK,MISFFTKTTDMMTSKKRWTALVVLAVSLFVVTMDMTILIMALPELVRELDPSGTQQLWIVDIYSLVLAGFIIPLSAFADKWGRKKALLTGFALFGLVSLAIFFAESAEFVIAIRFLLGIAGALIMPTTLSMIRVIFENPKERATALAVWSIASSIGAVFGPIIGGALLEQFSWHSAFLINVPFAIIAVVAGLFLLPESKLSKEKSHSWDIPSTILSIAGMIGLVWSIKEFSKEGLADIIPWVVIVLAITMIVIFVKRNLSSSDPMLDVRLFKKRSFSAGTIAAFMTMFAMASVLLLASQWLQVVEELSPFKAGLYLLPMAIGDMVFAPIAPGLAARFGPKIVLPSGIGIAAIGMFIMYFFGHPLSYSTMALALILVGAGMASLAVASALIMLETPTSKAGNAAAVEESMYDLGNVFGVAVLGSLSSMLYRVFLDISSFSSKGIVGDLAHVAEESVVGAVEVAKATGIKQLANEAVTSFNDAFVATALVGGIIMIIISIVVYLLIPKSLDITKQK,100,gnl|BL_ORD_ID|339|hsp_num:0,372,FALSE,None
LK1008,7_6 # 3807 # 4550 # -1 # ID=7_6;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.782,7_6,3807,4550,-,Strict,50,86.6557,vanY gene in vanF cluster,32.26,3002958,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGTCGCCCCCTCCCCCTCGCCGCGCTGGCCGCGCTCGCGCTGCTCGCGGCCGGCTGCGGCACGCCCGCCGCAGGCCCGTCCTCGGCGACGCCGGCTTCCGGCTCCTCGAGCGCGGCCGCGTCGTCCGGCGCCGCCTCGAGCACGGCGCCGTCGTCGAGCACGCACGCCGACCCGGCCGCCCTCGACGTCGTCGTGAACAAGACCCGCCCCGTGGCCCCGCCCGACTGGGCGCCCTCGGATCTGGTGGCCGTGCCCGGCAGCGAGCTGCCCCTGCGGGCGGAGGCCGCGACGGCGGCCGGTGACCTGCTGGGTGCGGCCGCGGCGGCGGGCCACGACCTCACCACCCTGAGCGCCTACCGCTCGTACGACTACCAGGTCCGGACGTACGGCCACTGGGTCGACGAGCTGGGCCGCGCCGAGGCCGACCGCGTCTCGGCGCGTCCGGGGCACTCCGAGCACCAGACCGGCCTGGCCTGGGACGTGGGCGATGCCGCGACCCCCGCGTGTGACCTGGAGGCGTGCTTCGGCGACACCGCCGCGGGCCGCTGGGTGGCCGCGCACGCCGCCGAGTACGGGTTCGTCATCCGCTATCCCGCCGGGGCCGAGGACGTGACGGGCTTCGACCACGAGCCCTGGCACCTGCGCTACGTCGGGTCCGCGGAGGCGGCCCGGGTCGAGGCGGCCGGCGGCGTCCTCGAGACCGCGTGGGGTCTGCCTCCGGCGCCCGACTATGCGGACTGA,MRRPLPLAALAALALLAAGCGTPAAGPSSATPASGSSSAAASSGAASSTAPSSSTHADPAALDVVVNKTRPVAPPDWAPSDLVAVPGSELPLRAEAATAAGDLLGAAAAAGHDLTTLSAYRSYDYQVRTYGHWVDELGRAEADRVSARPGHSEHQTGLAWDVGDAATPACDLEACFGDTAAGRWVAAHAAEYGFVIRYPAGAEDVTGFDHEPWHLRYVGSAEAARVEAAGGVLETAWGLPPAPDYAD,MKKWGLLLVFALFLVFIFNILPISQDKVEDRIYEQNDKDTSDDKMTAENMQKIELTEEQIYQGNLLLVNNEHPVHQKSIKSDIINLFTHKELTKGYGLLDNEIKLSEEIAGKFSEMIAAAEEDGVSNFLISSGYRDLDEQSRLYEEMGSDFALPAGHSEHNLGLSLDVGSTQMKMDKAPEGKWIEKNCWEYGFILRYPLDKTDVTGIQYEPWHIRYVGLPHSAIMQEMNLALEEYLDYLKEEKSISVRVDGKKYTISYDPISQNETIEVEVPADEQYEISGNNIDGVIVTTFS,84.3,gnl|BL_ORD_ID|1808|hsp_num:0,1899,FALSE,None
LK1330,115_4 # 942 # 1691 # -1 # ID=115_4;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.779,115_4,942,1691,-,Strict,50,85.1149,vanY gene in vanA cluster,36,3002955,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGTCGCACCCTCCCTCTCGCCGCGCTGGCCGCGCTCGCGCTGCTCGCGGCCGGTCGCGGCACGCCCGCCGCGGGCCCGTCCTCGACGCCGACGACGCCGACGTCCGGCTCCGCGAGCGCGGCCGCGTCGTCCCGCGCCGCCTCGAGCACGGCGCCGTCGTCGGGCACGCACGCCGACCCGGCCACCCTCGACGTCGTCGTGAACAAGACCCGCCCCGTGGCCCCGCCCGACTGGGCGCCCTCGGATCTGGTGGCCGTGCCCGGCAGCGAGCTGCCCCTGCGGGCGGAGGCCGCGACGGCGGCCGCTGACCTGCTGGATGCCGCCGCGGCGGCGGGCCACCGCCTCACCACCCTGAGCGCCTACCGCTCGTACGACTACCAGGTCCGGACGTACGGCCACTGGGTCGACGAGCTGGGCCGCGCCGAGGCCGACCGCGTCTCCGCGCGTCCGGGGTACTCCGAGCATCAGACCGGCCTGGCCTGGGACGTGGGCGACGCCGCGACCCCCGCGTGTGACCTGGAAGCGTGCTTCGGCGACACCGCCGCGGGCCGTTGGGTGGCCGAGCACGCCGCCGAGTACGGGTTCGTCATCCGCTATCCCGCCGGGGCCGAGGACGTGACGGGCTTCGCCCACGAGCCCTGGCATCTGCGCTACGTCGGGTCCGCGGAGGCGGCCCGGGTCGAGGCGGCCGGCGGCGTCCTCGAGACCGCGTGGGGTCTGCCGCCGGCGCCGGACTACGCGGACTGA,MRRTLPLAALAALALLAAGRGTPAAGPSSTPTTPTSGSASAAASSRAASSTAPSSGTHADPATLDVVVNKTRPVAPPDWAPSDLVAVPGSELPLRAEAATAAADLLDAAAAAGHRLTTLSAYRSYDYQVRTYGHWVDELGRAEADRVSARPGYSEHQTGLAWDVGDAATPACDLEACFGDTAAGRWVAEHAAEYGFVIRYPAGAEDVTGFAHEPWHLRYVGSAEAARVEAAGGVLETAWGLPPAPDYAD,MKKLFFLLLLLFLIYLGYDYVNEALFSQEKVEFQNYDQNPKEHLENSGTSENTQEKTITEEQVYQGNLLLINSKYPVRQESVKSDIVNLSKHDELINGYGLLDSNIYMSKEIAQKFSEMVNDAVKGGVSHFIINSGYRDFDEQSVLYQEMGAEYALPAGYSEHNSGLSLDVGSSLTKMERAPEGKWIEENAWKYGFILRYPEDKTELTGIQYEPWHIRYVGLPHSAIMKEKNFVLEEYMDYLKEEKTISVSVNGEKYEIFYYPVTKNTTIHVPTNLRYEISGNNIDGVIVTVFPGSTHTNSRR,82.18,gnl|BL_ORD_ID|4669|hsp_num:0,89,FALSE,None
LK1136,1_329 # 359589 # 360074 # -1 # ID=1_329;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.368,1_329,359589,360074,-,Strict,300,332.028,dfrC,99.38,3002865,protein homolog model,n/a,n/a,diaminopyrimidine antibiotic,antibiotic target replacement,trimethoprim resistant dihydrofolate reductase dfr,ATGACATTATCAATAATTGTCGCTCACGATAAACAAAGAGTCATTGGGTACCAAAATCAATTACCATGGCATTTACCAAATGATTTAAAGCATGTTAAACAACTGACCACTGGAAATACACTTGTAATGGGACGAAAAACTTTTAATTCTATCGGGAAACCACTGCCAAATAGACGTAACGTTGTGCTCACTAACCAAGCTTCATTTCACCATGAAGGGGTAGATGTTATAAACTCTCTTGATGAAATTAAAGAGTTATCTGGTCATGTTTTTATATTTGGAGGACAAACGTTATTCGAAGCAATGATTGACCAGGTAGATGATATGTATATCACAGTAATAGATGGGAAGTTTCAAGGAGACACTTTCTTTCCACCGTACACATTCGAAAACTGGGAGGTCGAATCTTCAGTGGAAGGTCAACTAGATGAAAAAAATACTATACCGCATACATTCTTACATTTAGTGCGTAGAAAAGGGGAATAG,MTLSIIVAHDKQRVIGYQNQLPWHLPNDLKHVKQLTTGNTLVMGRKTFNSIGKPLPNRRNVVLTNQASFHHEGVDVINSLDEIKELSGHVFIFGGQTLFEAMIDQVDDMYITVIDGKFQGDTFFPPYTFENWEVESSVEGQLDEKNTIPHTFLHLVRRKGE,MTLSIIVAHDKQRVIGYQNQLPWHLPNDLKHVKQLTTGNTLVMGRKTFNSIGKPLPNRRNVVLTNQASFHHEGVDVINSLDEIKELSGHVFIFGGQTLFEAMIDQVDDMYITVIDGKFQGDTFFPPYTFENWEVESSVEGQLDEKNTIPHTFLHLVRRKGK,100,gnl|BL_ORD_ID|1279|hsp_num:0,1397,FALSE,None
LK1136,2_126 # 136744 # 138144 # -1 # ID=2_126;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.351,2_126,136744,138144,-,Strict,525,559.296,norC,62.2,3007010,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGAATACATCACAAAAGTTTAGGGGAGATAATCGCTTATTATTAGGGATTATTTTAGGGGTTATTACATTTTGGTTATTTGCACAATCACTTGTAAATCTAGTCGTGCCATTACAATCATCATACAATAGTGATATTGGCACCATTAATATAGCAGTTAGCTTATCGGCACTATTTTCTGGTTTGTTTATTGTAGGTGCAGGAGATATTGCAGATAAAATTGGTAGAGTAAAAGTGACATACATAGGCTTAGCACTTAATATTGTTGGGTCAGTTTTAATCATTATTACGCCATTACCAAGTTTATTGATTATTGGACGGGCTATTCAAGGATTGTCAGCGGCGTGTATAATGCCAGCGACACTCGCAATCATTAATGAATATTATATCGGGACAGCACGACAACGTGCATTAAGCTACTGGTCTATCGGTTCATGGGGAGGTAGTGGTGTTTGTACTTTGTTTGGTGGTTTAATGGCAACTAACCTTGGATGGCGCTCAATCTTTATTGTTTCAATTATTCTGACAATATTATCCATGTTTCTCATTAAACATACACCCGAAACAAAAGCAGAGCCTATAGGAGATCAACCGACAGAGACAAAGAAATTTGATGTTGTTGGTTTAATCATCTTAGTGGTTAGCATGTTAAGTATTAATGTGATAATAACTCAAACCTCTCATTTTGGTTTGTTCTCACCATTTATTTTGGGACTTATTGCAATTTTTGTTATATCGTTAATTATATTCGTGATTTACGAAAATAAAATCAAACAACCACTTGTCGATTTTGATATCTTTAAAAACAAAGGTTATACAGGTGCAACGATTTCAAACTTTATGTTGAATGGTGTAGCTGGTGGTACATTGATTGTAGTAAATACTTTTTATCAGCAAAAATTAGATTTTAACTCTCAGGAAACAGGATATATTTCACTTACATACCTAATTGCAGTATTAATTATGATACGTGTGGGTGAAATGATATTACAATCGCTAGGACCTAAAAGACCTTTGTTACTCGGAAGTGCCTTGACCGTCATAGGATTAATATTATTATCTTTGACGTTTTTACCTAATGCTTGGTATATAGCGTCAAGTGTCATTGGTTATTTATTATTTGGTACCGGTTTAGGTATTTATGCAACACCATCCACGGATACAGCTGTTGCACAAGCACCAGATGATAAAGTAGGCGTCGCATCCGGTGTATATAAGATGGCATCATCCTTAGGAAATGCATTTGGTGTGGCCATCTCAAGTACAGTTTACAGCGTACTTGCGGCTCAACTGAATCTGACTTTAGGTGGTTTTACTGGAATAATGTTCAATGCGCTTATAGCATTATTAGCATTCCTATCTATTTTGTTCTTAATACCGAAAAAACAATCTAATGTATAA,MNTSQKFRGDNRLLLGIILGVITFWLFAQSLVNLVVPLQSSYNSDIGTINIAVSLSALFSGLFIVGAGDIADKIGRVKVTYIGLALNIVGSVLIIITPLPSLLIIGRAIQGLSAACIMPATLAIINEYYIGTARQRALSYWSIGSWGGSGVCTLFGGLMATNLGWRSIFIVSIILTILSMFLIKHTPETKAEPIGDQPTETKKFDVVGLIILVVSMLSINVIITQTSHFGLFSPFILGLIAIFVISLIIFVIYENKIKQPLVDFDIFKNKGYTGATISNFMLNGVAGGTLIVVNTFYQQKLDFNSQETGYISLTYLIAVLIMIRVGEMILQSLGPKRPLLLGSALTVIGLILLSLTFLPNAWYIASSVIGYLLFGTGLGIYATPSTDTAVAQAPDDKVGVASGVYKMASSLGNAFGVAISSTVYSVLAAQLNLTLGGFTGIMFNALIALLAFLSILFLIPKKQSNV,MNETYRGGNKLILGIVLGVITFWLFAQSLVNVVPNLQQSFGADMGTISIAVSLTALFSGMFVVGAGGLADKIGRVKMTNIGLLLSIIGSALIIITNLPALLILGRIIQGVSAACIMPSTLAIMKTYYEGAERQRALSYWSIGSWGGSGICSLFGGAVATTMGWRWIFIFSIIVAVLSMLLIKGTPETKSEVTNTHKFDVAGLIVLVVMLLSLNVVITKGAALGYTSLWFFGLIAIVIVAFFIFLNVEKKVDNPLIDFKLFENKPYTGATISNFLLNGVAGTLIVANTFVQQGLGYTALQAGYLSITYLIMVLLMIRVGEKLLQKMGSKRPMLLGTFIVIIGIALISLVFLPGIFYVISCVVGYLCFGLGLGIYATPSTDTAISNAPLDKVGVASGIYKMASSLGGAFGVAISGAVYAGAVAATSIHTGAMIALWVNVLMGIMAFIAILFAIPNDDKRVKDAK,100.87,gnl|BL_ORD_ID|4656|hsp_num:0,5726,FALSE,None
LK1136,3_101 # 105572 # 106735 # -1 # ID=3_101;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.326,3_101,105572,106735,-,Strict,700,753.821,norA,98.71,3000391,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGAAAAAGCAATTATTTATTCTTTATTTTAATATATTTCTTATATTTTTAGGGATTGGGTTAGTTATTCCTGTACTTCCTGTATATTTAAAGGATTTAGGATTAAAAGGTAGTGACTTAGGAATGCTAGTTGCTGCCTTTGCGTTATCACAAATGATTATTTCACCATTTGGTGGGACACTAGCTGATAAATTGGGAAAAAAATTAATTATATGTATCGGTTTAGTATTCTTTGCTGTCTCTGAATTTATGTTCGCAGCCGGTCAAAGTTTTACCATTTTAATCATTTCACGTATTTTAGGTGGTTTTAGTGCAGGCATGGTCATGCCTGGTGTAACAGGTATGATTGCAGATATTTCTCCAGGAGCTGATAAAGCTAAAAACTTTGGTTATATGTCGGCAATTATTAATTCAGGTTTTATATTAGGACCTGGATTTGGAGGGTTTTTAGCTGAAATTTCACATAGATTACCTTTCTATGTTGCTGGAACATTAGGTGTTGTTGCATTCATTATGTCAGTTTTATTAATTCATAATCCTCACAAAACAACCACAGATGGATTCCACCAATATCAACCAGAATTATTCACTAAAATTAATTGGAAAGTATTTATTACGCCAGTCATATTAACACTTGTATTAGCATTTGGTTTATCTGCTTTTGAAACATTGTTTTCTTTATATACAGCTGACAAAGTAAATTATACTCCTAAAGATATTTCGATAGCTATTATCGGTGGAGGCGTGTTTGGCGCATTATTCCAGGTATTCTTCTTTGATAAATTTATGAAATATATGAGTGAACTTAATTTTATTGCATGGTCATTACTATATTCAGCTGTTGTTCTCGTTATGTTAGTGCTTGCAAACGGTTATTGGACGATTATGATGATTAGCTTTGTTGTTTTTATAGGTTTTGATATGATTAGACCGGCTTTAACCAATTACTTCTCGAATATAGCAGGCAAGCGGCAAGGTTTTGCAGGTGGATTGAATTCAACTTTTACCAGTATGGGTAACTTTATAGGTCCTCTTGTAGCTGGTGCATTATTCGATGTTAATTTAGAGTTTCCTTTATATATGGCTATTGCGGTTTCATTAAGTGGAATTATCATTATTTTTATTGAAAAAGGACTTAAGTCACGTCGTAAAGAAGCAAATTAA,MKKQLFILYFNIFLIFLGIGLVIPVLPVYLKDLGLKGSDLGMLVAAFALSQMIISPFGGTLADKLGKKLIICIGLVFFAVSEFMFAAGQSFTILIISRILGGFSAGMVMPGVTGMIADISPGADKAKNFGYMSAIINSGFILGPGFGGFLAEISHRLPFYVAGTLGVVAFIMSVLLIHNPHKTTTDGFHQYQPELFTKINWKVFITPVILTLVLAFGLSAFETLFSLYTADKVNYTPKDISIAIIGGGVFGALFQVFFFDKFMKYMSELNFIAWSLLYSAVVLVMLVLANGYWTIMMISFVVFIGFDMIRPALTNYFSNIAGKRQGFAGGLNSTFTSMGNFIGPLVAGALFDVNLEFPLYMAIAVSLSGIIIIFIEKGLKSRRKEAN,MKKQLFILYFNIFLIFLGIGLVIPVLPVYLKDLGLKGSDLGMLVAAFALSQMIISPFGGTLADKLGKKLIICIGLVFFAVSEFMFAAGQSFTILIISRVLGGFSAGMVMPGVTGMIADISPGADKAKNFGYMSAIINSGFILGPGFGGFLAEISHRLPFYVAGTLGVVAFIMSVLLIHNPQKATTDGFHQYQPELFTKINWKVFITPVILTLVLAFGLSAFETLFSLYTADKVNYTPKDISIAIIGGGVFGALFQVFFFDKFMKYMSELNFIAWSLLYSAIVLVMLVLANGYWTIMIISFVVFIGFDMIRPALTNYFSNIAGKRQGFAGGLNSTFTSMGNFIGPLVAGALFDVNLEFPLYMAIAVSLSGIIIIFIEKGLKSRRKEAN,100,gnl|BL_ORD_ID|1427|hsp_num:0,1554,FALSE,None
LK1136,3_109 # 113865 # 114308 # 1 # ID=3_109;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.331,3_109,113865,114308,+,Strict,270,286.189,mgrA,95.24,3000815,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; cephalosporin; penam; tetracycline antibiotic; peptide antibiotic; disinfecting agents and antiseptics,antibiotic efflux,ATP-binding cassette (ABC) antibiotic efflux pump; major facilitator superfamily (MFS) antibiotic efflux pump,ATGTCTGAACAACATAATTTAAAAGAGCAGCTATGCTTTAGTTTGTACAACGCTCAAAGACAAGTTAATCGCTACTATTCAAACAAAGTCTTTAAAAAGTACAATCTAACATACCCACAATTTCTTGTTTTAACAATATTATGGGATGAATCACCTGTTAACGTCAAAAAGGTCGTTACAGAATTAGCACTTGATACTGGAACTGTATCACCATTACTCAAGAGAATGGAACAAGTTGATTTAATCAAACGTGAACGTTCTGAAGTAGATCAACGTGAAGTATTTATTCACTTAACAGACAAAAGTGAAATGATTAGGCCCGAATTAAGCAACGCATCTGAGAAAGTTGCAACTGCTTCTTCTTTATCTAAAGATGAGGTCAAAGAACTTAATCGTTTATTAGGTAAAGTCATCGATGCATTTATCGAAACAAAAGAAAAGTAA,MSEQHNLKEQLCFSLYNAQRQVNRYYSNKVFKKYNLTYPQFLVLTILWDESPVNVKKVVTELALDTGTVSPLLKRMEQVDLIKRERSEVDQREVFIHLTDKSEMIRPELSNASEKVATASSLSKDEVKELNRLLGKVIDAFIETKEK,MSDQHNLKEQLCFSLYNAQRQVNRYYSNKVFKKYNLTYPQFLVLTILWDESPVNVKKVVTELALDTGTVSPLLKRMEQVDLIKRERSEVDQREVFIHLTDKSETIRPELSNASDKVASASSLSQDEVKELNRLLGKVIHAFDETKEK,100,gnl|BL_ORD_ID|133|hsp_num:0,154,FALSE,None
LK1136,6_57 # 70619 # 71047 # -1 # ID=6_57;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.298,6_57,70619,71047,-,Strict,150,188.348,FosBx1,60.58,3007372,protein homolog model,n/a,n/a,phosphonic acid antibiotic,antibiotic inactivation,fosfomycin thiol transferase,ATGGAAATAACAAGTGTTAATCATATTTGTTTTTCAGTAAGTGATTTAAATACCTCTATACAATTTTATAAAGATATTTTACAAGGTGACTTATTAGTATCAGGGAGAACGACAGCATATTTAACTATTGGTCATACTTGGATTGCACTGAATCAAGAAAAAAATATACCAAGGAATGAAATAAACCATTCCTATACACACGTTGCTTTCTCCATAGATGAAGAAGATTTTCAAAAATGGATTCAATGGCTTAAAGAGAATCAAGTAAATATTTTAAAAGGGCGACCAAGAGATATTAAAGACAAAAAGTCGATATATTTTACAGATCCGGATGGGCATAAAATTGAATTACATACTGGGACATTAAAAGATAGAATGGAATATTATAAAAGTGAGAAGACGCATATGCAATTTTACGGTGAGTTTTGA,MEITSVNHICFSVSDLNTSIQFYKDILQGDLLVSGRTTAYLTIGHTWIALNQEKNIPRNEINHSYTHVAFSIDEEDFQKWIQWLKENQVNILKGRPRDIKDKKSIYFTDPDGHKIELHTGTLKDRMEYYKSEKTHMQFYGEF,MLRGINHICFSVSNLENSIMFYEKVLEGELLVKGRKLAYFNICGVWIALNEETHIPRNEIHQSYTHIAFSVEKEDFKCLIQRLEENDVHILQGRERDVRDCESIYFVDPDGHKFEFHSGTLQDRLNYYRDEKPHMTFY,102.9,gnl|BL_ORD_ID|4909|hsp_num:0,5900,FALSE,None
LK1136,20_24 # 19174 # 20640 # 1 # ID=20_24;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.312,20_24,19174,20640,+,Strict,800,1006.51,msrA,99.59,3000251,protein homolog model,n/a,n/a,macrolide antibiotic; streptogramin antibiotic; streptogramin B antibiotic,antibiotic target protection,msr-type ABC-F protein,ATGGAACAATATACAATTAAATTTAACCAAATCAATCATAAATTGACAGATTTACGATCACTTAACATCGATCATCTTTATGCTTACCAATTTGAAAAAATAGCACTTATTGGGGGTAATGGTACTGGCAAAACCACATTACTAAATATGATTGCTCAAAAAACAAAACCAGAATCTGGAACAGTTGAAACGAATGGCGAAATTCAATATTTTGAACAGCTTAACATGGATGTGGAAAATGATTTTAACACGTTAGACGGTAGTTTAATGAGTGAACTCCATATACCTATGCATACAACCGACAGTATGAGTGGTGGTGAAAAAGCAAAATATAAATTAGCTAATGTCATATCAAATTATAGTCCGATATTACTTTTAGATGAACCTACAAATCACTTGGATAAAATTGGTAAAGATTATCTGAATAATATTTTAAAATATTACTATGGTACTTTAATTATAGTAAGTCACGATAGAGCACTTATAGACCAAATTGCTGACACAATTTGGGATATACAAGAAGATGGCACAATAAGAGTGTTTAAAGGTAATTACACACAGTATCAAAATCAATATGAACAAGAACAGTTAGAACAACAACGTAAATATGAACAGTATATAAGTGAAAAACAAAGATTGTCCCAAGCCAGTAAAGCTAAACGAAATCAAGCGCAACAAATGGCACAAGCATCATCAAAACAAAAAAATAAAAGTATAGCACCAGATCGTTTAAGTGCATCAAAACAAAAAGGCACGGTTGAGAAGGCTGCTCAAAAACAAGCTAAGCATATTGAAAAAAGAATGGAACATTTGGAAGAAGTTGAAAAACCACAAAGTTATCATGAATTCAATTTTCCACAAAATAAAATTTATGATATCCATAATAATTATCCAATCATTGCACAAAATCTAACATTGGTTAAAGGAAGTCAAAAACTGCTAACACAAGTACGATTCCAAATACCATATGGCAAAAATATAGCGCTCGTAGGTGCAAATGGTGTAGGTAAGACAACTTTACTTGAAGCTATTTACCACCAAATAGAGGGAATTGATTGTTCTCCTAAAGTGCAAATGGCATACTATCGTCAACTTGCTTATGAAGACATGCGTGACGTTTCATTATTGCAATATTTAATGGATGAAACGGATTCATCAGAATCATTCAGTAGAGCTATTTTAAATAACTTGGGTTTAAATGAAGCACTTGAGCGTTCTTGTAATGTTTTGAGTGGTGGGGAAAGAACGAAATTATCGTTAGCAGTATTATTTTCAACGAAAGCGAATATGTTAATTTTGGATGAACCAACTAATTTTTTAGATATTAAAACATTAGAAGCATTAGAAATGTTTATGAATAAATATCCTGGAATCATTTTGTTTACATCACATGATACAAGGTTTGTTAAACATGTATCAGATAAAAAATGGGAATTAACAGGACAATCTATTCATGATATAACTTAA,MEQYTIKFNQINHKLTDLRSLNIDHLYAYQFEKIALIGGNGTGKTTLLNMIAQKTKPESGTVETNGEIQYFEQLNMDVENDFNTLDGSLMSELHIPMHTTDSMSGGEKAKYKLANVISNYSPILLLDEPTNHLDKIGKDYLNNILKYYYGTLIIVSHDRALIDQIADTIWDIQEDGTIRVFKGNYTQYQNQYEQEQLEQQRKYEQYISEKQRLSQASKAKRNQAQQMAQASSKQKNKSIAPDRLSASKQKGTVEKAAQKQAKHIEKRMEHLEEVEKPQSYHEFNFPQNKIYDIHNNYPIIAQNLTLVKGSQKLLTQVRFQIPYGKNIALVGANGVGKTTLLEAIYHQIEGIDCSPKVQMAYYRQLAYEDMRDVSLLQYLMDETDSSESFSRAILNNLGLNEALERSCNVLSGGERTKLSLAVLFSTKANMLILDEPTNFLDIKTLEALEMFMNKYPGIILFTSHDTRFVKHVSDKKWELTGQSIHDIT,MEQYTIKFNQINHKLTDLRSLNIDHLYAYQFEKIALIGGNGTGKTTLLNMIAQKTKPESGTVETNGEIQYFEQLNMDVENDFNTLDGSLMSELHIPMHTTDSMSGGEKAKYKLRNVISNYSPILLLDEPTNHLDKIGKDYLNNILKYYYGTLIIVSHDRALIDQIADTIWDIQEDGTIRVFKGNYTQYQNQYEQEQLEQQRKYEQYISEKQRLSQASKAKRNQAQQMAQASSKQKNKSIAPDRLSASKEKGTVEKAAQKQAKHIEKRMEHLEEVEKPQSYHEFNFPQNKIYDIHNNYPIIAQNLTLVKGSQKLLTQVRFQIPYGKNIALVGANGVGKTTLLEAIYHQIEGIDCSPKVQMAYYRQLAYEDMRDVSLLQYLMDETDSSESFSRAILNNLGLNEALERSCNVLSGGERTKLSLAVLFSTKANMLILDEPTNFLDIKTLEALEMFMNKYPGIILFTSHDTRFVKHVSDKKWELTGQSIHDIT,100,gnl|BL_ORD_ID|1105|hsp_num:0,1200,FALSE,None
LK1136,20_29 # 24679 # 25524 # 1 # ID=20_29;partial=00;start_type=TTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.277,20_29,24679,25524,+,Strict,500,511.531,PC1 beta-lactamase (blaZ),95.02,3000621,protein homolog model,n/a,n/a,penam,antibiotic inactivation,BlaZ beta-lactamase,TTGAAAAAGTTAATATTTTTAATTGCAATTGCTTTAGTTTTAAGTGCATGTAATTCAAACAGTTCACATGCCAAAGAGTTAAATGATTTAGAAAAAAAATATAATGCTCATATTGGTGTTTATGCTTTAGATACTAAAAGTGGTAAGGAAGTAAAATTTAATTCAGATAAGAGATTTGCCTATGCTTCGACTTCAAAAGCGATAAATAGTGCTATTTTGTTAGAACAAGTACCTTATAATAAGTTAAATAAAAAAATACATATTAACAAAGATGATATAGTTGCTTATTCTCCTATTTTAGAAAAATATGTAGGAAAAGATATCACTTTAAAAGAACTTATTGAGGCTTCAATGGCATATAGTGATAATACAGCAAACAATAAAATTATAAAAGAAATTGGTGGAATCAAAAAAGTTAAACAACGTCTAAAAGAACTAGGAGATAAAGTAACAAATCCAGTTAGATATGAGATAGAATTAAATTACTATTCACCAAAGAGCAAAAAAGATACTTCAACACCTGCTGCTTTCGGTAAGACTTTAAATAAACTTATCGCAAATGGAAAATTAAGCAAAGAAAACAAAAAATTCTTACTTGATTTAATGTTAAATAATAAAAGCGGAGATACTTTAATTAAAGACGGTGTTTCAAAAGACTGTAAGGTTGCTGATAAAAGTGGTCAAGCAATAACATATGCTTCTAGAAATGATGTTGCTTTTGTTTATCCTAAGGGCCAATCTGAACCTATTGTTTTAGTCATTTTTACGAATAAAGACAATAAAAGTGATAAGCCAAATGATAAGTTGATAAGTGAAACCGCCAAGAGTGTAATGAAGGAATTTTAA,MKKLIFLIAIALVLSACNSNSSHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFAYASTSKAINSAILLEQVPYNKLNKKIHINKDDIVAYSPILEKYVGKDITLKELIEASMAYSDNTANNKIIKEIGGIKKVKQRLKELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKTLNKLIANGKLSKENKKFLLDLMLNNKSGDTLIKDGVSKDCKVADKSGQAITYASRNDVAFVYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF,MKKLIFLIVIALVLSACNSNSSHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFAYASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDIALKELIEASMKYSDNTANNKIINEIGGIKKIKKRLKKLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKTLNKLIANGKLSKKNKNFLLDLMLNNKNGDTLIKDGIPKDYKVADKSGQAITYASRNDVAFVYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF,100,gnl|BL_ORD_ID|670|hsp_num:0,726,FALSE,None
LK1136,26_3 # 3274 # 3741 # -1 # ID=26_3;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.233,26_3,3274,3741,-,Strict,100,230.72,sepA,70.32,3007012,protein homolog model,n/a,n/a,disinfecting agents and antiseptics,antibiotic efflux,small multidrug resistance (SMR) antibiotic efflux pump,ATGAAATTTTTAAAAAATAAATCATATCATTTATTAGTAACACTTATTGTTCTCACTATATTTATTATTTCCGGAGCCATTTTTTTAACGTTTTTAGGCTTTGGTTTGTACGGTTTGAGTCGCATCCTTATTTATTTACACTTAGGCGATTTTAGTTACAATAAAGGCTTTTATGATAATTTAATATACTACGGTAGTTATATCGTTTTAGGCTATTTTACTTTATTTTCAATTGAGCATTTAATGGATTATTTTAAAAAGAATCTTCCAAAAAATCCATACTTTCAAGGTATTAACTTTCATCTTATCTCCTATATTGTTACTACAATTATGTTTTATTTTATAGTTCACATACACTATGTACATGTTAATATACATTTTTGGGTAATTATGATTATTATAGGATTTTTATTTGTATGTAAAGAAGTTTTTTATCCTGAAAGTAAAAATTTGAATAATAAAAAGTAA,MKFLKNKSYHLLVTLIVLTIFIISGAIFLTFLGFGLYGLSRILIYLHLGDFSYNKGFYDNLIYYGSYIVLGYFTLFSIEHLMDYFKKNLPKNPYFQGINFHLISYIVTTIMFYFIVHIHYVHVNIHFWVIMIIIGFLFVCKEVFYPESKNLNNKK,MIVNFFKHKFYNLLTTMIVLFVFVLSGAIFLTFLGFGLYGLSRILIYFRLGDFTYNRNMYDNLLYYGSYIIFGYFIIFAVEHLMDYFRKMLPENAYFRGATFHLISYTVATTLFYFIIHLHYVYINIDFWVIMVIIGFLYVCKLQFYPESKNLNNRK,98.73,gnl|BL_ORD_ID|4660|hsp_num:0,5728,FALSE,None
LK1136,26_4 # 3935 # 5272 # -1 # ID=26_4;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.298,26_4,3935,5272,-,Strict,200,611.683,sdrM,73.93,3007013,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGAATCTTAAGTCCATCATTACTGTAATGGCACTCATACTAATAATGTTTATGGCAGCTATAGAAACATCAATCATTTCATTAGCATTACCAACAATAAAAAATAGTTTGAATGCCGGTAATCTAGTTTCATTAGTATTTACCGTATATTTTATTGCTTTAGTCATAGCTAACCCTATCGTTGGTGAGCTCATGTCTAGATTTAAAATTATTAACATTGCTGTTGTAGGGGTATCATTGTTTGCCTTAGGTAGTTTAATGTCGGGATTAAGTCAGACGTTTACTTTTTTAATTATCTCTCGAATAGTACAAGGTTTTGGAGCAGGAGTTATGATGTCACTCTCACAAATAGTTCCAAAGTTGGCTTTTGAAATTCCGTTAAGATATAAAATTATGGGTATCGTCGGAAGTGTCTGGGGGATTTCGAGTATTATTGGTCCATTATTAGGTGGTGCGATTTTAGAGTTCGCTTCATGGCATTGGCTATTCTATATCAATATTCCTATTGCTATATTGGCAATAATACTTGTATTTATGACTTTTCATTTTCCTGATGAGACACAAGTACAACAGAGTCGTTTTGATATAAAAGGATTGATTATCTTTTATATCTTTATAGCTTTATTAATGTTTGGTTTACTCAACCAACATCATATTATTTTTAATATATTCTCAATTATTTTAGCTTTAGTTGTTTTATGGATACTATTTAAAGTAGAAAATAGTATCGAACAACCATTTTTACCAACAAAAGAATTTAACATATCAATAGTTCTAGTTTTTATAACGGATTTACTAATTGCGATAACACTGATGGGATATAATTTATATATACCAGTATATTTACAAGAAAAACTTGGTTTATCACCTTTACAAAGTGGATTTGTAATATTCCCGTTGTCTGTTGCTTGGATTACGCTTAATTTCAATTTAGCTAAAATAGAAGCGCATTTTACTAGAAAAACATTATATATTTGCTCATTTTTTGTTTTATTAGTTTGTAGTCTGATGATAATGTTTGGCTTAAAACTCCCATTGCTTATAGCTTTTGCGGTTATATTTGCAGGTTTAAGTTTTGGCTATATTTATACAAAAGATAGTGTTATTGTCCAAGAGGAAACTTCTCCAAAAAATATGAAAAAGATGATGTCGTTTTATGCATTGACAAAAAATTTAGGTTCGTCTGTCGGATCTACGATTATGGGATATATGTATGCACTAAATGTTGGATTATTTGGTTCTAATTTACACAATGTATTAGGATTAGTATCAATAATTTCAGTATGTTTAATTGTAATGTGGATGACATTATTTAAGAGCAATCCTATTCAATCTTAG,MNLKSIITVMALILIMFMAAIETSIISLALPTIKNSLNAGNLVSLVFTVYFIALVIANPIVGELMSRFKIINIAVVGVSLFALGSLMSGLSQTFTFLIISRIVQGFGAGVMMSLSQIVPKLAFEIPLRYKIMGIVGSVWGISSIIGPLLGGAILEFASWHWLFYINIPIAILAIILVFMTFHFPDETQVQQSRFDIKGLIIFYIFIALLMFGLLNQHHIIFNIFSIILALVVLWILFKVENSIEQPFLPTKEFNISIVLVFITDLLIAITLMGYNLYIPVYLQEKLGLSPLQSGFVIFPLSVAWITLNFNLAKIEAHFTRKTLYICSFFVLLVCSLMIMFGLKLPLLIAFAVIFAGLSFGYIYTKDSVIVQEETSPKNMKKMMSFYALTKNLGSSVGSTIMGYMYALNVGLFGSNLHNVLGLVSIISVCLIVMWMTLFKSNPIQS,MRLKSIITVIALILIMFMSAIESSIISLALPTIKQDLNAGNLISLIFTAYFIALVIANPIVGELLSRFKIIYVAIAGLLLFSIGSFMCGLSTNFTMLIISRVIQGFGSGVLMSLSQIVPKLAFEIPLRYKIMGIVGSVWGISSIIGPLLGGGILEFATWHWLFYINIPIAIIAIILVIWTFHFPEEETVAKSKFDTKGLTLFYVFIGLIMFALLNQQLLLLNFLSFILAIVVAMCLFKVEKHVSSPFLPVVEFNRSITLVFITDLLTAICLMGFNLYIPVYLQEQLGLSPLQSGLVIFPLSVAWITLNFNLHRIEAKLSRKVIYLLSFTLLLVSSIIISFGIKLPVLIAFVLILAGLSFGYIYTKDSVIVQEETSPLQMKKMMSFYGLTKNLGASIGSTIMGYLYAIQSGIFGPNLHNVLSAVAVISIGLIVLWVVFFKEQSSQSKE,99.55,gnl|BL_ORD_ID|4661|hsp_num:0,5729,FALSE,None
LK1231,61_5 # 3153 # 3902 # -1 # ID=61_5;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.779,61_5,3153,3902,-,Strict,50,83.5741,vanY gene in vanM cluster,34.46,3002961,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGTCGCACCCTCCCTCTCGCCGCGCTGGCCGCGCTCGCGCTGCTCGCGGCCGGTTGCGGCACGCCCGCCGCGGGCCCGTCCTCGACGCCGACGACGCCGACGTCCGGCTCCGCGAGCGCGGCCGCGTCGTCCCGCGCCGCCTCGAGCACGGCGCCGTCGTCGGGCACGCACGCCGACCCGGCCACCCTCGACGTCGTCGTGAACAAGACCCGCCCCGTGGCCCCGCCCGACTGGGCGCCCTCGGATCTGGTGGCCGTGCCCGGCAGCGAGCTGCCCCTGCGGGCGGAGGCCGCGACGGCGGCCGCTGACCTGCTGGATGCCGCCGCGGCGGCGGGCCACCGCCTCACCACCCTGAGCGCCTACCGCTCGTACGACTACCAGGTCCGGACGTACGGCCACTGGGTCGACGAGCTGGGCCGCGCCGAGGCCGACCGCGTCTCCGCGCGTCCGGGGTACTCCGAGCACCAGACCGGCCTGGCCTGGGACGTGGGCGACGCCGCGACCCCCGCGTGTGACCTGGAAGCGTGCTTCGGCGACACCGCCGCGGGCCGTTGGGTGGCCGCGCACGCCGCCGAGTACGGGTTCGTCATCCGCTATCCCGCCGGGGCCGAGGACGTGACGGGCTTCGATCACGAGCCGTGGCACCTGCGCTACGTCGGGTCCGCGGAGGCGGCCCGGGTCGAGGCGGCCGGCGGCGTCCTCGAGACCGCGTGGGGTCTGCCGCCGGCGCCGGACTACGCGGACTGA,MRRTLPLAALAALALLAAGCGTPAAGPSSTPTTPTSGSASAAASSRAASSTAPSSGTHADPATLDVVVNKTRPVAPPDWAPSDLVAVPGSELPLRAEAATAAADLLDAAAAAGHRLTTLSAYRSYDYQVRTYGHWVDELGRAEADRVSARPGYSEHQTGLAWDVGDAATPACDLEACFGDTAAGRWVAAHAAEYGFVIRYPAGAEDVTGFDHEPWHLRYVGSAEAARVEAAGGVLETAWGLPPAPDYAD,MVFQGNLLLVNNEYPVLEESIKTDVVNLFKHDELTKGYELLNREIYLSEKVAREFSEMVDAAEKEGVRHFSINSGFRNFDEQNALYQEMGSDYALPAGYSEHNLGLALDIGSTQMEMSEAPEGKWLEDNAWEYGFILRYPMDKTAITGIQYEPWHFRYVGLPHSAIIEEKNFALEEYLDFLKEQKSISGTIHGENYEISYYPITEKTDIEMPANLHYEISGNNMDGVIVTVYR,106.87,gnl|BL_ORD_ID|1673|hsp_num:0,1713,FALSE,None
LK1009,92_5 # 3204 # 3953 # -1 # ID=92_5;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.780,92_5,3204,3953,-,Strict,50,83.5741,vanY gene in vanM cluster,34.46,3002961,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGTCGCACCCTCCCCCTCGCCGCGCTGGCCGCGCTCGCGCTGCTCGCGGCCGGCTGCGGCACGCCCGCCGCGGGCCCGTCCTCGACACCGACGACGCCGACGTCCGGCTCCGCGAGCGCGGCCGCGTCGTCCCGCGCCGCCTCGAGCACGGCGCCGTCGTCGGGCACGCACGCCGACCCGGCCACCCTCGACGTCGTCGTGAACAAGACCCGCCCCGTGGCCCCGCCCGACTGGGCGCCCTCGGATCTGGTGGCCGTGCCCGGCAGCGAGCTGCCCCTGCGGGCGGAGGCCGCGACGGCGGCCGCTGACCTGCTGGATGCCGCCGCGGCGGCGGGCCACCGCCTCACCACCCTGAGCGCCTACCGCTCGTACGACTACCAGGTCCGGACGTACGGCCACTGGGTCGACGAGCTGGGCCGCGCCGAGGCCGACCGCGTCTCCGCGCGTCCGGGGTACTCCGAGCATCAGACCGGCCTGGCCTGGGACGTGGGCGACGCCGCGACCCCCGCGTGTGACCTGGAAGCGTGCTTCGGCGACACCGCCGCGGGCCGTTGGGTGGCCGCGCACGCCGCCGAGTACGGGTTCGTCATCCGCTACCCCGCCGGGGCCGAGGACGTGACGGGCTTCGCCCACGAGCCCTGGCATCTGCGCTACGTCGGGTCCGCGGAGGCGGCCCGGGTCGAGGCGGCCGGCGGCGTCCTCGAGACCGCGTGGGGTCTGCCGCCGGCACCCGACTACGCGGACTGA,MRRTLPLAALAALALLAAGCGTPAAGPSSTPTTPTSGSASAAASSRAASSTAPSSGTHADPATLDVVVNKTRPVAPPDWAPSDLVAVPGSELPLRAEAATAAADLLDAAAAAGHRLTTLSAYRSYDYQVRTYGHWVDELGRAEADRVSARPGYSEHQTGLAWDVGDAATPACDLEACFGDTAAGRWVAAHAAEYGFVIRYPAGAEDVTGFAHEPWHLRYVGSAEAARVEAAGGVLETAWGLPPAPDYAD,MVFQGNLLLVNNEYPVLEESIKTDVVNLFKHDELTKGYELLNREIYLSEKVAREFSEMVDAAEKEGVRHFSINSGFRNFDEQNALYQEMGSDYALPAGYSEHNLGLALDIGSTQMEMSEAPEGKWLEDNAWEYGFILRYPMDKTAITGIQYEPWHFRYVGLPHSAIIEEKNFALEEYLDFLKEQKSISGTIHGENYEISYYPITEKTDIEMPANLHYEISGNNMDGVIVTVYR,106.87,gnl|BL_ORD_ID|1673|hsp_num:0,1713,FALSE,None
LK1030,20_22 # 31301 # 33007 # -1 # ID=20_22;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.651,20_22,31301,33007,-,Strict,50,78.1814,vanW gene in vanI cluster,31.95,3003724,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanW; glycopeptide resistance gene cluster,AATCTTGTAGAAGTGACTACGGTAAATGCAACAGGTGCCCGCGGTGGGCGCGGGGTCAGCACCGGGAAGATTCTCCTCGGTGTGCTTCTCGGCGTGCTCGCGGTGCTGCTTGCGATCTACCTCGCCGACCTCGCAATGAACCGCGGGAACGTGCCGCGTGGCACCGCCGTCGGCGGTGTCGAGATCGGCGGCATGAGCCACGACGAGGCCACCGCGAAGCTCGAAGCAGAGCTCGGTGAGACGGCGAGCAACCCCGTGACGGTGAAGGCGGCATCGCAAAGCTCGCAGCTCGTGCCCGCCGAGTCCGGCCTCGGCATCGACTGGGAGGCGACCGTAGCAAGCGCGGGCGAAGAGTCCGCGAACCCGTTCACTCGCCTCGCCGGGCTGTTTCGCACCCGCGAAGTCGACATTGTGTCGACCGTGAACGAGGCCGCTCTCACCCCGCAGCTTGAGCGCGTGGCCGGCGAGTTGCACCTCGACCCCGCCGACGGCGCGATCGCCATCGAAGGCGGCGAGGCGAAAGTGACCGAACCGGTGCCGGGCCAGGAGGTTGACGAAACCGAGCTGTTCGAACGTGTCACCACCGGCTGGCTCAACCCCGACGGTGTAGAGGTCGAGCCGCGCGAAATCGAACCCGCTATCGGCGACCAGGCCATCAAGGAAGCCTTAGACGGGCCGGTTAAGGCGGCGCTGTCCGGAGCGTTGACACTGCACGGTCGCGACGGCGTCGACGGTGTCATTGCCCAAGAGCGCATCGGCGAGGTCGTCCAATTCCCCAACGTCGACGGCAAAATCGCCCCCGAGGTGAACGTGGAAAACGCCCAGGGCATCTTGGTCGAGCAGCTCGCTGCGACCGAGACGCAGATGAAAAACGCGCGCGTGCTGCCCGGCGGCGGGGTGGAACCGTCCGTCGATGGCTCCATCATCGACTGGGAGGCCGCGATGGACGGTTTCGACGAGCGGTTGATCGGTTCCGCCGAGCGCACCTGGGACGCGCAATACAAGGCCCGCCCGGCCGACTTCACTACAGAGGAAGCCCAACGTGCCAGGTTCGACGAGGTGGTGGGAAGTTTCACCACCGGCGGGTACAGCGGCGCATCCGGCACGAACATCGCTACGGTGGCCCGCGTTGTCAACGGCGCAATTGTCAACCCCGGTGAAACCTTCTCGCTCAACGGCTACACTGGCGCGCGCGGTGCCGCGCAGGGTTACGTCGAGTCGGGCATCATCGAAAATGGACGCCCCGGCAAGGCAGTGGGCGGCGGAATCTCCCAATTTGCCACGACCTTGTACAACGCGGCTTACTTTGCCGGCATGACGGATGTCGCCTCCACCCCGCACTCCTACTACATTTCACGCTACCCGGCTGGCAGGGAGGCGACCGTGTATGAAGGGGCGATTGACCTGCAATTCCGCAACGATTCGCCCCACCCGGTCAAGATTTCCACGAGCGTCGGGGGCGGCGAGGTGACGGTGAGCCTGATGGGCACCAAGACCGTCGAGGTGGAGTCCATCAACGGAGGGCGCTGGAACTACACCTCGCCGAAGCCCGTGACCGTCACCAGTGGTGACTGCATTCCCTCGGGCGGGGTGCAGGGCTTTACCACCTCCGATACCCGGATTGTGCGTGACCTCAGCGGCAATGAGATCAGTCGCAACACCTCCACCACGGTCTACGACCCGCAGCCCATCGTGCGCTGCGAGTAG,NLVEVTTVNATGARGGRGVSTGKILLGVLLGVLAVLLAIYLADLAMNRGNVPRGTAVGGVEIGGMSHDEATAKLEAELGETASNPVTVKAASQSSQLVPAESGLGIDWEATVASAGEESANPFTRLAGLFRTREVDIVSTVNEAALTPQLERVAGELHLDPADGAIAIEGGEAKVTEPVPGQEVDETELFERVTTGWLNPDGVEVEPREIEPAIGDQAIKEALDGPVKAALSGALTLHGRDGVDGVIAQERIGEVVQFPNVDGKIAPEVNVENAQGILVEQLAATETQMKNARVLPGGGVEPSVDGSIIDWEAAMDGFDERLIGSAERTWDAQYKARPADFTTEEAQRARFDEVVGSFTTGGYSGASGTNIATVARVVNGAIVNPGETFSLNGYTGARGAAQGYVESGIIENGRPGKAVGGGISQFATTLYNAAYFAGMTDVASTPHSYYISRYPAGREATVYEGAIDLQFRNDSPHPVKISTSVGGGEVTVSLMGTKTVEVESINGGRWNYTSPKPVTVTSGDCIPSGGVQGFTTSDTRIVRDLSGNEISRNTSTTVYDPQPIVRCE,MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVLAEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPELLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGMETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGGEFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSHSLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDEPDGYPVKPREWSK,152.28,gnl|BL_ORD_ID|4748|hsp_num:0,2242,FALSE,None
LK1030,5_137 # 126753 # 127124 # -1 # ID=5_137;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.656,5_137,126753,127124,-,Strict,200,223.402,Mycobacterium tuberculosis rpsL mutations conferring resistance to Streptomycin,90.91,3003395,protein variant model,K88R,n/a,aminoglycoside antibiotic,antibiotic target alteration,antibiotic-resistant rpsL,ATGCCAACTATCCAGCAGCTGGTCCGCAAAGGCCGCCACGATAAGCGCACCAAGGTCGCTACCGCGGCCCTGAAGGGCTCCCCGCAGCGCCGCGGTGTGTGCACCCGTGTATACACCACCACCCCGAAGAAGCCGAACTCCGCTCTGCGTAAGGTTGCCCGCGTGCGCCTGACCTCGGGCATCGAGGTCTCCGCATACATCCCCGGCGAGGGCCACAACCTGCAGGAGCACTCCATGGTGCTCGTACGCGGCGGCCGTGTGAGGGACCTTCCGGGCGTTCGCTACAAGATCATCCGCGGCGCGCTTGACACCCAGGGTGTTAAGGACCGCAAGCAGGCTCGCTCCCGCTACGGCGCGAAGAAGGGACAGTAA,MPTIQQLVRKGRHDKRTKVATAALKGSPQRRGVCTRVYTTTPKKPNSALRKVARVRLTSGIEVSAYIPGEGHNLQEHSMVLVRGGRVRDLPGVRYKIIRGALDTQGVKDRKQARSRYGAKKGQ,MPTIQQLVRKGRRDKISKVKTAALKGSPQRRGVCTRVYTTTPKKPNSALRKVARVKLTSQVEVTAYIPGEGHNLQEHSMVLVRGGRVKDLPGVRYKIIRGSLDTQGVKNRKQARSRYGAKKEKG,99.19,gnl|BL_ORD_ID|1956|hsp_num:0,1197,FALSE,None
LK1002,78_8 # 8886 # 9629 # 1 # ID=78_8;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.781,78_8,8886,9629,+,Strict,50,82.0333,vanY gene in vanF cluster,31.72,3002958,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGTCGCCCCCTCCCCCTCGCCGCGCTGGCCGCGCTCGCGCTGCTCGCGGCCGGCTGCGGCACGCCCGCCGCGGGCCCGTCCTCGGCGACGCCGGCTTCCGGCTCCTCGAGCGCGGCCGCGTCGTCCGGCGCCGCCTCGAGCACGGCGCCGTCGTCGAGCACGCACGCCGACCCGGCCGCCCTCGACGTCGTCGTGAACAAGACCCGCCCCGTGGCCCCGCCCGACTGGGCGCCCTCGGATCTGGTGGCCGTGCCCGGCAGCGAGCTGCCCCTGCGGGCGGAGGCCGCGACGGCGGCCGGTGACCTGCTGGGTGCGGCCGCGGCGGCGGGCCACGACCTCACCACCCTGAGCGCCTACCGCTCGTACGACTACCAGGTCCGGACGTACGGCCACTGGGTCGACGAGCTGGGCCGCGCCGAGGCCGACCGCGTCTCGGCGCGTCCGGGGTACTCCGAGCACCAGACCGGCCTGGCCTGGGACGTGGGCGACGCCGCGACCCCCGCGTGTGACCTGGAGGCGTGCTTCGGCGACACCGCCGCGGGCCACTGGGTGGCCGCGCACGCCGCCGAGTACGGGTTCGTCATCCGCTATCCCGCCGGGGCCGAGGACGTGACGGGCTTCGACCACGAGCCCTGGCACCTGCGCTACGTCGGGTCCACGGAGGCGGCCCGGGTCGAGGCGGCCGGCGGCGTCCTCGAGACCGCGTGGGGTCTGCCTCCGGCGCCCGACTACGCGGACTGA,MRRPLPLAALAALALLAAGCGTPAAGPSSATPASGSSSAAASSGAASSTAPSSSTHADPAALDVVVNKTRPVAPPDWAPSDLVAVPGSELPLRAEAATAAGDLLGAAAAAGHDLTTLSAYRSYDYQVRTYGHWVDELGRAEADRVSARPGYSEHQTGLAWDVGDAATPACDLEACFGDTAAGHWVAAHAAEYGFVIRYPAGAEDVTGFDHEPWHLRYVGSTEAARVEAAGGVLETAWGLPPAPDYAD,MKKWGLLLVFALFLVFIFNILPISQDKVEDRIYEQNDKDTSDDKMTAENMQKIELTEEQIYQGNLLLVNNEHPVHQKSIKSDIINLFTHKELTKGYGLLDNEIKLSEEIAGKFSEMIAAAEEDGVSNFLISSGYRDLDEQSRLYEEMGSDFALPAGHSEHNLGLSLDVGSTQMKMDKAPEGKWIEKNCWEYGFILRYPLDKTDVTGIQYEPWHIRYVGLPHSAIMQEMNLALEEYLDYLKEEKSISVRVDGKKYTISYDPISQNETIEVEVPADEQYEISGNNIDGVIVTTFS,84.3,gnl|BL_ORD_ID|1808|hsp_num:0,1899,FALSE,None
LK953,1_134 # 145943 # 147070 # -1 # ID=1_134;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.615,1_134,145943,147070,-,Strict,175,183.726,vanT gene in vanG cluster,32.6,3002972,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,glycopeptide resistance gene cluster; vanT,ATGTCAAGATGCCCGTCGCCCTCACACGCCATTGTTGATCTGTCTGCCATCGCTGCGAACCTCGCCGTCGTCAGGAAACGGGCTGGTGACCGGAAGGTCCTCTTCGCCGTCAAGGCCGATGCTTATGGGCACGGCGCCGTCGAAGTCTCCCGCTATGTCGAAAAACATCACTGCGCTGACTGGCTCGCCGTCGCCACTGTCGCGGAAGGCCAAGAGCTGGTGGAAGCCAGCATCACACTCCCCATCCTCAAGCTCTCCCCCGTTGACCCCTGGGACCTCGATGCCGCTATCGAATCCGGCATGCGTCTCACGGTGGTGGATTTCGACACCCTGGATGCAGTGAACTTTGCCGCCGGGAAACGGGGAGTTACCGTCAAGATCCACATTGCCGTCGATAGCGGTATGGGGCGTATTGGGTTGCGGCCGGAACAACTTGGCGAACTCACGGCCGCCGCGGATCGTGCCGAGAACGTCGAGGTCGAGGGAGTATTCACTCACCTGCCCATCAGTGACGTCCCCGAGGGAGAGGACTTCACGCGACGCGAGATAAGCACCTTCATGGATGCTGTATCCCGGATCGAGGCGGAGCGCGGACCCTTCCCACTGGTGCACCTTGCCAACTCCGGCGCCATCCTTGGGCATGACCTGGGACGAACGTCGATGGTGCGCGCAGGCATCGTCGGTTACGGATACGACCCCGACCCGCACGCTGATCGCGCCGAACTGCGCCCTGCTTTGTCCTGGGTGAGTCACGTCACCTTCGTCAAAACTGTCAATCCGGGCGACACTATTGGCTACGGAAGGACTTGGACCGCAGGCGAGACGACAAAAATCGCCACCGTGCCTGTCGGATACGCCGATGGGCTGTCGAGGGCGTTGTCGAACAAGGGGCGCGTGCTCATCGGAGGCGCTGTCCACCCCATCGTCGGTCGGGTGTGCATGGATCAGTTCATGGTCGATCTCGGCCCCGATCCGACTGCCACCGTGGGTGATGAGGTGGTTCTCATCGGAACCCAGGAAGACGAGGTCCTGACCGCCGACGACATGGCCGAGCAGCTCGGAACCATCAGTTACGAGATCACCTGTGACATTTCGAAGCGGGTGGATCGTCATTGGACCGGGGAATGA,MSRCPSPSHAIVDLSAIAANLAVVRKRAGDRKVLFAVKADAYGHGAVEVSRYVEKHHCADWLAVATVAEGQELVEASITLPILKLSPVDPWDLDAAIESGMRLTVVDFDTLDAVNFAAGKRGVTVKIHIAVDSGMGRIGLRPEQLGELTAAADRAENVEVEGVFTHLPISDVPEGEDFTRREISTFMDAVSRIEAERGPFPLVHLANSGAILGHDLGRTSMVRAGIVGYGYDPDPHADRAELRPALSWVSHVTFVKTVNPGDTIGYGRTWTAGETTKIATVPVGYADGLSRALSNKGRVLIGGAVHPIVGRVCMDQFMVDLGPDPTATVGDEVVLIGTQEDEVLTADDMAEQLGTISYEITCDISKRVDRHWTGE,MTKNESYSGIDYFRFIAALLIVAIHTSPLSSFSETGNFIFTRIVARVAVPFFFMTSGFFLISRYTCNAEKLGAFIKKTTLIYGVAILLYIPINVYNGYFKMDNLLPNIIKDIVFDGTLYHLWYLPASIIGAAIAWYLVKKVHYRKAFLIASILYIIGLFGDSYYGIVKSVSCLNVFYNLIFQLTDYTRNGIFFAPIFFVLGGYISDSQNRLSLKRSIVGFIVCFALMFGEALTLHHFDIQKHDSMYVLLLPSVYCLFNLLLHFRGKRRTGLRTISLIIYIIHPFMIVVIRLFAKLLHLQSLLVENSLVHYIAVCFASVVLAVVITALLSSLKPKKAKHTADTDRAYLEINLNNLEHNVNTLQKAMSPKCELMAVVKAEAYGHGMYEVTTYLEQIGVSSFAVATIDEGIRLRKYGISSEILILGYTSPSRAKELCKYELTQTLIDYRYSLLLNKQGYDIKAHIKIDTGMHRLGFSTEDKDKILAAFSLKHIKVAGIFTHLCAADSLEENDVAFTNKQIGSFYKVLDWLKSSGLNIPKVHIQSSYGLLNYPELECDYIRVGVALYGVLSSTNDKTKLELDLRPVLSLKAKVVLIRKIKQGESVGYSRAFTATRDSLIAILPIGYADGFPRNLSCGNSYVLIGGRQAPIVGKICMDQLAVDVTDIPNVKTGSIATLIGKDGKEEITAPMVAESAESITNELLSRMGHRLNIIRRA,52.67,gnl|BL_ORD_ID|1522|hsp_num:0,1561,FALSE,None
LK953,3_158 # 170538 # 170627 # 1 # ID=3_158;partial=01;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.533,3_158,170538,170627,+,Strict,350,20.7866,vanB,100,3000013,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,glycopeptide resistance gene cluster; Van ligase,ATGTGGCCCAACAATGAGGACGACCTCATAGTCGGCCCGGATACGGGTATGAAAAAAGTGCGTGTGGAGACAAGGATCAACCTCGTCTCC,MWPNNEDDLIVGPDTGMKKVRVETRINLVS,MNRIKVAIIFGGCSEEHDVSVKSAIEIAANIDTEKFDPHYIGITKNGVWKLCKKPCTEWEADSLPAILSPDRKTHGLLVMKESEYETRRIDVAFPVLHGKCGEDGAIQGLFVLSGIPYVGCDIQSSAACMDKSLAYILTKNAGIAVPEFQMIDKGDKPEAGALTYPVFVKPARSGSSFGVTKVNGTEELNAAIEAAGQYDGKILIEQAISGCEVGCAVMGNEDDLIVGEVDQIRLSHGIFRIHQENEPEKGSENAMITVPADIPVEERNRVQETAKKVYRVLGCRGLARVDLFLQEDGGIVLNEVNTLPGFTSYSRYPRMMAAAGITLPALIDSLITLALKR,8.77,gnl|BL_ORD_ID|1005|hsp_num:0,1098,TRUE,loose hit with at least 95 percent identity pushed strict
LK470,2_63 # 64839 # 65282 # -1 # ID=2_63;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.333,2_63,64839,65282,-,Strict,270,284.648,mgrA,94.56,3000815,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; cephalosporin; penam; tetracycline antibiotic; peptide antibiotic; disinfecting agents and antiseptics,antibiotic efflux,ATP-binding cassette (ABC) antibiotic efflux pump; major facilitator superfamily (MFS) antibiotic efflux pump,ATGTCTGAACAACATAATTTAAAAGAGCAGCTATGCTTTAGTTTGTACAATGCTCAAAGACAAGTTAATCGCTACTATTCTAACAAAGTCTTTAAAAAGTACAATCTAACATACCCACAATTTCTTGTTTTAACAATATTATGGGATGAATCACCTGTTAACGTCAAAAAGGTCGTTACAGAATTAGCACTTGATACTGGAACTGTATCGCCATTACTCAAGAGAATGGAACAAGTTGATTTAATCAAACGTGAACGTTCTGAAGTAGATCAACGTGAAGTATTTATTCACTTAACAGACAAAAGTGAAATGATTAGGCCCGAATTAAGCAACGCATCTGAGAAAGTTGCAACCGCTTCTTCTTTATCTAAAGAAGAGGTCAAAGAACTTAATCGCTTATTAGGTAAAGTCATCGATGCATTTATCGAAACAAAAGAAAAGTAA,MSEQHNLKEQLCFSLYNAQRQVNRYYSNKVFKKYNLTYPQFLVLTILWDESPVNVKKVVTELALDTGTVSPLLKRMEQVDLIKRERSEVDQREVFIHLTDKSEMIRPELSNASEKVATASSLSKEEVKELNRLLGKVIDAFIETKEK,MSDQHNLKEQLCFSLYNAQRQVNRYYSNKVFKKYNLTYPQFLVLTILWDESPVNVKKVVTELALDTGTVSPLLKRMEQVDLIKRERSEVDQREVFIHLTDKSETIRPELSNASDKVASASSLSQDEVKELNRLLGKVIHAFDETKEK,100,gnl|BL_ORD_ID|133|hsp_num:0,154,FALSE,None
LK470,2_71 # 72417 # 73580 # 1 # ID=2_71;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.320,2_71,72417,73580,+,Strict,700,757.288,norA,99.74,3000391,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGAAAAAACAATTATTCATTCTTTATTTTAATATATTTCTTATATTTTTAGGGATTGGATTAGTTATTCCTGTACTTCCTGTATATTTGAAGGATTTAGGATTAAAAGGTAGTGACTTAGGAATGCTAGTTGCTGCTTTTGCATTATCACAAATGATTATTTCACCATTTGGTGGGACACTAGCTGATAAATTGGGTAAAAAATTAATTATATGTATCGGTTTAGTATTCTTTGCTGTCTCTGAATTTATGTTCGCAGCCGGTCAAAGTTTTACCATTTTAATCATTTCACGTGTTTTAGGTGGCTTTAGTGCAGGCATGGTCATGCCTGGTGTAACAGCTATGATTGCAGATATTTCTCCAGGAGCTGATAAAGCTAAAAACTTTGGTTACATGTCGGCAATTATTAATTCAGGTTTTATATTAGGACCTGGATTTGGAGGCTTTTTAGCTGAAATTTCACATAGATTACCTTTCTATGTTGCTGGAACATTAGGTGTTGTTGCATTCATTATGTCAGTTTTATTAATTCATAATCCTCAAAAAGCAACTACAGATGGATTCCACCAATATCAACCTGAATTATTCACTAAAATTAATTGGAAAGTATTTATTACTCCAGTCATATTAACACTTGTATTAGCATTTGGTTTATCTGCTTTTGAAACATTATTTTCTTTATATACAGCTGACAAAGTAAATTATACTCCTAAAGATATTTCGATAGCTATTATCGGTGGAGGCGTGTTTGGCGCATTATTCCAAGTATTCTTCTTTGATAAATTTATGAAATATATGAGTGAACTTAATTTTATTGCATGGTCATTACTATATTCAGCCATTGTTCTCGTTATGTTAGTGCTTGCAAACGGTTATTGGACGATTATGATTATTAGTTTTGTTGTTTTTATAGGTTTTGATATGATTAGACCAGCTTTAACCAATTACTTCTCGAATATAGCAGGCAAACGGCAAGGTTTTGCAGGTGGATTGAATTCAACTTTTACCAGTATGGGTAACTTTATAGGTCCTCTTGTAGCTGGTGCATTATTCGATGTTAATTTAGAGTTTCCTTTATATATGGCTATTGCGGTTTCATTAAGTGGAATTATCATTATTTTTATTGAAAAAGGACTTAAGTCACGCCGTAAAGAAGCAAATTAA,MKKQLFILYFNIFLIFLGIGLVIPVLPVYLKDLGLKGSDLGMLVAAFALSQMIISPFGGTLADKLGKKLIICIGLVFFAVSEFMFAAGQSFTILIISRVLGGFSAGMVMPGVTAMIADISPGADKAKNFGYMSAIINSGFILGPGFGGFLAEISHRLPFYVAGTLGVVAFIMSVLLIHNPQKATTDGFHQYQPELFTKINWKVFITPVILTLVLAFGLSAFETLFSLYTADKVNYTPKDISIAIIGGGVFGALFQVFFFDKFMKYMSELNFIAWSLLYSAIVLVMLVLANGYWTIMIISFVVFIGFDMIRPALTNYFSNIAGKRQGFAGGLNSTFTSMGNFIGPLVAGALFDVNLEFPLYMAIAVSLSGIIIIFIEKGLKSRRKEAN,MKKQLFILYFNIFLIFLGIGLVIPVLPVYLKDLGLKGSDLGMLVAAFALSQMIISPFGGTLADKLGKKLIICIGLVFFAVSEFMFAAGQSFTILIISRVLGGFSAGMVMPGVTGMIADISPGADKAKNFGYMSAIINSGFILGPGFGGFLAEISHRLPFYVAGTLGVVAFIMSVLLIHNPQKATTDGFHQYQPELFTKINWKVFITPVILTLVLAFGLSAFETLFSLYTADKVNYTPKDISIAIIGGGVFGALFQVFFFDKFMKYMSELNFIAWSLLYSAIVLVMLVLANGYWTIMIISFVVFIGFDMIRPALTNYFSNIAGKRQGFAGGLNSTFTSMGNFIGPLVAGALFDVNLEFPLYMAIAVSLSGIIIIFIEKGLKSRRKEAN,100,gnl|BL_ORD_ID|1427|hsp_num:0,1554,FALSE,None
LK470,2_152 # 162232 # 163632 # 1 # ID=2_152;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.350,2_152,162232,163632,+,Strict,525,558.14,norC,61.99,3007010,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGAATACATCACAAAAGTTTAGGGGAGATAATCGCTTATTATTAGGGATTATTTTAGGGGTTATTACATTTTGGTTATTTGCACAATCACTTGTAAATCTAGTCGTGCCATTACAATCATCATACAATAGTGATATTGGTACTATTAATATAGCAGTTAGCTTATCGGCACTATTTTCTGGTCTGTTTATTGTAGGTGCAGGAGATATTGCAGATAAAATTGGTAGAGTAAAAGTGACGTACATAGGCTTAGCACTTAATATTGTTGGGTCGATTTTAATCATTATTACGCCATTACCAAGTCTATTGATTATTGGACGTGCTATTCAAGGATTGTCAGCGGCATGTATAATGCCAGCGACACTCGCAATCATTAATGAATATTATATCGGGACAGCACGACAACGTGCATTAAGCTACTGGTCCATCGGTTCATGGGGAGGTAGTGGTGTTTGTACTTTGTTTGGTGGTTTAATGGCAACTAACCTTGGATGGCGCTCAATCTTTATTGTTTCAATTATTCTGACAATATTATCCATGTTTCTCATTAAACATACACCCGAAACAAAAGCAGAGCCTATAGGAGATCAACCGACAGAGACAAAGAAATTTGATGTTGTTGGTTTAATCATCTTAGTGGTTAGTATGTTAAGTATTAATGTGATAATAACTCAAACCTCTCAATTTGGTTTGTTCTCACCATTTATTTTGGGACTTATTGCAATTTTTGTTATATCGTTAATTATATTCGTGATTTACGAAAATAAAATCAAACAACCACTTGTCGATTTTGATATCTTTAAAAACAAAGGTTATACAGGTGCAACGATTTCAAACTTTATGTTGAATGGTGTAGCTGGTGGTACATTGATTGTAGTAAATACTTTTTATCAGCAAAAATTAGATTTTAACTCTCAGGAAACAGGATATATTTCACTTACATACCTAATTGCAGTATTAATTATGATACGTGTGGGTGAAATGATATTACAATCGTTAGGACCTAAAAGACCTTTGTTACTCGGAAGTGCCTTGACCGTCATAGGATTAATATTATTATCTTTGACGTTTTTACCTAATGCTTGGTATATAGCGTCAAGTGTCATTGGTTATTTATTATTTGGTACCGGTTTAGGTGTTTATGCAACACCATCCACGGATACAGCTGTTGCACAAGCACCAGATGATAAAGTAGGCGTCGCATCCGGTGTATATAAGATGGCATCATCCTTAGGAAATGCATTTGGTGTGGCCATCTCAAGTACAGTTTACAGCGTACTTGCAGCCCAACTTAATCTGACTTTAGGTGGTTTTACTGGAGTAATGTTTAATGCGCTTATAGCATTATTAGCATTCCTTTCTATTTTGTTCTTAATACCGAAAAAACAGTCTAATGTATAA,MNTSQKFRGDNRLLLGIILGVITFWLFAQSLVNLVVPLQSSYNSDIGTINIAVSLSALFSGLFIVGAGDIADKIGRVKVTYIGLALNIVGSILIIITPLPSLLIIGRAIQGLSAACIMPATLAIINEYYIGTARQRALSYWSIGSWGGSGVCTLFGGLMATNLGWRSIFIVSIILTILSMFLIKHTPETKAEPIGDQPTETKKFDVVGLIILVVSMLSINVIITQTSQFGLFSPFILGLIAIFVISLIIFVIYENKIKQPLVDFDIFKNKGYTGATISNFMLNGVAGGTLIVVNTFYQQKLDFNSQETGYISLTYLIAVLIMIRVGEMILQSLGPKRPLLLGSALTVIGLILLSLTFLPNAWYIASSVIGYLLFGTGLGVYATPSTDTAVAQAPDDKVGVASGVYKMASSLGNAFGVAISSTVYSVLAAQLNLTLGGFTGVMFNALIALLAFLSILFLIPKKQSNV,MNETYRGGNKLILGIVLGVITFWLFAQSLVNVVPNLQQSFGADMGTISIAVSLTALFSGMFVVGAGGLADKIGRVKMTNIGLLLSIIGSALIIITNLPALLILGRIIQGVSAACIMPSTLAIMKTYYEGAERQRALSYWSIGSWGGSGICSLFGGAVATTMGWRWIFIFSIIVAVLSMLLIKGTPETKSEVTNTHKFDVAGLIVLVVMLLSLNVVITKGAALGYTSLWFFGLIAIVIVAFFIFLNVEKKVDNPLIDFKLFENKPYTGATISNFLLNGVAGTLIVANTFVQQGLGYTALQAGYLSITYLIMVLLMIRVGEKLLQKMGSKRPMLLGTFIVIIGIALISLVFLPGIFYVISCVVGYLCFGLGLGIYATPSTDTAISNAPLDKVGVASGIYKMASSLGGAFGVAISGAVYAGAVAATSIHTGAMIALWVNVLMGIMAFIAILFAIPNDDKRVKDAK,100.87,gnl|BL_ORD_ID|4656|hsp_num:0,5726,FALSE,None
LK470,3_72 # 72385 # 72870 # -1 # ID=3_72;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.364,3_72,72385,72870,-,Strict,300,331.643,dfrC,99.38,3002865,protein homolog model,n/a,n/a,diaminopyrimidine antibiotic,antibiotic target replacement,trimethoprim resistant dihydrofolate reductase dfr,ATGACATTATCAATAATTGTCGCTCACGATAAACAAAGAGTCATTGGGTACCAAAAGCAATTACCTTGGCACTTACCAAATGATTTAAAGCATGTTAAACAACTGACCACTGGGAATACACTTGTAATGGGACGGAAAACTTTTAATTCTATAGGGAAACCATTGCCAAATAGACGTAACGTCGTACTCACTAACCAAGCTTCATTTCACCATGAAGGGGTAGATGTTATAAACTCTCTTGATGAAATTAAAGAGTTATCTGGTCATGTTTTTATATTTGGAGGACAAACGTTATTCGAGGCAATGATTGACCAGGTAGATGATATGTATATCACAGTAATAGATGGAAAGTTTCAAGGAGACACATTCTTTCCACCATACACATTCGAAAACTGGGAAGTCGAATCTTCAGTAGAAGGTCAACTAGATGAAAAAAATACTATACCGCATACATTCTTACATTTAGTGCGTAGAAAAGGGAAATAG,MTLSIIVAHDKQRVIGYQKQLPWHLPNDLKHVKQLTTGNTLVMGRKTFNSIGKPLPNRRNVVLTNQASFHHEGVDVINSLDEIKELSGHVFIFGGQTLFEAMIDQVDDMYITVIDGKFQGDTFFPPYTFENWEVESSVEGQLDEKNTIPHTFLHLVRRKGK,MTLSIIVAHDKQRVIGYQNQLPWHLPNDLKHVKQLTTGNTLVMGRKTFNSIGKPLPNRRNVVLTNQASFHHEGVDVINSLDEIKELSGHVFIFGGQTLFEAMIDQVDDMYITVIDGKFQGDTFFPPYTFENWEVESSVEGQLDEKNTIPHTFLHLVRRKGK,100,gnl|BL_ORD_ID|1279|hsp_num:0,1397,FALSE,None
LK470,7_25 # 35050 # 35478 # -1 # ID=7_25;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.294,7_25,35050,35478,-,Strict,150,177.178,FosBx1,59.12,3007372,protein homolog model,n/a,n/a,phosphonic acid antibiotic,antibiotic inactivation,fosfomycin thiol transferase,ATGGAAATAACAAATGTTAATCATATTTGTTTTTCAGTGAGTGATTTAAATACCTCTATACAATTTTATAAAGATATTTTACATGGTGACTTATTAGTATCAGATAGAACGACAGCATATTTAACTATTGGTCATACTTGGATTGCACTGAATCAAGAAAAAAATATACCAAGGAATGAAATAAGTCATTCCTATACGCACGTTGCTTTCTCCATAGATGAAGAAGATTTTCAACAGTGGATTCAATGGCTTAAAGAGAATCAAGTAAATATTTTAAAAGGGCGACCAAGAGACATTAAAGACAAAAAATCGATATATTTTACAGATCTGGATGGGCATAAAATTGAATTACATACTGGAACATTAAAAGATAGAATGGAATATTATAAATGTGAGAAGACGCATATGCAATTTTACGATGAGTTTTGA,MEITNVNHICFSVSDLNTSIQFYKDILHGDLLVSDRTTAYLTIGHTWIALNQEKNIPRNEISHSYTHVAFSIDEEDFQQWIQWLKENQVNILKGRPRDIKDKKSIYFTDLDGHKIELHTGTLKDRMEYYKCEKTHMQFYDEF,MLRGINHICFSVSNLENSIMFYEKVLEGELLVKGRKLAYFNICGVWIALNEETHIPRNEIHQSYTHIAFSVEKEDFKCLIQRLEENDVHILQGRERDVRDCESIYFVDPDGHKFEFHSGTLQDRLNYYRDEKPHMTFY,102.9,gnl|BL_ORD_ID|4909|hsp_num:0,5900,FALSE,None
LK470,14_3 # 3365 # 3832 # -1 # ID=14_3;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.233,14_3,3365,3832,-,Strict,100,231.491,sepA,70.97,3007012,protein homolog model,n/a,n/a,disinfecting agents and antiseptics,antibiotic efflux,small multidrug resistance (SMR) antibiotic efflux pump,ATGAAATTTTTAAAAAATAAATCATATCATTTATTAGTAACACTTATTGTTCTCACTATATTTGTTATTTCCGGAGCAATTTTTTTAACATTTTTAGGCTTTGGTTTGTACGGTTTGAGTCGCATCCTTATTTATTTACACTTAGGCGATTTTAGTTACAATAAAGGCTTTTATGATAATTTAATATACTACGGTAGTTATATCGTTTTAGGCTATTTTACTTTATTTTCAATTGAGCATTTAATGGATTATTTTAAAAAGAATCTTCCAAAAAATCCATACTTTCAAGGTATTAACTTTCATCTCATCTCCTATATTGTTACTACAATTATGTTTTATTTTATAGTTCACATACACTATGTACATGTTAATATACATTTTTGGGTAATTATGATTATTATAGGATTTTTATTTGTATGTAAAGAAGTTTTTTATCCTGAAAGTAAAAATTTGAATAATAAAAAGTAA,MKFLKNKSYHLLVTLIVLTIFVISGAIFLTFLGFGLYGLSRILIYLHLGDFSYNKGFYDNLIYYGSYIVLGYFTLFSIEHLMDYFKKNLPKNPYFQGINFHLISYIVTTIMFYFIVHIHYVHVNIHFWVIMIIIGFLFVCKEVFYPESKNLNNKK,MIVNFFKHKFYNLLTTMIVLFVFVLSGAIFLTFLGFGLYGLSRILIYFRLGDFTYNRNMYDNLLYYGSYIIFGYFIIFAVEHLMDYFRKMLPENAYFRGATFHLISYTVATTLFYFIIHLHYVYINIDFWVIMVIIGFLYVCKLQFYPESKNLNNRK,98.73,gnl|BL_ORD_ID|4660|hsp_num:0,5728,FALSE,None
LK470,14_4 # 4023 # 5360 # -1 # ID=14_4;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.294,14_4,4023,5360,-,Strict,200,611.683,sdrM,73.26,3007013,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGAATCTTAAGTCTATCATTACTGTAATGGCACTCATACTAATAATGTTTATGGCAGCTATAGAAACATCTATTATTTCATTAGCATTACCAACAATAAAAAATAGTTTGAATGCCGGTAATCTAGTTTCATTAGTATTTACCGTATATTTTATTGCTTTAGTCATAGCTAACCCTATCGTTGGTGAACTTATGTCTAGATTTAAAATTATTTACATTGCTGTTGTAGGGGTATTATTGTTTGCCTTAGGTAGTTTAATGTCGGGATTAAGTCAGACGTTTACTTTTTTAATTATCTCTCGAACAGTACAAGGTTTTGGAGCAGGAGTTATGATGTCACTCTCACAAATAGTTCCTAAGTTGGCTTTTGAAATTCCTTTGAGATATAAAATTATGGGTATAGTTGGAAGTGTTTGGGGAATTTCGAGTATTATTGGCCCATTATTAGGTGGTGCGATTTTAGAGTTTGCTTCATGGCATTGGCTATTCTATATCAATATTCCTATTGCTATAGTGGCAATAATACTTGTACTTATGACTTTTCATTTTCCTGATGAGACACAAGTACAACAGAGTCGTTTTGATATAAAAGGATTGATTATCTTTTATATCTTTATAGCTTTATTAATGTTTGGTTTACTCAACCAACATCATATTATTTTTAACATATTCTCAATTATTTTAGCTTTAGCTGTTTTATGGCTACTATTTAAAATAGAAAATAGTATCGAACAACCATTTCTTCCAACAAAAGAATTTAACATATCAATAGTTCTAGTTTTTATAACGGATTTACTTATTGCGATAACACTGATGGGATATAATTTATATATACCAGTATATTTACAAGAAAAACTTAGTTTATCACCTTTACAAAGTGGATTTGTAATATTCCCGTTGTCTGTTGCTTGGATTACGCTTAATTTCAATTTAGGTAAAATAGAAGCGCATTTTACTAGAAAAACATTATATATTTGCTCATTTTTTGTTTTATTAGTTAGTAGTCTGATGATAATGTTTGGCTTAAAACTCCCATTGCTTATTGCTTTTGCGGTTGTTTTTGCAGGTTTAAGTTTTGGTTATATTTATACAAAAGATAGTGTTATTGTCCAAGAGGAAACTTCTCCAAAAAATATGAAAAAGATGATGTCATTTTATGCATTGACAAAAAATTTAGGTTCGTCAGTCGGATCTACGATTATGGGCTATATGTATGCACTAAATGTTGGTTTATTTGGTTCTAATTTACACAATGTATTAGGATTAGTCTTAATAATTGCAGTATGTTTAATTGTAATGTGGATGACATTATATAAAAGCAATACTATTCAATCTTAG,MNLKSIITVMALILIMFMAAIETSIISLALPTIKNSLNAGNLVSLVFTVYFIALVIANPIVGELMSRFKIIYIAVVGVLLFALGSLMSGLSQTFTFLIISRTVQGFGAGVMMSLSQIVPKLAFEIPLRYKIMGIVGSVWGISSIIGPLLGGAILEFASWHWLFYINIPIAIVAIILVLMTFHFPDETQVQQSRFDIKGLIIFYIFIALLMFGLLNQHHIIFNIFSIILALAVLWLLFKIENSIEQPFLPTKEFNISIVLVFITDLLIAITLMGYNLYIPVYLQEKLSLSPLQSGFVIFPLSVAWITLNFNLGKIEAHFTRKTLYICSFFVLLVSSLMIMFGLKLPLLIAFAVVFAGLSFGYIYTKDSVIVQEETSPKNMKKMMSFYALTKNLGSSVGSTIMGYMYALNVGLFGSNLHNVLGLVLIIAVCLIVMWMTLYKSNTIQS,MRLKSIITVIALILIMFMSAIESSIISLALPTIKQDLNAGNLISLIFTAYFIALVIANPIVGELLSRFKIIYVAIAGLLLFSIGSFMCGLSTNFTMLIISRVIQGFGSGVLMSLSQIVPKLAFEIPLRYKIMGIVGSVWGISSIIGPLLGGGILEFATWHWLFYINIPIAIIAIILVIWTFHFPEEETVAKSKFDTKGLTLFYVFIGLIMFALLNQQLLLLNFLSFILAIVVAMCLFKVEKHVSSPFLPVVEFNRSITLVFITDLLTAICLMGFNLYIPVYLQEQLGLSPLQSGLVIFPLSVAWITLNFNLHRIEAKLSRKVIYLLSFTLLLVSSIIISFGIKLPVLIAFVLILAGLSFGYIYTKDSVIVQEETSPLQMKKMMSFYGLTKNLGASIGSTIMGYLYAIQSGIFGPNLHNVLSAVAVISIGLIVLWVVFFKEQSSQSKE,99.55,gnl|BL_ORD_ID|4661|hsp_num:0,5729,FALSE,None
LK1018,75_8 # 8810 # 9553 # 1 # ID=75_8;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.778,75_8,8810,9553,+,Strict,50,79.7221,vanY gene in vanM cluster,33.78,3002961,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGTCGCACCCTCCCCTTCGCCGCGCTGGCCGCGCTCGCGCTGCTCGTGGCCGGTTGCGGCACGCCCGCCGCGGGCCCGTCCTCGGCGACGCCGGCTTCCGGCTCCTCGAGCGCGGCCGCGTCGTCCCGCGCCGCCTCGAGCACGGCGCCGTCGTCGAGCACGCACGCCGACCCGGCCGCCCTCGACGTCGTCGTGAACAAGACCCGCCCCATGGCCCCGCCCGACTGGGCGCCCTCGGATCTGGTGGCCGTGCCCGGCAGCGAGCTGCCCCTGCGCGCGGAGGCCGCGACGGCGGCCGGCGACCTGCTGGATGCCGCCGCGGCGGCGGGCCACCGCCTCACCACCCTGAGCGCCTACCGCTCGTACGACTACCAGGTCCGGACGTACGGCCACTGGGTCGACGAGCTGGGCCGCGCCGAGGCCGACCGCGTCTCGGCGCGTCCGGGGTACTCCGAGCACCAGACCGGCCTGGCCTGGGACGTGAGCGACGCCGCGACCCCCGCGTGTGACCTGGAGGCGTGCTTCGGCGACACCGCCGCGGGCCGCTGGGTGGCCGCGCACGCCGCCGAGTACGGGTTCGTCATCCGCTATCCCGCCGGGGCCGAGGACGTGACGGGCTTCGACCACGAGCCCTGGCACCTGCGCTACGTCGGGTCCGCGGAGGCGGCCCGGGTCGAGGCGGCCGGCGGCGTCCTCGAGACCGCGTGGGGCCTGCCTCCGGCGCCGGACTACGCGGACTGA,MRRTLPFAALAALALLVAGCGTPAAGPSSATPASGSSSAAASSRAASSTAPSSSTHADPAALDVVVNKTRPMAPPDWAPSDLVAVPGSELPLRAEAATAAGDLLDAAAAAGHRLTTLSAYRSYDYQVRTYGHWVDELGRAEADRVSARPGYSEHQTGLAWDVSDAATPACDLEACFGDTAAGRWVAAHAAEYGFVIRYPAGAEDVTGFDHEPWHLRYVGSAEAARVEAAGGVLETAWGLPPAPDYAD,MVFQGNLLLVNNEYPVLEESIKTDVVNLFKHDELTKGYELLNREIYLSEKVAREFSEMVDAAEKEGVRHFSINSGFRNFDEQNALYQEMGSDYALPAGYSEHNLGLALDIGSTQMEMSEAPEGKWLEDNAWEYGFILRYPMDKTAITGIQYEPWHFRYVGLPHSAIIEEKNFALEEYLDFLKEQKSISGTIHGENYEISYYPITEKTDIEMPANLHYEISGNNMDGVIVTVYR,106.01,gnl|BL_ORD_ID|1673|hsp_num:0,1713,FALSE,None
LK1091,22_5 # 3147 # 3896 # -1 # ID=22_5;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.789,22_5,3147,3896,-,Strict,50,82.4185,vanY gene in vanM cluster,35.14,3002961,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGTCGTCCCCTCCCCCGCGCCGCGCTGGCCGCGCTCGCGCTGCTCGCGGCCGGCTGCGGCACGCCCGCCGCGGGCCCGTCCTCGGCGCCGGCGACGCCGGCTCCCGGCTCCTCGAGCGCGGCCGCGTCGTCCGGCGCCGCCTCGAGCACGGCGCCGTCGTCGAGCGCGCACGCCGACCCGGCCGCCCTCGACGTCGTCGTGAACAAGACCCGCCCCATGGCCCCGCCCGACTGGGCGCCCTCGGATCTGGTGGCCGTGCCCGGCAGCGAGCTGCCCCTGCGCGCGGAGGCCGCGACGGCGGCCGGCGACCTGCTGGATGCCGCCGCGGCGGCGGGCCACCGCCTCACCACCCTGAGCGCCTACCGCTCGTACGACTACCAGGTCCGGACGTACGGCCACTGGGTCGACGAGCTGGGCCACGCCGAGGCCGACCGCGTCTCGGCGCGTCCGGGGTACTCCGAGCACCAGACCGGCCTGGCCTGGGACGTGGGCGACGCCGCGACCCCCGCGTGTGACCTGGAAGCGTGCTTCGGCGACACCGCCGCGGGCCGCTGGGTGGCCGCGCACGCCGCCGAGTACGGGTTCGTCATCCGCTACCCCGCCGGGGCCGAGGACGTGACGGGCTTCGCCCACGAACCGTGGCACCTGCGCTACGTCGGGTCCGCGGAGGCGGCCCGGGTCGAGGCGGCCGGCGGCGTCCTCGAGACCGCGTGGGGCCTGCCTCCGGCGCCGGACTACGCGGACTGA,MRRPLPRAALAALALLAAGCGTPAAGPSSAPATPAPGSSSAAASSGAASSTAPSSSAHADPAALDVVVNKTRPMAPPDWAPSDLVAVPGSELPLRAEAATAAGDLLDAAAAAGHRLTTLSAYRSYDYQVRTYGHWVDELGHAEADRVSARPGYSEHQTGLAWDVGDAATPACDLEACFGDTAAGRWVAAHAAEYGFVIRYPAGAEDVTGFAHEPWHLRYVGSAEAARVEAAGGVLETAWGLPPAPDYAD,MVFQGNLLLVNNEYPVLEESIKTDVVNLFKHDELTKGYELLNREIYLSEKVAREFSEMVDAAEKEGVRHFSINSGFRNFDEQNALYQEMGSDYALPAGYSEHNLGLALDIGSTQMEMSEAPEGKWLEDNAWEYGFILRYPMDKTAITGIQYEPWHFRYVGLPHSAIIEEKNFALEEYLDFLKEQKSISGTIHGENYEISYYPITEKTDIEMPANLHYEISGNNMDGVIVTVYR,106.87,gnl|BL_ORD_ID|1673|hsp_num:0,1713,FALSE,None
LK1275,30_24 # 24513 # 25262 # 1 # ID=30_24;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.777,30_24,24513,25262,+,Strict,50,83.5741,vanY gene in vanM cluster,34.46,3002961,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGTCGCACCCTCCCTCTCGCCGCGCTGGCCGCGCTCGCGCTGCTCGCGGCCGGTTGCGGCACGCCCGCCGCGGGCCCGTCCTCGACGCCGACGACGCCGACGTCCGGCTCCGCGAGCGCGGCCGCGTCGTCCCGCGCCGCCTCGAGCACGGCGCCGTCGTCGGGCACGCACGCCGACCCGGCCACCCTCGACGTCGTCGTGAACAAGACCCGCCCCGTGGCCCCGCCCGACTGGGCGCCCTCGGATCTGGTGGCCGTGCCCGGCAGCGAGCTGCCCCTGCGGGCGGAGGCCGCGACGGCGGCCGCTGACCTGCTGGATGCCGCCGCGGCGGCGGGCCACCGCCTCACCACCCTGAGCGCCTACCGCTCGTACGACTACCAGGTCCGGACGTACGGCCACTGGGTCGACGAGCTGGGCCGCGCCGAGGCCGACCGCGTCTCCGCGCGTCCGGGGTACTCCGAGCACCAGACCGGCCTGGCCTGGGACGTGGGCGACGCCGCGACCCCCGCGTGTGACCTGGAAGCGTGCTTCGGCGACACCGCCGCGGGCCGTTGGGTGGCCGCGCACGCCGCCGAGTACGGGTTCGTCATCCGCTATCCCGCCGGGGCCGAGGACGTGACGGGCTTCGATCACGAGCCGTGGCACCTGCGCTACGTCGGGTCCGCGGAGGCGGCCCGGGTCGAGGCGGCCGGCGGCGTCCTCGAGACCGCGTGGGGTCTGCCGCCGGCGCCGGACTACGCGGACTGA,MRRTLPLAALAALALLAAGCGTPAAGPSSTPTTPTSGSASAAASSRAASSTAPSSGTHADPATLDVVVNKTRPVAPPDWAPSDLVAVPGSELPLRAEAATAAADLLDAAAAAGHRLTTLSAYRSYDYQVRTYGHWVDELGRAEADRVSARPGYSEHQTGLAWDVGDAATPACDLEACFGDTAAGRWVAAHAAEYGFVIRYPAGAEDVTGFDHEPWHLRYVGSAEAARVEAAGGVLETAWGLPPAPDYAD,MVFQGNLLLVNNEYPVLEESIKTDVVNLFKHDELTKGYELLNREIYLSEKVAREFSEMVDAAEKEGVRHFSINSGFRNFDEQNALYQEMGSDYALPAGYSEHNLGLALDIGSTQMEMSEAPEGKWLEDNAWEYGFILRYPMDKTAITGIQYEPWHFRYVGLPHSAIIEEKNFALEEYLDFLKEQKSISGTIHGENYEISYYPITEKTDIEMPANLHYEISGNNMDGVIVTVYR,106.87,gnl|BL_ORD_ID|1673|hsp_num:0,1713,FALSE,None
LK494,1_183 # 196143 # 197255 # -1 # ID=1_183;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.518,1_183,196143,197255,-,Strict,250,261.151,vanG,37.4,3002909,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,glycopeptide resistance gene cluster; Van ligase,ATGGAATGGGTTTTTAAGATGGCAAAGTTGCGGGTAGGAATCGTATTTGGTGGTAAATCAGCGGAACATGAAGTGTCATTGCAATCGGCAAAAAATATTGTCGATGCCATCGACAAGACTCGCTTTGACGTTGTGCTGTTAGGTATTGATAAACAAGGGCAATGGCACGTCAGCGATGCCAGTAATTATCTGCTCAATTCAGACGACCCGGCGCATATTGCGTTGCGACCTTCTGAGACCAGCCTGGCGCAGGTACCGGGTAAACAAGCGCACCAGTTGATCGATGCACAAAACGGTCAACCGCTGCCGACGGTCGATGTTATTTTCCCGATCGTACATGGCACTCTGGGTGAAGATGGCTCTCTGCAGGGCATGCTGCGCGTGGCAAACCTACCGTTCGTAGGTTCTGATGTGCTGGGTTCTGCGGCCTGTATGGATAAAGACGTGACCAAACGTCTGCTGCGTGATGCCGGATTAAACATCGCGCCATTTATTACGCTCACTCGCGCCAATCGCAACAGCATCAGCTTTAGCGAAGTGGAATCCCGCCTGGGTCTGCCGTTGTTTGTAAAACCGGCCAACCAGGGATCGTCCGTTGGCGTCAGCAAAGTAACCAGCGAAGCCCAATACGATCAGGCCGTTGCGCTGGCATTTGAATTCGATCATAAAGTCGTGGTGGAGCAAGGGATCAAAGGCCGCGAGATCGAATGTGCGGTACTGGGCAACGATCATCCGCAGGCCAGTACTTGTGGAGAGATTGTGCTGAACAGCGATTTTTACGCTTACGACACTAAATACATTGACGATAACGGTGCCACAGTTGTCGTTCCGGCAGCAATTGCACCAGAGATTAACGACAAGATCCGCGAAATCGCCATTCAGGCCTACCAGACACTGGGCTGTGCCGGCATGGCGCGCGTGGACGTTTTCTTAACTGCTGAAAACGACGTTGTGATCAATGAGATCAACACGCTGCCAGGCTTTACCAACATCAGTATGTATCCGAAGCTGTGGCAGGCGAGCGGTTTAGGCTATACCGATTTGATCACTCGCCTGATCGAACTGGCGCTGGAACGCCATGCTGCGGATAGCGCGCTGAAAACCAGTATGTAA,MEWVFKMAKLRVGIVFGGKSAEHEVSLQSAKNIVDAIDKTRFDVVLLGIDKQGQWHVSDASNYLLNSDDPAHIALRPSETSLAQVPGKQAHQLIDAQNGQPLPTVDVIFPIVHGTLGEDGSLQGMLRVANLPFVGSDVLGSAACMDKDVTKRLLRDAGLNIAPFITLTRANRNSISFSEVESRLGLPLFVKPANQGSSVGVSKVTSEAQYDQAVALAFEFDHKVVVEQGIKGREIECAVLGNDHPQASTCGEIVLNSDFYAYDTKYIDDNGATVVVPAAIAPEINDKIREIAIQAYQTLGCAGMARVDVFLTAENDVVINEINTLPGFTNISMYPKLWQASGLGYTDLITRLIELALERHAADSALKTSM,MQNKKIAVIFGGNSTEYEVSLQSASAVFENINTNKFDIIPIGITRSGEWYHYTGEKEKILNNTWFEDSKNLCPVVVSQNRSVKGFLEIASDKYRIIKVDLVFPVLHGKNGEDGTLQGIFELAGIPVVGCDTLSSALCMDKDRAHKLVSLAGISVPKSVTFKRFNEEAAMKEIEANLTYPLFIKPVRAGSSFGITKVIEKQELDAAIELAFEHDTEVIVEETINGFEVGCAVLGIDELIVGRVDEIELSSGFFDYTEKYTLKSSKIYMPARIDAEAEKRIQEAAVTIYKALGCSGFSRVDMFYTPSGEIVFNEVNTIPGFTSHSRYPNMMKGIGLSFSQMLDKLIGLYVE,106.02,gnl|BL_ORD_ID|1069|hsp_num:0,1157,FALSE,None
LK494,1_278 # 292207 # 295356 # -1 # ID=1_278;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.532,1_278,292207,295356,-,Strict,1900,2004.56,acrB,94.66,3000216,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGCCTAATTTCTTTATCGATCGCCCAATATTTGCGTGGGTGATCGCCATTATCATCATGTTGGCAGGGGGGCTCGCGATCCTCAAATTGCCGGTAGCGCAATATCCGACTATTGCACCGCCAGCAGTGACGATCTCCGCGACCTACCCTGGCGCTGATGCCAAAACAGTACAGGATACTGTTACGCAGGTTATCGAACAGAATATGAACGGTATCGATAACTTGATGTACATGTCCTCTAACAGTGACTCCACGGGTACCGTGCAGATCACCCTGACCTTCCAGTCTGGTACTGATGCGGATATCGCACAGGTACAGGTGCAGAACAAACTGCAGCTGGCCATGCCGTTGCTGCCTCAGGAAGTACAGCAGCAAGGGGTTAGCGTTGAGAAGTCATCCAGCAGCTTCCTGATGGTTGTCGGTGTTATCAACACCAACGGCACCATGACGCAGGAGGATATTTCCGACTACGTTGGCGCCAACATGAAGGATGCCATTAGCCGTACTTCAGGCGTGGGCGACGTTCAGCTGTTTGGTTCTCAGTACGCGATGCGTATCTGGATGGATCCGAACAAACTGAACAACTTCCAGCTGACACCGGTTGATGTAATCAGCGCCATCAAAGCGCAGAACGCCCAGGTTGCAGCCGGTCAGTTAGGTGGTACGCCGCCGGTGAAAGGTCAGCAGCTTAACGCATCGATCATTGCGCAAACCCGTCTGACCTCCGCTGATGAGTTCGGCAAAATCCTGCTGAAAGTGAATCAGGATGGTTCCCAGGTTCGTCTGCGTGACGTGGCGAAAGTGGAACTGGGCGGTGAGAACTACGACATCATTGCGAAGTTCAACGGTAAACCGGCATCCGGTCTGGGTATCAAGCTGGCAACAGGTGCTAACGCCCTGGACACCGCAAACGCTATCCGCGAAGAACTGAAGAAGATGGAGCCGTTCTTCCCGTCAGGTCTGAAGATCGTTTACCCGTATGACACCACGCCGTTCGTGAAAATTTCTATTCACGAAGTAGTGAAAACGCTGGCAGAAGCAATCATCCTCGTGTTCCTGGTAATGTATCTGTTCCTGCAGAACTTCCGCGCGACGCTGATTCCGACTATCGCCGTGCCGGTGGTACTCTTGGGTACGTTTGCCGTCCTGGCGATTTTCGGCTTCTCAATAAATACCCTGACGATGTTCGGGATGGTGCTCGCCATCGGCCTGCTGGTGGATGACGCCATCGTGGTGGTCGAGAACGTTGAACGTGTAATGGCTGAGGAAGGACTACCGCCGAAGGAAGCAACGCGAAAATCGATGGGCCAGATTCAGGGCGCATTGGTGGGTATCGCGATGGTGCTGTCAGCGGTATTTATCCCAATGGCGTTCTTCGGGGGGTCGACCGGTGCAATTTACCGTCAGTTCTCCATCACCATTGTTTCCGCGATGGCGCTGTCTGTACTGGTGGCATTGATTCTGACCCCTGCCCTGTGTGCGACCATGCTCAAACCGATTGCTAAAGGCGATCACGGAGAAGGCAAAAAAGGTTTCTTCGGCTGGTTTAACCGCATGTTCGATAAGAGCACGCATCATTACACCGATAGCGTGGGCGGTATTCTGCGCAGCACCGGTCGTTATCTGGCGCTGTATCTGATTATCGTTGTGGGCATGGCCTATCTGTTCGTTCGTCTGCCAAGTTCGTTCCTGCCAGATGAAGACCAGGGGGTATTCCTGTCTATGGCTCAGCTGCCAGCGGGTGCGACGCAAGAGCGTACCCAGAAGGTACTGGACGAAATGACGGATTACTACCTGACCAAGGAAAAAGCGAACGTTGAATCGGTGTTTGCCGTTAACGGTTTCGGTTTTGCTGGTCGTGGTCAGAACACCGGCATCGCGTTCGTTTCTCTGAAAGACTGGAGTGAACGTCCTGGCGAAGAGAACAAGGTTGAAGCGATTACTCAGCGTGCAATGGGCGCATTCTCGCAGATTAAAGACGCGATGGTCTTTGCCTTTAACCTGCCAGCGATTGTGGAGTTAGGGACCGCAACCGGTTTTGACTTCCAGTTGATTGACCAGGCGGGTCTGGGCCATGAGAAGCTGACTCAGGCGCGTAACCAACTGTTTGGTGAAGTCGCGAAGCATCCTGATCTGTTGGTCGGTGTTCGTCCTAACGGTCTGGAAGATACGCCGCAGTTCAAGATCGATATCGATCAGGAAAAAGCGCAGGCTCTGGGCGTTTCCATTAGTGATATTAATACAACGCTGGGTGCAGCATGGGGCGGAAGCTACGTGAATGACTTCATCGACCGTGGTCGTGTGAAGAAAGTTTACGTCATGTCTGAAGCGAAATACCGTATGTTGCCGGAAGATATTGGAAACTGGTATGTCCGCGGTAGCGATGGACAGATGGTACCGTTCTCCGCCTTCTCTACCTCACGTTGGGAATACGGTTCGCCGCGTCTGGAACGCTATAACGGTTTGCCTTCCATGGAAATCTTAGGCCAGGCCGCTCCGGGTAAAAGTACCGGTGAAGCCATGGCGATGATGGAGCAACTGGCCAGCAAACTGCCATCCGGTATCGGTTATGACTGGACCGGTATGTCCTACCAGGAACGACTGTCCGGCAACCAGGCTCCTGCCCTGTATGCCATTTCACTGATCGTCGTATTCTTGTGTCTGGCAGCGTTGTACGAGAGCTGGTCAATTCCGTTCTCCGTAATGCTGGTTGTACCGCTGGGTGTTATCGGTGCATTGCTGGCAGCAACGTTCCGCGGCCTGACCAACGACGTTTACTTCCAGGTAGGCCTGCTTACAACCATTGGGTTGTCGGCGAAGAACGCGATACTTATCGTCGAATTCGCCAAAGACTTGATGGATAAAGAGGGTAAAGGTCTGATAGAGGCGACGCTGGACGCAGTACGCATGCGTTTACGTCCAATCCTGATGACGTCACTGGCCTTTATTCTGGGCGTAATGCCGCTGGTCATCAGCTCCGGCGCAGGCTCCGGTGCGCAGAACGCCGTTGGTACTGGCGTAATGGGTGGGATGGTGACGGCAACCGTGTTGGCGATCTTCTTTGTTCCGGTGTTCTTTGTGGTGGTACGCCGCCGCTTTAGCCGCAAAAATGAAGATATTGAGCATAGCCACTCAGTAGAGCATCATTGA,MPNFFIDRPIFAWVIAIIIMLAGGLAILKLPVAQYPTIAPPAVTISATYPGADAKTVQDTVTQVIEQNMNGIDNLMYMSSNSDSTGTVQITLTFQSGTDADIAQVQVQNKLQLAMPLLPQEVQQQGVSVEKSSSSFLMVVGVINTNGTMTQEDISDYVGANMKDAISRTSGVGDVQLFGSQYAMRIWMDPNKLNNFQLTPVDVISAIKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRLTSADEFGKILLKVNQDGSQVRLRDVAKVELGGENYDIIAKFNGKPASGLGIKLATGANALDTANAIREELKKMEPFFPSGLKIVYPYDTTPFVKISIHEVVKTLAEAIILVFLVMYLFLQNFRATLIPTIAVPVVLLGTFAVLAIFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVMAEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFIPMAFFGGSTGAIYRQFSITIVSAMALSVLVALILTPALCATMLKPIAKGDHGEGKKGFFGWFNRMFDKSTHHYTDSVGGILRSTGRYLALYLIIVVGMAYLFVRLPSSFLPDEDQGVFLSMAQLPAGATQERTQKVLDEMTDYYLTKEKANVESVFAVNGFGFAGRGQNTGIAFVSLKDWSERPGEENKVEAITQRAMGAFSQIKDAMVFAFNLPAIVELGTATGFDFQLIDQAGLGHEKLTQARNQLFGEVAKHPDLLVGVRPNGLEDTPQFKIDIDQEKAQALGVSISDINTTLGAAWGGSYVNDFIDRGRVKKVYVMSEAKYRMLPEDIGNWYVRGSDGQMVPFSAFSTSRWEYGSPRLERYNGLPSMEILGQAAPGKSTGEAMAMMEQLASKLPSGIGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFSVMLVVPLGVIGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGLIEATLDAVRMRLRPILMTSLAFILGVMPLVISSGAGSGAQNAVGTGVMGGMVTATVLAIFFVPVFFVVVRRRFSRKNEDIEHSHSVEHH,MPNFFIDRPIFAWVIAIIIMLAGGLAILKLPVAQYPTIAPPAVTISASYPGADAKTVQDTVTQVIEQNMNGIDNLMYMSSNSDSTGTVQITLTFESGTDADIAQVQVQNKLQLAMPLLPQEVQQQGVSVEKSSSSFLMVVGVINTDGTMTQEDISDYVAANMKDAISRTSGVGDVQLFGSQYAMRIWMNPNELNKFQLTPVDVITAIKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRLTSTEEFGKILLKVNQDGSRVLLRDVAKIELGGENYDIIAEFNGQPASGLGIKLATGANALDTAAAIRAELAKMEPFFPSGLKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQNFRATLIPTIAVPVVLLGTFAVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVMAEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGSTGAIYRQFSITIVSAMALSVLVALILTPALCATMLKPIAKGDHGEGKKGFFGWFNRMFEKSTHHYTDSVGGILRSTGRYLVLYLIIVVGMAYLFVRLPSSFLPDEDQGVFMTMVQLPAGATQERTQKVLNEVTHYYLTKEKNNVESVFAVNGFGFAGRGQNTGIAFVSLKDWADRPGEENKVEAITMRATRAFSQIKDAMVFAFNLPAIVELGTATGFDFELIDQAGLGHEKLTQARNQLLAEAAKHPDMLTSVRPNGLEDTPQFKIDIDQEKAQALGVSINDINTTLGAAWGGSYVNDFIDRGRVKKVYVMSEAKYRMLPDDIGDWYVRAADGQMVPFSAFSSSRWEYGSPRLERYNGLPSMEILGQAAPGKSTGEAMELMEQLASKLPTGVGYDWTGMSYQERLSGNQAPSLYAISLIVVFLCLAALYESWSIPFSVMLVVPLGVIGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGLIEATLDAVRMRLRPILMTSLAFILGVMPLVISTGAGSGAQNAVGTGVMGGMVTATVLAIFFVPVFFVVVRRRFSRKNEDIEHSHTVDHH,100,gnl|BL_ORD_ID|1011|hsp_num:0,1104,FALSE,None
LK494,1_279 # 295379 # 296572 # -1 # ID=1_279;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.523,1_279,295379,296572,-,Strict,670,692.575,Escherichia coli acrA,90.18,3004043,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGAACAAAAACAGAGGGTTAACGCCTCTGGCAGTCGTTCTGATGCTCTCAGGCAGCTTAGCGCTAACAGGATGTGACGACAAACAGGCCCAGCAAGGGGGCCAGCAAATGCCAGAGGTTGGAGTTGTTACGCTCAAAACTGAACCTCTACAGATCACAACCGAACTTCCGGGTCGCACCAGTGCGTTTCGTATTGCTGAAGTTCGTCCTCAGGTTAGCGGGATTATCCTGAAACGTAATTTCACGGAAGGTGGTGACATCGAAGCGGGTGTATCTCTCTATCAGATTGATCCTGCTACTTACCAGGCCGCTTATGAAAGTGCAAAAGGCGATCTGGCCAAAGCACAAGCCGCAGCAAATATTGCTCAACTGACGGTGAAACGTTATCAGAAACTGTTGGGTACTAAGTACATCAGCCAACAGGACTACGATAGCGCGTTGGCTGACGCACAGCAGGCAAACGCCGCCGTTGTTGCCGCGAAAGCTGCGGTAGAAACTGCACGCATCAATCTGGCTTACACCAAAGTGACGTCACCGATCAGCGGTCGCATTGGTAAATCATCCGTTACGGAAGGCGCTCTGGTGCAAAACGGTCAGGCGACCGCACTGGCGACCGTTCAGCAGTTGGATCCCATCTATGTAGACGTGACGCAGTCAAGCAACGACTTCCTGCGCCTGAAACAAGAGCTGGCCAACGGCACGCTGAAGCAAGAGAACGGTAAAGCGAAAGTCGAACTGGTGACCAATGACGGCATTAAATACCCGCAGTCCGGTACGCTGGAATTTTCTGATGTGACGGTAGATCAAACCACTGGGTCGATTACGTTACGCGCAATTTTCCCGAACCCGGATCATACCTTACTGCCGGGTATGTTCGTCCGCGCACGTCTGGAAGAAGGGATTAACCCAACTGCATTACTGGTTCCACAGCAAGGCGTTACCCGCACACCGCGTGGCGATGCCAGTGCATTGGTTATCGGTGCAGACAACAAAGTTGAAACTCGTCAAATTGTCGCCGCACAAGCGATTGGCGACAAATGGTTAGTCACTGATGGACTTAAGCCGGGCGACCGCGTGATTGTTACTGGGCTGCAGAAAGTACGTCCTGGCGCGCAGGTAAAAGCGCAGGAAATCACCGCTGATAACAACCAGCAAGGCCAAAGCGGTAGCCAGCCTGAACAGTCCAAGTCTTAA,MNKNRGLTPLAVVLMLSGSLALTGCDDKQAQQGGQQMPEVGVVTLKTEPLQITTELPGRTSAFRIAEVRPQVSGIILKRNFTEGGDIEAGVSLYQIDPATYQAAYESAKGDLAKAQAAANIAQLTVKRYQKLLGTKYISQQDYDSALADAQQANAAVVAAKAAVETARINLAYTKVTSPISGRIGKSSVTEGALVQNGQATALATVQQLDPIYVDVTQSSNDFLRLKQELANGTLKQENGKAKVELVTNDGIKYPQSGTLEFSDVTVDQTTGSITLRAIFPNPDHTLLPGMFVRARLEEGINPTALLVPQQGVTRTPRGDASALVIGADNKVETRQIVAAQAIGDKWLVTDGLKPGDRVIVTGLQKVRPGAQVKAQEITADNNQQGQSGSQPEQSKS,MNKNRGFTPLAVVLMLSGSLALTGCDDKQAQQGGQQMPAVGVVTVKTEPLQITTELPGRTSAYRIAEVRPQVSGIILKRNFKEGSDIEAGVSLYQIDPATYQATYDSAKGDLAKAQAAANIAQLTVNRYQKLLGTQYISKQEYDQALADAQQANAAVTAAKAAVETARINLAYTKVTSPISGRIGKSNVTEGALVQNGQATALATVQQLDPIYVDVTQSSNDFLRLKQELANGTLKQENGKAKVSLITSDGIKFPQDGTLEFSDVTVDQTTGSITLRAIFPNPDHTLLPGMFVRARLEEGLNPNAILVPQQGVTRTPRGDATVLVVGADDKVETRPIVASQAIGDKWLVTEGLKAGDRVVISGLQKVRPGVQVKAQEVTADNNQQAASGAQPEQSKS,100,gnl|BL_ORD_ID|2323|hsp_num:0,2661,FALSE,None
LK494,1_483 # 529908 # 530585 # -1 # ID=1_483;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.544,1_483,529908,530585,-,Strict,400,421.779,kdpE,90.62,3003841,protein homolog model,n/a,n/a,aminoglycoside antibiotic,antibiotic efflux,kdpDE,GTGACGAACGTACTGATTGTTGAAGATGAACAGGCTATCCGTCGCTTTCTGCGCACCGCGCTGGAAGCCGATGGTCTGCGTGTATATGAAGCGGAAACGCTGCAACGTGGTCTGCTGGAAGCCGCCACGCGAAAACCCGATCTCATCATTCTCGATCTCGGTCTGCCGGACGGTGACGGCATTGATTTTATTCGTGACCTGCGACAATGGAGCGCGATACCGGTAATTGTGCTTTCAGCCCGCAGCGAAGAAAGTGATAAAATTGCCGCCCTGGATGCCGGTGCCGATGACTATCTCAGTAAACCCTTTGGTATTGGCGAGCTACAGGCGCGATTGCGCGTGGCATTGCGTCGCCACGCCAGCGGCACGTCTCCCGAGCCGGTGGTGCATTTTTCCAACGTAAAAGTAGATATCGCCGCCCGGCTAGTACATCGTGGTGATGAAGAGATTCATTTGACGCCGATTGAGTTTCGCCTGTTAGCGGTACTGCTGAATAATGCCGGAAAGGTACTGACGCAGCGCCAGTTGCTCAATCAGGTTTGGGGACCAAACGCCGTCGAACACAGCCACTATCTGCGAATTTACATGGGACACCTGCGCCAGAAACTGGAACTGGACCCGGCACGTCCGCGTCATTTTCTGACCGAAACCGGGATTGGTTATCGGTTCATGCCATGA,MTNVLIVEDEQAIRRFLRTALEADGLRVYEAETLQRGLLEAATRKPDLIILDLGLPDGDGIDFIRDLRQWSAIPVIVLSARSEESDKIAALDAGADDYLSKPFGIGELQARLRVALRRHASGTSPEPVVHFSNVKVDIAARLVHRGDEEIHLTPIEFRLLAVLLNNAGKVLTQRQLLNQVWGPNAVEHSHYLRIYMGHLRQKLELDPARPRHFLTETGIGYRFMP,MTNVLIVEDEQAIRRFLRTALEGDGMRVFEAETLQRGLLEAATRKPDLIILDLGLPDGDGIEFIRDLRQWSAVPVIVLSARSEESDKIAALDAGADDYLSKPFGIGELQARLRVALRRHSATTAPDPLVKFSDVTVDLAARVIHRGEEEVHLTPIEFRLLAVLLNNAGKVLTQRQLLNQVWGPNAVEHSHYLRIYMGHLRQKLEQDPARPRHFITETGIGYRFML,100,gnl|BL_ORD_ID|2103|hsp_num:0,2331,FALSE,None
LK494,1_637 # 696461 # 697693 # 1 # ID=1_637;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.529,1_637,696461,697693,+,Strict,700,728.013,Escherichia coli mdfA,87.32,3001328,protein homolog model,n/a,n/a,tetracycline antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGCAGAACCGTTTATCTTCAGGCGCCCGTTTGGGGCGTCAGGCATTACTTTTCCCTCTCTGTCTGGTGCTTTACGAATTCTCTAGTTATATCGGCAACGATATGATCCAGCCTGGAATGTTGGCGGTGGTGGAGCAATACAATGCCGGATTAGATTGGGTACCCACATCCATGACCGCCTATCTGGCTGGCGGCATGTTTTTACAGTGGTTGTTAGGACCGCTATCGGATCGTGTTGGGCGTCGTCCGGTAATGTTAACCGGCGTGCTCTGGTTCATCGTGACCTGCCTTGCGACCCTGCTTGCACAGAATATTGAGCAATTTACTTTCCTGCGTTTTTTGCAGGGGATAAGCCTGTGCTTTATTGGTGCGGTGGGTTACGCCGCCATTCAGGAATCCTTTGAAGAAGCGGTCTGCATAAAAATTACCGCGCTGATGGCAAACGTGGCGCTGATTGCGCCGCTGCTGGGTCCGTTGGTAGGCGCAGCCTGGGTACATGTTCTGCCGTGGGAAGGGATGTTTATCCTGTTTGCTGCTCTGGCGGCCATCTCCTTTTTTGGTCTGCAACGCGCGATGCCGGAAACGGCAACCCGGCTGGGCGAAAAGCTGTCCATTCAAGAGCTGGGCAAAGATTATAAACTGGTGCTCAGAAACGTACGTTTTGTTGCAGGCGCACTGGCGTTGGGTTTTGTCAGCCTGCCGTTACTGGCGTGGATTGCGCAATCTCCGATTATTATCATCAGCGGAGAACATCTCAGTAGTTACGAATATGGCCTGTTGCAGGTGCCGATTTTTGGTGCGCTGATTGCCGGTAACCTGGTGCTGGCGCGTCTGACTTCGCGAAAAACCGTGCGTTCGCTGATTATCATGGGCGGCTGGCCAATTGCCGTTGGCCTGATTATTGCCGCTGCGGCCACGGTGGTGTCATCTCATGCATATCTATGGATGACGGCGGGTTTGAGTATCTATGCGTTTGGCATTGGCGTGGCGAATGCGGGGCTGGTGCGCCTGACGCTGTTTGCCAGTGAAATGAGTAAAGGTACGGTTTCTGCCGCAATGGGTATGTTGCAGATGCTGATTTTTACCGTTGGTATCGAGCTGAGTAAACACGCTTATCTGCTGGGAGGCAACGGCTTGTTCAGCTTGTTCAATCTGGCCAGCGGGGTGCTGTGGCTGATTCTTATGGTGATCTTCCTGAAAGATAAACGGGTAGGGGATTCCCGGGAAGGCTAA,MQNRLSSGARLGRQALLFPLCLVLYEFSSYIGNDMIQPGMLAVVEQYNAGLDWVPTSMTAYLAGGMFLQWLLGPLSDRVGRRPVMLTGVLWFIVTCLATLLAQNIEQFTFLRFLQGISLCFIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWVHVLPWEGMFILFAALAAISFFGLQRAMPETATRLGEKLSIQELGKDYKLVLRNVRFVAGALALGFVSLPLLAWIAQSPIIIISGEHLSSYEYGLLQVPIFGALIAGNLVLARLTSRKTVRSLIIMGGWPIAVGLIIAAAATVVSSHAYLWMTAGLSIYAFGIGVANAGLVRLTLFASEMSKGTVSAAMGMLQMLIFTVGIELSKHAYLLGGNGLFSLFNLASGVLWLILMVIFLKDKRVGDSREG,MQNKLASGARLGRQALLFPLCLVLYEFSTYIGNDMRQPGMLENVEQYQAGIEWVPTSMNAYLAGGMFIQWLLGPLSDRIGRRPVMLAGVVWFIVTCLAILLAQNIEQFTLLRFLHGISLCFIGAVGYDAIQESFEEAVCIKITALMANVALIAPLLGPLVGASWIHVLPWEGMFVLFAALAAISFFGLQRAMPETATRIGEKLSLKELGRDYKLVLKNGRFVAGALALGFLSLPLLAWIAQSPIIIITGEQLSSYEYGLLQVPIFGALIAGNLLLARLTSRRTVRSLIIMGGWPIMIGLLVAAAATVISSHAYLWMTAGLSIYAFGIGLANAGLVRLTLFASVMSKGTVSAAMGMLQMLIFTVGIEISKHAWLNGGNGLFNLFNLVNGILLLSLMVIFLKDKQMGNSHEG,100,gnl|BL_ORD_ID|2421|hsp_num:0,37,FALSE,None
LK494,1_691 # 759459 # 761207 # 1 # ID=1_691;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.509,1_691,759459,761207,+,Strict,1000,1152.89,msbA,95.19,3003950,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic efflux,ATP-binding cassette (ABC) antibiotic efflux pump,ATGCATAACGATAAAGATCTCTCTACGTGGCAGACGTTTCGCCGACTATGGCCAACCATAGCGCCTTTTAAATCGGGTCTGATCGTGGCGGGTATAGCGTTAGTCCTTAACGCGGCCAGCGATACCTTCATGTTATCGCTCCTTAAACCATTACTGGATGATGGTTTTGGTAAAACGGATCGTTCGGTGCTGCTGTGGATGCCGCTGGTGGTCATTGGGCTGATGATAGTTCGTGGCTTAACCAGTTATGTCTCCAGCTACTGTATCTCATGGGTGTCAGGCAAAGTGGTCATGACCATGCGTCGCCGCCTGTTTGGTCATATGATGGGCATGCCAGTCTCCTTTTTTGATAAACAGTCTACAGGTACGCTGTTGTCACGTATTACCTATGATTCAGAGCAGGTCGCGTCATCGTCTTCCGGCGCGCTGATCACCGTGGTACGTGAAGGGGCCTCAATCATTGGCCTGTTTATCATGATGTTCTATTACAGCTGGCAGCTGTCACTGATCCTGATTGTACTGGCGCCGATTGTGTCAGTGGCGATCCGTGTGGTTTCCAAGCGCTTTCGTAGCATCAGTAAAAACATGCAAAACACTATGGGGCAGGTTACGACCAGTGCGGAGCAGATGCTGAAAGGCCACAAAGAAGTTCTGATTTTTGGTGGTCAGGAAGTCGAAACCAAGCGCTTTGATAAGGTCAGCAACAAGATGCGTTTGCAGGGTATGAAGATGGTTTCCGCTTCTTCTATCTCCGATCCTATCATCCAGTTGATTGCGTCTCTGGCTCTGGCCTTCGTGTTATATGCGGCCAGCTTCCCAAGCGTAATGGAAAACCTGACGGCAGGGACAATTACGGTTGTCTTCTCCTCAATGATCGCGCTGATGCGTCCGTTGAAATCGCTGACCAACGTCAACGCGCAGTTCCAGCGCGGTATGGCGGCATGCCAGACCTTATTTACGATTCTGGATAGCGAACAGGAGAAAGATGAAGGTAAACGTGTTATCGAGCGTGCTACCGGCGATCTCGAGTTCCGCAACGTGACTTTCACCTATCCGGGACGTGAAGTACCGGCTCTGCGTAACATCAACCTGAATATTCCCGCGGGTAAAACCGTTGCTCTGGTTGGCCGTTCGGGCTCAGGGAAATCCACCATCGCCAGCCTGATTACGCGCTTCTACGATATTGATGAAGGGCAGATTCTGATGGACGGACACGATCTGCGTGAATATACCCTGGCATCCCTGCGCGATCAGGTTGCGTTGGTTTCGCAGAATGTGCACTTGTTTAACGATACGGTTGCCAACAACATCGCCTACGCGCGTACCGATATGTACAGCCGTGAGCAGATCGAAAAAGCGGCACAGATGGCCTACGCCATGGATTTCATCAACAAGATGGATAATGGCCTGGATACGGTGATTGGTGAAAACGGCGTCCTGCTTTCCGGCGGACAACGTCAGCGTATCGCTATCGCCCGTGCCTTGTTGCGTGACAGCCCAATTCTGATCCTTGATGAAGCAACATCAGCTCTTGATACCGAATCTGAACGTGCGATTCAGTCTGCGCTGGATGAGCTACAGAAAAACCGTACTTCTCTGGTCATTGCTCACCGTCTTTCAACCATTGAACAAGCCGACGAAATCATCGTGGTGGAGGATGGTCTGATTGTCGAGCGCGGAACCCATAGCGACCTGATTGAGCAGCGCGGGGTCTATGCGCAATTACACAAAATGCAATTCGGTCAATGA,MHNDKDLSTWQTFRRLWPTIAPFKSGLIVAGIALVLNAASDTFMLSLLKPLLDDGFGKTDRSVLLWMPLVVIGLMIVRGLTSYVSSYCISWVSGKVVMTMRRRLFGHMMGMPVSFFDKQSTGTLLSRITYDSEQVASSSSGALITVVREGASIIGLFIMMFYYSWQLSLILIVLAPIVSVAIRVVSKRFRSISKNMQNTMGQVTTSAEQMLKGHKEVLIFGGQEVETKRFDKVSNKMRLQGMKMVSASSISDPIIQLIASLALAFVLYAASFPSVMENLTAGTITVVFSSMIALMRPLKSLTNVNAQFQRGMAACQTLFTILDSEQEKDEGKRVIERATGDLEFRNVTFTYPGREVPALRNINLNIPAGKTVALVGRSGSGKSTIASLITRFYDIDEGQILMDGHDLREYTLASLRDQVALVSQNVHLFNDTVANNIAYARTDMYSREQIEKAAQMAYAMDFINKMDNGLDTVIGENGVLLSGGQRQRIAIARALLRDSPILILDEATSALDTESERAIQSALDELQKNRTSLVIAHRLSTIEQADEIIVVEDGLIVERGTHSDLIEQRGVYAQLHKMQFGQ,MHNDKDLSTWQTFRRLWPTIAPFKAGLIVAGVALILNAASDTFMLSLLKPLLDDGFGKTDRSVLVWMPLVVIGLMILRGITSYVSSYCISWVSGKVVMTMRRRLFGHMMGMPVSFFDKQSTGTLLSRITYDSEQVASSSSGALITVVREGASIIGLFIMMFYYSWQLSIILIVLAPIVSIAIRVVSKRFRNISKNMQNTMGQVTTSAEQMLKGHKEVLIFGGQEVETKRFDKVSNRMRLQGMKMVSASSISDPIIQLIASLALAFVLYAASFPSVMDSLTAGTITVVFSSMIALMRPLKSLTNVNAQFQRGMAACQTLFTILDSEQEKDEGKRVIERATGDVEFRNVTFTYPGRDVPALRNINLKIPAGKTVALVGRSGSGKSTIASLITRFYDIDEGEILMDGHDLREYTLASLRNQVALVSQNVHLFNDTVANNIAYARTEQYSREQIEEAARMAYAMDFINKMDNGLDTVIGENGVLLSGGQRQRIAIARALLRDSPILILDEATSALDTESERAIQAALDELQKNRTSLVIAHRLSTIEKADEIVVVEDGVIVERGTHNDLLEHRGVYAQLHKMQFGQ,100,gnl|BL_ORD_ID|2187|hsp_num:0,2423,FALSE,None
LK494,1_804 # 877219 # 878439 # -1 # ID=1_804;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.541,1_804,877219,878439,-,Strict,700,709.909,mdtG,90.91,3001329,protein homolog model,n/a,n/a,phosphonic acid antibiotic,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGTCACCCTCAGATGCTCCCATAAACTGGAAACGCAACCTCACCGTTGCCTGGTTAGGTTGTTTTTTAACCGGCGCAGCATTTAGCCTGGTCATGCCCTTTTTGCCCCTTTACGTCGAGAGTCTCGGCGTCACGGGACATAGCGCACTGAATATGTGGTCAGGCCTGGTCTTCAGCATCACCTTTCTTTTTTCCGCCATCGCCTCTCCTTTCTGGGGTGGCCTTGCCGATCGCAAGGGGCGAAAAATCATGCTGCTACGGTCTGCGTTGGGTATGGCTGTTGTGATGCTGCTGATGGGACTGGCGCAAAATATCTGGCAGTTCTTGATCCTGCGCGCCTTGTTGGGGCTGCTTGGTGGATTCATCCCCAATGCGAATGCACTGATCGCCACCCAGGTTCCACGCAATAAAAGCGGCTGGGCACTGGGAACGCTTTCCACCGGTGGTGTTAGTGGCGCACTGCTCGGGCCGCTAGCGGGCGGCCTCCTCGCGGATCAGTACGGACTGCGCCCCGTATTTTTCATCACCGCCAGCGTGCTGTTGGTCTGCTTCATCCTGACGCTATTTTTTATCCGCGAGCGTTTCCAGCCGGTGAGCAAGAAGGAAATGCTGCACATTCGTGAAGTCGTGGCCTCTTTAAAGAACCCCAAACTGGTGCTGAGCCTGTTTGTCACCACTTTGATCATTCAGGTAGCCACCGGTTCTATCGCGCCAATACTGACACTGTACGTTCGAGAGTTGGCTGGCAACGTCGGCAATATTGCGTTCATCAGTGGGATGATAGCCTCTGTCCCTGGCGTTGCGGCATTAATCAGTGCCCCTAAACTTGGCAAATTAGGCGATAGGATTGGCCCGGAGAAGATCCTGATCGTCGCGCTGATCGTTTCCGTGTTACTGCTAATTCCAATGTCATTTGTCCAGACGCCCTGGCAGCTTGGTATTCTGCGCTTTTTATTGGGGGCGGCCGACGGCGCTCTGCTCCCGGCGGTACAAACGCTGCTGGTCTATAACTCGACTAATCAAATAGCTGGACGTATTTTCAGTTATAACCAATCATTTCGCGACATTGGTAACGTAACAGGGCCTCTAATGGGGGCAGCGATATCCGCCAACTACGGTTTTCGTGCTGTATTCTGTGTGACCGCAGGAGTCGTACTGTTCAACGCCCTGTACTCGTGGAATAGCCTGCGCCGTCGTCGGAGTACAGAGGTCGCGGGATGA,MSPSDAPINWKRNLTVAWLGCFLTGAAFSLVMPFLPLYVESLGVTGHSALNMWSGLVFSITFLFSAIASPFWGGLADRKGRKIMLLRSALGMAVVMLLMGLAQNIWQFLILRALLGLLGGFIPNANALIATQVPRNKSGWALGTLSTGGVSGALLGPLAGGLLADQYGLRPVFFITASVLLVCFILTLFFIRERFQPVSKKEMLHIREVVASLKNPKLVLSLFVTTLIIQVATGSIAPILTLYVRELAGNVGNIAFISGMIASVPGVAALISAPKLGKLGDRIGPEKILIVALIVSVLLLIPMSFVQTPWQLGILRFLLGAADGALLPAVQTLLVYNSTNQIAGRIFSYNQSFRDIGNVTGPLMGAAISANYGFRAVFCVTAGVVLFNALYSWNSLRRRRSTEVAG,MSPCENDTPINWKRNLIVAWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSALNMWSGIVFSITFLFSAIASPFWGGLADRKGRKLMLLRSALGMGIVMVLMGLAQNIWQFLILRALLGLLGGFVPNANALIATQVPRNKSGWALGTLSTGGVSGALLGPMAGGLLADSYGLRPVFFITASVLILCFFVTLFCIREKFQPVSKKEMLHMREVVTSLKNPKLVLSLFVTTLIIQVATGSIAPILTLYVRELAGNVSNVAFISGMIASVPGVAALLSAPRLGKLGDRIGPEKILITALIFSVLLLIPMSYVQTPLQLGILRFLLGAADGALLPAVQTLLVYNSSNQIAGRIFSYNQSFRDIGNVTGPLMGAAISANYGFRAVFLVTAGVVLFNAVYSWNSLRRRRIPQVSN,99.51,gnl|BL_ORD_ID|550|hsp_num:0,603,FALSE,None
LK494,2_234 # 241803 # 242621 # 1 # ID=2_234;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.535,2_234,241803,242621,+,Strict,500,510.375,bacA,93.04,3002986,protein homolog model,n/a,n/a,peptide antibiotic,antibiotic target alteration,undecaprenyl pyrophosphate related proteins,ATGAGTGATATGCACTCGCTGCTGGTGGCGGCAATTTTGGGTGTGGTCGAAGGATTGACGGAATTTTTACCTGTTTCCAGTACCGGCCATATGATTATTGTTGGCCACCTGTTGGGTTTTGAGGGTGATACCGCAAAAACATTCGAGGTGGTGATCCAATTGGGGTCTATTCTGGCAGTGGTGGTGATGTTCTGGCGACGTTTGTTTGGCCTGATCGGCATTCACTTCGGCAAGGCCCCGCATGAAGGTACTGGCAAAGGTCGACTGACGCTGGGGCATATCCTGTTGGGGATGATTCCGGCGGTTGTACTGGGACTGGTGTTCCACGACACCATCAAGTCGCTGTTTAACCCGATCAACGTGATGTATGCGCTGGTGGTGGGTGGTGTACTGCTGATTGCTGCAGAATGCCTGAAGCCGAAAGAGCCGCGCGCGCCGGGTCTGGATGATATGACCTATCGCCAGGCATTTATGATTGGCTGTTTCCAGTGTCTGGCGCTGTGGCCGGGTTTTTCTCGCTCAGGGGCGACGATTTCTGGCGGTATGCTGATGGGCGTGAGCCGTTATGCGGCTTCTGAGTTTTCATTCCTGCTGGCGGTGCCGATGATGATGGGCGCGACGGCGCTGGATCTCTACAAGAGCTGGTCGTTCCTTAGCGCATCAGATTTACCGATGTTTGCAGTCGGTTTTGTGACGGCGTTTATCGTGGCGCTGGTCGCGATCAAAACCTTCCTGCAGCTGATTAAGCGTATCTCGTTCATTCCGTTTGCGATTTACCGCTTTGTTGTGGCGGCTGCCGTCTATGTGGTTTTTTTCTGA,MSDMHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAVVVMFWRRLFGLIGIHFGKAPHEGTGKGRLTLGHILLGMIPAVVLGLVFHDTIKSLFNPINVMYALVVGGVLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATISGGMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSWSFLSASDLPMFAVGFVTAFIVALVAIKTFLQLIKRISFIPFAIYRFVVAAAVYVVFF,MSDMHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAVVVMFWRRLFGLIGIHFGRPLQHEGESKGRLTLIHILLGMIPAVVLGLLFHDTIKSLFNPINVMYALVVGGLLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATISGGMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSWGFLTSGDIPMFAVGFITAFVVALIAIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF,99.63,gnl|BL_ORD_ID|1681|hsp_num:0,1820,FALSE,None
LK494,2_575 # 615529 # 615714 # 1 # ID=2_575;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.511,2_575,615529,615714,+,Strict,100,109.383,rsmA,85.25,3005069,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGCTGATTCTGACTCGTCGAGTTGGTGAGACCCTCATGATAGGCGATGAGGTCACCGTGACAGTTTTAGGGGTGAAGGGCAACCAGGTGCGCATTGGCGTAAACGCCCCGAAAGAAGTTTCTGTCCATCGTGAAGAGATCTACCAGCGTATCCAGGCTGAAAAATCCCAGCAGTCCAGTTACTAA,MLILTRRVGETLMIGDEVTVTVLGVKGNQVRIGVNAPKEVSVHREEIYQRIQAEKSQQSSY,MLILTRRVGETLMVGDDVTVTVLGVKGNQVRIGVNAPKEVAVHREEIYQRIQKEKDQEPNH,100,gnl|BL_ORD_ID|2794|hsp_num:0,3807,FALSE,None
LK494,2_581 # 622206 # 623744 # -1 # ID=2_581;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.559,2_581,622206,623744,-,Strict,900,945.266,emrB,95.22,3000074,protein homolog model,n/a,n/a,fluoroquinolone antibiotic,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGCAACAGCAAAAACCGCTGGAAGGCGCGCAGCTCGTCATAATGACGATCGCGCTGTCCCTGGCGACATTCATGCAGGTGCTGGACTCCACCATTGCTAACGTGGCGATCCCCACTATCGCCGGGAACCTCGGCTCTTCATTGAGCCAGGGAACCTGGGTGATCACCTCATTCGGGGTAGCGAACGCTATCTCTATTCCGATCACCGGCTGGCTGGCAAAACGCTTTGGCGAAGTAAGACTCTTTATGTGGTCAACTATCGCCTTCGTCATTGCGTCATGGGCATGCGGGATGTCCACCAGCCTGAACATGCTGATTTTCTTCCGCGTAATCCAGGGTATTGTCGCCGGTCCATTAATTCCGCTGTCACAGAGCCTGTTGCTGAATAACTATCCACCCGCCAAGCGTTCCATCGCCCTCGCGCTATGGTCGATGACGGTGATTGTTGCCCCGATATGTGGTCCTATTCTGGGGGGCTATATCAGCGACAACTATCACTGGGGCTGGATATTTTTTATCAACGTGCCAATCGGGGCTGCGGTGGTATTGATGACCCTGCAAACCCTGCGCGGTCGGGAAACCAAAACCGAGCAGCGGCGCATTGACGCCATTGGTCTGGCACTGCTGGTCATCGGTATCGGCAGTTTGCAGATTATGCTCGACCGCGGCAAAGAGCTGGACTGGTTCGCCTCGCAGGAGATTATCATCCTGACGGTGGTCGCCGTGGTTGCTATCAGCTTCCTGATCGTCTGGGAGCTTACCGACGAGCACCCGATTGTCGATCTCTCGCTGTTTAAGTCGCGCAACTTTACCATCGGCTGCCTGTGTATTAGCCTGGCCTATATGCTCTACTTCGGCGCCATCGTCCTGCTGCCGCAGCTATTGCAGGAGGTATACGGTTATACGGCAACCTGGGCTGGTCTGGCGTCAGCGCCGGTTGGGGTGATTCCGGTGATCCTGTCGCCGATTATCGGCCGCTTCGCGCACAAGCTGGATATGCGTCGGCTGGTGACGTTCAGTTTTATTATGTACGCCGTCTGTTTCTACTGGCGTGCGTGGACGTTCGAGCCGGGTATGGACTTTGGCGCATCGGCCTGGCCGCAGTTTATTCAGGGGTTCGCAGTAGCCTGCTTCTTTATGCCGCTGACGACCATCACGCTGTCCGGTTTACCGCCTGAGCGTCTGGCGGCTGCATCGAGCTTGTCTAACTTTACGCGAACGCTGGCCGGCTCTATTGGTACATCGATTACAACAACGATGTGGACTAACCGTGAGTCGCTGCACCATGCTCAGCTAACGGAATCTGTTAACCCCTACAACCCAAATGCTCAGGCAATGTACGACAAGCTGCAGGATTTAGGGATGACGCACCAGCAGGCGTCAGGGTGGATAGCCCAGCAGATCACTAATCAGGGTCTGATTATTTCCGCCAACGAAATCTTCTGGATGTCGGCGGGGATCTTCCTGGTTTTGCTTGGTCTGGTATGGTTCGCTAAACCGCCCTTCGGCGCGGGCGGCGGCGGCGGTGGAGCGCACTAA,MQQQKPLEGAQLVIMTIALSLATFMQVLDSTIANVAIPTIAGNLGSSLSQGTWVITSFGVANAISIPITGWLAKRFGEVRLFMWSTIAFVIASWACGMSTSLNMLIFFRVIQGIVAGPLIPLSQSLLLNNYPPAKRSIALALWSMTVIVAPICGPILGGYISDNYHWGWIFFINVPIGAAVVLMTLQTLRGRETKTEQRRIDAIGLALLVIGIGSLQIMLDRGKELDWFASQEIIILTVVAVVAISFLIVWELTDEHPIVDLSLFKSRNFTIGCLCISLAYMLYFGAIVLLPQLLQEVYGYTATWAGLASAPVGVIPVILSPIIGRFAHKLDMRRLVTFSFIMYAVCFYWRAWTFEPGMDFGASAWPQFIQGFAVACFFMPLTTITLSGLPPERLAAASSLSNFTRTLAGSIGTSITTTMWTNRESLHHAQLTESVNPYNPNAQAMYDKLQDLGMTHQQASGWIAQQITNQGLIISANEIFWMSAGIFLVLLGLVWFAKPPFGAGGGGGGAH,MQQQKPLEGAQLVIMTIALSLATFMQVLDSTIANVAIPTIAGNLGSSLSQGTWVITSFGVANAISIPLTGWLAKRVGEVKLFLWSTIAFAIASWACGVSSSLNMLIFFRVIQGIVAGPLIPLSQSLLLNNYPPAKRSIALALWSMTVIVAPICGPILGGYISDNYHWGWIFFINVPIGVAVVLMTLQTLRGRETRTERRRIDAVGLALLVIGIGSLQIMLDRGKELDWFSSQEIIILTVVAVVAICFLIVWELTDDNPIVDLSLFKSRNFTIGCLCISLAYMLYFGAIVLLPQLLQEVYGYTATWAGLASAPVGIIPVILSPIIGRFAHKLDMRRLVTFSFIMYAVCFYWRAYTFEPGMDFGASAWPQFIQGFAVACFFMPLTTITLSGLPPERLAAASSLSNFTRTLAGSIGTSITTTMWTNRESMHHAQLTESVNPFNPNAQAMYSQLEGLGMTQQQASGWIAQQITNQGLIISANEIFWMSAGIFLVLLGLVWFAKPPFGAGGGGGGAH,100,gnl|BL_ORD_ID|1706|hsp_num:0,1847,FALSE,None
LK494,2_582 # 623761 # 624933 # -1 # ID=2_582;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.536,2_582,623761,624933,-,Strict,675,703.36,emrA,88.72,3000027,protein homolog model,n/a,n/a,fluoroquinolone antibiotic,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGAGCGCAAATGCGGAGACTCAAACCCCGCAGCAACCGGTCAAGAAGAATGGCAAACGTAAAAGTCTGCTTCTCCTTCTGACCTTGCTCTTTATTATCATTGCCGTGGCATATGGGATTTATTGGTTTTTAGTACTGCGTCATTACGAAGATACAGACGATGCGTACGTGGCAGGGAACCAGGTTCAAATCATGGCGCAGGTATCAGGCAGCGTGACGAAAGTCTGGGCTGATAACACTGACTTTGTAAAACAAGGCGATGTGCTGGTCACCCTCGACCAGACAGATGCCAAACAGGCATTTGAAAAAGCCAAAACTGCGCTGGCCTCCAGCGTGCGTCAGACGCACCAGTTGATGATCAACAGCAAGCAGTTACAGGCCAACATTGAAGTGCAGAAAACAGCTCTGGCGCAGGCACAAAGCGATTTTAATCGCCGAGTCCCGCTGGGCAACGCCAACCTGATTGGCCGCGAAGAGCTGCAACATGCGCGTGATGCCGTCGCCAGCGCTCAGGCTCAGCTTGATGTCGCAATCCAACAATATAATGCTAACCAGGCAATGATTCTCGGCAGCAAGCTGGAAGATCAACCCGCCGTACAACAGGCCGCCACCGAAGTGCGCGATGCCTGGCTGGCGCTGGAACGTACCAGAATTGTCAGCCCAATGACCGGTTATGTATCCCGCCGCGCCGTACAGCCTGGTGCGCAGATTAGCCCAACCACGCCGTTAATGGCGGTTGTTCCGGCCACCAACCTGTGGGTGGATGCCAACTTCAAAGAAACACAGCTCGCCCACATTCGTATTGGTCAACCCGCGACGGTTGTCAGCGATATTTATGGCGATGACGTGAAATATACCGGTAAAGTTGTCGGCCTCGATATGGGAACGGGCAGCGCCTTCTCCTTGCTGCCAGCACAAAACGCGACCGGTAACTGGATCAAAGTCGTCCAGCGTCTGCCGGTGCGTATCGAACTGGATGCGCAGCAACTGGCACAGCATCCTTTGCGGATCGGTTTGTCTACGCTGGTTACAGTCGATACCTCCAATCGTGACGGACAAATTCTGGCAAGCCAGGTCCGCACCACGCCAGTATCAGAAAGTAATGCACGTGAAATCGACCTTGCTCCGGTCAATAAGATGATCGAAGAGATCGTGCGGGCCAACGCGGGCTAA,MSANAETQTPQQPVKKNGKRKSLLLLLTLLFIIIAVAYGIYWFLVLRHYEDTDDAYVAGNQVQIMAQVSGSVTKVWADNTDFVKQGDVLVTLDQTDAKQAFEKAKTALASSVRQTHQLMINSKQLQANIEVQKTALAQAQSDFNRRVPLGNANLIGREELQHARDAVASAQAQLDVAIQQYNANQAMILGSKLEDQPAVQQAATEVRDAWLALERTRIVSPMTGYVSRRAVQPGAQISPTTPLMAVVPATNLWVDANFKETQLAHIRIGQPATVVSDIYGDDVKYTGKVVGLDMGTGSAFSLLPAQNATGNWIKVVQRLPVRIELDAQQLAQHPLRIGLSTLVTVDTSNRDGQILASQVRTTPVSESNAREIDLAPVNKMIEEIVRANAG,MSANAETQTPQQPVKKSGKRKRLLLLLTLLFIIIAVAIGIYWFLVLRHFEETDDAYVAGNQIQIMSQVSGSVTKVWADNTDFVKEGDVLVTLDPTDARQAFEKAKTALASSVRQTHQLMINSKQLQANIEVQKIALAKAQSDYNRRVPLGNANLIGREELQHARDAVTSAQAQLDVAIQQYNANQAMILGTKLEDQPAVQQAATEVRNAWLALERTRIISPMTGYVSRRAVQPGAQISPTTPLMAVVPATNMWVDANFKETQIANMRIGQPVTITTDIYGDDVKYTGKVVGLDMGTGSAFSLLPAQNATGNWIKVVQRLPVRIELDQKQLEQYPLRIGLSTLVSVNTTNRDGQVLANKVRSTPVAVSTAREISLAPVNKLIDDIVKANAG,100,gnl|BL_ORD_ID|1610|hsp_num:0,1757,FALSE,None
LK494,2_583 # 625064 # 625594 # -1 # ID=2_583;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.493,2_583,625064,625594,-,Strict,280,345.125,emrR,94.29,3000516,protein homolog model,n/a,n/a,fluoroquinolone antibiotic,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGGATAGTTCGTTTACGCCCATTGAACAAATGCTAAAATTTCGCGCCAGCCGCTACGAAGAGTTCCCTTATCAGGAAGTGCTTCTGACTCGTCTATGCATGCACATGCAGGGCAAGCTGCTGGAAAATCGCAATAAGATGCTGAAAGCTCAAGGGATTAACGAGACGTTGTTTATGGCGTTGATTACGCTGGAGTCTCAGGAAAACCACAGTATTCAGCCTTCTGAACTGAGTTGTGCGCTTGGCTCGTCACGTACTAACGCTACCCGCATCGCGGATGAGTTAGAAAAACGTGGCTGGATCGAACGTCGCGAAAGCGATAACGATCGCCGCTGTCTGCATCTGCAATTGACCGAGAAAGGCCATGCATTTTTGCAAGAGGTGTTACCGCCTCAGCATAATTGCCTGCACCAGCTCTGGTCGTCTCTTAGCACCACCGAAAAAGATCAGCTTGAGCAAATTACCCGTAAACTTCTGACCCGTCTTGATCAGATGGAGCAGGATGGCGCGGTGTTAGAAGCGCTGCGCTAA,MDSSFTPIEQMLKFRASRYEEFPYQEVLLTRLCMHMQGKLLENRNKMLKAQGINETLFMALITLESQENHSIQPSELSCALGSSRTNATRIADELEKRGWIERRESDNDRRCLHLQLTEKGHAFLQEVLPPQHNCLHQLWSSLSTTEKDQLEQITRKLLTRLDQMEQDGAVLEALR,MDSSFTPIEQMLKFRASRHEDFPYQEILLTRLCMHMQSKLLENRNKMLKAQGINETLFMALITLESQENHSIQPSELSCALGSSRTNATRIADELEKRGWIERRESDNDRRCLHLQLTEKGHEFLREVLPPQHNCLHQLWSALSTTEKDQLEQITRKLLSRLDQMEQDGVVLEAMS,100,gnl|BL_ORD_ID|1225|hsp_num:0,1330,FALSE,None
LK494,3_1 # 3 # 131 # -1 # ID=3_1;partial=10;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.581,3_1,3,131,-,Strict,1200,21.557,arnA,100,3002985,protein homolog model,n/a,n/a,peptide antibiotic,antibiotic target alteration,pmr phosphoethanolamine transferase,ATGTCACAGCAGGGACTGCGCTTTACGCTCGACGTGGACGGGTTACTGGCGACGGATACCGCCGTCGTCAGCTTCACCCTCTGCCAGAATCTCTCCACCCCCTTTACACTCAGTGTCGATATCGCCAGC,MSQQGLRFTLDVDGLLATDTAVVSFTLCQNLSTPFTLSVDIAS,MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA,6.5,gnl|BL_ORD_ID|1513|hsp_num:0,1643,TRUE,loose hit with at least 95 percent identity pushed strict
LK494,3_188 # 195903 # 196886 # -1 # ID=3_188;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.535,3_188,195903,196886,-,Strict,550,600.897,PmrF,88.47,3003578,protein homolog model,n/a,n/a,peptide antibiotic,antibiotic target alteration,pmr phosphoethanolamine transferase,ATGTTTGAAGCAGCACCAATCAAAAAAGTCTCGGTGGTCATTCCCGTTTTTAATGAACAGGAAAGCCTGCCAGAGTTAATCAGACGCACCAGCGCCGCCTGCGAGAAATTGGGTAAAGACTATGAAATTCTGCTAATCGACGACGGCAGCAGTGACAATTCCGCTCAGTTGATGATGAACGCCTCCCAGGCACCAAACAGCCATATTGTTTCTATTTTGCTGAATCGCAATTACGGGCAACACTCGGCGATTATGGCCGGTTTCAGCCATGTCACTGGCGACTTGATCATCACACTGGATGCCGATTTGCAGAACCCGCCGGAGGAGATCCCTCGGTTGGTCGCCACAGCAGATGAGGGGTTTGATGTGGTGGGCACGGTGCGCCAGAACCGGCAGGACAGCGTATTTCGTAAGACCGCCTCACGAATGATCAACCATCTGATCCAACGAACCACCGGTAAAGCAATGGGCGACTACGGCTGCATGCTACGCGCCTATCGCCGTCACATCGTCGATGCCATGCTGCATTGCCAGGAGCGCAGCACCTTTATCCCTATTCTGGCCAACATTTTTGCCCGTCGCGCGACGGAGATCCCGGTACATCATGCAGAGCGCGAATTTGGTGATTCCAAATACAGCTTCATGCGTCTGATCAACCTGATGTATGACCTGGTGACTTGCCTTACCACAACACCGCTTCGCATGCTGAGTCTGTTGGGCAGCGTGATCGCCGCCACGGGCTTTACCTTATCAGTCTTGCTTGTTGTTCTGCGCCTGACGCTCGGCCCACAGTGGGCCGCGGAAGGGGTATTCATGCTGTTTGCCGTCCTGTTTACCTTTATCGGCGCACAGTTTATTGGCATGGGTTTACTCGGCGAATATATCGGTCGCATCTATAACGATGTCCGCGCCCGCCCCCGCTATTTTGTTCAACACGTTATCCGCCCACAAACCACGCAGTCAACCGAGGAAAACCGCGCATGA,MFEAAPIKKVSVVIPVFNEQESLPELIRRTSAACEKLGKDYEILLIDDGSSDNSAQLMMNASQAPNSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVATADEGFDVVGTVRQNRQDSVFRKTASRMINHLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCQERSTFIPILANIFARRATEIPVHHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRMLSLLGSVIAATGFTLSVLLVVLRLTLGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYNDVRARPRYFVQHVIRPQTTQSTEENRA,MFEIHPVKKVSVVIPVYNEQESLPELIRRTTTACESLGKEYEILLIDDGSSDNSAHMLVEASQAENSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEGYDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHERSTFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLGSIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYTDVRARPRYFVQQVIRPSSKENE,101.55,gnl|BL_ORD_ID|1937|hsp_num:0,2014,FALSE,None
LK494,3_358 # 388661 # 389383 # -1 # ID=3_358;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.544,3_358,388661,389383,-,Strict,450,476.093,baeR,97.08,3000828,protein homolog model,n/a,n/a,aminoglycoside antibiotic; aminocoumarin antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGACTGAGTTACCCATTGATGAAAACACGCCGCGTATTCTGATCGTGGAAGACGAACCCAAGCTGGGGCAACTGCTCATCGACTACCTGCGGGCAGCGAGCTACGCTCCTACGCTCATCAGCCACGGCGACCTGGTTCTGCCTTACGTGCGCCAAACACCGCCCGATCTGATCTTGTTGGATCTGATGCTGCCCGGTACCGATGGTCTGACCCTGTGTCGGGAAATCCGCCGCTTCTCAGAAGTCCCCATCATGATGGTAACCGCTAAAATCGAAGAGATTGATCGCCTGCTGGGGCTGGAGATCGGTGCAGATGATTATATTTGTAAACCGTACAGCCCGCGCGAAGTCGTCGCGCGTGTTAAAACGATCCTGCGCCGATGCAAACCGCAGCGCGAACTACAACAAATGGATGCAGAAAGCCCGCTTATCGTCGATGAAGGCCGTTTTCAGGCCTCCTGGCGTGGGAAGATGCTCGATTTAACGCCCGCCGAATTCCGCTTACTTAAAACGTTGTCACATGAGCCGGGAAAAGTATTCTCCCGAGAACAATTACTTAACCATCTCTATGACGATTATCGCGTCGTTACCGACCGCACCATCGACAGCCATATTAAGAACCTGCGACGCAAGCTGGAGTCGCTGGATGCTGAGCAGTCGTTTATCCGCGCGGTCTATGGCGTGGGGTATCGCTGGGAAGCCGACGCCTGCCGAATTGCTTAA,MTELPIDENTPRILIVEDEPKLGQLLIDYLRAASYAPTLISHGDLVLPYVRQTPPDLILLDLMLPGTDGLTLCREIRRFSEVPIMMVTAKIEEIDRLLGLEIGADDYICKPYSPREVVARVKTILRRCKPQRELQQMDAESPLIVDEGRFQASWRGKMLDLTPAEFRLLKTLSHEPGKVFSREQLLNHLYDDYRVVTDRTIDSHIKNLRRKLESLDAEQSFIRAVYGVGYRWEADACRIA,MTELPIDENTPRILIVEDEPKLGQLLIDYLRAASYAPTLISHGDQVLPYVRQTPPDLILLDLMLPGTDGLTLCREIRRFSDIPIVMVTAKIEEIDRLLGLEIGADDYICKPYSPREVVARVKTILRRCKPQRELQQQDAESPLIIDEGRFQASWRGKMLDLTPAEFRLLKTLSHEPGKVFSREQLLNHLYDDYRVVTDRTIDSHIKNLRRKLESLDAEQSFIRAVYGVGYRWEADACRIV,100,gnl|BL_ORD_ID|1231|hsp_num:0,1337,FALSE,None
LK494,3_361 # 392192 # 395272 # -1 # ID=3_361;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.561,3_361,392192,395272,-,Strict,1800,1894.01,mdtC,93.46,3000794,protein homolog model,n/a,n/a,aminocoumarin antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGAAATTTTTCGCGCTTTTCATTCATCGGCCGGTGGCGACCATTCTCATTTCGGTGGCTATCACCCTATGCGGTATTCTGGGCTTTCGTCTGCTGCCGGTCGCTCCGCTGCCGCAGGTGGATTTTCCGGTGATTATGGTCAGCGCATCATTACCCGGTGCCTCCCCTGAAACGATGGCGTCTTCGGTCGCAACTCCGCTGGAGCGCTCGCTGGGCCGCATCGCGGGCGTAAACGAAATGACTTCGAGTAGTTCGCTTGGCAGTACGCGTATTATTCTCGAATTCAAATTCGACCGTGACATCAATGGCGCGGCGCGGGACGTTCAGGCCGCGATTAACGCCGCGCAAAGCCTGCTGCCCAGCGGGATGCCGAGCCGACCAACGTATCGCAAAGCTAACCCTTCCGATGCGCCAATCATGATCCTGACGCTGACGTCGGACACTTACTCGCAGGGTGAACTGTACGATTTCGCATCAACACAACTGGCGCAGACCATCGCGCAAATCGACGGTGTGGGCGACGTGGACGTTGGAGGCAGTTCTCTGCCTGCCGTGCGGGTAGGACTCAACCCGCAGGCGTTGTTTAACCAGGGCGTGTCGCTGGACGACGTGCGTAGCGCGATCGACAATGCCAACGTGCGTAAGCCGCAGGGCGCTATCGAGAATGATACCCATCGCTGGCAGGTACAAACTAACGATGAGCTGAAAACCGCCGCCGAATATCAACCTATTATCATCCACTATAACAACGGCGCAGCGGTGCGACTGGGTGATGTTGCGTCTATAACCGACTCTGTACAGGACGTTCGTAACGCGGGGATGACCAACGCCAAACCGGCCATTCTGCTGATGATCCGCAAGCTGCCGGAAGCCAATATTATTCAGACGGTAGATAGCATTCGCGCCAAATTACCGGAGTTACAAACGCTGGTCCCGGCCGCCATCGATCTGCAAATCGCCCAGGACCGTTCACCCACCATTCGCGCTTCACTAGAGGAAGTCGAACAGACGCTGATTATCTCCGTGGCGCTGGTTATCCTGGTGGTCTTTGTTTTCCTGCGATCCGGGCGTGCGACTCTGATCCCCGCGGTAGCGGTTCCGGTCTCGCTGATCGGTACCTTTGCCGCCATGTATCTGTGCGGATTCAGCCTGAACAACCTGTCGTTGATGGCGTTAACCATTGCCACGGGATTTGTCGTAGATGACGCCATCGTGGTGCTGGAAAATATTGCCCGCCACCTGGAAGCGGGAATGAAGCCACTCCAGGCGGCGTTACAGGGTACGCGCGAAGTGGGATTCACTGTGCTTTCCATGAGCCTGTCGCTGGTGGCGGTATTCCTGCCGCTGCTGTTAATGGGCGGATTGCCTGGACGCCTGCTGCGCGAATTTGCCGTCACGCTGTCGGTTGCCATCGGTATCTCGCTGCTGGTGTCGCTGACATTAACGCCAATGATGTGCGGCTGGATGCTTAAATCCAGTGCCCCGCGTGAACAGTCGCGTAAACGGGGATTTGGTCGCATGCTGGTAGCGCTGCAGCAAAGCTACGGCACTTCACTTAAATGGGTACTGCGCCACACGCGACTGGTGGGCGTGGTATTACTCGGCACCATTGCGCTGAATATCTGGCTTTATATTTCCATCCCCAAAACCTTCTTCCCGGAGCAGGATACGGGCGTATTGATGGGAGGGATCCAGGCTGACCAGAGCATCTCTTTCCAGGCGATGCGCGGTAAACTGCAGGATTTTATGAAGATCATCCGCGACGATCCCGCGGTGAACAATGTCACCGGCTTTACCGGTGGGTCACGGGTTAACAGCGGGATGATGTTTATTACCCTCAAGCCACGCGATGAGCGCCGTGAAACCGCTCAGCAGGTGATCGACCGCCTGCGCGTTGCGCTTTCAAAAGAACCAGGTGCGAATCTGTTTCTGATGGCGGTGCAGGACATCCGCGTTGGCGGACGGCAGGCCAACGCCAGCTATCAATACACATTACTGTCCGACGATCTGGCGGCGCTGCGTGAGTGGGAACCGAAGATCCGTAAGGCGCTTGCCGCCCTGCCCCAACTGGCGGACGTCAACTCCGATCAGCAGGACAATGGCGCGGAGATGAATCTGATTTACGATCGCGACACCATGTCTCGTCTTGGGATCGACGTGGCGGCCGCCAACAGCCTGCTGAATAACGCCTTTGGTCAGCGACAAATTTCAACCATCTATCAGCCGATGAACCAGTACAAAGTGGTGATGGAGGTCGATCGACGTTACACCCAGGACATCAGCGCGCTGGACAAAATGTTCGTCATCAACAATGAAGGTAAGGCGATCCCGTTATCGTACTTTGCCAAATGGCAGCCAGCGAATGCCCCACTGTCTGTAAACCATCAGGGATTATCTGCCGCCTCAACCGTGTCGTTTAACCTGCCGACAGGTTCTTCACTGTCAGAAGCGACAGAGGCCATCAACAGAACCATGACCCAGCTAGGCGTCCCCTCCACGGTTCGTGGCAGCTTTGCCGGTACCGCCCAGGTATTTCAGGACACGATGAACTCGCAGGTGATCCTGATTATCGCCGCCATCGCCACCGTCTATATCGTGCTGGGTATGCTGTATGAAAGCTATGTACATCCGCTGACCATTCTCTCCACGCTACCTTCGGCAGGGGTCGGGGCTTTGCTGGCGCTGGAGCTGTTCAATGCCCCATTCAGCCTAATCGCCCTGATAGGGATCATGCTATTAATTGGAATTGTGAAGAAAAACGCCATCATGATGGTCGATTTTGCGCTGGAAGCGCAGAGAAACGGTAAGCTGCAGCCGGAAGAAGCTATTTTCCAGGCCTGCCTGTTGCGCTTTCGCCCAATCATGATGACCACGCTGGCGGCGTTATTTGGCGCACTGCCGTTAGTGTTATCCGCAGGGGATGGCTCTGAGCTGCGCCAGCCGTTGGGGATAACCATTGTCGGTGGGCTGGTCGTGAGCCAGCTCCTGACGCTGTACACCACGCCTGTGGTCTATCTCTTTTTCGACCGTCTGCGTCTGCGTTTTTCGCGTAAAAACAGCAAACCGGTAGCAGAGTTATGA,MKFFALFIHRPVATILISVAITLCGILGFRLLPVAPLPQVDFPVIMVSASLPGASPETMASSVATPLERSLGRIAGVNEMTSSSSLGSTRIILEFKFDRDINGAARDVQAAINAAQSLLPSGMPSRPTYRKANPSDAPIMILTLTSDTYSQGELYDFASTQLAQTIAQIDGVGDVDVGGSSLPAVRVGLNPQALFNQGVSLDDVRSAIDNANVRKPQGAIENDTHRWQVQTNDELKTAAEYQPIIIHYNNGAAVRLGDVASITDSVQDVRNAGMTNAKPAILLMIRKLPEANIIQTVDSIRAKLPELQTLVPAAIDLQIAQDRSPTIRASLEEVEQTLIISVALVILVVFVFLRSGRATLIPAVAVPVSLIGTFAAMYLCGFSLNNLSLMALTIATGFVVDDAIVVLENIARHLEAGMKPLQAALQGTREVGFTVLSMSLSLVAVFLPLLLMGGLPGRLLREFAVTLSVAIGISLLVSLTLTPMMCGWMLKSSAPREQSRKRGFGRMLVALQQSYGTSLKWVLRHTRLVGVVLLGTIALNIWLYISIPKTFFPEQDTGVLMGGIQADQSISFQAMRGKLQDFMKIIRDDPAVNNVTGFTGGSRVNSGMMFITLKPRDERRETAQQVIDRLRVALSKEPGANLFLMAVQDIRVGGRQANASYQYTLLSDDLAALREWEPKIRKALAALPQLADVNSDQQDNGAEMNLIYDRDTMSRLGIDVAAANSLLNNAFGQRQISTIYQPMNQYKVVMEVDRRYTQDISALDKMFVINNEGKAIPLSYFAKWQPANAPLSVNHQGLSAASTVSFNLPTGSSLSEATEAINRTMTQLGVPSTVRGSFAGTAQVFQDTMNSQVILIIAAIATVYIVLGMLYESYVHPLTILSTLPSAGVGALLALELFNAPFSLIALIGIMLLIGIVKKNAIMMVDFALEAQRNGKLQPEEAIFQACLLRFRPIMMTTLAALFGALPLVLSAGDGSELRQPLGITIVGGLVVSQLLTLYTTPVVYLFFDRLRLRFSRKNSKPVAEL,MKFFALFIYRPVATILLSVAITLCGILGFRMLPVAPLPQVDFPVIIVSASLPGASPETMASSVATPLERSLGRIAGVSEMTSSSSLGSTRIILQFDFDRDINGAARDVQAAINAAQSLLPSGMPSRPTYRKANPSDAPIMILTLTSDTYSQGELYDFASTQLAPTISQIDGVGDVDVGGSSLPAVRVGLNPQALFNQGVSLDDVRTAVSNANVRKPQGALEDGTHRWQIQTNDELKTAAEYQPLIIHYNNGGAVRLGDVATVTDSVQDVRNAGMTNAKPAILLMIRKLPEANIIQTVDSIRAKLPELQETIPAAIDLQIAQDRSPTIRASLEEVEQTLIISVALVILVVFLFLRSGRATIIPAVSVPVSLIGTFAAMYLCGFSLNNLSLMALTIATGFVVDDAIVVLENIARHLEAGMKPLQAALQGTREVGFTVLSMSLSLVAVFLPLLLMGGLPGRLLREFAVTLSVAIGISLLVSLTLTPMMCGWMLKASKPREQKRLRGFGRMLVALQQGYGKSLKWVLNHTRLVGVVLLGTIALNIWLYISIPKTFFPEQDTGVLMGGIQADQSISFQAMRGKLQDFMKIIRDDPAVDNVTGFTGGSRVNSGMMFITLKPRDERSETAQQIIDRLRVKLAKEPGANLFLMAVQDIRVGGRQSNASYQYTLLSDDLAALREWEPKIRKKLATLPELADVNSDQQDNGAEMNLVYDRDTMARLGIDVQAANSLLNNAFGQRQISTIYQPMNQYKVVMEVDPRYTQDISALEKMFVINNEGKAIPLSYFAKWQPANAPLSVNHQGLSAASTISFNLPTGKSLSDASAAIDRAMTQLGVPSTVRGSFAGTAQVFQETMNSQVILIIAAIATVYIVLGILYESYVHPLTILSTLPSAGVGALLALELFNAPFSLIALIGIMLLIGIVKKNAIMMVDFALEAQRHGNLTPQEAIFQACLLRFRPIMMTTLAALFGALPLVLSGGDGSELRQPLGITIVGGLVMSQLLTLYTTPVVYLFFDRLRLRFSRKPKQTVTE,100.1,gnl|BL_ORD_ID|1212|hsp_num:0,1315,FALSE,None
LK494,3_362 # 395273 # 398395 # -1 # ID=3_362;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.545,3_362,395273,398395,-,Strict,1800,1900.95,mdtB,92.88,3000793,protein homolog model,n/a,n/a,aminocoumarin antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGCAGGTGTTACCTCCGGACAACACTGGCGGACCATCGCGCCTGTTCATTCTGCGCCCCGTCGCCACTACGCTGCTGATGGTCGCGATTTTGCTTGCCGGTATTATCGGTTATCGCTTTCTGCCAATCGCCGCCTTACCTGAAGTGGATTACCCCACGATTCAGGTCGTGACGCTCTACCCTGGCGCCAGCCCGGACGTTATGACCTCGGCGGTAACCGCGCCGCTTGAACGTCAGTTTGGCCAGATGTCTGGCTTAAAACAGATGTCATCACAAAGCTCCGGTGGCGCATCGGTCGTTACGTTACAGTTTCAACTGACGCTCCCGCTGGATGTTGCCGAGCAAGAAGTTCAGGCCGCGATTAACGCCGCCACCAATTTATTACCTAGCGATCTACCTAACCCTCCGGTCTACAGCAAGGTAAACCCGGCAGATCCGCCGATCATGACGCTGGCGGTCACTTCCAGCGCCATGCCGATGACGCAGGTGGAAGATATGGTCGAAACCCGCGTCGCGCAGAAAATCTCTCAGGTATCCGGCGTGGGTCTGGTAACACTTTCCGGTGGGCAACGTCCGGCGGTCCGCGTGAAACTTAACGCTCAGGCCATTGCCGCACTCGGTCTTACCAGCGAAACCATCCGTACGGCCATTACCGGTGCCAACGTCAATTCAGCAAAAGGGAGTCTTGATGGCCCAACGCGCGCCGTTACCCTTTCAGCTAACGACCAAATGCAGTCCGCAGATGAATATCGTCAGCTCATTATTGCCTATAAAAACGGTGCGCCGGTTCGTCTGGGCGATGTTGCTACCGTCGAACAAGGAGCAGAAAACAGCTGGCTAGGTGCATGGGCAAATAAGCAACAAGCTATAGTGATGAATGTGCAGCGCCAGCCTGGGGCGAACATCATCGCCACGGCAGACAGTATCCGCCAGATGCTGCCACAGCTCACCGAAAGCCTGCCCAAATCGGTTAAGGTCAGCGTACTTTCCGATCGCACCACCAATATTCGTGCCTCTGTTGCAGACACCCAGTTCGAGTTGATGCTGGCGATAGCGCTGGTGGTGATGATTATCTACCTGTTTCTGCGCAATGTTCCGGCGACGATTATTCCTGCAGTCGCCGTACCGTTGTCGTTAATCGGCACCTTCGCGGTGATGGTATTTCTTGATTTCTCCATCAACAACCTGACCTTAATGGCGCTAACCATCGCGACAGGCTTTGTTGTGGATGACGCTATCGTGGTTATCGAGAATATTTCACGCTATATCGAAAAAGGCGAAAAACCGCTGACTGCTGCCCTGAAGGGCGCGGGCGAGATTGGTTTTACCATCATCTCTCTGACGTTTTCATTGATTGCGGTATTGATCCCACTGCTATTCATGGGCGATATCGTCGGGCGTTTGTTCCGTGAATTCGCCGTTACGCTGGCGGTGGCGATTCTGATTTCTGCCGTTGTCTCGCTCACTCTTACGCCGATGATGTGCGCGCGTATGCTGAATCAGGCCTCATTGCGTAAGCAAAATCGCTTCTCCCGCGCCTCAGAGCGAATGTTTGATCGCGTCATCACCGGGTACGGTCATTGGCTGGCAAAAGTACTTAACCACCCGTGGCTCACACTTAGCGTAGCGCTCGGCACGCTGGCATTGAGCGTCATGCTATGGGTTTTCATCCCCAAAGGTTTCTTCCCAATCCAGGACAACGGCATTATCCAGGGTACGCTACAGGCGCCGCAGTCCAGCTCATTCGCCAGCATGGCCGAGCGCCAGCGTCAGGTTTCAGATGTCATCCTTAAAGATCCGGCGGTAGAGAGCCTGACCGCTTTTGTCGGCGTGGATGGTACTAATCCGGCATTGAACAGCGCGCGTTTGCAAATCAACCTTAAACCACTGGATGAACGTGACGATCGGGTGCAGAAAGTGATTGCGCGCTTACAGGACGCGGTTGACAGGGTTCCCGGAGTTGACCTTTATCTTCAGCCTACTCAGGATCTGACGATTGATACTCAGGTGAGCCGGACGCAATATCAATTCACGCTGCAAGCGACATCCCTTGATGCCCTCAGCACCTGGGTTCCACAGCTGATAGCAAAACTAAATCAGCTACCGCAACTGTCCGACGTCAGCAGCGACTGGCAGGACAAAGGGCTGGTAGCGTATGTGAACGTCAATCGCGACAGCGCAAGCCGTTTGGGCATCAGCATGTCAGATGTCGACAACGCCCTGTACAACGCCTTCGGCCAGCGTTTGATTTCGACTATTTACACCCAGGCAAATCAATATCGCGTGGTGTTAGAACATAACACCAACAATACGCCGGGGCTTGCGGCACTGGATACAATACGTCTGACCAGTAGCGACGGTGGCATAGTACCGCTCAGCGCGATCGCCAGTATTGAACAGCGTTTTGCCCCGCTGTCGATTAACCACCTCGATCAGTTCCCGGTCACCACCATCTCGTTCAACGTGCCAGACGAACATTCGCTGGGTGATGCGGTACAGGCGATTCTGGATGCCGAAAAAACGCTTAACCTGCCCGCAAATATTACTACCCAGTTCCAGGGTAGCACGCTCGCCTTCCAGGCCGCGCTGGGAAATACCATCTGGTTGATTGTGGCTGCGGTTGTCGCGATGTATATCGTCCTCGGCGTGCTGTATGAGAGCTTTATTCACCCAATTACTATTCTCTCCACGCTGCCGACGGCGGGCGTCGGGGCACTGCTGGCGTTAATGATTGCCGGCAGCGAACTGGACGTCATCGCGATTATTGGCATTATTTTGCTCATCGGTATCGTCAAGAAAAACGCCATCATGATGATCGACTTTGCCCTTGCCGCGGAGCGCGAACAAGGCATGGCGCCGCGCGATGCTATTTTCCAGGCCTGTCTGCTGCGTTTCCGCCCAATTCTGATGACTACGCTGGCGGCACTGCTCGGCGCGTTGCCGCTGATGTTAAGTACCGGTGTGGGCGCAGAGTTACGCCGTCCGTTAGGCATTGGCATGGTCGGTGGACTGCTTGTGAGTCAGGTATTAACCCTGTTTACCACCCCGGTAATTTATCTGCTGTTTGACCGTCTGTCGCTGTATGTGAAAAGCCGCTTCCCGCGTCAGGAAGAGGAAGCGTAA,MQVLPPDNTGGPSRLFILRPVATTLLMVAILLAGIIGYRFLPIAALPEVDYPTIQVVTLYPGASPDVMTSAVTAPLERQFGQMSGLKQMSSQSSGGASVVTLQFQLTLPLDVAEQEVQAAINAATNLLPSDLPNPPVYSKVNPADPPIMTLAVTSSAMPMTQVEDMVETRVAQKISQVSGVGLVTLSGGQRPAVRVKLNAQAIAALGLTSETIRTAITGANVNSAKGSLDGPTRAVTLSANDQMQSADEYRQLIIAYKNGAPVRLGDVATVEQGAENSWLGAWANKQQAIVMNVQRQPGANIIATADSIRQMLPQLTESLPKSVKVSVLSDRTTNIRASVADTQFELMLAIALVVMIIYLFLRNVPATIIPAVAVPLSLIGTFAVMVFLDFSINNLTLMALTIATGFVVDDAIVVIENISRYIEKGEKPLTAALKGAGEIGFTIISLTFSLIAVLIPLLFMGDIVGRLFREFAVTLAVAILISAVVSLTLTPMMCARMLNQASLRKQNRFSRASERMFDRVITGYGHWLAKVLNHPWLTLSVALGTLALSVMLWVFIPKGFFPIQDNGIIQGTLQAPQSSSFASMAERQRQVSDVILKDPAVESLTAFVGVDGTNPALNSARLQINLKPLDERDDRVQKVIARLQDAVDRVPGVDLYLQPTQDLTIDTQVSRTQYQFTLQATSLDALSTWVPQLIAKLNQLPQLSDVSSDWQDKGLVAYVNVNRDSASRLGISMSDVDNALYNAFGQRLISTIYTQANQYRVVLEHNTNNTPGLAALDTIRLTSSDGGIVPLSAIASIEQRFAPLSINHLDQFPVTTISFNVPDEHSLGDAVQAILDAEKTLNLPANITTQFQGSTLAFQAALGNTIWLIVAAVVAMYIVLGVLYESFIHPITILSTLPTAGVGALLALMIAGSELDVIAIIGIILLIGIVKKNAIMMIDFALAAEREQGMAPRDAIFQACLLRFRPILMTTLAALLGALPLMLSTGVGAELRRPLGIGMVGGLLVSQVLTLFTTPVIYLLFDRLSLYVKSRFPRQEEEA,MQVLPPSSTGGPSRLFIMRPVATTLLMVAILLAGIIGYRALPVSALPEVDYPTIQVVTLYPGASPDVMTSAVTAPLERQFGQMSGLKQMSSQSSGGASVITLQFQLTLPLDVAEQEVQAAINAATNLLPSDLPNPPVYSKVNPADPPIMTLAVTSTAMPMTQVEDMVETRVAQKISQISGVGLVTLSGGQRPAVRVKLNAQAIAALGLTSETVRTAITGANVNSAKGSLDGPSRAVTLSANDQMQSAEEYRQLIIAYQNGAPIRLGDVATVEQGAENSWLGAWANKEQAIVMNVQRQPGANIISTADSIRQMLPQLTESLPKSVKVTVLSDRTTNIRASVDDTQFELMMAIALVVMIIYLFLRNIPATIIPGVAVPLSLIGTFAVMVFLDFSINNLTLMALTIATGFVVDDAIVVIENISRYIEKGEKPLAAALKGAGEIGFTIISLTFSLIAVLIPLLFMGDIVGRLFREFAITLAVAILISAVVSLTLTPMMCARMLSQESLRKQNRFSRASEKMFDRIIAAYGRGLAKVLNHPWLTLSVALSTLLLSVLLWVFIPKGFFPVQDNGIIQGTLQAPQSSSFANMAQRQRQVADVILQDPAVQSLTSFVGVDGTNPSLNSARLQINLKPLDERDDRVQKVIARLQTAVDKVPGVDLFLQPTQDLTIDTQVSRTQYQFTLQATSLDALSTWVPQLMEKLQQLPQLSDVSSDWQDKGLVAYVNVDRDSASRLGISMADVDNALYNAFGQRLISTIYTQANQYRVVLEHNTENTPGLAALDTIRLTSSDGGVVPLSSIAKIEQRFAPLSINHLDQFPVTTISFNVPDNYSLGDAVQAIMDTEKTLNLPVDITTQFQGSTLAFQSALGSTVWLIVAAVVAMYIVLGILYESFIHPITILSTLPTAGVGALLALLIAGSELDVIAIIGIILLIGIVKKNAIMMIDFALAAEREQGMSPREAIYQACLLRFRPILMTTLAALLGALPLMLSTGVGAELRRPLGIGMVGGLIVSQVLTLFTTPVIYLLFDRLALWTKSRFARHEEEA,100,gnl|BL_ORD_ID|757|hsp_num:0,820,FALSE,None
LK494,4_112 # 112170 # 112532 # 1 # ID=4_112;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.449,4_112,112170,112532,+,Strict,150,184.882,Klebsiella pneumoniae KpnE,80,3004580,protein homolog model,n/a,n/a,macrolide antibiotic; aminoglycoside antibiotic; cephalosporin; tetracycline antibiotic; peptide antibiotic; rifamycin antibiotic; disinfecting agents and antiseptics,antibiotic efflux,small multidrug resistance (SMR) antibiotic efflux pump,ATGTTTTACTGGATATTATTAGGTCTGGCCATCGCGGCTGAAATTACTGGTACGCTTTCAATGAAATGGGCAAGCGTCGGCCATGGTAATTCGGGCTTTATTTTAATGCTGGTAATGATCGCCTTATCGTATATTTTTCTCAGTTTTGCCGTTAAAAAAATTGCCCTTGGTGTGGCCTATGCCCTGTGGGAAGGGATCGGTATTTTATTTATTACGCTGTTTAGCGTGCTGTTATTTGACGAAACCTTGTCCACATTGAAGGTGGCAGGACTGGCTTCACTGGTGGTCGGCATTGTGCTGATTAAATCCGGCACCCGAAAGCCTGTTAAACCAGGCAAAGAGGTGACCCATGCAACAGTTTGA,MFYWILLGLAIAAEITGTLSMKWASVGHGNSGFILMLVMIALSYIFLSFAVKKIALGVAYALWEGIGILFITLFSVLLFDETLSTLKVAGLASLVVGIVLIKSGTRKPVKPGKEVTHATV,MFYWILLALAIIAEITGTLSMKWASVSGGHTGFILMLAMIALSYIFLAFAVKKIALGVAYALWEGIGILLITLFSVLLFDESLSLLKIAGLTTLVIGIVLIKSGTQKKASSQQEVAHAAV,100,gnl|BL_ORD_ID|2721|hsp_num:0,3283,FALSE,None
LK494,4_113 # 112519 # 112848 # 1 # ID=4_113;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.512,4_113,112519,112848,+,Strict,150,193.356,Klebsiella pneumoniae KpnF,88.99,3004583,protein homolog model,n/a,n/a,macrolide antibiotic; aminoglycoside antibiotic; cephalosporin; tetracycline antibiotic; peptide antibiotic; rifamycin antibiotic; disinfecting agents and antiseptics,antibiotic efflux,small multidrug resistance (SMR) antibiotic efflux pump,ATGCAACAGTTTGAATGGGTTCACGGTGCCTGGCTGGGTATGGCTATCGTGCTGGAAATCGTCGCTAACGTCTTTTTGAAATTTTCTGATGGTTTTCGCCGCAAGATTTATGGCGTGCTGTCGTTAGCTGCCGTATTAGCGGCCTTTAGCGCGCTGTCGCAAGCGGTAAAAGGTATTGACCTTTCTGTTGCCTACGCCTTGTGGGGCGGATTCGGTATTGCCGCGACGTTAGCGGCAGGTTGGGTGCTGTTTGGTCAGCGCCTGAATAATAAGGGCTGGATCGGCGTGATACTGCTACTGGCCGGAATGATAATGATAAAACTTGCCTGA,MQQFEWVHGAWLGMAIVLEIVANVFLKFSDGFRRKIYGVLSLAAVLAAFSALSQAVKGIDLSVAYALWGGFGIAATLAAGWVLFGQRLNNKGWIGVILLLAGMIMIKLA,MQQFEWIHAAWLAIAIVLEIIANVFLKFSDGFRRKIYGILSLAAVLGAFSALSQAVKGIDLSVAYALWGGFGIAATIAAGWVLFGQRLNNKGWAGVILLVAGMVLIKLA,100,gnl|BL_ORD_ID|2723|hsp_num:0,3286,FALSE,None
LK494,4_155 # 154407 # 154790 # -1 # ID=4_155;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.438,4_155,154407,154790,-,Strict,230,248.825,marA,93.7,3000263,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; penem; disinfecting agents and antiseptics,antibiotic efflux; reduced permeability to antibiotic,resistance-nodulation-cell division (RND) antibiotic efflux pump; General Bacterial Porin with reduced permeability to beta-lactams,ATGTCCAGACGCAATACTGACACAATCACTATTCATAGCATTTTGGACTGGATCGAAAATAACCTTGAATCGCCGCTCTCGCTGGAAAAGGTGTCTGAGCGTTCAGGTTACTCCAAATGGCACCTGCAACGGATGTTTAAAAAAGAAACCGGTCATTCACTGGGTCAATACATTCGCAGCCGTAAAATGACCGAAATAGCGCAAAAATTAAAAGAGAGTAACGAGCCCATTCTTTATCTGGCAGAGCGTTACGGTTTTGAGTCTCAGCAGACGCTGACCCGGACATTCAAAAACTATTTTGATGTTCCGCCGCACAAATACCGTATGACGAATATGCATGGCGAATCGCGCTATTTGCTTCCACTCAATCAATGTAATTGCTAA,MSRRNTDTITIHSILDWIENNLESPLSLEKVSERSGYSKWHLQRMFKKETGHSLGQYIRSRKMTEIAQKLKESNEPILYLAERYGFESQQTLTRTFKNYFDVPPHKYRMTNMHGESRYLLPLNQCNC,MSRRNTDAITIHSILDWIEDNLESPLSLEKVSERSGYSKWHLQRMFKKETGHSLGQYIRSRKMTEIAQKLKESNEPILYLAERYGFESQQTLTRTFKNYFDVPPHKYRMTNMQGESRFLHPLNHYNS,100,gnl|BL_ORD_ID|1772|hsp_num:0,1922,FALSE,None
LK494,4_420 # 440325 # 440738 # 1 # ID=4_420;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.464,4_420,440325,440738,+,Strict,240,233.417,H-NS,95.62,3000676,protein homolog model,n/a,n/a,macrolide antibiotic; fluoroquinolone antibiotic; cephalosporin; cephamycin; penam; tetracycline antibiotic,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGAGCGAAGCACTTAAAATTCTGAACAACATCCGTACTCTTCGTGCGCAGGCAAGAGAATGCACTCTGGAAACGCTTGAGGAAATGCTGGAAAAATTAGAAGTTGTAGTTAGCGAGCGTCGCGAAGAAGAAAGCGCTGCTGCCGCTGAAGTTGAAGAACGCACTCGTAAACTGCAACAATATCGTGAAATGCTGATCGCTGACGGCATTGATCCGAACGAACTGCTGAATAGCATGGCTGCTGTTAAATCTGGCACCAAAGCTAAACGCGCTGCACGTCCGGCTAAATATAGCTATGTTGACGAAAACGGTGAAACTAAAACCTGGACTGGTCAGGGTCGTACACCGGCAGTAATCAAAAAAGCGATGGAAGAGCAAGGTAAACAACTGGACGATTTCCTGATCAAGGAATAA,MSEALKILNNIRTLRAQARECTLETLEEMLEKLEVVVSERREEESAAAAEVEERTRKLQQYREMLIADGIDPNELLNSMAAVKSGTKAKRAARPAKYSYVDENGETKTWTGQGRTPAVIKKAMEEQGKQLDDFLIKE,MSEALKILNNIRTLRAQARECTLETLEEMLEKLEVVVNERREEESAAAAEVEERTRKLQQYREMLIADGIDPNELLNSLAAVKSGTKAKRAQRPAKYSYVDENGETKTWTGQGRTPAVIKKAMDEQGKSLDDFLIKQ,100,gnl|BL_ORD_ID|1144|hsp_num:0,1248,TRUE,loose hit with at least 95 percent identity pushed strict
LK494,5_133 # 148652 # 149599 # -1 # ID=5_133;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.432,5_133,148652,149599,-,Strict,500,574.704,leuO,85.71,3003843,protein homolog model,n/a,n/a,nucleoside antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGCCAGAAGTAAAAATAACAGATAAAACAAATATTATAGATATTGGGAAACCACAGCTTCGCATGGTTGATCTTAATTTATTAACCGTCTTTGATGCGGTGATGCAAGAACAAAACATTACCCGTGCCGCGCATACTTTGGGGATGTCGCAACCTGCTGTCAGTAATGCGGTCGCGCGCCTGAAAATTATGTTTAATGATGAGCTTTTTGTTCGTTATGGACGCGGTATCCAGCCGACAGCAAGAGCCTTCCAGCTATTTGGTTCTGTTCGCCAGGCATTGCAATTAGTGCAGAATGAACTGCCTGGATCGGGTTTTGAGCCAGCCAGCAGCGAGCGCGTATTCAATCTTTGCGTATGCAGCCCATTGGATAATATTCTGACCTCGTTGATTTATAATAGGGTTGAGCAAGTTGCACCAAACATTCATGTCGTATTTAAATCTTCACTCAATCAAAATACAGAGCATCAATTACGTTACCAGGAAACTGAATTCGTTATTAGCTATGAAGAGTTCCGACGTCCTGAATTTACCAGTATTCCGTTATTCAATGACGAAATGGTGTTAGTGGCAAGTAAAAAGCATCCGCGCATTAGTGGTCCTTTACTGGAAAGCAATGTCTATAATGAACAGCATGCGGTGGTGTCACTTGATCGCTTCGCATCATTCAGCCAACCGTGGTATGACACACCGGATAAACAATCCTCCGTGGCTTATCAGGGCATGGCATTAATTAGCGTTCTTAATATTGTGTCGCAAACGCATTTGGTCTCTATTGCGCCACGTTGGTTAGCAGAAGAATTTGCCGATTCTTTAGAACTACAGATCTTGCCTTTACCGTTAAAATTGAACAGCCGCACATGCTATCTTTCATGGCATGAAGCCGCAGGCCGGGATAAAGGACATCAATGGATGGAAGAGTTGTTAGTCTCCGTTTGTAAGCAGTAG,MPEVKITDKTNIIDIGKPQLRMVDLNLLTVFDAVMQEQNITRAAHTLGMSQPAVSNAVARLKIMFNDELFVRYGRGIQPTARAFQLFGSVRQALQLVQNELPGSGFEPASSERVFNLCVCSPLDNILTSLIYNRVEQVAPNIHVVFKSSLNQNTEHQLRYQETEFVISYEEFRRPEFTSIPLFNDEMVLVASKKHPRISGPLLESNVYNEQHAVVSLDRFASFSQPWYDTPDKQSSVAYQGMALISVLNIVSQTHLVSIAPRWLAEEFADSLELQILPLPLKLNSRTCYLSWHEAAGRDKGHQWMEELLVSVCKQ,MPEVQTDHPETAELSKPQLRMVDLNLLTVFDAVMQEQNITRAAHALGMSQPAVSNAVARLKVMFNDELFVRYGRGIQPTARAFQLFGSVRQALQLVQNELPGSGFEPASSERVFHLCVCSPLDSILTSQIYNHIEQIAPNIHVMFKSSLNQNTEHQLRYQETEFVISYEDFHRPEFTSVPLFKDEMVLVASKNHPTIKGPLLKHDVYNEQHAAVSLDRFASFSQTWYDTVDKQASIAYQGMAMMSVLSVVSQTHLVAIAPRWLAEEFAESLELQVLPLPLKQNSRTCYLSWHEAAGRDKGHQWMEEQLVSICKR,100.32,gnl|BL_ORD_ID|4928|hsp_num:0,5921,FALSE,None
LK494,5_278 # 313380 # 314621 # 1 # ID=5_278;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.555,5_278,313380,314621,+,Strict,700,715.687,mdtM,86.73,3001214,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; lincosamide antibiotic; nucleoside antibiotic; phenicol antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGCAACGGATTCTCGCGTTTTTCTCCCAACGCGCTACGACGCTATTTTTTCCTATTGCGTTGATTTTGTATGATTTCGCCGCCTATCTGTCGACGGACTTGATTCAGCCCGGCATCATTAATGTCGTACGCGATTTCAACGCCGACGTCACCCTGGCGCCCGCTGCGGTGAGCCTCTATCTGGCAGGCGGCATGGCGCTGCAATGGCTGTTGGGGCCACTTTCCGACCGGATTGGCCGTCGACCGGTGCTGATTGCGGGGGCGTTAATCTTTACCCTCGCCTGCGCTGCCACGCTGTTTACTACTTCAATGACGCAATTTCTGATCGCCCGATTTGTGCAGGGCACCAGCATCTGCTTTATCGCCACTGTGGGATATGTCACGGTGCAGGAGGCGTTTGGGCAAACGAAGGCCATTAAGTTAATGGCGATAATCACTTCCATTGTGTTGGTTGCACCGGTTATCGGCCCGCTCTCCGGAGCGGCGCTAATGCACTTTGTACACTGGAAGATCCTGTTTGCCATCATTGCCGTCATGGGGCTTATCGCCCTGATTGGGTTAATGCTAGCCATGCCGGAAACCGTCCAGCGCGGCGCGGTGCCGTTCAGTGCACGCGGCGTACTGCGTGACTTCCGCGACGTTTTCCGCAACCGGGTATTCCTGTTTGGCGCAGCCACGCTATCGCTAAGCTATATCCCGATGATGAGCTGGGTGGCGGTCTCACCGGTGATACTGATTGATGCGGGCGGCATGACTACATCGCAGTTTGCCTGGGCACAGGCCCCGGTGTTTGGCGCAGTGATCGTCGCCAATATGGTGGTGGTTCGTTTCGTGAAAGATCCGACCCGACCACGCTTTATCTGGCGGGCCGCACCTATACAGCTGAGCGGGCTGGCGGTGCTGATTGTCGGCAATTTACTGTGGCCACACGTCTGGCTGTGGTCAGTGCTGGGGACCAGCCTGTATGCGTTTGGCATTGGGATGATCTTCCCAACGTTATTCCGCTTTACGCTGTTTTCCAACAACTTACCGAAGGGTACGGTTTCCGCATCGTTAAATATGGTGATCCTGACGGTGATGGCGGTTTCTGTCGAAATTGGACGCTGGCTATGGTTTAACGGTGGCAGGATTTCGTTTCATCTGCTGGCGGTGGTGGCAGGTATTGCCGTCGTGTTCACGCTGGCAGGCTTACTCAAACGGGTACGCCAACATGAGGCAACGACGTTAGTCACTGAAAACTAA,MQRILAFFSQRATTLFFPIALILYDFAAYLSTDLIQPGIINVVRDFNADVTLAPAAVSLYLAGGMALQWLLGPLSDRIGRRPVLIAGALIFTLACAATLFTTSMTQFLIARFVQGTSICFIATVGYVTVQEAFGQTKAIKLMAIITSIVLVAPVIGPLSGAALMHFVHWKILFAIIAVMGLIALIGLMLAMPETVQRGAVPFSARGVLRDFRDVFRNRVFLFGAATLSLSYIPMMSWVAVSPVILIDAGGMTTSQFAWAQAPVFGAVIVANMVVVRFVKDPTRPRFIWRAAPIQLSGLAVLIVGNLLWPHVWLWSVLGTSLYAFGIGMIFPTLFRFTLFSNNLPKGTVSASLNMVILTVMAVSVEIGRWLWFNGGRISFHLLAVVAGIAVVFTLAGLLKRVRQHEATTLVTEN,MPRFFTRHAATLFFPMALILYDFAAYLSTDLIQPGIINVVRDFNADVSLAPAAVSLYLAGGMALQWLLGPLSDRIGRRPVLITGALIFTLACAATMFTTSMTQFLIARAIQGTSICFIATVGYVTVQEAFGQTKGIKLMAIITSIVLIAPIIGPLSGAALMHFMHWKVLFAIIAVMGFISFVGLLLAMPETVKRGAVPFSAKSVLRDFRNVFCNRLFLFGAATISLSYIPMMSWVAVSPVILIDAGSLTTSQFAWTQVPVFGAVIVANAIVARFVKDPTEPRFIWRAVPIQLVGLSLLIVGNLLSPHVWLWSVLGTSLYAFGIGLIFPTLFRFTLFSNKLPKGTVSASLNMVILMVMSVSVEIGRWLWFNGGRLPFHLLAVVAGVIVVFTLAGLLNRVRQHQAAELVEEQ,100.73,gnl|BL_ORD_ID|1098|hsp_num:0,1191,FALSE,None
LK494,6_23 # 18658 # 19290 # 1 # ID=6_23;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.496,6_23,18658,19290,+,Strict,400,432.95,CRP,99.05,3000518,protein homolog model,n/a,n/a,macrolide antibiotic; fluoroquinolone antibiotic; penam,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGGTGCTTGGCAAACCGCAAACAGACCCGACTCTCGAATGGTTCTTGTCTCATTGCCATATTCATAAGTACCCATCGAAGAGCACGCTGATTCACCAGGGTGAAAAAGCGGAAACGTTGTACTACATCGTTAAAGGCTCAGTGGCAGTGCTGATCAAAGATGAAGAAGGGAAAGAAATGATCCTTTCTTATCTGAATCAGGGCGATTTTATTGGTGAATTAGGCCTCTTCGAAGAAGGTCAGGAACGCAGCGCCTGGGTCCGTGCTAAAACTGCATGTGAAGTCGCTGAAATTTCCTACAAAAAATTTCGTCAATTAATCCAGGTCAATCCAGATATTCTGATGCGTCTGTCCTCTCAGATGGCTCGCCGTCTGCAGGTCACGTCTGAAAAAGTGGGCAACCTTGCCTTCCTCGACGTTACCGGTCGTATCGCGCAGACTCTGCTGAATCTGGCGAAACAGCCTGATGCGATGACCCACCCGGACGGCATGCAGATTAAAATCACCCGTCAGGAAATCGGCCAGATCGTTGGCTGCTCCCGTGAGACCGTCGGTCGTATTCTGAAGATGCTGGAAGATCAGAACCTGATCTCCGCACACGGTAAGACCATCGTCGTCTACGGCACACGTTAA,MVLGKPQTDPTLEWFLSHCHIHKYPSKSTLIHQGEKAETLYYIVKGSVAVLIKDEEGKEMILSYLNQGDFIGELGLFEEGQERSAWVRAKTACEVAEISYKKFRQLIQVNPDILMRLSSQMARRLQVTSEKVGNLAFLDVTGRIAQTLLNLAKQPDAMTHPDGMQIKITRQEIGQIVGCSRETVGRILKMLEDQNLISAHGKTIVVYGTR,MVLGKPQTDPTLEWFLSHCHIHKYPSKSKLIHQGEKAETLYYIVKGSVAVLIKDEEGKEMILSYLNQGDFIGELGLFEEGQERSAWVRAKTACEVAEISYKKFRQLIQVNPDILMRLSAQMARRLQVTSEKVGNLAFLDVTGRIAQTLLNLAKQPDAMTHPDGMQIKITRQEIGQIVGCSRETVGRILKMLEDQNLISAHGKTIVVYGTR,100,gnl|BL_ORD_ID|803|hsp_num:0,869,FALSE,None
LK494,9_11 # 13462 # 16575 # 1 # ID=9_11;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.559,9_11,13462,16575,+,Strict,1900,2039.62,acrD,95.18,3000491,protein homolog model,n/a,n/a,aminoglycoside antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGGCGAATTTTTTCATCGATCGCCCCATTTTTGCCTGGGTGTTAGCTATCCTGTTGTGCCTGACAGGAGCCCTGGCTATTTTTTCACTACCCGTTGAGCAATATCCCGATCTGGCGCCGCCAAACGTACGGGTCACCGCCAACTATCCTGGCGCCTCGGCTCAGACTCTGGAAAACACCGTCACCCAGGTGATCGAGCAGAACATGACCGGTCTCGATAACCTGATGTACATGTCGTCACAGAGCAGCGGGACAGGTCAGGCATCAGTTACGCTGAGCTTTGTCGCCGGAACCGATCCTGACGAGGCCGTCCAGCAGGTGCAAAACCAGCTGCAATCGGCAATGCGTAAGCTGCCGCAGGCGGTACAGGATCAGGGGGTCACGGTGCGTAAGACCGGGGACACCAATATTCTGACAATCGCCTTTGTCTCCACCGATGGCTCAATGGATAAGCAGGACATCGCCGACTATGTCGCCAGTAACATTCAGGATCCGCTCAGCCGTATTAACGGCGTGGGGGATATTGACGCTTACGGCTCACAGTACTCCATGCGTATCTGGCTTGACCCGGCCAAACTGAACAGTTTCCAGATGACCGCTAAAGATGTGACCGACGCTATCGAGTCACAGAATGCGCAGATTGCGGTCGGACAACTTGGCGGTACGCCTTCGGTGGACAAGCAGGCACTGAACGCGACGATCAACGCCCAGTCGCTACTGCAGACTCCTGATGAATTCCGCGCCATTACTCTACGTGTCAACCAGGATGGATCAGAAGTTAAACTGGGTGATGTGGCGACGGTCGAAATGGGTGCTGAAAAGTACGACTACCTCAGCCGGTTTAACGGCAACCCGGCTTCCGGCCTGGGCGTGAAACTGGCCTCCGGCGCCAATGAAATGGCAACGGCAGAGCTGGTGCTCAACCGCCTTGACGAACTGTCACAGTATTTTCCACATGGGCTGGAATATAAGGTGGCATATGAAACCACCTCCTTTGTCAAAGCCTCAATCATCGACGTGGTAAAAACCCTGCTGGAAGCGATCGCGCTGGTATTCCTCGTGATGTACCTGTTCCTGCAAAACTTCCGCGCCACGCTGATTCCCACCATCGCCGTTCCCGTCGTCCTGATGGGTACCTTCTCCGTGCTTTACGCCTTTGGCTATAGCGTTAACACCTTGACGATGTTTGCGATGGTGCTGGCGATCGGCCTGCTGGTCGATGACGCCATTGTGGTAGTGGAAAACGTCGAGCGTATTATGAGTGAGGAAGGGCTCACACCGCGGGAAGCGACACGGAAATCGATGGGGCAAATCCAGGGCGCGCTGGTTGGTATTGCCATGGTGCTGTCGGCGGTGTTTATCCCGATGGCCTTCTTCGGCGGCACTACCGGGGCTATTTACCGCCAGTTCTCGATTACTATCGTCTCCGCAATGGTGCTGTCTGTTCTGGTGGCGATGATCCTCACTCCTGCTCTGTGCGCCACCCTGCTCAAACCGCTGCATAAGGGCGAACATCACGGACAAACCGGTTTCTTCGCCTGGTTTAACCGAATGTTTAATCGCAACGCCGAGCGCTACGAAAAAGGCGTTGCCAGGATCCTGCACCGCAGCCTGCGCTGGATACTGATCTACGGCCTGCTGCTCGGCGGAATGGTTTTCCTGTTCCTGCGCCTGCCAACCTCCTTCCTGCCGCTGGAAGACCGCGGCATGTTTACCACCTCGGTACAGCTGCCTAGCGGCTCCACACAGCAGCAAACATTGAAAGTGGTTGAGGAAGTAGAGAAGTATTACTTCACCCATGAGAAAGACAACATTATGTCGGTCTTTTCCACGGTCGGTTCAGGCCCTGGCGGGAACGGTCAAAACGTGGCGCGTATGTTTGTCCGTTTAAAAGACTGGGATGAGCGCGACACCACTACCGGAACCTCTTTCGCCATCATTGAACGTGCGACCAAAGCCTTTAATAAGATTAAAGAAGCCCGCGTCTTCGCCAGTAGCCCTCCGGCTATCAGTGGCCTCGGAAGCTCTGCCGGTTTCGATATGGAGCTGCAGGATCACGCTGGTGCGGGGCATGACGCGTTAATGGCCGCGCGCGACAAGCTGATTGAGCTGGCCGGGAAGGATTCTTCCCTGACCCGCGTTCGTCATAACGGTCTGGACGACAGCCCGCAGTTGCAAATTGATATCGATCAGCGCAAAGCCCAGGCACTGGGCGTTTCCATCGACGACATCAACGATACATTGCAAACGGCCTGGGGTTCCAGCTACGTCAATGACTTTATGGACCGCGGTCGCGTGAAGAAGGTTTACGTGCAGGCGGCAGCAAAATATCGCATGCTCCCTGACGACATCAATTTGTGGTACGTCCGTAATAACAACGGTGGCATGGTGCCTTTCTCGGCCTTTGCCACGTCGCGCTGGGAAACCGGTTCACCGCGTCTGGAACGCTACAACGGCTACTCTGCGGTCGAGATTGTCGGAGAAGCCGCGCCCGGCGTCAGTACCGGTACAGCGATGGACATAATGGAATCGCTGGTGCGCCAGTTGCCGACCGGATTCGGCCTCGAATGGACTGCGATGTCTTATCAGGAACGGCTGTCGGGTTCTCAGGCCCCCGCCCTGTACGCCATTTCTCTGCTGGTGGTATTCCTGTGTCTGGCGGCCCTGTATGAAAGCTGGTCAGTTCCCTTCTCTGTCATGCTGGTTGTGCCGCTGGGGGTCATTGGTGCTCTGCTGGCGACCTGGATGCGCGGTCTGGAAAACGACGTGTACTTCCAGGTCGGGTTACTTACCGTTATCGGGCTATCGGCGAAGAACGCAATCTTGATTGTTGAATTCGCCAATGAGATGAACGAGAAAGGACACGATCTGCTCGATGCCACGCTCCACGCCTGTCGCCAGCGCTTGCGTCCGATTCTGATGACCTCGCTGGCGTTTATCTTTGGGGTTCTGCCGATGACCATCAGCAGTGGCGCAGGTTCTGGCGGTCAACATGCGGTGGGGACAGGCGTAATGGGCGGGATGATTTCAGCCACTATCCTGGCGATTTACTTCGTGCCCCTGTTCTTTGTGCTGGTACGCAGACGCTTCCCGTTGAAACCGCGCCCGGAATAA,MANFFIDRPIFAWVLAILLCLTGALAIFSLPVEQYPDLAPPNVRVTANYPGASAQTLENTVTQVIEQNMTGLDNLMYMSSQSSGTGQASVTLSFVAGTDPDEAVQQVQNQLQSAMRKLPQAVQDQGVTVRKTGDTNILTIAFVSTDGSMDKQDIADYVASNIQDPLSRINGVGDIDAYGSQYSMRIWLDPAKLNSFQMTAKDVTDAIESQNAQIAVGQLGGTPSVDKQALNATINAQSLLQTPDEFRAITLRVNQDGSEVKLGDVATVEMGAEKYDYLSRFNGNPASGLGVKLASGANEMATAELVLNRLDELSQYFPHGLEYKVAYETTSFVKASIIDVVKTLLEAIALVFLVMYLFLQNFRATLIPTIAVPVVLMGTFSVLYAFGYSVNTLTMFAMVLAIGLLVDDAIVVVENVERIMSEEGLTPREATRKSMGQIQGALVGIAMVLSAVFIPMAFFGGTTGAIYRQFSITIVSAMVLSVLVAMILTPALCATLLKPLHKGEHHGQTGFFAWFNRMFNRNAERYEKGVARILHRSLRWILIYGLLLGGMVFLFLRLPTSFLPLEDRGMFTTSVQLPSGSTQQQTLKVVEEVEKYYFTHEKDNIMSVFSTVGSGPGGNGQNVARMFVRLKDWDERDTTTGTSFAIIERATKAFNKIKEARVFASSPPAISGLGSSAGFDMELQDHAGAGHDALMAARDKLIELAGKDSSLTRVRHNGLDDSPQLQIDIDQRKAQALGVSIDDINDTLQTAWGSSYVNDFMDRGRVKKVYVQAAAKYRMLPDDINLWYVRNNNGGMVPFSAFATSRWETGSPRLERYNGYSAVEIVGEAAPGVSTGTAMDIMESLVRQLPTGFGLEWTAMSYQERLSGSQAPALYAISLLVVFLCLAALYESWSVPFSVMLVVPLGVIGALLATWMRGLENDVYFQVGLLTVIGLSAKNAILIVEFANEMNEKGHDLLDATLHACRQRLRPILMTSLAFIFGVLPMTISSGAGSGGQHAVGTGVMGGMISATILAIYFVPLFFVLVRRRFPLKPRPE,MANFFIDRPIFAWVLAILLCLTGTLAIFSLPVEQYPDLAPPNVRVTANYPGASAQTLENTVTQVIEQNMTGLDNLMYMSSQSSGTGQASVTLSFKAGTDPDEAVQQVQNQLQSAMRKLPQAVQNQGVTVRKTGDTNILTIAFVSTDGSMDKQDIADYVASNIQDPLSRVNGVGDIDAYGSQYSMRIWLDPAKLNSFQMTAKDVTDAIESQNAQIAVGQLGGTPSVDKQALNATINAQSLLQTPEQFRDITLRVNQDGSEVRLGDVATVEMGAEKYDYLSRFNGKPASGLGVKLASGANEMATAELVLNRLDELAQYFPHGLEYKVAYETTSFVKASIEDVVKTLLEAIALVFLVMYLFLQNFRATLIPTIAVPVVLMGTFSVLYAFGYSVNTLTMFAMVLAIGLLVDDAIVVVENVERIMSEEGLTPREATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGTTGAIYRQFSITIVAAMVLSVLVAMILTPALCATLLKPLKKGEHHGQKGFFAWFNQMFNRNAERYEKGVAKILHRSLRWIVIYVLLLGGMVFLFLRLPTSFLPLEDRGMFTTSVQLPSGSTQQQTLKVVEQIEKYYFTHEKDNIMSVFATVGSGPGGNGQNVARMFIRLKDWSERDSKTGTSFAIIERATKAFNQIKEARVIASSPPAISGLGSSAGFDMELQDHAGAGHDALMAARNQLLALAAENPELTRVRHNGLDDSPQLQIDIDQRKAQALGVAIDDINDTLQTAWGSSYVNDFMDRGRVKKVYVQAAAPYRMLPDDINLWYVRNKDGGMVPFSAFATSRWETGSPRLERYNGYSAVEIVGEAAPGVSTGTAMDIMESLVKQLPNGFGLEWTAMSYQERLSGAQAPALYAISLLVVFLCLAALYESWSVPFSVMLVVPLGVIGALLATWMRGLENDVYFQVGLLTVIGLSAKNAILIVEFANEMNQKGHDLFEATLHACRQRLRPILMTSLAFIFGVLPMATSTGAGSGGQHAVGTGVMGGMISATILAIYFVPLFFVLVRRRFPLKPRPE,100,gnl|BL_ORD_ID|1309|hsp_num:0,1427,FALSE,None
LK494,10_54 # 60181 # 61554 # 1 # ID=10_54;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.545,10_54,60181,61554,+,Strict,890,913.679,cpxA,98.03,3000830,protein homolog model,n/a,n/a,aminoglycoside antibiotic; aminocoumarin antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGATAGGGAGCTTAACCGCGCGCATCTTTGCCATCTTCTGGTTGACGCTGGCACTGGTGTTGATGTTGGTACTGATGTTACCCAAGCTCGACTCACGCCAGATGACCGAGCTACTGGACAGCGAGCAGCGCCAGGGGTTAATGATTGAGCAACACGTTGAAGCTGAACTGGCGAACGATCCACCCAACGATTTGATGTGGTGGCGTCGCTTGTTTCGGGCGATAGACAAGTGGGCGCCACCAGGACAGCGGTTATTACTTGTTACGACGGAAGGACGCGTGATCGGCGCAGAACGCAATGAAATGCAGATCATTCGTAACTTTATTGGTCAGGCCGATAACGCCGACCATCCGCAAAAGAAAAAATACGGTCGCGTTGAGATGGTCGGGCCTTTCTCCGTCAGAGACGGTGAAGATAACTACCAGCTGTATCTCATTCGACCAGCCAGCAGCTCACAATCTGACTTTATCAACCTGCTGTTTGACCGACCGCTGTTGTTGCTGATCGTCACCATGTTAGTCAGCTCTCCGCTATTGCTCTGGCTTGCCTGGAGTCTTGCGAAACCAGCGCGTAAGTTGAAAAACGCGGCGGATGAAGTGGCCCAGGGCAACCTGCGTCAACATCCGGAGCTGGAAGCCGGTCCGCAGGAGTTTCTGGCGGCAGGTGCCAGCTTTAACCAGATGGTGACGGCGCTAGAACGGATGATGACCACGCAGCAACGTCTGCTGTCGGACATCTCTCACGAGCTGAGAACACCGCTAACGCGTCTGCAACTGGGCACCGCTCTGCTGCGCCGTCGTAGCGGTGAGAGCAAAGAGCTGGAGCGCATTGAAACAGAAGCACACCGACTAGACAGCATGATCAACGACCTGCTGGTGATGTCACGTAATCAGCAGAAAAACGCGCTGGTCAGTGAAACGGTGAAAGCTAATCAGCTGTGGGGCGAAGTGCTGGATAACGCCGCCTTTGAAGCTGAGCAGATGGGTAAATCGCTCACGGTGAATTTCCCGCCGGGTCCGTGGCCGCTGTACGGTAACCCAAATGCGTTGGAAAGTGCGCTGGAAAACATTGTGCGCAATGCCCTGCGCTATTCACATACGAAGATTGAAGTTGGCTTCGCGGTGGATATCGACGGGATTACTATCACCGTGGACGACGATGGTCCAGGTGTAAGCCCTGAAGACAGAGAACAGATTTTCCGTCCGTTCTATCGTACCGATGAGGCGCGCGATCGCGAGTCTGGCGGAACAGGTCTGGGTCTGGCGATTGTTGAAACCGCAATCCAGCAGCATCGTGGCTGGGTGAAAGCCGAAGACAGCCCGCTGGGTGGTTTACGGCTGGTAATTTGGTTACCGCTGTATAAACGCGCTTAA,MIGSLTARIFAIFWLTLALVLMLVLMLPKLDSRQMTELLDSEQRQGLMIEQHVEAELANDPPNDLMWWRRLFRAIDKWAPPGQRLLLVTTEGRVIGAERNEMQIIRNFIGQADNADHPQKKKYGRVEMVGPFSVRDGEDNYQLYLIRPASSSQSDFINLLFDRPLLLLIVTMLVSSPLLLWLAWSLAKPARKLKNAADEVAQGNLRQHPELEAGPQEFLAAGASFNQMVTALERMMTTQQRLLSDISHELRTPLTRLQLGTALLRRRSGESKELERIETEAHRLDSMINDLLVMSRNQQKNALVSETVKANQLWGEVLDNAAFEAEQMGKSLTVNFPPGPWPLYGNPNALESALENIVRNALRYSHTKIEVGFAVDIDGITITVDDDGPGVSPEDREQIFRPFYRTDEARDRESGGTGLGLAIVETAIQQHRGWVKAEDSPLGGLRLVIWLPLYKRA,MIGSLTARIFAIFWLTLALVLMLVLMLPKLDSRQMTELLDSEQRQGLMIEQHVEAELANDPPNDLMWWRRLFRAIDKWAPPGQRLLLVTTEGRVIGAERSEMQIIRNFIGQADNADHPQKKKYGRVELVGPFSVRDGEDNYQLYLIRPASSSQSDFINLLFDRPLLLLIVTMLVSTPLLLWLAWSLAKPARKLKNAADEVAQGNLRQHPELEAGPQEFLAAGASFNQMVTALERMMTSQQRLLSDISHELRTPLTRLQLGTALLRRRSGESKELERIETEAQRLDSMINDLLVMSRNQQKNALVSETIKANQLWSEVLDNAAFEAEQMGKSLTVNFPPGPWPLYGNPNALESALENIVRNALRYSHTKIEVGFAVDKDGITITVDDDGPGVSPEDREQIFRPFYRTDEARDRESGGTGLGLAIVETAIQQHRGWVKAEDSPLGGLRLVIWLPLYKRS,100,gnl|BL_ORD_ID|131|hsp_num:0,152,FALSE,None
LK494,11_48 # 52091 # 53125 # 1 # ID=11_48;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.542,11_48,52091,53125,+,Strict,600,600.512,mdtN,88.34,3003548,protein homolog model,n/a,n/a,nucleoside antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGGAAAGCTCGTCGAAAAAAGCTCCGCGTAACAAACTTCCCGCGCTGATGCTGTTGGTACTTGCGCTGGTTATTTTGGTCTTCGTCATCTGGAAACTGGATAGCTCACCCGCGACCAATGACGCCTACGCCTCAGCCGACACCATCGATGTCGTGCCAGAAGTCAGTGGTCGCATTGTCGAACTGGCTGTTTCCGATAACCAGCAGGTCAAGCAAGGTGATGTGCTGTTTCGTATCGATCCCCGTATCTATGAAGCGAATCTGGCAAAAGCACAAGCGTCGCTCGCCGCTCTGGATAAACAGATCATGCTGACCCAGCGCAGCGTAGATGCACAACAATATGGTGCTGACTCCGTACGGGCTACGGTAGAAAAAGCGCGAGCAGCCGCTAAGCAAGCCAGCGATACTCTGCGCCGTACCGAACCACTACTGACGGAAGGTTTTGTCTCCGCGGAAGATGTTGATCGCGCCAGAACGGCACAACGCGCCTCAGCGGCAGATCTTAATGCGGTGTTATTACAGGCGCAGCAGGCTGCCAGCGCGGTGAGTGGCGTTGATGCCCTGGTAGCTCAGCGCATCGCCGTAGAAGCCGATATCGCCCTGACCAAACTGCATCTTGAAATGGCAACAGTACGCGCACCCTTCGATGGCCGCGTGGTGGCATTAAAAACCTCCGTCGGGCAGTTTGCTTCCGCCATGCGACCCATTTTTACCCTGATTGACACCCGTCACTGGTACGTAATCGCCAATTTTCGCGAAACAGAGCTGAAAAATATCCATGCAGGCACACCAGCCAATGTTCGCCTGATGAGCGACAGCGGCAAAGTGTTTGTCGGTAAAGTGGATTCAATCGGCTACGGTGTATTACCTGATGATGGTGGTATGGTGCTGGGCGGTTTGCCGCGTGTTTCCCGCTCTATCAACTGGGTTCGCGTTGCCCAACGCTTCCCGGTAAAAATCGTGGTAGATAAACCGGATGAAGAGATGTTTCGCATCGGCGCATCGGCGGTTGCTACCCTTGAGCCACAGAAATGA,MESSSKKAPRNKLPALMLLVLALVILVFVIWKLDSSPATNDAYASADTIDVVPEVSGRIVELAVSDNQQVKQGDVLFRIDPRIYEANLAKAQASLAALDKQIMLTQRSVDAQQYGADSVRATVEKARAAAKQASDTLRRTEPLLTEGFVSAEDVDRARTAQRASAADLNAVLLQAQQAASAVSGVDALVAQRIAVEADIALTKLHLEMATVRAPFDGRVVALKTSVGQFASAMRPIFTLIDTRHWYVIANFRETELKNIHAGTPANVRLMSDSGKVFVGKVDSIGYGVLPDDGGMVLGGLPRVSRSINWVRVAQRFPVKIVVDKPDEEMFRIGASAVATLEPQK,MESTPKKAPRSKFPALLVVALALVALVFVIWRVDSAPSTNDAYASADTIDVVPEVSGRIVELAVTDNQAVKQGDLLFRIDPRPYEANLAKAEASLAALDKQIMLTQRSVDAQQFGADSVNATVEKARAAAKQATDTLRRTEPLLKEGFVSAEDVDRARTAQRAAEADLNAVLLQAQSAASAVSGVDALVAQRAAVEADIALTKLHLEMATVRAPFDGRVISLKTSVGQFASAMRPIFTLIDTRHWYVIANFRETDLKNIRSGTPATIRLMSDSGKTFEGKVDSIGYGVLPDDGGLVLGGLPKVSRSINWVRVAQRFPVKIMVDKPDPEMFRIGASAVANLEPQ,100.29,gnl|BL_ORD_ID|1321|hsp_num:0,1442,FALSE,None
LK494,12_21 # 20122 # 21267 # -1 # ID=12_21;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.538,12_21,20122,21267,-,Perfect,700,785.793,CMY-97,100,3002110,protein homolog model,n/a,n/a,cephamycin,antibiotic inactivation,CMY beta-lactamase,ATGATGAAAAAATCGATATGCTGCGCGCTGCTGCTGACAGCCTCTTTCTCCACGTTTGCTGCCGCAAAAACAGAACAACAAATTGCCGATATCGTTAACCGCACCATCACACCACTGATGCAGGAGCAGGCTATTCCGGGCATGGCCGTGGCAATTATCTACGAGGGGAAACCTTATTACTTTACCTGGGGTAAAGCCGATATCGCCAATAACCACCCAGTCACGCAGCAAACGCTGTTTGAGCTAGGGTCGGTCAGTAAGACGTTTAACGGCGTGTTGGGCGGCGACGCTATCGCCCGCGGCGAAATTAAGCTCAGCGATCCGGTCACGAAATACTGGCCAGAACTGACAGGCAAACAGTGGCGGGGTATCAGCCTGCTGCACTTAGCCACCTATACAGCGGGTGGCCTGCCGCTGCAGATCCCCGATGACGTTACGGAGAAAGCCGCATTACTGCGCTTTTATCAAAACTGGCAACCACAATGGACTCCGGGCGCTAAGCGTCTTTACGCTAACTCCAGCATTGGTCTGTTTGGTGCGCTGGTGGTGAAACCTTCAGGTATGAGCTACGAAGAGGCAATGACCAGACGCGTCCTGCAACCATTAAAACTGGCGCATACCTGGATTACGGTTCCGCAAAGCGAACAAAAAAATTATGCCTGGGGCTATCGCGAAGGGAAGCCTGTACACGTTTCTCCGGGACAACTTGACGCCGAAGCCTATGGCGTGAAATCCAGCGTTATCGATATGGCCCGCTGGGTTCAGGCCAACATGGACGCCAGCCACGTTCAGGAGAAAACGCTCCAGCAGGGCATTGAGCTTGCGCAGTCTCGCTACTGGCGTATTGGTGATATGTACCAGGGATTAGGCTGGGAGATGCTGAACTGGCCGCTGAAAGCTGATTCGATCATCAACGGCAGCGACAGCAAAGTGGCATTGGCAGCGCTTCCCGCCGTTGAGGTAAACCCGCCAGCACCTGCCGTGAAAGCCTCATGGGTGCATAAAACAGGATCCACAGGCGGATTTGGCAGCTACGTTGCCTTCGTTCCAGAAAAAAACCTTGGCATCGTAATGTTGGCAAACAAAAGCTACCCCAACCCGGCTCGCGTCGAGGCGGCCTGGCGCATTCTTGAAAAACTGCAATAA,MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYYFTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWRGISLLHLATYTAGGLPLQIPDDVTEKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGALVVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEAYGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLANKSYPNPARVEAAWRILEKLQ,MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYYFTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWRGISLLHLATYTAGGLPLQIPDDVTEKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGALVVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEAYGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLANKSYPNPARVEAAWRILEKLQ,100,gnl|BL_ORD_ID|2918|hsp_num:0,3933,FALSE,None
LK494,3_197 # 205791 # 207149 # 1 # ID=3_197;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.536,3_197,205791,207149,+,Strict,850,887.486,Escherichia coli GlpT with mutation conferring resistance to fosfomycin,95.58,3003889,protein variant model,E448K,n/a,phosphonic acid antibiotic,antibiotic target alteration,antibiotic-resistant GlpT,ATGTTGAGCATTTTTAAACCAGCGTCACACACGGCGCGTTTACCTGCAGCGGAGATCGACCCGACATATCGTCGATTACGTTGGCAGATTTTTCTGGGGATTTTCTTTGGTTATGCCGCGTACTATCTGGTACGTAAGAACTTTGCCCTTGCGATGCCGTATCTGGTTGAGCAGGGATTCTCGCGTGGCGATCTGGGTTTTGCGTTGTCCGGTATCTCCATTGCTTACGGATTTTCGAAATTCATCATGGGGTCCGTTTCGGATCGCTCGAATCCGCGCGTTTTCCTGCCTGCGGGTCTGATACTGGCTGCGGCAGTGATGTTGTTTATGGGCTTTGTACCGTGGGCGACATCGAGCATTGCGATTATGTTTGTGCTGCTGTTCCTCTGCGGATGGTTCCAGGGGATGGGATGGCCGCCGTGTGGTCGTACCATGGTGCACTGGTGGTCGCAGAAAGAGCGTGGCGGCATCGTTTCCGTTTGGAACTGTGCGCATAACGTGGGTGGCGGTCTGCCTCCTCTGTTGTTCCTGCTGGGTATGGCCTGGTTCAATGACTGGAAAGCGGCGCTGTACATGCCTGCTTTCGGTGCGATCGTTGTCGCGCTGTTTGCTTTTGCTTTGATGCGTGATACGCCACAGTCCTGTGGTCTGCCGCCAATCGAAGAGTACAAGAACGATTATCCGGACGATTACAACGAGAAAGCGGAAGAAGAGCTGACTGCGAAGCAGATCTTCATGCAGTACGTACTGCCGAACAAACTGTTGTGGTACATCGCTATCGCCAACGTGTTTGTTTATCTGCTGCGCTACGGCATCCTGGACTGGTCGCCGACTTACCTGAAAGAAGTGAAGCATTTTGCACTGGATAAATCATCCTGGGCCTACTTCCTGTATGAATATGCGGGTATTCCGGGCACGCTGCTGTGTGGCTGGATGTCGGATAAAGTCTTCCGTGGAAACCGTGGCGCGACCGGCGTGTTCTTTATGACGCTGGTGACGATTGCGACCATCGTTTACTGGATGAACCCGGCAGGCAACCCGAACGTAGATATGGCTTGTATGATTATCATCGGCTTCCTGATCTACGGCCCGGTCATGTTGATTGGTCTGCATGCGCTGGAACTGGCACCGAAAAAAGCGGCAGGTACGGCGGCTGGCTTTACTGGTCTGTTCGGTTATCTCGGCGGTTCTGTGGCTGCGAGCGCCATTGTCGGCTACACCGTTGACTTCTTCGGTTGGGACGGCGGCTTTATGGTGATGATTGGCGGTAGCGTGCTGGCGGTTATTCTGCTGGTAGTCGTCATGATTGGCGAAAAACGCCATCACGAAGAGATCCAGCTCAAGCGTAACGGGGGCTAA,MLSIFKPASHTARLPAAEIDPTYRRLRWQIFLGIFFGYAAYYLVRKNFALAMPYLVEQGFSRGDLGFALSGISIAYGFSKFIMGSVSDRSNPRVFLPAGLILAAAVMLFMGFVPWATSSIAIMFVLLFLCGWFQGMGWPPCGRTMVHWWSQKERGGIVSVWNCAHNVGGGLPPLLFLLGMAWFNDWKAALYMPAFGAIVVALFAFALMRDTPQSCGLPPIEEYKNDYPDDYNEKAEEELTAKQIFMQYVLPNKLLWYIAIANVFVYLLRYGILDWSPTYLKEVKHFALDKSSWAYFLYEYAGIPGTLLCGWMSDKVFRGNRGATGVFFMTLVTIATIVYWMNPAGNPNVDMACMIIIGFLIYGPVMLIGLHALELAPKKAAGTAAGFTGLFGYLGGSVAASAIVGYTVDFFGWDGGFMVMIGGSVLAVILLVVVMIGEKRHHEEIQLKRNGG,MLSIFKPAPHKARLPAAEIDPTYRRLRWQIFLGIFFGYAAYYLVRKNFALAMPYLVEQGFSRGDLGFALSGISIAYGFSKFIMGSVSDRSNPRVFLPAGLILAAAVMLFMGFVPWATSSIAVMFVLLFLCGWFQGMGWPPCGRTMVHWWSQKERGGIVSVWNCAHNVGGGIPPLLFLLGMAWFNDWHAALYMPAFCAILVALFAFAMMRDTPQSCGLPPIEEYKNDYPDDYNEKAEQELTAKQIFMQYVLPNKLLWYIAIANVFVYLLRYGILDWSPTYLKEVKHFALDKSSWAYFLYEYAGIPGTLLCGWMSDKVFRGNRGATGVFFMTLVTIATIVYWMNPAGNPTVDMICMIVIGFLIYGPVMLIGLHALELAPKKAAGTAAGFTGLFGYLGGSVAASAIVGYTVDFFGWDGGFMVMIGGSILAVILLIVVMIGEKRRHEQLLQERNGG,100,gnl|BL_ORD_ID|2130|hsp_num:0,2372,FALSE,None
LK494,5_126 # 140771 # 142537 # -1 # ID=5_126;partial=00;start_type=ATG;rbs_motif=AGGA/GGAG/GAGG;rbs_spacer=11-12bp;gc_cont=0.546,5_126,140771,142537,-,Strict,500,592.038,Haemophilus influenzae PBP3 conferring resistance to beta-lactam antibiotics,52.75,3004446,protein variant model,"D350N, S357N",n/a,cephalosporin; cephamycin; penam,antibiotic target alteration,Penicillin-binding protein mutations conferring resistance to beta-lactam antibiotics,ATGAAAGCAGCGGCAAAAACGCACAAACCAAAACGCCAGGAAGAACAAGCCAACTTTATCAGTTGGCGTTTTGCGTTACTGTGCGGCTGTATTTTGCTGGCACTGGGTTTTCTACTGGGTCGCGTTGCCTGGCTGCAAATCATCGCGCCGGACATGCTGGTGCGTCAGGGTGATATGCGCTCTCTACGCGTCCAGGAAGTGTCTACATCGCGCGGAATGATTACCGACCGCTCTGGTCGTCCGCTGGCGGTGAGTGTTCCGGTTAAAGCTATATGGGCCGACCCGAAAGAAGTACATGATGCCGGCGGAGTGAGCGTTGGCGAACGCTGGAGAGCGCTGTCAACCGCGCTGAATCTCCCGCTCGATCAACTGGCTTCCCGCATTAACGCCAACCCGAAAGGGCGCTTTATCTATCTGGCGCGTCAGGTAAACCCTGACATGGCTGACTACATCAAAAAACTGAAGCTGCCAGGTATCCATCTGCGCGAAGAATCCCGCCGTTACTACCCTTCCGGGGAAGTGACTGCTCACCTCATCGGTTTTACGAACGTCGACAGCCAGGGCATTGAAGGCGTTGAGAAGAGCTTCGACAAGTGGCTCACCGGACAACCGGGCGAGCGTATTGTACGTAAAGACCGGTATGGCCGCGTCATTGAAGATATCTCTTCTACCGACAGCCAGGCGGCGCATAACCTCGCGTTGAGCATTGATGAGCGTTTACAGGCACTGGTCTACCGTGAACTGAATAACGCCGTGGCGTTCAACAAGGCGGAGTCAGGCAGTGCGGTACTGGTGGATGTGAACACCGGTGAAGTGCTGGCAATGGCCAACAGTCCGTCCTACAACCCGAACAATCTCACCGGTACGCCAAAAGACGCGATGCGTAACCGCACCATTACCGACGTGTTTGAACCGGGTTCTACCGTTAAACCGATGGTGGTGATGACCGCGCTGCAGCGCGGTGTGGTACGCGAAAATACGGTCCTCAACACTATCCCTTACCGAATTAATGGCCACGAAATCAAAGACGTGGCACGTTATAGCGAATTAACCCTCACCGGGGTTTTGCAGAAGTCGAGTAACGTCGGTGTTTCCAAGCTGGCGTTAGCGATGCCGTCCTCAGCGTTAGTAGATACTTACTCACGTTTTGGGCTGGGAAAAGCGACCAATTTGGGGTTGGTCGGAGAACGCAGTGGCTTATATCCTCAAAAACAACGGTGGTCTGACATAGAGAGGGCCACCTTCTCTTTCGGCTACGGGCTAATGGTAACGCCGTTACAGTTAGCGCGAGTCTATGCAACGATCGGCAGTTACGGCGTTTATCGTCCACTGTCGATTACTAAAGTTGACCCTCCAGTTCCGGGCGAGCGTATCTTCCCGGAAGCGACCGTACGTACCGTGGTGCACATGATGGAAAGCGTGGCGCTGCCCGGCGGCGGCGGCGTGAAGGCGGCGATTAAAGGTTATCGTATCGCCATTAAAACCGGTACAGCGAAAAAAGTAGGGCCGGATGGCCGCTACATCAACAAATACATTGCTTATACCGCAGGTGTTGCGCCTGCGAGTCAGCCGCGCTTCGCGCTGGTTGTTGTTATCAACGATCCGCAGGCGGGTAAATACTACGGTGGCGCCGTTTCCGCGCCGGTCTTTGGTGCCATCATGGGCGGCGTACTGCGTACCATGAACATCGAGCCGGATGCGCTGACAACGGGCGATAAAAATGAATTTGTGAATAATCAAGGCGAGGCAACAGGTGGCAGATCGTAA,MKAAAKTHKPKRQEEQANFISWRFALLCGCILLALGFLLGRVAWLQIIAPDMLVRQGDMRSLRVQEVSTSRGMITDRSGRPLAVSVPVKAIWADPKEVHDAGGVSVGERWRALSTALNLPLDQLASRINANPKGRFIYLARQVNPDMADYIKKLKLPGIHLREESRRYYPSGEVTAHLIGFTNVDSQGIEGVEKSFDKWLTGQPGERIVRKDRYGRVIEDISSTDSQAAHNLALSIDERLQALVYRELNNAVAFNKAESGSAVLVDVNTGEVLAMANSPSYNPNNLTGTPKDAMRNRTITDVFEPGSTVKPMVVMTALQRGVVRENTVLNTIPYRINGHEIKDVARYSELTLTGVLQKSSNVGVSKLALAMPSSALVDTYSRFGLGKATNLGLVGERSGLYPQKQRWSDIERATFSFGYGLMVTPLQLARVYATIGSYGVYRPLSITKVDPPVPGERIFPEATVRTVVHMMESVALPGGGGVKAAIKGYRIAIKTGTAKKVGPDGRYINKYIAYTAGVAPASQPRFALVVVINDPQAGKYYGGAVSAPVFGAIMGGVLRTMNIEPDALTTGDKNEFVNNQGEATGGRS,MVKFNSSRKSGKSKKTIRKLTAPETVKQNKPQKVFEKCFMRGRYMLSTVLILLGLCALVARAAYVQSINADTLSNEADKRSLRKDEVLSVRGSILDRNGQLLSVSVPMSAIVADPKTMLKENSLADKERIAALAEELGMTENDLVKKIEKNSKSGYLYLARQVELSKANYIRRLKIKGIILETEHRRFYPRVEEAAHVVGYTDIDGNGIEGIEKSFNSLLVGKDGSRTVRKDKRGNIVAHISDEKKYDAQDVTLSIDEKLQSMVYREIKKAVSENNAESGTAVLVDVRTGEVLAMATAPSYNPNNRVGVKSELMRNRAITDTFEPGSTVKPFVVLTALQRGVVKRDEIIDTTSFKLSGKEIVDVAPRAQQTLDEILMNSSNRGVSRLALRMPPSALMETYQNAGLSKPTDLGLIGEQVGILNANRKRWADIERATVAYGYGITATPLQIARAYATLGSFGVYRPLSITKVDPPVIGKRVFSEKITKDIVGILEKVAIKNKRAMVEGYRVGVKTGTARKIENGHYVNKYVAFTAGIAPISDPRYALVVLINDPKAGEYYGGAVSAPVFSNIMGYALRANAIPQDAEAAENTTTKSAKRIVYIGEHKNQKVN,96.39,gnl|BL_ORD_ID|2497|hsp_num:0,2886,FALSE,None
LK494,8_92 # 100187 # 101578 # 1 # ID=8_92;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.548,8_92,100187,101578,+,Strict,850,875.159,Escherichia coli UhpT with mutation conferring resistance to fosfomycin,95.68,3003890,protein variant model,E350Q,n/a,phosphonic acid antibiotic,antibiotic target alteration,antibiotic-resistant UhpT,ATGCTGGCCTTTCTCAACCAGGTGCGCAAGCCGACCCTGGATCTGCCGCTCGATGTGCGGCGCAAAATGTGGTTCAAACCGTTCATGCAGTCCTATCTGGTGGTATTTATCGGCTACCTGACCATGTACCTGATCCGCAAAAACTTCAACATCGCGCAGAACGACATGATCTCCACCTACGGGCTGAGCATGACGCAACTGGGGATGATTGGCCTGGGCTTCTCCATCACCTACGGCGTGGGAAAAACGCTGGTTTCCTACTACGCGGACGGCAAAAACACCAAGCAGTTCCTGCCGTTTATGCTGATCCTCTCTGCCATCTGTATGCTCGGCTTCAGCGCCAGCATGGGCGCGGGTTCAACCAGCCTGTTCCTGATGATTGCCTTCTACGCGCTGAGTGGTTTCTTCCAGAGTACCGGCGGCTCGTGTAGCTATTCCACCATCACCAAATGGACGCCGCGTCGCAAGCGGGGTTCTTATCTCGGTATGTGGAACATCTCCCACAACCTCGGCGGTGCGGGTGCGGCAGGCGTGGCGCTGTTTGGCGCTAACTATCTGTTCGACGGTCACGTCATCGGGATGTTTATCTTCCCGTCGATTATCGCGCTGATTGTTGGTTTTATCGGCCTGCGCTACGGCAGTGACTCCCCGGAATCTTATGGTCTTGGTAAAGCTGAAGAGTTGTTTGGCGAGGAGATCAGCGAAGAAGACAAAGAGACCGAAGAAAACGAGATGACGAAATGGCAGATCTTTGTTGAGTACGTGCTGAAAAACAAAGTGATCTGGTTGTTATGTTTCTCGAACATCTTCCTGTACGTAGTGCGTATCGGTATTGACCAGTGGTCCACCGTCTACGCTTTCCAGGAGCTAAAGCTCTCCAAAGAAGTGGCGATTCAGGGCTTTACCCTGTTTGAAGTGGGCGCGCTGGTCGGCACGCTGCTGTGGGGCTGGCTCTCTGACCTGGCGAATGGCCGCCGTGCGCTGGTGGCCTGCGTGGCGCTGGCGTTGATTATCGCCACCCTGGGCGTTTATCAGCACGCCAGCAACCAGTACGTTTATCTGGCTTCGCTGTTTGCGCTGGGCTTCCTGGTGTTTGGTCCGCAGCTGTTAATCGGCGTTGCTGCAGTCGGATTTGTACCGAAAAAAGCGATCGGCGCAGCCGATGGGATTAAAGGCACCTTTGCTTATCTGATTGGTGACAGCTTCGCCAAGCTTGGTCTGGGGATGATTGCCGACGGCACGCCGATTTTCGGCCTCACCGGCTGGGCAGGAACCTTCGCCGCGCTGGACACCGCCGCCATCGGTTGTATCTGTCTGATGGCCATCGTGGCCGTGTTTGAAGAACGTAAAATTCGCCGCGAGAAAAAGATTCAACAATTGAAAGTCGCTTAA,MLAFLNQVRKPTLDLPLDVRRKMWFKPFMQSYLVVFIGYLTMYLIRKNFNIAQNDMISTYGLSMTQLGMIGLGFSITYGVGKTLVSYYADGKNTKQFLPFMLILSAICMLGFSASMGAGSTSLFLMIAFYALSGFFQSTGGSCSYSTITKWTPRRKRGSYLGMWNISHNLGGAGAAGVALFGANYLFDGHVIGMFIFPSIIALIVGFIGLRYGSDSPESYGLGKAEELFGEEISEEDKETEENEMTKWQIFVEYVLKNKVIWLLCFSNIFLYVVRIGIDQWSTVYAFQELKLSKEVAIQGFTLFEVGALVGTLLWGWLSDLANGRRALVACVALALIIATLGVYQHASNQYVYLASLFALGFLVFGPQLLIGVAAVGFVPKKAIGAADGIKGTFAYLIGDSFAKLGLGMIADGTPIFGLTGWAGTFAALDTAAIGCICLMAIVAVFEERKIRREKKIQQLKVA,MLAFLNQVRKPTLDLPLEVRRKMWFKPFMQSYLVVFIGYLTMYLIRKNFNIAQNDMISTYGLSMTQLGMIGLGFSITYGVGKTLVSYYADGKNTKQFLPFMLILSAICMLGFSASMGSGSVSLFLMIAFYALSGFFQSTGGSCSYSTITKWTPRRKRGTFLGFWNISHNLGGAGAAGVALFGANYLFDGHVIGMFIFPSIIALIVGFIGLRYGSDSPESYGLGKAEELFGEEISEEDKETESTDMTKWQIFVEYVLKNKVIWLLCFANIFLYVVRIGIDQWSTVYAFQELKLSKAVAIQGFTLFEAGALVGTLLWGWLSDLANGRRGLVACIALALIIATLGVYQHASNEYIYLASLFALGFLVFGPQLLIGVAAVGFVPKKAIGAADGIKGTFAYLIGDSFAKLGLGMIADGTPVFGLTGWAGTFAALDIAAIGCICLMAIVAVMEERKIRREKKIQQLTVA,100,gnl|BL_ORD_ID|2129|hsp_num:0,2373,FALSE,None
LK494,24_1 # 1 # 921 # 1 # ID=24_1;partial=11;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.530,24_1,1,921,+,Strict,700,619.387,Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin,98.7,3003369,protein variant model,R234F,n/a,elfamycin antibiotic,antibiotic target alteration,elfamycin resistant EF-Tu,CGTGGTATCACCATCAACACTTCTCACGTTGAATATGACACCCCGACTCGCCACTACGCACACGTAGACTGCCCGGGCCACGCCGACTATGTTAAAAACATGATCACCGGTGCTGCGCAGATGGACGGCGCGATCCTGGTTGTTGCTGCGACTGACGGCCCGATGCCGCAGACTCGTGAGCACATCCTGCTGGGTCGTCAGGTAGGCGTTCCGTACATCATCGTGTTCCTGAACAAATGCGACATGGTTGATGACGAAGAGCTGCTGGAACTGGTAGAAATGGAAGTTCGTGAACTTCTGTCTCAGTACGATTTCCCGGGCGACGACACGCCGATCGTTCGTGGTTCTGCTCTGAAAGCGCTGGAAGGCGAAGCAGAGTGGGAAGCGAAAATCATCGAACTGGCTGGCTTCCTGGATTCTTACATCCCAGAACCAGAGCGTGCGATTGACAAGCCGTTCCTGCTGCCTATCGAAGACGTATTCTCCATCTCCGGTCGTGGTACCGTTGTTACCGGTCGTGTAGAGCGCGGTATCATCAAAGTTGGTGAAGAAGTTGAAATCGTTGGTATCAAAGAGACTGCTAAGTCTACCTGTACTGGCGTTGAAATGTTCCGCAAACTGCTGGACGAAGGCCGTGCTGGTGAGAACGTTGGTGTTCTGCTGCGTGGTATCAAACGTGAAGAAATCGAACGTGGTCAGGTACTGGCTAAGCCGGGCTCTATCAAGCCGCACACCAAGTTTGAATCTGAAGTGTACATTCTGTCCAAAGACGAAGGCGGCCGTCATACTCCGTTCTTCAAAGGCTACCGTCCGCAGTTCTACTTCCGTACTACTGACGTGACTGGTACCATCGAACTGCCGGAAGGCGTAGAGATGGTAATGCCGGGCGACAACATCAAAATGGTTGTTACCCTGATCCAC,RGITINTSHVEYDTPTRHYAHVDCPGHADYVKNMITGAAQMDGAILVVAATDGPMPQTREHILLGRQVGVPYIIVFLNKCDMVDDEELLELVEMEVRELLSQYDFPGDDTPIVRGSALKALEGEAEWEAKIIELAGFLDSYIPEPERAIDKPFLLPIEDVFSISGRGTVVTGRVERGIIKVGEEVEIVGIKETAKSTCTGVEMFRKLLDEGRAGENVGVLLRGIKREEIERGQVLAKPGSIKPHTKFESEVYILSKDEGGRHTPFFKGYRPQFYFRTTDVTGTIELPEGVEMVMPGDNIKMVVTLIH,MLSPEGESTIVRNIAVSKEKFERTKPHVNVGTIGHVDHGKTTLTAAITTVLAKTYGGAARAFDQIDNAPEEKARGITINTSHVEYDTPTRHYAHVDCPGHADYVKNMITGAAQMDGAILVVAATDGPMPQTREHILLGRQVGVPYIIVFLNKCDMVDDEELLELVEMEVRELLSQYDFPGDDTPIVRGSALKALEGDAEWEAKILELAGFLDSYIPEPERAIDKPFLLPIEDVFSISGRGTVVTGRVERGIIKVGEEVEIVGIKETQKSTCTGVEMFRKLLDEGRAGENVGVLLRGIKREEIERGQVLAKPGTIKPHTKFESEVYILSKDEGGRHTPFFKGYRPQFYFRTTDVTGTIELPEGVEMVMPGDNIKMVVTLIHPIAMDDGLRFAIREGGRTVGAGVVAKVLG,75.06,gnl|BL_ORD_ID|1970|hsp_num:0,2158,TRUE,loose hit with at least 95 percent identity pushed strict
LK494,4_156 # 154809 # 155243 # -1 # ID=4_156;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.487,4_156,154809,155243,-,Strict,210,272.707,Escherichia coli AcrAB-TolC with MarR mutations conferring resistance to ciprofloxacin and tetracycline,90.97,3003378,protein overexpression model,"Y137H, S3N",n/a,fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics,antibiotic target alteration; antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,GTGAAAAACACCAGTGATCTGTTTAACGAAATCATCCCACTGGGTCGTTTGATCTATATGGTTAATCAGAAAAAAGATCGTTTGCTAAACGACTATCTGTCACCGCTGGATATCACGGCATCGCAGTTCAAGGTGCTCTGCTCCATCCGTTGCGCGGTGTGCATCACCCCTGTCGAATTGAAAAAAGTGCTGTCTGTCGACCTTGGCGCCCTGACGCGGATGCTGGACAGACTGGCCTGTAAAGGCTGGATAGAAAGGCTTCCGAATCCACATGATAAGCGTGGCGTGCTGGTGAAACTCACCGAGCATGGCGCAGCAATTTGCGAGCAGTGTCATCAATTAGTAGGGCAAGACCTGCACCAGGAACTAACAAAAAACTTAACGGCGGATGAAGTAGCCACACTTGAGCACTTGCTTAAGAGAATCCTGCCGTAA,VKNTSDLFNEIIPLGRLIYMVNQKKDRLLNDYLSPLDITASQFKVLCSIRCAVCITPVELKKVLSVDLGALTRMLDRLACKGWIERLPNPHDKRGVLVKLTEHGAAICEQCHQLVGQDLHQELTKNLTADEVATLEHLLKRILP,MKSTSDLFNEIIPLGRLIHMVNQKKDRLLNEYLSPLDITAAQFKVLCSIRCAACITPVELKKVLSVDLGALTRMLDRLVCKGWVERLPNPNDKRGVLVKLTTGGAAICEQCHQLVGQDLHQELTKNLTADEVATLEYLLKKVLP,100,gnl|BL_ORD_ID|1984|hsp_num:0,431,FALSE,None
LK494,11_72 # 79969 # 80292 # 1 # ID=11_72;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.503,11_72,79969,80292,+,Strict,200,206.068,Escherichia coli soxS with mutation conferring antibiotic resistance,92.52,3003511,protein overexpression model,n/a,n/a,fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; penem; disinfecting agents and antiseptics,antibiotic target alteration; antibiotic efflux; reduced permeability to antibiotic,ATP-binding cassette (ABC) antibiotic efflux pump; major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump; General Bacterial Porin with reduced permeability to beta-lactams,ATGTCCCATCAGCAGATTATTCAGACCCTTATTGAATGGATTGATGAACATATCGATCAGCCGCTGAACATTGAGGCGGTTGCGAAAAAATCAGGTTACTCGAAGTGGTATTTACAGAGAATATTCCGCACAGTGACGCGCCAGACGCTGGGTGACTACATCCGCCAACGACGACTTCTGCTGGCGGCGGTTGAACTGAGGACGACTGAGCGACCTATTTTCGATATCGCGATGGATCTTGGTTATGTATCGCAACAAACCTTTTCGCGCGTGTTTCGCCGCGAGTTTGATCGTACCCCCAGCGATTACCGCCACCGCCTGTAA,MSHQQIIQTLIEWIDEHIDQPLNIEAVAKKSGYSKWYLQRIFRTVTRQTLGDYIRQRRLLLAAVELRTTERPIFDIAMDLGYVSQQTFSRVFRREFDRTPSDYRHRL,MSHQKIIQDLIAWIDEHIDQPLNIDVVAKKSGYSKWYLQRMFRTVTHQTLGDYIRQRRLLLAAVELRTTERPIFDIAMDLGYVSQQTFSRVFRRQFDRTPSDYRHRL,100,gnl|BL_ORD_ID|1975|hsp_num:0,2066,FALSE,None
LK1137,1_56 # 57308 # 57793 # -1 # ID=1_56;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.366,1_56,57308,57793,-,Strict,300,329.331,dfrC,98.76,3002865,protein homolog model,n/a,n/a,diaminopyrimidine antibiotic,antibiotic target replacement,trimethoprim resistant dihydrofolate reductase dfr,ATGACATTATCGATAATTGTCGCTCACGATAAACAAAGAGTCATTGGGTACCAAAATCAATTACCATGGCATTTACCAAATGATTTAAAGCATGTTAAACAACTGACCACTGGAAATACACTTGTAATGGGACGAAAAACTTTTAATTCTATCGAGAAACCACTGCCAAATAGACGTAACGTCGTACTCACTAACCAAGCTTCATTTCACCATGAAGGGGTAGATGTAATAAACTCTCTTGATGAAATTAAAGAGTTATCTGGTCATGTTTTTATATTTGGAGGACAAACGTTATTCGAAGCAATGATTGACCAGGTAGATGATATGTATATCACAGTAATAGATGGGAAGTTTCAAGGAGACACTTTCTTTCCACCGTACACATTTGAAAACTGGGAGGTCGAATCTTCAGTGGAAGGTCAACTAGATGAAAAAAATACTATACCGCATACATTCTTACATTTAGTGCGTAGAAAAGGGGAATAG,MTLSIIVAHDKQRVIGYQNQLPWHLPNDLKHVKQLTTGNTLVMGRKTFNSIEKPLPNRRNVVLTNQASFHHEGVDVINSLDEIKELSGHVFIFGGQTLFEAMIDQVDDMYITVIDGKFQGDTFFPPYTFENWEVESSVEGQLDEKNTIPHTFLHLVRRKGE,MTLSIIVAHDKQRVIGYQNQLPWHLPNDLKHVKQLTTGNTLVMGRKTFNSIGKPLPNRRNVVLTNQASFHHEGVDVINSLDEIKELSGHVFIFGGQTLFEAMIDQVDDMYITVIDGKFQGDTFFPPYTFENWEVESSVEGQLDEKNTIPHTFLHLVRRKGK,100,gnl|BL_ORD_ID|1279|hsp_num:0,1397,FALSE,None
LK1137,2_73 # 81915 # 83315 # 1 # ID=2_73;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.345,2_73,81915,83315,+,Strict,525,556.599,norC,61.99,3007010,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGAATACATCACAAAAGTTTAGGGGAGATAATCGCTTATTATTAGGGATTATTTTAGGGGTTATTACATTTTGGTTATTTGCACAATCACTTGTAAATCTAGTCGTGCCATTACAATCATCATACAATAGTGATATTGGCACCATTAATATAGCAGTTAGCTTATCGGCACTATTTTCTGGTTTGTTTATTGTAGGTGCAGGAGATATTGCAGATAAAATTGGTAGAGTAAAAATGACATACATAGGCTTAGCACTTAATATTGTTGGGTCAGTTTTAATCATTATTACACCATTACCAAGTTTATTGATTATTGGACGTGCTATTCAAGGATTGTCAGCGGCGTGTATAATGCCAGCGACACTCGCAATCATTAATGAATATTATATTGGGACAGCACGACAACGTGCATTAAGCTACTGGTCCATTGGTTCATGGGGAGGTAGTGGTGTTTGTACTTTTTTTGGTGGTTTAATGGCAACTAACCTTGGATGGCGCTCAATCTTTATTGTTTCAATTATTCTGACAATATTATCCATGTTTCTCATTAAACATACTCCCGAAACAAAAGCAGAGCCTATAGGAGATCAACCGACAGAGAAAAAGAAATTTGATGTTATTGGTTTAATCATCTTAGTGGTTAGCATGTTAAGTATTAATGTGATAATAACTCAAACCTCTCAATTTGGTTTGTTCTCACCATTTATTTTGGGACTTATTGCAATTTTTGTTATATCGTTAATTATATTCGTGATTTACGAAAATAAAATTAAACAACCGCTTGTCGATTTTGATATCTTTAAAAACAAAGGTTATACAGGTGCAACGATTTCAAACTTTATGTTGAATGGTGTAGCTGGTGGTACATTGATTGTAGTAAATACTTTTTATCAGCAAAAATTAGATTTTAACTCTCAGGAAACTGGATATATCTCACTTACATATCTAGTTGCAGTATTAATTATGATACGTGTGGGTGAAATGATATTACAATCGCTAGGACCTAAAAGACCTTTGTTACTCGGAAGTGCCTTGACCGTCATAGGATTAATATTATTATCTTTGACGTTTTTACCTAATGCTTGGTATATAGCGTCAAGTGTCGTTGGTTATTTATTATTTGGTACCGGTTTAGGTATTTATGCAACACCATCCACGGATACAGCTGTTGCACAAGCACCAGATGATAAAGTAGGCGTCGCATCCGGTGTATATAAGATGGCATCATCTTTAGGAAATGCATTTGGTGTGGCCATCTCAAGTACAGTTTACAGCGTACTTGCAGCTCAACTGAATCTGACTTTAGGTGGTTTTACTGGAGTAATGTTTAATGCGCTTATAGCATTATTAGCATTCCTATCTATTTTGTTCTTAATACCGAAAAAACAATCTAATGTATAA,MNTSQKFRGDNRLLLGIILGVITFWLFAQSLVNLVVPLQSSYNSDIGTINIAVSLSALFSGLFIVGAGDIADKIGRVKMTYIGLALNIVGSVLIIITPLPSLLIIGRAIQGLSAACIMPATLAIINEYYIGTARQRALSYWSIGSWGGSGVCTFFGGLMATNLGWRSIFIVSIILTILSMFLIKHTPETKAEPIGDQPTEKKKFDVIGLIILVVSMLSINVIITQTSQFGLFSPFILGLIAIFVISLIIFVIYENKIKQPLVDFDIFKNKGYTGATISNFMLNGVAGGTLIVVNTFYQQKLDFNSQETGYISLTYLVAVLIMIRVGEMILQSLGPKRPLLLGSALTVIGLILLSLTFLPNAWYIASSVVGYLLFGTGLGIYATPSTDTAVAQAPDDKVGVASGVYKMASSLGNAFGVAISSTVYSVLAAQLNLTLGGFTGVMFNALIALLAFLSILFLIPKKQSNV,MNETYRGGNKLILGIVLGVITFWLFAQSLVNVVPNLQQSFGADMGTISIAVSLTALFSGMFVVGAGGLADKIGRVKMTNIGLLLSIIGSALIIITNLPALLILGRIIQGVSAACIMPSTLAIMKTYYEGAERQRALSYWSIGSWGGSGICSLFGGAVATTMGWRWIFIFSIIVAVLSMLLIKGTPETKSEVTNTHKFDVAGLIVLVVMLLSLNVVITKGAALGYTSLWFFGLIAIVIVAFFIFLNVEKKVDNPLIDFKLFENKPYTGATISNFLLNGVAGTLIVANTFVQQGLGYTALQAGYLSITYLIMVLLMIRVGEKLLQKMGSKRPMLLGTFIVIIGIALISLVFLPGIFYVISCVVGYLCFGLGLGIYATPSTDTAISNAPLDKVGVASGIYKMASSLGGAFGVAISGAVYAGAVAATSIHTGAMIALWVNVLMGIMAFIAILFAIPNDDKRVKDAK,100.87,gnl|BL_ORD_ID|4656|hsp_num:0,5726,FALSE,None
LK1137,3_239 # 200298 # 201461 # -1 # ID=3_239;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.324,3_239,200298,201461,-,Strict,700,753.436,norA,98.97,3000391,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGAAAAAGCAATTATTTATTCTTTATTTTAATATATTTCTTATATTTTTAGGAATTGGGTTAGTTATTCCTGTACTTCCTGTATATTTAAAGGATTTAGGATTAAAAGGTAGTGACTTAGGAATGCTAGTTGCTGCCTTTGCATTATCACAAATGATTATTTCACCATTTGGTGGGACACTAGCTGATAAATTGGGGAAAAAATTAATTATATGTATCGGTTTAGTATTCTTTTCTGTCTCTGAATTTATGTTCGCAGCCGGTCAAAGTTTTACCATTTTAATCATTTCACGTGTTTTAGGTGGTTTTAGTGCAGGCATGGTCATGCCTGGTGTAACAGGTATGATTGCAGATATTTCTCCAGGAGCTGATAAAGCTAAAAACTTTGGTTATATGTCGGCAATTATTAATTCAGGTTTCATATTAGGGCCTGGATTTGGAGGGTTTTTAGCTGAAATTTCACATAGATTACCTTTCTATGTTGCTGGAACATTAGGTGTTGTTGCATTCATTATGTCAGTTTTATTAATTCATAATCCTCACAAAGCAACCACAGATGGATTCCACCAATATCAACCAGAATTATTCACTAAAATTAATTGGAAAGTATTTATTACGCCAGTTATATTAACACTTGTATTAGCATTTGGTTTATCTGCTTTTGAAACATTGTTTTCTTTATATACAGCTGACAAAGTAAATTATACTCCTAAAGATATTTCGATAGCTATTATCGGTGGAGGCGTGTTTGGCGCATTATTCCAGGTATTCTTCTTTGATAAATTTATGAAACATATGAGTGAACTTAATTTTATTGCATGGTCATTACTATATTCAGCTATTGTTCTCGTTATGTTAGTGCTTGCAAATGGTTATTGGACGATTATGATGATTAGCTTTGTTGTTTTTATAGGTTTTGATATGATTAGACCGGCTTTAACTAATTACTTCTCGAATATAGCAGGTAAACGGCAAGGTTTTGCAGGTGGATTGAATTCAACTTTTACCAGTATGGGTAACTTTATAGGTCCTCTTGTAGCTGGTGCATTATTCGATGTTAATTTAGAGTTTCCTTTATATATGGCTATTGCGGTTTCATTAAGTGGAATTATCATTATTTTTATTGAAAAAGGACTTAAGTCACGTCGTAAAGAAGCAAATTAA,MKKQLFILYFNIFLIFLGIGLVIPVLPVYLKDLGLKGSDLGMLVAAFALSQMIISPFGGTLADKLGKKLIICIGLVFFSVSEFMFAAGQSFTILIISRVLGGFSAGMVMPGVTGMIADISPGADKAKNFGYMSAIINSGFILGPGFGGFLAEISHRLPFYVAGTLGVVAFIMSVLLIHNPHKATTDGFHQYQPELFTKINWKVFITPVILTLVLAFGLSAFETLFSLYTADKVNYTPKDISIAIIGGGVFGALFQVFFFDKFMKHMSELNFIAWSLLYSAIVLVMLVLANGYWTIMMISFVVFIGFDMIRPALTNYFSNIAGKRQGFAGGLNSTFTSMGNFIGPLVAGALFDVNLEFPLYMAIAVSLSGIIIIFIEKGLKSRRKEAN,MKKQLFILYFNIFLIFLGIGLVIPVLPVYLKDLGLKGSDLGMLVAAFALSQMIISPFGGTLADKLGKKLIICIGLVFFAVSEFMFAAGQSFTILIISRVLGGFSAGMVMPGVTGMIADISPGADKAKNFGYMSAIINSGFILGPGFGGFLAEISHRLPFYVAGTLGVVAFIMSVLLIHNPQKATTDGFHQYQPELFTKINWKVFITPVILTLVLAFGLSAFETLFSLYTADKVNYTPKDISIAIIGGGVFGALFQVFFFDKFMKYMSELNFIAWSLLYSAIVLVMLVLANGYWTIMIISFVVFIGFDMIRPALTNYFSNIAGKRQGFAGGLNSTFTSMGNFIGPLVAGALFDVNLEFPLYMAIAVSLSGIIIIFIEKGLKSRRKEAN,100,gnl|BL_ORD_ID|1427|hsp_num:0,1554,FALSE,None
LK1137,3_247 # 208598 # 209041 # 1 # ID=3_247;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.331,3_247,208598,209041,+,Strict,270,286.189,mgrA,95.24,3000815,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; cephalosporin; penam; tetracycline antibiotic; peptide antibiotic; disinfecting agents and antiseptics,antibiotic efflux,ATP-binding cassette (ABC) antibiotic efflux pump; major facilitator superfamily (MFS) antibiotic efflux pump,ATGTCTGAACAACATAATTTAAAAGAGCAGCTATGCTTTAGTTTGTACAACGCTCAAAGACAAGTTAATCGCTACTATTCAAACAAAGTCTTTAAAAAGTACAATCTAACATACCCACAATTTCTTGTTTTAACAATATTATGGGATGAATCACCTGTTAACGTCAAAAAGGTCGTTACAGAATTAGCACTTGATACTGGAACTGTATCACCATTACTCAAGAGAATGGAACAAGTTGATTTAATCAAACGTGAACGTTCTGAAGTAGATCAACGTGAAGTATTTATTCACTTAACAGACAAAAGTGAAATGATTAGGCCCGAATTAAGCAACGCATCTGAGAAAGTTGCAACTGCTTCTTCTTTATCTAAAGATGAGGTCAAAGAACTTAATCGTTTATTAGGTAAAGTCATCGATGCATTTATCGAAACAAAAGAAAAGTAA,MSEQHNLKEQLCFSLYNAQRQVNRYYSNKVFKKYNLTYPQFLVLTILWDESPVNVKKVVTELALDTGTVSPLLKRMEQVDLIKRERSEVDQREVFIHLTDKSEMIRPELSNASEKVATASSLSKDEVKELNRLLGKVIDAFIETKEK,MSDQHNLKEQLCFSLYNAQRQVNRYYSNKVFKKYNLTYPQFLVLTILWDESPVNVKKVVTELALDTGTVSPLLKRMEQVDLIKRERSEVDQREVFIHLTDKSETIRPELSNASDKVASASSLSQDEVKELNRLLGKVIHAFDETKEK,100,gnl|BL_ORD_ID|133|hsp_num:0,154,FALSE,None
LK1137,9_56 # 53984 # 54829 # -1 # ID=9_56;partial=00;start_type=TTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.264,9_56,53984,54829,-,Strict,500,503.827,PC1 beta-lactamase (blaZ),94.66,3000621,protein homolog model,n/a,n/a,penam,antibiotic inactivation,BlaZ beta-lactamase,TTGAAAAAGTTAATACTTTTAATTGCAATTGCTTTAGTTTTAAGTGCATGTAATTCAACCAGTTCACATGCTAAAGAGTTAAATAATTTAGAAAAGAAATATAATGCTAATATTGGTGTCTATGCATTAGATACTAAAAGTGGTAAGGAAGTAAAATTTAATGCCGATAAGAGATTTGCCTATGCTTCAACTTCAAAAGCGATAAATAGTGCTATTTTGTTAGAACAAGTACCTTATAATAAGTTAAATAAAAAAGTACATATTAACAAAGATGATATAGTTGCTTATTCTCCTATTTTAGAAAAATATGTAGGAAAAGATATCACTTTAAAAGAACTTATTGAGGCTTCAATGAAGTATAGTGATAATACAGCAAACAATAAAATTATAAACGAAATCGGTGGAATCAAAAAAATTAAAAAACGTTTAAAAAAATTGGGAGATAAAGTAACAAATCCAGTTAGATATGAAATAGAATTAAATTACTATTCACCAAAGAGCAAAAAAGATACTTCAACGCCTGCTGCTTTCGGCAAGACTTTAAATAAACTTATCGCAAATGGAAAATTAAGCAAAAAAAATAAAAATTTCTTACTTGATTTAATGTTAAATAATAAAAACGGAGACACTTTAATTAAAGATGGTGTTCCAAAAGACTATAAGGTTGCTGATAAAAGTGGTCAAGCAATAACATATGCTTCTAGAAATGATGTAGCTTTTATTTATCCTAAGAACCAATCTGAACCTATTATTTTAGTCATTTTTACGAATAAAGACAATAAAAGTGATAAACCTAATGATAAATTGATAAGTGAAACCGCCAAGAATGTAATAAACAAATTTTAA,MKKLILLIAIALVLSACNSTSSHAKELNNLEKKYNANIGVYALDTKSGKEVKFNADKRFAYASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMKYSDNTANNKIINEIGGIKKIKKRLKKLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKTLNKLIANGKLSKKNKNFLLDLMLNNKNGDTLIKDGVPKDYKVADKSGQAITYASRNDVAFIYPKNQSEPIILVIFTNKDNKSDKPNDKLISETAKNVINKF,MKKLIFLIVIALVLSACNSNSSHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFAYASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDIALKELIEASMKYSDNTANNKIINEIGGIKKIKKRLKKLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKTLNKLIANGKLSKKNKNFLLDLMLNNKNGDTLIKDGIPKDYKVADKSGQAITYASRNDVAFVYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF,100,gnl|BL_ORD_ID|670|hsp_num:0,726,FALSE,None
LK1137,10_3 # 1156 # 1932 # -1 # ID=10_3;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.291,10_3,1156,1932,-,Strict,50,129.028,vanW gene in vanG cluster,32.69,3002965,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanW; glycopeptide resistance gene cluster,TTGGCAGTAAAAAAAGAAACATTAAAACGCCACATCATTAACTATAAGTCTAAAGATAATTTCGCCACACATAAATATCCTAATACTTTACCTAATATAGTTCATAAATATAGCTCTTATTTAATCAAGGAAGGAAAAGATATTGACCCAACCTTACAACACAACAAAGCTTTTAACATAAGTCTTTCAGCCTCAAAAATAAATAAAGTCATTATACATCCTGGTGAAATTTTTTCATTTTGGAATTTAGTCGGGAAAATTAATAAAAAAAATGGATACAAAGATGGGAGAGTTATTGTTAATAATAAAGTTCAAGCAGGTATGGGGGGAGGATTATGTAATTTAGCTAATACATTGAATTTATTAGTTATGCATAGCCCTTTAAAAGTTACTGAATTACACACTCATTCGGATGCTTTATCTCCTGATCATGGCACACGTGTACCATTTGGCACCGGTACATCCGTATCTTATAATTACGTCGATTATAGATTTAAAAACATAACCAATCAAAAAGTGCAAATATTAGTTTGGGTCGAAAATAATTATCTTAATGCCGAGTTAAGAAGTGAAGAACCTTTTAAATATAGATACGAGCTTGTCGAAGAAAATCATCACTTCACCAAAAAGAATGATATATTTTATCGTAAGTCTAAAATTTATAAAAGTACTATCGACCCCAACAAAAGTAAAATTCTTAATAAAGAGTTAGTACACGATAATAATTCAATAGTAATGTTTGATTATAGTTTAATTCCTAAAGAACTTATTAAGTAA,MAVKKETLKRHIINYKSKDNFATHKYPNTLPNIVHKYSSYLIKEGKDIDPTLQHNKAFNISLSASKINKVIIHPGEIFSFWNLVGKINKKNGYKDGRVIVNNKVQAGMGGGLCNLANTLNLLVMHSPLKVTELHTHSDALSPDHGTRVPFGTGTSVSYNYVDYRFKNITNQKVQILVWVENNYLNAELRSEEPFKYRYELVEENHHFTKKNDIFYRKSKIYKSTIDPNKSKILNKELVHDNNSIVMFDYSLIPKELIK,MIEVYKLTQRKRLTQLFPFLLPLRKWQRKKYFYFKMKFDGNRYAKKTSEKLLPNTVFETSSLMLNENSGFDMKYQINKVHNLKLAAKTINKVIIEPKETFSFWQLVRWADRHEKYKDGLNLVNGKIVGSYGGGLCQLSNMLFWLFLHTPLVIVERHGHAVESFPSTTEDLPCGTDATINEGWLDLKLRNDTDNTFQIEISFDDNFMYGRILSQSSVNIEYTVFNSSVSYFKREEKVYQIASVCRTEKDKMTGSQTEKELYVNQCEIAYKLPDDVKIEERGV,91.81,gnl|BL_ORD_ID|4743|hsp_num:0,1622,FALSE,None
LK1137,10_55 # 58284 # 58712 # 1 # ID=10_55;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.305,10_55,58284,58712,+,Strict,150,188.734,FosBx1,60.58,3007372,protein homolog model,n/a,n/a,phosphonic acid antibiotic,antibiotic inactivation,fosfomycin thiol transferase,ATGGAAATAACAAGTGTTAATCATATTTGTTTTTCAGTAAGTGATTTAAATACCTCTATACAATTTTATAAAGATATTTTACAAGGTGACTTATTAGTATCAGGTAGAACGACAGCATATTTAACTATTGGTCATACTTGGATTGCACTGAATCAAGAAAAAAATATACCAAGGAATGAAATAAACCATTCCTATACGCACGTTGCTTTCTCCATAGATGAAGAAGATTTTCAAAAGTGGATTCAATGGCTTAAAGAGAATCAAGTAAATATTTTAAAAGGGCGACCAAGAGACATTAAAGACAAAAAGTCGATATATTTTACAGATCCGGATGGGCATAAAATTGAATTACATACTGGGACACTAAAAGATAGAATGGAATATTATAAAAGTGAGAAGGCGCATATGCAATTTTACGATGAGTTTTGA,MEITSVNHICFSVSDLNTSIQFYKDILQGDLLVSGRTTAYLTIGHTWIALNQEKNIPRNEINHSYTHVAFSIDEEDFQKWIQWLKENQVNILKGRPRDIKDKKSIYFTDPDGHKIELHTGTLKDRMEYYKSEKAHMQFYDEF,MLRGINHICFSVSNLENSIMFYEKVLEGELLVKGRKLAYFNICGVWIALNEETHIPRNEIHQSYTHIAFSVEKEDFKCLIQRLEENDVHILQGRERDVRDCESIYFVDPDGHKFEFHSGTLQDRLNYYRDEKPHMTFY,102.9,gnl|BL_ORD_ID|4909|hsp_num:0,5900,FALSE,None
LK1137,13_108 # 90215 # 91552 # 1 # ID=13_108;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.300,13_108,90215,91552,+,Strict,200,610.527,sdrM,73.93,3007013,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGAATCTTAAGTCCATCATTACTGTAATGGCACTCATACTAATAATGTTTATGGCAGCTATAGAAACATCAATCATTTCATTAGCATTACCAACAATAAAAAATAGTTTGAATGCCGGTAATCTAGTTTCATTAGTATTTACCGTATATTTTATTGCTTTAGTCATAGCTAACCCTATCGTTGGTGAGCTCATGTCTAGATTTAAAATTATTAACATTGCTGTTGTAGGGGTATCATTGTTTGCCTTAGGTAGTTTAATGTCGGGATTAAGTCAGACGTTTACTTTTTTAATTATCTCTCGAATAGTACAAGGTTTTGGAGCAGGAGTTATGATGTCACTCTCACAAATAGTTCCAAAGTTGGCTTTTGAAATTCCGTTAAGATATAAAATTATGGGTATCGTCGGAAGTGTCTGGGGGATTTCGAGTATTATTGGTCCATTATTAGGTGGTGCGATTTTAGAGTTCGCTTCATGGCATTGGCTATTCTATATCAATATTCCTATTGCTATATTGGCAATAATACTTGTATTTATGACTTTTCATTTTCCTGATGAGACACAAGTACAACAGAGTCGTTTTGATATAAAAGGATTGATTATCTTTTATATCTTTATAGCTTTATTAATGTTTGGTTTACTCAACCAACATCATATTATTTTTAATATATTCTCAATTATTTTAGCTTTAGTTGTTTTATGGATGCTATTTAAAGTGGAAAATAGTTTCGAACAACCATTTTTACCAACGAAAGAATTTAACATATCAATAGTTCTAGTTTTTATAACGGATTTACTAATTGCGATAACATTGATGGGATATAATTTATATATACCAGTATATTTACAAGAAAAACTTGGTTTATCACCTTTACAAAGTGGATTTGTAATATTCCCGTTGTCTGTTGCTTGGATTACGCTTAATTTCAATTTAGCTAAAATAGAAGCGCATTTTACTAGAAAAACATTATATATTTGCTCATTCTTTGTTTTATTAGTTTGTAGTCTGATGATAATGTTTGGCTTAAAACTCCCATTGCTTATTGCTTTTGCGGTTATATTTGCAGGTTTAAGTTTTGGCTATATTTATACAAAAGATAGTGTTATTGTCCAAGAGGAAACTTCTCCAAAAAATATGAAAAAGATGATGTCGTTTTATGCATTGACAAAAAATTTAGGTTCGTCTGTCGGATCTACGATTATGGGATATATGTATGCACTAAATGTTGGTTTATTTGGTTCTAATTTACACAATGTATTAGGATTAGTATCAATAATTTCAGTATGTTTAATTGTAATGTGGATGACATTATTTAAGAGTAATCCTATTCAATCTTAG,MNLKSIITVMALILIMFMAAIETSIISLALPTIKNSLNAGNLVSLVFTVYFIALVIANPIVGELMSRFKIINIAVVGVSLFALGSLMSGLSQTFTFLIISRIVQGFGAGVMMSLSQIVPKLAFEIPLRYKIMGIVGSVWGISSIIGPLLGGAILEFASWHWLFYINIPIAILAIILVFMTFHFPDETQVQQSRFDIKGLIIFYIFIALLMFGLLNQHHIIFNIFSIILALVVLWMLFKVENSFEQPFLPTKEFNISIVLVFITDLLIAITLMGYNLYIPVYLQEKLGLSPLQSGFVIFPLSVAWITLNFNLAKIEAHFTRKTLYICSFFVLLVCSLMIMFGLKLPLLIAFAVIFAGLSFGYIYTKDSVIVQEETSPKNMKKMMSFYALTKNLGSSVGSTIMGYMYALNVGLFGSNLHNVLGLVSIISVCLIVMWMTLFKSNPIQS,MRLKSIITVIALILIMFMSAIESSIISLALPTIKQDLNAGNLISLIFTAYFIALVIANPIVGELLSRFKIIYVAIAGLLLFSIGSFMCGLSTNFTMLIISRVIQGFGSGVLMSLSQIVPKLAFEIPLRYKIMGIVGSVWGISSIIGPLLGGGILEFATWHWLFYINIPIAIIAIILVIWTFHFPEEETVAKSKFDTKGLTLFYVFIGLIMFALLNQQLLLLNFLSFILAIVVAMCLFKVEKHVSSPFLPVVEFNRSITLVFITDLLTAICLMGFNLYIPVYLQEQLGLSPLQSGLVIFPLSVAWITLNFNLHRIEAKLSRKVIYLLSFTLLLVSSIIISFGIKLPVLIAFVLILAGLSFGYIYTKDSVIVQEETSPLQMKKMMSFYGLTKNLGASIGSTIMGYLYAIQSGIFGPNLHNVLSAVAVISIGLIVLWVVFFKEQSSQSKE,99.55,gnl|BL_ORD_ID|4661|hsp_num:0,5729,FALSE,None
LK1137,13_109 # 91746 # 92213 # 1 # ID=13_109;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.233,13_109,91746,92213,+,Strict,100,226.098,sepA,69.68,3007012,protein homolog model,n/a,n/a,disinfecting agents and antiseptics,antibiotic efflux,small multidrug resistance (SMR) antibiotic efflux pump,ATGAAATTTTTAAAAAATAAATCATATCATTTATTAGTAACACTTATTGTTCTCACTATATTTATTATTTCCGGAGCCATTTTTTTAACGTTTTTAGGCTTTGGTTTGTACGGTTTGAGTCGCATCCTTATTTATTTACACTTAGGCGATTTTAGTTACAATAAAGGTTTTTATTTTAATTTAATATACTACGGTAGTTATATCGTATTAGGCTATTTTACTTTATTTTCAATTGAGCATTTAATGGATTATTTTAAAAAGAATCTTCCAAAAAATCCATACTTTCAAGGTATTAACTTTCATCTCATCTCCTACATTGTTACTACAATTATGTTTTATTTTATAGTTCACATACACTATGTACATGTTAATATACATTTTTGGGTAATTATGATTATTATAGGATTTTTATTTGTATGTAAAGAAGTTTTTTATCCTGAAAGTAAAAATTTGAATAATAAAAAGTAA,MKFLKNKSYHLLVTLIVLTIFIISGAIFLTFLGFGLYGLSRILIYLHLGDFSYNKGFYFNLIYYGSYIVLGYFTLFSIEHLMDYFKKNLPKNPYFQGINFHLISYIVTTIMFYFIVHIHYVHVNIHFWVIMIIIGFLFVCKEVFYPESKNLNNKK,MIVNFFKHKFYNLLTTMIVLFVFVLSGAIFLTFLGFGLYGLSRILIYFRLGDFTYNRNMYDNLLYYGSYIIFGYFIIFAVEHLMDYFRKMLPENAYFRGATFHLISYTVATTLFYFIIHLHYVYINIDFWVIMVIIGFLYVCKLQFYPESKNLNNRK,98.73,gnl|BL_ORD_ID|4660|hsp_num:0,5728,FALSE,None
LK1137,23_3 # 2138 # 5212 # -1 # ID=23_3;partial=00;start_type=TTG;rbs_motif=AGGAGG;rbs_spacer=5-10bp;gc_cont=0.287,23_3,2138,5212,-,Strict,2000,2086.61,Staphylococcus aureus mupA conferring resistance to mupirocin,99.51,3000521,protein homolog model,n/a,n/a,mupirocin-like antibiotic,antibiotic target alteration,antibiotic-resistant isoleucyl-tRNA synthetase (ileS),TTGACAAAGAAATATTTAAACACCCAGAATGAAATATCAGTATTTTGGAATACTCAAAAGATATTTAAAAAATCAATTGACAATAGAAAAGGACAGGAAAGTTTTGTTTTTTATGACGGCCCCCCAACTGCAAATGGCCTTCCTCATGCTGGCCATGTTCTTGGAAGAGTAATCAAGGATTTAGTTGCAAGATTAAAAACTATGCAAGGTTTTTATGTAGAAAGAAAAGCAGGATGGGATACCCATGGCTTACCAGTTGAATTAGAGGTTGAAAAAAAAATTGGAATTAAAGGAAAACAAGACATTGAAAAGTATGGAATAGAAAATTTTATAAATGAATGTAAAAAAAGTGTATTTAATTATGAAAAAGAATGGCGGGATTTTTCTAAAGATTTAGGATACTGGGTTGACATGGACTCCCCCTATATAACTCTTGAGAATAATTATATTGAAAGTGTATGGAATATATTATCTACATTCCATAAAAAAGGACTATTATATAAGGGACATAAGGTGACTCCTTATTGTACACATGATCAAACCGCTTTAAGTTCTCATGAAGTAGCGCAAGGCTATAAAAACGTTAAAGATTTATCAGCTGTTGTTAAATTTCAACTTACAAATAGTAAAGATACTTATTTCTTAAGTTGGACTACCACTCCCTGGACTTTGCCTGCAAATGTAGCATTAGCTATAAATAAAGATCTTAATTATTCAAAAATTCGGGTAGAAAATGAGTATTATATCTTAGCTACAGATCTAATTAATTCTATAATAACTGAAAAATACGAAATTATTGATACCTTTTCAGGAAGTAATTTAATTAATTTAAAATACATTCCTCCTTTTGAAAGCGACGGTTTAGTTAATGCATATTACGTTGTTGATGGAGAATTTGTTACTAACTCAGAAGGAACTGGTATTGTTCATATAGCACCAGCTCATGGGGAAGATGACTACCAATTGGTTTTAGAGCGTGATTTGGATTTCTTAAATGTTATAACAAGAGAAGGAGTATATAATGATAGGTTCCCTGAATTAGTTGGTAATAAAGCTAAAAATAGTGATATAGAAATCATAAAATTATTATCCAAAAAACAACTTTTATATAAAAAACAAAAATATGAGCATAATTATCCTCATTGTTGGAGATGTGGTAATCCTTTGATATATTATGCGATGGAAGGTTGGTTTATTAAAACAACTAATTTTAAGAATGAAATTATTAACAATAATAATAATATAGAGTGGTTTCCTTCTCATATTAAGGAAGGGAGAATGGGAAATTTCTTAGAAAATATGGTTGATTGGAACATTGGTAGAAATAGATATTGGGGAACACCATTAAATGTATGGATTTGCAATGATTGTAATCACGAATACGCACCAAGTAGTATTAAGGATTTACAAAATAATTCCATCAATAAAATTGATGAAGATATTGAGTTGCATAGACCTTATGTTGATAATATCACTCTTAGTTGCCCTAAGTGTAATGGGAAAATGTCTCGAGTAGAAGAAGTAATCGATGTTTGGTTTGATAGCGGCTCTATGCCGTTTGCTCAGCATCATTATCCTTTTGATAACCAGAAAATTTTTAATCAACACTTTCCAGCTGATTTTATTGCAGAAGGAGTTGATCAAACGAGAGGCTGGTTTTACAGTTTACTAGTAATTTCTACTATTCTAAAAGGAAAATCTTCTTATAAACGTGCTTTATCTTTAGGACATATTCTAGACAGTAATGGTAAAAAAATGTCTAAAAGTAAAGGAAACGTTATTAATCCAACTGAATTAATTAATAAGTACGGAGCCGATTCTTTAAGATGGGCCTTAATTTCGGATAGTGCTCCATGGAATAACAAAAGATTCTCAGAAAATATAGTAGCTCAGACCAAATCGAAATTTATAGATACGCTTGATAATATTTATAAATTTTATAATATGTATAATAAAATAGATCACTATAATCCTAATAATGAAATTACAAAAAGTAGAAATACATTAGATAATTGGGCTCTTTCTCGCTTAAACACCTTAATAAAAGAAAGTAATATTTATGTAAATAATTACGATTTCACTTCCGCAGCCAGATTAATTAACGAATATACCAATACAATAAGTAATTGGTATATTCGGAGATCGAGAGGACGATTTTGGGAACAAGGAATTTCTAACGATAAAAAAGATGCGTACAATACGCTTTATGAAATTTTAACAACTTTATCAAGACTAGTGGCTCCATTTGTTCCATTTATATCTGAAAAAATCCATTATAATTTGACTGGAAAAAGTGTGCATTTACAAGATTATCCACAATATAAAGAAAGTTTTATTAATCAAGCATTGGAAGATGAAATGCATACCGTTATAAAAATTGTAGAATTATCTAGACAGGCTCGCAAAAATGCAGATTTAAAAATTAAGCAACCTTTATCGAAAATGGTGATTAAACCTAATAGTCAATTAAACTTAAGTTTTTTACCTAATTACTATTCAATAATAAAAGACGAATTAAATATAAAAAACATTGAATTAACTGATAATATTAATGACTATATTACCTATGAGCTTAAATTGAATTTTTCTTCTGTGGGACCAAAACTAGGGAACAAAACGAAAAATATTCAAACATTGATAGACTCCCTATCAGAGTATGATAAAAAAAGTTTAATTGAGTCTAATAACTTCAAAAGTTTATCTTCTGATGCTGAGTTAACTAAGGATGATTTTATAATTAAAACCTTACCTAAGGATAGTTATCAACTCAGTGAAGATAATGACTGCGTTATATTATTAGATAAAAATTTATCTCCTGAATTAATTCGCGAAGGACATGCTAGAGAGCTCATTAGATTAATTCAACAATTAAGAAAAAAGAAAAATTTACCAATAAATCAACGTATTGATATTTATATCGGTGTAACTGGGGAATTATTAGAATCAATAAAAACCAATAAAAATATGTTTAAAGAAAATTTGCTGATTAAAAATATACACTTAAATGTTATAGATGAATATGAAAATACTATTCATTTTAATAATAAAGAAATAAAAATTTCCTTATTATATTAA,MTKKYLNTQNEISVFWNTQKIFKKSIDNRKGQESFVFYDGPPTANGLPHAGHVLGRVIKDLVARLKTMQGFYVERKAGWDTHGLPVELEVEKKIGIKGKQDIEKYGIENFINECKKSVFNYEKEWRDFSKDLGYWVDMDSPYITLENNYIESVWNILSTFHKKGLLYKGHKVTPYCTHDQTALSSHEVAQGYKNVKDLSAVVKFQLTNSKDTYFLSWTTTPWTLPANVALAINKDLNYSKIRVENEYYILATDLINSIITEKYEIIDTFSGSNLINLKYIPPFESDGLVNAYYVVDGEFVTNSEGTGIVHIAPAHGEDDYQLVLERDLDFLNVITREGVYNDRFPELVGNKAKNSDIEIIKLLSKKQLLYKKQKYEHNYPHCWRCGNPLIYYAMEGWFIKTTNFKNEIINNNNNIEWFPSHIKEGRMGNFLENMVDWNIGRNRYWGTPLNVWICNDCNHEYAPSSIKDLQNNSINKIDEDIELHRPYVDNITLSCPKCNGKMSRVEEVIDVWFDSGSMPFAQHHYPFDNQKIFNQHFPADFIAEGVDQTRGWFYSLLVISTILKGKSSYKRALSLGHILDSNGKKMSKSKGNVINPTELINKYGADSLRWALISDSAPWNNKRFSENIVAQTKSKFIDTLDNIYKFYNMYNKIDHYNPNNEITKSRNTLDNWALSRLNTLIKESNIYVNNYDFTSAARLINEYTNTISNWYIRRSRGRFWEQGISNDKKDAYNTLYEILTTLSRLVAPFVPFISEKIHYNLTGKSVHLQDYPQYKESFINQALEDEMHTVIKIVELSRQARKNADLKIKQPLSKMVIKPNSQLNLSFLPNYYSIIKDELNIKNIELTDNINDYITYELKLNFSSVGPKLGNKTKNIQTLIDSLSEYDKKSLIESNNFKSLSSDAELTKDDFIIKTLPKDSYQLSEDNDCVILLDKNLSPELIREGHARELIRLIQQLRKKKNLPINQRIDIYIGVTGELLESIKTNKNMFKENLLIKNIHLNVIDEYENTIHFNNKEIKISLLY,MTKKYLNTQNEISAFWNTQKIFKKSIDNRKGQESFVFYDGPPTANGLPHAGHVLGRVIKDLVARLKTMQGFYVERKAGWDTHGLPVELEVEKKIGIKGKQDIEKYGIENFINECKKSVFNYEKEWRDFSKDLGYWVDMDSPYITLENNYIESVWNILSTFHKKGLLYKGHKVTPYCTHDQTALSSHEVAQGYKNVKDLSAVVKFQLTNSKDTYFLSWTTTPWTLPANVALAINKDLNYSKIRVENEYYILATDLINSIITEKYEIIDTFSGSNLINLKYIPPFESDGLVNAYYVVDGEFVTNSEGTGIVHIAPAHGEDDYQLVLERDLDFLNVITREGVYNDRFPELVGNKAKNSDIEIIKLLSKKQLLYKKQKYEHNYPHCWRCGNPLIYYAMEGWFIKTTNFKNEIINNNNNIEWFPSHIKEGRMGNFLENMVDWNIGRNRYWGTPLNVWICNDCNHEYAPSSIKDLQNNSINKIDEDIELHRPYVDNITLSCPKCNGKMSRVEEVIDVWFDSGSMPFAQHHYPFDNQKIFNQHFPADFIAEGVDQTRGWFYSLLVISTILKGKSSYKRALSLGHILDSNGKKMSKSKGNVINPTELINKYGADSLRWALISDSAPWNNKRFSENIVAQTKSKFIDTLDNIYKFYNMYNKIDHYNPNNEITKSRNTLDNWALSRLNTLIKESNIYVNNYDFTSAARLINEYTNTISNWYIGDSRGRFWEQGISNDKKDAYNTLYEILTTLSRLVAPFVPFISEKIHYNLTGKSVHLQDYPQYKESFINQALEDEMHTVIKIVELSRQARKNADLKIKQPLSKMVIKPNSQLNLSFLPNYYSIIKDELNIKNIELTDNINDYITYELKLNFSSVGPKLGNKTKNIQTLIDSLSEYDKKSLIESNNFKSLSSDAELTKDDFIIKTLPKDSYQLSEDNDCVILLDKNLSPELIREGHARELIRLIQQLRKKKNLPINQRIDIYIGVTGELLESIKTNKNMFKENFVIKNIHLNVIDEYENTIHFNNKEIKISLLY,100,gnl|BL_ORD_ID|4701|hsp_num:0,2270,FALSE,None
LK1137,26_6 # 7802 # 8485 # 1 # ID=26_6;partial=00;start_type=ATG;rbs_motif=AAAA;rbs_spacer=11bp;gc_cont=0.332,26_6,7802,8485,+,Strict,50,105.916,vanY gene in vanB cluster,32.54,3002956,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGAAAAAATTATCTGTAATATTGATGACTAGCGCTTTATTACTTTCAGCTTGTTCACATCAATCTGAAAGCCACAATGACAAAAATGAAAGTAAAACTGCACATACAAATCAAGCCCAAAATAACGATAACAACCAAAAGAAGCATCGAAAAGTTGTTAAGGATGGTCGGACGTATGCAGATGGAATTTTAATTGTAAACAAAAATATTGATTTACCCTCCTCTTATAATCCAGGTGAAAATCCAAAAGCACAAAAAGCCTTAAAACAATTATTTGATGGTGCACAAAAAGATGATATTCACTTATATAAAATAAGTGGATATAGAAGCTATCCTACACAAGTTAAGTTATATAATAATTATGCGAAGCGTGATGGTAAAAAAGCAGCAGACAAATACAGTGCACGTCCAGGCTATTCTGAACACCAAACAGGTCTTACATTTGATGTTGGTGGCGTCGATTCAAATAAAAATCTATATGCTAGTTTTGGTAAAACTGAGGAAGGACGCTGGATAGCTAAGAATGCCCATAATTATGGGTTTATTATAAGATATCCTAAAAACAAAGAAAGCATCACAGGATATCAATATGAACCTTGGCATTTACGTTATTTAGGAAAAAAGAAGGCGACAAAAGTGTACAAATCTGGTGAAACATTAGAGGAATTTGTAGGCTTAAAATGA,MKKLSVILMTSALLLSACSHQSESHNDKNESKTAHTNQAQNNDNNQKKHRKVVKDGRTYADGILIVNKNIDLPSSYNPGENPKAQKALKQLFDGAQKDDIHLYKISGYRSYPTQVKLYNNYAKRDGKKAADKYSARPGYSEHQTGLTFDVGGVDSNKNLYASFGKTEEGRWIAKNAHNYGFIIRYPKNKESITGYQYEPWHLRYLGKKKATKVYKSGETLEEFVGLK,MEKSNYHSNVNHHKRHMKQSGEKRAFLWAFIISFTVCTLFLGWRLVSVLEATQLPPIPATHTGSGTGVAENPEENTLATAKEQGDEQEWSLILVNRQNPIPAQYDVELEQLSNGERIDIRISPYLQDLFDAARADGVYPIVASGYRTTEKQQEIMDEKVAEYKAKGYTSAQAKAEAETWVAVPGTSEHQLGLAVDINADGIHSTGNEVYRWLDENSYRFGFIRRYPPDKTEITGVSNEPWHYRYVGIEAATKIYHQGLCLEEYLNTEK,84.7,gnl|BL_ORD_ID|602|hsp_num:0,556,FALSE,None
LK1137,33_4 # 3104 # 4663 # -1 # ID=33_4;partial=00;start_type=ATG;rbs_motif=AAA;rbs_spacer=3bp;gc_cont=0.304,33_4,3104,4663,-,Strict,1050,1025.39,vgaA,97.69,3002829,protein homolog model,n/a,n/a,lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; pleuromutilin antibiotic,antibiotic target protection,vga-type ABC-F protein,ATGTTAGAGGGACTTCATATAAAACATTATGTTCAAGATCGTTTATTGTTGAACATAAATCGCCTAAAGATTTATCAGAATGATCGTATTGGTTTAGTTGGTAAAAATGGAAATGGAAAAACAACGTTACTTCACATATTATATAAAAAAATTGTGCCTGAAGAAGGTATTGTAAAACAATTTTCACATTGTGAACTTATTCCTCAATTGAAGCTCATAGAATCAACTAAAAGTGGTGGTGAAGTAACACGAAACTATATTCGGCAAGCGCTTGATAAAAATCCAGAACTGCTATTAGCAGATGAACCAACAACTAACTTAGATAATGACTATATAGAAAAATTAGAACAGGATTTAAAAAATTGGCATGGAGCATTTATTATAGTTTCACATGATCGCGCTTTTTTAGATAACTTGTGTACTACTATATGGGAAATTGAAGAAGGAAGAATAACTGAATATAAGGGGAATTATAGTAACTATGTTGAACAAAAAGAATTAGAAAGACATCGAGAAGAATTAGAATATGAAAAATATGAAAAAGAAAAGAAGCGATTGGAAAAAGCTATAAATATAAAAGAACAGAAAGCTCAACGAGCAACTAAAAAACCGAAAAACTTAAGTTCATCTGAAAGCAGAATAAAAGGAACAAAGCCATACTTTGCAGGTAAGCAGAAGAAGTTACGAAAAACTATAAAATCTCTAGAAACCAGACTAGAAAAACTTGAAAGCGTCGAAAAGAGAAACGAACTTCCTCCACTTAAAATGGATTTAGTGAATTTAGAAAGTGTAAAAAATAGAACTATAATACGTGGTGAAGATGTCTCGGGCACAATTGAAGGACGGGTATTGTGGAAAGCAAAAAGTTTTAGTATTCGTGGAGGAGACAAGATGGCAATTATCGGATCTAATGGTACAGGAAAGACAACGTTTATTAAAAAAATTGTTCATGGGAATCATGGTATTTCATTATCGCCATCTGTCAAAATCGGTTATTTTAGCCAAAAAATAGATACATTAGAATTAGATAAGAGTATTTTAGAAAATGTTCAATCTTCTTCACAACAAAATGAAACTCTTATTCGAACTATTCTAGCTAGAATGCATTTTTTTAGAGATGATGTTTATAAACCAATAAATGTCTTAAGTGGTGGAGAGCGAGTTAAAGTAGCACTAACTAAAGTATTCTTAAGTGAAGTTAACACGTTAGTACTAGATGAACCAACAAACTTTCTTGATATGGAAGCTATAGAGGCGTTTGAATCTTTGTTAAAGGAATATAATGGCAGTATAATCTTTGTATCTCACGATCGTAAATTTATCGAAAAAGTAGCCACTCGAATAATGACAATTGATAATAAAGAAATAAAAATATTTGATGGTACATATGAACAATTTAAACAAGCTGAAAAGCCAACAAGGAATATTAAAGAAGATAAAAAACTTTTACTTGAGACAAAAATTACAGAAGTACTCAGTCGATTGAGTATTGAACCTTCGGAAGAATTAGAACAAGAGTTTCAAAACTTAATAAATGAAAAAAGAAATTTAGATAAATAA,MLEGLHIKHYVQDRLLLNINRLKIYQNDRIGLVGKNGNGKTTLLHILYKKIVPEEGIVKQFSHCELIPQLKLIESTKSGGEVTRNYIRQALDKNPELLLADEPTTNLDNDYIEKLEQDLKNWHGAFIIVSHDRAFLDNLCTTIWEIEEGRITEYKGNYSNYVEQKELERHREELEYEKYEKEKKRLEKAINIKEQKAQRATKKPKNLSSSESRIKGTKPYFAGKQKKLRKTIKSLETRLEKLESVEKRNELPPLKMDLVNLESVKNRTIIRGEDVSGTIEGRVLWKAKSFSIRGGDKMAIIGSNGTGKTTFIKKIVHGNHGISLSPSVKIGYFSQKIDTLELDKSILENVQSSSQQNETLIRTILARMHFFRDDVYKPINVLSGGERVKVALTKVFLSEVNTLVLDEPTNFLDMEAIEAFESLLKEYNGSIIFVSHDRKFIEKVATRIMTIDNKEIKIFDGTYEQFKQAEKPTRNIKEDKKLLLETKITEVLSRLSIEPSEELEQEFQNLINEKRNLDK,MKIMLEGLNIKHYVQDRLLLNINRLKIYQNDRIGLIGKNGSGKTTLLHILYKKIVPEEGIVKQFSHCELIPQLKLIESTKSGGEVTRNYIRQALDKNPELLLADEPTTNLDNNYIEKLEQDLKNWHGAFIIVSHDRAFLDNLCTTIWEIDEGRITEYKGNYSNYVEQKELERHREELEYEKYEKEKKRLEKAINIKEQKAQRATKKPKNLSLSEGKIKGAKPYFAGKQKKLRKTVKSLETRLEKLESVEKRNELPPLKMDLVNLESVKNRTIIRGEDVSGTIEGRVLWKAKSFSIRGGDKMAIIGSNGTGKTTFIKKIVHGNPGISLSPSVKIGYFSQKIDTLELDKSILENVQSSSQQNETLIRTILARMHFFRDDVYKPISVLSGGERVKVALTKVFLSEVNTLVLDEPTNFLDMEAIEAFESLLKEYNGSIIFVSHDRKFIEKVATRIMTIDNKEIKIFDGTYEQFKQAEKPTRNIKEDKKLLLETKITEVLSRLSIEPSEELEQEFQNLINEKRNLDK,99.43,gnl|BL_ORD_ID|527|hsp_num:0,579,TRUE,loose hit with at least 95 percent identity pushed strict
LK561,17_46 # 51213 # 52325 # -1 # ID=17_46;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.607,17_46,51213,52325,-,Strict,175,197.593,vanT gene in vanG cluster,34.7,3002972,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,glycopeptide resistance gene cluster; vanT,ATGAATATGCTGCGCACTCGCATCGATTTGGATGCCATTGCCCACAATGTCCGTGTGCTGAAGCGTGCGGCGGGGCAAGCGCAGCTGATGTGCGTCGTCAAGGCTGATGCTTATGGGCATGGTGTGGAGCGCGTGGTCCCGGTGATGGAAAAAGCTGGTGCCGATCTTTTTGGTGTGGCCACGATTGCTGAGGCCAGGCGGTTGCGCGAGCTCGGAACCGAATTGCCGATCATGGCGTGGTTGTGGGATGCAGCCAGCCCGGATGCAGCAGTCCAGGTGGCAGAAGCTCTTGCCGACGATATCCAGTTGGTGGCGTCGTCGTTGTCACATTTACGGTTGCTTGCCGACGCCAACATCCCGGCGACGATCACGCTGAAGGTAGAAACCGGGATGCACCGCAACGGCATTGAGCCAGTGGATTGGCACCAGGCTTTTGCGCTTGCAAAAACTGCGCCTCATTTGACGGTGCGCGGGTTGATGTCGCACCTGGCGTGCGCGGACGAGCCGGACAATCCCGCGAATGCCGCGCAGCTGGAGCAGTTCCGTGATGCGATTGCGCAGGCACGTGCGGCCGGGCTGGAGGTCCCGGTCAACCATATTGCTAATTCGGCGGCTACTTTGGAATTCCCTGACGCACATTGTCAGCAGGTGCGCCCGGGTATTGCCTGTTATGGTTTGGAGCCTGCCGACGGCTACGAGCATGATCTGCGCCCGGCGATGACGTGGGCAGCAAACGTGCTGAACGTGAAGCCGATCAGCATGGGGGAAGCAACGTCGTATGGGCTGACCTGGAGTGCAGAACAGGACAGCTACCTGGCGGTGGTGCCGTGCGGCTACGCTGATGGTTTGCCGCGTAGTGTGCAGGGGAACCTAGAGGTGGGAATTTCTGGCAAGCGTTACCGGCAGGTCGGCCGTGTGTGTATGGACCAGATTCTGGTAGATCTCGGCGAGAATCCATGGGGTGTGCAACCGGGCGACGAGGCCGTGTTGTTTGGCGAGCGCGGCATGTCCGCCACGGAGCTGGCGACTGCCACCGGCACCATTAATTATGAGATCGTGACTCGTCCGGGCGGGCGCACCGTGCGGGAGTATGAAGGGGGAGTGCAGTTGTGA,MNMLRTRIDLDAIAHNVRVLKRAAGQAQLMCVVKADAYGHGVERVVPVMEKAGADLFGVATIAEARRLRELGTELPIMAWLWDAASPDAAVQVAEALADDIQLVASSLSHLRLLADANIPATITLKVETGMHRNGIEPVDWHQAFALAKTAPHLTVRGLMSHLACADEPDNPANAAQLEQFRDAIAQARAAGLEVPVNHIANSAATLEFPDAHCQQVRPGIACYGLEPADGYEHDLRPAMTWAANVLNVKPISMGEATSYGLTWSAEQDSYLAVVPCGYADGLPRSVQGNLEVGISGKRYRQVGRVCMDQILVDLGENPWGVQPGDEAVLFGERGMSATELATATGTINYEIVTRPGGRTVREYEGGVQL,MTKNESYSGIDYFRFIAALLIVAIHTSPLSSFSETGNFIFTRIVARVAVPFFFMTSGFFLISRYTCNAEKLGAFIKKTTLIYGVAILLYIPINVYNGYFKMDNLLPNIIKDIVFDGTLYHLWYLPASIIGAAIAWYLVKKVHYRKAFLIASILYIIGLFGDSYYGIVKSVSCLNVFYNLIFQLTDYTRNGIFFAPIFFVLGGYISDSQNRLSLKRSIVGFIVCFALMFGEALTLHHFDIQKHDSMYVLLLPSVYCLFNLLLHFRGKRRTGLRTISLIIYIIHPFMIVVIRLFAKLLHLQSLLVENSLVHYIAVCFASVVLAVVITALLSSLKPKKAKHTADTDRAYLEINLNNLEHNVNTLQKAMSPKCELMAVVKAEAYGHGMYEVTTYLEQIGVSSFAVATIDEGIRLRKYGISSEILILGYTSPSRAKELCKYELTQTLIDYRYSLLLNKQGYDIKAHIKIDTGMHRLGFSTEDKDKILAAFSLKHIKVAGIFTHLCAADSLEENDVAFTNKQIGSFYKVLDWLKSSGLNIPKVHIQSSYGLLNYPELECDYIRVGVALYGVLSSTNDKTKLELDLRPVLSLKAKVVLIRKIKQGESVGYSRAFTATRDSLIAILPIGYADGFPRNLSCGNSYVLIGGRQAPIVGKICMDQLAVDVTDIPNVKTGSIATLIGKDGKEEITAPMVAESAESITNELLSRMGHRLNIIRRA,51.97,gnl|BL_ORD_ID|1522|hsp_num:0,1561,FALSE,None
LK561,22_24 # 31127 # 32770 # -1 # ID=22_24;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.616,22_24,31127,32770,-,Strict,50,91.2781,vanW gene in vanI cluster,33.96,3003724,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanW; glycopeptide resistance gene cluster,GTGCTCGGCGTCTTCGTCGGGCTTTTCGTCATTGCTGGCATTGCCTACGCCATTGATGTCTCCACGAATCAGGGCAAGATCCCGCGTGCGACGTCCGTGGGTGGCGTCGATATTTCCTCCCTGGAGCGCGAGGATGCTCTGGCCAAACTTGACGACGAACTCCGCGAGGCAGAAAACGAACCCGTGCGTGTTGCCGCGGGCGAGAAAACCACGGAATTCGTACCTGCGCAGGCGGGGCTGCGTCTGGATTTGGAAGGCACGATTGCCGCTATTCCCGATGAGTCGATGAACCCATTTGTGCGTCTGGCCAGCTTCTTCCGTTCGACGAAGGAAGTCGACGTGCAAACCGCCGAGGACCCGGCCGCACTGAACCCGGAGCTGGACCGCATGCTCGGCGAGTTGCACCGGGACCCCGAAGATGGCGCAGTGTTCCTGGAAGCCGGCAACGTGGAACCGCGTGATGCCGTACCGGGCCAGGAAGTTGATCGCGCGCAGCTGCAAGAAGAGGTCACTAGCTCCTGGCTGGATCCGGAAGGCATTGCGGTAGAGCCGAGTGAGATCGAGCCGGTGATCAACCAGGATCAGGTGGATGCGATCGCCGAAGGCCTTGCTGCCAAGGCAGTCTCCGGCCCGCTGAAGGTGCACGGCCGCGAGAATATTACTGGCACGATTGAACCTGCGCGCGTCGGCGAGTTCGTGCATTTTGAAGCCCACGAAGGCCAGCTGGAGCCGCGTGTCGACGAGTCCAAGGCCCGGGACATTCTGGGCGAAGGCCTGGCGGAATCTGAGCGTCCGATGAAGAATGCTCGCTTGTCCATGTCTGGTGGCCAGCGGCAGGTTACCCCGCACGTCGACGGGGAAGTCATTGACTGGGAGCAGACGATGGCCGGTTTCGCCGAGCGCGTGCTGGGTGATGACCGCGAGTGGGATGCCACCTATGAGGACCAGCCAGCGACGTTTACCACCGCTGATGCCGAGGCTTCGACCTTTGACCAGGTGGTCGGTGAGTTCACCACCAGTGGTTATTCCCCAGCCTCGGGTACCAATATTTCGGTGATCTCCAATGCGCTCAACGGCACCATTGTCTCGCCGGGCGAGACGTTCTCCGTCAACCAGGCCACCGGTTCGCGCACCGCAGCGCAGGGCTATGTGGAATCTGGCGTGATTTATGAGGGCCGCGCAGACACCGCCGTCGGCGGCGGCATTTCGCAGTACGCCACCACCTTGTACAACGCGGCCTATTTTGCGGCCATGGAAGATGTTGCCCACACCCCGCACAGTTATTACATTTCTCGGTACCCGGCGGGGCGCGAGGCCACGCTGTACGACGGCGTGATCGACCTGAAGTTCCGCAACAATTCCAACCACCCGGTGCGCATTGAATCGAGCGTCGGCGGTGGTTCCGTGACCGTGCGCCTGATGGGCGTGAAGGAATACGAGGTGGAATCCATCAGTGGCGGCCGCTGGGCGCACACCAATCCACCGAAGCAGACCGTGAGTGGTTCCAACTGCATCCCAACGTCCGGTATCCCCGGCTTTACGACGTCTGATACCCGCGTGATCCGTACCTTGGGCGGCGCCGAGGTGTCGCGGAATACCCAGACCACCGTTTATGATCCACAGCCAATCGTGACCTGCGGCTAG,MLGVFVGLFVIAGIAYAIDVSTNQGKIPRATSVGGVDISSLEREDALAKLDDELREAENEPVRVAAGEKTTEFVPAQAGLRLDLEGTIAAIPDESMNPFVRLASFFRSTKEVDVQTAEDPAALNPELDRMLGELHRDPEDGAVFLEAGNVEPRDAVPGQEVDRAQLQEEVTSSWLDPEGIAVEPSEIEPVINQDQVDAIAEGLAAKAVSGPLKVHGRENITGTIEPARVGEFVHFEAHEGQLEPRVDESKARDILGEGLAESERPMKNARLSMSGGQRQVTPHVDGEVIDWEQTMAGFAERVLGDDREWDATYEDQPATFTTADAEASTFDQVVGEFTTSGYSPASGTNISVISNALNGTIVSPGETFSVNQATGSRTAAQGYVESGVIYEGRADTAVGGGISQYATTLYNAAYFAAMEDVAHTPHSYYISRYPAGREATLYDGVIDLKFRNNSNHPVRIESSVGGGSVTVRLMGVKEYEVESISGGRWAHTNPPKQTVSGSNCIPTSGIPGFTTSDTRVIRTLGGAEVSRNTQTTVYDPQPIVTCG,MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVLAEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPELLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGMETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGGEFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSHSLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDEPDGYPVKPREWSK,146.65,gnl|BL_ORD_ID|4748|hsp_num:0,2242,FALSE,None
LK1128,25_27 # 32723 # 33523 # -1 # ID=25_27;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.688,25_27,32723,33523,-,Strict,50,55.4546,vanY gene in vanB cluster,34.19,3002956,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCAGACACTGACGCGACGTGGCGCACTTCGACACGCCGGCCTCGCTGCGGCGACGACGGCCCTCGTGATCGAAGGGGCGCCGCAGGCTTTCGCAGCGGTTCCTGCGTCGAGGCAGGTGGCCCGTGCGGGGGCAACGTCGGTCCTCGTGCGACGGACGACCGCGACGCTTTCCTACCGCGTCAACGTGCGCGATCAGCCCACGCTGGAACCGCGCGCCCGGATCGTCGGGACGCTGGCGAGCACCACGACGCTGACAGGCTCCTACGACGCGAGCGGCCTGTGGTTCCGCATCGCCGAGGGTGGGTTCAAGGGGCGGTGGGTGACGTCCGCAGTCCTCGTCGCGACGACGGCGCGCGCGGTGAACGGCCGTCTGCCGATGTCGGCCGTCACACGACTGCCGAGCTGGAGCGTCAACGTCAGCAACCTGCCGCACGAGCCGCGGTATCTCTCGCGCGCGGCGGCCGTCGGATATCTCGGACTGGCCGCGGCTTTCAAGGCTCGTTTCGGTGTGGCGCTGACGATCACCGAGGCCTACCGCACCCTGAGCCGTCAGCAGCTGCTCTACCGCACTCTCGGCTACCCCCGCGCGGCCGTCCCTGGCACCTCGAACCACGGGTTGGGCAACGCGATCGACTTCGGCATCGCCCGCACGAACGCGATCAACTCGCCTCTGTACTTCGGGCGTTCTTACGACGTGTGGCTGACGGCCAACTCCAAGCGCTGGGGATTCGACCGCCCCGACTACATGGATCGGCGCGGGTCCAACCCCGAGTGGTGGCACTACAACTTCGTCGGGTGA,MQTLTRRGALRHAGLAAATTALVIEGAPQAFAAVPASRQVARAGATSVLVRRTTATLSYRVNVRDQPTLEPRARIVGTLASTTTLTGSYDASGLWFRIAEGGFKGRWVTSAVLVATTARAVNGRLPMSAVTRLPSWSVNVSNLPHEPRYLSRAAAVGYLGLAAAFKARFGVALTITEAYRTLSRQQLLYRTLGYPRAAVPGTSNHGLGNAIDFGIARTNAINSPLYFGRSYDVWLTANSKRWGFDRPDYMDRRGSNPEWWHYNFVG,MEKSNYHSNVNHHKRHMKQSGEKRAFLWAFIISFTVCTLFLGWRLVSVLEATQLPPIPATHTGSGTGVAENPEENTLATAKEQGDEQEWSLILVNRQNPIPAQYDVELEQLSNGERIDIRISPYLQDLFDAARADGVYPIVASGYRTTEKQQEIMDEKVAEYKAKGYTSAQAKAEAETWVAVPGTSEHQLGLAVDINADGIHSTGNEVYRWLDENSYRFGFIRRYPPDKTEITGVSNEPWHYRYVGIEAATKIYHQGLCLEEYLNTEK,99.25,gnl|BL_ORD_ID|602|hsp_num:0,556,FALSE,None
LK1128,28_16 # 15003 # 16742 # 1 # ID=28_16;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.675,28_16,15003,16742,+,Strict,50,65.4698,vanW gene in vanI cluster,28.29,3003724,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanW; glycopeptide resistance gene cluster,GTGGCGGACGACGAGCAGGTGCAGGCGACGCAGCCGGACGGCACGCGTCGGCGCAGGCATCTGGCCTGGTTCGGGGGCGCCGGTGTGCTCGCCGTGGCGGCGATCGGCTACGTCGGGGCCTGCTACCACTACAAGGACACGATCGCGGGCGGTACCACCGTCGCGGGCCGCAGCATCGGCGGGATGACGATGGAACAGGCCTCGCGTCAGGTCTCCGGCCTGCCGGGCCCGGGGGCGCAGCAGCAGGCCACCGTCACGGCCGACGGGCAGAAGTTCGCGTTCGAGCCGTCCAGCGCATGGAAGCCGGACGTGGCGCGCACGCTCGACGGCGTCACCGGGTTCAGCCTGTCGCCTACCCGCCTCATCCATCACATCAGCGGTGACGGCGGCGCCGTCACGCCGCGGTACACGGTCGACGAAGCGGCGCTGGCGCGTCTCGTCAAAAGCTCGGCGGGCACCTCGATCAAGGGCGCGCCCACGCAGGGCAAGGTGAAGTTCATCAACGGTGAGGTCGTCGTCGTCAAGGGCGCGCCGGGCAAGAGCGTCGACGAGAAGGCGGTCGCGAAGGACGTCGCCGAGCACTGGCCGGGCACCACGGCCTACACCACGAAGCTCGTCGACAAGCAGGCCGACGCGACGCAGGACGCCGTCACCGCGTTCGCGGCGGGGGATGCGAAGAAGGCGATGTCCGAGCCGCTGCAGGTCAAGGCCAATGGCGAGACCGTGACGATGAAACCCTCCGATGTCTCCGAGGTCATCTCCTCCGACACGGATGCGCACGGAAAGCCCTCCATCAAGGTCGACGCGGACGCACTGCTCGCCCACGTCCTCGAGCGCAGCACCGACATGCAGAACGACATCGCGACGGACGCGAAGGTCGTGTGGAAGGACGGGAAGCCGAGCGTGCAGCCGGGCAAGGCCGGCCAGCAGATCGACGCCTCGAAGGTGCAGTCGGTCGTCGCGGCAGCACTGACGGGCAACCACGTCGCGAACCTGCCCATGAAGCCGATGCAGCCGCAGGTGACCGAGAAGGACATCGACGTCTCGTCGCTGCCCACCACGTCGATGGCGCACTTCGAGTCCAAGTTGCCCGGCGGCGCCGAGAACGCCGCGCGCACCCACAACATCGAGACGGCGCTCGCGACGCTCAACGGGATGGTGGTCAGACCCGGTGAGCAGTTCTCACTGTTGCGTGCCCTGGGGTACTCGTTGACGAAGGAGAAGGGCTACGTCGAGGCGGGCACGCTGCAGGGCGGCATCCACGTCGACGGCATGGGCGGCGGCGTCTCCCAGGTCTCGACGGTGCTCTACAACACGGCGTTCTTCGCGGGCGTGCAGCTCGACGAGCACACCCCGCACGACGTCTACATCGATCGCTACCCGATGGGTCGTGAGGCAACCCTGTGGAACCCCGGCGTCGACAACACGTGGACGAACGACACCGGCCACCTCATCCTCATCAAGGCGGGCACGAGCGGCAACAAGGTCGTCATGGACTTCTACGGCACACGCCAGTACGACGTGTCGACGAAGACGGGGCCGAAGACCGACGTGGTGCAGCCGAAGCAACGCACCGTGAAGGACGTCAAGGGGTGCGAGAACTCCGTCGGAAACGGCACGCCAGGCTTCCAGGTCGACGTGTGGCGCACCCTCAAGAAGGGCTCGAACGTGGTGCGCACCGACAAGATCCACACGAAGTACCAACCCGACGACATCATCACCTGCGTCGGCTCGTCGTGA,MADDEQVQATQPDGTRRRRHLAWFGGAGVLAVAAIGYVGACYHYKDTIAGGTTVAGRSIGGMTMEQASRQVSGLPGPGAQQQATVTADGQKFAFEPSSAWKPDVARTLDGVTGFSLSPTRLIHHISGDGGAVTPRYTVDEAALARLVKSSAGTSIKGAPTQGKVKFINGEVVVVKGAPGKSVDEKAVAKDVAEHWPGTTAYTTKLVDKQADATQDAVTAFAAGDAKKAMSEPLQVKANGETVTMKPSDVSEVISSDTDAHGKPSIKVDADALLAHVLERSTDMQNDIATDAKVVWKDGKPSVQPGKAGQQIDASKVQSVVAAALTGNHVANLPMKPMQPQVTEKDIDVSSLPTTSMAHFESKLPGGAENAARTHNIETALATLNGMVVRPGEQFSLLRALGYSLTKEKGYVEAGTLQGGIHVDGMGGGVSQVSTVLYNTAFFAGVQLDEHTPHDVYIDRYPMGREATLWNPGVDNTWTNDTGHLILIKAGTSGNKVVMDFYGTRQYDVSTKTGPKTDVVQPKQRTVKDVKGCENSVGNGTPGFQVDVWRTLKKGSNVVRTDKIHTKYQPDDIITCVGSS,MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVLAEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPELLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGMETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGGEFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSHSLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDEPDGYPVKPREWSK,155.23,gnl|BL_ORD_ID|4748|hsp_num:0,2242,FALSE,None
LK1128,37_29 # 26492 # 27430 # 1 # ID=37_29;partial=00;start_type=ATG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.724,37_29,26492,27430,+,Strict,50,91.2781,vanY gene in vanF cluster,35.1,3002958,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGGCTGACGTGACGCGCCGCGCGGCCCTCGCCGCACCCGTGGCCGCGCTGGCGGCAGCCGCCGGAATCGCGGGTTCGGCCGGGGCGCTGGCGGCATCGACGACATCGCCCTCGCTCGTCACCGGCACTGACGCGGACGCGCTGCGCGCCCTGCACCTGCAAGCCCTCGCCGTGACGCCGAACGTCGCCGCCGTCGTCGCGCGGCTCCATGACGGCGAGTTGTGGGCGCACCAGGACGACGCGGTCGCCATCGAACGCGCCGCAGGTGGCGTCGTCGTCGTGGCGCTGCCGGTCAAGCACTCCGCCGTGAGCCGCATCGACATCAGCACCCCGAGCGCGCCCGACACGTCGGTGAGCGTCGACACGCGGCCGGACGCGCTGCGCTCGTCGTTGCTGCGCGTCGTCAACAAGCGCCTCGCGCTGGCCCGTTCGGACGAGCCGAAGAAGCTCCTCGCGGCGCACGGCGTCATGGTCGACGAGCGGCTGAGCAAGCCTCTCGACGCAATGTTCGCGCGCGCCGAGCGCGAGCACGTCGCGCTCGAAGCCGTCAGCGCACACCGCGACTTCGACGACCAGGCCCGCGTCTACGACGCCTACGCCGAGCGCGACGGCAAGCAGGCCGCCGACACGTACTCCGCGCGCCCCGGCCACTCCGAGCACCAGCTTGGCCTGGCCCTCGACGTGCGGGGCCTCGACCGTCAGCACGAGCTCGAGCCCGCATTCAAGGACACGCCCGTGGGTCGCTGGGTGGGCGCTCATGCGCACGAGTTCGGTTTCGTCGTGCGCTACCCCGAGGGCCAGCGCGCTGTGACGGGCTACGAACCCGAACCGTGGCACCTGCGTTACGTCGGCCCCGAGGCCGCAGCGTTCATGCATGCGCGACGCGACATCGCGACGCTCGAAAATCTCTTCGGCCTGCCCGCCGCGCCGGGATACTGA,MADVTRRAALAAPVAALAAAAGIAGSAGALAASTTSPSLVTGTDADALRALHLQALAVTPNVAAVVARLHDGELWAHQDDAVAIERAAGGVVVVALPVKHSAVSRIDISTPSAPDTSVSVDTRPDALRSSLLRVVNKRLALARSDEPKKLLAAHGVMVDERLSKPLDAMFARAEREHVALEAVSAHRDFDDQARVYDAYAERDGKQAADTYSARPGHSEHQLGLALDVRGLDRQHELEPAFKDTPVGRWVGAHAHEFGFVVRYPEGQRAVTGYEPEPWHLRYVGPEAAAFMHARRDIATLENLFGLPAAPGY,MKKWGLLLVFALFLVFIFNILPISQDKVEDRIYEQNDKDTSDDKMTAENMQKIELTEEQIYQGNLLLVNNEHPVHQKSIKSDIINLFTHKELTKGYGLLDNEIKLSEEIAGKFSEMIAAAEEDGVSNFLISSGYRDLDEQSRLYEEMGSDFALPAGHSEHNLGLSLDVGSTQMKMDKAPEGKWIEKNCWEYGFILRYPLDKTDVTGIQYEPWHIRYVGLPHSAIMQEMNLALEEYLDYLKEEKSISVRVDGKKYTISYDPISQNETIEVEVPADEQYEISGNNIDGVIVTTFS,106.48,gnl|BL_ORD_ID|1808|hsp_num:0,1899,FALSE,None
LK1239,3_91 # 95689 # 97302 # 1 # ID=3_91;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.656,3_91,95689,97302,+,Strict,50,78.1814,vanW gene in vanI cluster,35.16,3003724,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanW; glycopeptide resistance gene cluster,GTGCTCGCGGTGCTGCTTGCGATCTACCTCGCCGACCTCGCAATGAACCGCGGGAACGTGCCGCGTGGCACCGCCGTCGGCGGTGTCGAGATCGGCGGCATGAGCCACGACGAGGCCACCGCGAAGCTCGAAGCAGAGCTCGGTGAGACGGCGAGCAACCCCGTGACGGTGAAGGCGGCATCGCAAAGCTCGCAGCTCGTGCCCGCCGAGTCCGGCCTCGGCATCGACTGGGAGGCGACCGTAGCAAGCGCGGGCGAAGAGTCCGCGAACCCGTTCACTCGCCTCGCCGGGCTGTTTCGCACCCGCGAAGTCGACATTGTGTCGACCGTGAACGAGGCCGCTCTCACCCCGCAGCTTGAGCGCGTGGCCGGCGAGTTGCACCTCGACCCCGCCGACGGCGCGATCGCCATCGAAGGCGGCGAGGCGAAAGTGACCGAACCGGTGCCGGGCCAGGAGGTTGACGAAACCGAGCTGTTCGAACGTGTCACCACCGGCTGGCTCAACCCCGACGGTGTAGAGGTCGAGCCGCGCGAAATCGAACCCGCTATCGGCGACCAGGCCATCAAGGAAGCCTTAGACGGGCCGGTTAAGGCGGCGCTGTCCGGAGCGTTGACACTGCACGGTCGCGACGGCGTCGACGGTGTCATTGCCCAAGAGCGCATCGGCGAGGTCGTCCAATTCCCCAACGTCGACGGCAAAATCGCCCCCGAGGTGAACGTGGAAAACGCCCAGGGCATCTTGGTCGAGCAGCTCGCTGCGACCGAGACGCAGATGAAAAACGCGCGCGTGCTGCCCGGCGGCGGGGTGGAACCGTCCGTCGATGGCTCCATCATCGACTGGGAGGCCGCGATGGACGGTTTCGACGAGCGGTTGATCGGTTCCGCCGAGCGCACCTGGGACGCGCAATACAAGGCCCGCCCGGCCGACTTCACTACAGAGGAAGCCCAACGTGCCAGCTTCGACGAGGTGGTGGGAAGTTTCACCACCGGCGGGTACAGCGGCGCATCCGGCACGAACATCGCTACGGTGGCCCGCGTTGTCAACGGCGCAATTGTCAACCCCGGTGAAACCTTCTCGCTCAACGGCTACACTGGCGCGCGCGGTGCCGCGCAGGGTTACGTCGAGTCGGGCATCATCGAAAATGGACGCCCCGGCAAGGCAGTGGGCGGCGGAATCTCCCAATTTGCCACGACCTTGTACAACGCGGCTTACTTTGCCGGCATGACGGATGTCGCCTCCACCCCGCACTCCTACTACATTTCACGCTACCCGGCTGGCAGGGAGGCGACCGTGTATGAAGGGGCGATTGACCTGCAATTCCGCAACGATTCGCCCCACCCGGTCAAGATTTCCACGAGCGTCGGGGGCGGCGAGGTGACGGTGAGCCTGATGGGCACCAAGACCGTCGAGGTGGAGTCCATCAACGGAGGGCGCTGGGCCTACACCTCGCCGAAGCCCGTGACCGTCACCAGTGGTGACTGCATTCCCTCGGGCGGGGTACAGGGCTTTACCACCTCCGATACCCGGATTGTGCGTGACCTCAGCGGCAATGAGATCAGTCGCAACACCTCCACCACGGTCTACGACCCGCAGCCCATCGTGCGCTGCGAGTAG,MLAVLLAIYLADLAMNRGNVPRGTAVGGVEIGGMSHDEATAKLEAELGETASNPVTVKAASQSSQLVPAESGLGIDWEATVASAGEESANPFTRLAGLFRTREVDIVSTVNEAALTPQLERVAGELHLDPADGAIAIEGGEAKVTEPVPGQEVDETELFERVTTGWLNPDGVEVEPREIEPAIGDQAIKEALDGPVKAALSGALTLHGRDGVDGVIAQERIGEVVQFPNVDGKIAPEVNVENAQGILVEQLAATETQMKNARVLPGGGVEPSVDGSIIDWEAAMDGFDERLIGSAERTWDAQYKARPADFTTEEAQRASFDEVVGSFTTGGYSGASGTNIATVARVVNGAIVNPGETFSLNGYTGARGAAQGYVESGIIENGRPGKAVGGGISQFATTLYNAAYFAGMTDVASTPHSYYISRYPAGREATVYEGAIDLQFRNDSPHPVKISTSVGGGEVTVSLMGTKTVEVESINGGRWAYTSPKPVTVTSGDCIPSGGVQGFTTSDTRIVRDLSGNEISRNTSTTVYDPQPIVRCE,MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVLAEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPELLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGMETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGGEFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSHSLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDEPDGYPVKPREWSK,143.97,gnl|BL_ORD_ID|4748|hsp_num:0,2242,FALSE,None
LK444,2_299 # 355360 # 356214 # -1 # ID=2_299;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.559,2_299,355360,356214,-,Strict,400,478.404,ErmX,83.1,3000596,protein homolog model,n/a,n/a,macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic,antibiotic target alteration,Erm 23S ribosomal RNA methyltransferase,ATGTCTACATACGGATACGGCCGTCACGAACATGGCCAAAATTTTCTCACAGACCAAAAGATCATCAACACCATCGTCGATCTTGTAAAACAAACCACCGGCCCCATCATCGAGATCGGGCCGGGAAGCGGTGCCCTCACTCACCCGATATCCCGCTTGGGGAGGGCAATAACGGCAGTTGAGGTAGACGCAAAACTAGCTGCCAAACTCACAAAAAAGACCGCCTCGGCGTCGGTCGAAGTGGTCCATGATGATTTCCTTAACTTCCCGTTACCCGCCACTCCCTGCGTCATTGTGGGAAACATTCCCTTTCACCTCACCACTGCCATTCTTCGAAAGTTGTTGCATGCGCCGGCATGGACTGACGCTGTACTCCTCATGCAGTGGGAAGTCGCTCGCCGCCGGGCCGGGGTAGGCGCAAGCACGATGATGACGGCTCAGTGGTCCCCATGGTTCACGTTTCACCTTGGTTCCCGAGTACCAAGGTCTGCTTTCCGTCCACAGCCTAACGTTGACGGGGGGATCTTAGTGATCCGCCGGGTGGGTGACCCGAAGATCCCGATAGAGCAACGCAAAGCCTTTCAGGCTATGGTGCACACCGTTTTCACCGCCCGGGGACGCGGGATAGGGGAAATTCTCCGAAGGGCAGGGTTGTTTTCATCACGTTCAGATACACAATCATGGTTGCGCTCGCGAGGAATCGACCCCGCAACCCTACCCCCCAGATTGCGCACCAGCGACTGGATCGATCTCTTTCAGGTGACTGGTTCCTCTCCATCGCACCATCGGCCAATTTCACAATCGGGAAGTAGTCAACGCCCTCCTCAACGCAAAAAACGAGGCCGGCGGCGTTAA,MSTYGYGRHEHGQNFLTDQKIINTIVDLVKQTTGPIIEIGPGSGALTHPISRLGRAITAVEVDAKLAAKLTKKTASASVEVVHDDFLNFPLPATPCVIVGNIPFHLTTAILRKLLHAPAWTDAVLLMQWEVARRRAGVGASTMMTAQWSPWFTFHLGSRVPRSAFRPQPNVDGGILVIRRVGDPKIPIEQRKAFQAMVHTVFTARGRGIGEILRRAGLFSSRSDTQSWLRSRGIDPATLPPRLRTSDWIDLFQVTGSSPSHHRPISQSGSSQRPPQRKKRGRRR,MSAYGQGRHEHGQNFLTNHKIINSIIDLVKQTSGPIIEIGPGSGALTHPMAHLGRAITAVEVDAKLAAKITQETSSAAVEVVHDDFLNFRLPATPCVIVGNIPFHLTTAILRKLLHAPAWTDAVLLMQWEVARRRAGVGATTMMTAQWSPWFTFHLGSRVPRSAFRPQPNVDGGILVIRRVGDPKIPIEQRKAFQAMVHTVFTARGRGIGEILRRQGCFHHVQKHNHGCAREESTPRPYLPDCYTNDWIDLFQVTGSSLPHHRPISPSGSSQRPPQRKNRSRRR,100,gnl|BL_ORD_ID|872|hsp_num:0,950,FALSE,None
LK444,3_83 # 77334 # 79028 # 1 # ID=3_83;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.592,3_83,77334,79028,+,Strict,50,88.5817,vanW gene in vanI cluster,35.06,3003724,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanW; glycopeptide resistance gene cluster,GTGGCTGTGGCCAAACAAAAGTCTTCCTCCAGTCACCGTGGATTAAAGATTTTCCTCGGCATCGTCCTCGGTATCTTCGCGCTCTTCGGTGTGTTTTACGCTGTCGATTACGTGCTGAACAAGGACCATGTCCCGCGCGGGTCTACCGTTGCGGGGATTGACATCAGCACGCTGAGCGCGAATCACGCTGAGGCGAAGCTCGAAGAGCAGCTCGGTGATCTTTCCACTCACCCAGTGGCGTTGCGTGCCGGCGAACGCACGGCGGAGGTTCTGCCCGAGGAGGCGGGGCTGAGCATCGACTGGGAGAAGACGGTCGCGCAGGCGGGCAAGCAGACGGCAAACCCAGTTACCTGGGTGCGCAGTTTCTTTACTACCCGTGAGCTGGATTTGGTCAGCGATATCGATAACTCTAAGTTCGAGCCGCAGGTCGACCGTCTCGTCGGCGAACTGACTATTGCTCCCGTCGATGGTGAGGTCAAGCTTGTCGACGGCCGCGTGGAAACAACTCCACCGGTCATCGGCCAAGATGTCGACCGCAATGCGGTCAGCGGGGATTTGGCCGCCAAGTGGTTGTCGCCGGAGGGCATCGATGTAGAGACCACCGCGCACGACCCGGCTATCGGTGAGGAGCAGGTCCGTGAGGCAGCTGAGGGAGAGGCCGCCGATGCGGTGTCGGGCCCCATTGTTGCCAAGGGCCGTGATGGCAAAGATGGTGTAATTCCGCCGGAGCGCATGGCTGAAATCATCAGCTTTGTGCCGCGCGACGGCGGATTGGCCGCTGATATCAATGTCGACCGCGCACGCGAGATCCTCGAGGAGGGGCTGGCTGCTTCCGAGGTTGATAAGCGCAATGCGTCGATACGCTTTAGCGGTGGTGCGCGTGAAGTGGTCCCCTCGGTTGATGGCGTGGCCGTGAAGTGGGATGAAACTATGAAGGACTTCGCCGAGCGTGTGACTTCGACGGATAAGCGCGAGTTTGATGCGGTCTACGAGGACAAGCCCGCCACCTACACCACCGAACAAGCGGAAAGTGCCACCTTCGATGATGTCATTGGTGAGTTCACCACCGGTGGCTTCAGCTCGGCATCGGGAACAAACATTGCCCTGGTGTCGCAGATGGTCAACGGCGCATTCGTGGCGCCGGGCGATACATTCAGTCTGAACGGCTACACGGGTCCGCGCGGTACTGCGCAGGGTTTTGTCGAGTCGGGCATTATCCTCAACGGCCATGCGGATAAGGCTGTCGGTGGTGGCATTAGCCAGTTCGCCACCACTTTGTACAATGCTTCGTACTTTGCGGGCATGGAGGATGTCGCGCACACCCCGCACAGTTACTACATTTCGCGTTACCCGGCCGGCCGTGAGGCGACGGTGTACGAGGGCGCAATCGACCTAGCGTTTAAGAACAGTTCCGACACTCCGATTCTTATCGAGGCCGTTACTACTGGTTCCGACGTCACTGTGCGCATCAAGGGTGTGAAGAAGGTCAACGTCGAGTCCATCAATGGTGGCCGTTGGGCATACACGCAACCACAGCGTATGCAGGTCAGTGGCAGCTCTTGCCAGCCGTCGTCGGGTGCGCAGGGCTTCACCACTTCTGATACACGCGTTATTCGGGACCTCTCGGGCGCGGAAATCTCGCGTGAAACTCAGACTACGGTTTATGACCCGCAGCCAATTGTGTCCTGTGGCTAG,MAVAKQKSSSSHRGLKIFLGIVLGIFALFGVFYAVDYVLNKDHVPRGSTVAGIDISTLSANHAEAKLEEQLGDLSTHPVALRAGERTAEVLPEEAGLSIDWEKTVAQAGKQTANPVTWVRSFFTTRELDLVSDIDNSKFEPQVDRLVGELTIAPVDGEVKLVDGRVETTPPVIGQDVDRNAVSGDLAAKWLSPEGIDVETTAHDPAIGEEQVREAAEGEAADAVSGPIVAKGRDGKDGVIPPERMAEIISFVPRDGGLAADINVDRAREILEEGLAASEVDKRNASIRFSGGAREVVPSVDGVAVKWDETMKDFAERVTSTDKREFDAVYEDKPATYTTEQAESATFDDVIGEFTTGGFSSASGTNIALVSQMVNGAFVAPGDTFSLNGYTGPRGTAQGFVESGIILNGHADKAVGGGISQFATTLYNASYFAGMEDVAHTPHSYYISRYPAGREATVYEGAIDLAFKNSSDTPILIEAVTTGSDVTVRIKGVKKVNVESINGGRWAYTQPQRMQVSGSSCQPSSGAQGFTTSDTRVIRDLSGAEISRETQTTVYDPQPIVSCG,MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVLAEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPELLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGMETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGGEFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSHSLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDEPDGYPVKPREWSK,151.21,gnl|BL_ORD_ID|4748|hsp_num:0,2242,FALSE,None
LK519,5_130 # 142319 # 144013 # -1 # ID=5_130;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.658,5_130,142319,144013,-,Strict,50,78.9518,vanW gene in vanI cluster,33.33,3003724,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanW; glycopeptide resistance gene cluster,GTGACTACGGTAAATGCAACAGGTGCCCGCGGTGGGCGCGGGGTCAGCACCGGGAAGATTCTCCTCGGTGTGCTTCTCGGCGTGCTCGCGGTGCTGCTCGCGATCTACCTCGCCGACCTCGCAATGAACCGCGGGAACGTGCCGCGTGGCACCGCCGTCGGCGGTGTCGAGATCGGCGGCATGAGCCACGACGAGGCCACCGCGAAGCTCGAAGCAGAGCTCGGCGAGACGGCGAGTAACCCGGTGACGGTGAAGGCAGCGACGCAAAGCTCGCAGCTCGTGCCCGCCGAATCCGGCCTCGGCATCGACTGGGAGGCGACCGTAGCAAGCGCGGGCGAAGAGTCCGCGAACCCGTTCACTCGCCTCGCCGGGTTGTTTCGCACACGCGAAGTCGACATTGTGTCGACCGTGAACGAGGCCGCTCTCACCCCGCAGCTTGAGCGAGTGGCCGGCGAGTTGCACCTCGACCCCGCCGACGGCGCGATCGCCATCGACGGTGGCGAGGCGAAAGTGACCGAACCGGTGCCGGGCCAGGAGGTTGACAAAACCGAGCTGTTCGAACGTGTCACCACCGGCTGGCTCAACCCCGACGGTGTGGAGGTCGAGCCGCGCGAGATCGAACCCGCCATCGGCGACCAGGCGATCAAGGAAGCCTTAGACGGGCCGGTTAAGGCGGCGCTGTCCGGCGCCTTGACGCTGCACGGCCGCGACGGCGTCGACGGTGTCATTGCCCAAGAGCGCATCGGCGAGGTCGTCCAGTTCCCCAACGTCGACGGCAAAATCGCCCCCGAGGTGAACGTGGAAAGCGCCCAGGGCATCTTGGGCGAGCAGCTCGCTGCGACCGAGACGCAGATGAAAAACGCGCGCGTGCTGCCCGGCGGCGGGGTGGAACCGTCCGTCGACGGCTCCATTATCGACTGGGAGGCCGCGATGGACGGTTTCGACGAGCGGTTGATCGGTTCCGCCGAGCGCACCTGGGACGCGCAATACAAGGCCCGCCCGGCAGACTTCACTACAGAGGAAGCCCAACGTGCCACCTTCGACCAGGTGGTGGGAAGTTTCACCACCGGCGGGTACAGCGGCGCATCCGGCACGAACATCGCTACGGTGGCCCGCGTTGTCAACGGCGCAATTGTCAACCCCGGTGAAACCTTCTCGCTCAACGGCTACACCGGCGCGCGCGGTGCCGCGCAGGGTTACGTCGAGTCGGTCATCATCGAAAATGGACGCCCCGGCAAGGCAGTGGGTGGCGGAATCTCCCAATTTGCCACGACCTTGTACAACGCGGCTTACTTTGCCGGCATGACGGATGTCGCCTCCACCCCGCACTCCTACTACATCTCACGCTACCCGGCTGGCAGGGAGGCGACCGTGTATGAAGGGGCGATTGACCTGCAATTCCGCAACGATTCGCCCCACCCGGTCAAGATTTCCACGAGCGTCGGGGGCGGCGAGGTGACGGTGAGCCTGATGGGCACCAAGACCGTCGAGGTGGAGTCCATCAACGGAGGGCGCTGGGCCTACACCTCGCCGAAGCCCGTGACCGTCACCAGTGGTGACTGCATTCCCTCGGGCGGGGCGCAGGGCTTTACCACCTCCGATACCCGGATTGTGCGTGACCTCAGCGGCAATGAGATCAGTCGCAACACCTCCACCACGGTCTACGACCCGCAGCCCATCGTGCGCTGCGAATAG,MTTVNATGARGGRGVSTGKILLGVLLGVLAVLLAIYLADLAMNRGNVPRGTAVGGVEIGGMSHDEATAKLEAELGETASNPVTVKAATQSSQLVPAESGLGIDWEATVASAGEESANPFTRLAGLFRTREVDIVSTVNEAALTPQLERVAGELHLDPADGAIAIDGGEAKVTEPVPGQEVDKTELFERVTTGWLNPDGVEVEPREIEPAIGDQAIKEALDGPVKAALSGALTLHGRDGVDGVIAQERIGEVVQFPNVDGKIAPEVNVESAQGILGEQLAATETQMKNARVLPGGGVEPSVDGSIIDWEAAMDGFDERLIGSAERTWDAQYKARPADFTTEEAQRATFDQVVGSFTTGGYSGASGTNIATVARVVNGAIVNPGETFSLNGYTGARGAAQGYVESVIIENGRPGKAVGGGISQFATTLYNAAYFAGMTDVASTPHSYYISRYPAGREATVYEGAIDLQFRNDSPHPVKISTSVGGGEVTVSLMGTKTVEVESINGGRWAYTSPKPVTVTSGDCIPSGGAQGFTTSDTRIVRDLSGNEISRNTSTTVYDPQPIVRCE,MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVLAEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPELLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGMETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGGEFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSHSLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDEPDGYPVKPREWSK,151.21,gnl|BL_ORD_ID|4748|hsp_num:0,2242,FALSE,None
LK871,2_194 # 208264 # 209958 # -1 # ID=2_194;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.658,2_194,208264,209958,-,Strict,50,78.9518,vanW gene in vanI cluster,33.33,3003724,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanW; glycopeptide resistance gene cluster,GTGACTACGGTAAATGCAACAGGTGCCCGCGGTGGGCGCGGGGTCAGCACCGGGAAGATTCTCCTCGGTGTGCTGCTCGGTGTGCTCGCGGTGCTGCTCGCGATCTACCTCGCCGACCTCGCAATGAACCGCGGGAACGTGCCGCGTGGCACCGCCGTCGGCGGTGTCGAGATCGGCGGCATGAGCCAGGACGAGGCCACCGCGAAGCTCGAAGCAGAGCTCGGCGAGACGGCGAGCAACCCCGTGACGGTGAAGGCGGCGACGCAAAGCTCGCAGCTCGTGCCCGCCGAATCCGGCCTCGGCATCGACTGGGAGGCGACCGTAGCAAGCGCGGGCGAAGAGTCCGCGAACCCGTTCACTCGCCTCGCCGGGTTGTTTCGCACCCGCGAAGTCGACATTGTGTCGACCGTGAACGAGGCCGCTCTCACCCCGCAGCTTGAGCGAGTGGCCGGCGAGTTGCACCTCGACCCCGCCGACGGCGCGATCGCCATCGACGGTGGCGAGGCGAAAGTGACCGAACCGGTGCCGGGCCAGGAGGTTGACAAAACCGAGCTGTTCGAACGTGTCACCACCGGCTGGCTCAACCCCGACGGTGTGGAGGTCGAGCCGCGCGAGATCGAACCCGCTATCGGCGACCAGGCGATCAAGGAAGCCTTAGACGGGCCGGTTAAGGCGGCGCTGTCCGGCGCCTTGACGCTGCACGGCCGCGACGGCGTCGACGGTGTCATTGCCCAAGAGCGCATCGGCGAGGTCGTCCAGTTCCCCAACGTCGACGGCAAAATCGCCCCCGAGGTGAACGTGGAAAGCGCCCAGGGCATCTTGGGCGAGCAGCTCGCTGCGACCGAGACGCAGATGAAAAACGCGCGCGTGCTGCCCGGCGGCGGGGTGGAACCGTCCGTCGACGGCTCCATTATCGACTGGGAGGCCGCGATGGACGGTTTCGACGAGCGGTTGATCGGTTCCGCCGAGCGCACCTGGGACGCGCAATACAAGGCCCGCCCGGCAGACTTCACTACAGAGGAAGCCCAACGTGCCACCTTCGACCAGGTGGTGGGAAGTTTCACCACCGGCGGGTACAGCGGCGCATCCGGCACGAACATCGCTACGGTGGCCCGCGTTGTCAACGGCGCAATTGTCAACCCCGGTGAAACCTTCTCGCTCAACGGCTACACCGGCGCGCGCGGTGCCGCGCAGGGTTACGTCGAGTCGGTCATCATCGAAAATGGACGCCCCGGCAAGGCAGTGGGTGGCGGAATCTCCCAATTTGCCACGACCTTGTACAACGCGGCTTACTTTGCCGGCATGACGGATGTCGCCTCCACCCCGCACTCCTACTACATCTCACGCTACCCGGCTGGCAGGGAGGCGACCGTGTATGAAGGGGCGATTGACCTGCAATTCCGCAACGATTCGCCCCACCCGGTCAAGATTTCCACGAGCGTCGGGGGCGGCGAGGTGACAGTGAGCCTGATGGGCACCAAGACCGTCGAGGTGGAGTCCATCAACGGAGGGCGCTGGGCCTACACCTCGCCGAAGCCCGTGACCGTCACCAGTGGTGACTGCATTCCCTCGGGCGGGGCGCAGGGCTTTACCACCTCCGATACCCGGATTGTGCGTGACCTCAGCGGCAATGAGATCAGTCGCAACACCTCCACCACGGTCTACGACCCGCAGCCGATAGTGCGCTGCGAGTAG,MTTVNATGARGGRGVSTGKILLGVLLGVLAVLLAIYLADLAMNRGNVPRGTAVGGVEIGGMSQDEATAKLEAELGETASNPVTVKAATQSSQLVPAESGLGIDWEATVASAGEESANPFTRLAGLFRTREVDIVSTVNEAALTPQLERVAGELHLDPADGAIAIDGGEAKVTEPVPGQEVDKTELFERVTTGWLNPDGVEVEPREIEPAIGDQAIKEALDGPVKAALSGALTLHGRDGVDGVIAQERIGEVVQFPNVDGKIAPEVNVESAQGILGEQLAATETQMKNARVLPGGGVEPSVDGSIIDWEAAMDGFDERLIGSAERTWDAQYKARPADFTTEEAQRATFDQVVGSFTTGGYSGASGTNIATVARVVNGAIVNPGETFSLNGYTGARGAAQGYVESVIIENGRPGKAVGGGISQFATTLYNAAYFAGMTDVASTPHSYYISRYPAGREATVYEGAIDLQFRNDSPHPVKISTSVGGGEVTVSLMGTKTVEVESINGGRWAYTSPKPVTVTSGDCIPSGGAQGFTTSDTRIVRDLSGNEISRNTSTTVYDPQPIVRCE,MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVLAEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPELLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGMETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGGEFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSHSLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDEPDGYPVKPREWSK,151.21,gnl|BL_ORD_ID|4748|hsp_num:0,2242,FALSE,None
LK1049,36_5 # 3126 # 3869 # -1 # ID=36_5;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.778,36_5,3126,3869,-,Strict,50,80.1073,vanY gene in vanF cluster,34.67,3002958,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGTCGCACCCTCCCTCTCGCCGCGCTGGCCGCGCTCGCGCTGCTCGTGGCCGGTTGCGGCACGCCCGCCGCGGGCCCGTCCTCGGCGACGCCGGCTTCCGGCTCCGCGAGCGCGGCCGCGTCGTCCCGCGCCGCCTCGAGCACGGCGCCGTCGTCGAGCACGCACGCCGACCCGGCCGCCCTCGACGTCGTCGTGAACAAGACCCGCCCCGTGGCTCCGCCCGACTGGGCGCCCTCGGATCTGGTGGCCGTGCCCGGCAGCGAGCTGTCCCTGCGGGCGGAGGCCGCGACGGCGGCCGGTGACCTGCTGGATGCCGCCGCGGCGGCGGGCCACCGCCTCACCACCCTGAGCGCCTACCGCTCGTACGACTACCAGGTCCGGACGTACGGCCACTGGGTCGACGAGCTGGGCCGCGCCGAGGCCGACCGCGTCTCGGCGCGTCCGGGGTACTCCGAGCACCAGACCGGCCTGGCCTGGGACGTGGGCGACGCCGCGACCCCCGCGTGTGACCTGGAAGCGTGCTTCGGCGACACCGCCGCGGGCCGCTGGGTGGCCGCGCACGCCGCCGAGCACGGGTTCGTCATCCGCTACCCCGGCGGGGCCGAGGACGTGACGGGCTTCGCCCACGAGCCCTGGCACCTGCGCTATGTCGGGTCCGCGGAGGCGGCCCGGGTCGAGGCGGTCGGCGGCGTCCTCGAGACCGCATGGGGCCTGCCTCCGGCGCCGGACTACGCGGACTGA,MRRTLPLAALAALALLVAGCGTPAAGPSSATPASGSASAAASSRAASSTAPSSSTHADPAALDVVVNKTRPVAPPDWAPSDLVAVPGSELSLRAEAATAAGDLLDAAAAAGHRLTTLSAYRSYDYQVRTYGHWVDELGRAEADRVSARPGYSEHQTGLAWDVGDAATPACDLEACFGDTAAGRWVAAHAAEHGFVIRYPGGAEDVTGFAHEPWHLRYVGSAEAARVEAVGGVLETAWGLPPAPDYAD,MKKWGLLLVFALFLVFIFNILPISQDKVEDRIYEQNDKDTSDDKMTAENMQKIELTEEQIYQGNLLLVNNEHPVHQKSIKSDIINLFTHKELTKGYGLLDNEIKLSEEIAGKFSEMIAAAEEDGVSNFLISSGYRDLDEQSRLYEEMGSDFALPAGHSEHNLGLSLDVGSTQMKMDKAPEGKWIEKNCWEYGFILRYPLDKTDVTGIQYEPWHIRYVGLPHSAIMQEMNLALEEYLDYLKEEKSISVRVDGKKYTISYDPISQNETIEVEVPADEQYEISGNNIDGVIVTTFS,84.3,gnl|BL_ORD_ID|1808|hsp_num:0,1899,FALSE,None
LK1173,62_8 # 8907 # 9650 # 1 # ID=62_8;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.774,62_8,8907,9650,+,Strict,50,82.8037,vanY gene in vanA cluster,35.33,3002955,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGTCGCACCCTCCCTCTCGCCGCGCTGGCCGCGCTCGCGCTGCTCGTGGCCGGTTGCGGCACGCCCGCCGCGGGCCCGTCCTCGGCGACGCCGGCTTCCGGCTCCTCGAGCGCGGCCGCGTCGTCCCGCGCCGCCTCGAGCACGGCGCCGTCGTCGGGCACGCACGCCGACCCGGCCGCCCTCGACGTCGTCGTGAACAAGACCCGCCCCGTGGCCCCGCCCGACTGGGCGCCCTCGGATCTGGTGGCCGTGCCCGGCAGCGAGCTGCCCCTGCGGGCGGAGGCCGCGACGGCGGCCGGTGACCTGCTGGATGCCGCCGCGGCGGCGGGTCACCGCCTCACCACCCTGAGCGCCTACCGCTCGTACGACTACCAGGTCCGGACGTACGGCCACTGGGTCGACGAGCTGGGCCACGCCGAGGCCGACCGCGTCTCCGCTCGTCCGGGGTACTCCGAGCACCAGACCGGCCTGGCCTGGGACGTGGGCGACGCCGCGACCCCCGCGTGTGACCTGGAAGCGTGCTTCGGCGACACCGCCGCGGGCCGTTGGGTGGCCGCGCACGCCGCCGAGTACGGGTTCGTCATCCGCTATCCCGCCGGAGCCGAGGACGTGACGGGCTTCGCCCACGAGCCCTGGCATCTGCGCTACGTCGGGTCCGCGGAGGCGGCCCGGGTCGAGGCGGCCGGCGGCGTCCTCGAGACCGCGCGGGGTCTGCCGCCGGCGCCGGACTACGCGGACTGA,MRRTLPLAALAALALLVAGCGTPAAGPSSATPASGSSSAAASSRAASSTAPSSGTHADPAALDVVVNKTRPVAPPDWAPSDLVAVPGSELPLRAEAATAAGDLLDAAAAAGHRLTTLSAYRSYDYQVRTYGHWVDELGHAEADRVSARPGYSEHQTGLAWDVGDAATPACDLEACFGDTAAGRWVAAHAAEYGFVIRYPAGAEDVTGFAHEPWHLRYVGSAEAARVEAAGGVLETARGLPPAPDYAD,MKKLFFLLLLLFLIYLGYDYVNEALFSQEKVEFQNYDQNPKEHLENSGTSENTQEKTITEEQVYQGNLLLINSKYPVRQESVKSDIVNLSKHDELINGYGLLDSNIYMSKEIAQKFSEMVNDAVKGGVSHFIINSGYRDFDEQSVLYQEMGAEYALPAGYSEHNSGLSLDVGSSLTKMERAPEGKWIEENAWKYGFILRYPEDKTELTGIQYEPWHIRYVGLPHSAIMKEKNFVLEEYMDYLKEEKTISVSVNGEKYEIFYYPVTKNTTIHVPTNLRYEISGNNIDGVIVTVFPGSTHTNSRR,81.52,gnl|BL_ORD_ID|4669|hsp_num:0,89,FALSE,None
LK402,83_4 # 4106 # 4855 # 1 # ID=83_4;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.776,83_4,4106,4855,+,Strict,50,83.9593,vanY gene in vanM cluster,34.46,3002961,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGTCGCACCCTCCCTCTCGCCGCGCTGGCCGCGCTCGCGCTGCTCGTGGCCGGTTGCGGCACGCCCGCCGCGGGCCCGTCCTCGACGCCGACGACGCCGACGTCCGGCTCCGCGAGCGCGGCCGCGTCGTCCGGCGCCGCCTCGAGCACGGCGCCGTCGTCGGGCACGCACGCCGACCCGGCCACCCTCGACGTCGTCGTGAACAAGACCCGCCCCGTGGCCCCGCCCGACTGGGCGCCCTCGGATCTGGTGGCCGTGCCCGGCAGCGAGCTGTCCCTGCGGGCGGCGGCCGCGACGGCGGCCGGTGACCTGCTGGATGCCGCCGCGGCGGCGGGCCACCGCCTCACCACCCTGAGCGCCTACCGCTCGTACGACTACCAGGTCCGGACGTACGGCCACTGGGTCGACGAGCTGGGCCGCGCCGAGGCCGACCGCGTCTCGGCGCGTCCGGGGTACTCCGAGCACCAGACCGGCCTGGCCTGGGACGTGGGCGACGCCGCGACCCCCGCGTGTGACCTGGAAGCGTGCTTCGGCGACACCGCCGCGGGCCGCTGGGTGGCCGCGCACGCCGCCGAGTACGGGTTCGTCATCCGCTATCCCGTCGGGGCCGAGGACGTGACGGGCTTCGCCCACGAGCCCTGGCACCTGCGCTACGTCGGGTCCGCGGAGGCGGCCCGGGTCGAGGCGGCCGGCGGCGTCCTCGAGACCGCGTGGGGTCTGCCTCCGGCACCCGACTACGCGGACTGA,MRRTLPLAALAALALLVAGCGTPAAGPSSTPTTPTSGSASAAASSGAASSTAPSSGTHADPATLDVVVNKTRPVAPPDWAPSDLVAVPGSELSLRAAAATAAGDLLDAAAAAGHRLTTLSAYRSYDYQVRTYGHWVDELGRAEADRVSARPGYSEHQTGLAWDVGDAATPACDLEACFGDTAAGRWVAAHAAEYGFVIRYPVGAEDVTGFAHEPWHLRYVGSAEAARVEAAGGVLETAWGLPPAPDYAD,MVFQGNLLLVNNEYPVLEESIKTDVVNLFKHDELTKGYELLNREIYLSEKVAREFSEMVDAAEKEGVRHFSINSGFRNFDEQNALYQEMGSDYALPAGYSEHNLGLALDIGSTQMEMSEAPEGKWLEDNAWEYGFILRYPMDKTAITGIQYEPWHFRYVGLPHSAIIEEKNFALEEYLDFLKEQKSISGTIHGENYEISYYPITEKTDIEMPANLHYEISGNNMDGVIVTVYR,106.87,gnl|BL_ORD_ID|1673|hsp_num:0,1713,FALSE,None
LK1384,87_4 # 4156 # 4905 # 1 # ID=87_4;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.777,87_4,4156,4905,+,Strict,50,83.5741,vanY gene in vanM cluster,34.46,3002961,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGTCGCACCCTCCCTCTCGCCGCGCTGGCCGCGCTCGCGCTGCTCGCGGCCGGTTGCGGCACGCCCGCCGCGGGCCCGTCCTCGACGCCGACGACGCCGACGTCCGGCTCCGCGAGCGCGGCCGCGTCGTCCCGCGCCGCCTCGAGCACGGCGCCGTCGTCGGGCACGCACGCCGACCCGGCCACCCTCGACGTCGTCGTGAACAAGACCCGCCCCGTGGCCCCGCCCGACTGGGCGCCCTCGGATCTGGTGGCCGTGCCCGGCAGCGAGCTGCCCCTGCGGGCGGAGGCCGCGACGGCGGCCGCTGACCTGCTGGATGCCGCCGCGGCGGCGGGCCACCGCCTCACCACCCTGAGCGCCTACCGCTCGTACGACTACCAGGTCCGGACGTACGGCCACTGGGTCGACGAGCTGGGCCGCGCCGAGGCCGACCGCGTCTCCGCGCGTCCGGGGTACTCCGAGCACCAGACCGGCCTGGCCTGGGACGTGGGCGACGCCGCGACCCCCGCGTGTGACCTGGAAGCGTGCTTCGGCGACACCGCCGCGGGCCGTTGGGTGGCCGCGCACGCCGCCGAGTACGGGTTCGTCATCCGCTATCCCGCCGGGGCCGAGGACGTGACGGGCTTCGATCACGAGCCGTGGCACCTGCGCTACGTCGGGTCCGCGGAGGCGGCCCGGGTCGAGGCGGCCGGCGGCGTCCTCGAGACCGCGTGGGGTCTGCCGCCGGCGCCGGACTACGCGGACTGA,MRRTLPLAALAALALLAAGCGTPAAGPSSTPTTPTSGSASAAASSRAASSTAPSSGTHADPATLDVVVNKTRPVAPPDWAPSDLVAVPGSELPLRAEAATAAADLLDAAAAAGHRLTTLSAYRSYDYQVRTYGHWVDELGRAEADRVSARPGYSEHQTGLAWDVGDAATPACDLEACFGDTAAGRWVAAHAAEYGFVIRYPAGAEDVTGFDHEPWHLRYVGSAEAARVEAAGGVLETAWGLPPAPDYAD,MVFQGNLLLVNNEYPVLEESIKTDVVNLFKHDELTKGYELLNREIYLSEKVAREFSEMVDAAEKEGVRHFSINSGFRNFDEQNALYQEMGSDYALPAGYSEHNLGLALDIGSTQMEMSEAPEGKWLEDNAWEYGFILRYPMDKTAITGIQYEPWHFRYVGLPHSAIIEEKNFALEEYLDFLKEQKSISGTIHGENYEISYYPITEKTDIEMPANLHYEISGNNMDGVIVTVYR,106.87,gnl|BL_ORD_ID|1673|hsp_num:0,1713,FALSE,None
LK478,25_28 # 32850 # 33104 # -1 # ID=25_28;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.682,25_28,32850,33104,-,Strict,1900,22.3274,MuxC,100,3004075,protein homolog model,n/a,n/a,macrolide antibiotic; monobactam; tetracycline antibiotic; aminocoumarin antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGGCACACAAGAAGGGTGCGAGCTCCACTCGCAACGGCCGTGACTCCAACGCCCAGTACTTGGGTGTGAAGCGCTTCGGCGGCCAGTCCGTCAACGCCGGCGAGATCATCGTCCGCCAGCGTGGCACGCACTTCCACCCGGGCGTGAACGTGGGCCGCGGCAAGGACGACACCTTGTTCGCCCTGGCCGCCGGCGCCGTCGAATTCGGCACCCGCCGCGGTCGCCGCGTGGTCAACATCCAGACCGCCGAGTAA,MAHKKGASSTRNGRDSNAQYLGVKRFGGQSVNAGEIIVRQRGTHFHPGVNVGRGKDDTLFALAAGAVEFGTRRGRRVVNIQTAE,MSLSTPFIRRPVATTLLTLALLLAGTLSFGLLPVAPLPNVDFPAIVVSASLPGASPETMASSVATPLERSLGRIAGISEMTSSSSLGSTTVVLVFDLEKDIDGAAREVQAAINGAMSLLPSGMPNNPSYRKANPSDMPIMVLTLTSETQSRGEMYDLASTVLAPKLSQVQGVGQVSIGGSSLPAVRVDLNPDAMSQYGLSLDSVRTAIAAANSNGPKGAVEKDDKHWQVDANDQLRKAREYEPLVIHYNADNGAAVRLGDVAKVSDSVEDVRNAGFSDDLPAVLLIVTRQPGANIIEATDAIHAQLPVLQELLGPQVKLNVMDDRSPSIRASLEEAELTLLISVALVILVVFLFLRNGRATLIPSLAVPVSLIGTFAVMYLCDFSLNNLSLMALIIATGFVVDDAIVVVENIARRIEEGDPPIQAAITGARQVGFTVLSMTLSLVAVFIPLLLMGGLTGRLFREFAVTLSAAILVSLVVSLTLTPMLCARLLRPLKRPEGASLARRSDRFFAAFMLRYRASLGWALEHSRLMVVIMLACIAMNLWLFVVVPKGFLPQQDSGRLRGYAVADQSISFQSLSAKMGEYRKILSSDPAVENVVGFIGGGRWQSSNTGSFFVTLKPIGERDPVEKVLTRLRERIAKVPGAALYLNAGQDVRLGGRDSNAQYEFTLRSDDLTLLREWAPKVEAAMRKLPQLVDVNSDSQDKGVQTRLVIDRDRAATLGINVEMVDAVLNDSFGQRQVSTIFNPLNQYRVVMEVDQQYQQSPEILRQVQVIGNDGQRVPLSAFSHYEPSRAPLEVNHQGQFAATTLSFNLAPGAQIGPTREAIMQALEPLHIPVDVQTSFEGNAGAVQDTQNQMPWLILLALLAVYIVLGILYESYVHPLTILSTLPSAGVGALLALILCRSELSLIALIGIILLIGIVKKNAIMMIDFALEAERNHGLSPREAILEACMMRFRPIMMTTLAALLGALPLIFGIGGDAALRRPLGITIVGGLIGSQLLTLYTTPVVYLYLDRLRHWVNQKRGVRTDGALETPL,8.11,gnl|BL_ORD_ID|2369|hsp_num:0,2720,TRUE,loose hit with at least 95 percent identity pushed strict
LK478,37_30 # 23618 # 24046 # -1 # ID=37_30;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.671,37_30,23618,24046,-,Strict,50,55.8398,vanW gene in vanB cluster,40.28,3002964,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanW; glycopeptide resistance gene cluster,ATGGGACGCAAACTCTTCTCGGAGATCTCCCCTCTGACGTACCGGATCGCGGTGGAGCGTCAGAGATGGCAGCGCCGCGCCAAGGACCTCGGCAGACGCGGGGCGTTCGCCGCCGAGCGTTCGTCCCAGGACCTGCCCGTGAAGGTCTACCGTCACACCTCACTCATCCGGCGCACGCTCGGCAACACCGAGCTGGACCTGCAGGAGGGCAAGGCGCGCTCGCTGGAACTGTCCGCGCCGCTCGTGGACGGGATCGTGATCCGCCCGGGGCAGACGTTCTCCTTCTGGCGGCTCGTCGGCAATCCCACGCGTTCCCGCGGATACCTGCCGGGTGTGGTGATCAACGGTGACCACGCGGACGTGGGGATCGGCGGAGCATGTGCCAGTTCACCAACCTGCTGCACTGGATGGCGCTGCACTCACCACTGA,MGRKLFSEISPLTYRIAVERQRWQRRAKDLGRRGAFAAERSSQDLPVKVYRHTSLIRRTLGNTELDLQEGKARSLELSAPLVDGIVIRPGQTFSFWRLVGNPTRSRGYLPGVVINGDHADVGIGGACASSPTCCTGWRCTHH,MNRKRLTQRFPFLLPMRQAQRKICFYAGMRFDGCCYAQTIGEKTLPYLLFETDCALYNHNTGFDMIYQENKVFNLKLAAKTLNGLLIKPGETFSFWRLVRHADKDTPYKDGLTVANGKLTTMSGGGMCQMSNLLFWVFLHTPLTIIQRSGHVVKEFPEPNSDEIKGVDATISEGWIDLKVRNDTDCTYQIWVTLDDEKIIGQVFADKQPQALYKIANGSIQYVRESGGIYEYAKVERMQVALGTGEIIDCKLLYTNKCKICYPLPESVDIQEANQ,51.64,gnl|BL_ORD_ID|4680|hsp_num:0,1036,FALSE,None
LK478,48_8 # 7969 # 8949 # -1 # ID=48_8;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.728,48_8,7969,8949,-,Strict,50,100.138,vanY gene in vanA cluster,33.95,3002955,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGAACCGTCACGCGTCGCCCGGCCCTGCTCACCGCCCTGTTGGCCGCGCTGCTGCTCGTGGGCGGCATGGCGCCGGCCCACGCCGGGGCGGGGATCGACAACGAGTACCGCGCCCTGCCGAATCCCGGCGCGTGGTTGGGTAAGCCCACGTCCGCCGAACGTTGTGGCCTGCGGGACCGCGGCTGCTACCGGCAGTACCAGAAGGGCACGATCCACTGGACGCCCGCCACCGGCGCGCGGGCCCAGCGCGGCGGGATCCTGGCGAAATGGCGCGCGGAGGGATCCGAGCACGGTGCGCTGGGGTACCCCGTGACGCGGGAGAGGTGCTCGGGCGGTACGTGCGAGGTCCGCTACCAGCGCGGCCGGATCACGTGGACCGCCCAGGGTGGCGCCCGGGTCCACCGGGACATCGACAACGCCCGCAGCGTGTCCGTGGTCGTGAACAAGAAGCGCCCGCTGTCCCCGCGCAATCACGCCCCGGCCCCCCTGCGGTCGGTGGGCGGGGGAGTCCTGCTGCGCGACGACGCCGCGGCGGCCTATCAGCGCATGAGCCGGGCCGCGGCCGCCCAGGGCATCACGCTGGTGCCGGTGAGCGGGTACCGCGACTACAGCACGCAAGCGCGCCTCTACCGTGAGTACACGGCCCTGTACGGACAGGCCACGGCGGACACCATTTCCGCGCGGCCCGGTCACTCGGAACACCAGACCGGTCTGGCGATCGACGTGGGTGCCCCCGGGGCCACCTGCGGCCTGCTCCCGTGCTTCGGCACCACCCCGCAGGGCAGGTGGGTCGCCGCGAACGGGCACACCTACGGGTTCGTGGTGCGCTACCCGAACGGACACACCGCGACCACGGGCTACGCCTACGAACCATGGCACCTGCGCTACGTGGGACCCACCACGGCCAGGAGCGTGAAGAACAGCGGCTCGGCCACGCTGGAGTCCTACATGGGTCTGCCCCGGGCACCGAGGTACTGA,MRTVTRRPALLTALLAALLLVGGMAPAHAGAGIDNEYRALPNPGAWLGKPTSAERCGLRDRGCYRQYQKGTIHWTPATGARAQRGGILAKWRAEGSEHGALGYPVTRERCSGGTCEVRYQRGRITWTAQGGARVHRDIDNARSVSVVVNKKRPLSPRNHAPAPLRSVGGGVLLRDDAAAAYQRMSRAAAAQGITLVPVSGYRDYSTQARLYREYTALYGQATADTISARPGHSEHQTGLAIDVGAPGATCGLLPCFGTTPQGRWVAANGHTYGFVVRYPNGHTATTGYAYEPWHLRYVGPTTARSVKNSGSATLESYMGLPRAPRY,MKKLFFLLLLLFLIYLGYDYVNEALFSQEKVEFQNYDQNPKEHLENSGTSENTQEKTITEEQVYQGNLLLINSKYPVRQESVKSDIVNLSKHDELINGYGLLDSNIYMSKEIAQKFSEMVNDAVKGGVSHFIINSGYRDFDEQSVLYQEMGAEYALPAGYSEHNSGLSLDVGSSLTKMERAPEGKWIEENAWKYGFILRYPEDKTELTGIQYEPWHIRYVGLPHSAIMKEKNFVLEEYMDYLKEEKTISVSVNGEKYEIFYYPVTKNTTIHVPTNLRYEISGNNIDGVIVTVFPGSTHTNSRR,107.59,gnl|BL_ORD_ID|4669|hsp_num:0,89,FALSE,None
LK434,1_858 # 982540 # 984234 # -1 # ID=1_858;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.594,1_858,982540,984234,-,Strict,50,88.5817,vanW gene in vanI cluster,35.06,3003724,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanW; glycopeptide resistance gene cluster,GTGGCTGTGGCCAAACAAAAGTCTTCCTCCAGTCACCGCGGATTAAAGATTTTCCTCGGCATCGTCCTCGGTATCTTCGCGCTCTTCGGTGTGTTTTACGCTGTCGATTACGTGCTGAATAAGGACCATGTCCCGCGCGGGTCTACCGTTGCGGGGATTGACATCAGCACGCTGAGCGCGAACCACGCTGAGGCGAAGCTCGAAGAACAGCTCGGTGATCTTTCCACTCATCCAGTGGCGTTGCGTGCCGGCGAGCGCGCGGCGGAGGTTCTGCCCGAGGAGGCGGGGCTGAGCATCGACTGGGAGAAGACGGTCGCTCAGGCGGGCAAGCAGACGGCGAACCCAGTTACCTGGGTGCGCAGTTTCTTTACTACCCGTGAGCTGGATTTGGTCAGCGATATCGATAGCTCTAAGTTCGAACCGCAGGTCGACCGTCTCGTCGGCGAACTGACTATTGCTCCCGTCGATGGCGAGGTCAAGCTTGTTGACGGCCGCGTGGAAACAACTCCACCGGTCATCGGCCAAGATGTCGACCGCAATGCGGTCAGCGGGGATTTGGCCGCCAAGTGGTTGTCGCCGGAGGGCATCGATGTGGAGACCACCGCGCACGACCCGGCTATCGGTGAAGATCAGGTTCGTGAGGCAGCTGAGGGAGAGGCCGCCGATGCCGTGTCGGGTCCGATTGTTGCCAAGGGCCGCGATGGCAAAGATGGTGTAATTCCTCCGGAGCGCATGGCTGAGATCATCAGCTTTGTGCCGCGCGACGGCGGATTGGCCGCCGATATCAATGTCGACCGCGCACGCGAGATCCTCGAGGAGGGGCTGGCTGCTTCCGAGGTTGATAAGCGCAATGCGTCGATACGCTTCAGCGGTGGTTCGCGTGAAGTGGTCCCCTCAGTTGATGGCGTAGCCGTGAAGTGGGATGAAACTATGAAGGACTTCGCCGAGCGTGTGACTTCGACGGATAAGCGCGAGTTCGATGCGGTCTACGAGGACCAGCCCGCCACCTACACCACTGAACAAGCGGAAAGTGCGACCTTCGATGATGTCATTGGTGAGTTCACCACCGGTGGTTTCAGCTCGGCATCGGGAACAAACATTGCCCTGGTGTCTCAGATGGTCAACGGCGCATTCGTGGCGCCGGGCGATACATTCAGCCTGAACGGCTACACGGGGCCGCGCGGTACTGCGCAGGGCTTTGTCGAGTCGGGCATCATCCTCAACGGCCATGCGGACAAGGCTGTCGGCGGTGGCATTAGCCAGTTCGCCACTACTTTGTACAATGCTTCGTACTTTGCGGGCATGGAGGATGTCGCGCACACTCCGCACAGTTACTACATTTCGCGTTACCCGGCCGGCCGTGAAGCGACGGTGTACGAGGGCGCAATCGACCTGGCGTTTAAGAACAGTTCCGACACTCCGATTCTTATCGAGGCCGTTACTACTGGCTCCGACGTCACTGTGCGCATCAAGGGCGTGAAGCGGGTCAACGTCGAGTCCATCAATGGTGGCCGTTGGGCATACACGCAACCGCAGCGCATGCAGGTCAGTGGCAGCTCTTGCCAGCCGTCGTCGGGTGCGCAGGGTTTTACCACTTCCGACACACGCGTCATTCGGAACCTCTCTGGCGCGGAAATCTCGCGTGAAACTCAGACTACGGTTTATGACCCGCAGCCAATTGTGTCCTGTGGCTAG,MAVAKQKSSSSHRGLKIFLGIVLGIFALFGVFYAVDYVLNKDHVPRGSTVAGIDISTLSANHAEAKLEEQLGDLSTHPVALRAGERAAEVLPEEAGLSIDWEKTVAQAGKQTANPVTWVRSFFTTRELDLVSDIDSSKFEPQVDRLVGELTIAPVDGEVKLVDGRVETTPPVIGQDVDRNAVSGDLAAKWLSPEGIDVETTAHDPAIGEDQVREAAEGEAADAVSGPIVAKGRDGKDGVIPPERMAEIISFVPRDGGLAADINVDRAREILEEGLAASEVDKRNASIRFSGGSREVVPSVDGVAVKWDETMKDFAERVTSTDKREFDAVYEDQPATYTTEQAESATFDDVIGEFTTGGFSSASGTNIALVSQMVNGAFVAPGDTFSLNGYTGPRGTAQGFVESGIILNGHADKAVGGGISQFATTLYNASYFAGMEDVAHTPHSYYISRYPAGREATVYEGAIDLAFKNSSDTPILIEAVTTGSDVTVRIKGVKRVNVESINGGRWAYTQPQRMQVSGSSCQPSSGAQGFTTSDTRVIRNLSGAEISRETQTTVYDPQPIVSCG,MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVLAEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPELLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGMETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGGEFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSHSLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDEPDGYPVKPREWSK,151.21,gnl|BL_ORD_ID|4748|hsp_num:0,2242,FALSE,None
LK408,23_26 # 27053 # 27796 # 1 # ID=23_26;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.786,23_26,27053,27796,+,Strict,50,83.5741,vanY gene in vanF cluster,31.72,3002958,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGTCGCCCCCTCCCCCTCGCCGCGCTGGCCGCGCTCGCGCTGCTCGCGGCCGGCTGCGGCACGCCCGCCGCGGGCCCGTCCCCGGCGACGCCGGCTTCCGGCTCCTCGAGCGCGGCCGCGTCGTCCGGCGCCGCCTCGAGCGCGGCGCCGTCGTCGAGCACGCACGCCGACCCGGCCGCCCTCGACGTCGTCGTGAACAAGACCCGCCCCGTGGCCCCGCCCGACTGGGCGCCCTCGGATCTGGTGGCCGTGCCCGGCAGCGAGCTGCCCCTGCGGGCGGAGGCCGCGACGGCGGCCGGTGACCTGCTGGGTGCGGCCGCGGCGGCGGGCCACGACCTCACCACCCTGAGCGCCTACCGCTCGTACGACTACCAGGTCCGGACGTACGGCCGCTGGGTCGACGAGCTGGGCCGCGCCGAGGCCGACCGCGTCTCGGCGCGTCCGGGGTACTCCGAGCACCAGACCGGCCTGGCCTGGGACGTGGGCGACGCCGCGACCCCCGCGTGTGACCTGGAGGCGTGCTTCGGCGACACCGCCGCGGGCCGCTGGGTGGCCGCGCACGCCGCCGAGTACGGGTTCGTCATCCGCTATCCCGCCGGGGCCGAGGACGTGACGGGCTTCGACCACGAGCCCTGGCACCTGCGCTACGTCGGGTCCACGGAGGCGGCCCGGGTCGAGGCGGCCGGCGGCGTCCTCGAGACCGCGTGGGGTCTGCCTCCGGCGCCCGACTACGCGGACTGA,MRRPLPLAALAALALLAAGCGTPAAGPSPATPASGSSSAAASSGAASSAAPSSSTHADPAALDVVVNKTRPVAPPDWAPSDLVAVPGSELPLRAEAATAAGDLLGAAAAAGHDLTTLSAYRSYDYQVRTYGRWVDELGRAEADRVSARPGYSEHQTGLAWDVGDAATPACDLEACFGDTAAGRWVAAHAAEYGFVIRYPAGAEDVTGFDHEPWHLRYVGSTEAARVEAAGGVLETAWGLPPAPDYAD,MKKWGLLLVFALFLVFIFNILPISQDKVEDRIYEQNDKDTSDDKMTAENMQKIELTEEQIYQGNLLLVNNEHPVHQKSIKSDIINLFTHKELTKGYGLLDNEIKLSEEIAGKFSEMIAAAEEDGVSNFLISSGYRDLDEQSRLYEEMGSDFALPAGHSEHNLGLSLDVGSTQMKMDKAPEGKWIEKNCWEYGFILRYPLDKTDVTGIQYEPWHIRYVGLPHSAIMQEMNLALEEYLDYLKEEKSISVRVDGKKYTISYDPISQNETIEVEVPADEQYEISGNNIDGVIVTTFS,84.3,gnl|BL_ORD_ID|1808|hsp_num:0,1899,FALSE,None
LK1093,1_57 # 48814 # 48972 # -1 # ID=1_57;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.730,1_57,48814,48972,-,Strict,400,22.7126,Erm(35),100,3000604,protein homolog model,n/a,n/a,macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic,antibiotic target alteration,Erm 23S ribosomal RNA methyltransferase,GTGGGCCTCGTCCTGGCGGTGATCTGGGAGCTCATGGAGGCCGCGGGATCCGTGCTGGTCACCCCCGAGATCCACAACCCGCCCCTGGACACCGTGCTGGACATCGGCGCGGGGATGATCGGCGCGGCCATGGTGGGGCTGCGCCGCCGCCCGCTATGA,MGLVLAVIWELMEAAGSVLVTPEIHNPPLDTVLDIGAGMIGAAMVGLRRRPL,MTKKKLPVRFTGQHFTIDKVLIKDAIKESNINQHDTVLDIGAGKGFLTVHLLKNVDKVIAIENDVALSQHLRKKFIHAQNVQVVSCDYRNFVVPKVPFKVVSNIPFGITSDIFSSLMFENVEYFLCGSIILQSEPAKKLFSSKVYNPLTVLYHTYYDLKFLYEINPESFLPPPTVKSALLRIERKQISLDIGLKVKYLNFVSYMLQKPDLTVKTAMKSIFRKKQVRSISEKFGVDLNSKIVCLTPNQWKNCFLEMLEVVPEKFHPS,19.55,gnl|BL_ORD_ID|1315|hsp_num:0,1434,TRUE,loose hit with at least 95 percent identity pushed strict
LK1093,15_18 # 21766 # 22023 # 1 # ID=15_18;partial=00;start_type=ATG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.682,15_18,21766,22023,+,Strict,1900,22.3274,MuxC,100,3004075,protein homolog model,n/a,n/a,macrolide antibiotic; monobactam; tetracycline antibiotic; aminocoumarin antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGGCACATAAGAAGGGCGCAAGCTCCACCCGCAACGGCCGCGACTCCAACGCCCAGTACCTGGGCGTCAAGCGCTTCGGCGGCGAGTCCGTCAACGCCGGCTCGATCATCGTGCGTCAGCGCGGCACCCACTTCCACCCTGGTGAGAACGTGGGCCGCGGCAAGGACGACACCCTGTTCGCCCTGGCCACCGGCGAGGTGGCCTTCGGGACCAAGCGCGGCCGCAAGGTCGTCAACGTCCTCGCAGCGGCTGAGTGA,MAHKKGASSTRNGRDSNAQYLGVKRFGGESVNAGSIIVRQRGTHFHPGENVGRGKDDTLFALATGEVAFGTKRGRKVVNVLAAAE,MSLSTPFIRRPVATTLLTLALLLAGTLSFGLLPVAPLPNVDFPAIVVSASLPGASPETMASSVATPLERSLGRIAGISEMTSSSSLGSTTVVLVFDLEKDIDGAAREVQAAINGAMSLLPSGMPNNPSYRKANPSDMPIMVLTLTSETQSRGEMYDLASTVLAPKLSQVQGVGQVSIGGSSLPAVRVDLNPDAMSQYGLSLDSVRTAIAAANSNGPKGAVEKDDKHWQVDANDQLRKAREYEPLVIHYNADNGAAVRLGDVAKVSDSVEDVRNAGFSDDLPAVLLIVTRQPGANIIEATDAIHAQLPVLQELLGPQVKLNVMDDRSPSIRASLEEAELTLLISVALVILVVFLFLRNGRATLIPSLAVPVSLIGTFAVMYLCDFSLNNLSLMALIIATGFVVDDAIVVVENIARRIEEGDPPIQAAITGARQVGFTVLSMTLSLVAVFIPLLLMGGLTGRLFREFAVTLSAAILVSLVVSLTLTPMLCARLLRPLKRPEGASLARRSDRFFAAFMLRYRASLGWALEHSRLMVVIMLACIAMNLWLFVVVPKGFLPQQDSGRLRGYAVADQSISFQSLSAKMGEYRKILSSDPAVENVVGFIGGGRWQSSNTGSFFVTLKPIGERDPVEKVLTRLRERIAKVPGAALYLNAGQDVRLGGRDSNAQYEFTLRSDDLTLLREWAPKVEAAMRKLPQLVDVNSDSQDKGVQTRLVIDRDRAATLGINVEMVDAVLNDSFGQRQVSTIFNPLNQYRVVMEVDQQYQQSPEILRQVQVIGNDGQRVPLSAFSHYEPSRAPLEVNHQGQFAATTLSFNLAPGAQIGPTREAIMQALEPLHIPVDVQTSFEGNAGAVQDTQNQMPWLILLALLAVYIVLGILYESYVHPLTILSTLPSAGVGALLALILCRSELSLIALIGIILLIGIVKKNAIMMIDFALEAERNHGLSPREAILEACMMRFRPIMMTTLAALLGALPLIFGIGGDAALRRPLGITIVGGLIGSQLLTLYTTPVVYLYLDRLRHWVNQKRGVRTDGALETPL,8.2,gnl|BL_ORD_ID|2369|hsp_num:0,2720,TRUE,loose hit with at least 95 percent identity pushed strict
LK1093,34_18 # 22611 # 23363 # 1 # ID=34_18;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.708,34_18,22611,23363,+,Strict,50,85.8853,vanY gene in vanG cluster,30.92,3002959,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGACCACCCCCCTCCCCCGCCGCCTGGCCGCCTCCGTCACCCTGCTGGGCCTTCTGGGCCTCTCGGCATGCGGATCCGAGCAGCCGCAGGAGGACTCCAGCAGCTCCGCCGCCGCGGACTCCGCCCAGAGCGGCGGCGCGGAGGCAGAAGCTGAATCCGGCGCGGCCGCCGTGTCCGACGCCGACGTCGACACCTCCACCTCGACCGATGTGGTCGTCAACAAGGCGCGCCCGCTGGATCCGGAGGACTACGCCCCGGAGCCGCTCGAGGACATCGAGGGCCAGCAGCTGCGCGAGGACGCAGCCGGAGCCGCCCAGCAGATGCTCTCGGACATGCGAGACGAGGGCATCACCGTGAGCATCACCTCGGCCTACCGCCCCTACGACGAGCAGGTCACCACCTATCAGCACTGGGTCGACGTCAACGGCCAGGAGACCGCCGACACCATCTCGGCCCGCCCCGGGCACTCGGAGCACCAGACGGGTCTGGTCATGGACATCGCCGACGGCTCCGGCTGCGACCTGCAGGAGTGCTTCGCCGACACGGCAGCGGCCCAGTGGGCCGCCGAGCACGCGCAGGACTACGGATTCGTGCTGCGCTACCCCCAGGACGGCGAGGACGTCACGGGCTACGCCTACGAGCCCTGGCACTTCCGCTACATCGGCGAGGAGCGCGCCCAGGAGTTCGCCGACTCCGGAGCTGCCACGCTCGAGGAGTTCTACGGAACGGGCCCCGCACCGGACTACTCCTGA,MTTPLPRRLAASVTLLGLLGLSACGSEQPQEDSSSSAAADSAQSGGAEAEAESGAAAVSDADVDTSTSTDVVVNKARPLDPEDYAPEPLEDIEGQQLREDAAGAAQQMLSDMRDEGITVSITSAYRPYDEQVTTYQHWVDVNGQETADTISARPGHSEHQTGLVMDIADGSGCDLQECFADTAAAQWAAEHAQDYGFVLRYPQDGEDVTGYAYEPWHFRYIGEERAQEFADSGAATLEEFYGTGPAPDYS,MNHMNMKHRRRKRRRNQSFLFTGILLLVVVSASSFLWYGFGNAAKKDSVIEEMPFTITQDGMQAKEEIKKTVLETSYGGKQQVAEENHGNTQNAGTDEAWNLMLVNRDNAIPDNYEVNLVEVEGGERVDERIYEPLMEMLNAAREENWGELPMVVSGYRTQEKQQSLYDEKIAKFKKEGYSDSEAVRQAEQWVAVPGHSEHQLGFAVDINGATYDVYLWLQENSYKYGFIFRYPGSKTDITGTAEEVWHYRYVGVEAATEMYENGLCLEEYLEKKQSEN,89.61,gnl|BL_ORD_ID|4732|hsp_num:0,298,FALSE,None
LK1250,14_40 # 39909 # 40889 # 1 # ID=14_40;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.716,14_40,39909,40889,+,Strict,50,102.834,vanY gene in vanA cluster,35.4,3002955,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGAACCGTCATGCGTCGCCCGGCCCTGCTCACCGCCCTGTTGACCGCGCTGCTGCTCGTGGGCGGCATGGTACCGGCCCACGCCGGGGCGGGGATCGACAACGAGTACCGCGCCCTGCCGAATCCCGGCGCATGGTTGGGCAAGCCCACGTCCGCCGAACGCTGTGGCCTGCGGGACCGCGGCTGCTATCGGCAGTACCAGAAGGGCACGATCCACTGGACGTCCACGACCGGTGCGCGGGCCCAGCGCGGCGGGATCCTGGCGAAGTGGCGCGCGGAGGGCTCCGAGCACGGGGCCCTGGGGTACCCCGTGACGCGCGAGACCTGCACGGGTGGCACGTGCGAGGTCCGCTACCAGCGCGGCCGCATCACCTGGACCGCCCAGGGAGGAGCGCGGGTGCACCGGGACATCGACGATGCCCGCAGCGTGTCCGTGGTCGTGAACAAGAAACGCTCGCTGTCCCCGCGCACCTACGCCCCGGCTCCGTTACGTTCGGTGGGCGGGGGAGTCCTGCTACGGGACGACGCCGCAGCGGCCTACCAGCGCATGAGCCGTGCCGCGGCCGCACAGGGGGTCGCGCTGGTCCCGGTGAGCGGGTACCGCGACTACGGCACCCAAGCGCGCCTCTACCGCGAGTACACGGCCCTGTACGGACAGGCCACCGCCGACACCATTTCCGCGCGGCCCGGTCACTCCGAACATCAGACCGGCCTCGCGATCGACGTGGGCGCCCCCGGGGCCACCTGCGGTCTGCTCCCGTGCTTCGGCAACACCCCGCAGGGGAAGTGGATCGCCGCGAACGGGCACACCTACGGGTTCGTGGTGCGCTACCCCGACGGGCACACCGCAACCACCGGGTACGCCTACGAACCGTGGCACCTGCGCTACGTGGGCACCGCCACGGCCACGAGTTTGAAGAACAGCGGGTCCGCGACGGTGGAGTCCTACATGGGTCTGCCGCGGGCCCCGAAGTACTGA,MRTVMRRPALLTALLTALLLVGGMVPAHAGAGIDNEYRALPNPGAWLGKPTSAERCGLRDRGCYRQYQKGTIHWTSTTGARAQRGGILAKWRAEGSEHGALGYPVTRETCTGGTCEVRYQRGRITWTAQGGARVHRDIDDARSVSVVVNKKRSLSPRTYAPAPLRSVGGGVLLRDDAAAAYQRMSRAAAAQGVALVPVSGYRDYGTQARLYREYTALYGQATADTISARPGHSEHQTGLAIDVGAPGATCGLLPCFGNTPQGKWIAANGHTYGFVVRYPDGHTATTGYAYEPWHLRYVGTATATSLKNSGSATVESYMGLPRAPKY,MKKLFFLLLLLFLIYLGYDYVNEALFSQEKVEFQNYDQNPKEHLENSGTSENTQEKTITEEQVYQGNLLLINSKYPVRQESVKSDIVNLSKHDELINGYGLLDSNIYMSKEIAQKFSEMVNDAVKGGVSHFIINSGYRDFDEQSVLYQEMGAEYALPAGYSEHNSGLSLDVGSSLTKMERAPEGKWIEENAWKYGFILRYPEDKTELTGIQYEPWHIRYVGLPHSAIMKEKNFVLEEYMDYLKEEKTISVSVNGEKYEIFYYPVTKNTTIHVPTNLRYEISGNNIDGVIVTVFPGSTHTNSRR,107.59,gnl|BL_ORD_ID|4669|hsp_num:0,89,FALSE,None
LK1250,38_22 # 19307 # 20044 # -1 # ID=38_22;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.664,38_22,19307,20044,-,Strict,50,124.79,vanW gene in vanG cluster,32.99,3002965,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanW; glycopeptide resistance gene cluster,ATGAGACGCAAACTCTTCTCGGAGATCTCCCCACTGACCTACCGCATTGCGGTGGAGCGCCAGAGAGGGCAGCGGCGCGCGAAGGACCTCGGCAGACGCGGGGCGTTCGCCGCCGAGCGTTCGGCCGAGGACCTGCCCGTGAAGGTCTACCGTCACAACTCACTCATCCGGCGCACGCTCGGCAACACCGAGCTGGACCTGCAGGAGGGCAAGGCGCGCTCGCTGGAACTGTCCGCGCCGCTCGTGGACGGGATCGTGATCCGCCCGGGGCAGACGTTCTCCTTCTGGAGGCTCGTGGGCAATCCCACGCGTTCCCGCGGCTACCTGCCGGGTGTGGTGATCAACGGTGACCACGCGGACGTGGGGATCGGCGGGGGCATGTGCCAGTTCACCAACCTGCTGCACTGGATGGCGCTGCACTCGCCCCTGACCGTGGTGGAGCACCACCACCACAGAGGACTGGACCTGTTCCCCGACTTCAAGCGCCAGATCCCGTTCGGGACTGGGACGTCCATCATCTACAACTTCCTGGACTACCGGCTGCGCAACGACACCGGGCGGAGCTACCAGTTCCGCGTGTACGTGGACGACGAGTACCTGCGCGGTCAGCTGCTCTCGGACGACACCTCGCCGGAGAAGTTCTACATCCGCGAGGACGAGGCGTACTTCTACCGCGTCACGGATCCCGCGACGGGTGAGGAGCAGGTGCGCCGCCACAACGTGGTGCTGCGGGCCTGA,MRRKLFSEISPLTYRIAVERQRGQRRAKDLGRRGAFAAERSAEDLPVKVYRHNSLIRRTLGNTELDLQEGKARSLELSAPLVDGIVIRPGQTFSFWRLVGNPTRSRGYLPGVVINGDHADVGIGGGMCQFTNLLHWMALHSPLTVVEHHHHRGLDLFPDFKRQIPFGTGTSIIYNFLDYRLRNDTGRSYQFRVYVDDEYLRGQLLSDDTSPEKFYIREDEAYFYRVTDPATGEEQVRRHNVVLRA,MIEVYKLTQRKRLTQLFPFLLPLRKWQRKKYFYFKMKFDGNRYAKKTSEKLLPNTVFETSSLMLNENSGFDMKYQINKVHNLKLAAKTINKVIIEPKETFSFWQLVRWADRHEKYKDGLNLVNGKIVGSYGGGLCQLSNMLFWLFLHTPLVIVERHGHAVESFPSTTEDLPCGTDATINEGWLDLKLRNDTDNTFQIEISFDDNFMYGRILSQSSVNIEYTVFNSSVSYFKREEKVYQIASVCRTEKDKMTGSQTEKELYVNQCEIAYKLPDDVKIEERGV,87.19,gnl|BL_ORD_ID|4743|hsp_num:0,1622,FALSE,None
LK443,85_5 # 3138 # 3887 # -1 # ID=85_5;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.776,85_5,3138,3887,-,Strict,50,83.9593,vanY gene in vanM cluster,34.46,3002961,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGTCGCACCCTCCCTCTCGCCGCGCTGGCCGCGCTCGCGCTGCTCGTGGCCGGTTGCGGCACGCCCGCCGCGGGCCCGTCCTCGACGCCGACGACGCCGACGTCCGGCGCCGCGAGCGCGGCCGCGTCGTCCGGCGCCGCCTCGAGCACGGCGCCGTCGTCGAGCACGCACGCCGACCCGGCCGCCCTCGACGTCGTCGTGAACAAGACCCGCCCCGTGGCTCCGCCCGACTGGGCGCCCTCGGATCTGGTGGCCGTGCCCGGCAGCGAGCTGTCCCTGCGGGCGGAGGCCGCGACGGCGGCCGGTGACCTGCTGGATGCCGCCGCGGCGGCGGGTCACCGCCTCACCACCCTGAGCGCCTACCGCTCGTACGACTACCAGGTCCGGACGTACGGCCACTGGGTCGACGAGCTGGGCCGCGCCGAGGCCGACCGCGTCTCGGCGCGTCCGGGGTACTCCGAGCACCAGACCGGCCTGGCCTGGGACGTGGGCGACGCCGCGACCCCCGCGTGTGACCTGGAAGCGTGCTTCGGCGACACTGCCGCGGGCCGCTGGGTGGCCGCGCACGCCGCCGAGTACGGGTTCGTCATCCGCTATCCCGTCGGGGCCGAGGACGTGACGGGCTTCGCCCACGAGCCGTGGCACCTGCGCTACGTCGGGTCCGCGGAGGCGGCCCGGGTCGAGGCGGCCGGCGGCGTCCTCGAGACCGCGTGGGGCCTGCCTCCGGCGCCGGACTACGCGGACTGA,MRRTLPLAALAALALLVAGCGTPAAGPSSTPTTPTSGAASAAASSGAASSTAPSSSTHADPAALDVVVNKTRPVAPPDWAPSDLVAVPGSELSLRAEAATAAGDLLDAAAAAGHRLTTLSAYRSYDYQVRTYGHWVDELGRAEADRVSARPGYSEHQTGLAWDVGDAATPACDLEACFGDTAAGRWVAAHAAEYGFVIRYPVGAEDVTGFAHEPWHLRYVGSAEAARVEAAGGVLETAWGLPPAPDYAD,MVFQGNLLLVNNEYPVLEESIKTDVVNLFKHDELTKGYELLNREIYLSEKVAREFSEMVDAAEKEGVRHFSINSGFRNFDEQNALYQEMGSDYALPAGYSEHNLGLALDIGSTQMEMSEAPEGKWLEDNAWEYGFILRYPMDKTAITGIQYEPWHFRYVGLPHSAIIEEKNFALEEYLDFLKEQKSISGTIHGENYEISYYPITEKTDIEMPANLHYEISGNNMDGVIVTVYR,106.87,gnl|BL_ORD_ID|1673|hsp_num:0,1713,FALSE,None
LK1055,10_20 # 23546 # 23800 # -1 # ID=10_20;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.678,10_20,23546,23800,-,Strict,1900,22.3274,MuxC,100,3004075,protein homolog model,n/a,n/a,macrolide antibiotic; monobactam; tetracycline antibiotic; aminocoumarin antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGGCACACAAGAAGGGTGCGAGCTCCACTCGCAACGGCCGTGACTCCAACGCCCAGTACCTGGGTGTCAAGCGCTTCGGCGGCCAGTCCGTCAACGCCGGCGAGATCATCGTCCGCCAGCGTGGAACCCACTTCCACCCGGGCCTGAACATGGGCCGCGGCAAGGACGACACCCTGTTCGCCCTGGCCGCCGGTGTCGTCGAGTTCGGCACCCGTCGTGGCCGCCGCGTGGTCAACATCCAGACCGCCGAGTAG,MAHKKGASSTRNGRDSNAQYLGVKRFGGQSVNAGEIIVRQRGTHFHPGLNMGRGKDDTLFALAAGVVEFGTRRGRRVVNIQTAE,MSLSTPFIRRPVATTLLTLALLLAGTLSFGLLPVAPLPNVDFPAIVVSASLPGASPETMASSVATPLERSLGRIAGISEMTSSSSLGSTTVVLVFDLEKDIDGAAREVQAAINGAMSLLPSGMPNNPSYRKANPSDMPIMVLTLTSETQSRGEMYDLASTVLAPKLSQVQGVGQVSIGGSSLPAVRVDLNPDAMSQYGLSLDSVRTAIAAANSNGPKGAVEKDDKHWQVDANDQLRKAREYEPLVIHYNADNGAAVRLGDVAKVSDSVEDVRNAGFSDDLPAVLLIVTRQPGANIIEATDAIHAQLPVLQELLGPQVKLNVMDDRSPSIRASLEEAELTLLISVALVILVVFLFLRNGRATLIPSLAVPVSLIGTFAVMYLCDFSLNNLSLMALIIATGFVVDDAIVVVENIARRIEEGDPPIQAAITGARQVGFTVLSMTLSLVAVFIPLLLMGGLTGRLFREFAVTLSAAILVSLVVSLTLTPMLCARLLRPLKRPEGASLARRSDRFFAAFMLRYRASLGWALEHSRLMVVIMLACIAMNLWLFVVVPKGFLPQQDSGRLRGYAVADQSISFQSLSAKMGEYRKILSSDPAVENVVGFIGGGRWQSSNTGSFFVTLKPIGERDPVEKVLTRLRERIAKVPGAALYLNAGQDVRLGGRDSNAQYEFTLRSDDLTLLREWAPKVEAAMRKLPQLVDVNSDSQDKGVQTRLVIDRDRAATLGINVEMVDAVLNDSFGQRQVSTIFNPLNQYRVVMEVDQQYQQSPEILRQVQVIGNDGQRVPLSAFSHYEPSRAPLEVNHQGQFAATTLSFNLAPGAQIGPTREAIMQALEPLHIPVDVQTSFEGNAGAVQDTQNQMPWLILLALLAVYIVLGILYESYVHPLTILSTLPSAGVGALLALILCRSELSLIALIGIILLIGIVKKNAIMMIDFALEAERNHGLSPREAILEACMMRFRPIMMTTLAALLGALPLIFGIGGDAALRRPLGITIVGGLIGSQLLTLYTTPVVYLYLDRLRHWVNQKRGVRTDGALETPL,8.11,gnl|BL_ORD_ID|2369|hsp_num:0,2720,TRUE,loose hit with at least 95 percent identity pushed strict
LK1055,55_1 # 203 # 1186 # -1 # ID=55_1;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.726,55_1,203,1186,-,Strict,50,98.5969,vanY gene in vanF cluster,38.93,3002958,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGAAACCGTTCACGCGCCTGCCCTCCGCCCTTCTTGCCGTTCCGCTCGCCGCGACCCTGCTCTCGGCCGGAACGACTCCCGCGTCCGCCATGACGGGCATCGAGGCCGAGTACGACGCTCTGCCGCAGGCCCAGGACTGGCTCGGCGAGCCCACGTCCGAGGAGTCGTGCGAGCTCCGGGACGAGGGGTGCTACCGCGAGTACGACAAGGGCGCCATCTACTGGTCGCCCGACACGGGCGCGCGGGCGCAGCGCGGAGCGATCTACGCCCGGTGGCGAGCCGAGGGATCCGAGCACGGGCCGCTCGGCTACCCGGTGAGCCGGGAAACCTGTTCCGACGGGACGTGCGAGGTGCGCTACCAGCGCGGGAGCATCACGTGGACCGAGGCGGACGGCACCACCGTGCACCGGGACGTGGACGAGGCAGCCAGCGCGGGCGTCGTCGTCAACAAGCAGCGGGCGCTGTCCCCGCAGGACTACGCGCCCGCGCCGCTGCGGGACGTGGGCGGGGGCGTGCAGCTGCGCGACGACGCCGCGGCCGCGTACGAGCGGATGTCACGCGCCGCGGCGGAGCAGGGGGTGGAGCTCACGGCCGTGAGCGGGTACCGGGACTACGCCACGCAGGCGGGACTGTACGAGCAGTACACCGCGACGTATGGACGGGAGACCGCCGACTCGATCTCCGCGCGCCCCGGGCACTCGGAGCACCAGACCGGTCTGGCCATCGACGTGGGCGCGCCGGACGGTTCGTGCGCCCTGCTCGCGTGCTTCGAGGACACCCCTCAGGGCCGCTGGGTGGCCGATCACGCGCACGAGTACGGGTTCGTGGTGCGGTACCCGGACGGGCGCACGGGCACCACCGGCTACGCCTACGAGCCGTGGCACCTGCGCTACGTGGGCGAGGACACCGCCACGAGCGTGAAGGACAGTGGGGAACCCGATCTGGAGTCCTACCTGGGCCTGCCCGACGCTCCCAGCTACTGA,MKPFTRLPSALLAVPLAATLLSAGTTPASAMTGIEAEYDALPQAQDWLGEPTSEESCELRDEGCYREYDKGAIYWSPDTGARAQRGAIYARWRAEGSEHGPLGYPVSRETCSDGTCEVRYQRGSITWTEADGTTVHRDVDEAASAGVVVNKQRALSPQDYAPAPLRDVGGGVQLRDDAAAAYERMSRAAAEQGVELTAVSGYRDYATQAGLYEQYTATYGRETADSISARPGHSEHQTGLAIDVGAPDGSCALLACFEDTPQGRWVADHAHEYGFVVRYPDGRTGTTGYAYEPWHLRYVGEDTATSVKDSGEPDLESYLGLPDAPSY,MKKWGLLLVFALFLVFIFNILPISQDKVEDRIYEQNDKDTSDDKMTAENMQKIELTEEQIYQGNLLLVNNEHPVHQKSIKSDIINLFTHKELTKGYGLLDNEIKLSEEIAGKFSEMIAAAEEDGVSNFLISSGYRDLDEQSRLYEEMGSDFALPAGHSEHNLGLSLDVGSTQMKMDKAPEGKWIEKNCWEYGFILRYPLDKTDVTGIQYEPWHIRYVGLPHSAIMQEMNLALEEYLDYLKEEKSISVRVDGKKYTISYDPISQNETIEVEVPADEQYEISGNNIDGVIVTTFS,111.6,gnl|BL_ORD_ID|1808|hsp_num:0,1899,FALSE,None
LK960,13_28 # 33631 # 34392 # 1 # ID=13_28;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.705,13_28,33631,34392,+,Strict,50,82.4185,vanY gene in vanB cluster,32.32,3002956,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGAGCACCGCGCTCCCCCGCCGTCTGGCCGCCTCCGCCGCCCTGCTGAGCCTCCTGGGGCTGTCCGCCTGCGGCAACGAGCAGCCGGCGGGAGATCCCAGCGGCTCTACCTCCTCGCAGACGCCGCAGGACGGCAGCAATGATGCCGGCACCGACTCGAGCTCAGGCCCCGGCACGGCCGCGGCGGAGGCCGACGTCGACACCGCCTCCTCGACCGATGTGGTGGTCAACAAGGCACGTCCGCTGGATCCGCAGGACTATGCGCCGGAGCCGCTCGAGGACCTCGAAGGCCACCAGCTGCGCAAGGACGCAGCTGCAGCCGCGCAGCAGATGCTCTCGGACATGCGAGCGCAGGGCATCACCGTGAGCATCACCTCGGCATACCGCCCGTACGTCGAGCAGGTCTCCACGTATCAGCACTGGGTCGAGGTCAACGGCCAGGCGACGGCAGACACGATCTCGGCGCGGCCCGGGCACTCGGAGCACCAGACCGGCCTGGTCATGGATATCGCCGACGGCTCGGGCTGCGACCTGCAGGAGTGCTTCGCCGACACCGACGCGGCCCAGTGGGCCGCAGAGCATGCGCAGGACTACGGCTTCGTGCTGCGCTACCCGCGCGGCGGCGAGGACGTCACGGGCTACGCCTACGAGCCCTGGCACTACCGCTACATCGGCGAGCAGCGCGCCCGGGAGCTCTCCGAATCCGGGGCCGCCACCCTCGAGGAGTTCTACGGAACGGGCCCCGCTCCGGACTACTCCTAA,MSTALPRRLAASAALLSLLGLSACGNEQPAGDPSGSTSSQTPQDGSNDAGTDSSSGPGTAAAEADVDTASSTDVVVNKARPLDPQDYAPEPLEDLEGHQLRKDAAAAAQQMLSDMRAQGITVSITSAYRPYVEQVSTYQHWVEVNGQATADTISARPGHSEHQTGLVMDIADGSGCDLQECFADTDAAQWAAEHAQDYGFVLRYPRGGEDVTGYAYEPWHYRYIGEQRARELSESGAATLEEFYGTGPAPDYS,MEKSNYHSNVNHHKRHMKQSGEKRAFLWAFIISFTVCTLFLGWRLVSVLEATQLPPIPATHTGSGTGVAENPEENTLATAKEQGDEQEWSLILVNRQNPIPAQYDVELEQLSNGERIDIRISPYLQDLFDAARADGVYPIVASGYRTTEKQQEIMDEKVAEYKAKGYTSAQAKAEAETWVAVPGTSEHQLGLAVDINADGIHSTGNEVYRWLDENSYRFGFIRRYPPDKTEITGVSNEPWHYRYVGIEAATKIYHQGLCLEEYLNTEK,94.4,gnl|BL_ORD_ID|602|hsp_num:0,556,FALSE,None
LK960,31_9 # 5528 # 5686 # -1 # ID=31_9;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.723,31_9,5528,5686,-,Strict,400,22.7126,Erm(35),100,3000604,protein homolog model,n/a,n/a,macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic,antibiotic target alteration,Erm 23S ribosomal RNA methyltransferase,GTGGGCCTGGTCCTGGCGGTGATCTGGGAGCTCATGGAGGCCGCGGGATCCGTGCTGGTCACCCCCGAGATCCACAACCCGCCCCTGGACACAGTGCTGGACATCGGCGCGGGGATGATCGGCGCGGCCATGGTGGGGCTGCGCCGCCGCCCGCTGTGA,MGLVLAVIWELMEAAGSVLVTPEIHNPPLDTVLDIGAGMIGAAMVGLRRRPL,MTKKKLPVRFTGQHFTIDKVLIKDAIKESNINQHDTVLDIGAGKGFLTVHLLKNVDKVIAIENDVALSQHLRKKFIHAQNVQVVSCDYRNFVVPKVPFKVVSNIPFGITSDIFSSLMFENVEYFLCGSIILQSEPAKKLFSSKVYNPLTVLYHTYYDLKFLYEINPESFLPPPTVKSALLRIERKQISLDIGLKVKYLNFVSYMLQKPDLTVKTAMKSIFRKKQVRSISEKFGVDLNSKIVCLTPNQWKNCFLEMLEVVPEKFHPS,19.55,gnl|BL_ORD_ID|1315|hsp_num:0,1434,TRUE,loose hit with at least 95 percent identity pushed strict
LK960,42_5 # 3198 # 3455 # 1 # ID=42_5;partial=00;start_type=ATG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.686,42_5,3198,3455,+,Strict,1900,22.3274,MuxC,100,3004075,protein homolog model,n/a,n/a,macrolide antibiotic; monobactam; tetracycline antibiotic; aminocoumarin antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGGCACATAAGAAGGGCGCAAGCTCCACCCGCAACGGCCGCGACTCCAACGCCCAGTACCTGGGCGTCAAGCGCTTCGGCGGCGAGTCCGTCAACGCCGGCTCGATCATCGTGCGTCAGCGCGGCACCCACTTCCACCCCGGTGAGAACGTGGGCCGCGGCAAGGACGACACCCTGTTCGCCCTGGCCACCGGCGAGGTGGCCTTCGGGACCAAGCGCGGCCGCAAGGTCGTCAACGTCCTCGCAGCGGCTGAGTGA,MAHKKGASSTRNGRDSNAQYLGVKRFGGESVNAGSIIVRQRGTHFHPGENVGRGKDDTLFALATGEVAFGTKRGRKVVNVLAAAE,MSLSTPFIRRPVATTLLTLALLLAGTLSFGLLPVAPLPNVDFPAIVVSASLPGASPETMASSVATPLERSLGRIAGISEMTSSSSLGSTTVVLVFDLEKDIDGAAREVQAAINGAMSLLPSGMPNNPSYRKANPSDMPIMVLTLTSETQSRGEMYDLASTVLAPKLSQVQGVGQVSIGGSSLPAVRVDLNPDAMSQYGLSLDSVRTAIAAANSNGPKGAVEKDDKHWQVDANDQLRKAREYEPLVIHYNADNGAAVRLGDVAKVSDSVEDVRNAGFSDDLPAVLLIVTRQPGANIIEATDAIHAQLPVLQELLGPQVKLNVMDDRSPSIRASLEEAELTLLISVALVILVVFLFLRNGRATLIPSLAVPVSLIGTFAVMYLCDFSLNNLSLMALIIATGFVVDDAIVVVENIARRIEEGDPPIQAAITGARQVGFTVLSMTLSLVAVFIPLLLMGGLTGRLFREFAVTLSAAILVSLVVSLTLTPMLCARLLRPLKRPEGASLARRSDRFFAAFMLRYRASLGWALEHSRLMVVIMLACIAMNLWLFVVVPKGFLPQQDSGRLRGYAVADQSISFQSLSAKMGEYRKILSSDPAVENVVGFIGGGRWQSSNTGSFFVTLKPIGERDPVEKVLTRLRERIAKVPGAALYLNAGQDVRLGGRDSNAQYEFTLRSDDLTLLREWAPKVEAAMRKLPQLVDVNSDSQDKGVQTRLVIDRDRAATLGINVEMVDAVLNDSFGQRQVSTIFNPLNQYRVVMEVDQQYQQSPEILRQVQVIGNDGQRVPLSAFSHYEPSRAPLEVNHQGQFAATTLSFNLAPGAQIGPTREAIMQALEPLHIPVDVQTSFEGNAGAVQDTQNQMPWLILLALLAVYIVLGILYESYVHPLTILSTLPSAGVGALLALILCRSELSLIALIGIILLIGIVKKNAIMMIDFALEAERNHGLSPREAILEACMMRFRPIMMTTLAALLGALPLIFGIGGDAALRRPLGITIVGGLIGSQLLTLYTTPVVYLYLDRLRHWVNQKRGVRTDGALETPL,8.2,gnl|BL_ORD_ID|2369|hsp_num:0,2720,TRUE,loose hit with at least 95 percent identity pushed strict
LK960,99_8 # 6920 # 7792 # 1 # ID=99_8;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.684,99_8,6920,7792,+,Strict,50,125.946,vanW gene in vanG cluster,30.59,3002965,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanW; glycopeptide resistance gene cluster,ATGGCACGCCGTCTCTTCTCCGAGCTCTCGCCGACGACCTATCAGATCGCCCTCGCCCGCCGCCGGATGCAGCGCAGGATCGCCGACGGCCTCCGGCGCAGAAGCTTCGCGAAGAACACGACGCGGGAGTCGCTGCCGGCCAAGGTCTACACCCACAACTCGCTGATCCGCCGCCGCCTGGGCAATGCGCAGCCTGAGCTGCAGGAGGGCAAGGCCGTCTCCCTCGGTCTGGCCGCACCGCACGTGGACGGGATCCTGATCTGCCCCGGGGAGACCTTCTCCTTCTGGCGGCTGGTGGGCGAGCCCAGCGCCCGACGCGGCTTCCAGCCCGGCGTGGTGATCTTCGACGACCACGCGGAGACCGGGGTGGGAGGCGGGCTGTGCCAGTTCACCAACCTCCTGCACTGGATGGCGCTGCATTCGCCCCTGAGCATCGGGGAGCACCACCATCACTCCGGGCTCGATCTCTTCCCCGACTTCAAGCGGCAGATCCCGTTCGGCACCGGGACCTCCATCGTGTGGAACTTCCTGGACTACCGGCTGCGCAACGACACCGACATGACCTTCCAGTTCCGGGTCCGCACGGATGAGGAGCACCTGCGCGGCGAGCTGCGCGCAGATGCTCCGCTGGCCCAGAAGTTCCACGTCCGCGAGGAGGACGGGTGGTTCTACGAGGCGCTGGACCCGCAGACCGGGAAGCTGCAGGTGCGTCGGCACAACATCGTCAGCCGCAGCACGAGGGACAAGCGCACGGGCAACATCGTGGCGAGCGAGACCCTGCTCGAGAACGACGCCCTGGTGGTCTACGACCGCGACCGGATCAGCGAGCCGATCCGTCCGCTGCCGGAATCCGTCCGCGCCCCGCGCCGATAG,MARRLFSELSPTTYQIALARRRMQRRIADGLRRRSFAKNTTRESLPAKVYTHNSLIRRRLGNAQPELQEGKAVSLGLAAPHVDGILICPGETFSFWRLVGEPSARRGFQPGVVIFDDHAETGVGGGLCQFTNLLHWMALHSPLSIGEHHHHSGLDLFPDFKRQIPFGTGTSIVWNFLDYRLRNDTDMTFQFRVRTDEEHLRGELRADAPLAQKFHVREEDGWFYEALDPQTGKLQVRRHNIVSRSTRDKRTGNIVASETLLENDALVVYDRDRISEPIRPLPESVRAPRR,MIEVYKLTQRKRLTQLFPFLLPLRKWQRKKYFYFKMKFDGNRYAKKTSEKLLPNTVFETSSLMLNENSGFDMKYQINKVHNLKLAAKTINKVIIEPKETFSFWQLVRWADRHEKYKDGLNLVNGKIVGSYGGGLCQLSNMLFWLFLHTPLVIVERHGHAVESFPSTTEDLPCGTDATINEGWLDLKLRNDTDNTFQIEISFDDNFMYGRILSQSSVNIEYTVFNSSVSYFKREEKVYQIASVCRTEKDKMTGSQTEKELYVNQCEIAYKLPDDVKIEERGV,103.2,gnl|BL_ORD_ID|4743|hsp_num:0,1622,FALSE,None
LK1279,8_2 # 458 # 1207 # 1 # ID=8_2;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.680,8_2,458,1207,+,Strict,50,67.0106,vanY gene in vanB cluster,32.41,3002956,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,GTGTCGTGGATCGTGACGAGCATCCTCGCCGTCGGTGCCCTCGCGGTGTCGTGGATGGGTGTCAACCAGATTCTCCACGGAGCGCCTGCGGCCCCTCAGGCCGCGCCTGCGCAGAGCGCCGCACCGAGTGAAGCGCGTCCGACGCCGACGCTCGCCGCCGATGTGGATTCCCCGGATTCACTCTCGGTCGTGGTCGGCCCGAAGCGTCCGCTCGTGCAGCTCGAATATGCACCGGATGACCTTGTCGCGCTGGCGGATGTCGGGGTCGACGCCCCCGAGGGCGCGCAGCTGCGCCGTGACACGGCAGATGCGCTCCTGCAGCTCATCGCGACCGGCTGGCACACCTACGGCTACAGCATCTCGGCGGGGAAGGCGTACGTCGCCGCGAGCGACCAGGCTGCGCTCTACGAAGAGGCCGTTGCGGCCAAGGGTGAAGCTGAAGCGAAGGCGACGGTCGGCCAGCCCGGCCACTCCGAGTACCAGACAGGTCTGCTCGTGAACGTCACGCTCGACAACAACGAATGCTCGGAAGCCGCCTGCTTCTCGGAAACGTCGCAGGGCTCGTTCATCCTCGAGCATGCCCACGAGTACGGCTTCATCGTCCGCTACCCGGCGGGCGCCGAGGCTGAGACGGGCGTCTCGGCGCAGCCCTGGGTGCTTCGTTACGTCGGCAGTGAGATGGCCGCCCAAATCAAGCAGTCCGGCAAGGCGAGCCTCGAGAGCTACCTGGGCCTGCCGCCGAGCGCGTAG,MSWIVTSILAVGALAVSWMGVNQILHGAPAAPQAAPAQSAAPSEARPTPTLAADVDSPDSLSVVVGPKRPLVQLEYAPDDLVALADVGVDAPEGAQLRRDTADALLQLIATGWHTYGYSISAGKAYVAASDQAALYEEAVAAKGEAEAKATVGQPGHSEYQTGLLVNVTLDNNECSEAACFSETSQGSFILEHAHEYGFIVRYPAGAEAETGVSAQPWVLRYVGSEMAAQIKQSGKASLESYLGLPPSA,MEKSNYHSNVNHHKRHMKQSGEKRAFLWAFIISFTVCTLFLGWRLVSVLEATQLPPIPATHTGSGTGVAENPEENTLATAKEQGDEQEWSLILVNRQNPIPAQYDVELEQLSNGERIDIRISPYLQDLFDAARADGVYPIVASGYRTTEKQQEIMDEKVAEYKAKGYTSAQAKAEAETWVAVPGTSEHQLGLAVDINADGIHSTGNEVYRWLDENSYRFGFIRRYPPDKTEITGVSNEPWHYRYVGIEAATKIYHQGLCLEEYLNTEK,92.91,gnl|BL_ORD_ID|602|hsp_num:0,556,FALSE,None
LK1279,32_17 # 20024 # 21226 # 1 # ID=32_17;partial=01;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.700,32_17,20024,21226,+,Strict,50,98.9821,vanY gene in vanB cluster,36.27,3002956,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGAGCGACGGGCAGCACACGGGCCACGGCACGGAGGGTGCGAAGGCATCCCGCGGGATCGACCCGAGCTGGGCTGACCGCTACGTCGAGCCCGATATCTACGCCGATATCGACATTGAGGGCGCCGCCCCCGCGCGTCCCGCACGCGCCGCGAGCGCTGCACCAGCATCCTCGAGTCCCGCCAGTGGTGACACTGCAGCCCTCGACGAGACGCGCGTCCTCCCGGCCGAGGCAGCGCCGGGGCCGCTCGTTGACGAGGAGGCCGCTCCCGAGCCTTCCTCAGCGGATGTCGTCCCCGCCGCTGCGCCCGCGCCCGCGCCCAATACAGCCCGCAGCCAGCGGGCCGCCCGCAACACGCGTCGTCGTCGCCTCATCCTCGCTGGCGTGGTGCTCCTTGTCCTCGCGGCAGTCCTTGCCCTCCTCATCCCGCAGTTCTTCCGCGCACCTGAGCCGAACGGCTGGACGAACCACACCCAGCAGCCGAGCGTGTCGCCCGAGGGTGCAGCGCCCGGCGAGCAGCAGGATGCTGGCGCGAATAGCGATGCAGGTGCCGAAGCTCCGGTCGATGATGGCGCCCAAGCGTCGGCACCCGGCCAGCCGCTCACGCTCGACCAGACCTCGCCCGACAGCCTCACGGTGCTCGTGAACAAGCTTCACCCGCTCGAGCCCTCCACGTACGAGCCGAGCGACCTCGTCGACCTCTCCACCCTCGGCGTCTCCGCCTCCAACGGTCACCCGATGCGCAGCGAAGCCGCAACCGCGCTCGCCGAGATGTTCGCGGCAGCCCGCGCGGCCGGCTACGAACTTGACATGACGAGCGGCTACCGCCCCTACGCCACCCAGGAAGAGCTCTACAACGGCTTCGTGAGTTCGCTCGGGCAGGAGGGCGCGGACCTCACCTCGGCACGCCCCGGCTACAGCGAACACCAGACGGGTCTCGTCGCTGACATCTCCGAGATCGGCGGCACCTGCGCCCTCGCCACCTGCTTCGGCGACACCGGTGCAGGCGCCTGGCTTGCGGAGCACTCTTGGGAGTACGGCTTCATCCTCCGCTACCCGAACGGGCAGACCGAGGTGACCGGATACGAGTACGAGCCGTGGCACTTCCGCTACATCGGCCGCGAGGCAGCCACCTCGTACCGCAACAACGGGGCGACGAGCTTCGAGAGCTTCCTCGGCTCAACACCGGCGCCCGACTACGCG,MSDGQHTGHGTEGAKASRGIDPSWADRYVEPDIYADIDIEGAAPARPARAASAAPASSSPASGDTAALDETRVLPAEAAPGPLVDEEAAPEPSSADVVPAAAPAPAPNTARSQRAARNTRRRRLILAGVVLLVLAAVLALLIPQFFRAPEPNGWTNHTQQPSVSPEGAAPGEQQDAGANSDAGAEAPVDDGAQASAPGQPLTLDQTSPDSLTVLVNKLHPLEPSTYEPSDLVDLSTLGVSASNGHPMRSEAATALAEMFAAARAAGYELDMTSGYRPYATQEELYNGFVSSLGQEGADLTSARPGYSEHQTGLVADISEIGGTCALATCFGDTGAGAWLAEHSWEYGFILRYPNGQTEVTGYEYEPWHFRYIGREAATSYRNNGATSFESFLGSTPAPDYA,MEKSNYHSNVNHHKRHMKQSGEKRAFLWAFIISFTVCTLFLGWRLVSVLEATQLPPIPATHTGSGTGVAENPEENTLATAKEQGDEQEWSLILVNRQNPIPAQYDVELEQLSNGERIDIRISPYLQDLFDAARADGVYPIVASGYRTTEKQQEIMDEKVAEYKAKGYTSAQAKAEAETWVAVPGTSEHQLGLAVDINADGIHSTGNEVYRWLDENSYRFGFIRRYPPDKTEITGVSNEPWHYRYVGIEAATKIYHQGLCLEEYLNTEK,149.63,gnl|BL_ORD_ID|602|hsp_num:0,556,FALSE,None
LK518,5_121 # 123392 # 124312 # -1 # ID=5_121;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=11-12bp;gc_cont=0.644,5_121,123392,124312,-,Strict,50,95.9005,vanY gene in vanB cluster,33.04,3002956,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGGTTGAGTCCCGTGGGCAGGCGCTGCAGCGCCGTCGAGCTGTTTACCGGCGGCGTCGGGCTTGGGCTGCGGTGATTGCCGTGGTCCTGCTGGCCCTGCTGGTTTTTGGGCTCTATGCGGGCTTGAAAACCTGGGGGCTGCTGCCCAGCGGCCAGGACGCCGAGGAGTCGGAGGCCGCTGAGCTGTCGGGTAGTAATTCCGACGACGACCTTGCCTCCCCGGCGGGGTCCTCAGCAGCGGCCGCCGAACCGGAGCCTGAACCAACGCCCGAGCCGGAGCCTGAACCCGAGCGTGCCAGTGACCCGTCCTGGGACCCCGATTCCATCCATGTACTGGTGAATCGGCAGAACCCCTTTGAGCCGGTGGACTACGCACCCACTGATCTGGTGGTACCTGATGTTCCGCATTACGGTCCAGAAGCCGCCATGTCCCTGCGGCAGGAGCCCGCAGCCGCCCTGGAGGAGCTCATTGCCACCGGGCGCCAGGAGGGCATGGCCCTGGGACTGGTGAGCGGGTACCGCTCCTTCGACTATCAGTTCCAGATCTACTGGGCCCGCCATGCTGAGGTAGGCACCGAGGCCACGGACCTCTATATGTCCCGGCCGGGGTACTCCGAGCACCAGACCGGGTTGGCCGCGGATGTGATCAGTATCGAGAATCCTGACTGCATGCTCGGGGAGTGCTTCGCTGACACCCCCGAGGGGCAGTGGGTGGCGGAGAATGCGCACCGTTTCGGCTTCATCATCCGGTATCTGGAAGATATGGAGCACATCACCGGCTATCCCTATGAGCCGTGGCATCTGCGCTATGTGGGAGTCGAAACCGCCACCGAGGTCTTTGAGCTGGGCCTCACCCTAGAGAAGTACTGGGAGCAGCCAGCTGCCCCTGACTACGACGACGCCGAACCCGCCTACCCCTAA,MVESRGQALQRRRAVYRRRRAWAAVIAVVLLALLVFGLYAGLKTWGLLPSGQDAEESEAAELSGSNSDDDLASPAGSSAAAAEPEPEPTPEPEPEPERASDPSWDPDSIHVLVNRQNPFEPVDYAPTDLVVPDVPHYGPEAAMSLRQEPAAALEELIATGRQEGMALGLVSGYRSFDYQFQIYWARHAEVGTEATDLYMSRPGYSEHQTGLAADVISIENPDCMLGECFADTPEGQWVAENAHRFGFIIRYLEDMEHITGYPYEPWHLRYVGVETATEVFELGLTLEKYWEQPAAPDYDDAEPAYP,MEKSNYHSNVNHHKRHMKQSGEKRAFLWAFIISFTVCTLFLGWRLVSVLEATQLPPIPATHTGSGTGVAENPEENTLATAKEQGDEQEWSLILVNRQNPIPAQYDVELEQLSNGERIDIRISPYLQDLFDAARADGVYPIVASGYRTTEKQQEIMDEKVAEYKAKGYTSAQAKAEAETWVAVPGTSEHQLGLAVDINADGIHSTGNEVYRWLDENSYRFGFIRRYPPDKTEITGVSNEPWHYRYVGIEAATKIYHQGLCLEEYLNTEK,114.18,gnl|BL_ORD_ID|602|hsp_num:0,556,FALSE,None
LK409,88_4 # 4099 # 4848 # 1 # ID=88_4;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.776,88_4,4099,4848,+,Strict,50,83.9593,vanY gene in vanM cluster,34.46,3002961,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGTCGCACCCTCCCTCTCGCCGCGCTGGCCGCGCTCGCGCTGCTCGTGGCCGGTTGCGGCACGCCCGCCGCGGGCCCGTCCTCGACGCCGACGACGCCGACGTCCGGCTCCGCGAGCGCGGCCGCGTCGTCCGGCGCCGCCTCGAGCACGGCGCCGTCGTCGGGCACGCACGCCGACCCGGCCACCCTCGACGTCGTCGTGAACAAGACCCGCCCCGTGGCCCCGCCCGACTGGGCGCCCTCGGATCTGGTGGCCGTGCCCGGCAGCGAGCTGTCCCTGCGGGCGGCGGCCGCGACGGCGGCCGGTGACCTGCTGGATGCCGCCGCGGCGGCGGGCCACCGCCTCACCACCCTGAGCGCCTACCGCTCGTACGACTACCAGGTCCGGACGTACGGCCACTGGGTCGACGAGCTGGGCCGCGCCGAGGCCGACCGCGTCTCGGCGCGTCCGGGGTACTCCGAGCACCAGACCGGCCTGGCCTGGGACGTGGGCGACGCCGCGACCCCCGCGTGTGACCTGGAAGCGTGCTTCGGCGACACCGCCGCGGGCCGCTGGGTGGCCGCGCACGCCGCCGAGTACGGGTTCGTCATCCGCTATCCCGTCGGGGCCGAGGACGTGACGGGCTTCGCCCACGAGCCCTGGCACCTGCGCTACGTCGGGTCCGCGGAGGCGGCCCGGGTCGAGGCGGCCGGCGGCGTCCTCGAGACCGCGTGGGGTCTGCCTCCGGCACCCGACTACGCGGACTGA,MRRTLPLAALAALALLVAGCGTPAAGPSSTPTTPTSGSASAAASSGAASSTAPSSGTHADPATLDVVVNKTRPVAPPDWAPSDLVAVPGSELSLRAAAATAAGDLLDAAAAAGHRLTTLSAYRSYDYQVRTYGHWVDELGRAEADRVSARPGYSEHQTGLAWDVGDAATPACDLEACFGDTAAGRWVAAHAAEYGFVIRYPVGAEDVTGFAHEPWHLRYVGSAEAARVEAAGGVLETAWGLPPAPDYAD,MVFQGNLLLVNNEYPVLEESIKTDVVNLFKHDELTKGYELLNREIYLSEKVAREFSEMVDAAEKEGVRHFSINSGFRNFDEQNALYQEMGSDYALPAGYSEHNLGLALDIGSTQMEMSEAPEGKWLEDNAWEYGFILRYPMDKTAITGIQYEPWHFRYVGLPHSAIIEEKNFALEEYLDFLKEQKSISGTIHGENYEISYYPITEKTDIEMPANLHYEISGNNMDGVIVTVYR,106.87,gnl|BL_ORD_ID|1673|hsp_num:0,1713,FALSE,None
LK672,14_45 # 52759 # 54453 # 1 # ID=14_45;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.659,14_45,52759,54453,+,Strict,50,79.7221,vanW gene in vanI cluster,33.33,3003724,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanW; glycopeptide resistance gene cluster,GTGACTACGGTAAATGCAACAGGTGCCCGCGGTGGGCGCGGGGTCAGCACCGGGAAGATTCTCCTCGGTGTGCTTCTCGGCGTGCTCGCGGTGCTGCTTGCGATCTACCTCGCCGACCTCGCAATGAACCGCGGGAACGTGCCGCGTGGCACCGCCGTCGGCGGTGTCGAGATCGGCGGCATGAGCCACGACGAGGCCACCGCGAAGCTCGAAGCAGAGCTCGGTGAGACGGCGAGCAACCCCGTGACGGTGAAGGCGGCATCGCAAAGCTCGCAGCTCGTGCCCGCCGAGTCCGGCCTCGGCATCGACTGGGAGGCGACCGTAGCAAGCGCGGGCGAAGAGTCCGCGAACCCGTTCACTCGCCTCGCCGGGCTGTTTCGCACCCGCGAAGTCGACATTGTGTCGACCGTGAACGAGGCCGCTCTCACCCCGCAGCTTGAGCGCGTGGCCGGCGAGTTGCACCTCGACCCCGCCGACGGCGCGATCGCCATCGAAGGCGGCGAGGCGAAAGTGACCGAACCGGTGCCGGGCCAGGAGGTTGACAAAACCGAGCTGTTCGAACGTGTCACCACCGGCTGGCTCAACCCCGACGGTGTGGAGGTCGAGCCGCGCGAGATCGAACCCGCCATCGGCGACCAGGCGATCAAGGAAGCCTTAGACGGGCCGGTTAAGGCGGCGCTGTCCGGCGCCTTGACGCTGCACGGCCGCGACGGCGTCGACGGTGTCATTGCCCAAGAGCGCATCGGCGAGGTCGTCCAGTTCCCCAACGTCGACGGCAAAATCGCCCCCGAGGTGAACGTGGAAAGCGCCCAGGGCATCTTGGGCGAGCAGCTCGCTGCGACCGAGACGCAGATGAAAAACGCGCGCGTGCTGCCCGGCGGCGGGGTGGAACCGTCCGTCGACGGCTCCATTATCGACTGGGAGGCCGCGATGGACGGTTTCGACGAGCGGTTGATCGGTTCCGCCGAGCGCACCTGGGACGCGCAATACAAGGCCCGCCCGGCAGACTTCACTACAGAGGAAGCCCAACGTGCCACCTTCGACCAGGTGGTGGGAAGTTTCACCACCGGCGGGTACAGCGGCGCATCCGGCACGAACATCGCTACGGTGGCCCGCGTTGTCAACGGCGCAATTGTCAACCCCGGTGAAACCTTCTCGCTCAACGGCTACACCGGCGCGCGCGGTGCCGCGCAGGGTTACGTCGAGTCGGTCATCATCGAAAATGGACGCCCCGGCAAGGGAGTGGGTGGCGGAATCTCCCAATTTGCCACGACCTTGTACAACGCGGCTTACTTTGCCGGCATGACGGATGTCGCCTCCACCCCGCACTCCTACTACATCTCACGCTACCCGGCTGGCAGGGAGGCGACCGTGTATGAAGGGGCGATTGACCTGCAATTCCGCAACGATTCGCCCCACCCGGTCAAGATTTCCACGAGCGTCGGGGGCGGCGAGGTGACGGTGAGCCTGATGGGCACCAAGACCGTCGAGGTGGAGTCCATCAACGGAGGGCGCTGGGCCTACACCTCGCCGAAGCCCGTGACCGTCACCAGTGGTGACTGCATTCCCTCGGGCGGGGCGCAGGGCTTTACCACCTCCGATACCCGGATTGTGCGTGACCTCAGCGGCAATGAGATCAGTCGCAACACCTCCACCACGGTCTACGACCCGCAGCCGATAGTGCGCTGCGAATAG,MTTVNATGARGGRGVSTGKILLGVLLGVLAVLLAIYLADLAMNRGNVPRGTAVGGVEIGGMSHDEATAKLEAELGETASNPVTVKAASQSSQLVPAESGLGIDWEATVASAGEESANPFTRLAGLFRTREVDIVSTVNEAALTPQLERVAGELHLDPADGAIAIEGGEAKVTEPVPGQEVDKTELFERVTTGWLNPDGVEVEPREIEPAIGDQAIKEALDGPVKAALSGALTLHGRDGVDGVIAQERIGEVVQFPNVDGKIAPEVNVESAQGILGEQLAATETQMKNARVLPGGGVEPSVDGSIIDWEAAMDGFDERLIGSAERTWDAQYKARPADFTTEEAQRATFDQVVGSFTTGGYSGASGTNIATVARVVNGAIVNPGETFSLNGYTGARGAAQGYVESVIIENGRPGKGVGGGISQFATTLYNAAYFAGMTDVASTPHSYYISRYPAGREATVYEGAIDLQFRNDSPHPVKISTSVGGGEVTVSLMGTKTVEVESINGGRWAYTSPKPVTVTSGDCIPSGGAQGFTTSDTRIVRDLSGNEISRNTSTTVYDPQPIVRCE,MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVLAEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPELLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGMETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGGEFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSHSLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDEPDGYPVKPREWSK,151.21,gnl|BL_ORD_ID|4748|hsp_num:0,2242,FALSE,None
LK948,13_13 # 9327 # 11015 # -1 # ID=13_13;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.598,13_13,9327,11015,-,Strict,50,83.9593,vanW gene in vanI cluster,34.42,3003724,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanW; glycopeptide resistance gene cluster,GTGAAGAAGGCAGAAGGAAAAAACGGTGCAAAGGGCTGGCTTATCACGCTTGGCGTGATCGTGGGCTTCGTCCTCATTGCTGGCATCGCTTATGCCTGGGATGTCATAGCAAACCAGGACAAGATCCCGCGTAGCGTCTCCGTGGGCGGCGTGGATATCTCCGCCATGGAGCGCACCGCCGCCGTGGCCAAGCTTGAGGACGAGCTCAAGGGCGTTGAGACCCAACCCGTGACCGTGACCGCAGGCGATCTGCAGTCTGAATTTACCCCTGCCGAATCCGGCCTGGCCCTGGATAATCAGGCCGCCGTCGATGGCATCGAGGAACCTTCCCTCAACCCCATTACCCGCCTGGCCAGCTTCTTTCGCTCCACCGAAGATATCCCGGTAGAAACCGATGTGGACGATAGCAAGCTACAGCCCACCCTTGACCGCGTCAAAGACGAGCTTTCTACCGATCCGGTCGATGGCATGCTGGAGCTTAATAATGGCGAGCTCAAGGTCACCGATCCCACGTTGGGCCAGTCCGTAGACGGCACCGAATTACACGATGCGGTGGCGGCGAATTGGCTGGACAAAGACGGCGTGCAGGTGGAACCGGAAGAAATCGAGCCGGCCATTAATGAGGCGGCCATTGAAAAGATGCGCACCGGCGATGCCGCCAAGGCCCTGGATAATCCGCTGACCTTGAAGGCGAAAAATAACGTGACCGCCACGCTGAATAAGCCGGAGATTTCCCAGTTCACCAGCATTGAGAAAAAGGATGGCCAGCTGCACCTGGTAGTGGATAGCAACCGCGCGCAGCAATTGCTGCAAGAGCGCAGCGATGGCGCCGACGTGCCTGGCGTGAACGCCAAGGTGAAATTCGCCGGTGGCTCCAGGCAGGTCACCCCCTCCCAGGACGGCGAGATCATTGACTGGAAGCCCACCATGGAGGGCTTTGATGAGCGCGTGACTGGCGATGACCGCGAGTGGGACGCAACCTACAAGCCTGACCCTGCCGAGTTCTCCACCGAGGACGCCGAAAACGCGACGTTTAACGATACCGTGGGTGAGTTCACCACCGGCGGCTTCTCCTCCGCCTCTGGGCGCAATATCCAGCTCGTTGCCCAAGAGGTCAACGGCGCCGTTGTCAACCCCGGTGAGACCTTCTCCCTCAACGGCTATACCGGCCCCCGCGGCACCGCGCAGGGTTATGTGGAATCCGGCATCATCATCAACGGACACTCCGGTTCCGCCGTGGGCGGTGGCATCTCCCAATTCGCCACTACCCTGTATAACGCCGCGTACTTCGCCGGCATGCAAGATACCGCGCACACCCCGCACTCGTATTACATTTCCCGCTACCCAGCCGGCCGCGAGGCCACCGTGTACGAGGGTGCCATTGACCTGCAATTTACCAATACCTTCAATACTCCAGTGCAGATTGAGACCAGCTTTGGCGGCGGCAATATCACCGTCCGCTTGAAGGGTACTAAGACGGTAGAGGTGGAATCCATCAATAACGGCCGCTGGGCCAAGACCGAGCCACAGCCGATGTCCGTGCCAGGCAGCGACTGCTCGCCATCATCTGGAGCCCCAGGCTTTACGACGTCCGATACCCGCATCATCAAGGATCTCAGGGGCAAGGAGCTTTCCCGCGAGACCAAGACCACGGTTTACGACCCACAGCCCATCGTGCGGTGCGGCTAG,MKKAEGKNGAKGWLITLGVIVGFVLIAGIAYAWDVIANQDKIPRSVSVGGVDISAMERTAAVAKLEDELKGVETQPVTVTAGDLQSEFTPAESGLALDNQAAVDGIEEPSLNPITRLASFFRSTEDIPVETDVDDSKLQPTLDRVKDELSTDPVDGMLELNNGELKVTDPTLGQSVDGTELHDAVAANWLDKDGVQVEPEEIEPAINEAAIEKMRTGDAAKALDNPLTLKAKNNVTATLNKPEISQFTSIEKKDGQLHLVVDSNRAQQLLQERSDGADVPGVNAKVKFAGGSRQVTPSQDGEIIDWKPTMEGFDERVTGDDREWDATYKPDPAEFSTEDAENATFNDTVGEFTTGGFSSASGRNIQLVAQEVNGAVVNPGETFSLNGYTGPRGTAQGYVESGIIINGHSGSAVGGGISQFATTLYNAAYFAGMQDTAHTPHSYYISRYPAGREATVYEGAIDLQFTNTFNTPVQIETSFGGGNITVRLKGTKTVEVESINNGRWAKTEPQPMSVPGSDCSPSSGAPGFTTSDTRIIKDLRGKELSRETKTTVYDPQPIVRCG,MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVLAEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPELLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGMETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGGEFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSHSLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDEPDGYPVKPREWSK,150.67,gnl|BL_ORD_ID|4748|hsp_num:0,2242,FALSE,None
LK948,18_2 # 829 # 1683 # -1 # ID=18_2;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.564,18_2,829,1683,-,Strict,400,514.612,ErmX,90.14,3000596,protein homolog model,n/a,n/a,macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic,antibiotic target alteration,Erm 23S ribosomal RNA methyltransferase,ATGTCTGCATACGGACACGGCCGTCACGAGCATGGCCAAAATTTTCTCACCAACCACAAGATCATCAACTCCATCATCGACCTTGTGAAACAAACCTCCGGCCCCATCATTGAGATCGGACCAGGAAGCGGTGCCCTCACTCACCCGATGGCCCACTTGGGGAGGGCGATAACGGCAGTTGAAGTGGACGCAAAACTAGCTGCCAAAATCACACAAGAAACCTCCTCGGCGGCGGTCGAAGTGGTCCATGATGATTTCCTTAACTTCCGGTTACCCGCCACTCCCTGCGTCATTGTGGGAAACATTCCCTTTCACCTCACCACTGCCATTCTTCGAAAGTTGCTGCATGCGCCAGCATGGACTGACGCTGTACTCCTCATGCAGTGGGAAGTCGCTCGCCGCCGGGCCGGGGTAGGCGCAAGCACGATGATGACGGCTCAGTGGTCCCCATGGTTCACATTTCACCTGGGTTCTCGGGTACCAAGGCCTGCTTTCCGGCCACAGCCAAACGTTGACGGGGGGATCTTAGTGATCCGCCGGGTGGGTGACCCGAAGATTCCGATAGAGCAGCGCAAAGCCTTTCAGGCGATGGTGCACACCGTTTTCACTGCCCGGGGACGCGGGATAGGGGAAATTCTCCGAAGGGCAGGGTTGTTTTCATCACGTTCAGAAACACAATCATGGTTGCGCTCGCGAGGAATCGACCCCGCGACCCTACCTCCCAGATTGCACACCAACGACTGGATCGATCTCTTCCAGGTGACTGGTTCCTCTCTACCTCACCATCGACCCATTTCACCATCGGGAAGTAGTCAACGACCTCCTCAACGGAAAAACCGAAGCCGGCGGCGTTAA,MSAYGHGRHEHGQNFLTNHKIINSIIDLVKQTSGPIIEIGPGSGALTHPMAHLGRAITAVEVDAKLAAKITQETSSAAVEVVHDDFLNFRLPATPCVIVGNIPFHLTTAILRKLLHAPAWTDAVLLMQWEVARRRAGVGASTMMTAQWSPWFTFHLGSRVPRPAFRPQPNVDGGILVIRRVGDPKIPIEQRKAFQAMVHTVFTARGRGIGEILRRAGLFSSRSETQSWLRSRGIDPATLPPRLHTNDWIDLFQVTGSSLPHHRPISPSGSSQRPPQRKNRSRRR,MSAYGQGRHEHGQNFLTNHKIINSIIDLVKQTSGPIIEIGPGSGALTHPMAHLGRAITAVEVDAKLAAKITQETSSAAVEVVHDDFLNFRLPATPCVIVGNIPFHLTTAILRKLLHAPAWTDAVLLMQWEVARRRAGVGATTMMTAQWSPWFTFHLGSRVPRSAFRPQPNVDGGILVIRRVGDPKIPIEQRKAFQAMVHTVFTARGRGIGEILRRQGCFHHVQKHNHGCAREESTPRPYLPDCYTNDWIDLFQVTGSSLPHHRPISPSGSSQRPPQRKNRSRRR,100,gnl|BL_ORD_ID|872|hsp_num:0,950,FALSE,None
LK479,2_267 # 298544 # 299470 # 1 # ID=2_267;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.537,2_267,298544,299470,+,Strict,500,626.32,mphI,99.68,3003991,protein homolog model,n/a,n/a,macrolide antibiotic,antibiotic inactivation,macrolide phosphotransferase (MPH),ATGACAATAGCAAAACCAAATGATGATTATACACAAGTGATCCAAGAGATGCTGGAGATTGCCGGAAAACACGGGGTGAATTTGATTCCGGAGGGAATAGAGATGAATGAATCCGGCATGGATTTCCTTGTTGGATTCGCAGAGGAGGCAGGGACTGGAGCACGGTGGATTCTGCGGAAACCGAGACGACCGGATGTGCTGGACAGAGCAGATAACGAAGCTCGGGTCCTGAAGCTGATTCAATCCCATCTTTCGGTTGATGTACCGGATTGGTGGATTTACACGCCGGAGCTCATCGCCTATCCGCTGCTTAGCGGGCAGCCTGCCGCTTCCGTCAGCATGGAAGGATATGCATGGAATATGGATCATGAGAATCCGGGCGACGGGTTTATCCGCTCACTGGCTGAAGCGCTGGTTGCCTTGCATGGCGTCGATCATGACGCAGCCCGAGCAGCAGGTCTGCGGGTAAAGAGTCCCCAAGAGGTTCGTGATGAGACGGCGCGAAATATGGAAGACATCAAGAGCCGTCTGGGCGTTTCCGATGCGCTGTGGGAGAGATGGCAAAAATGGCTGGAGGAGGATTCCTACTGGCCGACGCATTCTGCCCTCATCCATGGCGATCTTCATCCCCCGCATATCCTGATTGATGAGCGCGTGCAGGTGACCGGACTTTTGGATTGGACGGAGTCCGAGGTAGCAAGTCCCGCCAAAGACTTCGTGTTATACTACGCTATTTATGGCGAGCATAATCTCCGTGTCCTGTTGGACCGGTATGAACAAGCCGGAGGGAAGGTATGGCCGCGCATGTTCGATCATATTGTCGAACAGCATGCCGCGTATCCCGTGCTGATCGCCCAGTTCGCTCTCCTGACAGGTCAGGAAGAGTATATGACGATGGCGCGGAATGCCTTGGGTTTGACAGAGTAA,MTIAKPNDDYTQVIQEMLEIAGKHGVNLIPEGIEMNESGMDFLVGFAEEAGTGARWILRKPRRPDVLDRADNEARVLKLIQSHLSVDVPDWWIYTPELIAYPLLSGQPAASVSMEGYAWNMDHENPGDGFIRSLAEALVALHGVDHDAARAAGLRVKSPQEVRDETARNMEDIKSRLGVSDALWERWQKWLEEDSYWPTHSALIHGDLHPPHILIDERVQVTGLLDWTESEVASPAKDFVLYYAIYGEHNLRVLLDRYEQAGGKVWPRMFDHIVEQHAAYPVLIAQFALLTGQEEYMTMARNALGLTE,MTIAKPNDDYTQVIQEMLEIAGKHGVNLIPEGIEMNESGMDFLVGFAEEAGTGARWILRKPRRPDVLDRADNEARVLKLIQSHLSVDVPDWRIYTPELIAYPLLSGQPAASVSMEGYAWNMDHENPGDGFIRSLAEALVALHGVDHDAARAAGLRVKSPQEVRDETARNMEDIKSRLGVSDALWERWQKWLEEDSYWPTHSALIHGDLHPPHILIDERVQVTGLLDWTESEVASPAKDFVLYYAIYGEHNLRVLLDRYEQAGGKVWPRMFDHIVEQHAAYPVLIAQFALLTGQEEYMTMARNALGLTE,100,gnl|BL_ORD_ID|2236|hsp_num:0,2527,FALSE,None
LK479,4_153 # 165540 # 165965 # -1 # ID=4_153;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.467,4_153,165540,165965,-,Strict,150,176.022,FosBx1,59.12,3007372,protein homolog model,n/a,n/a,phosphonic acid antibiotic,antibiotic inactivation,fosfomycin thiol transferase,ATGAAACTGCAGGCTATTAACCATCTCTGTTTTTCTGTTTCGGAATTGGAACGGTCCATCGCTTTTTATAGGGACGTATTTGAAGCCAAACTGCTGGTTAAAGGGAGAAAGCTGGCTTATTTTGATCTGAACGGACTGTGGATTGCTTTAAATGAAGAAGATGTCGACAGGAGCACCTCGAATAGAACATATACGCATATTGCCTTTACTATGGAAGAGGAGGAGTATGAAACAACGCTGCTTCGTCTGCAAGCGCTCCAGGTGGAGATTCTGCCGGGAAGGGCAAGGGACGAGAAGGACAAGAAGTCGATCTACTTCCTGGACCCGGATGGGCATATGTTCGAGTTTCATACGGGCTCCATGAATGACAGGCTGGACTATTACCGCGCGGATAAAGAGCATATGACCTTTTACGATGCCGAATAG,MKLQAINHLCFSVSELERSIAFYRDVFEAKLLVKGRKLAYFDLNGLWIALNEEDVDRSTSNRTYTHIAFTMEEEEYETTLLRLQALQVEILPGRARDEKDKKSIYFLDPDGHMFEFHTGSMNDRLDYYRADKEHMTFYDAE,MLRGINHICFSVSNLENSIMFYEKVLEGELLVKGRKLAYFNICGVWIALNEETHIPRNEIHQSYTHIAFSVEKEDFKCLIQRLEENDVHILQGRERDVRDCESIYFVDPDGHKFEFHSGTLQDRLNYYRDEKPHMTFY,102.17,gnl|BL_ORD_ID|4909|hsp_num:0,5900,FALSE,None
LK479,4_406 # 407909 # 409855 # -1 # ID=4_406;partial=00;start_type=ATG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.553,4_406,407909,409855,-,Strict,1200,1315.44,TaeA,99.38,3003986,protein homolog model,n/a,n/a,pleuromutilin antibiotic,antibiotic efflux,ATP-binding cassette (ABC) antibiotic efflux pump,ATGAATATTTTGACCGTCGAACAGGTAACAAAAAGCTATGGAGACAAAATTCTGTTTCAAGATGCATCCTTCGGAATGGAGGATCAGGATAAAATCGGCATTATCGGCGTGAATGGCACGGGGAAATCCACATTTCTGCGGGTCATCGCGGGGCTCGAACCGCCCGACTCCGGTAAAATATCGATGGGCAATCGCATCCGGGTTCGTTACCTCGCGCAGAATCCGGAGTTTGATCCGGACAAAACCGTCCTGCAGCAGGTGTTTGAGGGCGATCTTCCGGAGATGAAGGCCGTGCGGGAATACACTGAAACGATGGAACTGCTGGAGCTGCATCCAAGTCATGAGGAGCTCCAGCAGAAACTGCTGAAGCTCAATCAGACGCTGGATACGCTGCAGGCATGGCAGCTTGAAAGCGATGCGAAAACCATCCTGTCCAAGCTGGGGATTCGGAATTATGAAGCGAAGATGGGGACGCTGTCGGGCGGCCAGCGTAAGCGGGTGGCATTAGCCGCCGCCTTGATTCAGCCTTCCGACTTGCTTATTTTGGACGAGCCGACCAACCACATTGACAATGAATCCGTTGCCTGGCTGGAGCAGTATTTGCAGAAGCGCCGCGGCGCGCTGCTCATGATTACGCATGACCGGTATTTTCTGGACCGGGTGGCCAATGTTATGCTGGAGCTGGATCACGGACGGCTGTTTCGATATGAGGCGAATTACAGCCGTTTTCTGGAGCTGAAGGCAGAACGCGAGGAGCGTGAAGCCGCTTCCGAGCAAAAGCGCCAAAATTTGCTGCGGAGCGAGCTTGCCTGGATCCGCAGAGGGGCCAAGGCCCGCACGACCAAGCAGAAGGCGAGGATTGAACGTTTCGAGAAACTCAAGGATCAGGAGATGGTACACAGCTCCGGTGAACTGGACGTTTCGGTCGCTTCCACCCGCTTGGGACGCAAAATTCTGGAGATTGAAGGTCTCCGGATGAAGATCGACGACAAAACGTTAATTCAGGACCTTTCCTATATCGCCGTTCCCGAGGATCGGATAGGTATCGTAGGCCCGAATGGCAGCGGCAAATCCACACTGCTCAATCTGATTGCCGGGCGGATTCAGCCGGGTGGCGGGGAAGTCGTGCTCGGACCGACGGTCAAGCTCGGTTATTTCACGCAGGAGCATCAGGAGATGGACGGCAGTCAGCGCGTGATTGAGTATATCAAGGATGAGGCCGAGGTTGTCCGCACGGCGGACGGTTCGGCGATTACCGCAGCCCAGATGCTGGAACGCTTTCTGTTCCCGCCCGCGCTGCAGTGGACGCCGATTGCGAAGCTGTCCGGAGGCGAGAAGCGCCGCTTGTATCTGCTGCGGGTGCTGATGAGCGCACCGAATGTGCTGCTGCTTGATGAACCGACCAATGATTTGGATATCCAGACATTGTCCGTCCTGGAGCAGTATTTGGATGAGTTCCCGGGCGTCTGTATCGTGGTATCCCATGATCGCTTTTTCCTGGATCGAACCGTGGACAAGATTATGGCCTTTGAGGGCGACGGTCAGATTCGTGTCCATGTGGGCTCTTACAGCGAATATGCGGAATGGATGCAGCGTCACGGCGGTGAAGCTGCCGGGAGCAAGGCGGAAGCATCCATAGCCAAATCTGCTTCGGGGAGCAGCGATGGCACGGACAGCGATTCAGCTAAAGAAGCGCCGCGTGAGCGCTTGAAATTCAGTTACAAAGAACAACGGGAGTTTGAGCAGATTGACGGGCTCATCGAGGATACCGAGAGCAAGCTCGTTTCGATTCAATCCGAGATGGAGACCGCCGGCAGCGACGCAGCCAGGCTTCAGGAGCTGATGAAGGCTCAGGAGGAAACGGAGCGTGAACTGGAGCATCTGATGGAACGCTGGACCTATCTGAACGAGCTCGCGGAGAAGATTGAACAGAGCAAGAAATCGTAA,MNILTVEQVTKSYGDKILFQDASFGMEDQDKIGIIGVNGTGKSTFLRVIAGLEPPDSGKISMGNRIRVRYLAQNPEFDPDKTVLQQVFEGDLPEMKAVREYTETMELLELHPSHEELQQKLLKLNQTLDTLQAWQLESDAKTILSKLGIRNYEAKMGTLSGGQRKRVALAAALIQPSDLLILDEPTNHIDNESVAWLEQYLQKRRGALLMITHDRYFLDRVANVMLELDHGRLFRYEANYSRFLELKAEREEREAASEQKRQNLLRSELAWIRRGAKARTTKQKARIERFEKLKDQEMVHSSGELDVSVASTRLGRKILEIEGLRMKIDDKTLIQDLSYIAVPEDRIGIVGPNGSGKSTLLNLIAGRIQPGGGEVVLGPTVKLGYFTQEHQEMDGSQRVIEYIKDEAEVVRTADGSAITAAQMLERFLFPPALQWTPIAKLSGGEKRRLYLLRVLMSAPNVLLLDEPTNDLDIQTLSVLEQYLDEFPGVCIVVSHDRFFLDRTVDKIMAFEGDGQIRVHVGSYSEYAEWMQRHGGEAAGSKAEASIAKSASGSSDGTDSDSAKEAPRERLKFSYKEQREFEQIDGLIEDTESKLVSIQSEMETAGSDAARLQELMKAQEETERELEHLMERWTYLNELAEKIEQSKKS,MNILTVEQVTKSYGDKILFQDASFGMEDQDKIGIIGVNGTGKSTFLRVIAGLEPPDSGKISMGNRIRVRYLAQNPEFDPDKTVLQQVFEGDLPEMKAVREYTETMELLELHPSHEELQQKLLKLNQTLETLQAWQLESDAKTILSKLGIRNYEAKMGTLSGGQRKRVALAAALIQPSDLLILDEPTNHIDNESVAWLEQYLQKRRGALLMITHDRYFLDRVANVMLELDHGRLFRYEANYSRFLELKAEREEREAASEQKRQNLLRSELAWIRRGAKARTTKQKARIERFEKLKDQEMVHSSGELDVSVASTRLGRKILEIEGLRMKIDDKTLIQDLSYIAVPEDRIGIVGPNGSGKSTLLNLIAGRIQPGGGEVVLGPTVKLGYFTQEHQEMDGSQRVIEYIKDEAEVVRTADGSAITAAQMLERFLFPPALQWTPIAKLSGGEKRRLYLLRVLMSAPNVLLLDEPTNDLDIQTLSVLEQYLDEFPGVCIVVSHDRFFLDRTVDKIMAFEGDGQIRVHVGSYSEYAEWMQRHGGEASGSKAEASIAKSASGSSDGTDSDSAKEAPRERLKFSYKEQREFDQIDGLIEDTESKLASIQSEMETAGSDAARLQELMKAQEETERELEHLMERWTYLNELAEKIEQSKKS,100,gnl|BL_ORD_ID|2232|hsp_num:0,2522,FALSE,None
LK479,5_185 # 205299 # 206189 # 1 # ID=5_185;partial=00;start_type=ATG;rbs_motif=AGGAGG;rbs_spacer=5-10bp;gc_cont=0.539,5_185,205299,206189,+,Strict,550,593.964,vgbC,97.97,3003990,protein homolog model,n/a,n/a,streptogramin antibiotic; streptogramin B antibiotic,antibiotic inactivation,streptogramin vgb lyase,ATGCAGATCGCCGCACAGGAATACAAGACAGCGAATCGGGAATCGGGACCTTATGGTATTACGGCAAGACAAGATGGGACCATATGGTTCACGGAACAAAAAGGAAACCGGATCGGACGGCTCACCAAGGATGGGGATATGCGCACGTTCGAAGTGCCGACTCCGGATGCCGGGGTCATGTCCATCCTCTCTGCCCATACCGGTGACCTCTGGTTTACGGAGTACAAAGCGAATAAAATCGGAAGAATGACAATGGAAGGAACATTTACGGAATTCGAACTGCCTGAAGCCAATTCGTCCCCTTACGGCCTGGCGGAGGGTCCGGATGGAGTCATGTGGTTCACCGAGCTAAGCGGCAACCGAATCGGAAGGATAACGCCGGCAGGCATTATTACGGAATATGACTTACCATGCGAAGGATCGTACCCTTCCTATATTACAGCCGGTCCGGACGGCGCGTTGTGGTTTACGGAAAACCAGAACAACTGCATCGGCCGAATTACGGTGGACGGGAAGATTACCGAATACCGAATTCCAACAGAGCAATCCGGGCCGGTCGGCATCACGACAGGTGCCGATGGCGCTCTATGGTTTGTTCAAATCAATGGCAATCAAATCGGTCGAATCACAACGGCCGGGGAAATTACGGAATTCAGGCTCCCGTCCGGGAATGCCAGACCCCATGCCATCACGGCGGGCGTTTCCGGGGATCTATGGTTTACCGAATGGGGAGCCAATCAAATCGGACGAATTACCTGTACCGGGGACATTACCGAGTATCCAATCCCTACCCCCTCCGCAGAACCTCATGGCATAACCGTGGATTCCGGCGGCGAGGTCTGGTTCGCCGAGGAATGCGATCAGATCGGCCGGTTTACGATTCAGTATTAG,MQIAAQEYKTANRESGPYGITARQDGTIWFTEQKGNRIGRLTKDGDMRTFEVPTPDAGVMSILSAHTGDLWFTEYKANKIGRMTMEGTFTEFELPEANSSPYGLAEGPDGVMWFTELSGNRIGRITPAGIITEYDLPCEGSYPSYITAGPDGALWFTENQNNCIGRITVDGKITEYRIPTEQSGPVGITTGADGALWFVQINGNQIGRITTAGEITEFRLPSGNARPHAITAGVSGDLWFTEWGANQIGRITCTGDITEYPIPTPSAEPHGITVDSGGEVWFAEECDQIGRFTIQY,MQIAAQEYKTANRESGPYGITARQDRTIWFTEQKGNRIGRLTKDGDMRTFEVPTPDAGVMSILSAHTGDLWFTEYKANKIGRMTMEGTFAEFELPEANSSPYGLAEGPDGAIWFTELSGNRIGRITPAGIITEYDLPCEGSYPSYITAGPDGALWFTENQNNCIGRITVDGEITEYRIPTEQSGPVGITTGADGALWFVQINGNQIGRITTAGEITEFKLPSGNARPHAITAGVSGDLWFTEWGANQIGRITCTGDITEYPIPTPSAEPHGITVDSGGEVWFAEECDQIGRFTIQY,100,gnl|BL_ORD_ID|2246|hsp_num:0,2526,FALSE,None
LK479,6_185 # 205801 # 206286 # 1 # ID=6_185;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.504,6_185,205801,206286,+,Strict,300,325.479,cpaA,98.14,3003994,protein homolog model,n/a,n/a,aminoglycoside antibiotic,antibiotic inactivation,cpa acetyltransferase,ATGCCTCTTCGTATCACGGCCATGACCGAAACGTATGCCGATCAAATTATGCAATGGAGCTATGAACCTCCCTATGATTTCTACAACAGCGAACCGGATGAGGAGTTCCGGAAAGAACTTCTGGAGTGTTCGTATTACGCCATACTGGACGAGGTAGGGCAGCTCTTCGGCTTTTGCTGTACAGGCTCATCAGCCCAAATTCCGATCGCAATCCCGTTAGGTGCATATGACGAGGATCTGCTGGATTTCGGACTTGGGATGAAACCGGAATCGACCGGACAAGGCCGGGGAAAAGAGTTTCTCTCGTTCGTGCTGGCATCCATCGCTGAATTTCACAAGCGCCAATCGTTTCGGCTGACCGTTGCCAAATTCAATGAACGAGCCATTCGCTTGTATACCCAGCTGGGCTTCTCGGAAGTTGCAACGTTTGATTATGGCGGCACTACGTTCATAACGATGATCAAGAAGCCGGGCTCCGGATTGTAA,MPLRITAMTETYADQIMQWSYEPPYDFYNSEPDEEFRKELLECSYYAILDEVGQLFGFCCTGSSAQIPIAIPLGAYDEDLLDFGLGMKPESTGQGRGKEFLSFVLASIAEFHKRQSFRLTVAKFNERAIRLYTQLGFSEVATFDYGGTTFITMIKKPGSGL,MPLRITAMTETYADQIMQWSYEPPYDFYNSEPDEEFRKELLECSYYAILDKEGQLFGFCCTGSSAQIPIAIPLGAYDEDLLDFGLGMKPESTGQCRGKEFLSFVLASIAEFHKRQSFRLTVAKFNERAIRLYTQLGFSEVATFDYGGTTFITMIKKPGSGL,100,gnl|BL_ORD_ID|2238|hsp_num:0,2529,FALSE,None
LK479,7_100 # 103575 # 105833 # -1 # ID=7_100;partial=00;start_type=TTG;rbs_motif=AGGAGG;rbs_spacer=5-10bp;gc_cont=0.493,7_100,103575,105833,-,Strict,1450,1513.82,BahA,97.87,3003984,protein homolog model,n/a,n/a,peptide antibiotic,antibiotic inactivation,Bah amidohydrolase,TTGGAAATTCACAAAGAGAAAGAAAAAGAAAAAGGCGTTACTTTTTTTCGAAGAATCATGGCAAACCGGAAGCGACTTAGGCCGTTGTCCCCGGGGTGGAAAGGTGCGTCGCTTGGGCTCGGCGCCACCGGCTTTATTCTTATTCTGATACAGGCCAACTATCTATTGATGGGGCATGGTATCGCGATATTCAGCGTAGGCACATTCCTGTTTCTCTTTGCGGCAGCCCTTATAAGCGGCCTAGCATCAATGTTGCTGCATGGGGTCAAGAAACTACCAAGCCGTTATATTTGGATGTTGCTGTATTCCCTGATCATGTTTTTGTTCTGTTTTATTGTGCAGCCGGGCGTATCGGCAGTCTTCATCGTCTCTTTGGCCATTGTTTTATCTTTATTTGGTGCATTGGCTTATAAATTTGCAGCGGGAAGCTACAAGCAAGTGTCTAAAACCAGGAAAATCGGCGCGATGACCTGTTTGTCCTTGATCACCATCGCGATCTGCGCGGGCAGCTTCTGGCTGATTCGGGCCGGAGATGATGCCGCTCCGGACATCACATTGAAACAGCTGAAAACCTCAACCCGGTATGTAGATTCGACGATGAATAACCCGGCCGAACAAGGTGAGTATCCCGTCCAAAGCCTGTTATACGGAAGTCCTGACAACTATCGGACAGAATTTAACCAAAGCGGTTCCCTAACCACCCAAACGGTGGATGCGTCCAGGTTTGTTGAGAAATGGTCGTCGTTGCGCACGAAGTCGCTTGGGTTCGGACCCGAGGCCATGCCGTTAAACGGAAGAGTGTGGTATCCCGAAGGGGAGGGCACCTTTCCGCTTGTTTTGATTGTACATGGCAATCACTTAATGAATGATTATTCCGATCCGGGTTATGAATATCTCGGCAGGCTGCTCGCGAGCAAAGGGTATATATTTGTCTCCGTGGATGAAAATTTCCTCAATTTCTCCCCATATGAGGATCTATTCCTGATCAGCCCGCTGCTAAGTGAAAATCCGGCAAGGGGTCTGCTGCTGCTGGAGCATTTGCAAACCTGGAAGGACTGGAACAGCGATCCGGACAACCCGTTTTACCAAAAGGTCGATATGGAACGAATCGCCCTCATCGGTCATTCCCGGGGCGGCGAAGCGGTCGCGATCGCGGCAGCGTATAACAAACTTGGCCGTCATCCGGACCATGGGGATATCAAGTTTGATTATAACTTTTCGATCCGCTCGCTCATTTCCATTGCGGGAACGGACGGGCAATATAAGCCCCAAGGCAAACCTCTGCCGCTGCAAGACGTAAATTATCTGTCTTTGCATGGAGCTCATGATATGGATGTCAACAGCCTGGACGGTGCGAAGCAATATCACCGGATTCGTTATACCAAGGGCACAAATTACATGAAATCGCTGGTCTATATTTATGGAGCCAACCACGGCCAGTTTAACGGAGGCTGGGGCAGAGGGGATGGGGCAGGGTTGGGGAACCAACTGTTTAACCTACGTCAAATTATGCCACGGGATGAGCAGGAAACCATCGCAAAAGTGTTCATATCTTCGTTCCTGGATGCCACGCTGAAGGACCAACGGCAATTTAGGGAGGTGTTCAAGGATTTGGGTTACGCCAAGGAATGGATTCCCGACAATCTGTATGTGGGCAATTATTACGATTCGCAGACGACCTTGATCGCCGATTTTCATGAAGACATCGATCTGCTGAGCACCACGCTTCCTGGCGGCAGCCTGCGGGGCGAGAACCTGCAGCAATGGAAGGAAGAAAAGGTTAAGACAAAATGGGGCGAAGCGGATTACAGCGCGGTTCGCTTAGGCTGGAATTCGAACGGTTCGTCCGAGCCTGCGTCCTATACGGTTACTTTGCCGGATAACGGGGTGGAAACAGGAAGGGATAGCTCGATCGTATTTTCGCTGGCAGATGCACGCAAAACAGAAGAAAGCGGCGACCCGAAAGAGCTTATCAATTTTACGATTACGGTTGAAGATAGGAAGGGCCATCAGGCAACTCTTCCCCTCAGCCACATATCCAAGTTGCCGCCTGTTATTGAAGGTAAACTTCTCAAATGGCCATTTTCGTATGCAGGCAATACTTCAGAACCCGTATTTCAAAGTTATGATTTCCAATTAGACGATTATCACAAAATGAATCCGGACTTCAACCCGCAGCAGTTGAGCAAGATTCGCATCGAGTTCAATCTAACCAAGCGGGGAAGCATTCTGCTTCGTGATGTTGGCATTCGATCATAA,MEIHKEKEKEKGVTFFRRIMANRKRLRPLSPGWKGASLGLGATGFILILIQANYLLMGHGIAIFSVGTFLFLFAAALISGLASMLLHGVKKLPSRYIWMLLYSLIMFLFCFIVQPGVSAVFIVSLAIVLSLFGALAYKFAAGSYKQVSKTRKIGAMTCLSLITIAICAGSFWLIRAGDDAAPDITLKQLKTSTRYVDSTMNNPAEQGEYPVQSLLYGSPDNYRTEFNQSGSLTTQTVDASRFVEKWSSLRTKSLGFGPEAMPLNGRVWYPEGEGTFPLVLIVHGNHLMNDYSDPGYEYLGRLLASKGYIFVSVDENFLNFSPYEDLFLISPLLSENPARGLLLLEHLQTWKDWNSDPDNPFYQKVDMERIALIGHSRGGEAVAIAAAYNKLGRHPDHGDIKFDYNFSIRSLISIAGTDGQYKPQGKPLPLQDVNYLSLHGAHDMDVNSLDGAKQYHRIRYTKGTNYMKSLVYIYGANHGQFNGGWGRGDGAGLGNQLFNLRQIMPRDEQETIAKVFISSFLDATLKDQRQFREVFKDLGYAKEWIPDNLYVGNYYDSQTTLIADFHEDIDLLSTTLPGGSLRGENLQQWKEEKVKTKWGEADYSAVRLGWNSNGSSEPASYTVTLPDNGVETGRDSSIVFSLADARKTEESGDPKELINFTITVEDRKGHQATLPLSHISKLPPVIEGKLLKWPFSYAGNTSEPVFQSYDFQLDDYHKMNPDFNPQQLSKIRIEFNLTKRGSILLRDVGIRS,MEIHKEKEKEKGVTFFRRIMANRKRRGPLSPGWKGASLGLGATGFILILIQANYLLTGHGVGKFIVGTFLFLFAAALISGLASMLLHGVKKLPSRYIWMLLYSLIMFLFCFIVQPGVSAVFIVSLAIVLSLFGALAYKFAAGSYKQVSKTRKIGAMACLSLITIAIGAGSFWLIRAGDDAAPDITLKQLKTSTRYEDSTMNNPAEQGTYPVQSLLYGSPDNYRTEFNQSGSLTTQTVDASRFVEKWSSLRTKSLGFGPEAMPLNGRVWYPEGEGTFPLVLIVHGNHLMNDYSDPGYEYLGRLLASKGYIFVSVDENFLNFSPYEDLFLISPLLSENPARGLLLLEHLQTWKDWNSDPDNPFYQKVDMERIALIGHSRGGEAVAIAAAYNKLGRHPDHGDIKFDYNFSIRSLISIAGTDGQYKPQGKPLPLQDVNYLSLHGAHDMDVNSLDGAKQYHRIRYTKGTNYMKSLVYIYGANHGQFNGGWGRGDGAGLGNQLFNLRQIMPRDEQETIAKVFISSFLDATLKDQRQYREVFKDLGYAKEWIPDNLYVGNYYDSQTTLIADFHEDIDLQSTTLPGGSLRGENLQQWKEEKVKTKWGEADYSAVRLGWNSNGSSEPASYTVTLPDNGVETGRDSSIVFSLADARKTEESGDPKELINFTITVEDRKGHQASLPLSHISKLPPVIEGKLLKWPFSNAGNTSEPVFQSYDFQLDDYYKMNPDFNPQQLSKIRIEFNLTKRGSILLRDVGIRS,100,gnl|BL_ORD_ID|2231|hsp_num:0,2521,FALSE,None
LK479,7_262 # 310983 # 311765 # 1 # ID=7_262;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.475,7_262,310983,311765,+,Strict,50,102.064,vanY gene in vanB cluster,34.9,3002956,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCACAAAAAAATCGGAAAATCCATCATACCCACAGTCATCATCGGTACCGTTGTCACAAGCCTAGCCTTATCCAGTTTTCTAAGCAGCACCGGCATCGGCAAGGCGGAAGCAGCCGCTGCAGCTTCTTCCAGCTTATCATTTACTGCGTTTTTGGAAAACAACGCTCCTAACCGGACTATAAAAACGGTTCATGGTTTAAATATGGTCACCAATCTATCAAGCACCGTCGTACTCGTCAACAAGCAAAGAAATCTACCATCGAGTTATGTTCCGCAAGACTTGGTTGTACCCCGCATTCCATTCAGCTTCTCGGGACCCAGTCCTAAGAAACAGATGAAACGAGTAGCGGCAACTGCGCTCGAAAAATTGTTTGCGGCAGCCAAAAAAGACGGAATCGATCTCAAAGCTGTATCAGGCTACCGATCCTATGCCACCCAGAAGGCCATATTCGAACGCAACGCCCGTAATAAGGGCGAAGCCGCTAATAAAACAAGCGCTCGTCCTGGACAAAGCGAGCATCAGACCGGGCTGAGCATGGATATATCCAGTGCTTCCGTAGGGTATGCATTGGAGCAAAGCTTCGGAAATACCAAAGAAGGCAAATGGCTGAAAGCTAATGCACCGAAGTACGGATTTATCATTCGTTACGGAAAAGGCAAGGAGAAATTAACCGGCTATTCTTATGAGCCCTGGCATGTCCGTTACGTGGGCGTCTATATTGCAGGAGAAATCACGAGACAAAACCTGACGCTTGAGCAGTATCTGGGTCAATCCCATTAA,MHKKIGKSIIPTVIIGTVVTSLALSSFLSSTGIGKAEAAAAASSSLSFTAFLENNAPNRTIKTVHGLNMVTNLSSTVVLVNKQRNLPSSYVPQDLVVPRIPFSFSGPSPKKQMKRVAATALEKLFAAAKKDGIDLKAVSGYRSYATQKAIFERNARNKGEAANKTSARPGQSEHQTGLSMDISSASVGYALEQSFGNTKEGKWLKANAPKYGFIIRYGKGKEKLTGYSYEPWHVRYVGVYIAGEITRQNLTLEQYLGQSH,MEKSNYHSNVNHHKRHMKQSGEKRAFLWAFIISFTVCTLFLGWRLVSVLEATQLPPIPATHTGSGTGVAENPEENTLATAKEQGDEQEWSLILVNRQNPIPAQYDVELEQLSNGERIDIRISPYLQDLFDAARADGVYPIVASGYRTTEKQQEIMDEKVAEYKAKGYTSAQAKAEAETWVAVPGTSEHQLGLAVDINADGIHSTGNEVYRWLDENSYRFGFIRRYPPDKTEITGVSNEPWHYRYVGIEAATKIYHQGLCLEEYLNTEK,97.01,gnl|BL_ORD_ID|602|hsp_num:0,556,FALSE,None
LK479,7_269 # 319746 # 320468 # -1 # ID=7_269;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.499,7_269,319746,320468,-,Strict,450,497.664,AAC(2')-IIb,99.17,3003988,protein homolog model,n/a,n/a,aminoglycoside antibiotic,antibiotic inactivation,AAC(2'),ATGAACCATAGGAAAGGTAACGAGCCAACCGCTGCGGCACTGATGGAATTGCATGTTCGGGCGATGTTTACGCATGACGGGAATATGCAAATTCGCACCATCAACGAGCCTTGGCCGGGAGAGGAGCTTGCCCCGAGGTTTTTCATGGGTCGAACGATAGACGGCTCTTCGATCTGCAGGTTTCGTCATGATGTTCCCGAAGGAATTGCCGGGCAATTGAGGGCTTTGGTTGAAGATGAGCCTATCGTTACTGAAGAGGTTCTGACGAGGCCTAAACATTTTGCAGCTTATATGAACCTCCTTCGCGCTGAGCACTATACGAGTGGACCTTGTTATCGGATACCTGATCAAACAACGCAGGCCAAACAGACGGTAAGGATCACATCGGGAAATATTCGCGAATATTCGCTCACCGGTTTTGAATGGCTGACCACGGAAATTGATTATGACCAGCCTTGTGTTGCGCTCATTCATGAGAATAGGGTGGTGTCGGTTTGCCGCAGCGTCCGGATTACTGAACGAGCTCACGAAGCTGGGCTTGAAACGTCAGAGGAATTTCGTGGAAGAGGTTATGCGGCTGCTGTTGTTGCCGGATGGGCCATAGAGGTGCAAAAAATGGGCGCGCTGGCGTTGTACAGTACTTTATGGGGAAATAGCTCTTCCCGGAGAGTAGCAAATAAATTAGGGTTGTCCTATTACGGAGTTAACTTCACGATCAGTTGA,MNHRKGNEPTAAALMELHVRAMFTHDGNMQIRTINEPWPGEELAPRFFMGRTIDGSSICRFRHDVPEGIAGQLRALVEDEPIVTEEVLTRPKHFAAYMNLLRAEHYTSGPCYRIPDQTTQAKQTVRITSGNIREYSLTGFEWLTTEIDYDQPCVALIHENRVVSVCRSVRITERAHEAGLETSEEFRGRGYAAAVVAGWAIEVQKMGALALYSTLWGNSSSRRVANKLGLSYYGVNFTIS,MNHRKGNEPTAAALMELHVLAMFTHDGNMQIRTINEPWPGEELAPRFFMGRTIDGSSICRFRHDVPEGIAGQLRALVEDEPIVTEEVLTRPKHFAAYMNLLRAEHYTSGPCYRIPDQTTQAKQTVRITPGNIREYSLTGFEWLTTEIDYDQPCVALIHENRVVSVCRSVRITERAHEAGLETSEEFRGRGYAAAVVAGWAIEVQKMGALALYSTLWGNSSSRRVANKLGLSYYGVNFTIS,100,gnl|BL_ORD_ID|2234|hsp_num:0,2524,FALSE,None
LK479,8_121 # 127753 # 128655 # 1 # ID=8_121;partial=00;start_type=TTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.477,8_121,127753,128655,+,Strict,50,318.546,vanY gene in vanF cluster,53.62,3002958,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,TTGAAAAAGGGTTTGATCATGCTCGTTATATTTCTGTTGGTCGGATGCGAGTCCATTCTGACGGAGACGCCTAACGTGAAGGATAGGGTGGACAGTAGAGATGGACAGGAAGTGAAGACGGATTCCGGCACGCAATCGAATCAGACATCCGCTACGCAGACGATCCGTGTAACGGATGAACAAGTGACACGTGGAAATTTGGTTCTGGTTAATAAGGAGCAACCGCTTGATCCGGAAGCGGTGCCGAAGGATATCGTAACATTGTTTGAAAACCAAGACTTAATGCATGGTTATGTGGTTCTGGATAACACGATCCGGTTATCGCGCAGTGTGGCGGAGAATTTCCGTAATATGATTGAAGCCGCCGGAGAAGATGGAGTCAATCGCTTCATGATCAGCAGCGGGTATCGGGATGAAGACGAGCAAGAACAACTTTATCGTGAAAAAGGTTCCGATTACGCCTTGCCTCCAGGCTACAGCGAGCATAATCTCGGGCTCTCGATGGATATCGGATCGACTCAGCAGTCGATTGATCGATCGCCCGAAGGGAAATGGCTGAAGGAGCATGCATGGGCGCACGGATTCATTTTGCGCTATCCTCAGGACAAGACAGAGATTACAGGTATTCAGTATGAACCGTGGCATTTTCGTTATGTCGGGCAGCCGCACAGCATGATCATGAAGGAACTGAATCTTACCTTGGAGGAATATCTGGATTACCTAAAGGATCAATCCAGCTACAGAACAACCGTAGAGGGGAAGGAATACGAAATTAAGTATGTACCCGTGACATCCAAAGACATGGAGATTGAGATACCGGCAGGAAGCGAGTATGAGATATCTGGAAACAATATCGACGGAATCATAGTGACGGTACTGCTAAGCAAGGATGATGCGGAATGA,MKKGLIMLVIFLLVGCESILTETPNVKDRVDSRDGQEVKTDSGTQSNQTSATQTIRVTDEQVTRGNLVLVNKEQPLDPEAVPKDIVTLFENQDLMHGYVVLDNTIRLSRSVAENFRNMIEAAGEDGVNRFMISSGYRDEDEQEQLYREKGSDYALPPGYSEHNLGLSMDIGSTQQSIDRSPEGKWLKEHAWAHGFILRYPQDKTEITGIQYEPWHFRYVGQPHSMIMKELNLTLEEYLDYLKDQSSYRTTVEGKEYEIKYVPVTSKDMEIEIPAGSEYEISGNNIDGIIVTVLLSKDDAE,MKKWGLLLVFALFLVFIFNILPISQDKVEDRIYEQNDKDTSDDKMTAENMQKIELTEEQIYQGNLLLVNNEHPVHQKSIKSDIINLFTHKELTKGYGLLDNEIKLSEEIAGKFSEMIAAAEEDGVSNFLISSGYRDLDEQSRLYEEMGSDFALPAGHSEHNLGLSLDVGSTQMKMDKAPEGKWIEKNCWEYGFILRYPLDKTDVTGIQYEPWHIRYVGLPHSAIMQEMNLALEEYLDYLKEEKSISVRVDGKKYTISYDPISQNETIEVEVPADEQYEISGNNIDGVIVTTFS,102.39,gnl|BL_ORD_ID|1808|hsp_num:0,1899,FALSE,None
LK479,8_317 # 328345 # 330291 # -1 # ID=8_317;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.511,8_317,328345,330291,-,Strict,400,509.22,tetB(P),42.75,3000195,protein homolog model,n/a,n/a,tetracycline antibiotic,antibiotic target protection,tetracycline-resistant ribosomal protection protein,ATGAAGAACATATTGAATATTGGAGTTTTGGCCCATGTTGATGCCGGTAAAACCACACTAACGGAGCAAATCCTGTTCAGATCCGGCATTATTGACCAAGCAGGCTCCGTTGACCAAGGCAATACCATCACGGATTCGCTGGAGATTGAGCGAAGACGGGGCATCACGATAAAATCCGCTGCAGTATCCTTCATGCTGGGCGATCTAAAAATCAATCTGATCGATACGCCGGGACATGCCGATTTCATCTCGGAGGTCGAGCATTCACTGAGTGTGCTGGATGGCGTCATTCTGGTGATTTCCGCGGTTGAGGGCGTACAGGCCCAGACGCGGGTGCTCATGCAAACGCTGAAAGAACAACGGATTCCCACCCTTCTATTCATGAACAAGATCGATCGAATGGGCGCGAATTACCATAATGTCTTTACCATGATACGGAATCTGCTGGATGAACATATTTGCGAGATGAGCTCTGTAACTCATGAGGGCAGCGCAACCGTTCGGGTAGACGTGGCCGATCCCCATAACGCCGGGTGGGTCGAAATGTTGGCTCTGTCCAATGACGATCTGCTGAACGACTATGTCCAGGATATTCCCATATCACGCGAGCGGCTGCAGGGAGAATTACGCAGGCAAACCCAGCAAGGTAAAGCTTACCCTCTATTTGCAGGATCAGCAGCCAAAGGGATCGGCATCGAGCCGCTGCTTCATGCGCTTAGCGAATATTTCCCTGTTAATAACGCCTCGGAGCTTCAGCATGAATCGTTATCCGGCCTGGTGTTCAAAGTAATCAAATTTCCGAACGGAGAACGGAACGTATACCTCCGGCTGTTCGCCGGCAGTATCCAGGCGCGAGACGAGATTACGGTGATAACGCAGAATGGCAACATCACCATGTTCAAGGTAAAACACCTACATGCTCTGCACCACGGCAAATCCATACCGGTGAATCAGATCGATGCCGGAGACATTGCGATTCTCATGACCGATGAACTCAAGGTGGGCGACGTCATCGGTGCTGTTTCCGACAGGATGAAGAGGGTCCACTTTCAGAAGCCGCCGATTCAAATCCAGGTCTCGGCCAAGAATCCCGCGGAGGAGCATCAGCTTCACACGGCCTTAAGCGATCTCACCGAAGAGGATCCATTCCTGCAATATATCCAGGATTCGAAAACCAAGGAAAACATCATCCACGTATTCGGTAAAGTCCAGCAGGAAATTCTGCTGGAAACGATCCAGCAGCAATACGGCATCGAAGCAGTATTTTCAGCTCCGCGGGTCATTTGTATCGAGAAGCCTGTTGCTACCGGAGAGGCTGTTGAATTTATTGGCGAGTGTCCATTTTATGCAACGGTTGGCTTACGGGTTGAGCCTGGCGAGAGAGGAACCGGAATTCAGTATCGTCTGGAAGTGGAACTGGGCTCTCTCCCCTTATCCTTTCAGAAAGCGATCAAAGATACGGTGATTGAGGTGCTGCAGGAAGGTTTGTATGGATGGACCGTGACCGATATTATCGTGACGCTGACGCATACCGGTTACGCAAGTCCGGTTTCGACGGCAAAGGATTTTCGCAGCCTGACCCCGCTCGTCCTCATGGCTGCGCTGGGCAAAGCCGGAACGGAAGTCTACGAGCCTATCAACGTCATCCAATTCATTCTGCCTGAAATCAGCCTAAGCAAAGTATTGTCCAAGTTGGCGGCACTGGAAGGGACCTATCAGGAACCAACATTCCACAACCATGCTGTCCACGTTCATGGTACCATCCCCGTACGGACGACCGACTTGCTGAAAGCCGAAGTCCATTCCCTGACAAGCGGTGAGGGGATGCTCTCCGTTAAACCAGGAGGCTACGTGAAGGTGCAAGCCACCATCCCTGTGAATAAACGGCGACAAGTCAACCCGCTGAACCGCGGTGAATATATGCTTTATTTGAACAAGATCATGTAA,MKNILNIGVLAHVDAGKTTLTEQILFRSGIIDQAGSVDQGNTITDSLEIERRRGITIKSAAVSFMLGDLKINLIDTPGHADFISEVEHSLSVLDGVILVISAVEGVQAQTRVLMQTLKEQRIPTLLFMNKIDRMGANYHNVFTMIRNLLDEHICEMSSVTHEGSATVRVDVADPHNAGWVEMLALSNDDLLNDYVQDIPISRERLQGELRRQTQQGKAYPLFAGSAAKGIGIEPLLHALSEYFPVNNASELQHESLSGLVFKVIKFPNGERNVYLRLFAGSIQARDEITVITQNGNITMFKVKHLHALHHGKSIPVNQIDAGDIAILMTDELKVGDVIGAVSDRMKRVHFQKPPIQIQVSAKNPAEEHQLHTALSDLTEEDPFLQYIQDSKTKENIIHVFGKVQQEILLETIQQQYGIEAVFSAPRVICIEKPVATGEAVEFIGECPFYATVGLRVEPGERGTGIQYRLEVELGSLPLSFQKAIKDTVIEVLQEGLYGWTVTDIIVTLTHTGYASPVSTAKDFRSLTPLVLMAALGKAGTEVYEPINVIQFILPEISLSKVLSKLAALEGTYQEPTFHNHAVHVHGTIPVRTTDLLKAEVHSLTSGEGMLSVKPGGYVKVQATIPVNKRRQVNPLNRGEYMLYLNKIM,MKKIINIGIVAHVDAGKTTITENLLYYSGAIKSVGRVDLGNTQTDSMELERKRGITIKSSTISFNWNNVKVNIIDTPGHVDFISEVERSLNSLDGAILVISGVEGIQSQTRILFDTLKELNIPTIIFVNKLDRIGANFNKVFEEIKKNMSNKVVRLQEVYDVGSKAVYIKKLFDTCIINDDAINVLSDLDEAFLERYIGGIEPDKEEIQEKLSLYAREGSLYPVFCGAAAIGLGIEDLLDGICSYFPFASNDCESDLSGVVFKIERTSKNEKKVYVRLFGGKISVRDKIQVPNKEIAEKVKKINRLENGGVVEAQRIEAGDIGILYGLTSFQVGDVIGISNDKIKNISIAKPALKTTISAIDKEKNPELFKALTLLAEEDPLLAFAMNDIDKEIYVNLFGEVQMEILSSMLDDLYGIKVEFSNIETIYKETPKGFGASIMHMQEDLNPFWATVGLEIEPAGRGEGLRYISNVSVGSLPKSFQNAIEEAVIKTSKQGLFGWEVTDVKVTLSCGEFFSPASTPADFRNVTPMVFMEALYKAQTVLLEPLHEFELKIPQNALSKAVWDLETMRATFDNPIVIGDEFSIKGLIPVENSKEYKMKIASYTEGRGMFVTKFYGYKEASAEFSKARKKTTYDPLNKKEYLLHKLNAIRD,99.39,gnl|BL_ORD_ID|737|hsp_num:0,804,FALSE,None
LK479,9_253 # 286132 # 286764 # -1 # ID=9_253;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.415,9_253,286132,286764,-,Strict,400,431.795,VatI,99.52,3003987,protein homolog model,n/a,n/a,streptogramin antibiotic; streptogramin A antibiotic,antibiotic inactivation,streptogramin vat acetyltransferase,ATGACAGGACCGAATCCAAATGAGAGATATCCTATACCCGGAGATAACAATCTTCAGTTTATCAAGAACACGATTACAAAACCTAATATTATCGCAGGGGATTATTCATACTACTATGCCTTAAACGGAGAATCATTTGAGGATCAAGTATTGTATCATTATGAATTCATTGGAACTAAATTAATGATCGGCAAGTTTTGTTCCATTGCTTCCGAGGTCAGATTTATGATGGATGGAGGGAACCATCGGATGGACGGTTCTACCTTTCCATTTAATATCTTTGGAAACGGCTGGGAGAAATTCACTCCATCTTTGGATCAATTGCCGATCAAGGGAGATACGATCATTGGAAATGATGTGTGGATCGGAAGGCGTGCAACGATCATGTCGGGTGTAAGGATTGGCGACGGAGCTATCATTGCCGCTGAAGCTGTCGTTGTAAAGGATGTGGAGCCTTATACGATCGTTGGAGGCAATCCAGCGAAGGAGATCCGCAAGCGATATTCCACCGAAGTCATTCAAGAGTTATTGGATATTAAATGGTGGGATTGCGATATCGAAGTCATCAATCAATATATTGGCGCAATTGTAAGCGGAGATATGGACTTGCTTAGAAAAATGAGACAAAATTAG,MTGPNPNERYPIPGDNNLQFIKNTITKPNIIAGDYSYYYALNGESFEDQVLYHYEFIGTKLMIGKFCSIASEVRFMMDGGNHRMDGSTFPFNIFGNGWEKFTPSLDQLPIKGDTIIGNDVWIGRRATIMSGVRIGDGAIIAAEAVVVKDVEPYTIVGGNPAKEIRKRYSTEVIQELLDIKWWDCDIEVINQYIGAIVSGDMDLLRKMRQN,MTGPNPNERYPIPGDNNLQFIKNTITKPNIIAGDYSYYYALNGESFEDQVLYHYEFIGTKLMIGKFCSIASEVRFMMDGGNHRMDGSTFPFNIFGNGWEKFTPSLDQLPIKGDTIIGNDVWIGRRATIMSGVRIGDGAIIAAEAVVVKDVEPYTIVGGNPAKDIRKRYSTEVIQELLDIKWWDCDIEVINQYIGAIVSGDMDLLRKMRQN,100,gnl|BL_ORD_ID|2233|hsp_num:0,2523,FALSE,None
LK479,9_261 # 294552 # 297206 # -1 # ID=9_261;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.456,9_261,294552,297206,-,Strict,1500,1813.51,rphB,99.43,3003992,protein homolog model,n/a,n/a,rifamycin antibiotic,antibiotic inactivation,rifampin phosphotransferase,ATGCGTTCGTTGGTTCTCGATTTTCAGGAAATGGACAAAAAGCAGCTTGGGCTCGTTGGTGGAAAAGGGCTCCATTTAGGGGAATTATCAAAAATTGAGGGAATACGAGTTCCCGAAGGATTTTGCGTGACAACCATAGGATATCAAAGAGCCATCGAACAAAACGAAACGTATCAAGCTATGCTCAATCGACTAACCATGCTATCAGCAGAGGATCGAGATCAAATGGTTGAAATCAGCAGGAAGATCAGACAAACCATTATGGAGGTAGAAATTCCATCCGATGTAGTGACAGCAGTAACTCGCTATCTCTCCAGGTTTGGCGAGGAACAGGCTTATGCCGTACGATCCAGTGCAACTGCAGAAGATTTACCGCATGCCTCTTTTGCGGGTCAACAAGACACCTATCTAAACATCATCGGCGTCGATGCCATCTTGCAGCATATCAGCAAATGCTGGGCTTCCTTGTTTACAGATCGCGCGGTGATCTATCGCATGCAAAATGGATTTGACCATCGTCAAGTTTATTTATCCGTAGTCGTTCAAAGGATGGTTTTCCCCGAGGCTTCAGGGATATTATTCACCGCTGATCCGATGACTTCTAATCGAAAGCTGCTATCCATCGATGCCGGTTTCGGACTTGGAGAAGCACTGGTCTCTGGCTTGGTATCTGCCGATGGTTACAAAGTACGGGAAGGAGAAATCATCGAGAAGCGGATAGCAGCCAAAACATTGGCGATCTACGGACGAAAAGAAGGCGGAACAGAAACAAAGCAAATCGATCCCGATCAGCAAAAGTCACAAACACTTACGGATGAGCAAATTTTACAACTGGCACGCATCGGGAGACAGATTGAGGCTCATTTTGGCCAACCCCAAGATATCGAGTGGTGTTTGGCCCAGGATACCTTTTATATTGTCCAGAGTCGGCCAATCACGACGCTATACCCGATACCTGAAGCGAATGATCAAGAAAATCACGTATACGTATCTGTCGGTCATCAACAAATGATGACGGATCCCATGAAACCGCTGGGATTGTCTTTTTTCCTGCTAACGACTCCTGCACCCATGCGTACAGCTGGCGGAAGGTTGTTTGTTGATACTACGGCTATGCTGGCTTCACCGGTTAGCAGAGAAAATGTATTAAATACCCTGGGACAATCCGATCCACTCATCAAAGACGCTCTTATGACCATCTTAGAGCGAGGAGATTTTATAAAATCGCTACCCATCGCTGAAAATGAACAGACTCCCGGAAAAAACAATATATCGTCTGCGGGTTATCAACCGCCAATCGACCACGATCCGACAATCGTTTCTGATTTAATGGAACGTACTCAATCATCGATCGAAGTGTTGAAACAAAACATCCAAACGAAATCCGGATCCGATTTATTTGATTTTATATTGGAAGATATCCAGGAACTGAAGAAGAATTTATTTGACCCACAAAGCTCGGCTGTCATCATGGCTGCAATGAATGCTTCAACCTGGATCAACGAAAAAATGAATGAATGGTTAGGCGAAAAAAACGCAGCCGACACGCTTTCTCAATCCGTACCGGGCAATGTTACTTCGGAAATGGGTCTGGCGCTGCTGGATGTTGCAGACGTCATTCGTCCTTATCCGGAAATCATTGATTATTTGGAGCAAGCAAAAGATGATCACTTTTTGGATAAGCTGCTTACATTTGATGGCGGGCAGCAAGCTCAAGACGCGATCCTAGATTTTCTTGACAAATATGGCATGCGATGTGCTGGAGAAATCGATTTAACAAGAACTCGTTGGAGTGAAAAACCAATTGCGCTTGTTCCGTTGATTCTGGGTAACATCAAAAACTTCGAGCCTAATGCCAGCCATCGGAAATTCGAGCAAGGGCGGCAGGAAGCTTTGAAAAAAGAACAAGAGCTATTAGATCGATTGAAACAATTGCCGGACGGTGAAGGAAAAGCCCAAGAAACCAAACGAATGATTGACCTCATTCGGAATTTCATGGGTTATCGGGAATACCCGAAATACGGTATGGTAAATCGTTACTTTATTTATAAGCAGGCTTTACTGAAAGAGGCTGAACGACTCGTACAAGCGGGCGTTATTCATCATAAGGAAGATATATATTATCTCACTTTTGAAGAGCTTGACGAGGTCGTACGCACAAATAAACTGGATAACCCGGGTTCCATGGTCGAGCAGCAAGCAAAGCTTGCGATCAGACAGATGATCAGCAAACGAAAAGAGGAGTACAACGTATTTGAAAAACTAACTCCACCGCGCGTGATCACATCGGATGGCGAAATCATCGCAGGGGAGTACAAACGAGAAAATATCCCAGCCGAAGCTATTGTCGGCCTGCCTGTTTCTTCCGGAACGTTCGAAGGACGAGCGCGTGTCATCTTAAACATGGAAGACGCCGATCTCGAGGAAGGAGATATATTAGTCACCGCTTTTACCGACCCTAGCTGGACGCCTCTGTTTGTATCCATTAAGGGCTTGGTCACCGAAGTGGGCGGACTGATGACCCATGGAGCCGTTATCGCGCGTGAATATGGCTTATCGGCCGTTGTCGGCGTGGAGAATGCTACCAAACGGATAAAGGATGGGCAGCGCATTCGCGTACATGGGACTGAAGGGTATATTGAAATATTGTCATAG,MRSLVLDFQEMDKKQLGLVGGKGLHLGELSKIEGIRVPEGFCVTTIGYQRAIEQNETYQAMLNRLTMLSAEDRDQMVEISRKIRQTIMEVEIPSDVVTAVTRYLSRFGEEQAYAVRSSATAEDLPHASFAGQQDTYLNIIGVDAILQHISKCWASLFTDRAVIYRMQNGFDHRQVYLSVVVQRMVFPEASGILFTADPMTSNRKLLSIDAGFGLGEALVSGLVSADGYKVREGEIIEKRIAAKTLAIYGRKEGGTETKQIDPDQQKSQTLTDEQILQLARIGRQIEAHFGQPQDIEWCLAQDTFYIVQSRPITTLYPIPEANDQENHVYVSVGHQQMMTDPMKPLGLSFFLLTTPAPMRTAGGRLFVDTTAMLASPVSRENVLNTLGQSDPLIKDALMTILERGDFIKSLPIAENEQTPGKNNISSAGYQPPIDHDPTIVSDLMERTQSSIEVLKQNIQTKSGSDLFDFILEDIQELKKNLFDPQSSAVIMAAMNASTWINEKMNEWLGEKNAADTLSQSVPGNVTSEMGLALLDVADVIRPYPEIIDYLEQAKDDHFLDKLLTFDGGQQAQDAILDFLDKYGMRCAGEIDLTRTRWSEKPIALVPLILGNIKNFEPNASHRKFEQGRQEALKKEQELLDRLKQLPDGEGKAQETKRMIDLIRNFMGYREYPKYGMVNRYFIYKQALLKEAERLVQAGVIHHKEDIYYLTFEELDEVVRTNKLDNPGSMVEQQAKLAIRQMISKRKEEYNVFEKLTPPRVITSDGEIIAGEYKRENIPAEAIVGLPVSSGTFEGRARVILNMEDADLEEGDILVTAFTDPSWTPLFVSIKGLVTEVGGLMTHGAVIAREYGLSAVVGVENATKRIKDGQRIRVHGTEGYIEILS,MRSLVLDFQEMDKKQLGLVGGKGLHLGELSKIEGIRVPEGFCVTTIGYQRAIEQNETYQAMLNRLTMLSAEDRDQMVEISRKIRQTIMEVEIPSDVVTAVTRYLSRFGEEQAYAVRSSATAEDLPHASFAGQQDTYLNIIGVDAILQHISKCWASLFTDRAVIYRMQNGFDHRQVYLSVVVQRMVFPEASGILFTADPMTSNRKLLSIDAGFGLGEALVSGLVSADGYKVREGEIIEKRIAAKTLAIYGRKEGGTETKQIDPDQQKSQTLTDEQILQLARIGRQIEAHFGQPQDIEWCLAQDTFYIVQSRPITTLYPIPEANDQENHVYVSVGHQQMMTDPMKPLGLSFFLLTTPAPMRTAGGRLFVDTTAMLASPVSRENVLNTLGQSDPLIKDALMTILERGDFIKSLPIAENEQTPGKNNISSAGYQTPIDHDPTIVSDLMERTQSSIEVLKQNIQTKSGSDLFDFILEDIQELKKNLFDPQSSAVIMAAMNASTWINEKMNEWLGEKNAADTLSQSVPGNVTSEMGLALLDVADVIRPYPEIIDYLEQAKDDHFLDKLLTFDGGQQAQDAILDFLDKYGMRCAGEIDLTRTRWSEKPIALVPLILGNIKNFEPNASHRKFEQGRQEALKKEQELLDRLKQLPDGEGKAQETKRMIDLIRNFMGYREYPKYGMVNRYFIYKQALLKEAERLVQAGVIHHKEDIYYLTFEELDEVVRTNKLDNPGSMVEQQAKLAIRQMISKRKEEYNVFEKLTPPRVITSDGEIIAGEYKRENIPAEAIVGLPVSSGTVEGRARVILNMKDADLEEGDILVTAFTDPSWTPLFVSIKGLVTEVGGLMTHGAVIAREYGLPAVVGVENATKRIKDGQRIRVHGSEGYIEILS,100,gnl|BL_ORD_ID|2237|hsp_num:0,2528,FALSE,None
LK479,10_47 # 50952 # 52139 # -1 # ID=10_47;partial=00;start_type=TTG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.514,10_47,50952,52139,-,Strict,175,229.565,vanT gene in vanG cluster,38.21,3002972,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,glycopeptide resistance gene cluster; vanT,TTGCAAGCGATATATCGACCTACCCTGGCGGAGATCAACCTGGACCATCTGCGCGCCAACTATAACGCTTTTCGTGAGGCGCTGCCAAGCCACATGAAATTGCTTGCTTGTGTGAAGGCTAACGCCTATGGTCACGGAGCTGTAGAAGTGGCACGCGAACTTCAGCAATTGGGGGCGGCTTACTTAAGCGTAGCTTTCCTGGATGAAGCGCTCGAGCTTCGGCAAGGAGGCATCTCCAGCCCGATCCTGGTGCTCGGTTATACACCACCGGAGGCTGTAGAGATCGCTTATGAGCATGATGTAACCATAACCCTGTTCAGTTCGGAAGTGCTCCAAGCGATTAAGGCACTGCCGGTCCAGCCGGAGAAGCCACTCAAGGTACACATCAAGATTGACAGCGGAATGGGTCGTTTGGGCCTGCTTCCAGGCGAAGATGCAATTTCTTTTATAGAAGAAGTATTTTCACTGCCGCAGGTTGTTGTCGAAGGAATGTTTACCCATTTTGCAAGAGCGGATGAAAAGAACAAAGACTATACATTGGGACAGTACCGCCGTTTTCAGGGCGTAGCGGACGCTCTTCGGGATAAGGACTACCATATCCCGCTCATACATACGGGCAACAGCGCTGCTGCAATTGATACACCCGAATTATCCTATGATATGGTTCGTGTCGGCATCAGCTTGTACGGACTGTATCCTTCGGATGAGGTGAATCGAAAGACAGTCAGCCTCCGCCCTGTCATGACGTTAAAGACAAAGCTTGTCTACGTCAAAAATTTACCTCCGCATTCCGGTATCAGCTACGGGACGAAGTATGTAACGGAGGAGGAAGAGCAAATTGGAACCCTCCCCATCGGTTACGCCGATGGCTTCTCTCGTATGCTGAGCGGTAAAGTGGAAGTGCTGATACGCGGCCGCCGCGTCCCTGTTGTCGGAACCATCTGTATGGACCAATGTATGGTATCGCTCAAACCTTTCGCCGATGAGGCGGAACAAATTAAAGCTGGTGAAGAGGTTGTACTCATCGGTCAGCAGTCTGACGAATGCATCACGGCAGATGAGCTGGCGTCCAAGCTGGGGACGATCCACTACGAGGTCGTCTGCATGATTGCCCATCGGGTACCACGTCAGTATATACGCAATGATATACCCGTGAAGACCGTGAATGCACTCTGGAGCAACCTTTAA,MQAIYRPTLAEINLDHLRANYNAFREALPSHMKLLACVKANAYGHGAVEVARELQQLGAAYLSVAFLDEALELRQGGISSPILVLGYTPPEAVEIAYEHDVTITLFSSEVLQAIKALPVQPEKPLKVHIKIDSGMGRLGLLPGEDAISFIEEVFSLPQVVVEGMFTHFARADEKNKDYTLGQYRRFQGVADALRDKDYHIPLIHTGNSAAAIDTPELSYDMVRVGISLYGLYPSDEVNRKTVSLRPVMTLKTKLVYVKNLPPHSGISYGTKYVTEEEEQIGTLPIGYADGFSRMLSGKVEVLIRGRRVPVVGTICMDQCMVSLKPFADEAEQIKAGEEVVLIGQQSDECITADELASKLGTIHYEVVCMIAHRVPRQYIRNDIPVKTVNALWSNL,MTKNESYSGIDYFRFIAALLIVAIHTSPLSSFSETGNFIFTRIVARVAVPFFFMTSGFFLISRYTCNAEKLGAFIKKTTLIYGVAILLYIPINVYNGYFKMDNLLPNIIKDIVFDGTLYHLWYLPASIIGAAIAWYLVKKVHYRKAFLIASILYIIGLFGDSYYGIVKSVSCLNVFYNLIFQLTDYTRNGIFFAPIFFVLGGYISDSQNRLSLKRSIVGFIVCFALMFGEALTLHHFDIQKHDSMYVLLLPSVYCLFNLLLHFRGKRRTGLRTISLIIYIIHPFMIVVIRLFAKLLHLQSLLVENSLVHYIAVCFASVVLAVVITALLSSLKPKKAKHTADTDRAYLEINLNNLEHNVNTLQKAMSPKCELMAVVKAEAYGHGMYEVTTYLEQIGVSSFAVATIDEGIRLRKYGISSEILILGYTSPSRAKELCKYELTQTLIDYRYSLLLNKQGYDIKAHIKIDTGMHRLGFSTEDKDKILAAFSLKHIKVAGIFTHLCAADSLEENDVAFTNKQIGSFYKVLDWLKSSGLNIPKVHIQSSYGLLNYPELECDYIRVGVALYGVLSSTNDKTKLELDLRPVLSLKAKVVLIRKIKQGESVGYSRAFTATRDSLIAILPIGYADGFPRNLSCGNSYVLIGGRQAPIVGKICMDQLAVDVTDIPNVKTGSIATLIGKDGKEEITAPMVAESAESITNELLSRMGHRLNIIRRA,55.48,gnl|BL_ORD_ID|1522|hsp_num:0,1561,FALSE,None
LK479,13_19 # 17203 # 17859 # 1 # ID=13_19;partial=00;start_type=ATG;rbs_motif=AGGAGG;rbs_spacer=5-10bp;gc_cont=0.416,13_19,17203,17859,+,Strict,400,452.595,CatU,98.16,3003983,protein homolog model,n/a,n/a,phenicol antibiotic,antibiotic inactivation,chloramphenicol acetyltransferase (CAT),ATGATGAAGTTTCACATTATTAATGTTGAAGAGTGGACGAGAAAGCCTTATTATGAGCATTATCTTCGATCGAATAAATGCACCTTCAGCATCACCGTGGATATCGACATTACTCGCTTGTTGTATTCGTTAAAAGCTAATGGATTCAAGCTTTATCCAGCTTTTATTTATATGGTTACAAGAGTTGTCAATGATCGGGTTGAATTCAAAACTTCCTATAGTCCCGAAGGGGAATTGGGTTACTGGGATCGGATGACGCCGAGTTATACCTTTTTCCATAACGATGACCATACCTTCTCCTGTTTATGGACAGCATTTTCGAATGATTTCTATCGATTTCATGATCATTACGAGCAGGACATGGAGCAATATCGGGATACAAAAGGGCTGTTTGTTAAAGAGAATCCACCGCCGAACACGTTTCCCATATCCATGATACCCTGGGCAAGTTTTAGCGGATTTAATCTAAACATTGTCAATGAAGCAGACTATCTTCTTCCCATCATAACCGGCGGAAAATATACCGAGCAGGGTGGCCGTATGCTGCTTCCAGTCTCATTGCAGGTGCACCATGCTGTGTGTGATGGTTATCATGCCAGCATGTTCTTTCAGGAGTTGCAGAGCTTGGCGGATTCTTTTGAAGATTGGTTAACTTAA,MMKFHIINVEEWTRKPYYEHYLRSNKCTFSITVDIDITRLLYSLKANGFKLYPAFIYMVTRVVNDRVEFKTSYSPEGELGYWDRMTPSYTFFHNDDHTFSCLWTAFSNDFYRFHDHYEQDMEQYRDTKGLFVKENPPPNTFPISMIPWASFSGFNLNIVNEADYLLPIITGGKYTEQGGRMLLPVSLQVHHAVCDGYHASMFFQELQSLADSFEDWLT,MKFHIINVEEWTRKPYYEHYLRSNKCTFSITVDIDITRLLYSLKANGFKLYPAFIYMVTRVVNDRVEFKTSFSPEGELGYWDRMTPSYTFFHNDDHTFSCLWTAFSNDFYRFHDHYEQDMEQYRDTKGLFVKENPPPNTFPISMIPWTSFSGFNLNIVNEADYLLPIITGGKYTEQGGRVLLPVSLQVHHAVCDGYHASMFFKELQSLADSFEDWLT,100.46,gnl|BL_ORD_ID|2230|hsp_num:0,2520,FALSE,None
LK479,14_109 # 117565 # 118443 # -1 # ID=14_109;partial=00;start_type=ATG;rbs_motif=AGGA/GGAG/GAGG;rbs_spacer=11-12bp;gc_cont=0.560,14_109,117565,118443,-,Strict,50,110.923,vanY gene in vanB cluster,31.96,3002956,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGAATGCATTTTCGGGAAAACGAACACGATTTACAAGCGCAATGCTGTCATCCTTGCTGTTAGCAGGAGCCATTCTGGCAGGCTGTCAATCGGATGATGCGGGTTCCGGCAAGGAACAGGGTCAGGAATTGCAGTCGCCGGCTGAAGGCCAGGAAGGAAACACGCTTCCTGAGGCCGGCGCGGGCAATGAAGAGACTGGGGCTGAGGATCAGCAGGCGGATCCGGTCATGGCGAAGCGGAGCGAGAATGCCCTTCAGGCCACGATCCAGGAAAGCGGCGGCAAGCAGGTTGTAACCAATGCAGAGGCGATGACGGTGGTTGTGAATAAGCAGCGCAGCTTGCCGGATGGATATGAACCAAGTGACCTCGTGGAGCCGGATGTTCCATTTTCTTTTGATGAGCCGCACGAAAAACGGCACCTGAGAAAAGAAGCGGCAGACGCGCTCGAGGAATTGTTCGCTGCGGCCCAAGCAGACGGCATCGAGCTCCGGGCCGTGTCGGGATACCGTTCTTATGCCCGTCAAAAAACGATATACGAGAACAATGTTCGTACCAAAGGGGAAGCCGAGGCTAATCGTGTAAGCGCGGTGCCGGGTACGAGTGAGCATCAGACAGGCCTTACGATAGACGTGTCCAGTCCTAGCGCAGGCAATGCGCTGGAGGAAGCGTTCGGGCATACGGAGGAAGGGCAGTGGCTGGCGCAACGCGCGCCGGAATTCGGCTTTATCATTCGTTATCCGGAAGGGGCCGAGGATATTACCGGCTATGTATACGAGCCGTGGCATATCCGTTATGTAGGCAAGGATCTTGCGCCGGATATTGCCGACAGCGGCTTGACGCTGGAGGAATACTTCGATGAGGCGAACATTAAACTGTAA,MNAFSGKRTRFTSAMLSSLLLAGAILAGCQSDDAGSGKEQGQELQSPAEGQEGNTLPEAGAGNEETGAEDQQADPVMAKRSENALQATIQESGGKQVVTNAEAMTVVVNKQRSLPDGYEPSDLVEPDVPFSFDEPHEKRHLRKEAADALEELFAAAQADGIELRAVSGYRSYARQKTIYENNVRTKGEAEANRVSAVPGTSEHQTGLTIDVSSPSAGNALEEAFGHTEEGQWLAQRAPEFGFIIRYPEGAEDITGYVYEPWHIRYVGKDLAPDIADSGLTLEEYFDEANIKL,MEKSNYHSNVNHHKRHMKQSGEKRAFLWAFIISFTVCTLFLGWRLVSVLEATQLPPIPATHTGSGTGVAENPEENTLATAKEQGDEQEWSLILVNRQNPIPAQYDVELEQLSNGERIDIRISPYLQDLFDAARADGVYPIVASGYRTTEKQQEIMDEKVAEYKAKGYTSAQAKAEAETWVAVPGTSEHQLGLAVDINADGIHSTGNEVYRWLDENSYRFGFIRRYPPDKTEITGVSNEPWHYRYVGIEAATKIYHQGLCLEEYLNTEK,108.96,gnl|BL_ORD_ID|602|hsp_num:0,556,FALSE,None
LK479,15_27 # 25028 # 25579 # 1 # ID=15_27;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.513,15_27,25028,25579,+,Strict,275,373.629,AAC(6')-34,97.81,3003989,protein homolog model,n/a,n/a,aminoglycoside antibiotic,antibiotic inactivation,AAC(6'),ATGCTGGTGTACGAGGCTGGACCGATTACGGTTCGCGAGCTGGAGGAGAAGGATGAAATATCCTTAGCTTCTTGGCTGTCCAATCCGGATGTGCTGCAGTATTATGAGGGACGGGACAATCCTCACGACGTGGAGCGGGTGCGGGAGCATTTTTACGTGGATGATGATGAGACTCGCTGCATCATTGAGCATAATGGGAAACCGATCGGGTATATTCAGTTTTATCTTCTGGATGAAGAGACGTTAGGCGAGTATGGATATAACGGGAGTGATGCAGACTGCAGAACCTTCGCCACGGATCAATTCATCGGGGAGCCGGATTATTGGAATCGAGGCATCGGTACGAAGCTCATGACTTCCATGGTGGAGTATCTCGTGTTTCAGAGGCAGGCTGATCGGATCGTAATGGACCCGCAGGCATGGAATGAACGGGCGATTGCTTGTTACGAAAAGTGCGGCTTCCGGAAGGTGAGACTGCTGGAGAAGCATGAACAGCATGAAGGTGAACTGCGGGACTGCTGGATTATGGAGTATCGGGCAGAGCGAAAGTAA,MLVYEAGPITVRELEEKDEISLASWLSNPDVLQYYEGRDNPHDVERVREHFYVDDDETRCIIEHNGKPIGYIQFYLLDEETLGEYGYNGSDADCRTFATDQFIGEPDYWNRGIGTKLMTSMVEYLVFQRQADRIVMDPQAWNERAIACYEKCGFRKVRLLEKHEQHEGELRDCWIMEYRAERK,MRIGDLIREDGGIAMLVYEAGPITVRELEEKDEISLASWLSNPDVLQYYEGRDNPHDVERVREHFYVDDDETRCIIKYEGKPIGYIQFYLLDEETLGEYGYNESDADCRTFATDQFIGEPDYWNRGIGTKLMTSMVEYLVFQRQADRIVMDPQAWNERAIACYEKCGFRKVRLLEKHEQHEGELRDCWIMEYRAERK,92.89,gnl|BL_ORD_ID|2235|hsp_num:0,2525,FALSE,None
LK479,17_71 # 81427 # 82458 # 1 # ID=17_71;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.569,17_71,81427,82458,+,Strict,650,689.108,tetA(58),99.71,3003980,protein homolog model,n/a,n/a,tetracycline antibiotic,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGGAGCATGCATACAAAAAGAAAATAGAGCCAAAACCTGGCGACTTGGCCGTTGAGGCTTACGGACTGATCAAAACATTCGGAGATAACCGCGCCGTGGATGGGGTGGATCTGAACGTACGTACCGGAACGATCTACGGTGTACTTGGCCCGAATGGGGCAGGCAAGACGACCACCATCCGAATGCTGGCGACCTTGCTAAGACCGGATGCGGGTTCGGCCCGAATCTTCGGACATGATGTGCAGGCGGAATCGCAGATTGTCCGTCAGTTGATCGGGGTAACCGGCCAATACGCGTCGGTGGACGAATCGCTCAGCGCTACGGAGAATCTGATTATATTCTCACGTTTGCTTGGTTTGGGGCGTAAGGAGGCAAGGCGCAAGGCGGAAGAGCTGCTCGAGGAATTCGGTTTGTCGGAAGCCGCGAAGCGGCCGCTAAAAAATTTCTCCGGCGGCATGCGGAGAAGGCTGGATCTGGCGGCAAGCCTCATTGCCCAGCCGCCACTCATCTTCCTCGATGAACCGACGACGGGGCTGGATCCAAGGACGCGTTCCCAGATGTGGGATACGATCCGCCGATTGGTGAATACCGGTTCAACGGTATTGCTGACCACGCAGTATCTCGAGGAGGCGGACCAGCTGGCAGACCGCATCGCCGTTATCGATTACGGCCGGGTTGTGGCCGAGGGTACGGCCGATGAACTGAAGATGTCGGTGGGCACTTCCTCGCTGCATTTGACTGTCGAGGATTCGGTTGACATGGATCGCGCCCGCCATACCGTGGAACAAGTGTTAGGCGTCCATGCCAATGTATCGCCGGAAGCCGGAAAGATCACAGCGCCGATGGCTAATGCGGGTCTTGTTACAGACCTGTTGATCGAGCTGCGAACAGCAGGAATCGGCTTGTCCGAGATGAGCGTGCAGAAGCCGACCCTGGATGAGGTATTCCTGACGATCACAGGCCACGGCGTGAAGGAAGACGCTGCCCAAGAGTCTTATGAATCCAATGATCGGGAGGTGGCACGGGTATGA,MEHAYKKKIEPKPGDLAVEAYGLIKTFGDNRAVDGVDLNVRTGTIYGVLGPNGAGKTTTIRMLATLLRPDAGSARIFGHDVQAESQIVRQLIGVTGQYASVDESLSATENLIIFSRLLGLGRKEARRKAEELLEEFGLSEAAKRPLKNFSGGMRRRLDLAASLIAQPPLIFLDEPTTGLDPRTRSQMWDTIRRLVNTGSTVLLTTQYLEEADQLADRIAVIDYGRVVAEGTADELKMSVGTSSLHLTVEDSVDMDRARHTVEQVLGVHANVSPEAGKITAPMANAGLVTDLLIELRTAGIGLSEMSVQKPTLDEVFLTITGHGVKEDAAQESYESNDREVARV,MEHAYKKKIEPKPGDLAVEAYGLIKTFGDNRAVDGVDLNVRTGTIYGVLGPNGAGKTTTIRMLATLLRPDAGSARIFGHDVQAESQIVRQLIGVTGQYASVDESLSATENLIIFSRLLGLGRKEARRKAEELLEEFGLSEAAKRPLKNFSGGMRRRLDLAASLIAQPPLIFLDEPTTGLDPRTRSQMWDTIRRLVNTGSTVLLTTQYLEEADQLADRIAVIDYGRVVAEGTADELKMSVGTSSLHLTVEDSVDMDRACHTVEQVLGVHANVSPEAGKITAPMANAGLVTDLLIELRTAGIGLSEMSVQKPTLDEVFLTITGHGVKEDAAQESYESNDREVARV,100,gnl|BL_ORD_ID|2245|hsp_num:0,2517,FALSE,None
LK479,17_72 # 82455 # 83270 # 1 # ID=17_72;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.561,17_72,82455,83270,+,Strict,500,540.806,tetB(58),99.26,3003981,protein homolog model,n/a,n/a,tetracycline antibiotic,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGAGCAGCACCATGATTCAGCCTGGGACGGAACGTCAGCTTAAGAACCGCACGAGTTTGGGTCAGACGATTCGAAATTCGTTGACGATGGCCTACCGCGGGCTGCTGAAGCTCCGGCGCACGCCCGAGCAGTTGTTTGACGTCACGTTTCAGCCCATTATTTTTACGCTGATGTTCACTTATATTTTTGGGGGCGCCATCTCCGGTGACGTGGCGAGTTATTTGCCCGTCATCATTCCCGGCATCCTCGTCCAGACCGTGATCACGACCTCCGTCGTCACAGGCGTTCAGCTGCGCGAGGATATGGATAAAGGCGTATTCGACCGATTCAAATCGCTGCCGATTGCGCGCATCGCACCGCTGGCCGGTGCCCTGCTGGCAGACACGATTCGGTATACCATTGCGACAGTGCTTACCTTTACGATGGGATATATTATGGGGTACCGGCCCGAGGGCGGCTTGGGTTATGTTGCGCTTGCGGGGTTGGTCGTAATTTTGTGCTCATGGGCCATTAGCTGGATTTTTGCTTTCTGCGGCGTGATTGCAAGATCCGCCTCCGGCGTGCAGGGGATATCGATGATCGTGCTGTTTCCGCTCACGTTTCTCTCCAACGCGTTCGTGCCGGTGGATACGATGCCGGGCTGGCTGCAGTGGTTCGTCAATATGAATCCGATCTCGCATCTTGTGACAGCCGTTCGGGATCTCACCAACGCTGGCACCGTGGGCTGGGATCTCACGATATCCTTGGTTGGTGCCGCGGTTATCGTGGCGATCTTTGCTCCCATTACGGTTCGTGCGTACATGCGCCGCACTTGA,MSSTMIQPGTERQLKNRTSLGQTIRNSLTMAYRGLLKLRRTPEQLFDVTFQPIIFTLMFTYIFGGAISGDVASYLPVIIPGILVQTVITTSVVTGVQLREDMDKGVFDRFKSLPIARIAPLAGALLADTIRYTIATVLTFTMGYIMGYRPEGGLGYVALAGLVVILCSWAISWIFAFCGVIARSASGVQGISMIVLFPLTFLSNAFVPVDTMPGWLQWFVNMNPISHLVTAVRDLTNAGTVGWDLTISLVGAAVIVAIFAPITVRAYMRRT,MSSSMIQPGTERQLKNRTSLGQTVRNSLTMAYRGLLKLRRTPEQLFDVTFQPIIFTLMFTYIFGGAISGDVASYLPVIIPGILVQTVITTSVVTGVQLREDMDKGVFDRFKSLPIARIAPLAGALLADTIRYTIATVLTFTMGYIMGYRPEGGLGYVALAGLVVILCSWAISWIFAFCGVIARSASGVQGISMIVLFPLTFLSNAFVPVDTMPGWLQWFVNMNPISHLVTAVRDLTNAGTVGWDLTISLVGAAVIVAIFAPITVRAYMRRT,100,gnl|BL_ORD_ID|4710|hsp_num:0,2518,FALSE,None
LK479,18_14 # 18947 # 19810 # -1 # ID=18_14;partial=00;start_type=ATG;rbs_motif=AGGA/GGAG/GAGG;rbs_spacer=11-12bp;gc_cont=0.541,18_14,18947,19810,-,Strict,500,597.045,LlmA 23S ribosomal RNA methyltransferase,99.65,3003982,protein homolog model,n/a,n/a,lincosamide antibiotic,antibiotic target alteration,Llm 23S ribosomal RNA methyltransferase,ATGTATGTAGCTCAGGATTGGCAAGATTACGAGGTCATCGATACCGGAGGCGGAGAAAAGCTGGAACGCTGGGGTGACGTGATTCTCAGACGTCCGGATCCGCAGATCATATGGCCGATTGAACGTGAAGATGGACAGTGGCGCAGTGTGCACGGACACTATCATCGCAGTTCGTCGGGCGGCGGGCAGTGGGACATGAAAAAGCAGCTTCCGGACCGGTGGACCATCGCATACGACCAATTGAAATTTCATATTCGACCAACCAATTTTAAACATACCGGATTGTTTCCAGAGCAGGCAGCCAACTGGCGCTGGATGATGGATAAGATCGCTTCAGCCGGACGTCCGGTCAGCGTGCTGAACCTGTTCGCCTATACCGGCGGAGCAACCGTCGCGGCCGCCTCGGCCGGAGCTCAGGTTGTTCATGTGGATGCTGCGAAGGGAATGGTTCAATGGGCCAAGGAAAACGCGGCATTGTCCGGACTTGCCGACCGTCCTATCCGTTATATCACGGATGATGTGTTTAAATTCGTACAACGGGAGCAGCGTCGGGGGAACAAATACGATGCGATCATTATGGACCCTCCATCTTATGGCCGCGGACCAAGTGGAGAAACGTGGAAGCTTGAGCAAAGCTTGTATCCCTTCCTCGAAAGCTGCATGAGCATCGTATCGGATAATCCGCTGTTCATGCTGATCAACTCCTATACAACCGGGATCTCCCCTACCGTTCTGAATAACATGCTGACCATGACCATGAAGCCGAAATACGGCGGTACCATCAGTGCGGGAGAGATCGGATTGCCGATTACCCGCTCCGGCATGAACCTGCCGTGCGGCATCCTAGGTCGATGGGAGTCCTGA,MYVAQDWQDYEVIDTGGGEKLERWGDVILRRPDPQIIWPIEREDGQWRSVHGHYHRSSSGGGQWDMKKQLPDRWTIAYDQLKFHIRPTNFKHTGLFPEQAANWRWMMDKIASAGRPVSVLNLFAYTGGATVAAASAGAQVVHVDAAKGMVQWAKENAALSGLADRPIRYITDDVFKFVQREQRRGNKYDAIIMDPPSYGRGPSGETWKLEQSLYPFLESCMSIVSDNPLFMLINSYTTGISPTVLNNMLTMTMKPKYGGTISAGEIGLPITRSGMNLPCGILGRWES,MYVAQDWQDYEVIDTGGGEKLERWGDVILRRPDPQIIWPIEREDGQWRSVHGHYHRSSSGGGQWDMKKQLPDRWTISYDQLKFHIRPTNFKHTGLFPEQAANWRWMMDKIASAGRPVSVLNLFAYTGGATVAAASAGAQVVHVDAAKGMVQWAKENAALSGLADRPIRYITDDVFKFVQREQRRGNKYDAIIMDPPSYGRGPSGETWKLEQSLYPFLESCMSIVSDNPLFMLINSYTTGISPTVLNNMLTMTMKPKYGGTISAGEIGLPITRSGMNLPCGILGRWES,100,gnl|BL_ORD_ID|2229|hsp_num:0,2519,FALSE,None
LK479,18_36 # 41621 # 41722 # 1 # ID=18_36;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.490,18_36,41621,41722,+,Strict,990,20.4014,farB,100,3003962,protein homolog model,n/a,n/a,antibacterial free fatty acids,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGAAGGAACGCATTGTGGTTGTAGGCGGATATGGGCATGTAGGAAGGATCCTATGCGAGGAGTTAGGGGAGAAATATCCCGGTCTTGTATACGCTGCATGA,MKERIVVVGGYGHVGRILCEELGEKYPGLVYAA,MDYPPLKGAALAWVTLSLGLAVFMEVLDTTIANVAVPVIAGNLGAATTQGTWVITSFSVANAVSVPLTGFLAKRIGEVKLFTAAAVGFVITSWLCGIAPNLQSLVVFRILQGFIAGPLIPLSQSLLMASYPPAKRTLALALWAMTVVVAPVLGPILGGWISGNWHWGWIFFINIPIGIISAWITWKHLKYRETETVKMPTDYVGLTLMVVGIGALQMMLDRGKELDWFASGEIITLGVVALVCLSYFIVWELGEKYPIVDLSLFKDRNFTVGVIATSLGFMVYMGTLTLLPLVLQTNLGYTSTWAGLAAAPVGILPVFLSPLIGRFGNKIDMRLFVTASFLTFAFTFYWRTDFYADMDIGNVIWPQFWQGVGVAMFFLPLTTITLSHMKGGQIAAAGSLSNFLRVLMGGVGVSVVSTLWERREALHHTRFAEHITPYSATLHETAAHLSQHGVSDIQTLGIINNTITQQGFIIGSNEIFMAGSLLFIIMIPVIWLAKPPFHNGGGGGH,6.5,gnl|BL_ORD_ID|2192|hsp_num:0,2429,TRUE,loose hit with at least 95 percent identity pushed strict
LK479,22_1 # 189 # 1112 # 1 # ID=22_1;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=3-4bp;gc_cont=0.496,22_1,189,1112,+,Strict,50,117.472,vanW gene in vanI cluster,36.56,3003724,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanW; glycopeptide resistance gene cluster,ATGTCAGTCTTCGGTCTATTGTTTATGCTCTTGCAAGGGGATGAACCGGAAAACAACAATTTAATGATAACGCAAGAAGGCAAAGTCATGGCCAGCGTGAGCCGAAGCGAACATGCACTTGATGTATTCCCGCTGCTGGATATGGATAAATACAATCAATGGGTGGATGCGCTTGATCGGAAAACCTATCTGGAAGCCAGGAATGCCCGGATTGGCAGCAGCGGCCAAATCATTCCGGGGCAGAATGGTCATAGACTGGATCGACGCAAACTGCTGGAACGATATTATTCGTATTGGTACGGGACTGGGGGCGCTACCGTCGAAGCGCCAAGGTATCCGATATATCCGAAGGTGGATACCGAGCTTCTTGCCTCCATTCGGGTTAAACCGATAGGTTACTATGTCACCTATTTTAATTCCAACAACAAAAATCGTTCCCATAATATAGCATTAGCTGCCCAGGCGATTGACAGTGCAGTCGTGTTCCCCGGAGAAACCTTCTCGTTTAATCAGGTGGTTGGCATGAGAACAGTGGACAGAGGTTACAGACGTGCCGGCGTTATCGTCAGAGGTGAGTTATCAGAGGGAGTAGGAGGAGGGATCTGTCAGGTTTCTTCTACATTGTATAACGCCATTGACCGTGCAGGCTTGCAGATTGTAAAGCGCTACTCTCACAGCCGGAACGTCCCTTATGTGCTGCCGGGGCGCGATGCTACGGTGAGCTGGGGAGGCCCGGATTTTGTTTTTGAGAACGCCTATAATCAGCCTATCCTCATCCGGGCATTCGGTAATGGGGGAAGAATGACCGTTGCCATCTACTCTTCTGAACTCATAGAATATAAGCCGCGCAATGTACCAAGCATATCTAACCTGCTGCCGGAGGAGACGAGTGACACCAAGCACAATCCGGTAAACGGCGATTAA,MSVFGLLFMLLQGDEPENNNLMITQEGKVMASVSRSEHALDVFPLLDMDKYNQWVDALDRKTYLEARNARIGSSGQIIPGQNGHRLDRRKLLERYYSYWYGTGGATVEAPRYPIYPKVDTELLASIRVKPIGYYVTYFNSNNKNRSHNIALAAQAIDSAVVFPGETFSFNQVVGMRTVDRGYRRAGVIVRGELSEGVGGGICQVSSTLYNAIDRAGLQIVKRYSHSRNVPYVLPGRDATVSWGGPDFVFENAYNQPILIRAFGNGGRMTVAIYSSELIEYKPRNVPSISNLLPEETSDTKHNPVNGD,MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVLAEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPELLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGMETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGGEFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSHSLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDEPDGYPVKPREWSK,82.31,gnl|BL_ORD_ID|4748|hsp_num:0,2242,FALSE,None
LK479,26_33 # 46110 # 48068 # -1 # ID=26_33;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.538,26_33,46110,48068,-,Strict,325,333.954,tet(T),31.72,3000193,protein homolog model,n/a,n/a,tetracycline antibiotic,antibiotic target protection,tetracycline-resistant ribosomal protection protein,ATGAAAAAAACGATAGGCATGTTCGCCCATGTGGATGCAGGCAAAACCACGTTGGCGGAGCAGTTGTTATATATGACCGATACGATTCAGGAGCGCGGTCGCGTGGATCATCAGAGTGCTTTTCTTGATCGACATGACATTGAAAAGGAACGGGGCATCACCGTATTTGCCGATCAGGCTACCATGCATTTTAACGGGTCCACTTATTATTTAATCGATACGCCGGGTCACGTCGACTTCTCGCCGGAGATGGAGCGGGCCATTCAGGTCATGGACGCCGTCGTCGTCGTCATAAGTGCCGTGGAGGGTGTTGAAGGGCATACGGAGACGGTATGGCAGTTATTGCGCAAACATGGCGTCCCTACGTTCTTGTTTATTAATAAAATCGACCGGGAAGGCGCGGATGTGGCGCGTGTGTTTGCAGAGATTCGGAGTGAGCTTACCGAAGACGTCTGTATGATCACAGAGGAGGATATGCTGCACGAAGGCGTGATGCAGTCCTCGGTCATTGAGGCTATCGCGGAGCGGGACGAGAAGCTGCTGGAGCTGTATATGGAACCGGGATATGAGGTTTCACGGTGGCTGGATACGATGACCGCGATGATAAGAAAAGGGCAGCTATTCCCCTGCTTCGGCGGATCAGCTCTGCAAAACGTGGGCGTGTCCCATTTCTTGCATCAGCTGGATCTGCTGACGGTTACGGACTATGATCCCGGGGCTGATTTTGCCGGAACGGTATATAAGATTCGCCATGACGAACAGGGCGCAAGATTGACCTATATCAAGGCCACGGGCGGAACGCTGCGGGTTCGCGACGAAATGACTTATTTCTCCGGAACGGAGACGATCACGGAGAAGGTAACGCATATCCGTTTGATCAGCGGGGGGCGCGTGACGAATGTCGATCAGGTGCATGCGGGTGATCTGTTTGTCGTTACGGGTATTTCTTCAGCTTCGGCAGGGGATGGGCTTGGGACTCTGGGGGGTGGCCGGACGGTATATGAGCTTGTACCGACACTGAAGTCGAAGGTGCAATTCGAGTCCTCGATTCATCCCAAGGATATGCTTCGCGAATTCCGTCTGCTCGATGCGGAGGATCCTTCCCTGTCTGTACAGTGGGATGAGCATGCTCAGGCAATCCATATCCATGTGATGGGGATCATTCAGCTTGAAGTGTTGGAACGCATCGTGCTCGAGCGGTTCGGTTACCGGATCACCTTCGGTGAACCAGAGATTCTGTATAAAGAGACCATAACGGAAGCCGTTGTAGGCTGTGGTCATTTTGAACCGTTGAAGCATTATGCGGAGGTGCACCTCCGGCTGGAGCCTGGAGAGCGGAACAGCGGCATCGTGTTCGCCAATGCCTGTCATCCTGATGTGCTCCCGGTCAATTATCAGCATCTGGTCGCCCAGCATGTCGGCGAGAGGAATCATCACGGGCTGCTTACAGGCTCACCCGTCACGGACATCAAGATTACCCTGCTAAAAGGGCGGGCGCACAACAAACATACGCATGGCGGGGATTTCAGGGAAGCCACCTACCGTGCGTTGCGCCAAGGGCTGGAGAAGGCAGCCAATATGCTCTTGGAGCCTTACTATCACTTCAAGGTAAAGGTGGATGCCGAGTATGTCGGTCGGTTGATGTCGGATCTGACCCAGGCGAAGGCAAGCTTCGAGCCGCCGGAAACGGCGGGAAACAAAGTGACGGTCACGGGATCGGCTCCCGTATCGACCATGATGAGTTACAGCATGGAATTAGCCGCCTACACGAAGGGAAGAGGTACGATATCCCTGGTTTACGGCGGATATGGCCGGTGCCATAACGAGGCCGAGGTCATTGAACGTAAAGGATACGATAAAAATGCGGACCCGGAATACAGCTCCTCTTCGATATTTTGTGCGAAGGGAAGCGGTTATGCGGTGCCATGGGATGAAGCGGACCGTCATATGCATGTGTAA,MKKTIGMFAHVDAGKTTLAEQLLYMTDTIQERGRVDHQSAFLDRHDIEKERGITVFADQATMHFNGSTYYLIDTPGHVDFSPEMERAIQVMDAVVVVISAVEGVEGHTETVWQLLRKHGVPTFLFINKIDREGADVARVFAEIRSELTEDVCMITEEDMLHEGVMQSSVIEAIAERDEKLLELYMEPGYEVSRWLDTMTAMIRKGQLFPCFGGSALQNVGVSHFLHQLDLLTVTDYDPGADFAGTVYKIRHDEQGARLTYIKATGGTLRVRDEMTYFSGTETITEKVTHIRLISGGRVTNVDQVHAGDLFVVTGISSASAGDGLGTLGGGRTVYELVPTLKSKVQFESSIHPKDMLREFRLLDAEDPSLSVQWDEHAQAIHIHVMGIIQLEVLERIVLERFGYRITFGEPEILYKETITEAVVGCGHFEPLKHYAEVHLRLEPGERNSGIVFANACHPDVLPVNYQHLVAQHVGERNHHGLLTGSPVTDIKITLLKGRAHNKHTHGGDFREATYRALRQGLEKAANMLLEPYYHFKVKVDAEYVGRLMSDLTQAKASFEPPETAGNKVTVTGSAPVSTMMSYSMELAAYTKGRGTISLVYGGYGRCHNEAEVIERKGYDKNADPEYSSSSIFCAKGSGYAVPWDEADRHMHV,MKIINIGILAHVDAGKTTVTEGLLYKSGAINKIGRVDNATTTTDSMELERDRGITIRASTVSFNYNDTKVNIIDTPGHMDFIAEVERTLKVLDGAILVISAKEGIQVQTKVIFNTLVKLNIPTLIFVNKIDRKGVCLDEIYTQIQEKLTSNLAIMQSVKIKDKGDFELTNVRDDKVIQSQIIEKLLDINDYLAEKYINGDVIAEKEYNDVFLDEINNCNLYPVFHGSALKNIGIDELLFAITKYLPTKSYNTEDLLSAYVYKIDRDEKSRKMTFLRVFSGNIRTRQDVYINGTEETFKIKSLESIMNGEIVKVGQVNSGDIAIISNANSLKIGDYIGKKYDGILDIKIAQPALRASIKPCDLSKRSKLIEALFELTEEDPFLDCEINGDTGEIILRLFGNIQMEVIESLLKSRYKIDARFGELKTIYKERPKRNSKAVIHIEVPPNPYWASIGLSIEPLPIGSGLLYKTEVSYGYLNNSFQNAVKDAVEKACKEGLYGWEVTDLKVTFDYGLYYSPVSTPSDFRNLTPYVFWEALRKAGTEILEPYLKYTVQVPNDFCGRVMSDLRKMRASIEDIIAKGEETTLSGKIPVDTSKSYQSELLSYSNGKGIFITEPYGYDIYNDKPIINDIGNDNNDSNKEGLRYLFQKQDEN,100.15,gnl|BL_ORD_ID|1954|hsp_num:0,2037,FALSE,None
LK479,32_6 # 6110 # 7546 # 1 # ID=32_6;partial=00;start_type=ATG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.521,32_6,6110,7546,+,Strict,50,119.783,vanW gene in vanI cluster,37.72,3003724,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanW; glycopeptide resistance gene cluster,ATGAAAAAAATTCATCTTGGTCTCATCATTGTCATCAGTTTCGGTCTTCTCCTCTCCGTCGGCTTCGGTCTATTGACGATGTACGTGAACCAGAAGGAACTTCCGAAGGGGGTCGTTCTCTCCGGTTGGCAGGTAGGCGGTAAACCATCAGACGAGGTGCTGTCAGAGCTGGATCAACGGCTGCAGGCGATGACAGCGTTGAAGGTGAAGCTGCAATCGGACGCGCTCAAGGGACACACAGAAAGCTTCACTCTTCGAGAGGCCGGAGTTCAATTCAACGCAGCCGATTTTCAGGAGGCTATCGCCAGGTTGTCCGAAGGATCACTATGGGATCAAGTTCTTTACCGGCGTAACTTTCAGCTGGAATGGCATATATCCACGGACTGGGATCGCGATGTGTTAAAAAAGCGGCTGAGCGAAGACTGGCAAAAGGAACGCTTCGGGGAACCCGTCAATGCGGTACGGAGCATATCCGAAGATGATGTTGTCCGGTACACTCCGGAGAAAACGGCATACCGCATCGATTGGCCGGCATTCTATGAAGGGTTCAGCGCTGTGCTTCCGAATGAGTCTCACTTCACCGAGCCGAATCCAGATGAGATCATTACGGTTCCGCTGCCTCTCATCCGTCAAAAGCCCCCCGTTACCGTAAAATCGCTGCAGAATGAAGGGATTGAGCGCAAAATCGTTGAATTCTCCACCAGTCTCGGATCCAGCGGGCCTGGACGCGTTCATAACGTGACCGCCGCTGCCAAATCGGTTGACGGCATGATTCTGAAGCCCGGCGATGAATTCAATTATGCTCATATTATTGATACCGCGAAAAGGGAATACGGCTTTGAAGAAGCTCCTGTCATCGTGAACGGCAAGCTGGTCCCCGGAATCGGCGGCGGAATCTGCCAGGTATCCAGCACGGTGTATCATGCCGCCCTACTGATCGGACTGGAGATTACCGAAAGGCGGAATCATTCCCTTCCGGTCAGCTACCTGCCGAAGGGGCAGGATGCCACCTTCGCGGAAGGGGCGATCAATTTCCGTTTCCGGAACAATACAGGAAAGCATCTGCTTATTTTATCGGAAGTATCGCACGGTAATTTAACGCTGAAGATGTTTGGCACCTTCCCGGAAAATACGGAATATGAGCTTGTGTCCACCACCGTTGAAACCTTGCCGTCACCAGAGAAGGTCATTCACAATAACTCGCTGCCGCCAGGACTCAAGCAGGTGGTTCAGAACGGGAAGCCAGGCTATGTGGTTGAAACCTACCGAACCAAGAAAGTAAACGGCAAGGTTGTAGAGAAGGTTAAAATATCCAAGGATACCTATCGCCCCCAGAACAGCATCGTTGCCATCAATCCGACAAGCGAGGTCCAACTGCCGGAAGCGAATGATACACCGAAAGAGGAAGTGGTTGAGGACGGTATCAGCGCACCGTAA,MKKIHLGLIIVISFGLLLSVGFGLLTMYVNQKELPKGVVLSGWQVGGKPSDEVLSELDQRLQAMTALKVKLQSDALKGHTESFTLREAGVQFNAADFQEAIARLSEGSLWDQVLYRRNFQLEWHISTDWDRDVLKKRLSEDWQKERFGEPVNAVRSISEDDVVRYTPEKTAYRIDWPAFYEGFSAVLPNESHFTEPNPDEIITVPLPLIRQKPPVTVKSLQNEGIERKIVEFSTSLGSSGPGRVHNVTAAAKSVDGMILKPGDEFNYAHIIDTAKREYGFEEAPVIVNGKLVPGIGGGICQVSSTVYHAALLIGLEITERRNHSLPVSYLPKGQDATFAEGAINFRFRNNTGKHLLILSEVSHGNLTLKMFGTFPENTEYELVSTTVETLPSPEKVIHNNSLPPGLKQVVQNGKPGYVVETYRTKKVNGKVVEKVKISKDTYRPQNSIVAINPTSEVQLPEANDTPKEEVVEDGISAP,MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVLAEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPELLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGMETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGGEFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSHSLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDEPDGYPVKPREWSK,128.15,gnl|BL_ORD_ID|4748|hsp_num:0,2242,FALSE,None
LK617,1_552 # 588320 # 589207 # -1 # ID=1_552;partial=00;start_type=TTG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.303,1_552,588320,589207,-,Strict,50,101.679,vanY gene in vanG cluster,36.02,3002959,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,TTGAATAAGAAAAATAAGATAATAATATTGTTAACAGTATTAGTTTTTGCGATAAGTGGATGTAGTTTATTTAAAGATGGAAATGAAACACTATATGAGAAAAACACTGTCGACGAAGTAGAGACAAGTGAAGATACAAAAGATACGTCAGAAGAAAGCTTGATTGAAACAGAGACAGAATCAAAAGAAGAAACTGAAACTGAATCTGAAGAAGAAACTCAAGATGAAAAAACACCAGAGACACAAAAAGAAGAGATAGTTTATGAAAAAATTCCTAATGATGAGATTGATACATTTAATGGTATACCAATAAATTTTGAAAATTCATATAAAGTGATTTTTAGGGATGATAAATTAACTATTGTAAATAAGAAGTTTAGATTAGATCCAAAATATAGACCAGAAAATATTGTAAATATTGATGAAAAATATACTGTTTATGGATATGCTCAATTAGAAGGTGAAGCTTATGAAGCATTCTTGAAGATGAGAAATGCATCGGAGGCAGAAGGGCTTGATTTAAGAATTTCAACAGGATATAGAGACTATGATTTCCAAAAACAACTTTATACTGGCTATTTAGCAAAAGATAGTCAAGAAGAAGTTGATAAATTATCGGCAAGACCAGGACATTCAGAACATCAACTTGGTACAGCGGCTGATTTTTCTGGAGGTAAAAATAATCTTGAATCATTTACCGGTACTCCAGAGCAACTTTGGATGGCAAAAAATGCCCATAAATTTGGGTTTATTTTAAGATATCCAGAAGGTAAGGAAAATATAACAGGATATTCTGCAGAATCTTGGCATTATAGATATGTTGGTGATATTGCAGAGAAAATATATAATTCTGGACAAGTACTAGAAGAATATTTAGGAATAGAATAA,MNKKNKIIILLTVLVFAISGCSLFKDGNETLYEKNTVDEVETSEDTKDTSEESLIETETESKEETETESEEETQDEKTPETQKEEIVYEKIPNDEIDTFNGIPINFENSYKVIFRDDKLTIVNKKFRLDPKYRPENIVNIDEKYTVYGYAQLEGEAYEAFLKMRNASEAEGLDLRISTGYRDYDFQKQLYTGYLAKDSQEEVDKLSARPGHSEHQLGTAADFSGGKNNLESFTGTPEQLWMAKNAHKFGFILRYPEGKENITGYSAESWHYRYVGDIAEKIYNSGQVLEEYLGIE,MNHMNMKHRRRKRRRNQSFLFTGILLLVVVSASSFLWYGFGNAAKKDSVIEEMPFTITQDGMQAKEEIKKTVLETSYGGKQQVAEENHGNTQNAGTDEAWNLMLVNRDNAIPDNYEVNLVEVEGGERVDERIYEPLMEMLNAAREENWGELPMVVSGYRTQEKQQSLYDEKIAKFKKEGYSDSEAVRQAEQWVAVPGHSEHQLGFAVDINGATYDVYLWLQENSYKYGFIFRYPGSKTDITGTAEEVWHYRYVGVEAATEMYENGLCLEEYLEKKQSEN,105.73,gnl|BL_ORD_ID|4732|hsp_num:0,298,FALSE,None
LK617,2_164 # 183001 # 184104 # -1 # ID=2_164;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.301,2_164,183001,184104,-,Strict,175,228.794,vanT gene in vanG cluster,38.67,3002972,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,glycopeptide resistance gene cluster; vanT,ATGGGGAATAGTACAAATATTTTAGAAGTAAATATTAATAAAATAAGAAATAATATCAATATATTAGAAAATATTGCAAAGAAGAAATACTATGCTGTGGTGAAAGCAAACGCCTATGGTCTTGGTGCAGCAGAAATTGCAAAAAGAATTGAAGATATAGTTTATGGATATTGTGTAGCGACAATAGATGAAGCTGTTGAACTAAGAAAAGCAGGCATAAAAAAAGACATAATTGTTTTAGGATATATTTTACCGGAAAATTACCATTTACTCTCAGAATATAATATTATAACAACAATTTATAGCATTGATATTGCTAGAGAAATGGAAAAACTGGGTAAAAAAATAAGAGCACATATAAAAATTGAAACTGGTCACAATAGATTAGGATTTAAACCTGAAGATAAATCTTATGAAGAGATTATGGAAATCAATACATTTAAGAATATTTCTCTAGAGGGTATTTTTTCGCATTTATCTACGGCGGATGAAAAAGACTCATACTATACAGAGCTTCAACATAAAAGATTTGAAGAAGCAATAAATGCACTTAAAGATTTAACTAAAAACTGGATAAAGCATTTATCTAACGATGCGGCTATGATTGCTTATGATTTTGATTATGATGCTGTAAGATCCGGTATATCACTTTATGGAGTTTATCCTTCAGAATATATGAATGAAAATTATCATATCGGATTGGAGACTGCGTTTGAATTGAAATCAAGAATTTCTTTTATTAAGGAAATTGAAAAAGGAGATTCTGTATCATATGGTCGAACATTTATAGCTAAAGAAAAAATGAATATAGCGACTGTTTCAATAGGGTATGCAGATGGATATCACAGATTAATTTCAAATAGAGGATATGTGTTAATAAATGGGAAAAAAGCACAGATATTAGGTAATATTACCATGGATCAGATGATGGTTGATATTTCAAATATTGATGCTCAAATTCACGATGAAGTGGTGTTAATAGGTAAAAGTGGCGACGAGGAAATCACCCCTGAACAAGTTGCAAACTGGGCAGAAACAATTACATATGAAATAATGACATCTATTTCACCTAGGGTAAAGAGAACATACATATATGAGGAGTAA,MGNSTNILEVNINKIRNNINILENIAKKKYYAVVKANAYGLGAAEIAKRIEDIVYGYCVATIDEAVELRKAGIKKDIIVLGYILPENYHLLSEYNIITTIYSIDIAREMEKLGKKIRAHIKIETGHNRLGFKPEDKSYEEIMEINTFKNISLEGIFSHLSTADEKDSYYTELQHKRFEEAINALKDLTKNWIKHLSNDAAMIAYDFDYDAVRSGISLYGVYPSEYMNENYHIGLETAFELKSRISFIKEIEKGDSVSYGRTFIAKEKMNIATVSIGYADGYHRLISNRGYVLINGKKAQILGNITMDQMMVDISNIDAQIHDEVVLIGKSGDEEITPEQVANWAETITYEIMTSISPRVKRTYIYEE,MTKNESYSGIDYFRFIAALLIVAIHTSPLSSFSETGNFIFTRIVARVAVPFFFMTSGFFLISRYTCNAEKLGAFIKKTTLIYGVAILLYIPINVYNGYFKMDNLLPNIIKDIVFDGTLYHLWYLPASIIGAAIAWYLVKKVHYRKAFLIASILYIIGLFGDSYYGIVKSVSCLNVFYNLIFQLTDYTRNGIFFAPIFFVLGGYISDSQNRLSLKRSIVGFIVCFALMFGEALTLHHFDIQKHDSMYVLLLPSVYCLFNLLLHFRGKRRTGLRTISLIIYIIHPFMIVVIRLFAKLLHLQSLLVENSLVHYIAVCFASVVLAVVITALLSSLKPKKAKHTADTDRAYLEINLNNLEHNVNTLQKAMSPKCELMAVVKAEAYGHGMYEVTTYLEQIGVSSFAVATIDEGIRLRKYGISSEILILGYTSPSRAKELCKYELTQTLIDYRYSLLLNKQGYDIKAHIKIDTGMHRLGFSTEDKDKILAAFSLKHIKVAGIFTHLCAADSLEENDVAFTNKQIGSFYKVLDWLKSSGLNIPKVHIQSSYGLLNYPELECDYIRVGVALYGVLSSTNDKTKLELDLRPVLSLKAKVVLIRKIKQGESVGYSRAFTATRDSLIAILPIGYADGFPRNLSCGNSYVLIGGRQAPIVGKICMDQLAVDVTDIPNVKTGSIATLIGKDGKEEITAPMVAESAESITNELLSRMGHRLNIIRRA,51.54,gnl|BL_ORD_ID|1522|hsp_num:0,1561,FALSE,None
LK617,4_131 # 150413 # 151363 # 1 # ID=4_131;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.295,4_131,150413,151363,+,Strict,50,65.855,vanY gene in vanG cluster,53.7,3002959,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGAGTGACATTAGAAGAAATCAATTTTTAAGAAAAAAAATTAAAGAAAAAAAGAAAAAGCAAGAGAGAAGGATATTGGTGGCACTTGGATTAGTGGTTACTATAACCTCATCAATTGCTTTAATTTCTTTATCAAATACTAAAAACGTAAATGCGGACACTGCTCAACCGATTACCATTCAAGAAACAAGATCAGAAACTAAGAATGAAACAGAAAAAGAATCGGTTAAAACTGAAAAATCAGGAGCTGTTGACACTAAAAAATTCAACGATAAAATAATTGGGTATAAAAAGGTTGTTGAAGATTCAACTGTTTTGGAAACAATTAGTGAAAATCCAAAGAGATTATATGATGTAGTTGCTGGAGAATATATTGAATTTTTAGGCGAAGAAAATGGATGGTCAAAAGTTTCATATAAAGACATTGTGGGATATATTGAATCATCTGTTTTAGAAGATACTAAAGAAAATGAACTTAAAGTAGTGGATGGAGTGCTATTAGCTACTAAAAACTTTACCATTCCAACAGATTTTAAGACAAGGTTTAATGTTGAAGCAGAAAATGCTATGATGGTTATGTTTGAAGCTATGAAGAGAGATGGTTTAGAAATTAGCCTATCAAGAAAATATATTGAATCAGATGAAAATATTGAGGAAAATGCAGATACTAAATATCCATTCCCAAATATTGAACAACACGAATTAAGGACAGGAAGATCGATAGAATTTAGCATTCCAAATAGTGCTACAGCAATTAATTTTGAAGATACAGCACAAGGAAAATGGATTAAAAATAATTCTTATAAATTTGGATTTGTACAAAGATATCCAAGTGGAAAAGAAAATATAACAGGATTCATCGAAAATGATAGGATATATACTTATGTTGGATCTGAGATAGCTACAGAGATGCACAAAAATAATTTAACTATGGAAGAGTATTTTAGATAA,MSDIRRNQFLRKKIKEKKKKQERRILVALGLVVTITSSIALISLSNTKNVNADTAQPITIQETRSETKNETEKESVKTEKSGAVDTKKFNDKIIGYKKVVEDSTVLETISENPKRLYDVVAGEYIEFLGEENGWSKVSYKDIVGYIESSVLEDTKENELKVVDGVLLATKNFTIPTDFKTRFNVEAENAMMVMFEAMKRDGLEISLSRKYIESDENIEENADTKYPFPNIEQHELRTGRSIEFSIPNSATAINFEDTAQGKWIKNNSYKFGFVQRYPSGKENITGFIENDRIYTYVGSEIATEMHKNNLTMEEYFR,MNHMNMKHRRRKRRRNQSFLFTGILLLVVVSASSFLWYGFGNAAKKDSVIEEMPFTITQDGMQAKEEIKKTVLETSYGGKQQVAEENHGNTQNAGTDEAWNLMLVNRDNAIPDNYEVNLVEVEGGERVDERIYEPLMEMLNAAREENWGELPMVVSGYRTQEKQQSLYDEKIAKFKKEGYSDSEAVRQAEQWVAVPGHSEHQLGFAVDINGATYDVYLWLQENSYKYGFIFRYPGSKTDITGTAEEVWHYRYVGVEAATEMYENGLCLEEYLEKKQSEN,113.26,gnl|BL_ORD_ID|4732|hsp_num:0,298,FALSE,None
LK617,9_6 # 3391 # 4122 # -1 # ID=9_6;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.298,9_6,3391,4122,-,Perfect,450,494.582,23S rRNA (adenine(2058)-N(6))-methyltransferase Erm(A),100,3005099,protein homolog model,n/a,n/a,macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic,antibiotic target alteration,Erm 23S ribosomal RNA methyltransferase,ATGAAACAGAAAAACCCGAAAAATACGCAAAATTTCATTACATCTAAAAAGCATGTAAAGGAAATATTAAAATATACGAATATCAATAAACAAGATAAAATAATAGAAATTGGGTCAGGAAAAGGACATTTTACCAAGGAACTTGTGGAAATGAGTCAACGGGTGAATGCTATAGAGATTGATGAAGGTTTATGTCATGCCACGAAAAAAGCAGTTGAACCTTTTCAGAATATAAAAGTTATTCATGAGGATATTTTGAAGTTTAGCTTTCCTAAAAATACAGACTATAAAATATTTGGTAATATTCCCTACAATATTAGTACTGATATTGTAAAAAAGATTGCTTTTGATAGTCAAGCGAAATATAGCTACCTTATTGTAGAGAGGGGATTTGCTAAAAGGTTGCAAAATACCCAACGAGCTTTAGGTTTGCTGTTAATGGTGGAAATGGATATAAAAATTCTTAAAAAAGTGCCACGAGCATATTTTCACCCTAAGCCTAATGTAGATTCTGTATTGATTGTACTTGAAAGGCATAAACCATTTATTTTAAAGAAGGACTACAAAAAGTATAGATTTTTCGTTTATAAATGGGTAAACAGGGAATATCATGTTCTTTTTACTAAAAATCAATTAAGACAGGTGCTGAAGCATGCGAATGTTACTGATCTTGATAAATTATCCAATGAACAATTTTTGTCTGTTTTCAATAGTTACAAATTATTTCAATAA,MKQKNPKNTQNFITSKKHVKEILKYTNINKQDKIIEIGSGKGHFTKELVEMSQRVNAIEIDEGLCHATKKAVEPFQNIKVIHEDILKFSFPKNTDYKIFGNIPYNISTDIVKKIAFDSQAKYSYLIVERGFAKRLQNTQRALGLLLMVEMDIKILKKVPRAYFHPKPNVDSVLIVLERHKPFILKKDYKKYRFFVYKWVNREYHVLFTKNQLRQVLKHANVTDLDKLSNEQFLSVFNSYKLFQ,MKQKNPKNTQNFITSKKHVKEILKYTNINKQDKIIEIGSGKGHFTKELVEMSQRVNAIEIDEGLCHATKKAVEPFQNIKVIHEDILKFSFPKNTDYKIFGNIPYNISTDIVKKIAFDSQAKYSYLIVERGFAKRLQNTQRALGLLLMVEMDIKILKKVPRAYFHPKPNVDSVLIVLERHKPFILKKDYKKYRFFVYKWVNREYHVLFTKNQLRQVLKHANVTDLDKLSNEQFLSVFNSYKLFQ,100,gnl|BL_ORD_ID|2817|hsp_num:0,3831,FALSE,None
LK617,9_10 # 7113 # 7907 # -1 # ID=9_10;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.447,9_10,7113,7907,-,Strict,500,534.258,APH(3')-IIIa,99.62,3002647,protein homolog model,n/a,n/a,aminoglycoside antibiotic,antibiotic inactivation,APH(3'),ATGGCTAAAATGAGAATATCACCGGAATTGAAAAAACTGATCGAAAAATACCGCTGCGTAAAAGATACGGAAGGAATGTCTCCTGCTAAGGTATATAAGCTGGTGGGAGAAAATGAAAACCTATATTTAAAAATGACGGACAGCCGGTATAAAGGGACCACCTATGATGTGGAACGAGAAAAGGACATGATGCTATGGCTGGAAGGAAAGCTGCCTGTTCCAAAGGTCCTGCACTTTGAACGGCATGATGGCTGGAGCAATCTGCTCATGAGTGAGGCCGATGGCGTCCTTTGCTCGGAAGAGTATGAAGATGAACAAAGCCCTGAAAAGATTATCGAGCTGTATGCGGAGTGCATCAGGCTCTTTCACTCCATCGACATATCGGATTGTCCCTATACGAATAGCTTAGACAGCCGCTTAGCCGAATTGGATTACTTACTGAATAACGATCTGGCCGATGTGGATTGCGAAAACTGGGAAGAAGACACTCCATTTAAAGATCCGCGCGAGCTGTATGATTTTTTAAAGACGGAAAAGCCCGAAGAGGAACTTGTCTTTTCCCACGGCGACCTGGGAGACAGCAACATCTTTGTGAAAGATGGCAAAGTAAGTGGCTTTATTGATCTTGGGAGAAGCGGCAGGGCGGACAAGTGGTATGACATTGCCTTCTGCGTCCGATCGATCAGGGAGGATATCGGGGAAGAACAGTATGTCGAGCTATTATTTGACTTACTGGGGATCAAGCCTGATTGGGAGAAAATAAAATATTATATTTTACTGGATGAATTGTTTTAG,MAKMRISPELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRADKWYDIAFCVRSIREDIGEEQYVELLFDLLGIKPDWEKIKYYILLDELF,MAKMRISPELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRADKWYDIAFCVRSIREDIGEEQYVELFFDLLGIKPDWEKIKYYILLDELF,100,gnl|BL_ORD_ID|1227|hsp_num:0,1332,FALSE,None
LK617,9_11 # 8000 # 8542 # -1 # ID=9_11;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.379,9_11,8000,8542,-,Strict,300,370.548,SAT-4,99.44,3002897,protein homolog model,n/a,n/a,nucleoside antibiotic,antibiotic inactivation,streptothricin acetyltransferase (SAT),GTGATTACAGAAATGAAAGCAGGGCACCTGAAAGATATCGATAAACCCAGCGAACCATTTGAGGTGATAGGTAAGATTATACCGAGGTATGAAAACGAGAATTGGACCTTTACAGAATTACTCTATGAAGCGCCATATTTAAAAAGCTACCAAGACGAAGAGGATGAAGAGGATGAGGAGGCAGATTGCCTTGAATATATTGACAATACTGATAAGATAATATATCTTTACTACCAAGACGATAAATGCGTCGGAAAAGTTAAACTGCGAAAAAATTGGAACCGGTACGCTTATATAGAAGATATCGCCGTATGTAAGGATTTCAGGGGGCAAGGCATAGGCAGCGCGCTTATCAATATATCTATAGAATGGGCAAAGCATAAAAACTTGCATGGACTAATGCTTGAAACCCAGGACAATAACCTTATAGCTTGTAAATTCTATCATAATTGTGGTTTCAAAATCGGCTCCGTCGATACTATGTTATACGCCAACTTTGAAAACAACTTTGAAAAAGCTGTTTTCTGGTATTTAAGGTTTTAG,MITEMKAGHLKDIDKPSEPFEVIGKIIPRYENENWTFTELLYEAPYLKSYQDEEDEEDEEADCLEYIDNTDKIIYLYYQDDKCVGKVKLRKNWNRYAYIEDIAVCKDFRGQGIGSALINISIEWAKHKNLHGLMLETQDNNLIACKFYHNCGFKIGSVDTMLYANFENNFEKAVFWYLRF,MITEMKAEHLKDIDKPSEPFEVIGKIIPRYENENWTFTELLYEAPYLKSYQDEEDEEDEEADCLEYIDNTDKIIYLYYQDDKCVGKVKLRKNWNRYAYIEDIAVCKDFRGQGIGSALINISIEWAKHKNLHGLMLETQDNNLIACKFYHNCGFKIGSVDTMLYANFENNFEKAVFWYLRF,100,gnl|BL_ORD_ID|1483|hsp_num:0,1505,FALSE,None
LK617,9_12 # 8539 # 9447 # -1 # ID=9_12;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.361,9_12,8539,9447,-,Strict,500,573.933,aad(6),100,3002628,protein homolog model,n/a,n/a,aminoglycoside antibiotic,antibiotic inactivation,ANT(6),ATGAGATCAGAAAAAGAAATGATGGATTTAGTACTTTCTTTAGCAGAACAGGATGAACGTATTCGAATTGTGACCCTTGAGGGGTCACGCGCAAATATTAATATACCTAAAGATGAATTTCAGGATTATGATATTACATATTTTGTAAGTGATATAGAACCGTTTATATCTAATGATGACTGGCTTAATCAATTTGGGAATATAATAATGATGCAAAAGCCGGAGGATATGGAATTATTCCCACCTGAAGAAAAGGGATTTTCCTATCTTATGCTATTTGATGATTACAATAAAATTGATCTTACCTTATTGCCCTTGGAAGAGTTAGATAATTACCTAAAGGGCGATAAATTAATAAAGGTTCTAATTGATAAAGATTGTAGAATTAAAAGGGACATAGTTCCGACTGATATAGATTATCATGTAAGAAAGCCAAGCGCAAGGGAGTATGATGATTGCTGCAATGAATTTTGGAATGTAACACCTTATGTTATTAAAGGATTGTGCCGTAAGGAAATTTTATTTGCTATTGATCATTTTAATCAGATTGTTCGCCATGAGCTGCTGAGAATGATATCATGGAAGGTCGGCATCGAAACAGGCTTTAAATTAAGTGTAGGCAAGAACTATAAGTTTATTGAAAGGTATATATCCGAGGATTTGTGGGAGAAACTTTTGTCCACCTACCGGATGGATTCCTATGAAAACATATGGGAAGCATTATTTCTATGCCATCAATTGTTCAGGGCGGTATCCGGTGAGGTGGCGGAAAGGCTTCATTATGCCTATCCGGAGTATGATAGGAATATAACAAAATATACCAGGGACATGTATAAAAAATACACTGGTAAAACCGGCTGCCTGGATAGCACATATGCCGCTGATATAGAAGAGAGGCGGGAACAGTGA,MRSEKEMMDLVLSLAEQDERIRIVTLEGSRANINIPKDEFQDYDITYFVSDIEPFISNDDWLNQFGNIIMMQKPEDMELFPPEEKGFSYLMLFDDYNKIDLTLLPLEELDNYLKGDKLIKVLIDKDCRIKRDIVPTDIDYHVRKPSAREYDDCCNEFWNVTPYVIKGLCRKEILFAIDHFNQIVRHELLRMISWKVGIETGFKLSVGKNYKFIERYISEDLWEKLLSTYRMDSYENIWEALFLCHQLFRAVSGEVAERLHYAYPEYDRNITKYTRDMYKKYTGKTGCLDSTYAADIEERREQ,EGSRANINIPKDEFQDYDITYFVSDIEPFISNDDWLNQFGNIIMMQKPEDMELFPPEEKGFSYLMLFDDYNKIDLTLLPLEELDNYLKGDKLIKVLIDKDCRIKRDIVPTDIDYHVRKPSAREYDDCCNEFWNVTPYVIKGLCRKEILFAIDHFNQIVRHELLRMISWKVGIETGFKLSVGKNYKFIERYISEDLWEKLLSTYRMDSYENIWEALFLCHQLFRAVSGEVAERLHYAYPEYDRNITKYTRDMYKKYTGKTGCLDSTYAADIEERREQ,109.42,gnl|BL_ORD_ID|1433|hsp_num:0,1562,FALSE,None
LK1351,22_2 # 1070 # 1924 # 1 # ID=22_2;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.561,22_2,1070,1924,+,Strict,400,486.108,ErmX,84.51,3000596,protein homolog model,n/a,n/a,macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic,antibiotic target alteration,Erm 23S ribosomal RNA methyltransferase,ATGTCTACATACGGATACGGCCGTCACGAACATGGCCAAAATTTTCTCACAGACCACAAGATCATCAACTCCATCGTCGATCTTGTAAAACAAACCTCCGGCCCCATCATTGAGATCGGGCCAGGAAGCGGTGCCCTCACCCACCCGATATCCCACTTGGGGAGGGCAATAACGGCAGTTGAGGTAGACGCAAAACTAGCTGCCAAACTCACAAAAAAGACCGCCTCGGCGTCGGTCGAAGTGGTCCATGATGATTTCCTCAACTTCCCGTTACCCGCCACTCCCTGCGTCATTGTGGGAAACATTCCCTTTCACCTCACCACTGCCATTCTTCGAAAGTTGTTGCATGCGCCGGCATGGACTGACGCTGTACTCCTCATGCAGTGGGAAGTCGCTCGCCGCCGGGCCGGGGTAGGTGCAAGCACGATGATGACAGCTCAGTGGTCCCCATGGTTCACGTTTCACCTTGGTTCCCGAGTACCAAGGTTTGCTTTCCGGCCACAGCCAAACGTTGACGGGGGGATCTTAGTGATCCGCCGGGTGGGTGACCCGAAGATCCCGATAGAGCAACGCAAAGCCTTTCAGGCGATGGTGCACACCGTTTTCACCGCCCGGGGACGCGGGATAGGGGAAATTCTCCGAAGGGCAGGGTTGTTTTCATCACGTTCAGAGACACAATCATGGTTGCGCTCGCGAGGAATCGACCCCGCAACCCTACCTCCCAGATTGCACACCAGCGACTGGATCGATCTCTTCCAGGTGACTGGTTCCTCTTCACCGCGCCATCGGCCCATTTCACAATCGGGAAGTAGTCAACGCCCTCCTCAACGGAAAAATCGAGGCCGGCGGCGGTAA,MSTYGYGRHEHGQNFLTDHKIINSIVDLVKQTSGPIIEIGPGSGALTHPISHLGRAITAVEVDAKLAAKLTKKTASASVEVVHDDFLNFPLPATPCVIVGNIPFHLTTAILRKLLHAPAWTDAVLLMQWEVARRRAGVGASTMMTAQWSPWFTFHLGSRVPRFAFRPQPNVDGGILVIRRVGDPKIPIEQRKAFQAMVHTVFTARGRGIGEILRRAGLFSSRSETQSWLRSRGIDPATLPPRLHTSDWIDLFQVTGSSSPRHRPISQSGSSQRPPQRKNRGRRR,MSAYGQGRHEHGQNFLTNHKIINSIIDLVKQTSGPIIEIGPGSGALTHPMAHLGRAITAVEVDAKLAAKITQETSSAAVEVVHDDFLNFRLPATPCVIVGNIPFHLTTAILRKLLHAPAWTDAVLLMQWEVARRRAGVGATTMMTAQWSPWFTFHLGSRVPRSAFRPQPNVDGGILVIRRVGDPKIPIEQRKAFQAMVHTVFTARGRGIGEILRRQGCFHHVQKHNHGCAREESTPRPYLPDCYTNDWIDLFQVTGSSLPHHRPISPSGSSQRPPQRKNRSRRR,100,gnl|BL_ORD_ID|872|hsp_num:0,950,FALSE,None
LK1380,11_5 # 3135 # 3878 # -1 # ID=11_5;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.781,11_5,3135,3878,-,Strict,50,80.4925,vanY gene in vanF cluster,34.67,3002958,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGTCGCACCCTCCCTCTCGCCGCGCTGGCCGCGCTCGCGCTGCTCGTGGCCGGTTGCGGCACGCCCGCCGCGGGCCCGTCCTCGGCGACGCCGGCTTCCGGCTCCGCGAGCGCGGCCGCGTCGTCCCGCGCCGCCTCGAGCACGGCGCCGTCGTCGAGCACGCACGCCGACCCGGCCGCCCTCGACGTCGTCGTGAACAAGACCCGCCCCGTGGCCCCGCCCGACTGGGCGCCCTCGGATCTGCTGGCCGTGCCCGGCAGCGAGCTGCCCCTGCGGGCGGAGGCCGCGACGGCGGCCGGCGACCTGCTGGATGCCGCCGCGGCGGCGGGCCACCGCCTCACCACCCTGAGCGCCTACCGCTCGTACGACTACCAGGTCCGGACGTACGGCCACTGGGTCGACGAGCTGGGCCGCGCCGAGGCCGACCGCGTCTCGGCGCGTCCGGGGTACTCCGAGCACCAGACCGGCCTGGCCTGGGACGTGGGCGACGCCGCGACCCCCGCGTGTGACCTGGAAGCGTGCTTCGGCGACACCGCCGCGGGCCGCTGGGTGGCCGCGCACGCCGCCGAGCACGGGTTCGTCATCCGCTACCCCGCCGGGGCCGAGGACGTGACGGGCTTCGCCCACGAGCCCTGGCACCTGCGCTATGTCGGGTCCGCGGAGGCGGCCCGGGTCGAGGCGGTCGGCGGCGTCCTCGAGACCGCATGGGGTCTGCCTCCGGCGCCCGACTACGCGGACTGA,MRRTLPLAALAALALLVAGCGTPAAGPSSATPASGSASAAASSRAASSTAPSSSTHADPAALDVVVNKTRPVAPPDWAPSDLLAVPGSELPLRAEAATAAGDLLDAAAAAGHRLTTLSAYRSYDYQVRTYGHWVDELGRAEADRVSARPGYSEHQTGLAWDVGDAATPACDLEACFGDTAAGRWVAAHAAEHGFVIRYPAGAEDVTGFAHEPWHLRYVGSAEAARVEAVGGVLETAWGLPPAPDYAD,MKKWGLLLVFALFLVFIFNILPISQDKVEDRIYEQNDKDTSDDKMTAENMQKIELTEEQIYQGNLLLVNNEHPVHQKSIKSDIINLFTHKELTKGYGLLDNEIKLSEEIAGKFSEMIAAAEEDGVSNFLISSGYRDLDEQSRLYEEMGSDFALPAGHSEHNLGLSLDVGSTQMKMDKAPEGKWIEKNCWEYGFILRYPLDKTDVTGIQYEPWHIRYVGLPHSAIMQEMNLALEEYLDYLKEEKSISVRVDGKKYTISYDPISQNETIEVEVPADEQYEISGNNIDGVIVTTFS,84.3,gnl|BL_ORD_ID|1808|hsp_num:0,1899,FALSE,None
LK570,1_288 # 276864 # 278612 # -1 # ID=1_288;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.541,1_288,276864,278612,-,Strict,1000,1117.45,msbA,92.44,3003950,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic efflux,ATP-binding cassette (ABC) antibiotic efflux pump,ATGCAGAATGATAAAGATCTCTCCACGTGGCAGACCTTCCGCCGCCTCTGGCCGCTTATTGCGCCATTTAAAACCGGACTGATCGTCGCGGCAGTTGCGTTAGTCTTTAACGCCGCTAGTGATACCTTCATGCTATCGCTTCTTAAACCGTTACTGGATGATGGTTTTGGTAAAACGGATCGCTCAGTGCTGCTATGGATGCCGCTGGTCGTGATTGGGTTGATGTTACTGCGTGGCGTCACCAGCTATATTTCGAGCTACTGTATCTCGTGGGTTTCAGGCAAAGTCGTCATGACAATGCGCCGCCGTCTGTTCAGCCATATGATGGGGATGCCCGTCTCCTTCTTTGATAAACAGTCTACGGGTACCTTGCTGTCACGCATTACCTATGATTCCGAACAGGTTGCGTCATCCTCTTCCAGCGCCTTGATTACCGTCGTGCGCGAAGGCGCCTCGATCATCGGTCTGTTTGTGATGATGTTCTATTACAGCTGGCAGCTGTCGCTGATTCTGATCGTCCTGGCCCCCATCGTCTCGATGGCGATTCGCGTGGTATCGAAGCGTTTTCGTAATATCAGCAAGAATATGCAAAACACCATGGGGCAGGTGACCACCAGCGCAGAGCAGATGCTGAAAGGGCATAAAGAAGTGCTGATGTTTGGCGGTCAGGCGGTAGAAACCAAACGTTTTGATAAGGTCAGCAACAAAATGCGCTTGCAGGGGATGAAAATGGTCTCTGCGTCGTCTATTTCTGACCCGGTTATTCAGCTGATTGCGTCACTGGCGCTGGCATTTGTTCTCTATGCCGCCAGCTTCCCGAGCGTCATGGAAACGTTAACTGCCGGTACCATCACCGTCGTCTTCTCCTCGATGATCGCGTTGATGCGCCCGCTGAAGTCGCTGACTAACGTCAATGCTCAGTTCCAGCGCGGGATGGCCGCCTGCCAGACGCTGTTTGCGATTCTTGATTCCGAACAGGAAAAAGACGAAGGCAAGCTGGTTATCGAGCGGGCGAAGGGCAACCTGGAATTCAAAGACGTCACCTTTACCTATCCGGGCCGTGAAACGCCGGCGCTGCGAAATATCAACCTCAACATCCAGGAAGGTAAAACGGTCGCCCTGGTCGGGCGTTCGGGGTCGGGTAAATCGACCATCGCCAGCCTGATTACGCGCTTTTACGATATCGATAACGGCCAGATTTTGCTGGATGGCCACGATCTGCGTGAATACACTCTGGCATCCCTGCGCGATCAGGTGGCGCTGGTGTCGCAAAACGTTCATCTGTTCAACGATACCGTGGCCAACAACATTGCCTATGCGCGCACGGAAGAGTACAGCCGTGAGCAGATCGAAGAAGCGGCGCGTATGGCCTACGCGATGGACTTTATCAGCAAAATGGATAATGGCCTCGATACCGTTATCGGTGAGAACGGCGTACTGCTCTCCGGCGGTCAGCGTCAGCGTATTGCCATCGCGCGTGCGCTGCTGCGTAACAGCCCGATTCTGATTCTGGACGAAGCGACATCGGCGCTGGATACCGAGTCTGAACGCGCGATCCAGGCCGCCCTCGACGAACTGCAGAAAAACCGCACTTCGCTGGTGATTGCCCACCGTCTTTCCACCATCGAACAAGCCGATGAAATTGTGGTGGTGGAAGATGGCCGCATTGTCGAGCGCGGTAGCCATGCCGATCTGCTGGAACACCGCGGCGTGTACGCCCAGCTACATAAGATGCAGTTTGGCCAATGA,MQNDKDLSTWQTFRRLWPLIAPFKTGLIVAAVALVFNAASDTFMLSLLKPLLDDGFGKTDRSVLLWMPLVVIGLMLLRGVTSYISSYCISWVSGKVVMTMRRRLFSHMMGMPVSFFDKQSTGTLLSRITYDSEQVASSSSSALITVVREGASIIGLFVMMFYYSWQLSLILIVLAPIVSMAIRVVSKRFRNISKNMQNTMGQVTTSAEQMLKGHKEVLMFGGQAVETKRFDKVSNKMRLQGMKMVSASSISDPVIQLIASLALAFVLYAASFPSVMETLTAGTITVVFSSMIALMRPLKSLTNVNAQFQRGMAACQTLFAILDSEQEKDEGKLVIERAKGNLEFKDVTFTYPGRETPALRNINLNIQEGKTVALVGRSGSGKSTIASLITRFYDIDNGQILLDGHDLREYTLASLRDQVALVSQNVHLFNDTVANNIAYARTEEYSREQIEEAARMAYAMDFISKMDNGLDTVIGENGVLLSGGQRQRIAIARALLRNSPILILDEATSALDTESERAIQAALDELQKNRTSLVIAHRLSTIEQADEIVVVEDGRIVERGSHADLLEHRGVYAQLHKMQFGQ,MHNDKDLSTWQTFRRLWPTIAPFKAGLIVAGVALILNAASDTFMLSLLKPLLDDGFGKTDRSVLVWMPLVVIGLMILRGITSYVSSYCISWVSGKVVMTMRRRLFGHMMGMPVSFFDKQSTGTLLSRITYDSEQVASSSSGALITVVREGASIIGLFIMMFYYSWQLSIILIVLAPIVSIAIRVVSKRFRNISKNMQNTMGQVTTSAEQMLKGHKEVLIFGGQEVETKRFDKVSNRMRLQGMKMVSASSISDPIIQLIASLALAFVLYAASFPSVMDSLTAGTITVVFSSMIALMRPLKSLTNVNAQFQRGMAACQTLFTILDSEQEKDEGKRVIERATGDVEFRNVTFTYPGRDVPALRNINLKIPAGKTVALVGRSGSGKSTIASLITRFYDIDEGEILMDGHDLREYTLASLRNQVALVSQNVHLFNDTVANNIAYARTEQYSREQIEEAARMAYAMDFINKMDNGLDTVIGENGVLLSGGQRQRIAIARALLRDSPILILDEATSALDTESERAIQAALDELQKNRTSLVIAHRLSTIEKADEIVVVEDGVIVERGTHNDLLEHRGVYAQLHKMQFGQ,100,gnl|BL_ORD_ID|2187|hsp_num:0,2423,FALSE,None
LK570,1_805 # 857233 # 860379 # 1 # ID=1_805;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.554,1_805,857233,860379,+,Strict,1900,1961.04,acrB,92.66,3000216,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGCCTAATTTCTTTATCGATCGCCCCATATTCGCATGGGTGATCGCCATAATCATCATGCTTGCCGGGGGACTTGCGATCCTGAAGCTGCCTGTTGCGCAATATCCAACGATTGCGCCGCCGGCGGTCTCGATCACCGCAACCTACCCGGGTGCTGATGCGAAAACGGTGCAGGATACCGTGACGCAGGTTATCGAACAGAACATGAACGGTATCGATAACCTGATGTACATGTCCTCCAACAGTGACTCAACCGGTACGGTACAGATCACCCTGACCTTCCAGTCTGGTACGGATGCGGACATCGCGCAGGTACAGGTGCAGAACAAACTGCAGCTCGCCATGCCGCTGCTGCCGCAGGAAGTACAGCAACAGGGCGTGAGCGTGGAGAAATCCTCCAGCAGCTTCCTGATGGTTGTCGGCGTTATCAACACCAACGGCACCATGACGCAGGAGGATATCTCCGACTACGTTGGCGCCAACATGAAAGATGCGATCAGCCGTACGTCCGGCGTGGGTGACGTTCAGCTGTTTGGTTCCCAGTACGCGATGCGTATCTGGATGGATCCGAACAAACTGAACAACTTCCAGCTGACGCCGGTCGATGTCATTAGCGCGATTAAAGCCCAGAACGCCCAGGTAGCAGCCGGTCAGTTAGGCGGTACGCCGCCGGTGAAAGGCCAGCAGCTGAACGCCTCTATCATCGCGCAGACCCGTCTGAAATCCGCTGACGAATTCAGCAATATTCTGCTGAAAGTGAACCAGGACGGTTCGCAGGTTCGTCTGCGTGACGTAGCGAAAGTTGAGCTTGGTGGTGAAAACTATGACATCGTCGCGAAGTTTAATAACCAGCCGGCTTCCGGTCTGGGTATCAAACTGGCGACCGGCGCCAACGCCCTGGATACCGCCAACGCCATTCGCGCTGAACTGGCGAAAATGGAGCCCTACTTCCCGTCAGGCCTGAAGATTGTTTACCCGTATGACACCACGCCGTTCGTGAAAATCTCGATTCATGAAGTGGTTAAAACGCTGGTCGAAGCGATCATCCTGGTCTTCCTGGTTATGTATCTGTTCCTGCAGAACTTCCGCGCCACGTTGATTCCAACCATCGCGGTACCGGTCGTCTTGCTGGGTACTTTCGCCATCCTGGCCATTTTTGGCTTCTCGATAAACACCCTGACCATGTTTGGTATGGTGCTTGCGATAGGTCTGCTCGTCGATGACGCCATCGTGGTGGTGGAAAACGTCGAGCGTGTCATGGCGGAAGAAGGCCTGCCGCCGAAGGAAGCAACCCGTAAATCCATGGGCCAGATTCAGGGCGCACTGGTCGGTATCGCGATGGTGCTTTCTGCGGTATTTATCCCGATGGCCTTCTTCGGTGGTTCAACGGGTGCGATTTATCGTCAGTTCTCCATCACCATCGTTTCGGCGATGGCGCTGTCGGTGCTGGTTGCATTAATCCTGACCCCGGCGCTGTGCGCCACGATGCTGAAACCTATCGCTAAAGGCGGTCATGGCGAGCACAAAGGCTTCTTTGGCTGGTTTAACCGCATGTTCGATAAGAGCACGCACCATTACACCGATAGCGTAGGTAACATTCTGCGCAGTACCGGTCGTTACCTGGTGCTGTATCTGATTATCGTCGTCGGAATGGCCTGGCTGTTCGTCCGTCTGCCGAGCTCGTTCCTGCCAGATGAAGATCAGGGCGTATTCCTGAGCATGGCGCAGCTTCCTGCCGGCGCTACGCAGGAACGTACGCAGAAAGTGCTGGATGAGATGACGGACTACTACCTCACGAAAGAGAAAGCCAACGTCGAATCTGTGTTCGCCGTTAACGGCTTTGGCTTCGCGGGTCGTGGTCAGAACACCGGTATTGCGTTCGTTTCACTGAAAGACTGGAGCGAACGTCCGGGCAGCGAGAACAAGGTTGAAGCGATTACCGGTCGTGCGATGGCCCGTTTCTCGCAGATTAAAGACGCGATGGTCTTCGCCTTTAACCTGCCGGCTATCGTCGAACTGGGTACCGCAACCGGCTTTGACTTCCAGCTGATCGACCAGGGCGGCTTAGGTCACGAAAAACTGACTCAGGCACGTAACCAGCTGTTTGGTGAAGTGGCGAAGCACCCTGACCTGCTGGTCGGCGTTCGTCCTAACGGCCTGGAAGATACGCCGCAGTTCAAGGTGGATATTGACCAGGAGAAAGCGCAGGCGTTGGGCGTTTCTATCAGCGACATCAATACCACGCTGGGCGCAGCCTGGGGCGGTAGCTACGTCAATGACTTCATCGACCGCGGTCGCGTGAAGAAAGTGTACGTCATGTCCGAAGCGAAATACCGTATGCTGCCGGAAGATATTGGCAACTGGTACGTTCGCGGTAGCGATGGACAGATGGTGCCGTTCTCAGCCTTCTCCACCTCACACTGGGAGTATGGTTCACCGCGTCTGGAACGCTATAACGGTCTGCCGTCGATGGAAATCCTCGGTCAGGCGGCTCCGGGCAGAAGTACCGGTGAAGCGATGACGATGATGGAAGAGCTGGCCAAAAAACTGCCTTCGGGTATTGGTTATGACTGGACCGGTATGTCCTATCAGGAACGTCTGTCCGGTAACCAGGCGCCGGCGCTGTATGCCATCTCGCTGATCGTGGTATTCCTGTGTCTGGCGGCGCTGTATGAAAGCTGGTCGATACCGTTCTCCGTTATGCTGGTTGTCCCACTGGGGGTTATCGGTGCACTGCTGGCGGCAACGTTCCGTGGTCTGACGAACGACGTTTACTTCCAGGTAGGCCTGCTGACCACCATTGGTCTGTCGGCGAAGAACGCGATACTTATCGTAGAATTCGCCAAAGATCTGATGGATAAAGAAGGCAAGGGTCTGATTGAAGCGACCCTGGAAGCGGTACGTATGCGTCTGCGTCCAATCCTGATGACCTCACTGGCGTTTATCCTCGGGGTTATGCCGCTGGTCATTAGCTCCGGCGCAGGTTCCGGCGCACAGAACGCCGTAGGTACCGGCGTAATGGGCGGGATGGTGACGGCAACGGTTCTGGCTATCTTCTTTGTTCCGGTCTTCTTTGTGGTGGTTCGCCGCCGCTTCAGCAAGAAATCGGAAGACATTGAGCACAGCCATCCGACTGAGCATCATTAA,MPNFFIDRPIFAWVIAIIIMLAGGLAILKLPVAQYPTIAPPAVSITATYPGADAKTVQDTVTQVIEQNMNGIDNLMYMSSNSDSTGTVQITLTFQSGTDADIAQVQVQNKLQLAMPLLPQEVQQQGVSVEKSSSSFLMVVGVINTNGTMTQEDISDYVGANMKDAISRTSGVGDVQLFGSQYAMRIWMDPNKLNNFQLTPVDVISAIKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRLKSADEFSNILLKVNQDGSQVRLRDVAKVELGGENYDIVAKFNNQPASGLGIKLATGANALDTANAIRAELAKMEPYFPSGLKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQNFRATLIPTIAVPVVLLGTFAILAIFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVMAEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFIPMAFFGGSTGAIYRQFSITIVSAMALSVLVALILTPALCATMLKPIAKGGHGEHKGFFGWFNRMFDKSTHHYTDSVGNILRSTGRYLVLYLIIVVGMAWLFVRLPSSFLPDEDQGVFLSMAQLPAGATQERTQKVLDEMTDYYLTKEKANVESVFAVNGFGFAGRGQNTGIAFVSLKDWSERPGSENKVEAITGRAMARFSQIKDAMVFAFNLPAIVELGTATGFDFQLIDQGGLGHEKLTQARNQLFGEVAKHPDLLVGVRPNGLEDTPQFKVDIDQEKAQALGVSISDINTTLGAAWGGSYVNDFIDRGRVKKVYVMSEAKYRMLPEDIGNWYVRGSDGQMVPFSAFSTSHWEYGSPRLERYNGLPSMEILGQAAPGRSTGEAMTMMEELAKKLPSGIGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFSVMLVVPLGVIGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGLIEATLEAVRMRLRPILMTSLAFILGVMPLVISSGAGSGAQNAVGTGVMGGMVTATVLAIFFVPVFFVVVRRRFSKKSEDIEHSHPTEHH,MPNFFIDRPIFAWVIAIIIMLAGGLAILKLPVAQYPTIAPPAVTISASYPGADAKTVQDTVTQVIEQNMNGIDNLMYMSSNSDSTGTVQITLTFESGTDADIAQVQVQNKLQLAMPLLPQEVQQQGVSVEKSSSSFLMVVGVINTDGTMTQEDISDYVAANMKDAISRTSGVGDVQLFGSQYAMRIWMNPNELNKFQLTPVDVITAIKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRLTSTEEFGKILLKVNQDGSRVLLRDVAKIELGGENYDIIAEFNGQPASGLGIKLATGANALDTAAAIRAELAKMEPFFPSGLKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQNFRATLIPTIAVPVVLLGTFAVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVMAEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGSTGAIYRQFSITIVSAMALSVLVALILTPALCATMLKPIAKGDHGEGKKGFFGWFNRMFEKSTHHYTDSVGGILRSTGRYLVLYLIIVVGMAYLFVRLPSSFLPDEDQGVFMTMVQLPAGATQERTQKVLNEVTHYYLTKEKNNVESVFAVNGFGFAGRGQNTGIAFVSLKDWADRPGEENKVEAITMRATRAFSQIKDAMVFAFNLPAIVELGTATGFDFELIDQAGLGHEKLTQARNQLLAEAAKHPDMLTSVRPNGLEDTPQFKIDIDQEKAQALGVSINDINTTLGAAWGGSYVNDFIDRGRVKKVYVMSEAKYRMLPDDIGDWYVRAADGQMVPFSAFSSSRWEYGSPRLERYNGLPSMEILGQAAPGKSTGEAMELMEQLASKLPTGVGYDWTGMSYQERLSGNQAPSLYAISLIVVFLCLAALYESWSIPFSVMLVVPLGVIGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGLIEATLDAVRMRLRPILMTSLAFILGVMPLVISTGAGSGAQNAVGTGVMGGMVTATVLAIFFVPVFFVVVRRRFSRKNEDIEHSHTVDHH,99.9,gnl|BL_ORD_ID|1011|hsp_num:0,1104,FALSE,None
LK570,1_930 # 986687 # 987784 # 1 # ID=1_930;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.561,1_930,986687,987784,+,Strict,250,257.684,vanG,37.25,3002909,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,glycopeptide resistance gene cluster; Van ligase,ATGGCTAAGATGAGGGTTGGGATCGTTTTTGGCGGTAAGTCGGCAGAACATGAAGTGTCGCTGCAATCGGCGAAAAATATCGTTGAAGCAATTGATAAAACACGCTTTGATGTCGTTCTGCTCGGCATTGATAAACAGGGACTCTGGCATATCAACGATGCCGGTAACTATCTGTTAAACCCGCAGGATCCTGCCCGTATCGCCCTGCGTCCTTCCGACGTCACCCTGGCGCAAATTCCTGGCCGTGACGCGCAGCAGCTGATCAACGCCGACAGCGGCCAACCGCTGGCCGCCATCGATGTGATTTTCCCGATTGTTCACGGTACCCTCGGGGAAGACGGATCGCTGCAGGGCATGCTGCGCATGGCTAACCTGCCCTTCGTCGGTTCCGACGTCCTCGGGTCCGCCGCCTGTATGGACAAAGACGTCACCAAGCGCCTGCTGCGTGATGCCGGACTGGCGATTGCCCCGTTCATCACCCTGACCCGCGCCAATCGCCAGCAGTTCAGCTTTACGCAGGTGCAAGACAAACTCGGCCTGCCGCTGTTCGTCAAACCGGCCAACCAGGGTTCTTCGGTAGGCGTCAGCAAAGTCAACAGCGAAGAGCAGTACCAGCAGGCGGTCGCGTTGGCCTTTGAATTCGATCATAAAGTGGTGGTGGAACAAGGAATTAAAGGACGGGAAATTGAGTGTGCGGTGCTGGGGAACGATCATCCTCAGGCCAGTACCTGCGGCGAAATCGTCCTCAACAGCGAGTTCTACGCCTACGATACCAAGTACATCGACGATCAGGGGGCGAAAGTGGTGGTTCCTGCGGCCATTGCCAGCGATATCAACGATAAAATTCGCGATATTGCCATTCAGGCCTACCAGACGCTGGGCTGCAGCGGCATGGCCCGCGTTGATGTTTTCCTGACGGAAGAGAACGAAGTTATCATCAACGAAATCAATACGCTGCCAGGTTTTACCAACATCAGTATGTATCCGAAGCTGTGGCAGGCCAGCGGCCTGGACTACACCAGCCTGATCAGCCGCCTGATTGAACTGGCGCTGGAGCGCCATGCGGCAGACCGCGCGCTGAAGACATCCATGAACTGA,MAKMRVGIVFGGKSAEHEVSLQSAKNIVEAIDKTRFDVVLLGIDKQGLWHINDAGNYLLNPQDPARIALRPSDVTLAQIPGRDAQQLINADSGQPLAAIDVIFPIVHGTLGEDGSLQGMLRMANLPFVGSDVLGSAACMDKDVTKRLLRDAGLAIAPFITLTRANRQQFSFTQVQDKLGLPLFVKPANQGSSVGVSKVNSEEQYQQAVALAFEFDHKVVVEQGIKGREIECAVLGNDHPQASTCGEIVLNSEFYAYDTKYIDDQGAKVVVPAAIASDINDKIRDIAIQAYQTLGCSGMARVDVFLTEENEVIINEINTLPGFTNISMYPKLWQASGLDYTSLISRLIELALERHAADRALKTSMN,MQNKKIAVIFGGNSTEYEVSLQSASAVFENINTNKFDIIPIGITRSGEWYHYTGEKEKILNNTWFEDSKNLCPVVVSQNRSVKGFLEIASDKYRIIKVDLVFPVLHGKNGEDGTLQGIFELAGIPVVGCDTLSSALCMDKDRAHKLVSLAGISVPKSVTFKRFNEEAAMKEIEANLTYPLFIKPVRAGSSFGITKVIEKQELDAAIELAFEHDTEVIVEETINGFEVGCAVLGIDELIVGRVDEIELSSGFFDYTEKYTLKSSKIYMPARIDAEAEKRIQEAAVTIYKALGCSGFSRVDMFYTPSGEIVFNEVNTIPGFTSHSRYPNMMKGIGLSFSQMLDKLIGLYVE,104.58,gnl|BL_ORD_ID|1069|hsp_num:0,1157,FALSE,None
LK570,3_256 # 273660 # 275351 # 1 # ID=3_256;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.553,3_256,273660,275351,+,Strict,1000,1031.17,eptB,89.71,3005047,protein homolog model,n/a,n/a,peptide antibiotic,antibiotic target alteration,pmr phosphoethanolamine transferase,ATGAATTATATTAGAACGATGACACAGCAGAAAGTCAGCCTTTGGCTGGCGCTGTACATCGGCTGGTTTATGAACGTTGCTGTGCTTTTCCGTCGCCTTGATGGTTATGCGCAGGAATTTACCCTCTGGAAAGGGCTTTCCGGGATTGTGGAACTGGTTGCCACCGTGCTGGTGACGTTTTTCCTGCTACGTGTTCTGTCGCTGCTGGGGCGGCGCGTCTGGCGAATACTCGCCACGCTGGTGGTGATTTTCTCCGCTGCCGCCAGCTATTACATGACCTTCCTGAACGTGGTGATTGGCTACGGCATCATTGCGTCGGTGATGACCACGGATATCGACCTCTCTCAGGAGGTGGTGGGTTGGTATTTGATTCTGTGGCTGGCGCTGGTCAGCGCTCCGCCGCTGCTGCTTATCTGGAGTAACCGCTGCCAGCATACTCTGCTGCGGCAAATTCGGACGCCGGGCCAGCGGGTAAAAAATATCGCCATCGTTGCTCTCGCCGGGTTAATGGTCTGGGGACCGATTCGCCTGCTCGAACTGCGGCAGAAGGATGTTGAGCGTAGCTCTGAAGTCGATATGCCGAGCTACGGCGGGGTGATTGCCAACTCGTATCTGCCATCGAACTGGCTTTCCGCGCTGGGGCTGTACGCCTGGGCGCAGGTGGATGAGTCCTCAGATAACAAGTCGTTGATAAACCCTGCCAAAAAATTCACCTATGTCGAGCCGCAGGGCCTGGATGATACCTACGTAGTGTTCATTATCGGTGAAACCACCCGCTGGGACCATATGGGGATCCTGGGTTATAACCGCAATACCACGCCGAAGCTGGCTCAGGAGAAAAACCTGGTGGCCTTCCGCGGCTACTCCTGCGATACCGCGACCAAACTCTCTCTGCGCTGCATGTTTGTGCGTGAGGGTGGGGCGGAAGACAACCCGCAGCGAACGCTGAAAGAGCAAAACGTCTTTGCTGTCTTGCACCAGCTCGGCTTTACCGGCGACCTGTATGCGATGCAGAGCGAGATGTGGTTCTACAGCAATACCATGGCGAACAGCATTGCCTATCGTGAGCAGATTGGCGCTGAACCGCGTAACCGCGGCAAAAGCGTGGACGACATGCTGCTGGCGGATGAGGTTAAGCGCTCTTTGATGAAGAATGACCATGGTAAACACCTGATTATTCTCCATACCAAAGGTTCGCACTTTAACTATACCCAGCGTTACCCGCGCAGCTTTGCGCAGTGGCAGCCGGAGTGTGTGGGCGTGGACAGCAAATGCTCGAAAGCGGAGCTGATCAACTCTTACGATAATAGCGTGACCTATGTCGATCACTTTATCGTGAGCGTGCTGGACCAGCTGCGTGATAAGAAGGCGATTGTGTTCTATGCCGCCGATCACGGGGAGTCAATCAACGAGCATGAACACCTGCACGGTACGCCACGTAAGATGGCGCCGCCGGAACAGTTCCGTGTGCCGATGATGGTGTGGATGTCGGATAAATATCTGGCCGCGCCGGATCATGCTGCTTCGTTTGCCCGCCTCAAAGAGCAGGCGGCGATGAAAGTCCCGCGTCGTCATGTTGAGCTGTATGACACCATCATGGGTTGTCTGGGCTACACCTCGCCGGACGGTGGAATTAATGAGCATAACAACTGGTGCCGCGTTGCCGATGCGGGGAAAACCGTGGCGAAATAG,MNYIRTMTQQKVSLWLALYIGWFMNVAVLFRRLDGYAQEFTLWKGLSGIVELVATVLVTFFLLRVLSLLGRRVWRILATLVVIFSAAASYYMTFLNVVIGYGIIASVMTTDIDLSQEVVGWYLILWLALVSAPPLLLIWSNRCQHTLLRQIRTPGQRVKNIAIVALAGLMVWGPIRLLELRQKDVERSSEVDMPSYGGVIANSYLPSNWLSALGLYAWAQVDESSDNKSLINPAKKFTYVEPQGLDDTYVVFIIGETTRWDHMGILGYNRNTTPKLAQEKNLVAFRGYSCDTATKLSLRCMFVREGGAEDNPQRTLKEQNVFAVLHQLGFTGDLYAMQSEMWFYSNTMANSIAYREQIGAEPRNRGKSVDDMLLADEVKRSLMKNDHGKHLIILHTKGSHFNYTQRYPRSFAQWQPECVGVDSKCSKAELINSYDNSVTYVDHFIVSVLDQLRDKKAIVFYAADHGESINEHEHLHGTPRKMAPPEQFRVPMMVWMSDKYLAAPDHAASFARLKEQAAMKVPRRHVELYDTIMGCLGYTSPDGGINEHNNWCRVADAGKTVAK,MPQRQAVFYSSFSRFACMKYIRTMTQQKLSFWLALYIGWFMNVAVFFRRFDGYAQEFTFWKGLSGVVELVATVFVTFFLLRLLSLFGRRIWRILATLIVLFSAAASYYMTFLNVVIGYGIIASVMTTDIDLSKEVIGWHLILWLVVVSAPPLLFIWSNRCRHTLLRQLRTPGQRVKNVLIVVLAGLIVWGPIRLLELRQHDVERHSEVDMPSYGGVIANSYLPSNWLSALGLYAWAQVDESSDNKSLINPAKKFTYVAPEGLDDTYVVFIIGETTRWDHMGILDYSRNTTPELEKEKNLVAFRGYLCDTATKLSLRCMFVREGGAEDNPQRTLKEQNVFAVLHQLGFSGNLYAMQSEMWFYSNTMANNIAYREQIGAEPRNRGKSVDDMLLVDEMKRGMAQGNASGKHLIILHTKGSHFNYTQRYPRSFAQWKPECVGVDNKCSKAELINSYDNSVTYVDHFIVSVLDQLRDKKAIVFYAADHGESINEREHLHGTPRKMAPPEQFRVPMMVWMSDKYLENPDHAAAFAHLQQQAAMKVPRRHVELYDTIMGCLGYTSPDGGINENNNWCRWKK,98.08,gnl|BL_ORD_ID|2780|hsp_num:0,3791,FALSE,None
LK570,3_320 # 354783 # 355766 # 1 # ID=3_320;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.576,3_320,354783,355766,+,Strict,550,580.482,PmrF,84.21,3003578,protein homolog model,n/a,n/a,peptide antibiotic,antibiotic target alteration,pmr phosphoethanolamine transferase,ATGTTTACTTACCCACCCGTGAAAAAAGTCTCGGTCGTTATTCCGGTTTATAACGAACAGGAGAGCCTGCCTGAGCTGATTCGCCGTACGGATGCCGCCTGCGCGACGCTGGGCCGCCAGTATGAGATTCTGCTGGTCGACGATGGCAGCAGCGATGATTCTGCCCGCATGCTGACCGAGGCTGCTGAAGCCGAAGGCAGCCATGTGGTCGCGGTGTTGCTTAACCGCAACTATGGCCAGCACTCGGCCATTATGGCGGGATTCAGCCATGTGACCGGCGATCTGATTATTACCCTTGATGCCGACCTGCAAAACCCACCGGAAGAGATCCCGCGCCTGGTGGCGAAGGCGGACGAAGGTTACGACGTGGTCGGTACCGTTCGGCAGAACCGCCAGGACACCTTCTTCCGTAAAAGCGCGTCGAAGATGATCAACCGCCTGATTCAGCGCACCACCGGTAAAGCGATGGGGGACTACGGCTGCATGCTGCGCGCCTATCGCCGCCACATTATCGACGCGATGCTCAATTGCCATGAGCGCAGTACGTTTATCCCGATTCTGGCAAATACCTTCGCGCGCCGGGCGGTCGAAATCCCGGTGATGCACGCGGAGCGTGAATTTGGCGATTCCAAATACAGCTTTATGCGCCTGATTAATCTGATGTACGACCTGGTGACCTGTTTGACCACCACGCCGCTGCGTCTGCTGAGCGTCTTTGGCAGCGTGATTGCCCTGCTGGGCTTCGCTTTCGCCTTCCTGCTGGTGTTCCTGCGACTGGTATTTGGCCCGCAGTGGGCGGCGGAAGGGGTGTTCATGCTGTTTGCCGTGCTGTTCATGTTCATCGGTGCCCAGTTTGTCGGCATGGGGCTGCTCGGGGAGTATATCGGACGCATCTATAACGATGTCCGCGCCCGTCCCCGCTACTTTATTCAACGTGTTGTTCGTCAGCCGGAAACGGCGTCTCAAGAGGAAGATCGTTCATGA,MFTYPPVKKVSVVIPVYNEQESLPELIRRTDAACATLGRQYEILLVDDGSSDDSARMLTEAAEAEGSHVVAVLLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEGYDVVGTVRQNRQDTFFRKSASKMINRLIQRTTGKAMGDYGCMLRAYRRHIIDAMLNCHERSTFIPILANTFARRAVEIPVMHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRLLSVFGSVIALLGFAFAFLLVFLRLVFGPQWAAEGVFMLFAVLFMFIGAQFVGMGLLGEYIGRIYNDVRARPRYFIQRVVRQPETASQEEDRS,MFEIHPVKKVSVVIPVYNEQESLPELIRRTTTACESLGKEYEILLIDDGSSDNSAHMLVEASQAENSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEGYDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHERSTFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLGSIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYTDVRARPRYFVQQVIRPSSKENE,101.55,gnl|BL_ORD_ID|1937|hsp_num:0,2014,FALSE,None
LK570,3_440 # 488209 # 488841 # -1 # ID=3_440;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.507,3_440,488209,488841,-,Strict,400,432.95,CRP,99.05,3000518,protein homolog model,n/a,n/a,macrolide antibiotic; fluoroquinolone antibiotic; penam,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGGTGCTTGGCAAACCGCAAACAGACCCTACCCTCGAATGGTTCTTGTCTCATTGCCACATTCATAAGTACCCATCTAAAAGCACGCTGATCCACCAGGGTGAAAAAGCAGAAACGTTGTACTACATCGTCAAAGGCTCTGTGGCTGTGCTCATCAAGGATGAAGAAGGTAAAGAGATGATCCTCTCTTACCTCAACCAGGGCGATTTCATCGGTGAATTAGGCTTGTTTGAAGAAGGCCAGGAGCGTAGCGCCTGGGTACGTGCGAAAACCGCATGTGAAGTGGCCGAAATCTCCTACAAAAAATTCCGTCAGCTCATTCAGGTTAACCCGGATATCCTGATGCGCTTGTCGTCGCAGATGGCTCGCCGTCTGCAGGTGACCTCAGAAAAAGTGGGTAACCTTGCCTTCCTCGACGTCACCGGGCGCATCGCTCAGACGCTGTTGAACCTGGCAAAACAGCCGGATGCGATGACCCACCCTGATGGTATGCAAATTAAAATTACCCGTCAGGAAATTGGTCAGATCGTTGGCTGTTCCCGCGAAACCGTTGGCCGTATCCTGAAGATGCTGGAAGATCAGAACCTGATCTCCGCACACGGTAAAACTATCGTCGTATACGGTACGCGTTAA,MVLGKPQTDPTLEWFLSHCHIHKYPSKSTLIHQGEKAETLYYIVKGSVAVLIKDEEGKEMILSYLNQGDFIGELGLFEEGQERSAWVRAKTACEVAEISYKKFRQLIQVNPDILMRLSSQMARRLQVTSEKVGNLAFLDVTGRIAQTLLNLAKQPDAMTHPDGMQIKITRQEIGQIVGCSRETVGRILKMLEDQNLISAHGKTIVVYGTR,MVLGKPQTDPTLEWFLSHCHIHKYPSKSKLIHQGEKAETLYYIVKGSVAVLIKDEEGKEMILSYLNQGDFIGELGLFEEGQERSAWVRAKTACEVAEISYKKFRQLIQVNPDILMRLSAQMARRLQVTSEKVGNLAFLDVTGRIAQTLLNLAKQPDAMTHPDGMQIKITRQEIGQIVGCSRETVGRILKMLEDQNLISAHGKTIVVYGTR,100,gnl|BL_ORD_ID|803|hsp_num:0,869,FALSE,None
LK570,4_51 # 52027 # 55179 # 1 # ID=4_51;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.592,4_51,52027,55179,+,Strict,750,1205.66,adeF,61.15,3000777,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; tetracycline antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGGACTTTTCCCGCTTTTTTATCGACAGGCCAATTTTCGCCGCGGTGCTGTCGATTTTGATTTTTATTACCGGGCTCATCGCCATTCCGCTGCTGCCGGTCAGCGAATACCCTGACGTCGTACCGCCGAGTGTGCAGGTACGCGCGGAGTATCCGGGCGCCAACCCGAAAGTGATCGCTGAGACCGTGGCGACGCCGCTGGAAGAAGCGATCAACGGCGTCGAAAACATGATGTACATGAAGTCCGTCGCCGGCTCCGACGGCGTACTGGTTACCACCGTCACCTTCCGTCCTGGCACCGACCCCGATCAGGCGCAGGTTCAGGTACAAAACCGGGTATCACAGGCCGAAGCGCGTCTGCCGGAAGATGTACGCCGTCTGGGGATCACCACCCAGAAACAGTCGCCGACGCTCACCCTGGTGGTGCATCTGTTTTCGCCCAACGGAAAATACGATTCGCTGTATATGCGTAACTACGCCACCTTAAAAGTGAAGGACGAACTGGCGCGCCTGCCCGGCGTCGGCCAAATCCAGATTTTTGGTGCCGGCGAATACGCCATGCGAATCTGGCTGGATCCGAATAAGGTGGCCGCACGTGGGTTGACCGCCTCCGATGTGGTGACGGCGATGCAGGAGCAAAACGTGCAGGTGTCCGCCGGGCAGCTTGGCGCCGAGCCACTGCCGAAAGAGAGCGACTTCCTGATCTCGATTAACGCCCAGGGGCGTCTGCACACGGAAGAAGAGTTCGGCAATATCATTCTCAAAACGGCCCAGGATGGTTCGCTGGTACGCCTGCGCGACGTTGCACGCATCGAAATGGGGTCGGGCAGCTACGCGCTACGTTCCCAGCTTAACAATAAAGATGCGGTCGGGATCGGCATCTTCCAGTCGCCGGGGGCCAACGCCATTGATTTGTCGAATGCGGTACGCGCCAAAATGGACGAACTGTCCACGCGTTTCCCGGAAGACATGAAGTGGGCCGCCCCTTACGACCCCACCGTTTTTGTGCGCGACTCTATTCGCGCGGTGGTGCAAACCCTGCTCGAAGCGGTAGTGCTGGTGGTACTGGTGGTGATCCTGTTCCTGCAAACCTGGCGCGCATCGATTATTCCATTGATTGCCGTACCGGTCTCGGTGGTGGGGACGTTCGGTATTCTCTATCTGCTTGGCTTCTCGCTTAACACCCTGAGCCTGTTCGGTCTGGTTCTCGCCATTGGGATCGTGGTGGACGACGCGATTGTGGTGGTGGAAAACGTCGAGCGCAATATCGAGGAGGGGCTCGCCCCTCTGCAGGCGGCGCACCAGGCGATGCGTGAAGTTTCCGGGCCGATTATCGCCATCGCCCTGGTGCTGTGCGCGGTGTTCGTACCGATGGCCTTCCTCTCCGGCGTAACCGGGCAGTTCTATAAACAGTTTGCGGTGACGATCGCGATTTCGACGGTGATCTCGGCCATCAACTCGCTGACCCTCTCCCCGGCGCTGGCGGCCCTGCTGCTGAAGCCGCACGGCGCGCCAAGAGATCTCCCGACCCGGCTTATCGATCGTCTGTTCGGCTGGCTGTTCCGCCCGTTTAACCGCTTTTTCCATCGCAGCTCGCACGGTTACCAGGGGCTGGTTGGCAAAACGCTCGGACGACGTGGCGCCGTGTTTATTGTTTACCTGCTGCTGCTCGGCGCCGCCGGGGTGATGTTTAAAGCCGTGCCGGGCGGGTTTATTCCCACCCAGGACAAGCTCTACCTGATTGGCGGCGTGAAAATGCCGGAAGGTTCTTCGCTGGCCCGCACCGACGCGGTCATCCGTAAAATGAGCGAAATCGGGATGAACACTGAAGGCGTGGATTATGCGGTGGCGTTTCCAGGACTTAACGCGCTGCAATTCACCAATACGCCGAACACCGGTACGGTATTTTTTGGCCTGAAGCCGTTCGATCAGCGTAAACATTCTGCGGCGGAAATTAACGCCGAGATCAATGCCAAAATCGCGCAAATCCAGGAAGGCTTTGGCTTCTCAATCCTGCCGCCGCCGATTCTCGGCCTCGGCCAGGGGTCCGGTTACTCGCTGTATATTCAGGATCGAGGGGGCTTAGGCTACGGTGCGCTACAAACGGCGGTGAATACCCTGTCCGGGGCAATCATGCAAACGCCGGGAATGCACTTCCCTATTTCAACCTACCAGGCAAACGTACCGCAGCTGGATGTGCAGGTCGATCGCGACAAGGCGAAAGCGCAGGGGGTATCGCTGACCGATCTGTTCGGTACGCTGCAAACCTACCTGGGATCATCTTATGTGAACGACTTTAACCAGTTCGGCCGAACCTGGCGCGTCATGGCGCAGGCCGACGGGCCGTTCCGCGACAGCGTGGAGGATATTGCCAATCTGCGCACCCGGAATAACCAGGGTGAAATGGTGCCGATCGGCAGTATGGTCAATATCAGCACGACCTACGGGCCGGATCCGGTGATCCGCTACAACGGCTATCCGGCGGCGGATCTGATCGGCGACGCCGATCCTCGGGTACTCTCTTCCGCTCAGGCGATGACCAAACTGGCCGCGATGTCCGGCCAGCTGCTGCCGAATGGTATGAACATCGAATGGACGGATCTGAGCTTCCAGCAGGCCACCCAGGGCAACACGGCGCTGATTGTCTTCCCGGTGGCGGTACTTCTGGCGTTCCTGGTGCTGGCGGCGCTGTATGAAAGCTGGACGCTGCCGCTGGCGGTGATCCTCATTGTTCCGATGACTCTGCTCTCCGCCCTGTTCGGCGTCTGGCTCACCGGCGGCGATAATAACGTCTTCGTGCAGGTTGGACTGGTGGTGTTGATGGGGCTGGCTTGTAAAAACGCCATCCTGATTGTTGAGTTTGCTCGCGAGCTGGAAATTCAGGGGAAAGGGATCATGGAAGCCGCGCTGGAAGCCTGCCGCCTGCGTCTGCGTCCAATCGTGATGACCTCCATCGCCTTTATTGCCGGAACAATTCCGTTGATCCTCGGCCACGGAGCGGGCGCAGAAGTGCGCGGCGTCACCGGGATTACGGTGTTCTCCGGGATGCTCGGCGTGACGCTGTTTGGTCTGTTCCTGACGCCGGTGTTCTACGTCACGCTGCGTAAGCTGGTCACACGCGGTAAACCGGCGCTGGAAGCGCAGCCTGAATAG,MDFSRFFIDRPIFAAVLSILIFITGLIAIPLLPVSEYPDVVPPSVQVRAEYPGANPKVIAETVATPLEEAINGVENMMYMKSVAGSDGVLVTTVTFRPGTDPDQAQVQVQNRVSQAEARLPEDVRRLGITTQKQSPTLTLVVHLFSPNGKYDSLYMRNYATLKVKDELARLPGVGQIQIFGAGEYAMRIWLDPNKVAARGLTASDVVTAMQEQNVQVSAGQLGAEPLPKESDFLISINAQGRLHTEEEFGNIILKTAQDGSLVRLRDVARIEMGSGSYALRSQLNNKDAVGIGIFQSPGANAIDLSNAVRAKMDELSTRFPEDMKWAAPYDPTVFVRDSIRAVVQTLLEAVVLVVLVVILFLQTWRASIIPLIAVPVSVVGTFGILYLLGFSLNTLSLFGLVLAIGIVVDDAIVVVENVERNIEEGLAPLQAAHQAMREVSGPIIAIALVLCAVFVPMAFLSGVTGQFYKQFAVTIAISTVISAINSLTLSPALAALLLKPHGAPRDLPTRLIDRLFGWLFRPFNRFFHRSSHGYQGLVGKTLGRRGAVFIVYLLLLGAAGVMFKAVPGGFIPTQDKLYLIGGVKMPEGSSLARTDAVIRKMSEIGMNTEGVDYAVAFPGLNALQFTNTPNTGTVFFGLKPFDQRKHSAAEINAEINAKIAQIQEGFGFSILPPPILGLGQGSGYSLYIQDRGGLGYGALQTAVNTLSGAIMQTPGMHFPISTYQANVPQLDVQVDRDKAKAQGVSLTDLFGTLQTYLGSSYVNDFNQFGRTWRVMAQADGPFRDSVEDIANLRTRNNQGEMVPIGSMVNISTTYGPDPVIRYNGYPAADLIGDADPRVLSSAQAMTKLAAMSGQLLPNGMNIEWTDLSFQQATQGNTALIVFPVAVLLAFLVLAALYESWTLPLAVILIVPMTLLSALFGVWLTGGDNNVFVQVGLVVLMGLACKNAILIVEFARELEIQGKGIMEAALEACRLRLRPIVMTSIAFIAGTIPLILGHGAGAEVRGVTGITVFSGMLGVTLFGLFLTPVFYVTLRKLVTRGKPALEAQPE,MNISKFFIDRPIFAGVLSVLILLAGLLSVFQLPISEYPEVVPPSVVVRAQYPGANPKVIAETVASPLEESINGVEDMLYMQSQANSDGNLTITVNFKLGIDPDKAQQLVQNRVSQAMPRLPEDVQRLGVTTLKSSPTLTMVVHLTSPDNRYDMTYLRNYAVLNVKDRLARLQGVGEVGLFGSGDYAMRVWLDPQKVAQRNLTATEIVNAIREQNIQVAAGTIGASPSNSPLQLSVNAQGRLTTEQEFADIILKTAPDGAVTRLGDVARVELAASQYGLRSLLDNKQAVAIPIFQAPGANALQVSDQVRSTMKELSKDFPSSIKYDIVYDPTQFVRASIKAVVHTLLEAITLVVVVVILFLQTWRASIIPLLAVPVSIIGTFALMLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVERNIEAGLNPREATYRAMREVSGPIIAIALTLVAVFVPLAFMTGLTGQFYKQFAMTIAISTVISAFNSLTLSPALAALLLKGHDAKPDALTRIMNRVFGRFFALFNRVFSRASDRYSQGVSRVISHKASAMGVYAALLGLTVGISYIVPGGFVPAQDKQYLISFAQLPNGASLDRTEAVIRKMSDTALKQPGVESAVAFPGLSINGFTNSSSAGIVFVTLKPFDERKAKDLSANAIAGALNQKYSAIQDAYIAVFPPPPVMGLGTMGGFKLQLEDRGALGYSALNDAAQNFMKAAQSAPELGPMFSSYQINVPQLNVDLDRVKAKQQGVAVTDVFNTMQIYLGSQYVNDFNRFGRVYQVRAQADAPFRANPEDILQLKTRNSAGQMVPLSSLVNVTQTYGPEMVVRYNGYTSADINGGPAPGYSSSQAEAAVERIAAQTLPRGIKFEWTDLTYQKILAGNAGLWVFPISVLLVFLVLAAQYESLTLPLAVILIVPMGILAALTGVWLTAGDNNIFTQIGLMVLVGLACKNAILIVEFARELEMQGATAFKAAVEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMIGVTFFGLFLTPAFYVLIRTLNSKHKLHSAAVHEAPLASPHDH,99.15,gnl|BL_ORD_ID|132|hsp_num:0,153,FALSE,None
LK570,4_110 # 113151 # 113681 # 1 # ID=4_110;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.537,4_110,113151,113681,+,Strict,280,340.887,emrR,93.14,3000516,protein homolog model,n/a,n/a,fluoroquinolone antibiotic,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGGATAGTTCGTTTACTCCCATTGAGCAAATGCTCAAGTTCCGCGCCAGCCGTCACGAAGATTTCCCTTTCCAGGAGATTCTGCTCACCCGCCTCTGTATGCACATGCAAGGTAAGCTACTGGAAAACCGCAATAAGATGCTGAAAGCGCAGGGGATTAACGAGACATTATTTATGGCGCTGATCACGCTGGAGTCTCAGGAAAACCACAGTATTCAGCCTTCTGAGCTGAGCTGCGCGCTGGGATCGTCACGGACCAACGCAACCCGTATTGCCGATGAACTGGAAAAACGCGGCTGGATTGAGCGTCGCGAAAGCGACAACGATCGCCGCTGCCTGCATCTGCAACTCACCGACAAAGGTCATCAGTTTTTGCGCGAAGTTTTACCGCCGCAGCACAACTGCCTGCATCAGCTCTGGTCTTCTCTGAGCACCAGCGAGAAAGACCAGCTCGAGCACATCACCCGCAAACTGCTTAGCCGCCTTGACCAGATGGAAGAGGATGGCGTACTGGCGGAGTCGCTGCGTTAA,MDSSFTPIEQMLKFRASRHEDFPFQEILLTRLCMHMQGKLLENRNKMLKAQGINETLFMALITLESQENHSIQPSELSCALGSSRTNATRIADELEKRGWIERRESDNDRRCLHLQLTDKGHQFLREVLPPQHNCLHQLWSSLSTSEKDQLEHITRKLLSRLDQMEEDGVLAESLR,MDSSFTPIEQMLKFRASRHEDFPYQEILLTRLCMHMQSKLLENRNKMLKAQGINETLFMALITLESQENHSIQPSELSCALGSSRTNATRIADELEKRGWIERRESDNDRRCLHLQLTEKGHEFLREVLPPQHNCLHQLWSALSTTEKDQLEQITRKLLSRLDQMEQDGVVLEAMS,100,gnl|BL_ORD_ID|1225|hsp_num:0,1330,FALSE,None
LK570,4_111 # 113812 # 114984 # 1 # ID=4_111;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.582,4_111,113812,114984,+,Strict,700,735.332,Klebsiella pneumoniae KpnG,94.62,3004588,protein homolog model,n/a,n/a,macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; cephalosporin; penam; peptide antibiotic; penem,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGAGCGCAAATGCGGAGAGCCAAACCCCGCAGCAACCGGACAGCAAGAAGGGCAAACGCAAAGGCGCCCTTCTGCTACTGACATTGCTCTTTATTATTATTGCCGTGGCATACGGAGTTTATTGGTTTTTGGTACTGCGTCATTATGAAGAGACCGATGACGCTTACGTGGCAGGGAACCAGGTGCAAATCATGGCGCAGGTGTCCGGCAGCGTGACGAAAGTCTGGGCCGACAACACTGATTTCGTGCAGCAAGGCGACCCGCTGGTCACCCTGGACCAGACCGATGCCCAGCAGGCATTTGAAAAAGCGAAAACCCAGCTGGCCGCCAGCGTTCGCCAGACGCGTCAGCAGATGATCAACAGCAAACAGCTGCAGGCGAATATCGACGTCAAGAAAACGGCGCTCTCTCAGGCACAGACCGATCTCAATCGTCGTATCCCGCTGGGCGCCGCCAACCTGATTGGCCGCGAAGAGCTGCAGCACGCTCGCGATACCGTCGCCAGCGCCCAGGCCGAACTGGATGTCGCCATTCAGCAATTCAACGCTAACCAGGCTATCGTGCTGAATACCCGCCTGGAACAACAGCCGGCGGTTCTGCAGGCGGCGACGGATGTCCGCAACGCCTGGCTTGCGCTGCAGCGTACGCAAATCGTCAGCCCGATTAGCGGCTACGTTTCCCGTCGTGCCGTGCAGCCCGGCGCCCAGATTAGCCCCACCACGCCGCTGATGGCGGTCGTACCGGCCACCAACCTGTGGATCGACGCCAACTTTAAAGAGACTCAGCTGGCGCATATGCGCATCGGCCAGGAAGCGACCGTCATCAGCGATATTTACGGCGATGATGTGAAGTACACCGGCAAGGTCGTCGGGCTGGACATGGGGACCGGCAGCGCGTTCTCACTGCTGCCGGCACAAAACGCCACCGGTAACTGGATCAAAGTGGTCCAGCGTCTGCCGGTACGTATTGAGCTCGATGCCAAACAGCTGGCTGAACATCCGCTGCGTATTGGTCTTTCAACGCTGGTTGAAGTGAACACCACCAACCGCGACGGCGAAATGCTGGCTAACCAGACGCGCAAATCCCCGGTTTATGAAAGCAATGCCCGCGAAATCGCCCTTGAGCCGGTGAACAAACTGATCGACGGTATCATCCAGGCTAACGCGGGATAA,MSANAESQTPQQPDSKKGKRKGALLLLTLLFIIIAVAYGVYWFLVLRHYEETDDAYVAGNQVQIMAQVSGSVTKVWADNTDFVQQGDPLVTLDQTDAQQAFEKAKTQLAASVRQTRQQMINSKQLQANIDVKKTALSQAQTDLNRRIPLGAANLIGREELQHARDTVASAQAELDVAIQQFNANQAIVLNTRLEQQPAVLQAATDVRNAWLALQRTQIVSPISGYVSRRAVQPGAQISPTTPLMAVVPATNLWIDANFKETQLAHMRIGQEATVISDIYGDDVKYTGKVVGLDMGTGSAFSLLPAQNATGNWIKVVQRLPVRIELDAKQLAEHPLRIGLSTLVEVNTTNRDGEMLANQTRKSPVYESNAREIALEPVNKLIDGIIQANAG,MSANAESQTPQQPGSKKGKRKGALLLLTLLFIIIAVAYGIYWFLVLRHYEETDDAYVAGNQVQIMAQVAGSVTKVWADNTDYVQKGDPLVTLDRTDAQQAFEKAKTQLAASVRQTRQQMINSKQLQANIDVKKTALSQAQADLNRRIPLGAANLIGREELQHARDTVASAQAELDVAIQQYNANQAIVLGTRLEQQPAVLQAATEVRNAWLALQRTQIVSPISGYVSRRSVQPGAQIGTTTPLMAVVPATNLWIDANFKETQLAHMRIGQPATVISDIYGDDVKYTGKVVGLDMGTGSAFSLLPAQNATGNWIKVVQRLPVRIELDEKQLAEHPLRIGLSTLVEVNTTDRDGEMLASQVRSSPVYESNAREIALDPVNKLIDEIIQANAG,100,gnl|BL_ORD_ID|2733|hsp_num:0,3298,FALSE,None
LK570,4_112 # 115000 # 116538 # 1 # ID=4_112;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.600,4_112,115000,116538,+,Strict,700,933.324,Klebsiella pneumoniae KpnH,93.43,3004597,protein homolog model,n/a,n/a,macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; cephalosporin; penam; peptide antibiotic; penem,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGCAACCGCAAAAACCGCTGGAAGGCGCGCAGCTGGTCATCATGACCATTGCGCTGTCGCTTGCGACCTTCATGCAGGTGCTGGACTCCACTATCGCCAACGTGGCCATTCCGACCATTGCCGGTAACCTTGGCTCATCGTTGAGCCAGGGGACCTGGGTTATCACCTCCTTCGGGGTGGCGAATGCTATCTCTATACCGATCACCGGCTGGCTGGCAAAACGCGTCGGGGAAGTGAAGCTGTTCCTGTGGTCGACGGTGGCGTTTGCCATCGCCTCCTGGGCCTGCGGGATGTCCAACAGCCTGACGATGCTGATTTTCTTCCGCGTGATTCAGGGGATCGTCGCCGGTCCGTTGATTCCGCTGTCGCAAAGTCTGCTGCTCAGCAACTATCCGCCCGCCAAACGTTCTATCGCGCTGGCGCTGTGGTCGATGACGGTGATCGTCGCGCCGATTTGCGGCCCTATTCTCGGCGGCTATATCAGCGACAACTACCACTGGGGCTGGATCTTCTTCATCAACGTACCGATTGGCATCGCGGTGGTGGTGATGACGCTGCAAACCCTGCGCAGTCGCGAAACCCGTACCGAACAGCGGCGGATTGACGGCGTCGGCCTGGCGCTGCTGGTGATCGGTATCGGCAGCCTGCAGGTGATGCTTGACCGCGGTAAAGAGCTGGACTGGTTCGCCTCCAACGAGATTATCGTGCTGACAATCGTCGCGGTGATCGCCATCAGTTTCCTGATCGTCTGGGAGCTGACCGACGACAACCCGATCGTCGACCTCTCGCTCTTTAAATCGCGAAACTTCACCATTGGCTGTCTGTGCATCAGTCTCGCCTACATGCTCTACTTCGGTGCTATCGTGCTGCTGCCGCAGCTGCTGCAGGAGGTGTATGGTTATACCGCCACCTGGGCCGGTCTGGCTTCCGCACCGGTGGGGGTAATCCCGGTTATCCTGTCGCCAATTATCGGCCGCTTTGCCCATAAGCTCGATATGCGCCGGCTGGTGACCTTCAGCTTTATCATGTACGCGGTGTGCTTCTACTGGCGCGCCTGGACTTTCGAGCCCGGCATGGACTTCGGCGCCTCGGCGTGGCCGCAGTTTATCCAGGGCTTCGCGGTGGCCTGCTTCTTTATGCCGCTGACCACCATCACCCTGTCCGGCCTGCCGCCGGAACGGCTGGCGGCGGCATCAAGCCTGTCGAACTTCACCCGTACGCTGGCAGGGTCAATAGGCACCTCGATTACCACCACCATGTGGACTAACCGCGAGGCGCTGCACCATGCGCAGCTCACCGAGTCGGTGACGCCCTATAATCCCAACGCCCAGCAGATGTATGACCAGCTGCAGGGATTAGGGATGACTCAACAGCAGGCGTCCGGCTGGATAGCGCAGCAGATAACTAACCAGGGGCTGATTATCTCCGCCAACGAAATCTTCTGGTTCTCGGCGGCGATCTTTATCCTGCTGCTGGGGCTGGTGTGGTTTGCCAGACCGCCGTTTAGCGCCGGGGGCGGCGGCGGCGGTGCGCACTAA,MQPQKPLEGAQLVIMTIALSLATFMQVLDSTIANVAIPTIAGNLGSSLSQGTWVITSFGVANAISIPITGWLAKRVGEVKLFLWSTVAFAIASWACGMSNSLTMLIFFRVIQGIVAGPLIPLSQSLLLSNYPPAKRSIALALWSMTVIVAPICGPILGGYISDNYHWGWIFFINVPIGIAVVVMTLQTLRSRETRTEQRRIDGVGLALLVIGIGSLQVMLDRGKELDWFASNEIIVLTIVAVIAISFLIVWELTDDNPIVDLSLFKSRNFTIGCLCISLAYMLYFGAIVLLPQLLQEVYGYTATWAGLASAPVGVIPVILSPIIGRFAHKLDMRRLVTFSFIMYAVCFYWRAWTFEPGMDFGASAWPQFIQGFAVACFFMPLTTITLSGLPPERLAAASSLSNFTRTLAGSIGTSITTTMWTNREALHHAQLTESVTPYNPNAQQMYDQLQGLGMTQQQASGWIAQQITNQGLIISANEIFWFSAAIFILLLGLVWFARPPFSAGGGGGGAH,MQQQKPLEGAQLVIMTIALSLATFMQVLDSTIANVAIPTIAGNLGSSLSQGTWVITSFGVANAISIPLTGWLAKRVGEVKLFLWSTIAFAIASWACGVSSSLNMLIFFRVIQGIVAGPLIPLSQSLLLNNYPPAKRSIALALWSMTVIVAPICGPILGGYISDNYHWGWIFFINVPIGVAVVLMTLQTLRGRETRTERRRIDAVGLALLVIGIGSLQIMLDRGKELDWFSSQEIIILTVVAVVAICFLIVWELTDDNPIVDLSLFKSRNFTIGCLCISLAYMLYFGAIVLLPQLLQEVYGYTATWAGLASAPVGIIPVILSPIIGRFAHKLDMRRLVTFSFIMYAVCFYWRAYTFEPGMDFGASAWPQFIQGFAVACFFMPLTTITLSGLPPERLAAASSLSNFTRTLAGSIGTSITTTMWTNRESMHHAQLTESVNPFNPNAQAMYSQLEGLGMTQQQASGWIAQQITNQGLIISANEIFWMSAGIFLILLGLVWFAKPPFGAGGGGGGAH,100,gnl|BL_ORD_ID|2734|hsp_num:0,3299,FALSE,None
LK570,4_120 # 124567 # 124752 # -1 # ID=4_120;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.478,4_120,124567,124752,-,Strict,100,109.383,rsmA,85.25,3005069,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGCTGATTCTGACTCGTCGAGTTGGTGAGACCCTCATGATTGGAGATGAGGTCACTGTGACAGTTTTAGGGGTTAAGGGTAACCAGGTACGTATTGGCGTTAATGCCCCTAAAGAAGTCTCCGTGCATCGTGAAGAGATCTACCAGCGTATCCAGGCTGAAAAATCCCAGCAGTCCAGTTACTAA,MLILTRRVGETLMIGDEVTVTVLGVKGNQVRIGVNAPKEVSVHREEIYQRIQAEKSQQSSY,MLILTRRVGETLMVGDDVTVTVLGVKGNQVRIGVNAPKEVAVHREEIYQRIQKEKDQEPNH,100,gnl|BL_ORD_ID|2794|hsp_num:0,3807,FALSE,None
LK570,5_254 # 284896 # 288009 # 1 # ID=5_254;partial=00;start_type=ATG;rbs_motif=AGGA/GGAG/GAGG;rbs_spacer=11-12bp;gc_cont=0.578,5_254,284896,288009,+,Strict,1900,1925.21,acrD,89.1,3000491,protein homolog model,n/a,n/a,aminoglycoside antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGGCGAATTTTTTTATCGATCGCCCCATTTTCGCGTGGGTTCTGGCGATCCTGCTATGCCTGACCGGAACGCTCGCAATCTTGTCACTTCCCGTCGAGCAGTATCCCGATCTTGCGCCGCCTAACGTGCGCATTACCGCCAATTATCCAGGTGCCTCCGCACAAACGCTGGAAAATACCGTCACCCAGGTTATCGAGCAGAATATGACCGGCCTCGATAACCTGATGTATATGTCTTCCCAGAGCAGCTCTTCGGGTCAGGCGACGATTACGCTGACCTTTACCGCCGGAACCAATCCCAACGAAGCCATGCAGCAGGTACAAAACCAGCTGCAATCGGCAATGAAAAAACTGCCTCAGGATGTGCAAAATCAGGGGGTGACGGTACGTAAAACCGGCGATACCAACATTCTGACTATCGCGTTCGTCTCGACTGACGGCAGTATGGATAAGCAGGATATTGCCGACTACGTGGCCAGTAACATTCAGGAACCGCTCAGCCGCGTGAACGGAGTTGGCGACATTACGGCCTACGGCTCGCAATACTCAATGCGCATCTGGCTTGATCCGGCCAAACTCACCAGCGTGCAGATGACGGCGAAAGATGTCACCGACGCCATCGAATCACAGAATGCGCAGATCGCGGTCGGCCAGCTTGGCGGTACGCCGTCGGTCGATAATCAGTCGCTCAATGCCACCATTAACGCCCAGTCGCTGCTGCAAACGCCGCAGCAGTTCCGCGATATTACGCTGCGCGTGAATCCGGACGGCTCGCTGGTGACGCTCGGCGATGTGGCGAAAGTTGAACTGGGCGCGGAAAGCTACGATTACCTCAGCCGCTACAACCGCAACCCGGCCTCCGGCCTTGGCGTGCAGCTGGCCTCCGGGGCAAACGAAATGCAGACCGCGGAGCTGGTGCTCAATCGTCTGGATGAGCTGTCGCAGTATTTCCCTCACGGCCTTGAATATAAAATTGCCTACGAAACCACCTCCTTCGTGAAGGCCTCTATCCATGACGTGGTGAAAACGTTGCTGGAAGCCATCGTGCTGGTGTTCCTGGTGATGTACCTGTTCCTGCAAAACATCCGCGCAACGCTCATCCCAACCATTGCCGTACCGGTGGTTCTGATGGGGACTTTCGCCATCCTGTTTGCCTGCGGCTACAGTATCAACACCCTGACGATGTTCGCGATGGTGCTGGCGATAGGTCTGCTGGTGGACGATGCTATCGTGGTCGTCGAAAACGTTGAGCGCATCATGAGCGAAGAGGGCCTTTCGCCGCGTGAAGCGACGCGAAAATCCATGGGCCAGATTCAGGGGGCGCTGGTCGGGATCGCGATGGTACTGTCGGCGGTCTTTATCCCGATGGCCTTCTTCGGCGGCACAACCGGCGCCATTTACCGCCAGTTTTCTATTACCATCGTCTCGGCGATGGTGCTGTCGGTACTCGTGGCCATGATCCTCACGCCGGCCCTGTGCGCCACCTTGCTGAAACCCATGAAGAAAGGCGAAGAACACGGTAAAAAAGGCTTCTTCGGCTGGTTTAACCGTATGTTCAACCGTAACGCCAGCCGCTACGAAACAGCCGTGGGCAAAATTCTTCACCGCTCGCTGCGCTGGATAGCGATCTACGCGCTGCTGTTGGGGGGGATGGTCTTTATGTTCTTACGCCTCCCGACGTCGTTCCTGCCCCAGGAAGACCGCGGCATGTTCCTGACCTCGGTGCAGCTGCCGAGCGGCGCAACGCAGCAGCAGACCTTAAAAGTCGTGCAAAAAGTTGAGGACTATTTCTTTAATCATGAACAGGCCAACGTTGCTTCGATTTTTGCTACCGTGGGCTCTGGCCCGGGAGGCAACGGTCAGAACGTCGCGCGTATGTTTATCCGCCTGAAGGACTGGGATGAACGCGATGCGAAAACCGGTACCTCGTTTGCGATCATTGAACGTGCGACAAAAGCCTTTAACAGCATTAACGAGGCGCGGGTGTTCGCCACTAACCCGCCGGCAATCAGCGGACTGGGCAGCTCCGCCGGTTTTGATATGGAGCTTGAAGACCACGCCGGCAACGGGCACGCGGCGCTCATGGCAGCCCGCGATACGCTGCTCGATCTGGCGGCGAAAGATGAGCGGTTGACCCGGGTTCGCCATAACGGCCTTGACGATAGCCCACAGCTGCAGATTGATATCGATCAGCGGAAAGCCCAGGCGCTGGGCGTGGCTATTGACGATATCAACAACACGTTGCAAACCGCCTGGGGCTCAAGCTACGTGAACGATTTTATGGATCGTGGCCGCGTGAAGAAAGTCTACGTCCAGTCCGCCGCCCCTTACCGCATGCTGCCTGACGATATTAATCTGTGGTACGTGCGCAACAGCAGCGGCACCATGGTGCCCTTCTCGGCATTTGCCACCTCGCGCTGGCAAACCGGCTCCCCGCGCCTGGAGCGCTATAACGGCTACTCGGCGGTGGAAATCATCGGCGAAGCGGCTCCGGGCATCAGTACCGGTACCGCGATGGCTATCATGGAAGATCTGACCAGACAGCTGCCAAACGGCTTTGGGCTCGACTGGACGGCCATGTCCTATCAGGAACGGCTGTCCGGCGCGCAGGCACCGGCGCTGTACGCCATTTCGCTGCTGGTCGTGTTCTTGTGCCTGGCTGCGCTGTACGAGAGCTGGTCTATCCCCTTCTCGGTCATGCTGGTGGTGCCGCTGGGGGTTATCGGCGCGCTGCTGGCCACCTGGATGCGCGGTCTTGAAAACGACGTGTACTTCCAGGTTGGCCTGCTGACGGTCATCGGCCTGTCGGCGAAAAACGCCATTCTGATCGTCGAGTTTGCTAATGAGCTAAACGAGAAAGGGGAAGATTTACTCGCCGCCACGCTGTCGGCCTGTCGCCAGCGTCTGCGGCCGATCCTGATGACCTCGCTGGCCTTTATTTTTGGGGTCCTGCCGATGGCGACCAGCACCGGCGCCGGTTCCGGTAGCCAGCATGCCGTGGGTACCGGGGTCATGGGCGGGATGATTTCCGCCACCGTCCTGGCTATCTTCTTCGTTCCGCTATTCTTCGTACTGGTACGTCGACGCTTTCCGCAAAAAGAGCGCCCGCAATAA,MANFFIDRPIFAWVLAILLCLTGTLAILSLPVEQYPDLAPPNVRITANYPGASAQTLENTVTQVIEQNMTGLDNLMYMSSQSSSSGQATITLTFTAGTNPNEAMQQVQNQLQSAMKKLPQDVQNQGVTVRKTGDTNILTIAFVSTDGSMDKQDIADYVASNIQEPLSRVNGVGDITAYGSQYSMRIWLDPAKLTSVQMTAKDVTDAIESQNAQIAVGQLGGTPSVDNQSLNATINAQSLLQTPQQFRDITLRVNPDGSLVTLGDVAKVELGAESYDYLSRYNRNPASGLGVQLASGANEMQTAELVLNRLDELSQYFPHGLEYKIAYETTSFVKASIHDVVKTLLEAIVLVFLVMYLFLQNIRATLIPTIAVPVVLMGTFAILFACGYSINTLTMFAMVLAIGLLVDDAIVVVENVERIMSEEGLSPREATRKSMGQIQGALVGIAMVLSAVFIPMAFFGGTTGAIYRQFSITIVSAMVLSVLVAMILTPALCATLLKPMKKGEEHGKKGFFGWFNRMFNRNASRYETAVGKILHRSLRWIAIYALLLGGMVFMFLRLPTSFLPQEDRGMFLTSVQLPSGATQQQTLKVVQKVEDYFFNHEQANVASIFATVGSGPGGNGQNVARMFIRLKDWDERDAKTGTSFAIIERATKAFNSINEARVFATNPPAISGLGSSAGFDMELEDHAGNGHAALMAARDTLLDLAAKDERLTRVRHNGLDDSPQLQIDIDQRKAQALGVAIDDINNTLQTAWGSSYVNDFMDRGRVKKVYVQSAAPYRMLPDDINLWYVRNSSGTMVPFSAFATSRWQTGSPRLERYNGYSAVEIIGEAAPGISTGTAMAIMEDLTRQLPNGFGLDWTAMSYQERLSGAQAPALYAISLLVVFLCLAALYESWSIPFSVMLVVPLGVIGALLATWMRGLENDVYFQVGLLTVIGLSAKNAILIVEFANELNEKGEDLLAATLSACRQRLRPILMTSLAFIFGVLPMATSTGAGSGSQHAVGTGVMGGMISATVLAIFFVPLFFVLVRRRFPQKERPQ,MANFFIDRPIFAWVLAILLCLTGTLAIFSLPVEQYPDLAPPNVRVTANYPGASAQTLENTVTQVIEQNMTGLDNLMYMSSQSSGTGQASVTLSFKAGTDPDEAVQQVQNQLQSAMRKLPQAVQNQGVTVRKTGDTNILTIAFVSTDGSMDKQDIADYVASNIQDPLSRVNGVGDIDAYGSQYSMRIWLDPAKLNSFQMTAKDVTDAIESQNAQIAVGQLGGTPSVDKQALNATINAQSLLQTPEQFRDITLRVNQDGSEVRLGDVATVEMGAEKYDYLSRFNGKPASGLGVKLASGANEMATAELVLNRLDELAQYFPHGLEYKVAYETTSFVKASIEDVVKTLLEAIALVFLVMYLFLQNFRATLIPTIAVPVVLMGTFSVLYAFGYSVNTLTMFAMVLAIGLLVDDAIVVVENVERIMSEEGLTPREATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGTTGAIYRQFSITIVAAMVLSVLVAMILTPALCATLLKPLKKGEHHGQKGFFAWFNQMFNRNAERYEKGVAKILHRSLRWIVIYVLLLGGMVFLFLRLPTSFLPLEDRGMFTTSVQLPSGSTQQQTLKVVEQIEKYYFTHEKDNIMSVFATVGSGPGGNGQNVARMFIRLKDWSERDSKTGTSFAIIERATKAFNQIKEARVIASSPPAISGLGSSAGFDMELQDHAGAGHDALMAARNQLLALAAENPELTRVRHNGLDDSPQLQIDIDQRKAQALGVAIDDINDTLQTAWGSSYVNDFMDRGRVKKVYVQAAAPYRMLPDDINLWYVRNKDGGMVPFSAFATSRWETGSPRLERYNGYSAVEIVGEAAPGVSTGTAMDIMESLVKQLPNGFGLEWTAMSYQERLSGAQAPALYAISLLVVFLCLAALYESWSVPFSVMLVVPLGVIGALLATWMRGLENDVYFQVGLLTVIGLSAKNAILIVEFANEMNQKGHDLFEATLHACRQRLRPILMTSLAFIFGVLPMATSTGAGSGGQHAVGTGVMGGMISATILAIYFVPLFFVLVRRRFPLKPRPE,100,gnl|BL_ORD_ID|1309|hsp_num:0,1427,FALSE,None
LK570,6_136 # 151905 # 152855 # -1 # ID=6_136;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.470,6_136,151905,152855,-,Strict,500,510.76,leuO,75.8,3003843,protein homolog model,n/a,n/a,nucleoside antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGATAATTGAAACCTCTGAACCTGAACCCGCCCTCGAAAGAGGAATGATTAAACCTCAGCTTAGAACGGTCGATCTTAATCTGCTTACCGTTTTTGATGCGGTCATGCAGGAACAAAATATTACGCGGGCGGCGCATTCGCTGGGGATGTCTCAGCCTGCGGTGAGTAATGCCGTAGCGCGACTAAAAGTAATGTTTAACGATGAGCTGTTTGTACGGTATGGGCGGGGTATTCAGCCGACGGCTCGTGCATTTCAGCTATTTGGCTCAATACGCCAGGCGCTGCAGCTGGTGCAAAATGAGTTGCCGGGTTCCGATTTTGAGCCGATAAGCAGTGAGCGCGTATTTAATCTCTGCATTTGCAGCCCGTTAGATAACTATCTTACTTCGATTATATTTAACAAAGTTAACGAAGTTGCACCAAATATTCATTTGATTTTTAAAGCATCACTTAATCAAAACACCGAGCATCAATTACGCTATCAGGAAATAGAGTTTGTGGTTGGCTATGAGGAGTTTCGCCGCCCCGAGTTTGCCTGTGTGCCCTTGTTTAAAGATGAAATGATATTAGTAGCCAGCTGTAAACACCCGCGTATTTCCGGACCGGTGACGGAAGCGGATATTTATCGCGAAGAACATGCGGTTGTGGCTTTGGATCGCTATGCTTCGTTTAGCCTTCCCTGGTATAGCTCTGTCAATAAACAGACGCAAATTGCATATCAAGGGAATGCTATGGTCAGCGTGCTTAATGTGGTATCACAAACCCACATGGTGGCCATTGCCCCGAGCTGGCTGGCGAGGGAGTATGCAGAAAAGCTGAACCTGCAATTATTGCCGTTACCGCTAAAAGTGAATAGCCGCACCTGTTTTCTTTCCTGGCATGAGGCCGCCGGTAGAGATAAAGGTCATCAGTGGATGCAGGATCTGCTGGTGCGAATTTGCCAGCGCTAA,MIIETSEPEPALERGMIKPQLRTVDLNLLTVFDAVMQEQNITRAAHSLGMSQPAVSNAVARLKVMFNDELFVRYGRGIQPTARAFQLFGSIRQALQLVQNELPGSDFEPISSERVFNLCICSPLDNYLTSIIFNKVNEVAPNIHLIFKASLNQNTEHQLRYQEIEFVVGYEEFRRPEFACVPLFKDEMILVASCKHPRISGPVTEADIYREEHAVVALDRYASFSLPWYSSVNKQTQIAYQGNAMVSVLNVVSQTHMVAIAPSWLAREYAEKLNLQLLPLPLKVNSRTCFLSWHEAAGRDKGHQWMQDLLVRICQR,MPEVQTDHPETAELSKPQLRMVDLNLLTVFDAVMQEQNITRAAHALGMSQPAVSNAVARLKVMFNDELFVRYGRGIQPTARAFQLFGSVRQALQLVQNELPGSGFEPASSERVFHLCVCSPLDSILTSQIYNHIEQIAPNIHVMFKSSLNQNTEHQLRYQETEFVISYEDFHRPEFTSVPLFKDEMVLVASKNHPTIKGPLLKHDVYNEQHAAVSLDRFASFSQTWYDTVDKQASIAYQGMAMMSVLSVVSQTHLVAIAPRWLAEEFAESLELQVLPLPLKQNSRTCYLSWHEAAGRDKGHQWMEEQLVSICKR,100.64,gnl|BL_ORD_ID|4928|hsp_num:0,5921,FALSE,None
LK570,6_161 # 184727 # 187096 # 1 # ID=6_161;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.540,6_161,184727,187096,+,Strict,1500,1513.05,LptD,93.09,3005059,protein homolog model,n/a,n/a,peptide antibiotic; aminocoumarin antibiotic; rifamycin antibiotic,antibiotic efflux,ATP-binding cassette (ABC) antibiotic efflux pump,ATGACGGAACAACAAATACAACGTATGAAAAAACGTATTCCCAGCCTCCTGGCCACCATGATCGCCAGCGCCTTGTATAGCCAACAAGGCCTCGCCGCCGATCTCGCCACGCAATGTATGCTTGGCGTACCAAGCTATAATCGTCCCCTCGTTGAAGGTCAAACTAACGAGCTGCCGGTGACGATCAACGCCGATCATGCGAAGGGCAATTATCCTGATAACGCCGTATTTACCGGTAATGTTGACATTAACCAGGGTAATAGCCGTCTCCAGGCGGATGAGGTCCAGCTTCATCAGCAGCAGGCTGCTGGCCAGCCGCAGCCCGTTCGCACGGTTGATGCGCTCGGCAACGTTCACTATGACGATAATCAGGTTATCCTGAAAGGCCCGAAAGGCTGGTCAAACCTGAACACCAAAGATACCAATATCTGGCAGGGCGATTACCAGATGGTTGGTCGCCAGGGCCGCGGTACCGCCGACCTGATGAAACAGCGCGGCGAAAACCGCTATACCATTCTGGAAAACGGCAGCTTTACCTCCTGTCTGCCGGGTTCTGACACCTGGAGCGTCGTCGGTAGCGAAGTGATCCACGACCGCGAAGAACAGGTCGCCGAAATCTGGAACGCCCGTTTCAAACTCGGTTCGGTCCCTGTTTTCTATAGTCCTTACCTGCAGCTGCCGGTAGGCGACAAACGTCGTTCAGGCTTCCTGATTCCTAACGCCAAATACAGCACCAAAAATGGCGTAGAGTTTTCGCTGCCGTACTACTGGAATATCGCGCCGAACTTCGACGCCACCCTGACGCCGCACTACATGAGCAAGCGTGGCGGCGTGATGTGGGAAAACGAATTCCGCTATCTGACCAAAGCGGGGGCGGGGCTGTTCGAGTTTGACTACCTGCCGTCCGATAAAGTCTACCAGGACGATCACTCCAGCGACAGCAACAGCCGCCGCTGGTTGTTCTACTGGAATCATTCGGGTGTCATTGACCAGGTATGGCGTCTTAACGCCGACTACACCAAAGTCAGCGATCCGGACTACTTTAACGATTTCAGCTCGAAATACGGCTCCAGTACCGACGGCTACGCCACGCAGAAATTCAGCGCGGGCTACGTTAACCAGAACTTCGACGCCACCGTATCAACCAAACAGTTCCAGGTCTTCAACCGTGAGTCGAGCAACTCCTACGCCGCTCAACCGCAGCTGGACGTGAACTATTACCAGAACGATGTCGGTCCGTTCGATACCCATCTCTATGGTCAGGCGGTGCACTTCGTTAACACCAACGGCAACATGCCGGAAGCCACGCGTGTTCACTTCGAGCCGACGATCAACCTGCCGCTGTCTAACGGCTGGGGCAGTATTAATACCGAAGCCAAACTGCTGGCGACCCACTACCAGCAAAGCAACCTCGACAATTACAATTCGACCAATAATGCGGACTTAAAAGAGTCTGTTAACCGCGTCATGCCGCAGTTTAAAGTCGACGGTAAAATGGTCTTCGAGCGCGATCTGCAGGAGGGGTTCACCCAAACCCTCGAGCCGCGCATGCAGTATCTGTATATCCCGTATCGCGATCAGAGCCAAATCGGTTCCTATGACTCCACGCTGCTGCAGTCAGACTACAGCGGCCTGTTCCGCGACCGTACCTACAGCGGCCTGGACCGTATTGCTTCCGCGAACCAGCTCACTACCGGCGTGACTTCGCGCGTATATGATTCCGCCGCCGTTGAACGTTTTAATATTTCCGTTGGTCAAATCTATTATTTCACCGAGTCCCGGACCGGTGATGACAACATCAACTGGGAGAACAACGACACAACGGGTTCACTGGTATGGGCCGGCGATACTTACTGGCGCATCGCTGATAACTGGGGTTTACGCGGGGGAATTCAGTACGATACGCGTCTGGATAACGTCGCTACCGGTAACGGCACCGTGGAATACCGTCGCGATGAAAACCGTTTAATACAGCTTAACTATCGTTATGCCAGCCCGGAATACATTCAGGCCACGCTGCCGTCGTACTCCACCGCTGAGCAGTACAAAAATGGTATTTCTCAGGTGGGCATGACCGCCAGCTGGCCGGTTGTCGATCGCTGGTCGGTGGTGGGCGCATACTACTTTGATACCAATACCAGAAAGAGCGCCGACCAGATGTTAGGGGTCCAGTATAACTCCTGCTGCTACGCGATTCGCCTCGGCTATGAACGTAAGATCAACGGCTGGGATAGTAACGGCAACGGCGAGAGCAAATACGATAATACCTTTGGCATCAACATTGAGCTACGTGGCCTGAGCTCCAACTACGGTCTCGGCACTCAGCAGATGCTGCGTTCGAACATTTTACCGTACCAGAACTCCCTGTGA,MTEQQIQRMKKRIPSLLATMIASALYSQQGLAADLATQCMLGVPSYNRPLVEGQTNELPVTINADHAKGNYPDNAVFTGNVDINQGNSRLQADEVQLHQQQAAGQPQPVRTVDALGNVHYDDNQVILKGPKGWSNLNTKDTNIWQGDYQMVGRQGRGTADLMKQRGENRYTILENGSFTSCLPGSDTWSVVGSEVIHDREEQVAEIWNARFKLGSVPVFYSPYLQLPVGDKRRSGFLIPNAKYSTKNGVEFSLPYYWNIAPNFDATLTPHYMSKRGGVMWENEFRYLTKAGAGLFEFDYLPSDKVYQDDHSSDSNSRRWLFYWNHSGVIDQVWRLNADYTKVSDPDYFNDFSSKYGSSTDGYATQKFSAGYVNQNFDATVSTKQFQVFNRESSNSYAAQPQLDVNYYQNDVGPFDTHLYGQAVHFVNTNGNMPEATRVHFEPTINLPLSNGWGSINTEAKLLATHYQQSNLDNYNSTNNADLKESVNRVMPQFKVDGKMVFERDLQEGFTQTLEPRMQYLYIPYRDQSQIGSYDSTLLQSDYSGLFRDRTYSGLDRIASANQLTTGVTSRVYDSAAVERFNISVGQIYYFTESRTGDDNINWENNDTTGSLVWAGDTYWRIADNWGLRGGIQYDTRLDNVATGNGTVEYRRDENRLIQLNYRYASPEYIQATLPSYSTAEQYKNGISQVGMTASWPVVDRWSVVGAYYFDTNTRKSADQMLGVQYNSCCYAIRLGYERKINGWDSNGNGESKYDNTFGINIELRGLSSNYGLGTQQMLRSNILPYQNSL,MKKRIPSLLATMIASALYSQQGLAADLATQCMLGVPSYDRPLVEGRPGDLPVTINADHAKGNYPDNAVFTGNVDINQGNSRLRADEVQLHQQQAAGQAQPVRTVDALGNVHYDDNQVILKGPKAWSNLNTKDTNVWQGDYQMVGRQGRGTADLMKQRGENRYTILENGSFTSCLPGSDTWSVVGSEVIHDREEQVAEIWNARFKLGSVPIFYSPYLQLPVGDKRRSGFLIPNAKYSTKNGVEFSLPYYWNIAPNFDATITPHYMNKRGGVMWENEFRYLTQLGSGLTEFDYLPSDKVYEDDHSSDSNSRRWLFYWNHSGVIDQVWRLNADYTKVSDPDYFNDFSSKYGSSTDGYATQKFSAGYVNQNFDATVSTKQFQVFDRESSNSYSAEPQLDVNYYQNDVGPFDTHLYGQVAHFVNSNNNMPEATRVHFEPTINLPLSNGWGSLNTEAKLLATHYQQSNLDKYNAANGTDYKESVSRVMPQFKVDGKMVFERDLQEGFTQTLEPRVQYLYVPYRDQSEIGNYDSTLLQSDYTGLFRDRTYSGLDRIASANQVTTGLTSRVYDAAAVERFNISVGQIYYFTESRTGDDNINWENNDTTGSLVWAGDTYWRIADEWGLRGGIQYDTRLDNVATGNGTIEYRRDENRLVQLNYRYASPEYIQATLPSYSTAAQYKQGISQVGMTASWPIVDRWSVVGAYYYDTNTRKAANQMLGVQYNSCCYAIRLGYERKVNGWNSNDNGGESKYDNTFGINIELRGLSSNYGLGTQQMLRSNILPYQSSL,100.9,gnl|BL_ORD_ID|2786|hsp_num:0,3799,FALSE,None
LK570,6_307 # 335859 # 336278 # -1 # ID=6_307;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.645,6_307,335859,336278,-,Strict,200,263.462,fosA5,89.21,3003209,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; aminoglycoside antibiotic; phosphonic acid antibiotic,antibiotic inactivation,fosfomycin thiol transferase,ATGTTAAGCGGATTGAATCATCTGACCCTGGCGGTCAGCAGCCTGGCGCCGAGCGTGGCGTTTTATCACCAGCTGCTGGGGATGACGCTGCACGCGCGCTGGGACGGCGGGGCCTATCTCTCCTGCGGCGATCTGTGGCTGTGCCTGTCGCTGGATCCGCAGCGGCGCATCACTCCGCCGGAAGAGAGCGACTATACCCACTACGCCTTTAGCGTCGCCGAAGCCGACTTCGCCGGGTTCAGCGCGCGGCTGGAAACGGCCGGGGTGGCGGTGTGGAAGGTGAACCGCAGCGAAGGGGCGTCTTATTACTTCCTCGACCCTGACGGCCACAAGCTGGAGCTGCACGTCGGCAGCCTCGCCCTGCGCCTGGCGGCGTGCCGCGAGCAGCCGTATAAAGGGATGGTGTTTTATGACGAGTGA,MLSGLNHLTLAVSSLAPSVAFYHQLLGMTLHARWDGGAYLSCGDLWLCLSLDPQRRITPPEESDYTHYAFSVAEADFAGFSARLETAGVAVWKVNRSEGASYYFLDPDGHKLELHVGSLALRLAACREQPYKGMVFYDE,MLSGLNHLTLAVSQLAPSVAFYQQLLGMMLHARWDSGAYLSCGDLWLCLSLDPQRRVTPPEESDYTHYAFSISEADFASFAARLEAAGVAVWKLNRSEGASHYFLDPDGHKLELHVGSLAQRLAACREQPYKGMVFFAE,100,gnl|BL_ORD_ID|151|hsp_num:0,112,FALSE,None
LK570,8_141 # 150770 # 151150 # 1 # ID=8_141;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.472,8_141,150770,151150,+,Strict,230,243.817,marA,93.55,3000263,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; penem; disinfecting agents and antiseptics,antibiotic efflux; reduced permeability to antibiotic,resistance-nodulation-cell division (RND) antibiotic efflux pump; General Bacterial Porin with reduced permeability to beta-lactams,ATGTCCAGACGCAATAATGACGCCATCACTATCCATAGTATTTTGTCGTGGATTGAAGATAACCTGGAATCGCCCCTGTCGCTGGAAAAAGTGTCCGAGCGTTCTGGTTACTCCAAATGGCACCTGCAAAGAATGTTTAAAAAAGAGACCGGTCACTCCTTAGGCCAGTACATCCGCAGTCGCAAGCTGACGGAAATCGCGCAAAAACTCAAGCAGAGCAATGAGCCGATTTTGTACCTGGCAGAACGTTACGGTTTCGAATCGCAACAAACGCTGACGAGAACCTTTAAAAACTACTTCGACGTTCCGCCGCACAAATATCGCATGACCAATATGCCGGGTGAATCCCGCTATCTGATGCCACTAAACAACTGCTGTTAA,MSRRNNDAITIHSILSWIEDNLESPLSLEKVSERSGYSKWHLQRMFKKETGHSLGQYIRSRKLTEIAQKLKQSNEPILYLAERYGFESQQTLTRTFKNYFDVPPHKYRMTNMPGESRYLMPLNNCC,MSRRNTDAITIHSILDWIEDNLESPLSLEKVSERSGYSKWHLQRMFKKETGHSLGQYIRSRKMTEIAQKLKESNEPILYLAERYGFESQQTLTRTFKNYFDVPPHKYRMTNMQGESRFLHPLNHYNS,99.21,gnl|BL_ORD_ID|1772|hsp_num:0,1922,FALSE,None
LK570,8_226 # 232395 # 233270 # 1 # ID=8_226;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=11-12bp;gc_cont=0.615,8_226,232395,233270,+,Perfect,575,590.882,ORN-1,100,3006957,protein homolog model,n/a,n/a,carbapenem; cephalosporin,antibiotic inactivation,ORN beta-lactamase,ATGCGTCAATATCGATTCGCCCTTCTGCCATTGTTAGCCGCCCTGGCGCTCCCCGGTTGGGCGCATGAAGCCACGGTGACGACGGTTAAACAAGCCGAAAGCCAGCTGCAGGGCCGGGTCGGCTACGCCGAACTGGATTTAGCTTCCGGCCAACTGCTGTCCGGCTATCGCGCTGGCGAACGCTTCCCGATGATGAGCACCTTTAAAGTGCTGCTCTGCGGCGCAGTCTTGTCGCGCGTCGATACCGGTGAAGAACAGCTCGATCGCCGTATCCATTACCGGCAGCAGGATCTGGTGGAATACTCGCCGGTGACGGAGAAGCATCTTGCCGATGGGCTCACCGTGGGCGAACTGTGCGCGGCCGCCATTACCCTGAGCGATAATACGGCGGCAAACCTGCTGTTGACCACTCTCGGCGGCCCGCAGGGGCTGACCACGTTCCTGCGCCACAGCGGCGACCAGACTTCGCGACTCGACCGGTGGGAAACGGAACTCAATGAAGCGCGGCCGGGCGATGTGCGTGATACGACGACTCCGGAAGCGATGGCCAGGACACTGCGAAATCTGTTGACCGGCCGCGTGCTTTCCCCCGCCTCGCAGCAGCAGTTGCAACGCTGGATGGTAGAGGACAAAGTTGCGGGGCCGCTGTTGCGCTCTGCGCTGCCGGCGGGCTGGTTTATTGCCGATAAGACCGGAGCCGGCAATCGCGGCTCGCGCGGAATCATCGCCGCTCTCGGTCCGGACGGTAAAGCCGCGCGCATCGTGGTGATTTATTTAACCGCAACCCCGGCCTCAATGGATGAGCGCAATAAACAGATTGCGGCCATCGGTGAAACGCTGGTCAGGCACTGGTCCAAAGACGATAAAAGACCCTAG,MRQYRFALLPLLAALALPGWAHEATVTTVKQAESQLQGRVGYAELDLASGQLLSGYRAGERFPMMSTFKVLLCGAVLSRVDTGEEQLDRRIHYRQQDLVEYSPVTEKHLADGLTVGELCAAAITLSDNTAANLLLTTLGGPQGLTTFLRHSGDQTSRLDRWETELNEARPGDVRDTTTPEAMARTLRNLLTGRVLSPASQQQLQRWMVEDKVAGPLLRSALPAGWFIADKTGAGNRGSRGIIAALGPDGKAARIVVIYLTATPASMDERNKQIAAIGETLVRHWSKDDKRP,MRQYRFALLPLLAALALPGWAHEATVTTVKQAESQLQGRVGYAELDLASGQLLSGYRAGERFPMMSTFKVLLCGAVLSRVDTGEEQLDRRIHYRQQDLVEYSPVTEKHLADGLTVGELCAAAITLSDNTAANLLLTTLGGPQGLTTFLRHSGDQTSRLDRWETELNEARPGDVRDTTTPEAMARTLRNLLTGRVLSPASQQQLQRWMVEDKVAGPLLRSALPAGWFIADKTGAGNRGSRGIIAALGPDGKAARIVVIYLTATPASMDERNKQIAAIGETLVRHWSKDDKRP,100,gnl|BL_ORD_ID|3727|hsp_num:0,4795,FALSE,None
LK570,10_8 # 7298 # 10375 # -1 # ID=10_8;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.606,10_8,7298,10375,-,Strict,1800,1849.33,mdtC,90.93,3000794,protein homolog model,n/a,n/a,aminocoumarin antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGAAGTTTTTCGCCCTCTTCATTTACCGCCCGGTGGCGACGATTCTGATTTCGCTCGCCATCACCCTGTGCGGGGTACTCGGTTTCCGTCTGCTGCCGGTCGCCCCGCTGCCGCAGGTGGATTTCCCGGTGATCATGATCAGCGCCTCGCTGCCTGGCGCGTCGCCGGAAACCATGGCCTCGTCGGTGGCCACGCCGCTTGAACGCTCGCTCGGCCGGATCGCCGGCGTGTCGGAAATGACCTCCACCAGTTCGCTGGGCAGCACGCGCATTATTATGGAGTTCAATTTCGACCGCGATATTAACGGCGCCGCCCGCGATGTGCAGGCGGCGATCAACGCCGCGCAAAGCCTGCTGCCGAGCGGCATGCCAAGCCGCCCGACCTATCGCAAGGCCAACCCTTCCGATGCGCCGATTATGATCCTCACGCTCACATCGGATACCTACTCCCAGGGCGAGCTGTACGATTTTGCCTCGACTCAACTGGCACAAACCATCGCCCAGATTGACGGCGTTGGCGACGTCGACGTGGGCGGCAGCTCGCTGCCCGCGGTGCGCGTCGACCTCAACCCGCAGGCGCTGTTTAACCAGGGCGTGTCGCTGGACGCCGTGCGCACCGCTATCGATAACGCCAACGTCCGTAGACCGCAGGGGGCGCTGGAAGATCACAGCTCGCGCTGGCAGGTACAAACGAACGATGAGCTCAAAACCGCCGCGGAATACCAGCCGCTGATCGTACACTACAACAACGGCGCGGCGGTGCGTCTTGGCGACGTCGCGCAGATCAGCGATTCGGTGCAGGATGTGCGTAACGCCGGGATGACCAACGCGAAGCCGGCAATTTTGCTGATGATCCGCAAGCTGCCGGAAGCCAATATCATCCAGACGGTCGACAGCATTCGCGCCCGCCTGCCGGATCTGCAAAAAACCATTCCGGCGGCTATCGATCTGCAAATCGCCCAGGACCGCTCGCCGACCATCCGCGCCTCGCTGGAGGAAGTCGAGCAGACGCTGGTGATCTCGGTGGCGCTGGTGATCCTCGTGGTGTTCCTGTTTCTGCGCTCCGGCAGAGCCACGCTGATCCCGGCGGTGGCGGTGCCGGTCTCGCTGATTGGTACCTTTGCGGCCATGTACCTTTGTGACTTTAGCCTCAACAACCTGTCGCTGATGGCCCTGACCATCGCCACCGGCTTCGTCGTCGACGATGCTATCGTGGTGCTGGAAAATATCTCCCGCCATCTTGAGGCCGGGATGAAACCGCTGCAGGCGGCGCTGCAGGGGAGCCGTGAAGTCGGCTTCACCGTGCTGTCGATGAGTCTCTCGCTGGTGGCGGTCTTTTTACCGCTGCTGCTGATGGGCGGCCTGCCGGGGCGGCTGCTACGCGAATTCGCCGTCACCTTATCGGTGGCGATCGGCATCTCGCTGGCGGTCTCCCTTACCCTGACGCCGATGATGTGCGGCTGGCTGCTGAAGAGCGGTAAACCTTCTCAACCCACGCGTAACCGCGGTTTCGGCCGCCTGCTGGTCGCCGTGCAGGGCGGCTACGGTAAATCGCTGAAATGGGTCCTCAGACACAGCCGCATGACCGGTCTGGTGCTGTTGGGGACCATGGCGCTCAGCGTCTGGCTCTATATCTCTATTCCAAAAACCTTCTTCCCGGAGCAGGATACCGGCGTGCTGATGGGCGGCATTCAGGCTGACCAGAGTATCTCTTTCCAGGCGATGCGCGGCAAACTGCAGGACTTTATGCAGATCATTCGCGAAGATCCGGCGGTGGATAACGTGACCGGCTTTACCGGCGGCTCACGGGTGAACAGCGGGATGATGTTTATCACCCTTAAACCTCGCGACCAGCGACATGAAACGGCGCAGCAGATTATCGACCGGCTGCGTAAAAAACTGGCGAAAGAACCGGGCGCCAACCTGTTCTTAATGGCGGTGCAGGATATTCGCGTCGGCGGCCGTCAGGCCAACGCCAGCTATCAGTACACCCTGCTGTCAGACGATCTTTCGGCGCTGCGCGAATGGGAACCGAAGATTCGTAAAGCGCTGGCCGCGCTGCCGGAACTGGCGGACGTCAACTCTGACCAGCAGGATAACGGCGCCGAAATGGACCTCATCTACGATCGCGATACCATGTCGCGCCTCGGGATCAGCGTTCAGGATGCCAACAATCTGCTGAATAACGCTTTCGGCCAGCGGCAGATCTCGACGATTTACCAGCCGCTGAACCAGTATAAAGTGGTGATGGAGGTCGATCCGGTTTATACCCAGGACGTCAGCGCGCTGGATAAGATGTTTGTGATCAACAGCGAAGGTAAGCCGATCCCCCTCGCCTATTTCGCCCGCTGGCAGCCGGCTAACGCGCCGCTGTCGGTCAACCACCAGGGACTGTCGGCAGCGTCGACGATCTCCTTTAACCTGCCGACCGGTAAATCGCTGTCGGAAGCCAGCGATGCCATCAACCGCGCGATGACTCAGCTTGGAGTGCCTTCCAGCGTCCGGGGCTCCTATGCCGGCACCGCGCAGGTCTTCCAGCAGACCATGAACTCGCAGGTTATTTTGATTCTGGCCGCCATTGCGACGGTCTATATCGTGCTGGGGATCCTCTACGAAAGCTATGTGCATCCGTTAACGATTCTCTCCACCCTCCCCTCGGCGGGGGTAGGCGCGCTGCTGGCGCTGGAGCTCTTTGGCGCGCCGTTTAGCCTGATTGCGCTGATCGGCATCATGCTATTAATTGGGATAGTGAAGAAAAACGCCATCATGATGGTCGACTTTGCCCTCGAGGCGCAGCGCAACGGCAATCTGCCGCCGGAAGAGGCAATCTTCCAGGCCTGCCTGCTGCGTTTCCGCCCGATTATGATGACCACCTTAGCGGCGCTGTTTGGCGCGCTGCCGCTGGTGCTCTCGGGCGGCGACGGCTCGGAACTGCGTCAGCCGCTGGGGATCACCATCGTCGGTGGGCTGGTGATGAGTCAGCTGTTGACCCTCTACACTACGCCGGTGGTCTATCTGTTCTTTGACCGTCTGCGGTTGCGTTTTTCGCGAAAACTCAGCCAACCGGTAAGCGAATAA,MKFFALFIYRPVATILISLAITLCGVLGFRLLPVAPLPQVDFPVIMISASLPGASPETMASSVATPLERSLGRIAGVSEMTSTSSLGSTRIIMEFNFDRDINGAARDVQAAINAAQSLLPSGMPSRPTYRKANPSDAPIMILTLTSDTYSQGELYDFASTQLAQTIAQIDGVGDVDVGGSSLPAVRVDLNPQALFNQGVSLDAVRTAIDNANVRRPQGALEDHSSRWQVQTNDELKTAAEYQPLIVHYNNGAAVRLGDVAQISDSVQDVRNAGMTNAKPAILLMIRKLPEANIIQTVDSIRARLPDLQKTIPAAIDLQIAQDRSPTIRASLEEVEQTLVISVALVILVVFLFLRSGRATLIPAVAVPVSLIGTFAAMYLCDFSLNNLSLMALTIATGFVVDDAIVVLENISRHLEAGMKPLQAALQGSREVGFTVLSMSLSLVAVFLPLLLMGGLPGRLLREFAVTLSVAIGISLAVSLTLTPMMCGWLLKSGKPSQPTRNRGFGRLLVAVQGGYGKSLKWVLRHSRMTGLVLLGTMALSVWLYISIPKTFFPEQDTGVLMGGIQADQSISFQAMRGKLQDFMQIIREDPAVDNVTGFTGGSRVNSGMMFITLKPRDQRHETAQQIIDRLRKKLAKEPGANLFLMAVQDIRVGGRQANASYQYTLLSDDLSALREWEPKIRKALAALPELADVNSDQQDNGAEMDLIYDRDTMSRLGISVQDANNLLNNAFGQRQISTIYQPLNQYKVVMEVDPVYTQDVSALDKMFVINSEGKPIPLAYFARWQPANAPLSVNHQGLSAASTISFNLPTGKSLSEASDAINRAMTQLGVPSSVRGSYAGTAQVFQQTMNSQVILILAAIATVYIVLGILYESYVHPLTILSTLPSAGVGALLALELFGAPFSLIALIGIMLLIGIVKKNAIMMVDFALEAQRNGNLPPEEAIFQACLLRFRPIMMTTLAALFGALPLVLSGGDGSELRQPLGITIVGGLVMSQLLTLYTTPVVYLFFDRLRLRFSRKLSQPVSE,MKFFALFIYRPVATILLSVAITLCGILGFRMLPVAPLPQVDFPVIIVSASLPGASPETMASSVATPLERSLGRIAGVSEMTSSSSLGSTRIILQFDFDRDINGAARDVQAAINAAQSLLPSGMPSRPTYRKANPSDAPIMILTLTSDTYSQGELYDFASTQLAPTISQIDGVGDVDVGGSSLPAVRVGLNPQALFNQGVSLDDVRTAVSNANVRKPQGALEDGTHRWQIQTNDELKTAAEYQPLIIHYNNGGAVRLGDVATVTDSVQDVRNAGMTNAKPAILLMIRKLPEANIIQTVDSIRAKLPELQETIPAAIDLQIAQDRSPTIRASLEEVEQTLIISVALVILVVFLFLRSGRATIIPAVSVPVSLIGTFAAMYLCGFSLNNLSLMALTIATGFVVDDAIVVLENIARHLEAGMKPLQAALQGTREVGFTVLSMSLSLVAVFLPLLLMGGLPGRLLREFAVTLSVAIGISLLVSLTLTPMMCGWMLKASKPREQKRLRGFGRMLVALQQGYGKSLKWVLNHTRLVGVVLLGTIALNIWLYISIPKTFFPEQDTGVLMGGIQADQSISFQAMRGKLQDFMKIIRDDPAVDNVTGFTGGSRVNSGMMFITLKPRDERSETAQQIIDRLRVKLAKEPGANLFLMAVQDIRVGGRQSNASYQYTLLSDDLAALREWEPKIRKKLATLPELADVNSDQQDNGAEMNLVYDRDTMARLGIDVQAANSLLNNAFGQRQISTIYQPMNQYKVVMEVDPRYTQDISALEKMFVINNEGKAIPLSYFAKWQPANAPLSVNHQGLSAASTISFNLPTGKSLSDASAAIDRAMTQLGVPSTVRGSFAGTAQVFQETMNSQVILIIAAIATVYIVLGILYESYVHPLTILSTLPSAGVGALLALELFNAPFSLIALIGIMLLIGIVKKNAIMMVDFALEAQRHGNLTPQEAIFQACLLRFRPIMMTTLAALFGALPLVLSGGDGSELRQPLGITIVGGLVMSQLLTLYTTPVVYLFFDRLRLRFSRKPKQTVTE,100,gnl|BL_ORD_ID|1212|hsp_num:0,1315,FALSE,None
LK570,10_9 # 10376 # 13498 # -1 # ID=10_9;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.619,10_9,10376,13498,-,Strict,1800,1860.11,mdtB,90.87,3000793,protein homolog model,n/a,n/a,aminocoumarin antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGCAGGTATTACCCCCGAGCAGTACGGGCGGCCCTTCCCGACTGTTTATTCTGCGCCCGGTCGCCACCACGCTGCTGATGGTGGCGATTATGCTGGCGGGGATCATCGGCTATCGATTCCTGCCGGTTTCCGCCTTGCCGGAAGTGGATTATCCGACCATTCAGGTAGTCACCCTCTATCCCGGCGCCAGTCCGGACGTCGTCACATCGGCGATTACCGCCCCGCTGGAACGCCAGTTTGGCCAGATGTCGGGCCTGAAGCAGATGTCGTCGCAAAGTTCCGGCGGCGCCTCGGTGGTCACGCTCCAGTTCCAGCTTACCCTGCCGCTGGACGTGGCCGAACAGGAGGTCCAGGCCGCGATCAACGCCGCCACCAACCTGCTGCCATCCGACCTGCCGAACCCGCCGGTGTACAGTAAAGTCAACCCGGCCGATCCGCCGATCATGACCCTCGCGGTCACCTCTTCCGCCATTCCGATGACCCAGGTGGAAGATATGGTGGAGACCCGCGTGGCGCAGAAAATTTCCCAGGTCTCCGGCGTCGGGCTGGTGACCCTCGCGGGCGGTCAACGCCCGGCGGTCCGCGTGAAGCTCAATGCGCAGGCGATTGCCGCGCTGGGGCTGACCAGCGAAACCATCCGCACCGCTATCACCAGCGCCAACGTCAACTCGGCCAAAGGCAGCCTTGACGGCCCTTCCCGCGCCGTGACCCTCTCCGCTAACGATCAGATGCAGTCGGCGGAAGATTATCGCCGCCTGATCGTCGCCTGGCAGAACGGCGCGCCGATTCGTCTCGGCGATGTCGCTACCATTGAGCAAGGGGCGGAAAACAGCTGGCTCGGCGCATGGGCGAACAACCAGCAGGCGATCGTCATGAACGTTCAACGCCAGCCGGGAGCGAACATCATCGCCACCGCCGATAGCGTGCGTCAGATGCTGCCGCAGCTGACCGAGAGCCTGCCGAAGTCGGTCAAGGTGCAGGTCCTTTCCGACCGCACCACCAACATTCGCGCGTCGGTGAGCGATACCCAGTTTGAGCTGATGCTGGCGATTGCGCTGGTGGTGATGATCATCTACCTGTTCCTGCGCAACGTACCGGCGACCATTATCCCCGGCGTCGCCGTGCCGCTGTCGCTGGTGGGCACCTTCGCGGTGATGGTGTTCCTCGACTTCTCGATCAACAACCTGACGCTGATGGCGCTCACTATCGCCACCGGCTTCGTTGTCGATGACGCCATCGTGGTGATCGAAAACATCTCGCGCTATATCGAAAAGGGCGAAAAGCCGCTCGCCGCCGCGCTGAAAGGTGCCGGAGAGATCGGCTTTACCATCATCTCGTTGACCTTCTCGCTGATTGCGGTGCTGATCCCGCTGCTGTTTATGGGCGATATCGTCGGCCGGCTGTTCCGCGAGTTTGCCATTACCCTCGCGGTGGCAATATTAATTTCCGCCGTCGTCTCGCTGACGCTGACGCCAATGATGTGCGCGCGCATGCTCAGTCACGAGTCGCTGCGTAAGCAAAACCGCTTCTCGCGGGCCAGCGAGCGCTTCTTCGATCGGGTCATCGCCGCGTATGGTCGGATGCTTAGCCGGGTGCTGAATCACCCGTGGCTGACCCTGAGCGTGGCCTTAGGCACGCTGGTGCTGTCAATCATGCTGTGGGTCTTCATTCCGAAAGGCTTCTTCCCGATTCAGGACAACGGCATTATTCAGGGGACGTTACAGGCTCCGCAGTCCGCTTCGTTTGCGAATATGGCGCAGCGCCAGGAGCAGGTTTCCGCGGCGATCCTCAAAGACCCGGCCGTCGAGAGCCTGACCTCCTACGTCGGAGTGGACGGCACCAACCCGGCGCTGAATAGCGCCCGCCTGCAGATTAACCTCAAACCGCTGGATGAACGCGACGACCGTGTGCAGGCCGTGATTAGCCGCCTGCAAAAATCGGTGGACGGGATCCCCGGCGTCGAGCTCTACCTACAGCCGACGCAGGATCTGACTATCGATACCACCGTCAGCCGGACCCAGTATCAGTTCACCTTGCAGGCGAACTCGCTGGATGCCCTCAGTAACTGGGTGCCGCAGCTGCTGACGCGTCTCCAGGCGCTTCCGCAGCTCTCCGACGTCAGCAGCGACTGGCAGGATAAGGGCCTCGCCGCCTATATCAAAGTCGATCGCGACAGCGCCAGCCGTCTCGGCATCAGCATGGCCGATGTCGATAATGCGCTGTATAACGCCTTCGGCCAGCGGCTGATCTCGACCATCTACACTCAGGCCAACCAGTATCGCGTGGTGCTGGAGCATGACACCCAGGAGACGCCGGGGCTGGCGGCGCTGGACAATATTCGCCTGACCAGCAGCGGGGGCGGCATCGTGCCGCTGAAGTCCATCGCCAGTGTCGAGCAGCGCTTCGCGCCGCTGTCGATTAACCATCTCGATCAGTTCCCGGTGACCACCATTTCGTTCAACGTCCCGGATAACTACTCGCTGGGCGATGCGGTCGACGCCATCCTCGCCGCCGAACAGGCGCTGGATTTGCCTACCGATATCCGCACCCAGTTCCAGGGCAGCACCCTCGCCTTCCAGTCGGCGCTCGGCAACACCGTCTGGCTGGTGGTGGCGGCGGTCGTGGCGATGTATATCGTGCTCGGCGTGCTGTATGAAAGCTTTATCCACCCGATAACCATTCTGTCGACCTTACCGACCGCCGGCGTCGGCGCGCTGCTGGCGCTGTGGCTGGCAGGCAGCGAGCTGGATGTTATCGCCATTATCGGGATTATCCTGCTGATTGGTATCGTCAAGAAGAACGCCATCATGATGATCGACTTTGCGCTGGCCGCCGAACGCGAACAGGGCATGCCGCCACGTGAGGCGATTTATCAGGCCTGCCTGCTGCGTTTTCGCCCGATTCTGATGACCACGCTTGCCGCTCTGCTCGGCGCGCTGCCGCTGATGCTGAGCACCGGCGTCGGCGCCGAGCTACGGCGTCCTCTGGGTATCGGTATGGTGGGCGGTCTGATGTTAAGCCAGGTGCTGACGCTGTTCACCACCCCGGTTATCTATCTGCTCTTCGACCGCCTGTCGCTGTATATCAAGAGCCGCTTCCCACGGCATGAGGAGGAGGCGTAA,MQVLPPSSTGGPSRLFILRPVATTLLMVAIMLAGIIGYRFLPVSALPEVDYPTIQVVTLYPGASPDVVTSAITAPLERQFGQMSGLKQMSSQSSGGASVVTLQFQLTLPLDVAEQEVQAAINAATNLLPSDLPNPPVYSKVNPADPPIMTLAVTSSAIPMTQVEDMVETRVAQKISQVSGVGLVTLAGGQRPAVRVKLNAQAIAALGLTSETIRTAITSANVNSAKGSLDGPSRAVTLSANDQMQSAEDYRRLIVAWQNGAPIRLGDVATIEQGAENSWLGAWANNQQAIVMNVQRQPGANIIATADSVRQMLPQLTESLPKSVKVQVLSDRTTNIRASVSDTQFELMLAIALVVMIIYLFLRNVPATIIPGVAVPLSLVGTFAVMVFLDFSINNLTLMALTIATGFVVDDAIVVIENISRYIEKGEKPLAAALKGAGEIGFTIISLTFSLIAVLIPLLFMGDIVGRLFREFAITLAVAILISAVVSLTLTPMMCARMLSHESLRKQNRFSRASERFFDRVIAAYGRMLSRVLNHPWLTLSVALGTLVLSIMLWVFIPKGFFPIQDNGIIQGTLQAPQSASFANMAQRQEQVSAAILKDPAVESLTSYVGVDGTNPALNSARLQINLKPLDERDDRVQAVISRLQKSVDGIPGVELYLQPTQDLTIDTTVSRTQYQFTLQANSLDALSNWVPQLLTRLQALPQLSDVSSDWQDKGLAAYIKVDRDSASRLGISMADVDNALYNAFGQRLISTIYTQANQYRVVLEHDTQETPGLAALDNIRLTSSGGGIVPLKSIASVEQRFAPLSINHLDQFPVTTISFNVPDNYSLGDAVDAILAAEQALDLPTDIRTQFQGSTLAFQSALGNTVWLVVAAVVAMYIVLGVLYESFIHPITILSTLPTAGVGALLALWLAGSELDVIAIIGIILLIGIVKKNAIMMIDFALAAEREQGMPPREAIYQACLLRFRPILMTTLAALLGALPLMLSTGVGAELRRPLGIGMVGGLMLSQVLTLFTTPVIYLLFDRLSLYIKSRFPRHEEEA,MQVLPPSSTGGPSRLFIMRPVATTLLMVAILLAGIIGYRALPVSALPEVDYPTIQVVTLYPGASPDVMTSAVTAPLERQFGQMSGLKQMSSQSSGGASVITLQFQLTLPLDVAEQEVQAAINAATNLLPSDLPNPPVYSKVNPADPPIMTLAVTSTAMPMTQVEDMVETRVAQKISQISGVGLVTLSGGQRPAVRVKLNAQAIAALGLTSETVRTAITGANVNSAKGSLDGPSRAVTLSANDQMQSAEEYRQLIIAYQNGAPIRLGDVATVEQGAENSWLGAWANKEQAIVMNVQRQPGANIISTADSIRQMLPQLTESLPKSVKVTVLSDRTTNIRASVDDTQFELMMAIALVVMIIYLFLRNIPATIIPGVAVPLSLIGTFAVMVFLDFSINNLTLMALTIATGFVVDDAIVVIENISRYIEKGEKPLAAALKGAGEIGFTIISLTFSLIAVLIPLLFMGDIVGRLFREFAITLAVAILISAVVSLTLTPMMCARMLSQESLRKQNRFSRASEKMFDRIIAAYGRGLAKVLNHPWLTLSVALSTLLLSVLLWVFIPKGFFPVQDNGIIQGTLQAPQSSSFANMAQRQRQVADVILQDPAVQSLTSFVGVDGTNPSLNSARLQINLKPLDERDDRVQKVIARLQTAVDKVPGVDLFLQPTQDLTIDTQVSRTQYQFTLQATSLDALSTWVPQLMEKLQQLPQLSDVSSDWQDKGLVAYVNVDRDSASRLGISMADVDNALYNAFGQRLISTIYTQANQYRVVLEHNTENTPGLAALDTIRLTSSDGGVVPLSSIAKIEQRFAPLSINHLDQFPVTTISFNVPDNYSLGDAVQAIMDTEKTLNLPVDITTQFQGSTLAFQSALGSTVWLIVAAVVAMYIVLGILYESFIHPITILSTLPTAGVGALLALLIAGSELDVIAIIGIILLIGIVKKNAIMMIDFALAAEREQGMSPREAIYQACLLRFRPILMTTLAALLGALPLMLSTGVGAELRRPLGIGMVGGLIVSQVLTLFTTPVIYLLFDRLALWTKSRFARHEEEA,100,gnl|BL_ORD_ID|757|hsp_num:0,820,FALSE,None
LK570,17_6 # 5829 # 6158 # -1 # ID=17_6;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.548,17_6,5829,6158,-,Strict,150,195.282,Klebsiella pneumoniae KpnF,91.74,3004583,protein homolog model,n/a,n/a,macrolide antibiotic; aminoglycoside antibiotic; cephalosporin; tetracycline antibiotic; peptide antibiotic; rifamycin antibiotic; disinfecting agents and antiseptics,antibiotic efflux,small multidrug resistance (SMR) antibiotic efflux pump,ATGCAACAGTTTGAGTGGATTCACGGCGCCTGGCTGGCGCTGGCCATCGTGCTGGAAATTGTCGCTAACGTCTTTTTGAAATTTTCAGACGGTTTTCGTCGTAAAGTATACGGCATACTGTCGCTGCTGGCGGTGCTGGGTGCCTTCAGCGCGCTCTCGCAGGCGGTGAAGGGCATTGACCTGTCGGTGGCCTATGCGCTGTGGGGCGGTTTCGGTATTGCCGCCACGATTGCCGCAGGATGGATTCTGTTCGGCCAACGCTTAAATCATAAAGGCTGGATTGGCGTGATATTGCTGGTGACCGGGATGGTGCTGATTAAACTGGCGTAA,MQQFEWIHGAWLALAIVLEIVANVFLKFSDGFRRKVYGILSLLAVLGAFSALSQAVKGIDLSVAYALWGGFGIAATIAAGWILFGQRLNHKGWIGVILLVTGMVLIKLA,MQQFEWIHAAWLAIAIVLEIIANVFLKFSDGFRRKIYGILSLAAVLGAFSALSQAVKGIDLSVAYALWGGFGIAATIAAGWVLFGQRLNNKGWAGVILLVAGMVLIKLA,100,gnl|BL_ORD_ID|2723|hsp_num:0,3286,FALSE,None
LK570,17_7 # 6145 # 6507 # -1 # ID=17_7;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.482,17_7,6145,6507,-,Strict,150,199.904,Klebsiella pneumoniae KpnE,86.67,3004580,protein homolog model,n/a,n/a,macrolide antibiotic; aminoglycoside antibiotic; cephalosporin; tetracycline antibiotic; peptide antibiotic; rifamycin antibiotic; disinfecting agents and antiseptics,antibiotic efflux,small multidrug resistance (SMR) antibiotic efflux pump,ATGTTTTATTGGATCTTATTAGCGTTAGCAATCGTTGCTGAAATTACCGGCACACTTTCTATGAAATGGGCCAGCGTCAGCGGTGGACACACCGGCTTTATTTTAATGCTGGTGATGATTGCACTTTCCTATATATTTCTGGCTTTTGCCGTTAAAAAAATCGCCCTCGGTGTGGCCTATGCCCTGTGGGAGGGTATCGGTATTTTGCTGATCACTTTATTCAGCGTCCTGCTGTTTGATGAAGCGCTTTCGCCGATCAAAATGGCGGGGCTTGCGACGCTGGTGGTCGGGATCGTGTTAATTAAATCCGGTACCCAAAAAGCGGTGAAGCAGCCAACGGAGGCGGCCCATGCAACAGTTTGA,MFYWILLALAIVAEITGTLSMKWASVSGGHTGFILMLVMIALSYIFLAFAVKKIALGVAYALWEGIGILLITLFSVLLFDEALSPIKMAGLATLVVGIVLIKSGTQKAVKQPTEAAHATV,MFYWILLALAIIAEITGTLSMKWASVSGGHTGFILMLAMIALSYIFLAFAVKKIALGVAYALWEGIGILLITLFSVLLFDESLSLLKIAGLTTLVIGIVLIKSGTQKKASSQQEVAHAAV,100,gnl|BL_ORD_ID|2721|hsp_num:0,3283,FALSE,None
LK570,3_84 # 89501 # 90892 # 1 # ID=3_84;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.556,3_84,89501,90892,+,Strict,850,890.952,Escherichia coli UhpT with mutation conferring resistance to fosfomycin,96.27,3003890,protein variant model,E350Q,n/a,phosphonic acid antibiotic,antibiotic target alteration,antibiotic-resistant UhpT,ATGCTGGCCTTTCTAAACCAGGTGCGCAAGCCGACCCTGGATCTGCCGCTCGATGTGCGGCGTAAAATGTGGTTCAAACCGTTCATGCAGTCCTATCTGGTGGTCTTTATCGGCTACCTGACGATGTATCTGATCCGCAAAAACTTTAACATCGCCCAGAACGACATGATCTCCACCTACGGGTTGAGCATGACCCAGCTGGGGATGATTGGCCTGGGCTTCTCGATCACCTACGGCGTGGGTAAAACGCTGGTGTCCTACTACGCGGACGGGAAAAATACCAAGCAGTTCCTGCCGTTTATGCTGATCCTCTCCGCCATCTGTATGCTCGGCTTTAGCGCCAGTATGGGGGCCGGTTCAACCAGTCTGTTCCTGATGATCGCCTTCTATGCGCTGAGCGGTTTCTTCCAGAGCACCGGCGGTTCGTGTAGCTATTCAACCATTACCAAATGGACGCCACGTCGTAAGCGCGGCACCTTCCTCGGCTTCTGGAATATCTCTCACAACCTTGGCGGCGCGGGCGCTGCGGGCGTGGCGCTGTTCGGCGCGAACTATTTGTTCGACGGCCACGTTATCGGCATGTTCATCTTCCCGTCGATTATTGCGCTGATTGTCGGTTTTATCGGTCTGCGTTTTGGTAGCGACTCTCCGGAATCCTACGGCCTCGGCAATGCCGAAGAGCTGTTCGGCGAAGAGATCAGTGAAGAGGACAAAGAGACGGAAGAGAACGCCATGACCAAATGGCAGATTTTCGTCGAGTATGTCCTGAAAAACAAAGTCATCTGGCTGCTGTGCTTCTCCAACATCTTCCTCTATGTGGTGCGCATCGGTATCGATCAGTGGTCGACGGTCTATGCCTTCCAGGAGCTGAAGCTCTCCAAAGAGGTGGCGATTCAGGGCTTTACCCTGTTTGAAGTGGGCGCGCTGGTCGGAACGCTGCTGTGGGGCTGGCTGTCGGATCTGGCGAACGGCCGTCGTGCGCTGGTGGCCTGTATCGCGCTGGCGTTAATTATCGCAACCCTTGGCGTTTACCAGCATGCCAGCAACCAGTATGTCTATTTGATGTCGCTGTTTGCCTTAGGCTTCCTGGTCTTTGGCCCGCAGCTGCTGATCGGCGTTGCGGCCGTAGGGTTCGTCCCGAAAAAAGCTATCGGTGCGGCGGACGGTATCAAAGGCACCTTTGCTTACCTGATCGGCGACAGCTTTGCCAAACTGGGGCTGGGAATGATTGCCGACGGCACGCCGGTCTTTGGCCTGACCGGCTGGGCGGGTACCTTTGCGGCGCTGGATGCGGCAGCTATCGGCTGTATCTGCCTGATGGCTATCGTCGCGGTCTTTGAAGAACGTAAAATTCGTCGCGAGAAAAAGAAACCCGTTTTGCAGAATGCCTGA,MLAFLNQVRKPTLDLPLDVRRKMWFKPFMQSYLVVFIGYLTMYLIRKNFNIAQNDMISTYGLSMTQLGMIGLGFSITYGVGKTLVSYYADGKNTKQFLPFMLILSAICMLGFSASMGAGSTSLFLMIAFYALSGFFQSTGGSCSYSTITKWTPRRKRGTFLGFWNISHNLGGAGAAGVALFGANYLFDGHVIGMFIFPSIIALIVGFIGLRFGSDSPESYGLGNAEELFGEEISEEDKETEENAMTKWQIFVEYVLKNKVIWLLCFSNIFLYVVRIGIDQWSTVYAFQELKLSKEVAIQGFTLFEVGALVGTLLWGWLSDLANGRRALVACIALALIIATLGVYQHASNQYVYLMSLFALGFLVFGPQLLIGVAAVGFVPKKAIGAADGIKGTFAYLIGDSFAKLGLGMIADGTPVFGLTGWAGTFAALDAAAIGCICLMAIVAVFEERKIRREKKKPVLQNA,MLAFLNQVRKPTLDLPLEVRRKMWFKPFMQSYLVVFIGYLTMYLIRKNFNIAQNDMISTYGLSMTQLGMIGLGFSITYGVGKTLVSYYADGKNTKQFLPFMLILSAICMLGFSASMGSGSVSLFLMIAFYALSGFFQSTGGSCSYSTITKWTPRRKRGTFLGFWNISHNLGGAGAAGVALFGANYLFDGHVIGMFIFPSIIALIVGFIGLRYGSDSPESYGLGKAEELFGEEISEEDKETESTDMTKWQIFVEYVLKNKVIWLLCFANIFLYVVRIGIDQWSTVYAFQELKLSKAVAIQGFTLFEAGALVGTLLWGWLSDLANGRRGLVACIALALIIATLGVYQHASNEYIYLASLFALGFLVFGPQLLIGVAAVGFVPKKAIGAADGIKGTFAYLIGDSFAKLGLGMIADGTPVFGLTGWAGTFAALDIAAIGCICLMAIVAVMEERKIRREKKIQQLTVA,100,gnl|BL_ORD_ID|2129|hsp_num:0,2373,FALSE,None
LK570,6_128 # 143899 # 145665 # -1 # ID=6_128;partial=00;start_type=ATG;rbs_motif=AGGA/GGAG/GAGG;rbs_spacer=11-12bp;gc_cont=0.558,6_128,143899,145665,-,Strict,500,595.504,Haemophilus influenzae PBP3 conferring resistance to beta-lactam antibiotics,52.02,3004446,protein variant model,"D350N, S357N",n/a,cephalosporin; cephamycin; penam,antibiotic target alteration,Penicillin-binding protein mutations conferring resistance to beta-lactam antibiotics,ATGAAAGCAGCGCCGAAAACGCTAAAACCAAAACGTCAGGAAGAACAGGCCAGCTTTATTAGCTGGCGTTTTGCGTTGCTGTGCGGGTGTATTTTAATCGCGCTGGGTTTCCTGCTGGGTCGCGTGGCCTGGCTACAGGTGATCAGCCCGGACATGCTGGTTCGTCAGGGTGATATGCGTTCTTTACGCGTGCAGGAAGTCTCCACCGCCCGCGGAATGATTACCGACCGCTCCGGCCGCCCGCTGGCGGTGAGCGTGCCGGTGAAGGCTATCTGGGCGGATCCGAAAGAGCTGCACGATGCCGGCGGTGTCACTCTCGATAACCGCTGGAAGGCGTTGGCCGATGCGTTAAACATGCCGCTGGATCAGCTGGCATCGCGCATCAACACCAATCCGAGAATGCGTTTTATCTATCTGGCGCGTCAGGTTAATCCTGATATGGCGGATTACATCAAGAAGCTGAAGCTGCCAGGGATTCACATGCGCGAAGAGTCGCGCCGTTACTACCCGTCAGGTGAAGTTACCGCTCACCTCATTGGCTTCACCAACGTGGATAGCCAGGGGATTGAAGGCGTCGAGAAGAGCTTTGATAAATGGCTGACCGGTCAACCCGGGGAACGCATCGTGCGTAAAGACCGCTACGGCCGCGTTATTGAAGATATCTCCTCTACCGACAGCCAGGCCGCGCACAATCTGGCGTTGAGTATCGATGAGCGTCTGCAGGCGTTAGTTTATCGCGAACTGAATAATGCCGTGGCGTTTAACAAAGCCGAATCGGGGAGTGCGGTTCTGGTCGATGTCAGCACTGGCGAAGTGCTGGCGATGGCGAACAGCCCCTCTTATAACCCGAATAATTTCTCCGGTACGGCGAAAGACATCATGCGTAACCGCGCCATCACCGACGTGTTTGAACCGGGTTCGACGGTCAAGCCAATGGTGGTGATGACGGCGCTACAGCGCGGCATTGTGAACGAAAATACCGTGCTGAATACCATTCCTTACCGGATTAACGGCCACGAGATCAAAGACGTGGCGCGCTATAGCGAATTGACCCTGACCGGGGTATTACAGAAGTCGAGTAACGTCGGTGTCTCCAAACTGGCGTTAGCGATGCCGTCCTCAGCGTTAGTAGATACTTACTCACGTTTTGGACTCGGAAAAGCGACCAATTTGGGGTTGGTCGGAGAACGCAGTGGCTTATATCCTCAAAAACAACGGTGGTCTGACATAGAGAGGGCCACCTTTTCTTTCGGCTACGGGCTAATGGTAACGCCGTTACAGTTAGCGCGAGTCTATGCAACGATCGGCAGCTATGGCATCTATCGCCCGCTGTCGATTACCAAAGTTGATCCACCGGTTCCCGGTGAGCGCGTGTTCCCGGAACCTCTCGTTCGTACCGTCGTGCATATGATGGAAAGCGTGGCGCTGCCCGGTGGTGGCGGCGTGAAGGCGGCCATTAAAGGCTACCGCATTGCGATCAAAACCGGTACGGCGAAGAAAGTGGGGCCAGATGGCCGCTACATCAACAAATATATTGCTTACACCGCAGGCGTTGCGCCCGCCAGCCACCCGCGTTTTGCGCTGGTGGTGGTGATCAACGACCCGCAGGCGGGTAAATACTACGGCGGCGCCGTTTCCGCGCCGGTCTTCGGTGCCATCATGGGCGGCGTACTGCGCACCATGAACATCGAGCCGGATGCGTTGGCAACGGGCGAAAAAAGTGAATTTGTGATTAATCAAGGCGAGGGAACAGGTGGCAGATCGTAA,MKAAPKTLKPKRQEEQASFISWRFALLCGCILIALGFLLGRVAWLQVISPDMLVRQGDMRSLRVQEVSTARGMITDRSGRPLAVSVPVKAIWADPKELHDAGGVTLDNRWKALADALNMPLDQLASRINTNPRMRFIYLARQVNPDMADYIKKLKLPGIHMREESRRYYPSGEVTAHLIGFTNVDSQGIEGVEKSFDKWLTGQPGERIVRKDRYGRVIEDISSTDSQAAHNLALSIDERLQALVYRELNNAVAFNKAESGSAVLVDVSTGEVLAMANSPSYNPNNFSGTAKDIMRNRAITDVFEPGSTVKPMVVMTALQRGIVNENTVLNTIPYRINGHEIKDVARYSELTLTGVLQKSSNVGVSKLALAMPSSALVDTYSRFGLGKATNLGLVGERSGLYPQKQRWSDIERATFSFGYGLMVTPLQLARVYATIGSYGIYRPLSITKVDPPVPGERVFPEPLVRTVVHMMESVALPGGGGVKAAIKGYRIAIKTGTAKKVGPDGRYINKYIAYTAGVAPASHPRFALVVVINDPQAGKYYGGAVSAPVFGAIMGGVLRTMNIEPDALATGEKSEFVINQGEGTGGRS,MVKFNSSRKSGKSKKTIRKLTAPETVKQNKPQKVFEKCFMRGRYMLSTVLILLGLCALVARAAYVQSINADTLSNEADKRSLRKDEVLSVRGSILDRNGQLLSVSVPMSAIVADPKTMLKENSLADKERIAALAEELGMTENDLVKKIEKNSKSGYLYLARQVELSKANYIRRLKIKGIILETEHRRFYPRVEEAAHVVGYTDIDGNGIEGIEKSFNSLLVGKDGSRTVRKDKRGNIVAHISDEKKYDAQDVTLSIDEKLQSMVYREIKKAVSENNAESGTAVLVDVRTGEVLAMATAPSYNPNNRVGVKSELMRNRAITDTFEPGSTVKPFVVLTALQRGVVKRDEIIDTTSFKLSGKEIVDVAPRAQQTLDEILMNSSNRGVSRLALRMPPSALMETYQNAGLSKPTDLGLIGEQVGILNANRKRWADIERATVAYGYGITATPLQIARAYATLGSFGVYRPLSITKVDPPVIGKRVFSEKITKDIVGILEKVAIKNKRAMVEGYRVGVKTGTARKIENGHYVNKYVAFTAGIAPISDPRYALVVLINDPKAGEYYGGAVSAPVFSNIMGYALRANAIPQDAEAAENTTTKSAKRIVYIGEHKNQKVN,96.39,gnl|BL_ORD_ID|2497|hsp_num:0,2886,FALSE,None
LK570,28_1 # 1 # 882 # 1 # ID=28_1;partial=11;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.542,28_1,1,882,+,Strict,700,590.882,Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin,97.96,3003369,protein variant model,R234F,n/a,elfamycin antibiotic,antibiotic target alteration,elfamycin resistant EF-Tu,AAAGCTCGTGGTATCACCATCAACACTTCTCACGTTGAATATGACACCCCGACTCGCCACTACGCACACGTAGACTGCCCGGGCCACGCCGACTATGTTAAAAACATGATCACCGGTGCTGCTCAGATGGATGGCGCGATCCTGGTTGTTGCTGCGACTGACGGCCCGATGCCGCAGACTCGTGAGCACATCCTGCTGGGTCGTCAGGTAGGCGTTCCGTACATCATCGTGTTCCTGAACAAATGCGACATGGTTGATGACGAAGAGCTGCTGGAACTGGTTGAAATGGAAGTCCGTGAGCTGCTGTCTCAGTACGACTTCCCGGGCGACGACACGCCGATCGTTCGTGGTTCCGCTCTGAAAGCGCTGGAAGGCGAAGCAGACTGGGAAGCGAAAATCATCGAACTGGCTGGCTACCTGGATTCTTACATCCCGGAACCAGAGCGTGCGATTGACAAGCCGTTCCTGCTGCCGATCGAAGACGTATTCTCCATCTCCGGTCGTGGTACCGTTGTTACCGGTCGTGTAGAGCGCGGTATCATCAAAGTGGGCGAAGAAGTTGAAATCGTTGGTATCAAAGAGACTGCGAAGTCTACCTGTACTGGCGTTGAAATGTTCCGCAAACTGCTGGACGAAGGCCGTGCTGGTGAGAACGTTGGTGTTCTGCTGCGTGGTATCAAACGTGAAGAAATCGAACGTGGTCAGGTACTGGCTAAGCCGGGCTCTATCAAGCCGCACACCAAGTTCGAATCTGAAGTGTACATTCTGTCCAAAGACGAAGGCGGCCGTCATACTCCGTTCTTCAAAGGCTACCGTCCGCAGTTCTACTTCCGTACAACTGACGTGACTGGCACCATCGAACTGCCGGAAGGCGTAGAGATG,KARGITINTSHVEYDTPTRHYAHVDCPGHADYVKNMITGAAQMDGAILVVAATDGPMPQTREHILLGRQVGVPYIIVFLNKCDMVDDEELLELVEMEVRELLSQYDFPGDDTPIVRGSALKALEGEADWEAKIIELAGYLDSYIPEPERAIDKPFLLPIEDVFSISGRGTVVTGRVERGIIKVGEEVEIVGIKETAKSTCTGVEMFRKLLDEGRAGENVGVLLRGIKREEIERGQVLAKPGSIKPHTKFESEVYILSKDEGGRHTPFFKGYRPQFYFRTTDVTGTIELPEGVEM,MLSPEGESTIVRNIAVSKEKFERTKPHVNVGTIGHVDHGKTTLTAAITTVLAKTYGGAARAFDQIDNAPEEKARGITINTSHVEYDTPTRHYAHVDCPGHADYVKNMITGAAQMDGAILVVAATDGPMPQTREHILLGRQVGVPYIIVFLNKCDMVDDEELLELVEMEVRELLSQYDFPGDDTPIVRGSALKALEGDAEWEAKILELAGFLDSYIPEPERAIDKPFLLPIEDVFSISGRGTVVTGRVERGIIKVGEEVEIVGIKETQKSTCTGVEMFRKLLDEGRAGENVGVLLRGIKREEIERGQVLAKPGTIKPHTKFESEVYILSKDEGGRHTPFFKGYRPQFYFRTTDVTGTIELPEGVEMVMPGDNIKMVVTLIHPIAMDDGLRFAIREGGRTVGAGVVAKVLG,71.88,gnl|BL_ORD_ID|1970|hsp_num:0,2158,TRUE,loose hit with at least 95 percent identity pushed strict
LK570,8_140 # 150318 # 150752 # 1 # ID=8_140;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.492,8_140,150318,150752,+,Strict,210,256.144,Escherichia coli AcrAB-TolC with MarR mutations conferring resistance to ciprofloxacin and tetracycline,84.03,3003378,protein overexpression model,"Y137H, S3N",n/a,fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics,antibiotic target alteration; antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,GTGAAAAACACCAGCGATCTGTTTAACGAAATGATCCCCCTCGGTCGCTTGATCCAAATGGTTAACCAGAAAAAAGATCGCCTGCTCAACGAATATCTCTCGCCGATGGATATTACTTCCACCCAGTTTCGGGTGCTTTGTTCCATTCGTTGCGAAGTATGTATTACCCCCGTTGAGCTGAAAACCGTGCTGTCGGTCGACCCAGGCGCAATGACGCGCATGCTCGACCGTCTGGTCTGTAAAGGCTGGATTGAACGGTTACCCAACCCCAATGACAAACGCGGCGTACTGGTGCAACTAACACCAGACGGTGCAGCCCTTTGTGAGCAGTGTCATCAGGTTGTGGGTCAGAAATTGCACCAGGAATTAACAAAAAATCTGTCGGCGGATGAAGTGGTCAATCTTGAGCATTTACTCAAAAAAGTCCTGCCGTAA,VKNTSDLFNEMIPLGRLIQMVNQKKDRLLNEYLSPMDITSTQFRVLCSIRCEVCITPVELKTVLSVDPGAMTRMLDRLVCKGWIERLPNPNDKRGVLVQLTPDGAALCEQCHQVVGQKLHQELTKNLSADEVVNLEHLLKKVLP,MKSTSDLFNEIIPLGRLIHMVNQKKDRLLNEYLSPLDITAAQFKVLCSIRCAACITPVELKKVLSVDLGALTRMLDRLVCKGWVERLPNPNDKRGVLVKLTTGGAAICEQCHQLVGQDLHQELTKNLTADEVATLEYLLKKVLP,100,gnl|BL_ORD_ID|1984|hsp_num:0,431,FALSE,None
LK639,4_59 # 46434 # 46607 # -1 # ID=4_59;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.718,4_59,46434,46607,-,Strict,500,23.0978,APH(3')-Vc,100,3002651,protein homolog model,n/a,n/a,aminoglycoside antibiotic,antibiotic inactivation,APH(3'),ATGGAGACGACTGACCCCGCGGCCCAGTTCGCCGCCGCCTGGTGGGACTCACTCGACCCGGCCCGCCGAGTGCAGATCCACCGCTGGATCGCCGGCCGTGAGGCCACCCTCGACCACCCGCCCGTCCCCGGGCAGACCGACCTCCTCGCAGAACTCGACAGGACCAGACCATGA,METTDPAAQFAAAWWDSLDPARRVQIHRWIAGREATLDHPPVPGQTDLLAELDRTRP,MYAMLRRKYQHYEWTSVNEGDSGASVYRLAGQQPELYVKFAPREPENSAFDLAGEADRLTWLTRHGIPVPCIVECGGDDTSVFLVTEAVTGVSAAEEWPEHQRFAVVEAMADLARTLHELPVGGCPFDRSLAVTVAEARHNLREGLVDLDDLQEEHANWSGDQLLAELDRTRPEKEDLVLCHGDLCPNNVLLDPETCRVTGMIDVGRLGRADRHADLALAARELEIDEDPWFGPEYAQRFLERYGAHHVDENKMAFYQLLDEFF,21.59,gnl|BL_ORD_ID|634|hsp_num:0,687,TRUE,loose hit with at least 95 percent identity pushed strict
LK1404,33_27 # 25984 # 26829 # 1 # ID=33_27;partial=00;start_type=ATG;rbs_motif=AGGA/GGAG/GAGG;rbs_spacer=11-12bp;gc_cont=0.636,33_27,25984,26829,+,Perfect,400,567.385,Erm(36),100,3000605,protein homolog model,n/a,n/a,macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic,antibiotic target alteration,Erm 23S ribosomal RNA methyltransferase,ATGCCCACTTACCGTGGCGGCCGACATGAGCACGGCCAGAACTTCCTCACTGACCACACCACGATCGACCGGCTCTCACGGCTGGTAGGCGACTCGACCGGTCCGATCGTCGAGATCGGCCCGGGCCAGGGCAGGCTCACAAGAGAGCTGCAGAAGCTCGGCCGGTCCCTGACTGCTGTCGAGATCGATAGCCGGCTGGCGGACCGACTTGCATCGGCCAGTCAGTTCCGCGAGCAGAAACACGTAACCGTCGTCAACGCAGACTTCCTTCACTGGCCGCTACCGACCACTCCGTATGTGGTGGTCGGCAACGTTCCGTTCCACCTGACCACAGCCATCCTGCGCAGACTGCTGCACGATGGAGCATGGACCCAGGTGGTCCTGCTCGTGCAGTGGGAAGTGGCCCGCCGGCGTGCCGGCATCGGTGGTAGCAGCATGATGACCGCGCAGTGGTGGCCTTGGATCGACTTCAGCTTGCACGGGCGCGTGCCCCGGTCGGCGTTCAAGCCAGCCCCGAGCGTGGACGGTGGCCTCTTGGAGATGACTCGTCGTCCGGACCCATTGCTCAGCCCAGACGCGAGAGAGTCCTACCGACAGTTCGTCCATGACGTTTTCACCAGTAGGGGCAGGGGTATCGGCGAGATCCTGGCTAACGTATCCAGCTCACTCGGAAAGCGGGGAGCGCTCCAGTTGTTGAAGAGCGAGGGGATTCGCTCCTCGTCCCTGCCCAAAGATCTCTCAGCGGAGCAGTGGGCTCGCCTCTTTACCAGCGCGTCGCCTACGAAGAGTGCCAAAACCGGAAGGAACGCACACCCCGCCCACTCCGCACGGCGGCAAGGTCGATGA,MPTYRGGRHEHGQNFLTDHTTIDRLSRLVGDSTGPIVEIGPGQGRLTRELQKLGRSLTAVEIDSRLADRLASASQFREQKHVTVVNADFLHWPLPTTPYVVVGNVPFHLTTAILRRLLHDGAWTQVVLLVQWEVARRRAGIGGSSMMTAQWWPWIDFSLHGRVPRSAFKPAPSVDGGLLEMTRRPDPLLSPDARESYRQFVHDVFTSRGRGIGEILANVSSSLGKRGALQLLKSEGIRSSSLPKDLSAEQWARLFTSASPTKSAKTGRNAHPAHSARRQGR,MPTYRGGRHEHGQNFLTDHTTIDRLSRLVGDSTGPIVEIGPGQGRLTRELQKLGRSLTAVEIDSRLADRLASASQFREQKHVTVVNADFLHWPLPTTPYVVVGNVPFHLTTAILRRLLHDGAWTQVVLLVQWEVARRRAGIGGSSMMTAQWWPWIDFSLHGRVPRSAFKPAPSVDGGLLEMTRRPDPLLSPDARESYRQFVHDVFTSRGRGIGEILANVSSSLGKRGALQLLKSEGIRSSSLPKDLSAEQWARLFTSASPTKSAKTGRNAHPAHSARRQGR,100,gnl|BL_ORD_ID|818|hsp_num:0,888,FALSE,None
LK488,4_132 # 134578 # 135684 # 1 # ID=4_132;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.642,4_132,134578,135684,+,Strict,175,178.718,vanT gene in vanG cluster,33.15,3002972,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,glycopeptide resistance gene cluster; vanT,ATGGAACTTACTACGCTCACCATTGATCTGGATGCTATCGCCTCCAACGCCCGCGAGGTGCAGAAAGCTGCAGGTAACGCCGACGTGATGGCCGTGGTGAAAGCGAACGCCTACAACCACGGAGTCGATCTCGTCGTTCCCGTCTTGGAGAAGGCGGGTATCGCGGGTTTCGGCGTGGCGACGATCCCCGAGGCGCGCCAGGTGCGCGAGGTGACTGAGCTTCCCGTCCTCGCCTGGATTTGGCACCCTGAGCAAGATTTGCCTAGGCAGGAGGAGCACATTGACCTGGGGCTTGCGTCGATGGCACAGGCGCGGGCGCTCGCGGCGGATCCCACTCCACGCACCGTCACCCTCGTCATTGATACGGGGCTGAACCGCTCCGGGGTGGATGAAGAGAACTGGGAGGAGCTCTGCCGGTTCGTCGCCGGTGTTCCGCACCTTACGGTCACGGGTCTGTTCACCCACCTGGCCTGTGCCGACGAGGAGGACAATCCGCTGACGGGTGAGCAGGTGGACACCCTCACCCGCGCCCTCGCCGTCGCCCGTGCCTGCGGTCTCAACCCCACGCGCAACCACGTTGCGAACTCTCCGGGGGTTCTCACCAAGGGTGATCTTGGCTTTTCGACGGTTCGTCCCGGCCTTATTCTCTACGGCTACAGCCCCCTTCGCGAGGGCGATACCGCCGGATACACCCTCCGCCCCGCGATGACGTGGAGCGCCCACGTGACCATCGTGAAGAAGATCCACGCCGGCGAGGGGGCGTCCTACGGCATGACGTGGCACGCTCCGACGGATCGTTACACCGCCATCGTCCCCGTGGGCTACGCCGACGGCCTACCCCGCCGGATGCAGGGCAAACTGGAGGTCGCTATCGGTGGCAAGCGATACCCGCAGGTGGGGCGCGTGTGCATGGATCAGATTGTCGTTGATCTCGGCCCCGAAGAGCCACAGGTTCACCCCGGTGACGAGGCCTTCCTGTTTGGGCCCGGTGACCACGGTGAGATGACGGTGGATGAGTGGGCCGAGCACCTGGAGACCATCAACTATGAGGTGTTGTGCAGCCCGCGTGGGCGCGTGCAGCGTACGTATAGTGGGCGTGGAGAATAA,MELTTLTIDLDAIASNAREVQKAAGNADVMAVVKANAYNHGVDLVVPVLEKAGIAGFGVATIPEARQVREVTELPVLAWIWHPEQDLPRQEEHIDLGLASMAQARALAADPTPRTVTLVIDTGLNRSGVDEENWEELCRFVAGVPHLTVTGLFTHLACADEEDNPLTGEQVDTLTRALAVARACGLNPTRNHVANSPGVLTKGDLGFSTVRPGLILYGYSPLREGDTAGYTLRPAMTWSAHVTIVKKIHAGEGASYGMTWHAPTDRYTAIVPVGYADGLPRRMQGKLEVAIGGKRYPQVGRVCMDQIVVDLGPEEPQVHPGDEAFLFGPGDHGEMTVDEWAEHLETINYEVLCSPRGRVQRTYSGRGE,MTKNESYSGIDYFRFIAALLIVAIHTSPLSSFSETGNFIFTRIVARVAVPFFFMTSGFFLISRYTCNAEKLGAFIKKTTLIYGVAILLYIPINVYNGYFKMDNLLPNIIKDIVFDGTLYHLWYLPASIIGAAIAWYLVKKVHYRKAFLIASILYIIGLFGDSYYGIVKSVSCLNVFYNLIFQLTDYTRNGIFFAPIFFVLGGYISDSQNRLSLKRSIVGFIVCFALMFGEALTLHHFDIQKHDSMYVLLLPSVYCLFNLLLHFRGKRRTGLRTISLIIYIIHPFMIVVIRLFAKLLHLQSLLVENSLVHYIAVCFASVVLAVVITALLSSLKPKKAKHTADTDRAYLEINLNNLEHNVNTLQKAMSPKCELMAVVKAEAYGHGMYEVTTYLEQIGVSSFAVATIDEGIRLRKYGISSEILILGYTSPSRAKELCKYELTQTLIDYRYSLLLNKQGYDIKAHIKIDTGMHRLGFSTEDKDKILAAFSLKHIKVAGIFTHLCAADSLEENDVAFTNKQIGSFYKVLDWLKSSGLNIPKVHIQSSYGLLNYPELECDYIRVGVALYGVLSSTNDKTKLELDLRPVLSLKAKVVLIRKIKQGESVGYSRAFTATRDSLIAILPIGYADGFPRNLSCGNSYVLIGGRQAPIVGKICMDQLAVDVTDIPNVKTGSIATLIGKDGKEEITAPMVAESAESITNELLSRMGHRLNIIRRA,51.69,gnl|BL_ORD_ID|1522|hsp_num:0,1561,FALSE,None
LK488,8_2 # 1102 # 3021 # -1 # ID=8_2;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.531,8_2,1102,3021,-,Strict,300,1279.23,tet(W),97.18,3000194,protein homolog model,n/a,n/a,tetracycline antibiotic,antibiotic target protection,tetracycline-resistant ribosomal protection protein,ATGAAAATAATCAATATTGGAATTCTTGCCCATGTAGACGCTGGAAAGACGACCTTGACGGAGAGCCTGCTATATGCCAGCGGAGCCATTTCAGAACCGGGGAGCGTCGAAAAAGGGACAACGAGGACGGACACCATGTTTTTGGAGCGGCAGCGTGGGATTACCATTCAAGCGGCAGTCACTTCCTTCCAGTGGCACAGATGTAAAGTCAACATTGTGGATACGCCCGGCCACATGGATTTTTTGGCGGAGGTGTACCGCTCTTTGGCTGTTTTAGATGGGGCCATCTTGGTGATCTCCGCTAAAGATGGCGTGCAGGCCCAGACCCGTATTCTGTTCCATGCCCTGCGGAAAATGAACATTCCCACCGTTATCTTTATCAACAAGATCGACCAGGCTGGCGTTGATTTGCAGAGCGTGGTTCAGTCTGTTCGGGATAAGCTCTCCGCCGATATTATCATCAAGCAGACGGTGTCGCTGTCCCCGGAAATAGTCCTGGAGGAAAATACCGACATAGAAGCATGGGATGCGGTCATCGAAAATAACGATAAATTATTGGAAAAGTATATCGCAGGAGAACCAATCAGCCGGGAAAAACTTGTGCGGGAGGAACAGCGGCGGGTTCAAGACGCCTCCCTGTTCCCGGTCTATTATGGCAGCGCCAAAAAGGGCCTTGGCATTCAACCGTTGATGGATGCGGTGACAGGGCTGTTCCAACCGATTGGGGAACAGGGGAGCGCCGCCCTATGCGGCAGCGTTTTCAAGGTGGAGTATACAGATTGCGGCCAGCGGCGTGTCTATCTACGGCTATACAGCGGAACGCTGCGCCTGCGGGATACGGTGGCCCTGGCCGGGAGAGAAAAGCTGAAAATCACAGAGATGCGTATTCCATCCAAAGGGGAAATTGTTCGGACAGACACCGCTTATCCGGGTGAAATTGTTATCCTTCCCAGCGACAGCGTGAGGTTAAACGATGTATTAGGGGACCCAACCCGGCTCCCTCGTAAAAGGTGGCGTGAGGACCCCCTCCCCATGCTGCGGACGTCGATTGCGCCGAAAACGGCAGCGCAAAGAGAACGGCTGCTGGACGCTCTTACGCAACTTGCGGATACTGACCCGCTTTTGCGCTGCGAGGTGGATTCCATCACCCATGAGATCATTCTTTCTTTTTTGGGCCGGGTGCAGTTGGAGGTTGTTTCCGCTTTGCTGTCGGAAAAATACAAGCTTGAAACAGTGGTAAAGGAACCCACCGTCATTTATATGGAGCGGCCGCTCAAAGCAGCCAGCCACACCATCCATATCGAGGTGCCGCCCAACCCGTTTTGGGCATCCATCGGACTGTCTGTTACACCACTCCCGCTTGGCTCCGGTGTACAATACGAGAGCCGGGTTTCGCTGGGATACTTGAACCAGAGTTTTCAAAACGCTGTCAGGGATGGTATCCGTTACGGGCTGGAGCAGGGCTTGTTCGGCTGGAACGTAACGGACTGTAAGATTTGCTTTGAATACGGGCTTTATTACAGTCCGGTCAGCACGCCGGCGGACTTCCGCTCATTGGCCCCGATTGTATTGGAACAGGCATTGAAGGAATCAGGGACGCAACTGCTGGAACCTTATCTCTCCTTCACCCTCTATGCGCCCCGGGAATATCTTTCCAGGGCTTATCATGATGCACCGAAATACTGTGCCACCATCGAAACGGTCCAGGTAAAAAAGGATGAAGTTGTCTTTACTGGCGAGATTCCCGCCCGCTGTATACAGGCATACCGTACTGATCTGGCCTTTTACACCAACGGGCAGAGCGTATGCCTTACAGAACTGAAAGGGTATCAGGCCGCTGTCGGCAAGCCAGTCATCCAGCCCCGCCGTCCAAACAGCCGCCTGGACAAGGTGCGCTATATGTTTCAGAAGATAATGTAA,MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAVTSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMNIPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIENNDKLLEKYIAGEPISREKLVREEQRRVQDASLFPVYYGSAKKGLGIQPLMDAVTGLFQPIGEQGSAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKGEIVRTDTAYPGEIVILPSDSVRLNDVLGDPTRLPRKRWREDPLPMLRTSIAPKTAAQRERLLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPTVIYMERPLKAASHTIHIEVPPNPFWASIGLSVTPLPLGSGVQYESRVSLGYLNQSFQNAVRDGIRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYLSFTLYAPREYLSRAYHDAPKYCATIETVQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGQSVCLTELKGYQAAVGKPVIQPRRPNSRLDKVRYMFQKIM,MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAVTSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMNIPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIENNDELLEKYIAGEPISREKLAREEQQRVQDASLFPVYHGSAKNGLGIQPLMDAVTGLFQPIGEQGGAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKGEIVRTDTAYQGEIVILPSDSVRLNDVLGDQTRLPRKRWREDPLPMLRTTIAPKTAAQRERLLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPSVIYMERPLKAASHTIHIEVPPNPFWASIGLSVTPLSLGSGVQYESRVSLGYLNQSFQNAVRDGIRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYLSFILYAPQEYLSRAYHDAPKYCATIETAQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGRSVCLTELKGYQAAVGQPVIQPRRPNSRLDKVRHMFQKVM,100,gnl|BL_ORD_ID|456|hsp_num:0,389,FALSE,None
LK488,9_6 # 8605 # 10242 # 1 # ID=9_6;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.647,9_6,8605,10242,+,Strict,50,89.3521,vanW gene in vanI cluster,36.54,3003724,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanW; glycopeptide resistance gene cluster,ATGAAACGCATCGCACTTGCCATTGGCCTGTTTGTCCTGCTCCTCCTCGGTCTGTACGGGGTGGACACGGCGCTTGCGCAGGGCACCGTCCCCCGCGGCACCACGGTCGGTGGCGTCGCCATCGGTGGCATGAAGCCCGCTGATGCCCGCGAGAAACTCTCCGCCGAGTTCACCTACAAGCCCGTCGAGGTCTCCGCGAACGACATGCGCACCACCGTCGATCCGCAGGCCGCAGGCCTCGCCCCCGACTGGGACGCGACGATCGCGGCCGCTGGCACCCCGCCGCTCAACCCGATCACCAAGATCACCTCCTTCTTCACCACCACCGAGGTCCCGATCCAGTCCGAGGTAGGCGACGGTTTCGCCCCGGCGATGCAGGCAGTCGCAACTGAGCTCACCCGCGAGCCCGTCGACGGTGGTCTTGAGCTTGTCGACGGCTCCCCGCACCGCATTCCTCCCGTCATCGGTCAGACCGCTACCGAAGAGTCCGTTTCCGATGCCGTCCTCCACAATTGGCTCAACCCCGACGGCGTCACCGTCGACGTGACCGAGGTTCCGCCCGCCATCGGTGACGAGGAGATCGATGCCGCGGAAAAGGGGCCAGCCAAGAAGGCCCTGGCTGCCGACATTGTCGCCCACGGCAACGACAAGGTAGACGGCATCATCCCCCGCAACCGCATGGGGGAGATTCTTACTTTCGCGCCGGAGAACGGAGTTCTCCGGCCCGAGGTCAACGTGGAAAAGGCCCACGAGATTCTCAACGAGAACCTGCAGACCACCGACGTCGCCCACAAGAACGCCACCATCACGCTGACCGGCGGTGGCCGCAACGTCACCCCGCACGTCGACGGCACCGTTATCGATTGGGAGAAAACCCTCGAGGGCTTCCCTGACCGCGCCCTGGGTGACGAGAAGGAATTTGACGTCACGTACAAGCCCGAGCCCGCCACCTTCACCACGGAGCAGGCAGAAAACGCCACCTTTAACGACGTCGTCGGATCCTTCACCACCGGCGGATTCTCCGGCCCGTCCGGCACCAACATTGCGTTAGTTGCGCGAACGGTTAATGGTGCGATCGTCGCCCCCGGCGAGACCTTCTCCCTCAACGGCTACACCGGCCCCCGCGGCACCGCCCAGGGCTATGTGTCCTCCGGCGTGATCCTCAACGGCCACGCCGACACCGCCGTCGGTGGTGGTATTTCGCAATTTGCGACCACCCTCTACAACGCCTCGTACTTCTCGGCAATGACCGACATCGCCCACACCCCGCACAGCTACTACATCTCCCGCTACCCCGCAGGCCGCGAGGCCACCGTTTACGAGGGTGCCATCGACCTCGTCTTCCGCAACGACACCCCGAACCCCGTCCTCATCGAGGCAGGTGTGAGCGGCAACGAGGTCACCGTCACCTTCAAGGGCGTGAAGACGACGAACGTCCAGTCCATCCCCGGTGGCAAGTGGAACTACACTCAGCCGCAGCCGATGAGCGTCAGCGGGTCGAGTTGTTCGCCCTCCGGCGGTGCCCCCGGCTTCACCACATCGGATACACGGGTAGTGACTGACCTCGCCGGAACTGAGTTGTCGCGTACCTCCACCACCACGGTCTACGACCCGGTCCCCATCGTCCGCTGCTCCTAG,MKRIALAIGLFVLLLLGLYGVDTALAQGTVPRGTTVGGVAIGGMKPADAREKLSAEFTYKPVEVSANDMRTTVDPQAAGLAPDWDATIAAAGTPPLNPITKITSFFTTTEVPIQSEVGDGFAPAMQAVATELTREPVDGGLELVDGSPHRIPPVIGQTATEESVSDAVLHNWLNPDGVTVDVTEVPPAIGDEEIDAAEKGPAKKALAADIVAHGNDKVDGIIPRNRMGEILTFAPENGVLRPEVNVEKAHEILNENLQTTDVAHKNATITLTGGGRNVTPHVDGTVIDWEKTLEGFPDRALGDEKEFDVTYKPEPATFTTEQAENATFNDVVGSFTTGGFSGPSGTNIALVARTVNGAIVAPGETFSLNGYTGPRGTAQGYVSSGVILNGHADTAVGGGISQFATTLYNASYFSAMTDIAHTPHSYYISRYPAGREATVYEGAIDLVFRNDTPNPVLIEAGVSGNEVTVTFKGVKTTNVQSIPGGKWNYTQPQPMSVSGSSCSPSGGAPGFTTSDTRVVTDLAGTELSRTSTTTVYDPVPIVRCS,MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVLAEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPELLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGMETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGGEFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSHSLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDEPDGYPVKPREWSK,146.11,gnl|BL_ORD_ID|4748|hsp_num:0,2242,FALSE,None
LK488,31_2 # 744 # 1598 # -1 # ID=31_2;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.563,31_2,744,1598,-,Strict,400,514.612,ErmX,90.14,3000596,protein homolog model,n/a,n/a,macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic,antibiotic target alteration,Erm 23S ribosomal RNA methyltransferase,ATGTCTGCATACGGACACGGCCGTCACGAGCATGGCCAAAATTTTCTCACCAACCACAAGATCATCAACTCCATCATCGACCTTGTGAAACAAACCTCCGGCCCCATCATTGAGATCGGACCAGGAAGCGGTGCCCTCACTCACCCGATGGCCCACTTGGGGAGGGCGATAACGGCAGTTGAAGTGGACGCAAAACTAGCTGCCAAAATCACACAAGAAACCTCCTCGGCGGCGGTCGAAGTGGTCCATGATGATTTCCTTAACTTCCGGTTACCCGCCACTCCCTGCGTCATTGTGGGAAACATTCCCTTTCACCTCACCACTGCCATTCTTCGAAAGTTGCTGCATGCGCCAGCATGGACTGACGCTGTACTCCTCATGCAGTGGGAAGTCGCTCGCCGCCGGGCCGGGGTAGGCGCAAGCACGATGATGACGGCTCAGTGGTCCCCATGGTTCACATTTCACCTGGGTTCTCGGGTACCAAGGTCTGCTTTCCGGCCACAGCCAAACGTTGACGGGGGGATCTTAGTGATCCGCCGGGTGGGTGACCCGAAGATTCCGATAGAGCAGCGCAAAGCCTTTCAGGCGATGGTGCACACCGTTTTCACTGCCCGGGGACGCGGGATAGGGGAAATTCTCCGAAGGGCAGGGTTGTTTTCATCACGTTCAGAAACACAATCATGGTTGCGCTCGCGAGGAATCGACCCCGCGACCCTACCTCCCAGATTGCACACCAACGACTGGATCGATCTCTTCCAGGTGACTGGTTCCTCTCTACCTCACCATCGACCCATTTCACCATCGGGAAGTAGTCAACGACCTCCTCAACGGAAATACCGAAGCCGGCGGCGTTAA,MSAYGHGRHEHGQNFLTNHKIINSIIDLVKQTSGPIIEIGPGSGALTHPMAHLGRAITAVEVDAKLAAKITQETSSAAVEVVHDDFLNFRLPATPCVIVGNIPFHLTTAILRKLLHAPAWTDAVLLMQWEVARRRAGVGASTMMTAQWSPWFTFHLGSRVPRSAFRPQPNVDGGILVIRRVGDPKIPIEQRKAFQAMVHTVFTARGRGIGEILRRAGLFSSRSETQSWLRSRGIDPATLPPRLHTNDWIDLFQVTGSSLPHHRPISPSGSSQRPPQRKYRSRRR,MSAYGQGRHEHGQNFLTNHKIINSIIDLVKQTSGPIIEIGPGSGALTHPMAHLGRAITAVEVDAKLAAKITQETSSAAVEVVHDDFLNFRLPATPCVIVGNIPFHLTTAILRKLLHAPAWTDAVLLMQWEVARRRAGVGATTMMTAQWSPWFTFHLGSRVPRSAFRPQPNVDGGILVIRRVGDPKIPIEQRKAFQAMVHTVFTARGRGIGEILRRQGCFHHVQKHNHGCAREESTPRPYLPDCYTNDWIDLFQVTGSSLPHHRPISPSGSSQRPPQRKNRSRRR,100,gnl|BL_ORD_ID|872|hsp_num:0,950,FALSE,None
LK488,31_3 # 1787 # 3346 # 1 # ID=31_3;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.689,31_3,1787,3346,+,Strict,900,1008.05,Corynebacterium striatum tetA,99.03,3004639,protein homolog model,n/a,n/a,penam; tetracycline antibiotic,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGCCACCGCCGCGCAGAATGAAGACGTACAGCTGGTTCGTCCCGCCCGCGCCGCCAGCGGACGATCCGGCGCGGCTCCACCCGGCGCGCTGGAGCAGCGGGAACCGCGTGGTCAGGGACATGGTTGGCGCCTACCCGGGCGTGCTGGTGCTGCACATTCTGAGCTACCTCATCGGCTCCGGCATCGCCGCGTTTGTGCCGGTGGTGGTGGGCATGATCGTGGACGGCCTGGTGGGGGAAGAAAAGTTCAACGCATGGTGGCTCTTCGCGGTGCTGGTCGGCATCTTCATCATCCAATTCATCGGCGAGGCCACCGGCGACGGCCTGGCCACAGCCTCGGTGCGCCGCGTGACCCACAACGCGCAGCAGCACCTGTCCTCGGGCGTGCTGCGCCGCGGGGCGGGAGCGATGAGCCCCGGCACCGTACTCAACACCATCGACGCGGACGCGAACACCGTCGGCCGCTACCGCGAGCTGCTGTCGTTTCCGCTCATGGCCATCGGCTACGCGGTCTGCGCGATGGTGGCGATGTGGTCGGTCTCCCCGTGGATCTCACTGGCCATCCCGGCCAGCGCGCTGATCATCGCTCTGTTCGCCGCGTGGACCGCGGGGCCGGTGACGCGGGTGTCGTTGAAGCGTCGCGCCGCGGAGGCGGATGTCGCTGGCTTGGCCACGGATGCGTCGCAAGGCATTCGCACCGTCAAAGGCCTAGGCGCGGGTGCAACCGTGGCAACACGTTTTCACGCCGAAACGGCGAAGGCGAAGCGCTTGATGCTCACGCACCTGCGTGTGGAGGTGTGGCTCGGTTTCGCCAGGTTTTGCGTGGCGTGGCTGTGCAACCTTGGCATCGTGGGCTTGAGCGCGTGGATGACGCTGCGCGGGGAGATCACCCCGGGGCAGCTGACATCCGTGGCACTGTTGGTGCAGCCTGCGTTGACCATGGCGGGCTTAGCGTTCGGCGACCTGGCCAGCGGGTGGGGCAGGGCCGTCGCGAGTGGCCAGCGCATCGAGCAGCTGCACCACGCGGGCGACGACACCGCGGGGCCCGAGCTAACAGACACACCGGTCCCAGGCGCGGGGCTGTGGATTCTCGAGCCGGCGGAGCGTTCCTACGCCACCGCCGCCGCGTGGGCGCAGCGCGCAGACGTGCTGTTCCCGCCGCACACCGTCAACGTGTTTGAGGGCACCATCGCAGACAACGTGAACCCGCGCGGGGATGTGCCGGAGGACGTCGTCAAGCAGGCGCTCGCCGCCGCCCACTGCCAAGACATCCTCCGCAGGCTCGGCGGTATCAACGAAGCAGGCGAGTTGCCGGACGCACCGCTGGGCGAGGCCGGCCTGAACCTTTCCGGCGGGCAGCGCCAGCGCGTCGCGCTTGCCAGGGCGCTCGCCGCCGACCCGGAGGTGCTCATCCTGGACGACCCGACCACGGGGCTCGATTCCGTGACACAGGCGGACGTCGTGGCAGCCGTCGCCGCGCTCAGAGCAGACAAAACCACCGTGGTCATCACCGGAAACGCCGCGTGGCAGCACGCTGGAACCGAATTGGAGGTGGCGTAG,MPPPRRMKTYSWFVPPAPPADDPARLHPARWSSGNRVVRDMVGAYPGVLVLHILSYLIGSGIAAFVPVVVGMIVDGLVGEEKFNAWWLFAVLVGIFIIQFIGEATGDGLATASVRRVTHNAQQHLSSGVLRRGAGAMSPGTVLNTIDADANTVGRYRELLSFPLMAIGYAVCAMVAMWSVSPWISLAIPASALIIALFAAWTAGPVTRVSLKRRAAEADVAGLATDASQGIRTVKGLGAGATVATRFHAETAKAKRLMLTHLRVEVWLGFARFCVAWLCNLGIVGLSAWMTLRGEITPGQLTSVALLVQPALTMAGLAFGDLASGWGRAVASGQRIEQLHHAGDDTAGPELTDTPVPGAGLWILEPAERSYATAAAWAQRADVLFPPHTVNVFEGTIADNVNPRGDVPEDVVKQALAAAHCQDILRRLGGINEAGELPDAPLGEAGLNLSGGQRQRVALARALAADPEVLILDDPTTGLDSVTQADVVAAVAALRADKTTVVITGNAAWQHAGTELEVA,MKTYSWFVPPAPPADDPARLHPARWSSGNRVVRDMVGAYPGVLVLHILSYLIGSGISAFVPVVVGMIVDGLVGEEKFNAWWLFAVLVGIFIIQFIGEATGDGLATASVRRVTHNAQQHLSSGVLRRGAGAMSPGTVLNTIDADANTVGRYRELLSFPLMAIGYAVCAMVAMWSVSPWISLAIPASALIIALFAAWTAGPVTRVSLKRRAAEADVAGLATDASQGIRTVKGLGAGATVATRFHAETAKANGLMLTHLRVEVWLGFARFCVAWLCNLGIVGLSAWMTLRGEITPGQLTSVALLVQPALTMAGLAFGDLASGWGRAVASGQRIEQLHHAGDDAAGPEPTDTPVPGAGLWILEPAERSYATAAAWAQRADVLFPPHTVNVFEGTIADNVNPRGDVPEDVVKQALAAAHCQDILRRLGGINEAGELPDAPLGEAGLNLSGGQRQRVALARALAADPEVLILDDPTTGLDSVTQADVVAAVAALRADKTTVVITGNAAWQHAGTELEVA,101.17,gnl|BL_ORD_ID|2120|hsp_num:0,3337,FALSE,None
LK488,48_1 # 43 # 858 # -1 # ID=48_1;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.440,48_1,43,858,-,Perfect,500,565.459,APH(3')-Ia,100,3002641,protein homolog model,n/a,n/a,aminoglycoside antibiotic,antibiotic inactivation,APH(3'),ATGAGCCATATTCAACGGGAAACGTCTTGCTCGAGGCCGCGATTAAATTCCAACCTGGATGCTGATTTATATGGGTATAGATGGGCTCGCGATAATGTCGGGCAATCAGGTGCGACAATCTATCGATTGTATGGGAAGCCCAATGCGCCAGAGTTGTTTCTGAAACATGGCAAAGGTAGCGTTGCCAATGATGTTACAGATGAGATGGTCAGACTAAACTGGCTGACGGCATTTATGCCTCTTCCGACCATCAAGCATTTTATCCGTACTCCTGATGATGCATGGTTACTCACCACTGCGATCCCCGGGAAAACAGCATTCCAGGTATTAGAAGAATATCCTGATTCAGGTGAAAATATTGTTGATGCGCTGGCAGTGTTCCTGCGCCGGTTGCATTCGATTCCTGTTTGTAATTGTCCTTTTAACAGCGATCGCGTATTTCGTCTCGCTCAGGCGCAATCACGAATGAATAACGGTTTGGTTGATGCTAGTGATTTTGATGACGAGCGTAATGGCTGGCCTGTTGAACAAGTCTGGAAAGAAATGCATAAGCTTTTGCCATTCTCACCGGATTCAGTCGTCACTCATGGTGATTTCTCACTTGATAACCTTATTTTTGACGAGGGGAAATTAATAGGTTGTATTGATGTTGGACGAGTCGGAATCGCAGACCGATACCAGGATCTTGCCATCCTATGGAACTGCCTCGGTGAGTTTTCTCCTTCATTACAGAAACGGCTTTTTCAAAAATATGGTATTGATAATCCTGATATGAATAAATTGCAGTTTCATTTGATGCTCGATGAGTTTTTCTGA,MSHIQRETSCSRPRLNSNLDADLYGYRWARDNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIADRYQDLAILWNCLGEFSPSLQKRLFQKYGIDNPDMNKLQFHLMLDEFF,MSHIQRETSCSRPRLNSNLDADLYGYRWARDNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIADRYQDLAILWNCLGEFSPSLQKRLFQKYGIDNPDMNKLQFHLMLDEFF,100,gnl|BL_ORD_ID|262|hsp_num:0,291,FALSE,None
LK1021,6_11 # 13349 # 14332 # 1 # ID=6_11;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.722,6_11,13349,14332,+,Strict,50,98.2117,vanY gene in vanF cluster,39.69,3002958,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGAAACCGTTCACGCGCCTGCCCTCCGCCCTTCTGGCCGTTCCGCTCGCCGCGACCCTGCTCACGGCCGGAACGACTCCCGCGTCCGCCGTGACGGGCATCGAGGCCGAGTACGACGGCCTGCCGCAGGCCCAGGACTGGCTCGGCGAGCCCACGTCCGAGGAGTCGTGCGAGCTACGGGACAAGGGGTGCTACCGCGAGTACGACAAGGGCGCCATCTACTGGTCGCCCGACACGGGCGCGCGGGCGCAGCGCGGAGCGATCTACGCCCGGTGGCGGGCCGAGGGATCCGAGCACGGGCCGCTCGGCTACCCGGTGAGCCGGGAAACCTGTTCCGACGGGACGTGCGAGGTGCGCTACCAGCGCGGGAGCATCACGTGGACCGAGGCGGACGGCACCACCGTGCACCGGGACGTGGACGAGGCAGCCAGCGCGGGCGTCGTCGTCAACAAGCAGCGGGCGCTGTCCCCGCAGGACTACGCGCCCGCTCCGCTGCGGGACGTGGGCGGGGGCGTGCAGCTGCGCGACGACGCCGCGGCCGCGTACGAGCGGATGTCACGCGCTGCGGCGGAGCAGGGGGTGGAGCTCACAGCCGTGAGCGGGTACCGGGACTACGCCACGCAGGTGGGACTGTACGAGCAGTACACCTCGACGTACGGACGGGAGACCGCCGACTCGATCTCCGCGCGCCCCGGGCACTCGGAGCACCAGACCGGTCTGGCCATCGACGTGGGCGCGCCGGACGGTTCGTGCGCCCTGCTCGCGTGCTTCGAGGACACCCCTCAGGGCCGCTGGGTGGCCGATCACGCACACGAGTACGGGTTCGTGGTGCGGTACCCGGACGGGCGCACGGGCACCACCGGCTACGCCTACGAGCCGTGGCACCTGCGCTACGTGGGCGAGGACACCGCCACGAGCGTGAAGAACAGCGGGAAACCCGACCTGGAGTCCTACCTGGGCCTGCCCGACGCTCCCAGCTACTGA,MKPFTRLPSALLAVPLAATLLTAGTTPASAVTGIEAEYDGLPQAQDWLGEPTSEESCELRDKGCYREYDKGAIYWSPDTGARAQRGAIYARWRAEGSEHGPLGYPVSRETCSDGTCEVRYQRGSITWTEADGTTVHRDVDEAASAGVVVNKQRALSPQDYAPAPLRDVGGGVQLRDDAAAAYERMSRAAAEQGVELTAVSGYRDYATQVGLYEQYTSTYGRETADSISARPGHSEHQTGLAIDVGAPDGSCALLACFEDTPQGRWVADHAHEYGFVVRYPDGRTGTTGYAYEPWHLRYVGEDTATSVKNSGKPDLESYLGLPDAPSY,MKKWGLLLVFALFLVFIFNILPISQDKVEDRIYEQNDKDTSDDKMTAENMQKIELTEEQIYQGNLLLVNNEHPVHQKSIKSDIINLFTHKELTKGYGLLDNEIKLSEEIAGKFSEMIAAAEEDGVSNFLISSGYRDLDEQSRLYEEMGSDFALPAGHSEHNLGLSLDVGSTQMKMDKAPEGKWIEKNCWEYGFILRYPLDKTDVTGIQYEPWHIRYVGLPHSAIMQEMNLALEEYLDYLKEEKSISVRVDGKKYTISYDPISQNETIEVEVPADEQYEISGNNIDGVIVTTFS,111.6,gnl|BL_ORD_ID|1808|hsp_num:0,1899,FALSE,None
LK1021,33_20 # 23326 # 23580 # -1 # ID=33_20;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.675,33_20,23326,23580,-,Strict,1900,22.3274,MuxC,100,3004075,protein homolog model,n/a,n/a,macrolide antibiotic; monobactam; tetracycline antibiotic; aminocoumarin antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGGCACACAAGAAGGGTGCGAGCTCTACTCGCAACGGCCGTGACTCCAACGCCCAGTACCTGGGTGTCAAGCGCTTCGGCGGCCAGTCCGTCAACGCCGGCGAGATCATCGTCCGCCAGCGTGGAACCCACTTCCACCCGGGCCTGAACATGGGCCGCGGCAAGGACGACACCCTGTTCGCCCTGGCCGCCGGTGTCGTCGAGTTCGGCACCCGTCGTGGCCGCCGCGTGGTCAACATCCAGACCGCCGAGTAG,MAHKKGASSTRNGRDSNAQYLGVKRFGGQSVNAGEIIVRQRGTHFHPGLNMGRGKDDTLFALAAGVVEFGTRRGRRVVNIQTAE,MSLSTPFIRRPVATTLLTLALLLAGTLSFGLLPVAPLPNVDFPAIVVSASLPGASPETMASSVATPLERSLGRIAGISEMTSSSSLGSTTVVLVFDLEKDIDGAAREVQAAINGAMSLLPSGMPNNPSYRKANPSDMPIMVLTLTSETQSRGEMYDLASTVLAPKLSQVQGVGQVSIGGSSLPAVRVDLNPDAMSQYGLSLDSVRTAIAAANSNGPKGAVEKDDKHWQVDANDQLRKAREYEPLVIHYNADNGAAVRLGDVAKVSDSVEDVRNAGFSDDLPAVLLIVTRQPGANIIEATDAIHAQLPVLQELLGPQVKLNVMDDRSPSIRASLEEAELTLLISVALVILVVFLFLRNGRATLIPSLAVPVSLIGTFAVMYLCDFSLNNLSLMALIIATGFVVDDAIVVVENIARRIEEGDPPIQAAITGARQVGFTVLSMTLSLVAVFIPLLLMGGLTGRLFREFAVTLSAAILVSLVVSLTLTPMLCARLLRPLKRPEGASLARRSDRFFAAFMLRYRASLGWALEHSRLMVVIMLACIAMNLWLFVVVPKGFLPQQDSGRLRGYAVADQSISFQSLSAKMGEYRKILSSDPAVENVVGFIGGGRWQSSNTGSFFVTLKPIGERDPVEKVLTRLRERIAKVPGAALYLNAGQDVRLGGRDSNAQYEFTLRSDDLTLLREWAPKVEAAMRKLPQLVDVNSDSQDKGVQTRLVIDRDRAATLGINVEMVDAVLNDSFGQRQVSTIFNPLNQYRVVMEVDQQYQQSPEILRQVQVIGNDGQRVPLSAFSHYEPSRAPLEVNHQGQFAATTLSFNLAPGAQIGPTREAIMQALEPLHIPVDVQTSFEGNAGAVQDTQNQMPWLILLALLAVYIVLGILYESYVHPLTILSTLPSAGVGALLALILCRSELSLIALIGIILLIGIVKKNAIMMIDFALEAERNHGLSPREAILEACMMRFRPIMMTTLAALLGALPLIFGIGGDAALRRPLGITIVGGLIGSQLLTLYTTPVVYLYLDRLRHWVNQKRGVRTDGALETPL,8.11,gnl|BL_ORD_ID|2369|hsp_num:0,2720,TRUE,loose hit with at least 95 percent identity pushed strict
LK464,7_164 # 158036 # 158866 # 1 # ID=7_164;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.457,7_164,158036,158866,+,Strict,50,108.227,vanY gene in vanB cluster,32.63,3002956,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGTTAAAACCTATATTTGCAGCAACCGCTCTATCATCTTTCATTCTGATGGCTGGCTGTTCATCCGACCTGACCAGCGAGCATGAAAAAGAGCAAAAAGAAGAACAGCAGAGCTCCCAGGAGACTGAGAAAGAGACTGAGACCGACAAGAATAATGATTCAAAAGAATCGGCCCAGCGCCAGGTGGAGGTTGATGAAGCGGCTAAACCCGGACAGGCTGGCCTTCAGACGTTGGCCCATCCGGAAAGCATACCTGTACTTGTCAATAAACAATACAGCCTGCCTGAAGATTACAAACCTGCTGACCTTATCTACCCAAATGTGGATTTCATCTTTGAAGATAAAATCGAAAAAAGAATGATGCGAGAAGAAGCGGGAAAGGCTCTTGAATTAATGTTCCAAGCTGCCGAAAAAGACAATATGCACTTTGCCGGAGTTTCCGCTTATCGCTCTCACCAAAGACAGATCGAGGTCTTTAATAACTATGTGGCTAAGGACGGGGAAGAAAAAGCGAAAACCTACAGTGCAATGCCTGGGACAAGCGAGCATGAAACGGGACTCGCGATTGATGTCACGACTCACGATGGGGCATGTGCTGCCCAAGACTGCTTCGGTGATACTAAAGAAGCCGCCTGGCTTGCTGAACATGCACATGAATACGGATTTATCATCCGCTACCCTGAAGGCAAGGAAAACATCACAGGTTATAAATACGAACCATGGCATATCCGCTATGTTGGTGTCGATGCCGCAACTGAAATCTTTGAAGCGAAGATTACATTAGAAGAATACTATAATGCCGTACCAGTGGAAGCTGTATCGGATAATTAA,MLKPIFAATALSSFILMAGCSSDLTSEHEKEQKEEQQSSQETEKETETDKNNDSKESAQRQVEVDEAAKPGQAGLQTLAHPESIPVLVNKQYSLPEDYKPADLIYPNVDFIFEDKIEKRMMREEAGKALELMFQAAEKDNMHFAGVSAYRSHQRQIEVFNNYVAKDGEEKAKTYSAMPGTSEHETGLAIDVTTHDGACAAQDCFGDTKEAAWLAEHAHEYGFIIRYPEGKENITGYKYEPWHIRYVGVDAATEIFEAKITLEEYYNAVPVEAVSDN,MEKSNYHSNVNHHKRHMKQSGEKRAFLWAFIISFTVCTLFLGWRLVSVLEATQLPPIPATHTGSGTGVAENPEENTLATAKEQGDEQEWSLILVNRQNPIPAQYDVELEQLSNGERIDIRISPYLQDLFDAARADGVYPIVASGYRTTEKQQEIMDEKVAEYKAKGYTSAQAKAEAETWVAVPGTSEHQLGLAVDINADGIHSTGNEVYRWLDENSYRFGFIRRYPPDKTEITGVSNEPWHYRYVGIEAATKIYHQGLCLEEYLNTEK,102.99,gnl|BL_ORD_ID|602|hsp_num:0,556,FALSE,None
LK464,8_123 # 107643 # 109097 # 1 # ID=8_123;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.440,8_123,107643,109097,+,Strict,600,813.913,msr(G),81.29,3007042,protein homolog model,n/a,n/a,macrolide antibiotic; streptogramin antibiotic,antibiotic target protection,msr-type ABC-F protein,ATGGAACAAATATGTTTTGAATTAGAAAATGTCGAAGTGACTTATTTAGATAAAGAGATATTGAAGATTGATCGGTTGGCTGTACATCAATTTGACCGCATCGGCATCGTTGGGAAAAATGGTACAGGGAAAAGTACGTTATTGAAGTTGCTTGCTGGAGAAATTCAACCGACAAGCGGAAAAGTAAAGGGTTATGTTGATCGCGGCTATTTTGAGCAAGTTGAAGCGCCTGTTGTTGCAGAAGCTGATCCAGCGTTACTGGGAAAATTGGCAGTTCCGCGAAATTCAGGGTCGCTTAGCGGCGGTGAGCAAACGAGGCTGAAGCTTGCCCAATTGTTTACCCACTATAATGAAGCGTTGCTTATCGATGAGCCGACAACCCACTTGGATCAAGACGGCCTTTCGTTTTTACTTGATGAGTTACGCTATTACTATGGGGCGCTTGTCTTGATTAGTCATGACAGGGCTGTACTGGATGAACTCGTAACGACGATCTGGGAAGTGCATGAAGGCGAGGTACATGTATATTCAGGGAATTACAGCGAGTACATGGCACAGAAGCAGTTAAAACGTGAACAACAGACGCAGGCTCATGAACAATTCCTTAAAGAAAAGAGCCGGCTTGAAAAAGCGGCGCAGGAAAAAATGAAAAAGGCTGAAAAAATTGCTCAAGCTGGAAGATTGTCGAAAAAAGAGGCGAATGCAAAACCGAATAAAACGTTTATGACAAAATCGAAAGGCACAAGCCAAAAAGCCGCACAACGCGCAGCGAAGGCAATTGAGCAGCGAGCGGAAAAACTTCAGGAAGTGGAAGCTGTACAAGAGGAAAGGCAAATCGTATTTCGCCAGTCAAAGCAATTGGAATTGCATAATAAGTTCCCGATAATGGCGGACCGGCTGACTCTTCAAGTGGCGGGGAACGTATTATTGGATGAAGTGAGTTTCCAGCTGCCGCACGGTAAAAAAATAGCGATCACTGGCAGCAACGGCAGCGGTAAAAGTACTTTGCTGCACCATATTGCGAAAAATGGTGCCGGTTTAACGGTTTCTCCTAAAGCAAAAATGGGTTACTTCCGTCAAATGAGCTATAGATTTGCTGAAGATGAAACGGTACTTCAATTCCTGGGGAACCGCTCAGAATATGATGAAGGATTTTTAAGAAGTGTCCTGCATTCGATGCAGTTTACCGGGACGGATATACTGAAAAGCGTTCAGTCCTTAAGTGGCGGAGAAGCGATTCGCCTCCAGCTTTGTCAGTTGTTCTTAGGGGAATACAACATTCTGCTATTGGATGAACCGACTAATTTTCTGGATATTACTGCCATTGAAGCGTTGGAACGATTCATGGCTGGATATGAAGGCACGATCATATTTGTATCCCATGATTCAGCGTTCATAAAGCAGGTTGCCGATATTCAGTATCAACTTGAGGAGAAAAAATTGGTTCAAGTGTGA,MEQICFELENVEVTYLDKEILKIDRLAVHQFDRIGIVGKNGTGKSTLLKLLAGEIQPTSGKVKGYVDRGYFEQVEAPVVAEADPALLGKLAVPRNSGSLSGGEQTRLKLAQLFTHYNEALLIDEPTTHLDQDGLSFLLDELRYYYGALVLISHDRAVLDELVTTIWEVHEGEVHVYSGNYSEYMAQKQLKREQQTQAHEQFLKEKSRLEKAAQEKMKKAEKIAQAGRLSKKEANAKPNKTFMTKSKGTSQKAAQRAAKAIEQRAEKLQEVEAVQEERQIVFRQSKQLELHNKFPIMADRLTLQVAGNVLLDEVSFQLPHGKKIAITGSNGSGKSTLLHHIAKNGAGLTVSPKAKMGYFRQMSYRFAEDETVLQFLGNRSEYDEGFLRSVLHSMQFTGTDILKSVQSLSGGEAIRLQLCQLFLGEYNILLLDEPTNFLDITAIEALERFMAGYEGTIIFVSHDSAFIKQVADIQYQLEEKKLVQV,MEQICFELENVEVTYLDKEVLKIERLAVHQFDRIGIVGKNGAGKSTLLKLLAGIIKPTTGKVNRLVENGYFEQLETPSVRDADPVLLGKLDVPKDSNQLSGGEQTRMKLAKLFTHYYEALLIDEPTTHLDQEGISFLLDELRYYYGALVLISHDRSVLDELVTTIWEVHEGKVRIYSGNYSDYMAQKKLEREQQSQAHEQFIKEKSRLEKAAQEKMKKAEKVAQAGRLSKKDANAKPDKSFMTKSKGTSQKAMQRAAKAIEQRMEKLQEVDAVKEDRQINFHQSRNLELHNKFPIMADRFTLQVDNKVLLNEVSFQMPLGKKIAISGKNGAGKSTLLHHIAINAPGLTISPKAKIGYFRQMSYQYTRDETVLEFLKNRSEYDERFLRSVLHSMLFVGTDILKSVKSLSGGEAIRLQLCQLFLGEYNILLLDEPTNFLDIYAIEALERFITAYKGTIIFVSHDRRFIDCVADCIYFIEDQQLKLRG,99.79,gnl|BL_ORD_ID|4751|hsp_num:0,5743,FALSE,None
LK464,9_117 # 113299 # 113628 # 1 # ID=9_117;partial=00;start_type=TTG;rbs_motif=AGGAGG;rbs_spacer=5-10bp;gc_cont=0.388,9_117,113299,113628,+,Strict,75,86.6557,qacJ,45.12,3007014,protein homolog model,n/a,n/a,disinfecting agents and antiseptics,antibiotic efflux,small multidrug resistance (SMR) antibiotic efflux pump,TTGAATCCTTATGCATTTTTGGCAATTGCCATCCTAAGTGAAGTGTTTGGCAGTTCGATGTTAAAAGTATCAAACGGGTTTAAAAGGTTATTCCCTTCCATTGGTGTGGTTATTGGGATGGGTTTGGCTTTTTATTGCCTATCGTTATCTCTAATAACCATCCCTCTTGGAACGGCTTATGCCATTTGGTCGGGAATAGGCACAGCTTTAACTGCTTTAGTGGGGGTTATCGTTTATAAAGAAAGCTTTAACCTAACAAAATTTTTAGGTTTAGTCCTGATCATTGGCGGAGTGATTGTATTGAAACTCTCTAGTGAAGGCACTTCTTAA,MNPYAFLAIAILSEVFGSSMLKVSNGFKRLFPSIGVVIGMGLAFYCLSLSLITIPLGTAYAIWSGIGTALTALVGVIVYKESFNLTKFLGLVLIIGGVIVLKLSSEGTS,MPYLYLVIAIITEIIGTSFLKTAEGFTKLWPTLGTLISFGICFYFLSVTMKYLPLNVSYATWAGLGLVLTTIVSVVIFKESVNLISIFSIILIIIGVVLLNVFGSSH,101.87,gnl|BL_ORD_ID|4662|hsp_num:0,5730,FALSE,None
LK464,9_118 # 113654 # 114001 # 1 # ID=9_118;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.374,9_118,113654,114001,+,Strict,75,80.8777,qacJ,48.72,3007014,protein homolog model,n/a,n/a,disinfecting agents and antiseptics,antibiotic efflux,small multidrug resistance (SMR) antibiotic efflux pump,ATGAAAGGATACATAGCTTTAGGAATTTCAATCATAAGCGAAGTATTTGGTACGACCATGCTTAAGCTGTCTGAAGGCTTCACACATTTATTCGCTACATTTGGGGTTATGATAGGATTTGGTATAGCATTTTATAGTTTATCTGTATGTCTTAAAACAATTCCGTTAAGCTTAGCATACGCCATTTGGTCAGGAATAGGCACAGCTTTAACAGCATTGATTGGTGTGCTTTTATGGAATGAGCCATTTAGTATCACTACATTAGGCGGCTTAGTATTAATAATTGGCGGAGTGGTTTTACTAAATGCTTCCCATACCTCCAAACAAGCGGAAGGAGAATCAAACTAA,MKGYIALGISIISEVFGTTMLKLSEGFTHLFATFGVMIGFGIAFYSLSVCLKTIPLSLAYAIWSGIGTALTALIGVLLWNEPFSITTLGGLVLIIGGVVLLNASHTSKQAEGESN,MPYLYLVIAIITEIIGTSFLKTAEGFTKLWPTLGTLISFGICFYFLSVTMKYLPLNVSYATWAGLGLVLTTIVSVVIFKESVNLISIFSIILIIIGVVLLNVFGSSH,107.48,gnl|BL_ORD_ID|4662|hsp_num:0,5730,FALSE,None
LK464,49_16 # 15473 # 15979 # 1 # ID=49_16;partial=00;start_type=TTG;rbs_motif=TACAA;rbs_spacer=13bp;gc_cont=0.406,49_16,15473,15979,+,Strict,50,119.398,vanW gene in vanI cluster,44.06,3003724,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanW; glycopeptide resistance gene cluster,TTGCTTGCTATTCATCCAAAGGTTGACAGCGAAATACTTGCGGAAATTCGTGAAAAAAAGATAGGTGAATATAGAACCTATTTTAATGTCAACAATAAAAATCGTTCAAATAATATCTCACTTGCCGCAGAAGCCATTAATAATTATGTCGTGTTTCCAGGAGAGGTCTTTTCTTTTAACCAAGCTGTTGGCAAGAGATCTGTAGAAAAAGGATATATGCTCGCTCGGGTTATCGTTAAAGGAGAGTTTTCTGAAGGGATTGGCGGAGGGATTTGCCAGGTTTCATCCACCTTGTTTAATGCTATCGACAATGCAGGGTTGCAAACGGTTCAACGCTATTCCCATACAAGGAGCGTTCCGTATGTTCCATCTGGCCGCGATGCTACAGTAAGCTGGTATGGGCCTGATTTTAGTTTTAAAAACAAGTATAATCAACCGGATCCTGATCCGTGCTACGATCCAAGGAGGAATGGTGAGTATCATGGTTTACTCTTCAGATATGATTAA,MLAIHPKVDSEILAEIREKKIGEYRTYFNVNNKNRSNNISLAAEAINNYVVFPGEVFSFNQAVGKRSVEKGYMLARVIVKGEFSEGIGGGICQVSSTLFNAIDNAGLQTVQRYSHTRSVPYVPSGRDATVSWYGPDFSFKNKYNQPDPDPCYDPRRNGEYHGLLFRYD,MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVLAEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPELLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGMETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGGEFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSHSLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDEPDGYPVKPREWSK,45.04,gnl|BL_ORD_ID|4748|hsp_num:0,2242,FALSE,None
LK464,64_3 # 2615 # 3562 # 1 # ID=64_3;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.409,64_3,2615,3562,+,Strict,350,399.823,BcIII,62.7,3007101,protein homolog model,n/a,n/a,cephalosporin; penem,antibiotic inactivation,class A Bacillus cereus Bc beta-lactamase,ATGAACAAAAGATGGTTTTATCAAATACTGGCACCAATAGGCTTGGTGCTTATGGTTGCTGGCTGCTCAGATGAGGAAAAACAGGTTGTACAACAATCGGAAACAGAACAAACCGGGGGAACTAACCAAACATCGGAAAATATTACGGCAAAAGAAGCCACAATCAAGAAATTTGAACAACTTGAGAAGGAATATGATGCAAAGCTTGGGGTCTATGCCATTGATACAGGAACGAAAGAAACCGTGGAATTTCATGAGAACGAACGATTTGCGTTTACATCTACTCATAAGGCTCTGGCTGTAGGAGCACTTTTACAACAGAAATCAATAGAAGAACTTAATCAAAGAATTACCTATACAAGTGAGGATCTTGTTAATTATAATCCGATTACCGAAAAGCATGTTGATACGGGGATGACTCTTAAGGAGCTTTCTGATGCTTCGCTTCGATACAGTGACAATACTGCTGGAAACCTTATCCTTGAACAGCTGGGGGGACCGGCTGGATTTAAAAAAGTACTGGAGGGAATTGGAGATAATGTTACCAACCCTGAGCGAATTGAGCCAGATTTAAATGTAGTTAATCCTAGTGAAACGCATGATACGAGTACACCAATAGCACTTGCTACTAGTCTTCAGGCTTTTACATTGGGAGATGCACTTCCAACTGAGAAACGTGAACTTTTAATAGATTGGATGAAGAGAAATACTACTGGAGATGCGTTAATTCGTGCTGGAGTGCCGAAAGGTTGGGTAGTGGCTGATAAGACTGGAGCAGGATCATATGGTACGCGAAATGACATTGCGATCATTTGGCCATCAAAAGGAGATCCTATTGTTCTTGCTGTACTTTCAAGTCGTGATGAAAAAGAGGCTGATTATAACGACGAGCTTATTGCTGAGGCGACAGAAGAAGTAATTAAGGCCCTTAAAGTCAAAGGTAAATAG,MNKRWFYQILAPIGLVLMVAGCSDEEKQVVQQSETEQTGGTNQTSENITAKEATIKKFEQLEKEYDAKLGVYAIDTGTKETVEFHENERFAFTSTHKALAVGALLQQKSIEELNQRITYTSEDLVNYNPITEKHVDTGMTLKELSDASLRYSDNTAGNLILEQLGGPAGFKKVLEGIGDNVTNPERIEPDLNVVNPSETHDTSTPIALATSLQAFTLGDALPTEKRELLIDWMKRNTTGDALIRAGVPKGWVVADKTGAGSYGTRNDIAIIWPSKGDPIVLAVLSSRDEKEADYNDELIAEATEEVIKALKVKGK,MFVLNKFFTNSHYKKIVPVVLLSCATLIGCSNSNTQSESTKQTNQTNQVKQENIGNHAFAKLEKEYNAKLGIYALDTSTNQTVAYHADDRFAFASTSKSLAVGALLRQNSIEALDERITYTREDLSNYNPITEMHVDTGMTLKELADASVRYSDSTAHNLILKKLGGPSAFEKILRKMGDTVTNSERFEPELNEVNPGETHDTSTPKAIAKTLQSFTLGTVLPSEKRELLVDWMKRNTTGNKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLSILSNHDKEDAEYDDTLIADATKIVLETLKVTNK,99.68,gnl|BL_ORD_ID|4782|hsp_num:0,5775,FALSE,None
LK464,67_14 # 9227 # 10414 # -1 # ID=67_14;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.437,67_14,9227,10414,-,Strict,175,212.616,vanT gene in vanG cluster,35.5,3002972,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,glycopeptide resistance gene cluster; vanT,ATGGTGAGTGCAGGAAAGAAGGAAAAGGTCTTGGAAACGAAAATATTTCATCGAGATACGTGGGCAGAAGTAAATTTGGATAATATTTTTGAAAATATCTCTTCAATGAAAAAAAGTCTGAGAAAGGGCGTTAGTCTTTTCGCTGTCGTTAAAGCCAATGCTTATGGCCACGGGGACTATGAAGTGGCTAAAACGGCGCTTGATGCGGGGGCGGATTTTTTAAGTGTAGCTTTTTTGGATGAGGCTCTTGCCTTACGGAAAAAAGGTATATTGGCTCCGATTCTTGTCCTTGGGGCTTCTAGGCCTGAAAGTGCAGCGCTTGCTGCCGAGCATGGGATTTCCGTGACGGTTTTCGATGAAGCATGGTTGGAGAAGGCAAAGGATTTGTTGAAACCGGGACAAGTTTTGCAAATCCATGTAAAAGTGGATAGCGGCATGGGGAGAATCGGCATTCGAGATAAAGGTAAACTCATGAAAGTGGAAAGTTTGCTTAAGAGGGAAGCTTGTTTCAATTTCCAAGGGATATTCACTCATTTCGCGACTGCGGATGAAATGAAGACGGACTTATATGAAAAGCAGCTTGCTTTCTTTAAAGGGATGCTTTCCGAATTGACGGGAAAGCCGGAATATGTTCATGCAGCCAATAGTGCAGCTTCTTTAAGGTTCACCGATTTAGAATGGAATGCAATAAGAATGGGGATTTCCATGTATGGTTTGAGTCCTTCCATGGAAATGAAGCCGATATTGCCATTTCCATTAAAACAGGCTATATCATTGAGAACGGAGATGGTCGCGGTTAAACAGCTTGCTAAGGGTGAAAGCGTTAGTTATGGAGCGACTTATACATCTGAAGGTGATGAATGGATTGGAACTTTGCCAATCGGGTATGCTGACGGTTGGATCCGTAAGCTGCAAGGTCAGGAAGTTCTTGTGGATGGAAAAAGAGTGCCCATAGTCGGAAGGATTTGCATGGATCAATGCATGATCAAGCTTCCTGGACCATACCCTGTAGGAACAGTGGTCACATTAATCGGGAATGATGGGGATGAATCGATCACTGTCGATGAGATAGCGGCAAAACTGGAAACGATCAACTATGAGGTGACATGCATGATAGGAGCAAGAGTGCCCCGCATATATATGAAAGACAATCAGATGAATCATGCACGCAACTTCATTTTGGAATGA,MVSAGKKEKVLETKIFHRDTWAEVNLDNIFENISSMKKSLRKGVSLFAVVKANAYGHGDYEVAKTALDAGADFLSVAFLDEALALRKKGILAPILVLGASRPESAALAAEHGISVTVFDEAWLEKAKDLLKPGQVLQIHVKVDSGMGRIGIRDKGKLMKVESLLKREACFNFQGIFTHFATADEMKTDLYEKQLAFFKGMLSELTGKPEYVHAANSAASLRFTDLEWNAIRMGISMYGLSPSMEMKPILPFPLKQAISLRTEMVAVKQLAKGESVSYGATYTSEGDEWIGTLPIGYADGWIRKLQGQEVLVDGKRVPIVGRICMDQCMIKLPGPYPVGTVVTLIGNDGDESITVDEIAAKLETINYEVTCMIGARVPRIYMKDNQMNHARNFILE,MTKNESYSGIDYFRFIAALLIVAIHTSPLSSFSETGNFIFTRIVARVAVPFFFMTSGFFLISRYTCNAEKLGAFIKKTTLIYGVAILLYIPINVYNGYFKMDNLLPNIIKDIVFDGTLYHLWYLPASIIGAAIAWYLVKKVHYRKAFLIASILYIIGLFGDSYYGIVKSVSCLNVFYNLIFQLTDYTRNGIFFAPIFFVLGGYISDSQNRLSLKRSIVGFIVCFALMFGEALTLHHFDIQKHDSMYVLLLPSVYCLFNLLLHFRGKRRTGLRTISLIIYIIHPFMIVVIRLFAKLLHLQSLLVENSLVHYIAVCFASVVLAVVITALLSSLKPKKAKHTADTDRAYLEINLNNLEHNVNTLQKAMSPKCELMAVVKAEAYGHGMYEVTTYLEQIGVSSFAVATIDEGIRLRKYGISSEILILGYTSPSRAKELCKYELTQTLIDYRYSLLLNKQGYDIKAHIKIDTGMHRLGFSTEDKDKILAAFSLKHIKVAGIFTHLCAADSLEENDVAFTNKQIGSFYKVLDWLKSSGLNIPKVHIQSSYGLLNYPELECDYIRVGVALYGVLSSTNDKTKLELDLRPVLSLKAKVVLIRKIKQGESVGYSRAFTATRDSLIAILPIGYADGFPRNLSCGNSYVLIGGRQAPIVGKICMDQLAVDVTDIPNVKTGSIATLIGKDGKEEITAPMVAESAESITNELLSRMGHRLNIIRRA,55.48,gnl|BL_ORD_ID|1522|hsp_num:0,1561,FALSE,None
LK464,80_4 # 2709 # 3131 # -1 # ID=80_4;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.343,80_4,2709,3131,-,Strict,150,186.808,FosBx1,61.31,3007372,protein homolog model,n/a,n/a,phosphonic acid antibiotic,antibiotic inactivation,fosfomycin thiol transferase,GTGTCTATAAAAGGTTTGAATCACTTTTTATTTTCAGTTTCTGATTTAGACAGTTCCATAGAATTTTATCAAAAGGTTTTTGATGCGAAATTATTAGTTAAGGGCAGAACCACAGCCTATTTTGATTTGAATGGAATGTGGATTGCCCTGAATGAAGAAAAAGATATTCCCCGTAATGAAATAAGCCAATCATACACACATATCGCCTTTTCCATAGAAGAAGCCGACTTCATGAACATGTATGAGAAACTGATCGGATTGAATGTAAACATCCTGTCAGGACGTCCAAGAGATGAAAAGGATAAGAAGTCCATTTATTTCACTGATCCAGATGGTCATAAGTTTGAGTTTCATACAGGGACTTTACAAAATAGAATAGATTACTACAAACAAGAAAAAGCACATATGGAGTTTTTCGACTGA,MSIKGLNHFLFSVSDLDSSIEFYQKVFDAKLLVKGRTTAYFDLNGMWIALNEEKDIPRNEISQSYTHIAFSIEEADFMNMYEKLIGLNVNILSGRPRDEKDKKSIYFTDPDGHKFEFHTGTLQNRIDYYKQEKAHMEFFD,MLRGINHICFSVSNLENSIMFYEKVLEGELLVKGRKLAYFNICGVWIALNEETHIPRNEIHQSYTHIAFSVEKEDFKCLIQRLEENDVHILQGRERDVRDCESIYFVDPDGHKFEFHSGTLQDRLNYYRDEKPHMTFY,101.45,gnl|BL_ORD_ID|4909|hsp_num:0,5900,FALSE,None
LK464,91_3 # 1202 # 1675 # 1 # ID=91_3;partial=00;start_type=ATG;rbs_motif=AAAAA;rbs_spacer=8bp;gc_cont=0.352,91_3,1202,1675,+,Strict,400,315.849,vanR gene in vanF cluster,96.82,3002925,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,glycopeptide resistance gene cluster; vanR,ATGCCGATTATTTTTTTGAGCGCTAAAACGTCTGATTTTGATAAAGTGCAGGGACTCGTGATTGGAGCAGACGATTATATGACGAAACCATTTATACCCATTGAATTGGTAGCTCGGGTAAATGCACAGCTGCGGCGCTTTATGAAATTGAATCAACCTAAATACAAACAGAATTCAAACTTGGAATTTGGAGGATTAACGATTTCTCCTGAACAACGTACAGTTACTCTATATGGTAAGAATATTGAGTTAACACCGAAAGAGTTTAAAATTTTATATTTATTAGCCAGTAATCCAAATAAAGTCTATAATGCAGAAGATATTTTTCAGAAGGTATGGGGGGATGCATACTATGAAGGTGGGAATACCGTTATGGTTCATATTCGTACTTTGCGGAAAAAACTTGAAGAGGATAAACGAAAAAACAAATTGATAAAAACTGTATGGGGGGTAGGTTATAAATTCAATGGGTAA,MPIIFLSAKTSDFDKVQGLVIGADDYMTKPFIPIELVARVNAQLRRFMKLNQPKYKQNSNLEFGGLTISPEQRTVTLYGKNIELTPKEFKILYLLASNPNKVYNAEDIFQKVWGDAYYEGGNTVMVHIRTLRKKLEEDKRKNKLIKTVWGVGYKFNG,MKNITILIADDDAEIADLVAIHLEKEGYRVIKVSDGQETIDVIQNQPIDLLILDIMMPKMDGFEVTRRIREKHNMPIIFLSAKTSDFDKVQGLVIGADDYMTKPFIPIELVARVNAQLRRFMKLNQPKTKQNSNLEFGGLTISPEQRTVTLYGKNIELTPKEFEILFLLASNPNKVYRAEDIFQKVWGDAYYEGGNTVMVHIRTLRKKLEEDKRKNKLIQTVWGVGYKFNG,67.97,gnl|BL_ORD_ID|298|hsp_num:0,240,TRUE,loose hit with at least 95 percent identity pushed strict
LK464,91_5 # 2875 # 3738 # 1 # ID=91_5;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.351,91_5,2875,3738,+,Strict,50,461.84,vanY gene in vanF cluster,81.23,3002958,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGAAAAAGTGGGGATTTTTATTGGTTTTTGCATTATTTCTAGTTTTTATTTTTAAGATATTACCGATATCCCAAGATAAAGTAGAGGATCAACTTTATGAACAAAATGACAATACAGCTATTGAAAATTCTCAAAAGATTGAGATTACAGAAGAGCAGATCCATCAAGGGAATCTGCTTTTGGTTAACAGTGAATATGCTGTTCAACAAGCTGGCATAAAATCGGATATCATAAATTTATTTACACACAAAGAATTAAATACCGGATACCAGTTGCTTAATAATGAAATAAAATTATCAGAGGAAATAGCTGAAAAGTTTTCGGAGATGATAGCTGCGGCTGAAGAGGATGGGGTTAGTAATTTCTTAATTAACAGTGGTTATCGAGACTTTGATGAGCAAAACAAACTGTACAAGGAGATGGGCGCTGACTATGCTTTGCCAGCCGGGCATAGCGAACACAATTTAGGATTAGCACTCGATGTAGGGTCTACTCAAATGAAGATGAAAGAAGCACCTGAAGGAGAGTGGATAGAAGAAAATGCTTGGAAAAACGGCTTTATCTTACGCTATCCCGCGAATAAAACGGATATTACAGGAATTCAATATGAACCATGGCATATTCGCTATGTCGGCTTGCCTCACAGTGCGATCATGCAGGGAATGAATTTAGCTTTAGAAGAATATTTGGATTATTTAAAAGAAGAAAAGAGCATTTCTATTAGTGTTGAAGGGAAAAAATATACAATTTCATATTATCCCATTTCTCAAAACATGACAATTGAAGTTGAAGTACCAGCGAATGAACAGTATGAAATATCTGGTAATAATATTGATGGAGTGATTGTGACCACATTGAATTAG,MKKWGFLLVFALFLVFIFKILPISQDKVEDQLYEQNDNTAIENSQKIEITEEQIHQGNLLLVNSEYAVQQAGIKSDIINLFTHKELNTGYQLLNNEIKLSEEIAEKFSEMIAAAEEDGVSNFLINSGYRDFDEQNKLYKEMGADYALPAGHSEHNLGLALDVGSTQMKMKEAPEGEWIEENAWKNGFILRYPANKTDITGIQYEPWHIRYVGLPHSAIMQGMNLALEEYLDYLKEEKSISISVEGKKYTISYYPISQNMTIEVEVPANEQYEISGNNIDGVIVTTLN,MKKWGLLLVFALFLVFIFNILPISQDKVEDRIYEQNDKDTSDDKMTAENMQKIELTEEQIYQGNLLLVNNEHPVHQKSIKSDIINLFTHKELTKGYGLLDNEIKLSEEIAGKFSEMIAAAEEDGVSNFLISSGYRDLDEQSRLYEEMGSDFALPAGHSEHNLGLSLDVGSTQMKMDKAPEGKWIEKNCWEYGFILRYPLDKTDVTGIQYEPWHIRYVGLPHSAIMQEMNLALEEYLDYLKEEKSISVRVDGKKYTISYDPISQNETIEVEVPADEQYEISGNNIDGVIVTTFS,97.95,gnl|BL_ORD_ID|1808|hsp_num:0,1899,FALSE,None
LK1012,13_5 # 3145 # 3894 # -1 # ID=13_5;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.779,13_5,3145,3894,-,Strict,50,83.9593,vanY gene in vanM cluster,34.46,3002961,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGTCGCACCCTCCCTCTCGCCGCGCTGGCCGCGCTCGCGCTGCTCGTGGCCGGTTGCGGCACGCCCGCCGCGGGCCCGTCCTCGACGCCGACGACGCCGACGTCCGGCTCCGCGAGCGCGGCCGCGTCGTCCGGCGCCGCCTCGAGCACGGCGCCGTCGTCGGGCACGCACGCCGACCCGGCCGCCCTCGACGTCGTCGTGAACAAGACCCGCCCCGTGGCCCCGCCCGACTGGGCGCCCTCGGATCTGGTGGCCGTGCCCGGCAGCGAGCTGTCCCTGCGGGCGGCGGCCGCGACGGCGGCCGGTGACCTGCTGGATGCCGCCGCGGCGGCGGGCCACCGCCTCACCACCCTGAGCGCCTACCGCTCGTACGACTACCAGGTCCGGACGTACGGCCACTGGGTCGACGAGCTGGGCCGCGCCGAGGCCGACCGCGTCTCGGCGCGTCCGGGGTACTCCGAGCACCAGACCGGCCTGGCCTGGGACGTGGGCGACGCCGCGACCCCCGCGTGTGACCTGGAAGCGTGCTTCGGCGACACCGCCGCGGGCCGCTGGGTGGCCGCGCACGCCGCCGAGTACGGGTTCGTCATCCGCTATCCCGTCGGGGCCGAGGACGTGACGGGCTTCGCCCACGAGCCCTGGCACCTGCGCTACGTCGGGTCCGCGGAGGCGGCCCGGGTCGAGGCGGCCGGCGGCGTCCTCGAGACCGCGTGGGGTCTGCCTCCGGCACCCGACTACGCGGACTGA,MRRTLPLAALAALALLVAGCGTPAAGPSSTPTTPTSGSASAAASSGAASSTAPSSGTHADPAALDVVVNKTRPVAPPDWAPSDLVAVPGSELSLRAAAATAAGDLLDAAAAAGHRLTTLSAYRSYDYQVRTYGHWVDELGRAEADRVSARPGYSEHQTGLAWDVGDAATPACDLEACFGDTAAGRWVAAHAAEYGFVIRYPVGAEDVTGFAHEPWHLRYVGSAEAARVEAAGGVLETAWGLPPAPDYAD,MVFQGNLLLVNNEYPVLEESIKTDVVNLFKHDELTKGYELLNREIYLSEKVAREFSEMVDAAEKEGVRHFSINSGFRNFDEQNALYQEMGSDYALPAGYSEHNLGLALDIGSTQMEMSEAPEGKWLEDNAWEYGFILRYPMDKTAITGIQYEPWHFRYVGLPHSAIIEEKNFALEEYLDFLKEQKSISGTIHGENYEISYYPITEKTDIEMPANLHYEISGNNMDGVIVTVYR,106.87,gnl|BL_ORD_ID|1673|hsp_num:0,1713,FALSE,None
LK591,1_136 # 157208 # 157588 # -1 # ID=1_136;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.465,1_136,157208,157588,-,Strict,230,247.284,marA,94.35,3000263,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; penem; disinfecting agents and antiseptics,antibiotic efflux; reduced permeability to antibiotic,resistance-nodulation-cell division (RND) antibiotic efflux pump; General Bacterial Porin with reduced permeability to beta-lactams,ATGTCCAGACGCAATACTGACGCTATCACCATTCATAGCATTTTGGACTGGATCGAAGATAACCTGGAATCTCCACTCTCTCTTGAGAAAGTGTCTGAGCGTTCAGGTTACTCAAAATGGCACCTGCAACGGATGTTTAAAAAAGAGACCGGCCATTCATTAGGACAATATATTCGCAGCCGCAAGCTGACGGAGATTGCCCAAAAACTGAAAGAAAGCAATGAGCCGATCCTCTATCTGGCGGAACGCTACGGATTTGAATCGCAACAGACCCTGACGCGTACGTTCAAGAACTACTTTGACGTGCCGCCTCATAAGTACCGTATTACCAGTATGCCGGGTGAATCCCGTTATCTGTATCCGCTAAAACATTGCAGTTAA,MSRRNTDAITIHSILDWIEDNLESPLSLEKVSERSGYSKWHLQRMFKKETGHSLGQYIRSRKLTEIAQKLKESNEPILYLAERYGFESQQTLTRTFKNYFDVPPHKYRITSMPGESRYLYPLKHCS,MSRRNTDAITIHSILDWIEDNLESPLSLEKVSERSGYSKWHLQRMFKKETGHSLGQYIRSRKMTEIAQKLKESNEPILYLAERYGFESQQTLTRTFKNYFDVPPHKYRMTNMQGESRFLHPLNHYNS,99.21,gnl|BL_ORD_ID|1772|hsp_num:0,1922,FALSE,None
LK591,2_452 # 431523 # 433271 # -1 # ID=2_452;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.544,2_452,431523,433271,-,Strict,1000,1138.64,msbA,94.67,3003950,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic efflux,ATP-binding cassette (ABC) antibiotic efflux pump,ATGCATAACGACAAAGATCTCTCCACGTGGCAAACGTTCCGCCGGCTCTGGCCGATGATTGCTCCTTTCAAAACAGGCTTGATCGTGGCGGGCGTAGCGTTAATCCTCAACGCAGCCAGCGATACGTTTATGTTATCGCTTCTCAAACCGTTACTGGATGACGGTTTCGGTAAAACGGATCGTTCAGTGCTGCTATGGATGCCGCTGGTGGTTATTGGGCTGATGATCTTACGCGGAATCTCCAGCTATGTATCCAGCTACTGCATCTCCTGGGTATCCGGTAAAGTGGTGATGACCATGCGCCGCCGGCTGTTCAGCCATATGATGGGGATGCCGGTCTCGTTCTTTGACAAACAGTCAACCGGCACCCTGCTGTCGCGTATTACCTACGATTCAGAGCAGGTGGCGTCGTCCTCTTCCAGCGCACTGATTACCGTTGTGCGTGAAGGCGCATCCATCATCGGCCTGTTCGCGATGATGTTCTATTACAGCTGGCAACTGTCGCTGATCCTTATTGTGCTGGCGCCGATTGTCTCCATCGCGATCCGCGTGGTATCAAAGCGTTTTCGCAACATCAGTAAAAATATGCAGAATACGATGGGGCAGGTGACGACCAGCGCCGAGCAGATGCTGAAAGGCCATAAGGAAGTGTTGATTTTCGGCGGTCAGGAAGTCGAAACCAAACGCTTTGACAAGGTCAGCAACAGAATGCGCCTGCAAGGAATGAAAATGGTATCGGCCTCGTCGATTTCCGATCCGATCATTCAGCTGATTGCCTCTCTGGCCCTGGCCTTCGTCCTGTATGCCGCCAGTTTCCCGAGCGTCATGGAAACCCTGACTGCGGGTACCATTACGGTGGTGTTCTCATCCATGATTGCGCTGATGCGTCCGCTGAAATCGCTGACTAACGTCAACGCCCAGTTCCAGCGCGGGATGGCAGCCTGTCAGACGCTGTTCAGCATCCTCGATTCCGAACAGGAAAAAGATGAAGGTACACGCGTGATCGAGCGCGCTAAAGGCGACCTGGAATTCCGTAACGTCACCTTTACCTATCCAGGCCGTGAAGTGCCGGCGCTGCGTGATATCAGCCTGTCCATCCCGGCGGGTAAAACCGTTGCGCTGGTCGGTCGTTCCGGTTCGGGCAAGTCGACCATTGCCAGCCTGATTACCCGTTTCTACGATATCGACCAGGGCGAGATCCTGCTTGATGGTCACGACCTGCGGGAATATACCCTCCAGTCGCTGCGTAACCAGGTCGCGCTGGTCTCGCAGAACGTGCATCTGTTCAACGATACGGTGGCGAACAACATTGCGTATGCCCGTACCGAAGAGTACAGCCGTGAAGAGATTGAGAATGCGGCGCGTATGGCCTATGCGATGGACTTCATTAACAAAATGGATAACGGTCTGGATACGATCATTGGCGAAAACGGGGTGCTGCTCTCCGGTGGTCAGCGTCAGCGTATCGCGATTGCCCGTGCGCTGCTGCGCAACAGCCCGATTCTGATCCTCGATGAAGCAACGTCCGCACTGGATACGGAATCTGAACGCGCTATCCAGTCGGCTCTGGATGAATTACAGAAAAACCGTACCTCGCTGGTTATTGCGCACCGTCTGTCGACCATCGAACAGGCTGACGAAATCGTGGTGGTGGAAGATGGCGTGATCGTTGAACGCGGCAGCCATGCGGACCTGCTGGAACAGCGTGGTGTTTACGCGCAGCTTCATAAAATGCAGTTCGGTCAATGA,MHNDKDLSTWQTFRRLWPMIAPFKTGLIVAGVALILNAASDTFMLSLLKPLLDDGFGKTDRSVLLWMPLVVIGLMILRGISSYVSSYCISWVSGKVVMTMRRRLFSHMMGMPVSFFDKQSTGTLLSRITYDSEQVASSSSSALITVVREGASIIGLFAMMFYYSWQLSLILIVLAPIVSIAIRVVSKRFRNISKNMQNTMGQVTTSAEQMLKGHKEVLIFGGQEVETKRFDKVSNRMRLQGMKMVSASSISDPIIQLIASLALAFVLYAASFPSVMETLTAGTITVVFSSMIALMRPLKSLTNVNAQFQRGMAACQTLFSILDSEQEKDEGTRVIERAKGDLEFRNVTFTYPGREVPALRDISLSIPAGKTVALVGRSGSGKSTIASLITRFYDIDQGEILLDGHDLREYTLQSLRNQVALVSQNVHLFNDTVANNIAYARTEEYSREEIENAARMAYAMDFINKMDNGLDTIIGENGVLLSGGQRQRIAIARALLRNSPILILDEATSALDTESERAIQSALDELQKNRTSLVIAHRLSTIEQADEIVVVEDGVIVERGSHADLLEQRGVYAQLHKMQFGQ,MHNDKDLSTWQTFRRLWPTIAPFKAGLIVAGVALILNAASDTFMLSLLKPLLDDGFGKTDRSVLVWMPLVVIGLMILRGITSYVSSYCISWVSGKVVMTMRRRLFGHMMGMPVSFFDKQSTGTLLSRITYDSEQVASSSSGALITVVREGASIIGLFIMMFYYSWQLSIILIVLAPIVSIAIRVVSKRFRNISKNMQNTMGQVTTSAEQMLKGHKEVLIFGGQEVETKRFDKVSNRMRLQGMKMVSASSISDPIIQLIASLALAFVLYAASFPSVMDSLTAGTITVVFSSMIALMRPLKSLTNVNAQFQRGMAACQTLFTILDSEQEKDEGKRVIERATGDVEFRNVTFTYPGRDVPALRNINLKIPAGKTVALVGRSGSGKSTIASLITRFYDIDEGEILMDGHDLREYTLASLRNQVALVSQNVHLFNDTVANNIAYARTEQYSREQIEEAARMAYAMDFINKMDNGLDTVIGENGVLLSGGQRQRIAIARALLRDSPILILDEATSALDTESERAIQAALDELQKNRTSLVIAHRLSTIEKADEIVVVEDGVIVERGTHNDLLEHRGVYAQLHKMQFGQ,100,gnl|BL_ORD_ID|2187|hsp_num:0,2423,FALSE,None
LK591,3_185 # 209821 # 212934 # 1 # ID=3_185;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.584,3_185,209821,212934,+,Strict,1900,1986.07,acrD,92.09,3000491,protein homolog model,n/a,n/a,aminoglycoside antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGGCGAATTTTTTCATCGATCGCCCCATTTTTGCCTGGGTGCTTGCAATCCTGTTGTGTCTGACGGGTGTCCTGGCGATTACGTCCCTTCCTGTTGAGCAATACCCTGACCTCGCGCCCCCCAACGTGCGTATCACGGCGAACTACCCTGGCGCCTCGGCACAGACGCTGGAAAATACCGTCACCCAGGTTATCGAGCAGAACATGACGGGTCTCGATAACCTGATGTACATGTCCTCACAGAGCAGCGCCACGGGCCAGGCGACGGTAACCCTGAGCTTTACGGCGGGCACGGATCCGGATGAAGCGGTGCAGCAGGTGCAAAACCAGCTGCAATCGGCCCTGCGTAAACTGCCTCAGGCAGTGCAGAACCAGGGGGTGACCGTGCGTAAAACCGGTGACACCAATATTTTGACCATCGCGTTTGTTTCAACCGATGGCTCAATGGATAAGCAGGACATCGCGGACTACGTCGCCAGTAATATTCAGGACCCGCTCAGCCGTATCAACGGCGTTGGTGATATCGACGCCTACGGCTCGCAGTACTCCATGCGTATCTGGCTGGATCCCAACAAGCTGAACAGCGTGCAGATGACCGCCAAAGATGTCACCGACGCTATCGAATCGCAGAACGCCCAGATTGCCGTGGGGCAGCTCGGCGGTACCCCGTCCGTGGATAACCAGGCGCTTAATGCCACCATCAACTCGCAGTCGCTGCTCCAGACGCCTGAACAGTTCCGCGATATTACTCTGCGCGTGAATCAGGACGGTTCGGAAGTGCGTCTGGGGGATGTCGCCACCGTGGAAATGGGGGCGGAAAAATATGACTACCTGAGCCGCTTCAACGGCAATGCCGCGTCCGGGCTGGGGGTGAAACTGGCCTCCGGCGCCAACGAAATGGCGACCGCGCAGCGGGTCTTAGAGCGTCTGGATGAACTGTCGCATTACTTCCCGCACGGACTGGAGTACAAAGTCGCCTACGAAACCACCTCGTTCGTAAAAGCCTCCATCGAAGATGTGGTGAAAACCCTGCTCGAAGCTATCGCGCTGGTGTTCCTCGTGATGTACCTGTTCCTGCAAAACTTCCGCGCTACGCTGATCCCCACGATTGCGGTGCCGGTGGTGCTGCTGGGTACCTTTGCGGTGCTGTATGCCTTCGGTTACAGCATCAACACCCTGACCATGTTCGCCATGGTGCTGGCCATCGGTCTGCTGGTGGATGATGCCATCGTGGTGGTGGAAAACGTTGAGCGCATCATGAGCGAGGAAGGGCTTTCGCCCCGCGAGGCCACGCGCAAATCGATGGGACAGATTCAGGGCGCGCTGGTCGGTATCGCCATGGTGCTGTCGGCGGTATTTATCCCGATGGCGTTTTTTGGCGGCACCACGGGCGCGATTTATCGCCAGTTCTCGATCACCATCGTCTCTGCAATGGTGCTCTCCGTACTGGTGGCGATGATCCTTACCCCTGCCCTGTGCGCGACGCTGCTGAAACCGCTGCATAAGGGCGAACACCACGGTCAAAAAGGCTTCTTCGGCTGGTTTAACCGCATGTTTAACCGCAATGCGGCGCGCTATGAAGCGGGCGTGGGTAAAGTACTGCACCGCAGCGTGCGCTGGATGGTGGTTTATGTCCTGCTGCTCGGCGGCATGGTCTTCCTGTTCCTGCGGCTGCCAACCTCGTTCCTGCCGCTGGAAGATCGCGGCATGTTTATCACCTCCGTACAGTTACCCAGCGGCTCGACCCAGCAGCAGACCCTGAAAGTGGTGCAGAAGGTTGAGAACTACTTCCATACTCAGGAGAAAGATAACGTGGTCTCCGTCTTCTCCACCGTCGGCTCTGGCCCTGGCGGTAACGGGCAGAACGTGGCGCGTATGTTTGTGCGCCTGAAAGACTGGGACCAGCGCGACAGCGATACCGGCTCCTCCTTTGCCATCATTGAGCGTGCAACCAAAGCGTTCAACAAAATCAAGGAAGCGCGCGTTTTCGCCAGCAGCCCGCCCGCCATCAGCGGCCTGGGCAGCTCAGCCGGGTTTGATATGGAGCTTCAGGATCACGCTGGTGCCGGGCATGACGCGTTGATGGCTGCTCGCGACAAGCTGCTGGAGCTGGCCGGGAAAGATCCGCAGCTTACCCGCGTTCGTCATAACGGTCTGGATGACAGCCCTCAGCTACAGGTGGATATTGACCAGCGTAAAGCGCAGGCGCTGGGCGTCTCCATCGACGACATTAACGACACCCTGCAAACGGCATGGGGCTCAAGCTACGTGAATGACTTTATGGATCGCGGCCGCGTGAAGAAGGTCTACGTTCAGTCTGCCGCCAAATACCGCATGCTGCCGGACGATATCAACCGCTGGTATGTGCGCAATAACACCGGCGGCATGGTGCCGTTCTCGGCGTTTGCGACGTCACGCTGGGAGACCGGTTCACCGCGTCTGGAGCGTTACAACGGCTATTCGGCGCTGGAGATTGTCGGTGAAGCCGCGCCGGGCGTCAGTACCGGTACCGCAATGGATATAATGGAAAAACTGGTTCAGCAGTTACCGACCGGCTTTGGCCTGGAGTGGACGGCGATGTCCTACCAGGAACGGCTTTCCGGCGCTCAGGCGCCTGCCTTGTATGCCCTTTCGCTGCTGGTGGTGTTCCTCTGTCTGGCGGCGCTGTATGAAAGCTGGTCAGTGCCGTTCTCGGTGATGCTGGTGGTGCCTCTCGGGGTCATCGGAGCGCTGCTGGCAACCTGGATGCGCGGCCTGGAAAATGATGTCTATTTCCAGGTCGGACTCCTCACCGTAATCGGATTGTCGGCGAAAAACGCCATTCTGATCGTCGAATTTGCCAATGAGATGAATGCCAAAGGTCACGAACTGATGGCCGCCACGCTGCACGCCTGTCGTCAGCGCCTGCGTCCGATCCTGATGACTTCTCTGGCGTTTGTGTTTGGCGTCCTGCCGATGGCCACCAGCTCCGGCGCAGGCTCCAGCAGCCAGCACGCGGTGGGAACGGGCGTTATGGGGGGAATGATTTCGGCGACGATTCTGGCTATCTATTTCGTACCGCTGTTCTTTGTGCTGGTACGCCGTCGTTTCCCGCTGAAGGATAAGCCGGAATAA,MANFFIDRPIFAWVLAILLCLTGVLAITSLPVEQYPDLAPPNVRITANYPGASAQTLENTVTQVIEQNMTGLDNLMYMSSQSSATGQATVTLSFTAGTDPDEAVQQVQNQLQSALRKLPQAVQNQGVTVRKTGDTNILTIAFVSTDGSMDKQDIADYVASNIQDPLSRINGVGDIDAYGSQYSMRIWLDPNKLNSVQMTAKDVTDAIESQNAQIAVGQLGGTPSVDNQALNATINSQSLLQTPEQFRDITLRVNQDGSEVRLGDVATVEMGAEKYDYLSRFNGNAASGLGVKLASGANEMATAQRVLERLDELSHYFPHGLEYKVAYETTSFVKASIEDVVKTLLEAIALVFLVMYLFLQNFRATLIPTIAVPVVLLGTFAVLYAFGYSINTLTMFAMVLAIGLLVDDAIVVVENVERIMSEEGLSPREATRKSMGQIQGALVGIAMVLSAVFIPMAFFGGTTGAIYRQFSITIVSAMVLSVLVAMILTPALCATLLKPLHKGEHHGQKGFFGWFNRMFNRNAARYEAGVGKVLHRSVRWMVVYVLLLGGMVFLFLRLPTSFLPLEDRGMFITSVQLPSGSTQQQTLKVVQKVENYFHTQEKDNVVSVFSTVGSGPGGNGQNVARMFVRLKDWDQRDSDTGSSFAIIERATKAFNKIKEARVFASSPPAISGLGSSAGFDMELQDHAGAGHDALMAARDKLLELAGKDPQLTRVRHNGLDDSPQLQVDIDQRKAQALGVSIDDINDTLQTAWGSSYVNDFMDRGRVKKVYVQSAAKYRMLPDDINRWYVRNNTGGMVPFSAFATSRWETGSPRLERYNGYSALEIVGEAAPGVSTGTAMDIMEKLVQQLPTGFGLEWTAMSYQERLSGAQAPALYALSLLVVFLCLAALYESWSVPFSVMLVVPLGVIGALLATWMRGLENDVYFQVGLLTVIGLSAKNAILIVEFANEMNAKGHELMAATLHACRQRLRPILMTSLAFVFGVLPMATSSGAGSSSQHAVGTGVMGGMISATILAIYFVPLFFVLVRRRFPLKDKPE,MANFFIDRPIFAWVLAILLCLTGTLAIFSLPVEQYPDLAPPNVRVTANYPGASAQTLENTVTQVIEQNMTGLDNLMYMSSQSSGTGQASVTLSFKAGTDPDEAVQQVQNQLQSAMRKLPQAVQNQGVTVRKTGDTNILTIAFVSTDGSMDKQDIADYVASNIQDPLSRVNGVGDIDAYGSQYSMRIWLDPAKLNSFQMTAKDVTDAIESQNAQIAVGQLGGTPSVDKQALNATINAQSLLQTPEQFRDITLRVNQDGSEVRLGDVATVEMGAEKYDYLSRFNGKPASGLGVKLASGANEMATAELVLNRLDELAQYFPHGLEYKVAYETTSFVKASIEDVVKTLLEAIALVFLVMYLFLQNFRATLIPTIAVPVVLMGTFSVLYAFGYSVNTLTMFAMVLAIGLLVDDAIVVVENVERIMSEEGLTPREATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGTTGAIYRQFSITIVAAMVLSVLVAMILTPALCATLLKPLKKGEHHGQKGFFAWFNQMFNRNAERYEKGVAKILHRSLRWIVIYVLLLGGMVFLFLRLPTSFLPLEDRGMFTTSVQLPSGSTQQQTLKVVEQIEKYYFTHEKDNIMSVFATVGSGPGGNGQNVARMFIRLKDWSERDSKTGTSFAIIERATKAFNQIKEARVIASSPPAISGLGSSAGFDMELQDHAGAGHDALMAARNQLLALAAENPELTRVRHNGLDDSPQLQIDIDQRKAQALGVAIDDINDTLQTAWGSSYVNDFMDRGRVKKVYVQAAAPYRMLPDDINLWYVRNKDGGMVPFSAFATSRWETGSPRLERYNGYSAVEIVGEAAPGVSTGTAMDIMESLVKQLPNGFGLEWTAMSYQERLSGAQAPALYAISLLVVFLCLAALYESWSVPFSVMLVVPLGVIGALLATWMRGLENDVYFQVGLLTVIGLSAKNAILIVEFANEMNQKGHDLFEATLHACRQRLRPILMTSLAFIFGVLPMATSTGAGSGGQHAVGTGVMGGMISATILAIYFVPLFFVLVRRRFPLKPRPE,100,gnl|BL_ORD_ID|1309|hsp_num:0,1427,FALSE,None
LK591,3_220 # 249220 # 252372 # -1 # ID=3_220;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.598,3_220,249220,252372,-,Strict,750,1192.56,adeF,60.86,3000777,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; tetracycline antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGGACTTTTCCCGTTTTTTCATCGACAGGCCGATTTTTGCCGCCGTACTGTCGATTCTGATTTTTATCACAGGATTAATCGCCATCCCGCTGCTGCCGGTGAGCGAATACCCTGACGTCGTGCCGCCAAGCGTGCAGGTGCGCGCCGAGTACCCGGGCGCCAACCCGAAAGTGATTGCCGAGACCGTGGCAACGCCGCTGGAAGAGGCGATCAACGGCGTTGAGAACATGATGTACATGAAATCCGTCGCGGGCTCCGACGGCGTGCTGGTGACTACCGTCACCTTCCGTCCGGGCACCGACCCGGATCAGGCGCAGGTTCAGGTGCAAAACCGCGTCGCGCAGGCCGAAGCGCGTCTGCCGGAAGACGTGCGGCGTCTGGGCATCACGACTCAGAAACAGTCGCCAACGCTGACGCTGGTGGTGCATCTGTTTTCGCCTGGCGGTAAGTACGATTCACTGTATATGCGTAACTACGCCACGCTGAAGGTGAAGGACGAGCTGGCGCGTCTGCCCGGCGTGGGGCAGATTCAGATTTTCGGCTCGGGTGAATACGCGATGCGCGTCTGGCTGGACCCGAACAAGGTCGCGGCCCGCGGGCTGACCGCTTCGGACGTGGTCACGGCGATGCAGGAGCAGAACGTGCAGGTGTCCGCCGGGCAGCTTGGCGCCGAGCCGCTGCCGAAAGAGAGCGATTTCCTGATCTCCATTAACGCCCAGGGCCGCCTGCATACCGAAGACGAGTTCGGCAACATTGTCCTGAAAACCACGCAGGATGGTACGGTCGTCCGACTGCGCGACGTGGCGCGTGTCGAGATGGGGTCCGGCAGCTACGCGCTGCGCTCCCAGTTGAACAATAAAGACGCGGTCGGGATTGGTATCTTCCAGTCGCCGGGGGCAAACGCCATCGATCTGTCTAACGCGGTACGCGCCAAAATGGACGAACTGTCCACACGATTCCCGGACGATATGAAATGGGCGGCGCCTTACGACCCGACGGTGTTTGTACGCGACTCGATCCGCGCTGTGGTGCAAACGCTGCTGGAAGCGGTGGTGCTGGTCGTGCTGGTGGTGATCCTGTTCCTGCAAACCTGGCGCGCGTCGATAATCCCGCTGATTGCGGTGCCGGTATCGGTAGTGGGCACGTTCAGTATTCTCTACCTGCTGGGCTTTTCGCTGAATACCCTGAGCCTGTTCGGGCTGGTGCTGGCGATTGGTATCGTGGTGGACGATGCCATCGTGGTGGTGGAAAACGTCGAACGAAATATCGAAGAGGGGCTCGCCCCACTTGCGGCAGCGCATCAGGCGATGCGTGAAGTGTCCGGACCGATTATTGCCATTGCGCTGGTGCTGTGTGCGGTATTCGTTCCGATGGCGTTCCTCTCCGGCGTGACCGGTCAGTTCTACAAGCAGTTTGCGGTAACGATAGCCATTTCCACGGTGATTTCCGCGATCAACTCGCTGACGCTCTCGCCAGCGCTGGCCGCGCTGCTGTTGAAGCCGCATGGCGCCCCGAAAGATTTCCCGACCCGGCTTATCGATCGTCTGTTCGGCTGGATTTTCCGTCCGTTTAACCGCTTTTTCCACCGCAGCTCGACTGGCTATCAGGGGCTGGTGGGCAAAACGCTCGGCCGACGCGGGGCAGTGTTCGTGGTTTATTTGCTGCTGCTTTGCGCTGCGGGCGTGATGTTTAAAGCCGTTCCCGGCGGGTTTATTCCGACGCAGGATAAGCTGTACCTGATCGGCGGCGTGAAAATGCCGGAAGGCTCGTCGCTGGCGCGCACCGATGCGGTGATCCGCAAAATGAGCGAAATCGGGATGAATACCGAAGGCGTGGATTATGCGGTCGCGTTTCCTGGCCTGAATGCGCTCCAGTTCACCAATACGCCGAACACCGGGACGGTCTTCTTTGGCCTGAAGCCTTTCGACCAGCGTAAACATACTGCGGCGGAAATAAACGCGGAGATCAACGCGAAAATCGCGCAAATCCAGCAGGGCTTTGGCTTCTCGATTCTGCCGCCGCCGATTTTAGGTCTGGGCCAGGGATCGGGCTATTCGCTGTACATTCAGGATCGTGCTGGTCTGGGCTATGGCGCGCTGCAAAACGCGGTGAACACCATGTCCGGGGCGATTATGCAGACGCCGGGGATGCATTTCCCTATCTCAACCTACCAGGCAAACGTTCCGCAGCTGGATGTACAGGTTGACCGTGATAAGGCGAAAGCGCAGGGCGTGTCGCTCACCGATCTCTTCGGGACGCTGCAAACCTATCTGGGCTCGTCTTATGTGAATGACTTCAACCAGTTCGGTCGCACCTGGCGCGTAATGGCACAGGCCGACGGGCAGTTCCGCGACAGCGTGGAAGATATCGCGAATTTACGCACCCGTAATAGCCAGGGTGAAATGGTGCCGATTGGCAGTATGGTGAAAATCACGACCACCTACGGTCCGGACCCGGTGATCCGCTACAACGGCTACCCGGCGGCGGATCTGATTGGCGATGCCGACCCGCGCGTGCTCTCTTCCGCGCAGGCGATGACGCAGCTGGACGGTATGTCTCAGCAGATCCTGCCGAACGGGATGAATATTGAATGGACGGACCTGAGCTTCCAGCAGGCCACCCAGGGCAACAAGGCGCTGATCGTCTTCCCGGTCGCGGTGCTGCTGGCGTTCCTGGTGCTGGCGGCGCTGTATGAAAGCTGGACGCTGCCCCTGGCGGTGATCCTCATCGTGCCGATGACGATGCTCTCCGCGCTGTTCGGCGTCTGGCTGACCGGGGGCGATAATAACGTCTTCGTGCAGGTAGGGCTGGTGGTACTGATGGGGCTGGCCTGTAAAAACGCGATTCTTATCGTGGAGTTTGCCCGCGAGCTGGAAATTCAGGGCAAAGGCATTATGGAGGCCGCGCTGGAAGCGTGCCGCCTGCGTTTACGCCCGATTGTAATGACCTCTATCGCCTTTATTGCCGGGACCATTCCACTGATCCTTGGTCACGGGGCAGGGGCAGAAGTGCGCGGCGTCACCGGGATCACCGTGTTCGCCGGGATGCTGGGTGTGACGCTGTTTGGTCTGTTCCTGACGCCGGTCTTTTACGTGACGCTGCGTAAGTTCGTGACGCGCGGTAAAGCGGAAAGAGAGGTGTTGCCTGCGTAG,MDFSRFFIDRPIFAAVLSILIFITGLIAIPLLPVSEYPDVVPPSVQVRAEYPGANPKVIAETVATPLEEAINGVENMMYMKSVAGSDGVLVTTVTFRPGTDPDQAQVQVQNRVAQAEARLPEDVRRLGITTQKQSPTLTLVVHLFSPGGKYDSLYMRNYATLKVKDELARLPGVGQIQIFGSGEYAMRVWLDPNKVAARGLTASDVVTAMQEQNVQVSAGQLGAEPLPKESDFLISINAQGRLHTEDEFGNIVLKTTQDGTVVRLRDVARVEMGSGSYALRSQLNNKDAVGIGIFQSPGANAIDLSNAVRAKMDELSTRFPDDMKWAAPYDPTVFVRDSIRAVVQTLLEAVVLVVLVVILFLQTWRASIIPLIAVPVSVVGTFSILYLLGFSLNTLSLFGLVLAIGIVVDDAIVVVENVERNIEEGLAPLAAAHQAMREVSGPIIAIALVLCAVFVPMAFLSGVTGQFYKQFAVTIAISTVISAINSLTLSPALAALLLKPHGAPKDFPTRLIDRLFGWIFRPFNRFFHRSSTGYQGLVGKTLGRRGAVFVVYLLLLCAAGVMFKAVPGGFIPTQDKLYLIGGVKMPEGSSLARTDAVIRKMSEIGMNTEGVDYAVAFPGLNALQFTNTPNTGTVFFGLKPFDQRKHTAAEINAEINAKIAQIQQGFGFSILPPPILGLGQGSGYSLYIQDRAGLGYGALQNAVNTMSGAIMQTPGMHFPISTYQANVPQLDVQVDRDKAKAQGVSLTDLFGTLQTYLGSSYVNDFNQFGRTWRVMAQADGQFRDSVEDIANLRTRNSQGEMVPIGSMVKITTTYGPDPVIRYNGYPAADLIGDADPRVLSSAQAMTQLDGMSQQILPNGMNIEWTDLSFQQATQGNKALIVFPVAVLLAFLVLAALYESWTLPLAVILIVPMTMLSALFGVWLTGGDNNVFVQVGLVVLMGLACKNAILIVEFARELEIQGKGIMEAALEACRLRLRPIVMTSIAFIAGTIPLILGHGAGAEVRGVTGITVFAGMLGVTLFGLFLTPVFYVTLRKFVTRGKAEREVLPA,MNISKFFIDRPIFAGVLSVLILLAGLLSVFQLPISEYPEVVPPSVVVRAQYPGANPKVIAETVASPLEESINGVEDMLYMQSQANSDGNLTITVNFKLGIDPDKAQQLVQNRVSQAMPRLPEDVQRLGVTTLKSSPTLTMVVHLTSPDNRYDMTYLRNYAVLNVKDRLARLQGVGEVGLFGSGDYAMRVWLDPQKVAQRNLTATEIVNAIREQNIQVAAGTIGASPSNSPLQLSVNAQGRLTTEQEFADIILKTAPDGAVTRLGDVARVELAASQYGLRSLLDNKQAVAIPIFQAPGANALQVSDQVRSTMKELSKDFPSSIKYDIVYDPTQFVRASIKAVVHTLLEAITLVVVVVILFLQTWRASIIPLLAVPVSIIGTFALMLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVERNIEAGLNPREATYRAMREVSGPIIAIALTLVAVFVPLAFMTGLTGQFYKQFAMTIAISTVISAFNSLTLSPALAALLLKGHDAKPDALTRIMNRVFGRFFALFNRVFSRASDRYSQGVSRVISHKASAMGVYAALLGLTVGISYIVPGGFVPAQDKQYLISFAQLPNGASLDRTEAVIRKMSDTALKQPGVESAVAFPGLSINGFTNSSSAGIVFVTLKPFDERKAKDLSANAIAGALNQKYSAIQDAYIAVFPPPPVMGLGTMGGFKLQLEDRGALGYSALNDAAQNFMKAAQSAPELGPMFSSYQINVPQLNVDLDRVKAKQQGVAVTDVFNTMQIYLGSQYVNDFNRFGRVYQVRAQADAPFRANPEDILQLKTRNSAGQMVPLSSLVNVTQTYGPEMVVRYNGYTSADINGGPAPGYSSSQAEAAVERIAAQTLPRGIKFEWTDLTYQKILAGNAGLWVFPISVLLVFLVLAAQYESLTLPLAVILIVPMGILAALTGVWLTAGDNNIFTQIGLMVLVGLACKNAILIVEFARELEMQGATAFKAAVEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMIGVTFFGLFLTPAFYVLIRTLNSKHKLHSAAVHEAPLASPHDH,99.15,gnl|BL_ORD_ID|132|hsp_num:0,153,FALSE,None
LK591,3_221 # 252396 # 253571 # -1 # ID=3_221;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.598,3_221,252396,253571,-,Strict,670,692.189,oqxA,91.3,3003922,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; glycylcycline; tetracycline antibiotic; diaminopyrimidine antibiotic; nitrofuran antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGAGCCTGCAAAAAACCTGGGGTAACTTTCATCTGAGCGCGATGGGGGTGGTTTTACTCTCCGCGCTTCTCATCGGGTGCGATGACAGCGTCGCGCAAAATGCCGCGCCGCAAGCGCCCGTTGTCAGCGCTGCTGACGTGGTGGTGAAATCCATTAGCCAGTGGGACAGCTTTAACGGTCGCATTGAAGCGGTGGAAAGCGTTCAGCTGCGTCCGCGCGTCTCCGGCTACATTGAGAAAGTGAATTACACCGACGGCCAGGAGGTGAAAAAGGGCGAGGTGCTGTTCACGATTGATGACCGAACCTATCGCGCCGCGCTGGAACAGGCGCAGGCGAACCTGGCGAGAGCCAAAACGCAGGCCAGTCTGGCGCGAAGCGAGGCTAACCGTACCGATAAATTAGTCAATACCAACGTGGTGTCCCGCGAAGAGTGGGAGCAGCGCCGTTCCGCCGCTACCCAGGCGCAGGCCGATATTCGCGCCGCGCAGGCGGCGGTAGACGCTGCGCAACTTAACCTCGACTTCACCAAAGTGACCGCGCCTATCGACGGTCGCGCCAGCCGGGCGCTGATCACCAGCGGTAACCTGGTGACGGCGGGCGACAGCGCCAGCGTGCTCACCACCCTGGTCTCGCAGAAAACGGTTTATGTCTACTTCGACGTGGACGAGTCAACCTACCTTCACTATCAGAACCTGGCCCGCAGCGGGCAGCGGGTGTCCGGCGATCATGCGGCGCTGCCGGTGGAGATTGGCCTGACGGGCGAGGAGGGCTATCCCCATCAGGGCAAAGTGGATTTCCTGGATAACCAGCTCACGCCGGGTACCGGAACGATCCGCATGCGCGCGCTGCTGGATAACTCACAGCGTCAGTTCACGCCTGGACTCTTTGCCCGCGTGCGTCTGCCGGGCAGTGCGGAATTTAAAGCCACGCTTGTTGACGATAAGGCGGTGCTGACCGATCAGGATCGTAAATATGTCTATATCGTGGATAAAGACGGGAAAGCGCAGCGCCGCGACATTACGCCCGGGCGTCTGGCCGACGGTTTACGTATCGTACAGCAGGGGCTGAATCCCGGGGATAAAGTCATCGTCGATGGTTTACAAAAAGTGTTTATGCCGGGTATGCCGGTTAACGCGAAAACCGTTGCCATGACCGCCAGCGCCGCCCTCAACTGA,MSLQKTWGNFHLSAMGVVLLSALLIGCDDSVAQNAAPQAPVVSAADVVVKSISQWDSFNGRIEAVESVQLRPRVSGYIEKVNYTDGQEVKKGEVLFTIDDRTYRAALEQAQANLARAKTQASLARSEANRTDKLVNTNVVSREEWEQRRSAATQAQADIRAAQAAVDAAQLNLDFTKVTAPIDGRASRALITSGNLVTAGDSASVLTTLVSQKTVYVYFDVDESTYLHYQNLARSGQRVSGDHAALPVEIGLTGEEGYPHQGKVDFLDNQLTPGTGTIRMRALLDNSQRQFTPGLFARVRLPGSAEFKATLVDDKAVLTDQDRKYVYIVDKDGKAQRRDITPGRLADGLRIVQQGLNPGDKVIVDGLQKVFMPGMPVNAKTVAMTASAALN,MSLQKTWGNIHLTALGAMMLSFLLVGCDDSVAQNAAPPAPTVSAAKVLVKSISQWDSFNGRIEAVESVQLRPRVSGYIDKVNYTDGQEVKKGQVLFTIDDRTYRAALEQAQAALARAKTQASLAQSEANRTDKLVHTNLVSREEWEQRRSAAVQAQADIRAAQAAVDAAQLNLDFTKVTAPIDGRASRALITSGNLVTAGDTASVLTTLVSQKTVYVYFDVDESTYLHYQNLARRGQGASSDNQALPVEIGLVGEEGYPHQGKVDFLDNQLTPSTGTIRMRALLDNSQRLFTPGLFARVRLPGSAEFKATLIDDKAVLTDQDRKYVYIVDKDGKAQRRDITPGRLADGLRIVQKGLNPGDSVIVDGLQKVFMPGMPVNAKTVAMTSSATLN,100,gnl|BL_ORD_ID|2153|hsp_num:0,2399,FALSE,None
LK591,5_93 # 99329 # 99514 # 1 # ID=5_93;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.484,5_93,99329,99514,+,Strict,100,109.383,rsmA,85.25,3005069,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGCTGATTCTGACTCGTCGAGTTGGTGAGACCCTCATGATTGGGGATGAGGTCACCGTGACAGTTTTAGGGGTAAAGGGTAACCAGGTACGTATTGGTGTTAACGCTCCTAAAGAAGTATCTGTCCACCGTGAAGAGATCTACCAGCGTATCCAGGCTGAAAAATCCCAGCAGTCCAGTTACTGA,MLILTRRVGETLMIGDEVTVTVLGVKGNQVRIGVNAPKEVSVHREEIYQRIQAEKSQQSSY,MLILTRRVGETLMVGDDVTVTVLGVKGNQVRIGVNAPKEVAVHREEIYQRIQKEKDQEPNH,100,gnl|BL_ORD_ID|2794|hsp_num:0,3807,FALSE,None
LK591,5_100 # 106372 # 107919 # -1 # ID=5_100;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.600,5_100,106372,107919,-,Strict,900,936.021,emrB,93.86,3000074,protein homolog model,n/a,n/a,fluoroquinolone antibiotic,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGCAACAGCAAAAGCCGCAAAAACCGCTGGAGGGGGCGCAGCTGGTCATTATGACCATTGCGCTGTCGCTGGCGACATTCATGCAGGTGCTGGACTCCACCATCGCAAACGTGGCGATCCCTACGATCGCCGGGAACCTTGGCTCATCGCTGAGCCAGGGGACCTGGGTCATTACCTCGTTCGGGGTGGCGAACGCCATCTCCATTCCCATCACCGGCTGGCTGGCGAAGCGCGTCGGTGAAGTGAAGCTGTTCCTCTGGTCGACGATCCTGTTCGTGCTGGCCTCCTGGGCCTGCGGCATGTCCAGCAGCCTGACGATGCTGATTTTCTTCCGCGTCATCCAGGGGATTGTCGCCGGGCCGTTGATTCCGCTGTCGCAGAGTTTGCTGCTGAACAACTATCCGCCCGCCAAGCGCTCCATCGCGCTCGCGCTGTGGTCGATGACGGTGATCGTCGCCCCAATTTGCGGGCCAATCCTCGGCGGCTATATCAGCGATAACTATCACTGGGGCTGGATCTTCTTCATCAACGTGCCCATCGGTGCGCTGGTGGTGCTGATGACGCTACAGTCTCTGCGTGGTCGCGAAACGCGGACCGAACAGCGGCGGATCGACGGCATCGGGCTGGCACTGCTGGTTGTCGGCATCGGCAGCCTGCAAATCATGCTCGACCGCGGCAAAGAGCTGGACTGGTTTGCCTCTACGGAAATCATTGTGCTGACGGTGGTCGCCGTGGTGGCCATCAGCTTCCTGATTGTCTGGGAGCTGACGGACGATAATCCGATAGTCGACCTCTCGCTGTTTAAATCGCGAAACTTCACCATCGGCTGCCTCTGTATCAGTCTCGCCTATATGCTCTACTTCGGCGCGATTGTTCTGCTGCCGCAGCTGTTGCAGGAGGTGTACGGCTATACCGCAACCTGGGCGGGGCTGGCCTCCGCGCCGGTGGGGTTAATTCCGGTTCTGCTGTCGCCGATTATTGGCCGTTTCGCCCATAAGCTCGACATGCGCAGGCTGGTGACGTTCAGCTTCATCATGTACGCCGTGTGCTTCTACTGGCGCGCGTATACGTTTGAACCGGGAATGGACTTTGGCGCCTCCGCGTGGCCGCAGTTTATTCAGGGCTTCGCCGTAGCGTGCTTCTTTATGCCGCTGACCACCATTACGCTTTCCGGCTTACCGCCTGAGCGGATGGCGGCGGCATCGAGCCTGTCGAACTTCACCCGTACGCTGGCGGGCTCCATCGGGACTTCGATCACCACCACGCTGTGGACCAACCGGGAATCGATGCACCATGCTCAACTCACCGAAGCGGTGAACCCGTTCAACCCTAACGCTCAGCAGATGTATAGCCAGCTTGAGGGGATGGGGATGACGGAGCAGCAGGCGTCCGGCTGGCTTGCCCAGCAGATCACCAACCAGGGGCTGATTATCTCGGCAAACGAGATTTTCTGGATATCGGCGGGGATCTTCATCGTCCTGCTGGGGCTGGTGTGGTTTGCCAAACCACCGTTTGGGGCCGGTAGCGGGGGCGGTGGGGCGCACTAG,MQQQKPQKPLEGAQLVIMTIALSLATFMQVLDSTIANVAIPTIAGNLGSSLSQGTWVITSFGVANAISIPITGWLAKRVGEVKLFLWSTILFVLASWACGMSSSLTMLIFFRVIQGIVAGPLIPLSQSLLLNNYPPAKRSIALALWSMTVIVAPICGPILGGYISDNYHWGWIFFINVPIGALVVLMTLQSLRGRETRTEQRRIDGIGLALLVVGIGSLQIMLDRGKELDWFASTEIIVLTVVAVVAISFLIVWELTDDNPIVDLSLFKSRNFTIGCLCISLAYMLYFGAIVLLPQLLQEVYGYTATWAGLASAPVGLIPVLLSPIIGRFAHKLDMRRLVTFSFIMYAVCFYWRAYTFEPGMDFGASAWPQFIQGFAVACFFMPLTTITLSGLPPERMAAASSLSNFTRTLAGSIGTSITTTLWTNRESMHHAQLTEAVNPFNPNAQQMYSQLEGMGMTEQQASGWLAQQITNQGLIISANEIFWISAGIFIVLLGLVWFAKPPFGAGSGGGGAH,MQQQKPLEGAQLVIMTIALSLATFMQVLDSTIANVAIPTIAGNLGSSLSQGTWVITSFGVANAISIPLTGWLAKRVGEVKLFLWSTIAFAIASWACGVSSSLNMLIFFRVIQGIVAGPLIPLSQSLLLNNYPPAKRSIALALWSMTVIVAPICGPILGGYISDNYHWGWIFFINVPIGVAVVLMTLQTLRGRETRTERRRIDAVGLALLVIGIGSLQIMLDRGKELDWFSSQEIIILTVVAVVAICFLIVWELTDDNPIVDLSLFKSRNFTIGCLCISLAYMLYFGAIVLLPQLLQEVYGYTATWAGLASAPVGIIPVILSPIIGRFAHKLDMRRLVTFSFIMYAVCFYWRAYTFEPGMDFGASAWPQFIQGFAVACFFMPLTTITLSGLPPERLAAASSLSNFTRTLAGSIGTSITTTMWTNRESMHHAQLTESVNPFNPNAQAMYSQLEGLGMTQQQASGWIAQQITNQGLIISANEIFWMSAGIFLVLLGLVWFAKPPFGAGGGGGGAH,100.59,gnl|BL_ORD_ID|1706|hsp_num:0,1847,FALSE,None
LK591,5_102 # 109239 # 109769 # -1 # ID=5_102;partial=00;start_type=ATG;rbs_motif=AGGA/GGAG/GAGG;rbs_spacer=11-12bp;gc_cont=0.552,5_102,109239,109769,-,Strict,280,347.051,emrR,94.86,3000516,protein homolog model,n/a,n/a,fluoroquinolone antibiotic,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGGATAGTTCGTTTACGCCCATTGAACAAATGCTTAAGTTCCGCGCCAGTCGTCATGAGGACTTCCCGTATCAGGAAATCCTGCTGACCCGCCTGTGCATGCACATGCAGGGTAAGCTGCTGGAAAATCGTAACAAGATGCTGAAAGCGCAGGGGATTAACGAGACGTTGTTTATGGCGTTGATTACGCTGGAGTCTCAGGAAAATCACAGCATTCAGCCGTCGGAACTGAGCTGTGCGCTGGGGTCATCCCGTACCAATGCGACCCGTATCGCGGATGAACTGGAAAAGCGCGGCTGGATTGAACGCCGTGAAAGCGATAACGATCGCCGCTGCCTGCATCTGCAACTGACCGAGAAAGGTCACGAATTCTTGCGCGAAGTGCTGCCACCGCAGCACAACTGCCTGCACCAGCTCTGGTCTGCCCTCAGCACCGCCGAGCGCGACCAGCTTGAGCACATTACTCGCAAGCTGCTCACCCGTCTGGACCAGATGGATGAAGACGGCGTCATCCTTGAGGCGCTGCGCTAA,MDSSFTPIEQMLKFRASRHEDFPYQEILLTRLCMHMQGKLLENRNKMLKAQGINETLFMALITLESQENHSIQPSELSCALGSSRTNATRIADELEKRGWIERRESDNDRRCLHLQLTEKGHEFLREVLPPQHNCLHQLWSALSTAERDQLEHITRKLLTRLDQMDEDGVILEALR,MDSSFTPIEQMLKFRASRHEDFPYQEILLTRLCMHMQSKLLENRNKMLKAQGINETLFMALITLESQENHSIQPSELSCALGSSRTNATRIADELEKRGWIERRESDNDRRCLHLQLTEKGHEFLREVLPPQHNCLHQLWSALSTTEKDQLEQITRKLLSRLDQMEQDGVVLEAMS,100,gnl|BL_ORD_ID|1225|hsp_num:0,1330,FALSE,None
LK591,6_6 # 7392 # 7733 # -1 # ID=6_6;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.558,6_6,7392,7733,-,Strict,230,233.417,ramA,96.46,3000823,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; penem; disinfecting agents and antiseptics,antibiotic efflux; reduced permeability to antibiotic,resistance-nodulation-cell division (RND) antibiotic efflux pump; General Bacterial Porin with reduced permeability to beta-lactams,ATGACGATTTCCGCTCAGGTCATTGATACGATTGTCGAATGGATCGATGACAACCTACACCAGCCGTTACGCATCGAAGAGATTGCCCGCCATGCGGGTTACTCAAAATGGCATTTACAGCGGCTATTTATGCAGTACAAAGGCGAAAGTCTGGGGCGCTACATCCGCGAACGCAAGCTGCTGATGGCGGCGCGCGATCTGCGTGAGTCAGACGAGCGCGTGTACGATATCTGCCTGCGCTACGGGTTTGACTCGCAGCAGACGTTTACCCGCATCTTTACCCGCACCTTCAACCAGCCGCCCGGGGCGTATCGCAAAGAAAACCACGGTCGGGCGCACTGA,MTISAQVIDTIVEWIDDNLHQPLRIEEIARHAGYSKWHLQRLFMQYKGESLGRYIRERKLLMAARDLRESDERVYDICLRYGFDSQQTFTRIFTRTFNQPPGAYRKENHGRAH,MINQEAEGESSMTISAQIIDTIVEWIDDNLHQPLRIEEIARHAGYSKWHLQRLFMQYKGESLGRYIRERKLLLAARDLRESDARVYDICLRYGFDSQQTFTRIFTRTFNQPPGAYRKENHSRAH,91.13,gnl|BL_ORD_ID|1537|hsp_num:0,1665,FALSE,None
LK591,6_77 # 82538 # 85684 # 1 # ID=6_77;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.560,6_77,82538,85684,+,Strict,1900,1969.51,acrB,93.04,3000216,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGCCTAATTTCTTTATCGATCGCCCCATATTTGCGTGGGTGATCGCCATAATCATCATGCTGGCCGGGGGACTTGCGATCCTGAAGCTGCCTGTCGCGCAATATCCAACGATTGCGCCGCCGGCAGTGACGATCTCCGCAACCTACCCGGGCGCTGATGCCAAAACGGTGCAGGATACCGTTACGCAGGTTATCGAACAGAACATGAACGGTATCGATAACCTGATGTACATGTCCTCAAACAGTGACTCAACCGGTACGGTTCAGATCACCCTGACCTTTGAATCCGGTACGGATGCGGACATTGCACAGGTTCAGGTGCAGAACAAATTGCAGCTGGCGATGCCTCTGCTGCCGCAGGAAGTACAACAGCAAGGCGTGAGCGTCGAGAAATCGTCCAGTAGCTTCCTGATGGTTGTCGGCGTGATCAACACCAACGGCACCATGACGCAGGAGGATATTTCCGACTACGTGGGCGCCAACATGAAGGACGCCATCAGCCGTACGTCTGGTGTGGGTGACGTTCAGCTGTTCGGTTCCCAGTACGCGATGCGTATCTGGATGGATCCGAATAAACTGAACAACTTCCAGCTGACGCCGGTTGACGTTATCAGCGCAATTAAAGCGCAGAACGCCCAGGTTGCCGCCGGTCAGTTGGGTGGTACACCGCCGGTGAAAGGCCAGCAGCTTAACGCGTCGATCATCGCGCAAACGCGTCTGACCTCCGCCGATGAGTTCAGCAAAATTCTGCTGAAGGTGAATCAGGACGGTTCGCAGGTTCGCCTGCGTGACGTGGCGAAGGTTGAGCTGGGCGGTGAGAACTACGACATCATTGCGAAGTTCAACGGTAAACCGGCTTCCGGTCTGGGTATCAAACTGGCGACGGGCGCGAACGCCCTGGACACCGCGACGGCTATCCGTGCAGAACTGAAGAAGATGGAACCGTTCTTCCCGTCAGGTCTGAAAATCGTTTATCCGTATGACACCACGCCATTCGTTAAAATTTCGATTCACGAAGTGGTGAAAACCCTGGTTGAGGCGATCATTCTCGTCTTCCTGGTGATGTACTTGTTCCTGCAAAACTTCCGCGCAACGCTGATCCCAACCATCGCCGTGCCGGTTGTACTGCTCGGGACCTTCGCGGTGCTGGCGATATTTGGCTACTCGATAAACACCCTGACGATGTTCGGGATGGTGCTCGCCATCGGCCTGCTGGTGGATGACGCCATCGTGGTGGTCGAAAACGTCGAGCGTGTCATGGCGGAAGAAGGCCTGCCGCCGAAGGAAGCAACCCGTAAATCAATGGGCCAGATCCAGGGCGCGCTGGTCGGTATCGCGATGGTACTGTCTGCGGTATTTATCCCGATGGCCTTCTTTGGTGGCTCTACCGGTGCGATTTACCGTCAGTTCTCCATCACGATAGTTTCGGCGATGGCGCTGTCGGTACTGGTTGCACTGATCCTGACGCCAGCCCTGTGCGCGACGATGCTGAAGCCGATTCAGAAAGGCGGTCACGGCGAGCATAAAGGCTTCTTCGGCTGGTTCAACCGCATGTTTGATAAGAGTACGCACCACTACACCGACAGCGTGGGTAACATCCTGCGCAGCACCGGTCGTTACCTGCTGCTCTATATCATCATCGTGGTGGGCATGGCTTTCCTGTTCGTTCGTCTGCCAAGCTCGTTCCTGCCAGATGAAGACCAGGGCGTGTTCCTGAGTATGGCGCAGCTTCCGGCCGGTGCGACGCAAGAGCGTACGCAAAAGGTGCTGGATGAAATGACCGACTACTTCCTGACCAAAGAGAAAGACAACGTCGAATCCGTGTTTGCGGTTAACGGCTTTGGCTTCGCGGGTCGTGGTCAGAACACCGGTATCGCCTTCGTTTCTCTGAAAGACTGGTCTGAACGTCCGGGCGCAGAGAACAAGGTAGAAGCCATTACCGGCCGCGCGATGGGCACCTTCTCACAGATTAAAGATGCGATGGTCTTCGCCTTTAACCTGCCAGCGATTGTTGAACTGGGTACGGCGACCGGCTTCGACTTCCAGCTGATTGACCAGGGCGGTCTGGGCCACGAAAAACTGACTCAGGCGCGTAACCAGCTGTTTGGCGAGGTGGCAAAACACCCTGACCTGCTGGTGGGCGTACGTCCTAACGGTCTGGAAGATACGCCGCAGTACAAGATCGATATCGACCAGGAAAAAGCGCAGGCGCTGGGTGTTTCCATCAGCGACATTAATACCACGCTGGGTGCAGCCTGGGGTGGCAGCTACGTCAACGACTTCATCGACCGTGGTCGCGTGAAGAAAGTCTACGTGATGTCCGAAGCGCAATACCGTATGCTGCCGAACGATATCAACAACTGGTATGTTCGCGGCAGCGATGGCCAGATGGTGCCGTTCTCCGCCTTCTCAACCTCGCGCTGGGAATACGGTTCACCGCGTCTGGAGCGTTATAACGGCTTGCCATCGATGGAAATCCTCGGTCAGGCAGCCCCGGGCCGAAGCACCGGTGAAGCCATGAACCTGATGGAAGAACTGGCCAGCAAACTGCCTGCGGGTGTCGGCTACGACTGGACCGGCATGTCCTATCAGGAACGTCTGTCCGGTAACCAGGCCCCTGCCCTGTACGCCATTTCACTGATTGTGGTGTTCCTGTGTCTGGCGGCATTGTATGAGAGCTGGTCGATTCCATTCTCCGTTATGCTGGTGGTTCCGCTGGGGGTTATCGGTGCGCTGCTTGCCGCAACGTTCCGTGGGCTGACCAACGACGTTTACTTCCAGGTGGGCCTGCTGACAACCATTGGCTTGTCGGCGAAGAACGCGATACTAATCGTCGAATTCGCCAAAGATCTGATGGAGAAAGAAGGAAAAGGCCTGATTGAAGCAACGCTGGAAGCCGTTCGTATGCGTTTGCGTCCAATCCTGATGACGTCCCTGGCATTTATCCTCGGCGTTATGCCGCTGGTTATCAGCTCCGGCGCGGGCTCCGGCGCACAGAACGCAGTAGGTACCGGCGTAATGGGTGGGATGGTAACCGCGACCGTTCTTGCGATCTTCTTCGTACCGGTGTTCTTCGTGGTGGTTCGCCGCCGCTTCAGCCGTAAGAATGAAGACGTTGAGCACAATCATTCGGTAGAACATCACTGA,MPNFFIDRPIFAWVIAIIIMLAGGLAILKLPVAQYPTIAPPAVTISATYPGADAKTVQDTVTQVIEQNMNGIDNLMYMSSNSDSTGTVQITLTFESGTDADIAQVQVQNKLQLAMPLLPQEVQQQGVSVEKSSSSFLMVVGVINTNGTMTQEDISDYVGANMKDAISRTSGVGDVQLFGSQYAMRIWMDPNKLNNFQLTPVDVISAIKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRLTSADEFSKILLKVNQDGSQVRLRDVAKVELGGENYDIIAKFNGKPASGLGIKLATGANALDTATAIRAELKKMEPFFPSGLKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQNFRATLIPTIAVPVVLLGTFAVLAIFGYSINTLTMFGMVLAIGLLVDDAIVVVENVERVMAEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFIPMAFFGGSTGAIYRQFSITIVSAMALSVLVALILTPALCATMLKPIQKGGHGEHKGFFGWFNRMFDKSTHHYTDSVGNILRSTGRYLLLYIIIVVGMAFLFVRLPSSFLPDEDQGVFLSMAQLPAGATQERTQKVLDEMTDYFLTKEKDNVESVFAVNGFGFAGRGQNTGIAFVSLKDWSERPGAENKVEAITGRAMGTFSQIKDAMVFAFNLPAIVELGTATGFDFQLIDQGGLGHEKLTQARNQLFGEVAKHPDLLVGVRPNGLEDTPQYKIDIDQEKAQALGVSISDINTTLGAAWGGSYVNDFIDRGRVKKVYVMSEAQYRMLPNDINNWYVRGSDGQMVPFSAFSTSRWEYGSPRLERYNGLPSMEILGQAAPGRSTGEAMNLMEELASKLPAGVGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFSVMLVVPLGVIGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMEKEGKGLIEATLEAVRMRLRPILMTSLAFILGVMPLVISSGAGSGAQNAVGTGVMGGMVTATVLAIFFVPVFFVVVRRRFSRKNEDVEHNHSVEHH,MPNFFIDRPIFAWVIAIIIMLAGGLAILKLPVAQYPTIAPPAVTISASYPGADAKTVQDTVTQVIEQNMNGIDNLMYMSSNSDSTGTVQITLTFESGTDADIAQVQVQNKLQLAMPLLPQEVQQQGVSVEKSSSSFLMVVGVINTDGTMTQEDISDYVAANMKDAISRTSGVGDVQLFGSQYAMRIWMNPNELNKFQLTPVDVITAIKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRLTSTEEFGKILLKVNQDGSRVLLRDVAKIELGGENYDIIAEFNGQPASGLGIKLATGANALDTAAAIRAELAKMEPFFPSGLKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQNFRATLIPTIAVPVVLLGTFAVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVMAEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGSTGAIYRQFSITIVSAMALSVLVALILTPALCATMLKPIAKGDHGEGKKGFFGWFNRMFEKSTHHYTDSVGGILRSTGRYLVLYLIIVVGMAYLFVRLPSSFLPDEDQGVFMTMVQLPAGATQERTQKVLNEVTHYYLTKEKNNVESVFAVNGFGFAGRGQNTGIAFVSLKDWADRPGEENKVEAITMRATRAFSQIKDAMVFAFNLPAIVELGTATGFDFELIDQAGLGHEKLTQARNQLLAEAAKHPDMLTSVRPNGLEDTPQFKIDIDQEKAQALGVSINDINTTLGAAWGGSYVNDFIDRGRVKKVYVMSEAKYRMLPDDIGDWYVRAADGQMVPFSAFSSSRWEYGSPRLERYNGLPSMEILGQAAPGKSTGEAMELMEQLASKLPTGVGYDWTGMSYQERLSGNQAPSLYAISLIVVFLCLAALYESWSIPFSVMLVVPLGVIGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGLIEATLDAVRMRLRPILMTSLAFILGVMPLVISTGAGSGAQNAVGTGVMGGMVTATVLAIFFVPVFFVVVRRRFSRKNEDIEHSHTVDHH,99.9,gnl|BL_ORD_ID|1011|hsp_num:0,1104,FALSE,None
LK591,6_183 # 196202 # 197299 # 1 # ID=6_183;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.556,6_183,196202,197299,+,Strict,250,276.174,vanG,39.2,3002909,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,glycopeptide resistance gene cluster; Van ligase,ATGGCAAAGCAGCGCGTAGGTATTGTCTTTGGGGGAAAATCGGCAGAGCACGAGGTGTCATTGCAATCGGCTAAAAATATCGTTGATGCGATTGATAAAAGCCGTTTTGACGTGGTGTTGCTGGGCATTGATAAACAGGGCCAGTGGCATGTTAACGATGCCAGCCAGTATCTGTTACACGCTGACGATCCGGCGCACATTGCCCTTAATCCTTCTGATGTCAGCGTCGCAACGGTTCCAGGCGTGGAGCAGGGACAGCTTATCGATGCCGGGAACGCGCAGGCGCTGGCACAGATTGACGTAGTGTTCCCTATCGTTCACGGCACGCTGGGCGAAGACGGCTCTCTGCAAGGCATGTTGCGGATGGCAAACCTGCCGTTTGTCGGTTCCGATGTGCTGGGCTCTGCCGCCTGCATGGATAAAGACGTCACAAAACGTCTCCTGCGCGACGCCGGTCTGAATATTGCGCCGTTCGTGACGCTCACTCGCGCCAACCGCGATAAACACAGCTTCGCGCAGATCAAGGCGCAACTCGGCCTGCCGCTGTTTGTGAAACCGGCGAATCAGGGCTCGTCCGTCGGCGTCAGCAAAGTCACCAGCGAAGCGCAGTTTAACGATGCCGTTCGTCTGGCCTTTGAATTTGACCATAAGGTGGTGGTTGAGCAGGGAATTAACGGTCGTGAAATTGAGTGCGCCGTACTGGGCAACGACTTCCCGCAGGCGAGTACCTGTGGTGAAGTGGTACTGAACAGTGACTTCTATTCCTACGACACTAAATATATTGACGACAAAGGTGCCCAGGTTGTGGTTCCCGCCGCGCTCGATCCTGACGTTAACGACAAGATCCGGGCGATCGCCGTTGAAGCCTATCAGGCGCTGGGATGCTGTGGGATGGCGCGCGTCGACGTGTTTCTGACGCCGGATAACGAGGTGGTGATTAACGAAATCAACACTCTGCCGGGCTTTACCAATATCAGCATGTACCCGAAGCTGTGGCAGGCCAGCGGGATAAGCTATCCGGAACTGATCACCCGCCTGATTGAACTGGCGCTGGAGCGCCACGCCGCTGACAGCGCCCTGAAAAGTTCCGTTAACTAA,MAKQRVGIVFGGKSAEHEVSLQSAKNIVDAIDKSRFDVVLLGIDKQGQWHVNDASQYLLHADDPAHIALNPSDVSVATVPGVEQGQLIDAGNAQALAQIDVVFPIVHGTLGEDGSLQGMLRMANLPFVGSDVLGSAACMDKDVTKRLLRDAGLNIAPFVTLTRANRDKHSFAQIKAQLGLPLFVKPANQGSSVGVSKVTSEAQFNDAVRLAFEFDHKVVVEQGINGREIECAVLGNDFPQASTCGEVVLNSDFYSYDTKYIDDKGAQVVVPAALDPDVNDKIRAIAVEAYQALGCCGMARVDVFLTPDNEVVINEINTLPGFTNISMYPKLWQASGISYPELITRLIELALERHAADSALKSSVN,MQNKKIAVIFGGNSTEYEVSLQSASAVFENINTNKFDIIPIGITRSGEWYHYTGEKEKILNNTWFEDSKNLCPVVVSQNRSVKGFLEIASDKYRIIKVDLVFPVLHGKNGEDGTLQGIFELAGIPVVGCDTLSSALCMDKDRAHKLVSLAGISVPKSVTFKRFNEEAAMKEIEANLTYPLFIKPVRAGSSFGITKVIEKQELDAAIELAFEHDTEVIVEETINGFEVGCAVLGIDELIVGRVDEIELSSGFFDYTEKYTLKSSKIYMPARIDAEAEKRIQEAAVTIYKALGCSGFSRVDMFYTPSGEIVFNEVNTIPGFTSHSRYPNMMKGIGLSFSQMLDKLIGLYVE,104.58,gnl|BL_ORD_ID|1069|hsp_num:0,1157,FALSE,None
LK591,7_55 # 61770 # 62714 # 1 # ID=7_55;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.475,7_55,61770,62714,+,Strict,500,550.436,leuO,82.17,3003843,protein homolog model,n/a,n/a,nucleoside antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGCCAGAAAATAATATTAACCAACCACAGCCTTATGATGGGGTTAAGCCTCAGTTACGCACAGTGGATCTCAACCTGTTAACTGTATTTGATGCAGTTATGCAGGAGCAGAATATTACGCGAGCAGCGCAATCTCTGGGAATGTCTCAACCTGCCGTGAGTAATGCCGTAGCCAGACTTAAGGTGATGTTTAACGACGAGTTATTCGTCCGGTATGGAAGAGGTATCCAGCCCACGGCGCGTGCATTCCAGCTATTCGGTTCGATTCGTCAGGCGCTACAGCTGGTTCAAAATGAGCTTCCCGGCTCAGGGTTTGAACCTTTAAGCAGTGAGCGGGTTTTCCATCTCTGTGTTTGCAGTCCGTTAGACAATTATTTGACGTCTGTTATATATAATAAAGTTGAACAGATTGCTCCTAATATTCATCTCGTTTTTAAATCATCTTTAAATCAAAACACTGAGCACCAGCTTCGTTATCAGGAAACGGAGTTCGTTCTGGGCTACGAAGAGTTTCGCCGTCCAGAGTTTGCCTGTGTTCCGTTGTTTAAAGATGAAATGGTGTTAGTCGCCAGCAAAAAACATCCACGCATGAATTCGCCGCTGCGTGAAAGCGATGTTTACAGCGAGCAGCATGCCGTTGTTGCTCTGGACAGATATGCTTCGTTCAGTCAGCCGTGGTATGACACTGCCGATAAACAAGCCAGCGTGGCCTATCAGGGGATGGCGATGGTCAGCGTTTTAAATGTCGTTTCTCAGACGCAGCTAGTCGCTATTGCACCGCGCTGGCTTGCTGAAGAGTTCTCCGATTCGCTGAGCCTGCAAATTTTACCTCTGCCGCTCAAGCTGAATAGCCGTACCTGTTATCTTTCCTGGCATGAAGCGGCGGGGCGGGATAAAGGGCATCAGTGGATGGAAGAGTTGCTGATCAATATTTGTCGTCGATAA,MPENNINQPQPYDGVKPQLRTVDLNLLTVFDAVMQEQNITRAAQSLGMSQPAVSNAVARLKVMFNDELFVRYGRGIQPTARAFQLFGSIRQALQLVQNELPGSGFEPLSSERVFHLCVCSPLDNYLTSVIYNKVEQIAPNIHLVFKSSLNQNTEHQLRYQETEFVLGYEEFRRPEFACVPLFKDEMVLVASKKHPRMNSPLRESDVYSEQHAVVALDRYASFSQPWYDTADKQASVAYQGMAMVSVLNVVSQTQLVAIAPRWLAEEFSDSLSLQILPLPLKLNSRTCYLSWHEAAGRDKGHQWMEELLINICRR,MPEVQTDHPETAELSKPQLRMVDLNLLTVFDAVMQEQNITRAAHALGMSQPAVSNAVARLKVMFNDELFVRYGRGIQPTARAFQLFGSVRQALQLVQNELPGSGFEPASSERVFHLCVCSPLDSILTSQIYNHIEQIAPNIHVMFKSSLNQNTEHQLRYQETEFVISYEDFHRPEFTSVPLFKDEMVLVASKNHPTIKGPLLKHDVYNEQHAAVSLDRFASFSQTWYDTVDKQASIAYQGMAMMSVLSVVSQTHLVAIAPRWLAEEFAESLELQVLPLPLKQNSRTCYLSWHEAAGRDKGHQWMEEQLVSICKR,100,gnl|BL_ORD_ID|4928|hsp_num:0,5921,FALSE,None
LK591,9_157 # 178500 # 179732 # 1 # ID=9_157;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.583,9_157,178500,179732,+,Strict,700,720.694,Escherichia coli mdfA,87.47,3001328,protein homolog model,n/a,n/a,tetracycline antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGATAAACCGTTCTTCTTCCGGTAATCGTCTGGGTCGTCAGGCGTTACTTTTTCCTCTGTGTCTGGTGCTTTACGAATTCTCTACCTACATCGGCAACGACATGATCCAGCCAGGCATGCTGGCTGTGGTTGAGCAGTACAACGCAGGTATTGAGTGGGTACCTACATCCATGACCGCCTATCTGGCGGGCGGCATGTTTTTACAGTGGCTTTTAGGGCCGCTGTCGGATCGTATTGGCCGCCGCCCGGTGATGCTGACGGGCGTGGTGTGGTTTATCGTCACCTGTCTCGCCACGCTGCTGGCGCAGAACATTGAGCAATTCACGCTGCTGCGTTTCCTTCAGGGCGTGAGCCTGTGCTTTATTGGCGCCGTGGGCTACGCCGCTATTCAGGAGTCGTTTGAGGAGGCGGTATGTATCAAAATAACCGCGCTGATGGCGAACGTGGCGCTGATTGCGCCGCTTCTGGGGCCGCTGGTGGGAGCCGCATGGGTCCACGTTGCGCCGTGGGAAGGGATGTTCGTCCTCTTTGCCGCGCTTGCGGCCATCTCTTTCTTTGGGCTGCACCGTGCGATGCCGGAGACCGCCACCCGCCTGGGCGAAAAGCTCTCGCTTAAAGAGCTGGGGCGTGACTATAAGGCGGTGCTGAAAAACGGTCGTTTTGTCGCGGGCGCGCTGGCGACGGGCTTTGTCAGCCTGCCGCTGCTGGCGTGGATTGCCCAGTCGCCGGTCATTATCATCAGCGGCGAACAGCTTAGCAGCTATGAGTATGGCCTGTTACAGGTGCCGATTTTTGGCGCGCTGATTATCGGTAACCTGGTGCTGGCGCGTCTGACGTCCCGCCGTACCGTACGTTCGCTGATTATTATGGGTGGCTGGCCCATAGCGGCAGGGCTGATTATCGCGGCGGTGGCGACCGTAGTCTCGTCCCATGCGTACCTGTGGATGACGGCGGGGCTGAGCGTTTATGCGTTTGGTATTGGCGTGGCGAATGCCGGCCTGGTGCGCCTGACGCTGTTCGCCAGTGAAATGAGTAAAGGCACGGTGTCTGCCGCGATGGGGATGCTGCAAATGCTGATTTTCACCGTCGGAATTGAGGTGAGCAAGCATGCTTACGCGTTTGGCGGCAACGGGCTTTTCAGCCTGTTTAACCTCGCCAACGGCGTGCTGTGGATTGCCCTGATGGTGGTATTCCTGAAAGACAAACGCGTCGGAAACGCCCTGCAACCGTAA,MINRSSSGNRLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVEQYNAGIEWVPTSMTAYLAGGMFLQWLLGPLSDRIGRRPVMLTGVVWFIVTCLATLLAQNIEQFTLLRFLQGVSLCFIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWVHVAPWEGMFVLFAALAAISFFGLHRAMPETATRLGEKLSLKELGRDYKAVLKNGRFVAGALATGFVSLPLLAWIAQSPVIIISGEQLSSYEYGLLQVPIFGALIIGNLVLARLTSRRTVRSLIIMGGWPIAAGLIIAAVATVVSSHAYLWMTAGLSVYAFGIGVANAGLVRLTLFASEMSKGTVSAAMGMLQMLIFTVGIEVSKHAYAFGGNGLFSLFNLANGVLWIALMVVFLKDKRVGNALQP,MQNKLASGARLGRQALLFPLCLVLYEFSTYIGNDMRQPGMLENVEQYQAGIEWVPTSMNAYLAGGMFIQWLLGPLSDRIGRRPVMLAGVVWFIVTCLAILLAQNIEQFTLLRFLHGISLCFIGAVGYDAIQESFEEAVCIKITALMANVALIAPLLGPLVGASWIHVLPWEGMFVLFAALAAISFFGLQRAMPETATRIGEKLSLKELGRDYKLVLKNGRFVAGALALGFLSLPLLAWIAQSPIIIITGEQLSSYEYGLLQVPIFGALIAGNLLLARLTSRRTVRSLIIMGGWPIMIGLLVAAAATVISSHAYLWMTAGLSIYAFGIGLANAGLVRLTLFASVMSKGTVSAAMGMLQMLIFTVGIEISKHAWLNGGNGLFNLFNLVNGILLLSLMVIFLKDKQMGNSHEG,100,gnl|BL_ORD_ID|2421|hsp_num:0,37,FALSE,None
LK591,10_152 # 163310 # 166423 # 1 # ID=10_152;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.539,10_152,163310,166423,+,Strict,750,756.903,adeF,40.82,3000777,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; tetracycline antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGGCTAATTTCTTTATTCAACGGCCTGTTTTCGCCTGGGTACTCGCCATCATTCTGATGATTGCGGGCGGGCTGGCCATTTTAAAACTACCGGTCGCGCAATATCCGACCATTGCGCCGCCGGCGGTTGCGGTGACAGCAACCTACCCGGGCGCTGATGCCCAGACGGTACAGGACACCGTCACTCAGGTTATCGAACAGAACATGAACGGTATCGATAATTTGATGTACATGTCGTCCACCAGTGATTCCGCTGGTAACGTCACCATTACGCTGACGTTCGAGTCGGGTACAGATCCTGATATTGCGCAGGTGCAGGTTCAGAACAAACTCCAGCTCGCCATGCCGCTGCTGCCACAAGAAGTGCAGCAGCAGGGGATCGGCGTGGAGAAATCCAGCAGCAGCTTCCTGCTGGTTGCAGGCTTTGTGTCGGACAATAAAAACCTCACGCAGGATGATATCTCCGACTATGTCGCTTCTAATGTAAAAGATGCGATCAGCCGTACTTCCGGCGTCGGTGACGTGCAGCTGTTCGGTGCCCAGTATGCAATGCGCATCTGGCTGGACAGCAACGCGATGAACAAATATCAGCTCACGCCGCTGGATATCATTAACCAGCTAAAAACGCAGAACGACCAGATTGCTGCGGGCCAGTTGGGCGGAACACCGTCCGTACCTGGGCAGCAACTGAACGCCTCAATTATTGCTCAAACGCGTCTAAAATCGCCGGAGGAGTTTGGTCGTGTGACGCTGAAGGTGAACCAGGACGGTTCAATGGTCCACCTGAAAGATGTGGCCCGCATTGAGTTGGGTGGCGAAAACTACAACATGGTCACCAAAATCAATGGCCAGGCAGCAACGGGGCTGGGGATCAAGCTGGCGACTGGCGCAAACGCGCTGGATACCGCTGCCGCCATCAAGAGTAAACTGGCGCAGTTGCAGCCCTTCTTCCCTCAGGGCCTGAAAGTCGTGTATCCGTACGACACCACACCTTTCGTGAAGATCTCAATCCATGAAGTGGTGAAGACACTGTTTGAAGCGATTGTTCTCGTGTTCCTGGTGATGTACTTGTTCCTGCAAAACCTGCGGGCAACGCTTATTCCGACGATCGCCGTGCCCGTGGTGTTACTGGGCACCTTTGCGGTACTGGCTGCGTTCGGGTTCTCCATTAACACCCTGACGATGTTCGGGATGGTATTGGCTATAGGTCTGCTCGTCGATGACGCCATCGTGGTGGTCGAGAACGTAGAACGCGTCATGGTTGAGGACAAGCTGCCGCCAAAAGAGGCGACGCAGAAGTCGATGGAGCAAATCCAGGGCGCCCTGGTGGGCATTGCCATGGTGCTTTCGGCGGTATTTATCCCGATGGCATTCTTTGGTGGTTCAACCGGGGCTATCTATCGCCAGTTCTCGCTGACCATTGTCTCCGCGATGGCCTTGTCGGTACTGGTAGCGTTGATATTAACGCCTGCTCTTTGTGCAACGCTGCTCAAACCGGTTTCCAGCGAACATCATGAAAAGAAAGGTGGTTTCTTCGGCTGGTTTAACGCGCTCTTTGATAAAAGTGTGGAGCATTACAGCAACAGCGTGAGCGGCATTTTACGTAAGACCGGCCGCTATCTGCTGGTTTACGTCGTCATCGTCGGCGGCATGGCAGTTCTGTTCCTGCGCCTGCCTTCCTCCTTCCTGCCGGAAGAGGATCAGGGGGTGTTTATGACGATGGTTCAGTTGCCGGCAGGGGCGACGCAAATGCGTACTCAGCAGGTACTCGATCAGGTTCAGGATTATTACCTGACGAAAGAGAAAGCGAACGTTGAATCGGTCTTTACCGTAAACGGTTTTAGCTTTAGCGGACAGGGGCAGAACTCCGGTATCGCTTTCGTCAGCCTGAAGCCATGGGAAGAACGTCCGGGCAAGGAAAACGGCGTTGAGGCGATTGTCAGCCGCGCGACGAAAGCGTTCAGCCAGATCAAAGACGGTCTTGTATTTCCGTTTAACCTGCCTGCCATTAGTGAACTGGGTACCGCAACAGGCTTTGACTTTGAACTGATTGACCAGGCAAACCTGGGGCATACGCAGTTAACCCAGGCGCGTAACCAGCTGCTGGGCATGGTGAGAGAACATCCTGACTTACTGGTTCGCGTGCGTCCTAATGGACTGGAAGATACGCCACAGTTCAAGCTGGACGTCGATCAGGAGAAGGCACAGGCGCTGGGTGTGAGCGTGTCTGACGTCAATCAGACGATTTCAACAGCGCTGGGTGGCACCTATGTGAACGACTTTATCGATCACGGACGGGTGAAAAAAGTTTATGTCCAGGCTGATGCTCGCTTCCGTATGCTACCCGGAGACATTAACGGCCTGTATGTGCGTAGCGCTAACGGCGAAATGGTGCCTTTCTCTGCCTTTAGCAGCTCTCACTGGGTGTACGGTTCACCGCGTCTGGAACGTTACAATGGGATGCCATCAATGGAGATCCTCGGTGAGTCTGCCCCTGGCAAAAGTACCGGTGAGGCAATGGCGTTGATGGAAAGCCTTGCGTCAAAACTGCCTTCCGGCATCGGCTACGACTGGACGGGGATGTCTTATCAGGAACGACTTTCCGGGAATCAGGCTCCGGCGCTGTACGCCATTTCACTGATTGTGGTGTTCCTGTGTCTGGCGGCCCTCTATGAAAGTTGGTCAATTCCCTTCTCGGTCATGCTGGTTGTGCCGCTGGGGGTGATCGGCGCGCTTCTGGCTGCATCAATGCGAGGGCTGAACAATGACGTTTACTTCCAGGTTGGTCTGCTTACGACAATTGGTTTATCAGCCAAGAACGCCATACTGATCGTTGAGTTCGCCAAGGATCTCATGGATAAAGAAGGCAAAGGGATTATCGAAGCCACGCTTGAAGCCTCGCGTATGCGTCTGCGTCCTATCCTGATGACTTCCCTGGCATTCATCCTTGGTGTTATGCCTCTGGTCATCAGCAGCGGTGCAGGTAGTGGGGCACAAAATGCGGTCGGGACGGGCGTGATGGGCGGGATGCTGTCAGCCACCCTGTTGGCCATTTTCTTTGTTCCTGTTTTCTTTGTGGTTGTCCGGAGACGGTTTACAAAGCACAAGGATTAA,MANFFIQRPVFAWVLAIILMIAGGLAILKLPVAQYPTIAPPAVAVTATYPGADAQTVQDTVTQVIEQNMNGIDNLMYMSSTSDSAGNVTITLTFESGTDPDIAQVQVQNKLQLAMPLLPQEVQQQGIGVEKSSSSFLLVAGFVSDNKNLTQDDISDYVASNVKDAISRTSGVGDVQLFGAQYAMRIWLDSNAMNKYQLTPLDIINQLKTQNDQIAAGQLGGTPSVPGQQLNASIIAQTRLKSPEEFGRVTLKVNQDGSMVHLKDVARIELGGENYNMVTKINGQAATGLGIKLATGANALDTAAAIKSKLAQLQPFFPQGLKVVYPYDTTPFVKISIHEVVKTLFEAIVLVFLVMYLFLQNLRATLIPTIAVPVVLLGTFAVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVMVEDKLPPKEATQKSMEQIQGALVGIAMVLSAVFIPMAFFGGSTGAIYRQFSLTIVSAMALSVLVALILTPALCATLLKPVSSEHHEKKGGFFGWFNALFDKSVEHYSNSVSGILRKTGRYLLVYVVIVGGMAVLFLRLPSSFLPEEDQGVFMTMVQLPAGATQMRTQQVLDQVQDYYLTKEKANVESVFTVNGFSFSGQGQNSGIAFVSLKPWEERPGKENGVEAIVSRATKAFSQIKDGLVFPFNLPAISELGTATGFDFELIDQANLGHTQLTQARNQLLGMVREHPDLLVRVRPNGLEDTPQFKLDVDQEKAQALGVSVSDVNQTISTALGGTYVNDFIDHGRVKKVYVQADARFRMLPGDINGLYVRSANGEMVPFSAFSSSHWVYGSPRLERYNGMPSMEILGESAPGKSTGEAMALMESLASKLPSGIGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFSVMLVVPLGVIGALLAASMRGLNNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGIIEATLEASRMRLRPILMTSLAFILGVMPLVISSGAGSGAQNAVGTGVMGGMLSATLLAIFFVPVFFVVVRRRFTKHKD,MNISKFFIDRPIFAGVLSVLILLAGLLSVFQLPISEYPEVVPPSVVVRAQYPGANPKVIAETVASPLEESINGVEDMLYMQSQANSDGNLTITVNFKLGIDPDKAQQLVQNRVSQAMPRLPEDVQRLGVTTLKSSPTLTMVVHLTSPDNRYDMTYLRNYAVLNVKDRLARLQGVGEVGLFGSGDYAMRVWLDPQKVAQRNLTATEIVNAIREQNIQVAAGTIGASPSNSPLQLSVNAQGRLTTEQEFADIILKTAPDGAVTRLGDVARVELAASQYGLRSLLDNKQAVAIPIFQAPGANALQVSDQVRSTMKELSKDFPSSIKYDIVYDPTQFVRASIKAVVHTLLEAITLVVVVVILFLQTWRASIIPLLAVPVSIIGTFALMLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVERNIEAGLNPREATYRAMREVSGPIIAIALTLVAVFVPLAFMTGLTGQFYKQFAMTIAISTVISAFNSLTLSPALAALLLKGHDAKPDALTRIMNRVFGRFFALFNRVFSRASDRYSQGVSRVISHKASAMGVYAALLGLTVGISYIVPGGFVPAQDKQYLISFAQLPNGASLDRTEAVIRKMSDTALKQPGVESAVAFPGLSINGFTNSSSAGIVFVTLKPFDERKAKDLSANAIAGALNQKYSAIQDAYIAVFPPPPVMGLGTMGGFKLQLEDRGALGYSALNDAAQNFMKAAQSAPELGPMFSSYQINVPQLNVDLDRVKAKQQGVAVTDVFNTMQIYLGSQYVNDFNRFGRVYQVRAQADAPFRANPEDILQLKTRNSAGQMVPLSSLVNVTQTYGPEMVVRYNGYTSADINGGPAPGYSSSQAEAAVERIAAQTLPRGIKFEWTDLTYQKILAGNAGLWVFPISVLLVFLVLAAQYESLTLPLAVILIVPMGILAALTGVWLTAGDNNIFTQIGLMVLVGLACKNAILIVEFARELEMQGATAFKAAVEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMIGVTFFGLFLTPAFYVLIRTLNSKHKLHSAAVHEAPLASPHDH,97.92,gnl|BL_ORD_ID|132|hsp_num:0,153,FALSE,None
LK591,12_24 # 19259 # 20404 # -1 # ID=12_24;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.577,12_24,19259,20404,-,Perfect,700,783.482,ACT-44,100,3006239,protein homolog model,n/a,n/a,carbapenem; cephalosporin; cephamycin; penam,antibiotic inactivation,ACT beta-lactamase,ATGATGAAAAAATCCCTTTGCTGCGCCCTGCTGCTCGGCATCTCTTGCTCTGCTCTCGCCACGCCAGTGTCAGAAAAACAGCTGGCGGAGGTGGTAGCGAATACGGTTACCCCGCTGATGAAAGCCCAGTCTGTTCCAGGCATGGCGGTGGCCGTTATTTATCAGGGAAAACCGCACTATTACACGTTTGGCAAGGCCGATATCGCGGCGAATAAACCCGTTACGCCTCAGACCCTGTTCGAGCTGGGTTCTATAAGTAAAACCTTCACCGGCGTTTTAGGTGGGGATGCCATTGCTCGCGGTGAAATTTCGCTGGACGATCCGGTGACCAGATACTGGCCACAGCTGACGGGCAAGCAGTGGCAGGGTATTCGTATGCTGGATCTCGCCACCTACACCGCTGGCGGCCTGCCGCTACAGGTACCGGATGAGGTCACGGATAACGCCTCCCTGCTGCGCTTTTATCAAAACTGGCAGCCGCAGTGGAAGCCTGGCACAACGCGTCTTTACGCCAACGCCAGCATCGGTCTTTTTGGTGCGCTGGCGGTCAAACCTTCTGGCATGCCCTATGAGCAAGCCATGACGACGCGGGTCCTTAAGCCGCTCAAGCTGGACCATACCTGGATTAACGTGCCGAAAGCGGAAGAGGCGCATTACGCCTGGGGCTATCGTGACGGTAAAGCGGTGCGCGTTTCGCCGGGTATGCTGGATGCACAAGCCTATGGCGTGAAAACCAACGTGCAGGATATGGCGAACTGGGTCATGGCAAACATGGCGCCGGAGAACGTTGCTGATGCCTCACTTAAGCAGGGCATCGCGCTGGCGCAGTCGCGCTACTGGCGTATCGGGTCAATGTATCAGGGTCTGGGCTGGGAGATGCTCAACTGGCCCGTGGAGGCCAACACGGTGGTCGAGGGCAGCGACAGTAAGGTGGCGCTGGCGCCGTTGCCCGTGGCAGAAGTGAATCCACCGGCTCCCCCGGTCAAAGCGTCCTGGGTCCATAAAACGGGCTCTACTGGCGGGTTTGGCAGCTACGTGGCCTTTATTCCTGAAAAGCAGATCGGTATTGTGATGCTCGCGAATACAAACTATCCGAACCCGGCACGCGTTGAGGCGGCATACCATATCCTCGAGGCGCTACAGTAA,MMKKSLCCALLLGISCSALATPVSEKQLAEVVANTVTPLMKAQSVPGMAVAVIYQGKPHYYTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQWQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGALAVKPSGMPYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQAYGVKTNVQDMANWVMANMAPENVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEANTVVEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLANTNYPNPARVEAAYHILEALQ,MMKKSLCCALLLGISCSALATPVSEKQLAEVVANTVTPLMKAQSVPGMAVAVIYQGKPHYYTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQWQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGALAVKPSGMPYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQAYGVKTNVQDMANWVMANMAPENVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEANTVVEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLANTNYPNPARVEAAYHILEALQ,100,gnl|BL_ORD_ID|2362|hsp_num:0,4135,FALSE,None
LK591,14_29 # 23242 # 23874 # 1 # ID=14_29;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.509,14_29,23242,23874,+,Strict,400,432.95,CRP,99.05,3000518,protein homolog model,n/a,n/a,macrolide antibiotic; fluoroquinolone antibiotic; penam,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGGTGCTTGGCAAACCGCAAACAGACCCGACTCTCGAATGGTTCTTGTCTCATTGCCACATTCATAAGTACCCATCAAAGAGCACGCTGATTCACCAGGGTGAAAAAGCGGAAACGTTGTATTACATCGTTAAAGGCTCGGTGGCCGTGCTGATCAAAGATGAAGAAGGGAAAGAGATGATCCTTTCTTATCTGAACCAGGGCGATTTTATCGGTGAACTGGGCCTGTTTGAAGAAGGCCAGGAACGTAGCGCCTGGGTTCGTGCAAAAACAGCATGTGAAGTGGCTGAAATTTCTTACAAGAAATTCCGTCAGCTGATTCAGGTCAACCCTGACATCCTGATGCGTCTTTCTTCCCAGATGGCACGCCGTCTGCAAGTGACCTCTGAGAAGGTGGGTAACCTCGCCTTCCTGGACGTGACCGGTCGTATCGCGCAGACGCTGTTGAACCTGGCGAAACAGCCAGACGCCATGACCCACCCTGACGGTATGCAAATTAAAATTACCCGTCAGGAAATCGGTCAGATCGTCGGCTGCTCCCGTGAAACAGTGGGCCGTATCCTGAAGATGCTGGAAGACCAGAACCTGATCTCTGCCCACGGTAAAACTATCGTGGTCTACGGAACCCGTTAA,MVLGKPQTDPTLEWFLSHCHIHKYPSKSTLIHQGEKAETLYYIVKGSVAVLIKDEEGKEMILSYLNQGDFIGELGLFEEGQERSAWVRAKTACEVAEISYKKFRQLIQVNPDILMRLSSQMARRLQVTSEKVGNLAFLDVTGRIAQTLLNLAKQPDAMTHPDGMQIKITRQEIGQIVGCSRETVGRILKMLEDQNLISAHGKTIVVYGTR,MVLGKPQTDPTLEWFLSHCHIHKYPSKSKLIHQGEKAETLYYIVKGSVAVLIKDEEGKEMILSYLNQGDFIGELGLFEEGQERSAWVRAKTACEVAEISYKKFRQLIQVNPDILMRLSAQMARRLQVTSEKVGNLAFLDVTGRIAQTLLNLAKQPDAMTHPDGMQIKITRQEIGQIVGCSRETVGRILKMLEDQNLISAHGKTIVVYGTR,100,gnl|BL_ORD_ID|803|hsp_num:0,869,FALSE,None
LK591,18_48 # 54654 # 55475 # -1 # ID=18_48;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.568,18_48,54654,55475,-,Strict,500,512.686,bacA,95.24,3002986,protein homolog model,n/a,n/a,peptide antibiotic,antibiotic target alteration,undecaprenyl pyrophosphate related proteins,ATGAGCGATATGCACTCGCTGCTGGTGGCGGCAATACTGGGTGTGGTCGAAGGATTGACGGAGTTTTTGCCGGTGTCCAGTACGGGCCATATGATTATCGTTGGCCATCTCCTGGGCTTTGAAGGCGATACCGCAAAGACGTTTGAGGTGGTTATTCAGCTGGGCTCTATCCTGGCGGTGGTCGTGATGTTCTGGCGACGTCTGTTTGGTCTGATCGGTATCCACTTCGGGCGTTTGCCGCAGCGTGAAGGAGAGGGCAAAGGGCGCCTGACGCTGATTCATATTCTGCTCGGGATGATCCCGGCGGTGGTGCTGGGGCTGGTGTTCCACGACACCATTAAATCGCTCTTCAACCCGATTAACGTGATGTACGCGCTGGTTGTCGGCGGCTTCCTGCTGATTGCCGCCGAAGTGCTGAAGCCAAAAACCCCGCGTGCGGAAGGTCTGGACGATATGACGTATCGCCAGGCGTTTATGATTGGCTGCTTCCAGTGTCTGGCGCTGTGGCCGGGCTTCTCCCGTTCAGGGGCAACCATTTCCGGCGGGATGCTGATGGGCGTGAGCCGTTACGCGGCGTCTGAGTTCTCGTTCCTGCTGGCGGTGCCGATGATGATGGGCGCCACCGCGCTGGATCTCTACAAAAGCATCGGCTTCCTGACCGTGGGCGACATTCCGATGTTCGCCGTGGGCTTTATCACCGCCTTTATTGTGGCGTTGATCGCCATCAAAACCTTCCTGCAACTGATTAAGCGTATTTCGTTTATTCCGTTCGCGATCTACCGCTTTATCGTCGCGGCTGCCGTGTACGTGGTCTTCTTCTGA,MSDMHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAVVVMFWRRLFGLIGIHFGRLPQREGEGKGRLTLIHILLGMIPAVVLGLVFHDTIKSLFNPINVMYALVVGGFLLIAAEVLKPKTPRAEGLDDMTYRQAFMIGCFQCLALWPGFSRSGATISGGMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSIGFLTVGDIPMFAVGFITAFIVALIAIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF,MSDMHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAVVVMFWRRLFGLIGIHFGRPLQHEGESKGRLTLIHILLGMIPAVVLGLLFHDTIKSLFNPINVMYALVVGGLLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATISGGMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSWGFLTSGDIPMFAVGFITAFVVALIAIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF,100,gnl|BL_ORD_ID|1681|hsp_num:0,1820,FALSE,None
LK591,21_42 # 51204 # 52187 # 1 # ID=21_42;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.599,21_42,51204,52187,+,Strict,550,585.104,PmrF,85.23,3003578,protein homolog model,n/a,n/a,peptide antibiotic,antibiotic target alteration,pmr phosphoethanolamine transferase,ATGTTCAGTGCGCCGCCTGTACAAAAAGTTTCCGTGGTGATCCCGGTCTATAACGAGCAGGAGAGCCTGCCGGAACTCATCCGCCGCACGACTGCCGCCTGCGAGACGCTCGGCAAAGCTTATGAAATTCTGCTGGTTGACGACGGCAGCAGCGACGACTCCGCGCGGATGCTGACCGACGCCGCGCAAGCGGAGGGCAGCCACATTGTTGCCGTACTGCTCAACCGTAACTACGGCCAGCACTCGGCAATTATGGCCGGGTTCAGCCACGTTACGGGCGATCTGGTGATTACCCTGGATGCTGATCTGCAAAACCCGCCGGAAGAGATCCCGCGTCTGGTCGCCAAAGCCGACGAAGGCTACGACGTGGTCGGCACCGTGCGGCAAAACCGCCAGGACAGCCTGTTCCGTAAGCTGGCGTCTCGCACCATCAACCGTCTGATCCAGCGCACCACCGGTAAAGCGATGGGCGACTACGGCTGCATGCTGCGCGCCTATCGCCGCCACATCGTCGACGCCATGTTGCACTGCCATGAGCGCAGCACCTTCATTCCGATTCTGGCGAACATCTTTGCCCGTAAAGCGACGGAGATCCCGGTGCTGCACGCCGAGCGCGAGCACGGGGAGTCAAAGTACAGCTTTATGCGTCTCATCAACCTGATGTACGACCTGATCACCTGCCTGACCACCACGCCGCTGCGCCTGCTGAGCGTGTTCGGCAGCGTTATCGCGCTGGCCGGGTTTGCGCTTTCCGTTCTGCTGGTCGTTCTGCGGCTGGTCTTTGGTCCCCAGTGGGCGGCGGAAGGGGTCTTTATGCTGTTTGCCGTGCTGTTCACGTTCATTGGCGCCCAGTTCATCGGTATGGGTCTGCTGGGTGAGTACATTGGCCGTATTTACAACGATGTTCGCGCGCGTCCGCGCTATTTTATTCAACGTGTTGTCCGTCAGGAGCACCTGGCATCTCAAGAGGAAAACCACCCATGA,MFSAPPVQKVSVVIPVYNEQESLPELIRRTTAACETLGKAYEILLVDDGSSDDSARMLTDAAQAEGSHIVAVLLNRNYGQHSAIMAGFSHVTGDLVITLDADLQNPPEEIPRLVAKADEGYDVVGTVRQNRQDSLFRKLASRTINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHERSTFIPILANIFARKATEIPVLHAEREHGESKYSFMRLINLMYDLITCLTTTPLRLLSVFGSVIALAGFALSVLLVVLRLVFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYNDVRARPRYFIQRVVRQEHLASQEENHP,MFEIHPVKKVSVVIPVYNEQESLPELIRRTTTACESLGKEYEILLIDDGSSDNSAHMLVEASQAENSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEGYDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHERSTFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLGSIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYTDVRARPRYFVQQVIRPSSKENE,101.55,gnl|BL_ORD_ID|1937|hsp_num:0,2014,FALSE,None
LK591,30_39 # 39304 # 39666 # 1 # ID=30_39;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.460,30_39,39304,39666,+,Strict,150,195.667,Klebsiella pneumoniae KpnE,84.17,3004580,protein homolog model,n/a,n/a,macrolide antibiotic; aminoglycoside antibiotic; cephalosporin; tetracycline antibiotic; peptide antibiotic; rifamycin antibiotic; disinfecting agents and antiseptics,antibiotic efflux,small multidrug resistance (SMR) antibiotic efflux pump,ATGTTTTACTGGATTTTATTAGCTCTGGCGATCGTCGCTGAAATTACCGGCACCTTGTCGATGAAATGGGCAAGCGTGAGTGATGGCAGCACCGGTTTTATTTTGATGCTGGTCATGATTACGCTTTCCTATATTTTCCTCTCTTTTGCGGTTAAAAAAATCGCGCTGGGCGTGGCATACGCATTGTGGGAAGGTATTGGTATTTTATTGATTACGCTGTTTAGCGTCATGTTATTTGATGAAACCCTGACGACAATGAAAATTGCCGGGCTGACGACCCTGGTCGCAGGTATCGTGCTGATTAAATCGGGTACACGCAAACCGGCAAAACAGCAGAAGGAGCAGACCCATGCAGCAGTTTGA,MFYWILLALAIVAEITGTLSMKWASVSDGSTGFILMLVMITLSYIFLSFAVKKIALGVAYALWEGIGILLITLFSVMLFDETLTTMKIAGLTTLVAGIVLIKSGTRKPAKQQKEQTHAAV,MFYWILLALAIIAEITGTLSMKWASVSGGHTGFILMLAMIALSYIFLAFAVKKIALGVAYALWEGIGILLITLFSVLLFDESLSLLKIAGLTTLVIGIVLIKSGTQKKASSQQEVAHAAV,100,gnl|BL_ORD_ID|2721|hsp_num:0,3283,FALSE,None
LK591,30_40 # 39653 # 39982 # 1 # ID=30_40;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.552,30_40,39653,39982,+,Strict,150,192.2,Klebsiella pneumoniae KpnF,88.07,3004583,protein homolog model,n/a,n/a,macrolide antibiotic; aminoglycoside antibiotic; cephalosporin; tetracycline antibiotic; peptide antibiotic; rifamycin antibiotic; disinfecting agents and antiseptics,antibiotic efflux,small multidrug resistance (SMR) antibiotic efflux pump,ATGCAGCAGTTTGAATGGATCCACGCGGCCTGGCTGGCTTTCGCCATCGTTCTGGAAATTATTGCCAACGTCTTTCTGAAGTTCTCCGACGGTTTTCGTCGTAAAGCCTACGGCCTGTTATCGATTGCCGCGGTTCTGGGGGCGTTTAGCGCCCTGTCACAGGCGGTGAAAGGCATCGATCTGTCCGTAGCCTATGCGCTGTGGGGGGGCTTCGGTATTGCCGCCACCCTGGCGGCAGGCTGGATTATGTTCGGGCAGCGTTTAAACAATAAAGGCTGGATAGGGCTGGTATTACTGCTCGCCGGCATGATCATGATTAAACTGGCCTGA,MQQFEWIHAAWLAFAIVLEIIANVFLKFSDGFRRKAYGLLSIAAVLGAFSALSQAVKGIDLSVAYALWGGFGIAATLAAGWIMFGQRLNNKGWIGLVLLLAGMIMIKLA,MQQFEWIHAAWLAIAIVLEIIANVFLKFSDGFRRKIYGILSLAAVLGAFSALSQAVKGIDLSVAYALWGGFGIAATIAAGWVLFGQRLNNKGWAGVILLVAGMVLIKLA,100,gnl|BL_ORD_ID|2723|hsp_num:0,3286,FALSE,None
LK591,37_12 # 12259 # 12981 # -1 # ID=37_12;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.591,37_12,12259,12981,-,Strict,450,467.233,baeR,95,3000828,protein homolog model,n/a,n/a,aminoglycoside antibiotic; aminocoumarin antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGACCGAGTTACCGATTGACGACAACACACCGCGTATTTTGATCGTGGAAGACGAGCCTAAACTTGGACAACTGCTGATCGACTATTTGCGTGCCGCAAGTTACGCGCCAACGCTTATCAGCCACGGCGACCAGGTGCTGCCCTACGTGCGCCAGACGCCGCCGGATCTGATCCTGCTGGATCTGATGCTGCCGGGTACCGACGGCCTGACCCTGTGCCGGGAAATTCGTCGTTTCTCCGATGTGCCCATCGTGATGGTGACGGCCAAAATCGAAGAGATCGACCGTCTGCTGGGGCTCGAAATCGGCGCCGACGATTACATCTGCAAGCCTTACAGCCCGCGGGAGGTGGTCGCTCGGGTGAAAACCATCCTCCGCCGCTGTAAGCCGCAGCGTGAATTGCAGGTGCTGGATGCGCAAAGCCCGCTGATTGTCGACGAAAGCCGCTTCCAGGCGAGCTGGCGCAGCAAACTATTGGATCTTACCCCAGCGGAGTTCCGCCTGCTGAAAACGCTCTCCCACGAGCCGGGAAAAGTGTTTTCCCGCGAGCAGCTGCTCAACCATCTGTATGACGATTACCGCGTGGTGACCGACCGCACCATCGACAGCCACATCAAAAACCTGCGCCGCAAGCTGGAGGCACTGGACGCCGACCAGTCGTTTATTCGCGCGGTGTACGGCGTGGGTTATCGCTGGGAAGCGGATGCGTGCAGGATTGCTTAA,MTELPIDDNTPRILIVEDEPKLGQLLIDYLRAASYAPTLISHGDQVLPYVRQTPPDLILLDLMLPGTDGLTLCREIRRFSDVPIVMVTAKIEEIDRLLGLEIGADDYICKPYSPREVVARVKTILRRCKPQRELQVLDAQSPLIVDESRFQASWRSKLLDLTPAEFRLLKTLSHEPGKVFSREQLLNHLYDDYRVVTDRTIDSHIKNLRRKLEALDADQSFIRAVYGVGYRWEADACRIA,MTELPIDENTPRILIVEDEPKLGQLLIDYLRAASYAPTLISHGDQVLPYVRQTPPDLILLDLMLPGTDGLTLCREIRRFSDIPIVMVTAKIEEIDRLLGLEIGADDYICKPYSPREVVARVKTILRRCKPQRELQQQDAESPLIIDEGRFQASWRGKMLDLTPAEFRLLKTLSHEPGKVFSREQLLNHLYDDYRVVTDRTIDSHIKNLRRKLESLDAEQSFIRAVYGVGYRWEADACRIV,100,gnl|BL_ORD_ID|1231|hsp_num:0,1337,FALSE,None
LK591,37_15 # 15794 # 18871 # -1 # ID=37_15;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.613,37_15,15794,18871,-,Strict,1800,1880.92,mdtC,92.2,3000794,protein homolog model,n/a,n/a,aminocoumarin antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,GTGAAGTTTTTCGCCCTCTTCATTTACCGTCCGGTGGCGACGATTTTACTCTCCGTCGCTATCACCCTGTGCGGCGTGCTGGGCTTCCGGCTGCTGCCGGTGGCCCCGCTGCCGCAGGTCGATTTCCCGGTGATCATGGTCAGCGCCTCGCTGCCGGGTGCATCGCCGGAAACCATGGCGTCATCGGTGGCGACGCCGCTTGAGCGCTCGCTTGGGCGAATTGCCGGGGTTAACGAGATGACCTCCAGCAGTTCGCTGGGCAGCACGCGCATCATTCTGGAATTTAACTTCGACCGGGATATCAACGGCGCGGCGCGTGACGTGCAGGCCGCGATTAACGCCGCCCAAAGCCTGCTGCCGAGCGGCATGCCGAGCCGTCCAACCTACCGCAAGGCTAACCCGTCCGACGCGCCGATCATGATCCTGACGCTCACGTCAGGGACCTACTCCCAGGGCGAGCTGTACGATTTTGCCTCCACCCAGCTGGCGCAAACCATCGCCCAGATTGACGGCGTGGGCGACGTGGACGTCGGCGGCAGCTCTCTGCCCGCCGTGCGCGTGGGGCTGAATCCGCAGGCGCTGTTTAACCAGGGCGTGTCGCTGGACGACGTGCGTTCCGCCATCAGCAACGCCAACGTGCGTAAGCCGCAGGGCGCGATTGAGGACAGCAGCCACCGCTGGCAGATCCAGACCAACGACGAGCTGAAAACCGCCGCCGAGTATCAGCCGTTGATTATTCACTACAACAACGGCGCGGCGGTGCGCCTGAGCGACGTCGCCAGCGTCACCGATTCGGTGCAGGACGTGCGTAACGCCGGGATGACCAACGCCAAACCGGCGATTTTGCTGATGATCCGCAAGCTGCCGGAAGCCAACATCATCCAGACGGTGAACAGCATCCGCGCGCGCCTGCCGGAACTCCAGGAAACGATTCCGGCGGCCATCGACCTCCAGATTGCGCAGGACCGCTCCCCTACCATCCGCGCCTCGCTTGAGGAGGTAGAGCAAACGCTGATTATCTCCGTCGCGCTGGTGATCCTGGTGGTGTTCCTGTTCCTGCGCTCGGGGCGCGCCACGCTGATCCCGGCGGTGGCGGTTCCGGTATCGCTGATAGGCACCTTTGCCGCCATGTACCTGTGCGGGTTTAGTCTTAACAACCTGTCGCTGATGGCGCTGACGATTGCCACCGGGTTTGTAGTGGATGACGCCATCGTGGTGCTGGAGAATATCTCGCGCCATCTGGAAGCGGGCATGAAGCCGCTCCAGGCGGCGCTTCAGGGGACGCGCGAAGTGGGCTTCACGGTCCTGTCCATGAGCCTGTCGCTGGTGGCGGTGTTCCTGCCGCTGCTGCTGATGGGCGGCCTGCCGGGGCGACTGCTGCGCGAATTTGCCGTCACGCTTTCCGTCGCCATCGGTATCTCCCTGGTGATTTCGCTGACGCTGACGCCGATGATGTGCGGCTGGATGCTAAAGCGCAGCCAACCGCACTCGCAGCCGCGCAGGAAAGGCTTTGGCCGCGTCCTGATAGCGATGCAGTCAGGCTATGGCAAATCGCTGAAATGGGTGCTGAACCACACGCGTCTTGTCGGGCTGGTGCTGATCGGCACCATTGTGCTCAACGTCTGGATGTATATCACCATCCCGAAAACCTTCTTCCCGGAGCAGGATACCGGCGTGCTGATGGGCGGTATTCAGGCGGACCAGAGTATTTCGTTCCAGGCGATGCGGGGCAAACTGCAAGACTTTATGAAAATCATCCGGGAAGATCCGGCCGTGGATAACGTCACCGGCTTTACCGGCGGCTCGCGCGTTAACAGCGGGATGATGTTTATTACCCTTAAGCCGCGCGGTGAACGTCACGAAACGGCGCAGCAGATCATTGACCGCCTGCGGCTGAAGCTCGCCAAAGAGCCGGGGGCAAATCTGTTTTTGATGGCCGTTCAGGATATCCGCGTCGGCGGACGACAGGCTAACGCCAGCTATCAGTACACCCTGCTCTCGGATGACTTAGCCGCCCTGCGCGAATGGGAGCCGAAGATCCGTAAAGCGCTGGCCGCGCTGCCGCAGCTGGCGGACGTGAACTCCGACAGCCAGAATAACGGCGCGGAGATGGCGCTCACCTACGATCGCGAAACCATGTCCCGCCTGGGCATTAACGTTGAAGCGGCCAACAGCCTGCTTAACAACGCCTTCGGGCAGCGTGAAGTCTCCACCATCTATCAGCCGATGAACCAGTACAAGGTGGTGATGGAAGTTGATCCGCGCTACACCCAGGACATCAGCGCGCTGGACAAGATGTTTGTGATCAATAATGACGGCAAGGCGATCCCGCTGTCGTACTTCGCCAGCTGGCAGCCGTCGAACGCGCCGCTGTCGGTGAACCACCAGGGGCTTTCCGCCGCCTCGACCGTGTCGTTTAACCTGCCAACCGGCTCGTCGCTGTCTGAGGCCAGCGACGCCATCAACCGCGCCATGACCCAGCTCGGGGTGCCCTCCTCCGTGCGCGGCAGCTTTGCCGGTACGGCGCAGGTGTTCCAGGACACCATGAACTCGCAGGTCATTTTGATTCTGGCGGCTATTGCCACGGTTTATATCGTGCTGGGCGTGCTGTACGAAAGCTATGTGCACCCGTTGACCATTCTCTCCACGCTGCCTTCTGCGGGCGTGGGGGCGCTGCTGGCGCTGGAGCTGTTCGGTGCCCCGTTCAGCCTAATCGCGCTCATCGGGATCATGCTATTAATAGGTATTGTGAAGAAAAACGCGATTATGATGGTCGACTTTGCCCTGGACGCCCAGCGTAACGGCAACCTGACGCCGGACGAGGCGATATTCCAGGCCTGTCTGCTGCGTTTTCGCCCGATCATGATGACCACGCTGGCCGCGCTATTCGGTGCGCTACCGCTGGTTATATCCGGCGGTGACGGCTCTGAACTGCGCCAGCCGCTGGGGATCACGATTGTCGGCGGCCTGGTGATGAGCCAGCTGCTGACGCTCTACACCACGCCGGTAGTCTATCTGTTCTTTGACCGACTGCGGCTGCGTTTTTCGCGTAAAAAGAGAACCACGGTGACCGAGTAA,MKFFALFIYRPVATILLSVAITLCGVLGFRLLPVAPLPQVDFPVIMVSASLPGASPETMASSVATPLERSLGRIAGVNEMTSSSSLGSTRIILEFNFDRDINGAARDVQAAINAAQSLLPSGMPSRPTYRKANPSDAPIMILTLTSGTYSQGELYDFASTQLAQTIAQIDGVGDVDVGGSSLPAVRVGLNPQALFNQGVSLDDVRSAISNANVRKPQGAIEDSSHRWQIQTNDELKTAAEYQPLIIHYNNGAAVRLSDVASVTDSVQDVRNAGMTNAKPAILLMIRKLPEANIIQTVNSIRARLPELQETIPAAIDLQIAQDRSPTIRASLEEVEQTLIISVALVILVVFLFLRSGRATLIPAVAVPVSLIGTFAAMYLCGFSLNNLSLMALTIATGFVVDDAIVVLENISRHLEAGMKPLQAALQGTREVGFTVLSMSLSLVAVFLPLLLMGGLPGRLLREFAVTLSVAIGISLVISLTLTPMMCGWMLKRSQPHSQPRRKGFGRVLIAMQSGYGKSLKWVLNHTRLVGLVLIGTIVLNVWMYITIPKTFFPEQDTGVLMGGIQADQSISFQAMRGKLQDFMKIIREDPAVDNVTGFTGGSRVNSGMMFITLKPRGERHETAQQIIDRLRLKLAKEPGANLFLMAVQDIRVGGRQANASYQYTLLSDDLAALREWEPKIRKALAALPQLADVNSDSQNNGAEMALTYDRETMSRLGINVEAANSLLNNAFGQREVSTIYQPMNQYKVVMEVDPRYTQDISALDKMFVINNDGKAIPLSYFASWQPSNAPLSVNHQGLSAASTVSFNLPTGSSLSEASDAINRAMTQLGVPSSVRGSFAGTAQVFQDTMNSQVILILAAIATVYIVLGVLYESYVHPLTILSTLPSAGVGALLALELFGAPFSLIALIGIMLLIGIVKKNAIMMVDFALDAQRNGNLTPDEAIFQACLLRFRPIMMTTLAALFGALPLVISGGDGSELRQPLGITIVGGLVMSQLLTLYTTPVVYLFFDRLRLRFSRKKRTTVTE,MKFFALFIYRPVATILLSVAITLCGILGFRMLPVAPLPQVDFPVIIVSASLPGASPETMASSVATPLERSLGRIAGVSEMTSSSSLGSTRIILQFDFDRDINGAARDVQAAINAAQSLLPSGMPSRPTYRKANPSDAPIMILTLTSDTYSQGELYDFASTQLAPTISQIDGVGDVDVGGSSLPAVRVGLNPQALFNQGVSLDDVRTAVSNANVRKPQGALEDGTHRWQIQTNDELKTAAEYQPLIIHYNNGGAVRLGDVATVTDSVQDVRNAGMTNAKPAILLMIRKLPEANIIQTVDSIRAKLPELQETIPAAIDLQIAQDRSPTIRASLEEVEQTLIISVALVILVVFLFLRSGRATIIPAVSVPVSLIGTFAAMYLCGFSLNNLSLMALTIATGFVVDDAIVVLENIARHLEAGMKPLQAALQGTREVGFTVLSMSLSLVAVFLPLLLMGGLPGRLLREFAVTLSVAIGISLLVSLTLTPMMCGWMLKASKPREQKRLRGFGRMLVALQQGYGKSLKWVLNHTRLVGVVLLGTIALNIWLYISIPKTFFPEQDTGVLMGGIQADQSISFQAMRGKLQDFMKIIRDDPAVDNVTGFTGGSRVNSGMMFITLKPRDERSETAQQIIDRLRVKLAKEPGANLFLMAVQDIRVGGRQSNASYQYTLLSDDLAALREWEPKIRKKLATLPELADVNSDQQDNGAEMNLVYDRDTMARLGIDVQAANSLLNNAFGQRQISTIYQPMNQYKVVMEVDPRYTQDISALEKMFVINNEGKAIPLSYFAKWQPANAPLSVNHQGLSAASTISFNLPTGKSLSDASAAIDRAMTQLGVPSTVRGSFAGTAQVFQETMNSQVILIIAAIATVYIVLGILYESYVHPLTILSTLPSAGVGALLALELFNAPFSLIALIGIMLLIGIVKKNAIMMVDFALEAQRHGNLTPQEAIFQACLLRFRPIMMTTLAALFGALPLVLSGGDGSELRQPLGITIVGGLVMSQLLTLYTTPVVYLFFDRLRLRFSRKPKQTVTE,100,gnl|BL_ORD_ID|1212|hsp_num:0,1315,FALSE,None
LK591,37_16 # 18872 # 21994 # -1 # ID=37_16;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.616,37_16,18872,21994,-,Strict,1800,1853.95,mdtB,90.29,3000793,protein homolog model,n/a,n/a,aminocoumarin antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGCAGGTCTTGCCGCCGAGCTCTACAGGTGGGCCATCACGCCTGTTTATCTTACGTCCGGTTGCGACGACCCTGCTGATGGTGGCGATCCTGCTGGCCGGGATCATTGGCTACCGTTTTCTGCCCGTGTCGGCGCTGCCGGAAGTGGACTACCCGACCATTCAGGTTGTCACCCTCTATCCGGGCGCCAGTCCGGATGTGGTGACGTCCGCCATCACCGCCCCGCTGGAGCGTCAGTTTGGCCAGATGTCTGGCCTGAAGCAGATGTCTTCCCAGAGTTCCGGTGGCGCTTCGGTCGTCACGCTTCAGTTCCAGCTTACGCTGTCGCTGGACGTCGCTGAGCAGGAGGTGCAGGCCGCGATTAACGCCGCCACAAACCTGCTGCCGTCTGACCTGCCGAATCCACCTGTTTACAGCAAGGTCAACCCGGCGGATCCGCCGATCATGACCCTTGCCGTCACCTCCTCCGCCATGCCGATGACCCAGGTCGAAGACATGGTTGAAACCCGCGTGGCGCAGAAGATTTCGCAGGTGACCGGCGTGGGGCTGGTGACGCTGGCGGGCGGTCAACGCCCCGCCGTGCGCGTCAAACTGAATGCCCAGGCCATTGCGGCGCTGGGGTTAACCAGCGAAACCATTCGCACCGCCATCAGCAGCGCCAACGTCAACTCAGCGAAGGGTTCGCTGGACGGCCCGACCCGCGCGGTCACGCTCTCCGCCAACGACCAGATGCAGTCCGCCGATGAGTACCGTCAGCTGATCATTGCCTACCAGAACGGCGCGCCGATCCGTTTGGGCGACGTGGCAACCGTTGAACAAGGCGCGGAAAACAGCTGGCTCGGGGCGTGGGCCAATAAGCAGCAGGCGATTGTCATGAACGTTCAGCGCCAGCCGGGCGCGAACATTATTGATACCGCCGACAGCATTCGCACCATGCTGCCGCAGCTGGTGGAAAGCCTGCCAAAATCGGTCAGCGTGAAAGTGCTCTCTGACCGCACCACGAATATTCGCGCGTCAGTGACCGACACCCAGTTCGAGCTGATGCTGGCGATTGCGCTGGTGGTGATGATCATCTACCTGTTCCTGCGCAACGTCCCGGCAACCATCATTCCCGCCGTCGCCGTGCCGCTCTCGCTGGTCGGAACGTTCGCGGTGATGGTGTTCCTCGACTTCTCGATTAACAACCTGACGCTGATGGCGCTCACCATCGCCACCGGGTTTGTGGTGGACGACGCCATCGTGGTAATCGAGAACATCTCGCGCTATATCGAAAAAGGTGAAAAGCCGTTAGCCGCCGCGCTGAAGGGCGCGGGGGAGATTGGCTTTACCATTATCTCACTCACCTTCTCGCTGATTGCGGTGCTGATCCCGCTGCTGTTTATGGGCGATATCGTCGGGCGGCTGTTCCGCGAGTTTGCCGTGACGCTGGCGGTCGCCATTCTGATCTCTGCCGTGGTGTCGCTGACGCTGACGCCGATGATGTGCGCCCGCATGCTGAGCCACGAGTCCTTGCGCAAGCAAAACCGCTTCTCGCGCGCCTCCGAGCGGATGTTCGAGCGCATTATCGCCGCCTACGGCCGCGTGCTGGCGAAAGTGCTGAACCATCCGTGGGCAACGCTCGGCGTGGCGCTCGGCACCCTGGCGCTCAGCGTCATGCTGTGGATTTTCATTCCGAAAGGCTTCTTCCCGATTCAGGACAACGGCATTATTCAGGGCACGCTTCAGGCGCCGCAGACGGTCTCCTTCGCCAACATGGCGCAGCGCCAGCAGCAGGTGTCTGAGATCATCATGAAAGATCCGGCGGTGGAAAGCCTGACTGCCTACGTGGGCGTGGACGGCACCAACCCGTCGCTCAACAGCGCGCGCCTGCAAATTAACCTTAAACCGCTCGATGACCGCGACGATCGCGTTAACGCGGTGATTGAACGCCTGCAAAGCGCGGTGGCGCGCGTGCCGGGCATTGAGCTGTATCTGCAACCGATCCAGGATTTAACCATTGATACGCAGGTGAGCCGCACGCAGTACCAGTTTACGCTCCAGGCCACCTCGCTTGAGGCACTGAGCACCTGGGTGCCGCAGCTGGTGGACAAGCTGAAAGCACTGCCGCAGGTTTCTGACGTCAGCAGCGACTGGCAGGATAAAGGGCTGGCGGCGTACGTGAACGTCAACCGCGACACCGCCAGCCGTCTGGGCATTACCATGTCCGACGTGGATAACGCCCTGTATAACGCCTTTGGCCAGCGCCTGATCTCCACCATCTATACCCAGGCCAACCAGTATCGCGTGGTGCTGGAACATAACACCGAAAACACGCCCGGGCTGGCCGCGCTGGACACGGTGCGCCTGACCAGCAAAGACGGCGGGATTGTGCCGCTCAGCGCCATTGCCAGCGTGGAAGAGCGCCACACCCCACTGTCGATTAACCATCTCGATCAGTTCCCGTCCACCACCATTTCGTTCAACGTGCCGGACGGGTATTCCCTGGGCGAAGCGGTGGAGGCCATTCTGGGCGCGGAGAAAGAACTCAGCTTCCCGTCCGATATTCAGACCCAGTTCCAGGGCAGTACGCTGGCGTTCCAGGCCGCGCTGGGCAGCACCGTCTGGCTGATTGTCGCGGCGGTGGTGGCGATGTATATCGTGCTTGGCGTGCTGTATGAAAGCTTTATCCATCCGATCACCATCCTCTCCACCCTGCCGACAGCGGGCGTGGGGGCGTTGCTGGCGCTGATGCTGGCGGGGAGCGAGCTGGACGTCATTGCGATCATCGGCATCATCCTGCTTATCGGCATTGTGAAGAAAAACGCCATCATGATGATCGACTTTGCGCTGGCCGCCGAGCGCGAGCAGGGTATGGCGCCGCGCGAGGCCATTTACCAGGCCTGTCTGCTGCGTTTTCGTCCGATCCTGATGACCACCCTCGCCGCCCTGCTGGGCGCGCTGCCGCTGATGCTGAGCACCGGCGTGGGGGCCGAACTGCGCCGTCCGCTGGGCATCGGGATGGTGGGCGGCCTGCTGGTGAGCCAGGTGCTGACGCTGTTTACCACGCCGGTTATCTACCTGCTGTTTGACCGTCTGGCCCTGTGGACGAAAAGTCGCTTCCCGAAACGTGAAGAGGAGGCGTAA,MQVLPPSSTGGPSRLFILRPVATTLLMVAILLAGIIGYRFLPVSALPEVDYPTIQVVTLYPGASPDVVTSAITAPLERQFGQMSGLKQMSSQSSGGASVVTLQFQLTLSLDVAEQEVQAAINAATNLLPSDLPNPPVYSKVNPADPPIMTLAVTSSAMPMTQVEDMVETRVAQKISQVTGVGLVTLAGGQRPAVRVKLNAQAIAALGLTSETIRTAISSANVNSAKGSLDGPTRAVTLSANDQMQSADEYRQLIIAYQNGAPIRLGDVATVEQGAENSWLGAWANKQQAIVMNVQRQPGANIIDTADSIRTMLPQLVESLPKSVSVKVLSDRTTNIRASVTDTQFELMLAIALVVMIIYLFLRNVPATIIPAVAVPLSLVGTFAVMVFLDFSINNLTLMALTIATGFVVDDAIVVIENISRYIEKGEKPLAAALKGAGEIGFTIISLTFSLIAVLIPLLFMGDIVGRLFREFAVTLAVAILISAVVSLTLTPMMCARMLSHESLRKQNRFSRASERMFERIIAAYGRVLAKVLNHPWATLGVALGTLALSVMLWIFIPKGFFPIQDNGIIQGTLQAPQTVSFANMAQRQQQVSEIIMKDPAVESLTAYVGVDGTNPSLNSARLQINLKPLDDRDDRVNAVIERLQSAVARVPGIELYLQPIQDLTIDTQVSRTQYQFTLQATSLEALSTWVPQLVDKLKALPQVSDVSSDWQDKGLAAYVNVNRDTASRLGITMSDVDNALYNAFGQRLISTIYTQANQYRVVLEHNTENTPGLAALDTVRLTSKDGGIVPLSAIASVEERHTPLSINHLDQFPSTTISFNVPDGYSLGEAVEAILGAEKELSFPSDIQTQFQGSTLAFQAALGSTVWLIVAAVVAMYIVLGVLYESFIHPITILSTLPTAGVGALLALMLAGSELDVIAIIGIILLIGIVKKNAIMMIDFALAAEREQGMAPREAIYQACLLRFRPILMTTLAALLGALPLMLSTGVGAELRRPLGIGMVGGLLVSQVLTLFTTPVIYLLFDRLALWTKSRFPKREEEA,MQVLPPSSTGGPSRLFIMRPVATTLLMVAILLAGIIGYRALPVSALPEVDYPTIQVVTLYPGASPDVMTSAVTAPLERQFGQMSGLKQMSSQSSGGASVITLQFQLTLPLDVAEQEVQAAINAATNLLPSDLPNPPVYSKVNPADPPIMTLAVTSTAMPMTQVEDMVETRVAQKISQISGVGLVTLSGGQRPAVRVKLNAQAIAALGLTSETVRTAITGANVNSAKGSLDGPSRAVTLSANDQMQSAEEYRQLIIAYQNGAPIRLGDVATVEQGAENSWLGAWANKEQAIVMNVQRQPGANIISTADSIRQMLPQLTESLPKSVKVTVLSDRTTNIRASVDDTQFELMMAIALVVMIIYLFLRNIPATIIPGVAVPLSLIGTFAVMVFLDFSINNLTLMALTIATGFVVDDAIVVIENISRYIEKGEKPLAAALKGAGEIGFTIISLTFSLIAVLIPLLFMGDIVGRLFREFAITLAVAILISAVVSLTLTPMMCARMLSQESLRKQNRFSRASEKMFDRIIAAYGRGLAKVLNHPWLTLSVALSTLLLSVLLWVFIPKGFFPVQDNGIIQGTLQAPQSSSFANMAQRQRQVADVILQDPAVQSLTSFVGVDGTNPSLNSARLQINLKPLDERDDRVQKVIARLQTAVDKVPGVDLFLQPTQDLTIDTQVSRTQYQFTLQATSLDALSTWVPQLMEKLQQLPQLSDVSSDWQDKGLVAYVNVDRDSASRLGISMADVDNALYNAFGQRLISTIYTQANQYRVVLEHNTENTPGLAALDTIRLTSSDGGVVPLSSIAKIEQRFAPLSINHLDQFPVTTISFNVPDNYSLGDAVQAIMDTEKTLNLPVDITTQFQGSTLAFQSALGSTVWLIVAAVVAMYIVLGILYESFIHPITILSTLPTAGVGALLALLIAGSELDVIAIIGIILLIGIVKKNAIMMIDFALAAEREQGMSPREAIYQACLLRFRPILMTTLAALLGALPLMLSTGVGAELRRPLGIGMVGGLIVSQVLTLFTTPVIYLLFDRLALWTKSRFARHEEEA,100,gnl|BL_ORD_ID|757|hsp_num:0,820,FALSE,None
LK591,7_62 # 68864 # 70630 # 1 # ID=7_62;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=11-12bp;gc_cont=0.547,7_62,68864,70630,+,Strict,500,593.193,Haemophilus influenzae PBP3 conferring resistance to beta-lactam antibiotics,52.57,3004446,protein variant model,"D350N, S357N",n/a,cephalosporin; cephamycin; penam,antibiotic target alteration,Penicillin-binding protein mutations conferring resistance to beta-lactam antibiotics,ATGAAAGCAGCGGCAAAAACGCTAAAACCAAAACGCCAGGAAGAACAGGCCAACTTTGTCAGTTGGCGTTTTGCGTTGCTTTGCGGCTGCATTTTACTGGCGCTGGGTTTCCTGCTGGGACGCGTGGCGTGGCTACAAATCATCGCGCCTGACATGCTGGTACGTCAGGGTGATATGCGTTCTCTGCGCGTGCAGGAAGTTTCTACCTCTCGTGGGATGATCACCGATCGTTCCGGCCGTCCGCTGGCGGTGAGCGTGCCGGTGAAGGCGATCTGGGCCGATCCGAAAGAGTTACACGATGCAGGCGGGATCACCCTTGATAACCGCTGGAAGGCGCTGTCAGACGCGTTGAAAATGCCGCTGGATCAGCTGGCGTCGCGCGTTAACGCCAACCCGAAAGGGCGCTTTATCTATCTTGCCCGTCAGGTGAACCCTGACATGGCTGACTACATTAAGAAACTGAAGCTGCCCGGCATTCATCTGCGGGAAGAATCCCGCCGTTACTATCCTTCGGGCGAAGTCACCGCGCACCTGATTGGCTTTACCAACGTGGATAGCCAGGGGATTGAGGGCGTTGAAAAAAGCTTCGACAAGTGGCTTACCGGCCAGCCTGGCGAGCGAATCGTGCGTAAAGACCGCTATGGTCGCGTCATTGAAGACATTTCCTCGACAGACAGCCAGGCCGCGCACAACCTGGCCCTGAGTATTGATGAACGCTTGCAGGCGCTGGTCTATCGTGAGCTGAACAACGCCGTCGCGTTTAACAAGGCGGAATCGGGCAGCGCCGTGCTGGTGGATGTGGCGACAGGTGAAGTGCTGGCGATGGCCAGTAGCCCCTCATACAACCCGAATAATTTTGCCGGTACAGCAAAAGATGCAATGCGTAACCGCTCCATCACCGATGTGTTTGAACCCGGCTCAACCGTAAAACCTATGGTGGTGATGACGGCTCTACAGCGAGGCATCGTCAACGAAAATACCGTTCTGAATACGATTCCTTATCGAATTAACGGTCACGAAATCAAAGACGTGGCACGTTACAGCGAACTGACCCTGACCGGGGTCTTACAGAAGTCGAGTAACGTCGGTGTGTCAAAACTGGCGTTAGCGATGCCGTCCTCAGCGTTAGTAGATACTTACTCACGTTTTGGGCTGGGAAAGGCGACCAATTTGGGGTTGGTCGGAGAACGCAGTGGCTTATATCCTCAAAAACAACGGTGGTCTGACATAGAGAGGGCCACCTTCTCTTTCGGCTACGGGCTAATGGTAACTCCCTTACAGTTAGCGCGAGTCTACGCAACGATTGGCAGCTATGGCATTTATCGTCCGCTGTCGATCACCAAAGTTGATCCACCGGTTCCGGGGGAACGTGTTTTCCCGGAATCTATCGTTCGTACCGTCGTGCATATGATGGAAAGCGTCGCGTTACCTGGCGGTGGCGGCGTGAAGGCCGCAATTAAGGGCTATCGTATCGCCATTAAAACCGGTACAGCGAAAAAAGTGGGGCCGGACGGCCGCTATATCAACAAATACATTGCCTATACCGCAGGCGTAGCGCCTGCAAGCAATCCGCGTTTTGCACTGGTGGTCGTCATCAACGATCCGCAGGCGGGTAAATACTACGGCGGCGCCGTCTCCGCGCCTGTGTTCGGGGCTATTATGGGCGGCGTGTTGCGCACCATGAACATTGAACCGGATGCGCTGGCGACGGGCGAAAAAAGTGAATTTGTAATTAATCAAGGCGAGGGAACAGGTGGCAGATCGTAA,MKAAAKTLKPKRQEEQANFVSWRFALLCGCILLALGFLLGRVAWLQIIAPDMLVRQGDMRSLRVQEVSTSRGMITDRSGRPLAVSVPVKAIWADPKELHDAGGITLDNRWKALSDALKMPLDQLASRVNANPKGRFIYLARQVNPDMADYIKKLKLPGIHLREESRRYYPSGEVTAHLIGFTNVDSQGIEGVEKSFDKWLTGQPGERIVRKDRYGRVIEDISSTDSQAAHNLALSIDERLQALVYRELNNAVAFNKAESGSAVLVDVATGEVLAMASSPSYNPNNFAGTAKDAMRNRSITDVFEPGSTVKPMVVMTALQRGIVNENTVLNTIPYRINGHEIKDVARYSELTLTGVLQKSSNVGVSKLALAMPSSALVDTYSRFGLGKATNLGLVGERSGLYPQKQRWSDIERATFSFGYGLMVTPLQLARVYATIGSYGIYRPLSITKVDPPVPGERVFPESIVRTVVHMMESVALPGGGGVKAAIKGYRIAIKTGTAKKVGPDGRYINKYIAYTAGVAPASNPRFALVVVINDPQAGKYYGGAVSAPVFGAIMGGVLRTMNIEPDALATGEKSEFVINQGEGTGGRS,MVKFNSSRKSGKSKKTIRKLTAPETVKQNKPQKVFEKCFMRGRYMLSTVLILLGLCALVARAAYVQSINADTLSNEADKRSLRKDEVLSVRGSILDRNGQLLSVSVPMSAIVADPKTMLKENSLADKERIAALAEELGMTENDLVKKIEKNSKSGYLYLARQVELSKANYIRRLKIKGIILETEHRRFYPRVEEAAHVVGYTDIDGNGIEGIEKSFNSLLVGKDGSRTVRKDKRGNIVAHISDEKKYDAQDVTLSIDEKLQSMVYREIKKAVSENNAESGTAVLVDVRTGEVLAMATAPSYNPNNRVGVKSELMRNRAITDTFEPGSTVKPFVVLTALQRGVVKRDEIIDTTSFKLSGKEIVDVAPRAQQTLDEILMNSSNRGVSRLALRMPPSALMETYQNAGLSKPTDLGLIGEQVGILNANRKRWADIERATVAYGYGITATPLQIARAYATLGSFGVYRPLSITKVDPPVIGKRVFSEKITKDIVGILEKVAIKNKRAMVEGYRVGVKTGTARKIENGHYVNKYVAFTAGIAPISDPRYALVVLINDPKAGEYYGGAVSAPVFSNIMGYALRANAIPQDAEAAENTTTKSAKRIVYIGEHKNQKVN,96.39,gnl|BL_ORD_ID|2497|hsp_num:0,2886,FALSE,None
LK591,8_172 # 184054 # 185445 # -1 # ID=8_172;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.593,8_172,184054,185445,-,Strict,850,864.759,Escherichia coli UhpT with mutation conferring resistance to fosfomycin,94.17,3003890,protein variant model,E350Q,n/a,phosphonic acid antibiotic,antibiotic target alteration,antibiotic-resistant UhpT,ATGCTGGCCTTCTTAAATCAGGTGCGCAAGCCGACCCTGGATCTGCCGCTCGACGTGCGGCGCAAGATGTGGTTCAAACCGTTCATGCAGTCCTATCTGGTGGTCTTCATCGGCTACCTGACCATGTACCTGATCCGCAAAAACTTTAACATCGCGCAGAACGACATGATCTCAACCTACGGGCTGAGCATGACGCAGCTGGGGATGATTGGCCTGGGCTTCTCCATCACCTACGGCGTGGGGAAAACGGTTGTGTCCTACTACGCGGACGGCAAAAACACCAAGCAGTTCCTGCCGTTTATGCTGATCCTCTCCGCCATCTGTATGCTCGGCTTCAGCGCCAGCATGGGCGCGGGCTCCGTCAGCCTGTTCCTAATGATCGCCTTCTACGCCCTGAGCGGATTCTTCCAGAGTACCGGCGGGTCGTGCAGCTACTCCACCATCACCAAATGGACCCCGCGCCGCAAGCGGGGTTCGTACCTCGGCATGTGGAACATCTCCCACAACCTCGGCGGAGCGGGCGCGGCCGGCGTGGCGCTGTTCGGTGCGAACTACCTGTTCGACGGCCACGTGATTGGCATGTTTATCTTCCCGTCGATTATCGCCCTGATTGTCGGCTTTATCGGCCTGCGCTACGGCAGCGATTCCCCGGAATCCTACGGCCTCGGCAAAGCTGAAGAGCTGTTCGGGGAGGAGATCAGCGAGGAGGACAAAGAGACCGAAGAAAACGAGATGTCCAAATGGCAGATCTTTGTTGAGTACGTGCTGAAAAACAAAGTGATCTGGCTGCTCTGCTTCTCGAACATCTTCCTGTACGTGGTGCGTATCGGTATCGACCAGTGGTCCACCGTGTATGCCTTCCAGGAGCTGAAGCTCTCGAAAGAGGTGGCGATTCAGGGCTTCACCCTGTTCGAAGTAGGCGCGCTGGTCGGTACCCTGCTGTGGGGCTGGCTCTCGGACCTCGCCAACGGCCGTCGCGCGCTGGTGGCCTGCGTCGCGCTGGCGCTGATTATCGCCACGCTCGGCGTTTACCAGCACGCCAGCAACCAGTACGTTTACCTGGCGTCGCTGTTTGCGCTCGGCTTCCTGGTGTTCGGTCCGCAACTGCTGATCGGCGTGGCGGCGGTTGGCTTTGTGCCGAAAAAAGCGATCGGCGCAGCCGATGGGATTAAGGGCACCTTCGCCTACCTGATCGGCGACAGCTTCGCCAAGCTCGGTCTGGGCATGATCGCCGACGGCACGCCAATTTTCGGCCTCACCGGCTGGGCGGGCACCTTCGCCGCGCTGGATGCGGCAGCGATTGGCTGTATCGTCCTGATGGCGATGGTTGCGGTGCTGGAAGAGCGTAAGATCCGCCGCGAGAATCGTGCGCAGAAATTAAAAGTAGCCTGA,MLAFLNQVRKPTLDLPLDVRRKMWFKPFMQSYLVVFIGYLTMYLIRKNFNIAQNDMISTYGLSMTQLGMIGLGFSITYGVGKTVVSYYADGKNTKQFLPFMLILSAICMLGFSASMGAGSVSLFLMIAFYALSGFFQSTGGSCSYSTITKWTPRRKRGSYLGMWNISHNLGGAGAAGVALFGANYLFDGHVIGMFIFPSIIALIVGFIGLRYGSDSPESYGLGKAEELFGEEISEEDKETEENEMSKWQIFVEYVLKNKVIWLLCFSNIFLYVVRIGIDQWSTVYAFQELKLSKEVAIQGFTLFEVGALVGTLLWGWLSDLANGRRALVACVALALIIATLGVYQHASNQYVYLASLFALGFLVFGPQLLIGVAAVGFVPKKAIGAADGIKGTFAYLIGDSFAKLGLGMIADGTPIFGLTGWAGTFAALDAAAIGCIVLMAMVAVLEERKIRRENRAQKLKVA,MLAFLNQVRKPTLDLPLEVRRKMWFKPFMQSYLVVFIGYLTMYLIRKNFNIAQNDMISTYGLSMTQLGMIGLGFSITYGVGKTLVSYYADGKNTKQFLPFMLILSAICMLGFSASMGSGSVSLFLMIAFYALSGFFQSTGGSCSYSTITKWTPRRKRGTFLGFWNISHNLGGAGAAGVALFGANYLFDGHVIGMFIFPSIIALIVGFIGLRYGSDSPESYGLGKAEELFGEEISEEDKETESTDMTKWQIFVEYVLKNKVIWLLCFANIFLYVVRIGIDQWSTVYAFQELKLSKAVAIQGFTLFEAGALVGTLLWGWLSDLANGRRGLVACIALALIIATLGVYQHASNEYIYLASLFALGFLVFGPQLLIGVAAVGFVPKKAIGAADGIKGTFAYLIGDSFAKLGLGMIADGTPVFGLTGWAGTFAALDIAAIGCICLMAIVAVMEERKIRREKKIQQLTVA,100,gnl|BL_ORD_ID|2129|hsp_num:0,2373,FALSE,None
LK591,61_1 # 1 # 1077 # 1 # ID=61_1;partial=11;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.532,61_1,1,1077,+,Strict,700,718.383,Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin,98.05,3003369,protein variant model,R234F,n/a,elfamycin antibiotic,antibiotic target alteration,elfamycin resistant EF-Tu,ACCGTACTGGCTAAAACCTACGGCGGTGCTGCTCGTGCTTTCGACCAGATCGATAACGCACCAGAAGAAAAAGCTCGTGGTATCACCATCAACACCTCTCACGTTGAGTATGACACCCCGACTCGCCACTACGCACACGTAGACTGCCCAGGCCACGCCGACTATGTTAAAAACATGATCACCGGTGCTGCGCAGATGGACGGCGCGATCCTGGTTGTTGCTGCGACTGACGGCCCTATGCCTCAGACTCGTGAGCACATCCTGCTGGGTCGTCAGGTAGGCGTTCCTTTCATCATCGTGTTCCTGAACAAATGTGACATGGTTGATGACGAAGAGCTGCTGGAACTGGTAGAGATGGAAGTTCGTGAACTGCTGTCTCAGTACGATTTCCCAGGCGACGACACTCCAATCGTTCGTGGTTCCGCGCTGAAAGCGCTGGAAGGCGAAGCAGAGTGGGAAGAGAAAATCATCGAACTGGCTGGCTACCTGGATTCTTACATCCCAGAACCAGAGCGTGCGATTGACAAGCCATTCCTGCTGCCAATCGAAGACGTATTCTCCATCTCCGGTCGTGGTACCGTTGTTACCGGTCGTGTAGAGCGCGGTATCATCAAAGTTGGTGAAGAAGTTGAAATCGTTGGTATCAAAGAGACTGCGAAGTCTACCTGTACTGGCGTTGAAATGTTCCGCAAACTGCTGGACGAAGGCCGTGCTGGTGAGAACGTTGGTGTTCTGCTGCGTGGTATCAAACGTGAAGAAATCGAACGTGGTCAGGTTCTGGCGAAGCCAGGCTCAATCAAGCCACACACCAAGTTCGAATCTGAAGTGTACATTCTGTCCAAAGACGAAGGCGGCCGTCATACTCCGTTCTTCAAAGGCTACCGTCCACAGTTCTACTTCCGTACAACTGACGTGACCGGTACCATCGAACTGCCAGAAGGCGTAGAGATGGTAATGCCAGGCGACAACATCAAGATGGTTGTGACGCTGATCCACCCAATCGCGATGGACGACGGTCTGCGTTTCGCAATCCGTGAAGGCGGCCGTACCGTTGGCGCGGGCGTTGTTGCTAAAGTT,TVLAKTYGGAARAFDQIDNAPEEKARGITINTSHVEYDTPTRHYAHVDCPGHADYVKNMITGAAQMDGAILVVAATDGPMPQTREHILLGRQVGVPFIIVFLNKCDMVDDEELLELVEMEVRELLSQYDFPGDDTPIVRGSALKALEGEAEWEEKIIELAGYLDSYIPEPERAIDKPFLLPIEDVFSISGRGTVVTGRVERGIIKVGEEVEIVGIKETAKSTCTGVEMFRKLLDEGRAGENVGVLLRGIKREEIERGQVLAKPGSIKPHTKFESEVYILSKDEGGRHTPFFKGYRPQFYFRTTDVTGTIELPEGVEMVMPGDNIKMVVTLIHPIAMDDGLRFAIREGGRTVGAGVVAKV,MLSPEGESTIVRNIAVSKEKFERTKPHVNVGTIGHVDHGKTTLTAAITTVLAKTYGGAARAFDQIDNAPEEKARGITINTSHVEYDTPTRHYAHVDCPGHADYVKNMITGAAQMDGAILVVAATDGPMPQTREHILLGRQVGVPYIIVFLNKCDMVDDEELLELVEMEVRELLSQYDFPGDDTPIVRGSALKALEGDAEWEAKILELAGFLDSYIPEPERAIDKPFLLPIEDVFSISGRGTVVTGRVERGIIKVGEEVEIVGIKETQKSTCTGVEMFRKLLDEGRAGENVGVLLRGIKREEIERGQVLAKPGTIKPHTKFESEVYILSKDEGGRHTPFFKGYRPQFYFRTTDVTGTIELPEGVEMVMPGDNIKMVVTLIHPIAMDDGLRFAIREGGRTVGAGVVAKVLG,87.78,gnl|BL_ORD_ID|1970|hsp_num:0,2158,FALSE,None
LK591,1_137 # 157609 # 158043 # -1 # ID=1_137;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.476,1_137,157609,158043,-,Strict,210,270.011,Escherichia coli AcrAB-TolC with MarR mutations conferring resistance to ciprofloxacin and tetracycline,90.28,3003378,protein overexpression model,n/a,n/a,fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics,antibiotic target alteration; antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,GTGAAAAGCACCAGTGACCTCTTTAACGACATAATTCCACTGGGTCGTCTTATTCATATGGTTAACCAGAAAAAAGATCGCCTGCTCAATGACTATCTGTCACCGCTGGATATCACCGCAACACAGTTCAAAGTGCTGTGTTCCATTCGCTGCGAAGTGTGTATCACGCCGGTTGAGCTGAAAAAGGTGCTCTCTGTCGATCTGGGTGCGTTAACCCGCATGCTGGATCGTCTCGTCTGTAAAGGATGGATAGAACGAAGCCCTAACCCGAATGACAAACGTGGCGTACTGGTGAAACTGACCAGCGATGGCGCGGCCATGTGTGAGCAATGTCATCAATTAGTAGGACAAACACTGCACCAGGAACTGACAAAAAACTTATCGGCAGATGAAGTGGCAACGCTTGAGCTCTTACTCAAGAAAATCCTGCCGTAA,VKSTSDLFNDIIPLGRLIHMVNQKKDRLLNDYLSPLDITATQFKVLCSIRCEVCITPVELKKVLSVDLGALTRMLDRLVCKGWIERSPNPNDKRGVLVKLTSDGAAMCEQCHQLVGQTLHQELTKNLSADEVATLELLLKKILP,MKSTSDLFNEIIPLGRLIHMVNQKKDRLLNEYLSPLDITAAQFKVLCSIRCAACITPVELKKVLSVDLGALTRMLDRLVCKGWVERLPNPNDKRGVLVKLTTGGAAICEQCHQLVGQDLHQELTKNLTADEVATLEYLLKKVLP,100,gnl|BL_ORD_ID|1984|hsp_num:0,431,FALSE,None
LK591,13_52 # 59977 # 60303 # -1 # ID=13_52;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.511,13_52,59977,60303,-,Strict,200,202.216,Escherichia coli soxS with mutation conferring antibiotic resistance,90.65,3003511,protein overexpression model,n/a,n/a,fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; penem; disinfecting agents and antiseptics,antibiotic target alteration; antibiotic efflux; reduced permeability to antibiotic,ATP-binding cassette (ABC) antibiotic efflux pump; major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump; General Bacterial Porin with reduced permeability to beta-lactams,ATGTCGCATCAGCAAATTATTCAGACACTTATTGAATGGATTGATGAACATATCGACCAGCCGTTGAACATTGATGTGGTCGCTAAGAAGTCGGGCTATTCGAAATGGTATTTACAGAGAATGTTCCGCACCGTAATGCATCAAACGCTGGGTGATTACATTCGCCAGCGCAGGCTCCTGCTGGCGGCGCAGGCGTTACGCTCAACGCAGCGGCCCATTTTTGATATCGCAATGGATCTGGGCTATGTGTCGCAGCAGACCTTTTCCCGCGTCTTCCGCCGCGAGTTTGACCGTACGCCGAGCGACTACCGCCATCAGCTCAATTAA,MSHQQIIQTLIEWIDEHIDQPLNIDVVAKKSGYSKWYLQRMFRTVMHQTLGDYIRQRRLLLAAQALRSTQRPIFDIAMDLGYVSQQTFSRVFRREFDRTPSDYRHQLN,MSHQKIIQDLIAWIDEHIDQPLNIDVVAKKSGYSKWYLQRMFRTVTHQTLGDYIRQRRLLLAAVELRTTERPIFDIAMDLGYVSQQTFSRVFRRQFDRTPSDYRHRL,100.93,gnl|BL_ORD_ID|1975|hsp_num:0,2066,FALSE,None
LK952,6_41 # 39352 # 40206 # -1 # ID=6_41;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.560,6_41,39352,40206,-,Strict,400,486.108,ErmX,84.51,3000596,protein homolog model,n/a,n/a,macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic,antibiotic target alteration,Erm 23S ribosomal RNA methyltransferase,ATGTCTACATACGGATACGGCCGTCACGAACATGGCCAAAATTTTCTCACAGACCACAAGATCATCAACTCCATCGTCGATCTTGTAAAACAAACCTCCGGCCCCATCATTGAGATCGGGCCAGGAAGCGGTGCCCTCACCCACCCGATATCCCACTTGGGGAGGGCAATAACGGCAGTTGAGGTAGACGCAAAACTAGCTGCCAAACTCACAAAAAAGACCGCCTCGGCGTCGGTCGAAGTGGTCCATGATGATTTCCTCAACTTCCCGTTACCCGCCACTCCCTGCGTCATTGTGGGAAACATTCCCTTTCACCTCACCACTGCCATTCTTCGAAAGTTGTTGCATGCGCCGGCATGGACTGACGCTGTACTCCTCATGCAGTGGGAAGTCGCTCGCCGCCGGGCCGGGGTAGGTGCAAGCACGATGATGACAGCTCAGTGGTCCCCATGGTTCACGTTTCACCTTGGTTCCCGAGTACCAAGGTTTGCTTTCCGGCCACAGCCAAACGTTGACGGGGGGATCTTAGTGATCCGCCGGGTGGGTGACCCGAAGATCCCGATAGAGCAACGCAAAGCCTTTCAGGCGATGGTGCACACCGTTTTCACCGCCCGGGGACGCGGGATAGGGGAAATTCTCCGAAGGGCAGGGTTGTTTTCATCACGTTCAGAGACACAATCATGGTTGCGCTCGCGAGGAATCGACCCCGCAACCCTACCTCCCAGATTGCACACCAGCGACTGGATCGATCTCTTCCAGGTGACTGGTTCCTCTTCACCGCGCCATCGGCCCATTTCACAATCGGGAAGTAGTCAACGCCCTCCTCAACGGAAAAATCGAGGCCGGCGGCGGTAA,MSTYGYGRHEHGQNFLTDHKIINSIVDLVKQTSGPIIEIGPGSGALTHPISHLGRAITAVEVDAKLAAKLTKKTASASVEVVHDDFLNFPLPATPCVIVGNIPFHLTTAILRKLLHAPAWTDAVLLMQWEVARRRAGVGASTMMTAQWSPWFTFHLGSRVPRFAFRPQPNVDGGILVIRRVGDPKIPIEQRKAFQAMVHTVFTARGRGIGEILRRAGLFSSRSETQSWLRSRGIDPATLPPRLHTSDWIDLFQVTGSSSPRHRPISQSGSSQRPPQRKNRGRRR,MSAYGQGRHEHGQNFLTNHKIINSIIDLVKQTSGPIIEIGPGSGALTHPMAHLGRAITAVEVDAKLAAKITQETSSAAVEVVHDDFLNFRLPATPCVIVGNIPFHLTTAILRKLLHAPAWTDAVLLMQWEVARRRAGVGATTMMTAQWSPWFTFHLGSRVPRSAFRPQPNVDGGILVIRRVGDPKIPIEQRKAFQAMVHTVFTARGRGIGEILRRQGCFHHVQKHNHGCAREESTPRPYLPDCYTNDWIDLFQVTGSSLPHHRPISPSGSSQRPPQRKNRSRRR,100,gnl|BL_ORD_ID|872|hsp_num:0,950,FALSE,None
LK952,10_84 # 86987 # 88621 # 1 # ID=10_84;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.663,10_84,86987,88621,+,Strict,50,82.4185,vanW gene in vanI cluster,36.43,3003724,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanW; glycopeptide resistance gene cluster,GTGCTCGGCGCGGTTCTCGGCCTGCTCGCAGTCGTGGTGGCTATCTACCTCGCGGATCTAGCGCTCAACCGCGGCAACGTTCCGCGCGGCACCACCGTCGGCGGCGTGGCCATCGGCGGGATGGCTCCCGATGATGCACGCGATCGTCTCGAAGCAGAGCTCGGCGGGGTAGCGGACACACCGGTGGAGATTAGCGCGGCTACGCAGCGCGCGCAGCTCGTGCCCACCCGCGCGGGCCTCGGCATTGATTGGCAGGCGACGGTGGACGACGCGGGCATCCAGTCGGCCAACCCCATCCCTCGCCTGGTGGGGCTGTTCCGCACGCACGAGGTAGAGGTACGCAGCAGCGTCGACGAGGGCAAGCTCGGCCCGGAGTTGCAACGCGTCAAGGATGAGCTCTACCTCGCACCGAAAGACGGTGCCATCCAGATCCAAGGCGGCAAGGCCGAGGTCAAAGACCCCGAGCTTGGACAAGAGGTCGACCCCGGTGTACTGCGCGAGGCGGTCACGAGCGACTGGCTCGACCCGGACGGGGTAGAGGTGGAGCCGAAGCCGGTGCAGCCCGCGATCAACGATGAAGTGATCAAGGAAGCGATGGAGGACCCGGTCAAGACCGCGCTTTCCGGCCCGCTCAAGGTCAACGGCCGCGAGGATGCCACCGCGGTCATCCCCACCGAGCGCATGGGCGAAGTCGTGCAATTTGCCAACGTCGACGGGACGATTGTCCCCGAGGTACACCGTGAGGTCGCGGGCGCGATCCTGGGGGAGACGCTCGATGCTACCCAGACTGAAATGCATAACGCCCGCGTGCTCGAAGGTGGCGGTATTGAGCCCTCCACCGACGGCATCGCCGTGGACTGGGACGCCACCTTCGAAGGCTTCGAGGATCGCCTCCTGCGAGACGGCGAGCGAACCTGGGACGCCGACTACACACCAGTGCCAGCAGACTTCACTACCGAGGAAGCCGAAAACGCCACCTTCGACCAGGAGGTCAGCTCCTTTTCCACTGGTGGGTTCTCCGGGGCATCCGGCACCAACATCGCGCTCGTGGCCCAGACCGTCAACGGCGCGATCGTCAACCCCGGCGAGACCTTCTCGCTCAACGGCTACACCGGCCCGCGCGGCACGGCGCAGGGGTACGTGGAATCCGGCATCATCATCAACGGGCGCTCCGGTATGGCCGTCGGCGGCGGCATCTCCCAGTTCGCCACCACCTTGTACAACGCCGCCTACTTCGGCGGGATGACGGACATCGCGCACACACCGCACTCCTACTACATCTCCCGTTACCCGGCAGGCCGCGAAGCCACCGTCTACGAGGGCGCGATCGATTTGCAGTTCCGCAACGATTCGCCCACCCCGGTGCGCATCCAAACTGGTGTGAGCGGCGGCGAGATTACCGTGCGCCTGATGGGCGTCAAGCACGTCAACGTGGAATCCGCCAACGGCGGGCGCTGGGCGCAAACGCAGCCCAACACCGTCAACGCGGCCGGCCCGGGCTGCATCCCGTCGAGCGGCGCGCCGGGCTTTACCACCTCGGATACGCGCAGCATCTACGACCTTTCGGGCAACCTGATCGACCAGGAGACGCAGACCACGGTCTACGACCCCGAGCCGATTGTGAAGTGCGGCTAG,MLGAVLGLLAVVVAIYLADLALNRGNVPRGTTVGGVAIGGMAPDDARDRLEAELGGVADTPVEISAATQRAQLVPTRAGLGIDWQATVDDAGIQSANPIPRLVGLFRTHEVEVRSSVDEGKLGPELQRVKDELYLAPKDGAIQIQGGKAEVKDPELGQEVDPGVLREAVTSDWLDPDGVEVEPKPVQPAINDEVIKEAMEDPVKTALSGPLKVNGREDATAVIPTERMGEVVQFANVDGTIVPEVHREVAGAILGETLDATQTEMHNARVLEGGGIEPSTDGIAVDWDATFEGFEDRLLRDGERTWDADYTPVPADFTTEEAENATFDQEVSSFSTGGFSGASGTNIALVAQTVNGAIVNPGETFSLNGYTGPRGTAQGYVESGIIINGRSGMAVGGGISQFATTLYNAAYFGGMTDIAHTPHSYYISRYPAGREATVYEGAIDLQFRNDSPTPVRIQTGVSGGEITVRLMGVKHVNVESANGGRWAQTQPNTVNAAGPGCIPSSGAPGFTTSDTRSIYDLSGNLIDQETQTTVYDPEPIVKCG,MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVLAEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPELLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGMETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGGEFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSHSLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDEPDGYPVKPREWSK,145.84,gnl|BL_ORD_ID|4748|hsp_num:0,2242,FALSE,None
LK1347,35_15 # 13341 # 15119 # -1 # ID=35_15;partial=00;start_type=ATG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.591,35_15,13341,15119,-,Strict,50,50.0618,vanW gene in vanI cluster,23.67,3003724,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanW; glycopeptide resistance gene cluster,ATGGACTCACAGCTTGGGCCTGACGAGACCGCCACACAAGAGCAGTCTTCACCTCAGCCAGCCAACCGCCGCGCACGCAAAAAGCGTGCCGAGAAGCGTAAGCGTGGCGGGCTGATCGCAACGTCCATCACCGGCGGAGTCCTCCTGCTCGCCGGCGCCGCCTACGTCGGATCCGCGTGGTACACCTCGGACAAGCTGCCCGCCAACCTCACAGTCAGCGGAGTCGACATTTCCGGTCTCTCGACCGATGAGGCCGCCGCAAAGCTCGACAAAGAGCTCGGTAGCAAACTCACAAAAGAACTCACCCTCACCGCCGGAAACGCAACGACTAAAGTCACACCGGCAAAAGCTGGCATCGGCATCGACACTAAGGCGACCCTCGAAGAGCTTTCTGGCTGGAGCTGGAACCCTAAGACCATCATCGAACGCTTGAGCGGTTCCCAAGAAATCTCGATCAAACAAACAATCGATGACAAGCCACTGAAGAAGAAGGCGACAGAAGTCGCCGAAGCCCTCACAACCGATCCGGTCGAAGGCAAAGTCAACCTGACCGAAAACGGCCCGGAATTCACCGAACCGGAAAACGGCCACAAAGTGAGCGAAGAGCTCGCGCGCACCACCATCACCAAGAACGCGTTCGCGGCCAAGCGGTCCGTCTCTGTTGATGCAAAGGTCGTCGACCCACAGGTCAGCACCGACAAGTGGAACGAGTTCATCGATACGACCGTGGAGCCGTACCTTTCCGGCCCAGTCACAGTCAAAGCCGGCGATGAAACCGCGGAACTGAGCGTCAAAGACCTCAGTAAAGCCACCGTCGTCGAAGTCAAAGACTCGACCCCACAACTTAAAACCGACGACGACGCGCTTAAGTCCGCGGTCGAGGGTTCGAACTCCAAACTTCACTCGACGGCCCAGAACGCGAGCCTCAAGCTCGTCGGTAGCGGGGCAAACGCGAAAGCCGAGATCGTTCCAAGCAAGACCGGAAAGGGGCTGGACGCCAAAGAGCTCGGCGAGAAAGTCCGTGCAGCTGCTGAGTCGACCTCCGGCCGCACCGCGACCGTGACCCTCTCGACGCAAGAGCCGACCGTGACAACGGCGGACGCGAAGAAATGGAAGGTCACGAAAGTCGCCGAATTCGCGACCCCTTATCCATACGATCCAACACGCACCAAGAACCTTGTAGCCGGTTCGAAGCGCATCAACGGAAGCGTGATCGAGCCCGGTGAGTCCTTCGACCTTGCCCAAAAATTCGGTCCAGTGACCGAGGCCAACGGCTATTACTCATCCGGCGTGGTCGTCAACAGCGTGTCGACCAAGGCTGTCGGCGGTGGACTCTCCCAGATCGCAACCATGGCCTACAACGCGGGCTACCTAGCAGGCATGGACATCGAAGCATGGAGGGCACACAACCGCTGGTTCGACCGCTACCCAGCCGGCCGCGAGTCCACGTACTGGGAAGGCTCGATCAACGTCAAGTGGAAGAACAACACCAAAGCACCCGTTGTGGTCGCGATGTGGCTCGCCGATAACAAGGTTCACACCGCCGTGTACGGCCACAAGACCTGGGACGTCAAGACCTCAACGAGCGACTTCTACAACTACACGGACGGCCCGACCATCACATCCAACGACCCTCACTGCATCCCAGAATCCGGCGGTAAGAAAGGGTTCACCGTGGATGTGAGTCGAACCCGAACCAACGTCGAAACCGGTGAAGTGCTCAAAGACTCCCAGACCACCCGCTACGACGGCTGGCCGAAAGTCACCTGCACCCACTAG,MDSQLGPDETATQEQSSPQPANRRARKKRAEKRKRGGLIATSITGGVLLLAGAAYVGSAWYTSDKLPANLTVSGVDISGLSTDEAAAKLDKELGSKLTKELTLTAGNATTKVTPAKAGIGIDTKATLEELSGWSWNPKTIIERLSGSQEISIKQTIDDKPLKKKATEVAEALTTDPVEGKVNLTENGPEFTEPENGHKVSEELARTTITKNAFAAKRSVSVDAKVVDPQVSTDKWNEFIDTTVEPYLSGPVTVKAGDETAELSVKDLSKATVVEVKDSTPQLKTDDDALKSAVEGSNSKLHSTAQNASLKLVGSGANAKAEIVPSKTGKGLDAKELGEKVRAAAESTSGRTATVTLSTQEPTVTTADAKKWKVTKVAEFATPYPYDPTRTKNLVAGSKRINGSVIEPGESFDLAQKFGPVTEANGYYSSGVVVNSVSTKAVGGGLSQIATMAYNAGYLAGMDIEAWRAHNRWFDRYPAGRESTYWEGSINVKWKNNTKAPVVVAMWLADNKVHTAVYGHKTWDVKTSTSDFYNYTDGPTITSNDPHCIPESGGKKGFTVDVSRTRTNVETGEVLKDSQTTRYDGWPKVTCTH,MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVLAEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPELLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGMETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGGEFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSHSLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDEPDGYPVKPREWSK,158.71,gnl|BL_ORD_ID|4748|hsp_num:0,2242,FALSE,None
LK1347,36_12 # 10602 # 11552 # 1 # ID=36_12;partial=00;start_type=GTG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.624,36_12,10602,11552,+,Strict,50,107.071,vanY gene in vanA cluster,38.56,3002955,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,GTGAAAGGTAGGCACGCCGCCACGACCGCGAGGACTGTGCCGCGCTGGGCTCTTCCCCTGGGCGTGTTCCTTGCCGTTCTCGCGCTGATCCTCGTGATCGTGCTCCCCCGCTCTGGTGGCCAAACAACCAACGATGCTGAAACCAGCCCAGCGGCAACGTCACCTGACGCGAAGCAGCCAGCCGCAGCCACCGCATCGGACGCTAACAAAAACAAGCCAGCCGACGCCGACAAAGACCCTTCCAAGGGGAGCATCGCGGGACCGAAAATCAGCGCGGCTCCGTCCGCATCGGAATCAGAGTCTGAATCGGCCAGCCCTTCCGAATCCGCGCCGTCAAAGAAACCTTCCGAGAGCGACAAGCCCTCAGAAAGCGCTGAGGACCGCAGCCCCGAAATCCCGAGCGACCCCAACAACATCAAGGTCCTGGCTAACAAAAAGCGGCCCCTCGAACCGTTGACATACGCGCCTAAAGACCTCGTCCACATCGGCAGCGGGCAAAGCATGCGAAGCGAAGCCGCACAGGCTTTCAAAAAGCTACGCAACGCCGGGGCGGCATCCGGGGTGAACTTTCACCCCGTGAGCGGCTACAGGTCCTATAACCAGCAAGCCGCAACCTACAACCATTGGCGGGCCACGTACGGGCAACAGCACGCGGACTCCGTCTCCGCCGCCCCAGGCACCAGTGAGCATCAGCTGGGCCTCGCCGTCGACGTCTCCGACGGGATCTGCAACCTTAGGCGCTGCTTCGCGACCACGAATGCCGGGCAATGGGTCGCGCGGAACGCCCACAAGTACGGGTTTGTGGTCCGCTATCCCGAGGGTAAGACCGACGTCACCGGATATTGGTACGAACCGTGGCACCTGCGTTACGTCGGCACGGAGCTCGCGGGCGAGCTCACCTCGAAAGGGTTGACCCTCGAGGAGTACTACAAGTGGAAACCAGGCAAGTAA,MKGRHAATTARTVPRWALPLGVFLAVLALILVIVLPRSGGQTTNDAETSPAATSPDAKQPAAATASDANKNKPADADKDPSKGSIAGPKISAAPSASESESESASPSESAPSKKPSESDKPSESAEDRSPEIPSDPNNIKVLANKKRPLEPLTYAPKDLVHIGSGQSMRSEAAQAFKKLRNAGAASGVNFHPVSGYRSYNQQAATYNHWRATYGQQHADSVSAAPGTSEHQLGLAVDVSDGICNLRRCFATTNAGQWVARNAHKYGFVVRYPEGKTDVTGYWYEPWHLRYVGTELAGELTSKGLTLEEYYKWKPGK,MKKLFFLLLLLFLIYLGYDYVNEALFSQEKVEFQNYDQNPKEHLENSGTSENTQEKTITEEQVYQGNLLLINSKYPVRQESVKSDIVNLSKHDELINGYGLLDSNIYMSKEIAQKFSEMVNDAVKGGVSHFIINSGYRDFDEQSVLYQEMGAEYALPAGYSEHNSGLSLDVGSSLTKMERAPEGKWIEENAWKYGFILRYPEDKTELTGIQYEPWHIRYVGLPHSAIMKEKNFVLEEYMDYLKEEKTISVSVNGEKYEIFYYPVTKNTTIHVPTNLRYEISGNNIDGVIVTVFPGSTHTNSRR,104.29,gnl|BL_ORD_ID|4669|hsp_num:0,89,FALSE,None
LK1207,68_5 # 3111 # 3800 # -1 # ID=68_5;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.777,68_5,3111,3800,-,Strict,50,83.9593,vanY gene in vanM cluster,35.14,3002961,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,TTGCGCGGCACGCCCGCCGCGGGCCCGTCCTCGGCGACGCCGGCTTCCGGCTCCGCGAGCGCGGCCGCGTCGTCCCGCGCCGCCTCGAGCACGGCGCCGTCGTCGAGCACGCACGCCGACCCGGCCGCCCTCGACGTCGTCGTGAACAAGACCCGCCCCGTGGCCCCGCCCGACTGGGCGCCCTCGGATCTGGTGGCCGTGCCCGGCAGCGAGCTGCCCCTGCGCGCGGAGGCCGCGACGGCGGCCGGCGACCTGGTGGATGCCGCCGCGGCGGCGGGCCACCGCCTCACCACCCTGAGCGCCTACCGCTCGTACGACTACCAGGTCCGGACGTACGGCCACTGGGTCGACGAGCTGGGCCGCGCCGAGGCCGACCGCGTCTCCGCGCGTCCGGGGTACTCCGAGCATCAGACCGGCCTGGCCTGGGACGTGGGCGACGCCGCGACCCCCGCGTGTGACCTGGAAGCGTGCTTCGGCGACACCGCCGCGGGCCGCTGGGTGGCCGCGCACGCCGCCGAGTACGGGTTCGTCATCCGCTATCCCGCCGGGGCTGAGGACGTGACGGGCTTCGACCACGAGCCCTGGCACCTGCGCTACGTCGGGTCCACGGAGGCGGCCCGGGTCGAGGCGGCCGGCGGCGTCCTCGAGACCGCGTGGGGTCTGCCTCCGGCGCCCGACTACGCGGACTGA,MRGTPAAGPSSATPASGSASAAASSRAASSTAPSSSTHADPAALDVVVNKTRPVAPPDWAPSDLVAVPGSELPLRAEAATAAGDLVDAAAAAGHRLTTLSAYRSYDYQVRTYGHWVDELGRAEADRVSARPGYSEHQTGLAWDVGDAATPACDLEACFGDTAAGRWVAAHAAEYGFVIRYPAGAEDVTGFDHEPWHLRYVGSTEAARVEAAGGVLETAWGLPPAPDYAD,MVFQGNLLLVNNEYPVLEESIKTDVVNLFKHDELTKGYELLNREIYLSEKVAREFSEMVDAAEKEGVRHFSINSGFRNFDEQNALYQEMGSDYALPAGYSEHNLGLALDIGSTQMEMSEAPEGKWLEDNAWEYGFILRYPMDKTAITGIQYEPWHFRYVGLPHSAIIEEKNFALEEYLDFLKEQKSISGTIHGENYEISYYPITEKTDIEMPANLHYEISGNNMDGVIVTVYR,98.28,gnl|BL_ORD_ID|1673|hsp_num:0,1713,FALSE,None
LK1301,2_8 # 3410 # 3979 # -1 # ID=2_8;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.707,2_8,3410,3979,-,Strict,50,56.6102,vanY gene in vanB cluster,28.49,3002956,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGAACGCACAGATCATCACCCTCACCCTTGTCTCGGCCCTCGCCCTCGGCCTCACTGGCTGCGCCTCGACCGCACCCGCCGAGGAGGCTGCCGTGACCGTCCATGCCGGTGGTTCGGAGACCGACGGCGGGGCCCTTCCCGCGGCTGCGAGGATCGACGACGTCGACCTGCCGGGCATCGCGAACCTCGATGCGGACCTGCGCGCCGCGGTCCGGGAGGCCGCCGCCGAGGCCCTTGAGGACGGTGTCGTCTTCACCGTCAACAGCGGTTGGCGCTCTGCCTCCTACCAGCAGGGTCTCCTCGACGACGCGGTGAGCACGTACGGCTCGCGGACCGAAGCCGCCCGGTGGGTGGCCACCCCCGAGTCCTCACCGCACGTCACCGGCGACGCGGTCGACATCGGTCCCGTCGACGCCTCGAGCTGGCTCTCCCAGCACGGCGCGGACTTCGGGCTGTGCCAGATCTACGGCAACGAGATCTGGCACTACGAACTCCGCCCGGACGCCGCGACCTCCGGCTGCCCGCAACAGTACGCCGACCCGACCGAGGACCCACGCATGCGAAGATGA,MNAQIITLTLVSALALGLTGCASTAPAEEAAVTVHAGGSETDGGALPAAARIDDVDLPGIANLDADLRAAVREAAAEALEDGVVFTVNSGWRSASYQQGLLDDAVSTYGSRTEAARWVATPESSPHVTGDAVDIGPVDASSWLSQHGADFGLCQIYGNEIWHYELRPDAATSGCPQQYADPTEDPRMRR,MEKSNYHSNVNHHKRHMKQSGEKRAFLWAFIISFTVCTLFLGWRLVSVLEATQLPPIPATHTGSGTGVAENPEENTLATAKEQGDEQEWSLILVNRQNPIPAQYDVELEQLSNGERIDIRISPYLQDLFDAARADGVYPIVASGYRTTEKQQEIMDEKVAEYKAKGYTSAQAKAEAETWVAVPGTSEHQLGLAVDINADGIHSTGNEVYRWLDENSYRFGFIRRYPPDKTEITGVSNEPWHYRYVGIEAATKIYHQGLCLEEYLNTEK,70.52,gnl|BL_ORD_ID|602|hsp_num:0,556,FALSE,None
LK1301,5_78 # 74222 # 75331 # 1 # ID=5_78;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.601,5_78,74222,75331,+,Strict,50,56.6102,vanY gene in vanB cluster,40,3002956,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGGCCAAGTTGCTGTGGACCATTGCCGGGTCAATCTTCGCCCTCGTCGTCATCGTCGGAACTGGCGGTCTGATCATGTTTGTGCCGCTGATGGCTGGCTCCGGCGAAGACTCGGGTGGCGGTGATTGCTCCGCGGTGGTCGAGGGCGATGACGTAGTCAAAGACGTCACCGCGCCGATGCGCAAGAACGCAGAAGCGATCATCGTGGTTGCCGAGGAGGAGAAGATGCCCGAGGAGGCCGCGGTCGTGGCAATCATGGTGGCGATGCAGGAATCTCAGCTGGGCGCGGCTCCGGGGATTGACCAGCCCAACGGGGACGGCGATGCAGGGGTCTTCCAACAGCGTCAGAAGCCAGGCTGGTACGGCACACTCGAACAGGTCACCGACATCGACTACGCAGCGAAGATCTTCTACAAAGGTGTCGACATCACTCTGGAGGGGTTGAGCGAAGCTGAGAAGTCCGCGGCCGCCGGACCCGAGGGCTATCACATCCCAGGCCTGACCAACATCGATGGGTGGGAAGAGATGAAGCCAGGCACTGCTGCCCAGAAGGTGCAGCGATCTGCGTTCCCCGATGCCTATGACAAACACGAAAGCGTAGCTCGTGCCTTGGTCGGAGGCACCACGGTGGAGTGCGACGACGGTGGCGGTGGAGGGTCCGGTGACTGGGACGACCGCGACGGGAAGACCAAACCCGGCAAATGGGGAGGCTATGACAACGGCACAATCCCGCTCGAGGAACTCGACGAGATCCCATGGGCGAAAGGCGAGTATCTACGACCCGATGCGGCCGCTGACTTCAACAAACTCAATGCTGCGTTCAAAGCCAAGTTCGGATACAACATCGGCGTCACCGACTCCTATCGGACCTACGCCGAACAGGTGGAGCTGAAGAAGCGCAAAGGGAAGTGGGCAGCGACTCCAGGCACCTCAAATCACGGGTGGGCAATGGCCGTGGACTTGGGCACCGGCATCAACAATTTTGGTTCGAAGGAATACAACTGGATGAAAGACAACGCCACGAAATATGGATGGAAGCATCCGGATTGGGCCGAGCCGGGCGGGTCCCTGCCTGAGCCCTGGCACTGGGAGTACTATGGTCACGAATAA,MAKLLWTIAGSIFALVVIVGTGGLIMFVPLMAGSGEDSGGGDCSAVVEGDDVVKDVTAPMRKNAEAIIVVAEEEKMPEEAAVVAIMVAMQESQLGAAPGIDQPNGDGDAGVFQQRQKPGWYGTLEQVTDIDYAAKIFYKGVDITLEGLSEAEKSAAAGPEGYHIPGLTNIDGWEEMKPGTAAQKVQRSAFPDAYDKHESVARALVGGTTVECDDGGGGGSGDWDDRDGKTKPGKWGGYDNGTIPLEELDEIPWAKGEYLRPDAAADFNKLNAAFKAKFGYNIGVTDSYRTYAEQVELKKRKGKWAATPGTSNHGWAMAVDLGTGINNFGSKEYNWMKDNATKYGWKHPDWAEPGGSLPEPWHWEYYGHE,MEKSNYHSNVNHHKRHMKQSGEKRAFLWAFIISFTVCTLFLGWRLVSVLEATQLPPIPATHTGSGTGVAENPEENTLATAKEQGDEQEWSLILVNRQNPIPAQYDVELEQLSNGERIDIRISPYLQDLFDAARADGVYPIVASGYRTTEKQQEIMDEKVAEYKAKGYTSAQAKAEAETWVAVPGTSEHQLGLAVDINADGIHSTGNEVYRWLDENSYRFGFIRRYPPDKTEITGVSNEPWHYRYVGIEAATKIYHQGLCLEEYLNTEK,137.69,gnl|BL_ORD_ID|602|hsp_num:0,556,FALSE,None
LK1301,23_7 # 6762 # 8507 # -1 # ID=23_7;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.658,23_7,6762,8507,-,Strict,50,97.4413,vanW gene in vanI cluster,27.75,3003724,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanW; glycopeptide resistance gene cluster,ATGTCCACCCAGACCCTCGCAGGCAGCGCGCCTGATCCCTCGGCCGGCAGCTCGGCGGGCAGGCGCAAGCGACCCTGGATCATCGCGCTCCTCATCCTCGTCGGGCTCGCCGTCGTCTACCTCGCAATCGGCTTCTTCAGCGGCCGGGTCGTCGCCCCCGGCACGACCGTGGCCGGCGTCGACATCGGCTCGCAGAGCGCAGCCGATGCGAAGTCGACCCTTGAGGACGCCCTCGGGGAGAAGGCGAAGCAGGAGATCGAGCTCAGCGCCAAGGAGGCCACGGCGACGATCGATCCGGTGAAGTCGGGACTGGCCCTCGACGTCGACGGCACCGTCGCCCAGGTCACCGGGTTCACACTCAACCCTGCCATCCTCGCCGACCGGCTCTTCGGCGACAATGAGGTCTCACCCGTCCTCGCCGTCGACGACGCGACCTTCGACAAGAGCGCCGAGGCGGCCGCGAAGGGACTCGAGGTTGAACCCGTCGATGCGGAGCTGAGCTACGACAAGACGACGCCTGCGGTCAAGGACGCCGTGACCGGGCAGAGCGTGAGCGTGGAGAACATCCGCTCCGCCGTCGCCGCACAGTGGCTGGTCAAGGACAATCCGCTGCCCGTCGTCGTCGACGAGGTCGAACCCGACATCACGACCGCTGAAGCCAAGGACGTCGCCGACGGCTTCGCCGCCGATGCGGTCAAGGGCGACGTCACCGTCAAGGCCGTACCCGGCAAGGACGCCGACTCCGACGTCAAGGGTGGGGACCTGACGATCTCGCCGACGACGATCGCGAAGACCCTGAGCTTCGAGGCGAAGGATTCGAAGCTCGTGCCGAAGTTCGACGCCGAGAAGCTGCAGAAGCGGGCACTCGACGAGAACGAGGAGATCGGACGTCCCGCCAAGGACGCGACCTTCAAGGTCGTCGACGGCAAGCCGCAGGTCGTCGACTCCGAACCCGGCATCGGCATCAAGCCCGACGACCTCTCGAAGGCCGTGACCGATGCGATCAACGGCGACTCCGCAGCCGCCGAGGTGACCCTGGCCTCCGTCGAACCGGAGTTCACGACCGAGGACGCGAAGAAGGTCGACGTCTCGCAGACCGTCTCGGAGTTCTCCACTCCGTACAAGTCCGATCCCAACCGCGACAACAACCTCCGCGTCGCCTCGAAGGAGGTCTCGGGCACGGTCCTTCAGCCCGGCGAGCAGTTCTCCCTCAATGAGACGCTCGGCCCGCGGACCGCGGCCAACGGCTACAAGCCCGCAGGCGTCATCTCCGAAGGGCAGATGAAGGAGGACTTCGGCGGAGGAGTCTCGCAGGTGTCGACGACCCTGTTCAACGCCGCGTTCTTCGCCGGCTTCGAACTCAACGAGCATCAGGCGCATTCGCGCTACATCTCCCGCTACCCCGAGGGCCGGGAGACGACGCTCGACTACACCTCGATCGACCTCAAGTTCACGAACAACCAGAAGACCCCAGTCGTCCTCGACATGTACCTCTCGGGCGGAAAGGTCTACGCGAAGGTCTACGGAGTCAAGTACTACGACGTCGAAGCCGACTCTTCGGGCCGGTACGCGTTCACCTCGCCGGCGACGGTGACCGAGTCCGGTTCGTCGTGCACTCCGCAGTCACCGCGCGAGGGCTGGTCGATCAAGATCACGCGGACGATGAAGGAGATCGCCACGGGACGGGAGACGAAGGACTCCTTCGTCACGACCTACCGACCGGTCAACAAGGTCGAGTGCAAGTAG,MSTQTLAGSAPDPSAGSSAGRRKRPWIIALLILVGLAVVYLAIGFFSGRVVAPGTTVAGVDIGSQSAADAKSTLEDALGEKAKQEIELSAKEATATIDPVKSGLALDVDGTVAQVTGFTLNPAILADRLFGDNEVSPVLAVDDATFDKSAEAAAKGLEVEPVDAELSYDKTTPAVKDAVTGQSVSVENIRSAVAAQWLVKDNPLPVVVDEVEPDITTAEAKDVADGFAADAVKGDVTVKAVPGKDADSDVKGGDLTISPTTIAKTLSFEAKDSKLVPKFDAEKLQKRALDENEEIGRPAKDATFKVVDGKPQVVDSEPGIGIKPDDLSKAVTDAINGDSAAAEVTLASVEPEFTTEDAKKVDVSQTVSEFSTPYKSDPNRDNNLRVASKEVSGTVLQPGEQFSLNETLGPRTAANGYKPAGVISEGQMKEDFGGGVSQVSTTLFNAAFFAGFELNEHQAHSRYISRYPEGRETTLDYTSIDLKFTNNQKTPVVLDMYLSGGKVYAKVYGVKYYDVEADSSGRYAFTSPATVTESGSSCTPQSPREGWSIKITRTMKEIATGRETKDSFVTTYRPVNKVECK,MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVLAEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPELLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGMETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGGEFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSHSLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDEPDGYPVKPREWSK,155.76,gnl|BL_ORD_ID|4748|hsp_num:0,2242,FALSE,None
LK1147,83_6 # 4087 # 4812 # -1 # ID=83_6;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.778,83_6,4087,4812,-,Strict,50,83.5741,vanY gene in vanM cluster,34.46,3002961,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGTCGCCCCCTCCCCCTCGCCGCGCTGGCCGCGCTCGCGCTGCTCGCGGCCGGCTGCGGCACACCCGCCGCGGGCCCGTCCTCGGCGACGCCGGCCTCCGGCTCCTCAAGCGCGGCCGCGTCGTCCGGCGCCGCCTCGAGCACGCACGCCGACCCGGCCGCCCTCGACGTCGTCGTGAACAAGACCCGCCCCGTGGCTCCGCCCGACTGGGCGCCCTCGGATCTGGTGGCCGTGCCCGGCAGCGAGCTGTCCCTGCGGGCGGAGGCCGCGACGGCGGCCGGTGACCTGCTGGATGCCGCCGCGGCGGCGGGTCACCGCCTCACCACCCTGAGCGCCTACCGCTCGTACGACTACCAGGTCCGGACGTACGGCCACTGGGTCGACGAGCTGGGCCGCGCCGAGGCCGACCGCGTCTCGGCGCGTCCGGGGTACTCCGAGCACCAGACCGGCCTGGCCTGGGACGTGGGCGACGCCGCGACCCCCGCGTGTGACCTGGAAGCGTGCTTCGGCGACACTGCCGCGGGCCGCTGGGTGGCCGCGCACGCCGCCGAGTACGGGTTCGTCATCCGCTATCCCGTCGGGGCCGAGGACGTGACGGGCTTCGCCCACGAGCCGTGGCACCTGCGCTACGTCGGGTCCGCGGAGGCGGCCCGGGTCGAGGCGGCCGGCGGCGTCCTCGAGACCGCGTGGGGCCTGCCTCCGGCGCCGGACTACGCGGACTGA,MRRPLPLAALAALALLAAGCGTPAAGPSSATPASGSSSAAASSGAASSTHADPAALDVVVNKTRPVAPPDWAPSDLVAVPGSELSLRAEAATAAGDLLDAAAAAGHRLTTLSAYRSYDYQVRTYGHWVDELGRAEADRVSARPGYSEHQTGLAWDVGDAATPACDLEACFGDTAAGRWVAAHAAEYGFVIRYPVGAEDVTGFAHEPWHLRYVGSAEAARVEAAGGVLETAWGLPPAPDYAD,MVFQGNLLLVNNEYPVLEESIKTDVVNLFKHDELTKGYELLNREIYLSEKVAREFSEMVDAAEKEGVRHFSINSGFRNFDEQNALYQEMGSDYALPAGYSEHNLGLALDIGSTQMEMSEAPEGKWLEDNAWEYGFILRYPMDKTAITGIQYEPWHFRYVGLPHSAIIEEKNFALEEYLDFLKEQKSISGTIHGENYEISYYPITEKTDIEMPANLHYEISGNNMDGVIVTVYR,103.43,gnl|BL_ORD_ID|1673|hsp_num:0,1713,FALSE,None
LK1224,84_5 # 3146 # 3895 # -1 # ID=84_5;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.779,84_5,3146,3895,-,Strict,50,83.5741,vanY gene in vanM cluster,34.46,3002961,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGTCGCACCCTCCCTCTCGCCGCGCTGGCCGCGCTCGCGCTGCTCGCGGCCGGTTGCGGCACGCCCGCCGCGGGCCCGTCCTCGACGCCGACGACGCCGACGTCCGGCTCCGCGAGCGCGGCCGCGTCGTCCCGCGCCGCCTCGAGCACGGCGCCGTCGTCGGGCACGCACGCCGACCCGGCCACCCTCGACGTCGTCGTGAACAAGACCCGCCCCGTGGCCCCGCCCGACTGGGCGCCCTCGGATCTGGTGGCCGTGCCCGGCAGCGAGCTGCCCCTGCGGGCGGAGGCCGCGACGGCGGCCGCTGACCTGCTGGATGCCGCCGCGGCGGCGGGCCACCGCCTCACCACCCTGAGCGCCTACCGCTCGTACGACTACCAGGTCCGGACGTACGGCCACTGGGTCGACGAGCTGGGCCGCGCCGAGGCCGACCGCGTCTCCGCGCGTCCGGGGTACTCCGAGCACCAGACCGGCCTGGCCTGGGACGTGGGCGACGCCGCGACCCCCGCGTGTGACCTGGAAGCGTGCTTCGGCGACACCGCCGCGGGCCGTTGGGTGGCCGCGCACGCCGCCGAGTACGGGTTCGTCATCCGCTATCCCGCCGGGGCCGAGGACGTGACGGGCTTCGATCACGAGCCGTGGCACCTGCGCTACGTCGGGTCCGCGGAGGCGGCCCGGGTCGAGGCGGCCGGCGGCGTCCTCGAGACCGCGTGGGGTCTGCCGCCGGCGCCGGACTACGCGGACTGA,MRRTLPLAALAALALLAAGCGTPAAGPSSTPTTPTSGSASAAASSRAASSTAPSSGTHADPATLDVVVNKTRPVAPPDWAPSDLVAVPGSELPLRAEAATAAADLLDAAAAAGHRLTTLSAYRSYDYQVRTYGHWVDELGRAEADRVSARPGYSEHQTGLAWDVGDAATPACDLEACFGDTAAGRWVAAHAAEYGFVIRYPAGAEDVTGFDHEPWHLRYVGSAEAARVEAAGGVLETAWGLPPAPDYAD,MVFQGNLLLVNNEYPVLEESIKTDVVNLFKHDELTKGYELLNREIYLSEKVAREFSEMVDAAEKEGVRHFSINSGFRNFDEQNALYQEMGSDYALPAGYSEHNLGLALDIGSTQMEMSEAPEGKWLEDNAWEYGFILRYPMDKTAITGIQYEPWHFRYVGLPHSAIIEEKNFALEEYLDFLKEQKSISGTIHGENYEISYYPITEKTDIEMPANLHYEISGNNMDGVIVTVYR,106.87,gnl|BL_ORD_ID|1673|hsp_num:0,1713,FALSE,None
LK1134,6_87 # 102531 # 104219 # 1 # ID=6_87;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.593,6_87,102531,104219,+,Strict,50,80.1073,vanW gene in vanI cluster,33.54,3003724,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanW; glycopeptide resistance gene cluster,GTGAAAAAGGCAGAAGGAAAAAACGGTGCTAAAGGCTGGCTCATCGCGCTCGGTGTATTTGTCGGCCTTGTCCTGATCGCGGGTATTGCTTATGCCTGGGATGTCGCGGCAAACCAGGACAAGATTCCGCGCGCCGTTTCCGTCAACGGCGTGGACATCTCCGCCATGGATCGCACTGCCGCCGTGGAGAAGCTCGAAGATGAGCTTGCGGGCGTAGAGACCGAACCCGTTTCCGTCACCTCCGGTGACCTTCACACAGAACTCGTCCCTTCCGAATCGGGCCTTGCCCTGGATAACCAGCGGGCCGTGGACAATATTAAGGAGCCTTCCCTCAACCCTTTCACCCGCCTGTATAGCTTCTTCCGTTCCACCCGGGATATTCCGGTAGAGACCAACGTAGATGAAGCCCAGCTGCAGCCTGCCTTGGAGCGGGTGAAGAAAAACCTTTCCACCGACCCTGTCGATGGCATGTTGGAGCTTAACAACGGCGAGCTCAAGGTCACCGACCCGAAGCTTGGCCAAACCGTGGATGCCGGCTCCTTGCACAACGCGGTCACAGAAAACTGGCTCGATTCCGAGGGCGTGGGCGTGGACCCAGAAGAGGTAGAACCGGCCATCAATGATGCGGCCATCGAGGCCATGCGCACCGGCGACGCCGCTAAGGCGCTGGATAATCCGATTACCTTGAAGGCTAAAAATAATGTCACGGCTACCCTGAATAAGCCGGAAATCTCCCAATTCACCAGCATTGAAAAGAAGGACGGCAAGCTCAAGCTCGCCGTGGATACCAACCGCGCGCAGGAGCTGTTGGCGGAGCGCTCTGAGGGCGCCGATGTGCCCGGTGTGAATGCCAAGATTTCCTTCAACGGCAACGACAAGCAGGTCACCCCGTCCGAAGATGGCGAAATCATCGACTGGGAGCCGACCATGAAGGACTTTGACAAGCGTGTGACCGGTGACGACCGCGAGTGGGACGCTACTTATAAGCCGGACCCTGCCGAGTTCACCACCGAAGACGCCAAGAAGGCGACCTTTAACGATACCGTTGGCGAGTTCACAACCGAGGGCTATTCCGCTGCCTCGGGCAAGAACATCGAGCTGGTGGCCCAAGAGGTCAACGGCGCTGTAGTCAACCCCGGCGAGACCTTCTCCCTCAATGGCTACACCGGCCCCCGCGGCACTGCCCAGGGCTATGTGGAATCCGGCATCATTATTGATGGCCACTCCGGTTCCGCCGTCGGCGGTGGCATCTCCCAATTCGCCACTACCTTGTACAACGCTGCCTACTTTGCGGGCATGGAAGATACCGCCCACACCCCGCACTCGTACTATATTTCGCGCTACCCCGCCGGCCGCGAGGCCACCGTTTACGAAGGCGCCATCGACCTGCAGTTCACCAATACCTTCAACACCCCGGTCCGCATTGAGACCGACTTCGGGGGCGGCAAGATTACCGTGCGTTTGAAGGGCACCAAGACCGTTGACGTTGAGTCTGTGAACAATGGCCGCTGGGCCAATACCGACCCACAGCCGATGTCTGTGCCAGGCAGCGACTGCTCGCCTTCCTCTGGTGCGCCAGGCTTTACGACGTCTGATACCCGCATCATCAAGGACCTCGGCGGCAAAGAGCTCTCCCGCGAGACCACCACCACGGTCTACGACCCGCAGCCCATCGTCCGCTGCGGCTAG,MKKAEGKNGAKGWLIALGVFVGLVLIAGIAYAWDVAANQDKIPRAVSVNGVDISAMDRTAAVEKLEDELAGVETEPVSVTSGDLHTELVPSESGLALDNQRAVDNIKEPSLNPFTRLYSFFRSTRDIPVETNVDEAQLQPALERVKKNLSTDPVDGMLELNNGELKVTDPKLGQTVDAGSLHNAVTENWLDSEGVGVDPEEVEPAINDAAIEAMRTGDAAKALDNPITLKAKNNVTATLNKPEISQFTSIEKKDGKLKLAVDTNRAQELLAERSEGADVPGVNAKISFNGNDKQVTPSEDGEIIDWEPTMKDFDKRVTGDDREWDATYKPDPAEFTTEDAKKATFNDTVGEFTTEGYSAASGKNIELVAQEVNGAVVNPGETFSLNGYTGPRGTAQGYVESGIIIDGHSGSAVGGGISQFATTLYNAAYFAGMEDTAHTPHSYYISRYPAGREATVYEGAIDLQFTNTFNTPVRIETDFGGGKITVRLKGTKTVDVESVNNGRWANTDPQPMSVPGSDCSPSSGAPGFTTSDTRIIKDLGGKELSRETTTTVYDPQPIVRCG,MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVLAEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPELLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGMETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGGEFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSHSLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDEPDGYPVKPREWSK,150.67,gnl|BL_ORD_ID|4748|hsp_num:0,2242,FALSE,None
LK687,19_4 # 4409 # 6103 # 1 # ID=19_4;partial=00;start_type=GTG;rbs_motif=3Base/5BMM;rbs_spacer=13-15bp;gc_cont=0.657,19_4,4409,6103,+,Strict,50,78.9518,vanW gene in vanI cluster,33.33,3003724,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanW; glycopeptide resistance gene cluster,GTGACTACGGTAAATGCAACAGGTGCCCGTGGTGGGCGCGGGGTCAGCACCGGGAAGATTCTCCTCGGTGTGCTGCTCGGTGTGCTCGCGGTGCTGCTCGCGATCTACCTCGCCGACCTCGCAATGAACCGCGGGAACGTGCCGCGTGGCACCGCCGTCGGCGGTGTCGAGATCGGCGGCATGAGCCAGGACGAGGCCACCGCGAAGCTCGAAGCAGAGCTCGGCGAGACGGCGAGTAACCCGGTGACGGTGAAGGCGGCGACGCAAAGCTCGCAGCTCGTGCCCGCCGAATCCGGCCTCGGCATCGACTGGGAGGCGACCGTAGCAAGCGCGGGCGAAGAGTCCGCGAACCCGTTCACTCGCCTCGCCGGGTTGTTTCGCACACGCGAAGTCGACATTGTGTCGACCGTGAACGAGGCCGCTCTCACCCCGCAGCTTGAGCGAGTGGCCGGCGAGTTGCACCTCGACCCCGCCGACGGCGCGATCGCCATCGAAGGCGGCGAGGCGAAAGTGACCGAACCGGTGCCGGGCCAGGAGGTTGACAAAACCGAGCTGTTCGAACGTGTCACCACCGGCTGGCTCAACCCCGACGGTGTGGAGGTCGAGCCGCGCGAGATCGAACCCGCTATCGGCGACCAGGCGATCAAGGAAGCCTTAGACGGGCCGGTTAAGGCGGCGCTGTCCGGAGCGTTGACACTGCACGGTCGCGACGGCGTCGACGGTGTCATTGCCCAAGAGCGCATCGGCGAGGTCGTCCAGTTCCCCAACGTCGACGGCAAAATCGCCCCCGAGGTGAACGTGGAAAGCGCCCAGGGCATCTTGGGCGAGCAGCTCGCTGCGACCGAGACGCAGATGAAAAACGCGCGCGTGCTGCCCGGCGGCGGGGTGGAACCGTCCGTCGACGGCTCCATTATCGACTGGGAGGCCGCGATGGACGGTTTCGACGAGCGGTTGATCGGTTCCGCCGAGCGCACCTGGGACGCGCAATACAAGGCCCGCCCGGCAGACTTCACTACAGAGGAAGCCCAACGTGCCACCTTCGACCAGGTGGTGGGAAGTTTCACCACCGGCGGGTACAGGGGCGCATCCGGCACGAACATCGCTACGGTGGCCCGCGTTGTCAACGGCGCAATTGTCAACCCCGGTGAAACCTTCTCGCTCAACGGCTACACCGGCGCGCGCGGTGCCGCGCAGGGTTACGTCGAGTCGGTCATCATCGAAAATGGACGCCCCGGCAAGGCAGTGGGTGGCGGAATCTCCCAATTTGCCACGACCTTGTACAACGCGGCTTACTTTGCCGGCATGACGGATGTCGCCTCCACCCCGCACTCCTACTACATCTCACGCTACCCGGCTGGCAGGGAGGCGACCGTGTATGAAGGGGCGATTGACCTGCAATTCCGCAACGATTCGCCCCACCCGGTCAAGATTTCCACGAGCGTCGGGGGCGGCGAGGTGACGGTGAGCCTGATGGGCACCAAGACCGTCGAGGTGGAGTCCATCAACGGAGGGCGCTGGGCCTACACCTCGCCGAAGCCCGTGACGGTGACGAGCGGTGACTGCATTCCCTCGGGCGGGGCGCAGGGCTTTACCACCTCCGATACCCGGATTGTGCGTGACCTCAGCGGCAATGAGATCAGTCGCAACACCTCCACCACGGTCTACGACCCGCAGCCCATCGTGCGCTGCGGGTAG,MTTVNATGARGGRGVSTGKILLGVLLGVLAVLLAIYLADLAMNRGNVPRGTAVGGVEIGGMSQDEATAKLEAELGETASNPVTVKAATQSSQLVPAESGLGIDWEATVASAGEESANPFTRLAGLFRTREVDIVSTVNEAALTPQLERVAGELHLDPADGAIAIEGGEAKVTEPVPGQEVDKTELFERVTTGWLNPDGVEVEPREIEPAIGDQAIKEALDGPVKAALSGALTLHGRDGVDGVIAQERIGEVVQFPNVDGKIAPEVNVESAQGILGEQLAATETQMKNARVLPGGGVEPSVDGSIIDWEAAMDGFDERLIGSAERTWDAQYKARPADFTTEEAQRATFDQVVGSFTTGGYRGASGTNIATVARVVNGAIVNPGETFSLNGYTGARGAAQGYVESVIIENGRPGKAVGGGISQFATTLYNAAYFAGMTDVASTPHSYYISRYPAGREATVYEGAIDLQFRNDSPHPVKISTSVGGGEVTVSLMGTKTVEVESINGGRWAYTSPKPVTVTSGDCIPSGGAQGFTTSDTRIVRDLSGNEISRNTSTTVYDPQPIVRCG,MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVLAEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPELLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGMETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGGEFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSHSLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDEPDGYPVKPREWSK,151.21,gnl|BL_ORD_ID|4748|hsp_num:0,2242,FALSE,None
LK687,15_67 # 56071 # 56442 # -1 # ID=15_67;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.656,15_67,56071,56442,-,Strict,200,223.402,Mycobacterium tuberculosis rpsL mutations conferring resistance to Streptomycin,90.91,3003395,protein variant model,K88R,n/a,aminoglycoside antibiotic,antibiotic target alteration,antibiotic-resistant rpsL,ATGCCAACTATCCAGCAGCTGGTCCGCAAAGGCCGCCACGATAAGCGCACCAAGGTCGCTACCGCGGCCCTGAAGGGCTCCCCGCAGCGCCGCGGTGTGTGCACCCGTGTATACACCACCACCCCGAAGAAGCCGAACTCCGCTCTGCGTAAGGTTGCCCGCGTGCGCCTGACCTCGGGCATCGAGGTCTCCGCATACATCCCCGGCGAGGGCCACAACCTGCAGGAGCACTCCATGGTGCTCGTACGCGGCGGCCGTGTGAGGGACCTTCCGGGCGTTCGCTACAAGATCATCCGCGGCGCGCTTGACACCCAGGGTGTTAAGGACCGCAAGCAGGCTCGCTCCCGCTACGGCGCGAAGAAGGGACAGTAA,MPTIQQLVRKGRHDKRTKVATAALKGSPQRRGVCTRVYTTTPKKPNSALRKVARVRLTSGIEVSAYIPGEGHNLQEHSMVLVRGGRVRDLPGVRYKIIRGALDTQGVKDRKQARSRYGAKKGQ,MPTIQQLVRKGRRDKISKVKTAALKGSPQRRGVCTRVYTTTPKKPNSALRKVARVKLTSQVEVTAYIPGEGHNLQEHSMVLVRGGRVKDLPGVRYKIIRGSLDTQGVKNRKQARSRYGAKKEKG,99.19,gnl|BL_ORD_ID|1956|hsp_num:0,1197,FALSE,None
LK428,3_1 # 62 # 907 # -1 # ID=3_1;partial=00;start_type=TTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.265,3_1,62,907,-,Strict,500,504.597,PC1 beta-lactamase (blaZ),95.02,3000621,protein homolog model,n/a,n/a,penam,antibiotic inactivation,BlaZ beta-lactamase,TTGAAAAAGTTAATACTTTTAATTGCAATTGCTTTAGTTTTAAGTGCATGTAATTCAACCAGTTCACATGCTAAAGAGTTAAATAATTTAGAAAAGAAATATAATGCTAATATTGGTGTCTATGCATTAGATACTAAAAGTGGTAAGGAAGTAAAATTTAATGCCGATAAGAGATTTGCCTATGCTTCAACTTCAAAAGCGATAAATAGTGCTATTTTGTTAGAACAAGTACCTTATAATAAGTTAAATAAAAAAGTACATATTAACAAAGATGATATAGTTGCTTATTCTCCTATTTTAGAAAAATATGTAGGAAAAGATATCACTTTAAAAGAACTTATTGAGGCTTCAATGAAGTATAGTGATAATACAGCAAACAATAAAATTATAAACGAAATCGGTGGAATCAAAAAAATTAAAAAACGTTTAAAAAAATTGGGAGATAAAGTAACAAATCCAGTTAGATATGAAATAGAATTAAATTACTATTCACCAAAGAGCAAAAAAGATACTTCAACGCCTGCTGCTTTCGGCAAGACTTTAAATAAACTTATCGCAAATGGAAAATTAAGCAAAAAAAATAAAAATTTCTTACTTGATTTAATGTTAAATAATAAAAACGGAGACACTTTAATTAAAGATGGTGTTCCAAAAGACTATAAGGTTGCTGATAAAAGTGGTCAAGCAATAACATATGCTTCTAGAAATGATGTAGCTTTTGTTTATCCTAAGAACCAATCTGAACCTATTATTTTAGTCATTTTTACGAATAAAGACAATAAAAGTGATAAACCTAATGATAAATTGATAAGTGAAACCGCCAAGAATGTAATAAACAAATTTTAA,MKKLILLIAIALVLSACNSTSSHAKELNNLEKKYNANIGVYALDTKSGKEVKFNADKRFAYASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMKYSDNTANNKIINEIGGIKKIKKRLKKLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKTLNKLIANGKLSKKNKNFLLDLMLNNKNGDTLIKDGVPKDYKVADKSGQAITYASRNDVAFVYPKNQSEPIILVIFTNKDNKSDKPNDKLISETAKNVINKF,MKKLIFLIVIALVLSACNSNSSHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFAYASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDIALKELIEASMKYSDNTANNKIINEIGGIKKIKKRLKKLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKTLNKLIANGKLSKKNKNFLLDLMLNNKNGDTLIKDGIPKDYKVADKSGQAITYASRNDVAFVYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF,100,gnl|BL_ORD_ID|670|hsp_num:0,726,FALSE,None
LK428,3_179 # 189001 # 190401 # 1 # ID=3_179;partial=00;start_type=ATG;rbs_motif=AGGA/GGAG/GAGG;rbs_spacer=11-12bp;gc_cont=0.335,3_179,189001,190401,+,Strict,525,532.717,norC,59.31,3007010,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGGAGTCTTCAAAAGAATTTAAGGGAGATAATCGGTTACTCGTTGGAATTATTATTAGTGTATTAACATTTTGGTTGTTTGCGCAATCGTTACTTAATATTGTGCCAACACTACAATCATCATTTAATACCGATTTGGGTACTATTAATATTGCAGTGAGCTTATCTGCCTTATTTTCTGGTTTGTTTATTGTAGGTGCTGGAGATGTTGCTGATAAATTTGGTCGCGTCAAAATGACTTATTTGGGACTAGGCTTAAATATCATTGGTTCATTATTATTGATTATTACACCAGTTCCATGGTTATTACTGATTGGACGTGCTTTGCAAGGTTTATCAGGTGCATTCATTATGCCATCAACTCTTGCGATAATTAATGAATATTACATAGGAAAAGAAAGACAACGTGCATTAAGTTTTTGGTCTATTGGCTCATGGGGCGGAAGTGGAATATGTTCATTGTTCGGTGGATTTATCGCTTCAACAATAGGATGGCAATGGATTTTTATTATTTCTATTGCTTTGTCAATACTTTCATTTTTCTTAATTAAACACACGCCAGAAACAAAAAATGAACCAGATACGGATACAGACAATAGCGGTTCAAAATTTGATTTTATAGGTTTGATTTTATTAGTTATTACATTATTAAGTGTCAATGTGATGGTAACACAAGCTTCTGATCGTGGATTATTATCACCTGTCATTCTATCGTTATTTGTAATATTTTTAATTGCTGGTATATTCTTTGTTCTTCGTGAATTTAAAACTGAGAACCCACTTGTTGATTTTAGTTTATTTAAGAATAAAGGATATAGTGGTGCTACACTTTCAAACTTCATGCTAAATGGAGTAGCAGGTGGTACGCTTATCGTAGTAAATACATATTACCAAAGTCATTTAGGTTTCACTTCATTACAAGCAGGTTTAATCTCTATCACTTATTTAGTAGCAGTGCTTGTAATGATTCGTGTAGGTGAAAAACTATTACAAAAATTAGGTGCTAAAAAGCCATTGCTTATAGGTAGTGGATTTACATTTTTAGGGTTACTACTTTTATCACTAACCTTCTTACCTAATTTGTTTTATATTATTTCAAGTATTATTGGTTACCTACTATTTGGTATTGGGCTTGGTATGTATGCCACACCATCTACAGATACAGCAGTTGATCAAGCGCCAGATGATAAAGTGGGTGTTGCCTCTGGATTGTATAAAATGGCTTCATCACTAGGAAATGCATTTGGTGTAGCTTTATCAAGTACGATTTATGGTGTTTGTGCAGCGAAAATGAATTTAGAACTTGGTGGTTTAGCGGGCGTACTCTTTAATGCCATCATCGTTTTAACTGCTTTCTTTGTCATTTTCTTCTTAATTCCAAATAAAGCTAAACGTGCTTAA,MESSKEFKGDNRLLVGIIISVLTFWLFAQSLLNIVPTLQSSFNTDLGTINIAVSLSALFSGLFIVGAGDVADKFGRVKMTYLGLGLNIIGSLLLIITPVPWLLLIGRALQGLSGAFIMPSTLAIINEYYIGKERQRALSFWSIGSWGGSGICSLFGGFIASTIGWQWIFIISIALSILSFFLIKHTPETKNEPDTDTDNSGSKFDFIGLILLVITLLSVNVMVTQASDRGLLSPVILSLFVIFLIAGIFFVLREFKTENPLVDFSLFKNKGYSGATLSNFMLNGVAGGTLIVVNTYYQSHLGFTSLQAGLISITYLVAVLVMIRVGEKLLQKLGAKKPLLIGSGFTFLGLLLLSLTFLPNLFYIISSIIGYLLFGIGLGMYATPSTDTAVDQAPDDKVGVASGLYKMASSLGNAFGVALSSTIYGVCAAKMNLELGGLAGVLFNAIIVLTAFFVIFFLIPNKAKRA,MNETYRGGNKLILGIVLGVITFWLFAQSLVNVVPNLQQSFGADMGTISIAVSLTALFSGMFVVGAGGLADKIGRVKMTNIGLLLSIIGSALIIITNLPALLILGRIIQGVSAACIMPSTLAIMKTYYEGAERQRALSYWSIGSWGGSGICSLFGGAVATTMGWRWIFIFSIIVAVLSMLLIKGTPETKSEVTNTHKFDVAGLIVLVVMLLSLNVVITKGAALGYTSLWFFGLIAIVIVAFFIFLNVEKKVDNPLIDFKLFENKPYTGATISNFLLNGVAGTLIVANTFVQQGLGYTALQAGYLSITYLIMVLLMIRVGEKLLQKMGSKRPMLLGTFIVIIGIALISLVFLPGIFYVISCVVGYLCFGLGLGIYATPSTDTAISNAPLDKVGVASGIYKMASSLGGAFGVAISGAVYAGAVAATSIHTGAMIALWVNVLMGIMAFIAILFAIPNDDKRVKDAK,100.87,gnl|BL_ORD_ID|4656|hsp_num:0,5726,FALSE,None
LK428,5_184 # 198586 # 199257 # -1 # ID=5_184;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.330,5_184,198586,199257,-,Strict,50,107.457,vanY gene in vanB cluster,35.52,3002956,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGAAAAAATTCTCTGCAGTCCTAATGACAAGCGCTTTATTACTTTCAGCTTGCTCACATAGTAATGATGAAAATGAAAATAATACTAAACAAACATCTCAAACTAATAAAAGTGATGACAATCATCAAAAACATAAAAAAGTTATTAAAGAGGGTCGTACATATATCGATGGTATTTTAATTGTAAATAAAAATATAGGTCTTCCTTCAAATTATAATCCTGGTGAAGATCCAAAAGCCCAACAAGCCTTACAACAATTATTTAGTGCTGCACAAAAAGAGGGTATTAACTTATACAAAATGAGTGGCTACAGAAGTTATCCTACTCAAGTTCAACTATACAATCGTTATGCTGCACGCGATGGTAAAAAAGCTGCAGATAAATATAGCGCACGTCCTGGCTATTCAGAACATCAAACAGGTCTTACATTTGACATCGGTGGCGTTAATTCAGATAAAAACTTATATGCAAGTTTCGGAAAAACAAAAGAAGGTCAATGGATTGCGAAAAACGCCCATAAATACGGCTTTATTGTGAGATATCCTAAAGGAAAAGAAAAAATTACTGGTTATCAATACGAACCATGGCATTTACGTTATTTAGGAAAAGATACTGCAACCAAAGTATATCAATCCGGTAAAACATTAGAAGAATATGTAGGGTTAAAATAA,MKKFSAVLMTSALLLSACSHSNDENENNTKQTSQTNKSDDNHQKHKKVIKEGRTYIDGILIVNKNIGLPSNYNPGEDPKAQQALQQLFSAAQKEGINLYKMSGYRSYPTQVQLYNRYAARDGKKAADKYSARPGYSEHQTGLTFDIGGVNSDKNLYASFGKTKEGQWIAKNAHKYGFIVRYPKGKEKITGYQYEPWHLRYLGKDTATKVYQSGKTLEEYVGLK,MEKSNYHSNVNHHKRHMKQSGEKRAFLWAFIISFTVCTLFLGWRLVSVLEATQLPPIPATHTGSGTGVAENPEENTLATAKEQGDEQEWSLILVNRQNPIPAQYDVELEQLSNGERIDIRISPYLQDLFDAARADGVYPIVASGYRTTEKQQEIMDEKVAEYKAKGYTSAQAKAEAETWVAVPGTSEHQLGLAVDINADGIHSTGNEVYRWLDENSYRFGFIRRYPPDKTEITGVSNEPWHYRYVGIEAATKIYHQGLCLEEYLNTEK,83.21,gnl|BL_ORD_ID|602|hsp_num:0,556,FALSE,None
LK428,6_2 # 1504 # 2022 # -1 # ID=6_2;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.239,6_2,1504,2022,-,Strict,100,210.69,sepA,62.58,3007012,protein homolog model,n/a,n/a,disinfecting agents and antiseptics,antibiotic efflux,small multidrug resistance (SMR) antibiotic efflux pump,ATGATAAAGTGGCATTATAAAGTATGGATGAAAAGAGGAGGAAAGAGAGAAATGAAATTTTCTAATCAAAAATTTAATGGTATCTTTCCGACTCTTCTTATTCTTCTTATTTTTATTCTATCAGGTTGTATATTTTTAATATTTTTAGGATTTGGGTTATTTGGATTAAGTCGAATTCTTATTTTTTTAAAATTAGGATTCTTTACATATAATAAGGATTTATTCAGCAATTTAGTATATTACGGTAGCTATATAGTATTTGGATACTTTTTGCTATTCGCTATTGAGCATTTAATGGATTACTTTAGAAAGCAATTACCTAATAATCCATATTTTAATGGAACACTATTTCATTTAATTTCATATGTGATTACGACTATTCTATTCTATTTTGTTATTCATATTCATTACGTATATATTAAAATTGAATTTTGGGTTATTGCATTAATTATTGGAATACTATATTTATGTAAAATGATTTTTTATCCAGATAGCGAAGACTTGAATGATAAGAAGTAA,MIKWHYKVWMKRGGKREMKFSNQKFNGIFPTLLILLIFILSGCIFLIFLGFGLFGLSRILIFLKLGFFTYNKDLFSNLVYYGSYIVFGYFLLFAIEHLMDYFRKQLPNNPYFNGTLFHLISYVITTILFYFVIHIHYVYIKIEFWVIALIIGILYLCKMIFYPDSEDLNDKK,MIVNFFKHKFYNLLTTMIVLFVFVLSGAIFLTFLGFGLYGLSRILIYFRLGDFTYNRNMYDNLLYYGSYIIFGYFIIFAVEHLMDYFRKMLPENAYFRGATFHLISYTVATTLFYFIIHLHYVYINIDFWVIMVIIGFLYVCKLQFYPESKNLNNRK,109.55,gnl|BL_ORD_ID|4660|hsp_num:0,5728,FALSE,None
LK428,6_3 # 2046 # 3386 # -1 # ID=6_3;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.295,6_3,2046,3386,-,Strict,200,576.244,sdrM,67.49,3007013,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGAAATTAAAATCAATAGGTATTGTGGTTACTTTGGTTTTAACAATGTTTATGGCAGCAATTGAAAGTTCAATTATTTCACTAGCATTGCCTACCATTCGTAAAGATTTGAATGCTGGTACAGCAGTGCCATTAGTCTTTACCGTTTATTTTATAGCACTTGTAGTAGCAAATCCTATTGTGGGTGAACTTCTCACAAGATTTAAGATTCTATATATAGCTGTAGTCGGCTTACTATTATTTGGTATTGGAAGTTTTATGTCAGGCATGAGTGAGACGTTTATAATGTTAATTATTTCAAGAGCCATCCAGGGACTTGGCGCAGGAGTTATGATGTCTTTGACTCAAATTGTACCAAAACTAGCATTTGAAATTCCGCTTCGTTACAAAATAATGGGCATCGTTGGAAGTGTCTGGGGAATTTCAAGTATTCTTGGACCGTTATTAGGTGGTGGAATATTAGAAGTTGCAACATGGCATTGGTTGTTTTATATCAATATACCAATAGCATTGATAGCTATTGTTTTAGCTTTTCTTACTTTTCATTTTCCAGAAGAAGCGGAAGTACAACATATACACTTTGATGTAAAAGGATTATCTTTGTTTTATATTTTTATTGGACTTCTTATGTTTAGTTTATTAAATAAAACAGGTGTTACTTTTAATATTATTGCATTAATACTAGCAATAGTTATATTATTCGTTTTATTCAAATATGAAAATAAAACAGATATGCCTTTTTTACCAATAAGTGAATTTAATAAATCAATTTCACTGGTATTTATAACTGATTTACTTATAGCAATATGTCTAATGGGGTATAACTTATATATACCTGTTTATTTACAAGATCATTTAAAATTATCTCCAATACAAAGTGGATTAGTGATATTTCCACTTTCTGTTGCATGGTTAGCTTTAAACTTCAACTTAGCTAAAGTAGAATCAAAATTTTCAAGAAAAAAACTATATATAGGAGCTTTCATATCATTAATTTTAAGTAATATGATTTTAGTATTTGGACTTCATATTCCTCTTATTATTGCGGGAGCTGTGATTCTTGCAGGATTGAGTTTTGGCTTTGTTTATACTAAAGACAGTGTTATTGTTCAAGAAGAAACAAGTCCTAAATATATGAAAAAAATGATGTCATTCTATGCATTAACTAAAAATTTAGGATCATCTATAGGATCTACATTGATGGGGTCATTATATGCACTTCAATTTGGTTTATTAGGAGGTAACTTCTATAATATATTAACTGTAATCACAATTGTTGCGCTTATATTAATTTTAATGTGGGCATTTTTATTTGAAGAGAATAAAGAAGGTATAAAATAA,MKLKSIGIVVTLVLTMFMAAIESSIISLALPTIRKDLNAGTAVPLVFTVYFIALVVANPIVGELLTRFKILYIAVVGLLLFGIGSFMSGMSETFIMLIISRAIQGLGAGVMMSLTQIVPKLAFEIPLRYKIMGIVGSVWGISSILGPLLGGGILEVATWHWLFYINIPIALIAIVLAFLTFHFPEEAEVQHIHFDVKGLSLFYIFIGLLMFSLLNKTGVTFNIIALILAIVILFVLFKYENKTDMPFLPISEFNKSISLVFITDLLIAICLMGYNLYIPVYLQDHLKLSPIQSGLVIFPLSVAWLALNFNLAKVESKFSRKKLYIGAFISLILSNMILVFGLHIPLIIAGAVILAGLSFGFVYTKDSVIVQEETSPKYMKKMMSFYALTKNLGSSIGSTLMGSLYALQFGLLGGNFYNILTVITIVALILILMWAFLFEENKEGIK,MRLKSIITVIALILIMFMSAIESSIISLALPTIKQDLNAGNLISLIFTAYFIALVIANPIVGELLSRFKIIYVAIAGLLLFSIGSFMCGLSTNFTMLIISRVIQGFGSGVLMSLSQIVPKLAFEIPLRYKIMGIVGSVWGISSIIGPLLGGGILEFATWHWLFYINIPIAIIAIILVIWTFHFPEEETVAKSKFDTKGLTLFYVFIGLIMFALLNQQLLLLNFLSFILAIVVAMCLFKVEKHVSSPFLPVVEFNRSITLVFITDLLTAICLMGFNLYIPVYLQEQLGLSPLQSGLVIFPLSVAWITLNFNLHRIEAKLSRKVIYLLSFTLLLVSSIIISFGIKLPVLIAFVLILAGLSFGYIYTKDSVIVQEETSPLQMKKMMSFYGLTKNLGASIGSTIMGYLYAIQSGIFGPNLHNVLSAVAVISIGLIVLWVVFFKEQSSQSKE,99.78,gnl|BL_ORD_ID|4661|hsp_num:0,5729,FALSE,None
LK428,16_12 # 8403 # 9947 # -1 # ID=16_12;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.355,16_12,8403,9947,-,Strict,990,1000.35,qacA,99.81,3003046,protein homolog model,n/a,n/a,fluoroquinolone antibiotic,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGATTTCATTTTTTACAAAAACTACTGATATGATGACATCAAAAAAAAGATGGACTGCACTAGTAGTATTAGCTGTTAGTTTGTTTGTTGTTACAATGGATATGACAATATTAATTATGGCTTTACCGGAATTAGTAAGAGAGTTAGAGCCTTCTGGTACCCAACAGTTATGGATAGTTGATATATACTCTCTTGTTTTAGCTGGCTTTATAATTCCATTGAGTGCCTTTGCTGATAAATGGGGAAGAAAAAAAGCATTATTAACTGGATTTGCTTTATTTGGCCTCGTTTCATTAGCTATATTTTTCGCAGAAAGTGCAGAGTTCGTAATAGCTATTCGATTTTTACTTGGTATTGCAGGTGCTTTAATAATGCCAACTACTCTTTCAATGATAAGAGTAATTTTTGAAAACCCTAAAGAAAGGGCCACTGCATTAGCTGTATGGTCAATCGCTTCATCGATAGGTGCTGTTTTTGGACCAATTATCGGAGGAGCTTTACTTGAGCAATTTTCATGGCACTCGGCATTTTTAATTAATGTACCGTTTGCGATAATAGCAGTTGTAGCAGGTTTATTTTTATTACCAGAGTCTAAGTTATCAAAAGAAAAGTCTCACTCGTGGGATATTCCTTCTACAATTTTATCAATTGCAGGCATGATTGGACTGGTATGGAGTATCAAAGAATTTTCAAAAGAAGGACTAGCAGATATTATTCCATGGGTTGTAATAGTATTAGCAATTACCATGATAGTGATATTTGTTAAACGTAATTTATCAAGTTCTGATCCAATGTTAGACGTAAGACTTTTTAAAAAGAGATCATTTTCAGCTGGTACAATTGCTGCATTTATGACAATGTTTGCAATGGCATCTGTTTTGTTATTAGCTTCACAATGGTTACAGGTTGTGGAAGAACTTTCTCCTTTTAAAGCTGGCTTATACCTATTACCTATGGCAATAGGAGATATGGTGTTTGCACCAATTGCACCCGGATTAGCGGCGCGATTTGGACCGAAAATAGTGTTACCTTCCGGAATTGGAATTGCAGCCATTGGCATGTTTATTATGTATTTCTTTGGTCATCCATTATCATATTCTACAATGGCTTTAGCATTAATTTTAGTTGGAGCTGGTATGGCTTCACTAGCAGTTGCATCTGCTCTAATAATGTTAGAAACACCTACATCAAAAGCAGGTAATGCAGCTGCTGTTGAAGAGTCTATGTATGACCTTGGAAATGTTTTTGGTGTAGCAGTACTTGGTAGCCTATCTTCTATGCTTTATCGTGTATTTTTAGATATTTCATCTTTTTCATCAAAAGGTATAGTTGGAGATTTAGCTCATGTAGCTGAAGAATCTGTAGTGGGCGCTGTCGAAGTAGCTAAAGCTACGGGGATAAAACAGCTTGCAAACGAGGCTGTAACATCATTTAATGATGCTTTTGTAGCAACTGCTTTAGTAGGTGGGATTATCATGATTATCATTTCAATAGTTGTCTATTTGTTAATTCCCAAATCACTTGATATAACTAAACAAAAATAG,MISFFTKTTDMMTSKKRWTALVVLAVSLFVVTMDMTILIMALPELVRELEPSGTQQLWIVDIYSLVLAGFIIPLSAFADKWGRKKALLTGFALFGLVSLAIFFAESAEFVIAIRFLLGIAGALIMPTTLSMIRVIFENPKERATALAVWSIASSIGAVFGPIIGGALLEQFSWHSAFLINVPFAIIAVVAGLFLLPESKLSKEKSHSWDIPSTILSIAGMIGLVWSIKEFSKEGLADIIPWVVIVLAITMIVIFVKRNLSSSDPMLDVRLFKKRSFSAGTIAAFMTMFAMASVLLLASQWLQVVEELSPFKAGLYLLPMAIGDMVFAPIAPGLAARFGPKIVLPSGIGIAAIGMFIMYFFGHPLSYSTMALALILVGAGMASLAVASALIMLETPTSKAGNAAAVEESMYDLGNVFGVAVLGSLSSMLYRVFLDISSFSSKGIVGDLAHVAEESVVGAVEVAKATGIKQLANEAVTSFNDAFVATALVGGIIMIIISIVVYLLIPKSLDITKQK,MISFFTKTTDMMTSKKRWTALVVLAVSLFVVTMDMTILIMALPELVRELDPSGTQQLWIVDIYSLVLAGFIIPLSAFADKWGRKKALLTGFALFGLVSLAIFFAESAEFVIAIRFLLGIAGALIMPTTLSMIRVIFENPKERATALAVWSIASSIGAVFGPIIGGALLEQFSWHSAFLINVPFAIIAVVAGLFLLPESKLSKEKSHSWDIPSTILSIAGMIGLVWSIKEFSKEGLADIIPWVVIVLAITMIVIFVKRNLSSSDPMLDVRLFKKRSFSAGTIAAFMTMFAMASVLLLASQWLQVVEELSPFKAGLYLLPMAIGDMVFAPIAPGLAARFGPKIVLPSGIGIAAIGMFIMYFFGHPLSYSTMALALILVGAGMASLAVASALIMLETPTSKAGNAAAVEESMYDLGNVFGVAVLGSLSSMLYRVFLDISSFSSKGIVGDLAHVAEESVVGAVEVAKATGIKQLANEAVTSFNDAFVATALVGGIIMIIISIVVYLLIPKSLDITKQK,100,gnl|BL_ORD_ID|339|hsp_num:0,372,FALSE,None
LK405,1_429 # 454303 # 454797 # -1 # ID=1_429;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.430,1_429,454303,454797,-,Strict,300,338.576,dfrE,98.78,3002875,protein homolog model,n/a,n/a,diaminopyrimidine antibiotic,antibiotic target replacement,trimethoprim resistant dihydrofolate reductase dfr,ATGTTAGCAGCCATTTGGGCCCAAGATGAACAAGGCGTGATTGGGAAAGAAGGCAAATTGCCTTGGCATTTACCCAACGACTTGAAATTTTTCAAGGAAAAAACAATTCATAATACATTGGTCTTAGGACGTGCAACTTTCGAAGGCATGGGATGTCGTCCGTTACCAAATCGAACAACGATTGTTCTTACCAGTAATCCGGATTACCAAGCTGAAGGCGTTTTGGTTATGCATTCCGTAGAGGAGATTCTTGCGTATGCTGACAACTATGAAGGCGTGACCGTTATTGGTGGAGGTTCTGTCGTTTTTAAAGAACTGATTCCCGCATGTGATGTCTTATATCGGACGATGATTCATGAAACATTTGAAGGCGACACCTTCTTTCCAGAAATCGACTGGTCTGTTTGGGAAAAAGTTGCCACTGTTCCCGGCGTCGTGGACGAGAAAAATCTCTATGCACATGACTATGAAACGTATCATCGAAACGATAAATAA,MLAAIWAQDEQGVIGKEGKLPWHLPNDLKFFKEKTIHNTLVLGRATFEGMGCRPLPNRTTIVLTSNPDYQAEGVLVMHSVEEILAYADNYEGVTVIGGGSVVFKELIPACDVLYRTMIHETFEGDTFFPEIDWSVWEKVATVPGVVDEKNLYAHDYETYHRNDK,MLAAIWAQDEQGVIGKEGKLPWHLPNDLKFFKEKTIHNTLVLGRATFEGMGCRPLPNRTTIVLTSNPDYRAEGVLVMHSVEEILAYADNYEGVTVIGGGSVVFKELIPACDVLYRTMIHETFEGDTFFPEIDWFVWEKVATVPGVVDEKNLYAHDYETYHRNDK,100,gnl|BL_ORD_ID|1421|hsp_num:0,1544,FALSE,None
LK405,1_846 # 904942 # 906096 # -1 # ID=1_846;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.360,1_846,904942,906096,-,Strict,720,739.184,emeA,97.71,3003551,protein homolog model,n/a,n/a,disinfecting agents and antiseptics,antibiotic efflux,multidrug and toxic compound extrusion (MATE) transporter,ATGACGAAAAAAAATAGTATGATGTACTTAGCAATTTCTAACTTATTTCTTGTTTTTCTAGGCGTAGGCCTAGTCATTCCCGTAATTCCCCAATTAAAAGAAGAAATGCATTTTTCTGGTACCACAATGGGAATGATGATTTCTATTTTTGCGATTGCCCAATTAATCACATCGCCAATCGCAGGTGTCCTTTCGGATAAAATTGGTCGGAAAAAAATGATTGCGACGGGCATGTTGGTTTTTTCAATTTCTGAGTTATTATTTGGTTTAGCCCAAGCGAAAAGCGGTTTTTATATTTCTCGTGGTTTAGGTGGGATTGCCGCCGCTTTATTAATGCCGTCAGTGACAGCCTTTGTGGCAGATATGACCACGATTTCTGAACGTCCGAAAGCGATGGGACTTGTGTCAGCCGCAATTAGTGGTGGTTTTATTATCGGACCAGGAGTTGGTGGTTTTATTGCTTATTTAGGTATTCGCGCTCCATTTTTTGCGGCCGCATTTTTAGCGTTTATTGGTTTTATTTTGACATTAACTGTTTTGAAGGAGCCAGAGAAACGAATTTTAGCCGCTGTTGAAGCGAAAAAAGGTTCCTTTATGGATATTTTAAGAAATCCAATGTTTACCTCATTATTTGTGATTATCTTAATTTCCTCTTTTGGCCTGCAAGCGTTCGAATCTATTTATAGTATTATGGCGACTATTAATTTTGGCTTTACCACAAGTGAAATAGCAATCGTGATTACGGTTAGTGGTATTTTAGCGTTGATTTGTCAGTTGTTTTTCTTTGATGCAATCGTCCAAAAAATAGGTGAAATGGGTTTAATCCAATTAACCTTTTTTGCAAGTGCCATTTTTATTGCCGTGATTGCCTTTACAAAAAATAATTTAGTTGTTGTATTTTCAACGTTTATTGTCTTTTTAGCGTTTGACTTGTTTAGACCAGCAGTAACTACTTATTTATCCAAACATGCTGGAGATCAACAAGGAACCATCAACGGACTAAATTCGACATTTACAAGTTTTGGTAATATTTTAGGACCAATGGCAGCAGGAGCTTTATTTGATATCAATCACTTTTTCCCTTATTATGTTTCAGCAGTAATTCTGTTAGGAACGGGCTTTTTATCGTTATTTTTAAATCGAAATAAGATGTAA,MTKKNSMMYLAISNLFLVFLGVGLVIPVIPQLKEEMHFSGTTMGMMISIFAIAQLITSPIAGVLSDKIGRKKMIATGMLVFSISELLFGLAQAKSGFYISRGLGGIAAALLMPSVTAFVADMTTISERPKAMGLVSAAISGGFIIGPGVGGFIAYLGIRAPFFAAAFLAFIGFILTLTVLKEPEKRILAAVEAKKGSFMDILRNPMFTSLFVIILISSFGLQAFESIYSIMATINFGFTTSEIAIVITVSGILALICQLFFFDAIVQKIGEMGLIQLTFFASAIFIAVIAFTKNNLVVVFSTFIVFLAFDLFRPAVTTYLSKHAGDQQGTINGLNSTFTSFGNILGPMAAGALFDINHFFPYYVSAVILLGTGFLSLFLNRNKM,MTKKNSMMYLAISNLFLVFLGVGLVIPVIPQLKEEMHFSGTTMGMMISIFAIAQLITSPIAGVLSDKIGRKKMIATGMLVFSISELLFGLAQAKSGFYISRGLGGIAAALLMPSVTAFVADMTTISERPKAMGLVSAAISGGFIIGPGVGGFIIGPGVGGFIAYLGIRAPFFAAAFLAFIGFILTLTVLKEPEKRILAAVEAKKGSFMDILRNPMFTSLFVIILISSFGLQAFESIYSIMATINFGFTTSEIAIVITVSGILALICQLFFFDAIVQKIGEMGLIQLTFFASAIFIAVIAFTKNNLVVVFSTFIVFLAFDLFRPAVTTYLSKHAGDQQGTINGLNSTFTSFGNILGPMAAGALFDINHFFPYYVSAVILLGTGFLSLFLNRNKM,97.71,gnl|BL_ORD_ID|565|hsp_num:0,618,FALSE,None
LK405,2_369 # 403048 # 404544 # -1 # ID=2_369;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.375,2_369,403048,404544,-,Strict,1000,1007.28,lsaA,98.59,3000300,protein homolog model,n/a,n/a,lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic; pleuromutilin antibiotic,antibiotic target protection,lsa-type ABC-F protein,ATGTCGAAAATTGAACTAAAACAACTATCTTTTGCCTATGATAATCAAGAAGCGTTGCTTTTTGATCAGGCAAATATCACGATGGATACCAATTGGAAATTAGGATTGATTGGCCGCAATGGCCGTGGGAAAACAACCTTATTAAGATTGTTACAAAAGCAGTTGGATTACCAAGGAGAGATTCTTCATCAAGTCGATTTCGTCTATTTTCCACAAACAGTTGCAGAAGAACAACAGCTCACTTATTATGTCTTACAAGAGGTGACTTCTTTTGAACAGTGGAAATTAGAACGAGAATTAACGCTTTTAAACGTTGATCCTGAAGTTTTATGGCGGCCCTTTTCTTCTTTATCAGGCGGCGAAAAGACGAAAGTTTTATTAGGTCTTCTTTTTATTGAAGAAAATGCCTTTCCTTTAATTGACGAGCCAACAAATCATTTAGATCTAGCTGGCAGACAACAAGTAGCTGAATATTTGAAGAAAAAGAAACATGGATTTATTTTAGTCAGCCACGATCGGGCATTTGTTGATGAAGTAGTTGATCATATTTTGGCGATTGAAAAAAGTCAATTGACGCTGTATCAAGGGAATTTTTCTATTTATGAAGAGCAAAAAAAATTAAGAGATGCTTTTGAACTAGCAGAAAATGAAAAAATCAAAAAAGAAGTCAATCGCTTGAAAGAAACCGCTCGTAAAAAAGCGGAATGGTCGATGAACCGTGAAGGTGATAAGTACGGCAACGCTAAGGAAAAAGGGAGCGGGGCGATTTTTGATACAGGAGCCATTGGTGCCCGGGCAGCGCGCGTAATGAAGCGCTCGAAACACATTCAACAACGCGCCGAAACACAATTAGCAGAAAAAGAAAAACTATTAAAAGATCTTGAGTATATTGATCCTTTGTCAATGGATTATCAGCCAACGCATCACAAAACATTATTGACGGTGGAAGAGCTTCGTCTAGGCTACGAGAAAAATTGGCTATTTGCGCCACTTTCTTTTTCAATAAACGCGGGAGAAATTGTTGGAATAACAGGGAAAAATGGCTCAGGAAAATCGAGCTTAATTCAGTATTTATTGGATAATTTTTCTGGGGATTCAGAAGGCGAAGCCACTTTGGCTCACCAATTAACCATTTCTTATGTGCGCCAAGATTATGAAGACAATCAAGGAACTTTATCCGAATTTGCAGAGAAAAATCAGTTAGATTACACCCAATTTTTAAATAACTTACGAAAACTTGGGATGGAGCGTGCCGTTTTCACTAATCGAATTGAACAAATGAGTATGGGGCAACGGAAAAAAGTCGAAGTAGCCAAATCATTGTCTCAATCAGCAGAGCTTTATATTTGGGATGAACCCCTTAATTACTTGGATGTGTTTAATCATCAACAATTAGAAGCGCTAATCTTATCTGTGAAGCCTGCAATGCTAGTGATTGAGCATGATGCGCATTTCATGAAGAAAATAACGGATAAAAAAATTGTCTTGAAATCATAA,MSKIELKQLSFAYDNQEALLFDQANITMDTNWKLGLIGRNGRGKTTLLRLLQKQLDYQGEILHQVDFVYFPQTVAEEQQLTYYVLQEVTSFEQWKLERELTLLNVDPEVLWRPFSSLSGGEKTKVLLGLLFIEENAFPLIDEPTNHLDLAGRQQVAEYLKKKKHGFILVSHDRAFVDEVVDHILAIEKSQLTLYQGNFSIYEEQKKLRDAFELAENEKIKKEVNRLKETARKKAEWSMNREGDKYGNAKEKGSGAIFDTGAIGARAARVMKRSKHIQQRAETQLAEKEKLLKDLEYIDPLSMDYQPTHHKTLLTVEELRLGYEKNWLFAPLSFSINAGEIVGITGKNGSGKSSLIQYLLDNFSGDSEGEATLAHQLTISYVRQDYEDNQGTLSEFAEKNQLDYTQFLNNLRKLGMERAVFTNRIEQMSMGQRKKVEVAKSLSQSAELYIWDEPLNYLDVFNHQQLEALILSVKPAMLVIEHDAHFMKKITDKKIVLKS,MSKIELKQLSFAYDNQEALLFDQANITMDTNWKLGLIGRNGRGKTTLLRLLQKQLDYQGEILHQVDFVYFPQTVAEEQQLTYYVLQEVTSFEQWKLERELTLLNVDPEVLWRPFSSLSGGEKTKVLLGLLFIEENAFPLIDEPTNHLDLAGRQQVAEYLKKKKHGFILVSHDRAFVDEVVDHILAIEKSQLTLYQGDFSIYEEQKKLRDAFELAENEKIKKEVNRLKETARKKAEWSMNREGDKYGNAKEKGSGAIFDTGAIGARAARVMKRSKHIQQRAETQLAEKEKLLKDLEYIDPLSMDYQPTHHKTLLTVEELRLGYEKNWLFTPISFSINAGEIVGITGKNGSGKSSLIQYLLGDFSGDSEGEATLAHQLTISYVRQDYEDNQGTLSEFAEKNQLDYTQFLNNLRKLGMERAVFTNRIEQMSMGQRKKVEVAKSLSQSAELYIWDEPLNYLDVFNHQQLEALILSVRPAMLVIEHDAHFMKKITDKKIALKS,100,gnl|BL_ORD_ID|1191|hsp_num:0,1298,FALSE,None
LK405,3_372 # 398737 # 399852 # 1 # ID=3_372;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.438,3_372,398737,399852,+,Strict,175,205.297,vanT gene in vanG cluster,34.24,3002972,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,glycopeptide resistance gene cluster; vanT,ATGGTCGTTGGATGGCATCGTCCTACACGGTTACATATCGATACGCAAGCAATTACTGAAAATGTCCAAAAGGAATGTCAACGTTTGCCAGAAGGAACCGCTTTATTTGCGGTTGTAAAAGCGAACGGCTATGGGCATGGCGCCGTAGAATCCGCTAAAGCGGCGAAAAAAGGTGGCGCGACAGGTTTTTGTGTCGCCTTATTGGATGAAGCAATTGAATTGAGAGAAGCAGGTGTTCAGGACCCCATTTTAATTTTGAGTGTGGTAGACTTAGCTTATGTGCCTTTGTTGATTCAATATGATTTGTCTGTAACGGTAGCTACACAAGAATGGTTAGAAGCTGCTCTTCAACAACTAACGCCTGAGAGTAACACGCCATTACGTGTTCACTTAAAAGTCGATACTGGCATGGGACGGATTGGCTTTTTAACCCCGGAAGAGACTAAGCAAGCAGTGCGGTTTGTTCAATCCCACAAAGAATTTTTATGGGAAGGGATTTTTACTCATTTTTCAACAGCTGATGAAATCGATACAAGCTATTTTGAAAAACAAGCAGGGCGTTTTAAGGCTGTTCTAGCAGTTTTAGAAGAGTTACCACGGTATGTCCATGTTAGCAATAGTGCGACAGCGTTATGGCATCCTGATGTGCCAGGAAACATGATTCGCTATGGAGTAGCCATGTATGGATTGAACCCTTCAGGTAATAAGCTGGCCCCAAGCTATGCGTTAAAGCCGGCCTTACGGTTGACCAGTGAACTTATCCATGTAAAACGCTTAGCGGCTGGTGAAGGGATTGGCTATGGCGAAACCTACGTAACTGAAGCTGAAGAATGGATTGGGACAGTGCCAATCGGCTATGCAGATGGCTGGTTGCGTCATCTCCAAGGATTTACAGTGCTCGTGAATGGTAAGCGTTGCGAAATCGTCGGACGAGTGTGTATGGATCAATGTATGATTCGTTTAGCAGAAGAAGTTCCTGTCGGCTCAGTCGTTACATTAGTTGGAAAAGATGGCAATGAAGAAAATACGTTACAAATGGTAGCCGAAAAATTAGAAACCATTCATTATGAAGTTGCATGTACTTTCTCACAAAGAATCCCCAGAGAATATAACTAG,MVVGWHRPTRLHIDTQAITENVQKECQRLPEGTALFAVVKANGYGHGAVESAKAAKKGGATGFCVALLDEAIELREAGVQDPILILSVVDLAYVPLLIQYDLSVTVATQEWLEAALQQLTPESNTPLRVHLKVDTGMGRIGFLTPEETKQAVRFVQSHKEFLWEGIFTHFSTADEIDTSYFEKQAGRFKAVLAVLEELPRYVHVSNSATALWHPDVPGNMIRYGVAMYGLNPSGNKLAPSYALKPALRLTSELIHVKRLAAGEGIGYGETYVTEAEEWIGTVPIGYADGWLRHLQGFTVLVNGKRCEIVGRVCMDQCMIRLAEEVPVGSVVTLVGKDGNEENTLQMVAEKLETIHYEVACTFSQRIPREYN,MTKNESYSGIDYFRFIAALLIVAIHTSPLSSFSETGNFIFTRIVARVAVPFFFMTSGFFLISRYTCNAEKLGAFIKKTTLIYGVAILLYIPINVYNGYFKMDNLLPNIIKDIVFDGTLYHLWYLPASIIGAAIAWYLVKKVHYRKAFLIASILYIIGLFGDSYYGIVKSVSCLNVFYNLIFQLTDYTRNGIFFAPIFFVLGGYISDSQNRLSLKRSIVGFIVCFALMFGEALTLHHFDIQKHDSMYVLLLPSVYCLFNLLLHFRGKRRTGLRTISLIIYIIHPFMIVVIRLFAKLLHLQSLLVENSLVHYIAVCFASVVLAVVITALLSSLKPKKAKHTADTDRAYLEINLNNLEHNVNTLQKAMSPKCELMAVVKAEAYGHGMYEVTTYLEQIGVSSFAVATIDEGIRLRKYGISSEILILGYTSPSRAKELCKYELTQTLIDYRYSLLLNKQGYDIKAHIKIDTGMHRLGFSTEDKDKILAAFSLKHIKVAGIFTHLCAADSLEENDVAFTNKQIGSFYKVLDWLKSSGLNIPKVHIQSSYGLLNYPELECDYIRVGVALYGVLSSTNDKTKLELDLRPVLSLKAKVVLIRKIKQGESVGYSRAFTATRDSLIAILPIGYADGFPRNLSCGNSYVLIGGRQAPIVGKICMDQLAVDVTDIPNVKTGSIATLIGKDGKEEITAPMVAESAESITNELLSRMGHRLNIIRRA,52.11,gnl|BL_ORD_ID|1522|hsp_num:0,1561,FALSE,None
LK405,7_87 # 96935 # 98653 # 1 # ID=7_87;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.383,7_87,96935,98653,+,Strict,960,1168.3,efrA,99.83,3003948,protein homolog model,n/a,n/a,macrolide antibiotic; fluoroquinolone antibiotic; rifamycin antibiotic,antibiotic efflux,ATP-binding cassette (ABC) antibiotic efflux pump,ATGTGGCGTTACACAATGCGTTATAAGAAATTACTTTTCGCTGATTTTATTTGTGTGTTTGGTTTTATTTTAATTGAATTAGGCTTGCCGACCATTTTAGCAAGAATGATTGACAAAGGAATTATTCCTAAAGATATGGACTATATTTATCAGCAAGGGATTTGGATGGTTGTAATTACGATTATTGGTGTCGCAATGAATATTTTGCTGGGGTACTTTGGTGCCAGAATTACAACAAATATTGTTCGTGATATTCGTGATGATTTATTTGAAAAGATTCAAACTTTCTCACACAGTGAATATGAAAGTATTGGGGTTTCTTCCTTAATTACGCGAACTACCAATGATGCATACCAAATTATGCTCTTCATGGGAAATATTTTACGTCTTGGCTTTATGACGCCAGTGATGTTTATTGCCAGTCTTTACATGGTGATGCGAACGAGTCCGTCGTTAGGAATGTACGTTTTAGGTGCCTTGCCTTTTCTGCTGCTAGCAGTTGTCGGGATTGCTCGTTTGTCAGAACCGTTATCTAAAAAGCAACAAAAGAACTTAGATGGAATCAATGGGATTTTAAGAGAAAATCTTTCTGGATTGCGGGTAATACGCGCATTTGTTAATGAAAAATTTGAAGAATCTCGTTTTAATAAAGTCAATGAAACTTACACTAAAAGTTCAAAAAGTTTGTTTCGTTTAATGGCAGCAGCCCAACCAGGGTTCTTTTTCTTATTTAATATTGTGATGGTCTTAATCATTTGGAGCGGGACTGTTCAAATCAGCCATGGGGATTTAGAAGTTGGGAATTTAATAGCTTTTATTGAATATATTTTCCATGCGCTGTTCTCGTTTATGTTATTTGCCAGTGTCTTTATGATGTATCCTCGGGCTGCGGTTTCGGCTTCACGGATTCAAGAAGCCTTAGACATGGAACCAGCTATTCGTGAAGAAGAAGGCGTAACAGAAACAGCTACTAAAGGCTATCTAGAGTTTAAAAATGTAACCTTTGCCTATCCTGGACATGCGGAAAGCCCAGTCATCCGCAATGTAAGTTTTAAGGCGTCACCTGGTGAAACAGTGGCCTTCATTGGGAGCACAGGTAGTGGGAAATCAACATTAATTCAATTGATTCCACGGTTTTATGATGTATCAGAAGGTGAAATTTTAATCGATGGAGTGAACGTAAAAGAGTACAAACTTAGTGCATTACGCAATAAGATTGGCTATATTCCACAAAAAGCGTTACTTTTTACTGGTACAATTGCTGATAACCTTCGCTACGGTAAGGAAGATGCGACGTTAGAAGAAATGGAACGAGCAATTGACATTGCTCAAGCCACAGAATTTGTTTCACAAAAACCGCAAGGCTATGATGAACCTCTTTCAGAAGGTGGCACGAACTTTTCTGGTGGTCAAAAACAACGTTTAGCTATCGCACGGGCGATTATTCGCAATCCGGAAATTTATATATTTGATGATAGTTTTTCTGCGTTAGATTATCAAACAGATGCAAATTTACGAGCGCGTCTGAAAAAAGAAACAACAGAATCCACTGTTTTAATTGTGGCACAACGTGTTGGAACAATTATGCATGCGGACCGCATTGTTGTTTTAAACGAAGGCGACGTGGTCGGAATTGGCACACATCGTGAATTACTTGAGACTTGTCCAATTTACTATGATATTGCGGCTTCTCAATTGTCAGAGGAGGAATTAGCATGA,MWRYTMRYKKLLFADFICVFGFILIELGLPTILARMIDKGIIPKDMDYIYQQGIWMVVITIIGVAMNILLGYFGARITTNIVRDIRDDLFEKIQTFSHSEYESIGVSSLITRTTNDAYQIMLFMGNILRLGFMTPVMFIASLYMVMRTSPSLGMYVLGALPFLLLAVVGIARLSEPLSKKQQKNLDGINGILRENLSGLRVIRAFVNEKFEESRFNKVNETYTKSSKSLFRLMAAAQPGFFFLFNIVMVLIIWSGTVQISHGDLEVGNLIAFIEYIFHALFSFMLFASVFMMYPRAAVSASRIQEALDMEPAIREEEGVTETATKGYLEFKNVTFAYPGHAESPVIRNVSFKASPGETVAFIGSTGSGKSTLIQLIPRFYDVSEGEILIDGVNVKEYKLSALRNKIGYIPQKALLFTGTIADNLRYGKEDATLEEMERAIDIAQATEFVSQKPQGYDEPLSEGGTNFSGGQKQRLAIARAIIRNPEIYIFDDSFSALDYQTDANLRARLKKETTESTVLIVAQRVGTIMHADRIVVLNEGDVVGIGTHRELLETCPIYYDIAASQLSEEELA,MKLMWRYTMRYKKLLFADFICVFGFILIELGLPTILARMIDKGIIPKDMDYVYQQGIWMVVITIIGVAMNILLGYFGARITTNIVRDIRDDLFEKIQTFSHSEYESIGVSSLITRTTNDAYQIMLFMGNILRLGFMTPVMFIASLYMVMRTSPSLGMYVLGALPFLLLAVVGIARLSEPLSKKQQKNLDGINGILRENLSGLRVIRAFVNEKFEESRFNKVNETYTKSSKSLFRLMAAAQPGFFFLFNIVMVLIIWSGTVQISHGDLEVGNLIAFIEYIFHALFSFMLFASVFMMYPRAAVSASRIQEALDMEPAIREEEGVTETATKGYLEFKNVTFAYPGHAESPVIRNVSFKASPGETVAFIGSTGSGKSTLIQLIPRFYDVSEGEILIDGVNVKEYKLSALRNKIGYIPQKALLFTGTIADNLRYGKEDATLEEMERAIDIAQATEFVSQKPQGYDEPLSEGGTNFSGGQKQRLAIARAIIRNPEIYIFDDSFSALDYQTDANLRARLKKETTESTVLIVAQRVGTIMHADRIVVLNEGDVVGIGTHRELLETCPIYYDIAASQLSEEELA,99.48,gnl|BL_ORD_ID|2184|hsp_num:0,2421,FALSE,None
LK405,7_88 # 98650 # 100419 # 1 # ID=7_88;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.387,7_88,98650,100419,+,Strict,710,660.988,efrB,96.13,3003949,protein homolog model,n/a,n/a,macrolide antibiotic; fluoroquinolone antibiotic; rifamycin antibiotic,antibiotic efflux,ATP-binding cassette (ABC) antibiotic efflux pump,ATGAAACACGCCTTTTCTTCTATGAAACGAATCGGTCGCTATATTAAACCGTACCGAGTGACGTTTTATTTAGTTATTTTATTTACAATATTAACCGTTGCCTTTAATGCAGCGTTGCCTTATTTGACTGGATTACCAACGACAGAAATTAGCCGTAATATTGCGGCTGGCGAATCCATTAATTTTGATTATGTAATCCAATGTTTAATTTGGATTTTAGTTGTGGGAACAGGTTATTGTGTGGCACAATTTTTGTCAGGCTTTTTAATGACGAATGTCGTTCAACAATCCATGCGCGATTTACGTCGCGATATTGAAGAAAAAATCAATCGTTTGCCAGTTTCTTATTTTGATAAGAACCAACAAGGAAATATTTTGTCACGGGTGACGAACGATGTGGATGCTGTCAGCAATGCGATGCAACAAAGTTTTATCAATATTGTTTCGGCAGTCTTAGGGATTGTGATGGCGGTAGTGATGATGTTCTTGATCAATCCGCTGATGGCGATTTTTTCAGTGATTATGATTCCGTTGTCTCTGATTATTTCCAGAACAATTGTTAAAATCTCCCAGAAATATTTCCAAGGAATGCAAAATTCTTTAGGAGACTTAAATGGTTATGTCCAAGAAAATATGACTGGGTTCAGTGTTTTAAAACTATATGGTCGGGAAAAAGAAACCCTTGAAGGCTTTAAACAAGTCAATCATCGTTTAAATGGTTTTGGCTTCAAAGCATCCTTTATCTCAGGATTAATGTTGCCATTGGTTCAAATGACCGCTTATGGGACCTATATCGGGGTAGCTGTCCTTGGTAGTTACTATGTGGTTGCTGGTGTGATCGTAGTGGGGCAATTACAAGCGTTTATTCAATATATTTGGCAAATTAGCCAACCAATGGGGAATATTACGCAGTTGTCTGCAGCTTTACAAAGCGCTTCAGCTTCGACCATGCGGATTTTTGAAATCCTAGATGAACCAGAAGAAGAACTTAACGAACAAGATGTTCCTTTACCAGAACCTATTTTAGGCTCTGTTGAATTTGAAAATGTCAGCTTTAGTTATGACCCAGAAAAACCGTTAATTCGTAATTTGAACTTTAAAGTTGATGCGGGCCAAATGGTTGCGATTGTGGGACCAACTGGCGCTGGGAAAACAACCTTAATCAACTTACTGATGCGTTTTTATGATGTAACAGAAGGCGCCATTAAAATTGATGGCATTGACACGAAAAAAATGAACCGTAGTGATGTCCGTTCTGTATTTGGAATGGTATTGCAAGATGCTTGGTTGTATAAAGGTACCATTGCAGATAATATTCGTTTTGGGAAGTTGGATGCCACGGATTATGAAGTTGTGGATGCAGCGAAAACGGCCAATGTGGATCACTTCATTCGGACAATGCCAGATGGGTATGAAATGGAAATCAATTCTGAGGGAGATAACGTTTCCCTTGGTCAAAAACAATTGTTGACCATTGCCCGAGCGGTAATTTCTGATCCAAAAATTTTGATTTTAGATGAGGCGACTAGTTCAGTCGATACACGCTTGGAAGCCTTAATTCAAAAAGCAATGGATCGTGTTATGGAAGGACGAACGAGTTTCGTTATTGCCCACCGCCTATCAACTATTCGTGAAGCTGATTTAATTCTTGTTATGAAACAAGGAGAAATCATTGAAAAAGGTACGCATCATGAGTTGCTGGAACAAGGTGGCTTCTATGAAAAACTATACAATAGTCAATTTGCTGAAGAAGGCGACTATGAGGAATAA,MKHAFSSMKRIGRYIKPYRVTFYLVILFTILTVAFNAALPYLTGLPTTEISRNIAAGESINFDYVIQCLIWILVVGTGYCVAQFLSGFLMTNVVQQSMRDLRRDIEEKINRLPVSYFDKNQQGNILSRVTNDVDAVSNAMQQSFINIVSAVLGIVMAVVMMFLINPLMAIFSVIMIPLSLIISRTIVKISQKYFQGMQNSLGDLNGYVQENMTGFSVLKLYGREKETLEGFKQVNHRLNGFGFKASFISGLMLPLVQMTAYGTYIGVAVLGSYYVVAGVIVVGQLQAFIQYIWQISQPMGNITQLSAALQSASASTMRIFEILDEPEEELNEQDVPLPEPILGSVEFENVSFSYDPEKPLIRNLNFKVDAGQMVAIVGPTGAGKTTLINLLMRFYDVTEGAIKIDGIDTKKMNRSDVRSVFGMVLQDAWLYKGTIADNIRFGKLDATDYEVVDAAKTANVDHFIRTMPDGYEMEINSEGDNVSLGQKQLLTIARAVISDPKILILDEATSSVDTRLEALIQKAMDRVMEGRTSFVIAHRLSTIREADLILVMKQGEIIEKGTHHELLEQGGFYEKLYNSQFAEEGDYEE,LDTCRIFRRNAKSPVNIAKHAKFIRRLKWLCSENMTGFSVLKLYVRKKKPLKGFKQVNHRFKWFGFKASFISGLMLPLVQMTAYGTYIGVAVLGSYYVVAGVIVVGQLQAFIQYIWQISQPMGNITQLSAALQSASASTMRIFEILDEPEEELNEQDVPLPEPILGSVEFENVSFSYDPEKPLIRNLNFKVDAGQMVAIVGPTGAGKTTLINLLMRFYDVTEGAIKIDGIDTKKMNRSDVRSVFGMVLQDAWLYKGTIADNIRFGKLDATDYEVVDAAKTANVDHFIRTMPDGYEMEINSEGDNVSLGQKQLLTIARAVISDPKILILDEATSSVDTRLEALIQKAMDRVMEGRTSFVIAHR,162.71,gnl|BL_ORD_ID|2185|hsp_num:0,2422,TRUE,loose hit with at least 95 percent identity pushed strict
LK405,10_21 # 18637 # 19347 # -1 # ID=10_21;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.360,10_21,18637,19347,-,Strict,50,204.912,vanY gene in vanB cluster,51.5,3002956,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGAAATTTAAAGTTACAATTGGTGTCGCTATTTTAGGCCTTTTTATTGTGGGCATGGCTGTTAAACAAGTTGCTGAGAAAAAAATAGTTTCAATAGGAAATGAGCAAGCCCTCAGTTTAGAGGAAGAGGAAAAAATGAGTTCTCCTGAAGAAGGCGATCAATCATGGAAATTATTATTAGTAAATCAAACGCATCAGATTCCTGAAGATTATCAAATCCAATTAAAAAAATTACCTAACAAACAGGCAGTGGATAAACGAATTTATCCAGCTTTGAACAGGATGTTTAAAGATGCCAAAAGACAAGGCTTCTATCTTGAAGTCACTTCTAGTTATCGAACAAATGAAGAGCAAAAAGAAATTATGGCAGAAAAAGTACAGGCTTTTCAAGATCAAGGATTCAGCGAACAAGAAGCGATTGAAACAGCTGAAAGTTGGGTAGCAGTGCCGAGAACTAGTGAACATGAAGTAGGTTTAGCAGTGGATATAAATGCGCAAAGTAAGCGATCTACTGACGAAGAAGTCTACGCTTGGTTGGCAAAGAACGCCTATAAATATGGATTTATTCTTCGTTATCCTTCAGACAAAGTGGAAATTACGGGTGTTAGTTATGAACCTTGGCATTATCGATATGTGGGTAAAAAAGCAGCACTAGAGATTCAAAAAGCGAGTCTAACGTTAGAAGAATACTTAGCAGAAAATAATAATTAA,MKFKVTIGVAILGLFIVGMAVKQVAEKKIVSIGNEQALSLEEEEKMSSPEEGDQSWKLLLVNQTHQIPEDYQIQLKKLPNKQAVDKRIYPALNRMFKDAKRQGFYLEVTSSYRTNEEQKEIMAEKVQAFQDQGFSEQEAIETAESWVAVPRTSEHEVGLAVDINAQSKRSTDEEVYAWLAKNAYKYGFILRYPSDKVEITGVSYEPWHYRYVGKKAALEIQKASLTLEEYLAENNN,MEKSNYHSNVNHHKRHMKQSGEKRAFLWAFIISFTVCTLFLGWRLVSVLEATQLPPIPATHTGSGTGVAENPEENTLATAKEQGDEQEWSLILVNRQNPIPAQYDVELEQLSNGERIDIRISPYLQDLFDAARADGVYPIVASGYRTTEKQQEIMDEKVAEYKAKGYTSAQAKAEAETWVAVPGTSEHQLGLAVDINADGIHSTGNEVYRWLDENSYRFGFIRRYPPDKTEITGVSNEPWHYRYVGIEAATKIYHQGLCLEEYLNTEK,88.06,gnl|BL_ORD_ID|602|hsp_num:0,556,FALSE,None
LK719,5_41 # 43190 # 43939 # 1 # ID=5_41;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.776,5_41,43190,43939,+,Strict,50,82.8037,vanY gene in vanM cluster,34.46,3002961,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGTCGCACCCTCCCTCTCGCCGCGCTGGCCGCGCTCGCGCTGCTCGTGGCCGGTTGCGGCACGCCCGCCGCGGGCCCGTCCTCGACGCCGACGACGCCGGCTTCCGGCTCCTCGAGCGCGGCCGCGTCGTCCCGCGCCGCCTCGAGCACGGCGCCGTCGTCGAGCACGCACGCCGACCCGGCCGCCCTCGACGTCGTCGTGAACAAGACCCGCCCCATGGCCCCGCCCGACTGGGCGCCCTCGGATCTGGTGGCCGTGCCCGGCAGCGAGCTGCCCCTGCGCGCGGAGGCCGCGACGGCGGCCGGTGACCTGCTGGATGCCGCCGCGGCGGCGGGCCACCGCCTCACCACCCTGAGCGCCTACCGCTCGTACGACTACCAGGTCCGGACGTACGGCCACTGGGTCGACGAGCTGGGCCGCGCCGAGGCCGACCGCGTCTCGGCGCGTCCGGGGTACTCCGAGCACCAGACCGGCCTGGCCTGGGACGTGGGCGACGCCGCGACCCCCGCGTGTGACCTGGAAGCGTGCTTCGGCGACACCGCCGCGGGCCGCTGGGTGGCCGCACACGCCGCCGAGTACGGGTTCGTCATCCGCTACCCCGCCGGGGCCGAGGACGTGACGGGCTTCGCCCACGAGCCGTGGCACCTGCGCTACGTCGGGTCCGCGGAGGCGGCCCGGGTCGAGGCGGCCGGCGGCGTCCTCGAGACCGCGTGGGGTCTGCCGCCGGCACCCGACTACGCGGACTGA,MRRTLPLAALAALALLVAGCGTPAAGPSSTPTTPASGSSSAAASSRAASSTAPSSSTHADPAALDVVVNKTRPMAPPDWAPSDLVAVPGSELPLRAEAATAAGDLLDAAAAAGHRLTTLSAYRSYDYQVRTYGHWVDELGRAEADRVSARPGYSEHQTGLAWDVGDAATPACDLEACFGDTAAGRWVAAHAAEYGFVIRYPAGAEDVTGFAHEPWHLRYVGSAEAARVEAAGGVLETAWGLPPAPDYAD,MVFQGNLLLVNNEYPVLEESIKTDVVNLFKHDELTKGYELLNREIYLSEKVAREFSEMVDAAEKEGVRHFSINSGFRNFDEQNALYQEMGSDYALPAGYSEHNLGLALDIGSTQMEMSEAPEGKWLEDNAWEYGFILRYPMDKTAITGIQYEPWHFRYVGLPHSAIIEEKNFALEEYLDFLKEQKSISGTIHGENYEISYYPITEKTDIEMPANLHYEISGNNMDGVIVTVYR,106.87,gnl|BL_ORD_ID|1673|hsp_num:0,1713,FALSE,None
LK936,14_42 # 47278 # 48972 # 1 # ID=14_42;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.654,14_42,47278,48972,+,Strict,50,77.7962,vanW gene in vanI cluster,31.95,3003724,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanW; glycopeptide resistance gene cluster,GTGACTACGGTAAATGCAACAGGTGCCCGCGGTGGGCGCGGGGTCAGCACCGGGAAGATTCTCCTCGGTGTGCTTCTCGGCGTGCTCGCGGTGCTGCTTGCGATCTACCTCGCCGACCTCGCAATGAACCGCGGGAACGTGCCGCGTGGCACCGCCGTCGGCGGTGTCGAGATCGGCGGCATGAGCCACGACGAGGCCACCGCGAAGCTCGAAGCAGAGCTCGGTGAGACGGCGAGCAACCCCGTGACGGTGAAGGCGGCATCGCAAAGCTCGCAGCTCGTGCCCGCCGAGTCCGGCCTCGGCATCGACTGGGAGGCGACCGTAGCAAGCGCGGGCGAAGAGTCCGCGAACCCGTTCACTCGCCTCGCCGGGCTGTTTCGCACCCGCGAAGTCGACATTGTGTCGACCGTGAACGAGGCCGCTCTCACCCCGCAGCTTGAGCGCGTGGCCGGCGAGTTGCACCTCGACCCCGCCGACGGCGCGATCGCCATCGAAGGCGGCGAGGCGAAAGTGACCGAACCGGTGCCGGGCCAGGAGGTTGACGAAACCGAGCTGTTCGAACGTGTCACCACCGGCTGGCTCAACCCCGACGGTGTAGAGGTCGAGCCGCGCGAAATCGAACCCGCTATCGGCGACCAGGCCATCAAGGAAGCCTTAGACGGGCCGGTTAAGGCGGCGCTGTCCGGAGCGTTGACACTGCACGGTCGCGACGGCGTCGACGGTGTCATTGCCCAAGAGCGCATCGGCGAGGTCGTCCAATTCCCCAACGTCGACGGCAAAATCGCCCCCGAGGTGAACGTGGAAAACGCCCAGGGCATCTTGGTCGAGCAGCTCGCTGCGACCGAGACGCAGATGAAAAACGCGCGCGTGCTGCCCGGCGGCGGGGTGCAACCGTCCGTCGATGGCTCCATCATCGACTGGGAGGCCGCGATGGACGGTTTCGACGAGCGGTTGATCGGTTCCGCCGAGCGCACCTGGGACGCGCAATACAAGGCCCGCCCGGCCGACTTCACTACAGAGGAAGCCCAACGTGCCAGGTTCGACGAGGTGGTGGGAAGTTTCACCACCGGCGGGTACAGCGGCGCATCCGGCACGAACATCGCTACGGTGGCCCGCGTTGTCAACGGCGCAATTGTCAACCCCGGTGAAACCTTCTCGCTCAACGGCTACACTGGCGCGCGCGGTGCCGCGCACGGTTACGTCGAGTCGGGCATCATCGAAAATGGACGCCCCGGCAAGGCAGTGGGCGGCGGAATCTCCCAATTTGCCACGACCTTGTACAACGCGGCTTACTTTGCCGGCATGACGGATGTCGCCTCCACCCCGCACTCCTACTACATTTCACGCTACCCGGCTGGCAGGGAGGCGACCGTGTATGAAGGGGCGATTGACCTGCAATTCCGCAACGATTCGCCCCACCCGGTCAAGATTTCCACGAGCGTCGGGGGCGGCGAGGTGACGGTGAGCCTGATGGGCACCAAGACCGTCGAGGTGGAGTCCATCAACGGAGGGCGCTGGAACTACACCTCGCCGAAGCCCGTGACCGTCACCAGTGGTGACTGCATTCCCTCGGGCGGGGTGCAGGGCTTTACCACCTCCGATACCCGGATTGTGCGTGACCTCAGCGGCAATGAGATCAGTCGCAACACCTCCACCACGGTCTACGACCCGCAGCCCATCGTGCGCTGCGAGTAG,MTTVNATGARGGRGVSTGKILLGVLLGVLAVLLAIYLADLAMNRGNVPRGTAVGGVEIGGMSHDEATAKLEAELGETASNPVTVKAASQSSQLVPAESGLGIDWEATVASAGEESANPFTRLAGLFRTREVDIVSTVNEAALTPQLERVAGELHLDPADGAIAIEGGEAKVTEPVPGQEVDETELFERVTTGWLNPDGVEVEPREIEPAIGDQAIKEALDGPVKAALSGALTLHGRDGVDGVIAQERIGEVVQFPNVDGKIAPEVNVENAQGILVEQLAATETQMKNARVLPGGGVQPSVDGSIIDWEAAMDGFDERLIGSAERTWDAQYKARPADFTTEEAQRARFDEVVGSFTTGGYSGASGTNIATVARVVNGAIVNPGETFSLNGYTGARGAAHGYVESGIIENGRPGKAVGGGISQFATTLYNAAYFAGMTDVASTPHSYYISRYPAGREATVYEGAIDLQFRNDSPHPVKISTSVGGGEVTVSLMGTKTVEVESINGGRWNYTSPKPVTVTSGDCIPSGGVQGFTTSDTRIVRDLSGNEISRNTSTTVYDPQPIVRCE,MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVLAEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPELLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGMETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGGEFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSHSLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDEPDGYPVKPREWSK,151.21,gnl|BL_ORD_ID|4748|hsp_num:0,2242,FALSE,None
LK955,25_7 # 7936 # 9549 # 1 # ID=25_7;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.656,25_7,7936,9549,+,Strict,50,78.1814,vanW gene in vanI cluster,35.16,3003724,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanW; glycopeptide resistance gene cluster,GTGCTCGCGGTGCTGCTTGCGATCTACCTCGCCGACCTCGCAATGAACCGCGGGAACGTGCCGCGTGGCACCGCCGTCGGCGGTGTCGAGATCGGCGGCATGAGCCACGACGAGGCCACCGCGAAGCTCGAAGCAGAGCTCGGTGAGACGGCGAGCAACCCCGTGACGGTGAAGGCGGCATCGCAAAGCTCGCAGCTCGTGCCCGCCGAGTCCGGCCTCGGCATCGACTGGGAGGCGACCGTAGCAAGCGCGGGCGAAGAGTCCGCGAACCCGTTCACTCGCCTCGCCGGGCTGTTTCGCACCCGCGAAGTCGACATTGTGTCGACCGTGAACGAGGCCGCTCTCACCCCGCAGCTTGAGCGCGTGGCCGGCGAGTTGCACCTCGACCCCGCCGACGGCGCGATCGCCATCGAAGGCGGCGAGGCGAAAGTGACCGAACCGGTGCCGGGCCAGGAGGTTGACGAAACCGAGCTGTTCGAACGTGTCACCACCGGCTGGCTCAACCCCGACGGTGTAGAGGTCGAGCCGCGCGAAATCGAACCCGCTATCGGCGACCAGGCCATCAAGGAAGCCTTAGACGGGCCGGTTAAGGCGGCGCTGTCCGGAGCGTTGACACTGCACGGTCGCGACGGCGTCGACGGTGTCATTGCCCAAGAGCGCATCGGCGAGGTCGTCCAATTCCCCAACGTCGACGGCAAAATCGCCCCCGAGGTGAACGTGGAAAACGCCCAGGGCATCTTGGTCGAGCAGCTCGCTGCGACCGAGACGCAGATGAAAAACGCGCGCGTGCTGCCCGGCGGCGGGGTGGAACCGTCCGTCGATGGCTCCATCATCGACTGGGAGGCCGCGATGGACGGTTTCGACGAGCGGTTGATCGGTTCCGCCGAGCGCACCTGGGACGCGCAATACAAGGCCCGCCCGGCCGACTTCACTACAGAGGAAGCCCAACGTGCCAGCTTCGACGAGGTGGTGGGAAGTTTCACCACCGGCGGGTACAGCGGCGCATCCGGCACGAACATCGCTACGGTGGCCCGCGTTGTCAACGGCGCAATTGTCAACCCCGGTGAAACCTTCTCGCTCAACGGCTACACTGGCGCGCGCGGTGCCGCGCAGGGTTACGTCGAGTCGGGCATCATCGAAAATGGACGCCCCGGCAAGGCAGTGGGCGGCGGAATCTCCCAATTTGCCACGACCTTGTACAACGCGGCTTACTTTGCCGGCATGACGGATGTCGCCTCCACCCCGCACTCCTACTACATTTCACGCTACCCGGCTGGCAGGGAGGCGACCGTGTATGAAGGGGCGATTGACCTGCAATTCCGCAACGATTCGCCCCACCCGGTCAAGATTTCCACGAGCGTCGGGGGCGGCGAGGTGACGGTGAGCCTGATGGGCACCAAGACCGTCGAGGTGGAGTCCATCAACGGAGGGCGCTGGGCCTACACCTCGCCGAAGCCCGTGACCGTCACCAGTGGTGACTGCATTCCCTCGGGCGGGGTACAGGGCTTTACCACCTCCGATACCCGGATTGTGCGTGACCTCAGCGGCAATGAGATCAGTCGCAACACCTCCACCACGGTCTACGACCCGCAGCCCATCGTGCGCTGCGAGTAG,MLAVLLAIYLADLAMNRGNVPRGTAVGGVEIGGMSHDEATAKLEAELGETASNPVTVKAASQSSQLVPAESGLGIDWEATVASAGEESANPFTRLAGLFRTREVDIVSTVNEAALTPQLERVAGELHLDPADGAIAIEGGEAKVTEPVPGQEVDETELFERVTTGWLNPDGVEVEPREIEPAIGDQAIKEALDGPVKAALSGALTLHGRDGVDGVIAQERIGEVVQFPNVDGKIAPEVNVENAQGILVEQLAATETQMKNARVLPGGGVEPSVDGSIIDWEAAMDGFDERLIGSAERTWDAQYKARPADFTTEEAQRASFDEVVGSFTTGGYSGASGTNIATVARVVNGAIVNPGETFSLNGYTGARGAAQGYVESGIIENGRPGKAVGGGISQFATTLYNAAYFAGMTDVASTPHSYYISRYPAGREATVYEGAIDLQFRNDSPHPVKISTSVGGGEVTVSLMGTKTVEVESINGGRWAYTSPKPVTVTSGDCIPSGGVQGFTTSDTRIVRDLSGNEISRNTSTTVYDPQPIVRCE,MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVLAEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPELLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGMETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGGEFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSHSLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDEPDGYPVKPREWSK,143.97,gnl|BL_ORD_ID|4748|hsp_num:0,2242,FALSE,None
LK1098,1_8 # 11536 # 13068 # -1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.561,1_8,11536,13068,-,Strict,700,816.994,Klebsiella pneumoniae KpnH,79.16,3004597,protein homolog model,n/a,n/a,macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; cephalosporin; penam; peptide antibiotic; penem,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGCAGGCGCCACTGACCGGAGCAAGACTGGCCTGGATGACTATCGCCCTGTCACTGGCGACCTTCATGCAGGTGCTCGACTCCACTATCGCCAACGTGGCGATCCCGACGATCGCCGGTAACCTGGGTTCCTCTAACTCTCAGGGAACCTGGGTGATTACCTCATTCGGGGTGGCGAATGCCATCTCCATCCCGATCACCGGCTGGCTGGCCAAGCGGCTCGGCGAAGTGCGTCTGTTTATGTGGTCAACAGCGCTGTTTGCCATCTCCTCCTGGTTATGCGGTATTTCCAACAGCCTGGGCATGCTGATTTTCTTCCGCGTGATCCAGGGTCTGGTGGCCGGGCCGCTGATCCCGCTGTCGCAGAGTCTGCTGCTCAATAACTATCCTCCCGCAAAACGCACTATGGCGCTGGCACTCTGGTCAGTCACCATTGTTATCGCGCCGATCTGCGGGCCTATCCTCGGCGGCTATATCAGTGACAACTATCACTGGGGCTGGATTTTCTTCATCAACGTGCCGTTCGGGATTGTGATCATGATGCTGACCGCAAAAACCCTGGAGGGCAGGGAAACCAAAACGGAAATCCGTCCGATTGATACTGTCGGGCTGATCCTGCTGGTGGTGGGGGTTGGTTGTCTGCAGATTATGCTCGACCAGGGCAAAGAGCTGGACTGGTTTAACTCGACGGAGATTATTGTCCTGACCGTGATAGCTGTGGTTGCCATCGCCTTCCTGATCGTCTGGGAACTGACGGATGATCACCCCGTGGTGGACCTGTCTCTGTTTAAGAGCAGGAACTTCACAATAGGTTGCCTCAGCCTCAGTCTGGCTTATATGCTCTATTTCGGCACCATTGTTCTGCTGCCGCAGCTGTTGCAGGGGGTATTCGGCTACACTGCCACCTGGGCGGGACTGGCTTCCGCGCCGGTCGGTATTCTGCCGCTGCTGATCACACCGCTTATCGGCAAATATGCCCATAAAGTGGATTACCGGATCATTGTGACATTCAGCTTCATTATGTATACCGTCTGTTTCTACTGGCGGGCCTATACGTTTGAGCCGGGAATGGACTTTGCCGCCGCAGCCTGGCCGCAGTTTGTACAGGGGCTGGCAATCGCCTGTTTCTTTATGCCGCTGACCACCATTACGCTTTCCGGCCTGCCGCCGGAGAAAATGGCGTCGGCATCCAGCCTGTCAAACTTTACGCGGACACTGGCCGGCGCTATCGGAACATCGATCACCACCACGATGTGGACACAGCGGGAGTCCATGCATCACGCCAATTTTGCCGAGCATATCAACCCGTTCAGCCCGGATACACAGCAGATGTATCACACGCTGGGTGAAATGGGGATGTCGCAGCAGCAATCATCGGCCTATATCGCAAAAGTGATCACCGACCAGGGGCTGATTATCTCTGCGAACGAGATTTTCTGGCTCTCTGCCGGTGTCTTCCTGGTGCTGATGCTGCTGGTCTGGTTTGCCAAACCACCGTTTACTGCCGGTGGCGGCGGCGGTGGTGCACATTAA,MQAPLTGARLAWMTIALSLATFMQVLDSTIANVAIPTIAGNLGSSNSQGTWVITSFGVANAISIPITGWLAKRLGEVRLFMWSTALFAISSWLCGISNSLGMLIFFRVIQGLVAGPLIPLSQSLLLNNYPPAKRTMALALWSVTIVIAPICGPILGGYISDNYHWGWIFFINVPFGIVIMMLTAKTLEGRETKTEIRPIDTVGLILLVVGVGCLQIMLDQGKELDWFNSTEIIVLTVIAVVAIAFLIVWELTDDHPVVDLSLFKSRNFTIGCLSLSLAYMLYFGTIVLLPQLLQGVFGYTATWAGLASAPVGILPLLITPLIGKYAHKVDYRIIVTFSFIMYTVCFYWRAYTFEPGMDFAAAAWPQFVQGLAIACFFMPLTTITLSGLPPEKMASASSLSNFTRTLAGAIGTSITTTMWTQRESMHHANFAEHINPFSPDTQQMYHTLGEMGMSQQQSSAYIAKVITDQGLIISANEIFWLSAGVFLVLMLLVWFAKPPFTAGGGGGGAH,MQQQKPLEGAQLVIMTIALSLATFMQVLDSTIANVAIPTIAGNLGSSLSQGTWVITSFGVANAISIPLTGWLAKRVGEVKLFLWSTIAFAIASWACGVSSSLNMLIFFRVIQGIVAGPLIPLSQSLLLNNYPPAKRSIALALWSMTVIVAPICGPILGGYISDNYHWGWIFFINVPIGVAVVLMTLQTLRGRETRTERRRIDAVGLALLVIGIGSLQIMLDRGKELDWFSSQEIIILTVVAVVAICFLIVWELTDDNPIVDLSLFKSRNFTIGCLCISLAYMLYFGAIVLLPQLLQEVYGYTATWAGLASAPVGIIPVILSPIIGRFAHKLDMRRLVTFSFIMYAVCFYWRAYTFEPGMDFGASAWPQFIQGFAVACFFMPLTTITLSGLPPERLAAASSLSNFTRTLAGSIGTSITTTMWTNRESMHHAQLTESVNPFNPNAQAMYSQLEGLGMTQQQASGWIAQQITNQGLIISANEIFWMSAGIFLILLGLVWFAKPPFGAGGGGGGAH,99.61,gnl|BL_ORD_ID|2734|hsp_num:0,3299,FALSE,None
LK1098,1_376 # 382197 # 382628 # -1 # ID=1_376;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=3-4bp;gc_cont=0.530,1_376,382197,382628,-,Strict,100,154.066,FosA8,52.9,3007371,protein homolog model,n/a,n/a,phosphonic acid antibiotic,antibiotic inactivation,fosfomycin thiol transferase,ATGTTAACAGGAATGAATCATCTGACCCTGGCGGTCGCCGATTTGGATCGCAGCCTGCATTTTTACCGCGATATTCTGAAAATGACGCTGCATACCCGCTGGAAATACGGCGCTTACCTGACCTGCGGGGAGTTGTGGATCTGTTTATCAGCAGACCCGGAAATCATTCACCGGCCTATTCATCAGGGTTATACCCACTACGCTTTCACCCTTCCTCCCGAACAGTTCCCGGCCTTCCGCTCGCTTCTCGCTGCTCATCAGATAACACTCTGGAAACGTAACCGCAGTGAAGGTGATTCCGTCTATTTTCTTGACCCGGACGGGCATCAGCTTGAGGCGCATTCCGGCGGAATACAGCAGCGGCTGGATGCCTGCCGCGAAGCGCCGTATGAAGAGATGATATTTCCGGCACCCGGGCAGATTAATGTGTAA,MLTGMNHLTLAVADLDRSLHFYRDILKMTLHTRWKYGAYLTCGELWICLSADPEIIHRPIHQGYTHYAFTLPPEQFPAFRSLLAAHQITLWKRNRSEGDSVYFLDPDGHQLEAHSGGIQQRLDACREAPYEEMIFPAPGQINV,MLNALNHLTLAVSNLPASITFWRDLLGLRLHAEWHTGAYLTCGDLWLCLSYDETRTFIPPQNSDYTHYAFSVEPEHFDAVAQKLKDAGVTVWKENKSEGASFYFLDPDGHKLELHVGDLAARLAACREKPYAGMVFTSDEA,101.42,gnl|BL_ORD_ID|4908|hsp_num:0,5899,FALSE,None
LK1098,2_333 # 383046 # 383237 # 1 # ID=2_333;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.432,2_333,383046,383237,+,Strict,100,107.842,rsmA,86.89,3005069,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGCTTATTCTGACTCGTCGAGTTGGTGAAACACTCATGATAGGCGATGAGGTAACAGTGACTGTACTGGGTGTTAAAGGAAACCAGGTACGAATTGGTGTCAACGCCCCCAAAGAGGTTTCTGTTCACCGTGAAGAAATTTACCAGCGGATCCAGGCTGAAAAATCTCAACCCAATAACAATAACTATTAA,MLILTRRVGETLMIGDEVTVTVLGVKGNQVRIGVNAPKEVSVHREEIYQRIQAEKSQPNNNNY,MLILTRRVGETLMVGDDVTVTVLGVKGNQVRIGVNAPKEVAVHREEIYQRIQKEKDQEPNH,103.28,gnl|BL_ORD_ID|2794|hsp_num:0,3807,FALSE,None
LK1098,4_89 # 103081 # 104574 # 1 # ID=4_89;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.550,4_89,103081,104574,+,Strict,700,707.983,Klebsiella pneumoniae KpnH,68.29,3004597,protein homolog model,n/a,n/a,macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; cephalosporin; penam; peptide antibiotic; penem,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGAAACTGGTCTGGGCGACCATCGCGCTGTCGATGGCCACCTTTATGCAGGTGCTGGACTCCACTATTGCCAACGTGGCGATCCCGACCATTTCCGGCGATCTCGGTGCTTCTGTCTCTCAGGGCACCTGGGTTATTACCTCATTCGGGGTATCCAACGCGATTTCCATCGCGATTACCGGGTTTCTGGCAAAGCGTTTCGGGGAAGTACGGGTGTTTATCTGGTCCACCGGGCTGTTTACCCTGACGTCACTGCTGTGCGGGTTATCAGAAAGCCTGGAAATGCTGATTTTCTTCCGCGTGTTACAGGGCGGGGTGGCCGGGCCGATTATCCCGCTCTCACAAAGCCTGCTGCTGAAAAGTTACCCGCCCGCCAAACAGAATACCGCGCTGGCACTCTGGTCGATGACCATCATTCTGGCGCCGGTGTTCGGGCCGATTATGGGCGGCTATATCAGTGATAACTTCCACTGGGGCTGGATTTTCTTTATCAACGTGCCTATCGGTATTGCGGTGGTACTGGTCAGCCTGATGCTGCTGCGCGGTATGGAATCGAAGGTGACAAAGGTTCCGCTCAATGTGATTGGCTTGTCGCTGCTGGTGGTCGGGATCGGCTGTCTGCAAATCCTGCTGGATAAAGGGAAAGATCTCGGCTGGCTGGAGTCAGATGAAATTGTCGCACTGGCCATTATTGCAGCCGTTGCGCTGGTCTTCCTGGTGATCTGGGAACTGACGGATAAAAACCCGATTGTCGAGTTGTCGCTGTTTAAGTCGCGTAACTTTACCATCGGCACACTGTCGGTCAGTCTGGCGTATATGGTCTATTTCGGCGCAATTGTACTGCTGCCGCAGCTGCTCCAGGAGGTGTACGGCTATACGGCTGAATGGGCAGGGCTGGCGCTGGCGCCTATCGGGCTGGTGCCGATACTGATTTCCGCGTTTGTCGGTAAAATCTCCAATGTGGTGGATTTGCGCTGGATTGTAACCTTTAGTTTCGTGGTGTATTCCGTCTGTTTCTACTGGCGCGCCTATACTTTCGAGCCACAGATGGGGTTCTATGCCTCGGTCTGGCCGCAGCTGGTGCAGGGTTTTGCAGTGGCCTGTTTCTTTATGCCGCTCACCACCATCACGCTTTCCGGTCTGCCGCCGGAGAAACTGGCCTCGGCCTCCGCGCTGGCCAATTTCTTCCGGACACTGGCGGGATCTATCGGTACATCGATCACCACCACGCTGTGGAGCCGTCGCGAATCGTTACATCATTCTCAGCTTACGGAATCCATCACCGCGTATAATCCGGAATCGGTACAGATGTATCAGGAGATGGCGCAGCACGGGTTATCAGAAGCGCAGACCTCCGCCTATCTGGCGAAGGAAATTACCGCCCAGGGGCTGATTATCAGTGCCAATGAGATTTTCTGGCTCTCCGGCGGCGTCTTCATCGGATTGATTGTTCTTATCTGGTTTGCCCGGCCGCCGTTTGCCACAAAATCCTGA,MKLVWATIALSMATFMQVLDSTIANVAIPTISGDLGASVSQGTWVITSFGVSNAISIAITGFLAKRFGEVRVFIWSTGLFTLTSLLCGLSESLEMLIFFRVLQGGVAGPIIPLSQSLLLKSYPPAKQNTALALWSMTIILAPVFGPIMGGYISDNFHWGWIFFINVPIGIAVVLVSLMLLRGMESKVTKVPLNVIGLSLLVVGIGCLQILLDKGKDLGWLESDEIVALAIIAAVALVFLVIWELTDKNPIVELSLFKSRNFTIGTLSVSLAYMVYFGAIVLLPQLLQEVYGYTAEWAGLALAPIGLVPILISAFVGKISNVVDLRWIVTFSFVVYSVCFYWRAYTFEPQMGFYASVWPQLVQGFAVACFFMPLTTITLSGLPPEKLASASALANFFRTLAGSIGTSITTTLWSRRESLHHSQLTESITAYNPESVQMYQEMAQHGLSEAQTSAYLAKEITAQGLIISANEIFWLSGGVFIGLIVLIWFARPPFATKS,MQQQKPLEGAQLVIMTIALSLATFMQVLDSTIANVAIPTIAGNLGSSLSQGTWVITSFGVANAISIPLTGWLAKRVGEVKLFLWSTIAFAIASWACGVSSSLNMLIFFRVIQGIVAGPLIPLSQSLLLNNYPPAKRSIALALWSMTVIVAPICGPILGGYISDNYHWGWIFFINVPIGVAVVLMTLQTLRGRETRTERRRIDAVGLALLVIGIGSLQIMLDRGKELDWFSSQEIIILTVVAVVAICFLIVWELTDDNPIVDLSLFKSRNFTIGCLCISLAYMLYFGAIVLLPQLLQEVYGYTATWAGLASAPVGIIPVILSPIIGRFAHKLDMRRLVTFSFIMYAVCFYWRAYTFEPGMDFGASAWPQFIQGFAVACFFMPLTTITLSGLPPERLAAASSLSNFTRTLAGSIGTSITTTMWTNRESMHHAQLTESVNPFNPNAQAMYSQLEGLGMTQQQASGWIAQQITNQGLIISANEIFWMSAGIFLILLGLVWFAKPPFGAGGGGGGAH,97.07,gnl|BL_ORD_ID|2734|hsp_num:0,3299,FALSE,None
LK1098,4_280 # 299591 # 300232 # 1 # ID=4_280;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.428,4_280,299591,300232,+,Strict,420,439.884,catII from Escherichia coli K-12,97.18,3004656,protein homolog model,n/a,n/a,phenicol antibiotic,antibiotic inactivation,chloramphenicol acetyltransferase (CAT),ATGAATTTTACCCGGATTGACCTGAATACCTGGAATCGCAGGGAACATTTTGCCCTTTATCGTCAGCAGATTAAATGCGGATTCAGCCTGACCACCAAACTCGATATTATCGCTTTGCGTACCGCACTGGCGGAAACCGGTTATAAGTTTTATCCGCTGATGATTTACCTGATCTCCCGGGCTGTTAATCAGTTTCCGGAGTTCCGGATGGCAATGAAAGACAATGAACTTATTTACTGGGATCAGTCAGACCCGGTTTTTACTGTCTTTCATAAAGAAACCGAAACATTCTCCGTACTGTCCTGCCGTTATTTTCCGGATCTCAGCGAGTTTATGGCAGGTTATAATGCGGTAACAGCAGAACATCAGCATGATACCGGATTGTTTCCGCAGGGAAATTTACCGGAGAATCACCTGAATATATCATCATTACCCTGGGTAAGTTTTGACGGATTTAATCTGAATATCACCGGAAATGATGATTACTTTGCCCCGGTTTTTACGATGGCAAAGTTTCAGCAGGAAGGTGACCGCGTACTATTACCTGTTTCTGTACAGGTTCATCATGCAGTCTGTGATGGTTTTCATGCAGCAAGGTTTATTAATACACTTCAGATGATGTGTGACAACATACTGAAATAA,MNFTRIDLNTWNRREHFALYRQQIKCGFSLTTKLDIIALRTALAETGYKFYPLMIYLISRAVNQFPEFRMAMKDNELIYWDQSDPVFTVFHKETETFSVLSCRYFPDLSEFMAGYNAVTAEHQHDTGLFPQGNLPENHLNISSLPWVSFDGFNLNITGNDDYFAPVFTMAKFQQEGDRVLLPVSVQVHHAVCDGFHAARFINTLQMMCDNILK,MNFTRIDLNTWNRREHFALYRQQIKCGFSLTTKLDITALRTALAETGYKFYPLMIYLISRAVNQFPEFRMALKDNELIYWDQSDPVFTVFHKETETFSALSCRYFPDLSEFMAGYNAVTAEYQHDTRLFPQGNLPENHLNISSLPWVSFDGFNLNITGNDDYFAPVFTMAKFQQEGDRVLLPVSVQVHHAVCDGFHAARFINTLQLMCDNILK,100,gnl|BL_ORD_ID|2199|hsp_num:0,3355,FALSE,None
LK1098,5_23 # 19425 # 20057 # 1 # ID=5_23;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.483,5_23,19425,20057,+,Strict,400,428.328,CRP,97.62,3000518,protein homolog model,n/a,n/a,macrolide antibiotic; fluoroquinolone antibiotic; penam,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGGTTCTCGGCAAGCCACAAACAGACCCCACGCTTGAATGGTTTTTGTCTCACTGCCATATCCACAAATATCCATCCAAAAGCACGCTTATTCATCAGGGCGAAAAGGCAGAAACACTCTACTATATTGTAAAAGGTTCTGTTGCGGTGCTGATCAAAGATGAAGAAGGCAAAGAGATGATTTTATCCTATCTCAACCAGGGTGATTTCATCGGTGAACTCGGATTATTTGAGGAAGGACAGGAACGTACAGCGTGGGTACGGGCAAAAAGCGCCTGCGAAGTTGCAGAAATCTCGTACAAAAAGTTCCGCCAGCTTATCCAGGTTAACCCGGATATCCTTATGCGCCTTTCCGCGCAGATGGCAAGCCGCCTGCAAACCACATCAGAAAAGGTCGGAAACCTTGCATTCCTTGATGTGACAGGCCGCATCGCCCAGACATTACTGAACCTGGCAAAACAGCCGGATGCAATGACTCATCCGGACGGCATGCAAATCAAAATTACCCGTCAGGAAATCGGCCAGATTGTGGGATGTTCCCGCGAAACCGTCGGTCGTATTCTGAAGATGCTGGAAGATCAAAACCTGATCTCCGCACACGGTAAAACTATCGTGGTATACGGCACCCGTTAA,MVLGKPQTDPTLEWFLSHCHIHKYPSKSTLIHQGEKAETLYYIVKGSVAVLIKDEEGKEMILSYLNQGDFIGELGLFEEGQERTAWVRAKSACEVAEISYKKFRQLIQVNPDILMRLSAQMASRLQTTSEKVGNLAFLDVTGRIAQTLLNLAKQPDAMTHPDGMQIKITRQEIGQIVGCSRETVGRILKMLEDQNLISAHGKTIVVYGTR,MVLGKPQTDPTLEWFLSHCHIHKYPSKSKLIHQGEKAETLYYIVKGSVAVLIKDEEGKEMILSYLNQGDFIGELGLFEEGQERSAWVRAKTACEVAEISYKKFRQLIQVNPDILMRLSAQMARRLQVTSEKVGNLAFLDVTGRIAQTLLNLAKQPDAMTHPDGMQIKITRQEIGQIVGCSRETVGRILKMLEDQNLISAHGKTIVVYGTR,100,gnl|BL_ORD_ID|803|hsp_num:0,869,FALSE,None
LK1098,8_39 # 40237 # 41376 # 1 # ID=8_39;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.528,8_39,40237,41376,+,Perfect,700,774.237,DHA-1,100,3002132,protein homolog model,n/a,n/a,cephalosporin; cephamycin,antibiotic inactivation,DHA beta-lactamase,ATGAAAAAATCGTTATCTGCAACACTGATTTCCGCTCTGCTGGCGTTTTCCGCCCCGGGGTTTTCTGCCGCTGATAATGTCGCGGCGGTGGTGGACAGCACCATTAAACCGCTGATGGCACAGCAGGATATTCCCGGGATGGCGGTTGCCGTCTCCGTAAAGGGTAAGCCCTATTATTTCAATTATGGTTTTGCCGATATTCAGGCAAAACAGCCGGTCACTGAAAATACACTATTTGAGCTCGGATCTGTAAGTAAAACTTTCACAGGTGTGCTGGGTGCGGTTTCTGTGGCGAAAAAAGAGATGGCGCTGAATGATCCGGCGGCAAAATACCAGCCGGAGCTGGCTCTGCCGCAGTGGAAGGGGATCACATTGCTGGATCTGGCTACCTATACCGCAGGCGGACTGCCGTTACAGGTGCCGGATGCGGTAAAAAGCCGTGCGGATCTGCTGAATTTCTATCAGCAGTGGCAGCCGTCCCGGAAACCGGGCGATATGCGTCTGTATGCAAACAGCAGTATCGGCCTGTTTGGTGCTCTGACCGCAAACGCGGCGGGGATGCCGTATGAGCAGTTGCTGACTGCACGGATCCTGGCACCGCTGGGGTTATCTCACACCTTTATTACTGTGCCGGAAAGTGCGCAAAGCCAGTATGCGTACGGTTATAAAAACAAAAAACCGGTCCGCGTGTCGCCGGGACAGCTTGATGCGGAATCTTACGGCGTGAAATCCGCCTCAAAAGATATGCTGCGCTGGGCGGAAATGAATATGGAGCCGTCACGGGCCGGTAATGCGGATCTGGAAATGGCAATGTATCTCGCCCAGACCCGCTACTATAAAACCGCCGCGATTAACCAGGGGCTGGGCTGGGAAATGTATGACTGGCCGCAGCAGAAAGATATGATCATTAACGGTGTGACCAACGAGGTCGCATTGCAGCCGCATCCGGTAACAGACAACCAGGTTCAGCCGTATAACCGTGCTTCCTGGGTGCATAAAACGGGCGCAACAACTGGTTTCGGCGCCTATGTCGCCTTTATTCCGGAAAAACAGGTGGCGATTGTGATTCTGGCGAATAAAAACTACCCGAATACCGAAAGAGTCAAAGCTGCACAGGCTATTTTGAGTGCACTGGAATAA,MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYFNYGFADIQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMALNDPAAKYQPELALPQWKGITLLDLATYTAGGLPLQVPDAVKSRADLLNFYQQWQPSRKPGDMRLYANSSIGLFGALTANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESYGVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKDMIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANKNYPNTERVKAAQAILSALE,MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYFNYGFADIQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMALNDPAAKYQPELALPQWKGITLLDLATYTAGGLPLQVPDAVKSRADLLNFYQQWQPSRKPGDMRLYANSSIGLFGALTANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESYGVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKDMIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANKNYPNTERVKAAQAILSALE,100,gnl|BL_ORD_ID|802|hsp_num:0,868,FALSE,None
LK1098,14_7 # 4159 # 5364 # 1 # ID=14_7;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.434,14_7,4159,5364,+,Strict,700,785.023,tet(B),99.25,3000166,protein homolog model,n/a,n/a,tetracycline antibiotic,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGAATAGTTCGACAAAGATCGCATTGGTAATTACGTTACTCGATGCCATGGGGATTGGCCTTATCATGCCAGTCTTGCCAACGTTATTACGTGAATTTATTGCTTCGGAAGATATCGCTAACCACTTTGGCGTATTGCTTGCACTTTATGCGTTAATGCAGGTTATCTTTGCTCCTTGGCTTGGAAAAATGTCTGACCGATTTGGTCGGCGCCCAGTGCTGTTGTTGTCATTAATAGGCGCATCGCTGGATTACTTATTGCTGGCTTTTTCAAGTGCGCTTTGGATGCTGTATTTAGGCCGTTTGCTTTCAGGGATCACAGGAGCTACTGGGGCTGTCGCGGCATCGGTCATTGCCGATACCACCTCAGCTTCTCAACGCGTGAAGTGGTTCGGTTGGTTAGGGGCAAGTTTTGGGCTTGGTTTAATAGCGGGGCCTATTATTGGTGGTTTTGCAGGAGAGATTTCACCGCATAGTCCCTTTTTTATCGCTGCGTTGCTAAATATTGTCGCTTTCCTTGTGGTTATGTTTTGGTTCCGTGAAACCAAAAATACACGTGATAATACAGATACCGAAGTAGGGGTTGAGACGCAATCGAATTCGGTATACATCACTTTATTTAAAACGATGCCCATTTTGTTGATTATTTATTTTTCAGCGCAATTGATAGGCCAAATTCCCGCAACGGTGTGGGTGCTATTTACCGAAAATCGTTTTGGATGGAATAGCATGATGGTTGGCTTTTCATTAGCGGGTCTTGGTCTTTTACACTCAGTATTCCAAGCCTTTGTGGCAGGAAGAATAGCCACTAAATGGGGCGAAAAAACGGCAGTACTGCTCGGATTTATTGCAGATAGTAGTGCATTTGCCTTTTTAGCGTTTATATCTGAAGGTTGGTTAGTTTTCCCTGTTTTAATTTTATTGGCTGGTGGTGGGATCGCTTTACCTGCATTACAGGGAGTGATGTCTATCCAAACAAAGAGTCATCAGCAAGGTGCTTTACAGGGATTATTGGTGAGCCTTACCAATGCAACCGGTGTTATTGGCCCATTACTGTTTGCTGTTATTTATAATCATTCACTACCAATTTGGGATGGCTGGATTTGGATTATTGGTTTAGCGTTTTACTGTATTATTATCCTGCTATCGATGACCTTCATGTTAACCCCTCAAGCTCAGGGGAGTAAACAGGAGACAAGTGCTTAG,MNSSTKIALVITLLDAMGIGLIMPVLPTLLREFIASEDIANHFGVLLALYALMQVIFAPWLGKMSDRFGRRPVLLLSLIGASLDYLLLAFSSALWMLYLGRLLSGITGATGAVAASVIADTTSASQRVKWFGWLGASFGLGLIAGPIIGGFAGEISPHSPFFIAALLNIVAFLVVMFWFRETKNTRDNTDTEVGVETQSNSVYITLFKTMPILLIIYFSAQLIGQIPATVWVLFTENRFGWNSMMVGFSLAGLGLLHSVFQAFVAGRIATKWGEKTAVLLGFIADSSAFAFLAFISEGWLVFPVLILLAGGGIALPALQGVMSIQTKSHQQGALQGLLVSLTNATGVIGPLLFAVIYNHSLPIWDGWIWIIGLAFYCIIILLSMTFMLTPQAQGSKQETSA,MNSSTKIALAITLLDAMGIGLIMPVLPTLLREFIASEDIANHFGVLLALYALMQVIFAPWLGKMSDRFGRRPVLLLSLIGASLDYLLLAFSSALWMLYLGRLLSGITGATGAVAASVIADTTSASQRVKWFGWLGASFGLGLIAGPIIGGFAGEISPHSPFFIAALLNIVTFLVVMFWFRETKNTRDNTDTEVGVETQSNSVYITLFKTMPILLIIYFSAQLIGQIPATVWVLFTENRFGWNSMMVGFSLAGLGLLHSVFQAFVAGRIATKWGEKTAVLLGFIADSSAFAFLAFISEGWLVFPVLILLAGGGIALPALQGVMSIQTKSHQQGALQGLLVSLNNATGVIGPLLFAVIYNHSLPIWDGWIWIIGLAFYCIIILLSMTFMLTPQAQGSKQETSA,100,gnl|BL_ORD_ID|439|hsp_num:0,458,FALSE,None
LK1098,4_137 # 158337 # 160130 # 1 # ID=4_137;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.551,4_137,158337,160130,+,Strict,500,584.334,Haemophilus influenzae PBP3 conferring resistance to beta-lactam antibiotics,51.61,3004446,protein variant model,D350N,n/a,cephalosporin; cephamycin; penam,antibiotic target alteration,Penicillin-binding protein mutations conferring resistance to beta-lactam antibiotics,ATGAAAAGCAGAAAAGCAGCAGGCAAAACGCAGGGCGGTGCCCGTATCAAACGTCCGGAAGAAAAAGCCAGTTTTATCAGCTGGCGTTTTGCGTTGTTATGCGGCGGTATCGGGCTTGCCCTGGCCGCGCTGCTGATCCGGGTCGCGTATTTACAGATTATCAACCCGGACATGCTGGTCAAAGAGGGCGACATGCGCTCGCTGCGCGTCCAGGAGATCCCGACCGCACGCGGTATGATCAGCGACCGTATGGGGCGTCCGCTGGCGGTCAGTGTGCCGGTAAACGCCGTCTGGGCTGATCCGAAAGAGTTAGCCGACAAAGGCGGGGTAGGGGATGACACCCGCTGGCGCGCACTGTCCGAAGCGCTGAATATCCCGCTCGAACAGGTGAAAAGCAAAGTCACGGCGAACCCGAAAGGCCGCTTTGTCTATCTGGCGCGTCAGGTGAACCCGACTATCGGCGATTATGTGAAAAAACTGAATCTGCCGGGGATTTATTTACAGGCGGAATCAAAACGGTATTACCCGTCCGGCTCTGTGACTGCTCACATTATTGGTGTCACCAATATTGATGATGAAGGGATTGAAGGGGTCGAGAAAAGCTTTGACCGCTGGCTGACCGGGGTTCCGGGGCAGCGGACAGTCCGTAAAGATCGCGGCGGCCGTGTTATTGAAGATACTATCGCCCGCGAAAGTCAGGCCGGGCACAACCTGACACTCAGTATTGATGAGCGTTTACAGGCGCTGGTATACCGCGAAATCAGCAGTGCGGTGGCACTGAACAAAGCGGAATCCGGCACGGCGATTCTGGTGGATGTGAACACCGGGGAAATTCTGGCGATGGCGAACAGCCCGTCCTATAACCCGAACAACCTCCAGGGCACGCCGAAAGATGCTATGCGTAACCGCGCTATCACCGATATTTTTGAACCGGGCTCGACGGTAAAACCGTTGGTGGTGATGACAGCACTGCACAACAACATCATCAAACCGAACAGCGTGGTGAATACTTATCCGTACCGGATCAGTGGTCATGAAATCAAAGACGTGGCGCGTTATGCCGAACTGACCATCACCGGTATTTTACAGAAGTCGAGTAACGTAGGTGTCTCAAGACTTGCGTTAGCGATGCCCGCTCAGGAACTCGTGGACGTCTATTCGCGTTTCGGGCTGGGAAAACCGACCAATCTGGGGCTGGTCGGAGAAAGCAGTGGCATATACCCAAGTAAAAAAACACGGTGGTCTGAGCTTGAAAGGGCCACCTTTTCTTTCGGTTACGGGCTGATGGTAACACCGTTACAGTTAGCACGGGCCTATGCAACAATCGGCAGTTTCGGGATTTACCGCCCGCTGTCCATCACAAAAGTGGATCCGCCGGTGCCGGGCACCCGCGTCTTCCCTGAGCCGGTGATGAAAACCGTGGTTCAGATGATGGAAAGCGTTGCGTTACCGGGCGGCGGCGGAACGCGCGCTGCGATCAAAGGGTACCGCGTGGCCATTAAAACCGGGACCGCGAAAAAAGTGGGCGATGACGGCAAATACGTGAACCGTTATATCGCTTACACCGCCGGGGTTGCACCGGCAAGCCGTCCGCGTTTTGCACTGGTTGTGATTATCAACGACCCGCAGGGCGGCAAGTATTACGGGGGTGCGATCTCTGCACCGGTATTCGGTGCCATCATGGGCGGTGTTCTGCGGACAATGAACGTGGAACCCGATGCGCTGACACCGGAAGAACAAACTAATGAAGTGGTTATTAATAAACCAAAAGAGGGTACAAGTGGCAGATCGTAA,MKSRKAAGKTQGGARIKRPEEKASFISWRFALLCGGIGLALAALLIRVAYLQIINPDMLVKEGDMRSLRVQEIPTARGMISDRMGRPLAVSVPVNAVWADPKELADKGGVGDDTRWRALSEALNIPLEQVKSKVTANPKGRFVYLARQVNPTIGDYVKKLNLPGIYLQAESKRYYPSGSVTAHIIGVTNIDDEGIEGVEKSFDRWLTGVPGQRTVRKDRGGRVIEDTIARESQAGHNLTLSIDERLQALVYREISSAVALNKAESGTAILVDVNTGEILAMANSPSYNPNNLQGTPKDAMRNRAITDIFEPGSTVKPLVVMTALHNNIIKPNSVVNTYPYRISGHEIKDVARYAELTITGILQKSSNVGVSRLALAMPAQELVDVYSRFGLGKPTNLGLVGESSGIYPSKKTRWSELERATFSFGYGLMVTPLQLARAYATIGSFGIYRPLSITKVDPPVPGTRVFPEPVMKTVVQMMESVALPGGGGTRAAIKGYRVAIKTGTAKKVGDDGKYVNRYIAYTAGVAPASRPRFALVVIINDPQGGKYYGGAISAPVFGAIMGGVLRTMNVEPDALTPEEQTNEVVINKPKEGTSGRS,MVKFNSSRKSGKSKKTIRKLTAPETVKQNKPQKVFEKCFMRGRYMLSTVLILLGLCALVARAAYVQSINADTLSNEADKRSLRKDEVLSVRGSILDRNGQLLSVSVPMSAIVADPKTMLKENSLADKERIAALAEELGMTENDLVKKIEKNSKSGYLYLARQVELSKANYIRRLKIKGIILETEHRRFYPRVEEAAHVVGYTDIDGNGIEGIEKSFNSLLVGKDGSRTVRKDKRGNIVAHISDEKKYDAQDVTLSIDEKLQSMVYREIKKAVSENNAESGTAVLVDVRTGEVLAMATAPSYNPNNRVGVKSELMRNRAITDTFEPGSTVKPFVVLTALQRGVVKRDEIIDTTSFKLSGKEIVDVAPRAQQTLDEILMNSSNRGVSRLALRMPPSALMETYQNAGLSKPTDLGLIGEQVGILNANRKRWADIERATVAYGYGITATPLQIARAYATLGSFGVYRPLSITKVDPPVIGKRVFSEKITKDIVGILEKVAIKNKRAMVEGYRVGVKTGTARKIENGHYVNKYVAFTAGIAPISDPRYALVVLINDPKAGEYYGGAVSAPVFSNIMGYALRANAIPQDAEAAENTTTKSAKRIVYIGEHKNQKVN,97.87,gnl|BL_ORD_ID|2497|hsp_num:0,2886,FALSE,None
LK1098,5_198 # 208670 # 211084 # 1 # ID=5_198;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.521,5_198,208670,211084,+,Strict,1200,1661.74,Morganella morganii gyrB conferring resistance to fluoroquinolones,100,3003306,protein variant model,S463A,n/a,fluoroquinolone antibiotic,antibiotic target alteration,fluoroquinolone resistant gyrB,ATGTCGAATACCTATGACTCCTCAAGTATCAAAGTATTAAAAGGGCTGGACGCGGTGCGTAAACGCCCGGGAATGTACATTGGTGATACCGATGACGGAACCGGTTTACACCACATGGTCTTCGAGGTTGTTGACAACGCTATCGACGAAGCCCTCGCCGGTTACTGTAAAGACATCATTGTGACCATTCACAATGATAATTCAGTCTCCGTACAGGATGACGGCCGCGGTATCCCGACCGGGATCCATGAAGAAGAAGGCGTCTCCGCCGCAGAAGTTATCATGACTGTTCTGCACGCCGGCGGGAAGTTCGATGATAACTCCTATAAAGTCTCAGGCGGCCTGCACGGCGTCGGGGTCTCTGTTGTTAACGCCCTGTCTGAAAAACTGGAACTGGTTATCCGCCGTGACGGCAAAGTTCACGAGCAGATCTACCGCCATGGTGAACCTCAGGATCGCCTGACTGTTGTCGGCGAAACCGATAAAACCGGGACACGCGTGCGTTTCTGGCCGAGCATGGACACCTTCAAAGGCGAGACTGAATTCCAGTACGACATTCTGGCAAAACGCCTGCGCGAACTCTCCTTCCTGAACTCCGGTGTATCGATCCGTCTGATCGATAAACGCGACGGCAAAGAAGATCACTTCCACTACGAAGGCGGTATCAAAGCGTTCGTGGAATATTTAAGCCGCGCCAAAACTTCGATTCATAACAACGTTTTCTATTTCTCCACTGAGAAAGACGATATCGGCGTGGAAATCTCCATGCAGTGGAATGACTCCTTCCAGGAAAACGTATACTGCTTCACCAACAACATTCCGCAGCGCGACGGTGGTGCTCACCTCGCCGGTTTCCGCGCCGCCATGACCCGTACCCTCAACAGCTATATTGAGAAAGAAGGGCTGAATAAAAAATCCAAAGTCAGCACCACCGGGGATGATGCCCGTGAAGGGCTGGTGGCGGTAATTTCCGTCAAAGTGCCGGATCCGAAATTCTCCTCTCAGACCAAAGACAAGCTGGTCTCTTCCGAAGTGAAAACGGCGGTTGAAACCCTGATGAACGAAAAGCTGTCTGAATATCTGGATGAAAACCCGAACGACACCAAAATCATTGTCGGCAAAATTATTGATGCCGCACGCGCCCGTGAAGCTGCACGCCGTGCCCGTGAAATGACCCGCCGTAAAGGCGCGCTGGATTTAGCCGGTCTGCCGGGTAAACTGGCGGACTGTCAGGAACGCGACCCGGCATTCTCCGAACTGTACTTAGTGGAAGGGGACTCTGCGGGCGGCTCTGCAAAACAGGGGCGTAACCGTAAGAACCAGGCAATCTTACCGCTGAAAGGTAAAATCCTGAACGTTGAGAAGGCGCGTTTTGATAAAATGCTGGCTTCTCAGGAAGTTGCCACCCTGATCACCGCACTCGGCTGCGGTATCGGCCGCGACGAATACAACCCGGACAAACTGCGCTATCACAGCATCATCATCATGACCGATGCCGACGTCGATGGTTCACACATCCGTACCCTGTTACTGACTTTCTTCTACCGTCAGATGCCGGAAATCATTGAGCGCGGTTATGTGTATATCGCACAGCCGCCGCTGTATAAAGTGAAAAAAGGCAAGCAGGAACAGTATATTAAAGATGACGAAGCGATGGAGCAGTATCAGGTCTCTATCGCACTGGATGGCGCGGCACTGTATGTAAACGAAAATGCAGCTCCGATTCAGGGCGAACATCTGGAAAAACTGCTGCACGAATACAACGGCGCACACAAAATTATCCGCCGTTTAGAGCGTCTCTATCCGCTGGCACTGTTAAACAGCCTGGTCTACCAGCCGAAACTGGAAGAATCCGCGCTGCTGAACAAAACCGAGGTGGAAGCCTGGGCACAGAGCCTGACAGAGCGCCTGACCCGTCATGAAGAGCACGGCAGCACCTACAGCTACCGTATTGCGGAAAACAAAGAGCGCCAGCTGTTTGAGCCGGTACTGACTATCCGTACCCACGGTGTGGATACTGACTACAATCTGGATTTCGATTTTGTTCACGGCAGCGAATATGCCCGTATCTCCAAACTGGGTGAGCTTATCCGTGGTCTGATTGAAGAAGGTGCTTATGTTGTCCGTGGTGAACGCCGTCAGAACGTCAGCAACTTTGAGCAGGCACTGGACTGGCTGATGAAAGAATCACGCCGTGGTCTGGCTGTACAGCGCTATAAAGGGCTGGGTGAAATGAACCCGGAACAGCTGTGGGAAACCACAATGAACCCGGAAACCCGCCGTATGTTGCAGGTCACGGTAAAAGATGCGATTGCAACGGATCAGTTATTCACCACACTGATGGGTGATGATGTTGAACCGCGCCGTGCCTTTATCGAAGAGAATGCCCTGAAAGCGGCAAACATCGACGTATAA,MSNTYDSSSIKVLKGLDAVRKRPGMYIGDTDDGTGLHHMVFEVVDNAIDEALAGYCKDIIVTIHNDNSVSVQDDGRGIPTGIHEEEGVSAAEVIMTVLHAGGKFDDNSYKVSGGLHGVGVSVVNALSEKLELVIRRDGKVHEQIYRHGEPQDRLTVVGETDKTGTRVRFWPSMDTFKGETEFQYDILAKRLRELSFLNSGVSIRLIDKRDGKEDHFHYEGGIKAFVEYLSRAKTSIHNNVFYFSTEKDDIGVEISMQWNDSFQENVYCFTNNIPQRDGGAHLAGFRAAMTRTLNSYIEKEGLNKKSKVSTTGDDAREGLVAVISVKVPDPKFSSQTKDKLVSSEVKTAVETLMNEKLSEYLDENPNDTKIIVGKIIDAARAREAARRAREMTRRKGALDLAGLPGKLADCQERDPAFSELYLVEGDSAGGSAKQGRNRKNQAILPLKGKILNVEKARFDKMLASQEVATLITALGCGIGRDEYNPDKLRYHSIIIMTDADVDGSHIRTLLLTFFYRQMPEIIERGYVYIAQPPLYKVKKGKQEQYIKDDEAMEQYQVSIALDGAALYVNENAAPIQGEHLEKLLHEYNGAHKIIRRLERLYPLALLNSLVYQPKLEESALLNKTEVEAWAQSLTERLTRHEEHGSTYSYRIAENKERQLFEPVLTIRTHGVDTDYNLDFDFVHGSEYARISKLGELIRGLIEEGAYVVRGERRQNVSNFEQALDWLMKESRRGLAVQRYKGLGEMNPEQLWETTMNPETRRMLQVTVKDAIATDQLFTTLMGDDVEPRRAFIEENALKAANIDV,MSNTYDSSSIKVLKGLDAVRKRPGMYIGDTDDGTGLHHMVFEVVDNAIDEALAGYCKDIIVTIHNDNSVSVQDDGRGIPTGIHEEEGVSAAEVIMTVLHAGGKFDDNSYKVSGGLHGVGVSVVNALSEKLELVIRRDGKVHEQIYRHGEPQDRLTVVGETDKTGTRVRFWPSMDTFKGETEFQYDILAKRLRELSFLNSGVSIRLIDKRDGKEDHFHYEGGIKAFVEYLSRAKTSIHNNVFYFSTEKDDIGVEISMQWNDSFQENVYCFTNNIPQRDGGAHLAGFRAAMTRTLNSYIEKEGLNKKSKVSTTGDDAREGLVAVISVKVPDPKFSSQTKDKLVSSEVKTAVETLMNEKLSEYLDENPNDTKIIVGKIIDAARAREAARRAREMTRRKGALDLAGLPGKLADCQERDPAFSELYLVEGDSAGGSAKQGRNRKNQAILPLKGKILNVEKARFDKMLASQEVATLITALGCGIGRDEYNPDKLRYHSIIIMTDADVDGSHIRTLLLTFFYRQMPEIIERGYVYIAQPPLYKVKKGKQEQYIKDDEAMEQYQVSIALDGAALYVNENAAPIQGEHLEKLLHEYNGAHKIIRRLERLYPLALLNSLVYQPKLEESALLNKTEVEAWAQSLTERLTRHEEHGSTYSYRIAENKERQLFEPVLTIRTHGVDTDYNLDFDFVHGSEYARISKLGELIRGLIEEGAYVVRGERRQNVSNFEQALDWLMKESRRGLAVQRYKGLGEMNPEQLWETTMNPETRRMLQVTVKDAIATDQLFTTLMGDDVEPRRAFIEENALKAANIDV,100,gnl|BL_ORD_ID|1996|hsp_num:0,535,FALSE,None
LK1098,14_6 # 3454 # 4077 # -1 # ID=14_6;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.402,14_6,3454,4077,-,Strict,400,427.172,tetR,100,3003479,protein overexpression model,n/a,n/a,tetracycline antibiotic,antibiotic target alteration; antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGTCTAGATTAGATAAAAGTAAAGTGATTAACAGCGCATTAGAGCTGCTTAATGAGGTCGGAATCGAAGGTTTAACAACCCGTAAACTCGCCCAGAAGCTAGGTGTAGAGCAGCCTACATTGTATTGGCATGTAAAAAATAAGCGGGCTTTGCTCGACGCCTTAGCCATTGAGATGTTAGATAGGCACCATACTCACTTTTGCCCTTTAGAAGGGGAAAGCTGGCAAGATTTTTTACGTAATAACGCTAAAAGTTTTAGATGTGCTTTACTAAGTCATCGCGATGGAGCAAAAGTACATTTAGGTACACGGCCTACAGAAAAACAGTATGAAACTCTCGAAAATCAATTAGCCTTTTTATGCCAACAAGGTTTTTCACTAGAGAATGCATTATATGCACTCAGCGCTGTGGGGCATTTTACTTTAGGTTGCGTATTGGAAGATCAAGAGCATCAAGTCGCTAAAGAAGAAAGGGAAACACCTACTACTGATAGTATGCCGCCATTATTACGACAAGCTATCGAATTATTTGATCACCAAGGTGCAGAGCCAGCCTTCTTATTCGGCCTTGAATTGATCATATGCGGATTAGAAAAACAACTTAAATGTGAAAGTGGGTCTTAA,MSRLDKSKVINSALELLNEVGIEGLTTRKLAQKLGVEQPTLYWHVKNKRALLDALAIEMLDRHHTHFCPLEGESWQDFLRNNAKSFRCALLSHRDGAKVHLGTRPTEKQYETLENQLAFLCQQGFSLENALYALSAVGHFTLGCVLEDQEHQVAKEERETPTTDSMPPLLRQAIELFDHQGAEPAFLFGLELIICGLEKQLKCESGS,MMSRLDKSKVINSALELLNEVGIEGLTTRKLAQKLGVEQPTLYWHVKNKRALLDALAIEMLDRHHTHFCPLEGESWQDFLRNNAKSFRCALLSHRDGAKVHLGTRPTEKQYETLENQLAFLCQQGFSLENALYALSAVGHFTLGCVLEDQEHQVAKEERETPTTDSMPPLLRQAIELFDHQGAEPAFLFGLELIICGLEKQLKCESGS,99.52,gnl|BL_ORD_ID|442|hsp_num:0,276,FALSE,None
LK466,3_86 # 80364 # 81476 # 1 # ID=3_86;partial=00;start_type=ATG;rbs_motif=3Base/5BMM;rbs_spacer=13-15bp;gc_cont=0.572,3_86,80364,81476,+,Strict,175,181.8,vanT gene in vanG cluster,31.25,3002972,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,glycopeptide resistance gene cluster; vanT,ATGAACATGCTGCGCACTCGCATCGACTTGGATGCCATCGCCCACAATGTCCGTGTGCTTAAGCGGGCGGCAGGCGAAGCGCAGCTGATGTGCGTCGTCAAGGCTGACGCTTACGGTCACGGCATGGAGCGCGTGGTTCCGGTAATGGAAAAATCAGGCGCTGACCTTTTTGGTGTGGCCACGATCGCCGAAGCCCAACGCTTGCGTGAACTCGGTACAGAACTACCGGTCATGGCGTGGTTGTGGGATGCCGCGAGCCAGGATGCTGCACAGGTAGTTGCAGATGCTCTTGCCGACGACATCCAGTTGGCTGCGCCGTCATTAGATCACCTGGCCGTGCTCGTTAACGCTGGCATCCCTGCGACGATCACGCTGAAAGTTGAAACAGGGATGCATCGTAATGGCATTGATCCCGCTGATTGGCAGCGTGCCTTCGAGATGGCGAAAAATGCCCCACACCTGGCCGTGCGCGGGTTGATGTCACATCTGGCGTGTGCGGATGAGCCGGATAATCCTGCTAATGCCGCGCAGCTTGAGCAATTCCGCGCCGCAATTAGGCAAGCACGCGCCATGGGCTTGGAGGTTCCGGTCAACCATATAGCTAATTCGGCCGCGACCGTGCAGCTCCCTGATACTCATTTTCAACAAGTTCGCCCGGGCATTGCCTGCTATGGGTTGCAACCCGCCGCTGGTTTTGCACATGAGCTACGCCCGGCGATGACTTGGGCAGGTACTGTCGTTAACGTCAAGCCCATTACCGCAGGTGAAGCCGCCTCCTATGGCTTGACTTGGCGGGCAGGAAAGACTGGGTATTTGGCGGTTATCCCTTGTGGCTACGCTGATGGTTTGCCACGCAGTATCCAGGGGCATCTTGTGGTGGGCATTTCTGGGAAGTGTTATCCGCAGGTTGGGCGAGTATGCATGGATCAGATTTTGCTGGATCTTGGCGAAAACCCCTTCGGCGTGCAACCGGGTGATGAAGCAGTGTTGTTTGGGGAAGGTGGCATGTCTGCCACGGAGTTGGCCGATGCTACGGGAACTATTAATTATGAGATCGTGACTCGCCCTGGCGGGCGCACTGTTCGGGAGTATGAAGGGGGAATCCAGCTATGA,MNMLRTRIDLDAIAHNVRVLKRAAGEAQLMCVVKADAYGHGMERVVPVMEKSGADLFGVATIAEAQRLRELGTELPVMAWLWDAASQDAAQVVADALADDIQLAAPSLDHLAVLVNAGIPATITLKVETGMHRNGIDPADWQRAFEMAKNAPHLAVRGLMSHLACADEPDNPANAAQLEQFRAAIRQARAMGLEVPVNHIANSAATVQLPDTHFQQVRPGIACYGLQPAAGFAHELRPAMTWAGTVVNVKPITAGEAASYGLTWRAGKTGYLAVIPCGYADGLPRSIQGHLVVGISGKCYPQVGRVCMDQILLDLGENPFGVQPGDEAVLFGEGGMSATELADATGTINYEIVTRPGGRTVREYEGGIQL,MTKNESYSGIDYFRFIAALLIVAIHTSPLSSFSETGNFIFTRIVARVAVPFFFMTSGFFLISRYTCNAEKLGAFIKKTTLIYGVAILLYIPINVYNGYFKMDNLLPNIIKDIVFDGTLYHLWYLPASIIGAAIAWYLVKKVHYRKAFLIASILYIIGLFGDSYYGIVKSVSCLNVFYNLIFQLTDYTRNGIFFAPIFFVLGGYISDSQNRLSLKRSIVGFIVCFALMFGEALTLHHFDIQKHDSMYVLLLPSVYCLFNLLLHFRGKRRTGLRTISLIIYIIHPFMIVVIRLFAKLLHLQSLLVENSLVHYIAVCFASVVLAVVITALLSSLKPKKAKHTADTDRAYLEINLNNLEHNVNTLQKAMSPKCELMAVVKAEAYGHGMYEVTTYLEQIGVSSFAVATIDEGIRLRKYGISSEILILGYTSPSRAKELCKYELTQTLIDYRYSLLLNKQGYDIKAHIKIDTGMHRLGFSTEDKDKILAAFSLKHIKVAGIFTHLCAADSLEENDVAFTNKQIGSFYKVLDWLKSSGLNIPKVHIQSSYGLLNYPELECDYIRVGVALYGVLSSTNDKTKLELDLRPVLSLKAKVVLIRKIKQGESVGYSRAFTATRDSLIAILPIGYADGFPRNLSCGNSYVLIGGRQAPIVGKICMDQLAVDVTDIPNVKTGSIATLIGKDGKEEITAPMVAESAESITNELLSRMGHRLNIIRRA,51.97,gnl|BL_ORD_ID|1522|hsp_num:0,1561,FALSE,None
LK466,10_2 # 837 # 1691 # -1 # ID=10_2;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.564,10_2,837,1691,-,Strict,400,514.612,ErmX,90.14,3000596,protein homolog model,n/a,n/a,macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic,antibiotic target alteration,Erm 23S ribosomal RNA methyltransferase,ATGTCTGCATACGGACACGGCCGTCACGAGCATGGCCAAAATTTTCTCACCAACCACAAGATCATCAACTCCATCATCGACCTTGTGAAACAAACCTCCGGCCCCATCATTGAGATCGGACCAGGAAGCGGTGCCCTCACTCACCCGATGGCCCACTTGGGGAGGGCGATAACGGCAGTTGAAGTGGACGCAAAACTAGCTGCCAAAATCACACAAGAAACCTCCTCGGCGGCGGTCGAAGTGGTCCATGATGATTTCCTTAACTTCCGGTTACCCGCCACTCCCTGCGTCATTGTGGGAAACATTCCCTTTCACCTCACCACTGCCATTCTTCGAAAGTTGCTGCATGCGCCAGCATGGACTGACGCTGTACTCCTCATGCAGTGGGAAGTCGCTCGCCGCCGGGCCGGGGTAGGCGCAAGCACGATGATGACGGCTCAGTGGTCCCCATGGTTCACATTTCACCTGGGTTCTCGGGTACCAAGGCCTGCTTTCCGGCCACAGCCAAACGTTGACGGGGGGATCTTAGTGATCCGCCGGGTGGGTGACCCGAAGATTCCGATAGAGCAGCGCAAAGCCTTTCAGGCGATGGTGCACACCGTTTTCACTGCCCGGGGACGCGGGATAGGGGAAATTCTCCGAAGGGCAGGGTTGTTTTCATCACGTTCAGAAACACAATCATGGTTGCGCTCGCGAGGAATCGACCCCGCGACCCTACCTCCCAGATTGCACACCAACGACTGGATCGATCTCTTCCAGGTGACTGGTTCCTCTCTACCTCACCATCGACCCATTTCACCATCGGGAAGTAGTCAACGACCTCCTCAACGGAAAAACCGAAGCCGGCGGCGTTAA,MSAYGHGRHEHGQNFLTNHKIINSIIDLVKQTSGPIIEIGPGSGALTHPMAHLGRAITAVEVDAKLAAKITQETSSAAVEVVHDDFLNFRLPATPCVIVGNIPFHLTTAILRKLLHAPAWTDAVLLMQWEVARRRAGVGASTMMTAQWSPWFTFHLGSRVPRPAFRPQPNVDGGILVIRRVGDPKIPIEQRKAFQAMVHTVFTARGRGIGEILRRAGLFSSRSETQSWLRSRGIDPATLPPRLHTNDWIDLFQVTGSSLPHHRPISPSGSSQRPPQRKNRSRRR,MSAYGQGRHEHGQNFLTNHKIINSIIDLVKQTSGPIIEIGPGSGALTHPMAHLGRAITAVEVDAKLAAKITQETSSAAVEVVHDDFLNFRLPATPCVIVGNIPFHLTTAILRKLLHAPAWTDAVLLMQWEVARRRAGVGATTMMTAQWSPWFTFHLGSRVPRSAFRPQPNVDGGILVIRRVGDPKIPIEQRKAFQAMVHTVFTARGRGIGEILRRQGCFHHVQKHNHGCAREESTPRPYLPDCYTNDWIDLFQVTGSSLPHHRPISPSGSSQRPPQRKNRSRRR,100,gnl|BL_ORD_ID|872|hsp_num:0,950,FALSE,None
LK466,15_20 # 21488 # 23131 # -1 # ID=15_20;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.604,15_20,21488,23131,-,Strict,50,91.2781,vanW gene in vanI cluster,33.96,3003724,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanW; glycopeptide resistance gene cluster,GTGCTCGGCGTCTTCGTCGGGCTTTTCGTCATTGCTGGCATTGCCTACGCCATTGATGTCTCCACGAATCAGGGCAAAATCCCGCGTGCGACGTCCGTGGGTGGCGTCGATATTTCCTCCCTGGAGCGCGAGGATGCTTTGGCCAAGCTTGACGACGAACTCCGCGAGGCAGAAAACGAACCCGTGCGCGTTACCGCAGGCGAAAAAACCACGGAATTTGTGCCAGCGCAGGCGGGGTTGCGTCTGGACTTGGAAGGCACCATTGCCGCTATTCCCGATGAGTCGATGAACCCACTTGTGCGCCTGGCCAGCTTCTTCCGTTCGACGAAGGAAGTCGACGTACAAACCGCCGAGGATCCGGCCGTGCTGAACCCGGAGCTAGACCGCATGGTTGGCGAGCTGCACCGGGACCCAGAAGATGGTGCGGTGTTCCTGGAAGCCGGCAACGTGGAACCGCGTGATGCCGTACCGGGCCAGGAAGTTGATCGCGCACAGCTGCAAGAAGAGGTTGCTAGCTCCTGGTTGGATCCGGAAGGCATCGCGGTAGAGCCGAATGAGATCGAGCCGGTGATTAACCAGGATCAGGTGGATGCGATAGCCGAAGGCCTTGCTGCCAAGGCGGTGTCCGGCCCGCTGAAGGTGCACGGCCGCGAGAATATTACGGGCACGATTGAACCCGCGCGCGTCGGCGAGTTCGTGCATTTTGAAGCCCACGAAGGCCACTTGGAGCCACGTGTCGACGAGTCCAAGGCCCGGGACATCCTGGGCGAAGGCCTGGCGGAATCCGAACGCCCGATGAAAAATGCTCGCTTGTCTATGTCTGGTGGCCAGCGTCAGATCACCCCGCACGTGGACGGCGAAGTCATTGACTGGGAGCAGACCATGGCCGGTTTCGCCGAGCGCGTGTTGGGTGATGACCGCGAGTGGGATGCGACTTATCAAGACAAACCAGCGACGTTTACCACCGCGGATGCCGAGGCTTCGACCTTTGACCAGGTGGTTGGTGAGTTCACCACTAGTGGTTACTCCCCAGCCTCGGGCACGAATATTTCGGTGATTTCCAATGCGCTTAACGGCACCATTGTGTCGCCGGGCGAGACCTTCTCCGTGAACCAGGCCACCGGCTCGCGCACCGCAGCGCAGGGCTATGTGGAATCCGGCGTGATTTATGAGGGCCGCGCAGACACCGCCGTCGGCGGCGGTATTTCGCAGTACGCTACCACCTTGTATAACGCGGCCTACTTCGCAGCCATGGAAGATGTTGCCCATACCCCGCACAGTTATTACATTTCTCGGTACCCGGCGGGGCGCGAGGCCACGCTGTACGACGGCGTGATCGACCTGAAGTTCCGCAACAATTCCAACCACCCGGTGCGCATTGAATCGAGCGTCGGCGGTGGTTCCGTGACCGTGCGCCTGATGGGCGTGAAGGAATACGAGGTGGAATCCATCAGTGGCGGTCGTTGGGCGCACACCAATCCACCGAAGCAAAAAGTCAGTGGATCTAACTGCATCCCAACCTCCGGTATTCCGGGCTTTACGACGTCCGACACCCGGGTGATCCGCACCCTGGGTGGTGCCGAGGTGTCGCGGAATACTCAGACCACCGTCTATGATCCGCAGCCGATCGTGACCTGCGGCTAG,MLGVFVGLFVIAGIAYAIDVSTNQGKIPRATSVGGVDISSLEREDALAKLDDELREAENEPVRVTAGEKTTEFVPAQAGLRLDLEGTIAAIPDESMNPLVRLASFFRSTKEVDVQTAEDPAVLNPELDRMVGELHRDPEDGAVFLEAGNVEPRDAVPGQEVDRAQLQEEVASSWLDPEGIAVEPNEIEPVINQDQVDAIAEGLAAKAVSGPLKVHGRENITGTIEPARVGEFVHFEAHEGHLEPRVDESKARDILGEGLAESERPMKNARLSMSGGQRQITPHVDGEVIDWEQTMAGFAERVLGDDREWDATYQDKPATFTTADAEASTFDQVVGEFTTSGYSPASGTNISVISNALNGTIVSPGETFSVNQATGSRTAAQGYVESGVIYEGRADTAVGGGISQYATTLYNAAYFAAMEDVAHTPHSYYISRYPAGREATLYDGVIDLKFRNNSNHPVRIESSVGGGSVTVRLMGVKEYEVESISGGRWAHTNPPKQKVSGSNCIPTSGIPGFTTSDTRVIRTLGGAEVSRNTQTTVYDPQPIVTCG,MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVLAEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPELLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGMETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGGEFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSHSLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDEPDGYPVKPREWSK,146.65,gnl|BL_ORD_ID|4748|hsp_num:0,2242,FALSE,None
LK1072,106_5 # 3111 # 3836 # -1 # ID=106_5;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.778,106_5,3111,3836,-,Strict,50,83.5741,vanY gene in vanM cluster,34.46,3002961,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGTCGCCCCCTCCCCCTCGCCGCGCTGGCCGCGCTCGCGCTGCTCGCGGCCGGCTGCGGCACACCCGCCGCGGGCCCGTCCTCGGCGACGCCGGCCTCCGGCTCCTCAAGCGCGGCCGCGTCGTCCGGCGCCGCCTCGAGCACGCACGCCGACCCGGCCGCCCTCGACGTCGTCGTGAACAAGACCCGCCCCGTGGCTCCGCCCGACTGGGCGCCCTCGGATCTGGTGGCCGTGCCCGGCAGCGAGCTGTCCCTGCGGGCGGAGGCCGCGACGGCGGCCGGTGACCTGCTGGATGCCGCCGCGGCGGCGGGTCACCGCCTCACCACCCTGAGCGCCTACCGCTCGTACGACTACCAGGTCCGGACGTACGGCCACTGGGTCGACGAGCTGGGCCGCGCCGAGGCCGACCGCGTCTCGGCGCGTCCGGGGTACTCCGAGCACCAGACCGGCCTGGCCTGGGACGTGGGCGACGCCGCGACCCCCGCGTGTGACCTGGAAGCGTGCTTCGGCGACACTGCCGCGGGCCGCTGGGTGGCCGCGCACGCCGCCGAGTACGGGTTCGTCATCCGCTATCCCGTCGGGGCCGAGGACGTGACGGGCTTCGCCCACGAGCCGTGGCACCTGCGCTACGTCGGGTCCGCGGAGGCGGCCCGGGTCGAGGCGGCCGGCGGCGTCCTCGAGACCGCGTGGGGCCTGCCTCCGGCGCCGGACTACGCGGACTGA,MRRPLPLAALAALALLAAGCGTPAAGPSSATPASGSSSAAASSGAASSTHADPAALDVVVNKTRPVAPPDWAPSDLVAVPGSELSLRAEAATAAGDLLDAAAAAGHRLTTLSAYRSYDYQVRTYGHWVDELGRAEADRVSARPGYSEHQTGLAWDVGDAATPACDLEACFGDTAAGRWVAAHAAEYGFVIRYPVGAEDVTGFAHEPWHLRYVGSAEAARVEAAGGVLETAWGLPPAPDYAD,MVFQGNLLLVNNEYPVLEESIKTDVVNLFKHDELTKGYELLNREIYLSEKVAREFSEMVDAAEKEGVRHFSINSGFRNFDEQNALYQEMGSDYALPAGYSEHNLGLALDIGSTQMEMSEAPEGKWLEDNAWEYGFILRYPMDKTAITGIQYEPWHFRYVGLPHSAIIEEKNFALEEYLDFLKEQKSISGTIHGENYEISYYPITEKTDIEMPANLHYEISGNNMDGVIVTVYR,103.43,gnl|BL_ORD_ID|1673|hsp_num:0,1713,FALSE,None
LK583,1_110 # 122696 # 125809 # -1 # ID=1_110;partial=00;start_type=ATG;rbs_motif=AGGA/GGAG/GAGG;rbs_spacer=11-12bp;gc_cont=0.609,1_110,122696,125809,-,Strict,1900,1956.03,acrD,91.22,3000491,protein homolog model,n/a,n/a,aminoglycoside antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGGCGAATTTCTTTATCGATCGCCCCATTTTTGCATGGGTGCTGGCAATCCTGTTATGCCTGACGGGCACCCTTGCCATTTTGTCGCTGCCGGTTGAACAGTATCCCGACCTCGCCCCGCCGAATGTGCGGATCACCGCCAACTATCCCGGCGCCTCCGCGCAAACCCTGGAGAATACCGTCACTCAGGTTATCGAACAGAATATGACCGGCCTCGATAACCTGATGTATATGTCCTCCCAGAGCAGCGCCACCGGCCAGGCGACGATCACCCTCAGCTTTACCGCCGGTACCGACCCGGATGAAGCCGTGCAGCAGGTTCAGAACCAGCTACAGTCGGCGATGCGTAAGCTGCCGCAGGCGGTGCAAAACCAGGGGGTGACGGTGCGCAAGACCGGTGATACCAATATCCTGACGCTCGCCTTCGTCTCCACTGACGGCAGTATGGATAAACAAGATATCGCCGACTACGTCGCCAGTAACATCCAGGACCCGCTCAGCCGCGTCAACGGCGTGGGGGATATCGACGCCTACGGTTCGCAATACTCAATGCGCATCTGGCTCGACCCGGCGAAGCTCAACAGCTACCAGATGACCACCAAGGATGTTACCGACGCCATCAGTTCGCAGAACGCCCAGATTGCCGTCGGCCAGCTTGGCGGGACGCCTTCGGTCGATAAGCAAGCGCTGAACGCCACCATCAACTCGCAATCTCTGCTGCAAACCCCGGAGCAGTTCCGCAATATCACTCTGCGCGTCAATCAGGATGGTTCAGAGGTGACGCTGGGCGATGTCGCCACCGTCGAGATGGGGGCGGAGAAGTACGACTATCTTAGCCGCTACAACCGCCAGCCGGCCTCAGGCCTCGGGATCAAGCTGGCTTCCGGCGCCAACGAAATGGCCACCGCGGAGCGCGTGATCAATCGCCTCAATGAGCTGGCGCAGTTTTTCCCCCACGGTCTGGAATATAAGGTCGCCTACGAGACCACCTCCTTCGTGAAGGCTTCCATCACCGACGTGGTGAAAACCCTGCTGGAGGCGATCCTGCTGGTCTTCCTCGTGATGTATCTGTTCCTGCAGAACTTCCGCGCCACCCTGATCCCGACCATCGCCGTGCCGGTGGTGCTGATGGGCACTTTCGCGGTGCTGTATGCCTGTGGCTACAGCATCAACACCCTGACGATGTTCGCGATGGTGTTGGCGATCGGCCTGCTGGTGGATGACGCCATCGTGGTGGTGGAGAACGTCGAGCGCATCATGAGCGAGGAGGGCCTGTCGCCACGCGAGGCGACCCGCAAATCGATGGGACAAATTCAGGGCGCGCTGGTGGGGATCGCGATGGTGCTGTCGGCGGTATTCGTGCCGATGGCCTTCTTCGGCGGCACCACCGGCGCCATCTATCGCCAGTTCTCAATCACTATCGTCGCGGCGATGGTCCTCTCGGTGCTGGTGGCCATGATCCTCACCCCTGCCCTTTGCGCCACGCTGCTTAAGCCTGTTAAGCCAGGTGAATCCCATGAAAGAAAAGGCTTCTTCGGCTGGTTCAACCGCACCTTCAACCGCAGCGCCAGCCGCTACGAAACCTTCGTCGGCAAAATACTGCACCGCTCGCTGCGCTGGATGCTGATCTACGTCCTCCTGCTCGGCGGGATGGTGTTCCTGTTTCTGCATTTGCCGACCTCGTTCCTGCCGCTGGAGGATCGCGGGATGTTCACCACCTCGGTCCAGTTGCCGAGCGGCAGCACCCAGCAGCAGACGCTGAAGGTGGTGCAGAAGGCGGAAGATTACTTTCTCAATAACGAGAAGCAGAACGTCGAGTCGGTGTTCGCTACCGTTGGCTCCGGTCCCGGCGGCAATGGGCAGAACGTGGCCCGCATGTTCGTTCGTCTCAAAGACTGGGACCAGCGCGACCCGCAAACCGGCACCTCCTTTGCCATTATTGAACGCGCCACCAAAGCGTTTAATCAGATTAACGAAGCGCGGGTTATCGCCAGCAGCCCGCCGGCGATCAGCGGCCTCGGCAGTTCGGCAGGCTTCGATATGGAGCTGGAGGATCATGCCGGGAAGGGGCACGATGCGCTGATGGCGGCGCGCGATACGCTACTTGAGCTGGCCGGGAAAAATCCGCTGTTGACCCGCGTTCGGCATAACGGGCTCGATGACAGCCCGCAGCTGCAGGTCGATATCGATCAGCGTAAAGCGCAGGCGCTTGGCGTCTCCATTGACGACATCAACGATACGCTGCAAACCGCGTGGGGGTCGAGCTACGTCAACGACTTTATGGATCGCGGCCGGGTAAAGAAAGTCTACGTCCAGGCGGCGGCGAAATACCGGATGCTGCCTGACGATATCAATCTTTGGTACGTGCGCAACAGCAGCGGTACGATGGTGCCATTCTCGGCCTTCGCCACCTCGCGCTGGGAGACCGGCTCGCCGCGGCTGGAGCGCTACAATGGCTACTCAGCGGTGGAGATCGTCGGTGAGGCGGCGCCGGGTATCAGTACCGGTACCGCGATGGACATGATGGAGAAGCTGGCCGCGCAGTTACCCACCGGCTTTGGCCTCGAATGGACCGCCATGTCCTACCAGGAACGCCTCTCTGGCGCTCAGGCGCCGGCCCTGTACGCGATTTCTCTGCTGGTGGTGTTCCTGTGCCTGGCGGCGCTGTACGAGAGCTGGTCAGTGCCGTTCTCGGTGATGCTGGTGGTGCCGCTGGGGGTGATTGGCGCCCTGCTGGCGACCTGGATGCGCGGGCTGGAGAATGACGTGTACTTCCAGGTGGGTCTGTTGACGGTGATCGGCCTGTCGGCGAAAAACGCCATTCTGATCGTCGAGTTCGCCAATGAGCTCAACGAGAAGGGCCAGGATCTGCTCAGCGCCACGCTGTCGGCTTGCCGTCAGCGCCTGCGCCCCATCCTGATGACCTCGCTGGCGTTCATCTTCGGCGTGCTGCCGATGGCGACCAGCACCGGCGCCGGTTCCGGCAGCCAGCATGCGGTCGGCACCGGAGTGATGGGCGGGATGATCTCCGCCACCGTGCTGGCGATCTTTTTCGTGCCGCTGTTCTTTGTGCTGGTGCGTCGCCGTTTTCCGCTAAAGGAGCGTCCGCAATAA,MANFFIDRPIFAWVLAILLCLTGTLAILSLPVEQYPDLAPPNVRITANYPGASAQTLENTVTQVIEQNMTGLDNLMYMSSQSSATGQATITLSFTAGTDPDEAVQQVQNQLQSAMRKLPQAVQNQGVTVRKTGDTNILTLAFVSTDGSMDKQDIADYVASNIQDPLSRVNGVGDIDAYGSQYSMRIWLDPAKLNSYQMTTKDVTDAISSQNAQIAVGQLGGTPSVDKQALNATINSQSLLQTPEQFRNITLRVNQDGSEVTLGDVATVEMGAEKYDYLSRYNRQPASGLGIKLASGANEMATAERVINRLNELAQFFPHGLEYKVAYETTSFVKASITDVVKTLLEAILLVFLVMYLFLQNFRATLIPTIAVPVVLMGTFAVLYACGYSINTLTMFAMVLAIGLLVDDAIVVVENVERIMSEEGLSPREATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGTTGAIYRQFSITIVAAMVLSVLVAMILTPALCATLLKPVKPGESHERKGFFGWFNRTFNRSASRYETFVGKILHRSLRWMLIYVLLLGGMVFLFLHLPTSFLPLEDRGMFTTSVQLPSGSTQQQTLKVVQKAEDYFLNNEKQNVESVFATVGSGPGGNGQNVARMFVRLKDWDQRDPQTGTSFAIIERATKAFNQINEARVIASSPPAISGLGSSAGFDMELEDHAGKGHDALMAARDTLLELAGKNPLLTRVRHNGLDDSPQLQVDIDQRKAQALGVSIDDINDTLQTAWGSSYVNDFMDRGRVKKVYVQAAAKYRMLPDDINLWYVRNSSGTMVPFSAFATSRWETGSPRLERYNGYSAVEIVGEAAPGISTGTAMDMMEKLAAQLPTGFGLEWTAMSYQERLSGAQAPALYAISLLVVFLCLAALYESWSVPFSVMLVVPLGVIGALLATWMRGLENDVYFQVGLLTVIGLSAKNAILIVEFANELNEKGQDLLSATLSACRQRLRPILMTSLAFIFGVLPMATSTGAGSGSQHAVGTGVMGGMISATVLAIFFVPLFFVLVRRRFPLKERPQ,MANFFIDRPIFAWVLAILLCLTGTLAIFSLPVEQYPDLAPPNVRVTANYPGASAQTLENTVTQVIEQNMTGLDNLMYMSSQSSGTGQASVTLSFKAGTDPDEAVQQVQNQLQSAMRKLPQAVQNQGVTVRKTGDTNILTIAFVSTDGSMDKQDIADYVASNIQDPLSRVNGVGDIDAYGSQYSMRIWLDPAKLNSFQMTAKDVTDAIESQNAQIAVGQLGGTPSVDKQALNATINAQSLLQTPEQFRDITLRVNQDGSEVRLGDVATVEMGAEKYDYLSRFNGKPASGLGVKLASGANEMATAELVLNRLDELAQYFPHGLEYKVAYETTSFVKASIEDVVKTLLEAIALVFLVMYLFLQNFRATLIPTIAVPVVLMGTFSVLYAFGYSVNTLTMFAMVLAIGLLVDDAIVVVENVERIMSEEGLTPREATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGTTGAIYRQFSITIVAAMVLSVLVAMILTPALCATLLKPLKKGEHHGQKGFFAWFNQMFNRNAERYEKGVAKILHRSLRWIVIYVLLLGGMVFLFLRLPTSFLPLEDRGMFTTSVQLPSGSTQQQTLKVVEQIEKYYFTHEKDNIMSVFATVGSGPGGNGQNVARMFIRLKDWSERDSKTGTSFAIIERATKAFNQIKEARVIASSPPAISGLGSSAGFDMELQDHAGAGHDALMAARNQLLALAAENPELTRVRHNGLDDSPQLQIDIDQRKAQALGVAIDDINDTLQTAWGSSYVNDFMDRGRVKKVYVQAAAPYRMLPDDINLWYVRNKDGGMVPFSAFATSRWETGSPRLERYNGYSAVEIVGEAAPGVSTGTAMDIMESLVKQLPNGFGLEWTAMSYQERLSGAQAPALYAISLLVVFLCLAALYESWSVPFSVMLVVPLGVIGALLATWMRGLENDVYFQVGLLTVIGLSAKNAILIVEFANEMNQKGHDLFEATLHACRQRLRPILMTSLAFIFGVLPMATSTGAGSGGQHAVGTGVMGGMISATILAIYFVPLFFVLVRRRFPLKPRPE,100,gnl|BL_ORD_ID|1309|hsp_num:0,1427,FALSE,None
LK583,1_372 # 422574 # 423296 # -1 # ID=1_372;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.606,1_372,422574,423296,-,Strict,450,457.218,baeR,92.08,3000828,protein homolog model,n/a,n/a,aminoglycoside antibiotic; aminocoumarin antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGACTGAATTGCCTGTAGATGAAAACACCCCACGCATCCTTATCGTGGAAGATGAACCGAAGCTCGGCCAGCTGCTGATTGATTATCTGCAGGCCGCCGGCTATGCGCCTACGCTGATTAACCACGGTGACAAGGTCCTGCCCTACGTTCGGCAGACGCCGCCGCATCTGATCCTGCTGGATCTGATGCTGCCCGGTACCGACGGTCTGACGCTGTGCCGGGAAATTCGCCGCTTCTCCGATGTTCCGGTGGTGATGGTGACGGCGAAAATCGAAGAGATCGACCGTTTGCTGGGGCTGGAAATAGGCGCCGACGACTATATCTGCAAGCCCTACAGCCCGCGGGAAGTGGTCGCCCGGGTAAAAACCATCCTCCGCCGCTGCAAGCCGCAGCGCGATCTGCAGGCGCTGGACGCCCAGAGCCCGCTGATTGTCGACGAAGGTCGTTTTCAGGCCTCCTGGCGCGACAAGCTGCTGGACCTCACTCCCGCCGAGTTCCGGCTGCTGAAAACCCTCTCCCAGGAGCCGGGCAAAGTGTTCTCCCGCGAACAGCTACTCAACCATCTGTATGACGATTATCGGGTAGTCACCGATCGCACCATCGACAGCCACATCAAGAACCTGCGGCGCAAGCTGGAGGCGCTGGACGCCGAGCAGTCGTTTATCCGCGCGGTGTATGGCGTTGGCTACCGCTGGGAAGCGGACGCCTGCCGGCTGGCGTAG,MTELPVDENTPRILIVEDEPKLGQLLIDYLQAAGYAPTLINHGDKVLPYVRQTPPHLILLDLMLPGTDGLTLCREIRRFSDVPVVMVTAKIEEIDRLLGLEIGADDYICKPYSPREVVARVKTILRRCKPQRDLQALDAQSPLIVDEGRFQASWRDKLLDLTPAEFRLLKTLSQEPGKVFSREQLLNHLYDDYRVVTDRTIDSHIKNLRRKLEALDAEQSFIRAVYGVGYRWEADACRLA,MTELPIDENTPRILIVEDEPKLGQLLIDYLRAASYAPTLISHGDQVLPYVRQTPPDLILLDLMLPGTDGLTLCREIRRFSDIPIVMVTAKIEEIDRLLGLEIGADDYICKPYSPREVVARVKTILRRCKPQRELQQQDAESPLIIDEGRFQASWRGKMLDLTPAEFRLLKTLSHEPGKVFSREQLLNHLYDDYRVVTDRTIDSHIKNLRRKLESLDAEQSFIRAVYGVGYRWEADACRIV,100,gnl|BL_ORD_ID|1231|hsp_num:0,1337,FALSE,None
LK583,1_375 # 426185 # 429262 # -1 # ID=1_375;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.637,1_375,426185,429262,-,Strict,1800,1862.81,mdtC,91.41,3000794,protein homolog model,n/a,n/a,aminocoumarin antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,GTGAAGTTTTTCGCCCTCTTCATTTACCGCCCGGTGGCGACGATCCTCATCTCGCTGGCCATCACCCTGTGCGGCATTCTCGGCTTCCGGCTGCTGCCGGTAGCCCCGCTGCCGCAGGTGGACTTCCCGGTGATCATGGTTAGCGCCTCGCTGCCGGGAGCCTCGCCGGAGACCATGGCCTCGTCGGTGGCCACCCCGCTGGAGCGCTCCCTGGGGCGGATTGCCGGGGTCAATGAGATGACCTCCTCCAGCTCGCTCGGCAGCACCCGCATCATTCTCGAGTTTAACTTCGACCGCGATATCAACGGCGCGGCGCGCGACGTTCAGGCGGCGATCAACGCCGCGCAAAGCCTGCTGCCGAGCGGAATGCCCAGCCGGCCGACCTATCGCAAAGCCAATCCGTCAGATGCGCCGATCATGATCCTGACGCTGACCTCGGACACCTACTCCCAGGGTGAGCTGTATGATTTCGCCTCCACCCAGCTGGCGCAGACCATCGCGCAGATCGACGGCGTGGGCGATGTCGACGTCGGCGGCAGCTCCCTGCCGGCGGTGCGCGTCGACCTCAACCCGCAGGCGCTGTTTAACCAGGGCGTGTCGCTGGACGCGGTGCGCACCGCCATCAGCGACGCCAACGTGCGCAAACCGCAGGGGGCGCTGGAGGACAGCGCGCACCGCTGGCAGGTGCAGACCAACGATGAGCTGAAGACCGCCGCCGACTATCAGCCGCTGATCGTCCACTATCAAAATGGCGCCGCGGTGCGGCTGGGAGATGTCGCCACCGTCTCGGATTCGGTGCAGGACGTACGCAATGCCGGGATGACCAACGCCAAACCGGCGATCCTGCTAATGATCCGCAAACTGCCGGAAGCCAATATTATCCAGACGGTGGACAGCATCCGCGCCCGCCTGCCGGAGCTGCAGCAGACCATTCCGGCGGCTATCGACCTGCAGATCGCCCAGGACCGCTCGCCGACCATCCGCGCCTCGCTGGAGGAGGTGGAGCAGACGCTGGTGATTTCGGTGGCGCTGGTGATCCTCGTGGTGTTCCTGTTCCTGCGCTCGGGGCGCGCCACACTGATCCCGGCCGTCGCCGTCCCGGTATCCTTAATCGGCACCTTCGCCGCGATGTATTTGTGCGGCTTCAGCCTCAATAACCTGTCGCTGATGGCCCTGACCATCGCCACCGGCTTCGTGGTGGATGACGCTATCGTGGTGCTGGAGAATATCTCCCGCCATCTGGAGGCGGGGATGAAACCTCTGCAGGCGGCGCTGCAGGGGAGCCGCGAGGTCGGCTTTACCGTGCTGTCGATGAGCCTGTCGCTGGTGGCGGTGTTTCTGCCGCTGCTGCTGATGTGCGGCCTGCCCGGCCGCCTGCTGCGCGAGTTCGCCGTCACCCTGTCGGTGGCGATCGGCATCTCGCTGGCGGTCTCCCTCACCCTGACGCCGATGATGTGCGGCTGGCTGCAGAAAAGCGGCAAGCCCCACCAGCCGACGCGCAACCGCGGCTTTGGCCGCCTGCTGGTGGCCGTGCAGGGCGGCTATGGTAAATCGTTAAAATGGGTGCTGAAGCATAGCCGCCTGACCGGCCTGGTGGTGCTGGGCACCATCGCCCTCAGCGTCTGGCTCTACATTTCGATCCCGAAAACCTTCTTCCCGGAGCAGGACACCGGGGTGCTGATGGGCGGCATTCAGGCCGACCAGAGCATCTCCTTCCAGGCGATGCGCGGCAAGCTGCAGGACTTTATGAAGATCATTCGCGAAGATCCGGCGGTGGATAACGTCACCGGCTTTACCGGCGGCTCGCGGGTCAACAGCGGGATGATGTTTATCACCCTCAAGCCGCGCGACCAGCGCCACGAGACGGCGCAGCAGGTGATCGACCGGCTGCGCAAAAAGCTGGCCAACGAGCCCGGGGCCAACCTGTTCCTGATGGCGGTGCAGGATATCCGCGTCGGCGGCCGGCAGTCGAACGCTAGCTATCAGTACACCCTGCTGTCCGACGACCTGTCGGCGCTGCGCGAGTGGGAGCCGAAGATCCGCAAAGCGCTGGCGGCGCTGCCGGAGCTGGCGGACGTCAACTCGGATCAGCAGGACAATGGCGCCGAAATGGACCTGGTCTATGACCGGGATACCATGTCGCGCCTCGGCATCAGCGTCCAGGACGCCAACAACCTGCTGAACAACGCCTTTGGCCAGCGGCAGATCTCTACCATCTACCAGCCGCTCAACCAGTATAAGGTGGTGATGGAGGTGGATCCGGCCTACACCCAGGACGTCAGCGCCCTGGATAAGATGTTCGTCATTAACAGCGACGGCAAGCCGATCCCGCTGGCCTACTTCGCCAAATGGCAGCCGGCCAATGCCCCGCTGTCGGTGAACCACCAGGGGCTGTCGGCGGCATCCACTATCTCCTTTAACCTGCCCACCGGCCGCTCGCTGTCGGAAGCCAGCGAGGCCATTGACCGCGCGATGACCCAGCTCGGGGTGCCGTCGAGCGTGCGCGGCTCCTTTGCCGGTACCGCTCAGGTGTTCCAGCAGACCATGAACGCGCAGGTGATCCTGATCCTCGCGGCTATCGCCACGGTCTATATCGTGCTGGGGGTGCTATATGAGAGCTATGTGCATCCGTTGACCATCCTCTCGACGCTGCCCTCCGCCGGGGTGGGCGCTCTGCTGGCGCTGGAGATCTTCGATGCCCCGTTCAGCCTAATCGCCCTGATTGGGATTATGTTATTAATTGGCATCGTTAAGAAAAACGCCATCATGATGGTTGATTTTGCCCTGGAGGCGCAGCGTAACGGCAACCTGACGCCGGAAGAGGCGATTTTCCAGGCCTGCCTGCTGCGTTTCCGGCCGATTATGATGACCACCCTCGCCGCGCTGTTCGGCGCCCTGCCGCTGGTGCTCTCCGGGGGCGATGGCTCTGAGCTGCGCCAGCCGCTGGGGATCACCATCGTCGGCGGTCTGGTGATGAGCCAGCTGTTAACGCTCTACACCACGCCGGTGGTCTATCTTTTCTTTGACCGTCTGCGGCTGCGTTTTTCGCGTCACTCCTCTCAACCGGTAAGCGAATAA,MKFFALFIYRPVATILISLAITLCGILGFRLLPVAPLPQVDFPVIMVSASLPGASPETMASSVATPLERSLGRIAGVNEMTSSSSLGSTRIILEFNFDRDINGAARDVQAAINAAQSLLPSGMPSRPTYRKANPSDAPIMILTLTSDTYSQGELYDFASTQLAQTIAQIDGVGDVDVGGSSLPAVRVDLNPQALFNQGVSLDAVRTAISDANVRKPQGALEDSAHRWQVQTNDELKTAADYQPLIVHYQNGAAVRLGDVATVSDSVQDVRNAGMTNAKPAILLMIRKLPEANIIQTVDSIRARLPELQQTIPAAIDLQIAQDRSPTIRASLEEVEQTLVISVALVILVVFLFLRSGRATLIPAVAVPVSLIGTFAAMYLCGFSLNNLSLMALTIATGFVVDDAIVVLENISRHLEAGMKPLQAALQGSREVGFTVLSMSLSLVAVFLPLLLMCGLPGRLLREFAVTLSVAIGISLAVSLTLTPMMCGWLQKSGKPHQPTRNRGFGRLLVAVQGGYGKSLKWVLKHSRLTGLVVLGTIALSVWLYISIPKTFFPEQDTGVLMGGIQADQSISFQAMRGKLQDFMKIIREDPAVDNVTGFTGGSRVNSGMMFITLKPRDQRHETAQQVIDRLRKKLANEPGANLFLMAVQDIRVGGRQSNASYQYTLLSDDLSALREWEPKIRKALAALPELADVNSDQQDNGAEMDLVYDRDTMSRLGISVQDANNLLNNAFGQRQISTIYQPLNQYKVVMEVDPAYTQDVSALDKMFVINSDGKPIPLAYFAKWQPANAPLSVNHQGLSAASTISFNLPTGRSLSEASEAIDRAMTQLGVPSSVRGSFAGTAQVFQQTMNAQVILILAAIATVYIVLGVLYESYVHPLTILSTLPSAGVGALLALEIFDAPFSLIALIGIMLLIGIVKKNAIMMVDFALEAQRNGNLTPEEAIFQACLLRFRPIMMTTLAALFGALPLVLSGGDGSELRQPLGITIVGGLVMSQLLTLYTTPVVYLFFDRLRLRFSRHSSQPVSE,MKFFALFIYRPVATILLSVAITLCGILGFRMLPVAPLPQVDFPVIIVSASLPGASPETMASSVATPLERSLGRIAGVSEMTSSSSLGSTRIILQFDFDRDINGAARDVQAAINAAQSLLPSGMPSRPTYRKANPSDAPIMILTLTSDTYSQGELYDFASTQLAPTISQIDGVGDVDVGGSSLPAVRVGLNPQALFNQGVSLDDVRTAVSNANVRKPQGALEDGTHRWQIQTNDELKTAAEYQPLIIHYNNGGAVRLGDVATVTDSVQDVRNAGMTNAKPAILLMIRKLPEANIIQTVDSIRAKLPELQETIPAAIDLQIAQDRSPTIRASLEEVEQTLIISVALVILVVFLFLRSGRATIIPAVSVPVSLIGTFAAMYLCGFSLNNLSLMALTIATGFVVDDAIVVLENIARHLEAGMKPLQAALQGTREVGFTVLSMSLSLVAVFLPLLLMGGLPGRLLREFAVTLSVAIGISLLVSLTLTPMMCGWMLKASKPREQKRLRGFGRMLVALQQGYGKSLKWVLNHTRLVGVVLLGTIALNIWLYISIPKTFFPEQDTGVLMGGIQADQSISFQAMRGKLQDFMKIIRDDPAVDNVTGFTGGSRVNSGMMFITLKPRDERSETAQQIIDRLRVKLAKEPGANLFLMAVQDIRVGGRQSNASYQYTLLSDDLAALREWEPKIRKKLATLPELADVNSDQQDNGAEMNLVYDRDTMARLGIDVQAANSLLNNAFGQRQISTIYQPMNQYKVVMEVDPRYTQDISALEKMFVINNEGKAIPLSYFAKWQPANAPLSVNHQGLSAASTISFNLPTGKSLSDASAAIDRAMTQLGVPSTVRGSFAGTAQVFQETMNSQVILIIAAIATVYIVLGILYESYVHPLTILSTLPSAGVGALLALELFNAPFSLIALIGIMLLIGIVKKNAIMMVDFALEAQRHGNLTPQEAIFQACLLRFRPIMMTTLAALFGALPLVLSGGDGSELRQPLGITIVGGLVMSQLLTLYTTPVVYLFFDRLRLRFSRKPKQTVTE,100,gnl|BL_ORD_ID|1212|hsp_num:0,1315,FALSE,None
LK583,1_376 # 429263 # 432385 # -1 # ID=1_376;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.647,1_376,429263,432385,-,Strict,1800,1832.38,mdtB,90,3000793,protein homolog model,n/a,n/a,aminocoumarin antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGCAGGTGTTACCCCCAGGCCGCACCGGCGGCCCGTCCCGGCTGTTTATTATGCGTCCGGTGGCCACCACTCTGCTGATGGTGGCTATCCTGCTGGCCGGGATCATCGGCTACCGCTTTCTGCCGGTCTCCGCCCTGCCGGAGGTCGATTACCCGACCATTCAGGTAGTCACCCTCTATCCGGGCGCCAGCCCGGACGTGGTGACCTCCGCCATCACCGCCCCGCTGGAGCGCCAGTTCGGCCAGATGTCAGGCCTCAAGCAGATGTCGTCGCAAAGCTCCGGCGGCGCCTCGGTAGTCACGCTGCAGTTCCAGCTGACCCTGCCGCTGGACGTCGCCGAGCAGGAAGTGCAGGCGGCCATTAACGCCGCCACCAACCTGCTGCCGAGCGATCTGCCCAACCCGCCGGTCTACAGCAAGGTGAACCCGGCGGATCCGCCGATCATGACTCTCGCCGTCACCTCCTCCGCCATCCCGATGACCCAGGTTGAGGACATGGTGGAGACCCGGGTGGCGCAGAAGATCTCCCAGGTTTCCGGCGTCGGTCTGGTGACCCTCGCCGGCGGCCAGCGCCCGGCGGTGCGGGTGAAGCTTAACGCCCAGGCCATCGCCGCCCTCGGCCTGACCAGCGAAACCGTGCGCACCGCTATCACCAGCGCCAACGTTAACTCCGCGAAAGGCAGCCTCGACGGTCCGGCCCGCGCGGTGACGCTTTCCGCTAACGATCAGATGCAGTCCGCTGAGGATTATCGCCGGCTGATTATCGCTTATCAGAACGGGGCGCCGATCCGGCTCGGCGATGTCGCCAGCGTCGAACAAGGGGCCGAAAACAGCTGGCTCGGGGCATGGGCCAACCAGCAGCGGGCCATCGTGATGAACGTCCAGCGCCAGCCGGGGGCCAACATCATCGACACCGCCGACAGCATTCGCCAGATGCTGCCGCAGCTCACCGAGAGCCTGCCGAAATCGGTGAAGGTGCAGGTCCTCTCCGACCGGACCACTAACATCCGCGCCTCGGTGCGCGACACCCAGTTTGAGCTGATGCTGGCCATCGCCCTGGTGGTGATGATCATCTATCTGTTCCTGCGCAACGTGCCGGCGACCATTATTCCCGGCGTCGCGGTGCCGCTGTCGCTGGTGGGCACTTTCGCGGTGATGGTGTTCCTCGACTTCTCGATCAACAACCTGACGCTGATGGCCCTGACCATCGCCACCGGCTTCGTGGTGGATGATGCCATCGTGGTGATCGAGAACATCTCGCGCTATATCGAAAAAGGCGAGAAGCCGCTGGCCGCCGCGCTGAAGGGCGCGGGGGAGATCGGCTTCACCATCATCTCCCTCACCTTCTCGCTGATCGCGGTGCTGATCCCGCTGCTGTTTATGGGCGATATCGTCGGCCGCCTGTTCCGCGAATTCGCCGTCACCCTTGCCGTCGCTATTCTTATCTCGGCGGTGGTCTCCCTGACCCTGACGCCGATGATGTGCGCCCGCATGTTAAGCCACGAATCGCTGCGTAAGCAGAACCGATTCTCGCGGGCCAGCGAGCGTTTCTTCGAACGGGTGATCGCCGTCTATGGCCGCTGGCTGAGCCGGGTGCTGAACCATCCGTGGCTGACGCTCGGCGTCGCCCTGAGCACCCTGGCGCTGTCGATTATCCTGTGGGTCTTTATCCCGAAAGGCTTTTTCCCGATCCAGGATAACGGCATTATCCAGGGTACCCTCCAGGCGCCGCAGTCGGTCTCCTTCGCCAGCATGGCCGAGCGCCAGCGGCAGGTGGCCAGCATTATCCTTAAGGATCCGGCGGTGGAGAGTCTGACCTCCTTCGTCGGCGTCGACGGCACCAACCCGGCGCTGAACAGCGCCCGTCTGCAGATCAACCTCAAGCCGCTGGATGAACGCGACGACCGCGTCCAGACGGTGATAAGCCGCCTGCAGCAGGCGGTGGACGGCGTCCCCGGCGTGGCGCTCTACCTGCAGCCGACCCAGGACCTGACCATCGACACCACGGTGAGCCGCACCCAGTATCAGTTCACCCTGCAGGCAAACTCCCTCGAGGCGCTGAGCACCTGGGTGCCGCCGCTGCTCAGCCGCCTGCAGGCCCAGCCGCAGCTGGCCGACGTCAGCAGCGACTGGCAGGACAAAGGCCTGGCCGCCTATATCAAGGTGGATCGCGACAGCGCCAGCCGCCTCGGCATCTCAATGGCCGATGTCGATAACGCGCTGTACAACGCCTTCGGCCAGCGGCTGATCTCCACTATTTACACTCAGGCGAATCAGTATCGCGTGGTGCTCGAGCAGGATACCGTGGCGACGCCGGGCCTGGCGGCGCTGGAGAATATCCGCCTCACCAGCAGCGACGGCGGCATCGTGCCGTTGACCGCCATCGCCACGGTGGAGCAGCGCTTTACCCCGCTGTCGGTGAACCACCTCGATCAGTTCCCGGTGACCACCATCTCGTTTAACGTCCCGGACAACTACTCGCTGGGCGAAGCGGTGGAGGCGATCCTCGCCGCCGAACAGTCGCTGGATTTCCCGACCGATATTCGCACCCAGTTCCAGGGCAGCTCGCTGGCCTTCCAGTCGGCGCTCGGCAGCACCGTCTGGCTGGTGGTCGCCGCGGTGGTGGCGATGTATATCGTGCTGGGGGTGCTGTACGAGAGCTTTATCCATCCGATCACGATTCTCTCCACCCTGCCCACCGCCGGGGTCGGGGCGCTGCTGGCGCTGTGGCTGGCGGGCAGCGAGCTGGACGTGATCGCCATCATCGGCATCATTCTGCTGATCGGCATCGTGAAGAAGAACGCCATCATGATGATCGACTTCGCGCTGGCCGCTGAGCGCGAGCAGGGCATGCCGCCGCGGGAAGCGATCTACCAGGCCTGTCTGCTGCGTTTTCGGCCGATCCTGATGACTACCCTCGCCGCCCTGCTCGGCGCCCTGCCGCTGATGCTGAGCACCGGCGTTGGCGCCGAGCTGCGGCGTCCGCTGGGGATCGGTATGGTCGGCGGTCTGATGCTCAGCCAGGTGCTGACCCTGTTCACCACCCCGGTGATCTATCTGCTGTTCGACCGCCTGTCGCTGCACCTGAAGCGCCGCTTCCCGCGTCAGGAAGAGGAGGCGTAA,MQVLPPGRTGGPSRLFIMRPVATTLLMVAILLAGIIGYRFLPVSALPEVDYPTIQVVTLYPGASPDVVTSAITAPLERQFGQMSGLKQMSSQSSGGASVVTLQFQLTLPLDVAEQEVQAAINAATNLLPSDLPNPPVYSKVNPADPPIMTLAVTSSAIPMTQVEDMVETRVAQKISQVSGVGLVTLAGGQRPAVRVKLNAQAIAALGLTSETVRTAITSANVNSAKGSLDGPARAVTLSANDQMQSAEDYRRLIIAYQNGAPIRLGDVASVEQGAENSWLGAWANQQRAIVMNVQRQPGANIIDTADSIRQMLPQLTESLPKSVKVQVLSDRTTNIRASVRDTQFELMLAIALVVMIIYLFLRNVPATIIPGVAVPLSLVGTFAVMVFLDFSINNLTLMALTIATGFVVDDAIVVIENISRYIEKGEKPLAAALKGAGEIGFTIISLTFSLIAVLIPLLFMGDIVGRLFREFAVTLAVAILISAVVSLTLTPMMCARMLSHESLRKQNRFSRASERFFERVIAVYGRWLSRVLNHPWLTLGVALSTLALSIILWVFIPKGFFPIQDNGIIQGTLQAPQSVSFASMAERQRQVASIILKDPAVESLTSFVGVDGTNPALNSARLQINLKPLDERDDRVQTVISRLQQAVDGVPGVALYLQPTQDLTIDTTVSRTQYQFTLQANSLEALSTWVPPLLSRLQAQPQLADVSSDWQDKGLAAYIKVDRDSASRLGISMADVDNALYNAFGQRLISTIYTQANQYRVVLEQDTVATPGLAALENIRLTSSDGGIVPLTAIATVEQRFTPLSVNHLDQFPVTTISFNVPDNYSLGEAVEAILAAEQSLDFPTDIRTQFQGSSLAFQSALGSTVWLVVAAVVAMYIVLGVLYESFIHPITILSTLPTAGVGALLALWLAGSELDVIAIIGIILLIGIVKKNAIMMIDFALAAEREQGMPPREAIYQACLLRFRPILMTTLAALLGALPLMLSTGVGAELRRPLGIGMVGGLMLSQVLTLFTTPVIYLLFDRLSLHLKRRFPRQEEEA,MQVLPPSSTGGPSRLFIMRPVATTLLMVAILLAGIIGYRALPVSALPEVDYPTIQVVTLYPGASPDVMTSAVTAPLERQFGQMSGLKQMSSQSSGGASVITLQFQLTLPLDVAEQEVQAAINAATNLLPSDLPNPPVYSKVNPADPPIMTLAVTSTAMPMTQVEDMVETRVAQKISQISGVGLVTLSGGQRPAVRVKLNAQAIAALGLTSETVRTAITGANVNSAKGSLDGPSRAVTLSANDQMQSAEEYRQLIIAYQNGAPIRLGDVATVEQGAENSWLGAWANKEQAIVMNVQRQPGANIISTADSIRQMLPQLTESLPKSVKVTVLSDRTTNIRASVDDTQFELMMAIALVVMIIYLFLRNIPATIIPGVAVPLSLIGTFAVMVFLDFSINNLTLMALTIATGFVVDDAIVVIENISRYIEKGEKPLAAALKGAGEIGFTIISLTFSLIAVLIPLLFMGDIVGRLFREFAITLAVAILISAVVSLTLTPMMCARMLSQESLRKQNRFSRASEKMFDRIIAAYGRGLAKVLNHPWLTLSVALSTLLLSVLLWVFIPKGFFPVQDNGIIQGTLQAPQSSSFANMAQRQRQVADVILQDPAVQSLTSFVGVDGTNPSLNSARLQINLKPLDERDDRVQKVIARLQTAVDKVPGVDLFLQPTQDLTIDTQVSRTQYQFTLQATSLDALSTWVPQLMEKLQQLPQLSDVSSDWQDKGLVAYVNVDRDSASRLGISMADVDNALYNAFGQRLISTIYTQANQYRVVLEHNTENTPGLAALDTIRLTSSDGGVVPLSSIAKIEQRFAPLSINHLDQFPVTTISFNVPDNYSLGDAVQAIMDTEKTLNLPVDITTQFQGSTLAFQSALGSTVWLIVAAVVAMYIVLGILYESFIHPITILSTLPTAGVGALLALLIAGSELDVIAIIGIILLIGIVKKNAIMMIDFALAAEREQGMSPREAIYQACLLRFRPILMTTLAALLGALPLMLSTGVGAELRRPLGIGMVGGLIVSQVLTLFTTPVIYLLFDRLALWTKSRFARHEEEA,100,gnl|BL_ORD_ID|757|hsp_num:0,820,FALSE,None
LK583,2_504 # 499985 # 500359 # 1 # ID=2_504;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.509,2_504,499985,500359,+,Strict,230,243.432,marA,92.74,3000263,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; penem; disinfecting agents and antiseptics,antibiotic efflux; reduced permeability to antibiotic,resistance-nodulation-cell division (RND) antibiotic efflux pump; General Bacterial Porin with reduced permeability to beta-lactams,ATGTCCAGACGTAATAATGACGCCATCACTATCCATAGTATTTTGTCGTGGATCGAGGATAACCTGGAATCGCCCCTGTCGCTGGAAAAAGTGTCTGAGCGCTCCGGTTACTCTAAGTGGCACCTGCAACGTATGTTTAAGAAAGAGACCGGCCATTCCCTCGGCCAATACATCCGCAGCCGCAAGCTGACGGAGATTGCGCAGAAGCTCAAGCAGAGCAATGAGCCAATCCTGTACCTGGCGGAACGCTATGGTTTCGAGTCGCAGCAGACCCTGACGCGAACGTTCAAGAACTATTTCGATGTTCCGCCCCACAAGTATCGCATAACGAATGTACCTGGCGAATCCCGCTATCTACATCCGCTAAATAACTGA,MSRRNNDAITIHSILSWIEDNLESPLSLEKVSERSGYSKWHLQRMFKKETGHSLGQYIRSRKLTEIAQKLKQSNEPILYLAERYGFESQQTLTRTFKNYFDVPPHKYRITNVPGESRYLHPLNN,MSRRNTDAITIHSILDWIEDNLESPLSLEKVSERSGYSKWHLQRMFKKETGHSLGQYIRSRKMTEIAQKLKESNEPILYLAERYGFESQQTLTRTFKNYFDVPPHKYRMTNMQGESRFLHPLNHYNS,97.64,gnl|BL_ORD_ID|1772|hsp_num:0,1922,FALSE,None
LK583,2_524 # 520462 # 521322 # 1 # ID=2_524;partial=00;start_type=ATG;rbs_motif=AGGA/GGAG/GAGG;rbs_spacer=11-12bp;gc_cont=0.628,2_524,520462,521322,+,Perfect,550,581.637,SHV-110,100,3001159,protein homolog model,n/a,n/a,carbapenem; cephalosporin; penam,antibiotic inactivation,SHV beta-lactamase,ATGCGTTATATTCGCCTGTGTATTATCTCCCTGTTAGCCACCCTGCCGCTGGCGGTACACGCCAGCCCGCAGCCGCTTGAGCAAATTAAACAAAGCGAAAGCCAGCTGTCGGGCCGCGTAGGCATGATAGAAATGGATCTGGCCAGCGGCCGCACGCTGACCGCCTGGCGCGCCGATGAACGCTTTCCCATGATGAGCACCTTTAAAGTAGTGCTCTGCGGCGCAGTGCTGGCGCGGGTGGATGCCGGTGACGAACAGCTGGAGCGAAAGATCCACTATCGCCAGCAGGATCTGGTGGACTACTCTCCGGTCAGCGAAAAACACCTTGCCGACGGCATGACGGTCGGCGAACTCTGTGCCGCCGCCATTACCATGAGCGATAACAGCGCCGCCAATCTGCTGCTGGCCACCGTCGGCGGCCCCGCAGGATTGACTGCCTTTTTGCGCCAGATCGACGACAACGTCACCCGCCTTGACCGCTGGGAAACGGAACTGAATGAGGCGCTTCCCGGCGACGCCCGCGACACCACTACCCCGGCCAGCATGGCCGCGACCCTGCGCAAGCTGCTGACCAGCCAGCGTCTGAGCGCCCGTTCGCAACGGCAGCTGCTGCAGTGGATGGTGGACGATCGGGTCGCCGGACCGTTGATCCGCTCCGTGCTGCCGGCGGGCTGGTTTATCGCCGATAAGACCGGAGCTGGCGAGCGGGGTGCGCGCGGGATTGTCGCCCTGCTTGGCCCGAATAACAAAGCAGAGCGCATTGTGGTGATTTATCTGCGGGATACGCCGGCGAGCATGGCCGAGCGAAATCAGCAAATCGCCGGGATCGGCGCGGCGCTGATCGAGCACTGGCAACGCTAA,MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADERFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAANLLLATVGGPAGLTAFLRQIDDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR,MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADERFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAANLLLATVGGPAGLTAFLRQIDDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR,100,gnl|BL_ORD_ID|1440|hsp_num:0,1573,FALSE,None
LK583,3_33 # 30610 # 31785 # 1 # ID=3_33;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.599,3_33,30610,31785,+,Perfect,670,798.119,oqxA,100,3003922,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; glycylcycline; tetracycline antibiotic; diaminopyrimidine antibiotic; nitrofuran antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGAGCCTGCAAAAAACCTGGGGAAACATTCACCTGACCGCGCTCGGCGCGATGATGCTCTCCTTTCTGCTCGTCGGCTGCGACGACAGCGTCGCGCAAAACGCTGCGCCTCCCGCCCCGACGGTCAGCGCCGCTAAGGTGCTGGTGAAGTCGATCAGTCAGTGGGATAGTTTTAACGGTCGCATTGAAGCGGTGGAGAGCGTTCAGCTTCGCCCTCGCGTCTCGGGATACATTGATAAAGTGAATTACACCGACGGCCAGGAGGTGAAAAAGGGCCAGGTGCTGTTCACGATAGATGACAGAACCTATCGCGCCGCGCTGGAGCAGGCGCAGGCGGCGTTGGCAAGAGCCAAAACGCAGGCCAGCCTGGCGCAAAGCGAGGCGAACCGCACCGATAAATTAGTCCATACCAACCTCGTCTCCCGTGAAGAGTGGGAGCAGCGCCGGTCAGCCGCGGTTCAGGCGCAGGCCGACATTCGCGCCGCGCAGGCGGCGGTGGATGCCGCGCAGCTTAACCTCGACTTCACCAAAGTGACCGCCCCTATTGACGGCCGCGCCAGCCGGGCGCTGATCACCAGCGGTAACCTGGTCACCGCGGGCGACACCGCCAGCGTGCTCACCACCCTGGTCTCGCAGAAGACGGTGTACGTCTACTTTGACGTCGACGAGTCAACCTACCTCCACTATCAAAACCTCGCCCGCCGCGGGCAAGGCGCGTCCAGCGATAATCAGGCGCTTCCGGTGGAGATTGGCCTGGTTGGCGAGGAGGGTTACCCCCACCAGGGCAAAGTGGATTTTCTCGATAATCAGTTAACGCCGAGTACCGGCACCATCCGCATGCGTGCGCTGCTGGATAACTCGCAGCGTCTGTTCACGCCAGGGCTGTTTGCCCGCGTGCGTCTGCCGGGCAGCGCAGAGTTCAAAGCCACGCTTATCGACGACAAAGCGGTACTGACCGATCAGGATCGTAAATACGTCTATATCGTTGATAAAGATGGTAAAGCACAGCGCCGCGACATTACCCCAGGGCGGCTGGCAGACGGTTTACGCATCGTTCAGAAGGGGTTGAATCCTGGGGATAGCGTCATCGTCGACGGCTTACAAAAAGTGTTTATGCCGGGTATGCCGGTTAACGCCAAAACCGTTGCCATGACCTCCAGCGCCACCCTTAACTGA,MSLQKTWGNIHLTALGAMMLSFLLVGCDDSVAQNAAPPAPTVSAAKVLVKSISQWDSFNGRIEAVESVQLRPRVSGYIDKVNYTDGQEVKKGQVLFTIDDRTYRAALEQAQAALARAKTQASLAQSEANRTDKLVHTNLVSREEWEQRRSAAVQAQADIRAAQAAVDAAQLNLDFTKVTAPIDGRASRALITSGNLVTAGDTASVLTTLVSQKTVYVYFDVDESTYLHYQNLARRGQGASSDNQALPVEIGLVGEEGYPHQGKVDFLDNQLTPSTGTIRMRALLDNSQRLFTPGLFARVRLPGSAEFKATLIDDKAVLTDQDRKYVYIVDKDGKAQRRDITPGRLADGLRIVQKGLNPGDSVIVDGLQKVFMPGMPVNAKTVAMTSSATLN,MSLQKTWGNIHLTALGAMMLSFLLVGCDDSVAQNAAPPAPTVSAAKVLVKSISQWDSFNGRIEAVESVQLRPRVSGYIDKVNYTDGQEVKKGQVLFTIDDRTYRAALEQAQAALARAKTQASLAQSEANRTDKLVHTNLVSREEWEQRRSAAVQAQADIRAAQAAVDAAQLNLDFTKVTAPIDGRASRALITSGNLVTAGDTASVLTTLVSQKTVYVYFDVDESTYLHYQNLARRGQGASSDNQALPVEIGLVGEEGYPHQGKVDFLDNQLTPSTGTIRMRALLDNSQRLFTPGLFARVRLPGSAEFKATLIDDKAVLTDQDRKYVYIVDKDGKAQRRDITPGRLADGLRIVQKGLNPGDSVIVDGLQKVFMPGMPVNAKTVAMTSSATLN,100,gnl|BL_ORD_ID|2153|hsp_num:0,2399,FALSE,None
LK583,3_34 # 31809 # 34961 # 1 # ID=3_34;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.612,3_34,31809,34961,+,Strict,2000,2114.73,oqxB,99.81,3003923,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; glycylcycline; tetracycline antibiotic; diaminopyrimidine antibiotic; nitrofuran antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGGACTTTTCCCGCTTTTTTATCGACAGGCCGATTTTCGCCGCGGTGCTGTCGATTTTAATTTTTATCACCGGGTTAATCGCTATCCCACTGCTGCCGGTGAGCGAATATCCGGATGTCGTCCCGCCGAGCGTCCAGGTGCGCGCGGAATATCCCGGCGCCAACCCGAAAGTGATTGCCGAGACCGTGGCGACGCCGCTGGAGGAAGCGATCAACGGCGTTGAAAACATGATGTACATGAAATCGGTCGCCGGCTCCGACGGCGTGCTGGTCACCACCGTCACCTTCCGCCCGGGTACCGACCCGGATCAGGCGCAGGTTCAGGTGCAGAACCGCGTCGCGCAGGCCGAAGCGCGTCTGCCGGAGGATGTACGCCGTCTGGGGATCACCACCCAGAAGCAGTCTCCGACGCTGACCCTGGTGGTGCATCTGTTTTCGCCAAACGGTAAGTACGACTCGCTGTATATGCGCAACTACGCCACGCTGAAAGTGAAGGATGAGCTGGCGCGCCTGCCCGGCGTCGGCCAGATCCAGATTTTTGGCTCCGGTGAATATGCGATGCGCGTCTGGCTGGATCCCAATAAGGTCGCGGCCCGCGGTCTGACGGCTTCGGATGTGGTGACGGCGATGCAGGAGCAAAACGTCCAGGTGTCTGCCGGACAGCTTGGCGCCGAGCCGCTGCCGCAGGAGAGCGATTTCCTGATCTCCATTAACGCCCAGGGCCGTCTGCATACCGAAGAAGAGTTTGGCAATATCATTCTGAAAACGGCGCAGGACGGCTCGCTGGTCCGCCTGCGCGACGTGGCGCGCATCGAGATGGGTTCCGGTAGCTATGCGCTGCGCTCCCAGCTCAACAATAAGGATGCGGTCGGGATCGGTATCTTCCAGTCACCCGGCGCTAACGCCATCGATCTGTCGAACGCGGTACGCGCCAAAATGGCCGAGCTGGCCACCCGCTTCCCGGAAGATATGCAATGGGCGGCGCCGTACGACCCGACGGTTTTCGTCCGCGACTCCATCCGCGCGGTGGTGCAGACGCTGCTGGAGGCGGTAGTGCTGGTGGTGCTGGTAGTGATCCTGTTCCTGCAGACCTGGCGCGCGTCGATTATCCCGCTGATCGCCGTGCCGGTATCGGTGGTGGGTACCTTCAGCATTCTCTATCTGCTGGGCTTCTCGCTGAATACCCTGAGCCTGTTCGGGCTGGTACTGGCTATCGGTATCGTGGTGGACGACGCCATCGTGGTGGTGGAGAACGTCGAGCGTAATATCGAAGAGGGGCTTGCGCCGCTTGCCGCGGCGCATCAGGCGATGCGTGAGGTCTCCGGGCCGATTATCGCCATTGCGCTGGTGCTGTGTGCGGTGTTCGTGCCGATGGCGTTTCTCTCCGGGGTCACCGGCCAGTTCTACAAACAGTTCGCGGTGACCATCGCCATCTCGACGGTGATCTCGGCCATCAACTCGCTGACGCTCTCCCCGGCGCTGGCGGCCCTGCTGTTAAAGCCGCACGGCGCGAAGAAAGACCTCCCTACCCGGCTGATCGATCGCCTGTTTGGCTGGATTTTCCGTCCGTTTAACCGCTTTTTCCTGCGCAGCTCGAACGGCTATCAGGGACTGGTAGGCAAAACGCTTGGACGCCGTGGCGCAGTGTTTGCGGTGTACCTGCTGCTGCTCTGCGCCGCTGGGGTGATGTTTAAAGTCGTCCCCGGCGGGTTTATTCCCACCCAGGATAAGTTGTATCTCATTGGCGGCGTGAAGATGCCGGAAGGGTCGTCGCTGGCGCGCACCGACGCGGTGATCCGCAAAATGAGCGAGATCGGGATGAATACCGAAGGGGTCGACTATGCGGTCGCTTTCCCGGGGCTTAACGCGCTGCAGTTCACCAACACGCCGAATACCGGGACGGTCTTTTTTGGCCTGAAACCGTTCGACCAGCGCAAACACACGGCGGCGGAAATTAACGCGGAGATCAACGCCAAAATCGCGCAAATCCAGCAGGGCTTTGGCTTCTCCATCCTGCCGCCGCCGATTTTAGGACTGGGTCAGGGTTCCGGCTACTCCCTGTACATCCAGGATCGCGGAGGGCTGGGCTATGGCGCGCTGCAAAGCGCGGTGAATGCGATGTCCGGGGCGATTATGCAAACGCCGGGGATGCACTTCCCGATCTCGACTTACCAGGCTAACGTGCCGCAGCTGGACGTGCAGGTCGATCGCGATAAGGCGAAAGCGCAGGGGGTATCGCTAACCGAGCTATTCGGTACGCTGCAGACCTATCTCGGCTCGTCTTATGTCAATGACTTTAACCAGTTCGGGCGTACCTGGCGCGTGATGGCCCAGGCCGATGGGCCATACCGCGAGAGCGTGGAAGATATCGCCAATCTGCGCACCCGCAATAATCAAGGCGAAATGGTGCCGATCGGCAGTATGGTGAATATCAGTACCACCTACGGGCCGGATCCGGTGATCCGCTACAACGGTTATCCGGCGGCGGACCTGATTGGCGATGCCGATCCGCGGGTCCTCTCTTCTTCGCAGGCGATGACGCATCTGGAGGAGCTGTCAAAGCAGATCCTGCCGAATGGGATGAATATTGAGTGGACGGATCTCAGCTTCCAGCAGGCCACCCAGGGCAACACGGCGCTGATCGTCTTCCCGGTGGCGGTGCTGCTGGCGTTCCTCGTGCTGGCCGCGCTGTATGAAAGCTGGACCCTGCCGCTGGCAGTGATCCTTATCGTGCCGATGACGATGCTCTCCGCGCTGTTTGGTGTCTGGCTGACCGGGGGCGATAACAACGTCTTCGTGCAGGTGGGGCTGGTGGTCCTGATGGGCCTGGCCTGTAAAAACGCCATTCTGATCGTCGAGTTTGCCCGCGAGCTGGAGATCCAGGGGAAAGGCATCATGGAAGCCGCCCTGGAGGCGTGCCGCCTGCGTCTGCGCCCGATCGTGATGACCTCCATCGCCTTTATCGCCGGGACCATTCCGCTGATCCTCGGCCACGGCGCGGGGGCGGAAGTCCGCGGCGTCACCGGGATCACGGTGTTCTCCGGGATGCTGGGCGTGACGCTCTTCGGTCTGTTCCTGACGCCGGTGTTTTACGTGACGCTGCGGAAACTGGTGACCCGCAGGAAGCCGGTCCAGGAGGATCTGCCCGCCTAG,MDFSRFFIDRPIFAAVLSILIFITGLIAIPLLPVSEYPDVVPPSVQVRAEYPGANPKVIAETVATPLEEAINGVENMMYMKSVAGSDGVLVTTVTFRPGTDPDQAQVQVQNRVAQAEARLPEDVRRLGITTQKQSPTLTLVVHLFSPNGKYDSLYMRNYATLKVKDELARLPGVGQIQIFGSGEYAMRVWLDPNKVAARGLTASDVVTAMQEQNVQVSAGQLGAEPLPQESDFLISINAQGRLHTEEEFGNIILKTAQDGSLVRLRDVARIEMGSGSYALRSQLNNKDAVGIGIFQSPGANAIDLSNAVRAKMAELATRFPEDMQWAAPYDPTVFVRDSIRAVVQTLLEAVVLVVLVVILFLQTWRASIIPLIAVPVSVVGTFSILYLLGFSLNTLSLFGLVLAIGIVVDDAIVVVENVERNIEEGLAPLAAAHQAMREVSGPIIAIALVLCAVFVPMAFLSGVTGQFYKQFAVTIAISTVISAINSLTLSPALAALLLKPHGAKKDLPTRLIDRLFGWIFRPFNRFFLRSSNGYQGLVGKTLGRRGAVFAVYLLLLCAAGVMFKVVPGGFIPTQDKLYLIGGVKMPEGSSLARTDAVIRKMSEIGMNTEGVDYAVAFPGLNALQFTNTPNTGTVFFGLKPFDQRKHTAAEINAEINAKIAQIQQGFGFSILPPPILGLGQGSGYSLYIQDRGGLGYGALQSAVNAMSGAIMQTPGMHFPISTYQANVPQLDVQVDRDKAKAQGVSLTELFGTLQTYLGSSYVNDFNQFGRTWRVMAQADGPYRESVEDIANLRTRNNQGEMVPIGSMVNISTTYGPDPVIRYNGYPAADLIGDADPRVLSSSQAMTHLEELSKQILPNGMNIEWTDLSFQQATQGNTALIVFPVAVLLAFLVLAALYESWTLPLAVILIVPMTMLSALFGVWLTGGDNNVFVQVGLVVLMGLACKNAILIVEFARELEIQGKGIMEAALEACRLRLRPIVMTSIAFIAGTIPLILGHGAGAEVRGVTGITVFSGMLGVTLFGLFLTPVFYVTLRKLVTRRKPVQEDLPA,MDFSRFFIDRPIFAAVLSILIFITGLIAIPLLPVSEYPDVVPPSVQVRAEYPGANPKVIAETVATPLEEAINGVENMMYMKSVAGSDGVLVTTVTFRPGTDPDQAQVQVQNRVAQAEARLPEDVRRLGITTQKQSPTLTLVVHLFSPGGKYDSLYMRNYATLKVKDELARLPGVGQIQIFGSGEYAMRVWLDPNKVAARGLTASDVVTAMQEQNVQVSAGQLGAEPLPQESDFLISINAQGRLHTEEEFGNIILKTAQDGSLVRLRDVARIEMGSGSYALRSQLNNKDAVGIGIFQSPGANAIDLSNAVRAKMAELATRFPEDMQWAAPYDPTVFVRDSIRAVVQTLLEAVVLVVLVVILFLQTWRASIIPLIAVPVSVVGTFSILYLLGFSLNTLSLFGLVLAIGIVVDDAIVVVENVERNIEEGLAPLAAAHQAMREVSGPIIAIALVLCAVFVPMAFLSGVTGQFYKQFAVTIAISTVISAINSLTLSPALAALLLKPHGAKKDLPTRLIDRLFGWIFRPFNRFFLRSSNGYQGLVGKTLGRRGAVFAVYLLLLCAAGVMFKVVPGGFIPTQDKLYLIGGVKMPEGSSLARTDAVIRKMSEIGMNTEGVDYAVAFPGLNALQFTNTPNTGTVFFGLKPFDQRKHTAAEINAEINAKIAQIQQGFGFSILPPPILGLGQGSGYSLYIQDRGGLGYGALQSAVNAMSGAIMQTPGMHFPISTYQANVPQLDVQVDRDKAKAQGVSLTDLFGTLQTYLGSSYVNDFNQFGRTWRVMAQADGPYRESVEDIANLRTRNNQGEMVPIGSMVNISTTYGPDPVIRYNGYPAADLIGDADPRVLSSSQAMTHLEELSKQILPNGMNIEWTDLSFQQATQGNTALIVFPVAVLLAFLVLAALYESWTLPLAVILIVPMTMLSALFGVWLTGGDNNVFVQVGLVVLMGLACKNAILIVEFARELEIQGKGIMEAALEACRLRLRPIVMTSIAFIAGTIPLILGHGAGAEVRGVTGITVFSGMLGVTLFGLFLTPVFYVTLRKLVTRRKPVQEDLPA,100,gnl|BL_ORD_ID|2154|hsp_num:0,2400,FALSE,None
LK583,3_79 # 79216 # 79746 # 1 # ID=3_79;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.520,3_79,79216,79746,+,Strict,280,338.961,emrR,92.57,3000516,protein homolog model,n/a,n/a,fluoroquinolone antibiotic,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGGATAGTTCGTTTACTCCCATTGAGCAAATGCTCAAGTTCCGCGCCAGCCGCCATGAAGATTTCCCGTTTCAGGAGATCCTGTTAACTCGTCTTTGCATGCATATGCAAGGTAAGCTGCTGGAAAATCGCAATAAAATGCTCAAAGCGCAGGGAATTAACGAGACATTATTTATGGCGCTGATTACGCTGGAGTCACAGGAAAACCACAGCATCCAGCCGTCCGAGCTGAGCTGTGCGCTGGGCTCGTCACGTACCAACGCCACCCGTATCGCTGATGAACTGGAAAAACGCGGCTGGATTGAGCGCCGCGAGAGCGATAACGATCGTCGCTGTTTGCATCTGCAACTGACCGAAAAGGGCCATCAGTTTTTGCGTGAAGTCCTGCCGCCGCAGCATAACTGCCTGCATCAGCTGTGGTCTTCACTTAGCACCAGCGAAAAAGATCAGCTCGAACACATCACCCGCAAACTCCTGAGCCGCCTTGATCAGATGGAAGAAGAAGGCGTGCTAGCGGACTCTCTACGCTAA,MDSSFTPIEQMLKFRASRHEDFPFQEILLTRLCMHMQGKLLENRNKMLKAQGINETLFMALITLESQENHSIQPSELSCALGSSRTNATRIADELEKRGWIERRESDNDRRCLHLQLTEKGHQFLREVLPPQHNCLHQLWSSLSTSEKDQLEHITRKLLSRLDQMEEEGVLADSLR,MDSSFTPIEQMLKFRASRHEDFPYQEILLTRLCMHMQSKLLENRNKMLKAQGINETLFMALITLESQENHSIQPSELSCALGSSRTNATRIADELEKRGWIERRESDNDRRCLHLQLTEKGHEFLREVLPPQHNCLHQLWSALSTTEKDQLEQITRKLLSRLDQMEQDGVVLEAMS,100,gnl|BL_ORD_ID|1225|hsp_num:0,1330,FALSE,None
LK583,3_80 # 79872 # 81044 # 1 # ID=3_80;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.590,3_80,79872,81044,+,Strict,700,788.875,Klebsiella pneumoniae KpnG,99.74,3004588,protein homolog model,n/a,n/a,macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; cephalosporin; penam; peptide antibiotic; penem,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGAGTGCAAATGCGGAGAGCCAAACCCCGCAGCAACCAGGCAGCAAAAAAGGAAAGCGTAAAGGCGCCCTTCTGTTGTTGACATTGCTCTTCATTATTATTGCCGTGGCATATGGGATTTACTGGTTTCTGGTACTGCGTCACTACGAAGAGACCGACGATGCCTACGTGGCAGGGAATCAGGTACAAATTATGGCTCAGGTCGCGGGCAGCGTGACCAAAGTCTGGGCTGACAACACGGACTACGTGCAGAAAGGCGATCCGCTGGTCACGCTCGATCGGACCGATGCCCAACAGGCGTTTGAAAAGGCTAAGACCCAACTGGCCGCCAGCGTGCGTCAGACCCGCCAGCAGATGATCAACAGCAAGCAGCTGCAGGCAAATATCGACGTCAAAAAAACCGCCCTCGCCCAGGCGCAGGCTGACCTGAACCGCCGCATCCCGCTGGGCGCCGCGAACCTCATTGGCCGCGAAGAGCTGCAGCACGCCCGCGATACCGTCGCCAGCGCACAGGCCGAACTCGACGTGGCAATCCAGCAGTACAACGCCAACCAGGCGATCGTGCTGGGCACCAGGCTGGAACAGCAGCCGGCGGTGCTCCAGGCGGCCACTGAAGTGCGTAACGCCTGGCTGGCCCTGCAGCGTACGCAGATCGTCAGCCCGATTAGCGGCTACGTTTCCCGTCGCTCGGTACAGCCTGGCGCGCAGATCGGCACCACCACGCCGCTGATGGCGGTGGTCCCGGCGACCAACCTGTGGATCGATGCTAACTTTAAAGAGACTCAGCTGGCGCATATGCGTATCGGCCAGCCGGCCACCGTGATCAGCGATATCTATGGCGATGACGTGAAATACACCGGTAAAGTGGTCGGTCTGGATATGGGCACCGGCAGCGCCTTCTCTCTGCTGCCGGCGCAGAATGCTACCGGCAACTGGATCAAAGTGGTACAGCGTTTGCCGGTTCGTATCGAGCTGGATGAAAAACAACTAGCGGAACACCCGCTGCGCATCGGCCTCTCGACGCTGGTGGAAGTCAACACCACCGATCGCGATGGTGAAATGCTGGCAAGCCAGGTGCGGAGCTCCCCGGTTTACGAGAGCAATGCCCGTGAAATCGCTCTCGATCCGGTTAATAAGCTGATAGACGAGATCATTCAGGCCAACGCCGGATAA,MSANAESQTPQQPGSKKGKRKGALLLLTLLFIIIAVAYGIYWFLVLRHYEETDDAYVAGNQVQIMAQVAGSVTKVWADNTDYVQKGDPLVTLDRTDAQQAFEKAKTQLAASVRQTRQQMINSKQLQANIDVKKTALAQAQADLNRRIPLGAANLIGREELQHARDTVASAQAELDVAIQQYNANQAIVLGTRLEQQPAVLQAATEVRNAWLALQRTQIVSPISGYVSRRSVQPGAQIGTTTPLMAVVPATNLWIDANFKETQLAHMRIGQPATVISDIYGDDVKYTGKVVGLDMGTGSAFSLLPAQNATGNWIKVVQRLPVRIELDEKQLAEHPLRIGLSTLVEVNTTDRDGEMLASQVRSSPVYESNAREIALDPVNKLIDEIIQANAG,MSANAESQTPQQPGSKKGKRKGALLLLTLLFIIIAVAYGIYWFLVLRHYEETDDAYVAGNQVQIMAQVAGSVTKVWADNTDYVQKGDPLVTLDRTDAQQAFEKAKTQLAASVRQTRQQMINSKQLQANIDVKKTALSQAQADLNRRIPLGAANLIGREELQHARDTVASAQAELDVAIQQYNANQAIVLGTRLEQQPAVLQAATEVRNAWLALQRTQIVSPISGYVSRRSVQPGAQIGTTTPLMAVVPATNLWIDANFKETQLAHMRIGQPATVISDIYGDDVKYTGKVVGLDMGTGSAFSLLPAQNATGNWIKVVQRLPVRIELDEKQLAEHPLRIGLSTLVEVNTTDRDGEMLASQVRSSPVYESNAREIALDPVNKLIDEIIQANAG,100,gnl|BL_ORD_ID|2733|hsp_num:0,3298,FALSE,None
LK583,3_81 # 81060 # 82598 # 1 # ID=3_81;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=3-4bp;gc_cont=0.611,3_81,81060,82598,+,Strict,700,937.947,Klebsiella pneumoniae KpnH,94.02,3004597,protein homolog model,n/a,n/a,macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; cephalosporin; penam; peptide antibiotic; penem,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGCAACAGCAAAAACCGCTGGAAGGCGCGCAGCTGGTCATTATGACCATTGCGCTGTCGCTCGCGACGTTCATGCAGGTGCTGGATTCCACTATCGCCAACGTGGCGATCCCGACCATTGCCGGCAACCTTGGCTCGTCGCTGAGCCAGGGGACCTGGGTCATCACCTCGTTCGGGGTCGCTAACGCCATCTCCATCCCGATCACCGGCTGGCTGGCCAAGCGCGTCGGCGAGGTGAAGCTGTTCCTGTGGTCAACCACCGCCTTCGCCATTGCCTCCTGGGCCTGCGGCGTCTCCAACAGCCTGACGATGCTGATTTTCTTCCGCGTCATTCAGGGGATCGTCGCCGGACCGCTGATCCCGCTGTCGCAAAGTCTGCTGCTCAGCAACTATCCCCCGGCGAAGCGCTCTATCGCTCTGGCGCTGTGGTCGATGACGGTGATTGTCGCACCCATCTGCGGTCCGATCCTTGGCGGCTATATCAGCGATAACTATCACTGGGGCTGGATCTTCTTTATCAACGTGCCCATTGGCGTGGCGGTGGTGCTGATGACCCTGCAGACCCTGCGCAACCGGGAAACCAAAACCGAACAGCGGCGGATCGACGGCGTCGGTCTGGCGCTGCTGATCATCGGTATCGGTAGCCTGCAGGTGATGCTGGACCGGGGTAAAGAGCTGGACTGGTTCTCCTCCAATGAGATTATCATTCTGACCATCGTGGCGGTGGTGGCGATAAGCTTCCTGATCGTCTGGGAGCTAACCGACGATAACCCGATTGTCGATCTGTCGCTATTTAAGTCGCGCAACTTCACCATCGGCTGCCTCTGTATCAGTCTGGCCTATATGCTCTACTTCGGCGCCATCGTGCTGCTGCCGCAGCTGTTGCAGGAGGTATACGGCTACACCGCGACCTGGGCCGGCCTGGCGTCGGCGCCGGTGGGGGTGATCCCGGTCATTCTGTCGCCGATTATCGGCCGCTTCGCGCATAAGCTCGACATGCGGCGGCTGGTCACCTTCAGCTTTATTATGTACGCGGTCTGCTTCTACTGGCGCGCCTGGACCTTCGAACCGGGGATGGACTTTGGCGCCTCGGCGTGGCCACAGTTTATCCAGGGCTTCGCGGTGGCCTGCTTCTTCATGCCGTTGACCACCATCACCCTCTCCGGCCTGCCGCCGGAGCGGCTGGCGGCGGCGTCGAGCCTGTCGAACTTCACCCGTACCCTTGCCGGCTCCATCGGGACCTCGATCACCACCACCCTGTGGACCAACCGCGAGGCGCTGCATCATGCGCAGCTCACCGAATCGGTGACCCCCTTTAACCCCAACGCGCAGCAGATATACGATCAGCTGCAGGGCATGGGAATGACGCAGCAGCAGGCGTCCGGCTGGATAGCGCAGCAGATAACCAACCAGGGGCTCATTATCTCCGCCAACGAAATCTTCTGGATTTCTGCGGCTATTTTCATCCTGCTGTTGGGGCTGGTGTGGTTCGCCAGACCACCGTTCAGCGCCGGCGGAGGCGGCGGCGGCGCGCACTAA,MQQQKPLEGAQLVIMTIALSLATFMQVLDSTIANVAIPTIAGNLGSSLSQGTWVITSFGVANAISIPITGWLAKRVGEVKLFLWSTTAFAIASWACGVSNSLTMLIFFRVIQGIVAGPLIPLSQSLLLSNYPPAKRSIALALWSMTVIVAPICGPILGGYISDNYHWGWIFFINVPIGVAVVLMTLQTLRNRETKTEQRRIDGVGLALLIIGIGSLQVMLDRGKELDWFSSNEIIILTIVAVVAISFLIVWELTDDNPIVDLSLFKSRNFTIGCLCISLAYMLYFGAIVLLPQLLQEVYGYTATWAGLASAPVGVIPVILSPIIGRFAHKLDMRRLVTFSFIMYAVCFYWRAWTFEPGMDFGASAWPQFIQGFAVACFFMPLTTITLSGLPPERLAAASSLSNFTRTLAGSIGTSITTTLWTNREALHHAQLTESVTPFNPNAQQIYDQLQGMGMTQQQASGWIAQQITNQGLIISANEIFWISAAIFILLLGLVWFARPPFSAGGGGGGAH,MQQQKPLEGAQLVIMTIALSLATFMQVLDSTIANVAIPTIAGNLGSSLSQGTWVITSFGVANAISIPLTGWLAKRVGEVKLFLWSTIAFAIASWACGVSSSLNMLIFFRVIQGIVAGPLIPLSQSLLLNNYPPAKRSIALALWSMTVIVAPICGPILGGYISDNYHWGWIFFINVPIGVAVVLMTLQTLRGRETRTERRRIDAVGLALLVIGIGSLQIMLDRGKELDWFSSQEIIILTVVAVVAICFLIVWELTDDNPIVDLSLFKSRNFTIGCLCISLAYMLYFGAIVLLPQLLQEVYGYTATWAGLASAPVGIIPVILSPIIGRFAHKLDMRRLVTFSFIMYAVCFYWRAYTFEPGMDFGASAWPQFIQGFAVACFFMPLTTITLSGLPPERLAAASSLSNFTRTLAGSIGTSITTTMWTNRESMHHAQLTESVNPFNPNAQAMYSQLEGLGMTQQQASGWIAQQITNQGLIISANEIFWMSAGIFLILLGLVWFAKPPFGAGGGGGGAH,100,gnl|BL_ORD_ID|2734|hsp_num:0,3299,FALSE,None
LK583,3_89 # 90457 # 90642 # -1 # ID=3_89;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.478,3_89,90457,90642,-,Strict,100,109.383,rsmA,85.25,3005069,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGCTGATTCTGACTCGTCGAGTTGGTGAGACCCTCATGATTGGAGATGAGGTCACTGTGACAGTTTTAGGGGTGAAGGGTAACCAGGTTCGTATTGGCGTAAACGCCCCTAAAGAAGTGTCTGTTCACCGTGAAGAGATCTACCAGCGTATTCAGGCTGAAAAATCCCAGCAGTCCAGTTACTAA,MLILTRRVGETLMIGDEVTVTVLGVKGNQVRIGVNAPKEVSVHREEIYQRIQAEKSQQSSY,MLILTRRVGETLMVGDDVTVTVLGVKGNQVRIGVNAPKEVAVHREEIYQRIQKEKDQEPNH,100,gnl|BL_ORD_ID|2794|hsp_num:0,3807,FALSE,None
LK583,4_134 # 140590 # 142263 # 1 # ID=4_134;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.571,4_134,140590,142263,+,Strict,1000,1160.98,eptB,99.46,3005047,protein homolog model,n/a,n/a,peptide antibiotic,antibiotic target alteration,pmr phosphoethanolamine transferase,ATGAAATATATTAGAACGATGACGCAGCAGAAGCTTAGTTTTTGGCTGGCGCTGTACATCGGCTGGTTTATGAACGTCGCCGTTTTTTTCCGGCGTTTCGATGGTTATGCTCAAGAGTTCACTTTCTGGAAAGGGCTTTCCGGTGTTGTTGAACTGGTTGCCACGGTATTTGTCACCTTCTTCCTGTTACGTCTTCTGTCGCTGTTCGGCCGCCGTATCTGGCGCATTCTGGCGACGCTGATTGTCCTGTTTTCCGCCGCGGCGAGTTACTACATGACGTTCCTCAATGTGGTGATTGGCTACGGGATTATCGCTTCGGTGATGACCACCGATATCGACCTGTCGAAAGAGGTCATCGGCTGGCACCTGATCCTCTGGCTGGTGGCGGTGAGCGCGCCGCCGTTGCTGTTCATCTGGAGCAACCGCTGCCGCCATACGCTGCTGCGCCAGCTGCGCACCCCGGGCCAGCGGGTTAAAAACGTGCTGATCGTGGTGCTGGCCGGACTGATTGTCTGGGGACCCATCCGCCTGCTAGAGCTGCGCCAGCATGATGTGGAGCGCCATTCGGAAGTGGATATGCCGAGCTATGGCGGGGTGATCGCCAACTCTTACCTGCCGTCGAACTGGTTGTCGGCGCTGGGTCTGTACGCCTGGGCGCAGGTGGATGAATCCTCAGACAACAAATCGCTGATTAACCCGGCGAAGAAGTTCACCTACGTCGCGCCGGAAGGTCTGGATGATACCTACGTGGTGTTTATCATTGGCGAAACGACCCGCTGGGACCATATGGGCATCCTCGGCTATAGCCGCAATACCACGCCAGAGCTGGAGAAAGAGAAGAATCTCGTCGCCTTCCGCGGTTACTCGTGCGATACCGCTACCAAACTGTCGTTACGCTGCATGTTTGTGCGCGAGGGCGGGGCGGAAGATAACCCCCAGCGGACGCTCAAAGAGCAGAATGTCTTTGCCGTGCTGCATCAGCTGGGCTTCAGCGGCAATCTGTACGCCATGCAGAGCGAGATGTGGTTCTACAGCAACACGATGGCCAACAATATCGCCTACCGCGAGCAGATTGGCGCCGAGCCGCGCAACCGCGGTAAGAGCGTTGACGATATGCTGCTGGTGGATGAGATGAAGCGCGGTATGGCGCAGGGCAACGCCTCCGGTAAGCATCTGATCATTCTCCACACCAAAGGCTCCCACTTTAACTACACCCAACGCTACCCGCGCAGCTTCGCCCAGTGGAAACCGGAGTGCGTCGGCGTCGACAACAAGTGCTCGAAAGCGGAACTGATCAATTCCTACGACAATAGCGTGACCTATGTCGATCACTTTATCGTCAGCGTCCTCGACCAGCTGCGGGATAAGAAAGCGATTGTGTTCTATGCCGCCGACCACGGGGAGTCGATTAACGAGCGTGAACACCTGCACGGTACGCCACGCAAGATGGCGCCGCCGGAGCAGTTCCGCGTGCCGATGATGGTGTGGATGTCGGATAAGTACCTGGAAAATCCCGATCACGCCGCCGCGTTTGCCCATCTGCAGCAGCAGGCCGCGATGAAGGTGCCGCGCCGTCACGTCGAGCTGTACGACACCATTATGGGCTGCCTCGGCTATACCTCGCCGGATGGCGGGATCAATGAGAACAACAACTGGTGCCGGTGGAAAAAGTAA,MKYIRTMTQQKLSFWLALYIGWFMNVAVFFRRFDGYAQEFTFWKGLSGVVELVATVFVTFFLLRLLSLFGRRIWRILATLIVLFSAAASYYMTFLNVVIGYGIIASVMTTDIDLSKEVIGWHLILWLVAVSAPPLLFIWSNRCRHTLLRQLRTPGQRVKNVLIVVLAGLIVWGPIRLLELRQHDVERHSEVDMPSYGGVIANSYLPSNWLSALGLYAWAQVDESSDNKSLINPAKKFTYVAPEGLDDTYVVFIIGETTRWDHMGILGYSRNTTPELEKEKNLVAFRGYSCDTATKLSLRCMFVREGGAEDNPQRTLKEQNVFAVLHQLGFSGNLYAMQSEMWFYSNTMANNIAYREQIGAEPRNRGKSVDDMLLVDEMKRGMAQGNASGKHLIILHTKGSHFNYTQRYPRSFAQWKPECVGVDNKCSKAELINSYDNSVTYVDHFIVSVLDQLRDKKAIVFYAADHGESINEREHLHGTPRKMAPPEQFRVPMMVWMSDKYLENPDHAAAFAHLQQQAAMKVPRRHVELYDTIMGCLGYTSPDGGINENNNWCRWKK,MPQRQAVFYSSFSRFACMKYIRTMTQQKLSFWLALYIGWFMNVAVFFRRFDGYAQEFTFWKGLSGVVELVATVFVTFFLLRLLSLFGRRIWRILATLIVLFSAAASYYMTFLNVVIGYGIIASVMTTDIDLSKEVIGWHLILWLVVVSAPPLLFIWSNRCRHTLLRQLRTPGQRVKNVLIVVLAGLIVWGPIRLLELRQHDVERHSEVDMPSYGGVIANSYLPSNWLSALGLYAWAQVDESSDNKSLINPAKKFTYVAPEGLDDTYVVFIIGETTRWDHMGILDYSRNTTPELEKEKNLVAFRGYLCDTATKLSLRCMFVREGGAEDNPQRTLKEQNVFAVLHQLGFSGNLYAMQSEMWFYSNTMANNIAYREQIGAEPRNRGKSVDDMLLVDEMKRGMAQGNASGKHLIILHTKGSHFNYTQRYPRSFAQWKPECVGVDNKCSKAELINSYDNSVTYVDHFIVSVLDQLRDKKAIVFYAADHGESINEREHLHGTPRKMAPPEQFRVPMMVWMSDKYLENPDHAAAFAHLQQQAAMKVPRRHVELYDTIMGCLGYTSPDGGINENNNWCRWKK,97.04,gnl|BL_ORD_ID|2780|hsp_num:0,3791,FALSE,None
LK583,4_190 # 216921 # 217904 # 1 # ID=4_190;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.605,4_190,216921,217904,+,Strict,550,577.785,PmrF,83.69,3003578,protein homolog model,n/a,n/a,peptide antibiotic,antibiotic target alteration,pmr phosphoethanolamine transferase,ATGCTTACTTACCCTCCCGTGAAGAAGGTCTCGGTGGTTATCCCGGTTTATAACGAACAGGATAGCCTGCCGGAACTGCTTCGTCGTACGGATGCCGCCTGCGCCACCCTGGGGCGGCAATATGAAATTCTGTTGATCGACGATGGCAGCAGCGACGATTCCGCGCGCATGCTCACCGAAGCCGCCGAGGCGGAAGGCAGCCACGTCGTCGCCGTGCTGTTAAACCGTAACTACGGCCAGCACTCGGCGATCATGGCCGGCTTCAGCCATGTAACCGGCGATCTGATTATTACCCTCGACGCCGACCTGCAAAACCCGCCGGAGGAGATCCCGCGGCTGGTGGCGAAGGCTGATGAAGGTTACGACGTGGTGGGCACCGTCCGCCAGAACCGTCAGGACAGCATCTTCCGTAAAACCGCGTCGAAGATGATCAACCGCCTGATCCAGCGCACCACCGGCAAAGCGATGGGCGACTACGGCTGCATGCTGCGCGCTTACCGCCGCCATATCATCGACGCCATGCTCAACTGCCATGAGCGCAGCACCTTTATCCCGATCCTGGCGAATACCTTCGCCCGGCGCGCGGTGGAGATCCCGGTGATGCACGCCGAGCGCGAATTCGGCGACTCCAAATACAGCTTTATGCGCCTGATCAACCTGATGTACGACCTGGTGACCTGTCTGACCACCACGCCGCTGCGTCTGCTCAGCATTTTCGGCAGCGTGATTGCCCTGCTGGGCTTCGCCTTCGGCCTGCTGCTGGTGGTGCTGCGTCTGGCCTTCGGCCCGCAGTGGGCGGCGGAAGGGGTGTTTATGCTCTTCGCCGTGCTGTTCATGTTCATCGGCGCCCAGTTTGTCGGTATGGGCCTGCTCGGGGAGTATATCGGCCGCATCTATAACGACGTGCGCGCCCGCCCCCGCTACTTTATTCAACGTGTTGTTCGCCAGCCGGAAACGGCATCTAAAGAGGAAGATCGTTCATGA,MLTYPPVKKVSVVIPVYNEQDSLPELLRRTDAACATLGRQYEILLIDDGSSDDSARMLTEAAEAEGSHVVAVLLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEGYDVVGTVRQNRQDSIFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIIDAMLNCHERSTFIPILANTFARRAVEIPVMHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRLLSIFGSVIALLGFAFGLLLVVLRLAFGPQWAAEGVFMLFAVLFMFIGAQFVGMGLLGEYIGRIYNDVRARPRYFIQRVVRQPETASKEEDRS,MFEIHPVKKVSVVIPVYNEQESLPELIRRTTTACESLGKEYEILLIDDGSSDNSAHMLVEASQAENSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEGYDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHERSTFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLGSIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYTDVRARPRYFVQQVIRPSSKENE,101.55,gnl|BL_ORD_ID|1937|hsp_num:0,2014,FALSE,None
LK583,4_193 # 220785 # 222440 # 1 # ID=4_193;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.609,4_193,220785,222440,+,Strict,1000,1094.34,ArnT,99.27,3005053,protein homolog model,n/a,n/a,peptide antibiotic,antibiotic target alteration,pmr phosphoethanolamine transferase,ATGAAAAGCATTCGCTATGGCGTCTCTCTGATTGCGCTGTTTGCGCTGTATTATCTGCTGCCGCTCAATTTCCGTTTGCTTTGGCAACCCGACGAAACCCGCTACGCGGAGATCAGCCGTGAAATGCTGGCCACCGGCGACTGGGTGGTACCGCATTTTCTCGGCCTGCGCTACTTCGAAAAACCGATTGCCGGTTACTGGGTCAACAGTATCGGTCAGTGGCTGTTTGGCCATAATAACTTCGGCGTACGCTTCGGGTCGGTCTTCGCCATCACCATGACCGCCCTGCTGGTGGCCTGGCTGGCGTGGCGGATCTTTCGTGATAAGCGGGTAGCTATCCTGTCGCCGATTATCTTCCTCACCGCGATGCTGGTGTATGCGATTGGCACCTATGCGGTGCTGGACCCGATGATCACCCTGTGGCTGGCGCTGGCGATGTGCAGCTTCTGGGGCGCGGCGCAGGCGCAGAGCCGCAGCGGCAAAATACTGGGCTACGTGCTGCTGGGCGTCGCCTGCGGGATGGGGGTGATGACCAAAGGCTTCCTGGCGCTGGCGGTGCCGGTGGTGGGCGTTCTGCCATGGGTGATCGCCCGTAAACGCTGGCGTGAAGTGCTGACCTACGGCTGGCTGGCGGTGATTGTCTGTACGCTGGTGGTGCTGCCCTGGGGGCTGGCTATCGCCCAGCGCGAGCCGGACTTCTGGCGCTACTTCTTCTGGGTCGAGCATATTCAGCGTTTTGCTGAAAAAGACGCCCAGCACAAAGCGCCGTTCTGGTACTACATCCCGTTCCTGATCGCCGGCAGTCTGCCGTGGCTGGCCCTGCTGCCGGGGGCGCTAAAGCGCGGCTGGCTTGAGCGCGATGAGGCCCGCGGCGCGCTGTATCTGTTAGGTTGGGTGGCGATGCCGTTCCTGTTCTTCAGTATCGCCAAAGGCAAACTGCCGACCTATATTCTGCCGTGCTTTGCGCCGCTGTCGATCCTGATGGCCCGCTACGCGCTGGAGGCCGCAAAGACCGGCGCGAAAGCGTTGCGCATCAACGGGATGATCAACCTGGGCGTTGGTTTGCTGGGGCTTATCGCTGTGCTGGTGGTCTCGCCGTGGGGCTTCATGCATAAGCCGGTGTGGACCAAGATTGAGCTGTATAAATGTCTGCTGGCGGCGATCGCTTTTGCCGTCTGGGCGCTGATGGGCTGGCTGGCGATGAAAGACTCTGGCCGCCGCTGGAGCCTCGCCGCGCTCTGTCCGCTCGGCCTGGCGCTGCTGGTGGGCTTCGCCATCCCGGACCGGGTTATCGACAGCAAACAGCCGCAGTTCCTCGTGGATATCGTCAGCGAATCCCTGCAGCCCAGCCGTTACGTCCTGACCAACAACGTTGGGATCGCCGGCGGCCTGGCCTGGGAGCTGAAGCGAAGCGATATTATTATGTTCGACAAACAGGGTGAGCTGAAGTACGGTCTCGACTGGCCGGATGCTCAGGGAAGCTTTGTCAGCCAGGCCGGTTTTGCCGACTGGCTGGCCGCGCATCGTCAGCAGGGGCCGGTCTCGCTGGTGCTGTTGATGGATAAAGGAGAGAGTATGCTCGACTTACCGTTACCGAAACCGGATAACGCCTACGAGCTGGGCCGGGTCGTTTTCCTTCAGTACCTGCCGCAATGA,MKSIRYGVSLIALFALYYLLPLNFRLLWQPDETRYAEISREMLATGDWVVPHFLGLRYFEKPIAGYWVNSIGQWLFGHNNFGVRFGSVFAITMTALLVAWLAWRIFRDKRVAILSPIIFLTAMLVYAIGTYAVLDPMITLWLALAMCSFWGAAQAQSRSGKILGYVLLGVACGMGVMTKGFLALAVPVVGVLPWVIARKRWREVLTYGWLAVIVCTLVVLPWGLAIAQREPDFWRYFFWVEHIQRFAEKDAQHKAPFWYYIPFLIAGSLPWLALLPGALKRGWLERDEARGALYLLGWVAMPFLFFSIAKGKLPTYILPCFAPLSILMARYALEAAKTGAKALRINGMINLGVGLLGLIAVLVVSPWGFMHKPVWTKIELYKCLLAAIAFAVWALMGWLAMKDSGRRWSLAALCPLGLALLVGFAIPDRVIDSKQPQFLVDIVSESLQPSRYVLTNNVGIAGGLAWELKRSDIIMFDKQGELKYGLDWPDAQGSFVSQAGFADWLAAHRQQGPVSLVLLMDKGESMLDLPLPKPDNAYELGRVVFLQYLPQ,MKSIRYGVSLIALFALYYLLPLNFRLLWQPDETRYAEISREMLATGDWVVPHFLGLRYFEKPIAGYWINSIGQWLFGHNNFGVRFGSVFAITMTALLVAWLAWRIFRDKRVAILSLIIFLTAMLVYAIGTYAVLDPMITLWLALAMCSFWGAVQAHSRSGKILGYVLLGVACGMGVMTKGFLALAVPVVGVLPWVIARKRWREVLTYGWLAVIVCTLVVLPWGLAIAQREPDFWRYFFWVEHIQRFAEKDAQHKAPFWYYIPFLIAGSLPWLALLPGALKRGWLERDEARGALYLLGWVAMPFLFFSIAKGKLPTYILPCFAPLSILMARYALEAAKTGAKALRINGMINLGVGLLGLIAVLVVSPWGFMHKPVWTKIELYKCLLAAIAFAVWALMGWLAMKDSGRRWSLAALCPLGLALLVGFAIPDRVIDSKQPQFLVDIVSESLQPSRYVLTNNVGIAGGLAWELKRSDIIMFDKQGELKYGLDWPDAQGSFVSQAGFADWLAAHRQQGPVSLVLLMDKGESMLDLPLPKPDNAYELGRVVFLQYLPQ,100,gnl|BL_ORD_ID|2785|hsp_num:0,3795,FALSE,None
LK583,4_294 # 332552 # 333184 # -1 # ID=4_294;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.520,4_294,332552,333184,-,Strict,400,432.95,CRP,99.05,3000518,protein homolog model,n/a,n/a,macrolide antibiotic; fluoroquinolone antibiotic; penam,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGGTGCTTGGCAAACCGCAAACAGACCCTACCCTTGAATGGTTCTTGTCTCATTGCCACATTCATAAGTACCCATCAAAGAGCACGCTGATCCACCAGGGTGAAAAAGCAGAAACGCTGTACTACATCGTTAAAGGCTCCGTGGCTGTACTCATCAAGGATGAAGAAGGTAAAGAGATGATCCTCTCCTACCTCAACCAGGGCGATTTCATCGGTGAATTAGGCCTGTTTGAAGAGGGTCAGGAGCGTAGCGCCTGGGTACGGGCGAAAACCGCATGTGAAGTGGCCGAAATCTCTTATAAGAAATTCCGTCAGCTGATCCAGGTGAACCCGGACATTCTGATGCGTCTCTCTTCGCAAATGGCTCGCCGTCTGCAGGTCACGTCTGAGAAAGTGGGCAACCTTGCCTTCCTCGACGTGACGGGCCGTATCGCCCAGACGCTGCTGAACCTGGCGAAGCAACCGGATGCCATGACCCACCCGGACGGTATGCAAATTAAAATTACCCGCCAGGAAATTGGTCAGATCGTCGGCTGCTCTCGTGAAACCGTTGGTCGTATTTTGAAAATGCTGGAAGATCAGAACCTGATTTCCGCGCACGGTAAAACCATCGTCGTCTACGGCACCCGTTAA,MVLGKPQTDPTLEWFLSHCHIHKYPSKSTLIHQGEKAETLYYIVKGSVAVLIKDEEGKEMILSYLNQGDFIGELGLFEEGQERSAWVRAKTACEVAEISYKKFRQLIQVNPDILMRLSSQMARRLQVTSEKVGNLAFLDVTGRIAQTLLNLAKQPDAMTHPDGMQIKITRQEIGQIVGCSRETVGRILKMLEDQNLISAHGKTIVVYGTR,MVLGKPQTDPTLEWFLSHCHIHKYPSKSKLIHQGEKAETLYYIVKGSVAVLIKDEEGKEMILSYLNQGDFIGELGLFEEGQERSAWVRAKTACEVAEISYKKFRQLIQVNPDILMRLSAQMARRLQVTSEKVGNLAFLDVTGRIAQTLLNLAKQPDAMTHPDGMQIKITRQEIGQIVGCSRETVGRILKMLEDQNLISAHGKTIVVYGTR,100,gnl|BL_ORD_ID|803|hsp_num:0,869,FALSE,None
LK583,6_38 # 38606 # 39703 # -1 # ID=6_38;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.594,6_38,38606,39703,-,Strict,250,260.766,vanG,38.66,3002909,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,glycopeptide resistance gene cluster; Van ligase,ATGGCAAAGATGAGGGTTGGGATCGTTTTTGGCGGCAAGTCGGCGGAGCATGAAGTGTCGCTGCAGTCAGCGAAGAATATCGTGGAAGCGATTGATAAATCGCGCTTCGATGTGGTTCTGTTGGGTATTGATAAACAGGGGCTGTGGCATATCAACGACGCCGGCAACTACCTGCTCAACGCACAGGATCCTGCCCGCATTGCCCTGCGCCCTTCCACGGTGACTCTGGCGCAGATCCCGGGCCGCGAAGCGCAGCAGCTGATTAACGCCGAAAGCGGCCAACCGCTGGCGGCCATCGATGTGATTTTCCCGATCGTCCACGGCACGCTGGGTGAAGATGGCTCCCTGCAGGGGATGCTGCGCATGGCGAATCTGCCGTTCGTCGGCTCCGATGTGCTGGGCTCTGCAGCCTGTATGGACAAAGACGTGACCAAACGTCTGCTGCGCGACGCCGGGCTCGCCGTCGCCCCGTTTATCACACTCACCCGCGCCAACCGCGCGCAGTTCAGCTTTGCCGATGTCGAAGCGAAGCTTGGCCTGCCGCTGTTCGTTAAGCCGGCTAATCAGGGCTCGTCGGTTGGCGTCAGCAAAGTTAAAAACGAAGAGCAGTACCATCAGGCGGTGGCCCTGGCCTTCGAATTTGACCATAAAGTGGTGGTGGAGCAAGGCATTAAAGGGCGGGAAATTGAGTGTGCGGTGCTGGGTAACGACCACCCGCAGGCCAGCACCTGCGGTGAAATCGTCCTCAACAGCGAGTTTTACGCCTACGACACCAAGTATATCGACGATCAGGGCGCGCAGGTGGTAGTCCCGGCCGCTATCGCCCCTGAGATCAACGACAAAATTCGTGCTATCGCGGTGCAGGCCTACCAGACCCTGGGCTGCAGCGGCATGGCTCGTGTCGACGTGTTCCTCACCGCCGACAACGAGGTGGTGATCAACGAGATCAACACCCTGCCGGGCTTTACCAACATCAGCATGTATCCGAAGCTGTGGCAGGCCAGCGGTCTCGACTACACCAGCCTGATCACCCGCCTGATTGAGCTGGCGCTGGAGCGCCATGCCGCGGACCGGGCGCTGAAAACCTCCATGAACTAA,MAKMRVGIVFGGKSAEHEVSLQSAKNIVEAIDKSRFDVVLLGIDKQGLWHINDAGNYLLNAQDPARIALRPSTVTLAQIPGREAQQLINAESGQPLAAIDVIFPIVHGTLGEDGSLQGMLRMANLPFVGSDVLGSAACMDKDVTKRLLRDAGLAVAPFITLTRANRAQFSFADVEAKLGLPLFVKPANQGSSVGVSKVKNEEQYHQAVALAFEFDHKVVVEQGIKGREIECAVLGNDHPQASTCGEIVLNSEFYAYDTKYIDDQGAQVVVPAAIAPEINDKIRAIAVQAYQTLGCSGMARVDVFLTADNEVVINEINTLPGFTNISMYPKLWQASGLDYTSLITRLIELALERHAADRALKTSMN,MQNKKIAVIFGGNSTEYEVSLQSASAVFENINTNKFDIIPIGITRSGEWYHYTGEKEKILNNTWFEDSKNLCPVVVSQNRSVKGFLEIASDKYRIIKVDLVFPVLHGKNGEDGTLQGIFELAGIPVVGCDTLSSALCMDKDRAHKLVSLAGISVPKSVTFKRFNEEAAMKEIEANLTYPLFIKPVRAGSSFGITKVIEKQELDAAIELAFEHDTEVIVEETINGFEVGCAVLGIDELIVGRVDEIELSSGFFDYTEKYTLKSSKIYMPARIDAEAEKRIQEAAVTIYKALGCSGFSRVDMFYTPSGEIVFNEVNTIPGFTSHSRYPNMMKGIGLSFSQMLDKLIGLYVE,104.58,gnl|BL_ORD_ID|1069|hsp_num:0,1157,FALSE,None
LK583,6_159 # 160208 # 163354 # -1 # ID=6_159;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.569,6_159,160208,163354,-,Strict,1900,1941.39,acrB,91.52,3000216,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGCCTAATTTCTTTATCGATCGCCCCATATTTGCATGGGTGATCGCCATTATCATCATGCTGGCTGGGGGATTATCAATCCTCAAATTGCCGGTGGCGCAATATCCGACGATTGCGCCGCCAGCAATTTCCATTACCGCCATGTACCCCGGTGCTGACGCCGAAACGGTGCAGAACACCGTAACTCAGGTTATCGAACAGAATATGAACGGTATCGATCACCTGATGTACATGTCCTCAAATGGCGACTCCACCGGTACGGCAACCATTACGCTGACCTTCGAATCCGGTACCGATCCGGATATCGCCCAGGTTCAGGTTCAGAACAAGCTGGCGCTGGCGACGCCTCTGCTGCCGCAAGAAGTACAGCAGCAAGGGATTAGCGTTGAGAAAGCGTCCAGCAGCTTCCTGATGGTTGTCGGCGTCATTAACACCAACGGCACCATGAACCAGGACGATATTTCGGACTACGTGGCGGCCAACATGAAGGATCCGATTAGCCGTACCAGCGGCGTCGGCGACGTTCAGCTATTCGGTTCCCAGTATGCGATGCGTATCTGGATGGATCCAAACAAACTGAACAACTTCCAGCTTACGCCGGTGGATGTGATCAGCGCCCTGAAAGCGCAGAACGCCCAGGTGGCCGCGGGCCAGTTAGGCGGTACGCCGCCGGTGAAAGGCCAGCAGCTTAACGCCTCGATCATCGCGCAGACGCGTCTGACCAATACGGAAGAGTTTGGCAACATCCTGCTGAAGGTGAACCAGGACGGTTCCCAGGTTCGTCTGCGTGATGTCGCCAAAATTGAGCTGGGCGGCGAAAGCTATGACGTAGTGGCGAAGTTTAACGGCCAGCCGGCATCCGGTCTGGGTATTAAACTGGCTACCGGCGCGAACGCGCTGGATACCGCCAACGCTATTCGCGCTGAACTGGCGAAGATGGAGCCGTTTTTCCCGTCGGGGATGAAGATCGTTTACCCGTATGACACCACCCCGTTCGTGAAAATTTCTATTCACGAAGTGGTTAAAACGCTGGTGGAAGCGATCATCCTGGTGTTCCTGGTCATGTATCTGTTCCTGCAGAACTTCCGCGCCACCCTGATCCCCACCATCGCGGTACCGGTGGTCCTGTTAGGCACCTTCGCGGTGCTGGCGGCGTTTGGCTTCTCGATAAACACCCTGACGATGTTCGGGATGGTGCTCGCCATCGGCCTGTTGGTGGATGACGCCATCGTGGTGGTAGAGAACGTCGAGCGCGTGATGGCGGAAGAGGGTCTGCCGCCGAAAGAAGCGACGCGTAAATCGATGGGACAGATTCAGGGCGCGCTGGTAGGTATCGCTATGGTGCTGTCGGCGGTATTTATCCCGATGGCGTTCTTCGGCGGCTCAACCGGGGCCATCTATCGCCAGTTCTCCATCACTATCGTTTCCGCGATGGCGCTGTCGGTACTGGTGGCGTTAATCCTGACGCCGGCGCTGTGCGCCACGATGCTGAAACCCATTCAGAAAGGCAGCCATGGCGCGACCACCGGCTTCTTCGGCTGGTTTAACCGCATGTTTGATAAGAGCACGCACCATTACACCGACAGCGTAGGCAACATTCTGCGCAGCACCGGTCGTTATCTGGTGCTGTATCTGATCATCGTGGTGGGTATGGCATGGCTGTTCGTCCGTCTGCCGAGCTCGTTCCTGCCGGACGAGGACCAGGGGGTATTCCTGAGTATGGCGCAGCTGCCTGCCGGCGCCACCCAGGAGCGTACGCAGAAAGTGCTGGATGAGATGACGAATTACTATCTCACCAAAGAGAAGGACAACGTGGAATCCGTGTTTGCGGTTAACGGCTTCGGTTTCGCCGGCCGCGGCCAGAACACCGGTATCGCGTTCGTTTCGCTGAAAGACTGGAGCCAGCGTCCGGGTGAGGAAAACAAAGTTGAAGCGATCACCGCGAGAGCAATGGGCTACTTCTCGCAGATTAAAGATGCGATGGTCTTCGCCTTTAACCTGCCGGCTATCGTTGAACTGGGTACCGCGACCGGCTTTGACTTCGAGCTGATTGACCAGGGCGGTCTGGGCCACGAAAAACTGACCCAGGCGCGTAACCAACTGTTTGGCATGGTGGCGCAGCATCCTGACGTGCTGACCGGCGTGCGCCCTAACGGTCTGGAAGATACACCGCAGTTTAAAATCGATATCGATCAGGAGAAAGCTCAGGCGCTGGGCGTCTCCATCAGCGACATTAACACCACGCTGGGCGCAGCCTGGGGCGGAAGCTATGTCAACGACTTTATCGACCGCGGCCGCGTGAAGAAAGTGTACATCATGTCCGAAGCGAAATACCGTATGCTGCCGGAAGATATCGGCAAGTGGTATGTTCGCGGCAGCGATGGTCAGATGGTGCCGTTCTCTGCTTTCTCGACCTCGCGTTGGGAATACGGTTCGCCGCGTCTGGAACGCTACAACGGTCTGCCGTCACTGGAAATCCTCGGTCAGGCCGCGCCAGGCAAGAGTACCGGTGAGGCGATGGCGCTGATGGAAGAGCTGGCGGGTAAACTGCCTTCCGGTATCGGCTACGACTGGACCGGGATGTCTTATCAGGAGCGACTGTCCGGCAACCAGGCCCCTGCCCTGTATGCCATTTCGCTGATTGTCGTCTTCCTGTGTCTGGCGGCGCTGTATGAGAGCTGGTCGATTCCGTTCTCGGTTATGCTGGTCGTCCCCTTGGGTGTGGTCGGTGCGCTGTTAGCCGCCACCTTCCGCGGGCTAACCAACGACGTTTACTTCCAGGTGGGTCTGCTGACCACCATCGGCCTGTCGGCGAAGAACGCAATATTGATCGTTGAATTCGCCAAAGACCTGATGGAGAAAGAGGGCAAAGGGCTGATTGAGGCGACGCTTGAAGCAGTACGTATGCGTCTACGTCCAATCCTGATGACATCTCTGGCGTTCATCCTCGGGGTAATGCCGCTAGTTATCAGCTCCGGCGCCGGCTCCGGTGCGCAGAACGCCGTCGGTACAGGCGTAATGGGCGGGATGGTGACCGCGACGATCCTGGCGATCTTCTTCGTGCCGGTGTTCTTTGTGGTGGTTCGTCGCCGCTTTAGCAAAAAATCGGAAGATATAGAGCACAGCCATCAGGTTGAGCATCATTAA,MPNFFIDRPIFAWVIAIIIMLAGGLSILKLPVAQYPTIAPPAISITAMYPGADAETVQNTVTQVIEQNMNGIDHLMYMSSNGDSTGTATITLTFESGTDPDIAQVQVQNKLALATPLLPQEVQQQGISVEKASSSFLMVVGVINTNGTMNQDDISDYVAANMKDPISRTSGVGDVQLFGSQYAMRIWMDPNKLNNFQLTPVDVISALKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRLTNTEEFGNILLKVNQDGSQVRLRDVAKIELGGESYDVVAKFNGQPASGLGIKLATGANALDTANAIRAELAKMEPFFPSGMKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQNFRATLIPTIAVPVVLLGTFAVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVMAEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFIPMAFFGGSTGAIYRQFSITIVSAMALSVLVALILTPALCATMLKPIQKGSHGATTGFFGWFNRMFDKSTHHYTDSVGNILRSTGRYLVLYLIIVVGMAWLFVRLPSSFLPDEDQGVFLSMAQLPAGATQERTQKVLDEMTNYYLTKEKDNVESVFAVNGFGFAGRGQNTGIAFVSLKDWSQRPGEENKVEAITARAMGYFSQIKDAMVFAFNLPAIVELGTATGFDFELIDQGGLGHEKLTQARNQLFGMVAQHPDVLTGVRPNGLEDTPQFKIDIDQEKAQALGVSISDINTTLGAAWGGSYVNDFIDRGRVKKVYIMSEAKYRMLPEDIGKWYVRGSDGQMVPFSAFSTSRWEYGSPRLERYNGLPSLEILGQAAPGKSTGEAMALMEELAGKLPSGIGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFSVMLVVPLGVVGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMEKEGKGLIEATLEAVRMRLRPILMTSLAFILGVMPLVISSGAGSGAQNAVGTGVMGGMVTATILAIFFVPVFFVVVRRRFSKKSEDIEHSHQVEHH,MPNFFIDRPIFAWVIAIIIMLAGGLAILKLPVAQYPTIAPPAVTISASYPGADAKTVQDTVTQVIEQNMNGIDNLMYMSSNSDSTGTVQITLTFESGTDADIAQVQVQNKLQLAMPLLPQEVQQQGVSVEKSSSSFLMVVGVINTDGTMTQEDISDYVAANMKDAISRTSGVGDVQLFGSQYAMRIWMNPNELNKFQLTPVDVITAIKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRLTSTEEFGKILLKVNQDGSRVLLRDVAKIELGGENYDIIAEFNGQPASGLGIKLATGANALDTAAAIRAELAKMEPFFPSGLKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQNFRATLIPTIAVPVVLLGTFAVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVMAEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGSTGAIYRQFSITIVSAMALSVLVALILTPALCATMLKPIAKGDHGEGKKGFFGWFNRMFEKSTHHYTDSVGGILRSTGRYLVLYLIIVVGMAYLFVRLPSSFLPDEDQGVFMTMVQLPAGATQERTQKVLNEVTHYYLTKEKNNVESVFAVNGFGFAGRGQNTGIAFVSLKDWADRPGEENKVEAITMRATRAFSQIKDAMVFAFNLPAIVELGTATGFDFELIDQAGLGHEKLTQARNQLLAEAAKHPDMLTSVRPNGLEDTPQFKIDIDQEKAQALGVSINDINTTLGAAWGGSYVNDFIDRGRVKKVYVMSEAKYRMLPDDIGDWYVRAADGQMVPFSAFSSSRWEYGSPRLERYNGLPSMEILGQAAPGKSTGEAMELMEQLASKLPTGVGYDWTGMSYQERLSGNQAPSLYAISLIVVFLCLAALYESWSIPFSVMLVVPLGVIGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGLIEATLDAVRMRLRPILMTSLAFILGVMPLVISTGAGSGAQNAVGTGVMGGMVTATVLAIFFVPVFFVVVRRRFSRKNEDIEHSHTVDHH,99.9,gnl|BL_ORD_ID|1011|hsp_num:0,1104,FALSE,None
LK583,6_160 # 163377 # 164570 # -1 # ID=6_160;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.562,6_160,163377,164570,-,Strict,770,738.413,Klebsiella pneumoniae acrA,95.24,3004041,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGAACAAAAACAGAGGGTTAACGCCTCTGGCGGTCGTTCTGATGCTCTCAGGCAGCTTAGCGCTAACAGGATGTGACGATAAACCGGCTCAACAGGGAGCCCAGCACATGCCGGAAGTCGGTATTGTGACGCTCAAATCCGCACCTCTACAAATAACCACCGAACTGCCAGGCCGTACCAGCGCCTATCGCATTGCGGAAGTCCGTCCTCAGGTCAGTGGCATTATTTTAAAACGTAACTTCGTGGAAGGTAGCGATATCCAGGCCGGCGTCTCCCTGTATCAGATCGATCCAGCCACCTATCAGGCCAGCTATGACAGCGCCAAAGGCGACCTGGCAAAAGCCCAGGCGGCGGCAAACATGGATCAACTGACGGTCAAGCGTTATCAGAAACTGTTGGGCACCAAATATATTAGTCAACAAGACTACGATACCGCCGTTGCGACGGCGCAGCAGAGCAATGCGGCCGTGGTCGCGGCGAAAGCGGCCGTTGAAACCGCGCGCATCAATCTGGCCTACACCAAAGTCACCTCGCCGATCAGCGGCCGGATTGGTAAATCCGCCGTGACCGAAGGGGCGCTGGTACAGAATGGTCAAACGACCGCCCTGGCAACCGTTCAGCAGCTGGATCCGATCTATGTTGACGTCACCCAGTCGAGCAATGATTTCCTGCGCCTGAAGCAGGAGCTAGCCGACGGCCGCCTGAAACAGGAAAACGGCAAAGCGAAAGTGGAGCTGGTGACTAATGACGGTCTTAAGTATCCGCAGTCCGGCACGCTGGAATTCTCGGATGTCACCGTCGATCAGACCACCGGCTCAATCACGCTACGCGCTATTTTCCCGAACCCGGATCACACCCTGCTTCCGGGGATGTTCGTCCGTGCCCGTCTGGAAGAAGGGATTAACCCTGACGCCCTGCTGGTACCGCAACAGGGTGTTACCCGTACGCCGCGCGGCGACGCCAGCGTCATGGTAGTGGGGGAAGGCGATAAAGTCGAAGTCCGCCAGGTCACTGCTTCTCAGGCGATCGGCGATAAATGGCTGGTCACTGACGGTCTGAAATCCGGCGATCGCGTTATCGTCACCGGCCTGCAAAAAATCAAACCAGGTGTGCAGGTAAAAGCGCAGGAAGTAGCTTCTGATGATAAACAGCAAGCCGCAGGCAACGCGCCATCAGAACAAACCAAGTCTTAA,MNKNRGLTPLAVVLMLSGSLALTGCDDKPAQQGAQHMPEVGIVTLKSAPLQITTELPGRTSAYRIAEVRPQVSGIILKRNFVEGSDIQAGVSLYQIDPATYQASYDSAKGDLAKAQAAANMDQLTVKRYQKLLGTKYISQQDYDTAVATAQQSNAAVVAAKAAVETARINLAYTKVTSPISGRIGKSAVTEGALVQNGQTTALATVQQLDPIYVDVTQSSNDFLRLKQELADGRLKQENGKAKVELVTNDGLKYPQSGTLEFSDVTVDQTTGSITLRAIFPNPDHTLLPGMFVRARLEEGINPDALLVPQQGVTRTPRGDASVMVVGEGDKVEVRQVTASQAIGDKWLVTDGLKSGDRVIVTGLQKIKPGVQVKAQEVASDDKQQAAGNAPSEQTKS,MNKNRGLTPLAVVLMLSGSLALTGCDDKPAQQGAQHMPEVGIVTLKSAPLQITTELPGRTSAYRIAEVRPQVSGIILKRNFVEGSDIQAGVFLYQIDPATYQGSYDSAKGDLAKAQAAANMDQLTVKRYQKLLGTQYISQQDYDPAVATAQQNNAAVVAAKTAVETARINLAYTQKSPLRSAAGSGKSPVTEGALVQNGQTTALATVQQVDPIYVDVTQSSNDFLRLKQELADARLKQENGKAKVELVTNDGLKYPQSGTLEFSDVTVDQTTGSITLRAIFPNPDHTLLPGMFVRARLEEGINPDALLVPQQGVTRTPRGDASVMVVGEGDKVEVRQVTASQAIGDKWLVTDGLKSGDRVIVTGLQKIKPGVQVKAQEVASDDKQQAAGNAPSEQTKS,99.75,gnl|BL_ORD_ID|2321|hsp_num:0,2659,TRUE,loose hit with at least 95 percent identity pushed strict
LK583,7_135 # 152109 # 153059 # -1 # ID=7_135;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.508,7_135,152109,153059,-,Strict,500,541.576,leuO,83.44,3003843,protein homolog model,n/a,n/a,nucleoside antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGTTAATTGAAACTCCAGAATATAAATCAGCCCCCGGACAGGAAGTCGTTAAACCTCAACTACGGATGGTTGATCTCAATCTGCTTACCGTTTTTGATGCGGTTATGCAAGAGCAGAATATTACTCGTGCCGCCCATACGCTCGGCATGTCACAACCCGCGGTGAGCAATGCGGTTTCACGACTGAAAGTGATGTTTAATGATGAGCTTTTTGTGCGCTATGGCCGCGGTATTCAGCCGACGGCGCGCGCCTATCAGCTGTTTGGCTCGGTACGCCAGGCGCTGCAGCTGGTCCAAAACGAATTGCCAGGCTCCGGTTTTGAACCACTGAGCAGTGAGCGCGTGTTCCATCTGTGCGTCTGCAGCCCGCTGGATAACATCCTGACGTCGGTTATTTTTAATAAAGTTGCAGAGATAGCACCCAATATTCATTTAGTCTTTAAGTCTGCGCTGAATCAAAATACGGAACATCAGCTACGTTATCAGGAAACAGAATTCGTAATCGGTTATGAAGAGTTCCGTCGCCCTGAGTTTGCCTGCGTTCCGTTATTTAAAGACGAAATGGTCCTGGTCGCCAGTCGCAACCATCCGCGTATTTCCGGGCCGATGATGGAGGCGGATATTTATCGCGAGGAGCATGCCGCCGTTGCTCTCGACCGGTATGCCTCATTTAGTTTGCCGTGGTATGACACGGCCGATAAACAAGCGCGTATCGCCTATCAGGGTAATGCGATGGTCAGCGTATTAAACGTAGTATCGCAAACCCAGATGGTGGCCATTGCCCCGCGCTGGCTGGCAGATGAATTTGCTGACAAGCTTGCCCTGCAAATATTACCTTTGCCGTTGAAGGTCAACAGTCGGACCTGCTATCTCTCCTGGCACGAAGCCGCTGGTCGTGATAAAGGCCACCAGTGGATGGAAGAGCTGCTGGTGGACATTTGCAAGCGCTGA,MLIETPEYKSAPGQEVVKPQLRMVDLNLLTVFDAVMQEQNITRAAHTLGMSQPAVSNAVSRLKVMFNDELFVRYGRGIQPTARAYQLFGSVRQALQLVQNELPGSGFEPLSSERVFHLCVCSPLDNILTSVIFNKVAEIAPNIHLVFKSALNQNTEHQLRYQETEFVIGYEEFRRPEFACVPLFKDEMVLVASRNHPRISGPMMEADIYREEHAAVALDRYASFSLPWYDTADKQARIAYQGNAMVSVLNVVSQTQMVAIAPRWLADEFADKLALQILPLPLKVNSRTCYLSWHEAAGRDKGHQWMEELLVDICKR,MPEVQTDHPETAELSKPQLRMVDLNLLTVFDAVMQEQNITRAAHALGMSQPAVSNAVARLKVMFNDELFVRYGRGIQPTARAFQLFGSVRQALQLVQNELPGSGFEPASSERVFHLCVCSPLDSILTSQIYNHIEQIAPNIHVMFKSSLNQNTEHQLRYQETEFVISYEDFHRPEFTSVPLFKDEMVLVASKNHPTIKGPLLKHDVYNEQHAAVSLDRFASFSQTWYDTVDKQASIAYQGMAMMSVLSVVSQTHLVAIAPRWLAEEFAESLELQVLPLPLKQNSRTCYLSWHEAAGRDKGHQWMEEQLVSICKR,100.64,gnl|BL_ORD_ID|4928|hsp_num:0,5921,FALSE,None
LK583,7_165 # 191590 # 193938 # 1 # ID=7_165;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.557,7_165,191590,193938,+,Perfect,1500,1619.75,LptD,100,3005059,protein homolog model,n/a,n/a,peptide antibiotic; aminocoumarin antibiotic; rifamycin antibiotic,antibiotic efflux,ATP-binding cassette (ABC) antibiotic efflux pump,ATGAAAAAACGTATTCCCAGCCTCCTGGCTACGATGATTGCCAGCGCCTTGTATAGCCAACAAGGCCTCGCTGCCGATCTCGCAACGCAATGTATGCTTGGCGTGCCAAGCTATGATCGTCCGCTCGTGGAAGGTCGTCCTGGCGATCTGCCGGTGACGATTAACGCCGATCATGCGAAGGGCAACTACCCGGACAACGCCGTCTTTACCGGCAACGTCGATATTAACCAGGGGAATAGTCGCCTCCGCGCCGACGAAGTTCAGCTGCACCAGCAGCAGGCCGCGGGCCAGGCGCAGCCGGTGCGCACGGTGGACGCGCTGGGCAACGTGCATTACGACGATAACCAGGTGATCCTCAAAGGGCCAAAAGCCTGGTCGAATCTGAATACCAAAGATACCAACGTCTGGCAGGGCGATTATCAAATGGTCGGACGCCAGGGACGCGGCACCGCCGACCTGATGAAACAGCGCGGTGAAAACCGCTATACCATTCTCGAAAACGGCAGCTTTACCTCCTGTCTGCCGGGCTCCGACACCTGGAGCGTCGTCGGCAGCGAAGTTATCCACGATCGCGAAGAGCAGGTTGCCGAGATCTGGAACGCCCGCTTCAAGCTTGGCTCTGTGCCGATTTTCTATAGCCCCTACCTGCAGCTGCCGGTGGGCGATAAGCGTCGTTCAGGCTTCCTGATCCCGAACGCGAAATACAGCACCAAAAACGGCGTGGAATTCTCCCTGCCGTACTACTGGAACATCGCGCCAAACTTCGATGCCACCATTACTCCGCACTATATGAACAAACGCGGCGGCGTGATGTGGGAAAACGAGTTCCGCTATCTGACCCAGCTCGGCAGCGGCTTAACTGAATTCGACTACCTGCCGTCGGATAAAGTCTACGAAGACGACCACTCGAGCGACAGCAACAGCCGCCGCTGGCTGTTCTACTGGAACCACTCAGGGGTTATCGATCAGGTATGGCGTCTGAACGCTGACTACACCAAGGTCAGCGATCCTGACTACTTCAACGACTTCAGCTCGAAATATGGTTCCAGTACCGATGGCTATGCGACGCAGAAATTCAGCGCCGGTTACGTCAACCAGAACTTTGACGCCACGGTATCGACCAAACAGTTCCAGGTCTTTGACCGCGAATCGAGCAACTCCTATTCGGCTGAGCCGCAGCTCGACGTCAACTACTACCAGAATGATGTCGGTCCGTTCGATACCCATCTCTATGGACAGGTTGCCCATTTTGTTAACTCGAATAACAACATGCCGGAAGCGACCCGCGTTCACTTCGAACCGACGATCAACCTGCCGCTGTCCAACGGTTGGGGCAGTCTGAATACCGAAGCCAAGCTGCTGGCGACTCACTACCAGCAGAGCAACCTCGATAAGTACAATGCCGCCAACGGCACTGACTATAAAGAGTCCGTCAGCCGCGTAATGCCGCAGTTTAAAGTCGACGGCAAAATGGTCTTTGAACGCGACCTGCAGGAGGGATTCACCCAAACGCTGGAACCGCGCGTGCAGTATCTGTACGTGCCGTACCGCGATCAGAGTGAAATCGGCAACTACGACTCCACGCTGTTGCAGTCGGATTACACCGGTCTGTTCCGCGACCGTACCTATAGCGGTCTGGACCGCATCGCGTCGGCTAATCAGGTCACCACCGGGCTCACCTCGCGCGTGTATGATGCCGCCGCGGTGGAACGTTTTAATATTTCCGTTGGTCAAATCTACTATTTCACCGAGTCACGCACCGGTGATGACAACATCAACTGGGAGAACAACGATACCACGGGTTCACTGGTCTGGGCCGGCGATACCTACTGGCGCATTGCCGATGAATGGGGTCTGCGCGGGGGGATCCAGTACGATACGCGTCTGGATAACGTTGCCACTGGTAACGGCACCATTGAATACCGTCGCGATGAGAACCGCTTAGTCCAGCTTAACTATCGTTACGCCAGCCCGGAATATATTCAGGCCACGCTGCCGTCATATTCCACCGCGGCACAATATAAACAGGGTATTTCGCAGGTGGGGATGACCGCCAGTTGGCCGATTGTCGATCGCTGGTCCGTGGTCGGGGCCTACTACTACGATACTAATACCCGGAAAGCAGCAAACCAGATGTTGGGTGTGCAGTATAACTCCTGCTGCTACGCCATCCGTCTTGGCTACGAACGTAAAGTCAACGGCTGGAACAGCAACGACAACGGCGGCGAGAGCAAATACGATAACACCTTCGGAATCAATATCGAATTGCGCGGTCTGAGCTCTAACTACGGCCTCGGCACCCAGCAGATGCTGCGCTCGAACATTTTACCGTACCAGAGCTCCCTGTGA,MKKRIPSLLATMIASALYSQQGLAADLATQCMLGVPSYDRPLVEGRPGDLPVTINADHAKGNYPDNAVFTGNVDINQGNSRLRADEVQLHQQQAAGQAQPVRTVDALGNVHYDDNQVILKGPKAWSNLNTKDTNVWQGDYQMVGRQGRGTADLMKQRGENRYTILENGSFTSCLPGSDTWSVVGSEVIHDREEQVAEIWNARFKLGSVPIFYSPYLQLPVGDKRRSGFLIPNAKYSTKNGVEFSLPYYWNIAPNFDATITPHYMNKRGGVMWENEFRYLTQLGSGLTEFDYLPSDKVYEDDHSSDSNSRRWLFYWNHSGVIDQVWRLNADYTKVSDPDYFNDFSSKYGSSTDGYATQKFSAGYVNQNFDATVSTKQFQVFDRESSNSYSAEPQLDVNYYQNDVGPFDTHLYGQVAHFVNSNNNMPEATRVHFEPTINLPLSNGWGSLNTEAKLLATHYQQSNLDKYNAANGTDYKESVSRVMPQFKVDGKMVFERDLQEGFTQTLEPRVQYLYVPYRDQSEIGNYDSTLLQSDYTGLFRDRTYSGLDRIASANQVTTGLTSRVYDAAAVERFNISVGQIYYFTESRTGDDNINWENNDTTGSLVWAGDTYWRIADEWGLRGGIQYDTRLDNVATGNGTIEYRRDENRLVQLNYRYASPEYIQATLPSYSTAAQYKQGISQVGMTASWPIVDRWSVVGAYYYDTNTRKAANQMLGVQYNSCCYAIRLGYERKVNGWNSNDNGGESKYDNTFGINIELRGLSSNYGLGTQQMLRSNILPYQSSL,MKKRIPSLLATMIASALYSQQGLAADLATQCMLGVPSYDRPLVEGRPGDLPVTINADHAKGNYPDNAVFTGNVDINQGNSRLRADEVQLHQQQAAGQAQPVRTVDALGNVHYDDNQVILKGPKAWSNLNTKDTNVWQGDYQMVGRQGRGTADLMKQRGENRYTILENGSFTSCLPGSDTWSVVGSEVIHDREEQVAEIWNARFKLGSVPIFYSPYLQLPVGDKRRSGFLIPNAKYSTKNGVEFSLPYYWNIAPNFDATITPHYMNKRGGVMWENEFRYLTQLGSGLTEFDYLPSDKVYEDDHSSDSNSRRWLFYWNHSGVIDQVWRLNADYTKVSDPDYFNDFSSKYGSSTDGYATQKFSAGYVNQNFDATVSTKQFQVFDRESSNSYSAEPQLDVNYYQNDVGPFDTHLYGQVAHFVNSNNNMPEATRVHFEPTINLPLSNGWGSLNTEAKLLATHYQQSNLDKYNAANGTDYKESVSRVMPQFKVDGKMVFERDLQEGFTQTLEPRVQYLYVPYRDQSEIGNYDSTLLQSDYTGLFRDRTYSGLDRIASANQVTTGLTSRVYDAAAVERFNISVGQIYYFTESRTGDDNINWENNDTTGSLVWAGDTYWRIADEWGLRGGIQYDTRLDNVATGNGTIEYRRDENRLVQLNYRYASPEYIQATLPSYSTAAQYKQGISQVGMTASWPIVDRWSVVGAYYYDTNTRKAANQMLGVQYNSCCYAIRLGYERKVNGWNSNDNGGESKYDNTFGINIELRGLSSNYGLGTQQMLRSNILPYQSSL,100,gnl|BL_ORD_ID|2786|hsp_num:0,3799,FALSE,None
LK583,9_120 # 131956 # 133188 # 1 # ID=9_120;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.602,9_120,131956,133188,+,Strict,700,705.671,Escherichia coli mdfA,85.37,3001328,protein homolog model,n/a,n/a,tetracycline antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGCAAAATTATTCGCTTTCAGGCCGCCGCCTCGGAAGGCAGGCGCTGTTGTTCCCGTTATGTCTGGTGCTGTACGAATTTTCCACTTATATCGGCAACGATATGATTCAGCCTGGCATGTTAGCCGTGGTGCAGGAATTTCAGGTGGGCAACGAATGGGTACCTACCTCAATGACTGCCTATCTGGCAGGCGGCATGTTTTTACAGTGGCTGCTGGGGCCGCTGTCGGATCGTATTGGCCGCCGTCCGGTGATGTTGACTGGCGTAGTATGGTTCATCGTCACCTGCCTGGCGACGCTGCTGGCGCAGACCATTGAGCAGTTTACCCTGCTGCGCTTCCTGCAGGGGATCAGCCTGTGCTTTATTGGCGCGGTGGGCTATGCGGCGATACAGGAGTCCTTTGAGGAGGCGGTGTGTATCAAAATCACCGCCCTGATGGCTAACGTGGCGCTGATAGCCCCGCTGCTGGGGCCGCTGGTGGGCGCCGCCTGGGTGCATATCCTGCCGTGGGAGATGATGTTTGTCCTGTTCGCCGTGCTGGCGGCCATCTCGTTCTTCGGCCTGCAGCGGGCGATGCCGGAGACCGCGACGCGGCTGGGCGAAAAGCTGTCGGTGAAAGAGCTGGGCCGCGACTATCGGCTGGTGCTGAAGAACCTGCGCTTCGTCGCCGGCGCGCTGGCCACTGGCTTTGTCAGCCTGCCGCTGCTGGCGTGGATTGCCCAGTCGCCGGTGATTATTATCAGCGGCGAACAGGCCACCAGCTATGAGTACGGCATGCTGCAGGTGCCGATTTTCGGGGCGCTGATTGCCGGCAACCTGGTGCTGGCGCGCCTGACTGCGCGCCGGACCGTGCGCTCGCTGATTATCATGGGCGGTTGGCCGATCATGTTTGGCCTGATCCTCTCTGCGGCGGCGACCGTGGTCTCTTCCCACGCTTATCTGTGGATGACGGCCGGTCTGAGCTTCTACGCCTTCGGGATTGGCCTCGCGAACGCCGGCCTGGTGCGTTTAACCCTGTTCGCCAGCGAGATGAGTAAAGGCACGGTCTCGGCGGCGATGGGAATGCTGCAGATGCTGATCTTCACCGTCGGCATCGAGCTCAGCAAACATGCTTACGAGCTGGGCGGCAACGGGCTGTTCAGCCTGTTTAACCTGCTGGGTGGGGTACTATGGCTGGGGCTGATGATTTACTTTCTGAAAGATAAAAGCGTCGGCAATTCGCAGCAGGGGTAG,MQNYSLSGRRLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVQEFQVGNEWVPTSMTAYLAGGMFLQWLLGPLSDRIGRRPVMLTGVVWFIVTCLATLLAQTIEQFTLLRFLQGISLCFIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWVHILPWEMMFVLFAVLAAISFFGLQRAMPETATRLGEKLSVKELGRDYRLVLKNLRFVAGALATGFVSLPLLAWIAQSPVIIISGEQATSYEYGMLQVPIFGALIAGNLVLARLTARRTVRSLIIMGGWPIMFGLILSAAATVVSSHAYLWMTAGLSFYAFGIGLANAGLVRLTLFASEMSKGTVSAAMGMLQMLIFTVGIELSKHAYELGGNGLFSLFNLLGGVLWLGLMIYFLKDKSVGNSQQG,MQNKLASGARLGRQALLFPLCLVLYEFSTYIGNDMRQPGMLENVEQYQAGIEWVPTSMNAYLAGGMFIQWLLGPLSDRIGRRPVMLAGVVWFIVTCLAILLAQNIEQFTLLRFLHGISLCFIGAVGYDAIQESFEEAVCIKITALMANVALIAPLLGPLVGASWIHVLPWEGMFVLFAALAAISFFGLQRAMPETATRIGEKLSLKELGRDYKLVLKNGRFVAGALALGFLSLPLLAWIAQSPIIIITGEQLSSYEYGLLQVPIFGALIAGNLLLARLTSRRTVRSLIIMGGWPIMIGLLVAAAATVISSHAYLWMTAGLSIYAFGIGLANAGLVRLTLFASVMSKGTVSAAMGMLQMLIFTVGIEISKHAWLNGGNGLFNLFNLVNGILLLSLMVIFLKDKQMGNSHEG,100,gnl|BL_ORD_ID|2421|hsp_num:0,37,FALSE,None
LK583,12_44 # 43756 # 44880 # -1 # ID=12_44;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.522,12_44,43756,44880,-,Strict,700,751.51,Klebsiella pneumoniae OmpK37,99.47,3004122,protein homolog model,n/a,n/a,monobactam; carbapenem; cephalosporin; cephamycin; penam; penem,reduced permeability to antibiotic,General Bacterial Porin with reduced permeability to beta-lactams,ATGAAAAGAAAAGTACTGGCCCTCGTTATTCCGGCTTTATTAGCCGCCGGTGCCGCGCATGCGGCGGAAATTTATAATAAAGACGGGAATAAATTAGATCTCTATGGCAAGGTAGATGGTCTGCATTATTTCTCCAGCGACTCGAAAAAAGACGGCGATCAAACTTATTTACGTTTTGGCTTTAAAGGCGAAACCCAGATCAACGATATGCTTACCGGCTATGGCCAGTGGGAATATAACGTTCAGGCCAACAACACCGAGACCTCCAGCGATCAGGCGTGGACCCGTCTGGCATTCGCCGGTATCAAAGTGGGCGATTACGGCTCCTTCGACTATGGACGTAACTACGGCGTGCTGTACGACGTTGAAGGCTGGACCGATATGCTGCCGGAGTTCGGCGGCGACTCCTACACCTATGCGGATAACTTTATGGCAGGCCGCGCCAACGGCGTCGCAACCTACCGTAACAGCGATTTCTTCGGTCTGGTGGAGGGTCTGAACTTCGCCCTGCAGTATCAGGGTAAAAACGAAGGCCAGAACGCGCAGGATATCAACGTCGGCACCAATAACCGCAGCAGCGACAGCGATGTTCGCTTTGACAATGGCGATGGTTTCGGCCTCTCCACTTCCTACGACTTCGGCATGGGCATCAGCGCGGCGGCAGCTTACACCTCGTCTGACCGTACTAACGATCAGATGACCCAGACCAACGCGCGCGGCGATAAAGCGGAAGCCTGGACCGCCGGCCTGAAGTACGACGCCAACGATATCTACCTGGCGACCATGTATTCTGAAACCCGCAATATGACCCCGTACGGCAATGACGGCGTGGCCAATAAAACGCAAAACTTCGAAGTCACCGCGCAGTATCAGTTCGACTTCGGCCTGCGTCCGGCCATCTCCTACCTGCAGTCCAAAGGCAAAGATCTGTACAATAACGGCCGCTATGCCGATAAAGATCTGGTCAAATATATGGACGTTGGCGCAACCTATTACTTCAACCGTAATATGTCCACCTATGTTGATTACAAAATCAACCTGCTGGATGGTAACGACAAATTCTACGAAGACAACGGTATCTCTACCGATAACATCGTCGCCCTGGGCCTTGTTTACCAGTTCTGA,MKRKVLALVIPALLAAGAAHAAEIYNKDGNKLDLYGKVDGLHYFSSDSKKDGDQTYLRFGFKGETQINDMLTGYGQWEYNVQANNTETSSDQAWTRLAFAGIKVGDYGSFDYGRNYGVLYDVEGWTDMLPEFGGDSYTYADNFMAGRANGVATYRNSDFFGLVEGLNFALQYQGKNEGQNAQDINVGTNNRSSDSDVRFDNGDGFGLSTSYDFGMGISAAAAYTSSDRTNDQMTQTNARGDKAEAWTAGLKYDANDIYLATMYSETRNMTPYGNDGVANKTQNFEVTAQYQFDFGLRPAISYLQSKGKDLYNNGRYADKDLVKYMDVGATYYFNRNMSTYVDYKINLLDGNDKFYEDNGISTDNIVALGLVYQF,MKRKVLALVIPALLAAGAAHAAEIYNKDGNKLDLYGKVDGLHYFSSDSKKDGDQTYLRFGFKGETQINDILTGYGQWEYNVQANNTETSSDQAWTRLAFAGIKVGDYGSFDYGRNYGVLYDVEGWTDILPEFGGDSYTYADNFMAGRANGVATYRNSDFFGLVEGLNFALQYQGKNEGQNAQDINVGTNNRSSDSDVRFDNGDGFGLSTSYDFGMGISAAAAYTSSDRTNDQMTQTNARGDKAEAWTAGLKYDANDIYLATMYSETRNMTPYGNDGVANKTQNFEVTAQYQFDFGLRPAISYLQSKGKDLYNNGRYADKDLVKYMDVGATYYFNRNMSTYVDYKINLLDGNDKFYEDNGISTDNIVALGLVYQF,100,gnl|BL_ORD_ID|2627|hsp_num:0,2785,FALSE,None
LK583,13_133 # 133579 # 133998 # -1 # ID=13_133;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.607,13_133,133579,133998,-,Strict,280,285.034,FosA6,99.28,3004111,protein homolog model,n/a,n/a,phosphonic acid antibiotic,antibiotic inactivation,fosfomycin thiol transferase,ATGCTGAGTGGACTGAATCACCTGACCCTGGCAGTCAGCCAGCTGGCGCCGAGCGTGGCGTTTTATCAGCAGCTACTGGGCATGACGCTGCATGCCCGCTGGGACAGCGGGGCTTATCTCTCCTGCGGCGATTTGTGGCTGTGCCTGTCGCTGGATCCGCAGCGGCGCGTTACTCCGCCGGAAGAGAGCGACTACACCCATTATGCGTTTAGTATTAGCGAAGCCGATTTTGCTAGCTTCGCCGCCCGCCTTGAGGCTGCCGGCGTGGCGATCTGGAAGCTGAACCGTAGCGAAGGCGCTTCGCACTATTTCCTCGATCCCGATGGCCATAAGCTGGAGCTGCACGTCGGCAGTCTCGCCCAGCGGCTGGCCGCCTGCCGCGAACAGCCGTATAAGGGGATGGTGTTTTTTGATCAGTGA,MLSGLNHLTLAVSQLAPSVAFYQQLLGMTLHARWDSGAYLSCGDLWLCLSLDPQRRVTPPEESDYTHYAFSISEADFASFAARLEAAGVAIWKLNRSEGASHYFLDPDGHKLELHVGSLAQRLAACREQPYKGMVFFDQ,MLSGLNHLTLAVSQLAPSVAFYQQLLGMTLHARWDSGAYLSCGDLWLCLSLDPQRRVTPPEESDYTHYAFSISEADFASFAARLEAAGVAIWKLNRSEGASHYFLDPDGHKLELHVGSLAQRLAACREQQYKGMVFFDQ,100,gnl|BL_ORD_ID|2399|hsp_num:0,2779,FALSE,None
LK583,15_15 # 17742 # 19490 # 1 # ID=15_15;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.569,15_15,17742,19490,+,Strict,1000,1126.69,msbA,92.78,3003950,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic efflux,ATP-binding cassette (ABC) antibiotic efflux pump,ATGCAGAACGATAAAGATCTCTCCACGTGGCAGACCTTCCGCCGACTTTGGCCGATTATCGCGCCGTTTAAAGCCGGGCTAATCGTAGCGGCGGTGGCGTTGGTGCTTAACGCGGGCAGTGACACCTTCATGTTATCGCTTCTTAAACCGTTATTGGATGATGGTTTTGGTAAAACGGATCGCTCAGTGCTGCTATGGATGCCGCTGGTGGTTATCGGCCTGATGGTGCTGCGTGGGATCACCAGCTACATCTCGAGCTATTGTATTTCCTGGGTTTCCGGCAAAGTGGTGATGACCATGCGTCGTCGCCTGTTCGGCCACATGATGGGTATGCCGGTGGCCTTCTTTGACAAGCAGTCTACCGGAACGCTGCTGTCACGCATCACCTATGATTCTGAGCAGGTCGCCTCCTCCTCTTCCAGCGCGCTGATCACCGTGGTCCGCGAAGGGGCATCGATTATCGGTCTGTTCGTGATGATGTTCTATTACAGCTGGCAGCTGTCGCTGATCCTGATCGTACTGGCGCCGATTGTGTCGGTGGCGATCCGCGTGGTCTCCAAGCGTTTTCGCAATATCAGTAAGAATATGCAGAACACGATGGGGCAGGTCACCACCAGCGCCGAGCAGATGCTGAAAGGGCACAAAGAGGTGCTGATGTTTGGCGGCCAGGAAGTGGAAACCAAACGTTTTGATAAAGTCAGCAATAAAATGCGTCTGCAGGGGATGAAGATGGTTTCCGCCTCGTCTATCTCCGACCCGATCATTCAGCTTATCGCCTCCCTGGCGCTGGCCTTTGTCCTGTATGCCGCCAGCTTCCCGAGCGTGATGGACACCCTGACCGCCGGGACCATTACCGTGGTCTTCTCCTCGATGATTGCGCTGATGCGTCCGCTGAAGTCGCTGACCAACGTCAATGCCCAGTTCCAGCGCGGGATGGCGGCGTGCCAGACGCTGTTTGCGATCCTCGATTCCGAGCAGGAAAAAGACGAAGGTACGCGGGTCATTGAGCGGGCGAAAGGCAATCTCAAGTTCGAGAACGTCACCTTTACCTACCCGGGTCGCGAAGTGGCCGCGCTGCGCAATATCAATCTCGATATCCCGGAAGGGAAAACCGTGGCGCTGGTGGGGCGCTCAGGGTCGGGTAAATCGACCATTGCCAGCCTGATCACCCGCTTCTACGATGTCGACGAGGGGCAGATCCTGCTGGATGGCCACGACCTGCGCGAGTACAAGCTGAGCTCGCTGCGCGACCAGGTGGCGCTGGTTTCACAAAACGTGCATCTGTTCAACGATACCGTCGCCAACAATATCGCCTATGCCCGTACCGAAGAGTACAGCCGCGAGCAGATTGAAGAGGCCGCGCGCATGGCCTACGCCATGGATTTCATCAACAAGATGGATAATGGTCTGGATACCATCATCGGCGAGAATGGCGTGATGCTGTCCGGCGGCCAGCGCCAGCGTATTGCTATTGCCCGCGCGCTGCTGCGTAACAGCCCGATCCTGATCCTCGATGAAGCTACCTCGGCGCTGGATACCGAGTCCGAGCGTGCCATTCAGGCGGCGCTGGATGAGCTGCAGAAAAACCGTACCTCGCTGGTTATCGCTCACCGTCTGTCGACCATTGAGCAGGCTGATGAAATCGTGGTGGTTGAAGACGGGCGGATCGTGGAGCGCGGAACGCACCATGACCTGCTGGAGCATAAGGGCGTGTACGCCCAGCTGCATAAGATGCAATTCGGCGAATGA,MQNDKDLSTWQTFRRLWPIIAPFKAGLIVAAVALVLNAGSDTFMLSLLKPLLDDGFGKTDRSVLLWMPLVVIGLMVLRGITSYISSYCISWVSGKVVMTMRRRLFGHMMGMPVAFFDKQSTGTLLSRITYDSEQVASSSSSALITVVREGASIIGLFVMMFYYSWQLSLILIVLAPIVSVAIRVVSKRFRNISKNMQNTMGQVTTSAEQMLKGHKEVLMFGGQEVETKRFDKVSNKMRLQGMKMVSASSISDPIIQLIASLALAFVLYAASFPSVMDTLTAGTITVVFSSMIALMRPLKSLTNVNAQFQRGMAACQTLFAILDSEQEKDEGTRVIERAKGNLKFENVTFTYPGREVAALRNINLDIPEGKTVALVGRSGSGKSTIASLITRFYDVDEGQILLDGHDLREYKLSSLRDQVALVSQNVHLFNDTVANNIAYARTEEYSREQIEEAARMAYAMDFINKMDNGLDTIIGENGVMLSGGQRQRIAIARALLRNSPILILDEATSALDTESERAIQAALDELQKNRTSLVIAHRLSTIEQADEIVVVEDGRIVERGTHHDLLEHKGVYAQLHKMQFGE,MHNDKDLSTWQTFRRLWPTIAPFKAGLIVAGVALILNAASDTFMLSLLKPLLDDGFGKTDRSVLVWMPLVVIGLMILRGITSYVSSYCISWVSGKVVMTMRRRLFGHMMGMPVSFFDKQSTGTLLSRITYDSEQVASSSSGALITVVREGASIIGLFIMMFYYSWQLSIILIVLAPIVSIAIRVVSKRFRNISKNMQNTMGQVTTSAEQMLKGHKEVLIFGGQEVETKRFDKVSNRMRLQGMKMVSASSISDPIIQLIASLALAFVLYAASFPSVMDSLTAGTITVVFSSMIALMRPLKSLTNVNAQFQRGMAACQTLFTILDSEQEKDEGKRVIERATGDVEFRNVTFTYPGRDVPALRNINLKIPAGKTVALVGRSGSGKSTIASLITRFYDIDEGEILMDGHDLREYTLASLRNQVALVSQNVHLFNDTVANNIAYARTEQYSREQIEEAARMAYAMDFINKMDNGLDTVIGENGVLLSGGQRQRIAIARALLRDSPILILDEATSALDTESERAIQAALDELQKNRTSLVIAHRLSTIEKADEIVVVEDGVIVERGTHNDLLEHRGVYAQLHKMQFGQ,100,gnl|BL_ORD_ID|2187|hsp_num:0,2423,FALSE,None
LK583,15_55 # 68861 # 69931 # -1 # ID=15_55;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.556,15_55,68861,69931,-,Strict,700,729.169,OmpA,99.72,3005044,protein homolog model,n/a,n/a,peptide antibiotic,reduced permeability to antibiotic,General Bacterial Porin with reduced permeability to peptide antibiotics,ATGAAAAAGACAGCTATCGCGATTGCAGTGGCACTGGCTGGCTTCGCTACCGTAGCGCAGGCCGCTCCGAAAGATAACACCTGGTATGCAGGTGGTAAACTGGGTTGGTCCCAGTATCACGACACCGGTTTCTACGGTAACGGTTTCCAGAACAACAACGGTCCGACCCGTAACGATCAGCTTGGTGCTGGTGCGTTCGGTGGTTACCAGGTTAACCCGTACCTCGGTTTCGAAATGGGTTATGACTGGCTGGGCCGTATGGCATATAAAGGCAGCGTTGACAACGGTGCTTTCAAAGCTCAGGGCGTTCAGCTGACCGCTAAACTGGGTTACCCGATCACTGACGATCTGGACATCTACACCCGTCTGGGCGGCATGGTTTGGCGCGCTGACTCCAAAGGCAACTACGCTTCTACCGGCGTTTCCCGTAGCGAACACGACACTGGCGTTTCCCCAGTATTTGCTGGCGGCGTAGAGTGGGCTGTTACTCGTGACATCGCTACCCGTCTGGAATATCAGTGGGTTAACAACATCGGCGACGCGGGCACTGTGGGTACCCGTCCTGATAACGGCATGCTGAGCCTGGGCGTTTCCTACCGCTTCGGTCAGGAAGATGCTGCACCGGTTGTTGCTCCGGCTCCGGCTCCGGCTCCGGAAGTGGCTACCAAGCACTTCACCCTGAAGTCTGACGTTCTGTTCAACTTCAACAAAGCTACCCTGAAACCGGAAGGTCAGCAGGCTCTGGATCAGCTGTACACTCAGCTGAGCAACATGGATCCGAAAGACGGTTCCGCTGTTGTTCTGGGCTACACCGACCGCATCGGTTCCGAAGCTTACAACCAGCAGCTGTCTGAGAAACGTGCTCAGTCCGTTGTTGACTACCTGGTTGCTAAAGGCATCCCGGCTGGCAAAATCTCCGCTCGCGGCATGGGTGAATCCAACCCGGTTACTGGCAACACCTGTGACAACGTGAAAGCTCGCGCTGCCCTGATCGATTGCCTGGCTCCGGATCGTCGTGTAGAGATCGAAGTTAAAGGCTACAAAGAAGTTGTAACTCAGCCGGCGGCTTAA,MKKTAIAIAVALAGFATVAQAAPKDNTWYAGGKLGWSQYHDTGFYGNGFQNNNGPTRNDQLGAGAFGGYQVNPYLGFEMGYDWLGRMAYKGSVDNGAFKAQGVQLTAKLGYPITDDLDIYTRLGGMVWRADSKGNYASTGVSRSEHDTGVSPVFAGGVEWAVTRDIATRLEYQWVNNIGDAGTVGTRPDNGMLSLGVSYRFGQEDAAPVVAPAPAPAPEVATKHFTLKSDVLFNFNKATLKPEGQQALDQLYTQLSNMDPKDGSAVVLGYTDRIGSEAYNQQLSEKRAQSVVDYLVAKGIPAGKISARGMGESNPVTGNTCDNVKARAALIDCLAPDRRVEIEVKGYKEVVTQPAA,MRSFVTSWRILDDNEAQKMKKTAIAIAVALAGFATVAQAAPKDNTWYAGGKLGWSQYHDTGFYGNGFQNNNGPTRNDQLGAGAFGGYQVNPYLGFEMGYDWLGRMAYKGSVDNGAFKAQGVQLTAKLGYPITDDLDIYTRLGGMVWRADSKGNYASTGVSRSEHDTGVSPVFAGGVEWAVTRDIATRLEYQWVNNIGDAGTVGTRPDNGMLSLGVSYRFGQEDAAPVVAPAPAPAPEVATKHFTLKSDVLFNFNKATLKPEGQQALDQLYTQLSNMDPKDGSAVVLGYTDRIGSEAYNQQLSEKRAQSVVDYLVAKGIPAGKISARGMGESTPVTGNTCDNVKARAALIDCLAPDRRVEIEVKGYKEVVTQPAA,95.19,gnl|BL_ORD_ID|2776|hsp_num:0,3787,FALSE,None
LK583,16_75 # 83128 # 83697 # -1 # ID=16_75;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.618,16_75,83128,83697,-,Strict,750,24.2534,tet(E),100,3000173,protein homolog model,n/a,n/a,tetracycline antibiotic,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGGGCGCCTCTGGCACCCTTCCCGTACACGCCCCTGGGGTGACTTTCCTCATCCCCGCTTTGTCCGGAGAGTTGATATGGAACTTCGCCAGCGGGGCGATCTCTGATCGGATCGGTCGTCGTCCGGTGCTGATGGGCATTACCGTGCTGGCCCTGCTCACCACCTGGCCGGTGATGCACTGGCTCACCGTCGCGCCCGATTTCACCCGTATGACGCTGGTCCTGCTATGGTTCTCGTTCTTCTTTGGCATGCATAACGGCGCGATGGTCGCGGCGCTTACCGAAGTGATGCCGGTACACGTCCGCACCGTGGGCTTTTCGCTGGCCTTTAGTCTCGCTACTGCCATTTTCGGCGACCTGACGCCAGCTATTTCCACCGCCCTGGTCGAGCTCACCGGCGATAAAAGCCCGCCGGGCTGGTGGCTAATGTGCGCCGCGCTGTGCGGATTCATTGCCACCGCGCTACTGTTCGTGCGGCTGAGCCGCGGCTATCAGCCGGCGGAGAGTCAGCGCAAAAAAACAAACGGGCGGAGATATGCCCCGCCCGTTTGCCGCTGTCGTCTGATTTAA,MGASGTLPVHAPGVTFLIPALSGELIWNFASGAISDRIGRRPVLMGITVLALLTTWPVMHWLTVAPDFTRMTLVLLWFSFFFGMHNGAMVAALTEVMPVHVRTVGFSLAFSLATAIFGDLTPAISTALVELTGDKSPPGWWLMCAALCGFIATALLFVRLSRGYQPAESQRKKTNGRRYAPPVCRCRLI,MNRTVMMALVIIFLDAMGIGIIMPVLPALLREFVGKANVAENYGVLLALYAMMQVIFAPLLGRWSDRIGRRPVLLLSLLGATLDYALMATASVVWVLYLGRLIAGITGATGAVAASTIADVTPEESRTHWFGMMGACFGGGMIAGPVIGGFAGQLSVQAPFMFAAAINGLAFLVSLFILHETHNANQVSDELKNETINETTSSIREMISPLSGLLVVFFIIQLIGQIPATLWVLFGEERFAWDGVMVGVSLAVFGLTHALFQGLAAGFIAKHLGERKAIAVGILADGCGLFLLAVITQSWMVWPVLLLLACGGITLPALQGIISVRVGQVAQGQLQGVLTSLTHLTAVIGPLVFAFLYSATRETWNGWVWIIGCGLYVVALIILRFFHPGRVIHPINKSDVQQRI,46.67,gnl|BL_ORD_ID|147|hsp_num:0,142,TRUE,loose hit with at least 95 percent identity pushed strict
LK583,28_23 # 26563 # 26925 # 1 # ID=28_23;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.471,28_23,26563,26925,+,Strict,150,223.402,Klebsiella pneumoniae KpnE,99.17,3004580,protein homolog model,n/a,n/a,macrolide antibiotic; aminoglycoside antibiotic; cephalosporin; tetracycline antibiotic; peptide antibiotic; rifamycin antibiotic; disinfecting agents and antiseptics,antibiotic efflux,small multidrug resistance (SMR) antibiotic efflux pump,ATGTTTTATTGGATTTTATTAGCTTTAGCAATTATTGCTGAAATTACCGGCACCTTGTCTATGAAATGGGCAAGCGTGAGCGGCGGGCACACCGGCTTTATTTTAATGCTGGCCATGATTGCCCTGTCATATATTTTTCTTGCCTTTGCGGTTAAAAAGATTGCCCTCGGTGTGGCCTATGCGTTGTGGGAAGGGATCGGTATTTTACTGATTACCCTGTTCAGCGTGCTGCTGTTTGATGAGAGTCTGTCCCTGCTGAAAATAGCCGGCTTGACCACCCTGGTGATAGGGATCGTCTTAATTAAGTCCGGCACCCAGAAAAAAGCGTCTTCCAAGCAGGAGGTGGCCCATGCAGCAGTTTGA,MFYWILLALAIIAEITGTLSMKWASVSGGHTGFILMLAMIALSYIFLAFAVKKIALGVAYALWEGIGILLITLFSVLLFDESLSLLKIAGLTTLVIGIVLIKSGTQKKASSKQEVAHAAV,MFYWILLALAIIAEITGTLSMKWASVSGGHTGFILMLAMIALSYIFLAFAVKKIALGVAYALWEGIGILLITLFSVLLFDESLSLLKIAGLTTLVIGIVLIKSGTQKKASSQQEVAHAAV,100,gnl|BL_ORD_ID|2721|hsp_num:0,3283,FALSE,None
LK583,28_24 # 26912 # 27241 # 1 # ID=28_24;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.588,28_24,26912,27241,+,Perfect,150,206.453,Klebsiella pneumoniae KpnF,100,3004583,protein homolog model,n/a,n/a,macrolide antibiotic; aminoglycoside antibiotic; cephalosporin; tetracycline antibiotic; peptide antibiotic; rifamycin antibiotic; disinfecting agents and antiseptics,antibiotic efflux,small multidrug resistance (SMR) antibiotic efflux pump,ATGCAGCAGTTTGAGTGGATCCACGCCGCCTGGCTGGCAATCGCCATTGTGCTGGAAATTATTGCCAACGTCTTTTTGAAGTTTTCCGACGGCTTCCGCCGCAAGATCTACGGCATCCTGTCCCTGGCGGCAGTATTGGGCGCGTTCAGCGCCCTGTCGCAGGCGGTTAAAGGGATCGATCTCTCGGTCGCCTATGCGCTGTGGGGCGGCTTCGGTATCGCGGCGACCATCGCCGCCGGCTGGGTGCTGTTTGGTCAGCGTCTGAATAACAAAGGCTGGGCGGGGGTTATCCTGCTGGTAGCCGGCATGGTGTTAATTAAACTCGCCTGA,MQQFEWIHAAWLAIAIVLEIIANVFLKFSDGFRRKIYGILSLAAVLGAFSALSQAVKGIDLSVAYALWGGFGIAATIAAGWVLFGQRLNNKGWAGVILLVAGMVLIKLA,MQQFEWIHAAWLAIAIVLEIIANVFLKFSDGFRRKIYGILSLAAVLGAFSALSQAVKGIDLSVAYALWGGFGIAATIAAGWVLFGQRLNNKGWAGVILLVAGMVLIKLA,100,gnl|BL_ORD_ID|2723|hsp_num:0,3286,FALSE,None
LK583,7_128 # 144124 # 145890 # -1 # ID=7_128;partial=00;start_type=ATG;rbs_motif=AGGA/GGAG/GAGG;rbs_spacer=11-12bp;gc_cont=0.564,7_128,144124,145890,-,Strict,500,595.89,Haemophilus influenzae PBP3 conferring resistance to beta-lactam antibiotics,52.37,3004446,protein variant model,"D350N, S357N",n/a,cephalosporin; cephamycin; penam,antibiotic target alteration,Penicillin-binding protein mutations conferring resistance to beta-lactam antibiotics,ATGAAAGCAGCGCCAAAAACGCCTAAAGCAAAACGTCAGGAAGAACAGGCCAACTTTATCAGTTGGCGTTTTGCGTTGCTGTGCGGCTGTATTCTGCTGGCGCTGGCTTTTCTGCTGGGTCGCGTCGCCTGGCTACAGGTGATCAGCCCCGATATGCTGGTGCGCCAGGGCGATATGCGTTCTCTGCGCGTACAGGAAGTGTCCACCGCGCGCGGGATGATTACCGATCGCTCCGGACGTCCGCTGGCGGTCAGCGTGCCGGTGAAGGCTATCTGGGCCGACCCGAAAGAGCTCCATGACGCCGGTGGGGTTACCCTGGATACGCGCTGGAAAGCGCTGGCGGATGCCCTCAATATGCCGCTGGATCAGCTGGCGACGCGCATCAATACCAATCCGCGGATGCGGTTTATCTATCTGGCGCGTCAGGTTAATCCTGACATGGCCGATTACATCAAGAAGCTGAAGCTGCCGGGCATTCATCTGCGCGAAGAATCCCGTCGTTACTACCCTTCCGGGGAAGTAACCGCTCACCTCATCGGCTTTACCAACGTCGATAGCCAGGGGATTGAAGGGGTTGAGAAAAGCTTTGATAAATGGCTTACCGGTCAGCCGGGCGAGCGTATCGTACGTAAAGACCGCTATGGCCGGGTAATTGAAGACATCTCTTCTACCGATAGCCAGGCAGCGCACAACCTGGCGCTGAGTATCGACGAACGCCTGCAGGCGCTGGTCTATCGCGAGCTGAACAACGCCGTGGCCTTTAACAAAGCCGAGTCGGGCAGCGCCGTGTTAGTGGATGTTAACACCGGTGAAGTGCTGGCGATGGCCAACAGCCCATCCTATAACCCGAACAACTTCGCCGGTACGGCAAAAGACACCATGCGTAACCGTGCGATTACCGACGTGTTTGAGCCGGGTTCGACGGTGAAACCGATGGTGGTCATGACGGCGCTGCAGCGCGGTATCGTCAACGAAAATACCGTGCTCAATACCGTGCCTTATCGAATTAACGGCCACGAAATCAAAGATGTGGCGCGCTACAGCGAATTGACCCTGACCGGGGTGCTACAGAAGTCGAGTAACGTCGGTGTTTCTAAGCTGGCGTTAGCGATGCCGTCCTCAGCGTTAGTAGATACTTACTCACGTTTTGGGCTTGGAAAGGCGACCAATTTGGGGTTGGTCGGAGAACGCAGTGGCTTATATCCTCAAAAACAACGGTGGTCTGACATAGAGAGGGCCACCTTTTCTTTCGGCTATGGGCTAATGGTAACCCCGTTACAGTTAGCGCGAGTCTACGCAACGATTGGCAGCTATGGCATCTATCGCCCGTTGTCGATTACCAAGGTTGATCCTCCGGTTCCGGGCGAGCGCGTCTTCCCGGAATCACTCGTTCGTACCGTCGTTCATATGATGGAAAGCGTGGCGCTGCCCGGCGGCGGCGGTGTGAAAGCGGCGATCAAAGGCTATCGCATCGCGATTAAAACCGGTACGGCGAAAAAAGTGGGGCCGGATGGCCGCTATATCAACAAATATATTGCTTACACCGCAGGCGTTGCGCCCGCCAGCCATCCGCGCTTCGCGCTGGTGGTGGTGATCAACGACCCGCAGGCAGGTAAATACTACGGTGGCGCCGTTTCCGCGCCGGTCTTCGGTGCCATCATGGGCGGCGTATTGCGCACCATGAACATCGAGCCGGATGCGCTGGCAACGGGCGAAAAAAGTGAATTTGTAATTAATCAAGGCGAGGGAACAGGTGGCAGATCGTAA,MKAAPKTPKAKRQEEQANFISWRFALLCGCILLALAFLLGRVAWLQVISPDMLVRQGDMRSLRVQEVSTARGMITDRSGRPLAVSVPVKAIWADPKELHDAGGVTLDTRWKALADALNMPLDQLATRINTNPRMRFIYLARQVNPDMADYIKKLKLPGIHLREESRRYYPSGEVTAHLIGFTNVDSQGIEGVEKSFDKWLTGQPGERIVRKDRYGRVIEDISSTDSQAAHNLALSIDERLQALVYRELNNAVAFNKAESGSAVLVDVNTGEVLAMANSPSYNPNNFAGTAKDTMRNRAITDVFEPGSTVKPMVVMTALQRGIVNENTVLNTVPYRINGHEIKDVARYSELTLTGVLQKSSNVGVSKLALAMPSSALVDTYSRFGLGKATNLGLVGERSGLYPQKQRWSDIERATFSFGYGLMVTPLQLARVYATIGSYGIYRPLSITKVDPPVPGERVFPESLVRTVVHMMESVALPGGGGVKAAIKGYRIAIKTGTAKKVGPDGRYINKYIAYTAGVAPASHPRFALVVVINDPQAGKYYGGAVSAPVFGAIMGGVLRTMNIEPDALATGEKSEFVINQGEGTGGRS,MVKFNSSRKSGKSKKTIRKLTAPETVKQNKPQKVFEKCFMRGRYMLSTVLILLGLCALVARAAYVQSINADTLSNEADKRSLRKDEVLSVRGSILDRNGQLLSVSVPMSAIVADPKTMLKENSLADKERIAALAEELGMTENDLVKKIEKNSKSGYLYLARQVELSKANYIRRLKIKGIILETEHRRFYPRVEEAAHVVGYTDIDGNGIEGIEKSFNSLLVGKDGSRTVRKDKRGNIVAHISDEKKYDAQDVTLSIDEKLQSMVYREIKKAVSENNAESGTAVLVDVRTGEVLAMATAPSYNPNNRVGVKSELMRNRAITDTFEPGSTVKPFVVLTALQRGVVKRDEIIDTTSFKLSGKEIVDVAPRAQQTLDEILMNSSNRGVSRLALRMPPSALMETYQNAGLSKPTDLGLIGEQVGILNANRKRWADIERATVAYGYGITATPLQIARAYATLGSFGVYRPLSITKVDPPVIGKRVFSEKITKDIVGILEKVAIKNKRAMVEGYRVGVKTGTARKIENGHYVNKYVAFTAGIAPISDPRYALVVLINDPKAGEYYGGAVSAPVFSNIMGYALRANAIPQDAEAAENTTTKSAKRIVYIGEHKNQKVN,96.39,gnl|BL_ORD_ID|2497|hsp_num:0,2886,FALSE,None
LK583,17_14 # 11199 # 12590 # -1 # ID=17_14;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.583,17_14,11199,12590,-,Strict,850,864.374,Escherichia coli UhpT with mutation conferring resistance to fosfomycin,95.03,3003890,protein variant model,E350Q,n/a,phosphonic acid antibiotic,antibiotic target alteration,antibiotic-resistant UhpT,ATGCTGGCCTTTCTGAATCAGGTGCGCAAGCCGACCCTGGATCTGCCGCTCGATGTGCGGCGCAAAATGTGGTTCAAACCTTTCATGCAGTCCTATCTGGTGGTCTTCATCGGCTACCTGACCATGTACCTGATCCGCAAGAACTTTAACATCGCGCAGAACGACATGATCTCCACCTACGGGTTGAGCATGACCCAGCTGGGGATGATTGGCCTGGGCTTCTCCATCACCTACGGCGTGGGCAAGACGCTGGTCTCTTATTATGCCGACGGCAAAAACACCAAGCAGTTCCTGCCGTTTATGCTGATCCTCTCCGCCATCTGTATGCTGGGCTTTAGCGCCAGCATGGGGGCGGGTTCTACCAGCCTGTTCCTGATGATCGCCTTCTATGCGCTGAGCGGTTTCTTCCAGAGCACCGGCGGCTCGTGCAGCTATTCCACCATCACCAAGTGGACGCCCAGACGCAAACGCGGCACTTTCCTCGGCTTCTGGAATATCTCCCACAACCTCGGCGGCGCGGGCGCGGCGGGCGTGGCGCTGTTTGGCGCCAACTATCTGTTCGACGGCCATGTGATCGGCATGTTTATCTTCCCGTCGATTATTGCGCTGATCGTTGGCTTTATCGGCCTGCGCTACGGTAGCGACTCTCCGGAATCCTACGGCCTCGGCACGGCGGAAGAGCTGTTTGGCGAAGCGATCAGCGAAGAGGACAAAGAGACCGAAGAAAATGCGATGACCAAGTGGCAGATCTTTGTTGAGTACGTGCTGAAAAACAAAGTGATCTGGCTGCTGTGCTTCTCCAACATCTTCCTCTACGTGGTGCGTATCGGTATCGATCAGTGGTCCACCGTGTACGCCTTCCAGGAGCTGAAGCTGTCTAAAGAGGTGGCGATTCAGGGCTTTACCCTGTTTGAAGTCGGCGCGCTGGTTGGCACGCTACTGTGGGGCTGGCTGTCGGATCTGGCCAACGGCCGCCGCGCGCTGGTGGCCTGCATCGCGCTGGCGCTGATTATCGCCACCCTTGGGGTTTACCAACACGCCAGCAACCAGTACGTCTATCTGGCCTCGTTATTTGCGCTGGGCTTCCTGGTGTTTGGTCCGCAGCTGTTGATCGGCGTCGCCGCCGTCGGTTTCGTACCGAAAAAAGCGATCGGCGCCGCCGATGGGATCAAGGGCACCTTCGCCTATCTGATCGGCGATAGCTTCGCCAAACTGGGTCTCGGGATGATCGCCGACGGCACCCCGGTCTTCGGCCTGACCGGCTGGGCCGGCACCTTTGCGGCGCTGGACGCCGCCGCCGTCGGCTGTATCTGCCTGATGGCCATCGTGGCTATCTTTGAAGAGCGTAAAATTCGCCGCGAGAAAAAGAACCGTATTTTGCAGACCGCCTGA,MLAFLNQVRKPTLDLPLDVRRKMWFKPFMQSYLVVFIGYLTMYLIRKNFNIAQNDMISTYGLSMTQLGMIGLGFSITYGVGKTLVSYYADGKNTKQFLPFMLILSAICMLGFSASMGAGSTSLFLMIAFYALSGFFQSTGGSCSYSTITKWTPRRKRGTFLGFWNISHNLGGAGAAGVALFGANYLFDGHVIGMFIFPSIIALIVGFIGLRYGSDSPESYGLGTAEELFGEAISEEDKETEENAMTKWQIFVEYVLKNKVIWLLCFSNIFLYVVRIGIDQWSTVYAFQELKLSKEVAIQGFTLFEVGALVGTLLWGWLSDLANGRRALVACIALALIIATLGVYQHASNQYVYLASLFALGFLVFGPQLLIGVAAVGFVPKKAIGAADGIKGTFAYLIGDSFAKLGLGMIADGTPVFGLTGWAGTFAALDAAAVGCICLMAIVAIFEERKIRREKKNRILQTA,MLAFLNQVRKPTLDLPLEVRRKMWFKPFMQSYLVVFIGYLTMYLIRKNFNIAQNDMISTYGLSMTQLGMIGLGFSITYGVGKTLVSYYADGKNTKQFLPFMLILSAICMLGFSASMGSGSVSLFLMIAFYALSGFFQSTGGSCSYSTITKWTPRRKRGTFLGFWNISHNLGGAGAAGVALFGANYLFDGHVIGMFIFPSIIALIVGFIGLRYGSDSPESYGLGKAEELFGEEISEEDKETESTDMTKWQIFVEYVLKNKVIWLLCFANIFLYVVRIGIDQWSTVYAFQELKLSKAVAIQGFTLFEAGALVGTLLWGWLSDLANGRRGLVACIALALIIATLGVYQHASNEYIYLASLFALGFLVFGPQLLIGVAAVGFVPKKAIGAADGIKGTFAYLIGDSFAKLGLGMIADGTPVFGLTGWAGTFAALDIAAIGCICLMAIVAVMEERKIRREKKIQQLTVA,100,gnl|BL_ORD_ID|2129|hsp_num:0,2373,FALSE,None
LK583,51_1 # 3 # 1037 # -1 # ID=51_1;partial=11;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.546,51_1,3,1037,-,Strict,700,691.804,Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin,97.97,3003369,protein variant model,R234F,n/a,elfamycin antibiotic,antibiotic target alteration,elfamycin resistant EF-Tu,CTGGCTAAAACCTACGGTGGTTCCGCTCGCGCATTCGACCAGATCGATAACGCGCCGGAAGAAAAAGCTCGTGGTATCACCATCAACACCTCTCACGTTGAATATGACACCCCGACTCGCCACTACGCGCACGTAGACTGCCCGGGCCACGCCGACTATGTTAAAAACATGATCACCGGTGCTGCGCAGATGGACGGCGCGATCCTGGTTGTTGCTGCGACTGACGGCCCGATGCCGCAGACTCGTGAGCACATCCTGCTGGGTCGTCAGGTAGGCGTTCCGTACATCATCGTGTTCCTGAACAAATGCGACATGGTTGATGACGAAGAGCTGCTGGAACTGGTTGAGATGGAAGTTCGTGAACTGCTGTCTCAGTACGATTTCCCGGGCGACGACACTCCGATCGTTCGTGGTTCTGCTCTGAAAGCGCTGGAAGGCGACGCAGAGTGGGAAGCGAAAATCATCGAACTGGCTGGCCACCTGGATACCTATATCCCGGAACCAGAGCGTGCGATTGACAAGCCGTTCCTGCTGCCGATCGAAGACGTATTCTCCATCTCCGGTCGTGGTACCGTTGTTACCGGTCGTGTAGAGCGCGGTATCATCAAAGTAGGTGAAGAAGTTGAAATCGTTGGTATCAAAGAAACCGCGAAAACCACCTGTACTGGCGTTGAAATGTTCCGCAAACTGCTGGACGAAGGCCGTGCTGGTGAGAACGTAGGTGTTCTGCTGCGTGGTATCAAACGTGAAGAAATCGAACGTGGTCAGGTACTGGCTAAGCCGGGCACCATCAACCCGCACACCAAGTTCGAATCTGAAGTGTACATCCTGTCCAAAGACGAAGGCGGCCGTCATACTCCGTTCTTCAAAGGCTACCGTCCGCAGTTCTACTTCCGTACTACTGATGTGACTGGCACCATCGAACTGCCGGAAGGCGTAGAGATGGTAATGCCGGGCGACAACATCAAAATGGTTGTTACCCTGATCCACCCGATCGCGATGGACGACGGTCTGCGTTTCGCAATCCGTGAAGGC,LAKTYGGSARAFDQIDNAPEEKARGITINTSHVEYDTPTRHYAHVDCPGHADYVKNMITGAAQMDGAILVVAATDGPMPQTREHILLGRQVGVPYIIVFLNKCDMVDDEELLELVEMEVRELLSQYDFPGDDTPIVRGSALKALEGDAEWEAKIIELAGHLDTYIPEPERAIDKPFLLPIEDVFSISGRGTVVTGRVERGIIKVGEEVEIVGIKETAKTTCTGVEMFRKLLDEGRAGENVGVLLRGIKREEIERGQVLAKPGTINPHTKFESEVYILSKDEGGRHTPFFKGYRPQFYFRTTDVTGTIELPEGVEMVMPGDNIKMVVTLIHPIAMDDGLRFAIREG,MLSPEGESTIVRNIAVSKEKFERTKPHVNVGTIGHVDHGKTTLTAAITTVLAKTYGGAARAFDQIDNAPEEKARGITINTSHVEYDTPTRHYAHVDCPGHADYVKNMITGAAQMDGAILVVAATDGPMPQTREHILLGRQVGVPYIIVFLNKCDMVDDEELLELVEMEVRELLSQYDFPGDDTPIVRGSALKALEGDAEWEAKILELAGFLDSYIPEPERAIDKPFLLPIEDVFSISGRGTVVTGRVERGIIKVGEEVEIVGIKETQKSTCTGVEMFRKLLDEGRAGENVGVLLRGIKREEIERGQVLAKPGTIKPHTKFESEVYILSKDEGGRHTPFFKGYRPQFYFRTTDVTGTIELPEGVEMVMPGDNIKMVVTLIHPIAMDDGLRFAIREGGRTVGAGVVAKVLG,84.35,gnl|BL_ORD_ID|1970|hsp_num:0,2158,TRUE,loose hit with at least 95 percent identity pushed strict
LK583,2_503 # 499530 # 499964 # 1 # ID=2_503;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.547,2_503,499530,499964,+,Strict,210,253.447,Escherichia coli AcrAB-TolC with MarR mutations conferring resistance to ciprofloxacin and tetracycline,84.03,3003378,protein overexpression model,n/a,n/a,fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics,antibiotic target alteration; antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGAAAAGTACCAGCGACCTGTTTAATGAAATGATCCCGCTGGGTCGCTTGATCCAGATGGTTAACCAGAAAAAAGATCGCCTGCTCAATGACTACCTCTCACCTATGGATATTACCGCGACCCAGTTTCGCGTGCTCTGCTCCATTCGTTGCGAAGTATGTATTACCCCCGTTGAGCTGAAAACCGTGCTTTCCGTCGATCCGGGCGCGATGACGCGCATGCTCGACCGCCTGGCGTGCAAAGGCTGGATTGAACGGTTACCCAACCCCGCTGACAAGCGCGGCGTGCTGGTGCAGTTGACGCCGGACGGCGCAGCCCTTTGCGAGCAGTGTCATCAGGTTGTGGGTCAGAAGTTACACCAGGAGTTAACGAAAAATCTGTCGGCGGACGAAGTCGCCATGCTTGAGCAACTGCTCAAGAAGGTCCTGCCGTAA,MKSTSDLFNEMIPLGRLIQMVNQKKDRLLNDYLSPMDITATQFRVLCSIRCEVCITPVELKTVLSVDPGAMTRMLDRLACKGWIERLPNPADKRGVLVQLTPDGAALCEQCHQVVGQKLHQELTKNLSADEVAMLEQLLKKVLP,MKSTSDLFNEIIPLGRLIHMVNQKKDRLLNEYLSPLDITAAQFKVLCSIRCAACITPVELKKVLSVDLGALTRMLDRLVCKGWVERLPNPNDKRGVLVKLTTGGAAICEQCHQLVGQDLHQELTKNLTADEVATLEYLLKKVLP,100,gnl|BL_ORD_ID|1984|hsp_num:0,431,FALSE,None
LK1145,100_5 # 3108 # 3857 # -1 # ID=100_5;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.776,100_5,3108,3857,-,Strict,50,83.5741,vanY gene in vanM cluster,34.46,3002961,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGTCGCACCCTCCCTCTCGCCGCGCTGGCCGCGCTCGCGCTGCTCGTGGCCGGTTGCGGCACGCCCGCCGCGGGCCCGTCCTCGACGCCGACGACGCCGACGTCCGGCTCCGCGAGCGCGGCCGCGTCGTCCCGCGCCGCCTCGAGCACGGCGCCGTCGTCGGGCACGCACGCCGACCCGGCCACCCTCGACGTCGTCGTGAACAAGACCCGCCCCGTGGCTCCGCCCGACTGGGCGCCCTCGGATCTGGTGGCCGTGCCCGGCAGCGAGCTGCCCCTGCGGGCGGAGGCCGCGACGGCGGCCGCTGACCTGCTGGATGCCGCCGCGGCGGCGGGCCACCGCCTCACCACCCTGAGCGCCTACCGCTCGTACGACTATCAGGTCCGGACGTACGGCCACTGGGTCGACGAGCTGGGCCGCGCCGAGGCGGACCGCGTCTCGGCGCGTCCGGGGTACTCCGAGCACCAGACCGGCCTGGCCTGGGACGTGGGCGACGCCGCGACCCCCGCGTGTGACCTCGAGGCGTGCTTCGGCGACACCGCCGCGGGCCGTTGGGTGGCCGCGCACGCCGCCGAGTACGGGTTCGTCATCCGCTATCCCGCCGGGGCCGAGGACGTGACGGGCTTCGATCACGAGCCGTGGCACCTGCGCTACGTCGGGTCCGCGGAGGCGGCCCGGGTCGAGGCGGCCGGCGGCGTCCTCGAGACCGCGTGGGGTCTGCCGCCGGCGCCGGACTACGCGGACTGA,MRRTLPLAALAALALLVAGCGTPAAGPSSTPTTPTSGSASAAASSRAASSTAPSSGTHADPATLDVVVNKTRPVAPPDWAPSDLVAVPGSELPLRAEAATAAADLLDAAAAAGHRLTTLSAYRSYDYQVRTYGHWVDELGRAEADRVSARPGYSEHQTGLAWDVGDAATPACDLEACFGDTAAGRWVAAHAAEYGFVIRYPAGAEDVTGFDHEPWHLRYVGSAEAARVEAAGGVLETAWGLPPAPDYAD,MVFQGNLLLVNNEYPVLEESIKTDVVNLFKHDELTKGYELLNREIYLSEKVAREFSEMVDAAEKEGVRHFSINSGFRNFDEQNALYQEMGSDYALPAGYSEHNLGLALDIGSTQMEMSEAPEGKWLEDNAWEYGFILRYPMDKTAITGIQYEPWHFRYVGLPHSAIIEEKNFALEEYLDFLKEQKSISGTIHGENYEISYYPITEKTDIEMPANLHYEISGNNMDGVIVTVYR,106.87,gnl|BL_ORD_ID|1673|hsp_num:0,1713,FALSE,None
LK413,1_178 # 177536 # 177979 # -1 # ID=1_178;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.340,1_178,177536,177979,-,Strict,270,276.174,mgrA,92.47,3000815,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; cephalosporin; penam; tetracycline antibiotic; peptide antibiotic; disinfecting agents and antiseptics,antibiotic efflux,ATP-binding cassette (ABC) antibiotic efflux pump; major facilitator superfamily (MFS) antibiotic efflux pump,ATGTCTGATCAACATAATTTAAAAGAGCAACTATGCTTTAGTTTGTACAATGCTCAAAGACAAGTAAATCGCTACTACTCAAACAAAGTCTTTAAAAAGTACAATCTAACTTACCCACAATTCCTTGTATTAACTATTTTATGGGACGAGTCACCTGTAAACGTTAAGAAGGTTGTGACTGAACTAGCACTTGATACTGGTACAGTATCCCCACTATTAAAAAGAATGGAACAAGTTGATTTAATCAAACGTGAACGTTCCGAAGTCGATCAACGTGAAGTATTTATTCACTTGACTGATAAAAGCGAAAAAATTAGACCCGAACTTAGCACTGCTTCTGAAAAAGTTGCAACTGCATCATCATTATCACTTGAAGAAGTGGATGAACTTAACCGATTATTAGGTAAAGTCATCGATGCATTTAATGAAGCTAAAGATAATTAA,MSDQHNLKEQLCFSLYNAQRQVNRYYSNKVFKKYNLTYPQFLVLTILWDESPVNVKKVVTELALDTGTVSPLLKRMEQVDLIKRERSEVDQREVFIHLTDKSEKIRPELSTASEKVATASSLSLEEVDELNRLLGKVIDAFNEAKDN,MSDQHNLKEQLCFSLYNAQRQVNRYYSNKVFKKYNLTYPQFLVLTILWDESPVNVKKVVTELALDTGTVSPLLKRMEQVDLIKRERSEVDQREVFIHLTDKSETIRPELSNASDKVASASSLSQDEVKELNRLLGKVIHAFDETKEK,100,gnl|BL_ORD_ID|133|hsp_num:0,154,FALSE,None
LK413,2_3 # 3062 # 3529 # -1 # ID=2_3;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.231,2_3,3062,3529,-,Strict,100,228.024,sepA,70.32,3007012,protein homolog model,n/a,n/a,disinfecting agents and antiseptics,antibiotic efflux,small multidrug resistance (SMR) antibiotic efflux pump,ATGAAGTTTTTTAGAAATAAGATGTACAATTTAATATCTACACTTATTGTTCTTACTATTTTTATTATATCAGGAACGATTTTTTTGATGTTTTTAGGATTTGGATTATATGGCTTAAGTAGGATTTTAATATATTTTAAATTAGGATATTTTGGCTATAATAAAAGCTTTTACGACAATATTTTCTATTATGGTAGTTATATTGTTTTAGGATACTTCACTTTATTCGCAGTTGAACATCTTATGGATTACTTTAGAAAACGTTTGCCACAAAATCCATATTTCCAAGGAATTACTTATCATTTAATTGGTTATTCAGTTACTACAATATTGTTTTATTTTATAATACATGTCCATTACACATATATTGATATTAAGTTTTGGGTGATTATGGTAATTATTGGATTCTTATATATTTGTAAAGAAATTTTCTATCCAGATAGCACAAATTTAAATAACAAAAAGTAA,MKFFRNKMYNLISTLIVLTIFIISGTIFLMFLGFGLYGLSRILIYFKLGYFGYNKSFYDNIFYYGSYIVLGYFTLFAVEHLMDYFRKRLPQNPYFQGITYHLIGYSVTTILFYFIIHVHYTYIDIKFWVIMVIIGFLYICKEIFYPDSTNLNNKK,MIVNFFKHKFYNLLTTMIVLFVFVLSGAIFLTFLGFGLYGLSRILIYFRLGDFTYNRNMYDNLLYYGSYIIFGYFIIFAVEHLMDYFRKMLPENAYFRGATFHLISYTVATTLFYFIIHLHYVYINIDFWVIMVIIGFLYVCKLQFYPESKNLNNRK,98.73,gnl|BL_ORD_ID|4660|hsp_num:0,5728,FALSE,None
LK413,2_4 # 3649 # 4986 # -1 # ID=2_4;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.309,2_4,3649,4986,-,Strict,200,630.558,sdrM,76.64,3007013,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGAGATTAAAATCGATGATAACGGTATTAGCATTAATTTTGATAATGTTTATGGCTGCGATTGAAGCATCAATTATTTCACTAGCAATGCCGACCATTCGTCAAGATTTAAATGCTGGAAGCTTTATTTCTTTAGTATTTACAGCATATTTTATTGCTTTAGTTATAGCAAACCCGATTGTTGGTGAACTAATGTCGCGATTTAAAATTATATATATCGCTATCACAGGGTTAGTTTTATTTGCAATAGGTAGTTTTATGTCAGGTACAAGTGAAACTTTTATGATGCTCATTATATCTAGAGTCATTCAAGGATTTGGTGCTGGTGTGATGATGTCGTTATCACAAATTGTTCCTAAACTTGCATTTGAAATCCCATTAAGATATAAAATCATGGGCATAGTAGGAAGTGTTTGGGGTGTATCAAGTATTATAGGTCCACTTTTAGGTGGAGGTATACTTGAAATAGCAACTTGGCATTGGCTTTTCTTCATTAATATTCCGATTGCCATTATTGCGATTATATTAGTCATTTTTACATTCCATTTTCCAGAGGAAGAAATCATATCTAAGACAAACTTTGATGTAAAAGGTTTAAGTTTATTTTATGTATTTATTGGTTTATTAATGTTTAGCTTGCTTAATCAAAATCAAGTTTTATTGAATGTTTTATCACTATTACTTGCATTATTGATAGGGTATATTTTATATAAAGTTGAAAAAACAACTGATCACCTATTTTTACCAGTGGTAGAATTTAATAAATCCATTGCCTTAGTATTTATTACAGATTTACTCATTGCCATTTGTTTAATGGGCTTCAATTTATATATTCCAGTATATCTACAAGAACAAATCGGTTTATCACCGCTTCAAAGTGGATTTGTTATTTTTCCATTATCTGTAGCATGGATAATCTTAAACTTTAACCTAGCTAAATTAGAAGCGAAGTTTTCAAGAAAAGCATTATATATTGGCGCATTTACCTTCCTAATCATTGGAAGTATCATTATTATTTTCGGTATAAAAACCCCTTTACTTATAGCATTTAGCGTTATTCTTGCTGGCTTGAGTTTTGGGTTTGTATATACAAAAGATAGTGTCATTGTGCAAGAGGAAACATCTCCACATCAAATGAAAAAAATGATGTCATTTTACGCATTGACTAAAAACTTAGGGTCTTCAATTGGATCAACGGTTATGGGTTATATGTATGCTATGAAAGCAGGTTGGTTCGGTAGCAATTTGCATAATGTACTAGGTTTAGCAATTATTATTGCAATTGTATTAGTTGCATTATGGAGTTTCATTTATAAGAACAAACCGGTGACTAACTAA,MRLKSMITVLALILIMFMAAIEASIISLAMPTIRQDLNAGSFISLVFTAYFIALVIANPIVGELMSRFKIIYIAITGLVLFAIGSFMSGTSETFMMLIISRVIQGFGAGVMMSLSQIVPKLAFEIPLRYKIMGIVGSVWGVSSIIGPLLGGGILEIATWHWLFFINIPIAIIAIILVIFTFHFPEEEIISKTNFDVKGLSLFYVFIGLLMFSLLNQNQVLLNVLSLLLALLIGYILYKVEKTTDHLFLPVVEFNKSIALVFITDLLIAICLMGFNLYIPVYLQEQIGLSPLQSGFVIFPLSVAWIILNFNLAKLEAKFSRKALYIGAFTFLIIGSIIIIFGIKTPLLIAFSVILAGLSFGFVYTKDSVIVQEETSPHQMKKMMSFYALTKNLGSSIGSTVMGYMYAMKAGWFGSNLHNVLGLAIIIAIVLVALWSFIYKNKPVTN,MRLKSIITVIALILIMFMSAIESSIISLALPTIKQDLNAGNLISLIFTAYFIALVIANPIVGELLSRFKIIYVAIAGLLLFSIGSFMCGLSTNFTMLIISRVIQGFGSGVLMSLSQIVPKLAFEIPLRYKIMGIVGSVWGISSIIGPLLGGGILEFATWHWLFYINIPIAIIAIILVIWTFHFPEEETVAKSKFDTKGLTLFYVFIGLIMFALLNQQLLLLNFLSFILAIVVAMCLFKVEKHVSSPFLPVVEFNRSITLVFITDLLTAICLMGFNLYIPVYLQEQLGLSPLQSGLVIFPLSVAWITLNFNLHRIEAKLSRKVIYLLSFTLLLVSSIIISFGIKLPVLIAFVLILAGLSFGYIYTKDSVIVQEETSPLQMKKMMSFYGLTKNLGASIGSTIMGYLYAIQSGIFGPNLHNVLSAVAVISIGLIVLWVVFFKEQSSQSKE,99.55,gnl|BL_ORD_ID|4661|hsp_num:0,5729,FALSE,None
LK413,2_174 # 153267 # 153422 # -1 # ID=2_174;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=11-12bp;gc_cont=0.327,2_174,153267,153422,-,Strict,500,22.3274,OXA-665,100,3004478,protein homolog model,n/a,n/a,carbapenem; cephalosporin; penam,antibiotic inactivation,OXA beta-lactamase,ATGTCTCAACAGGAGCTAGCTAGGCGCATTGGTGTATCAAGACAGACAATCAATATGATAGAAAATGATAAATATAATCCATCGCTTAAACTATGTATAAACATAGCTAAAGTATTATCCGTTACACTTAATGATTTATTTTGGGAAGGTGATTAA,MSQQELARRIGVSRQTINMIENDKYNPSLKLCINIAKVLSVTLNDLFWEGD,MKKNLFACLVLSTALTQVACSTLQTTADPSTQASTAQQSIKSYFDEVQTKGVIVIKQDGQLQTYGNDLSRANTEYVPASTFKILNALIGLENHKVTLNEVFKWDGQKRSFPTWEKDMNLAEAMKLSAVPVYQELARRIGVDLMAQEVKRLNFGNAQIGTQVDNFWLVGPLKVTPVQEVEFVEQLAHKQLPFKPEVQETVQQMILLQEVKGNKIYAKSGWGMDLDPQVGWLTGWVEQPNGKKVAFSLNMEMKPKMSGSIRNEITLKALENLGVI,18.68,gnl|BL_ORD_ID|2591|hsp_num:0,2910,TRUE,loose hit with at least 95 percent identity pushed strict
LK413,3_22 # 24982 # 26370 # -1 # ID=3_22;partial=00;start_type=ATG;rbs_motif=AGGA/GGAG/GAGG;rbs_spacer=11-12bp;gc_cont=0.354,3_22,24982,26370,-,Strict,525,530.02,norC,58.39,3007010,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGAATCAACAACAAGAATTTAAAGGTAATAATAGATTATTAATTGGTATTGTTTTATCGGTGTTAACATTTTGGCTATTTGCGACGTCATTAGTTAACGTGATTCCAACATTGACGCAAGCATTTCATAGTCGTTTAGAGACAATCAGTATAGCCGTCAGTCTAACAGCACTCTTTTGTGGAATGTTTGTTGTAGGTGCTGGCGGTCTTGCTGATACATATGGGCGTGTCAAATTAACGAATATCGGTTTGTGGCTTAATATCATAGGATCATTACTTGTTATTGCTACATCTTTTGTGCCATTACTATTAATAGGAAGAGCAATTCAAGGTTTATCCGCAGCAGCCATTATGCCGGCGACTTTAGCAATAGTGAAAACATACTATCACGGTAAAGATAGACAACGCGCATTGAGTTTTTGGTCCATAGGCTCTTGGGGTGGCTCAGGTTTAGCATCTATATTTGGTGGTGTAATGACTACATTTTTAGGATGGAAATATATATTTATATTTTCTATTATCGCGTCGCTTATTGCGTTGTTGCTTATTAAAGGCACACCAGAAACAACTGCATACCAAGGCAAAGAGAAGAAACGCTTTGATGTTATAGGTGTAGGGTTGCTTGTTTTAATTATGCTCAGTATCAATATTATTATTACGCAAGGGTCAAAGATGGGATGGCTTTCTATATTTATCATATGTTTGATATGTTTTTTTATTACGATGGCTATCATATTTTATTACTTTGAAAGAAAATCATCGTATCCATTAATAGATTTTAATCTTTTTAATAATAGATTATATTCGGTTGCAACATTAGCTAACTTTTTACTAAATACAGTGGCAGGAACACTCATTGTTGCGAATACGTTTGTACAACAAGGTTTAGGATTTTCTGCTTTTAAAGCAGGTATGTTATCAATCACATATTTAGTTGCTGTGCTTTCTATGATAAGAGTTGGCGAAATGTTTTTAAGAAAAGTGGGACCCAGACAACCAATGTTACTTGGTACGTTTTCAACCATGTTAGGCGTGTTATTCATGTCGATGACTATGCTCTCGGTTACAAGTTACATTGTAGTTTGTGTATTAGGTTATTTGTTATTTGGATTGGGATTAGGTTTGTTTGCAACACCATCCACAGATACTGCCATTTCCAATTGTTCAGAATCAGAAGTAGGTGTGGCAGCAGGTATATATAAAATGGCCTCATCTTTAGGTGGTGCATTTGGTATTACTTTAGCCGGTACGATTTATAGTGTAATGGCAAGTACATCTTCTATTGCTACTGGTGCTATGATAAGCTTCTGGTTTAATGCTTTAATGGCATTAAGTTCATTTTTAGTAGTTTGTGTAGCTTTGCCCAAATTATCACGTCGCTCAAAATAA,MNQQQEFKGNNRLLIGIVLSVLTFWLFATSLVNVIPTLTQAFHSRLETISIAVSLTALFCGMFVVGAGGLADTYGRVKLTNIGLWLNIIGSLLVIATSFVPLLLIGRAIQGLSAAAIMPATLAIVKTYYHGKDRQRALSFWSIGSWGGSGLASIFGGVMTTFLGWKYIFIFSIIASLIALLLIKGTPETTAYQGKEKKRFDVIGVGLLVLIMLSINIIITQGSKMGWLSIFIICLICFFITMAIIFYYFERKSSYPLIDFNLFNNRLYSVATLANFLLNTVAGTLIVANTFVQQGLGFSAFKAGMLSITYLVAVLSMIRVGEMFLRKVGPRQPMLLGTFSTMLGVLFMSMTMLSVTSYIVVCVLGYLLFGLGLGLFATPSTDTAISNCSESEVGVAAGIYKMASSLGGAFGITLAGTIYSVMASTSSIATGAMISFWFNALMALSSFLVVCVALPKLSRRSK,MNETYRGGNKLILGIVLGVITFWLFAQSLVNVVPNLQQSFGADMGTISIAVSLTALFSGMFVVGAGGLADKIGRVKMTNIGLLLSIIGSALIIITNLPALLILGRIIQGVSAACIMPSTLAIMKTYYEGAERQRALSYWSIGSWGGSGICSLFGGAVATTMGWRWIFIFSIIVAVLSMLLIKGTPETKSEVTNTHKFDVAGLIVLVVMLLSLNVVITKGAALGYTSLWFFGLIAIVIVAFFIFLNVEKKVDNPLIDFKLFENKPYTGATISNFLLNGVAGTLIVANTFVQQGLGYTALQAGYLSITYLIMVLLMIRVGEKLLQKMGSKRPMLLGTFIVIIGIALISLVFLPGIFYVISCVVGYLCFGLGLGIYATPSTDTAISNAPLDKVGVASGIYKMASSLGGAFGVAISGAVYAGAVAATSIHTGAMIALWVNVLMGIMAFIAILFAIPNDDKRVKDAK,100,gnl|BL_ORD_ID|4656|hsp_num:0,5726,FALSE,None
LK413,3_120 # 134913 # 136280 # -1 # ID=3_120;partial=00;start_type=TTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.297,3_120,134913,136280,-,Strict,50,133.265,vanW gene in vanG cluster,29.29,3002965,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanW; glycopeptide resistance gene cluster,TTGAATATTTTATTTCCATCAGTATATTTAGATAGTGTTTATGCGATAGATTATGAAAAAGTTAAAGAATTAGGCTATAAAGCTATAATTTTTGATATAGACAGTACTTTAGTCCCTCATGGTGATGACACATCTGACCAAGTAGATGAATTATTTGCACACATTCATGATGTAGGATTAAAAACATTGTTATTATCTAACAATAGCGATGAACGAATTGCGCTTTTTAACAGAAATATTCAAACTTTGTATATCCCTATGGCGAATAAACCTCACAAACCTAATTTTTTTAAAGCTATCGATATGTTAGGTGTTAATCGCTCAGAAGTTTTACTTGTTGGCGATCAAATCTTTACAGATGTTTTAGGGGCAAATTTATGTGGCATTGACAATGTATTGGTTAATTTCTTAAAACATAAAGAAGATATCAATATAGGTAAAAAACGCCAAGTAGAAAAACTTATTTTACAAGTTTATACACTGTTATATAAAAAGAGAAAGCATAGACTATCAGATATAGTAGTAGGAGATTATAAAAAAATGGATAAAAAGAAAAAATTGTTCTGTGAAATTCATCCCGCTTTTTATGCGATTTCAGTACGCAAAGGTATATTGAAAAGACACGTTGATAATCTAAGACAAAAAACAAAGTTTGCTCGTACATTTAAAAAAGAACAATTGCCAAATGTGGTTCATAGTTATTCGACACACTTGATTAAAAAAGGTAAAGATATTGATCCTGAATTACAATACAATAAAGCATATAATATTCAACTAGCTTCTTCTAAAATGGATGGGATTATAATAAAACCTGGTGAAGAATTTTCATTTTGGAAGCTAGTGGGTAAGATTAATAAGAAAAATGGTTATAAAGATGGCAGAGTCATTATAAATAACAAAGTACAACCAGGTATGGGGGGTGGACTTTGTAATTTAGCCAATTCAATCAATTTACTTATACAACATAGTCCATTAGAAGTTATTGAATTACATACGCATTCCGATGCTTTATCACCAGACCATGGCAAGCGAGTACCATTCGGAACAGGCACGTCTATCACGTATAACTACATTGATTATCGTTTTAAAAATACAACGGATCAAACGGTTCAGATTAATTTATGGGTTGAAAATGAAACCTCTTATGCAGAGTTAAGAAGTGAAAAGCCGTTTCCAGTCAAATTTAATTTGATTGAAAGAGATCATCATTTTACTAAAGTGGATGGTAAATTTTACCGTAAGTCTAATATTTATAAAGAAACAATTGATAAGAAAACGAATAAAGTCATAAAAGAAGAGTTAGTATATAAAAACAATTCTGAAGTATTGTTTGATTATGATTTAATACCGAAAGATTTAGTAGTATAA,MNILFPSVYLDSVYAIDYEKVKELGYKAIIFDIDSTLVPHGDDTSDQVDELFAHIHDVGLKTLLLSNNSDERIALFNRNIQTLYIPMANKPHKPNFFKAIDMLGVNRSEVLLVGDQIFTDVLGANLCGIDNVLVNFLKHKEDINIGKKRQVEKLILQVYTLLYKKRKHRLSDIVVGDYKKMDKKKKLFCEIHPAFYAISVRKGILKRHVDNLRQKTKFARTFKKEQLPNVVHSYSTHLIKKGKDIDPELQYNKAYNIQLASSKMDGIIIKPGEEFSFWKLVGKINKKNGYKDGRVIINNKVQPGMGGGLCNLANSINLLIQHSPLEVIELHTHSDALSPDHGKRVPFGTGTSITYNYIDYRFKNTTDQTVQINLWVENETSYAELRSEKPFPVKFNLIERDHHFTKVDGKFYRKSNIYKETIDKKTNKVIKEELVYKNNSEVLFDYDLIPKDLVV,MIEVYKLTQRKRLTQLFPFLLPLRKWQRKKYFYFKMKFDGNRYAKKTSEKLLPNTVFETSSLMLNENSGFDMKYQINKVHNLKLAAKTINKVIIEPKETFSFWQLVRWADRHEKYKDGLNLVNGKIVGSYGGGLCQLSNMLFWLFLHTPLVIVERHGHAVESFPSTTEDLPCGTDATINEGWLDLKLRNDTDNTFQIEISFDDNFMYGRILSQSSVNIEYTVFNSSVSYFKREEKVYQIASVCRTEKDKMTGSQTEKELYVNQCEIAYKLPDDVKIEERGV,161.92,gnl|BL_ORD_ID|4743|hsp_num:0,1622,FALSE,None
LK413,12_7 # 6808 # 7308 # 1 # ID=12_7;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.319,12_7,6808,7308,+,Strict,50,92.8189,vanY gene in vanF cluster,36.96,3002958,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGGTGAATAAGCAAATTAAATTACCAAAAGACTATAATCCTGGGGAAAATCCTAAAGCAGTGAAAGCATTAAATAAAATGATTACTGATGCGAAAAAAGATCATATCAATTTATACAAAATTAGTGGCTTCAGAAGCTATCAAACTCAAATTCAATTATTCAATAATTATAAAGCTAGAGATGATGAAAAAGCAGCTAATAAATATAGCTCTAAACCAGGTCATTCAGAACATCAAACTGGTTTATCATTCGATGTGGGTGCACAGGGATCTGATAAAAACTTATACCGCAGTTTTGGTAAAACCAAAGAAGGTCAATGGATTAAACGCCATGCAGATGAATATGGCTTTATTATTAGATATGGTAAAGGCAAAGAAAATGAAACTGGCTATCAATATGAGCCATGGCATTTACGCTATTTAGGTAAAGAGAAAGCCAAAGAAGTCAAAGAGTCTGGCCAAAGTTTAGAATCTTATTTAGGTTTATATCCTAAAAAATAA,MVNKQIKLPKDYNPGENPKAVKALNKMITDAKKDHINLYKISGFRSYQTQIQLFNNYKARDDEKAANKYSSKPGHSEHQTGLSFDVGAQGSDKNLYRSFGKTKEGQWIKRHADEYGFIIRYGKGKENETGYQYEPWHLRYLGKEKAKEVKESGQSLESYLGLYPKK,MKKWGLLLVFALFLVFIFNILPISQDKVEDRIYEQNDKDTSDDKMTAENMQKIELTEEQIYQGNLLLVNNEHPVHQKSIKSDIINLFTHKELTKGYGLLDNEIKLSEEIAGKFSEMIAAAEEDGVSNFLISSGYRDLDEQSRLYEEMGSDFALPAGHSEHNLGLSLDVGSTQMKMDKAPEGKWIEKNCWEYGFILRYPLDKTDVTGIQYEPWHIRYVGLPHSAIMQEMNLALEEYLDYLKEEKSISVRVDGKKYTISYDPISQNETIEVEVPADEQYEISGNNIDGVIVTTFS,56.66,gnl|BL_ORD_ID|1808|hsp_num:0,1899,FALSE,None
LK413,14_13 # 9419 # 10798 # -1 # ID=14_13;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.291,14_13,9419,10798,-,Strict,200,223.402,mdeA,40.05,3007011,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; aminoglycoside antibiotic; penam; tetracycline antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGAATTCTTCTAAGTATTTCGATCATTTAATTGTTTTTACAGCAGGAATAGGAATGTTTTTATCCACCCTTGATAGCGGAATTATCAATGTCGCATTACCCACTTTATCTAAATCTTTTAATGTTGATACTTCTTTTATTACTTGGAGTGTCACACTATATACTTTATTATTAACAGGCACAATTATAATATTTGGGAGACTAAGCGATAAATACAGTCGTTTAAATATATATAGTTTAGGATTAACTATTTTTTTAATAGCTTCTATTTTATGCGGTTTTTCAAACAACGTCATACAATTAATCGTTTTTCGTGGTTTACAAGGTATAGGTGCAGCAATGTTACAAGGAACTGCTACGGCTATTATTACTACAACCATTCCTGAAAATAGACAAGGTTCTGCGTTAGGAACGTTAAGTATTCTATTAGGAATAGGTCCTGTTTTAGGTCCAAGTATTGGAGGTCTTTTAATATCTGTAGGTAATTGGAGATGGATATTTTGGATCAATATTCCCTTTATATTTATCGGTTTAATCGGCTGTTTATTTTTAAAAAGATATATTAAAGAGCAAAAAAGTACGTCTATCCATTTAGATATACGTGGAAATTCATTATTATTTCTATCTATCTTTTGTTTATTAATAAGTTTAACATCTTGGTCTTATCACTCAATTTTTAATATATCAGTATATGGCAATTTCCTAATCTTTATTGTTTCTTTTTGCCTATTTATTATATGGGAGTTAAAAACAAATCATCCTATCATCGATTTACGTTTATTCAAGAATGTATCATTTTCATCTCCAATATTTGCAATATTTGTATTTGGAGGTACAGCATCTTTAGGTTTTATCATTCCTCCATATATTTTAGAAAAGATTAATCATCTTTCAGCTTGGCAAATAGGATTAGTTAACCTTGCTTCTCCTTTAGGATTAGTACTTATTTCAAAAATATCTGGTAAATTAATTTCTCGCATTGGCAATATTGTATTAATGACTACAGGACTAATTATTATGATTGTGGCATATACAAGCCTAGGATTATTACAATATATATTAAATCCAGTGACAATAAGCTTATTATTACTAATATATGGTATAGGAGGAGGTTTTTTCCTACCGTCTAATACTTCAGCAATAATGGGAACTGTATCTCAAGATATGCAAGGTACTGCTGGAGCTACACAAAGAATGGTTCAAAATATAGGTATTGCTTTTTATACAGCAGTTACTTCATTATTTATCAGTAATTCATCAAATTCAGATAAACTCATAGAAGGGTCAAGTCATGCATGGTTATTTGCATCAATAACACTCTTTTTAGCATTATTACCTTTTTTATTAAAAATATTAAAGACTAAATATGAACCTAATTAA,MNSSKYFDHLIVFTAGIGMFLSTLDSGIINVALPTLSKSFNVDTSFITWSVTLYTLLLTGTIIIFGRLSDKYSRLNIYSLGLTIFLIASILCGFSNNVIQLIVFRGLQGIGAAMLQGTATAIITTTIPENRQGSALGTLSILLGIGPVLGPSIGGLLISVGNWRWIFWINIPFIFIGLIGCLFLKRYIKEQKSTSIHLDIRGNSLLFLSIFCLLISLTSWSYHSIFNISVYGNFLIFIVSFCLFIIWELKTNHPIIDLRLFKNVSFSSPIFAIFVFGGTASLGFIIPPYILEKINHLSAWQIGLVNLASPLGLVLISKISGKLISRIGNIVLMTTGLIIMIVAYTSLGLLQYILNPVTISLLLLIYGIGGGFFLPSNTSAIMGTVSQDMQGTAGATQRMVQNIGIAFYTAVTSLFISNSSNSDKLIEGSSHAWLFASITLFLALLPFLLKILKTKYEPN,MTKHLQDFLITVIAGMGMLLSTLDTGIINVALSFLRGQFQTTTNIASFTITGYTLALAISILPLGVLSDKFGKLKISYLGFVLFGLSSLFCGFANSIGWLITGRIIQGMGAAALQATSAALITTLVSEDRKNSAISILGVMIGLGPVLGPSLGGILLSLNLWRFIFWINVPFALIVIICNHYLLTKVSEQTSEWTLDSLGTVLNASMLVCLLLGLSLLSKPHLLGISLILIIISFLIGIWFYRLECSKESALVNVKGLSENPRVLSYLFQTVAFGFASAMIFLLPPFIFEQLYHLGVGQTGFLVLGAPAGLVLFSRISGKINDGSKNKSFSHIGLGIIILSLIFLLLLTPSWPYLFLTLGLFIYGIGGGYFQPANMASIMLASPMKMQGSTGALQRMVQNIAISAGSAIGSTCLNLWSNNLLLATRIGWGITLVLVILSLKELTPFKMTNKTE,101.32,gnl|BL_ORD_ID|4659|hsp_num:0,5727,FALSE,None
LK413,16_2 # 2259 # 2465 # 1 # ID=16_2;partial=00;start_type=ATG;rbs_motif=3Base/5BMM;rbs_spacer=13-15bp;gc_cont=0.208,16_2,2259,2465,+,Strict,700,23.0978,ACC-3,100,3001817,protein homolog model,n/a,n/a,monobactam; cephalosporin; penam,antibiotic inactivation,ACC beta-lactamase,ATGATATTTAATAAAAAAATTGAATTAGAATATAAATTTGAAGATGAAGTGACCATTTGTAGAGACATTTATAAGGTTAGCGATAGCAATAGTGAAAATGGAAAGAATTATATTTATAATCAATCACAAAAATATTGGGTTATTAATTTTAAAAAGGGAGAGTTTAATTTTTTAAAGAAGAAAACAAAATTTAGAAAAAGTAGTTAA,MIFNKKIELEYKFEDEVTICRDIYKVSDSNSENGKNYIYNQSQKYWVINFKKGEFNFLKKKTKFRKSS,MRKKMQNTLKMLSVITCLALTAQGAMASEMDQAKIKDTVDSLIQPLMQKNNIPGMSVAVTLNGKNYIYNYGLASKQPQQPVTDNTLFEVGSLSKTFAATLASYAQVSGKLSLDKSISHYVPELRGSSFDHISVLNAGTHTTGLALFMPEEVKNTDQLMAYLKAWKPADPAGTHRVYSNIGTGLLGMIAAQSMGMTYEDAIEKTLLPKLGMTHTYLNVPADQAENYAWGYNKKNEPIHVNMEVLGNEAYGIRTNASDLIRYVQANMGQLKLDGNSTLQKALTDTHIGYFKSGKITQDLMWEQLPYPVSLPDLLTGNDMAMTKSVATPIVPPLPPQENVWINKTGSTNGFGAYIAFVPAKKMGIVMLANKNYSIDQRVT,18.04,gnl|BL_ORD_ID|1304|hsp_num:0,1422,TRUE,loose hit with at least 95 percent identity pushed strict
LK1054,18_46 # 55184 # 56827 # 1 # ID=18_46;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.708,18_46,55184,56827,+,Strict,50,86.2705,vanW gene in vanI cluster,33.33,3003724,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanW; glycopeptide resistance gene cluster,GTGCTCGCCGTCGTCGCCGTGATCACGCTCGTCCTCGCCGCGGAGTTCGTGGCCACCCGCTCCGATTCCCCACGCAACGCCGTCGTCGGCGGTATCGATGCGGGCGGTCGGAACTCCGCCGAACTCACCTCCGTACTCGACGAGCTGACGGCGCGCTCGCGACAACCGGTCGTCTTGCGGACGCCGGAGGGCTCGGCCGAGGTCGCGCCCGCCGAGCTGGGACTCACATACGACGCCGATGCGACGCGGGCTCGTCTCCTCGAGCAACCGCGCAATCCGCTCGTCCGTCTGGCCGCGCTGCTCGGCCGCGACTTCGACGTCGAGCCGGTCGTCACGCTGGATCGGACGGCGATGAACGCGGCGCTCGACGCCCAGCGCGCGTCACTCGAGAAGGCCGCGGTCGAGGGTGGTGTGCACTACGACGGCACCGAGCCCGTCGGGGATCAGCCCGCCAAGGGTGAACGCATCGCGCGAGACGCTGCCGCCGCGACCCTCCTCGACCGTTGGCTGGACGGCGCCCCCGTCGACCTGCCCATGGAACCCTTCTCGCCGACGGTGAGCGCCGAGGTCGTGGCCGCGACCGTCGCCGGACCGGCCGAACGGGTGGTCGCGGCTCCCGTGAGTCTCGTGGACCGCCGCAAACGGACGGTCGAGGTGCCCGCGGGAGACCTGGCGTCGATGGTGACCTTCGGGCCCGACGGCCGCGGCGGGCTCACCCCCCGAGCCGACGAGAAGGTGGGGCGCGAGATCCTCGCCCCCGACCTCGACGCCTCGCAACGGGCCCCCGTCAGCGCGACGTTCAGTCTGGCGTCCGGCCGTCCGCAGGTGGTGCCGGGCGTCGACGGCGCCGCGATCAACTGGCCGAAGACCCTGGCCGCCGTCGCCACGAGTGCGGCGGCCGACGGTGGCGATCGCAGGGTCGAGGTCGTCTACGACGACGTCGAGCCGAAGCTCACGACCGATGCCGCGCGCAAGCTCGGGGTCACCGAACTGATCAGCGAGTACACCACCGGTGGCTTCTCGAGCGCTTCCGGGGAGAACATCCGGCTCGTCGCCGCCGAGGTCGACGGGGCCCTCGTCCTGCCCGGAAAGGTGTTCTCGCTCAACGGGCACACCGGGCCGCGCGGAGCGGAGCAGGGGTACGTGGAGTCGACGATCATCGACCACGGTCGGGCGTCGAACGCGGTCGGCGGCGGGATCTCCCAGTTCGCGACGACCCTGTACAACGCGACCTATTTCGCCGGGCTCGAAGACGTCGACCACACCGAGCACGCGTACTACATCTCGCGGTACCCGGAGGCGCGGGAGGCGACCGTGTTCGAAGGCGCCATCGACCTAAAGTTCCGCAACAACACGCGGCACGGCGTGCTGATCGAGACCGCCTGGTCGCCGTCGTCGGTGACGGTTCGGCTCTGGGGAACGAAGGCGTTCGAGGTCGAGTCGGTCACGGGTGAGCGGGTTGCCCCCACCGATCCGCCGCGAGTCCGCGTTCCGCGCGGGGACGACTGCATCCCGAGCAGCGGGAGCAAGGGTTTCACGGCATCGGACACCCGGATCATCAAGGACGCGCGTACCGGACGGGAGATCGATCGGTCCACCCGCACCGTCCGCTACGCGCCCGAACCCATCGTGAAGTGCGTCTGA,MLAVVAVITLVLAAEFVATRSDSPRNAVVGGIDAGGRNSAELTSVLDELTARSRQPVVLRTPEGSAEVAPAELGLTYDADATRARLLEQPRNPLVRLAALLGRDFDVEPVVTLDRTAMNAALDAQRASLEKAAVEGGVHYDGTEPVGDQPAKGERIARDAAAATLLDRWLDGAPVDLPMEPFSPTVSAEVVAATVAGPAERVVAAPVSLVDRRKRTVEVPAGDLASMVTFGPDGRGGLTPRADEKVGREILAPDLDASQRAPVSATFSLASGRPQVVPGVDGAAINWPKTLAAVATSAAADGGDRRVEVVYDDVEPKLTTDAARKLGVTELISEYTTGGFSSASGENIRLVAAEVDGALVLPGKVFSLNGHTGPRGAEQGYVESTIIDHGRASNAVGGGISQFATTLYNATYFAGLEDVDHTEHAYYISRYPEAREATVFEGAIDLKFRNNTRHGVLIETAWSPSSVTVRLWGTKAFEVESVTGERVAPTDPPRVRVPRGDDCIPSSGSKGFTASDTRIIKDARTGREIDRSTRTVRYAPEPIVKCV,MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVLAEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPELLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGMETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGGEFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSHSLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDEPDGYPVKPREWSK,146.65,gnl|BL_ORD_ID|4748|hsp_num:0,2242,FALSE,None
LK1188,1_222 # 246055 # 247191 # -1 # ID=1_222;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.694,1_222,246055,247191,-,Strict,175,178.333,vanT gene in vanG cluster,31.98,3002972,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,glycopeptide resistance gene cluster; vanT,ATGAGCCTCACCGCTCCCGTCGTCGCCACCATCGACCTGGACGCCATCGCCTCGAACCTGCGCGGCCTTCGCGCGAAACTTCCGTCCGGCACGGCGATGCTGGCGGCGGTGAAGGGCAATGCCTATGGCCATGGTGCCGTCCCTGTGTCGCGTTTCCTCCAGTCGCAGCGGCTGGTCGAGATGCTGGGCGTGGCGACCGTCGCTGAGGGCATCCAGCTGCGCGATGCCGGGGTCGGGCTGCCGATCCTGAAGCTGAGCCACTGCCTGCCCGATGAGGTCGCCCGCGCCGTCGGGGCCGGGCTGAGCCTGACGGTCGTCGACGAGGACACCATTCGCACCGCAGCGAACGCTGTCGAGGACACGACGGTGGGCGTCCACGTGAAGCTTGATTCGGGCATGGGACGCATCGGCGCCCCGCTCGAGGACGCCCCCCGCCTCGCACGACTCGTGCGCGACCTGCCCGGCATCAGCCTGGATGGGATCTTCACCCACCTGCCCGTCAGCGACGTGGCAGACGACGGCGGCTTCACCCGCGACCAACTCGCCCGCTTCCGCGCGGCAGTGGAGGCGGTGCAGGCCGAGGTCGGCCCGGTGCCGTTCGTCCACGCCGCGAACTCCGGGGCGATCCTGGGGGCGGAGGACCTGGACGGCTTCACGCTGGCGCGTCCGGGGGTCTCGGTCTACGGCTACTACCCGGACGCCACCACCCCGCGCTCGGTGGAGTTGACCCAGGCGCTGCGGTGGACGACACGACTGCTCTTCCGCAAGCTCGTCACCGCGGGAACGACGGTGGGATACGGCCGCACCTGGACTGCCGACCGCGACACCTGGGTCGGGACGCTCCCGGTCGGGTACGCCGACGGCTTCAGCCGATTGAACTCGAATAGGGGTCGGGTGCTGGTCAATGGGCGCAGCGTGCCGATCGTGGGGCGGATCTGCATGGACCAGTGCATGGTTGACCTCGGCCCCGACTCGGCTGACCAGGTCGGCGATGAGGTCGTTCTGCTGGGCGGCCAGGGCGAGGAGTTCATCAGCACCGAGGAGATGGCTGAGCTGATGGGAACCATCACCTACGAGGTGACCTGTCTGATCGCGCCGCGCGTCGAGCGAATCCACCGCTCGGCGGCTCAGCGATAG,MSLTAPVVATIDLDAIASNLRGLRAKLPSGTAMLAAVKGNAYGHGAVPVSRFLQSQRLVEMLGVATVAEGIQLRDAGVGLPILKLSHCLPDEVARAVGAGLSLTVVDEDTIRTAANAVEDTTVGVHVKLDSGMGRIGAPLEDAPRLARLVRDLPGISLDGIFTHLPVSDVADDGGFTRDQLARFRAAVEAVQAEVGPVPFVHAANSGAILGAEDLDGFTLARPGVSVYGYYPDATTPRSVELTQALRWTTRLLFRKLVTAGTTVGYGRTWTADRDTWVGTLPVGYADGFSRLNSNRGRVLVNGRSVPIVGRICMDQCMVDLGPDSADQVGDEVVLLGGQGEEFISTEEMAELMGTITYEVTCLIAPRVERIHRSAAQR,MTKNESYSGIDYFRFIAALLIVAIHTSPLSSFSETGNFIFTRIVARVAVPFFFMTSGFFLISRYTCNAEKLGAFIKKTTLIYGVAILLYIPINVYNGYFKMDNLLPNIIKDIVFDGTLYHLWYLPASIIGAAIAWYLVKKVHYRKAFLIASILYIIGLFGDSYYGIVKSVSCLNVFYNLIFQLTDYTRNGIFFAPIFFVLGGYISDSQNRLSLKRSIVGFIVCFALMFGEALTLHHFDIQKHDSMYVLLLPSVYCLFNLLLHFRGKRRTGLRTISLIIYIIHPFMIVVIRLFAKLLHLQSLLVENSLVHYIAVCFASVVLAVVITALLSSLKPKKAKHTADTDRAYLEINLNNLEHNVNTLQKAMSPKCELMAVVKAEAYGHGMYEVTTYLEQIGVSSFAVATIDEGIRLRKYGISSEILILGYTSPSRAKELCKYELTQTLIDYRYSLLLNKQGYDIKAHIKIDTGMHRLGFSTEDKDKILAAFSLKHIKVAGIFTHLCAADSLEENDVAFTNKQIGSFYKVLDWLKSSGLNIPKVHIQSSYGLLNYPELECDYIRVGVALYGVLSSTNDKTKLELDLRPVLSLKAKVVLIRKIKQGESVGYSRAFTATRDSLIAILPIGYADGFPRNLSCGNSYVLIGGRQAPIVGKICMDQLAVDVTDIPNVKTGSIATLIGKDGKEEITAPMVAESAESITNELLSRMGHRLNIIRRA,53.09,gnl|BL_ORD_ID|1522|hsp_num:0,1561,FALSE,None
LK1188,6_59 # 64861 # 66594 # -1 # ID=6_59;partial=00;start_type=TTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.651,6_59,64861,66594,-,Strict,50,101.293,vanW gene in vanI cluster,33.33,3003724,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanW; glycopeptide resistance gene cluster,TTGTCTGAACCCGTCCAGAGCCAAGATCGTCCCCGCCGCGGGCGCACCGGAGTGATCGTGGGCTCGGTCCTCGGAGGGCTCCTGCTGCTGGTGGCCGCGGCCTATGTCGCCGGGTACTTCATGGCCAGCAACAAGACTCCCCGCAATGCCTCGGTGGAGGGGGTCTCCATCGGCGGCTTGACCCACGGGGAGGCCGTGAACGTCCTGAACGAACAGCTCGGCCCAAGGTATGACAAGCCGATCACCCTCGAGGGCGATGGCAACAGCGCGCAGTTGAAGCCCTCTGAAGCGGGCATGGTCGTCGACTTCGACCGGACCGTGGCCAAGGCCGGAGCCGGCCGCTCGTGGGACCCGGTCAAGATCTGGAACGTGCTGCGCGGGGGAGGCGCCATCGGTGCTGTGACCCGGATCGACCAGTCCGCCCTGGACAGGGCAGTGGCCTCGACGGCCTCCACCTTCGCCACCGAAGGCAAGGACGCCACCATCGCGATCGAGGGCATCAAGGCTGTCACCACCCCGCACACCCCGTCGGTCACGCTCAACCAGTCCGCGACCGCCAAGGCAGTCCGCAAGGCCTGGCCGACGTCCGACAAGGTCCAGGTCGCCGTCGACACAGCCGACCCCGAGATCACCACTGACGAGGTCGACAAGGTCAAGAAGGAGTACGCCGACCCGGCCCTCTCCGGTCCGATCGTGGTCAAGGCGGGCCCGAAGACCTTCAACCTGGACGTCAAGACCATCGCCGCCGCCACCACCTTCACCGCCAAGGACGGCAACGTCACCGCGGCCACCGACATGGAGAAGGTGTGGAAGGAGGCTGAGAAGGACATGGACAGCCTCGGCTTCGCCAAGGGCAAGGACGCCCGGTTCACCTTCAAGGCCGGCAAGCCCTTCATCGACCCGTCGGTTGATGGCGTGGGTGTGGACAAGAAGTCCTTCATCGACACCGTCGGACCCGCGATCACCAAGACCGGCCAGGACCGCACTGTTTCGGTGAAGGTCACCAAGCAGCCGCCGACGTTCAGCACCGGGGACGCCGAGAAGTTGGGCGTCAAGGAGGTCATCGGCGAGTTCACCACCCAGTTCCCCTACGCCGAGTACCGCAACATCAACCTCTCCAGGGTGGCGAGCGTGATCAACGGCAAGCTGGTCAAGCCCGGCGAAGTGTTCAGCATGAACGACACCCTGGGTGAACGCACCAAGGCCAATGGCTACGTCGACGGCTACGTGATCCAGGGGTCGCGGTTGAAGAAGGAGACCGGCGGTGGCGTCTCCCAGTCCGCCACCACGCTGTTCAACGCCATCTTCTTCGCCGGGCTGGAGGATGTGGAGCACCACCCCCACACCCTCTACTTCCCGCGCTACCCGGCCGGACGCGAGGCCACGCTCTACTACGGCAAGCTGGACCTCAAGTTCCGCAACAACACCAACTACGGGGTCGTGATCCAGGCCTACGTCCAGAAGGCCGCTCCCGGGGGCCAGGGCTCGATGACCATCAAGATCTGGTCCACCAAGACCTGGGATGCGGTCAAGTCCACCGAGCTGGTCAAGACCGACTACTACGACGCCCCTGACCAGACCAACGACGAGCCTGACTGCGAGCCCCAGGCCAAATCGCCCGGCTTCACCGTGAACTGGAAGCGGGAGTTCTACAAGGGGGGCAAGGTGGTCAAGTCCGAGCCCTACCGCTGGACCTACGCCGCGACCCCGCAGATCACCTGCACCAAGTCCTGA,MSEPVQSQDRPRRGRTGVIVGSVLGGLLLLVAAAYVAGYFMASNKTPRNASVEGVSIGGLTHGEAVNVLNEQLGPRYDKPITLEGDGNSAQLKPSEAGMVVDFDRTVAKAGAGRSWDPVKIWNVLRGGGAIGAVTRIDQSALDRAVASTASTFATEGKDATIAIEGIKAVTTPHTPSVTLNQSATAKAVRKAWPTSDKVQVAVDTADPEITTDEVDKVKKEYADPALSGPIVVKAGPKTFNLDVKTIAAATTFTAKDGNVTAATDMEKVWKEAEKDMDSLGFAKGKDARFTFKAGKPFIDPSVDGVGVDKKSFIDTVGPAITKTGQDRTVSVKVTKQPPTFSTGDAEKLGVKEVIGEFTTQFPYAEYRNINLSRVASVINGKLVKPGEVFSMNDTLGERTKANGYVDGYVIQGSRLKKETGGGVSQSATTLFNAIFFAGLEDVEHHPHTLYFPRYPAGREATLYYGKLDLKFRNNTNYGVVIQAYVQKAAPGGQGSMTIKIWSTKTWDAVKSTELVKTDYYDAPDQTNDEPDCEPQAKSPGFTVNWKREFYKGGKVVKSEPYRWTYAATPQITCTKS,MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVLAEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPELLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGMETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGGEFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSHSLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDEPDGYPVKPREWSK,154.69,gnl|BL_ORD_ID|4748|hsp_num:0,2242,FALSE,None
LK1188,11_48 # 52411 # 52782 # 1 # ID=11_48;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.651,11_48,52411,52782,+,Strict,200,227.254,Mycobacterium tuberculosis rpsL mutations conferring resistance to Streptomycin,90.24,3003395,protein variant model,K88R,n/a,aminoglycoside antibiotic,antibiotic target alteration,antibiotic-resistant rpsL,GTGCCTACCATCCAGCAGCTGGTCCGCAAGGGCCGCACTGACAAGGTCAGCAAGAGCAAGTCCGCTGCGCTGAAGGGTTCGCCCCAGCGCCGCGGGGTGTGCACGCGTGTGTACACCACCACCCCCAAGAAGCCGAACTCGGCCCTGCGCAAGGTTGCCCGTGTGCGCCTTTCCTCGGGTATCGAGGTCACCGCCTACATCCCCGGTGTGGGTCACAACCTGCAGGAGCACTCGATGGTGCTCGTGCGTGGCGGTCGTGTGCGCGACCTGCCGGGTGTCCGTTACAAGATTGTCCGCGGCGCTCTCGACACCCAGGGTGTCAAGAATCGCAAGCAGGCCCGCAGCCGCTACGGCGCGAAGAAGGAGAAGTAA,MPTIQQLVRKGRTDKVSKSKSAALKGSPQRRGVCTRVYTTTPKKPNSALRKVARVRLSSGIEVTAYIPGVGHNLQEHSMVLVRGGRVRDLPGVRYKIVRGALDTQGVKNRKQARSRYGAKKEK,MPTIQQLVRKGRRDKISKVKTAALKGSPQRRGVCTRVYTTTPKKPNSALRKVARVKLTSQVEVTAYIPGEGHNLQEHSMVLVRGGRVKDLPGVRYKIIRGSLDTQGVKNRKQARSRYGAKKEKG,99.19,gnl|BL_ORD_ID|1956|hsp_num:0,1197,FALSE,None
LK572,50_11 # 12223 # 13206 # 1 # ID=50_11;partial=00;start_type=ATG;rbs_motif=3Base/5BMM;rbs_spacer=13-15bp;gc_cont=0.663,50_11,12223,13206,+,Strict,50,99.3673,vanY gene in vanM cluster,35.1,3002961,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCCGCGTAAACAGATGTCTCGAACGGTCCTCTTCTCCGCACTCCTGGCGTTGGTGTTCTCCATGCTGGGAACCGCTCCCGCCATGGCCGGGGCCGGTATCGACAACGAGTACCGTTCGCTGGGGGGCGCCAGCGGATGGCTGGGCAAAGCCACGTCCTCCGAACGCTGCGGTCTTCGCGACGCCGGCTGCTACCGGCAGTACCAGGGCGGCACCATCCACTGGTCTCCCAGCACGGGTGCCCGCGCGCAGCGCGGCGGCATCCTGCAGCGCTGGCGGGTCGAGGGCTCCGAGCACGGCAACCTGGGATACCCCAAGGTGCGCGAAACCTGCAGCGGCAACTCGTGCGTGGTCCACTATCAGCGCGGCATCATCCGGTGGACCAAGGGCAAGGGCACCACGGTCAGTCGAGACATCGATCGTGCCACCAGCTCGTCCGTGATTGTGAACAAGAAGCGGCCCCTGAACCCTCGGGCCTACGGTCCCGGGCCCCTGTGGAACGTGGGCGGTGGGGTGCAGCTGCGCAGTGACGCTGCGGCCGCCTATCAGCGGATGAGCCAGGCTGCGGCCAACCAGGGTGTAACCCTGGTGCCGGTCAGCGGTTACCGCTCCTATTCGACCCAGAACAGCCTGTACTGGAACTATGTGGCGATGTACGGACAGGCCACCGCGGACACTATTTCCGCGCGTCCCGGATACTCGGAGCACCAGACCGGCCTGGCCATTGACGTGGGAGCACCCGGGGGAGTGTGCGGACTGCAGGCCTGCTTCGGCAACACACCCCAGGGCCGCTGGGTGGCCGCCAACGGCCACAAGTACGGCTTTGTGGTGCGCTACCCCAGCGGTTACACCGGGACTCACGGCTACGCCTACGAACCGTGGCACCTGCGCTACGTGGGAACGCCCACGTCCAACAGCTTGAAGAACAACGGCTACATCACCCTGGAGGGCTACCTGGGCCTGCCCAACGCACCTCGCTACTGA,MPRKQMSRTVLFSALLALVFSMLGTAPAMAGAGIDNEYRSLGGASGWLGKATSSERCGLRDAGCYRQYQGGTIHWSPSTGARAQRGGILQRWRVEGSEHGNLGYPKVRETCSGNSCVVHYQRGIIRWTKGKGTTVSRDIDRATSSSVIVNKKRPLNPRAYGPGPLWNVGGGVQLRSDAAAAYQRMSQAAANQGVTLVPVSGYRSYSTQNSLYWNYVAMYGQATADTISARPGYSEHQTGLAIDVGAPGGVCGLQACFGNTPQGRWVAANGHKYGFVVRYPSGYTGTHGYAYEPWHLRYVGTPTSNSLKNNGYITLEGYLGLPNAPRY,MVFQGNLLLVNNEYPVLEESIKTDVVNLFKHDELTKGYELLNREIYLSEKVAREFSEMVDAAEKEGVRHFSINSGFRNFDEQNALYQEMGSDYALPAGYSEHNLGLALDIGSTQMEMSEAPEGKWLEDNAWEYGFILRYPMDKTAITGIQYEPWHFRYVGLPHSAIIEEKNFALEEYLDFLKEQKSISGTIHGENYEISYYPITEKTDIEMPANLHYEISGNNMDGVIVTVYR,140.34,gnl|BL_ORD_ID|1673|hsp_num:0,1713,FALSE,None
LK572,65_2 # 583 # 1068 # 1 # ID=65_2;partial=00;start_type=ATG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.650,65_2,583,1068,+,Strict,400,23.483,ErmQ,100,3000593,protein homolog model,n/a,n/a,macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic,antibiotic target alteration,Erm 23S ribosomal RNA methyltransferase,ATGAGCGGTGAGACAACGGACACAGTGACGGTAATGGCCCGGACCATGTCGGCCCTGGGGCGACTCACCACGCGGTCCAGGATGCGGCGGGAGCTCGGCGGTCAGAGCGCCAAACTCTCCCCCACCGACATGTGGCTGGTTGACCGAGTCAGCGAGTTCGGTCCGGCGCGCATGTCCGAGCTGGCCACATGGCAATCCGTGGATCGCTCGACCATGACCACGCAGGTCGGCAAGCTCGAGAAGATGGGCCTGGTGCAGCGTGCACCGGACCCACAGGACCGCCGCGCCATTGTGGTGTGGGTGACCGAGGCGGGGCGCCAGTTGCACGAAGAAAGCCGCGCAGCTGCCTGCGCGGCTTTCGACAGCATGTTGGCCGAATGGAGTGATGCGGAGCGTCGTCAGCTGACCGAGTCACTCACCCACCTGGTGGACAGTCTGGAGAAGCATCTCTCCACCAAGTCCGAGGATCACAGCACGGAGCGGTAG,MSGETTDTVTVMARTMSALGRLTTRSRMRRELGGQSAKLSPTDMWLVDRVSEFGPARMSELATWQSVDRSTMTTQVGKLEKMGLVQRAPDPQDRRAIVVWVTEAGRQLHEESRAAACAAFDSMLAEWSDAERRQLTESLTHLVDSLEKHLSTKSEDHSTER,MKAKSNNYRGKVDISVSQNFITSKNTIYKLIKKTNISKNDFVIEIGPGKGHITEALCEKSYWVTAIELDRSLYGNLINKFKSKNNVTLINKDFLNWKLPKKREYKVFSNIPFYITTKIIKKLLLEELNSPTDMWLVMEKGSAKRFMGIPRESKLSLLLKTKFDIKIVHYFNREDFHPMPSVDCVLVYFKRKYKYDISKDEWNEYTSFISKSINNLRDVFTKNQIHAVIKYLGINLNNISEVSYNDWIQLFRYKQKID,62.65,gnl|BL_ORD_ID|272|hsp_num:0,303,TRUE,loose hit with at least 95 percent identity pushed strict
LK1270,8_4 # 4414 # 6108 # 1 # ID=8_4;partial=00;start_type=GTG;rbs_motif=3Base/5BMM;rbs_spacer=13-15bp;gc_cont=0.658,8_4,4414,6108,+,Strict,50,77.411,vanW gene in vanI cluster,32.61,3003724,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanW; glycopeptide resistance gene cluster,GTGACTACGGTAAATGCAACAGGTGCCCGTGGTGGGCGCGGGGTCAGCACCGGGAAGATTCTCCTCGGTGTGCTGCTCGGTGTGCTCGCGGTGCTGCTCGCGATCTACCTCGCCGACCTCGCAATGAACCGCGGGAACGTGCCGCGTGGCACCGCCGTCGGCGGTGTCGAGATCGGCGGCATGAGCCAGGACGAGGCCACCGCGAAGCTCGAAGCAGAGCTCGGCGAGACGGCGAGTAACCCGGTGACGGTGAAGGCGGCGACGCAAAGCTCGCAGCTCGTGCCCGCCGAATCCGGCCTCGGCATCGACTGGGAGGCGACCGTAGCAAGCGCGGGCGAAGAGTCCGCGAACCCGTTCACTCGCCTCGCCGGGTTGTTTCGCACACGCGAAGTCGACATTGTGTCGACCGTGAACGAGGCCGCTCTCACCCCGCAGCTTGAGCGAGTGGCCGGCGAGTTGCACCTCGACCCCGCCGACGGCGCGATCGCCATCGACGGTGGCGAGGCGAAAGTGACCGAACCGGTGCCGGGCCAGGAGGTTGACAAAACCGAGCTGTTCGAACGTGTCACCACCGGCTGGCTCAACCCCGACGGTGTGGAGGTCGAGCCGCGCGAGATCGAACCCGCTATCGGCGACCAGGCGATCAAGGAAGCCTTAGACGGGCCGGTTAAGGCGGCGCTGTCCGGCGCCTTGACGCTGCACGGCCGCGACGGCGTCGACGGTGTCATTGCCCAAGAGCGCATCGGCGAGGTCGTCCAGTTCCCCAACGTCGACGGCAAAATCGCCCCCGAGGTGAACGTGGAAAGCGCCCAGGGCATCTTGGGCGAGCAGCTCGCTGCGACCGAGACGCAGATGAAAAACGCGCGCGTGCTGCCCGGCGGCGGGGTGGAACCGTCCGTCGACGGCTCCATTATCGACTGGGAGGCCGCGATGGACGGTTTCGACGAGCGGTTGATCGGTTCCGCCGAGCGCACCTGGGACGCGCAATACAAGGCCCGCCCGGCAGACTTCACTACAGAGGAAGCCCAACGTGCCACCTTCGACCAGGTGGTGGGAAGTTTCACCACCGGCGGGTACAGCGGCGCATCCGGCACGAACATCGCTACGGTGGCCCGCGTTGTCAACGGCGCAATTGTCAACCCCGGTGAAACCTTCTCGCTCAACGGCTACACCGGCGCGCGCGGTGCCGCGCAGGGTTACGTCGAGTCGGTCATCATCGAAAATGGACGCCCCGGCAAGGCAGTGGGTGGCGGAATCTCCCAATTTGCCGCGACCTTGTACAACGCGGCTTACTTTGCCGGCATGACGGATGTCGCCTCCACCCCGCACTCCTACTACATCTCACGCTACCCGGCTGGCAGGGAGGCGACCGTGTATGAAGGGGCGATTGACCTGCAATTCCGCAACGATTCGCCCCACCCGGTCAAGATTTCCACGAGCGTCGGGGGCGGCGAGGTGACGGTGAGCCTGATGGGCACCAAGACCGTCGAGGTGGAGTCCATCAACGGAGGGCGCTGGGCCTACACCTCGCCGAAGCCCGTGACCGTCACCAGTGGTGACTGCATTCCCTCGGGCGGGGCGCAGGGCTTTACCACCTCCGATACCCGGATTGTGCGTGACCTCAGCGGCAATGAGATCAGTCGCAACACCTCCACCACGGTCTACGACCCGCAGCCCATCGTGCGCTGCGAGTAG,MTTVNATGARGGRGVSTGKILLGVLLGVLAVLLAIYLADLAMNRGNVPRGTAVGGVEIGGMSQDEATAKLEAELGETASNPVTVKAATQSSQLVPAESGLGIDWEATVASAGEESANPFTRLAGLFRTREVDIVSTVNEAALTPQLERVAGELHLDPADGAIAIDGGEAKVTEPVPGQEVDKTELFERVTTGWLNPDGVEVEPREIEPAIGDQAIKEALDGPVKAALSGALTLHGRDGVDGVIAQERIGEVVQFPNVDGKIAPEVNVESAQGILGEQLAATETQMKNARVLPGGGVEPSVDGSIIDWEAAMDGFDERLIGSAERTWDAQYKARPADFTTEEAQRATFDQVVGSFTTGGYSGASGTNIATVARVVNGAIVNPGETFSLNGYTGARGAAQGYVESVIIENGRPGKAVGGGISQFAATLYNAAYFAGMTDVASTPHSYYISRYPAGREATVYEGAIDLQFRNDSPHPVKISTSVGGGEVTVSLMGTKTVEVESINGGRWAYTSPKPVTVTSGDCIPSGGAQGFTTSDTRIVRDLSGNEISRNTSTTVYDPQPIVRCE,MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVLAEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPELLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGMETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGGEFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSHSLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDEPDGYPVKPREWSK,151.21,gnl|BL_ORD_ID|4748|hsp_num:0,2242,FALSE,None
LK1348,3_73 # 81654 # 83363 # 1 # ID=3_73;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.674,3_73,81654,83363,+,Strict,50,87.4261,vanW gene in vanI cluster,34.81,3003724,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanW; glycopeptide resistance gene cluster,GTGCAAGCCCAACGCGGGACCAGCGGCGGACCCGGTGAGTCCGGCAGTGGATCCCGCGGCCTGAAGATCGCCGCCGGTTTCCTCGTCGGCCTCATTGTGCTCCTGCTGGGGCTCTACCTGGCCGATGTCGCGTTCAACCGCGGAAACGTTCCGCGCGGCACCGCCGTCGGCGGGGTCGAGGTCGGGGGGATGGCACCTGCGGAGGCCGTCGATAAGCTCAGCGCTGAGCTCGGCGGCGTCAACGACGAGCCCGTCACCGTCGCCGCCGGTGAGAAGACCACCGAATTCGTCCCTGCGAGTGCCGGGCTGGGTCCCGACTGGCAGGCCACGATCGACGCCGCCGGCACCGAATCGCTCAACCCCGTCACGCGGCTTATGGGTCTGTTCCGCACCACAGAGGTGGACATTGTCTCCACCGCCGACGAGGCCGCGCTGGCGCCCACTGTCGAGCGCGTCGCGAAAGACCTCACCGTCGAACCTGTCGACGGCACGGTGGCCATCAAGGACGGCAAAGCCGACGTCAAAGACCCGCAGCCCGGCCAGAACATTCCCGCCGACGAGCTGAAGCGCGCCATGACCTCCAACTGGCTCAACCCCGACGGCGTCGAAGTCGAGCCGGACATCACCGACCCGGCGATCGACGAGAAGCTGGTCAAAGACACCGTCGACGGCCCCGTCGCGCGCGCCCTCGACGGCCCGCTGACCCTGAAGGGCCGCGACGACACCGACGCCGTCATCGACTCCGACCGCATCGGCGAGGTGGTGACATTCCGCAACGACCCCGGCCAGCGCCGCATCGTTCCCGAGGTTGACTCCGAGGCTGCCCAGGGCATCCTCGCCGAGCAGCTCAAAGACACCGTCAAGGAAGGCAAGAACGCGACCATCTCAGCGTCCGGCGAGGTCACTCCGTCCGTCGACGGCATCGAGATCCGCTGGGACGAGACCATGAAGAGCTTCGGCGACCGCGTGCTCGGCGACGAGTCACGCACCTGGGACGCCGACTACCGCGACACCCCCGCCACCTTCACCACCGAGCAGGCTGAGAGCGCGACCTTCAACGACGTCGTCGGCGAATTCACCACCGGCGGGTACAGCTCTGCTTCCGGCACCAATATCTCGATCGTCGCCAACACCGTCGACGGTGCTGTGGTCAGTCCCGGCGAGACCTTCTCACTCAACGGCTACACCGGCCCCCGCGGCACCGCGCAGGGCTACGTGTCTTCCGGCATCATCATCGACGGACGTGCCGGAAACGCCGTCGGCGGCGGCATCTCCCAGTTCGCCACCACCTTGTACAACGCCTCCTACTTCGCGGGCATGACCGACGTCGACCACACCCCGCACTCCTACTACATCTCCCGCTACCCGGCCGGCCGCGAAGCCACCGTTTACGAAGGCGCCATCGACTTAGCCTTCAAGAACGACACTCCGCACCCGGTGAAGATCGAGACCAGCTTCGGCGGCGGCGAGATCACCGTCCGCTTCAAGGGCGTCAAGGACCGCGAGGTCGAATCCGTCAACGGCGGCCGCTGGGCCTACACCTCTCCGTCGCCGAAGAGCGTCTCCGGAGGCGAGTGCATCCCGTCCGGGGGTGCCCAGGGCTTCACCACCTCCGACACCCGCATCGTCCGCGACCTGTCCGGCAACGAGATCTCCCGCGAAACCCAGACCACGGTGTACAACCCGCAGCCGATCGTGCAGTGCGGCTAG,MQAQRGTSGGPGESGSGSRGLKIAAGFLVGLIVLLLGLYLADVAFNRGNVPRGTAVGGVEVGGMAPAEAVDKLSAELGGVNDEPVTVAAGEKTTEFVPASAGLGPDWQATIDAAGTESLNPVTRLMGLFRTTEVDIVSTADEAALAPTVERVAKDLTVEPVDGTVAIKDGKADVKDPQPGQNIPADELKRAMTSNWLNPDGVEVEPDITDPAIDEKLVKDTVDGPVARALDGPLTLKGRDDTDAVIDSDRIGEVVTFRNDPGQRRIVPEVDSEAAQGILAEQLKDTVKEGKNATISASGEVTPSVDGIEIRWDETMKSFGDRVLGDESRTWDADYRDTPATFTTEQAESATFNDVVGEFTTGGYSSASGTNISIVANTVDGAVVSPGETFSLNGYTGPRGTAQGYVSSGIIIDGRAGNAVGGGISQFATTLYNASYFAGMTDVDHTPHSYYISRYPAGREATVYEGAIDLAFKNDTPHPVKIETSFGGGEITVRFKGVKDREVESVNGGRWAYTSPSPKSVSGGECIPSGGAQGFTTSDTRIVRDLSGNEISRETQTTVYNPQPIVQCG,MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVLAEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPELLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGMETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGGEFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSHSLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDEPDGYPVKPREWSK,152.55,gnl|BL_ORD_ID|4748|hsp_num:0,2242,FALSE,None
LK1348,20_5 # 6220 # 7074 # 1 # ID=20_5;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.563,20_5,6220,7074,+,Strict,400,486.878,ErmX,84.51,3000596,protein homolog model,n/a,n/a,macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic,antibiotic target alteration,Erm 23S ribosomal RNA methyltransferase,ATGTCTACATACGGATACGGCCGTCACGAACATGGCCAAAATTTTCTCACAGACCACAAGATCATCAACTCCATCGTCGATCTTGTAAAACAAACCTCCGGCCCCATCATTGAGATCGGGCCAGGAAGCGGTGCCCTCACTCACCCGATATCCCACTTGGGGAGGGCAATAACGGCAGTTGAGGTAGACGCAAAACTAGCTGCCAAACTCACAAAAAAGACCGCCTCGGCGTCGGTCGAAGTGGTCCATGATGATTTCCTCAACTTCCCGTTACCCGCCACTCCCTGCGTCATTGTGGGAAACATTCCCTTTCACCTCACCACTGCCATTCTTCGAAAGTTGTTGCATGCGCCGGCATGGACTGCCGCTGTACTCCTCATGCAGTGGGAAGTCGCTCGCCGCCGGGCCGGGGTAGGTGCAAGCACGATGATGACAGCTCAGTGGTCCCCATGGTTCACGTTTCACCTTGGTTCCCGAGTACCAAGGTCTGCTTTCCGGCCACAGCCAAACGTTGACGGGGGGATCTTAGTGATCCGCCGGGTGGGTGACCCGAAGATCCCGATAGAGCAACGCAAAGCCTTTCAGGCGATGGTGCACACCGTTTTCACCGCCCGGGGACGCGGGATAGGGGAAATTCTCCGAAGGGCAGGGTTGTTTTCATCACGTTCAGAGACACAATCATGGTTGCGCTCGCGAGGAATCGACCCCGCAACCCTACCTCCCAGATTGCACACCAGCGACTGGATCGATCTCTTCCAGGTGACTGGTTCCTCTTCACCGCGCCATCGGCCCATTTCACAATCGGGAAGTAGTCAACGCCCTCCTCAACGGAAAAATCGAGGCCGGCGGCGGTAA,MSTYGYGRHEHGQNFLTDHKIINSIVDLVKQTSGPIIEIGPGSGALTHPISHLGRAITAVEVDAKLAAKLTKKTASASVEVVHDDFLNFPLPATPCVIVGNIPFHLTTAILRKLLHAPAWTAAVLLMQWEVARRRAGVGASTMMTAQWSPWFTFHLGSRVPRSAFRPQPNVDGGILVIRRVGDPKIPIEQRKAFQAMVHTVFTARGRGIGEILRRAGLFSSRSETQSWLRSRGIDPATLPPRLHTSDWIDLFQVTGSSSPRHRPISQSGSSQRPPQRKNRGRRR,MSAYGQGRHEHGQNFLTNHKIINSIIDLVKQTSGPIIEIGPGSGALTHPMAHLGRAITAVEVDAKLAAKITQETSSAAVEVVHDDFLNFRLPATPCVIVGNIPFHLTTAILRKLLHAPAWTDAVLLMQWEVARRRAGVGATTMMTAQWSPWFTFHLGSRVPRSAFRPQPNVDGGILVIRRVGDPKIPIEQRKAFQAMVHTVFTARGRGIGEILRRQGCFHHVQKHNHGCAREESTPRPYLPDCYTNDWIDLFQVTGSSLPHHRPISPSGSSQRPPQRKNRSRRR,100,gnl|BL_ORD_ID|872|hsp_num:0,950,FALSE,None
LK533,1_243 # 263865 # 264350 # -1 # ID=1_243;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.362,1_243,263865,264350,-,Perfect,300,333.569,dfrC,100,3002865,protein homolog model,n/a,n/a,diaminopyrimidine antibiotic,antibiotic target replacement,trimethoprim resistant dihydrofolate reductase dfr,ATGACATTATCAATAATTGTCGCTCACGATAAACAAAGAGTCATTGGGTACCAAAATCAATTACCTTGGCACTTACCAAATGATTTAAAGCATGTTAAACAACTGACCACTGGGAATACACTTGTAATGGGACGGAAAACTTTTAATTCTATAGGGAAGCCATTACCAAATAGACGTAACGTCGTACTCACTAACCAAGCTTCATTTCACCATGAAGGGGTAGATGTTATAAACTCTCTTGATGAAATTAAAGAGTTATCTGGTCATGTTTTTATATTTGGAGGACAAACGTTATTCGAGGCAATGATTGACCAGGTAGATGATATGTATATCACAGTAATAGATGGAAAGTTTCAAGGAGACACATTCTTTCCACCATACACATTCGAAAACTGGGAAGTCGAATCTTCAGTAGAAGGTCAACTAGATGAAAAAAATACTATACCGCATACATTCTTACATTTAGTGCGTAGAAAAGGGAAATAG,MTLSIIVAHDKQRVIGYQNQLPWHLPNDLKHVKQLTTGNTLVMGRKTFNSIGKPLPNRRNVVLTNQASFHHEGVDVINSLDEIKELSGHVFIFGGQTLFEAMIDQVDDMYITVIDGKFQGDTFFPPYTFENWEVESSVEGQLDEKNTIPHTFLHLVRRKGK,MTLSIIVAHDKQRVIGYQNQLPWHLPNDLKHVKQLTTGNTLVMGRKTFNSIGKPLPNRRNVVLTNQASFHHEGVDVINSLDEIKELSGHVFIFGGQTLFEAMIDQVDDMYITVIDGKFQGDTFFPPYTFENWEVESSVEGQLDEKNTIPHTFLHLVRRKGK,100,gnl|BL_ORD_ID|1279|hsp_num:0,1397,FALSE,None
LK533,2_245 # 220266 # 220709 # -1 # ID=2_245;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.333,2_245,220266,220709,-,Strict,270,284.648,mgrA,94.56,3000815,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; cephalosporin; penam; tetracycline antibiotic; peptide antibiotic; disinfecting agents and antiseptics,antibiotic efflux,ATP-binding cassette (ABC) antibiotic efflux pump; major facilitator superfamily (MFS) antibiotic efflux pump,ATGTCTGAACAACATAATTTAAAAGAGCAGCTATGCTTTAGTTTGTACAATGCTCAAAGACAAGTTAATCGCTACTATTCTAACAAAGTCTTTAAAAAGTACAATCTAACATACCCACAATTTCTTGTTTTAACAATATTATGGGATGAATCACCTGTTAACGTCAAAAAGGTCGTTACAGAATTAGCACTTGATACTGGAACTGTATCGCCATTACTCAAGAGAATGGAACAAGTTGATTTAATCAAACGTGAACGTTCTGAAGTAGATCAACGTGAAGTATTTATTCACTTAACAGACAAAAGTGAAATGATTAGGCCCGAATTAAGCAACGCATCTGAGAAAGTTGCAACCGCTTCTTCTTTATCTAAAGAAGAGGTCAAAGAACTTAATCGCTTATTAGGTAAAGTCATCGATGCATTTATCGAAACAAAAGAAAAGTAA,MSEQHNLKEQLCFSLYNAQRQVNRYYSNKVFKKYNLTYPQFLVLTILWDESPVNVKKVVTELALDTGTVSPLLKRMEQVDLIKRERSEVDQREVFIHLTDKSEMIRPELSNASEKVATASSLSKEEVKELNRLLGKVIDAFIETKEK,MSDQHNLKEQLCFSLYNAQRQVNRYYSNKVFKKYNLTYPQFLVLTILWDESPVNVKKVVTELALDTGTVSPLLKRMEQVDLIKRERSEVDQREVFIHLTDKSETIRPELSNASDKVASASSLSQDEVKELNRLLGKVIHAFDETKEK,100,gnl|BL_ORD_ID|133|hsp_num:0,154,FALSE,None
LK533,2_253 # 227843 # 229006 # 1 # ID=2_253;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.323,2_253,227843,229006,+,Strict,700,754.977,norA,99.48,3000391,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGAAAAAACAATTATTTATTCTTTATTTTAATATATTTCTTATATTTTTAGGAATTGGATTAGTCATTCCTGTACTTCCTGTATATTTAAAGGATTTAGGATTAAAAGGTAGTGACTTAGGAATGCTAGTTGCTGCTTTTGCATTATCACAAATGATTATTTCACCATTTGGTGGGACACTAGCTGATAAATTGGGTAAAAAATTAATTATATGTATCGGTTTAGTATTCTTTGCTGTCTCTGAATTTATGTTCGCAGCCGGTCAAAGTTTTACCATTTTAATCATTTCACGTGTTTTAGGTGGCTTTAGTGCAGGCATGGTCATGCCTGGTGTAACAGGTATGATTGCAGATATTTCTCCAGGAGCTGATAAAGCTAAAAACTTTGGTTATATGTCGGCAATTATTAATTCAGGTTTTATATTAGGACCTGGATTTGGAGGCTTTTTAGCTGAAATTTCACATAGATTACCTTTCTATGTTGCTGGAACATTAGGTGTTGTTGCATTCATTATGTCAGTTTTATTAATTCATAATCCTCACAAAGCAACCACAGATGGATTCCACCAATATCAACCTGAATTATTAACTAAAATTAATTGGAAAGTATTTATTACGCCAGTCATATTAACACTTGTATTAGCATTTGGTTTATCTGCTTTTGAAACATTATTTTCTTTATATACAGCTGACAAAGTAAATTATACTCCTAAAGATATTTCGATAGCTATTATCGGTGGAGGCGTGTTTGGCGCATTATTCCAAGTATTCTTCTTTGATAAATTTATGAAATATATGAGTGAACTCAATTTTATTGCATGGTCATTACTATATTCAGCCATTGTTCTCGTTATGTTAGTGCTTGCAAACGGTTATTGGACGATTATGATTATTAGCTTTGTTGTTTTTATAGGTTTTGATATGATTAGACCGGCTTTAACCAATTACTTCTCGAATATAGCAGGCAAACGGCAAGGTTTTGCAGGTGGATTGAATTCAACTTTTACCAGTATGGGTAACTTTATAGGTCCCCTTGTAGCTGGTGCATTATTCGATGTTAATTTAGAGTTTCCTTTATATATGGCTATTGCGGTTTCATTAAGTGGAATTATCATTATTTTTATTGAAAAAGGACTTAAGTCACGCCGTAAAGAAGCAAATTAA,MKKQLFILYFNIFLIFLGIGLVIPVLPVYLKDLGLKGSDLGMLVAAFALSQMIISPFGGTLADKLGKKLIICIGLVFFAVSEFMFAAGQSFTILIISRVLGGFSAGMVMPGVTGMIADISPGADKAKNFGYMSAIINSGFILGPGFGGFLAEISHRLPFYVAGTLGVVAFIMSVLLIHNPHKATTDGFHQYQPELLTKINWKVFITPVILTLVLAFGLSAFETLFSLYTADKVNYTPKDISIAIIGGGVFGALFQVFFFDKFMKYMSELNFIAWSLLYSAIVLVMLVLANGYWTIMIISFVVFIGFDMIRPALTNYFSNIAGKRQGFAGGLNSTFTSMGNFIGPLVAGALFDVNLEFPLYMAIAVSLSGIIIIFIEKGLKSRRKEAN,MKKQLFILYFNIFLIFLGIGLVIPVLPVYLKDLGLKGSDLGMLVAAFALSQMIISPFGGTLADKLGKKLIICIGLVFFAVSEFMFAAGQSFTILIISRVLGGFSAGMVMPGVTGMIADISPGADKAKNFGYMSAIINSGFILGPGFGGFLAEISHRLPFYVAGTLGVVAFIMSVLLIHNPQKATTDGFHQYQPELFTKINWKVFITPVILTLVLAFGLSAFETLFSLYTADKVNYTPKDISIAIIGGGVFGALFQVFFFDKFMKYMSELNFIAWSLLYSAIVLVMLVLANGYWTIMIISFVVFIGFDMIRPALTNYFSNIAGKRQGFAGGLNSTFTSMGNFIGPLVAGALFDVNLEFPLYMAIAVSLSGIIIIFIEKGLKSRRKEAN,100,gnl|BL_ORD_ID|1427|hsp_num:0,1554,FALSE,None
LK533,3_109 # 117472 # 118872 # 1 # ID=3_109;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.350,3_109,117472,118872,+,Strict,525,558.91,norC,61.99,3007010,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGAATACATCACAAAAGTTTAGGGGAGATAATCGCTTATTATTAGGGATTATTTTAGGGGTTATTACATTTTGGTTATTTGCACAATCACTTGTAAATCTAGTCGTGCCATTACAATCATCATACAATAGTGATATTGGTACTATTAATATAGCAGTTAGCTTATCGGCACTATTTTCTGGTCTGTTTATTGTAGGTGCAGGAGATATTGCAGATAAAATTGGTAGAGTAAAAGTGACATACATAGGCTTAGCACTTAATATTGTTGGGTCGGTTTTAATCATTATTACGCCATTACCAAGTCTATTGATTATTGGACGTGCTATTCAAGGATTGTCAGCGGCATGTATAATGCCAGCGACACTCGCAATCATTAATGAATATTATATCGGGACAGCACGACAACGTGCATTAAGCTACTGGTCCATCGGTTCATGGGGAGGTAGTGGTGTTTGTACTTTGTTTGGTGGTTTAATGGCAACTAACCTTGGATGGCGCTCAATCTTTATTGTTTCAATTATTCTGACAATATTATCCATGTTTCTCATTAAACATACACCCGAAACAAAAGCAGAGCCTATAGGAGATCAACCGACAGAGACAAAGAAATTTGATGTTGTTGGTTTAATCATCTTAGTGGTTAGTATGTTAAGTATTAATGTGATAATAACTCAAACCTCTCAATTTGGTTTGTTCTCACCATTTATTTTGGGACTTATTGCAATTTTTGTTATATCGTTAATTATATTCGTGATTTACGAAAATAAAATCAAACAACCACTTGTCGATTTTGATATCTTTAAAAACAAAGGTTATACAGGTGCAACGATTTCAAACTTTATGTTGAATGGTGTAGCTGGTGGTACATTGATTGTAGTAAATACTTTTTATCAGCAAAAATTAGATTTTAACTCTCAGGAAACAGGATATATTTCACTTACATACCTAATTGCAGTATTAATTATGATACGTGTGGGTGAAATGATATTACAATCGTTAGGACCTAAAAGACCTTTGTTACTCGGAAGTGCCTTGACCGTCATAGGATTAATATTATTATCTTTGACGTTTTTACCTAATGCTTGGTATATAGCGTCAAGTGTCATTGGTTATTTATTATTTGGTACCGGTTTAGGTGTTTATGCAACACCATCCACGGATACAGCTGTTGCACAAGCACCAGATGATAAAGTAGGCGTCGCATCCGGTGTATATAAGATGGCATCATCCTTAGGAAATGCATTTGGTGTGGCCATCTCAAGTACAGTTTACAGCGTACTTGCAGCCCAACTTAATCTGACTTTAGGTGGTTTTACTGGAGTAATGTTTAATGCGCTTATAGCATTATTAGCATTCCTTTCTATTTTGTTCTTAATACCGAAAAAACAGTCTAATGTATAA,MNTSQKFRGDNRLLLGIILGVITFWLFAQSLVNLVVPLQSSYNSDIGTINIAVSLSALFSGLFIVGAGDIADKIGRVKVTYIGLALNIVGSVLIIITPLPSLLIIGRAIQGLSAACIMPATLAIINEYYIGTARQRALSYWSIGSWGGSGVCTLFGGLMATNLGWRSIFIVSIILTILSMFLIKHTPETKAEPIGDQPTETKKFDVVGLIILVVSMLSINVIITQTSQFGLFSPFILGLIAIFVISLIIFVIYENKIKQPLVDFDIFKNKGYTGATISNFMLNGVAGGTLIVVNTFYQQKLDFNSQETGYISLTYLIAVLIMIRVGEMILQSLGPKRPLLLGSALTVIGLILLSLTFLPNAWYIASSVIGYLLFGTGLGVYATPSTDTAVAQAPDDKVGVASGVYKMASSLGNAFGVAISSTVYSVLAAQLNLTLGGFTGVMFNALIALLAFLSILFLIPKKQSNV,MNETYRGGNKLILGIVLGVITFWLFAQSLVNVVPNLQQSFGADMGTISIAVSLTALFSGMFVVGAGGLADKIGRVKMTNIGLLLSIIGSALIIITNLPALLILGRIIQGVSAACIMPSTLAIMKTYYEGAERQRALSYWSIGSWGGSGICSLFGGAVATTMGWRWIFIFSIIVAVLSMLLIKGTPETKSEVTNTHKFDVAGLIVLVVMLLSLNVVITKGAALGYTSLWFFGLIAIVIVAFFIFLNVEKKVDNPLIDFKLFENKPYTGATISNFLLNGVAGTLIVANTFVQQGLGYTALQAGYLSITYLIMVLLMIRVGEKLLQKMGSKRPMLLGTFIVIIGIALISLVFLPGIFYVISCVVGYLCFGLGLGIYATPSTDTAISNAPLDKVGVASGIYKMASSLGGAFGVAISGAVYAGAVAATSIHTGAMIALWVNVLMGIMAFIAILFAIPNDDKRVKDAK,100.87,gnl|BL_ORD_ID|4656|hsp_num:0,5726,FALSE,None
LK533,7_61 # 66142 # 66570 # 1 # ID=7_61;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.301,7_61,66142,66570,+,Strict,150,186.037,FosBx1,60.58,3007372,protein homolog model,n/a,n/a,phosphonic acid antibiotic,antibiotic inactivation,fosfomycin thiol transferase,ATGGAAATAACAAGTGTTAATCATATTTGTTTTTCAGTAAGTGATTTAAATACCTCTATACAATTTTATAAAGATATTTTACAAGGTGACTTATTAGTATCAGGTAGAACGACAGCATATTTAACTATTGGTCATACTTGGATAGCACTGAATCAAGAAAAAAATATACCAAGGAATGAAATAAGTCATTCCTATACGCACGTTGCTTTCTCCATAGATGAAGAAGATTTTCAAAAGTGGATTCAATGGCTTAAAGAGAATCAAGTAAATATTTTAAAAGGGCGACCAAGAGACATTAAAGACAAAAAGTCGATATATTTTACAGATCCGGATGGGCATAAAATTGAATTACATACTGGGACATTAAAAGATAGAATGGAATATTATAAATGTGAGAAGACGCATATGCAATTTTACGATGAGTTTTGA,MEITSVNHICFSVSDLNTSIQFYKDILQGDLLVSGRTTAYLTIGHTWIALNQEKNIPRNEISHSYTHVAFSIDEEDFQKWIQWLKENQVNILKGRPRDIKDKKSIYFTDPDGHKIELHTGTLKDRMEYYKCEKTHMQFYDEF,MLRGINHICFSVSNLENSIMFYEKVLEGELLVKGRKLAYFNICGVWIALNEETHIPRNEIHQSYTHIAFSVEKEDFKCLIQRLEENDVHILQGRERDVRDCESIYFVDPDGHKFEFHSGTLQDRLNYYRDEKPHMTFY,102.9,gnl|BL_ORD_ID|4909|hsp_num:0,5900,FALSE,None
LK533,8_62 # 50319 # 51164 # -1 # ID=8_62;partial=00;start_type=TTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.262,8_62,50319,51164,-,Strict,500,503.827,PC1 beta-lactamase (blaZ),94.66,3000621,protein homolog model,n/a,n/a,penam,antibiotic inactivation,BlaZ beta-lactamase,TTGAAAAAGTTAATACTTTTAATTGCAATTGCTTTAGTTTTAAGTGCATGTAATTCAACCAGTTCACATGCTAAAGAGTTAAATAATTTAGAAAAGAAATATAATGCTAATATTGGTGTCTATGCATTAGATACTAAAAGTGGTAAGGAAGTAAAATTTAATGCCGATAAGAGATTTGCCTATGCTTCAACTTCAAAAGCGATAAATAGTGCTATTTTGTTAGAACAAGTACCTTATAATAAGTTAAATAAAAAAGTACATATTAACAAAGATGATATAGTTGCTTATTCTCCTATTTTAGAAAAATATGTAGGAAAAGATATCACTTTAAAAGAACTTATTGAAGCTTCAATGAAGTATAGTGATAATACAGCAAACAATAAAATTATAAACGAAATCGGTGGAATCAAAAAAATTAAAAAACGTTTAAAAAAATTGGGAGATAAAGTAACAAATCCAGTTAGATATGAAATAGAATTAAATTACTATTCACCAAAGAGCAAAAAAGATACTTCAACGCCTGCTGCTTTCGGCAAGACTTTAAATAAACTTATCGCAAATGGAAAATTAAGCAAAAAAAATAAAAATTTCTTACTTGATTTAATGTTAAATAATAAAAACGGAGACACTTTAATTAAAGATGGTGTTCCAAAAGACTATAAGGTTGCTGATAAAAGTGGTCAAGCAATAACATATGCTTCTAGAAATGATGTAGCTTTTATTTATCCTAAGAACCAATCTGAACCTATTATTTTAGTCATTTTTACGAATAAAGACAATAAAAGTGATAAACCTAATGATAAATTGATAAGTGAAACCGCCAAGAATGTAATAAACAAATTTTAA,MKKLILLIAIALVLSACNSTSSHAKELNNLEKKYNANIGVYALDTKSGKEVKFNADKRFAYASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMKYSDNTANNKIINEIGGIKKIKKRLKKLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKTLNKLIANGKLSKKNKNFLLDLMLNNKNGDTLIKDGVPKDYKVADKSGQAITYASRNDVAFIYPKNQSEPIILVIFTNKDNKSDKPNDKLISETAKNVINKF,MKKLIFLIVIALVLSACNSNSSHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFAYASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDIALKELIEASMKYSDNTANNKIINEIGGIKKIKKRLKKLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKTLNKLIANGKLSKKNKNFLLDLMLNNKNGDTLIKDGIPKDYKVADKSGQAITYASRNDVAFVYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF,100,gnl|BL_ORD_ID|670|hsp_num:0,726,FALSE,None
LK533,10_111 # 91105 # 92442 # 1 # ID=10_111;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.293,10_111,91105,92442,+,Strict,200,612.453,sdrM,73.26,3007013,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGAATCTTAAGTCTATCATTACTGTAATGGCACTCATACTAATAATGTTTATGGCAGCTATAGAAACATCAATTATTTCATTAGCATTACCAACAATAAAAAATAGTTTGAATGCCGGTAATCTAGTTTCATTAGTATTTACCGTATATTTTATTGCTTTAGTCATAGCTAACCCTATCGTTGGTGAACTTTTGTCTAGATTTAAAATTATTTACATTGCTGTTGTAGGGGTATTATTGTTTGCCTTAGGTAGTTTAATGTCGGGATTAAGTCAGACGTTTACTTTTTTAATTATCTCTAGAATAGTACAAGGTTTTGGAGCAGGAGTTATGATGTCACTCTCACAAATAGTTCCTAAGTTGGCTTTTGAAATTCCTTTGAGATATAAAATTATGGGTATTGTTGGAAGTGTCTGGGGAATTTCGAGTATTATTGGTCCATTATTAGGTGGTGCGATTTTAGAGTTTGCTTCATGGCATTGGCTATTCTATATCAATATTCCTATTGCTATAGTGGCAATAATACTTGTATTTATGACTTTTCATTTTCCTGATGAGACACAAGTACAACAGAGTCGTTTTGATATAAAAGGATTGATTATCTTTTATATCTTTATAGCTTTATTAATGTTTGGTTTACTCAACCAACATCATATTATTTTTAACATATTCTCAATTATTTTAGCTTTAGCTGTTTTATGGCTACTATTTAAAATAGAAAATAGTATCGAACAACCATTTCTTCCAACAAAAGAATTTAACATATCAATAGTTCTAGTTTTTATAACGGATTTACTAATTGCGATAACACTGATGGGATATAATTTATATATACCAGTATATTTACAAGAAAAACTTAGTTTATCACCTTTACAAAGTGGATTTGTAATATTCCCGTTGTCTGTTGCTTGGATTACGCTTAATTTCAATTTAGCTAAAATAGAAGCGCATTTTACTAGAAAAACATTATATATTTGCTCATTTTTTGTTTTATTAGTTAGTAGTCTGATGATAATGTTTGGTTTAAAACTCCCATTGCTTATTGCTTTTGCGGTTGTATTTGCAGGTTTAAGTTTTGGCTATATTTATACAAAAGATAGTGTTATTGTCCAAGAGGAAACTTCTCCAAAAAATATGAAAAAGATGATGTCGTTTTATGCATTGACAAAAAATTTAGGTTCGTCAGTCGGATCTACGATTATGGGATATATGTATGCACTAAATGTTGGTTTATTTGGTTCTAATATACACAATGTATTAGGATTAGTCTTAATAATTGCAGTATGTTTAATTGTAATGTGGATGACATTATATAAAAGCAATACTATTCAATCTTAG,MNLKSIITVMALILIMFMAAIETSIISLALPTIKNSLNAGNLVSLVFTVYFIALVIANPIVGELLSRFKIIYIAVVGVLLFALGSLMSGLSQTFTFLIISRIVQGFGAGVMMSLSQIVPKLAFEIPLRYKIMGIVGSVWGISSIIGPLLGGAILEFASWHWLFYINIPIAIVAIILVFMTFHFPDETQVQQSRFDIKGLIIFYIFIALLMFGLLNQHHIIFNIFSIILALAVLWLLFKIENSIEQPFLPTKEFNISIVLVFITDLLIAITLMGYNLYIPVYLQEKLSLSPLQSGFVIFPLSVAWITLNFNLAKIEAHFTRKTLYICSFFVLLVSSLMIMFGLKLPLLIAFAVVFAGLSFGYIYTKDSVIVQEETSPKNMKKMMSFYALTKNLGSSVGSTIMGYMYALNVGLFGSNIHNVLGLVLIIAVCLIVMWMTLYKSNTIQS,MRLKSIITVIALILIMFMSAIESSIISLALPTIKQDLNAGNLISLIFTAYFIALVIANPIVGELLSRFKIIYVAIAGLLLFSIGSFMCGLSTNFTMLIISRVIQGFGSGVLMSLSQIVPKLAFEIPLRYKIMGIVGSVWGISSIIGPLLGGGILEFATWHWLFYINIPIAIIAIILVIWTFHFPEEETVAKSKFDTKGLTLFYVFIGLIMFALLNQQLLLLNFLSFILAIVVAMCLFKVEKHVSSPFLPVVEFNRSITLVFITDLLTAICLMGFNLYIPVYLQEQLGLSPLQSGLVIFPLSVAWITLNFNLHRIEAKLSRKVIYLLSFTLLLVSSIIISFGIKLPVLIAFVLILAGLSFGYIYTKDSVIVQEETSPLQMKKMMSFYGLTKNLGASIGSTIMGYLYAIQSGIFGPNLHNVLSAVAVISIGLIVLWVVFFKEQSSQSKE,99.55,gnl|BL_ORD_ID|4661|hsp_num:0,5729,FALSE,None
LK533,10_112 # 92633 # 93100 # 1 # ID=10_112;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.233,10_112,92633,93100,+,Strict,100,231.106,sepA,70.97,3007012,protein homolog model,n/a,n/a,disinfecting agents and antiseptics,antibiotic efflux,small multidrug resistance (SMR) antibiotic efflux pump,ATGAAATTTTTAAAAAATAAATCATATCATTTATTAGTAACACTTATTGTTCTCACTATATTTGTTATTTCCGGAGCAATTTTTTTAACATTTTTAGGCTTTGGTTTATACGGTTTGAGTCGCATCCTTATTTATTTACACTTAGGCGATTTTAGTTACAATAAAGGCTTTTATGATAATTTAATGTACTACGGTAGTTATATCGTTTTAGGCTATTTTACTTTATTTTCAATTGAGCATTTAATGGATTATTTTAAAAAGAATCTTCCAAAAAATCCATACTTTCAAGGTATTAACTTTCATCTCATCTCCTATATTGTTACTACAATTATGTTTTATTTTATAGTTCACATACACTATGTACATGTTAATATACATTTTTGGGTAATTATGATTATTATAGGATTTTTATTTGTATGTAAAGAAATTTTTTATCCTGAAAGTAAAAATTTGAACAATAAAAAGTAA,MKFLKNKSYHLLVTLIVLTIFVISGAIFLTFLGFGLYGLSRILIYLHLGDFSYNKGFYDNLMYYGSYIVLGYFTLFSIEHLMDYFKKNLPKNPYFQGINFHLISYIVTTIMFYFIVHIHYVHVNIHFWVIMIIIGFLFVCKEIFYPESKNLNNKK,MIVNFFKHKFYNLLTTMIVLFVFVLSGAIFLTFLGFGLYGLSRILIYFRLGDFTYNRNMYDNLLYYGSYIIFGYFIIFAVEHLMDYFRKMLPENAYFRGATFHLISYTVATTLFYFIIHLHYVYINIDFWVIMVIIGFLYVCKLQFYPESKNLNNRK,98.73,gnl|BL_ORD_ID|4660|hsp_num:0,5728,FALSE,None
LK533,27_1 # 2 # 1411 # 1 # ID=27_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.312,27_1,2,1411,+,Strict,1050,944.495,vgaA,99.79,3002829,protein homolog model,n/a,n/a,lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; pleuromutilin antibiotic,antibiotic target protection,vga-type ABC-F protein,ATTGTGCCTGAAGAAGGTATTGTAAAACAATTTTCACATTGTGAACTTATTCCTCAATTGAAGCTCATAGAATCAACTAAAAGTGGTGGTGAAGTAACACGAAACTATATTCGGCAAGCGCTTGATAAAAATCCAGAACTGCTATTAGCAGATGAACCAACAACTAACTTAGATAATAACTATATAGAAAAATTAGAACAGGATTTAAAAAATTGGCATGGAGCATTTATTATAGTTTCACATGATCGCGCTTTTTTAGATAACTTGTGTACTACTATATGGGAAATTGACGAGGGGAGAATAACTGAATATAAGGGGAATTATAGTAACTATGTTGAACAAAAAGAATTAGAAAGACATCGAGAAGAATTAGAATATGAAAAATATGAAAAAGAAAAGAAACGATTGGAAAAAGCTATAAATATAAAAGAACAGAAAGCTCAACGAGCAACTAAAAAACCGAAAAACTTAAGTTTATCTGAAGGCAAAATAACAGGAGCAAAGCCATACTTTGCAGGTAAGCAAAAGAAGTTACGAAAAACTGTAAAATCTCTAGAAACCAGACTAGAAAAACTTGAAAGCGTCGAAAAGAGAAACGAACTTCCTCCACTTAAAATGGATTTAGTGAACTTAGAAAGTGTAAAAAATAGAACTATAATACGTGGTGAAGATGTCTCGGGTACAATTGAAGGACGGGTATTGTGGAAAGCAAAAAGTTTTAGTATTCGCGGAGGAGACAAGATGGCAATTATCGGATCTAATGGTACAGGAAAGACAACGTTTATTAAAAAAATTGTGCATGGGAATCCTGGTATTTCATTATCGCCATCTGTCAAAATCGGTTATTTTAGCCAAAAAATAGATACATTAGAATTAGATAAGAGTATTTTAGAAAACGTTCAATCTTCTTCACAACAAAATGAAACTCTTATTCGAACTATTCTAGCTAGAATGCATTTTTTTAGAGATGATGTTTATAAACCAATAAGTGTTTTAAGTGGTGGAGAGCGAGTTAAAGTAGCACTAACTAAAGTATTCTTAAGTGAAGTTAATACGTTGGTATTAGATGAACCAACAAACTTTCTTGATATGGAAGCTATAGAGGCGTTTGAATCTTTGTTAAAGGAATATAATGGCAGTATAATCTTTGTATCTCACGATCGTAAATTTATCGAAAAAGTAGCCACTCGAATAATGACAATTGATAATAAAGAAATAAAAATATTTGATGGCACATATGAACAATTTAAACAAGCTGAAAAGCCAACAAGGAATATTAAAGAAGATAAAAAACTTTTACTTGAGACAAAAATTACAGAAGTACTCAGTCGATTGAGTATTGAACCTTCGGAAGAATTAGAACAAGAGTTTCAAAACTTAATAAATGAAAAAAGAAATTTAGATAAATAA,IVPEEGIVKQFSHCELIPQLKLIESTKSGGEVTRNYIRQALDKNPELLLADEPTTNLDNNYIEKLEQDLKNWHGAFIIVSHDRAFLDNLCTTIWEIDEGRITEYKGNYSNYVEQKELERHREELEYEKYEKEKKRLEKAINIKEQKAQRATKKPKNLSLSEGKITGAKPYFAGKQKKLRKTVKSLETRLEKLESVEKRNELPPLKMDLVNLESVKNRTIIRGEDVSGTIEGRVLWKAKSFSIRGGDKMAIIGSNGTGKTTFIKKIVHGNPGISLSPSVKIGYFSQKIDTLELDKSILENVQSSSQQNETLIRTILARMHFFRDDVYKPISVLSGGERVKVALTKVFLSEVNTLVLDEPTNFLDMEAIEAFESLLKEYNGSIIFVSHDRKFIEKVATRIMTIDNKEIKIFDGTYEQFKQAEKPTRNIKEDKKLLLETKITEVLSRLSIEPSEELEQEFQNLINEKRNLDK,MKIMLEGLNIKHYVQDRLLLNINRLKIYQNDRIGLIGKNGSGKTTLLHILYKKIVPEEGIVKQFSHCELIPQLKLIESTKSGGEVTRNYIRQALDKNPELLLADEPTTNLDNNYIEKLEQDLKNWHGAFIIVSHDRAFLDNLCTTIWEIDEGRITEYKGNYSNYVEQKELERHREELEYEKYEKEKKRLEKAINIKEQKAQRATKKPKNLSLSEGKIKGAKPYFAGKQKKLRKTVKSLETRLEKLESVEKRNELPPLKMDLVNLESVKNRTIIRGEDVSGTIEGRVLWKAKSFSIRGGDKMAIIGSNGTGKTTFIKKIVHGNPGISLSPSVKIGYFSQKIDTLELDKSILENVQSSSQQNETLIRTILARMHFFRDDVYKPISVLSGGERVKVALTKVFLSEVNTLVLDEPTNFLDMEAIEAFESLLKEYNGSIIFVSHDRKFIEKVATRIMTIDNKEIKIFDGTYEQFKQAEKPTRNIKEDKKLLLETKITEVLSRLSIEPSEELEQEFQNLINEKRNLDK,89.85,gnl|BL_ORD_ID|527|hsp_num:0,579,TRUE,loose hit with at least 95 percent identity pushed strict
LK533,27_6 # 6332 # 6487 # 1 # ID=27_6;partial=01;start_type=ATG;rbs_motif=TAA;rbs_spacer=14bp;gc_cont=0.263,27_6,6332,6487,+,Strict,1050,103.605,vgaALC,96.15,3002830,protein homolog model,n/a,n/a,lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; pleuromutilin antibiotic,antibiotic target protection,vga-type ABC-F protein,ATGAAAATAATGTTAGAGGGACTTCATATAAAACATTATGTTCAAGATCGTTTATTGTTGAACATAAATCGCCTAAATATTTATCAGAATGATCGTATTGGTTTAATTGGTAAAAATGGAAGTGGAAAAACAACGTTACTTCACATATTATATAAA,MKIMLEGLHIKHYVQDRLLLNINRLNIYQNDRIGLIGKNGSGKTTLLHILYK,MKILLEGLHIKHYVQDRLLLNINRLKIYQNDRIGLIGKNGSGKTTLLHILYKKIVPEEGIVKQFSHCELIPQLKLIESTKSGGEVTRNYIRQALDKNPELLLADEPTTNLDNNYIEKLEQDLKNWHGAFIIVSHDRAFLDNLCTTIWEIDEGRITEYKGNYSNYVEQKELERHREELEYEKYEKEKKRLEKAINIKEQKAQRATKKPKNLSSSEGKIKVTKPYFASKQKKLRKTVKSLETRLEKLERVEKRNELPPLKMDLVNLESVKNRTIIRGEDVSGTIEGRVLWKAKSFSIRGGDKMAIIGSNGTGKTTFIKKIVHGNPGISLSPSVKIGYFSQKIDTLELDKSILENVQSSSQQNETLIRTILARMHFFRDDVYKPISVLSGGERVKVALTKVFLSEVNTLVLDEPTNFLDMEAIEAFESLLKEYNGSIIFVSHDRKFIEKVATRIMTIDNKEIKIFDGTYEQFKQAEKPTRNIKEDKKLLLETKITEVLSRLSIEPSEELEQEFQNLINEKRNLDK,9.96,gnl|BL_ORD_ID|138|hsp_num:0,159,TRUE,loose hit with at least 95 percent identity pushed strict
LK533,30_1 # 1 # 291 # -1 # ID=30_1;partial=10;start_type=ATG;rbs_motif=TAA;rbs_spacer=12bp;gc_cont=0.278,30_1,1,291,-,Strict,75,134.42,qacJ,72.29,3007014,protein homolog model,n/a,n/a,disinfecting agents and antiseptics,antibiotic efflux,small multidrug resistance (SMR) antibiotic efflux pump,ATGCCTTATATTTATTTAATAATAGCCATAAGTACTGAAGTTATTGGAAGTGCATTTCTTAAATCTTCAGAAGGCTTTTCAAAATTTATACCATCCTTAGGAACAATAATTTCATTTGGAATTTGTTTCTATTTTTTAAGTAAAACAATGCAACACCTACCACTAAATATAACTTATGCAACTTGGGCGGGACTAGGTTTAGTCTTAACAACCGTAGTCTCAATAATTATTTTCAAAGAACAAATAAATCTAATAACTATAGTATCTATAGTTTTAATCATAGTCGGCGTA,MPYIYLIIAISTEVIGSAFLKSSEGFSKFIPSLGTIISFGICFYFLSKTMQHLPLNITYATWAGLGLVLTTVVSIIIFKEQINLITIVSIVLIIVGV,MPYLYLVIAIITEIIGTSFLKTAEGFTKLWPTLGTLISFGICFYFLSVTMKYLPLNVSYATWAGLGLVLTTIVSVVIFKESVNLISIFSIILIIIGVVLLNVFGSSH,90.65,gnl|BL_ORD_ID|4662|hsp_num:0,5730,FALSE,None
LK1026,46_5 # 3155 # 3904 # -1 # ID=46_5;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.779,46_5,3155,3904,-,Strict,50,83.5741,vanY gene in vanM cluster,34.46,3002961,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGTCGCACCCTCCCTCTCGCCGCGCTGGCCGCGCTCGCGCTGCTCGCGGCCGGTTGCGGCACGCCCGCCGCGGGCCCGTCCTCGACGCCGACGACGCCGACGTCCGGCTCCGCGAGCGCGGCCGCGTCGTCCCGCGCCGCCTCGAGCACGGCGCCGTCGTCGGGCACGCACGCCGACCCGGCCACCCTCGACGTCGTCGTGAACAAGACCCGCCCCGTGGCCCCGCCCGACTGGGCGCCCTCGGATCTGGTGGCCGTGCCCGGCAGCGAGCTGCCCCTGCGGGCGGAGGCCGCGACGGCGGCCGCTGACCTGCTGGATGCCGCCGCGGCGGCGGGCCACCGCCTCACCACCCTGAGCGCCTACCGCTCGTACGACTACCAGGTCCGGACGTACGGCCACTGGGTCGACGAGCTGGGCCGCGCCGAGGCCGACCGCGTCTCCGCGCGTCCGGGGTACTCCGAGCACCAGACCGGCCTGGCCTGGGACGTGGGCGACGCCGCGACCCCCGCGTGTGACCTGGAAGCGTGCTTCGGCGACACCGCCGCGGGCCGTTGGGTGGCCGCGCACGCCGCCGAGTACGGGTTCGTCATCCGCTATCCCGCCGGGGCCGAGGACGTGACGGGCTTCGATCACGAGCCGTGGCACCTGCGCTACGTCGGGTCCGCGGAGGCGGCCCGGGTCGAGGCGGCCGGCGGCGTCCTCGAGACCGCGTGGGGTCTGCCGCCGGCGCCGGACTACGCGGACTGA,MRRTLPLAALAALALLAAGCGTPAAGPSSTPTTPTSGSASAAASSRAASSTAPSSGTHADPATLDVVVNKTRPVAPPDWAPSDLVAVPGSELPLRAEAATAAADLLDAAAAAGHRLTTLSAYRSYDYQVRTYGHWVDELGRAEADRVSARPGYSEHQTGLAWDVGDAATPACDLEACFGDTAAGRWVAAHAAEYGFVIRYPAGAEDVTGFDHEPWHLRYVGSAEAARVEAAGGVLETAWGLPPAPDYAD,MVFQGNLLLVNNEYPVLEESIKTDVVNLFKHDELTKGYELLNREIYLSEKVAREFSEMVDAAEKEGVRHFSINSGFRNFDEQNALYQEMGSDYALPAGYSEHNLGLALDIGSTQMEMSEAPEGKWLEDNAWEYGFILRYPMDKTAITGIQYEPWHFRYVGLPHSAIIEEKNFALEEYLDFLKEQKSISGTIHGENYEISYYPITEKTDIEMPANLHYEISGNNMDGVIVTVYR,106.87,gnl|BL_ORD_ID|1673|hsp_num:0,1713,FALSE,None
LK569,76_8 # 8820 # 9569 # 1 # ID=76_8;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.787,76_8,8820,9569,+,Strict,50,82.4185,vanY gene in vanM cluster,35.14,3002961,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGTCGTCCCCTCCCCCGCGCCGCGCTGGCCGCGCTCGCGCTGCTCGCGGCCGGCTGCGGCACGCCCGCCGCGGGCCCGTCCTCGGCGCCGGCGACGCCGGCTCCCGGCTCCTCGAGCGCGGCCGCGTCGTCCGGCGCCGCCTCGAGCACGGCGCCGTCGTCGAGCGCGCACGCCGACCCGGCCGCCCTCGACGTCGTCGTGAACAAGACCCGCCCCGTGGCCCCGCCCGATTGGGCGCCTTCGGATCTGCTGGCCGTGCCCGGCAGCGAGCTGCCCCTGCGGGCGGAGGCCGCGACGGCGGCCGGCGACCTGCTGGATGCCGCCGCGGCGGCGGGCCACCGCCTCACCACCCTGAGCGCCTACCGCTCGTACGACTACCAGGTCCGGACGTACGGCCACTGGGTCGACGAGCTGGGCCACGCCGAGGCCGACCGCGTCTCGGCGCGTCCGGGGTACTCCGAACACCAGACCGGCCTGGCGTGGGACGTGGGCGACGCCGCGACCCCCGCGTGTGACCTGGAAGCGTGCTTCGGCGACACCGCCGCGGGCCGCTGGGTGGCCGCGCACGCCGCCGAGTACGGGTTCGTCATCCGCTACCCCGCCGGGGCCGAGGACGTGACGGGCTTCGCCCACGAGCCGTGGCACCTGCGCTACGTCGGGTCCGCGGAGGCGGCCCGGGTCGAGGCGGCCGGCGGCGTCCTCGAGACCGCGTGGGGCCTGCCTCCGGCGCCGGACTACGCGGACTGA,MRRPLPRAALAALALLAAGCGTPAAGPSSAPATPAPGSSSAAASSGAASSTAPSSSAHADPAALDVVVNKTRPVAPPDWAPSDLLAVPGSELPLRAEAATAAGDLLDAAAAAGHRLTTLSAYRSYDYQVRTYGHWVDELGHAEADRVSARPGYSEHQTGLAWDVGDAATPACDLEACFGDTAAGRWVAAHAAEYGFVIRYPAGAEDVTGFAHEPWHLRYVGSAEAARVEAAGGVLETAWGLPPAPDYAD,MVFQGNLLLVNNEYPVLEESIKTDVVNLFKHDELTKGYELLNREIYLSEKVAREFSEMVDAAEKEGVRHFSINSGFRNFDEQNALYQEMGSDYALPAGYSEHNLGLALDIGSTQMEMSEAPEGKWLEDNAWEYGFILRYPMDKTAITGIQYEPWHFRYVGLPHSAIIEEKNFALEEYLDFLKEQKSISGTIHGENYEISYYPITEKTDIEMPANLHYEISGNNMDGVIVTVYR,106.87,gnl|BL_ORD_ID|1673|hsp_num:0,1713,FALSE,None
LK945,8_40 # 25938 # 26057 # -1 # ID=8_40;partial=00;start_type=ATG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.750,8_40,25938,26057,-,Strict,2200,20.0162,Bifidobacterium bifidum ileS conferring resistance to mupirocin,100,3003730,protein homolog model,n/a,n/a,mupirocin-like antibiotic,antibiotic target alteration,antibiotic-resistant isoleucyl-tRNA synthetase (ileS),ATGCCGGGCGACGTCTGCTGGCGGTGCGCGCTGGGCCACCACCACGCGTGCACCGGCTGCTCGTGCTGCGGCCGTCGCCCCCGCAAGAACGAGGGCGGGGTCACCGCCTACCCGCGGTGA,MPGDVCWRCALGHHHACTGCSCCGRRPRKNEGGVTAYPR,MSETTNSHVYPKANEGGETASVAPNPSFPNMEETVLKYWDKDDTFNKSVERNPSGDHSQNEFVFFDGPPFANGLPHYGHLLTGYAKDVIPRYQTMKGRKVNRVFGWDTHGLPAELEAQKELGIDSVDQIEKMGIDKFNDACRASVLKYTHEWQDYVHRQARWVDFEHGYKTLNIPYMESVMWAFKQLYEKGLAYQGYRVLPYCPKDQTPLSAHELRMDADVYQDRQDTTVSVAVKLRDEEDAYAVFWTTTPWTVPTNFAIVVGADIDYVEVRPTQGKYAGKKFYFGKPLLSKYEKELGEDYEVVRELKGSEMAGWRYWPVFPYFAGDKAESEGNVPGPEGYQIFTADYVDTVEGTGLVHQAPYGEDDMNTLNAHGIKSTDVLDAGCRFTAQCPDYEGMYVFDANKPILRNLRNGDGPLAEIPAEHRAILFQEKSYVHSYPHCWRCATPLIYKPVSSWFVSVTKIKPRLLELNQQINWIPENVKDGQFGKWLANARDWSISRNRFWGSPIPVWVSDDPKYPRVDVYGSLEELKADFGDYPRDKDGNVNMHRPWIDNLTRVNPDDPTGKSHMHRISDVLDCWFESGSMSFAQFHYPFENKEKFEQHFPADYIVEYIGQTRGWFYLLHVMATALFDRPAFKNVICHGIVLGSDGQKMSKHLRNYPDVNGVFDKYGSDAMRWFLMSSPILRGGNLIVTAEGIRDTVRQVMLPVWSSYYFFTLYANAANGGAGFDARQLRADEVAGLPEMDRYLLARTRRLVERVEKSLDEFAISDACDAASDFIDVLTNWYIRNTRDRFWKEDVNAFNTLYTVLEVFMRVLAPLAPMESESVWRGLTGGESVHLADWPYVADEKTGEATELGRVLVDDPALVDAMEKVREIVSGALSLRKAAQIRVRQPLAKLTVVVEDVDAVKAYDEILKSELNIKDIEFCTMEDAGSQGLKIVHELKVNARAAGPRLGKQVQFAIKASKTGAWHVDAATGAPVVETPNGEVALEAGEYELINRVEEENAAEADASVSAALPTGGFVILDTVLTADLEAEGYARDVIRAVQDARKAADLDIADRIALVLTVPSANVADVERFRDLIAHETLATSFAVKEGAELGVEVAKA,3.52,gnl|BL_ORD_ID|4696|hsp_num:0,2278,TRUE,loose hit with at least 95 percent identity pushed strict
LK945,56_1 # 3 # 119 # 1 # ID=56_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.658,56_1,3,119,+,Strict,500,20.0162,RSD2-2,100,3006983,protein homolog model,n/a,n/a,carbapenem; cephalosporin,antibiotic inactivation,RSD2 beta-lactamase,CCCCCCCCCCCCGCCAACCGACCTGACTACCAGGAAACTGGTGCGGTGCACCTCCTGTGGGTGCCTTACAGCATCGACACGTGCACATGGTCGGTGTGGTTGGACGGCCCGCTGTAG,PPPPANRPDYQETGAVHLLWVPYSIDTCTWSVWLDGPL,MQTNLIYAMEENAQIKTLFEAADVNATFILYDLQKDTIVGYDKVRSEKRYLPASTFKIANSLIGLATGAVKTVDEPIPYNGPSNPFIAAWKEDMGLKKAIAMSNVPIYQELARRIGLTRMQKYLKDLHYGNESVGEHVDRFWLDGPLQISAVEQVLFLKGLVQETLPFSKNIQKDVKSILLIEKTNAYRLYGKTGLQNAHEKGIGWFVGWIEKSEGTYIFAFNMDMTDMSDAPKRINLSKTCLTILGLLNSE,15.08,gnl|BL_ORD_ID|4572|hsp_num:0,5640,TRUE,loose hit with at least 95 percent identity pushed strict
LK945,636_2 # 1519 # 1728 # 1 # ID=636_2;partial=01;start_type=GTG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.771,636_2,1519,1728,+,Strict,400,21.9422,VIM-61,100,3005509,protein homolog model,n/a,n/a,carbapenem; cephalosporin; cephamycin; penam; penem,antibiotic inactivation,VIM beta-lactamase,GTGAGCGGGATCCAGGACGCCCTGGAAGCGGCGCTGCGGCACCGGCGCGACGCGGACGAGCTGCTGCTGATCGCCGACGAGACGGCCGCCGCGCACCTGCGCTGGGCGGGCAACGCGCTGACCACGAACGGCAGCGTCCGGTCCCGCCGGGTGACGGCGGTGGCGGTACGGGACGGCGCGGCCGGCGTACACGTCGGGCTGGTCGGGCAC,MSGIQDALEAALRHRRDADELLLIADETAAAHLRWAGNALTTNGSVRSRRVTAVAVRDGAAGVHVGLVGH,MFQIRSFLVGISAFVMAVLGSAAYSAQPGGEYPTVDDIPVGEVRLYKIGDGVWSHIATQKLGDTVYSSNGLIVRDADELLLIDTAWGAKNTVALLAEIEKQIGLPVTRSISTHFHDDRVGGVDVLRAAGVATYTSPLTRQLAEAAGNEVPAHSLKALSSSGDVVRFGPVEVFYPGAAHSGDNLVVYVPAVRVLFGGCAVHEASRESAGYVADANLAEWPATIKRIQQRYPEAEVVIPGHGLPGGLELLQHTTNVVKTHKVRPVAE,26.42,gnl|BL_ORD_ID|4641|hsp_num:0,5710,TRUE,loose hit with at least 95 percent identity pushed strict
LK1113,1_63 # 68659 # 69408 # 1 # ID=1_63;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.777,1_63,68659,69408,+,Strict,50,83.1889,vanY gene in vanM cluster,34.67,3002961,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGTCGCACCCTCCCTCTCGCCGCGCTGGCCGCGCTCGCGCTGCTCGTGGCCGGTTGCGGCACGCCCGCCGCGGGCCCGTCCTCGACGCCGACGACGCCGACGTCCGGCTCCGCGAGCGCGGCCGCGTCGTCCGGCGCCGCCTCGAGCACGGCGCCGTCGTCGGGCACGCACGCCGACCCGGCCACCCTCGACGTCGTCGTGAACAAGACCCGCCCCGTGGCCCCGCCCGACTGGGCGCCCTCGGATCTGGTGGCCGTGCCCGGCAGCGAGCTGTCCCTGCGGGCGGCGGCCGCGACGGCGGCCGGTGACCTGCTGGATGCCGCCGCGGCGGCGGGCCACCGCCTCACCACCCTGAGCGCCTACCGCTCGTACGACTACCAGGTCCGGACGTACGGCCACTGGGTCGACGAGCTGGGCCACGCCGAGGCCGACCGCGTCTCGGCGCGTCCGGGGTACTCCGAGCACCAGACCGGCCTGGCCTGGGACGTGGGCGACGCCGCGACCCCCGCGTGTGACCTGGAAGCGTGCTTCGGCGACACCGCCGCGGGCCGCTGGGTGGCCGCGCACGCCGCCGAGTACGGGTTCGTCATCCGCTACCCCGCCGGGGCCGAGGACGTGACGGGCTTCGCCCACGAGCCGTGGCACCTGCGCTACGTCGGGTCCGCGGAGGCGGCCCGGGTCGAGGCGGCCGGCGGCGTCCTCGAGACCGCGTGGGGTCTGCCTCCGGCACCCGACTACGCGGACTGA,MRRTLPLAALAALALLVAGCGTPAAGPSSTPTTPTSGSASAAASSGAASSTAPSSGTHADPATLDVVVNKTRPVAPPDWAPSDLVAVPGSELSLRAAAATAAGDLLDAAAAAGHRLTTLSAYRSYDYQVRTYGHWVDELGHAEADRVSARPGYSEHQTGLAWDVGDAATPACDLEACFGDTAAGRWVAAHAAEYGFVIRYPAGAEDVTGFAHEPWHLRYVGSAEAARVEAAGGVLETAWGLPPAPDYAD,MVFQGNLLLVNNEYPVLEESIKTDVVNLFKHDELTKGYELLNREIYLSEKVAREFSEMVDAAEKEGVRHFSINSGFRNFDEQNALYQEMGSDYALPAGYSEHNLGLALDIGSTQMEMSEAPEGKWLEDNAWEYGFILRYPMDKTAITGIQYEPWHFRYVGLPHSAIIEEKNFALEEYLDFLKEQKSISGTIHGENYEISYYPITEKTDIEMPANLHYEISGNNMDGVIVTVYR,106.87,gnl|BL_ORD_ID|1673|hsp_num:0,1713,FALSE,None
LK419,74_7 # 4338 # 5087 # -1 # ID=74_7;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.783,74_7,4338,5087,-,Strict,50,83.5741,vanY gene in vanM cluster,34.46,3002961,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGTCGCCCCCTCCCGCTCGCCGCGCTGGCCGCGCTCGCGCTGCTCGCGGCCGGCTGCGGCACGCCCGCCGCGGGCCCGTCCTCGACGCCGACGACGCCGACGTCCGGCTCCGCGAGCGCGGCCGCGTCGTCCCGCGCCGCCTCGAGCACGGCGCCGTCGTCGGGCACGCACGCCGACCCGGCCACCCTCGACGTCGTCGTGAACAAGACCCGCCCCGTGGCCCCGCCCGACTGGGCGCCCTCGGATCTGGTGGCCGTGCCCGGCAGCGAGCTGCCCCTGCGGGCGGAGGCCGCGACGGCGGCCGCTGACCTGCTGGATGCCGCCGCGGCGGCGGGCCACCGCCTCACCACCCTGAGCGCCTACCGCTCGTACGACTACCAGGTCCGGACGTACGGCCACTGGGTCGACGAGCTGGGCCGCGCCGAGGCCGACCGCGTCTCCGCGCGTCCGGGGTACTCCGAGCATCAGACCGGCCTGGCCTGGGACGTGGGCGACGCCGCGACCCCCGCGTGTGACCTGGAAGCGTGCTTCGGCGACACCGCCGCGGGCCGTTGGGTGGCCGCGCACGCCGCCGAGTACGGGTTCGTCATCCGCTACCCCGCCGGGGCCGAGGACGTGACGGGCTTCGCCCACGAGCCCTGGCATCTGCGCTACGTCGGGTCCGCGGAGGCGGCCCGGGTCGAGGCGGCCGGCGGCGTCCTCGAGACCGCGTGGGGTCTGCCGCCGGCGCCGGACTACACGGACTGA,MRRPLPLAALAALALLAAGCGTPAAGPSSTPTTPTSGSASAAASSRAASSTAPSSGTHADPATLDVVVNKTRPVAPPDWAPSDLVAVPGSELPLRAEAATAAADLLDAAAAAGHRLTTLSAYRSYDYQVRTYGHWVDELGRAEADRVSARPGYSEHQTGLAWDVGDAATPACDLEACFGDTAAGRWVAAHAAEYGFVIRYPAGAEDVTGFAHEPWHLRYVGSAEAARVEAAGGVLETAWGLPPAPDYTD,MVFQGNLLLVNNEYPVLEESIKTDVVNLFKHDELTKGYELLNREIYLSEKVAREFSEMVDAAEKEGVRHFSINSGFRNFDEQNALYQEMGSDYALPAGYSEHNLGLALDIGSTQMEMSEAPEGKWLEDNAWEYGFILRYPMDKTAITGIQYEPWHFRYVGLPHSAIIEEKNFALEEYLDFLKEQKSISGTIHGENYEISYYPITEKTDIEMPANLHYEISGNNMDGVIVTVYR,106.87,gnl|BL_ORD_ID|1673|hsp_num:0,1713,FALSE,None
LK441,95_5 # 3052 # 3795 # -1 # ID=95_5;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.774,95_5,3052,3795,-,Strict,50,83.9593,vanY gene in vanM cluster,35.81,3002961,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGTCGCACCCTCCCTCTCGCCGCGCTGGCCGCGCTCGCGCTGCTCGTGGCCGGTTGCGGCACGCCCGCCGCGGGCCCGTCCCCGGCGACGCCGGCTTCCGGCTCCGCGAGCGCGGCCGCGTCGTCCCGCGCCGCCTCGAGCACGGCGCCGTCGTCGAGCACGCACGCCGACCCGGCCGCCCTCGACGTCGTCGTGAACAAGACCCGCCCCGTGGCTCCGCCCGACTGGGCGCCCTCGGATCTGGTGGCCGTGCCCGGCAGCGAGCTGCCCCTGCGCGCGGAGGCCGCGACGGCGGCCGGCGACCTGGTGGATGCCGCCGCGGCGGCGGGCCACCGCCTCACCACCCTGAGCGCCTACCGTTCGTACGACTACCAGGTCCGGACGTATGGCCACTGGGTCGACGAGCTGGGCCACGCCGAGGCCGACCGCGTCTCCGCGCGTCCGGGGTACTCCGAGCATCAGACCGGCCTGGCCTGGGACGTGGGCGACGCCGCGACCCCCGCGTGTGACCTGGAAGCGTGCTTCGGCGACACCGCCGCGGGCCGTTGGGTGGCGGCGCACGCCGCCGAGTACGGGTTCGTCGTCCGCTATCCCGCCGGGGCCGAGGACGTGACGGGCTTCGATCACGAGCCGTGGCACCTGCGCTACGTCGGGTCCGCGGAGGCGGCCCGGGTCGAGGCGGCCGGCGGCGTCCTCGAGACCGCGTGGGGTCTGCCGCCGGCACCCGACTACGCGGACTGA,MRRTLPLAALAALALLVAGCGTPAAGPSPATPASGSASAAASSRAASSTAPSSSTHADPAALDVVVNKTRPVAPPDWAPSDLVAVPGSELPLRAEAATAAGDLVDAAAAAGHRLTTLSAYRSYDYQVRTYGHWVDELGHAEADRVSARPGYSEHQTGLAWDVGDAATPACDLEACFGDTAAGRWVAAHAAEYGFVVRYPAGAEDVTGFDHEPWHLRYVGSAEAARVEAAGGVLETAWGLPPAPDYAD,MVFQGNLLLVNNEYPVLEESIKTDVVNLFKHDELTKGYELLNREIYLSEKVAREFSEMVDAAEKEGVRHFSINSGFRNFDEQNALYQEMGSDYALPAGYSEHNLGLALDIGSTQMEMSEAPEGKWLEDNAWEYGFILRYPMDKTAITGIQYEPWHFRYVGLPHSAIIEEKNFALEEYLDFLKEQKSISGTIHGENYEISYYPITEKTDIEMPANLHYEISGNNMDGVIVTVYR,106.01,gnl|BL_ORD_ID|1673|hsp_num:0,1713,FALSE,None
LK942,2_130 # 150186 # 151880 # -1 # ID=2_130;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.657,2_130,150186,151880,-,Strict,50,79.7221,vanW gene in vanI cluster,33.77,3003724,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanW; glycopeptide resistance gene cluster,GTGACTACGGTAAATGCAACAGGTGCCCGCGGTGGGCGCGGGGTCGGCACCGGGAAGATTCTCCTCGGTGTGCTTCTCGGCGTGCTCGCGGTGCTGCTCGCGATCTACCTCGCCGACCTCGCAATGAACCGCGGGAACGTGCCGCGTGGCACCGCCGTCGGCGGTGTCGAGATCGGCGGCATGAGCCACGACGAGGCCACCGCGAAGCTCGAAGCAGAGCTCGGCGAGACGGCGAGCAACCCGGTGACGGTGAAGGCGGCATCGCAAAGCTCGCAGCTCGTGCCCGCCGAGTCCGGCCTCGGCATCGACTGGGAGGCGACCGTAGCAAGCGCGGGCGAAGAGTCCGCGAACCCGTTCACTCGCCTCGCCGGGTTGTTTCGCACCCGCGAAGTCGACATTGTGTCGACCGTGAACGAGGCCGCTCTCACCCCGCAGCTTGAGCGCGTGGCCGGCGAGTTGCACCTCGACCCCGCCGACGGCGCGATCGCCATCGAAGGCGGCGAGGCGAAAGTGACCGAACCGGTGCCGGGCCAGGAGGTTGACAAAACCGAGCTGTTCGAACGTGTCACCACCGGCTGGCTCAACCCTGACGGTGTAGAGGTCGAGCCGCGCGAAATCGAACCCGCTATCGGCGACCAGGCCATCAAGGAAGCCTTAGACGGGCCGGTTAAGGCGGCGCTGTCCGGAGCGTTGACACTGCACGGTCGCGACGGCATCGACGGTGTCATTGCCCAAGAGCGCATCGGCGAGGTCGTCCAATTCCCTAACGTCGACGGCAAAATCGCCCCCGAGGTGAACGTGGAAAACGCCCAGGGCATCTTGGTCGAGCAGCTCGCTGCGACCGAGACGCAGATGAAAAACGCGCGCGTGCTGCCCGGCGGCGGGGTGGAACCGTCCGTCGACGGCTCCATCATCGACTGGGAGGCCGCGATGGACGGTTTCGACGAGCGGTTGATCGGTTCCGCCGAGCGCACCTGGGACGCGCAATATAAGGCCCGCCCGGCCGACTTCACCACTGAAGAGGCCAACAATGCCACCTTCGACCAGGTCGTCGGCTCCTTTACCACCAGCGGCTACAGCTCGGCCTCGGGCACCAACATCGCGGTGGTGGCACGCGCGGTCGAAGGAGCGATTGTCAACCCAGGCGAGACGTTCTCGCTCAACGGCTACACCGGCCCGCGCGGCACCGCGCAGGGCTACGTTTCGTCCGGGATCATCGAAAACGGCCGGCCCGGCACCGCCGTCGGCGGTGGTATCTCCCAGTTCGCCACCACCTTGTACAACGCGGCCTACTTTGCGGGAATGACCGACGTGGCCTCCACGCCGCACTCCTACTACATCTCCCGCTACCCCACGGGCCGCGAGGCAACCGTCTTCGAGGGCGCGATCGACCTGCAGTTCCGAAACGACTCGCCTTATCCGGTGAAGATCACCTCCAAGGTCGGCGGTGGGGAGGTCACCGTGAGTCTGATGGGTGTGAAAACCGTCGAGGTGGAGTCCATCAATGGAGGGCGCTGGGCCTACACCTCGCCGAAGCCCGTGACCGTCACCAGTGGTGACTGCATTCCCTCGGGCGGGGTGCAGGGCTTTACCACCTCCGATACCCGGATTGTGCGTGACCTCAGCGGCAATGAGATCAGTCGCAACACCTCCACCACGGTCTACGACCCGCAGCCCATCGTTCGCTGCGAGTAG,MTTVNATGARGGRGVGTGKILLGVLLGVLAVLLAIYLADLAMNRGNVPRGTAVGGVEIGGMSHDEATAKLEAELGETASNPVTVKAASQSSQLVPAESGLGIDWEATVASAGEESANPFTRLAGLFRTREVDIVSTVNEAALTPQLERVAGELHLDPADGAIAIEGGEAKVTEPVPGQEVDKTELFERVTTGWLNPDGVEVEPREIEPAIGDQAIKEALDGPVKAALSGALTLHGRDGIDGVIAQERIGEVVQFPNVDGKIAPEVNVENAQGILVEQLAATETQMKNARVLPGGGVEPSVDGSIIDWEAAMDGFDERLIGSAERTWDAQYKARPADFTTEEANNATFDQVVGSFTTSGYSSASGTNIAVVARAVEGAIVNPGETFSLNGYTGPRGTAQGYVSSGIIENGRPGTAVGGGISQFATTLYNAAYFAGMTDVASTPHSYYISRYPTGREATVFEGAIDLQFRNDSPYPVKITSKVGGGEVTVSLMGVKTVEVESINGGRWAYTSPKPVTVTSGDCIPSGGVQGFTTSDTRIVRDLSGNEISRNTSTTVYDPQPIVRCE,MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVLAEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPELLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGMETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGGEFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSHSLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDEPDGYPVKPREWSK,151.21,gnl|BL_ORD_ID|4748|hsp_num:0,2242,FALSE,None
LK1015,1_202 # 224532 # 226214 # 1 # ID=1_202;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.305,1_202,224532,226214,+,Strict,400,778.859,salE,68.32,3007029,protein homolog model,n/a,n/a,lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; pleuromutilin antibiotic,antibiotic target protection,sal-type ABC-F protein,ATGTTCAGATTGTTAAGGCATGTCGTATCCCTTAAGAAAGAGGGAATTGGTATGTCTTTTTATTTTGTTCAAAAACCATTTGAAAAATTTGGTAAAAATTTAATTAACTCTGTAGAAATTCAAATTGATAAAGGCGAACATATTGCAATGATAGGTAACAATGGCGTAGGCAAAACGACTTTGTTAGAAGCGATAAAATCGAAATATAAAGATGAAACTTATTTAATGTACCAAAATATGTTAGCTTATGAACACTTAACAGGGTTAGATTATGTAATGGAAATAAACCCCGAAATATTGCAGATAAAGCAAAAACTTGAAGACAATTATGAATATATTGCAGACTTTAGTGCATTAAATGGTTACGAATTTGAACAGAGTATTATTACGCAAGCGAATCAAATGAATTTAACAGAAAAAGATTTAGAAAAACAAATTCAAGATTTAAGTGGTGGTCAACAAACACGACTGGCGTTATTAAAAGCATTCATGTCAAACAAACCACTGATCTTACTGGATGAACCCACGAATCATTTAGATTTAGAAATGTTGGAACAACTGATTAGAAAAATTCAAAAATCAAAACGTACGATTGTTTATGTATCACACCAGCGTGATTTTATCGATCATACAGCGACTCATGTCATTGAAGTAACATCTGAAAAAACGAATAAATATAATGGTAATTATTCCAAGTACCGTGAAATTAAAGATTTAACGTTACAAACACAACAAAATATGTACGAAAAGCAACAAAAAGAAATAGCAGAACTTAATCGCACGATACAACGAATCCAAACATGGCATCATTCAGCACAACAAAAAGCAAGTGTTCGTAGCCCTATTGAGCAGAAGAAGCTTAGTAAGTTAGCTCAAAAGGCTAAAGTAAAAGAAAAACAAATGACCGAAAAATTAAATGAGAAGACCATAAACCAGCCAGATAACGAACAAAAACATTATCATTTTAATCATGAAACCCAATTACGTAAGCGTTTTTTAATTCATTTTGAAGACTTCAATGTTGTTATAAGTGAACATCATGTATTTGAACATGCGCATTTCGAAATGAAACAAAAAGAAAACGTATTAATAACGGGACCAAATGGAAGCGGAAAATCTCTTTTAATTGCGATGATCAGACAAAAGATATTTGCTAATCAAGGACATTTAAAAATCACACCTTCACTAAAAATTGGATATTTCGATCAGACGAACAAAAATTTGAATGAAGCAGAATCTCCACTGATGATGCTATTAAGTACGAATAAAATATCAAGAAGCGAAGCGCAAACTATATTAGCTTCATTTGGTTTTAAAGAGGAAAAAATTAATGCACCAATTGGTCAATTATCTATGGGAGAGAAAAGTAGATTTCAATTTGTACTGCTATATTGCTCTGGTGCCAATTTATTAATTTTAGATGAGCCAACTAATTATTTTGATATTTCAACACAGGACTTAATTTTAAATATGATAAAAAGTTTTAACGGTCAAGTATTAGTTGTGAGCCATGATGAGTATTTTCAAGCTAGGTTTAAAGCGACACACTGGGAAATTAGAAATAAAAAATTATATAACTTAACCCAAAATAAAAAGACAAAATCAAATGTAAACGAAACATTAACATTGTTAGATGAATATGAAATGATAGATGAAAATGGTCATTTTGAAACAGACAACTAG,MFRLLRHVVSLKKEGIGMSFYFVQKPFEKFGKNLINSVEIQIDKGEHIAMIGNNGVGKTTLLEAIKSKYKDETYLMYQNMLAYEHLTGLDYVMEINPEILQIKQKLEDNYEYIADFSALNGYEFEQSIITQANQMNLTEKDLEKQIQDLSGGQQTRLALLKAFMSNKPLILLDEPTNHLDLEMLEQLIRKIQKSKRTIVYVSHQRDFIDHTATHVIEVTSEKTNKYNGNYSKYREIKDLTLQTQQNMYEKQQKEIAELNRTIQRIQTWHHSAQQKASVRSPIEQKKLSKLAQKAKVKEKQMTEKLNEKTINQPDNEQKHYHFNHETQLRKRFLIHFEDFNVVISEHHVFEHAHFEMKQKENVLITGPNGSGKSLLIAMIRQKIFANQGHLKITPSLKIGYFDQTNKNLNEAESPLMMLLSTNKISRSEAQTILASFGFKEEKINAPIGQLSMGEKSRFQFVLLYCSGANLLILDEPTNYFDISTQDLILNMIKSFNGQVLVVSHDEYFQARFKATHWEIRNKKLYNLTQNKKTKSNVNETLTLLDEYEMIDENGHFETDN,MSFYFAQKPFEMFGKTLIQSVDLQFEKGEHIAVIGNNGVGKTTLLKALNNKYKEDTYLMDQNMTTFGNMTGIDYVISLNTELFHLKQALMDNYEKVSDYIALNGYEFEQTIITKAKQMALTEADLDKPIKVLSGGQQTRLALLRAFISNKPLILLDEPTNHLDQEMIDQLINHIQQSKRTIIYVSHHRGFIDQTASHVIEITPESTRKFNGNYKQYKEIKDLESQTEQRIYNKQQKEIQDLERTIKRVQTWHHSAQQKASVRNPIEQKKLSKLAQRAKVKEKQLNQKLQEKHIQEPSKETKSYYFSHQTSLPKRFLIRFEDVSVNIDGQAIYKHAHFEMKQNENILLTGPNGSGKSLFIALIRQHLSPDEGIIEITPSLKIGYFDHTNNNLNEAESPLSMLLVRTNITRSQAQTLLASFNFDKDQIKKPIRYLSMGEKSRLQFVLLYFSGANLLVLDEPTNYFDIVTQDLILSMIQSFTGQVLIVTHDSYLQSQFKAVHWEIKNQQLYNVSLTHTRESNLDETLKLLGEYKFIDENGHFETDN,103.13,gnl|BL_ORD_ID|4730|hsp_num:0,5740,FALSE,None
LK1015,1_982 # 1003006 # 1003329 # 1 # ID=1_982;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.287,1_982,1003006,1003329,+,Strict,75,134.806,qacJ,70.09,3007014,protein homolog model,n/a,n/a,disinfecting agents and antiseptics,antibiotic efflux,small multidrug resistance (SMR) antibiotic efflux pump,ATGCCTTATTTATTATTAATTTTAGCTATAGTAGGAGAAGTCATAGGTAGTGCATTTCTTAAATCATCTGAAGGTTTTTCTAAGCTTTTTCCAACTTTGGCAACAATTATTTCATTTCTTGCATGCTTTTATTTTTTAAGCAAAACTTTACAATATTTACCATTAAATATTACATATGCTAGTTGGGCTGGACTTGGTTTGGTACTTACAACGATTGTGTCAGTTGTAATTTTCAAAGAACAAATTAATTTGATGAGTGTCATTTCAATTACTATTATTATTGTGGGTGTTGTATTACTTAATACTTTTGGGTCAACTCATTAG,MPYLLLILAIVGEVIGSAFLKSSEGFSKLFPTLATIISFLACFYFLSKTLQYLPLNITYASWAGLGLVLTTIVSVVIFKEQINLMSVISITIIIVGVVLLNTFGSTH,MPYLYLVIAIITEIIGTSFLKTAEGFTKLWPTLGTLISFGICFYFLSVTMKYLPLNVSYATWAGLGLVLTTIVSVVIFKESVNLISIFSIILIIIGVVLLNVFGSSH,100,gnl|BL_ORD_ID|4662|hsp_num:0,5730,FALSE,None
LK1015,2_3 # 3076 # 3531 # -1 # ID=2_3;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.259,2_3,3076,3531,-,Strict,100,206.838,sepA,68.28,3007012,protein homolog model,n/a,n/a,disinfecting agents and antiseptics,antibiotic efflux,small multidrug resistance (SMR) antibiotic efflux pump,ATGAAATATATAAAGTATTTATTTACGACGCTTATTGTACTTTCGGTATTTATCATTTCAGGTGCTATATTTCTTGCATTCTTAGGATTTGGTTTATATGGATTAAGTCGTATCCTTATATTTTTTCATCTAGCATACTTTGGTTATAATAAAAGCTTTTATGATAACTTAATCTATTATGGTAGCTATATCGTATTGGGTTATTTTACATTATTTATCATTGAAAATTTAATGGATTATTTTAGGAAAAAACTACCAGACAACCCTTATTTTCAAGGGATAACGTATCATTTAATAACATTTACTGTTACCACATTACTATTCTATTTTATAGTTCACATTCATTATGCGTATATAGATATTGATTTTTGGGTAATTGTTGTAATTATGGGTATGTTATTTGTATGTAAAGAAGTCTTTTATCCTGATAGCGAAAATCTTAATCAGAATAAATAG,MKYIKYLFTTLIVLSVFIISGAIFLAFLGFGLYGLSRILIFFHLAYFGYNKSFYDNLIYYGSYIVLGYFTLFIIENLMDYFRKKLPDNPYFQGITYHLITFTVTTLLFYFIVHIHYAYIDIDFWVIVVIMGMLFVCKEVFYPDSENLNQNK,MIVNFFKHKFYNLLTTMIVLFVFVLSGAIFLTFLGFGLYGLSRILIYFRLGDFTYNRNMYDNLLYYGSYIIFGYFIIFAVEHLMDYFRKMLPENAYFRGATFHLISYTVATTLFYFIIHLHYVYINIDFWVIMVIIGFLYVCKLQFYPESKNLNNRK,96.18,gnl|BL_ORD_ID|4660|hsp_num:0,5728,FALSE,None
LK1015,2_4 # 3720 # 5063 # -1 # ID=2_4;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.304,2_4,3720,5063,-,Strict,200,512.686,sdrM,62.42,3007013,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGAATATAAAAACATTTGGTGTTGTTGTTGCATTAATATTAATTATGTTTATGTCTGCAATTGAAACATCAATCGTTTCATTAGCATTGCCAACTATAAAAGAAGATTTAAATGTGACTGGTTCAATATCACTGATATTTTCAGTTTACTTTATAGCAATTGTGATTGCTAATCCAATTGTAGGTGAATTATTGGATCGCACTAAAATTATATACATAACACTTTTGGGATTAGTATTTTTTACAATTGGAAGTTTTTTTTCAGGTATAAGTAGTACATTTGGTATTTTAATTATCTCGCGCTTTATTCAGGGATTGGGTGCTGGAATAATGATGGCTTTGAGCCAAATTGTCCCTAAGCTTGCTTTTGCAATTCCTTTAAGATATAAAATTATGGGAATTGTCGGTAGTGTATGGGGGATATCAAGTATTATAGGTCCGGTCTTAGGTGGTGGAATTTTAGAATTAGCTACTTGGCATTGGTTGTTTTTCGTTAATATACCTATCGCTATCATCGCCATGTTATTGGTAGTATTTACGTTTCACTTTAAACATGAACAGACGACAACTTCACATAAATTAGATATGAAAGGACTTATGTTATTTTATCTGTTTGTTTTCTTTTTAATGTTTACAGTAATGAATAACAGTCAGTGGTATTTAAATTGTCTTTCATTTATTATAGCAATTATTATGGGTATGATATTAATTAAAAATGAAAAGGGTGTAGCAGCGCCTTTCTTCCCTGTTAAAGAATTTAATAAAACTATCATACTCGTTTTTACTACAGATTTTTTATATGCAATGATACTGATGGGATATAATTTATATATGCCAATATATCTACAAGAAGAACTGGGACTATCTCCCTTGCAGAGTGGATTTGTTATTTTTCCAATTTCCTTTGCTTGGTTAGTGTTGAATTTTAATTTAAATAGGTTAGAAGCAAAAATGTCTAGAAAAGGTTTGTATATATTTGCTTTTACTCTTTTAACAATATGTGGCATTTTTATATTCGCAGGTACAAAAACACCGATATTTATAGCGTTTAGTTTATTGCTGGCTGGTGTTAGTTTTGGAACAGTGTATACGAAAGACAGTGTAATAACTCAAGAAGAAACGTCACCTCAGAATATGAAACGCATGATGTCACTATATACATTAACGAAAAGTCTAGGTAATTCTATCGGTTCTACAATTATGGGAACAGTTTATGGTTTAACGGTTTCATTTATCCATTTACCGATACACAATGTGATTATACTTAGTCTTATCATCTTGTTTATATTGTTTGTACTTTGGCAGACACAATATAAACAAGATAATCACAAATGCAATTCTTAG,MNIKTFGVVVALILIMFMSAIETSIVSLALPTIKEDLNVTGSISLIFSVYFIAIVIANPIVGELLDRTKIIYITLLGLVFFTIGSFFSGISSTFGILIISRFIQGLGAGIMMALSQIVPKLAFAIPLRYKIMGIVGSVWGISSIIGPVLGGGILELATWHWLFFVNIPIAIIAMLLVVFTFHFKHEQTTTSHKLDMKGLMLFYLFVFFLMFTVMNNSQWYLNCLSFIIAIIMGMILIKNEKGVAAPFFPVKEFNKTIILVFTTDFLYAMILMGYNLYMPIYLQEELGLSPLQSGFVIFPISFAWLVLNFNLNRLEAKMSRKGLYIFAFTLLTICGIFIFAGTKTPIFIAFSLLLAGVSFGTVYTKDSVITQEETSPQNMKRMMSLYTLTKSLGNSIGSTIMGTVYGLTVSFIHLPIHNVIILSLIILFILFVLWQTQYKQDNHKCNS,MRLKSIITVIALILIMFMSAIESSIISLALPTIKQDLNAGNLISLIFTAYFIALVIANPIVGELLSRFKIIYVAIAGLLLFSIGSFMCGLSTNFTMLIISRVIQGFGSGVLMSLSQIVPKLAFEIPLRYKIMGIVGSVWGISSIIGPLLGGGILEFATWHWLFYINIPIAIIAIILVIWTFHFPEEETVAKSKFDTKGLTLFYVFIGLIMFALLNQQLLLLNFLSFILAIVVAMCLFKVEKHVSSPFLPVVEFNRSITLVFITDLLTAICLMGFNLYIPVYLQEQLGLSPLQSGLVIFPLSVAWITLNFNLHRIEAKLSRKVIYLLSFTLLLVSSIIISFGIKLPVLIAFVLILAGLSFGYIYTKDSVIVQEETSPLQMKKMMSFYGLTKNLGASIGSTIMGYLYAIQSGIFGPNLHNVLSAVAVISIGLIVLWVVFFKEQSSQSKE,100,gnl|BL_ORD_ID|4661|hsp_num:0,5729,FALSE,None
LK1015,2_245 # 230373 # 231764 # -1 # ID=2_245;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.356,2_245,230373,231764,-,Strict,525,546.969,norC,61.49,3007010,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGGAATCAGAACAACCATTCGAAGGAGATAACAGACTTCTTTTAGGTATTTTTTTAAGCGTAATAACATTTTGGTTGTTTGCTCAATCGCTCGTTAATATCGTTCCTGCATTAGAAACATCTTTCACAACTAGTTATGGAACGATTAACGTAGCCGTAAGTTTAACCGCATTATTATGTGGTTTGTTTGTTGTAGGTACAGGAGGACTTGCAGATCGATATGGTAGGGTCAAAATGACTTATATCGGTTTGACTTTAAGCGTTCTTGGATCATTACTTATTATCATTCCAGGATTTGTCCCTTTGTTAGTACTTGGGAGAGCAATACAGGGGCTATCTGCAGCATGTATCATGCCTTCGACATTAGCAATTATAAATGAATACTATATTGGAAGAAGGCGACAACGTGCGTTAAGTTACTGGTCTATCGGTTCATGGGGTGGTACTGGAATTTGTTCGTTTTTTGGTGGCATCATGGCTACCTTTGTAGGATGGCGATCTATATTTATTATTTCAATAATAGTAGCTTTAGTGTCTATGTATTTAATCAAACACACGCCAGAAACGAAAGCCGTTCAAACCGAGGCATCAAAATGTGCCAAATTTGATTTTGTAGGGCTAATTATATTAATAGTTGCAATGCTGAGTGTCAATTTAATCATTACACAATCTTCAAATTATGGTTTCTTTTCACCGCTTATTTTGATGTTAATTGTGATATTCATCATTTCAATTATTGTATTTATATTATTTGAAAACAAAGTTAAAAACCCATTGATAGATTTTAAACTTTTTAAACATAAAGCATACAGTGGTGCTACAGTGTCAAACTTTTTACTAAATGCTGTAGCAGGAACGCTTATTGTTGCGAATACTTATTTTCAATCGGGATTACATTTCACCTCATTCCAATCTGGTATGATGACTATTACTTATTTAGTAGCTGTTTTAATCATGATTAGAGTCGGAGAAAAAATCCTACAGGAAGTCGGTCCTAAAAAACCAATGCTTATAGGTGCAGGGCTTAATGCGATAGGGATTCTATTAATCTCGTTAACCTTTTTACCTACGCCTGTTTATGTCATCAGTTGTGTGTTAGGTTACTTAATTTATGGTGTAGGCTTAGGTATGTATGCCACACCTTCAACAGATACAGCTGTTACTACTGCGCCAGAAGATAAGGTAGGTGTCGCGTCTGGTGTATATAAAATGGCATCTTCACTTGGTAACTCATTTGGCGTAGCTATTTCAGGGACAATATTTACGATTATGTCAGCTCGTGACAATATTCATGTTGGTGCCATGTATGGACTGTGGTTTAATGCTGCATTAGCAATCATTGCATTTGTATTTGTATGGTTATTAGTTCCGAAAAAGCAATTTAATAATTAG,MESEQPFEGDNRLLLGIFLSVITFWLFAQSLVNIVPALETSFTTSYGTINVAVSLTALLCGLFVVGTGGLADRYGRVKMTYIGLTLSVLGSLLIIIPGFVPLLVLGRAIQGLSAACIMPSTLAIINEYYIGRRRQRALSYWSIGSWGGTGICSFFGGIMATFVGWRSIFIISIIVALVSMYLIKHTPETKAVQTEASKCAKFDFVGLIILIVAMLSVNLIITQSSNYGFFSPLILMLIVIFIISIIVFILFENKVKNPLIDFKLFKHKAYSGATVSNFLLNAVAGTLIVANTYFQSGLHFTSFQSGMMTITYLVAVLIMIRVGEKILQEVGPKKPMLIGAGLNAIGILLISLTFLPTPVYVISCVLGYLIYGVGLGMYATPSTDTAVTTAPEDKVGVASGVYKMASSLGNSFGVAISGTIFTIMSARDNIHVGAMYGLWFNAALAIIAFVFVWLLVPKKQFNN,MNETYRGGNKLILGIVLGVITFWLFAQSLVNVVPNLQQSFGADMGTISIAVSLTALFSGMFVVGAGGLADKIGRVKMTNIGLLLSIIGSALIIITNLPALLILGRIIQGVSAACIMPSTLAIMKTYYEGAERQRALSYWSIGSWGGSGICSLFGGAVATTMGWRWIFIFSIIVAVLSMLLIKGTPETKSEVTNTHKFDVAGLIVLVVMLLSLNVVITKGAALGYTSLWFFGLIAIVIVAFFIFLNVEKKVDNPLIDFKLFENKPYTGATISNFLLNGVAGTLIVANTFVQQGLGYTALQAGYLSITYLIMVLLMIRVGEKLLQKMGSKRPMLLGTFIVIIGIALISLVFLPGIFYVISCVVGYLCFGLGLGIYATPSTDTAISNAPLDKVGVASGIYKMASSLGGAFGVAISGAVYAGAVAATSIHTGAMIALWVNVLMGIMAFIAILFAIPNDDKRVKDAK,100.22,gnl|BL_ORD_ID|4656|hsp_num:0,5726,FALSE,None
LK1015,2_380 # 376389 # 377786 # -1 # ID=2_380;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.333,2_380,376389,377786,-,Strict,525,617.846,norC,68.93,3007010,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGACGCAACAGGGAAATACGAAGAGTTATCAAGGTGACAACAAATTAATATTAGGTATTGTATTAGGGGTTGTCACTTTTTGGTTATTTGCGCAATCTTTATTAAACGTAGTTCCTACGTTACAACAATCATTTAATAGTAATATTGGTACAATCAGTATAGCTGTTAGTATTACAGCATTATTCTCAGGGATGTTTGTTGTTGGTGCAGGAAGTCTAGCGGATAAAGTAGGACGTGTGAGAATAACATATTTTGGTTTATGGTTAAGTATCATTGGTTCTTTATTGATTATAATTAGTAATCTACCAATACTACTTATCATAGGAAGGGTAATTCAAGGTTTATCAGCAGCAGCAATCATGCCTTCAACTTTAGCAATTATGAAGACATATTTTGAAGGTAAAGATAGACAGCGTGCACTGAGTTACTGGTCGATTGGTTCATGGGGTGGCTCAGGTTTAGCATCTTTATTCGGTGGTATGGTTTCAACTTTTATTGGTTGGAGATGGATTTTTATTTTATCTATCATTGTTGCACTAATTGCAATGTTATTAATAAAAGGGACACCGGAAACGAAATCTGATAGTACAACAAACTTGAAATTTGATTTTACTGGGCTAATTCTTTTTGTAGTTATGATGTTAAGTATTAATGTCGTGATTACGCAAAGTGGTACATTTGGCATGCTTTCACCTATAATAATAGGATTGCTTATTGTATTTATTATCACAACTATAGCTTTTGTCATAGTTGAAAACAAAAAGCATAATCCATTAATTGATTTTAAATTATTTAAAAATAAAGCTTATACAGGCGCGACATTATCAAATTTCTTACTTAATGGTGTTGCAGGTGCCTTGCTGGTAGCCAATACATTCGTTCAAAAAGGTATAGGTTTCAACGCATTCCAAACAGGACTTTTATCGATTACATATTTGGTTACTGTATTGTTGATGATTAGAGTCGGTGAAAAAGTTTTACAAAAAGTGGGTGCTAAAAAACCGATGTTGTTAGGTACAACATTTAATATGGTTGGTATTATTTTAATATCATTTACATTTTTGCCAAGCGCACTATATGTCGTAGTATGTATCATAGGTTATTTACTATACGGATTAGGATTAGGTTTTTATGCGACACCTTCTACAGATATGGCGATATCTAATTCTCCTGAAGATAAAGTTGGTGTAGCATCGGGTATTTATAAAATGGCTTCCTCATTAGGTGGTGCGTTTGGTATAGCTTTATCAGGAGCATTATATGGCGTTGTTACAGAAGCTACAAATGTGAAATTTGGAGCGATGGCTGGTTTATGGCTAAATGTATTAATGGCATTGCTTTCATTCGTTATTATTCTTTTAGCTGTGCCATCATTTAAGAAACAAAATAAAGCATAA,MTQQGNTKSYQGDNKLILGIVLGVVTFWLFAQSLLNVVPTLQQSFNSNIGTISIAVSITALFSGMFVVGAGSLADKVGRVRITYFGLWLSIIGSLLIIISNLPILLIIGRVIQGLSAAAIMPSTLAIMKTYFEGKDRQRALSYWSIGSWGGSGLASLFGGMVSTFIGWRWIFILSIIVALIAMLLIKGTPETKSDSTTNLKFDFTGLILFVVMMLSINVVITQSGTFGMLSPIIIGLLIVFIITTIAFVIVENKKHNPLIDFKLFKNKAYTGATLSNFLLNGVAGALLVANTFVQKGIGFNAFQTGLLSITYLVTVLLMIRVGEKVLQKVGAKKPMLLGTTFNMVGIILISFTFLPSALYVVVCIIGYLLYGLGLGFYATPSTDMAISNSPEDKVGVASGIYKMASSLGGAFGIALSGALYGVVTEATNVKFGAMAGLWLNVLMALLSFVIILLAVPSFKKQNKA,MNETYRGGNKLILGIVLGVITFWLFAQSLVNVVPNLQQSFGADMGTISIAVSLTALFSGMFVVGAGGLADKIGRVKMTNIGLLLSIIGSALIIITNLPALLILGRIIQGVSAACIMPSTLAIMKTYYEGAERQRALSYWSIGSWGGSGICSLFGGAVATTMGWRWIFIFSIIVAVLSMLLIKGTPETKSEVTNTHKFDVAGLIVLVVMLLSLNVVITKGAALGYTSLWFFGLIAIVIVAFFIFLNVEKKVDNPLIDFKLFENKPYTGATISNFLLNGVAGTLIVANTFVQQGLGYTALQAGYLSITYLIMVLLMIRVGEKLLQKMGSKRPMLLGTFIVIIGIALISLVFLPGIFYVISCVVGYLCFGLGLGIYATPSTDTAISNAPLDKVGVASGIYKMASSLGGAFGVAISGAVYAGAVAATSIHTGAMIALWVNVLMGIMAFIAILFAIPNDDKRVKDAK,100.65,gnl|BL_ORD_ID|4656|hsp_num:0,5726,FALSE,None
LK1015,2_605 # 639463 # 640143 # -1 # ID=2_605;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.320,2_605,639463,640143,-,Strict,50,108.227,vanY gene in vanM cluster,36.81,3002961,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGAATAAATTTAAATTATTGATTATCATGTTGTATTTAGTCTTAGTTGGATGTTCTGCTCAAGAAAATGAAGCTGAGCATAAAGACAGTAAAAATCATGAAAAACAGCAAAGTAGCAATAGTGAAAATAAGCATCACAAAGAAGTGAAGCATGGTGTAACGTATATTGATGATATTTTAATTGTGAACAAAGATATTTCGTTACCAGAACATTTTAACCCTGGAGAAAATAAAAAAGCACGTCATGCATTACAGAAACTTTTAAATGATGGTAATAAACAAGGATTTCAATTATCAAACGCTAGTGGTTTCAGAAGTTATCAAAGTCAAGAGCAGTTATTTGACCAATATGTTCAAAGAGATGGAGAAAAAGCAGCCAATAAATATAGTGCGAAACCAGGACATTCTGAACATCAAACTGGACTGACATACGACATTGTTTCTGAGAATACAGACAACAACTTTAAAACTTCTTTTGGTAAGACCGAGGAAGGTCAGTGGCTCAAAGACAATGCTTACAAGTACGGTTTTATCATCAGATATCCCAAGAATAAAACACATATTACGGGATACCAATATGAACCGTGGCATATCAGGTATGTTGGAAAAGATACAGCTAAAAAATTATATAAAAGTAATGAAACATTAGAAGAGTACTTAGATCTATATCCAAAAAAATAA,MNKFKLLIIMLYLVLVGCSAQENEAEHKDSKNHEKQQSSNSENKHHKEVKHGVTYIDDILIVNKDISLPEHFNPGENKKARHALQKLLNDGNKQGFQLSNASGFRSYQSQEQLFDQYVQRDGEKAANKYSAKPGHSEHQTGLTYDIVSENTDNNFKTSFGKTEEGQWLKDNAYKYGFIIRYPKNKTHITGYQYEPWHIRYVGKDTAKKLYKSNETLEEYLDLYPKK,MVFQGNLLLVNNEYPVLEESIKTDVVNLFKHDELTKGYELLNREIYLSEKVAREFSEMVDAAEKEGVRHFSINSGFRNFDEQNALYQEMGSDYALPAGYSEHNLGLALDIGSTQMEMSEAPEGKWLEDNAWEYGFILRYPMDKTAITGIQYEPWHFRYVGLPHSAIIEEKNFALEEYLDFLKEQKSISGTIHGENYEISYYPITEKTDIEMPANLHYEISGNNMDGVIVTVYR,97,gnl|BL_ORD_ID|1673|hsp_num:0,1713,FALSE,None
LK1015,5_112 # 106011 # 106655 # 1 # ID=5_112;partial=00;start_type=TTG;rbs_motif=AGGA/GGAG/GAGG;rbs_spacer=11-12bp;gc_cont=0.295,5_112,106011,106655,+,Perfect,400,440.269,FusF,100,3004663,protein homolog model,n/a,n/a,fusidane antibiotic,antibiotic target protection,Target protecting FusB-type protein conferring resistance to Fusidic acid,TTGGAAAAACAAATTTATCCATATCAATTTAACTATATTAAAGAACGAATCGCACATTTACTTAATGCTTATAAATCAGTAAATGACTTAAATACAATTGCTTCTATAAAAGAAACAACTAAAATAGACATTTATCAGCAGTTTCATCAAATAGATGATACGTTGACTGAAGCGATTGAAAAATTAATGAACATACGTATTACTAAAGTACAAGTAGATAAAATATTAGAAACTTTACAGACATACGTTATACCCTTTGAACACCCTTCAAAAAAACAAGTCGAAAAAACTTTTCGTAAAATTAAAAAGCTTAAATCACCGCTTATTAGTGATGAAATCCTTTTGGAAAGTACTTATATCGGATGGAACGATATCGCTTCAAACAGAAAATTTATCATCTATTATAACGAGCAAGGAACTTTAACAGGTTTTTATGGCGACATTGCTAACCAAACCGTTAAGGGCTATTGCGCAATTTGTAATAAAGAATCTAATGTCGCTCTATTTATGCGTAAAACACGTACTTCTGGTGATGGACAATATACCAAAAAAGGTGACTATATTTGTTTTGACAGTATCAAATGTAATCAACAATTGTCGGATATTACACAATTTTATCAATTTGTCGATAAAATCCACTCATAA,MEKQIYPYQFNYIKERIAHLLNAYKSVNDLNTIASIKETTKIDIYQQFHQIDDTLTEAIEKLMNIRITKVQVDKILETLQTYVIPFEHPSKKQVEKTFRKIKKLKSPLISDEILLESTYIGWNDIASNRKFIIYYNEQGTLTGFYGDIANQTVKGYCAICNKESNVALFMRKTRTSGDGQYTKKGDYICFDSIKCNQQLSDITQFYQFVDKIHS,MEKQIYPYQFNYIKERIAHLLNAYKSVNDLNTIASIKETTKIDIYQQFHQIDDTLTEAIEKLMNIRITKVQVDKILETLQTYVIPFEHPSKKQVEKTFRKIKKLKSPLISDEILLESTYIGWNDIASNRKFIIYYNEQGTLTGFYGDIANQTVKGYCAICNKESNVALFMRKTRTSGDGQYTKKGDYICFDSIKCNQQLSDITQFYQFVDKIHS,100,gnl|BL_ORD_ID|2207|hsp_num:0,3364,FALSE,None
LK1015,6_9 # 6878 # 8026 # -1 # ID=6_9;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.342,6_9,6878,8026,-,Strict,175,184.882,vanT gene in vanG cluster,32.07,3002972,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,glycopeptide resistance gene cluster; vanT,ATGACTGATAAGTATTATAGATCCACATATTTAAACGTAGATTTAAATGCAATTGTGGCAAATTTTCAAGTTTTCCAAAAATTACACCCAAATAAAACGGTGATGCCAATCGTAAAAGCGAATGCTTATGGTCTTGGCAGCGTGAAAATCGCACGTTACCTTATGGATCATGGCGCTGATTTTTTTGGCGTAGCAACTTTGGATGAAGCGATAGAATTAAGAATGCACGGTATAGATGCTAAAATTTTAATATTAGGCGTTATACCTACATATAATATTAATAAAGCCATACAACATCGCGTAGCAATCACCATTCCATCAAAAGCATGGTTAGTTGAAGCGTTAAAAGAAATTCCAGAAGATAACGACAAAGATTTATGGTTACATGTAAAAATAGATACTGGCATGGGAAGATTAGGTATTAAAGATGCAGCGGAATATAAAGAAGTTATTGAGTTAATCCATAACCATGATCATGTAGTATTTGAAGGGGTGTTTACGCATTTTGCATGTGCAGATGAACCTGGAGAATCAATGAATCAGCAACAAAGTTTATTTGAATCAATTGTCAATGAAGAAGAAAAGCCACAGTATATACATTCGCAAAATTCTGCAGGTGCATTAATGAAAGATAGCCAATTCTGTAATTCAGTGCGGGTGGGTATATCATTATACGGTTATTATCCTTCAAGTTATGTTAAAGACAGTGTGAAAATACATTTAAAACCAAGTGCGCAATGGATTAGTGAAATTGTACAAACAAAAGTCTTGCAACCAGGCGAATCTGTGAGTTACGGCAGTATTTATACAGCGACAGAACCTACAAAAATCGGTATTATTCCTGTTGGTTATGCAGATGGATTTCCAAGAATGATGACCGGATTTAATGTAAATGTTAACAGCAAACAATGTGAAATTATTGGAAAAGTTTGCATGGATCAAATAATTATTAAAATTCCAGAAGAAATTCAAACTGGTGATAAAGTGATATTGTTGGATCATCATTCAGACAGTGAACAATCTGTGGAAGCGCTGGCATATCAACAACATACTATCAATTATGAAGTTTTATGTCGCTTAAATAGGAGATTGCCACGTATCTATTATGGTACTCAAGACCTAGAAATCCTTAATGAATTACTAAAATAG,MTDKYYRSTYLNVDLNAIVANFQVFQKLHPNKTVMPIVKANAYGLGSVKIARYLMDHGADFFGVATLDEAIELRMHGIDAKILILGVIPTYNINKAIQHRVAITIPSKAWLVEALKEIPEDNDKDLWLHVKIDTGMGRLGIKDAAEYKEVIELIHNHDHVVFEGVFTHFACADEPGESMNQQQSLFESIVNEEEKPQYIHSQNSAGALMKDSQFCNSVRVGISLYGYYPSSYVKDSVKIHLKPSAQWISEIVQTKVLQPGESVSYGSIYTATEPTKIGIIPVGYADGFPRMMTGFNVNVNSKQCEIIGKVCMDQIIIKIPEEIQTGDKVILLDHHSDSEQSVEALAYQQHTINYEVLCRLNRRLPRIYYGTQDLEILNELLK,MTKNESYSGIDYFRFIAALLIVAIHTSPLSSFSETGNFIFTRIVARVAVPFFFMTSGFFLISRYTCNAEKLGAFIKKTTLIYGVAILLYIPINVYNGYFKMDNLLPNIIKDIVFDGTLYHLWYLPASIIGAAIAWYLVKKVHYRKAFLIASILYIIGLFGDSYYGIVKSVSCLNVFYNLIFQLTDYTRNGIFFAPIFFVLGGYISDSQNRLSLKRSIVGFIVCFALMFGEALTLHHFDIQKHDSMYVLLLPSVYCLFNLLLHFRGKRRTGLRTISLIIYIIHPFMIVVIRLFAKLLHLQSLLVENSLVHYIAVCFASVVLAVVITALLSSLKPKKAKHTADTDRAYLEINLNNLEHNVNTLQKAMSPKCELMAVVKAEAYGHGMYEVTTYLEQIGVSSFAVATIDEGIRLRKYGISSEILILGYTSPSRAKELCKYELTQTLIDYRYSLLLNKQGYDIKAHIKIDTGMHRLGFSTEDKDKILAAFSLKHIKVAGIFTHLCAADSLEENDVAFTNKQIGSFYKVLDWLKSSGLNIPKVHIQSSYGLLNYPELECDYIRVGVALYGVLSSTNDKTKLELDLRPVLSLKAKVVLIRKIKQGESVGYSRAFTATRDSLIAILPIGYADGFPRNLSCGNSYVLIGGRQAPIVGKICMDQLAVDVTDIPNVKTGSIATLIGKDGKEEITAPMVAESAESITNELLSRMGHRLNIIRRA,53.65,gnl|BL_ORD_ID|1522|hsp_num:0,1561,FALSE,None
LK1015,10_18 # 17049 # 18515 # -1 # ID=10_18;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.311,10_18,17049,18515,-,Strict,800,1006.51,msrA,99.59,3000251,protein homolog model,n/a,n/a,macrolide antibiotic; streptogramin antibiotic; streptogramin B antibiotic,antibiotic target protection,msr-type ABC-F protein,ATGGAACAATATACAATTAAATTTAACCAAATCAATCATAAATTGACAGATTTACGATCACTTAACATCGATCATCTTTATGCTTACCAATTTGAAAAAATAGCACTTATTGGGGGTAATGGTACTGGCAAAACCACATTACTAAATATGATTGCTCAAAAAACAAAACCAGAATCTGGAACAGTTGAAACGAATGGCGAAATTCAATATTTTGAACAGCTTAACATGGATGTGGAAAATGATTTTAACACGTTAGACGGTAGTTTAATGAGTGAACTCCATATACCTATGCATACAACCGACAGTATGAGTGGTGGTGAAAAAGCAAAATATAAATTAGCTAATGTCATATCAAATTATAGTCCGATATTACTTTTAGATGAACCTACAAATCACTTGGATAAAATTGGTAAAGATTATCTGAATAATATTTTAAAATATTACTATGGTACTTTAATTATAGTAAGTCACGATAGAGCACTTATAGACCAAATTGCTGACACAATTTGGGATATACAAGAAGATGGCACAATAAGAGTGTTTAAAGGTAATTACACACAGTATCAAAATCAATATGAACAAGAACAGTTAGAACAACAACGTAAATATGAACAGTATATAAGTGAAAAACAAAGATTGTCCCAAGCCAGTAAAGCTAAACGAAATCAAGCGCAACAAATGGCACAAGCATCATCAAAACAAAAAAATAAAAGTATAGCACCAGATCGTTTAAGTGCATCAAAACAAAAAGGCACGGTTGAGAAGGCTGCTCAAAAACAAGCTAAGCATATTGAAAAAAGAATGGAACATTTGGAAGAAGTTGAAAAACCACAAAGTTATCATGAATTCAATTTTCCACAAAATAAAATTTATGATATCCATAATAATTATCCAATCATTGCACAAAATCTAACATTGGTTAAAGGAAGTCAAAAACTGCTAACACAAGTACGATTCCAAATACCATATGGCAAAAATATAGCGCTCGTAGGTGCAAATGGTGTAGGTAAGACAACTTTACTTGAAGCTATTTACCACCAAATAGAGGGAATTGATTGTTCTCCTAAAGTGCAAATGGCATACTATCGTCAACTTGCTTATGAAGACATGCGTGACGTTTCATTATTGCAATATTTAATGGATGAAACGGATTCATCAGAATCATTCAGTAGAGCTATTTTAAATAACTTGGGTTTAAATGAAGCACTTGAACGTTCTTGTAATGTTTTGAGTGGTGGGGAAAGAACGAAATTATCGTTAGCAGTATTATTTTCAACGAAAGCGAATATGTTAATTTTGGATGAACCAACTAATTTTTTAGATATTAAAACATTAGAAGCATTAGAAATGTTTATGAATAAATATCCTGGAATCATTTTGTTTACATCACATGATACAAGGTTTGTTAAACATGTATCAGATAAAAAATGGGAATTAACAGGACAATCTATTCATGATATAACTTAA,MEQYTIKFNQINHKLTDLRSLNIDHLYAYQFEKIALIGGNGTGKTTLLNMIAQKTKPESGTVETNGEIQYFEQLNMDVENDFNTLDGSLMSELHIPMHTTDSMSGGEKAKYKLANVISNYSPILLLDEPTNHLDKIGKDYLNNILKYYYGTLIIVSHDRALIDQIADTIWDIQEDGTIRVFKGNYTQYQNQYEQEQLEQQRKYEQYISEKQRLSQASKAKRNQAQQMAQASSKQKNKSIAPDRLSASKQKGTVEKAAQKQAKHIEKRMEHLEEVEKPQSYHEFNFPQNKIYDIHNNYPIIAQNLTLVKGSQKLLTQVRFQIPYGKNIALVGANGVGKTTLLEAIYHQIEGIDCSPKVQMAYYRQLAYEDMRDVSLLQYLMDETDSSESFSRAILNNLGLNEALERSCNVLSGGERTKLSLAVLFSTKANMLILDEPTNFLDIKTLEALEMFMNKYPGIILFTSHDTRFVKHVSDKKWELTGQSIHDIT,MEQYTIKFNQINHKLTDLRSLNIDHLYAYQFEKIALIGGNGTGKTTLLNMIAQKTKPESGTVETNGEIQYFEQLNMDVENDFNTLDGSLMSELHIPMHTTDSMSGGEKAKYKLRNVISNYSPILLLDEPTNHLDKIGKDYLNNILKYYYGTLIIVSHDRALIDQIADTIWDIQEDGTIRVFKGNYTQYQNQYEQEQLEQQRKYEQYISEKQRLSQASKAKRNQAQQMAQASSKQKNKSIAPDRLSASKEKGTVEKAAQKQAKHIEKRMEHLEEVEKPQSYHEFNFPQNKIYDIHNNYPIIAQNLTLVKGSQKLLTQVRFQIPYGKNIALVGANGVGKTTLLEAIYHQIEGIDCSPKVQMAYYRQLAYEDMRDVSLLQYLMDETDSSESFSRAILNNLGLNEALERSCNVLSGGERTKLSLAVLFSTKANMLILDEPTNFLDIKTLEALEMFMNKYPGIILFTSHDTRFVKHVSDKKWELTGQSIHDIT,100,gnl|BL_ORD_ID|1105|hsp_num:0,1200,FALSE,None
LK1015,18_2 # 594 # 3668 # -1 # ID=18_2;partial=00;start_type=TTG;rbs_motif=AGGAGG;rbs_spacer=5-10bp;gc_cont=0.287,18_2,594,3668,-,Strict,2000,2088.54,Staphylococcus aureus mupA conferring resistance to mupirocin,99.61,3000521,protein homolog model,n/a,n/a,mupirocin-like antibiotic,antibiotic target alteration,antibiotic-resistant isoleucyl-tRNA synthetase (ileS),TTGACAAAGAAATATTTAAACACCCAGAATGAAATATCAGCATTTTGGAATACTCAAAAGATATTTAAAAAATCAATTGACAATAGAAAAGGACAGGAAAGTTTTGTTTTTTATGACGGCCCCCCAACTGCAAATGGCCTTCCTCATGCTGGCCATGTTCTTGGAAGAGTAATCAAGGATTTAGTTGCAAGATTAAAAACTATGCAAGGTTTTTATGTAGAAAGAAAAGCAGGATGGGATACCCATGGCTTACCAGTTGAATTAGAGGTTGAAAAAAAAATTGGAATTAAAGGAAAACAAGACATTGAAAAGTATGGAATAGAAAATTTTATAAATGAATGTAAAAAAAGTGTATTTAATTATGAAAAAGAATGGCGGGATTTTTCTAAAGATTTAGGATACTGGGTTGACATGGACTCCCCCTATATAACTCTTGAGAATAATTATATTGAAAGTGTATGGAATATATTATCTACATTCCATAAAAAAGGACTATTATATAAGGGACATAAGGTGACTCCTTATTGTACACATGATCAAACCGCTTTAAGTTCTCATGAAGTAGCGCAAGGCTATAAAAACGTTAAAGATTTATCAGCTGTTGTTAAATTTCAACTTACAAATAGTAAAGATACTTATTTCTTAAGTTGGACTACCACTCCCTGGACTTTGCCTGCAAATGTAGCATTAGCTATAAATAAAGATCTTAATTATTCAAAAATTCGGGTAGAAAATGAGTATTATATCTTAGCTACAGATCTAATTAATTCTATAATAACTGAAAAATACGAAATTATTGATACCTTTTCAGGAAGTAATTTAATTAATTTAAAATACATTCCTCCTTTTGAAAGCGACGGTTTAGTTAATGCATATTACGTTGTTGATGGAGAATTTGTTACTAACTCAGAAGGAACTGGTATTGTTCATATAGCACCAGCTCATGGGGAAGATGACTACCAATTGGTTTTAGAGCGTGATTTGGATTTCTTAAATGTTATAACAAGAGAAGGAGTATATAATGATAGGTTCCCTGAATTAGTTGGTAATAAAGCTAAAAATAGTGATATAGAAATCATAAAATTATTATCCAAAAAACAACTTTTATATAAAAAACAAAAATATGAGCATAATTATCCTCATTGTTGGAGATGTGGTAATCCTTTGATATATTATGCGATGGAAGGTTGGTTTATTAAAACAACTAATTTTAAGAATGAAATTATTAACAATAATAATAATATAGAGTGGTTTCCTTCTCATATTAAGGAAGGGAGAATGGGAAATTTCTTAGAAAATATGGTTGATTGGAACATTGGTAGAAATAGATATTGGGGAACACCATTAAATGTATGGATTTGCAATGATTGTAATCACGAATACGCACCAAGTAGTATTAAGGATTTACAAAATAATTCCATCAATAAAATTGATGAAGATATTGAGTTGCATAGACCTTATGTTGATAATATCACTCTTAGTTGCCCTAAGTGTAATGGGAAAATGTCTCGAGTAGAAGAAGTAATCGATGTTTGGTTTGATAGCGGCTCTATGCCGTTTGCTCAGCATCATTATCCTTTTGATAACCAGAAAATTTTTAATCAACACTTTCCAGCTGATTTTATTGCAGAAGGAGTTGATCAAACGAGAGGCTGGTTTTACAGTTTACTAGTAATTTCTACTATTCTAAAAGGAAAATCTTCTTATAAACGTGCTTTATCTTTAGGACATATTCTAGACAGTAATGGTAAAAAAATGTCTAAAAGTAAAGGAAACGTTATTAATCCAACTGAATTAATTAATAAGTACGGAGCCGATTCTTTAAGATGGGCCTTAATTTCGGATAGTGCTCCATGGAATAACAAAAGATTCTCAGAAAATATAGTAGCTCAGACCAAATCGAAATTTATAGATACGCTTGATAATATTTATAAATTTTATAATATGTATAATAAAATAGATCACTATAATCCTAATAATGAAATTACAAAAAGTAGAAATACATTAGATAATTGGGCTCTTTCTCGCTTAAACACCTTAATAAAAGAAAGTAATATTTATGTAAATAATTACGATTTCACTTCCGCAGCCAGATTAATTAACGAATATACCAATACAATAAGTAATTGGTATATTCGGAGATCGAGAGGACGATTTTGGGAACAAGGAATTTCTAACGATAAAAAAGATGCGTACAATACGCTTTATGAAATTTTAACAACTTTATCAAGACTAGTGGCTCCATTTGTTCCATTTATATCTGAAAAAATCCATTATAATTTGACTGGAAAAAGTGTGCATTTACAAGATTATCCACAATATAAAGAAAGTTTTATTAATCAAGCATTGGAAGATGAAATGCATACCGTTATAAAAATTGTAGAATTATCTAGACAGGCTCGCAAAAATGCAGATTTAAAAATTAAGCAACCTTTATCGAAAATGGTGATTAAACCTAATAGTCAATTAAACTTAAGTTTTTTACCTAATTACTATTCAATAATAAAAGACGAATTAAATATAAAAAACATTGAATTAACTGATAATATTAATGACTATATTACCTATGAGCTTAAATTGAATTTTTCTTCTGTGGGACCAAAACTAGGGAACAAAACGAAAAATATTCAAACATTGATAGACTCCCTATCAGAGTATGATAAAAAAAGTTTAATTGAGTCTAATAACTTCAAAAGTTTATCTTCTGATGCTGAGTTAACTAAGGATGATTTTATAATTAAAACCTTACCTAAGGATAGTTATCAACTCAGTGAAGATAATGACTGCGTTATATTATTAGATAAAAATTTATCTCCTGAATTAATTCGCGAAGGACATGCTAGAGAGCTCATTAGATTAATTCAACAATTAAGAAAAAAGAAAAATTTACCAATAAATCAACGTATTGATATTTATATCGGTGTAACTGGGGAATTATTAGAATCAATAAAAACCAATAAAAATATGTTTAAAGAAAATTTGCTGATTAAAAATATACACTTAAATGTTATAGATGAATATGAAAATACTATTCATTTTAATAATAAAGAAATAAAAATTTCCTTATTATATTAA,MTKKYLNTQNEISAFWNTQKIFKKSIDNRKGQESFVFYDGPPTANGLPHAGHVLGRVIKDLVARLKTMQGFYVERKAGWDTHGLPVELEVEKKIGIKGKQDIEKYGIENFINECKKSVFNYEKEWRDFSKDLGYWVDMDSPYITLENNYIESVWNILSTFHKKGLLYKGHKVTPYCTHDQTALSSHEVAQGYKNVKDLSAVVKFQLTNSKDTYFLSWTTTPWTLPANVALAINKDLNYSKIRVENEYYILATDLINSIITEKYEIIDTFSGSNLINLKYIPPFESDGLVNAYYVVDGEFVTNSEGTGIVHIAPAHGEDDYQLVLERDLDFLNVITREGVYNDRFPELVGNKAKNSDIEIIKLLSKKQLLYKKQKYEHNYPHCWRCGNPLIYYAMEGWFIKTTNFKNEIINNNNNIEWFPSHIKEGRMGNFLENMVDWNIGRNRYWGTPLNVWICNDCNHEYAPSSIKDLQNNSINKIDEDIELHRPYVDNITLSCPKCNGKMSRVEEVIDVWFDSGSMPFAQHHYPFDNQKIFNQHFPADFIAEGVDQTRGWFYSLLVISTILKGKSSYKRALSLGHILDSNGKKMSKSKGNVINPTELINKYGADSLRWALISDSAPWNNKRFSENIVAQTKSKFIDTLDNIYKFYNMYNKIDHYNPNNEITKSRNTLDNWALSRLNTLIKESNIYVNNYDFTSAARLINEYTNTISNWYIRRSRGRFWEQGISNDKKDAYNTLYEILTTLSRLVAPFVPFISEKIHYNLTGKSVHLQDYPQYKESFINQALEDEMHTVIKIVELSRQARKNADLKIKQPLSKMVIKPNSQLNLSFLPNYYSIIKDELNIKNIELTDNINDYITYELKLNFSSVGPKLGNKTKNIQTLIDSLSEYDKKSLIESNNFKSLSSDAELTKDDFIIKTLPKDSYQLSEDNDCVILLDKNLSPELIREGHARELIRLIQQLRKKKNLPINQRIDIYIGVTGELLESIKTNKNMFKENLLIKNIHLNVIDEYENTIHFNNKEIKISLLY,MTKKYLNTQNEISAFWNTQKIFKKSIDNRKGQESFVFYDGPPTANGLPHAGHVLGRVIKDLVARLKTMQGFYVERKAGWDTHGLPVELEVEKKIGIKGKQDIEKYGIENFINECKKSVFNYEKEWRDFSKDLGYWVDMDSPYITLENNYIESVWNILSTFHKKGLLYKGHKVTPYCTHDQTALSSHEVAQGYKNVKDLSAVVKFQLTNSKDTYFLSWTTTPWTLPANVALAINKDLNYSKIRVENEYYILATDLINSIITEKYEIIDTFSGSNLINLKYIPPFESDGLVNAYYVVDGEFVTNSEGTGIVHIAPAHGEDDYQLVLERDLDFLNVITREGVYNDRFPELVGNKAKNSDIEIIKLLSKKQLLYKKQKYEHNYPHCWRCGNPLIYYAMEGWFIKTTNFKNEIINNNNNIEWFPSHIKEGRMGNFLENMVDWNIGRNRYWGTPLNVWICNDCNHEYAPSSIKDLQNNSINKIDEDIELHRPYVDNITLSCPKCNGKMSRVEEVIDVWFDSGSMPFAQHHYPFDNQKIFNQHFPADFIAEGVDQTRGWFYSLLVISTILKGKSSYKRALSLGHILDSNGKKMSKSKGNVINPTELINKYGADSLRWALISDSAPWNNKRFSENIVAQTKSKFIDTLDNIYKFYNMYNKIDHYNPNNEITKSRNTLDNWALSRLNTLIKESNIYVNNYDFTSAARLINEYTNTISNWYIGDSRGRFWEQGISNDKKDAYNTLYEILTTLSRLVAPFVPFISEKIHYNLTGKSVHLQDYPQYKESFINQALEDEMHTVIKIVELSRQARKNADLKIKQPLSKMVIKPNSQLNLSFLPNYYSIIKDELNIKNIELTDNINDYITYELKLNFSSVGPKLGNKTKNIQTLIDSLSEYDKKSLIESNNFKSLSSDAELTKDDFIIKTLPKDSYQLSEDNDCVILLDKNLSPELIREGHARELIRLIQQLRKKKNLPINQRIDIYIGVTGELLESIKTNKNMFKENFVIKNIHLNVIDEYENTIHFNNKEIKISLLY,100,gnl|BL_ORD_ID|4701|hsp_num:0,2270,FALSE,None
LK1015,21_1 # 139 # 462 # 1 # ID=21_1;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.287,21_1,139,462,+,Strict,75,141.354,qacJ,71.03,3007014,protein homolog model,n/a,n/a,disinfecting agents and antiseptics,antibiotic efflux,small multidrug resistance (SMR) antibiotic efflux pump,ATGCCTTATATTTATTTAATAATATCCATAAGTACTGAAGTTATTGGAAGTGCATTTCTTAAATCTTCAGAAGGCTTTTCAAAATTTATACCATCCTTAGGAACAATAATTTCATTTGGAATTTGTTTCTATTTTTTAAGTAAAACAATGCAACACCTACCACTAAATATAACTTATGCAACTTGGGCGGGACTAGGTTTAGTCTTAACAACCGTAGTCTCAATAATTATTTTCAAAGAACAAATAAATCTAATAACTATAGTATCTATAGTTTTAATCATAGTCGGCGTAGTTTCGTTAAACATTTTCGGAACATCGCATTAA,MPYIYLIISISTEVIGSAFLKSSEGFSKFIPSLGTIISFGICFYFLSKTMQHLPLNITYATWAGLGLVLTTVVSIIIFKEQINLITIVSIVLIIVGVVSLNIFGTSH,MPYLYLVIAIITEIIGTSFLKTAEGFTKLWPTLGTLISFGICFYFLSVTMKYLPLNVSYATWAGLGLVLTTIVSVVIFKESVNLISIFSIILIIIGVVLLNVFGSSH,100,gnl|BL_ORD_ID|4662|hsp_num:0,5730,FALSE,None
LK1073,67_9 # 10218 # 10961 # 1 # ID=67_9;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.777,67_9,10218,10961,+,Strict,50,83.9593,vanY gene in vanM cluster,34.46,3002961,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGTCGCACCCTCCCTCTCGCCGCGCTGGCCGCGCTCGCGCTGCTCGTGGCCGGTTGCGGCACGCCCGCCGCGGGCCCGTCCCCGGCGACGCCGGCTTCCGGCTCCGCGAGCGCGGCCGCGTCGTCCCGCGCCGCCTCGAGCACGGCGCCGTCGTCGAGCACGCACGCCGACCCGGCCGCCCTCGACGTCGTCGTGAACAAGACCCGCCCCGTGGCTCCGCCCGACTGGGCGCCCTCGGATCTGGTGGCCGTGCCCGGCAGCGAGCTGTCCCTGCGGGCGGAGGCCGCGACGGCGGCCGGTGACCTGCTGGATGCCGCCGCGGCGGCGGGTCACCGCCTCACCACCCTGAGCGCCTACCGCTCGTACGACTACCAGGTCCGGACGTACGGCCACTGGGTCGACGAGCTGGGCCGCGCCGAGGCCGACCGCGTCTCGGCGCGTCCGGGGTACTCCGAGCACCAGACCGGCCTGGCCTGGGACGTGGGCGACGCCGCGACCCCCGCGTGTGACCTGGAAGCGTGCTTCGGCGACACCGCCGCGGGCCGCTGGGTGGCCGCGCACGCCGCCGAGTACGGGTTCGTCATCCGCTATCCCGTCGGGGCCGAGGACGTGACGGGCTTCGCCCACGAGCCGTGGCACCTGCGCTACGTCGGGTCCGCGGAGGCGGCCCGGGTCGAGGCGGCCGGCGGCGTCCTCGAGACCGCGTGGGGCCTGCCTCCGGCGCCGGACTACGCGGACTGA,MRRTLPLAALAALALLVAGCGTPAAGPSPATPASGSASAAASSRAASSTAPSSSTHADPAALDVVVNKTRPVAPPDWAPSDLVAVPGSELSLRAEAATAAGDLLDAAAAAGHRLTTLSAYRSYDYQVRTYGHWVDELGRAEADRVSARPGYSEHQTGLAWDVGDAATPACDLEACFGDTAAGRWVAAHAAEYGFVIRYPVGAEDVTGFAHEPWHLRYVGSAEAARVEAAGGVLETAWGLPPAPDYAD,MVFQGNLLLVNNEYPVLEESIKTDVVNLFKHDELTKGYELLNREIYLSEKVAREFSEMVDAAEKEGVRHFSINSGFRNFDEQNALYQEMGSDYALPAGYSEHNLGLALDIGSTQMEMSEAPEGKWLEDNAWEYGFILRYPMDKTAITGIQYEPWHFRYVGLPHSAIIEEKNFALEEYLDFLKEQKSISGTIHGENYEISYYPITEKTDIEMPANLHYEISGNNMDGVIVTVYR,106.01,gnl|BL_ORD_ID|1673|hsp_num:0,1713,FALSE,None
LK1274,16_5 # 3216 # 3965 # -1 # ID=16_5;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.783,16_5,3216,3965,-,Strict,50,83.5741,vanY gene in vanM cluster,34.46,3002961,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGTCGCCCCCTCCCGCTCGCCGCGCTGGCCGCGCTCGCGCTGCTCGCGGCCGGCTGCGGCACGCCCGCCGCGGGCCCGTCCTCGACGCCGACGACGCCGACGTCCGGCTCCGCGAGCGCGGCCGCGTCGTCCCGCGCCGCCTCGAGCACGGCGCCGTCGTCGGGCACGCACGCCGACCCGGCCACCCTCGACGTCGTCGTGAACAAGACCCGCCCCGTGGCCCCGCCCGACTGGGCGCCCTCGGATCTGGTGGCCGTGCCCGGCAGCGAGCTGCCCCTGCGGGCGGAGGCCGCGACGGCGGCCGCTGACCTGCTGGATGCCGCCGCGGCGGCGGGCCACCGCCTCACCACCCTGAGCGCCTACCGCTCGTACGACTACCAGGTCCGGACGTACGGCCACTGGGTCGACGAGCTGGGCCGCGCCGAGGCCGACCGCGTCTCCGCGCGTCCGGGGTACTCCGAGCATCAGACCGGCCTGGCCTGGGACGTGGGCGACGCCGCGACCCCCGCGTGTGACCTGGAAGCGTGCTTCGGCGACACCGCCGCGGGCCGTTGGGTGGCCGCGCACGCCGCCGAGTACGGGTTCGTCATCCGCTACCCCGCCGGGGCCGAGGACGTGACGGGCTTCGCCCACGAGCCCTGGCATCTGCGCTACGTCGGGTCCGCGGAGGCGGCCCGGGTCGAGGCGGCCGGCGGCGTCCTCGAGACCGCGTGGGGTCTGCCGCCGGCGCCGGACTACACGGACTGA,MRRPLPLAALAALALLAAGCGTPAAGPSSTPTTPTSGSASAAASSRAASSTAPSSGTHADPATLDVVVNKTRPVAPPDWAPSDLVAVPGSELPLRAEAATAAADLLDAAAAAGHRLTTLSAYRSYDYQVRTYGHWVDELGRAEADRVSARPGYSEHQTGLAWDVGDAATPACDLEACFGDTAAGRWVAAHAAEYGFVIRYPAGAEDVTGFAHEPWHLRYVGSAEAARVEAAGGVLETAWGLPPAPDYTD,MVFQGNLLLVNNEYPVLEESIKTDVVNLFKHDELTKGYELLNREIYLSEKVAREFSEMVDAAEKEGVRHFSINSGFRNFDEQNALYQEMGSDYALPAGYSEHNLGLALDIGSTQMEMSEAPEGKWLEDNAWEYGFILRYPMDKTAITGIQYEPWHFRYVGLPHSAIIEEKNFALEEYLDFLKEQKSISGTIHGENYEISYYPITEKTDIEMPANLHYEISGNNMDGVIVTVYR,106.87,gnl|BL_ORD_ID|1673|hsp_num:0,1713,FALSE,None
LK938,220_2 # 1460 # 2440 # -1 # ID=220_2;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.760,220_2,1460,2440,-,Strict,500,528.865,mphO,92.43,3004543,protein homolog model,n/a,n/a,macrolide antibiotic,antibiotic inactivation,macrolide phosphotransferase (MPH),GTGCGCGCGACCGGGCAGACTGCCGGGATGACCGAGACCTCCCCCTCGAGCCCTGCGTCAGCCACGGCCGACGCAGGGACTCCCCCGCCCGCCGACCTCGAGCAGCTCCTCGCCCTCGCCGCCGATCACGGGCTCGACCTCCTCGGCGACTCGCTGCGGACCGAGGAGATCGGCCTCGACTTCCGCGTCGCGTTCGCCCGGGCACGGGACGGGCAGGACTGGGTGCTGCGCATCCCCCGTCGCGCCGAGGTGCTGGCCCGCGCCGCGGTCGAGGGCCGGCTGCTCGCCCACCTCGCCCCGCACCTGGACATCGCGATCCCCGACTGGCGGATCAGCACGGAGCGCCTGATCGCCTATCCCCTCCTGCCCGGCACCCCGGGGCTGACCGTCGACCCCGACGGCACGGTCCGGTGGCACGTGGACATGGCCTCGACCGAGTACGCCCGCACCCTCGGCACCTTCCTCGCCCAGCTCCACGCGGTGGACCCGGTCGCGGCCACCGCCACCGGGATCCCGTCCCTCACCCCGGCGGAGGTCCGCGACCGGTGGCGCGAGGACCTCGCCCGCGTCGCCGAGGCCTTTCCGATCGCACCCGCGCTGCGGGAGCGCTGGGAGGCGTGGCTGGCGGAGGACTCCTACTGGCCGGACCGCAGCGTGCTCACCCACGGCGAGGTCTATCCCGGGCACACCCTCGTGCGCGGCGAGCGGCTCAGCGCGGTGCTGGACTGGACCACCGCGTCCGTCGGCGATCCGGCGCGGGACGTCATGTTCCACCGCGCGAGCGCTCCCCCGGAGGCCTTCGCGGCGACGCTCGCCGCCTACGAGGCCGGCGGCGGGACCGTCCACCCGCGGCTCGGCGAGCACGCCGAGGAGATGTTCTCCGCCTCCCCGCTCGCGTACGGGCTCTATGCGCTGACGACCGGCGCGGAGGAGCACCGCGTCGCGGCGGCCGCCGCGCTCGACCCGCCGGACGCCGACTGA,MRATGQTAGMTETSPSSPASATADAGTPPPADLEQLLALAADHGLDLLGDSLRTEEIGLDFRVAFARARDGQDWVLRIPRRAEVLARAAVEGRLLAHLAPHLDIAIPDWRISTERLIAYPLLPGTPGLTVDPDGTVRWHVDMASTEYARTLGTFLAQLHAVDPVAATATGIPSLTPAEVRDRWREDLARVAEAFPIAPALRERWEAWLAEDSYWPDRSVLTHGEVYPGHTLVRGERLSAVLDWTTASVGDPARDVMFHRASAPPEAFAATLAAYEAGGGTVHPRLGEHAEEMFSASPLAYGLYALTTGAEEHRVAAAAALDPPDAD,MTETSPSSPSSATADAGTPPPADLEQLLALAADHGLDLLGDSLRTEEIGLDFRVAFARSRDWQDWVLRIPRRAEVLARAAVEGRLLAHLAPHLDIAIPDWRISTERLIAYPLLPGTPGLTVSADGTVEWHVDMASTEYARALGTFLAQLHTVDPEEAAATGIPSRTPSEVRGVWREDLTRVAEAFPIAPALRERWEAWLAEDSYWPDRSVLTHGEVYPGHTLVEGERLSAVLDWTTASVGDPARDLMFHRSSAPPEAFAATLAAYVAGGGTLHPRLGEHAEEMFSASPLAYGLYALETGEEEHRAAAAAALDPPDAD,102.84,gnl|BL_ORD_ID|2692|hsp_num:0,3219,FALSE,None
LK950,1_180 # 195840 # 197534 # -1 # ID=1_180;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.657,1_180,195840,197534,-,Strict,50,79.7221,vanW gene in vanI cluster,33.77,3003724,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanW; glycopeptide resistance gene cluster,GTGACTACGGTAAATGCAACAGGTGCCCGCGGTGGGCGCGGGGTCGGCACCGGGAAGATTCTCCTCGGTGTGCTTCTCGGCGTGCTCGCGGTGCTGCTCGCGATCTACCTCGCCGACCTCGCAATGAACCGCGGGAACGTGCCGCGTGGCACCGCCGTCGGCGGTGTCGAGATCGGCGGCATGAGCCACGACGAGGCCACCGCGAAGCTCGAAGCAGAGCTCGGCGAGACGGCGAGCAACCCGGTGACGGTGAAGGCGGCATCGCAAAGCTCGCAGCTCGTGCCCGCCGAGTCCGGCCTCGGCATCGACTGGGAGGCGACCGTAGCAAGCGCGGGCGAAGAGTCCGCGAACCCGTTCACTCGCCTCGCCGGGTTGTTTCGCACCCGCGAAGTCGACATTGTGTCGACCGTGAACGAGGCCGCTCTCACCCCGCAGCTTGAGCGCGTGGCCGGCGAGTTGCACCTCGACCCCGCCGACGGCGCGATCGCCATCGAAGGCGGCGAGGCGAAAGTGACCGAACCGGTGCCGGGCCAGGAGGTTGACAAAACCGAGCTGTTCGAACGTGTCACCACCGGCTGGCTCAACCCTGACGGTGTAGAGGTCGAGCCGCGCGAAATCGAACCCGCTATCGGCGACCAGGCCATCAAGGAAGCCTTAGACGGGCCGGTTAAGGCGGCGCTGTCCGGAGCGTTGACACTGCACGGTCGCGACGGCATCGACGGTGTCATTGCCCAAGAGCGCATCGGCGAGGTCGTCCAATTCCCTAACGTCGACGGCAAAATCGCCCCCGAGGTGAACGTGGAAAACGCCCAGGGCATCTTGGTCGAGCAGCTCGCTGCGACCGAGACGCAGATGAAAAACGCGCGCGTGCTGCCCGGCGGCGGGGTGGAACCGTCCGTCGACGGCTCCATCATCGACTGGGAGGCCGCGATGGACGGTTTCGACGAGCGGTTGATCGGTTCCGCCGAGCGCACCTGGGACGCGCAATATAAGGCCCGCCCGGCCGACTTCACCACTGAAGAGGCCAACAATGCCACCTTTGACCAGGTCGTCGGCTCCTTTACCACCAGCGGCTACAGCTCGGCCTCGGGCACCAACATCGCGGTGGTGGCACGCGCGGTCGAAGGAGCGATTGTCAACCCAGGCGAGACGTTCTCGCTCAACGGCTACACCGGCCCGCGCGGCACCGCGCAGGGCTACGTTTCGTCCGGGATCATCGAAAACGGCCGGCCCGGCACCGCCGTCGGCGGTGGTATCTCCCAGTTCGCCACCACCTTGTACAACGCGGCCTACTTTGCGGGAATGACCGACGTGGCCTCCACGCCGCACTCCTACTACATCTCCCGCTACCCCACGGGCCGCGAGGCAACCGTCTTCGAGGGCGCGATCGACCTGCAGTTCCGAAACGACTCGCCTTATCCGGTGAAGATCACCTCCAAGGTCGGCGGTGGGGAGGTCACCGTGAGTCTGATGGGTGTGAAAACCGTCGAGGTGGAGTCCATCAATGGAGGGCGCTGGGCCTACACCTCGCCGAAGCCCGTGACCGTCACCAGTGGTGACTGCATTCCCTCGGGCGGGGTGCAGGGCTTTACCACCTCCGATACCCGGATTGTGCGTGACCTCAGCGGCAATGAGATCAGTCGCAACACCTCCACCACGGTCTACGACCCGCAGCCCATCGTTCGCTGCGAGTAG,MTTVNATGARGGRGVGTGKILLGVLLGVLAVLLAIYLADLAMNRGNVPRGTAVGGVEIGGMSHDEATAKLEAELGETASNPVTVKAASQSSQLVPAESGLGIDWEATVASAGEESANPFTRLAGLFRTREVDIVSTVNEAALTPQLERVAGELHLDPADGAIAIEGGEAKVTEPVPGQEVDKTELFERVTTGWLNPDGVEVEPREIEPAIGDQAIKEALDGPVKAALSGALTLHGRDGIDGVIAQERIGEVVQFPNVDGKIAPEVNVENAQGILVEQLAATETQMKNARVLPGGGVEPSVDGSIIDWEAAMDGFDERLIGSAERTWDAQYKARPADFTTEEANNATFDQVVGSFTTSGYSSASGTNIAVVARAVEGAIVNPGETFSLNGYTGPRGTAQGYVSSGIIENGRPGTAVGGGISQFATTLYNAAYFAGMTDVASTPHSYYISRYPTGREATVFEGAIDLQFRNDSPYPVKITSKVGGGEVTVSLMGVKTVEVESINGGRWAYTSPKPVTVTSGDCIPSGGVQGFTTSDTRIVRDLSGNEISRNTSTTVYDPQPIVRCE,MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVLAEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPELLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGMETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGGEFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSHSLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDEPDGYPVKPREWSK,151.21,gnl|BL_ORD_ID|4748|hsp_num:0,2242,FALSE,None
LK1390,37_24 # 23048 # 23365 # 1 # ID=37_24;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.667,37_24,23048,23365,+,Strict,800,22.7126,mef(B),100,3003107,protein homolog model,n/a,n/a,macrolide antibiotic,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,GTGGAGCAACTTGCAGATCGCGGCGTCATCCGCGCAGCCCTGGACGACTTCGGACATGCCTGGGGTCAACGCATCGCCCGCTGGCGCGCCGATGGACAAACCCACACGGAGAAGTCCTTCGCCCAGCAGTTCTGGTCCGACCTGCTGCGCACCTTCGAGGTGATCCCCGAGCGCATCGACCTGTTCGAGCGCGGGGCCGCGCGCGCCTCCACCGGTGGGGCCGGCTACATCGACTTCTTCTGGTCCGGTGTCGCCCTGGGCGAGGCCAAGTCCCTGGGCTCTGACCTCGACGTAGTTGAGTCCCGCATAGTGGTGTAG,MEQLADRGVIRAALDDFGHAWGQRIARWRADGQTHTEKSFAQQFWSDLLRTFEVIPERIDLFERGAARASTGGAGYIDFFWSGVALGEAKSLGSDLDVVESRIVV,MNRIKNWKKQFAVIYTGQAFSILGSAAVQFAVIWWLTIQTESAITLTIASLVAFLPNMLIGPFAGVWIDRYNRRTVMILADGLVAVSSIILGAAFLLVETPPIWFIYIVLFLRGLGNTFHGPAMQAAIPMFVPADMLTKAGGWGNMIQSISNMMGPVLGAALMSFLPISSIMIVDILGAAFAIVCLLFVIIPDITQTNEKMSVLSDMKQGFIAMKANKPLMAVFSPMLLMTILYMPLGSLFPLLARSHFMGEAWHNSIVEFVFAGGLLLSSLVIGVWGGMKRRFFMASLAIGLMGLATLISGALPTSGFWIFVICCFFLGASGTFMNVPVMAYVQESIAPEMMGKVFSLLMTAMTLSMPIGLLVAGPVVEVIGVNTWFFWSGVALIVNAVLCRILTRRYDKVTMKPQVD,25.67,gnl|BL_ORD_ID|1198|hsp_num:0,1198,TRUE,loose hit with at least 95 percent identity pushed strict
LK1390,85_4 # 4127 # 4870 # 1 # ID=85_4;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.777,85_4,4127,4870,+,Strict,50,80.1073,vanY gene in vanA cluster,29.67,3002955,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanY; glycopeptide resistance gene cluster,ATGCGTCGCACCCTCCCTCTCGCCGCGCTGGCCGCGCTCGCGCTGCTCGTGGCCGGTTGCGGCACGCCCGCCGCGGGCCCGTCCTCGGCGACGCCGGCTTCCGGCTCCTCGAGCGCGGCCGCGTCGTCCGGTGCCGCCTCGAGCACGGCGCCGTCGTCGAGCACGCACGCCGACCCGGCCGCCCTCGACGTCGTCGTGAACAAGACCCGCCCCGTGGCCCCGCCCGACTGGGCGCCCTCGGATCTGGTGGCCGTGCCCGGCAGCGAGCTGCCCCTGCGGGCGGAGGCCGCGACGGCGGCCGGTGACCTGCGGGATGCGGCCGCGGCGGCGGGCCACGACCTCACCACCCTGAGCGCCTACCGCTCGTACGACTACCAGGTCCGGACGTACGGCCACTGGGTCGACGAGCTGGGCCGCGCCGAGGCGGACCGCGTCTCGGCGCGTCCGGGGTACTCCGAGCACCAGACCGGCCTGGCCTGGGACGTGGGCGACGCCGCGACCCCCGCGTGTGACCTGGAGGCGTGCTTCGGCGACACCGCCGCGGGCCGCTGGGTGGCCGCGCACGCCGCCGAGCACGGGTTCGTCATCCGCTATCCCGCCGGGGCCGAGGACGTGACGGGCTTCGACCACGAGCCCTGGCACCTGCGCTACGTCGGGTCCGCGGAGGCGGCCCGGGTCGAGGCGGCCGGCGGCGTCCTCGAGACCGCATGGGGTCTGCCTCCGGCGCCCGACTACGCGGACTGA,MRRTLPLAALAALALLVAGCGTPAAGPSSATPASGSSSAAASSGAASSTAPSSSTHADPAALDVVVNKTRPVAPPDWAPSDLVAVPGSELPLRAEAATAAGDLRDAAAAAGHDLTTLSAYRSYDYQVRTYGHWVDELGRAEADRVSARPGYSEHQTGLAWDVGDAATPACDLEACFGDTAAGRWVAAHAAEHGFVIRYPAGAEDVTGFDHEPWHLRYVGSAEAARVEAAGGVLETAWGLPPAPDYAD,MKKLFFLLLLLFLIYLGYDYVNEALFSQEKVEFQNYDQNPKEHLENSGTSENTQEKTITEEQVYQGNLLLINSKYPVRQESVKSDIVNLSKHDELINGYGLLDSNIYMSKEIAQKFSEMVNDAVKGGVSHFIINSGYRDFDEQSVLYQEMGAEYALPAGYSEHNSGLSLDVGSSLTKMERAPEGKWIEENAWKYGFILRYPEDKTELTGIQYEPWHIRYVGLPHSAIMKEKNFVLEEYMDYLKEEKTISVSVNGEKYEIFYYPVTKNTTIHVPTNLRYEISGNNIDGVIVTVFPGSTHTNSRR,81.52,gnl|BL_ORD_ID|4669|hsp_num:0,89,FALSE,None
LK894,1_426 # 438818 # 441964 # 1 # ID=1_426;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.557,1_426,438818,441964,+,Strict,1900,1966.04,acrB,92.85,3000216,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGCCTAATTTCTTTATCGATCGCCCCATATTTGCATGGGTGATCGCCATAATCATCATGTTGGCAGGGGGGCTTTCGATTATGAAACTCCCCGTGGCGCAATATCCAACGATTGCGCCGCCAGCAGTGACGATCTCGGCCACCTATCCGGGGGCTGATGCGAAAACGGTGCAGGACACCGTGACACAGGTTATCGAACAGAACATGAACGGTATCGATAACCTGATGTACATGTCCTCGAACAGTGACTCCACCGGTACGGTGCAGATCACCCTGACCTTCCAGTCCGGTACCGACGCAGATATCGCCCAGGTACAGGTGCAGAATAAGCTGCAGCTGGCGATGCCGCTGCTGCCGCAGGAAGTACAACAACAGGGCGTGAGCGTGGAGAAATCCTCCAGTAGCTTCCTGATGGTTGTCGGGGTTATCAACACTAACGGCACCATGACGCAGGAGGATATTTCCGACTACGTGGGCGCCAATATGAAGGATGCCATCAGCCGTACCTCCGGCGTCGGCGACGTTCAGCTGTTCGGTTCCCAGTACGCGATGCGTATCTGGATGGACCCGACGAAGCTAAACAACTTCCAGTTAACTCCGGTAGATGTCATCAACGCCATTAAAGCGCAGAACGCCCAGGTCGCGGCAGGTCAGTTAGGCGGTACGCCGCCGGTGAAAGGCCAGCAGTTGAACGCCTCGATCATCGCCCAAACGCGTCTGACTTCCGCTGATGAATTCAGCAAGATTCTGCTGAAAGTCAATCAGGATGGTTCACAGGTTCGTCTGCGCGACGTGGCGAAAGTTGAACTCGGCGGCGAAAACTACGACATCATCGCGAAGTTCAACGGCCAACCGGCTTCTGGTCTGGGGATTAAACTGGCCACCGGCGCTAACGCCCTGGATACCGCCAACGCCATCCGCGCAGAGCTGGCGAAGATGGAACCGTACTTCCCGTCAGGCCTGAAAATCGTCTACCCGTACGATACTACCCCGTTCGTGAAAATCTCTATTCATGAAGTGGTAAAAACGCTGGTGGAAGCGATCATCCTGGTGTTCCTGGTCATGTATCTGTTCCTGCAGAACTTCCGCGCCACGCTGATCCCGACCATTGCGGTACCGGTGGTATTGCTTGGGACATTCGCCATCCTGGCGGTGTTTGGCTTCTCGATAAACACCCTGACGATGTTCGGGATGGTGCTGGCCATCGGCTTGCTGGTGGATGACGCCATCGTGGTAGTAGAAAACGTCGAGCGCGTAATGGCGGAGGAAGGATTGCCGCCGAAAGAAGCGACCCGTAAGTCGATGGGTCAGATTCAGGGCGCGTTGGTCGGTATTGCGATGGTACTGTCGGCGGTATTTATCCCGATGGCCTTCTTCGGCGGTTCAACCGGCGCGATTTATCGCCAGTTCTCGATCACTATCGTTTCCGCGATGGCGCTGTCGGTACTGGTAGCGCTGATTCTGACGCCAGCGCTGTGCGCCACCATGCTGAAACCGATTCAGAAAGGCGGCCATGGCGAGCACAAAGGCTTCTTTGGCTGGTTTAACCGCATGTTCGATAAGAGCACGCACCACTACACCGACAGCGTAGGCAACATTCTGCGTAGTACCGGTCGTTACCTGGTGCTGTATCTGATTATCGTCGTCGGTATGGCTTACCTGTTCGTTCGTCTGCCAAGCTCCTTCCTGCCGGACGAAGACCAGGGCGTGTTCCTGAGTATGGCGCAGCTTCCGGCGGGCGCGAGTCAGGAACGTACGCAGAAAGTCCTCGACGAGATGACTGACTACTACCTGACCAAAGAGAAGAACAACGTTGAATCGGTGTTCGCGGTTAACGGTTTTGGTTTTGCTGGTCGCGGTCAGAACACCGGTATCGCCTTCGTGTCGTTAAAAGACTGGAGCGAACGCCCGGGTTCAGAAAACAAAGTTGAAGCGATTACCGGCCGCGCGATGGCCCGTTTCTCGCAGATTAAAGATGCGATGGTCTTCGCGTTTAACCTGCCGGCGATCGTCGAACTGGGTACCGCTACCGGCTTTGACTTCCAGCTCATCGATCAGGGTGGTTTAGGGCATGAGAAATTAACTCAGGCGCGTAACCAGCTGTTTGGTATGGTTGCTCAGCATCCCGATCTGCTGGTTGGCGTGCGTCCTAACGGCCTGGAAGATACGCCGCAGTTCAAGATCGATATCGATCAGGAAAAAGCGCAGGCGCTGGGCGTTTCAATTAGCGACATCAACACCACCCTCGGCGCGGCATGGGGCGGCAGCTACGTCAACGACTTCATCGACCGCGGTCGCGTGAAGAAAGTGTACGTCATGTCTGAAGCGAAATACCGTATGCTGCCAGAGGATATCGGCAACTGGTATGTACGCGGCAGCGATGGCCAAATGGTGCCGTTCTCCGCCTTCTCCACTTCCCATTGGGAATATGGTTCACCGCGTCTGGAACGTTACAACGGTCTGCCGTCGATGGAAATCCTCGGTCAGGCAGCGCCGGGCCGCAGTACGGGTGAAGCGATGGCGATGATGGAACAGCTGGCAAGCAAACTGCCTTCAGGCGTCGGTTACGACTGGACCGGTATGTCCTATCAGGAACGCCTGTCAGGCAACCAGGCCCCGGCGCTGTATGCTATCTCGCTTATCGTCGTCTTCCTGTGTCTGGCGGCGTTGTACGAGAGCTGGTCGATTCCGTTCTCCGTCATGCTGGTGGTACCGTTGGGTGTTGTTGGCGCGCTGTTAGCGGCAACCTTCCGCGGGCTGACTAACGACGTTTACTTCCAGGTCGGCCTGCTGACGACCATCGGCCTGTCGGCGAAGAACGCGATACTTATCGTTGAATTCGCCAAAGACCTGATGGAAAAAGAAGGCAAAGGCCTGATTGAAGCGACGCTGGAAGCAGTACGTATGCGTCTGCGTCCAATCCTGATGACCTCTCTGGCGTTTATCCTCGGGGTAATGCCGCTGGTTATCAGCTCTGGCGCAGGTTCCGGCGCACAGAACGCCGTAGGTACCGGCGTAATGGGCGGAATGGTGACCGCGACGGTTCTGGCCATCTTCTTCGTGCCGGTATTCTTCGTGGTGGTTCGTCGCCGCTTCACTAAGAAAACTGAAGATATTGAGCATAACCATCCGGTTGAGCATCATTAA,MPNFFIDRPIFAWVIAIIIMLAGGLSIMKLPVAQYPTIAPPAVTISATYPGADAKTVQDTVTQVIEQNMNGIDNLMYMSSNSDSTGTVQITLTFQSGTDADIAQVQVQNKLQLAMPLLPQEVQQQGVSVEKSSSSFLMVVGVINTNGTMTQEDISDYVGANMKDAISRTSGVGDVQLFGSQYAMRIWMDPTKLNNFQLTPVDVINAIKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRLTSADEFSKILLKVNQDGSQVRLRDVAKVELGGENYDIIAKFNGQPASGLGIKLATGANALDTANAIRAELAKMEPYFPSGLKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQNFRATLIPTIAVPVVLLGTFAILAVFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVMAEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFIPMAFFGGSTGAIYRQFSITIVSAMALSVLVALILTPALCATMLKPIQKGGHGEHKGFFGWFNRMFDKSTHHYTDSVGNILRSTGRYLVLYLIIVVGMAYLFVRLPSSFLPDEDQGVFLSMAQLPAGASQERTQKVLDEMTDYYLTKEKNNVESVFAVNGFGFAGRGQNTGIAFVSLKDWSERPGSENKVEAITGRAMARFSQIKDAMVFAFNLPAIVELGTATGFDFQLIDQGGLGHEKLTQARNQLFGMVAQHPDLLVGVRPNGLEDTPQFKIDIDQEKAQALGVSISDINTTLGAAWGGSYVNDFIDRGRVKKVYVMSEAKYRMLPEDIGNWYVRGSDGQMVPFSAFSTSHWEYGSPRLERYNGLPSMEILGQAAPGRSTGEAMAMMEQLASKLPSGVGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFSVMLVVPLGVVGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMEKEGKGLIEATLEAVRMRLRPILMTSLAFILGVMPLVISSGAGSGAQNAVGTGVMGGMVTATVLAIFFVPVFFVVVRRRFTKKTEDIEHNHPVEHH,MPNFFIDRPIFAWVIAIIIMLAGGLAILKLPVAQYPTIAPPAVTISASYPGADAKTVQDTVTQVIEQNMNGIDNLMYMSSNSDSTGTVQITLTFESGTDADIAQVQVQNKLQLAMPLLPQEVQQQGVSVEKSSSSFLMVVGVINTDGTMTQEDISDYVAANMKDAISRTSGVGDVQLFGSQYAMRIWMNPNELNKFQLTPVDVITAIKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRLTSTEEFGKILLKVNQDGSRVLLRDVAKIELGGENYDIIAEFNGQPASGLGIKLATGANALDTAAAIRAELAKMEPFFPSGLKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQNFRATLIPTIAVPVVLLGTFAVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVMAEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGSTGAIYRQFSITIVSAMALSVLVALILTPALCATMLKPIAKGDHGEGKKGFFGWFNRMFEKSTHHYTDSVGGILRSTGRYLVLYLIIVVGMAYLFVRLPSSFLPDEDQGVFMTMVQLPAGATQERTQKVLNEVTHYYLTKEKNNVESVFAVNGFGFAGRGQNTGIAFVSLKDWADRPGEENKVEAITMRATRAFSQIKDAMVFAFNLPAIVELGTATGFDFELIDQAGLGHEKLTQARNQLLAEAAKHPDMLTSVRPNGLEDTPQFKIDIDQEKAQALGVSINDINTTLGAAWGGSYVNDFIDRGRVKKVYVMSEAKYRMLPDDIGDWYVRAADGQMVPFSAFSSSRWEYGSPRLERYNGLPSMEILGQAAPGKSTGEAMELMEQLASKLPTGVGYDWTGMSYQERLSGNQAPSLYAISLIVVFLCLAALYESWSIPFSVMLVVPLGVIGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGLIEATLDAVRMRLRPILMTSLAFILGVMPLVISTGAGSGAQNAVGTGVMGGMVTATVLAIFFVPVFFVVVRRRFSRKNEDIEHSHTVDHH,99.9,gnl|BL_ORD_ID|1011|hsp_num:0,1104,FALSE,None
LK894,1_543 # 559018 # 560115 # 1 # ID=1_543;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.563,1_543,559018,560115,+,Strict,250,261.536,vanG,39.04,3002909,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,glycopeptide resistance gene cluster; Van ligase,ATGGCTAAAATGAGGGTTGGGATCGTTTTTGGCGGTAAGTCGGCAGAACATGAAGTGTCGCTGCAGTCAGCCAAAAATATCGTCGAAGCAATTGATAAAACGCGCTTTGATGTTGTGCTGCTGGGAATCGATAAACAGGGGCTTTGGCATATCAACGATGCCAGCAACTATCTGCTGAACCCGCAGGATCCCGCCCATATCGCGCTGCGCCCGTCCGACGTGACGCTGGCGCAAATTCCCGGTCGCGATGCCCATCAGTTGATCAATGCCGATAGCGGCCAGCCGCTGGCGGCCATCGACGTTATCTTCCCGATTGTTCACGGCACCCTTGGCGAAGATGGTTCGCTGCAGGGGATGTTGCGGATGGCGAATTTGCCGTTCGTCGGATCCGATGTGCTGGGCTCCGCCGCCTGCATGGATAAAGACGTCACTAAACGCCTGCTTCGCGATGCCGGTCTGTCAATTGCGCCGTTCATCACTCTGACTCGCGCCAACCGCCAGCAGTTCAGCTTTGCCGATGTCAAAGCGAAGCTGGGGTTACCGCTGTTCGTGAAGCCCGCAAACCAGGGTTCTTCCGTCGGCGTCAGCAAAGTGAAGAGCGAAGAAGAGTACCTGCAGGCCGTCGCGTTAGCCTTTGAATTCGACCATAAAGTGGTAGTTGAACAAGGGATTAAGGGCCGTGAAATCGAGTGCGCGGTGCTGGGCAATGATTATCCTCAGGCCAGCACCTGCGGGGAGATCGTTCTCAATAGCGAATTCTATGCCTACGATACCAAGTACATTGATGACAAAGGCGCGCAGGTGGTGGTTCCGGCAGCCATCGCCCCGGAGATCAACGACAAAATCCGCGATATCGCCGTCCGTGCTTACCAAACGCTCGGCTGCAGCGGAATGGCCCGCGTGGACGTCTTCCTGACGGAAGATAACGAGGTGGTGATCAACGAAATCAACACGCTGCCTGGCTTTACCAACATCAGCATGTATCCGAAGCTGTGGCAGGCCAGCGGCCTGGATTACACCAGCCTGATAAGCCGCCTGATCGAGCTGGCGCTGGAACGCCACGCCGCCGACCGCGCGCTGAAAACCTCAATGAACTAA,MAKMRVGIVFGGKSAEHEVSLQSAKNIVEAIDKTRFDVVLLGIDKQGLWHINDASNYLLNPQDPAHIALRPSDVTLAQIPGRDAHQLINADSGQPLAAIDVIFPIVHGTLGEDGSLQGMLRMANLPFVGSDVLGSAACMDKDVTKRLLRDAGLSIAPFITLTRANRQQFSFADVKAKLGLPLFVKPANQGSSVGVSKVKSEEEYLQAVALAFEFDHKVVVEQGIKGREIECAVLGNDYPQASTCGEIVLNSEFYAYDTKYIDDKGAQVVVPAAIAPEINDKIRDIAVRAYQTLGCSGMARVDVFLTEDNEVVINEINTLPGFTNISMYPKLWQASGLDYTSLISRLIELALERHAADRALKTSMN,MQNKKIAVIFGGNSTEYEVSLQSASAVFENINTNKFDIIPIGITRSGEWYHYTGEKEKILNNTWFEDSKNLCPVVVSQNRSVKGFLEIASDKYRIIKVDLVFPVLHGKNGEDGTLQGIFELAGIPVVGCDTLSSALCMDKDRAHKLVSLAGISVPKSVTFKRFNEEAAMKEIEANLTYPLFIKPVRAGSSFGITKVIEKQELDAAIELAFEHDTEVIVEETINGFEVGCAVLGIDELIVGRVDEIELSSGFFDYTEKYTLKSSKIYMPARIDAEAEKRIQEAAVTIYKALGCSGFSRVDMFYTPSGEIVFNEVNTIPGFTSHSRYPNMMKGIGLSFSQMLDKLIGLYVE,104.58,gnl|BL_ORD_ID|1069|hsp_num:0,1157,FALSE,None
LK894,1_598 # 612834 # 613994 # -1 # ID=1_598;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.599,1_598,612834,613994,-,Strict,550,630.943,CMY-132,78.48,3003652,protein homolog model,n/a,n/a,cephamycin,antibiotic inactivation,CMY beta-lactamase,ATGGAAAAATACTTCATGATGAAAAAATCCCTTACAGGCGTACTGCTGCTGGGCGCCTCATTTTCGACGTTTGCCGCGCCGCAAACGGCGGAGCAGCTGCGCGAACTGGTCAATCAGACCATCACGCCGTTAATGAAAGAACAGGCGATACCGGGCATGGCGGTGGCGGTGATCTATCACGGCAAACCCTACTATTTCACCTGGGGCCAGGCCGATGTTGCCGGGCAGCGTCCGGTGACGCGACAGACGTTGTTTGAGCTGGGCTCTGTTAGTAAGACTTTCACCGGCGTGCTGGGCGGCGATGCGGTGGCGCGCGGTGAAATTAAGCTCAGCGATCCGGCGCAGAAGTACTGGCCGCAGCTCACCGGCCAGCAGTGGCAGGGGATCTCGCTGCTGCATCTCGCCACCTATACCGCAGGCGGTCTGCCGCTGCAGGTTCCGGACGAGGTGACGGATGAAGCGGCATTACTGCGTTACTATCAGAACTGGCAACCGCAGTGGGCGCCGGGTAGTAAACGGCTGTACGCCAATGCCAGCATTGGCCTGTTCGGCGCGCTGGCGGTGAAACCTTCCGGCATGAGCTTTGAACAGGCGATGAGCCAGCGGGTATTGCAGCCGTTAAAACTGAGCCACACCTGGATTAACGTACCACCCGCCCAGAGCAAGGACTACGCCTGGGGTTATCGTGAAGGTAAAGCGGTACATGTTTCGCCGGGGCAGCTGGACGCTGAGGCTTACGGCGTGAAGTCGAGCATTGAGGATATGGCGCACTGGGTGCTGGCGAATATGAACCGCGAGACGGTGCAGGATAAAAACCTGCGGCAGGGGATCCAGCTGGCGCAGTCGCGCTACTGGCGGGCTGGGGAGATGTATCAGGGCCTCGGCTGGGAGATGCTGAACTGGCCGGTGTCGGCCGAGGTGCTGATTAACGGCAGCGATAATAAGGTGGCGCTCGCCGCGACGCCGGTAACGGCGGTCAATCCGCCCGCGCCGCCGGTGAAAGCCTCGTGGGTACATAAAACCGGCTCCACCGGCGGATTCGGCAGTTACGTGGCCTTTATCCCGCAACAGGATCTCGGCATCGTGATGTTGGCGAATAAAAGCTACCCCAACCCGGAGCGGGTGAAGGCGGCGTATCATATTCTTGAGGCGCTGCAATAA,MEKYFMMKKSLTGVLLLGASFSTFAAPQTAEQLRELVNQTITPLMKEQAIPGMAVAVIYHGKPYYFTWGQADVAGQRPVTRQTLFELGSVSKTFTGVLGGDAVARGEIKLSDPAQKYWPQLTGQQWQGISLLHLATYTAGGLPLQVPDEVTDEAALLRYYQNWQPQWAPGSKRLYANASIGLFGALAVKPSGMSFEQAMSQRVLQPLKLSHTWINVPPAQSKDYAWGYREGKAVHVSPGQLDAEAYGVKSSIEDMAHWVLANMNRETVQDKNLRQGIQLAQSRYWRAGEMYQGLGWEMLNWPVSAEVLINGSDNKVALAATPVTAVNPPAPPVKASWVHKTGSTGGFGSYVAFIPQQDLGIVMLANKSYPNPERVKAAYHILEALQ,MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYYFTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGALAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEAYGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKKLGIVMLANKSYPNPVRVEAAWRILEKLQ,101.31,gnl|BL_ORD_ID|2621|hsp_num:0,3577,FALSE,None
LK894,1_633 # 650930 # 651067 # 1 # ID=1_633;partial=00;start_type=ATG;rbs_motif=GGxGG;rbs_spacer=3-4bp;gc_cont=0.630,1_633,650930,651067,+,Strict,850,21.1718,OpmH,100,3003682,protein homolog model,n/a,n/a,disinfecting agents and antiseptics,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGCCGCCGGTTGTGCCTCCGGCCCCGGTGATGACCTGTTTTGTCGGGTGGCGGCTAACGCCTTACCCGACCTACGCCGGCTACAGTAATGTGCAGTTTGGTAGCCCGGATAAGGCGCAACGCGCCGCCGGGCAATAA,MPPVVPPAPVMTCFVGWRLTPYPTYAGYSNVQFGSPDKAQRAAGQ,MLRRLSLAAAVAAATGVAWAAQPTPLPTKTDLISVYKEAVDNNADLAAAQADYLARKEVVPQARAGLLPQLGAGARVGDTRIAFDERPATVKRNSQVVQATLSQPLFRADRWFQWQAAKETSDQARLEFSATQQDLILRSAETYFTVLRAQDNLATSKAEEAAFKRQLDQANERFDVGLSDKTDVLEAQASYDTARANRLIAEQRVDDAFQALVTLTNRDYSAIEGMRHTLPVVPPAPNDAKAWVDTAVQQNLRLLASNYAVNAAEETLRQRKAGHLPTLDAVAQYQKGDNDALGFANSAANPLVHYGKYVDERSIGLELNIPIYSGGLTSSQVRESYQRLNQSEQSREGQRRQVVQDTRNLHRAVNTDVEQVQARRQAIISNQSSLEATEIGYQVGTRNIVDVLNAQRQLYAAVRDYNNSRYDYILDTLRLKQAAGTLSPADLEALSAYLKQDYDPDKDFLPPDLAKAAAEQLQSKPRQQY,9.34,gnl|BL_ORD_ID|2005|hsp_num:0,2195,TRUE,loose hit with at least 95 percent identity pushed strict
LK894,2_408 # 414419 # 414802 # 1 # ID=2_408;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.479,2_408,414419,414802,+,Strict,230,241.121,marA,91.2,3000263,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; penem; disinfecting agents and antiseptics,antibiotic efflux; reduced permeability to antibiotic,resistance-nodulation-cell division (RND) antibiotic efflux pump; General Bacterial Porin with reduced permeability to beta-lactams,ATGTCCAGACGCAATAACGACGCCATCACTATCCATAGTATTTTGTCGTGGATCGAAGAGAACCTGGAATCTCCATTGTCGCTGGAGAAAGTTTCGGAGCGCTCAGGTTACTCCAAATGGCACCTGCAAAGAATGTTCAAGAAAGAGACCGGCCACTCGCTGGGCCAGTACATCCGCAGTCGTAAGCTGACGGAGATTGCGCAAAAACTCAAGCAGAGCAACGAGCCAATTTTGTATCTGGCTGAACGTTACGGTTTTGAATCGCAACAGACGCTGACGCGAACGTTTAAAAACTACTTCGATGTTCCGCCGCACAAATATCGCATCACCAACGTTCCGGGAGAATCCCGCTACCTGATGCCGCTAAATAATTATTGTTGTTAA,MSRRNNDAITIHSILSWIEENLESPLSLEKVSERSGYSKWHLQRMFKKETGHSLGQYIRSRKLTEIAQKLKQSNEPILYLAERYGFESQQTLTRTFKNYFDVPPHKYRITNVPGESRYLMPLNNYCC,MSRRNTDAITIHSILDWIEDNLESPLSLEKVSERSGYSKWHLQRMFKKETGHSLGQYIRSRKMTEIAQKLKESNEPILYLAERYGFESQQTLTRTFKNYFDVPPHKYRMTNMQGESRFLHPLNHYNS,100,gnl|BL_ORD_ID|1772|hsp_num:0,1922,FALSE,None
LK894,2_457 # 463007 # 463336 # -1 # ID=2_457;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.561,2_457,463007,463336,-,Strict,150,195.667,Klebsiella pneumoniae KpnF,92.66,3004583,protein homolog model,n/a,n/a,macrolide antibiotic; aminoglycoside antibiotic; cephalosporin; tetracycline antibiotic; peptide antibiotic; rifamycin antibiotic; disinfecting agents and antiseptics,antibiotic efflux,small multidrug resistance (SMR) antibiotic efflux pump,ATGCAACAGTTTGAGTGGATTCACGGCGCCTGGCTGGCGCTGGCTATCGTACTGGAAATAACCGCGAACGTATTGCTGAAATTTTCCGACGGCTTCCGTCGTAAGATCTACGGTATTCTGTCGCTGGCGGCGGTGTTAGGGGCCTTTAGCGCCCTGTCGCAGGCGGTAAAAGGTATCGACCTGTCCGTCGCTTATGCGCTGTGGGGCGGATTCGGGATTGCGGCCACCATTGCCGCTGGCTGGATCCTCTTTGGTCAGCGTCTGAACCATAAAGGTTGGGTTGGCGTCGTGCTGCTGGTGGCCGGTATGGTATTGATAAAACTGGCCTGA,MQQFEWIHGAWLALAIVLEITANVLLKFSDGFRRKIYGILSLAAVLGAFSALSQAVKGIDLSVAYALWGGFGIAATIAAGWILFGQRLNHKGWVGVVLLVAGMVLIKLA,MQQFEWIHAAWLAIAIVLEIIANVFLKFSDGFRRKIYGILSLAAVLGAFSALSQAVKGIDLSVAYALWGGFGIAATIAAGWVLFGQRLNNKGWAGVILLVAGMVLIKLA,100,gnl|BL_ORD_ID|2723|hsp_num:0,3286,FALSE,None
LK894,2_458 # 463323 # 463685 # -1 # ID=2_458;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.466,2_458,463323,463685,-,Strict,150,199.904,Klebsiella pneumoniae KpnE,85.83,3004580,protein homolog model,n/a,n/a,macrolide antibiotic; aminoglycoside antibiotic; cephalosporin; tetracycline antibiotic; peptide antibiotic; rifamycin antibiotic; disinfecting agents and antiseptics,antibiotic efflux,small multidrug resistance (SMR) antibiotic efflux pump,ATGTTTTATTGGATTTTATTAGCCTTAGCTATCGTCGCTGAAATTACCGGCACGTTGTCTATGAAATGGGCAAGCGTCAGCGGCGGTCATACAGGTTATATTTTAATGCTGGCAATGATTGCGCTTTCCTATATTTTCCTGGCCTTCGCCGTTAAAAAAATTGCTCTCGGTGTGGCGTATGCGCTATGGGAAGGTATCGGTATTCTGTTGATTACCGTATTTAGCGTGCTGCTGTTCGATGAAAGCCTGTCTATCGTAAAACTTGCCGGGCTGGCAACGCTGGTCGCGGGTATTGTGCTGATTAAGTCCGGCACAAAGAAAGCGGTGAAACAGCGTGAGGAGACAGCTCATGCAACAGTTTGA,MFYWILLALAIVAEITGTLSMKWASVSGGHTGYILMLAMIALSYIFLAFAVKKIALGVAYALWEGIGILLITVFSVLLFDESLSIVKLAGLATLVAGIVLIKSGTKKAVKQREETAHATV,MFYWILLALAIIAEITGTLSMKWASVSGGHTGFILMLAMIALSYIFLAFAVKKIALGVAYALWEGIGILLITLFSVLLFDESLSLLKIAGLTTLVIGIVLIKSGTQKKASSQQEVAHAAV,100,gnl|BL_ORD_ID|2721|hsp_num:0,3283,FALSE,None
LK894,3_105 # 114226 # 117339 # -1 # ID=3_105;partial=00;start_type=ATG;rbs_motif=AGGA/GGAG/GAGG;rbs_spacer=11-12bp;gc_cont=0.579,3_105,114226,117339,-,Strict,1900,1941.39,acrD,90.74,3000491,protein homolog model,n/a,n/a,aminoglycoside antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGGCGAATTTCTTTATCGATCGCCCCATCTTTGCCTGGGTTTTGGCTATTCTGTTGGTCCTGACCGGCACGTTGGCAATTTTGTCGCTCCCCGTAGAACAATATCCGGATTTGGCGCCGCCTAACGTCCGGGTGACGGCCAATTATCCCGGCGCCTCCGCGCAGACGCTGGAGAATACCGTGACCCAGGTTATCGAACAGAATATGACCGGCCTCGATAACCTCATGTACATGTCATCGCAAAGTAGCGCCACCGGTCAGGCAACGGTTACTCTGAGCTTTACCGCCGGTACCGACCCGGATGAGGCCGTGCAGCAGGTACAAAACCAGCTGCAATCGGCGATGCGTAAACTGCCGCAGGCGGTACAGAATCAGGGGGTCACGGTGCGCAAAACCGGCGACACCAACATTCTCACTCTTGCGTTTGTCTCTACCGACGGCAGCATGGATAAGCAGGATATTGCCGACTACGTCGCCAGTAACGTGCAGGATCCTCTAAGCCGCGTCAACGGCGTCGGCGATATCGACGCCTACGGTTCACAGTACTCAATGCGTATCTGGCTCGATCCGGCGAAACTCAACAGCTATCAGATGACGGCGAAAGATGTGACTGACGCCATCGAATCGCAGAACGCGCAGATTGCCGTCGGCCAGTTGGGCGGTACCCCGTCGGTGGATAAACAGGCGCTGAACGCCACCATCAACTCACAATCGCTGCTGCAAACGCCGCAGCAGTTCCGTGATATTACCCTGCGCGTGAATCAGGATGGTTCGGAAGTCACGCTGGGCGACGTCGCCAGCGTCGAAATGGGCGCTGAAAAATATGATTATCTGAGCCGCTATAATCGTCAGGCCGCTTCGGGACTGGGAATTAAGCTCGCCTCCGGCGCCAACGAAATGGCCACCGCCGAGCGCGTTATCGCCCGTCTTGATGAACTGTCGCAATATTTTCCGCACGGGCTGCAGTATAAAGTCGCCTACGAGACCACCTCTTTTGTCAAAGCCTCGATTACCGATGTGGTAAAAACGCTGCTGGAGGCGATTCTGCTGGTGTTCCTGGTCATGTATTTGTTCTTGCAGAACTTCCGCGCGACCCTGATCCCGACCATCGCCGTGCCGGTGGTATTGATGGGCACCTTCGCGGTGCTCTACGCCTGCGGCTACAGTATTAACACCCTGACGATGTTCGCGACTGTGCTGGCTATCGGCCTGCTGGTCGATGACGCCATCGTCGTGGTCGAAAACGTCGAGCGCATTATGAGCGAGGAAGGGCTCTCGCCGCGCGAAGCGACGCGAAAATCGATGAAGCAGATCCAGGGCGCGCTGGTCGGTATCGCTATGGTGCTATCGGCGGTATTCGTGCCCATGGCCTTCTTCGGCGGCACCACCGGCGCCATTTACCGCCAGTTCTCCATTACCATCGTTTCAGCAATGGTGCTGTCGGTGCTGGTAGCGATGATCCTCACCCCGGCGCTGTGCGCCACGCTGTTAAAACCGATTCACAAAGGCGAAGTACATGGTCAAACAGGGTTCTTTGGCTGGTTTAACCGCGCCTTCAACCGCAGCGCCAGCCGCTATGAAACTTTCGTAGGCAAAATTCTCCACCGCTCGCTGCGCTGGATTTTGATTTACGTCCTGCTGCTCGGCGGCATGGTGCTGCTGTTCCTGCATCTGCCGACTTCGTTCCTGCCGCTGGAAGACCGCGGTATGTTCACCACCTCGATACAGCTTCCGAGCGGTTCCACCCAACAGCAGACGCTGAAAGTGGTGCAGAAAGCGGAAGATTATTTCCTCAATAACGAGAAGAGTAACGTCGAGTCGGTATTTGCTACCGTCGGCTCCGGCCCCGGCGGCAACGGCCAGAACGTCGCTCGTATGTTTGTCCGCCTTAAAGACTGGGACCAGCGAGACCCGACAACCGGTTCCTCGTTCGCTATCATTGAGCGCGCGACCAAAGCCTTCAATAAAATTAAAGAAGCGCGCGTTTTTGCCAGCAGCCCACCGGCCATCAGCGGTCTTGGCAGCTCCGCGGGCTTCGATATGGAGCTCGAAGACCACGCCGGTAATGGTCACGAGGCGTTGATGTCAGCACGCGACAAGCTGCTGGAGCTGGCGGCGAACAACGACCAGCTCACCCGCGTTCGCCACAACGGTCTGGACGACAGCCCGCAGCTACAGGTTGATATCGACCAGCGTAAAGCCCAGGCGCTGGGGGTCTCTATTGATGATATTAACGATACGCTGCAGACCGCCTGGGGTTCGAGCTACGTAAACGACTTTATGGATCGCGGACGCGTGAAGAAGGTCTACGTCCAGGCGGCGGCAAAATATCGCATGCTGCCTGACGATATCAATTTGTGGTATGTGCGTAACAGTAGCGGCACCATGGTACCGTTCTCCGCCTTCGCCACCTCGCGTTGGGAAACGGGTTCACCGCGCCTCGAACGTTACAATGGCTACTCAGCGGTCGAGATCGTCGGTGAGGCCGCGCCAGGCGTCAGTACCGGTACCGCCATGACCATCATGGAAGAGTTAGCCAAACAGCTACCAAACAGTTTCGGCCTTGAATGGACGGCGATGTCCTACCAGGAACGCCTCTCTGGCGCTCAGGCACCTGCCCTGTACGCCATTTCGCTGCTGGTGGTGTTCCTGTGTCTGGCGGCGCTATATGAAAGCTGGTCGGTACCGTTCTCGGTGATGCTGGTGGTGCCGCTGGGAGTTATCGGCGCGCTGCTGGCGACCTGGATGCGCGGCCTGGAAAACGACGTCTACTTCCAGGTTGGCCTGCTGACGGTCATCGGCCTGTCGGCAAAGAATGCCATCCTGATTGTTGAGTTCGCCAACGAACTGAACCAGAAAGGCGAAGATCTGCTGATCGCCACGCTTTCGGCCTGCCGCCAACGTCTACGCCCGATACTGATGACCTCGCTGGCGTTTATCTTCGGCGTGCTGCCGATGGCCACCAGTACCGGCGCGGGTTCCGGCAGTCAGCATGCGGTCGGTACCGGCGTCATGGGCGGGATGCTCTCCGCCACCGTGCTGGCCATCTTCTTTGTGCCGCTGTTCTTCGTGTTGGTGCGCCGCCGCTTCCCGCTGAAAGAGAGGCCGGAATAA,MANFFIDRPIFAWVLAILLVLTGTLAILSLPVEQYPDLAPPNVRVTANYPGASAQTLENTVTQVIEQNMTGLDNLMYMSSQSSATGQATVTLSFTAGTDPDEAVQQVQNQLQSAMRKLPQAVQNQGVTVRKTGDTNILTLAFVSTDGSMDKQDIADYVASNVQDPLSRVNGVGDIDAYGSQYSMRIWLDPAKLNSYQMTAKDVTDAIESQNAQIAVGQLGGTPSVDKQALNATINSQSLLQTPQQFRDITLRVNQDGSEVTLGDVASVEMGAEKYDYLSRYNRQAASGLGIKLASGANEMATAERVIARLDELSQYFPHGLQYKVAYETTSFVKASITDVVKTLLEAILLVFLVMYLFLQNFRATLIPTIAVPVVLMGTFAVLYACGYSINTLTMFATVLAIGLLVDDAIVVVENVERIMSEEGLSPREATRKSMKQIQGALVGIAMVLSAVFVPMAFFGGTTGAIYRQFSITIVSAMVLSVLVAMILTPALCATLLKPIHKGEVHGQTGFFGWFNRAFNRSASRYETFVGKILHRSLRWILIYVLLLGGMVLLFLHLPTSFLPLEDRGMFTTSIQLPSGSTQQQTLKVVQKAEDYFLNNEKSNVESVFATVGSGPGGNGQNVARMFVRLKDWDQRDPTTGSSFAIIERATKAFNKIKEARVFASSPPAISGLGSSAGFDMELEDHAGNGHEALMSARDKLLELAANNDQLTRVRHNGLDDSPQLQVDIDQRKAQALGVSIDDINDTLQTAWGSSYVNDFMDRGRVKKVYVQAAAKYRMLPDDINLWYVRNSSGTMVPFSAFATSRWETGSPRLERYNGYSAVEIVGEAAPGVSTGTAMTIMEELAKQLPNSFGLEWTAMSYQERLSGAQAPALYAISLLVVFLCLAALYESWSVPFSVMLVVPLGVIGALLATWMRGLENDVYFQVGLLTVIGLSAKNAILIVEFANELNQKGEDLLIATLSACRQRLRPILMTSLAFIFGVLPMATSTGAGSGSQHAVGTGVMGGMLSATVLAIFFVPLFFVLVRRRFPLKERPE,MANFFIDRPIFAWVLAILLCLTGTLAIFSLPVEQYPDLAPPNVRVTANYPGASAQTLENTVTQVIEQNMTGLDNLMYMSSQSSGTGQASVTLSFKAGTDPDEAVQQVQNQLQSAMRKLPQAVQNQGVTVRKTGDTNILTIAFVSTDGSMDKQDIADYVASNIQDPLSRVNGVGDIDAYGSQYSMRIWLDPAKLNSFQMTAKDVTDAIESQNAQIAVGQLGGTPSVDKQALNATINAQSLLQTPEQFRDITLRVNQDGSEVRLGDVATVEMGAEKYDYLSRFNGKPASGLGVKLASGANEMATAELVLNRLDELAQYFPHGLEYKVAYETTSFVKASIEDVVKTLLEAIALVFLVMYLFLQNFRATLIPTIAVPVVLMGTFSVLYAFGYSVNTLTMFAMVLAIGLLVDDAIVVVENVERIMSEEGLTPREATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGTTGAIYRQFSITIVAAMVLSVLVAMILTPALCATLLKPLKKGEHHGQKGFFAWFNQMFNRNAERYEKGVAKILHRSLRWIVIYVLLLGGMVFLFLRLPTSFLPLEDRGMFTTSVQLPSGSTQQQTLKVVEQIEKYYFTHEKDNIMSVFATVGSGPGGNGQNVARMFIRLKDWSERDSKTGTSFAIIERATKAFNQIKEARVIASSPPAISGLGSSAGFDMELQDHAGAGHDALMAARNQLLALAAENPELTRVRHNGLDDSPQLQIDIDQRKAQALGVAIDDINDTLQTAWGSSYVNDFMDRGRVKKVYVQAAAPYRMLPDDINLWYVRNKDGGMVPFSAFATSRWETGSPRLERYNGYSAVEIVGEAAPGVSTGTAMDIMESLVKQLPNGFGLEWTAMSYQERLSGAQAPALYAISLLVVFLCLAALYESWSVPFSVMLVVPLGVIGALLATWMRGLENDVYFQVGLLTVIGLSAKNAILIVEFANEMNQKGHDLFEATLHACRQRLRPILMTSLAFIFGVLPMATSTGAGSGGQHAVGTGVMGGMISATILAIYFVPLFFVLVRRRFPLKPRPE,100,gnl|BL_ORD_ID|1309|hsp_num:0,1427,FALSE,None
LK894,4_139 # 151182 # 152873 # 1 # ID=4_139;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.548,4_139,151182,152873,+,Strict,1000,1034.63,eptB,91.16,3005047,protein homolog model,n/a,n/a,peptide antibiotic,antibiotic target alteration,pmr phosphoethanolamine transferase,ATGAAATACATTAAAACGATGTCGCAGCAGAAGCTAAGTTTTTGGCTTGCGCTGTACATCGGCTGGTTTATGAACGCCGCGGTGTTTTTCCGCCGCTTCGATGGCTACGCTCAAGAGTTTACCGTCTGGAAAGGGTTGTCCGGGTTGGTGGAACTGGTAGCGACGGTTCTGGTTACTTTCTTCCTTCTGCGCCTGCTGTCGTTATTCGGCCGCCGGGTATGGCGCATATTAGCGACGCTGGTGGTGCTGTTTTCCGCGGCGGCAAGCTATTACATGACCTTCCTCAACGTGGTCATTGGCTACGGTATTATCGCTTCGGTGATGACCACCGATATTGACCTGTCGAAAGAGGTCATTGGCTGGCATCTGATCCTGTGGCTGGCCGCGGTTAGCGCTTTACCGCTACTGCTTATCTGGAGCAACCGCTGCCGTAAGACGCTGCTACAGCAGGTGAAAACGCCAGGTCAGCGGGCGAAAAATATCCTGATAGTCGTGCTGGCCGGGCTGATGGTCTGGGGGCCGATTCGCCTGCTGGAAGTGCGCCAGAAGAACGTCGAGCGCAATTCAGAAGTCGATATGCCGAGCTACGGCGGCGTGATTGCCAACTCTTACCTGCCTTCTAACTGGCTGTCGGCGCTCGGGCTGTACGCCTGGGCGCAGGTGGATGAGTCGTCCGATAATAAGTCGCTGATTAACCCCGCGAAAAAATTCACCTACGTAGCGCCGCAGGATCTTGATGATACTTATGTGGTGTTTATTATCGGCGAGACCACCCGCTGGGATCATATGGGTATTCTCGGCTATAACCGTAATACCACGCCGAAGCTGGCGCAGGAGAAGAATCTTGTCGCCTTCCGCGGCACCTCTTGCGATACCGCCACCAAGCTGTCGTTGCGTTGTATGTTCGTGCGCGAGGGCGGGGCGGATGATAATCCGCAGCGGACGCTGAAAGAGCAGAATGTGTTTGCTGTTCTGCACCAGTTAGGCTTTGCCGGCGACCTGTACGCGATGCAGAGCGAGATGTGGTTCTACAGCAATACGATGGCCAACAATATCGCCTATCGCGAGCAGATCGGCGCCGAGCCGCACAACCGCGGCAAGAACGTGGATGATATGCTGCTGGTCGATGAAATGAAACGCGGCATGGAGCAAAACCCGAGCGGCAAGCGTCTGATTATTCTCCATACCAAGGGGTCGCATTTTAACTATACCCAGCGATATCCACGCAGCTTTGCGCAGTGGAAACCAGAATGTGTAGGGGTGGACAGCAAATGTTCGAAGGCCGAGTTGATTAACTCCTACGATAACAGCGTCACTTATGTGGATCACTTTATCGTCAGCGTGCTGGACCAACTGCGGGATAAAAAGGCTATCGTGTTCTACGCCGCCGATCACGGCGAGTCGATTAATGAACACGAACATCTGCACGGCACGCCGCGTATGATGGCGCCGCCGGAGCAGTTCCGCGTGCCGATGATGGTCTGGATGTCGGATAAGTATCTGGCGAATCCGGATCACGCCGCCTCCTTTGCGCGCCTCAAGCAGCAGGCGGCAATGAAGGTTCCGCACCGTCACGTTGAGCTGTATGACACCATTATGGGTTGCCTTGGTTATACCTCGCCGGATGGTGGGATTAATGAGAACAACAACTGGTGTCGCGTGTCGGCTTCGAAGAAAGCGGCGAAGGAATAG,MKYIKTMSQQKLSFWLALYIGWFMNAAVFFRRFDGYAQEFTVWKGLSGLVELVATVLVTFFLLRLLSLFGRRVWRILATLVVLFSAAASYYMTFLNVVIGYGIIASVMTTDIDLSKEVIGWHLILWLAAVSALPLLLIWSNRCRKTLLQQVKTPGQRAKNILIVVLAGLMVWGPIRLLEVRQKNVERNSEVDMPSYGGVIANSYLPSNWLSALGLYAWAQVDESSDNKSLINPAKKFTYVAPQDLDDTYVVFIIGETTRWDHMGILGYNRNTTPKLAQEKNLVAFRGTSCDTATKLSLRCMFVREGGADDNPQRTLKEQNVFAVLHQLGFAGDLYAMQSEMWFYSNTMANNIAYREQIGAEPHNRGKNVDDMLLVDEMKRGMEQNPSGKRLIILHTKGSHFNYTQRYPRSFAQWKPECVGVDSKCSKAELINSYDNSVTYVDHFIVSVLDQLRDKKAIVFYAADHGESINEHEHLHGTPRMMAPPEQFRVPMMVWMSDKYLANPDHAASFARLKQQAAMKVPHRHVELYDTIMGCLGYTSPDGGINENNNWCRVSASKKAAKE,MPQRQAVFYSSFSRFACMKYIRTMTQQKLSFWLALYIGWFMNVAVFFRRFDGYAQEFTFWKGLSGVVELVATVFVTFFLLRLLSLFGRRIWRILATLIVLFSAAASYYMTFLNVVIGYGIIASVMTTDIDLSKEVIGWHLILWLVVVSAPPLLFIWSNRCRHTLLRQLRTPGQRVKNVLIVVLAGLIVWGPIRLLELRQHDVERHSEVDMPSYGGVIANSYLPSNWLSALGLYAWAQVDESSDNKSLINPAKKFTYVAPEGLDDTYVVFIIGETTRWDHMGILDYSRNTTPELEKEKNLVAFRGYLCDTATKLSLRCMFVREGGAEDNPQRTLKEQNVFAVLHQLGFSGNLYAMQSEMWFYSNTMANNIAYREQIGAEPRNRGKSVDDMLLVDEMKRGMAQGNASGKHLIILHTKGSHFNYTQRYPRSFAQWKPECVGVDNKCSKAELINSYDNSVTYVDHFIVSVLDQLRDKKAIVFYAADHGESINEREHLHGTPRKMAPPEQFRVPMMVWMSDKYLENPDHAAAFAHLQQQAAMKVPRRHVELYDTIMGCLGYTSPDGGINENNNWCRWKK,98.08,gnl|BL_ORD_ID|2780|hsp_num:0,3791,FALSE,None
LK894,4_197 # 220764 # 221747 # 1 # ID=4_197;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.576,4_197,220764,221747,+,Strict,550,577.015,PmrF,83.59,3003578,protein homolog model,n/a,n/a,peptide antibiotic,antibiotic target alteration,pmr phosphoethanolamine transferase,ATGCTTACTTATCTTCCCGTAAAAAAAGTCTCGGTGGTTATCCCGGTTTATAACGAACAGGATAGTCTGCCGGAACTGCTGCGTCGTACCGACGCCGCCTGTGCGACGCTAGGGCGCCAATATGAAATTCTGCTGATCGACGACGGCAGCAGCGACGATTCCGCGCGCATGCTGACCGAGGCCGCCGAAGCCGAAGGCAGCCACGTGGTGGCGGTGCTGTTGAACCGCAACTACGGCCAGCACTCGGCGATTATGGCCGGTTTCAGCCATGTCACCGGCGATCTGATCATCACCCTCGATGCCGACTTGCAAAACCCGCCGGAAGAGATCCCGCGGCTGGTGGCAAAAGCCGATGAAGGCTATGACGTGGTCGGTACCGTGCGCCAGAACCGTCAGGACAGCATCTTCCGTAAATCTGCCTCGAAGATGATTAACCGCCTGATTCAGCGAACCACCGGTAAAGCCATGGGCGATTACGGCTGCATGTTGCGTGCCTATCGCCGCCATATCATCGACGCCATGCTCAACTGCCATGAGCGCAGCACCTTTATCCCGATTCTGGCGAATACCTTCGCCCGCCGGGCGGTCGAGATCCCGGTGATGCACGCCGAGCGCGAATTCGGCGACTCCAAATATAGCTTCATGCGTCTGATTAACCTGATGTATGACCTGGTGACCTGTCTGACCACCACCCCGCTGCGTTTACTGAGTATTTTCGGCAGCGTGATAGCCCTGTTGGGCTTTGCCTTCGGTCTGCTGCTGGTGGTGCTGCGTCTGGCCTTCGGTCCGCAATGGGCGGCGGAAGGGGTGTTCATGCTCTTCGCCGTGCTGTTTATGTTCATCGGCGCCCAGTTTGTCGGTATGGGCCTGCTCGGGGAGTATATCGGCCGCATCTATAACGATGTTCGCGCCCGTCCCCGTTACTTTATTCAACGTGTTGTTCGCCAGCCGGAAACGGCGTCTCAAGAGGAAGATCGTTCATGA,MLTYLPVKKVSVVIPVYNEQDSLPELLRRTDAACATLGRQYEILLIDDGSSDDSARMLTEAAEAEGSHVVAVLLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEGYDVVGTVRQNRQDSIFRKSASKMINRLIQRTTGKAMGDYGCMLRAYRRHIIDAMLNCHERSTFIPILANTFARRAVEIPVMHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRLLSIFGSVIALLGFAFGLLLVVLRLAFGPQWAAEGVFMLFAVLFMFIGAQFVGMGLLGEYIGRIYNDVRARPRYFIQRVVRQPETASQEEDRS,MFEIHPVKKVSVVIPVYNEQESLPELIRRTTTACESLGKEYEILLIDDGSSDNSAHMLVEASQAENSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEGYDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHERSTFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLGSIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYTDVRARPRYFVQQVIRPSSKENE,101.55,gnl|BL_ORD_ID|1937|hsp_num:0,2014,FALSE,None
LK894,4_200 # 224625 # 226280 # 1 # ID=4_200;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.584,4_200,224625,226280,+,Strict,1000,1017.68,ArnT,90.2,3005053,protein homolog model,n/a,n/a,peptide antibiotic,antibiotic target alteration,pmr phosphoethanolamine transferase,ATGAAAAGCATTCGTTATGGCATCTCTCTGGTTGTACTCTTTGCGCTGTATTACTTATTGCCGTTAAATTTCCGTTTGCTGTGGCAGCCTGATGAAACCCGCTATGCCGAGATCAGTCGTGAAATGCTGGCCTCCGGCGACTGGGTGGTGCCGCATCTGCTGGGCCTGCGTTACTTTGAAAAGCCGATTGCCGGTTACTGGATTAACAGTATTGGTCAGTGGCTATTTGGTCATAATAACTTTGGCGTGCGTTTCGGTTCGGTCTTCGCCATTACCGTCAGCGCGTTGCTGGTGGCGTGGTTGGCGTGGCGTATTTTCCGCGATAAACGCGTGGCGATCCTGTCGCCGGTTATCTTCCTGACCGCGATGCTGGTATACGGTATCGGAACCTATGCGGTGCTGGATCCGATGATCACCATGTGGCTGGCGCTGGCGATGTGCAGCTTCTGGGGAGCCTCCCAGGCGCAGAGCCGCAGCGGGAAGATGTTGGGTTATGTCCTGCTGGGAGTCGCCTGCGGTATGGGGGTGATGACCAAGGGCTTCCTGGCGCTGGCGGTACCGGTGGTTGGCGTGCTGCCGTGGGTGATGGCGCGTAAACGCTGGCGCGAAGTGCTGACCTACGGCTGGCTGGCGGTGGCGGTCTGTACGTTGGTGGTGCTGCCGTGGGGATTGGCTATTGCCAATCGCGAACCCGATTTCTGGCGCTATTTCTTCTGGGTCGAGCATATTCAGCGTTTCGCTGAGAAAGACGCGCAGCATAAAGCGCCGTTCTGGTACTACATTCCGTTCCTGATTGCCGGCAGCCTGCCGTGGTTGGCGCTGTTACCGGGCGCGCTGAAGCGCGGCTGGAGCGAGCGCGATGATGCCCGCGGCGCGCTGTATCTGCTAGGCTGGATAGCGATGCCGTTCCTGTTCTTCAGCATCGCCAAGGGAAAACTGCCGACCTACATTCTGCCGTGCTTTATGCCGCTGTCGATTTTGATGGCCCGCTACGCGCTGGATGCCGCGAAGGCGGGGGCGAAAGCGCTGCGCATCAACGGCATGATCAACCTCGGTTTTGGTCTGATCGGCCTGGTCGCCGTGCTGGTGGTCTCGCCGTGGGGCGTCATGCATAAGCCGGTGTGGACGAAGATCGAGCTGTATAAATGTCTGCTGGCGGCGATTGCCTTTGCCGTATGGGCGCTGATGGGCTGGCTGGCGATAAAAGACAACGGTCGTCGCTGGACGCTGGCCGCCATCTGTCCGCTGGGAGTGGCGCTGCTGGTGGGCTTCGCTATCCCGGATCGGGTTATCGACAGCAAACAGCCGCAGTTTCTGGTGGATATTGTTAGCGAATCGCTGGCGCCAAGCCGCTATGTACTGACCAACAGCGTCGGTATCGGAGCGGGGCTGGCGTGGGAGCTCAAGCGTGACGACATCATCCTGTATGAAAGGCAGGGGGAGCTAAAATATGGCCTCGGCTGGCCGGATGCGCAGAGCAAATTCGTGTCGACTCAAGCTTTTGCTGATTGGCTGGCGGCGCACCGCCAGCAGGGACCGATCTCACTGGTGCTGCTGATGGATAAAGGTGAAACGATGAACGAACTGGCGTTACCGAAACCTGATAACTCCTACGAGCTGGGGCGCGTGGTGTTTATTCAGTATCTGCCGCAATGA,MKSIRYGISLVVLFALYYLLPLNFRLLWQPDETRYAEISREMLASGDWVVPHLLGLRYFEKPIAGYWINSIGQWLFGHNNFGVRFGSVFAITVSALLVAWLAWRIFRDKRVAILSPVIFLTAMLVYGIGTYAVLDPMITMWLALAMCSFWGASQAQSRSGKMLGYVLLGVACGMGVMTKGFLALAVPVVGVLPWVMARKRWREVLTYGWLAVAVCTLVVLPWGLAIANREPDFWRYFFWVEHIQRFAEKDAQHKAPFWYYIPFLIAGSLPWLALLPGALKRGWSERDDARGALYLLGWIAMPFLFFSIAKGKLPTYILPCFMPLSILMARYALDAAKAGAKALRINGMINLGFGLIGLVAVLVVSPWGVMHKPVWTKIELYKCLLAAIAFAVWALMGWLAIKDNGRRWTLAAICPLGVALLVGFAIPDRVIDSKQPQFLVDIVSESLAPSRYVLTNSVGIGAGLAWELKRDDIILYERQGELKYGLGWPDAQSKFVSTQAFADWLAAHRQQGPISLVLLMDKGETMNELALPKPDNSYELGRVVFIQYLPQ,MKSIRYGVSLIALFALYYLLPLNFRLLWQPDETRYAEISREMLATGDWVVPHFLGLRYFEKPIAGYWINSIGQWLFGHNNFGVRFGSVFAITMTALLVAWLAWRIFRDKRVAILSLIIFLTAMLVYAIGTYAVLDPMITLWLALAMCSFWGAVQAHSRSGKILGYVLLGVACGMGVMTKGFLALAVPVVGVLPWVIARKRWREVLTYGWLAVIVCTLVVLPWGLAIAQREPDFWRYFFWVEHIQRFAEKDAQHKAPFWYYIPFLIAGSLPWLALLPGALKRGWLERDEARGALYLLGWVAMPFLFFSIAKGKLPTYILPCFAPLSILMARYALEAAKTGAKALRINGMINLGVGLLGLIAVLVVSPWGFMHKPVWTKIELYKCLLAAIAFAVWALMGWLAMKDSGRRWSLAALCPLGLALLVGFAIPDRVIDSKQPQFLVDIVSESLQPSRYVLTNNVGIAGGLAWELKRSDIIMFDKQGELKYGLDWPDAQGSFVSQAGFADWLAAHRQQGPVSLVLLMDKGESMLDLPLPKPDNAYELGRVVFLQYLPQ,100,gnl|BL_ORD_ID|2785|hsp_num:0,3795,FALSE,None
LK894,4_316 # 351657 # 352289 # -1 # ID=4_316;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.512,4_316,351657,352289,-,Strict,400,432.95,CRP,99.05,3000518,protein homolog model,n/a,n/a,macrolide antibiotic; fluoroquinolone antibiotic; penam,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGGTGCTTGGCAAACCGCAAACAGACCCTACCCTTGAATGGTTCTTGTCTCATTGCCACATTCATAAGTACCCATCAAAGAGCACGCTGATTCACCAGGGTGAGAAAGCGGAAACGCTTTACTACATCGTAAAAGGCTCCGTGGCTGTACTCATCAAGGATGAAGAAGGTAAAGAGATGATCCTCTCTTACCTCAACCAGGGCGATTTCATCGGTGAATTAGGCCTGTTTGAAGAAGGTCAGGAACGTAGTGCCTGGGTACGTGCGAAAACCGCATGTGAAGTGGCCGAGATCTCTTACAAAAAATTCCGTCAGTTAATCCAGGTGAACCCGGACATCCTGATGCGCCTCTCCTCGCAGATGGCGCGTCGTCTGCAGGTCACTTCCGAGAAAGTCGGTAACCTTGCTTTCCTCGACGTGACGGGCCGTATCGCTCAGACCTTACTGAATCTGGCGAAACAGCCTGATGCCATGACTCACCCGGACGGGATGCAGATCAAAATCACCCGCCAGGAAATTGGCCAGATCGTCGGTTGCTCTCGTGAAACCGTCGGCCGTATTCTGAAGATGCTGGAAGATCAAAACCTGATCTCGGCACACGGTAAAACTATCGTCGTCTACGGTACCCGTTAA,MVLGKPQTDPTLEWFLSHCHIHKYPSKSTLIHQGEKAETLYYIVKGSVAVLIKDEEGKEMILSYLNQGDFIGELGLFEEGQERSAWVRAKTACEVAEISYKKFRQLIQVNPDILMRLSSQMARRLQVTSEKVGNLAFLDVTGRIAQTLLNLAKQPDAMTHPDGMQIKITRQEIGQIVGCSRETVGRILKMLEDQNLISAHGKTIVVYGTR,MVLGKPQTDPTLEWFLSHCHIHKYPSKSKLIHQGEKAETLYYIVKGSVAVLIKDEEGKEMILSYLNQGDFIGELGLFEEGQERSAWVRAKTACEVAEISYKKFRQLIQVNPDILMRLSAQMARRLQVTSEKVGNLAFLDVTGRIAQTLLNLAKQPDAMTHPDGMQIKITRQEIGQIVGCSRETVGRILKMLEDQNLISAHGKTIVVYGTR,100,gnl|BL_ORD_ID|803|hsp_num:0,869,FALSE,None
LK894,5_2 # 987 # 4097 # -1 # ID=5_2;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=11-12bp;gc_cont=0.526,5_2,987,4097,-,Strict,750,751.125,adeF,40.84,3000777,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; tetracycline antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGTCTAAGTTCTTCATTCATCGACCGGTGTTTGCATGGGTGCTGGCGATCATCATGATGATTGCCGGCGGCCTCGCCATCATGCAGCTTCCTATCGCGCAATATCCCACGATTGCGCCGCCCGCGGTAGCCATCTCGGCAACCTACCCGGGTGCAGATGCGCAAACCGTGCAGGACACCGTCACCCAGGTTATCGAACAGAACATGAATGGTATCGATAATCTGATGTACATGTCCTCTACCAGTGATTCATCCGGTAGCGTGACCATCACGCTCACTTTTCAATCCGGCACCGATCCGGATATCGCCCAGGTGCAGGTGCAGAACAAACTGCAACTGGCGACGCCGCTGCTGCCACAGGAAGTACAGCAGCAAGGTATTAGCGTTGAGAAATCCAGTAGCAGCTTCCTGCTGGTTGCCGGATTTATTTCTGATAATCAAAGCACTACCCAGGATGATATTTCCGACTACGTTGCCTCCAACATCAAAGACCCTATCAGCCGCCTTAACGGCGTGGGCGATGTACAGTTGTTCGGTGCGCAATATGCCATGCGTATCTGGCTCGACGGCAACCTGCTGAATAAATATAACCTCACGCCGGTTGATGTTATCAACCAGCTGAAAGTGCAAAACGATCAGATCGCCGCCGGACAGCTTGGCGGTACACCATCGGTTAAAGGTCAACAGCTTAATGCCTCGATCATTGCTCAGACTCGCCTGAAAGATCCTGAGGAATTCGGTAAAGTCACGCTGCGGGTTAACGCCGATGGTTCCGTGGTTCGCCTGAAGGATGTCGCGCGCATTGAACTGGGCGGCGAGAACTATAACGTTGTCGCGCGCATTAATGGCAAACCCGCCTCTGGTTTGGGGATCAAGCTGGCGACCGGCGCCAATGCGTTAGATACCGCTACGGCGATTAAAGCGAAACTTGCCGAGCTGCAGCCCTTCTTCCCGCAAGGGATGAAAGTTGTTTATCCCTACGACACCACGCCGTTCGTTAAAATCTCCATTCACGAAGTGGTCAAAACGCTGTTTGAAGCCATTATCCTCGTCTTCCTCGTGATGTATCTGTTCCTGCAGAACATTCGCGCAACGCTTATCCCGACGATCGCTGTGCCGGTCGTCTTGCTGGGTACTTTTGCGGTGCTGGCGATGTTCGGCTACTCCATCAACACGCTAACCATGTTTGGCATGGTGCTGGCGATAGGGCTACTGGTCGACGATGCCATCGTGGTGGTAGAGAACGTTGAGCGCGTCATGGTCGAGGACAAGCTTTCCCCCGTTGAAGCCACAGAGAAATCAATGGAGCAGATTCAGGGGGCGCTGGTTGGTATCGCCATGGTGCTCTCGGCGGTATTCGTCCCGATGGCCTTCTTTGGCGGCTCGACCGGGGCGATTTATCGTCAGTTCTCCATCACTATCGTTTCCGCGATGGCGCTGTCTGTACTGGTCGCGCTGGTACTGACCCCGGCGCTATGCGCAACCATGTTAAAGCCAGCATCCGCAGACCATCATGGCAAAAAGGGGTTCTTCGGCTGGTTTAATGCCAGGTTCGACCAAAGCGTTAACCACTACACCAATAGCGTAAGCGGGATCCTGCGCGGCACCGGGCGCTACCTGGTTATCTATCTGCTGATCGTTATCGGCATGGCAATGCTGTTTGTCCGCTTGCCTACATCCTTCCTGCCTGATGAAGACCAGGGCGTGTTCCTGACCATGGTTCAGTTACCTGCTGGCGCTACGCAAGAGCGTACGCAAAAGGTGCTCGACTCCGTCAGCGACTACTATCTACAGAAAGAGAAAGCTAATGTTGAGAGCGTGTTCACTGTTAACGGCTTTAGCTTCAGCGGACAAGGACAAAACTCCGGTATGGCGTTTGTCAGTCTGAAACCATGGGAAGAGCGCAGCGGTTCGGAAAACGGCGTTGAAGCCATTATTAAGCGTGCCACCGCCGCATTTAGCCAGATTAAAGATGCAATGGTCTTCCCGTTCAACATGCCGGCCATCATCGAGTTAGGTACCGCGACCGGTTTCGACTTTGAGCTGATTGACCAGGGTGGCTTAGGACACACACAGCTAACTCAGGCACGAAACCAGCTTCTGGGGATGGTAAAACAGCATCCGGAACAGCTGGTACGCGTTCGCCCTAATGGCCTTGAAGATACACCGCAGTTTAAACTCGACGTCGATCAAGAGAAAGCGCAGGCGCTGGGCGTCTCGTTATCCGACATTAACGAAACGATATCAGCTGCACTGGGCGGCTATTATGTGAATGACTTTATTGACCGCGGCCGCGTGAAGAAAGTCTACGTTCAGGCCGATGCCAGTTTCCGTATGCTACCCGGTGATATCAATAACATGTATGTCCGCAGCTCTAACGGTGAAATGGTGCCGTTCTCGGCATTTGTTACTTCACGTTGGGTATATGGTTCTCCGCGTCTCGAACGTTACAACGGCCTGCCTTCGATGGAAATCCTCGGCGAAGCGGCTCCGGGTAAGAGTACCGGGGAAGCCATGGCTTTGATGGAGCAACTGGCCAGTAAACTGCCTGCAGGTATCGGTTATGACTGGACGGGCTTGTCTTATCAGGAACGTTTATCAGGTAACCAGGCGCCAGCGCTATATGCTATTTCGCTGATAGTCGTCTTCCTCTGTCTGGCAGCACTCTATGAAAGCTGGTCTATTCCATTCTCCGTTATGCTGGTTGTGCCATTAGGAGTTATCGGCGCATTATTAGCAGCCTCAGTTAGAGGATTGAATAATGACGTTTATTTCCAGGTTGGCCTGTTAACAACTATTGGTTTATCTGCGAAGAACGCCATTCTTATTGTTGAGTTCGCCAAAGACCTTATGGATAAAGAAGGCAAAGGTATTATCGAGGCGACCCTGGAAGCATCCCGTATGCGTCTGCGCCCTATATTAATGACTTCATTAGCCTTTATTCTCGGGGTCATGCCGTTAGTAATTAGCCATGGCGCTGGTAGTGGCGCGCAAAACGCTGTCGGTACCGGCGTGATGGGCGGTATGCTTACCGCAACGCTGCTGGCCATCTTCTTCGTGCCGGTGTTCTTTGTGGTTGTAAGGCGTCGCTTTACCCGCCACGTAGAATAA,MSKFFIHRPVFAWVLAIIMMIAGGLAIMQLPIAQYPTIAPPAVAISATYPGADAQTVQDTVTQVIEQNMNGIDNLMYMSSTSDSSGSVTITLTFQSGTDPDIAQVQVQNKLQLATPLLPQEVQQQGISVEKSSSSFLLVAGFISDNQSTTQDDISDYVASNIKDPISRLNGVGDVQLFGAQYAMRIWLDGNLLNKYNLTPVDVINQLKVQNDQIAAGQLGGTPSVKGQQLNASIIAQTRLKDPEEFGKVTLRVNADGSVVRLKDVARIELGGENYNVVARINGKPASGLGIKLATGANALDTATAIKAKLAELQPFFPQGMKVVYPYDTTPFVKISIHEVVKTLFEAIILVFLVMYLFLQNIRATLIPTIAVPVVLLGTFAVLAMFGYSINTLTMFGMVLAIGLLVDDAIVVVENVERVMVEDKLSPVEATEKSMEQIQGALVGIAMVLSAVFVPMAFFGGSTGAIYRQFSITIVSAMALSVLVALVLTPALCATMLKPASADHHGKKGFFGWFNARFDQSVNHYTNSVSGILRGTGRYLVIYLLIVIGMAMLFVRLPTSFLPDEDQGVFLTMVQLPAGATQERTQKVLDSVSDYYLQKEKANVESVFTVNGFSFSGQGQNSGMAFVSLKPWEERSGSENGVEAIIKRATAAFSQIKDAMVFPFNMPAIIELGTATGFDFELIDQGGLGHTQLTQARNQLLGMVKQHPEQLVRVRPNGLEDTPQFKLDVDQEKAQALGVSLSDINETISAALGGYYVNDFIDRGRVKKVYVQADASFRMLPGDINNMYVRSSNGEMVPFSAFVTSRWVYGSPRLERYNGLPSMEILGEAAPGKSTGEAMALMEQLASKLPAGIGYDWTGLSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFSVMLVVPLGVIGALLAASVRGLNNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGIIEATLEASRMRLRPILMTSLAFILGVMPLVISHGAGSGAQNAVGTGVMGGMLTATLLAIFFVPVFFVVVRRRFTRHVE,MNISKFFIDRPIFAGVLSVLILLAGLLSVFQLPISEYPEVVPPSVVVRAQYPGANPKVIAETVASPLEESINGVEDMLYMQSQANSDGNLTITVNFKLGIDPDKAQQLVQNRVSQAMPRLPEDVQRLGVTTLKSSPTLTMVVHLTSPDNRYDMTYLRNYAVLNVKDRLARLQGVGEVGLFGSGDYAMRVWLDPQKVAQRNLTATEIVNAIREQNIQVAAGTIGASPSNSPLQLSVNAQGRLTTEQEFADIILKTAPDGAVTRLGDVARVELAASQYGLRSLLDNKQAVAIPIFQAPGANALQVSDQVRSTMKELSKDFPSSIKYDIVYDPTQFVRASIKAVVHTLLEAITLVVVVVILFLQTWRASIIPLLAVPVSIIGTFALMLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVERNIEAGLNPREATYRAMREVSGPIIAIALTLVAVFVPLAFMTGLTGQFYKQFAMTIAISTVISAFNSLTLSPALAALLLKGHDAKPDALTRIMNRVFGRFFALFNRVFSRASDRYSQGVSRVISHKASAMGVYAALLGLTVGISYIVPGGFVPAQDKQYLISFAQLPNGASLDRTEAVIRKMSDTALKQPGVESAVAFPGLSINGFTNSSSAGIVFVTLKPFDERKAKDLSANAIAGALNQKYSAIQDAYIAVFPPPPVMGLGTMGGFKLQLEDRGALGYSALNDAAQNFMKAAQSAPELGPMFSSYQINVPQLNVDLDRVKAKQQGVAVTDVFNTMQIYLGSQYVNDFNRFGRVYQVRAQADAPFRANPEDILQLKTRNSAGQMVPLSSLVNVTQTYGPEMVVRYNGYTSADINGGPAPGYSSSQAEAAVERIAAQTLPRGIKFEWTDLTYQKILAGNAGLWVFPISVLLVFLVLAAQYESLTLPLAVILIVPMGILAALTGVWLTAGDNNIFTQIGLMVLVGLACKNAILIVEFARELEMQGATAFKAAVEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMIGVTFFGLFLTPAFYVLIRTLNSKHKLHSAAVHEAPLASPHDH,97.83,gnl|BL_ORD_ID|132|hsp_num:0,153,FALSE,None
LK894,6_189 # 197726 # 199474 # -1 # ID=6_189;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.537,6_189,197726,199474,-,Strict,1000,1121.69,msbA,92.27,3003950,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic efflux,ATP-binding cassette (ABC) antibiotic efflux pump,ATGCAGAACGATAAAGATCTCTCCACGTGGCAGACCTTCCGCCGACTTTGGCCGATGATAGCGCCGTTTAAAGCCGGGCTAATCGTAGCGGCCGTGGCGTTGGTGCTTAACGCGGCAAGTGATACCTTCATGTTATCGCTTCTTAAACCGTTATTGGATGATGGTTTTGGTAAAACGGATCGCTCAGTGCTGATATGGATGCCGCTGGTAGTGATCGGTTTGATGGTGCTGCGCGGGATTACCAGCTATATCTCGAGCTACTGTATCTCCTGGGTTTCCGGCAAAGTGGTGATGACGATGCGTCGCCGCCTATTCGGCCATATGATGGGAATGCCCGTCGCCTTCTTCGACAAACAGTCCACCGGGACATTGCTGTCGCGTATCACCTATGATTCTGAGCAGGTCGCGTCATCTTCTTCCAGCGCCTTGATTACCGTTGTGCGAGAGGGGGCGTCGATTATCGGCCTGTTCGCCATGATGTTCTATTACAGCTGGCAATTGTCGCTGATTCTTATCGTGCTGGCGCCGATTGTGTCAGTCGCGATTCGGGTCGTCTCGAAGCGTTTTCGTAATATCAGTAAGAATATGCAGAACACTATGGGCCAGGTGACCACCAGCGCGGAACAGATGCTCAAAGGGCATAAAGAAGTGCTGATGTTCGGCGGTCAGGAAGTCGAAACTAAGCGTTTTGACAAAGTCAGTAATAAGATGCGCCTGCAGGGGATGAAAATGGTCTCCGCGTCCTCTATCTCCGACCCGGTCATTCAACTGATTGCCTCTCTGGCTCTGGCCTTTGTGCTTTATGCGGCGAGCTTCCCAAGCGTCATGGAAACCCTGACCGCCGGTACCATCACCGTGGTCTTTTCTTCGATGATTGCGCTAATGCGTCCGCTTAAATCCCTGACTAACGTCAACGCGCAGTTCCAGCGTGGGATGGCGGCATGTCAGACGCTGTTCTCCATTCTGGATTCCGAGCAGGAGAAAGATGAAGGCACGCGCGTGATTGAGCGCGCCAAAGGTAACCTGGAATTCCACAACGTCACCTTTAGCTATCCTGGTCGCGAAGTTGCCGCGCTGCGTAACATTAATCTGAGCATTCCGGAGGGAAAAACCGTAGCGCTGGTAGGGCGTTCCGGCTCAGGTAAATCCACCATTGCCAGCCTGATTACCCGTTTTTATGATGTTGACGAGGGGCAAATTCTGCTGGATGGCCACGATCTGCGCGAGTACAAACTGAGCTCGTTGCGTGACCAGGTGGCGCTGGTTTCGCAGAACGTGCACCTGTTCAATGACACCGTCGCCAATAACATCGCCTATGCGCGTACCGAAGAGTACACCCGCGAGCAAATTGAAGAAGCGGCGCGTATGGCCTATGCGATGGACTTTATCAACAAGATGGATAATGGCCTGGACACGATTATCGGCGAGAATGGCGTCATGCTCTCCGGCGGTCAACGTCAGCGTATCGCTATTGCGCGCGCGCTGCTGCGCAACAGCCCTATCCTGATCCTCGATGAAGCCACCTCGGCACTGGATACCGAGTCGGAACGTGCGATTCAGGCGGCACTGGATGAACTGCAGAAAAACCGTACATCACTGGTTATCGCCCACCGTCTGTCGACAATCGAGCAGGCTGACGAAATCGTGGTTGTGGAAGATGGGCGTATCGTTGAGCGCGGTGGCCATCTGGAGCTGCTGGAGCATAAAGGCGTTTACGCGCAGCTACATAAGATGCAATTCGGTCAATGA,MQNDKDLSTWQTFRRLWPMIAPFKAGLIVAAVALVLNAASDTFMLSLLKPLLDDGFGKTDRSVLIWMPLVVIGLMVLRGITSYISSYCISWVSGKVVMTMRRRLFGHMMGMPVAFFDKQSTGTLLSRITYDSEQVASSSSSALITVVREGASIIGLFAMMFYYSWQLSLILIVLAPIVSVAIRVVSKRFRNISKNMQNTMGQVTTSAEQMLKGHKEVLMFGGQEVETKRFDKVSNKMRLQGMKMVSASSISDPVIQLIASLALAFVLYAASFPSVMETLTAGTITVVFSSMIALMRPLKSLTNVNAQFQRGMAACQTLFSILDSEQEKDEGTRVIERAKGNLEFHNVTFSYPGREVAALRNINLSIPEGKTVALVGRSGSGKSTIASLITRFYDVDEGQILLDGHDLREYKLSSLRDQVALVSQNVHLFNDTVANNIAYARTEEYTREQIEEAARMAYAMDFINKMDNGLDTIIGENGVMLSGGQRQRIAIARALLRNSPILILDEATSALDTESERAIQAALDELQKNRTSLVIAHRLSTIEQADEIVVVEDGRIVERGGHLELLEHKGVYAQLHKMQFGQ,MHNDKDLSTWQTFRRLWPTIAPFKAGLIVAGVALILNAASDTFMLSLLKPLLDDGFGKTDRSVLVWMPLVVIGLMILRGITSYVSSYCISWVSGKVVMTMRRRLFGHMMGMPVSFFDKQSTGTLLSRITYDSEQVASSSSGALITVVREGASIIGLFIMMFYYSWQLSIILIVLAPIVSIAIRVVSKRFRNISKNMQNTMGQVTTSAEQMLKGHKEVLIFGGQEVETKRFDKVSNRMRLQGMKMVSASSISDPIIQLIASLALAFVLYAASFPSVMDSLTAGTITVVFSSMIALMRPLKSLTNVNAQFQRGMAACQTLFTILDSEQEKDEGKRVIERATGDVEFRNVTFTYPGRDVPALRNINLKIPAGKTVALVGRSGSGKSTIASLITRFYDIDEGEILMDGHDLREYTLASLRNQVALVSQNVHLFNDTVANNIAYARTEQYSREQIEEAARMAYAMDFINKMDNGLDTVIGENGVLLSGGQRQRIAIARALLRDSPILILDEATSALDTESERAIQAALDELQKNRTSLVIAHRLSTIEKADEIVVVEDGVIVERGTHNDLLEHRGVYAQLHKMQFGQ,100,gnl|BL_ORD_ID|2187|hsp_num:0,2423,FALSE,None
LK894,11_23 # 26337 # 27287 # 1 # ID=11_23;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.486,11_23,26337,27287,+,Strict,500,525.398,leuO,80.46,3003843,protein homolog model,n/a,n/a,nucleoside antibiotic; disinfecting agents and antiseptics,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGTTAATTGAAAATACTGAATATAAATCAGCCCCGGGACAGGAAGTCGTCAAACCACAACTGCGGATGGTGGATCTCAACCTGCTGACCGTCTTTGATGCGGTGATGCAGGAACAAAATATTACCCGTGCGGCCCACACTCTCGGCATGTCCCAACCGGCGGTGAGTAACGCGGTATCTCGTCTCAAGGTGATGTTTAATGATGAACTGTTTGTTCGCTATGGGCGTGGCATTCAGCCAACGGCGCGGGCCTATCAGCTGTTCGGCTCAGTACGCCAGGCATTGCAACTGGTGCAAAATGAGTTGCCGGGTTCCGGTTTTGAACCGCTGAGCAGTGAGCGCGTATTTAACCTCTGCGTTTGTAGCCCATTGGATAATTACTTAACCTCGCTAATATTTAATAAAGTTGGTGAAATCGCGCCAAATATTCATCTGGTCTTTAAATCAGCGCTACATCAAAACACCGAACATCAGCTGCGTTATCAGGAAATTGAATTCGTTATCGGTTATGAAGAGTTCCGTCGCCCGGAGTTTGCCTGCATACCTTTATTCAAAGATGAAATGGTTCTGGTGGCCAACCGTAAACATCCGCGTATTTCCGGGCCGCTAACGGAAGCGGATATTTATCAGGAAGAGCACGCGGTCGTCGCATTGGATCGTTATGCGTCATTTAGCCAGCCGTGGTATGACTCCGTGGATAAACAATCCTGTATTGCTTATCAGGGTAATGCCATGGTTAGCGTATTAAACGTGGTGTCGCAAACCCACATGGTGGCAATAGCGCCACGTTGGTTGGCCAATGAATTCGCTGATAAATTAGATTTGCAGATCTTACCGTTGCCGCTGAAGGTCAACAGCCGTACCTGCTTCCTCTCCTGGCACGAAGCGGCCGGTCGTGATAAAGGCCATCAATGGATGGAAGAGTTATTGGCGAATATCTGTCAGCGCTAA,MLIENTEYKSAPGQEVVKPQLRMVDLNLLTVFDAVMQEQNITRAAHTLGMSQPAVSNAVSRLKVMFNDELFVRYGRGIQPTARAYQLFGSVRQALQLVQNELPGSGFEPLSSERVFNLCVCSPLDNYLTSLIFNKVGEIAPNIHLVFKSALHQNTEHQLRYQEIEFVIGYEEFRRPEFACIPLFKDEMVLVANRKHPRISGPLTEADIYQEEHAVVALDRYASFSQPWYDSVDKQSCIAYQGNAMVSVLNVVSQTHMVAIAPRWLANEFADKLDLQILPLPLKVNSRTCFLSWHEAAGRDKGHQWMEELLANICQR,MPEVQTDHPETAELSKPQLRMVDLNLLTVFDAVMQEQNITRAAHALGMSQPAVSNAVARLKVMFNDELFVRYGRGIQPTARAFQLFGSVRQALQLVQNELPGSGFEPASSERVFHLCVCSPLDSILTSQIYNHIEQIAPNIHVMFKSSLNQNTEHQLRYQETEFVISYEDFHRPEFTSVPLFKDEMVLVASKNHPTIKGPLLKHDVYNEQHAAVSLDRFASFSQTWYDTVDKQASIAYQGMAMMSVLSVVSQTHLVAIAPRWLAEEFAESLELQVLPLPLKQNSRTCYLSWHEAAGRDKGHQWMEEQLVSICKR,100.64,gnl|BL_ORD_ID|4928|hsp_num:0,5921,FALSE,None
LK894,14_43 # 47388 # 50540 # -1 # ID=14_43;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.565,14_43,47388,50540,-,Strict,2000,2064.66,oqxB,97.24,3003923,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; glycylcycline; tetracycline antibiotic; diaminopyrimidine antibiotic; nitrofuran antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGGACTTTTCCCGCTTTTTTATCGACAGGCCGATTTTTGCCGCCGTGCTGTCGATTCTGATTTTTATCACCGGCTTGATCGCCATTCCGCTGTTGCCGGTCAGCGAATATCCTGATGTCGTACCGCCTAGCGTGCAGGTGCGGGCGGAATATCCCGGCGCCAACCCGAAAGTGATCGCCGAAACCGTGGCGACGCCATTGGAAGAAGCCATCAACGGCGTCGAAAATATGATGTACATGAAGTCCGTCGCAGGCTCTGACGGCGTATTGGTTACTACCGTCACTTTCCGTCCGGGAACCGACCCCGATCAGGCGCAGGTTCAGGTGCAAAACCGGGTCTCGCAGGCCGAGGCGCGTCTCCCGGAAGATGTCCGCCGTTTAGGCATCACCACCCAGAAGCAATCGCCAACGCTGACGTTGGTGGTGCATCTGTTTTCACCCAGCGGTAAGTACGATTCACTGTATATGCGTAACTACGCCACGTTGAAAGTCAAAGATGAACTCGCGCGTTTGCCCGGCGTCGGACAGATCCAGATTTTTGGCTCGGGTGAATATGCGATGCGCATCTGGCTGGATCCCAATAAGGTTGCGGCGCGCGGGTTAACCGCATCGGATGTGGTGACTGCGATGCAGGAGCAAAACGTTCAGGTTTCCGCCGGACAGCTGGGCGCCGAGCCGCTGCCGAAAGAGAGCGATTTTTTGATCTCTATTAACGCCCAGGGGCGTCTGCATACGGAAGAAGAGTTTGGCAATATTATTCTGAAAACGGCGCAAGACGGTTCGCTGGTGCGCCTGCGCGACGTGGCGCGTATCGAAATGGGCTCGGGTAGCTATGCGTTACGTTCCCAGCTTAACAATAAAGACGCGGTCGGGATTGGTATTTTCCAGTCGCCGGGGGCGAATGCTATCGATTTGTCTAACGCCGTACGCGCGAAAATGAACGAACTCTCTACCCGTTTCCCGGAAGATATGAAATGGGCGGCGCCGTACGATCCGACCGTGTTTGTGCGCGATTCGATTCGCGCGGTGGTGCAAACGCTGCTGGAAGCGGTAGTGTTAGTGGTGCTGGTGGTAATTTTGTTCCTGCAGACGTGGCGTGCGTCGATTATTCCGCTTATCGCGGTGCCGGTATCGGTGGTGGGTACCTTCAGCATTCTTTATCTGCTGGGCTTTTCGCTGAATACCCTGAGTCTGTTCGGGTTGGTACTGGCGATCGGTATCGTCGTGGATGATGCCATCGTGGTGGTGGAAAACGTCGAACGAAACATCGAAGAGGGGCTGGCTCCGCTAGCGGCGGCGCATCAGGCGATGCGCGAAGTCTCCGGGCCGATTATCGCTATCGCGCTGGTGCTGTGCGCGGTGTTTGTGCCGATGGCGTTCCTCTCCGGGGTAACGGGGCAGTTTTATAAGCAGTTTGCGGTGACGATTGCGATATCGACGGTGATCTCCGCCATCAACTCCCTGACGCTCTCGCCAGCGCTGGCTGCGCTGCTGTTAAAACCGCACGGCGCGGCGAAAGACTTCCCGACCCGGCTTATCGATCGCTTGTTCGGCTGGATTTTCCGTCCGTTTAACCGTTTTTTCCATCGTAGCTCAAACGGCTATCAGGGGCTGGTAGGCAAAACGCTCGGGCGACGCGGCGCGGTGTTTGTGGTCTACGTCCTGCTGCTCTGCGCCGCTGGCGTGATGTTTAAAGTCGTACCCGGCGGGTTTATTCCGACGCAGGATAAACTGTATTTAATTGGCGGCGTGAAAATGCCCGAAGGCTCTTCACTGGCGCGCACCGACGCCGTGATCCGCAAAATGAGCGAAATCGGTATGAATACCGAAGGCGTGGATTATGCGGTGGCTTTTCCGGGGCTTAATGCGCTGCAGTTCACCAATACGCCGAACACCGGGACGGTCTTTTTTGGTCTGAAACCGTTCGATCAGCGAAAACACACCGCAGCGGAAATTAATGCCGAGATTAATGCCAAAATCGCGCAAATTCAGCAGGGCTTTGGTTTCTCGATTCTGCCGCCGCCGATTTTAGGGCTGGGTCAGGGTTCCGGCTATTCACTGTATATTCAGGATCGCGCCGGTCTGGGTTATGGCGCGTTGCAAAACGCGGTGAACGCGATGTCGGGTTCGATTATGCAGACGCCGGGGATGCATTTCCCGATATCGACCTATCAGGCGAACGTGCCGCAGCTGGATGTGCAGGTCGATCGAGATAAAGCGAAAGCGCAGGGCGTGTCGTTGACCGACCTTTTCGGGACGCTGCAAACTTATCTGGGGTCATCGTATGTGAATGACTTTAACCAGTTTGGGCGTACCTGGCGCGTAATGGCGCAGGCTGACGGGCCGTTCCGCGACAGCGTGGAAGATATTGCTAATTTACGCACCCGCAATAATCAGGGCGAAATGGTGCCGATTGGCAGTATGGTGAATATTAATACCACCTACGGACCGGATCCGGTGATTCGCTACAATGGTTATCCGGCGGCGGATTTGATTGGCGATGCCGATCCCCGCGTGCTCTCGTCCACCCAGGCGATGACGCAGCTGGCAGGCATGTCTAAGCAGATACTGCCGAATGGGATGAATATTGAGTGGACGGATCTCAGCTTCCAGCAGGCTACGCAGGGCAATACGGCGCTGATCGTCTTCCCGGTCGCGGTCCTGCTGGCATTCCTGGTGCTGGCGGCGCTATATGAAAGCTGGACGCTACCGCTGGCGGTGATCCTTATCGTCCCGATGACCATGCTCTCCGCGCTGTTTGGCGTCTGGCTGACCGGCGGCGACAATAACGTATTTGTGCAGGTAGGGCTGGTGGTGCTGATGGGGCTGGCGTGTAAAAACGCGATTCTGATTGTCGAGTTTGCCCGCGAACTGGAAATTCAGGGCAAAGGGATTATGGAAGCGGCGCTGGAAGCCTGTCGTCTGCGTTTACGTCCGATTATCATGACCTCGATTGCCTTTATTGCCGGGACGATTCCGCTGATTCTTGGCCATGGCGCGGGGGCGGAAGTGCGCGGCGTCACCGGGATCACGGTGTTCTCCGGTATGCTCGGCGTGACGCTGTTTGGGCTGTTCCTGACGCCGGTGTTTTACGTGACGCTGCGAAAACTGGTGACGCGCGGCGAACCGGTTAGGGACGTCCTGCCTGAGTAG,MDFSRFFIDRPIFAAVLSILIFITGLIAIPLLPVSEYPDVVPPSVQVRAEYPGANPKVIAETVATPLEEAINGVENMMYMKSVAGSDGVLVTTVTFRPGTDPDQAQVQVQNRVSQAEARLPEDVRRLGITTQKQSPTLTLVVHLFSPSGKYDSLYMRNYATLKVKDELARLPGVGQIQIFGSGEYAMRIWLDPNKVAARGLTASDVVTAMQEQNVQVSAGQLGAEPLPKESDFLISINAQGRLHTEEEFGNIILKTAQDGSLVRLRDVARIEMGSGSYALRSQLNNKDAVGIGIFQSPGANAIDLSNAVRAKMNELSTRFPEDMKWAAPYDPTVFVRDSIRAVVQTLLEAVVLVVLVVILFLQTWRASIIPLIAVPVSVVGTFSILYLLGFSLNTLSLFGLVLAIGIVVDDAIVVVENVERNIEEGLAPLAAAHQAMREVSGPIIAIALVLCAVFVPMAFLSGVTGQFYKQFAVTIAISTVISAINSLTLSPALAALLLKPHGAAKDFPTRLIDRLFGWIFRPFNRFFHRSSNGYQGLVGKTLGRRGAVFVVYVLLLCAAGVMFKVVPGGFIPTQDKLYLIGGVKMPEGSSLARTDAVIRKMSEIGMNTEGVDYAVAFPGLNALQFTNTPNTGTVFFGLKPFDQRKHTAAEINAEINAKIAQIQQGFGFSILPPPILGLGQGSGYSLYIQDRAGLGYGALQNAVNAMSGSIMQTPGMHFPISTYQANVPQLDVQVDRDKAKAQGVSLTDLFGTLQTYLGSSYVNDFNQFGRTWRVMAQADGPFRDSVEDIANLRTRNNQGEMVPIGSMVNINTTYGPDPVIRYNGYPAADLIGDADPRVLSSTQAMTQLAGMSKQILPNGMNIEWTDLSFQQATQGNTALIVFPVAVLLAFLVLAALYESWTLPLAVILIVPMTMLSALFGVWLTGGDNNVFVQVGLVVLMGLACKNAILIVEFARELEIQGKGIMEAALEACRLRLRPIIMTSIAFIAGTIPLILGHGAGAEVRGVTGITVFSGMLGVTLFGLFLTPVFYVTLRKLVTRGEPVRDVLPE,MDFSRFFIDRPIFAAVLSILIFITGLIAIPLLPVSEYPDVVPPSVQVRAEYPGANPKVIAETVATPLEEAINGVENMMYMKSVAGSDGVLVTTVTFRPGTDPDQAQVQVQNRVAQAEARLPEDVRRLGITTQKQSPTLTLVVHLFSPGGKYDSLYMRNYATLKVKDELARLPGVGQIQIFGSGEYAMRVWLDPNKVAARGLTASDVVTAMQEQNVQVSAGQLGAEPLPQESDFLISINAQGRLHTEEEFGNIILKTAQDGSLVRLRDVARIEMGSGSYALRSQLNNKDAVGIGIFQSPGANAIDLSNAVRAKMAELATRFPEDMQWAAPYDPTVFVRDSIRAVVQTLLEAVVLVVLVVILFLQTWRASIIPLIAVPVSVVGTFSILYLLGFSLNTLSLFGLVLAIGIVVDDAIVVVENVERNIEEGLAPLAAAHQAMREVSGPIIAIALVLCAVFVPMAFLSGVTGQFYKQFAVTIAISTVISAINSLTLSPALAALLLKPHGAKKDLPTRLIDRLFGWIFRPFNRFFLRSSNGYQGLVGKTLGRRGAVFAVYLLLLCAAGVMFKVVPGGFIPTQDKLYLIGGVKMPEGSSLARTDAVIRKMSEIGMNTEGVDYAVAFPGLNALQFTNTPNTGTVFFGLKPFDQRKHTAAEINAEINAKIAQIQQGFGFSILPPPILGLGQGSGYSLYIQDRGGLGYGALQSAVNAMSGAIMQTPGMHFPISTYQANVPQLDVQVDRDKAKAQGVSLTDLFGTLQTYLGSSYVNDFNQFGRTWRVMAQADGPYRESVEDIANLRTRNNQGEMVPIGSMVNISTTYGPDPVIRYNGYPAADLIGDADPRVLSSSQAMTHLEELSKQILPNGMNIEWTDLSFQQATQGNTALIVFPVAVLLAFLVLAALYESWTLPLAVILIVPMTMLSALFGVWLTGGDNNVFVQVGLVVLMGLACKNAILIVEFARELEIQGKGIMEAALEACRLRLRPIVMTSIAFIAGTIPLILGHGAGAEVRGVTGITVFSGMLGVTLFGLFLTPVFYVTLRKLVTRRKPVQEDLPA,100,gnl|BL_ORD_ID|2154|hsp_num:0,2400,FALSE,None
LK894,14_44 # 50564 # 51739 # -1 # ID=14_44;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.573,14_44,50564,51739,-,Strict,670,701.434,oqxA,92.58,3003922,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; glycylcycline; tetracycline antibiotic; diaminopyrimidine antibiotic; nitrofuran antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGAGCCTGCAAAAAACCTGGGGAAAACGTCATCTGACTGCAGTAGGTATGGTGCTACTCTCGGCGCTGCTCGCCGGCTGCGATGAAGGCGTCGCGCAAAACGCCGCGCCGCAAGCGCCTGCCGTCAGCGCCGCTGAGGTGGTGGTGAAATCCATTAGCCAGTGGGATAGCTTTAATGGCCGGATTGAGGCGGTGGAAAGCGTGCAGCTCCGTCCCCGCGTTTCTGGTTATATTGATAAAGTGAATTACACCGACGGTCAGGAGGTGAAGAAGGGGGAGGTGTTATTCACCATTGACGATCGAACCTATCGCGCGGCGCTGGAACAGGCGCAGGCAACCTTGGCGAGAGCGAAAACGCAAGCCAGCCTGGCGCGCAGTGAAGCAAACCGCACCGATAAATTAATCAATACCAATCTGGTTTCCCGTGAAGAGTGGGAGCAGCGCCGCTCCGCTGCGGTCCAGGCGCAAGCGGATATTCGCGCCGCCCAGGCGGCGGTTGATGCCGCGCAGCTTAATCTGGACTTCACCAAAGTGACCGCGCCTATTGATGGCCGTGCCAGCCGCGCGTTAATCACCAGCGGTAATCTGGTCACCGCTGGTGATACCGCCAGCGTTCTTACCACGCTGGTGTCGCAGAAAACGGTTTATGTCTACTTTGACGTGGATGAGTCGACCTATCTTCACTACCAAAATCTTGCCCGCAGGGGGCAGGGGGCCTCCAGCAGCCACCAGGCATTACCGGTTGAGATCGGCCTTGTGGGCGAAGAGGGCTACCCTCATCAGGGCAAAGTGGATTTTCTGGATAATCAGTTAACGCCGAGCACCGGTACGATCCGCATGCGCGCGCTGCTGGACAATTCGCAGCGTCTGTTCACGCCGGGACTCTTTGCCCGTGTCCGCTTGCCGGGTAGCGCTGAATTCAAAGCCACGCTTATCGACGACAAAGCGGTACTGACCGATCAGGACCGTAAATATGTCTATATCGTTGATAAAGAGGGTAAAGCCCAGCGTCGCGATATTGCGCCGGGGCGGTTGGCTGCCGGTTTACGTATCGTCAAGCAGGGGCTGAACCCTGGGGATAAAGTCATCGTCGATGGTTTGCAAAAAGTGTTTATGCCGGGAATGCCGGTTAACGCGAAGACCGTTGCCATGACCACCAGCGCCGCCCTCAACTGA,MSLQKTWGKRHLTAVGMVLLSALLAGCDEGVAQNAAPQAPAVSAAEVVVKSISQWDSFNGRIEAVESVQLRPRVSGYIDKVNYTDGQEVKKGEVLFTIDDRTYRAALEQAQATLARAKTQASLARSEANRTDKLINTNLVSREEWEQRRSAAVQAQADIRAAQAAVDAAQLNLDFTKVTAPIDGRASRALITSGNLVTAGDTASVLTTLVSQKTVYVYFDVDESTYLHYQNLARRGQGASSSHQALPVEIGLVGEEGYPHQGKVDFLDNQLTPSTGTIRMRALLDNSQRLFTPGLFARVRLPGSAEFKATLIDDKAVLTDQDRKYVYIVDKEGKAQRRDIAPGRLAAGLRIVKQGLNPGDKVIVDGLQKVFMPGMPVNAKTVAMTTSAALN,MSLQKTWGNIHLTALGAMMLSFLLVGCDDSVAQNAAPPAPTVSAAKVLVKSISQWDSFNGRIEAVESVQLRPRVSGYIDKVNYTDGQEVKKGQVLFTIDDRTYRAALEQAQAALARAKTQASLAQSEANRTDKLVHTNLVSREEWEQRRSAAVQAQADIRAAQAAVDAAQLNLDFTKVTAPIDGRASRALITSGNLVTAGDTASVLTTLVSQKTVYVYFDVDESTYLHYQNLARRGQGASSDNQALPVEIGLVGEEGYPHQGKVDFLDNQLTPSTGTIRMRALLDNSQRLFTPGLFARVRLPGSAEFKATLIDDKAVLTDQDRKYVYIVDKDGKAQRRDITPGRLADGLRIVQKGLNPGDSVIVDGLQKVFMPGMPVNAKTVAMTSSATLN,100,gnl|BL_ORD_ID|2153|hsp_num:0,2399,FALSE,None
LK894,15_93 # 108099 # 111221 # 1 # ID=15_93;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.586,15_93,108099,111221,+,Strict,1800,1853.57,mdtB,90.67,3000793,protein homolog model,n/a,n/a,aminocoumarin antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGCAAGTATTACCCCCAAGCAGTACGGGCGGCCCTTCCCGACTGTTTATTATGCGTCCGGTGGCGACAACGCTATTGATGGTCGCCATTCTGCTGGCCGGTATCATCGGCTATCGCTTCCTGCCGGTCTCCGCGCTGCCGGAAGTTGACTACCCGACCATTCAGGTAGTAACGCTCTACCCCGGCGCCAGCCCGGATGTGGTGACGTCATCGATTACCGCACCGCTGGAACGCCAGTTTGGTCAGATGTCCGGCCTTAAGCAGATGTCCTCACAAAGCTCGGGCGGCGCGTCGGTCATTACCCTGCAGTTCCAGTTGACCCTGGCGCTGGATGTCGCCGAACAGGAAGTGCAGGCGGCCATCAACGCCGCGACCAACCTGCTGCCGTCTGATTTACCCAACCCGCCGGTTTACAGCAAAGTTAACCCGGCGGATCCGCCGATCATGACCCTGGCCGTGACCTCCAGCGCGATGCCGATGACGCAGGTTGAAGATATGGTGGAAACTCGGGTAGCGCAGAAGATATCTCAGGTTTCCGGGGTCGGCCTGGTGACGCTGGCCGGCGGCCAACGTCCTGCGGTGCGCGTTAAGCTCAATGCCCAGGCGATCGCCGCGTTAGGTTTGACCAGCGAAACCGTGCGTACCGCCATTACCAGCGCCAACGTGAATTCAGCGAAAGGTAGCCTTGACGGCCCGGCCCGCGCGGTCACCCTTTCCGCCAACGATCAGATGCAGTCGGCGGAAGATTACCGTCGGCTGATTATCGCCTATCAGAACGGCGCGCCGATCCGTCTTGGCGATATCGCGACCATCGAACAGGGCGCCGAGAACGCCTGGCTGGGGGCGTGGGCCAATAAGCAGCGGGCGATCGTGATGAACGTCCAACGCCAGCCGGGAGCGAACATCATCGCCACCGCCGACAGCATCCGCCAGATGCTGCCGCAACTGACCGAGAGCCTGCCTAAATCCGTTAAGGTACAGGTGCTTTCTGACCGCACCACCAATATTCGCGCGTCGGTCAGCGATACCCAGTTCGAATTGCTGCTGGCCATCGCGCTGGTGGTGATGATCATTTATCTCTTTTTACGCAATGTCCCGGCGACTATCATTCCCGGCGTCGCCGTGCCGCTATCGCTGGTCGGTACCTTCGCGGTCATGGTGTTCCTCGATTTTTCGATTAACAACCTGACGCTAATGGCATTGACCATCGCCACCGGTTTCGTCGTCGATGACGCCATCGTGGTCATTGAAAATATCTCTCGCTACATTGAAAAGGGCGAAAAACCGCTGGCCGCCGCGCTGAAAGGCGCGGGGGAAATCGGCTTCACGATTATTTCATTAACCTTCTCGCTGATTGCCGTACTGATTCCGCTGCTGTTTATGGGTGATATCGTTGGGCGATTGTTCCGTGAATTCGCCATTACCCTGGCGGTGGCGATTCTGATTTCGGCGGTGGTCTCGCTGACCCTGACGCCGATGATGTGCGCGCGGATGTTAAGCCACGAATCGCTGCGCAAACAAAACCGCTTTTCGCGGGCCAGCGAGCGTTTCTTCGAGCGGGTGATTGCCGTCTATGGCCGCTGGCTGAGCCGGGTACTAAACCACCCATGGCTAACGTTGAGCGTGGCGTTAAGCACCCTGGCGTTATCGATTCTGCTGTGGGTCTTTATCCCGAAAGGCTTCTTCCCAATCCAGGATAACGGCATTATTCAGGGCACGTTACAGGCCCCGCAGTCGGTGTCGTTCGCCAGTATGGCGCAACGCCAGCAGCAGGTATCCGATCTGATTCTGAAAGATCCGGCGGTTGAAAGCCTGACGTCGTTCGTCGGCGTTGATGGCACCAACCCAGCGCTGAACAGCGCGCGACTGCAGATTAACCTCAAACCACTGGATGAACGCGACGATCGCGTGCAAACGGTCATCAGCCGTCTGCAGCAATCGGTGGCAAGCGTACCGGGTATTGAGCTTTATCTTCAGCCAACGCAGGATCTGACTATCGATACCACCGTCAGTCGCACTCAGTATCAGTTTACCCTGCAGGCTAACTCGCTTGATGCGCTGAGCAACTGGGTGCCGCAATTGCTGTCGCGCCTGCAATCCTTGCCCCAGCTTGCCGACGTCAGCAGCGACTGGCAGGATAAAGGGCTCGCGGCTTATATTAATGTCGATCGCGATAGCGCCAGCCGGCTGGGTATTTCCATGGCGGATGTCGATAACGCGCTGTATAACGCCTTTGGCCAACGGCTGATCTCGACAATTTATACCCAGGCCAATCAATATCGCGTGGTACTGGAGCACGACACCCAGGCGACGCCGGGGCTGGCGGCTCTGGATAATATCCGCCTCACCAGCAGCGATGGCGGTATCGTGCCGCTGAAATCCATCGCCAGCGTCGAGCAGCGTTTTACCCCGCTGTCGGTGAACCATCTCGATCAGTTCCCGGTGACCACCATTTCATTCAACGTGCCGGATAACTACTCCCTCGGCGAAGCGGTAGAGGCTATTTTGTCAGCCGAGCAGTCGCTGGATTTCCCAAGCGACATCCGCACCCAGTTCCAGGGCAGTTCCCTCGCATTCCAGTCGGCGCTCGGTAGCACCGTCTGGCTGGTCGTCGCGGCGGTCGTCGCCATGTATATCGTCCTCGGCGTGCTGTACGAAAGCTTCATTCATCCCATCACCATTCTTTCTACCCTGCCGACCGCTGGCGTCGGGGCGCTGCTGGCGCTATGGCTGGCAGGGAGCGAGTTGGATGTGATTGCCATCATCGGCATCATTCTGCTGATTGGTATCGTGAAGAAAAACGCCATCATGATGATTGACTTTGCCCTCGCCGCCGAGCGCGAGCAGGGAATGCCGCCGCGCGAAGCCATTTATCAGGCCTGCCTGCTGCGCTTTCGTCCGATTCTGATGACCACCCTCGCCGCCCTGCTCGGCGCGCTGCCCTTGATGCTCAGCACCGGCGTCGGCGCCGAGCTGCGTCGTCCGCTGGGTATTGGTATGGTCGGTGGTCTGATGCTCAGCCAGGTACTGACGTTATTCACCACGCCGGTGATTTATCTGCTGTTCGACCGGCTATCGCTGTATATGAAGAGCCGCTTCCCGCGCCGTGAAGAGGAGGCGTAA,MQVLPPSSTGGPSRLFIMRPVATTLLMVAILLAGIIGYRFLPVSALPEVDYPTIQVVTLYPGASPDVVTSSITAPLERQFGQMSGLKQMSSQSSGGASVITLQFQLTLALDVAEQEVQAAINAATNLLPSDLPNPPVYSKVNPADPPIMTLAVTSSAMPMTQVEDMVETRVAQKISQVSGVGLVTLAGGQRPAVRVKLNAQAIAALGLTSETVRTAITSANVNSAKGSLDGPARAVTLSANDQMQSAEDYRRLIIAYQNGAPIRLGDIATIEQGAENAWLGAWANKQRAIVMNVQRQPGANIIATADSIRQMLPQLTESLPKSVKVQVLSDRTTNIRASVSDTQFELLLAIALVVMIIYLFLRNVPATIIPGVAVPLSLVGTFAVMVFLDFSINNLTLMALTIATGFVVDDAIVVIENISRYIEKGEKPLAAALKGAGEIGFTIISLTFSLIAVLIPLLFMGDIVGRLFREFAITLAVAILISAVVSLTLTPMMCARMLSHESLRKQNRFSRASERFFERVIAVYGRWLSRVLNHPWLTLSVALSTLALSILLWVFIPKGFFPIQDNGIIQGTLQAPQSVSFASMAQRQQQVSDLILKDPAVESLTSFVGVDGTNPALNSARLQINLKPLDERDDRVQTVISRLQQSVASVPGIELYLQPTQDLTIDTTVSRTQYQFTLQANSLDALSNWVPQLLSRLQSLPQLADVSSDWQDKGLAAYINVDRDSASRLGISMADVDNALYNAFGQRLISTIYTQANQYRVVLEHDTQATPGLAALDNIRLTSSDGGIVPLKSIASVEQRFTPLSVNHLDQFPVTTISFNVPDNYSLGEAVEAILSAEQSLDFPSDIRTQFQGSSLAFQSALGSTVWLVVAAVVAMYIVLGVLYESFIHPITILSTLPTAGVGALLALWLAGSELDVIAIIGIILLIGIVKKNAIMMIDFALAAEREQGMPPREAIYQACLLRFRPILMTTLAALLGALPLMLSTGVGAELRRPLGIGMVGGLMLSQVLTLFTTPVIYLLFDRLSLYMKSRFPRREEEA,MQVLPPSSTGGPSRLFIMRPVATTLLMVAILLAGIIGYRALPVSALPEVDYPTIQVVTLYPGASPDVMTSAVTAPLERQFGQMSGLKQMSSQSSGGASVITLQFQLTLPLDVAEQEVQAAINAATNLLPSDLPNPPVYSKVNPADPPIMTLAVTSTAMPMTQVEDMVETRVAQKISQISGVGLVTLSGGQRPAVRVKLNAQAIAALGLTSETVRTAITGANVNSAKGSLDGPSRAVTLSANDQMQSAEEYRQLIIAYQNGAPIRLGDVATVEQGAENSWLGAWANKEQAIVMNVQRQPGANIISTADSIRQMLPQLTESLPKSVKVTVLSDRTTNIRASVDDTQFELMMAIALVVMIIYLFLRNIPATIIPGVAVPLSLIGTFAVMVFLDFSINNLTLMALTIATGFVVDDAIVVIENISRYIEKGEKPLAAALKGAGEIGFTIISLTFSLIAVLIPLLFMGDIVGRLFREFAITLAVAILISAVVSLTLTPMMCARMLSQESLRKQNRFSRASEKMFDRIIAAYGRGLAKVLNHPWLTLSVALSTLLLSVLLWVFIPKGFFPVQDNGIIQGTLQAPQSSSFANMAQRQRQVADVILQDPAVQSLTSFVGVDGTNPSLNSARLQINLKPLDERDDRVQKVIARLQTAVDKVPGVDLFLQPTQDLTIDTQVSRTQYQFTLQATSLDALSTWVPQLMEKLQQLPQLSDVSSDWQDKGLVAYVNVDRDSASRLGISMADVDNALYNAFGQRLISTIYTQANQYRVVLEHNTENTPGLAALDTIRLTSSDGGVVPLSSIAKIEQRFAPLSINHLDQFPVTTISFNVPDNYSLGDAVQAIMDTEKTLNLPVDITTQFQGSTLAFQSALGSTVWLIVAAVVAMYIVLGILYESFIHPITILSTLPTAGVGALLALLIAGSELDVIAIIGIILLIGIVKKNAIMMIDFALAAEREQGMSPREAIYQACLLRFRPILMTTLAALLGALPLMLSTGVGAELRRPLGIGMVGGLIVSQVLTLFTTPVIYLLFDRLALWTKSRFARHEEEA,100,gnl|BL_ORD_ID|757|hsp_num:0,820,FALSE,None
LK894,15_94 # 111222 # 114299 # 1 # ID=15_94;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.590,15_94,111222,114299,+,Strict,1800,1868.59,mdtC,92,3000794,protein homolog model,n/a,n/a,aminocoumarin antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,GTGAAGTTCTTCGCTCTCTTCATTTATCGGCCGGTGGCGACGATTCTTATCTCGCTGGCGATTACCCTATGCGGGATCCTCGGATTCCGCCTGCTGCCGGTCGCACCGCTGCCGCAGGTGGATTTCCCGGTGATCATGATTAGCGCCTCGCTGCCCGGCGCCTCGCCGGAAACCATGGCCTCGTCGGTGGCAACACCGCTGGAACGCTCGCTGGGGCGCATTGCCGGGGTCAATGAAATGACCTCGTCGAGCTCGCTTGGCAGTACCCGCATCATCATGGAGTTTAATTTCGATCGCGATATTAACGGCGCTGCCCGCGACGTGCAGGCGGCGATTAATGCCGCGCAAAGTTTGCTGCCGAGCGGGATGCCCAGCCGCCCCACGTATCGCAAAGCTAATCCGTCCGATGCGCCGATCATGATCCTGACGCTCACCTCGGATACCTATTCGCAAGGCGAGTTGTACGATTTCGCGTCAACCCAGCTGGCGCAAACCATCGCGCAGATTGACGGCGTCGGCGATGTCGACGTCGGCGGCAGCTCACTGCCGGCGGTGCGCGTCGACCTTAACCCGCAGGCGCTATTTAACCAGGGCGTCTCACTGGACGCCGTGCGCAGCGCCATTGATAACGCCAACGTGCGTCGCCCGCAGGGCGCGCTGGAAGATAAGACCCACCGCTGGCAGGTGCAGACCAACGATGAATTGAAAACCGCGGCGGAATATTTGCCGGTGATCGTCCACTACAATAACGGCGCGGCGGTACGCCTTGGCGACGTGGCAAAAGTGACGGATTCAGTGCAGGATGTGCGTAACGCCGGGATGACCAACGCCAAACCGGCGATCCTGTTGATGATCCGCAAGCTGCCGGAAGCCAACATCATTCAGACGGTTGATAGCATTCGCGCCCGCCTGCCGGAACTACAGCGTACCATCCCCGCCGCCATTGACTTACAGATTGCGCAGGATCGTTCGCCCACTATCCGCGCATCGCTGGAAGAGGTCGAACAAACGCTGGTGATTTCGGTCGCGCTGGTGATTCTGGTGGTCTTTCTGTTTTTGCGCTCCGGGCGCGCAACGCTTATCCCGGCCGTCGCCGTGCCGGTATCGTTAATCGGTACCTTTGCCGCGATGTATTTGTGCGGCTTCAGCCTCAATAATCTGTCGTTAATGGCGCTGACCATCGCCACCGGTTTCGTCGTCGACGACGCCATCGTGGTGCTGGAGAATATTTCCCGCCATCTTGAGGCGGGAATGAAACCGCTGCAGGCCGCGTTACAGGGCAGCCGTGAAGTCGGCTTTACCGTGCTGTCGATGAGCCTGTCGCTGGTGGCGGTGTTCTTACCGCTGCTGCTGATGGGCGGCCTGCCGGGTCGTCTGCTGCGCGAGTTCGCCGTCACGCTATCGGTAGCGATCGGTATTTCGCTCGCCGTGTCGCTCACGCTGACGCCAATGATGTGCGGCTGGCTGCTGAAAAGCGGCAAACCTCATGAACCAACGCGCAAGCGTGGCTTTGGCCGCCTGCTGGTCACTATTCAGGGCGGCTATGGCAAATCGTTAAAATGGGTGCTGAAGCATAGTCGCCTGACTGGCCTGGTGCTGCTCGGTACGATGGCGCTCAGCGTGTGGCTGTATATCGCCATTCCGAAAACCTTCTTCCCGGAGCAGGACACCGGGGTGCTGATGGGCGGCATTCAGGCGGATCAGAGTATTTCGTTCCAGGCGATGCGCGGCAAACTGCAGGACTTTATGAAGATCATCCGCGAGGATCCGGCGGTCGATAACGTGACCGGTTTTACCGGCGGCTCGCGGGTGAATAGCGGTATGATGTTTATCACCCTGAAACCGCGCGATCAGCGCCACGAAACGGCGCAGCAAATCATCGACCGGCTGCGGAAAAAACTGGCGAAAGAGCCCGGCGCTAATCTGTTCCTGATGGCGGTGCAGGATATCCGCGTTGGCGGACGTCAGTCGAACGCCAGCTATCAGTACACCCTGTTATCGGACGATCTGTCGGCGCTGCGTGAATGGGAGCCAAAAATCCGCAAGGCGCTGGCGGCGCTCCCGGAACTGGCCGACGTTAACTCGGATCAGCAAGATAATGGCGCGGAGATGGATCTGGTCTACGACCGCGACACCATGTCACGCCTGGGCGTCAGCGTGCAGGATGCCAACAGCCTGTTAAACAACGCTTTCGGCCAGCGGCAGATCTCGACCATCTATCAACCTTTGAACCAGTACAAAGTGGTGATGGAAGTCGATCCGCTTTATACCCAGGACGTTAGCGCGCTGGAGCAAATGTTTGTCATTAGTAACGACGGTAAACCCATCCCGCTGTCATACTTCGCCAAATGGCAACCGGCGAATGCACCGCTTTCGGTCAACCACCAGGGGCTATCGGCCGCCTCGACCATCTCCTTCAACCTGCCGACCGGCAAATCGCTGTCGGAAGCCAGCGACGCCATTGACCGGGCGATGACCCAGCTTGGCGTGCCGTCGAGCGTGCGAGGATCGTTTGCCGGCACCGCACAGGTATTCCAGCAGACGATGAACTCACAGGTGATCCTGATTATCGCCGCCATCGCCACGGTGTATATCGTGCTGGGGATCCTCTACGAAAGCTACGTGCATCCGTTAACCATTCTCTCAACCCTTCCGTCAGCGGGGGTTGGCGCGCTGCTGGCGCTGGAATTATTTGGCGCCCCATTCAGCCTAATCGCCCTGATAGGGATCATGCTATTAATTGGCATCGTAAAGAAAAACGCCATCATGATGGTCGATTTCGCCCTTGAAGCGCAGCGTACCGGCAATCTTCGGCCGGAAGAAGCGATATTCCAGGCCTGTTTGCTGCGTTTTCGCCCGATCATGATGACCACCCTGGCGGCGCTATTCGGCGCGCTGCCGCTGGTGCTATCGGGCGGCGACGGGTCCGAACTGCGGCAGCCGTTGGGGATCACCATTGTCGGTGGTCTGGTCATGAGCCAGCTGCTGACGCTGTACACCACCCCGGTGGTCTATTTGTTCTTTGATCGTTTGCGGCTGCGTTTTACGCGCAAGCCAGCTCAACCGGTAAGCGAATAA,MKFFALFIYRPVATILISLAITLCGILGFRLLPVAPLPQVDFPVIMISASLPGASPETMASSVATPLERSLGRIAGVNEMTSSSSLGSTRIIMEFNFDRDINGAARDVQAAINAAQSLLPSGMPSRPTYRKANPSDAPIMILTLTSDTYSQGELYDFASTQLAQTIAQIDGVGDVDVGGSSLPAVRVDLNPQALFNQGVSLDAVRSAIDNANVRRPQGALEDKTHRWQVQTNDELKTAAEYLPVIVHYNNGAAVRLGDVAKVTDSVQDVRNAGMTNAKPAILLMIRKLPEANIIQTVDSIRARLPELQRTIPAAIDLQIAQDRSPTIRASLEEVEQTLVISVALVILVVFLFLRSGRATLIPAVAVPVSLIGTFAAMYLCGFSLNNLSLMALTIATGFVVDDAIVVLENISRHLEAGMKPLQAALQGSREVGFTVLSMSLSLVAVFLPLLLMGGLPGRLLREFAVTLSVAIGISLAVSLTLTPMMCGWLLKSGKPHEPTRKRGFGRLLVTIQGGYGKSLKWVLKHSRLTGLVLLGTMALSVWLYIAIPKTFFPEQDTGVLMGGIQADQSISFQAMRGKLQDFMKIIREDPAVDNVTGFTGGSRVNSGMMFITLKPRDQRHETAQQIIDRLRKKLAKEPGANLFLMAVQDIRVGGRQSNASYQYTLLSDDLSALREWEPKIRKALAALPELADVNSDQQDNGAEMDLVYDRDTMSRLGVSVQDANSLLNNAFGQRQISTIYQPLNQYKVVMEVDPLYTQDVSALEQMFVISNDGKPIPLSYFAKWQPANAPLSVNHQGLSAASTISFNLPTGKSLSEASDAIDRAMTQLGVPSSVRGSFAGTAQVFQQTMNSQVILIIAAIATVYIVLGILYESYVHPLTILSTLPSAGVGALLALELFGAPFSLIALIGIMLLIGIVKKNAIMMVDFALEAQRTGNLRPEEAIFQACLLRFRPIMMTTLAALFGALPLVLSGGDGSELRQPLGITIVGGLVMSQLLTLYTTPVVYLFFDRLRLRFTRKPAQPVSE,MKFFALFIYRPVATILLSVAITLCGILGFRMLPVAPLPQVDFPVIIVSASLPGASPETMASSVATPLERSLGRIAGVSEMTSSSSLGSTRIILQFDFDRDINGAARDVQAAINAAQSLLPSGMPSRPTYRKANPSDAPIMILTLTSDTYSQGELYDFASTQLAPTISQIDGVGDVDVGGSSLPAVRVGLNPQALFNQGVSLDDVRTAVSNANVRKPQGALEDGTHRWQIQTNDELKTAAEYQPLIIHYNNGGAVRLGDVATVTDSVQDVRNAGMTNAKPAILLMIRKLPEANIIQTVDSIRAKLPELQETIPAAIDLQIAQDRSPTIRASLEEVEQTLIISVALVILVVFLFLRSGRATIIPAVSVPVSLIGTFAAMYLCGFSLNNLSLMALTIATGFVVDDAIVVLENIARHLEAGMKPLQAALQGTREVGFTVLSMSLSLVAVFLPLLLMGGLPGRLLREFAVTLSVAIGISLLVSLTLTPMMCGWMLKASKPREQKRLRGFGRMLVALQQGYGKSLKWVLNHTRLVGVVLLGTIALNIWLYISIPKTFFPEQDTGVLMGGIQADQSISFQAMRGKLQDFMKIIRDDPAVDNVTGFTGGSRVNSGMMFITLKPRDERSETAQQIIDRLRVKLAKEPGANLFLMAVQDIRVGGRQSNASYQYTLLSDDLAALREWEPKIRKKLATLPELADVNSDQQDNGAEMNLVYDRDTMARLGIDVQAANSLLNNAFGQRQISTIYQPMNQYKVVMEVDPRYTQDISALEKMFVINNEGKAIPLSYFAKWQPANAPLSVNHQGLSAASTISFNLPTGKSLSDASAAIDRAMTQLGVPSTVRGSFAGTAQVFQETMNSQVILIIAAIATVYIVLGILYESYVHPLTILSTLPSAGVGALLALELFNAPFSLIALIGIMLLIGIVKKNAIMMVDFALEAQRHGNLTPQEAIFQACLLRFRPIMMTTLAALFGALPLVLSGGDGSELRQPLGITIVGGLVMSQLLTLYTTPVVYLFFDRLRLRFSRKPKQTVTE,100,gnl|BL_ORD_ID|1212|hsp_num:0,1315,FALSE,None
LK894,15_97 # 117164 # 117886 # 1 # ID=15_97;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.553,15_97,117164,117886,+,Strict,450,460.299,baeR,93.75,3000828,protein homolog model,n/a,n/a,aminoglycoside antibiotic; aminocoumarin antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGAGCGAATTACCTATTGATGAAAACACGCCGCGCATTTTAATCGTGGAAGACGAGCCCAAACTCGGTCAGTTGTTGATCGACTATTTGCAAGCTGCGAGCTATGCGCCAACGCTCATTGCGCATGGCGATCAGGTACTGCCCTACGTCCGCCAGACGCCCCCGCATTTGATCCTGCTGGATTTAATGCTGCCGGGCACTGACGGCCTGACCCTGTGCCGCGAAATCCGCCGATTTTCCGAGATACCGATTGTGATGGTCACTGCCAAAATCGAGGAGATCGATCGCCTGCTGGGGCTGGAAATCGGCGCCGATGACTATATCTGCAAACCGTACAGCCCGCGTGAAGTCGTGGCCCGTGTGAAGACGATCCTGCGTCGCTGTAAACCACAGCGCGACCTGCAGGCTCTGGATGCGCAAAGTCCGCTAATTGTTGACGAAAGCCGCTTCCAGGCCTCGTGGCGCGAAAAAATGCTGGACCTGACTCCCGCCGAGTTTCGGCTATTAAAAACGCTGTCGCAGGAGCCGGGTAAAGTCTTCTCCCGTGAACAACTGCTCAATCATCTGTACGACGATTATCGCGTAGTTACCGACCGTACCATCGACAGCCATATTAAAAATCTGCGCCGTAAGCTGGAATCGCTGGACGCGGAGCAGTCGTTTATTCGCGCCGTCTACGGCGTTGGCTATCGCTGGGAAGCCGACGCCTGTAGAATGGCTTGA,MSELPIDENTPRILIVEDEPKLGQLLIDYLQAASYAPTLIAHGDQVLPYVRQTPPHLILLDLMLPGTDGLTLCREIRRFSEIPIVMVTAKIEEIDRLLGLEIGADDYICKPYSPREVVARVKTILRRCKPQRDLQALDAQSPLIVDESRFQASWREKMLDLTPAEFRLLKTLSQEPGKVFSREQLLNHLYDDYRVVTDRTIDSHIKNLRRKLESLDAEQSFIRAVYGVGYRWEADACRMA,MTELPIDENTPRILIVEDEPKLGQLLIDYLRAASYAPTLISHGDQVLPYVRQTPPDLILLDLMLPGTDGLTLCREIRRFSDIPIVMVTAKIEEIDRLLGLEIGADDYICKPYSPREVVARVKTILRRCKPQRELQQQDAESPLIIDEGRFQASWRGKMLDLTPAEFRLLKTLSHEPGKVFSREQLLNHLYDDYRVVTDRTIDSHIKNLRRKLESLDAEQSFIRAVYGVGYRWEADACRIV,100,gnl|BL_ORD_ID|1231|hsp_num:0,1337,FALSE,None
LK894,17_8 # 6630 # 8168 # -1 # ID=17_8;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=3-4bp;gc_cont=0.596,17_8,6630,8168,-,Strict,700,941.799,Klebsiella pneumoniae KpnH,94.62,3004597,protein homolog model,n/a,n/a,macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; cephalosporin; penam; peptide antibiotic; penem,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGCAACAGCAAAAACCGCTCGAAGGCGCGCAACTGGTCATCATGACCATTGCGCTGTCGCTGGCGACTTTCATGCAGGTGCTGGACTCCACTATCGCCAACGTGGCTATTCCGACCATTGCCGGTAACCTTGGCTCGTCGCTGAGTCAGGGAACCTGGGTCATCACCTCGTTTGGGGTGGCGAACGCTATCTCCATCCCGATTACCGGCTGGCTGGCGAAGCGCGTCGGCGAAGTGAAACTCTTCGTCTGGTCGACGGTGGCATTCGCCATCGCCTCCTGGGCCTGCGGGGTGTCGAACAGCCTGACGATGCTGATTTTCTTCCGCGTGATTCAGGGGATCGTCGCCGGTCCGCTGATCCCGCTATCGCAGAGTCTACTGCTCAGCAACTACCCGCCAGCGAAACGCTCAATCGCGCTGGCGCTGTGGTCAATGACGGTCATCGTCGCGCCGATTTGCGGCCCGATTCTCGGCGGCTATATCAGCGATAACTACCACTGGGGCTGGATCTTCTTCATCAACGTGCCGATTGGCGTGGCGGTGGTTCTCATGACGCTGCAGACCCTGCGTGGCCGCGAAACCCGCACCGAACAGCGGCGTATCGACGGCGTCGGGCTGGCGTTGCTGATTATCGGGATCGGTAGCCTGCAGGTGATGCTCGACCGCGGTAAAGAACTCGACTGGTTCGCTTCCAACGAGATTATCATCCTGACCATCGTGGCGGTGGTGGCGATAAGTTTCCTTATCGTCTGGGAGCTGACCGACGATAACCCGATAGTCGACCTGTCGCTGTTTAAGTCGCGTAACTTTACCATCGGCTGTTTGTGTATCAGCCTGGCCTATATGCTCTACTTCGGCGCCATTGTATTGCTGCCGCAGCTTCTGCAGGAGGTATACGGCTACACCGCCACCTGGGCCGGTTTGGCTTCGGCGCCGGTCGGAGTGATCCCGGTCATTCTGTCGCCGATTATCGGCCGCTTTGCTCATAAGCTCGATATGCGGCGGCTGGTGACCTTCAGCTTTATTATGTATGCGGTGTGCTTCTACTGGCGCGCGTGGACCTTTGAACCGGGAATGGACTTCGGCGCATCGGCCTGGCCGCAGTTTATCCAGGGTTTTGCGGTGGCCTGTTTCTTCATGCCGCTGACCACCATCACTCTCTCTGGCCTCCCGCCGGAGCGGCTGGCGGCGGCGTCGAGCTTGTCGAACTTTACCCGAACCCTTGCCGGCTCCATCGGTACCTCAATTACCACCACCATGTGGACCAACCGCGAGGCGTTGCACCATGCGCAGCTCACCGAGTCGGTGACGCCGTTCAACCCCAACGCCCAGCAGATGTACGATCAGCTGCAGGGTATGGGAATGACCCAGCAGCAGGCTTCCGGCTGGATTGCCCAGCAGATAACCAACCAGGGGTTGATTATCTCCGCCAACGAAATCTTCTGGGTTTCGGCGGGGATCTTTATCCTTCTGCTAGGCCTGGTGTGGTTCGCCAGGCCGCCGTTCAGCGCCGGCGGCGGTGGCGGGGGCGCGCACTAA,MQQQKPLEGAQLVIMTIALSLATFMQVLDSTIANVAIPTIAGNLGSSLSQGTWVITSFGVANAISIPITGWLAKRVGEVKLFVWSTVAFAIASWACGVSNSLTMLIFFRVIQGIVAGPLIPLSQSLLLSNYPPAKRSIALALWSMTVIVAPICGPILGGYISDNYHWGWIFFINVPIGVAVVLMTLQTLRGRETRTEQRRIDGVGLALLIIGIGSLQVMLDRGKELDWFASNEIIILTIVAVVAISFLIVWELTDDNPIVDLSLFKSRNFTIGCLCISLAYMLYFGAIVLLPQLLQEVYGYTATWAGLASAPVGVIPVILSPIIGRFAHKLDMRRLVTFSFIMYAVCFYWRAWTFEPGMDFGASAWPQFIQGFAVACFFMPLTTITLSGLPPERLAAASSLSNFTRTLAGSIGTSITTTMWTNREALHHAQLTESVTPFNPNAQQMYDQLQGMGMTQQQASGWIAQQITNQGLIISANEIFWVSAGIFILLLGLVWFARPPFSAGGGGGGAH,MQQQKPLEGAQLVIMTIALSLATFMQVLDSTIANVAIPTIAGNLGSSLSQGTWVITSFGVANAISIPLTGWLAKRVGEVKLFLWSTIAFAIASWACGVSSSLNMLIFFRVIQGIVAGPLIPLSQSLLLNNYPPAKRSIALALWSMTVIVAPICGPILGGYISDNYHWGWIFFINVPIGVAVVLMTLQTLRGRETRTERRRIDAVGLALLVIGIGSLQIMLDRGKELDWFSSQEIIILTVVAVVAICFLIVWELTDDNPIVDLSLFKSRNFTIGCLCISLAYMLYFGAIVLLPQLLQEVYGYTATWAGLASAPVGIIPVILSPIIGRFAHKLDMRRLVTFSFIMYAVCFYWRAYTFEPGMDFGASAWPQFIQGFAVACFFMPLTTITLSGLPPERLAAASSLSNFTRTLAGSIGTSITTTMWTNRESMHHAQLTESVNPFNPNAQAMYSQLEGLGMTQQQASGWIAQQITNQGLIISANEIFWMSAGIFLILLGLVWFAKPPFGAGGGGGGAH,100,gnl|BL_ORD_ID|2734|hsp_num:0,3299,FALSE,None
LK894,17_9 # 8184 # 9356 # -1 # ID=17_9;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.587,17_9,8184,9356,-,Strict,700,738.028,Klebsiella pneumoniae KpnG,93.85,3004588,protein homolog model,n/a,n/a,macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; cephalosporin; penam; peptide antibiotic; penem,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGAGCGAAAATGCGGCGAGCCAAACTCCGCAGCAATCAGGCAGCAAGAAAGGGAAACGCAAAGGCGCCCTTCTGCTCCTGACCTTGCTCTTTGTTATTGTGGCCGTAGCCTACGGCATTTATTGGTTTTTAGTCCTGCGTCATTATGAAGAGACCGATGACGCTTATGTGGCAGGGAACCAGGTACAGATCATGGCGCAGGTTTCCGGCAGCGTGACTAAGGTCTGGGCCGACAACACCGACTTTGTGCAACAAGGCGATCCGCTGGTCACCCTTGACCAGACCGACGCCCAGCAGGCGTTTGAAAAAGCCAAAACCCAGCTGGCGGCAAGCGTGCGCCAGACTCGCCAGCAGATGATCAACAGCAAGCAGCTGCAGGCGAATATTGACGTCAAAAAAACCGCCCTCGCCCAGGCGCAGGCAGACCTTAATCGTCGTATCCCGCTGGGTGCCGCGAACCTGATTGGCCGCGAAGAGCTGCAGCACGCACGTGACACCGTCGCCAGCGCGCAGGCCGAACTCGACGTCGCCATTCAACAGTACAACGCCAATCAGGCAATCGTACTGGGCACCAAACTGGAACAGCAGCCGGCGGTGCTGCAGGCGGCGACCGAAGTCCGCAACGCCTGGCTGGCGCTGCAGCGTACGCAAATCGTCAGCCCGATTAGCGGCTACGTTTCTCGCCGCTCGGTGCAGCCTGGCGCGCAGATCGGTACCACTACCCCGCTGATGGCGGTGGTTCCAGCCACCAACCTGTGGGTTGACGCCAACTTTAAAGAGACCCAGCTCGCCCATATGCGTATCGGCCAGCCGGCGACCATCGTCAGCGATATCTACGGCGATGACGTGAAGTACACCGGTAAAGTGGTCGGCCTGGATATGGGTACCGGCAGCGCCTTCTCCCTGCTGCCGGCGCAAAACGCCACCGGTAACTGGATCAAAGTCGTCCAGCGTCTGCCGGTTCGTATCGAGATAGATGCTAAACAGCTGGCGCAACATCCGCTGCGCATCGGCCTGTCGACGCTGGTTGAAGTAGACACCAGCAATCGCGAAGGCGAGATGCTGGCAAGCCAGGTACGAAGCTCGCCGGTCTATGAAAGTAATGCCCGTGAAATCGGCCTTGAGCCGGTGAATAAACTGATCGACGGTATCATCCAGGCCAACGCCGGATAA,MSENAASQTPQQSGSKKGKRKGALLLLTLLFVIVAVAYGIYWFLVLRHYEETDDAYVAGNQVQIMAQVSGSVTKVWADNTDFVQQGDPLVTLDQTDAQQAFEKAKTQLAASVRQTRQQMINSKQLQANIDVKKTALAQAQADLNRRIPLGAANLIGREELQHARDTVASAQAELDVAIQQYNANQAIVLGTKLEQQPAVLQAATEVRNAWLALQRTQIVSPISGYVSRRSVQPGAQIGTTTPLMAVVPATNLWVDANFKETQLAHMRIGQPATIVSDIYGDDVKYTGKVVGLDMGTGSAFSLLPAQNATGNWIKVVQRLPVRIEIDAKQLAQHPLRIGLSTLVEVDTSNREGEMLASQVRSSPVYESNAREIGLEPVNKLIDGIIQANAG,MSANAESQTPQQPGSKKGKRKGALLLLTLLFIIIAVAYGIYWFLVLRHYEETDDAYVAGNQVQIMAQVAGSVTKVWADNTDYVQKGDPLVTLDRTDAQQAFEKAKTQLAASVRQTRQQMINSKQLQANIDVKKTALSQAQADLNRRIPLGAANLIGREELQHARDTVASAQAELDVAIQQYNANQAIVLGTRLEQQPAVLQAATEVRNAWLALQRTQIVSPISGYVSRRSVQPGAQIGTTTPLMAVVPATNLWIDANFKETQLAHMRIGQPATVISDIYGDDVKYTGKVVGLDMGTGSAFSLLPAQNATGNWIKVVQRLPVRIELDEKQLAEHPLRIGLSTLVEVNTTDRDGEMLASQVRSSPVYESNAREIALDPVNKLIDEIIQANAG,100,gnl|BL_ORD_ID|2733|hsp_num:0,3298,FALSE,None
LK894,17_10 # 9488 # 10018 # -1 # ID=17_10;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.531,17_10,9488,10018,-,Strict,280,335.109,emrR,93.57,3000516,protein homolog model,n/a,n/a,fluoroquinolone antibiotic,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGGATAGTTCGTTTACTCCCATTGAGCAGATGCTCAAATTCCGCGCCAGCCGCCATGAAGATTTCCCTTTCCAGGAGATTCTCCTCACCCGTCTCTGTATGCACATGCAGGGTAAGCTGCTGGAAAACCGTAACAAAATGCTGAAAGCGCAAGGGATTAACGAGACATTATTTATGGCGCTGATAACGCTTGAGTCTCAGGAAAATCACAGCATTCAACCTTCCGAGCTGAGCTGCGCGCTGGGTTCGTCACGCACTAATGCCACCCGCATCGCCGACGAACTGGAAAAACGCGGCTGGATCGAACGTCGTGAAAGCGACAACGATCGTCGCTGCCTGCACCTGCAGCTGACCGACAAAGGTCATCAATTCTTGCGCGAGGTATTACCTCCGCAGCACAACTGTCTACACCAGCTGTGGTCTTCTTTAAGCACCGCGGAAAAAGACCAGCTGGAGCACATCACCCGTAAACTGCTTGGCCGCCTCGACCAAATGGAAGAAGACGGCGCGCTGGCGGGATCCCTGCGCTAA,MDSSFTPIEQMLKFRASRHEDFPFQEILLTRLCMHMQGKLLENRNKMLKAQGINETLFMALITLESQENHSIQPSELSCALGSSRTNATRIADELEKRGWIERRESDNDRRCLHLQLTDKGHQFLREVLPPQHNCLHQLWSSLSTAEKDQLEHITRKLLGRLDQMEEDGALAGSLR,MDSSFTPIEQMLKFRASRHEDFPYQEILLTRLCMHMQSKLLENRNKMLKAQGINETLFMALITLESQENHSIQPSELSCALGSSRTNATRIADELEKRGWIERRESDNDRRCLHLQLTEKGHEFLREVLPPQHNCLHQLWSALSTTEKDQLEQITRKLLSRLDQMEQDGVVLEAMS,100,gnl|BL_ORD_ID|1225|hsp_num:0,1330,FALSE,None
LK894,23_30 # 30111 # 30530 # 1 # ID=23_30;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.610,23_30,30111,30530,+,Strict,200,275.789,fosA5,94.96,3003209,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; aminoglycoside antibiotic; phosphonic acid antibiotic,antibiotic inactivation,fosfomycin thiol transferase,ATGTTGAGCGGATTAAATCATCTGACCCTGGCGGTCAGCCAGCTGGCGCCGAGCGTGGCGTTTTATCATCAGCTACTCGGCATGACGCTGCACGCGCGCTGGGATAGCGGCGCGTATCTTTCCTGCGGCGATCTGTGGCTGTGCCTGTCGCTGGATCCGCAGCGGCGCGTCACTCCGCCGGAGGAGAGCGACTACACCCATTATGCGTTTAGCATCAGCGAGGCGGATTTCGCCAGCTTTGCCGCCCGTCTTGAGGTCGCTGGCGTAGCGGTATGGAAGCTAAACCGTAGCGAAGGCGAATCGCACTATTTCCTCGACCCCGACGGCCACAAGCTGGAGCTACATGTTGGCAACCTCGCCCAGCGCCTGGTCGCCTGCCGCGAGCAGCCGTATAAGGGGATGGTGTTTTTTGGCGAGTGA,MLSGLNHLTLAVSQLAPSVAFYHQLLGMTLHARWDSGAYLSCGDLWLCLSLDPQRRVTPPEESDYTHYAFSISEADFASFAARLEVAGVAVWKLNRSEGESHYFLDPDGHKLELHVGNLAQRLVACREQPYKGMVFFGE,MLSGLNHLTLAVSQLAPSVAFYQQLLGMMLHARWDSGAYLSCGDLWLCLSLDPQRRVTPPEESDYTHYAFSISEADFASFAARLEAAGVAVWKLNRSEGASHYFLDPDGHKLELHVGSLAQRLAACREQPYKGMVFFAE,100,gnl|BL_ORD_ID|151|hsp_num:0,112,FALSE,None
LK894,25_1 # 657 # 842 # -1 # ID=25_1;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.468,25_1,657,842,-,Strict,100,109.383,rsmA,85.25,3005069,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGCTGATTCTGACTCGTCGAGTTGGTGAGACCCTCATGATTGGAGATGAGGTCACTGTGACAGTTTTAGGGGTTAAGGGTAACCAGGTACGTATTGGTGTCAACGCCCCTAAAGAAGTCTCTGTACATCGTGAAGAAATCTACCAGCGTATCCAGGCTGAAAAATCCCAGCAGTCCAGTTACTAA,MLILTRRVGETLMIGDEVTVTVLGVKGNQVRIGVNAPKEVSVHREEIYQRIQAEKSQQSSY,MLILTRRVGETLMVGDDVTVTVLGVKGNQVRIGVNAPKEVAVHREEIYQRIQKEKDQEPNH,100,gnl|BL_ORD_ID|2794|hsp_num:0,3807,FALSE,None
LK894,11_30 # 33515 # 35281 # 1 # ID=11_30;partial=00;start_type=ATG;rbs_motif=AGGA/GGAG/GAGG;rbs_spacer=11-12bp;gc_cont=0.564,11_30,33515,35281,+,Strict,500,595.119,Haemophilus influenzae PBP3 conferring resistance to beta-lactam antibiotics,52.02,3004446,protein variant model,"D350N, S357N",n/a,cephalosporin; cephamycin; penam,antibiotic target alteration,Penicillin-binding protein mutations conferring resistance to beta-lactam antibiotics,ATGAAAGCAGCGCCGAAAACGCCAAAAGCAAAACGTCAGGAAGAACAGGCCAACTTTATTAGTTGGCGTTTTGCGTTGCTGTGCGGATGTATTTTAATCGCTCTCGCCTTCCTGCTTGGCCGCGTCGCGTGGCTGCAGGTGGTGAGCCCGGATATGCTGGTGCGTCAGGGAGATATGCGTTCCCTTCGTGTGCAGGAAGTGTCAACCGCGCGCGGCATGATTACCGACCGCTCCGGCCGCCCGCTGGCGGTCAGCGTGCCGGTAAAAGCCATCTGGGCCGACCCGAAAGAGCTGCATGATGCCGGAGGCGTGACGCTCGATAACCGCTGGAAAGCGTTAGCCGATGCGCTGAACATGCCGCTGGACCAGCTGGCATCGCGCATCAACAGCAACCCGCGGATGCGTTTTATCTATCTGGCGCGTCAGGTGAACCCTGACATGGCTGACTACATCAAAAAACTGAAGCTGCCGGGGATTCATCTGCGTGAGGAGTCTCGCCGTTACTATCCGTCAGGCGAAGTAACCGCTCACCTCATTGGCTTCACCAACGTCGATAGCCAGGGGATTGAAGGGGTTGAGAAAAGCTTTGATAAGTGGCTGACCGGCCAGCCGGGCGAGCGTATCGTGCGTAAAGACCGCTATGGTCGCGTGATCGAAGACATTTCTTCCACCGACAGCCAGGCGGCGCATAACCTCGCGCTGAGCATCGACGAGCGCCTGCAGGCGCTGGTATATCGCGAACTGAATAATGCGGTGGCGTTCAACAAAGCGGAATCAGGCACCGCCGTTTTGGTTGACGTCAACACCGGTGAAGTGCTGGCGATGGCGAATAGCCCGTCGTACAACCCGAATAATTTCGCGGGTACGTCCAAAGATACCATGCGTAACCGCGCCATCACCGACGTATTCGAACCGGGTTCAACGGTCAAACCGATGGTGGTGATGACGGCGCTGCAGCGCGGCATCGTCAATGAAAATACCGTGCTGAACACCATTCCATATCGAATTAACGGCCACGAAATCAAAGACGTGGCGCGCTATAGCGAATTAACCCTGACCGGGGTGCTACAGAAGTCGAGTAACGTCGGCGTTTCTAAGCTGGCGTTAGCGATGCCGTCCTCAGCGTTAGTAGATACTTACTCACGTTTTGGGCTTGGAAAGGCGACCAATTTGGGGTTGGTCGGAGAACGCAGTGGCTTATATCCTCAAAAACAACGGTGGTCTGACATAGAGAGGGCCACCTTTTCTTTCGGCTACGGGCTAATGGTAACTCCGTTACAGTTAGCGCGAGTCTACGCAACGATTGGCAGCTACGGCATCTATCGCCCGCTGTCGATTACCAAAGTTGATCCACCGGTTCCGGGCGAGCGCGTGTTCCCGGAATCACTGGTTCGTACCGTCGTTCATATGATGGAAAGCGTGGCGCTGCCCGGCGGCGGCGGCGTGAAAGCGGCGATCAAAGGCTATCGCATCGCGATTAAAACCGGTACGGCGAAAAAAGTGGGGCCGGATGGCCGCTACATCAACAAATATATTGCTTACACCGCAGGCGTTGCGCCCGCCAGCCACCCGCGTTTCGCGCTGGTGGTGGTGATCAACGACCCGCAGGCAGGTAAATACTACGGTGGCGCCGTTTCCGCGCCGGTATTCGGTGCCATCATGGGCGGCGTATTGCGCACCATGAACGTCGAACCGGATGCGCTGGCAACGGGCGAAAAAAGTGAATTTGTGATTAATCAAGGCGAGGGAACAGGTGGCAGATCGTAA,MKAAPKTPKAKRQEEQANFISWRFALLCGCILIALAFLLGRVAWLQVVSPDMLVRQGDMRSLRVQEVSTARGMITDRSGRPLAVSVPVKAIWADPKELHDAGGVTLDNRWKALADALNMPLDQLASRINSNPRMRFIYLARQVNPDMADYIKKLKLPGIHLREESRRYYPSGEVTAHLIGFTNVDSQGIEGVEKSFDKWLTGQPGERIVRKDRYGRVIEDISSTDSQAAHNLALSIDERLQALVYRELNNAVAFNKAESGTAVLVDVNTGEVLAMANSPSYNPNNFAGTSKDTMRNRAITDVFEPGSTVKPMVVMTALQRGIVNENTVLNTIPYRINGHEIKDVARYSELTLTGVLQKSSNVGVSKLALAMPSSALVDTYSRFGLGKATNLGLVGERSGLYPQKQRWSDIERATFSFGYGLMVTPLQLARVYATIGSYGIYRPLSITKVDPPVPGERVFPESLVRTVVHMMESVALPGGGGVKAAIKGYRIAIKTGTAKKVGPDGRYINKYIAYTAGVAPASHPRFALVVVINDPQAGKYYGGAVSAPVFGAIMGGVLRTMNVEPDALATGEKSEFVINQGEGTGGRS,MVKFNSSRKSGKSKKTIRKLTAPETVKQNKPQKVFEKCFMRGRYMLSTVLILLGLCALVARAAYVQSINADTLSNEADKRSLRKDEVLSVRGSILDRNGQLLSVSVPMSAIVADPKTMLKENSLADKERIAALAEELGMTENDLVKKIEKNSKSGYLYLARQVELSKANYIRRLKIKGIILETEHRRFYPRVEEAAHVVGYTDIDGNGIEGIEKSFNSLLVGKDGSRTVRKDKRGNIVAHISDEKKYDAQDVTLSIDEKLQSMVYREIKKAVSENNAESGTAVLVDVRTGEVLAMATAPSYNPNNRVGVKSELMRNRAITDTFEPGSTVKPFVVLTALQRGVVKRDEIIDTTSFKLSGKEIVDVAPRAQQTLDEILMNSSNRGVSRLALRMPPSALMETYQNAGLSKPTDLGLIGEQVGILNANRKRWADIERATVAYGYGITATPLQIARAYATLGSFGVYRPLSITKVDPPVIGKRVFSEKITKDIVGILEKVAIKNKRAMVEGYRVGVKTGTARKIENGHYVNKYVAFTAGIAPISDPRYALVVLINDPKAGEYYGGAVSAPVFSNIMGYALRANAIPQDAEAAENTTTKSAKRIVYIGEHKNQKVN,96.39,gnl|BL_ORD_ID|2497|hsp_num:0,2886,FALSE,None
LK894,16_83 # 87691 # 89082 # 1 # ID=16_83;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.575,16_83,87691,89082,+,Strict,850,865.144,Escherichia coli UhpT with mutation conferring resistance to fosfomycin,95.25,3003890,protein variant model,E350Q,n/a,phosphonic acid antibiotic,antibiotic target alteration,antibiotic-resistant UhpT,ATGCTGGCCTTTCTGAATCAGGTGCGCAAGCCGACCCTGGATCTGCCGCTCGATGTGCGGCGCAAAATGTGGTTCAAACCTTTCATGCAGTCCTATCTGGTGGTCTTCATCGGCTACCTGACCATGTACCTGATCCGCAAAAACTTTAACATCGCGCAGAACGACATGATCTCCACCTACGGGTTGAGCATGACGCAGCTGGGGATGATTGGCCTGGGCTTTTCCATTACCTACGGCGTGGGCAAGACGCTCGTCTCTTATTATGCCGACGGTAAAAATACCAAGCAGTTCCTGCCGTTTATGCTGATCCTCTCCGCCATCTGTATGCTGGGCTTTAGCGCCAGCATGGGGGCGGGTTCAACCAGCCTGTTCCTGATGATCGCCTTCTATGCGCTGAGCGGTTTCTTCCAGAGCACCGGCGGTTCGTGCAGCTATTCCACCATCACCAAGTGGACGCCCAGACGCAAACGCGGCACCTTCCTCGGCTTCTGGAATATCTCCCACAACCTCGGCGGCGCGGGTGCGGCGGGCGTGGCGCTGTTTGGCGCCAACTATCTGTTCGACGGCCATGTGATAGGCATGTTTATCTTCCCGTCGATTATTGCGCTGATCGTCGGCTTTATTGGCCTGCGCTACGGTAGCGACTCTCCGGAATCCTACGGCCTCGGCACGGCGGAAGAGCTGTTTGGCGAAGCGATCAGCGAAGAGGACAAAGAGACCGAAGAAAATGCGATGACCAAGTGGCAGATCTTTGTTGAGTACGTGCTGAAAAACAAAGTGATCTGGCTGCTGTGCTTCTCCAACATCTTCCTCTACGTGGTGCGTATCGGTATCGATCAGTGGTCCACCGTGTATGCCTTCCAGGAGCTGAAGCTGTCTAAAGAGGTGGCGATTCAGGGCTTTACTCTGTTTGAGGTCGGCGCGCTGGTCGGCACGCTACTGTGGGGCTGGTTGTCGGATCTGGCCAACGGCCGCCGCGCGCTGGTGGCCTGCATCGCGCTGGCGCTGATTATCGCCACCCTCGGGGTTTACCAACATGCCAGCAACCAGTACGTCTATCTGGCCTCGTTGTTTGCGCTGGGCTTCCTGGTGTTTGGTCCGCAGCTGTTGATCGGCGTCGCCGCCGTCGGTTTCGTACCGAAAAAAGCGATCGGCGCCGCCGATGGAATCAAGGGTACCTTCGCCTATCTGATCGGCGATAGCTTCGCCAAGCTGGGTCTTGGGATGATCGCCGACGGCACGCCGGTCTTCGGCCTGACCGGCTGGGCCGGCACCTTTGCGGCGCTGGACGCCGCCGCCATCGGCTGTATCTGCCTGATGGCCATCGTGGCTATCTTCGAAGAGCGTAAAATTCGCCGCGAGAAAAAGAATCGAGTTTTGCAGACTGCCTGA,MLAFLNQVRKPTLDLPLDVRRKMWFKPFMQSYLVVFIGYLTMYLIRKNFNIAQNDMISTYGLSMTQLGMIGLGFSITYGVGKTLVSYYADGKNTKQFLPFMLILSAICMLGFSASMGAGSTSLFLMIAFYALSGFFQSTGGSCSYSTITKWTPRRKRGTFLGFWNISHNLGGAGAAGVALFGANYLFDGHVIGMFIFPSIIALIVGFIGLRYGSDSPESYGLGTAEELFGEAISEEDKETEENAMTKWQIFVEYVLKNKVIWLLCFSNIFLYVVRIGIDQWSTVYAFQELKLSKEVAIQGFTLFEVGALVGTLLWGWLSDLANGRRALVACIALALIIATLGVYQHASNQYVYLASLFALGFLVFGPQLLIGVAAVGFVPKKAIGAADGIKGTFAYLIGDSFAKLGLGMIADGTPVFGLTGWAGTFAALDAAAIGCICLMAIVAIFEERKIRREKKNRVLQTA,MLAFLNQVRKPTLDLPLEVRRKMWFKPFMQSYLVVFIGYLTMYLIRKNFNIAQNDMISTYGLSMTQLGMIGLGFSITYGVGKTLVSYYADGKNTKQFLPFMLILSAICMLGFSASMGSGSVSLFLMIAFYALSGFFQSTGGSCSYSTITKWTPRRKRGTFLGFWNISHNLGGAGAAGVALFGANYLFDGHVIGMFIFPSIIALIVGFIGLRYGSDSPESYGLGKAEELFGEEISEEDKETESTDMTKWQIFVEYVLKNKVIWLLCFANIFLYVVRIGIDQWSTVYAFQELKLSKAVAIQGFTLFEAGALVGTLLWGWLSDLANGRRGLVACIALALIIATLGVYQHASNEYIYLASLFALGFLVFGPQLLIGVAAVGFVPKKAIGAADGIKGTFAYLIGDSFAKLGLGMIADGTPVFGLTGWAGTFAALDIAAIGCICLMAIVAVMEERKIRREKKIQQLTVA,100,gnl|BL_ORD_ID|2129|hsp_num:0,2373,FALSE,None
LK894,40_1 # 1 # 939 # 1 # ID=40_1;partial=11;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.537,40_1,1,939,+,Strict,700,631.713,Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin,98.4,3003369,protein variant model,R234F,n/a,elfamycin antibiotic,antibiotic target alteration,elfamycin resistant EF-Tu,CAGATCGATAACGCGCCGGAAGAAAAAGCTCGTGGTATCACCATCAACACTTCCCACGTTGAATATGACACCCCGACTCGCCACTACGCGCACGTAGACTGCCCGGGCCACGCCGACTATGTTAAAAACATGATCACCGGTGCTGCTCAGATGGATGGCGCGATCCTGGTTGTTGCTGCGACTGACGGCCCGATGCCGCAGACTCGTGAGCACATCCTGCTGGGTCGTCAGGTAGGCGTTCCGTACATCATCGTGTTCCTGAACAAATGCGACATGGTTGATGACGAAGAGCTGCTGGAACTGGTTGAGATGGAAGTTCGTGAACTGCTGTCTCAGTACGATTTCCCGGGCGACGACACTCCGATCGTTCGTGGTTCTGCTCTGAAAGCGCTGGAAGGCGACGCAGAGTGGGAAGCGAAAATCATCGAACTGGCTGGCTTCCTGGATTCTTATATCCCAGAACCAGAGCGTGCGATTGACAAGCCGTTCCTGCTGCCGATCGAAGACGTATTCTCCATCTCCGGTCGTGGTACCGTTGTTACCGGTCGTGTAGAGCGCGGTATCATCAAAGTTGGTGAAGAAGTTGAAATCGTTGGTATCAAAGACACCGCGAAAACCACCTGTACTGGCGTTGAAATGTTCCGCAAACTGCTGGACGAAGGCCGTGCTGGTGAGAACGTAGGCGTTCTGCTGCGTGGTATCAAACGTGAAGAAATCGAACGTGGTCAGGTACTGGCTAAGCCGGGCAGCATCAAGCCGCACACCAAGTTCGAATCTGAAGTGTACATCCTGTCCAAAGACGAAGGCGGCCGTCATACTCCGTTCTTCAAAGGCTACCGTCCGCAGTTCTACTTCCGTACTACTGACGTGACTGGTACCATCGAACTGCCGGAAGGCGTAGAGATGGTAATGCCGGGCGACAACATCAAAATGGTTGTT,QIDNAPEEKARGITINTSHVEYDTPTRHYAHVDCPGHADYVKNMITGAAQMDGAILVVAATDGPMPQTREHILLGRQVGVPYIIVFLNKCDMVDDEELLELVEMEVRELLSQYDFPGDDTPIVRGSALKALEGDAEWEAKIIELAGFLDSYIPEPERAIDKPFLLPIEDVFSISGRGTVVTGRVERGIIKVGEEVEIVGIKDTAKTTCTGVEMFRKLLDEGRAGENVGVLLRGIKREEIERGQVLAKPGSIKPHTKFESEVYILSKDEGGRHTPFFKGYRPQFYFRTTDVTGTIELPEGVEMVMPGDNIKMVV,MLSPEGESTIVRNIAVSKEKFERTKPHVNVGTIGHVDHGKTTLTAAITTVLAKTYGGAARAFDQIDNAPEEKARGITINTSHVEYDTPTRHYAHVDCPGHADYVKNMITGAAQMDGAILVVAATDGPMPQTREHILLGRQVGVPYIIVFLNKCDMVDDEELLELVEMEVRELLSQYDFPGDDTPIVRGSALKALEGDAEWEAKILELAGFLDSYIPEPERAIDKPFLLPIEDVFSISGRGTVVTGRVERGIIKVGEEVEIVGIKETQKSTCTGVEMFRKLLDEGRAGENVGVLLRGIKREEIERGQVLAKPGTIKPHTKFESEVYILSKDEGGRHTPFFKGYRPQFYFRTTDVTGTIELPEGVEMVMPGDNIKMVVTLIHPIAMDDGLRFAIREGGRTVGAGVVAKVLG,76.53,gnl|BL_ORD_ID|1970|hsp_num:0,2158,TRUE,loose hit with at least 95 percent identity pushed strict
LK894,2_407 # 413967 # 414401 # 1 # ID=2_407;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.510,2_407,413967,414401,+,Strict,210,246.514,Escherichia coli AcrAB-TolC with MarR mutations conferring resistance to ciprofloxacin and tetracycline,80.56,3003378,protein overexpression model,S3N,n/a,fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics,antibiotic target alteration; antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGGAAAACACCAACAATCTGTTCAACGAGATGATCCCTCTCGGCCGATTGATCCAGATGGTTAACCAGAAAAAAGATCGACTGCTCAACGACTACCTTTCACCCATGGATATCACCGCTACCCAATTTCGGGTGCTCTGTTCCATTCGCTGCGAGGTATGTACGACACCCGTTGAGCTGAAGACCGTTCTGTCGGTCGATCCAGGCGCAATGACGCGCATGCTCGACAGACTCGTCTGCAAAGGCTGGATAGAACGGTTGCCCAACCCCAATGACAAGCGCGGCATTCTGGTGCAACTGACTCCAGAAGGCGCAGCCCTTTGTGAGCACTGTCATCAGGTTGTGGGTCAAAAATTGCACCAGGAACTAACAAAAAATCTAACGGCAGACGAAGTGGTCATGCTTGAGCAACTGCTCAAGAAAGTCCTGCCGTAA,MENTNNLFNEMIPLGRLIQMVNQKKDRLLNDYLSPMDITATQFRVLCSIRCEVCTTPVELKTVLSVDPGAMTRMLDRLVCKGWIERLPNPNDKRGILVQLTPEGAALCEHCHQVVGQKLHQELTKNLTADEVVMLEQLLKKVLP,MKSTSDLFNEIIPLGRLIHMVNQKKDRLLNEYLSPLDITAAQFKVLCSIRCAACITPVELKKVLSVDLGALTRMLDRLVCKGWVERLPNPNDKRGVLVKLTTGGAAICEQCHQLVGQDLHQELTKNLTADEVATLEYLLKKVLP,100,gnl|BL_ORD_ID|1984|hsp_num:0,431,FALSE,None
LK894,21_18 # 20154 # 20483 # 1 # ID=21_18;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.509,21_18,20154,20483,+,Strict,200,204.142,Escherichia coli soxS with mutation conferring antibiotic resistance,91.59,3003511,protein overexpression model,n/a,n/a,fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; penem; disinfecting agents and antiseptics,antibiotic target alteration; antibiotic efflux; reduced permeability to antibiotic,ATP-binding cassette (ABC) antibiotic efflux pump; major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump; General Bacterial Porin with reduced permeability to beta-lactams,ATGTCCCATCAGGATATTATCCAAACGCTTATTGAATGGATTGATGAACATATCGATCAACCACTTAACATTGATGTAGTCGCTAAAAAATCGGGATACTCGAAATGGTATCTGCAGCGGATGTTCCGTACCGTCACCCACCAAACGCTGGGTGATTACATTCGCCAGCGCCGGCTACTGCTCGCCGCTGAGGCGCTAAGGACCACGCAACGCCCTATTTTTGATATTGCGATGGATTTGGGATACGTCTCGCAACAGACGTTCTCGCGGGTGTTCCGCCGGGAGTTCGATCGCACTCCCAGCGACTACCGTCATCAGATTTCCGCCTGA,MSHQDIIQTLIEWIDEHIDQPLNIDVVAKKSGYSKWYLQRMFRTVTHQTLGDYIRQRRLLLAAEALRTTQRPIFDIAMDLGYVSQQTFSRVFRREFDRTPSDYRHQISA,MSHQKIIQDLIAWIDEHIDQPLNIDVVAKKSGYSKWYLQRMFRTVTHQTLGDYIRQRRLLLAAVELRTTERPIFDIAMDLGYVSQQTFSRVFRRQFDRTPSDYRHRL,101.87,gnl|BL_ORD_ID|1975|hsp_num:0,2066,FALSE,None